Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
AATF	"BFR2, CHE-1, CHE1, DED"	ENSG00000275700	"Apoptosis antagonizing transcription factor"	Q9NY61	17	36948875-37056871	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004940, HPA075963"	Uncertain		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA004940: AB_1078075, HPA075963: "	"unprognostic (1.10e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.30e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.94e-2)"	"prognostic unfavourable (6.62e-5)"	"unprognostic (3.06e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (4.14e-5)"	"unprognostic (2.18e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.53e-3)"	"unprognostic (3.21e-3)"	8.2	6.8	5.7	11.4	9.8	14.4	7.1	7.5	6.9	7.5	8.8	9.2	7.5	6.2	9.7	6.3	7.6	8.2	7.5	9.8	5.9		7.6	8.7	6.8	11.0	10.1	4.5	11.1	8.8	8.5	5.2	11.1	8.3	7.1	8.6	4.6	6.7	9.2	13.0	8.3	8.5	8.5	7.9	11.2	7.0	8.7	10.2	18.5	9.5	7.2	13.1	10.4	13.5	19.4	18.8	32.1	27.3	20.5	27.2	19.0	20.4	33.1	7.2	14.4	9.7	11.3	13.3	13.2	9.7	15.0	13.3	22.7	14.3	37.0	16.8	11.4	18.1	27.2	15.2	20.3	18.8	20.3	17.2	13.1	15.9	11.9	27.7	14.6	9.9	27.3	19.4	17.3	10.8	23.8	11.2	12.9	15.0	30.3	20.9	9.1	12.7	19.7	21.7	19.9	12.5	18.1	15.7	6.8	19.4	8.0	17.7	13.9	14.3	12.1	11.6	19.7	24.5	41.3	12.6	17.9	27.9	14.5	20.7	20.5	14.2	20.2	32.1	23.9	27.3	23.5	18.0	21.5	25.0	18.8	19.4	19.6	19.6	26.1	20.5	25.9	17.4	27.2	19.0										
ABCA12	"DKFZP434G232, ICR2B, LI2"	ENSG00000144452	"ATP binding cassette subfamily A member 12"	Q86UK0	2	214931542-215138428	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 23.1;tongue: 29.3"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 28.0;SK-BR-3: 13.1;T-47d: 6.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"cerebral cortex: 1.6;hippocampal formation: 1.8"	HPA078239			Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoli, Cytosol"	"HPA078239: "	"unprognostic (6.12e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.09e-4)"	"unprognostic (6.52e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.35e-4)"	"unprognostic (2.50e-2)"	"unprognostic (7.69e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (5.08e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	6.9	0.1	0.1	6.2	0.3	0.0	1.4	0.0	0.0	4.4	8.4	0.1	0.0	0.0	0.6	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	6.1	4.9	0.0	0.1	0.4	0.0	0.3	0.0	0.1	23.1	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.1	0.0	29.3	6.1	0.1	3.7	0.0	0.2	0.8	0.0	0.0	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	28.0	0.0	2.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	2.0	0.0	13.1	0.0	6.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.0	0.0	0.0
ABCC4	"EST170205, MOAT-B, MOATB, MRP4"	ENSG00000125257	"ATP binding cassette subfamily C member 4"	O15439	13	95019829-95301475	"Plasma proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 35.0"	"Group enriched"	"Detected in many"	4	"HEL: 60.4;HMC-1: 66.1;RPTEC TERT1: 17.8"	"Cancer enriched"	"Detected in all"	8	"prostate cancer: 90.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA002476	Enhanced		Approved	"Nucleoli,Golgi apparatus,Plasma membrane"				"Nucleoli, Plasma membrane"	"Golgi apparatus"	"HPA002476: AB_1844434"	"unprognostic (8.77e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavourable (9.89e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.40e-2)"	"unprognostic (9.96e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.55e-2)"	"prognostic favourable (2.25e-10)"	"unprognostic (7.44e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.35e-2)"	3.2	1.7	3.8	11.8	4.7	2.9	6.2	1.0	4.6	4.4	11.6	10.3	3.9	4.1	5.8	16.4	3.0	8.6	10.3	3.5	5.7	3.9	19.6	1.9	13.8	7.4	6.6	2.2	7.2	3.5	7.0	2.8	1.8	7.4	35.0	7.3	6.0	3.3	5.2	7.6	4.5	7.4	11.1	6.5	3.8	8.2	3.8	7.0	3.4	6.6	3.1	5.8	25.6	13.4	3.6	4.1	1.0	4.8	4.1	3.6	3.4	4.4	7.8	1.3	2.3	2.4	3.2	0.3	3.6	3.6	3.2	2.8	10.8	3.3	2.5	2.3	4.8	6.0	2.0	1.7	4.0	7.3	3.0	60.4	2.4	2.1	5.0	6.9	66.1	2.4	0.8	2.3	4.7	4.1	6.2	0.1	4.3	1.4	1.2	1.1	1.5	1.9	1.8	3.6	6.5	17.8	10.0	3.2	2.3	1.2	0.2	2.5	0.0	3.7	6.7	3.4	2.2	2.8	4.2	0.0	0.0	1.0	6.5	3.9	1.6	0.6	1.2	0.4	3.2	1.2	2.7	3.6	2.6	3.6	4.1	2.7	1.6	3.5	1.0	4.1	4.8	0.7	3.3	3.4	3.8	4.7	1.0	4.6	5.7	3.9	6.6	2.2	7.4	7.0
ABCC8	"ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2"	ENSG00000006071	"ATP binding cassette subfamily C member 8"	Q09428	11	17392498-17476879	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Diabetes mellitus, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.0;pancreas: 25.5;pituitary gland: 26.6"	"Group enriched"	"Detected in some"	5	"A549: 4.6;AN3-CA: 3.7;SCLC-21H: 6.5"	"Cancer enriched"	"Detected in some"	9	"pancreatic cancer: 16.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"CAB011451, HPA042318"	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol"				Nucleoli	"Golgi apparatus, Cytosol"	"CAB011451: , HPA042318: "	"unprognostic (4.30e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.73e-2)"	"unprognostic (9.48e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.53e-3)"	"unprognostic (6.04e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.72e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.88e-5)"	"unprognostic (2.72e-2)"	"unprognostic (1.85e-1)"	1.3	6.7	4.4	0.8	6.1	0.9	4.0	28.0	12.3	3.0	1.3	2.6	7.7	1.9	3.1	3.7	0.8	1.2	0.9	2.9	5.1	4.8	1.0	0.8	2.9	0.8	3.6	7.2	0.9	25.5	1.0	26.6	1.6	8.5	2.8	1.3	0.7	0.9	8.5	2.3	1.1	1.5	1.3	4.0	0.9	3.5	1.1	2.3	0.0	6.2	0.0	0.8	0.7	0.8	0.1	0.0	0.5	0.0	0.1	0.2	0.0	0.0	4.6	0.1	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	6.5	0.9	0.0	0.1	0.1	0.1	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	4.4	6.1	28.0	12.3	5.1	4.8	3.6	7.2	8.5	2.3
ABCF3	EST201864	ENSG00000161204	"ATP binding cassette subfamily F member 3"	Q9NUQ8	3	184186023-184194012	"Predicted intracellular proteins"	"Antiviral defense"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036332	Approved		Approved	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA036332: AB_10603571"	"unprognostic (1.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.10e-2)"	"unprognostic (3.81e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (4.16e-5)"	"unprognostic (5.18e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.53e-2)"	13.0	47.0	18.9	10.6	19.7	12.4	12.7	23.0	27.2	15.3	12.1	15.4	33.8	13.1	13.5	11.1	16.1	15.0	10.8	22.9	15.4	16.8	16.5	22.3	12.1	12.7	15.4	15.1	17.8	19.7	41.6	17.9	16.0	19.8	13.3	11.8	15.5	21.4	30.1	33.8	15.2	12.8	10.8	12.3	14.9	13.3	12.6	18.6	8.8	15.4	14.4	14.2	12.5	13.8	16.1	16.4	13.9	19.4	14.5	25.4	21.5	21.9	13.6	7.8	15.0	22.7	12.8	15.4	15.9	17.8	21.7	17.0	23.2	8.8	13.2	32.3	17.1	21.1	12.1	16.8	11.3	16.9	11.6	11.4	11.9	13.6	19.2	12.8	11.7	18.8	15.5	15.3	15.3	15.5	10.5	16.0	15.3	26.4	12.5	8.2	11.8	18.8	12.6	13.0	22.3	11.9	13.3	13.5	7.8	16.5	31.8	14.7	43.0	11.2	15.1	11.6	12.7	18.2	23.6	18.2	17.5	17.1	18.1	12.8	14.2	5.3	18.6	13.9	22.7	19.4	23.5	16.0	20.1	18.7	16.4	16.1	25.4	20.5	9.3	14.5	19.1	10.1	17.2	21.5	18.9	19.7	23.0	27.2	15.4	16.8	15.4	15.1	19.8	18.6
ABHD14B	"CIB, MGC15429"	ENSG00000114779	"Abhydrolase domain containing 14B"	Q96IU4	3	51968510-51983409	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 51.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036444, HPA036642"	Supported		Approved	Nucleoplasm,Nucleoli,Cytosol			2600000	Nucleoli	"Nucleoplasm, Cytosol"	"HPA036444: AB_10672221, HPA036642: AB_10672225"	"unprognostic (8.97e-2)"	"prognostic favourable (6.92e-5)"	"unprognostic (1.84e-1)"	"prognostic favourable (5.42e-5)"	"unprognostic (1.07e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.35e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.95e-2)"	"prognostic favourable (2.93e-5)"	"unprognostic (1.16e-1)"	"unprognostic (3.55e-1)"	"unprognostic (9.70e-2)"	"unprognostic (3.70e-2)"	40.0	34.2	6.2	19.8	7.5	11.4	25.2	10.7	7.0	21.9	33.6	8.6	32.1	30.3	19.6	21.7	27.7	22.0	32.9	12.2	6.2	5.8	42.6	78.4	21.5	35.1	7.8	7.3	29.5	45.0	14.2	15.2	11.4	6.7	30.9	20.2	29.1	39.4	35.0	11.7	16.0	58.7	22.6	8.9	23.3	18.7	11.2	6.2	26.0	35.3	15.2	32.5	24.6	16.9	24.9	15.5	12.5	9.4	9.9	27.2	14.0	10.1	8.7	0.7	10.2	28.4	25.3	2.6	4.0	4.8	7.5	8.7	6.4	20.2	11.5	3.2	14.1	5.1	6.3	5.8	5.7	15.6	6.8	18.0	7.5	25.1	15.3	10.1	18.6	32.7	20.1	7.6	10.3	9.1	10.4	18.3	14.4	9.9	4.4	7.7	0.9	22.2	11.4	1.4	51.6	13.6	4.2	4.3	4.6	10.2	19.1	32.6	27.5	6.9	8.5	4.0	18.8	9.0	2.4	23.4	10.9	4.7	8.6	32.3	6.9	12.5	9.4	4.2	18.3	7.6	27.2	24.9	23.0	22.4	15.5	18.7	23.4	21.3	0.8	9.9	4.8	11.3	16.3	14.0	6.2	7.5	10.7	7.0	6.2	5.8	7.8	7.3	6.7	6.2
ABTB1	"BPOZ, Btb3, BTBD21, EF1ABP"	ENSG00000114626	"Ankyrin repeat and BTB domain containing 1"	Q969K4	3	127672935-127680920	"Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 107.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 107.3"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 107.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035022, HPA035023"	Uncertain		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA035022: AB_10669998, HPA035023: AB_10602104"	"unprognostic (6.76e-2)"	"unprognostic (9.18e-3)"	"unprognostic (2.11e-2)"	"unprognostic (6.34e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.00e-3)"	"unprognostic (4.43e-2)"	"unprognostic (2.12e-2)"	"unprognostic (9.81e-2)"	"unprognostic (4.48e-3)"	"unprognostic (4.55e-3)"	"unprognostic (2.86e-1)"	"prognostic unfavourable (1.13e-4)"	"unprognostic (2.88e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.98e-2)"	"unprognostic (7.92e-3)"	20.4	13.7	11.7	17.7	20.1	42.3	14.2	43.4	27.2	15.4	14.3	13.8	12.9	12.3	15.6	10.9	9.6	13.1	17.6	20.4	10.9	8.2	11.4	8.3	15.5	22.1	9.7	15.8	15.8	11.2	7.8	15.3	12.0	11.4	13.5	4.9	12.4	15.2	14.5	25.1	11.6	13.0	13.3	7.5	41.4	11.7	5.9	12.5	17.8	10.2	9.1	10.4	14.6	17.4	2.9	3.8	107.3	8.6	3.2	5.8	5.1	3.1	7.5	0.7	1.5	7.2	6.8	5.7	5.0	8.6	3.4	4.8	0.2	6.6	1.4	8.9	3.8	1.4	0.0	3.7	0.8	14.5	2.1	2.3	13.4	1.8	5.7	0.3	7.0	8.5	4.0	3.5	0.9	3.6	0.1	10.2	3.7	5.0	3.4	9.8	0.6	8.3	2.1	4.2	9.7	5.1	1.9	7.0	4.6	3.6	4.3	18.1	1.1	2.5	6.5	3.6	3.0	6.4	1.6	8.3	2.7	0.4	8.4	2.9	5.6	4.5	8.6	20.5	2.4	6.2	2.3	2.5	2.6	2.3	3.8	2.9	2.2	1.9	107.3	3.2	5.4	2.4	5.8	5.1	11.7	20.1	43.4	27.2	10.9	8.2	9.7	15.8	11.4	12.5
AC008560.1		ENSG00000253251	"Uncharacterized protein FLJ26957 "	Q6ZNX1	5	65624765-65630891	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA066071, HPA068764"	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA066071: , HPA068764: "	"unprognostic (7.87e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.52e-2)"	"unprognostic (5.58e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.24e-3)"	"unprognostic (5.09e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.94e-1)"	"prognostic favourable (1.17e-4)"	5.8	7.1	7.3	6.5	13.1	31.5	10.0	8.7	13.3	5.4	6.6	7.1	5.5	7.0	5.9	7.4	6.3	5.3	6.1	4.9	8.2	7.9	11.6	9.7	6.2	9.9	9.9	8.0	5.9	8.7	3.8	13.1	6.5	11.3	10.7	7.6	5.7	6.4	6.6	6.6	7.0	7.6	7.8	9.1	8.9	6.0	7.5	8.6	10.4	6.9	6.4	8.3	5.3	5.0	5.0	4.4	13.4	4.1	6.3	8.8	2.9	2.8	3.7	5.7	12.0	3.3	3.8	6.8	4.3	3.8	6.1	7.8	6.4	8.7	5.1	4.9	5.0	3.6	5.5	5.2	9.2	6.7	6.9	4.6	9.7	8.5	2.6	5.0	8.0	2.3	7.3	6.4	6.8	4.1	6.5	12.0	5.0	7.1	7.2	7.3	4.5	2.2	5.0	5.4	7.9	5.1	6.1	7.8	5.9	3.8	3.5	10.8	4.2	4.5	3.2	5.7	7.5	4.4	6.8	7.6	13.9	11.3	4.2	6.2	5.3	13.4	4.1	7.5	5.4	3.7	5.7	5.0	6.5	5.6	3.7	4.9	8.8	8.1	4.3	6.3	4.1	4.4	7.9	2.9	7.3	13.1	8.7	13.3	8.2	7.9	9.9	8.0	11.3	8.6
AC012476.1		ENSG00000285396			15	40695129-40732158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in some"	5	"lymphoid tissue: 19.5;testis: 16.7"	"Not detected"	"Not detected"											"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA039310	Approved		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA039310: "																		0.4	0.8	0.0	4.2	0.0	0.9	0.0	0.0	0.1	0.1	1.5	0.0	0.0	0.0	0.1	0.8	2.1	0.2	1.4	0.9	0.0		0.2	0.3	0.8	0.9	0.0	0.0	0.3	0.5	0.9	0.0	3.9	0.0	0.1	0.0	0.0	0.3	0.0	1.8	0.9	1.2	0.0	0.2	3.0	1.6	16.7	0.0	19.5	0.1	2.1	6.1	0.0	0.0	1.3	1.0	2.3	0.4	1.2	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.5	1.2	0.2	1.0	0.2	1.1	0.3	0.4	1.3	0.2	0.3	2.3	1.2	0.1	1.0	0.3	0.1										
AC118549.1		ENSG00000036549	"ZZ-type zinc finger-containing protein 3 "	Q8IYH5	1	77562416-77683419	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053663, HPA054913, HPA066197"	Uncertain		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA053663: , HPA054913: , HPA066197: "	"unprognostic (1.30e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.13e-3)"	"unprognostic (5.38e-3)"	"unprognostic (8.77e-2)"	"prognostic unfavourable (6.96e-5)"	"unprognostic (2.91e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.43e-1)"	17.8	17.4	20.8	14.1	23.6	11.6	21.6	20.4	20.3	18.1	16.2	16.1	18.3	12.1	18.3	14.3	14.5	15.3	12.1	13.7	16.9	11.7	18.8	20.0	12.3	15.8	24.1	17.8	24.1	14.5	19.0	28.2	13.9	14.4	16.0	13.0	10.5	15.2	16.8	19.0	16.9	12.4	17.0	16.2	11.5	13.5	9.9	23.6	17.9	26.5	8.6	16.0	20.1	14.9	7.9	7.4	5.6	5.1	7.4	10.4	5.0	13.2	6.8	12.5	9.6	11.0	17.5	13.3	17.0	15.7	15.7	17.3	7.6	7.1	17.4	15.3	14.2	12.2	16.5	11.0	23.8	13.6	13.1	21.6	13.7	9.4	17.0	22.2	6.1	13.3	17.0	17.4	34.1	16.0	20.9	13.6	15.2	6.3	11.1	6.9	18.6	15.5	13.1	21.5	8.9	11.0	14.1	15.8	13.3	10.2	11.7	30.0	7.0	12.2	13.1	13.7	16.8	22.1	21.9	10.2	14.3	18.5	13.4	19.5	10.4	0.1	4.6	5.6	6.9	5.1	10.4	7.9	8.2	8.1	7.4	7.9	10.2	9.2	0.9	7.4	4.7	5.0	10.4	5.0	20.8	23.6	20.4	20.3	16.9	11.7	24.1	17.8	14.4	23.6
AC138696.1		ENSG00000264668			8	143247110-143276403	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.1"	"Low lineage specificity"	"Detected in single"											"HPA047232, HPA056268"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"				Nucleoli	"Nucleoplasm, Plasma membrane"	"HPA047232: , HPA056268: "	"unprognostic (2.24e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.56e-3)"		"unprognostic (1.87e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.80e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.20e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.59e-2)"	"unprognostic (4.06e-1)"	3.6	4.8	6.2	2.5	4.4	1.5	2.5	5.8	7.3	3.3	3.8	4.7	2.5	2.6	5.7	2.7	2.8	7.8	2.0	2.7	6.2	4.8	2.6	1.9	2.7	2.5	4.8	3.0	5.8	6.8	4.6	4.5	2.2	4.2	3.0	2.2	3.8	3.6	3.9	4.7	1.8	3.1	3.2	3.7	2.7	2.7	3.5	3.6	1.5	2.7	1.5	2.6	3.6	4.4	0.6	0.6	0.0	0.2	0.9	2.1	0.1	1.3	0.0	0.0	0.8	4.7	0.3	0.5	1.3	3.0	1.5	0.6	0.0	1.8	0.2	0.8	0.3	0.7	0.0	0.6	0.5	0.0	1.4	0.3	0.0	0.0	0.0	0.3	0.6	2.8	1.2	0.0	1.0	0.9	0.0	0.1	0.0	0.0	3.2	0.0	3.0	0.9	1.6	2.8	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.7	0.9	0.9	0.0	0.0	0.7	2.9	0.1	2.2	0.7	1.6	1.1	0.3	0.4	0.0	0.0	0.0	0.1	0.0	2.1	0.2	0.0	0.1	0.0	0.6	0.3	0.0	0.0	0.9	0.2	0.6	0.3	0.1	6.2	4.4	5.8	7.3	6.2	4.8	4.8	3.0	4.2	3.6
AC245033.1		ENSG00000260836			15	82536788-82573194	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in many"	5	"brain: 11.3"	"Cell line enriched"	"Detected in some"	5	"U-2197: 18.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA055060	Uncertain		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum"	"Nucleoli, Cytosol"	"HPA055060: "									"unprognostic (2.91e-2)"									1.5	0.9	5.3	0.9	7.1	0.9	1.3	6.1	11.3	0.9	1.0	1.4	0.0	0.9	0.9	0.9	1.5	0.9	0.9	1.3	3.9	1.6	0.9	1.0	1.1	0.9	3.2	6.1	0.9	1.0	0.9	2.0	1.0	7.3	1.1	1.1	1.9	0.9	0.9	2.0	0.9	1.4	0.9	2.4	1.1	0.9	1.4	1.7	0.0	1.0	0.0	1.0	1.7	0.8	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	1.7	0.0	0.0	0.0	0.7	0.7	18.5	0.3	0.0	0.2	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	5.3	7.1	6.1	11.3	3.9	1.6	3.2	6.1	7.3	1.7
ACADVL	"ACAD6, LCACD, VLCAD"	ENSG00000072778	"Acyl-CoA dehydrogenase very long chain"	P49748	17	7217125-7225273	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019006, HPA020595"	Enhanced		Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol			19000000	"Nucleoli, Mitochondria"	"Nucleoplasm, Cytosol"	"HPA019006: AB_1844478, HPA020595: AB_1844479"	"unprognostic (4.81e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.21e-1)"	"prognostic favourable (6.87e-4)"	"unprognostic (3.55e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.84e-3)"	32.7	69.2	22.8	18.2	21.1	15.1	24.1	19.8	18.4	21.1	44.0	16.5	26.7	51.7	17.4	19.7	31.5	14.2	24.4	118.2	20.2	12.2	35.2	90.0	17.3	9.8	18.5	16.8	15.5	67.8	31.5	32.3	40.2	20.9	22.1	24.2	20.0	27.4	29.0	132.3	20.3	51.2	25.0	15.7	21.9	28.7	11.5	18.6	14.6	29.6	36.9	21.2	22.4	31.8	8.3	32.0	37.9	29.0	11.6	14.9	20.0	33.2	31.9	13.1	18.0	56.6	20.8	24.8	24.5	34.1	28.0	17.4	12.9	30.2	17.8	20.5	51.4	25.7	8.8	26.8	24.8	56.5	9.0	9.5	22.7	19.6	27.2	9.0	24.8	23.2	24.6	23.4	36.9	25.1	12.2	21.8	44.9	12.6	9.4	10.9	6.2	12.6	13.1	14.5	42.4	62.2	30.4	3.5	8.6	34.6	44.0	20.1	20.2	13.9	25.0	24.8	18.6	12.5	23.9	20.4	9.5	0.9	45.6	16.0	18.0	6.8	29.0	37.9	13.5	18.0	12.4	8.3	10.9	14.9	32.0	7.6	8.3	10.2	6.3	11.6	12.0	26.0	9.7	20.0	22.8	21.1	19.8	18.4	20.2	12.2	18.5	16.8	20.9	18.6
ACOX1	PALMCOX	ENSG00000161533	"Acyl-CoA oxidase 1"	Q15067	17	75941507-75979363	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 95.6"	"Cell line enhanced"	"Detected in all"		"BEWO: 34.6;RT4: 46.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 22.9;neutrophil: 38.6"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021094, HPA021192, HPA021195, HPA028759"	Approved		Approved	Nucleoli,Peroxisomes			160000	Peroxisomes	Nucleoli	"CAB021094: AB_10261667, HPA021192: AB_1844527, HPA021195: AB_1844528, HPA028759: AB_10601352"	"unprognostic (7.47e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.36e-1)"	"unprognostic (7.49e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.38e-2)"	"prognostic favourable (5.25e-7)"	"unprognostic (3.39e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.46e-2)"	21.8	12.9	8.8	8.3	10.2	4.2	13.6	6.4	9.8	6.4	26.5	8.2	9.6	31.0	6.6	6.7	19.5	6.0	12.3	16.0	8.3	7.9	20.8	95.6	9.2	7.5	8.2	8.3	7.6	28.7	9.8	8.9	13.6	7.8	9.5	14.3	11.3	9.5	9.1	18.3	13.4	53.1	7.9	6.7	7.2	13.6	6.2	6.3	7.1	9.1	11.4	10.6	10.6	7.9	1.6	3.3	38.6	5.8	2.1	2.7	2.2	5.3	7.6	2.5	3.8	13.0	5.5	34.6	3.9	3.9	4.7	5.4	5.3	8.8	3.1	4.2	6.6	3.2	10.5	4.1	7.4	2.8	3.1	4.0	4.3	17.3	7.1	3.4	2.6	9.1	3.2	5.3	3.5	11.7	4.0	3.0	5.2	15.7	7.4	2.5	1.8	6.5	4.1	7.6	3.6	8.0	46.6	3.0	4.5	11.1	17.5	3.7	10.7	3.8	7.8	6.5	4.8	5.3	3.7	5.0	3.4	1.2	3.8	3.1	3.8	22.9	5.8	1.6	2.1	4.5	2.7	1.6	2.0	2.7	3.3	1.6	2.4	2.3	38.6	2.1	2.8	2.9	2.6	2.2	8.8	10.2	6.4	9.8	8.3	7.9	8.2	8.3	7.8	6.3
ACOXL	FLJ11042	ENSG00000153093	"Acyl-CoA oxidase like"	Q9NUZ1	2	110732573-111118222	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 29.7;lung: 20.8;placenta: 23.8"	"Group enriched"	"Detected in some"	4	"A-431: 8.9;RPMI-8226: 16.2;RT4: 20.8;U-266/70: 14.1"	"Group enriched"	"Detected in some"	6	"lung cancer: 0.6;prostate cancer: 1.1;testis cancer: 2.1;urothelial cancer: 2.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.1"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA035392, HPA035393"			Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA035392: , HPA035393: "	"unprognostic (1.62e-1)"	"unprognostic (7.30e-2)"	"unprognostic (6.77e-4)"	"unprognostic (2.93e-7)"	"unprognostic (1.32e-2)"	"unprognostic (7.84e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.31e-2)"	"unprognostic (7.24e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.72e-1)"	"prognostic favourable (6.48e-4)"	0.3	0.3	0.2	0.5	0.4	1.6	0.3	0.2	0.4	0.4	0.4	0.2	2.3	0.0	0.3	29.7	0.2	0.5	0.4	0.3	0.2	0.2	0.6	0.2	20.8	0.6	0.2	0.2	0.2	0.4	4.9	0.7	23.8	0.4	4.1	0.1	0.2	0.5	0.2	0.3	0.4	0.3	2.6	0.2	1.3	0.4	4.6	0.2	0.6	1.5	0.2	0.9	8.5	5.2	1.0	0.6	4.1	1.1	0.7	0.6	0.3	8.9	0.0	0.2	0.3	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.6	0.6	0.2	0.1	0.1	1.0	0.0	0.0	0.0	0.2	3.1	0.2	0.4	0.2	0.0	0.1	0.2	0.1	0.9	0.0	0.1	0.0	1.4	1.4	0.1	3.2	0.7	0.4	3.1	0.4	0.1	0.1	16.2	0.0	20.8	2.0	0.4	0.1	0.4	0.1	0.2	0.9	0.3	0.2	0.4	0.2	0.1	14.1	3.6	0.5	0.1	0.2	0.2	2.2	1.1	0.5	0.4	0.7	0.2	1.0	0.4	0.6	0.2	0.8	0.5	0.4	4.1	0.7	0.4	0.6	0.4	0.3	0.2	0.4	0.2	0.3	0.2	0.2	0.2	0.2	0.4	0.2
ACSL3	"ACS3, FACL3, PRO2194"	ENSG00000123983	"Acyl-CoA synthetase long chain family member 3"	O95573	2	222860934-222944639	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 206.1"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 92.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011315, HPA071021"	Approved		Approved	"Nucleoli,Lipid droplets"				Nucleoli	"Lipid droplets"	"HPA011315: AB_1848344, HPA071021: "	"unprognostic (1.87e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.35e-3)"	"unprognostic (7.53e-2)"	"unprognostic (2.07e-2)"	"prognostic unfavourable (2.75e-4)"	"prognostic unfavourable (8.78e-4)"	"unprognostic (3.90e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.60e-1)"	14.7	17.0	22.8	9.9	26.0	16.3	51.5	19.4	45.9	15.3	16.5	16.1	11.6	12.7	10.9	18.4	28.3	9.0	11.8	22.7	20.9	22.8	17.9	22.3	15.6	10.5	19.6	21.2	11.7	10.3	206.1	8.8	19.1	24.4	44.4	16.7	14.4	34.2	15.5	19.1	11.4	12.7	12.2	22.2	9.7	28.3	13.7	14.2	13.5	17.3	11.2	8.7	14.6	15.4	15.0	22.5	21.8	16.8	16.6	20.1	16.5	9.9	17.6	27.0	29.3	11.8	29.3	7.5	12.7	33.0	15.2	32.2	15.8	25.7	4.8	7.4	12.1	29.4	5.8	28.3	19.8	8.6	11.1	11.2	14.3	17.7	26.0	7.4	5.5	15.1	40.1	25.2	44.0	16.6	21.2	18.3	21.5	21.2	14.4	8.7	13.7	9.2	7.9	22.9	8.1	21.9	40.9	14.2	10.6	7.5	20.3	92.7	10.2	18.1	11.4	10.2	16.3	8.8	9.3	6.5	3.1	16.5	11.0	6.9	30.9	16.6	14.6	21.8	20.1	16.8	19.3	11.6	12.8	14.6	15.7	15.0	18.7	16.7	21.8	16.6	15.9	22.5	9.5	16.5	22.8	26.0	19.4	45.9	20.9	22.8	19.6	21.2	24.4	14.2
ACTL6B	"ACTL6, BAF53B"	ENSG00000077080	"Actin like 6B"	O94805	7	100643097-100656461	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 43.6"	"Group enriched"	"Detected in some"	75	"SCLC-21H: 21.0;SH-SY5Y: 21.4"	"Group enriched"	"Detected in some"	11	"glioma: 3.9;pancreatic cancer: 1.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045126	Uncertain		Approved	Nucleoli				Nucleoli		"HPA045126: AB_10961265"	"unprognostic (3.31e-2)"	"unprognostic (6.89e-2)"		"unprognostic (4.59e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.27e-3)"	"unprognostic (4.81e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.26e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.01e-4)"	"unprognostic (1.64e-1)"	"unprognostic (6.84e-2)"		"unprognostic (2.01e-2)"	1.1	3.8	9.4	1.1	17.4	1.1	1.0	25.9	43.6	1.0	1.2	0.8	0.0	1.3	1.0	1.0	1.0	1.0	1.0	1.0	9.7	9.9	1.1	1.0	1.1	1.0	5.3	12.2	1.0	2.2	1.0	7.0	1.0	9.4	1.0	1.1	0.3	1.0	1.0	1.0	1.1	1.2	1.1	1.6	1.0	2.0	1.7	1.9	0.0	1.1	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	17.4	25.9	26.8	9.7	9.9	5.3	12.2	9.4	1.9
ACTR10	"ACTR11, Arp10, Arp11, HARP11"	ENSG00000131966	"Actin related protein 10 homolog"	Q9NZ32	14	58200080-58235636	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071251			Approved	Nucleoli				Nucleoli		"HPA071251: "	"prognostic unfavourable (3.24e-4)"	"unprognostic (4.61e-2)"	"unprognostic (6.22e-3)"	"unprognostic (2.03e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.36e-2)"	"prognostic unfavourable (2.71e-5)"	"unprognostic (3.20e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.86e-1)"	"unprognostic (2.36e-1)"	"prognostic favourable (8.48e-8)"	"unprognostic (1.01e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.43e-2)"	"unprognostic (8.48e-2)"	31.5	22.8	23.8	12.5	27.2	15.8	23.4	16.2	32.3	16.4	23.3	13.6	16.1	10.1	18.2	18.3	18.3	17.6	14.8	27.3	21.8	28.4	20.5	15.4	17.7	16.7	32.5	26.7	19.4	18.5	19.2	18.9	21.3	33.7	22.2	15.2	14.6	35.8	17.6	21.4	26.4	12.8	21.0	18.5	17.5	14.1	13.8	9.7	14.6	18.2	13.2	14.4	13.7	16.3	7.4	5.9	15.8	9.8	7.2	12.0	5.1	3.3	1.9	3.8	1.6	13.2	6.4	1.9	2.6	3.0	4.4	5.3	2.9	3.9	5.0	3.9	5.6	3.4	5.0	3.9	6.0	2.8	12.7	2.0	3.7	5.4	11.2	3.5	3.0	8.2	5.8	3.7	7.4	5.7	1.6	4.1	8.3	9.2	4.6	13.0	1.9	17.7	3.2	6.8	3.0	7.7	4.3	2.2	2.4	5.1	4.0	12.5	7.1	5.9	4.8	4.5	9.2	4.1	2.2	2.4	1.5	5.3	4.9	2.7	2.6	15.8	7.3	10.3	8.4	8.9	12.0	7.4	9.6	8.2	5.3	5.6	10.0	10.2	9.9	7.2	9.8	5.9	6.7	5.1	23.8	27.2	16.2	32.3	21.8	28.4	32.5	26.7	33.7	9.7
ACVR1	"ACVR1A, ACVRLK2, ALK2, SKR1"	ENSG00000115170	"Activin A receptor type 1"	Q04771	2	157736444-157875862	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007505, HPA046514"	Approved		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA007505: AB_1844752, HPA046514: "	"unprognostic (6.99e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.99e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.65e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavourable (5.17e-4)"	18.9	9.2	18.0	10.0	12.7	1.6	38.7	15.3	12.2	25.2	14.4	7.4	8.4	8.9	24.8	26.8	11.0	16.6	20.5	18.8	18.7	8.6	21.7	18.9	22.5	15.1	10.4	7.9	18.5	12.3	11.3	17.0	14.2	12.3	16.8	10.5	14.3	18.1	13.6	15.6	12.8	11.5	29.2	12.3	9.2	11.8	8.8	10.9	7.5	34.0	14.6	6.9	16.1	32.5	1.4	2.4	3.8	2.6	1.9	10.0	1.6	2.1	4.2	4.9	6.4	25.0	26.1	6.9	15.1	25.2	12.1	13.0	3.3	4.7	0.0	7.0	16.4	5.9	3.5	8.2	13.1	14.5	3.0	8.6	2.5	4.8	19.8	0.6	10.2	32.6	15.6	24.9	31.8	13.2	3.1	2.4	15.3	3.7	0.1	0.2	7.4	7.7	1.4	6.6	1.8	15.8	7.9	4.4	5.4	5.8	3.3	20.7	1.7	2.3	19.0	18.5	6.1	9.1	5.7	1.6	1.2	0.1	19.0	0.5	19.9	3.8	2.6	0.2	1.1	1.7	1.2	1.4	7.8	2.5	1.8	0.8	3.1	1.5	0.8	1.9	2.3	2.4	10.0	1.6	18.0	12.7	15.3	12.2	18.7	8.6	10.4	7.9	12.3	10.9
ADAMTS12		ENSG00000151388	"ADAM metallopeptidase with thrombospondin type 1 motif 12"	P58397	5	33523535-33892192	"Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 17.3;BJ hTERT+: 15.7;hTEC/SVTERT24-B: 22.6;U-2 OS: 17.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA035973, HPA075079"	Uncertain		Approved	Nucleoli,Mitochondria	"Secreted to extracellular matrix"			Nucleoli	Mitochondria	"HPA035973: AB_10669663, HPA075079: "	"unprognostic (6.18e-3)"	"unprognostic (3.12e-4)"	"unprognostic (1.05e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.60e-2)"	"unprognostic (3.49e-3)"	"unprognostic (3.78e-3)"	"unprognostic (3.39e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.27e-7)"	"unprognostic (4.45e-3)"	"unprognostic (1.47e-1)"	"unprognostic (5.85e-2)"	"prognostic unfavourable (6.78e-4)"	13.7	5.4	0.2	2.5	0.8	0.0	17.6	0.3	1.0	6.0	3.0	2.3	2.6	0.6	13.0	4.4	1.4	3.1	5.9	1.4	0.3	0.6	2.0	2.1	9.4	4.2	1.2	0.2	4.9	8.7	1.2	0.9	5.5	2.1	6.7	1.4	2.7	4.4	4.2	4.1	2.0	1.6	9.4	6.5	0.6	1.8	5.0	0.3	0.1	2.6	4.1	1.6	4.3	7.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	12.9	0.4	11.7	0.0	17.3	8.3	0.0	6.0	15.7	8.0	9.8	0.0	0.0	0.0	0.0	4.2	0.4	0.3	7.9	11.2	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	6.5	0.0	22.6	5.9	0.0	0.0	0.0	12.9	0.0	0.0	0.0	2.4	0.0	0.0	13.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	17.5	0.1	3.6	2.0	1.5	0.0	12.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.3	1.0	0.3	0.6	1.2	0.2	2.1	0.3
ADAR	"ADAR1, G1P1, IFI4"	ENSG00000160710	"Adenosine deaminase, RNA specific"	P55265	1	154582062-154627999	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, mRNA processing, RNA-mediated gene silencing"	"DNA-binding, Hydrolase, RNA-binding"	"Aicardi-Goutieres syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003890, HPA051519, CAB056157"	Enhanced		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"CAB056157: , HPA003890: AB_1078103, HPA051519: AB_2681520"	"unprognostic (3.46e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.13e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavourable (7.30e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.94e-2)"	36.1	33.1	30.3	36.6	44.4	43.1	29.7	41.4	50.8	30.7	28.2	33.3	19.9	31.4	38.0	26.5	27.7	32.9	28.9	24.0	25.7	38.1	31.5	36.0	34.7	41.3	27.3	32.6	39.2	29.5	46.2	38.4	33.9	39.8	28.8	31.1	32.2	36.7	30.2	14.0	27.0	40.6	36.3	24.4	47.7	29.1	21.9	26.9	57.6	32.8	16.7	41.9	29.7	27.6	7.8	6.1	25.1	8.6	6.4	9.7	5.6	26.1	30.3	26.0	32.0	26.3	27.3	31.0	18.0	36.3	60.5	52.6	26.1	25.8	47.2	29.2	28.8	25.5	33.2	34.3	30.8	45.8	16.7	24.6	21.5	14.8	28.7	34.7	27.3	26.5	25.1	31.0	31.8	31.0	23.2	36.3	21.1	32.0	41.9	17.9	43.0	22.9	40.1	21.4	37.9	20.8	29.2	25.9	30.9	31.2	50.4	37.0	33.9	42.7	28.2	21.8	21.4	17.9	20.9	43.1	47.1	50.7	21.1	22.9	24.5	6.9	6.6	12.0	9.4	8.3	8.8	7.8	9.4	9.7	6.1	6.2	8.8	8.6	25.1	6.4	8.6	5.5	7.1	5.6	30.3	44.4	41.4	50.8	25.7	38.1	27.3	32.6	39.8	26.9
ADTRP	"AIG1L, C6orf105, dJ413H6.1"	ENSG00000111863	"Androgen dependent TFPI regulating protein"	Q96IZ2	6	11712054-11807046	"Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 48.3;intestine: 61.2;retina: 38.0;seminal vesicle: 48.0"	"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 10.3;HUVEC TERT2: 35.2;RPMI-8226: 13.3;TIME: 19.0;U-138 MG: 12.7;U-266/84: 14.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"pons and medulla: 12.4"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 10.5;T-reg: 9.8"	"Lineage enriched"	"Detected in many"	7	"T-cells: 10.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048113	Uncertain		Uncertain	Nucleoli				Nucleoli		"HPA048113: "	"unprognostic (6.82e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.14e-3)"	"unprognostic (3.04e-3)"	"unprognostic (1.41e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.90e-1)"	"prognostic unfavourable (1.13e-5)"	"unprognostic (2.61e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.26e-1)"	0.8	0.4	0.6	10.6	0.8	0.0	0.9	0.3	2.1	0.4	21.8	1.5	48.3	22.4	0.4	4.0	0.9	0.5	0.3	0.5	1.2	0.4	3.8	1.0	3.9	2.0	0.4	1.1	0.4	0.6	0.8	0.3	0.3	12.4	1.7	16.2	38.0	0.7	48.0	0.4	12.7	61.2	0.5	0.4	1.0	11.4	14.1	0.1	0.8	0.7	0.6	3.2	2.7	0.5	0.2	0.2	1.4	0.3	0.1	10.5	1.5	1.6	0.0	0.0	0.0	0.2	0.3	0.0	0.5	0.3	0.4	0.3	1.5	0.8	0.0	0.7	0.3	0.7	0.0	4.7	0.6	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.1	0.0	8.7	3.5	10.3	35.2	8.5	0.0	1.2	0.0	0.0	0.2	0.1	2.4	0.0	0.1	13.3	0.7	0.1	0.0	0.1	0.6	0.0	0.3	0.0	0.3	19.0	12.7	0.9	0.3	1.0	0.5	14.9	0.0	2.6	0.5	0.1	1.4	0.1	0.0	0.0	0.3	2.3	0.2	2.8	0.2	0.1	0.1	10.5	0.8	0.2	0.1	0.2	0.2	9.8	1.5	0.6	0.8	0.3	2.1	1.2	0.4	0.4	1.1	12.4	0.1
AEN	"FLJ12484, FLJ12562, ISG20L1"	ENSG00000181026	"Apoptosis enhancing nuclease"	Q8WTP8	15	88621296-88632282	"Predicted intracellular proteins"	"Apoptosis, DNA damage"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048599			Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"				Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA048599: AB_2756313"	"unprognostic (8.64e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-2)"	"prognostic favourable (1.72e-4)"	"unprognostic (1.52e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.08e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.00e-2)"	"unprognostic (7.88e-2)"	"unprognostic (8.58e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.71e-2)"	"unprognostic (6.10e-2)"	9.4	10.4	6.5	10.2	7.2	14.8	11.2	2.8	5.0	8.0	7.8	4.9	13.4	5.0	9.3	10.2	8.9	7.0	23.0	8.2	4.7	8.5	7.9	17.4	9.1	15.4	13.1	3.1	11.2	18.8	6.7	21.3	11.0	7.8	11.6	9.1	4.3	14.5	9.1	18.8	5.9	8.0	10.6	9.3	14.2	11.1	14.3	4.6	14.0	16.6	10.9	13.7	12.5	5.4	9.3	4.1	0.6	3.6	3.0	15.0	7.6	4.9	22.2	13.9	11.9	6.2	7.5	29.5	17.8	16.3	13.7	16.9	18.2	9.7	21.5	5.7	9.7	7.2	51.2	14.4	11.6	5.2	20.2	11.5	9.0	30.1	15.2	9.5	11.6	9.2	12.7	17.1	14.1	11.4	18.1	12.2	16.7	11.6	11.7	8.0	33.5	12.9	15.4	9.9	15.9	5.7	10.8	11.0	10.1	7.2	8.2	13.7	6.8	10.9	10.4	14.0	19.6	5.7	23.9	23.7	15.9	18.4	12.9	10.7	27.4	0.0	1.8	0.6	5.3	3.1	10.0	9.3	9.1	6.9	4.1	9.3	10.0	8.8	0.4	3.0	3.6	2.4	15.0	7.6	6.5	7.2	2.8	5.0	4.7	8.5	13.1	3.1	7.8	4.6
AGPAT4	"dJ473J16.2, LPAAT-delta"	ENSG00000026652	"1-acylglycerol-3-phosphate O-acyltransferase 4"	Q9NRZ5	6	161129979-161274061	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.0"	"Cell line enhanced"	"Detected in many"		"AF22: 19.8;HEL: 14.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053287, HPA060525"	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles"				"Golgi apparatus"	"Nucleoli, Vesicles"	"HPA053287: , HPA060525: "	"unprognostic (5.69e-2)"	"prognostic unfavourable (1.45e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.14e-2)"	"unprognostic (6.67e-3)"	"unprognostic (1.94e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.67e-1)"	"prognostic unfavourable (4.08e-4)"	"unprognostic (1.82e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.63e-4)"	"unprognostic (5.51e-2)"	5.6	4.2	10.5	3.5	19.1	8.0	4.5	9.6	26.6	5.3	4.2	35.6	1.0	2.6	10.7	4.5	5.2	7.2	8.0	2.9	14.2	11.8	5.2	2.0	6.1	2.0	25.8	12.4	10.0	2.3	1.3	9.8	14.6	27.4	3.7	4.4	0.7	2.7	4.9	2.1	1.9	2.5	8.5	49.0	5.2	3.0	4.2	19.8	0.6	4.8	2.0	2.2	4.0	3.8	1.1	1.9	0.6	3.5	5.8	7.0	2.1	0.3	0.8	19.8	3.9	3.7	7.6	0.8	0.7	0.2	1.5	2.5	1.1	3.5	0.5	1.4	3.1	0.3	3.6	3.0	1.4	2.2	6.2	14.8	3.5	0.0	2.9	0.1	2.1	9.1	1.5	4.0	2.1	4.6	7.3	6.8	1.8	0.0	1.0	1.6	4.7	7.6	0.0	0.9	0.4	4.3	0.3	11.5	4.4	3.0	1.6	0.8	0.8	1.0	5.1	2.1	2.6	1.4	3.3	0.5	0.7	0.0	7.8	0.8	1.3	0.0	3.5	0.0	7.0	2.8	2.3	0.4	3.3	4.1	1.9	1.1	1.7	2.7	0.6	5.8	2.5	1.5	2.9	2.1	10.5	19.1	9.6	15.8	14.2	11.8	25.8	12.4	27.4	19.8
AGTPBP1	"CCP1, KIAA1035, Nna1"	ENSG00000135049	"ATP/GTP binding protein 1"	Q9UPW5	9	85546539-85742029	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 48.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057208	Approved		Approved	Nucleoli,Vesicles				"Nucleoli, Vesicles"		"HPA057208: "	"unprognostic (2.15e-1)"	"unprognostic (3.78e-2)"	"unprognostic (4.93e-3)"	"unprognostic (6.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.95e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.26e-3)"	"unprognostic (5.69e-3)"	"unprognostic (6.31e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.60e-3)"	"unprognostic (1.25e-1)"	7.9	5.7	13.1	8.6	14.6	48.2	6.0	14.2	21.4	5.1	5.0	21.6	1.8	3.8	5.0	4.2	5.4	4.2	5.3	11.2	17.3	13.5	6.8	4.5	11.9	16.0	18.8	14.5	3.5	6.4	8.0	4.8	6.0	23.5	4.9	5.9	7.4	3.9	3.4	13.6	6.0	4.3	6.4	24.1	12.8	5.3	12.5	14.4	8.8	5.8	4.3	7.8	5.7	3.8	1.6	10.7	20.3	9.5	4.5	6.6	5.7	2.9	5.7	16.8	6.7	3.5	3.8	6.4	4.4	3.8	4.5	5.1	3.0	5.1	18.3	3.7	4.5	1.7	7.8	5.6	4.3	19.4	6.9	3.1	6.9	5.4	7.3	14.1	3.7	3.5	6.6	4.2	14.5	7.2	3.9	14.7	2.0	4.6	10.9	8.4	11.7	4.0	10.0	6.2	5.6	7.8	3.2	20.4	14.5	5.0	5.5	9.1	2.1	4.6	7.1	2.9	5.2	18.5	5.2	10.1	8.4	8.4	6.2	13.9	5.9	20.3	9.5	8.3	6.6	5.7	6.4	1.6	3.3	5.1	10.7	1.2	2.7	5.2	14.0	4.5	4.3	1.7	3.4	5.7	13.1	14.6	14.2	21.4	17.3	13.5	18.8	14.5	23.5	14.4
AKAP11	"AKAP220, DKFZp781I12161, FLJ11304, KIAA0629, PPP1R44, PRKA11"	ENSG00000023516	"A-kinase anchoring protein 11"	Q9UKA4	13	42272153-42323267	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039089	Enhanced		Approved	"Nucleoli,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoli	"HPA039089: AB_10674279"	"unprognostic (6.43e-2)"	"prognostic unfavourable (9.26e-4)"	"unprognostic (4.91e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.02e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.49e-3)"	"unprognostic (7.44e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.10e-1)"	11.2	13.6	21.7	10.0	42.3	3.0	11.0	19.9	30.7	17.1	9.1	9.0	5.9	6.9	13.0	15.2	10.2	10.2	9.7	10.4	18.3	17.9	12.9	9.9	10.2	13.4	16.4	22.8	14.6	6.4	11.6	14.5	7.2	20.3	11.1	10.1	6.7	7.6	12.4	5.7	9.1	8.1	13.4	21.4	11.7	9.5	18.1	16.0	5.6	13.3	4.6	12.6	10.4	9.4	3.0	1.6	4.2	1.4	4.8	2.7	0.7	9.2	9.5	11.7	6.9	15.4	18.9	5.1	12.6	10.5	7.6	7.2	10.4	7.7	19.1	4.9	14.1	11.1	10.1	10.5	14.7	20.3	4.7	5.4	6.6	5.1	12.1	13.4	13.3	13.8	10.9	15.5	13.6	11.1	17.7	7.8	15.3	7.0	7.8	4.3	6.9	4.5	6.5	8.2	9.2	7.6	6.9	5.0	7.2	9.6	6.4	4.5	5.5	7.3	15.4	12.9	6.7	19.5	9.5	3.0	3.7	9.9	16.5	6.9	9.0	4.2	0.9	1.2	1.7	1.1	2.1	2.7	2.4	1.6	1.0	3.0	2.1	2.1	0.3	4.8	1.4	1.6	2.7	0.7	21.7	42.3	19.9	24.6	18.3	17.9	16.4	22.8	20.3	16.0
AL121900.2		ENSG00000284776			20	18567453-18744216	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBF TERT88: 22.4"									"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA040981	Uncertain		Uncertain	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA040981: AB_10673268"																		4.0	5.7	4.0	4.4	5.8	5.8	6.0	4.5	14.1	3.6	6.2	2.0	6.0	5.2	7.4	5.9	4.5	5.4	5.4	7.8	4.4		15.4	6.3	4.7	6.9	4.5	5.4	7.7	16.1	8.3	5.3	4.4	7.6	4.6	6.4	3.1	8.8	8.2	12.2	1.1	5.5	5.9	4.3	5.8	0.9	6.8	5.4	3.6	5.1	9.9	6.8	5.7	6.4	4.9	6.9	2.9	4.8	3.9	5.9	1.7	3.7	1.7	7.7	3.8	2.6	8.9	0.5	2.3	6.4	6.1	0.7	0.9	5.5	0.5	1.8	7.6	3.4	4.8	14.8	22.4	0.9	0.3	5.0	2.0	2.0	3.0	9.8	5.8	0.0	14.1	4.5	7.3	7.8	0.9	7.8	5.2	2.8	1.7	0.8	2.1	0.0	0.3	4.0	5.3	4.8	4.6	7.7	2.0	0.2	6.3	3.1	4.9	6.4	0.0	8.3	0.4	7.0	5.2	1.7	8.3	1.5	5.0	1.6	5.5	2.9	3.2	2.7	4.8	4.8	5.9	4.9	5.4	3.6	6.9	2.9	1.7	3.4	1.9	3.9	2.8	1.2	4.5	1.7										
AL136454.1		ENSG00000231767			1	192716132-192716653	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 7.4;SK-MEL-30: 6.5;THP-1: 7.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA041344, HPA049132, HPA054087"	Uncertain		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA041344: , HPA049132: , HPA054087: "	"unprognostic (2.56e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.64e-2)"	"unprognostic (3.78e-1)"	"unprognostic (5.09e-2)"	"unprognostic (7.80e-3)"	"prognostic favourable (5.72e-4)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (6.48e-4)"	"unprognostic (3.07e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.80e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.62e-2)"	1.7	0.9	0.3	2.3	0.6	1.9	2.6	0.9	0.9	1.3	0.7	0.0	3.9	2.8	1.8	2.5	0.8	0.7	1.8	0.8	0.5		1.2	0.4	1.3	3.3	1.7	0.2	2.6	7.3	0.0	0.0	0.6	0.8	1.5	0.0	0.4	5.9	4.2	3.4	0.1	1.6	0.6	0.7	3.0	1.2	0.4	1.0	0.2	0.6	2.5	0.8	3.0	2.3	6.1	2.6	1.3	1.9	4.5	7.4	6.4	1.7	0.7	0.5	1.0	0.5	0.0	4.3	0.2	0.9	0.0	0.6	0.0	1.3	0.4	4.3	0.0	1.7	0.3	0.5	0.0	1.4	0.9	0.7	0.9	3.2	0.4	1.2	2.2	0.5	0.8	0.3	0.0	0.3	0.2	1.3	0.0	0.9	1.5	7.4	1.9	0.4	1.7	0.5	1.0	0.6	2.1	1.3	2.7	0.3	2.6	6.5	1.7	7.6	0.8	1.1	2.0	1.4	3.9	2.5	1.8	1.4	1.4	1.2	0.2	1.3	1.4	0.7	3.2	1.9	4.6	6.1	5.7	3.5	2.6	5.8	7.4	7.0	0.4	4.5	1.4	2.4	3.6	6.4										
AL162231.1		ENSG00000187186			9	34664163-34666112	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"testis: 68.6"	"Cell line enhanced"	"Detected in many"		"HeLa: 27.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA069617	Enhanced		Approved	"Nucleoli,Endoplasmic reticulum,Vesicles"				Vesicles	"Nucleoli, Endoplasmic reticulum"	"HPA069617: "	"unprognostic (8.20e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavourable (6.63e-5)"	"unprognostic (2.30e-1)"	"unprognostic (2.46e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.99e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.39e-5)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.08e-3)"	"unprognostic (2.00e-2)"	3.0	6.9	12.1	2.1	21.6	1.8	2.9	6.9	20.2	2.3	1.8	1.9	1.1	2.8	4.0	13.9	1.8	1.8	2.2	9.1	11.8	9.5	4.9	2.5	2.2	1.4	9.6	12.2	7.8	6.2	3.4	13.1	2.3	7.0	3.7	1.2	1.8	4.6	2.1	21.9	2.2	2.0	3.8	5.0	1.0	1.4	68.6	5.3	0.6	3.5	2.0	0.7	1.5	2.5	4.0	11.8	12.0	2.5	3.5	2.9	1.6	0.3	5.9	5.4	7.0	4.5	2.2	4.9	4.7	1.4	2.9	3.4	0.9	2.3	0.0	0.6	3.1	1.3	3.5	1.6	0.5	12.6	0.6	0.0	27.7	1.7	1.1	2.5	4.4	2.4	1.9	1.8	1.8	0.8	3.1	7.2	2.1	0.0	0.5	2.6	4.5	1.5	0.0	5.2	0.9	5.3	0.0	5.6	9.1	3.3	1.1	7.9	2.8	7.2	1.1	10.4	14.5	3.3	1.1	7.7	2.6	1.0	12.9	1.5	14.3	12.0	2.5	2.6	1.8	1.3	1.7	4.0	2.3	1.0	0.8	1.6	2.9	1.5	3.5	3.5	0.8	11.8	2.0	1.6	12.1	21.6	6.9	20.2	11.8	9.5	9.6	12.2	7.0	5.3
ALG14	MGC19780	ENSG00000172339	"ALG14, UDP-N-acetylglucosaminyltransferase subunit"	Q96F25	1	94974407-95072945	"Disease related genes, Predicted membrane proteins"			"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031829	Approved		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA031829: "	"unprognostic (7.79e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.75e-3)"	"unprognostic (1.36e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.01e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.55e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.93e-1)"	5.8	13.2	6.8	4.1	8.5	4.6	6.8	5.6	8.0	5.5	7.5	8.5	7.0	8.5	5.4	11.3	5.7	4.8	6.1	6.3	7.0	7.2	8.9	15.1	5.3	7.5	8.2	4.7	5.3	12.6	5.8	6.6	6.3	8.4	5.1	8.7	6.9	14.5	9.8	7.2	5.0	9.2	4.4	9.4	5.8	6.0	10.0	4.2	3.7	8.5	6.2	5.3	4.8	4.2	4.9	5.8	3.1	3.9	2.8	3.8	1.9	5.1	3.3	2.8	2.5	2.2	3.7	2.5	3.7	4.0	3.9	3.3	3.8	1.8	2.7	3.9	4.6	3.6	3.2	3.6	4.7	5.7	5.4	1.5	3.6	5.8	3.5	3.6	1.0	4.1	3.6	2.9	2.9	3.3	2.8	3.5	3.7	2.5	3.8	2.3	1.7	4.7	2.4	5.6	2.9	4.3	3.0	2.5	3.2	2.1	7.1	6.2	3.1	3.1	2.5	2.5	2.7	4.4	7.8	2.2	2.1	2.4	1.8	1.8	2.0	3.1	3.2	1.1	2.5	3.9	2.4	4.9	3.1	3.1	4.5	4.4	2.9	3.0	2.7	2.8	1.9	5.8	3.8	1.9	6.8	8.5	5.6	8.0	7.0	7.2	8.2	4.7	8.4	4.2
AMDHD2	CGI-14	ENSG00000162066	"Amidohydrolase domain containing 2"	Q9Y303	16	2520357-2531422	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA041184, HPA041321"	Enhanced		Approved	Nucleoli,Cytosol			69000	"Nucleoli, Cytosol"		"HPA041184: AB_10803998, HPA041321: AB_10795588"	"unprognostic (1.20e-1)"	"prognostic favourable (5.19e-4)"	"unprognostic (7.86e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.88e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.30e-1)"	"unprognostic (8.37e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.20e-1)"	12.8	16.9	8.6	11.4	10.1	12.7	10.9	7.3	16.0	9.4	8.8	11.1	11.3	19.5	10.4	11.9	8.4	9.0	14.6	11.8	7.1	4.8	15.3	10.5	20.0	15.8	9.8	11.3	8.1	10.1	6.5	7.5	10.7	8.9	8.6	2.4	10.9	16.1	9.6	10.2	15.0	19.1	7.2	8.3	22.2	11.5	25.7	7.9	7.3	9.9	11.0	8.9	9.3	8.0	9.8	17.1	16.6	15.8	4.9	8.1	4.8	6.4	8.8	1.9	4.0	2.1	1.7	14.3	5.9	2.5	4.7	5.9	6.3	11.6	3.0	4.2	1.1	5.9	1.1	1.6	0.1	3.8	5.3	4.3	7.9	8.2	8.0	3.1	14.1	4.0	1.7	3.4	0.5	2.9	9.8	7.2	1.9	15.6	5.0	8.6	4.1	6.8	19.7	3.0	11.0	1.3	3.6	7.3	7.2	3.8	9.2	15.5	9.5	0.8	4.0	5.3	8.1	10.5	3.0	15.2	9.7	5.9	5.9	5.9	6.6	9.9	6.1	16.5	7.4	15.8	5.5	9.8	5.9	5.3	2.3	7.4	5.0	4.2	16.6	4.9	15.2	17.1	8.1	4.8	8.6	10.1	7.3	16.0	7.1	4.8	9.8	11.3	8.9	7.9
ANAPC11	"APC11, Apc11p, HSPC214, MGC882"	ENSG00000141552	"Anaphase promoting complex subunit 11"	Q9NYG5	17	81890790-81900991	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA021989, HPA027838"	Approved		Enhanced	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA021989: AB_1844915, HPA027838: AB_10600978"	"unprognostic (9.00e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.76e-1)"	"unprognostic (4.93e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.13e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.76e-2)"	"unprognostic (8.07e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.16e-1)"	29.3	26.1	44.9	21.9	34.1	39.6	27.2	19.5	31.8	19.4	26.3	14.8	30.3	26.1	19.2	27.5	31.7	24.6	26.0	63.6	32.9	26.7	25.9	38.4	18.5	26.7	35.2	31.8	17.2	40.3	12.6	20.6	25.7	29.8	25.4	12.2	18.1	48.8	24.0	94.2	21.6	24.8	25.4	27.6	18.9	25.9	42.2	27.3	18.5	32.5	45.7	17.0	23.5	25.5	54.9	107.5	74.0	80.1	43.1	52.8	80.4	40.9	96.2	22.9	33.9	18.3	20.9	26.3	19.9	15.6	18.0	20.6	39.5	36.1	12.9	22.2	17.5	23.9	9.1	25.4	6.5	19.0	69.7	19.3	42.7	59.5	20.5	14.4	17.1	23.1	23.1	18.4	15.1	28.9	26.4	37.7	18.7	73.7	35.0	23.8	21.6	71.8	14.6	21.8	25.9	16.4	36.8	28.8	46.8	21.4	33.8	38.8	41.3	35.2	17.2	35.1	28.1	37.6	37.2	18.5	7.7	16.3	36.9	22.0	28.0	70.1	80.1	74.0	45.3	63.7	42.8	54.9	46.4	49.5	64.6	51.6	45.2	43.5	40.5	43.1	59.3	107.5	52.8	80.4	44.9	34.1	19.5	31.8	32.9	26.7	35.2	31.8	29.8	27.3
ANG	"RAA1, RNASE5"	ENSG00000214274	Angiogenin	P03950	14	20684177-20698971	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation, Stress response"	"Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein synthesis inhibitor"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"liver: 371.4"	"Cell line enriched"	"Detected in many"	5	"Hep G2: 56.6"	"Cancer enriched"	"Detected in all"	17	"liver cancer: 279.2"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 18.1;myeloid DC: 10.4"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA055896			Approved	"Nucleoli,Actin filaments"	"Secreted to blood"	307535000	230000000	Nucleoli	"Actin filaments"	"HPA055896: "	"unprognostic (2.50e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.77e-2)"	"prognostic favourable (6.85e-4)"	"unprognostic (5.71e-3)"	"unprognostic (6.99e-2)"	"prognostic favourable (7.83e-5)"	"unprognostic (1.16e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.19e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.69e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.09e-1)"	17.0	0.9	0.7	2.6	0.7	0.7	16.4	0.5	0.7	14.4	9.0	0.7	6.6	3.5	10.7	10.3	8.0	3.8	13.3	3.8	0.8	0.7	10.6	371.4	6.9	2.3	1.0	0.1	17.7	9.0	1.3	1.1	1.9	0.8	17.5	6.5	5.5	20.2	7.7	3.5	4.0	7.4	9.7	1.5	1.5	7.9	7.1	0.4	0.0	4.2	5.5	3.6	14.3	15.0	4.5	10.4	0.3	18.1	0.0	0.9	4.8	1.4	3.7	0.9	0.0	9.3	11.2	0.1	1.6	3.2	0.4	1.5	2.2	1.9	0.1	0.4	4.5	1.4	1.0	1.1	0.5	6.2	1.4	0.3	2.0	56.6	2.0	1.4	0.2	9.0	0.9	0.5	1.9	2.1	0.0	10.4	1.3	0.2	0.3	0.4	0.2	4.1	0.2	1.5	4.2	0.9	1.1	0.0	0.1	1.6	0.6	2.5	1.5	0.2	1.8	0.6	1.1	0.5	0.2	2.2	1.7	0.2	1.1	0.7	1.8	0.0	18.1	0.0	0.3	2.1	0.2	4.5	0.9	0.8	10.4	2.4	0.2	0.2	0.3	0.0	0.1	1.6	0.4	4.8	0.7	0.7	0.5	0.6	0.8	0.7	1.0	0.1	0.8	0.4
ANKRD18A	"FLJ35740, KIAA2015"	ENSG00000180071	"Ankyrin repeat domain 18A"	Q8IVF6	9	38571358-38620660	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"bone marrow: 24.4;brain: 11.1;testis: 19.1"	"Cell line enhanced"	"Detected in many"		"HL-60: 16.9;THP-1: 8.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA046346, HPA046695, HPA049923, HPA051288"	Uncertain		Supported	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA046346: , HPA046695: , HPA049923: , HPA051288: "	"unprognostic (4.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.94e-5)"	"unprognostic (2.31e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.14e-1)"	0.5	0.7	1.4	0.8	9.1	24.4	1.1	0.4	4.1	1.0	2.1	8.5	2.4	0.9	0.7	1.1	1.4	1.2	2.7	1.1	3.0	2.2	1.5	1.2	1.5	0.8	4.8	2.3	0.4	4.1	2.5	3.2	0.7	8.7	1.6	1.5	0.4	0.9	3.9	0.4	2.4	1.5	0.7	11.1	0.5	2.0	19.1	6.9	0.0	3.8	0.0	0.5	0.7	0.8	0.4	0.0	1.1	0.0	0.1	1.7	0.1	4.6	3.6	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.0	2.0	0.0	0.9	3.5	3.3	0.0	0.0	4.8	0.0	4.8	2.8	0.0	16.9	0.4	0.0	2.3	0.0	3.1	0.0	1.6	0.4	0.3	4.3	0.1	0.8	3.7	2.1	0.0	6.4	6.4	2.1	1.9	1.5	3.0	2.3	0.5	0.1	2.5	8.0	4.4	0.0	1.3	0.1	0.0	0.3	0.5	0.0	0.0	0.0	2.0	0.0	0.0	1.1	0.5	0.0	0.7	0.0	1.3	0.8	0.0	0.4	0.7	1.7	0.5	0.1	0.0	0.0	1.0	0.1	1.4	9.1	0.4	4.1	3.0	2.2	4.8	2.3	8.7	6.9
ANKRD18B	bA255A11.3	ENSG00000230453	"Ankyrin repeat domain 18B"	A2A2Z9	9	33524394-33573009	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 12.9;testis: 26.9"	"Cell line enhanced"	"Detected in many"		"NB-4: 20.5"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 12.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046346, HPA046695, HPA049923, HPA051288"	Uncertain		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA046346: , HPA046695: , HPA049923: , HPA051288: "	"unprognostic (4.71e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.29e-4)"	"unprognostic (1.45e-2)"	"unprognostic (9.84e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.54e-4)"	"unprognostic (1.01e-2)"	"unprognostic (6.43e-5)"	"unprognostic (4.89e-2)"	"unprognostic (9.75e-4)"	"unprognostic (8.25e-2)"	"unprognostic (5.18e-2)"	1.5	0.9	4.3	0.1	0.4	0.2	1.3	12.9	3.9	0.3	0.2	0.2	0.1	0.0	0.5	1.0	2.1	1.0	0.9	0.3	2.1	1.3	0.1	0.4	0.7	0.1	1.0	1.4	0.1	0.1	0.1	1.6	1.3	2.6	2.0	0.3	0.2	0.2	0.1	1.4	5.5	0.2	0.1	1.0	0.9	0.0	26.9	0.1	0.1	0.9	1.6	0.7	1.2	1.1	0.5	0.8	0.1	0.2	0.0	0.8	0.1	7.4	8.4	0.7	0.2	0.3	1.4	0.7	1.6	1.7	2.1	2.3	1.5	0.2	0.2	0.4	0.2	1.7	4.5	1.6	2.8	0.1	4.5	8.1	9.8	3.1	0.0	2.7	0.6	1.1	4.5	2.9	7.5	3.8	4.4	2.1	2.6	1.2	0.2	20.5	7.2	3.7	0.0	10.3	1.5	1.2	1.8	0.2	7.2	3.4	0.3	0.5	5.9	10.0	3.8	1.7	7.5	3.4	2.9	1.2	0.8	0.1	0.8	0.1	1.2	0.0	0.1	0.1	0.3	0.1	0.7	0.4	0.2	0.6	0.0	0.5	0.4	0.8	0.1	0.0	0.2	0.8	0.1	0.1	4.3	0.4	12.9	3.9	2.1	1.3	1.0	1.4	2.6	0.1
ANKRD30A	NY-BR-1	ENSG00000148513	"Ankyrin repeat domain 30A"	Q9BXX3	10	37125788-37384111	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	38	"breast: 31.7;testis: 17.8"	"Group enriched"	"Detected in some"	33	"A549: 3.8;U-266/70: 15.2"	"Cancer enriched"	"Detected in single"	37	"breast cancer: 11.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA071849			Uncertain	Nucleoli				Nucleoli		"HPA071849: "	"unprognostic (2.79e-1)"											"unprognostic (2.81e-1)"	"unprognostic (1.01e-7)"	"unprognostic (1.41e-1)"		"unprognostic (5.93e-1)"		0.6	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANKRD30B	NY-BR-1.1	ENSG00000180777	"Ankyrin repeat domain 30B"	Q9BXX2	18	14728272-14852738	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	17	"testis: 42.2"	"Cell line enriched"	"Detected in some"	7	"U-2197: 31.3"	"Cancer enhanced"	"Detected in single"		"breast cancer: 2.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA060455, HPA071849"	Uncertain		Uncertain	Nucleoli				Nucleoli		"HPA060455: , HPA071849: "	"unprognostic (1.53e-1)"		"unprognostic (1.50e-1)"		"unprognostic (1.01e-2)"				"unprognostic (1.65e-1)"	"unprognostic (1.86e-1)"	"unprognostic (9.74e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.55e-9)"	"unprognostic (1.38e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.98e-2)"		0.3	0.2	1.2	0.1	2.5	0.1	2.3	0.0	1.8	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.9	0.9	0.1	0.1	0.1	0.1	0.4	1.2	0.1	0.6	0.1	0.0	0.1	1.0	0.1	0.2	2.5	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	42.2	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.7	2.5	0.1	31.3	0.0	4.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.5	0.0	1.8	0.9	0.9	0.4	1.2	1.0	0.0
ANKRD49	"FGIF, FLJ20189, GBIF"	ENSG00000168876	"Ankyrin repeat domain 49"	Q8WVL7	11	94493629-94499583	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040273, HPA048137"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"				"Nucleoplasm, Nucleoli"	"Golgi apparatus"	"HPA040273: AB_10674991, HPA048137: "	"unprognostic (1.52e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.06e-3)"	"unprognostic (1.46e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.21e-3)"	"prognostic unfavourable (9.96e-4)"	"unprognostic (6.32e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.40e-2)"	"prognostic favourable (6.16e-4)"	9.8	9.0	10.2	10.7	10.8	19.6	12.7	18.6	10.9	15.6	14.8	4.5	9.5	11.2	15.1	19.6	13.2	8.2	7.9	5.7	9.5	6.9	13.3	11.0	10.4	17.5	7.2	8.5	12.3	15.6	9.1	27.9	16.3	7.7	12.6	13.1	7.7	12.1	10.7	7.9	8.8	19.2	9.6	12.5	21.3	12.1	5.3	8.5	22.6	18.0	9.9	19.2	11.9	9.3	20.5	17.7	34.7	15.1	17.3	19.6	10.5	6.4	2.9	7.5	6.5	7.4	9.5	9.1	10.1	9.0	10.6	12.5	14.0	12.6	16.9	15.5	7.1	14.0	9.1	6.9	8.5	13.1	7.4	14.5	11.3	4.7	8.5	12.7	11.6	6.6	17.2	8.2	11.4	8.3	13.7	10.0	7.0	4.4	13.5	23.2	4.3	7.2	11.0	8.4	8.4	10.0	6.8	7.5	7.7	6.9	6.9	6.3	14.1	8.6	5.1	9.6	6.8	10.5	5.0	5.8	13.5	17.9	3.2	15.4	5.5	34.7	15.1	12.6	14.9	12.5	16.3	20.5	15.9	13.1	11.4	19.6	19.6	17.9	27.1	17.3	9.3	17.7	19.1	10.5	10.2	10.8	18.6	10.9	9.5	6.9	7.2	8.5	7.7	8.5
ANKS6	"ANKRD14, FLJ36928, NPHP16, SAMD6"	ENSG00000165138	"Ankyrin repeat and sterile alpha motif domain containing 6"	Q68DC2	9	98731329-98796965	"Disease related genes, Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Joubert syndrome, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 31.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA008355	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA008355: AB_2058277"	"unprognostic (1.66e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.31e-2)"	"unprognostic (9.15e-3)"	"unprognostic (6.90e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.29e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.00e-1)"	"unprognostic (5.94e-2)"	"prognostic favourable (3.44e-5)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.68e-1)"	5.0	3.7	5.8	4.3	9.9	1.8	4.8	31.2	9.5	7.3	6.5	9.4	2.6	5.9	6.0	7.4	7.5	7.8	7.7	2.9	6.9	6.1	7.7	1.8	7.2	3.4	10.1	4.4	9.6	18.1	10.0	2.8	2.8	11.4	3.6	7.3	4.2	3.1	3.5	3.3	4.4	5.4	8.9	6.1	2.5	7.7	6.1	9.2	1.8	13.4	2.4	4.5	5.4	6.4	0.9	0.0	0.0	0.1	0.0	2.1	0.2	5.4	8.3	7.7	13.4	6.4	5.2	5.2	4.0	6.9	4.5	5.4	4.6	4.0	10.2	3.1	5.7	16.5	5.6	6.8	2.4	14.2	5.8	2.5	5.0	1.9	6.3	1.3	1.7	6.4	8.5	6.2	6.3	5.1	17.2	2.4	3.4	9.1	0.5	2.6	12.1	9.1	6.8	19.1	0.8	8.2	3.4	5.0	5.7	1.7	9.9	4.5	0.0	2.8	5.2	4.8	5.2	12.9	3.9	4.8	8.0	1.7	6.7	4.6	6.8	0.0	0.1	0.0	1.3	0.0	0.7	0.9	0.7	2.1	0.0	0.6	1.8	0.9	0.0	0.0	0.0	0.0	1.1	0.2	5.8	9.9	31.2	9.5	6.9	6.1	10.1	4.4	11.4	9.2
ANXA10	ANX14	ENSG00000109511	"Annexin A10"	Q9UJ72	4	168092515-168187690	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"gallbladder: 33.5;stomach 1: 105.3"	"Group enriched"	"Detected in some"	6	"PC-3: 41.0;RT4: 55.4"	"Group enriched"	"Detected in many"	5	"pancreatic cancer: 62.4;stomach cancer: 42.2;urothelial cancer: 19.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA005469	Enhanced		Approved	Nucleoplasm,Nucleoli,Vesicles				"Nucleoplasm, Nucleoli"	Vesicles	"HPA005469: AB_1844849"	"unprognostic (2.29e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.69e-1)"	"unprognostic (2.29e-2)"	"prognostic favourable (3.64e-6)"	"unprognostic (1.18e-3)"	"unprognostic (2.88e-1)"	"unprognostic (8.61e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-3)"	"unprognostic (8.41e-2)"	"unprognostic (4.01e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.89e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	1.4	0.1	4.2	0.1	0.1	0.5	0.0	33.5	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	1.5	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.4	0.1	0.1	105.3	0.1	0.1	0.1	0.1	0.1	0.1	11.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.0	0.0	0.2	0.0	0.0	55.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
AP002495.1		ENSG00000254469	"Putative short transient receptor potential channel 2-like protein "	Q6ZNB5	11	71865509-71928654	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA051121, HPA051124"	Uncertain		Enhanced	Nucleoli				Nucleoli		"HPA051121: , HPA051124: "	"unprognostic (1.66e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.32e-3)"	"unprognostic (9.79e-4)"	"unprognostic (5.91e-3)"	"unprognostic (5.04e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.60e-1)"	"unprognostic (3.12e-3)"	5.8	6.9	8.2	7.7	7.3	9.1	7.3	7.4	8.7	7.5	6.3	11.6	21.7	6.1	9.2	13.2	6.2	7.2	5.0	4.8	6.4	4.9	7.6	5.1	5.4	8.9	6.8	5.4	12.1	7.2	7.4	12.7	4.8	6.6	7.2	8.5	10.4	7.9	15.7	5.9	8.8	7.5	6.4	6.5	7.9	6.9	9.7	11.9	11.6	8.7	3.6	12.2	7.1	6.8	6.0	7.5	3.4	4.5	1.8	8.5	3.2	2.8	6.4	5.1	4.8	1.9	2.0	3.2	3.3	2.5	3.5	3.3	7.5	7.2	6.2	3.0	2.1	9.2	5.4	3.4	3.9	9.0	4.7	9.9	7.1	4.4	1.4	4.8	3.4	2.6	1.6	5.7	4.6	5.2	6.7	9.2	3.5	5.8	4.8	3.5	5.5	4.7	4.0	18.6	4.3	3.7	3.6	7.6	7.8	4.8	4.5	10.1	6.5	2.3	4.8	2.7	4.8	5.2	2.0	5.7	9.0	7.7	4.6	5.1	4.4	3.4	3.0	2.5	4.6	4.5	2.9	4.2	8.5	6.3	3.5	6.0	8.2	6.8	2.6	1.8	2.7	7.5	7.1	3.2	8.2	7.3	7.4	8.7	6.4	4.9	6.8	5.4	6.6	11.9
APOC3		ENSG00000110245	"Apolipoprotein C3"	P02656	11	116829706-116833072	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Lipid transport, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 714.1"	"Group enriched"	"Detected in some"	19	"CACO-2: 27.8;Hep G2: 75.2"	"Cancer enriched"	"Detected in many"	643	"liver cancer: 4021.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"HPA065365, HPA073918"	Supported		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Secreted to blood"	88520000000	97000000000	Nucleoplasm	"Nucleoli, Cell Junctions"	"HPA065365: , HPA073918: "							"prognostic favourable (3.77e-4)"				"unprognostic (2.33e-1)"		"prognostic unfavourable (6.87e-5)"	"unprognostic (1.60e-2)"	"unprognostic (5.21e-2)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	38.7	0.1	0.1	31.7	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.4	714.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	91.3	0.1	0.1	0.3	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	27.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	75.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.6	0.9	0.0	0.0	0.3	1.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1
APTX	"AOA, AOA1, AXA1, EAOH, EOAHA, FLJ20157"	ENSG00000137074	Aprataxin	Q7Z2E3	9	32972606-33025168	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Hydrolase"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064930	Supported		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA064930: "	"unprognostic (9.18e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.78e-3)"	"unprognostic (3.48e-3)"	"unprognostic (3.49e-2)"	"prognostic favourable (6.01e-5)"	"unprognostic (7.87e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.50e-2)"	12.9	20.3	17.5	11.2	18.4	19.9	16.5	15.1	21.7	12.0	15.2	19.3	9.3	11.7	14.7	12.9	19.1	14.7	8.0	11.9	13.3	13.9	17.9	23.4	12.6	11.8	16.4	16.5	11.8	14.3	15.8	14.3	12.1	20.2	12.1	18.1	14.6	12.5	11.9	14.1	20.6	13.8	14.6	15.7	11.7	12.5	18.2	14.5	8.8	10.5	12.6	16.1	13.4	12.1	17.1	18.4	16.1	20.8	26.4	19.4	15.0	21.2	16.1	12.3	10.6	12.5	11.0	16.2	14.2	14.8	17.4	19.2	21.4	7.5	16.6	8.6	11.9	11.3	20.0	19.1	21.6	22.4	8.2	9.8	23.1	21.8	14.6	15.8	9.4	14.7	23.4	19.9	25.9	16.6	14.8	16.5	16.2	9.1	14.2	23.2	18.7	17.3	12.8	8.5	11.8	14.3	12.9	8.5	7.2	13.0	11.7	9.5	13.3	6.5	10.2	9.7	12.9	16.7	14.6	7.2	11.8	16.6	14.4	12.9	7.7	9.1	17.7	14.9	13.4	16.3	17.6	17.0	15.2	15.5	18.4	17.1	18.0	14.6	16.1	26.4	20.8	17.9	19.4	15.0	17.5	18.4	15.1	21.7	13.3	13.9	16.4	16.5	20.2	14.5
ARHGAP11A	KIAA0013	ENSG00000198826	"Rho GTPase activating protein 11A"	Q6P4F7	15	32615144-32639949	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.4;lymphoid tissue: 35.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA040419, HPA040830"	Enhanced		Approved	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA040419: AB_10796121, HPA040830: AB_10805830"	"unprognostic (5.00e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.41e-2)"	"prognostic unfavourable (2.05e-4)"	"prognostic unfavourable (8.69e-4)"	"unprognostic (4.87e-2)"	"unprognostic (7.71e-2)"	"prognostic unfavourable (2.92e-5)"	"unprognostic (3.43e-2)"	"unprognostic (1.07e-12)"	"unprognostic (7.37e-2)"	"unprognostic (5.23e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.64e-2)"	1.9	1.5	2.0	17.2	2.9	16.4	3.3	1.1	3.9	1.6	5.4	1.6	0.5	4.3	2.3	0.5	7.5	0.5	4.1	1.4	2.2	1.9	0.8	1.2	2.0	9.4	4.4	0.8	0.8	3.1	0.9	1.0	4.7	2.0	1.2	6.7	0.8	2.0	0.5	1.7	3.2	9.6	3.3	8.9	5.0	2.6	6.4	1.9	35.0	1.0	5.3	10.3	2.6	2.7	0.9	1.7	2.6	1.8	0.5	3.8	1.1	23.3	25.1	20.2	13.3	1.4	3.7	12.0	23.7	13.7	22.6	17.5	17.3	11.9	13.5	7.5	13.9	17.4	14.2	12.4	30.5	26.7	8.2	43.0	22.7	8.8	0.5	31.9	17.3	1.2	1.5	18.2	14.4	16.6	29.8	32.3	26.1	9.5	16.8	10.7	12.6	14.8	19.9	45.1	10.6	8.0	12.4	19.4	13.4	24.8	12.9	5.4	18.3	30.7	12.8	30.5	22.6	12.8	25.2	11.8	18.6	37.4	13.1	38.1	26.6	0.1	1.1	2.6	2.3	1.8	0.9	0.9	3.8	3.3	1.7	0.7	1.5	2.0	0.0	0.5	0.3	0.6	2.8	1.1	2.0	2.9	1.1	3.9	2.2	1.9	4.4	0.8	2.0	1.9
ARID5A	"MRF-1, RP11-363D14"	ENSG00000196843	"AT-rich interaction domain 5A"	Q03989	2	96536743-96552638	"Predicted intracellular proteins, Transcription factors"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"HDLM-2: 71.4;RPMI-8226: 31.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002860, HPA023879"	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA002860: , HPA023879: AB_1845014"	"prognostic favourable (2.05e-6)"	"unprognostic (1.08e-3)"	"unprognostic (1.69e-2)"	"unprognostic (3.89e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (4.24e-8)"	"unprognostic (2.74e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.13e-2)"	20.1	4.1	6.8	24.5	8.7	14.6	26.2	3.1	8.8	10.5	14.6	4.9	4.1	7.2	17.5	16.1	9.1	11.5	16.8	17.8	7.0	5.5	5.4	7.2	26.0	29.0	10.7	3.1	11.4	9.8	3.8	6.6	13.0	17.4	14.7	3.7	11.4	8.2	5.1	26.1	7.3	12.3	33.1	13.6	14.9	10.1	5.4	6.2	12.4	8.2	7.7	15.7	19.5	12.0	5.2	12.8	21.4	5.3	17.7	11.5	8.8	0.8	0.3	0.4	1.4	0.8	0.9	2.1	1.4	4.8	1.7	1.5	0.8	0.2	0.2	0.9	0.8	1.2	0.3	0.0	0.5	71.4	1.1	1.7	0.3	1.6	0.9	1.2	1.3	0.6	1.6	1.3	0.2	1.5	1.4	10.8	0.6	0.7	2.3	4.2	0.9	0.0	3.2	3.0	31.5	0.2	0.6	0.6	0.2	0.1	0.1	1.1	0.0	2.6	1.3	1.5	1.8	1.6	1.2	6.7	5.2	0.8	0.8	2.9	1.3	7.2	5.3	21.4	11.5	4.8	11.1	4.4	9.7	10.7	7.1	5.2	10.8	10.5	15.3	17.7	3.3	12.8	11.0	8.8	6.8	8.7	3.1	8.8	7.0	5.5	10.7	3.1	17.4	6.2
ARL2	ARFL2	ENSG00000213465	"ADP ribosylation factor like GTPase 2"	P36404	11	65014113-65022184	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA044610	Supported		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Focal adhesion sites,Cytosol"				Nucleoplasm	"Nucleoli, Golgi apparatus, Focal adhesion sites, Cytosol"	"HPA044610: AB_10964207"	"unprognostic (9.23e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (4.58e-4)"	"unprognostic (1.61e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.34e-1)"	"unprognostic (9.85e-3)"	"unprognostic (6.43e-2)"	"unprognostic (6.87e-3)"	"prognostic favourable (7.70e-4)"	"unprognostic (2.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.39e-1)"	"unprognostic (1.24e-2)"	39.6	32.0	37.3	17.7	78.7	19.8	26.8	16.1	46.5	21.2	23.5	34.7	13.4	23.9	26.8	20.2	23.7	35.2	22.4	52.6	34.8	32.7	33.8	6.6	23.1	14.8	36.1	38.2	27.2	29.9	22.5	15.4	25.5	32.7	25.3	15.5	30.3	26.9	33.1	78.3	19.6	23.4	28.2	44.9	16.7	18.9	31.4	28.7	7.9	26.3	23.6	12.9	24.7	22.8	43.7	37.8	18.7	21.8	21.0	40.7	34.7	35.8	57.1	17.7	26.2	48.1	36.6	16.1	17.7	40.9	25.4	25.1	16.1	24.8	13.8	33.8	24.9	23.0	18.6	31.1	12.1	14.5	29.2	13.9	25.8	24.3	36.9	16.9	12.7	28.8	26.1	21.1	47.4	33.7	32.9	25.9	17.0	42.4	14.0	38.1	27.7	46.7	7.4	19.4	33.3	27.3	15.6	33.0	18.6	15.1	15.7	49.7	16.5	20.8	25.3	47.8	16.1	38.0	18.2	8.9	12.5	8.5	22.6	24.5	38.8	10.2	21.8	18.7	34.8	21.2	37.6	43.7	32.2	33.6	27.6	37.3	36.8	40.7	2.8	21.0	12.4	37.8	20.6	34.7	37.3	78.7	16.1	46.5	34.8	32.7	36.1	38.2	32.7	28.7
ARL9		ENSG00000196503	"ADP ribosylation factor like GTPase 9"	Q6T311	4	56505209-56525481	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.7;testis: 12.6"	"Cell line enhanced"	"Detected in some"		"HSkMC: 4.3;REH: 8.5;SCLC-21H: 9.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA072942	Enhanced		Approved	Nucleoli,Mitochondria				Mitochondria	Nucleoli	"HPA072942: "	"unprognostic (9.91e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.24e-3)"	"unprognostic (6.86e-3)"	"unprognostic (3.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.93e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.79e-6)"	"unprognostic (1.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.29e-2)"	1.3	1.1	4.4	0.8	4.9	3.4	2.0	1.5	7.1	1.3	1.3	0.6	2.4	1.0	2.0	1.1	1.1	1.2	2.4	0.8	3.9	3.2	0.5	0.5	0.6	1.0	1.3	2.9	3.0	0.4	0.4	1.6	0.3	8.7	2.2	1.0	1.9	0.9	3.8	0.4	4.1	1.0	3.7	2.5	0.8	1.0	12.6	0.6	0.1	1.1	1.2	0.7	1.5	2.5	2.1	2.2	1.6	0.4	1.4	1.4	0.1	0.0	0.5	0.5	0.5	1.1	2.8	0.1	0.9	0.5	2.1	2.1	0.4	0.7	0.7	0.0	1.4	0.2	0.4	0.2	1.1	0.1	0.1	0.3	0.0	0.1	2.7	0.2	0.7	4.3	0.6	1.8	0.4	2.0	0.2	0.9	2.0	0.0	0.3	0.1	2.2	1.3	8.5	0.0	0.1	0.1	0.3	9.0	0.1	0.3	0.4	0.2	0.2	0.1	0.4	0.3	0.4	0.0	0.1	0.3	0.4	0.4	0.1	0.0	0.3	0.8	0.4	0.4	0.7	0.4	0.4	1.0	1.2	1.0	0.3	2.1	1.4	0.6	1.6	1.4	0.4	2.2	1.0	0.1	4.4	4.9	1.5	7.1	3.9	3.2	1.3	2.9	8.7	0.6
ARNTL2	"bHLHe6, BMAL2, CLIF, MOP9, PASD9"	ENSG00000029153	"Aryl hydrocarbon receptor nuclear translocator like 2"	Q8WYA1	12	27332854-27425289	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 30.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 34.6;U-2197: 47.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA059074	Uncertain		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA059074: "	"unprognostic (6.86e-2)"	"unprognostic (6.16e-2)"	"unprognostic (5.88e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.84e-3)"	"unprognostic (2.97e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (5.29e-6)"	"unprognostic (5.26e-2)"	"prognostic unfavourable (1.56e-5)"	"unprognostic (7.81e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.79e-1)"	3.5	1.3	5.7	9.8	5.9	2.2	3.3	3.6	10.6	6.8	3.1	1.1	0.0	2.9	1.5	0.5	30.0	1.5	3.9	1.9	9.1	2.8	1.6	10.3	2.7	5.0	2.1	6.8	0.9	2.3	2.4	1.5	14.7	2.6	1.9	3.5	0.0	9.2	0.9	1.0	7.7	2.8	4.7	2.0	1.2	10.9	2.8	1.3	3.8	1.2	15.4	21.1	5.9	12.5	0.6	1.4	4.5	0.5	0.5	1.5	0.2	21.5	5.5	1.2	0.4	1.1	3.3	17.4	7.6	10.1	5.0	7.9	5.2	16.8	0.1	4.3	3.6	8.9	3.6	26.8	12.8	34.6	4.6	4.1	3.6	4.3	1.4	8.3	1.8	1.2	2.4	17.5	13.7	23.5	2.1	8.8	5.7	2.6	4.5	4.6	9.5	19.4	8.5	20.3	1.3	4.2	12.4	4.0	0.6	3.9	0.6	0.1	0.8	2.7	15.9	16.3	9.4	47.3	31.6	1.3	2.3	0.0	14.0	6.8	3.2	4.5	0.5	0.5	0.2	0.3	0.2	0.5	0.2	0.2	1.4	0.6	0.2	0.3	2.4	0.5	0.2	0.3	1.5	0.2	5.7	5.9	3.6	10.6	9.1	2.8	2.1	6.8	2.6	1.3
ARPP21	"ARPP-21, R3HDM3, TARPP"	ENSG00000172995	"CAMP regulated phosphoprotein 21"	Q9UBL0	3	35638945-35794496	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 146.9;lymphoid tissue: 41.2;skeletal muscle: 43.6"	"Group enriched"	"Detected in some"	8	"MOLT-4: 34.9;REH: 19.4;RH-30: 11.1"	"Cancer enhanced"	"Detected in single"		"glioma: 1.3"	"Region enriched"	"Detected in all"	5	"basal ganglia: 146.9"	"Cell type enriched"	"Detected in single"	30	"plasmacytoid DC: 12.1"	"Lineage enriched"	"Detected in single"	30	"dendritic cells: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017303	Enhanced		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA017303: AB_1845049"	"unprognostic (1.72e-4)"				"unprognostic (2.35e-1)"	"unprognostic (1.10e-2)"	"unprognostic (6.61e-2)"		"unprognostic (6.30e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.27e-1)"	"unprognostic (7.42e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.52e-1)"		1.2	1.3	12.3	1.5	146.9	4.6	1.1	27.8	67.9	1.1	1.4	0.3	0.0	1.3	1.1	1.1	3.2	1.1	1.1	1.1	6.8	2.8	2.0	2.9	1.2	1.2	3.9	11.5	1.1	1.1	1.1	1.9	1.1	6.7	2.0	1.5	0.0	1.1	1.3	43.6	1.1	1.4	1.1	0.8	1.2	1.1	1.1	14.8	41.2	1.5	3.5	1.5	1.1	0.1	0.1	12.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	34.9	0.0	0.0	1.4	19.4	11.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	12.1	0.0	0.0	12.3	146.9	27.8	14.7	6.8	2.8	3.9	11.5	6.7	14.8
ASNA1	"ARSA-I, GET3, TRC40"	ENSG00000198356	"ArsA arsenite transporter, ATP-binding, homolog 1 (bacterial)"	O43681	19	12737139-12748323	"Predicted intracellular proteins, Transporters"	Transport	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045951, HPA048087"	Approved		Enhanced	Nucleoplasm,Nucleoli			52000	Nucleoli	Nucleoplasm	"HPA045951: , HPA048087: "	"unprognostic (2.87e-1)"	"prognostic favourable (9.53e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.39e-2)"	"prognostic favourable (4.27e-5)"	"unprognostic (6.11e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.32e-3)"	"prognostic unfavourable (8.47e-4)"	22.3	33.9	32.3	23.1	32.8	35.1	22.2	28.2	51.9	23.5	27.2	26.1	23.6	24.7	24.8	30.3	33.3	30.7	28.9	48.0	30.5	27.9	46.9	28.5	21.2	26.6	29.2	26.5	24.2	30.3	23.8	25.2	32.0	27.3	21.8	18.3	30.9	26.7	21.5	35.7	28.9	24.7	21.3	24.5	26.5	24.2	30.9	18.5	25.8	40.7	28.0	23.5	28.7	20.6	12.5	27.1	16.0	26.9	9.3	20.2	19.4	33.2	27.5	14.8	31.8	29.4	18.1	18.2	17.3	23.9	33.6	26.5	21.5	16.6	15.4	27.1	22.4	17.9	20.4	23.1	16.1	23.6	31.9	13.2	20.8	24.4	31.4	19.5	25.8	20.9	20.4	27.1	16.1	23.7	16.4	20.9	26.2	74.5	25.8	15.7	37.3	51.8	19.2	22.9	30.0	31.3	28.5	27.4	23.3	23.4	31.6	27.7	26.0	18.9	20.2	47.5	16.1	52.6	40.2	37.6	63.2	14.1	33.4	32.1	26.2	16.0	26.9	15.0	16.1	20.4	13.7	12.5	14.4	14.2	27.1	10.6	10.4	12.8	9.6	9.3	23.7	17.8	20.2	19.4	32.3	32.8	28.2	51.9	30.5	27.9	29.2	26.5	27.3	18.5
ASXL1	KIAA0978	ENSG00000171456	"Additional sex combs like 1, transcriptional regulator"	Q8IXJ9	20	32358330-32439319	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor"	"Cancer-related genes, Craniosynostosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064156			Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA064156: "	"unprognostic (1.49e-1)"	"unprognostic (5.97e-2)"	"unprognostic (8.36e-2)"	"prognostic unfavourable (2.86e-4)"	"unprognostic (6.69e-2)"	"prognostic favourable (9.16e-4)"	"unprognostic (2.01e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.32e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.84e-3)"	"unprognostic (5.47e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.06e-1)"	24.3	19.6	19.0	35.0	18.2	39.0	24.7	28.3	23.8	32.4	22.7	17.7	16.9	15.6	32.4	22.2	14.3	20.5	21.6	17.9	19.7	10.7	21.2	25.2	27.3	26.7	20.3	14.7	28.1	27.1	21.2	16.3	19.8	18.2	20.6	16.4	16.6	17.4	23.3	25.5	18.2	21.8	21.8	12.2	28.2	19.7	32.1	23.0	47.4	26.8	15.8	29.0	23.2	35.3	9.8	3.1	1.3	0.8	1.7	14.6	1.9	22.6	13.2	20.7	11.4	9.5	11.8	18.0	15.2	13.0	26.6	19.7	39.1	14.6	21.4	9.8	18.7	15.8	17.4	14.6	21.7	32.0	9.4	34.2	20.9	21.4	8.5	14.2	14.2	13.1	9.8	18.5	13.9	14.6	16.5	11.6	12.3	6.9	19.4	11.5	5.0	15.2	11.3	24.7	9.2	10.9	10.9	9.5	14.9	27.6	9.2	12.1	13.1	10.1	15.1	28.3	24.7	13.0	16.9	13.6	14.5	15.8	14.3	37.9	10.8	0.0	0.8	1.3	4.4	0.7	3.5	9.8	5.2	5.6	0.7	5.8	5.8	5.9	0.9	1.7	0.7	3.1	14.6	1.9	19.0	18.2	28.3	23.8	19.7	10.7	20.3	14.7	18.2	23.0
ATAD1	FLJ14600	ENSG00000138138	"ATPase family, AAA domain containing 1"	Q8NBU5	10	87751512-87841343	"Enzymes, Predicted membrane proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037569	Uncertain		Approved	Nucleoli,Mitochondria				Nucleoli	Mitochondria	"HPA037569: AB_10672496"	"unprognostic (9.92e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.24e-2)"	"unprognostic (6.60e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.35e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.67e-2)"	"prognostic favourable (3.98e-6)"	"unprognostic (2.35e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.45e-2)"	"unprognostic (4.22e-2)"	16.2	21.3	20.4	15.1	26.2	8.0	19.4	22.4	29.8	19.2	15.9	14.4	16.0	13.5	19.6	17.0	17.3	14.8	13.3	39.9	20.4	22.2	20.6	22.1	14.1	14.2	20.4	17.1	19.1	12.6	25.6	24.9	30.2	31.2	24.3	18.4	19.8	15.8	20.4	32.1	14.4	14.1	18.4	18.2	12.5	14.0	19.8	14.7	18.0	20.1	18.5	15.7	18.9	15.2	9.0	7.3	6.7	7.6	9.8	13.5	7.4	9.8	9.3	11.9	11.3	14.4	12.7	9.0	10.0	16.6	10.3	11.6	8.4	28.6	9.5	7.7	8.3	16.4	9.9	8.5	12.1	8.5	13.4	7.8	13.0	10.3	17.1	21.2	5.4	12.6	23.8	10.9	27.1	6.8	7.6	12.4	11.4	6.0	13.6	14.4	8.8	6.5	9.3	7.6	10.4	15.8	7.6	7.6	16.6	8.8	6.3	20.1	16.5	10.0	8.4	9.4	8.4	6.3	13.0	16.7	15.3	12.2	10.4	14.8	7.2	6.7	3.8	5.7	9.2	5.9	13.5	9.0	10.3	11.4	7.3	7.6	11.8	11.6	2.2	9.8	7.6	5.5	9.3	7.4	20.4	26.2	22.4	29.8	20.4	22.2	20.4	17.1	31.2	14.7
ATF3		ENSG00000162772	"Activating transcription factor 3"	P18847	1	212565334-212620777	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 138.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 43.4;HDLM-2: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 6.1;intermediate monocyte: 5.5;myeloid DC: 2.2;non-classical monocyte: 8.1"	"Group enriched"	"Detected in many"	12	"dendritic cells: 2.2;granulocytes: 6.1;monocytes: 8.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA001562	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA001562: AB_1078233"	"unprognostic (2.66e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.27e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.73e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.65e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.08e-2)"	41.5	21.5	9.5	41.0	7.1	9.4	30.2	3.0	8.0	30.0	16.2	15.3	36.4	5.0	34.9	28.6	31.4	38.1	33.4	31.8	6.5	6.9	19.4	36.1	42.8	4.6	13.5	6.5	23.1	16.0	15.1	12.4	65.1	9.4	30.4	15.0	8.1	12.1	138.4	13.2	39.5	11.4	76.1	13.0	5.4	31.6	10.7	12.4	1.5	45.5	37.3	7.4	38.3	33.8	0.3	2.2	6.1	8.1	0.0	0.4	0.8	6.6	0.4	13.4	2.8	1.3	3.4	43.4	4.8	3.9	4.1	9.9	8.9	5.0	0.1	2.2	0.3	3.7	8.0	1.3	6.8	31.7	7.7	0.5	3.9	3.1	24.6	2.8	7.5	6.0	21.6	11.5	26.9	0.8	3.1	25.3	0.6	0.8	8.5	1.8	9.6	2.8	2.5	8.9	5.7	0.5	0.9	6.0	6.1	6.2	11.2	18.8	6.5	2.0	0.8	1.2	6.4	4.0	2.1	20.0	8.4	2.2	4.0	1.5	3.5	6.1	0.9	0.0	0.4	5.5	0.4	0.1	0.1	0.0	2.2	0.3	0.0	0.0	0.3	0.0	8.1	1.1	0.0	0.8	9.5	7.1	3.0	8.0	6.5	6.9	13.5	6.5	9.4	12.4
ATF6B	"CREBL1, G13"	ENSG00000213676	"Activating transcription factor 6 beta"	Q99941	6	32115264-32128253	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046871	Uncertain		Approved	Nucleoplasm,Nucleoli			31000000	Nucleoplasm	Nucleoli	"HPA046871: AB_10963542"	"unprognostic (2.93e-3)"	"unprognostic (1.56e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.37e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.68e-2)"	"unprognostic (9.03e-2)"	"unprognostic (3.66e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.10e-2)"	11.7	19.4	23.1	13.7	29.4	24.9	14.3	20.2	19.1	17.8	20.2	15.4	9.8	11.2	19.2	32.7	20.0	27.7	15.4	11.0	19.4	11.4	13.5	14.0	15.6	17.0	20.6	16.5	22.6	18.4	38.1	16.1	21.1	16.9	16.8	18.8	14.1	16.2	14.0	7.1	17.8	15.9	9.4	12.8	22.8	20.2	19.5	17.0	21.7	21.2	11.8	21.0	18.0	16.4	4.4	5.7	6.6	4.1	5.6	4.9	4.4	0.8	2.9	8.1	3.0	6.1	6.9	3.0	3.3	3.2	7.3	9.2	9.5	15.9	14.5	11.7	29.4	4.7	11.0	22.1	5.4	2.9	12.1	1.1	15.3	10.1	20.1	1.1	17.6	11.5	9.8	1.3	20.4	19.9	19.1	19.3	18.7	7.5	10.1	7.1	2.4	0.5	0.7	3.5	6.4	6.6	1.4	0.5	0.8	14.3	7.8	19.4	24.4	1.8	8.6	4.0	4.5	6.5	9.9	19.3	8.3	6.8	9.3	6.7	9.9	6.6	2.2	1.9	4.9	4.1	4.7	4.4	2.8	2.3	5.7	3.4	1.8	3.5	2.5	5.6	3.7	3.8	4.5	4.4	23.1	29.4	20.2	19.1	19.4	11.4	20.6	16.5	16.9	17.0
ATG10	"APG10L, DKFZP586I0418, FLJ13954"	ENSG00000152348	"Autophagy related 10"	Q9H0Y0	5	81972025-82276857	"Predicted intracellular proteins"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044163	Approved		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA044163: "	"unprognostic (1.20e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavourable (3.22e-5)"	"unprognostic (5.60e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.30e-3)"	"unprognostic (4.43e-1)"	8.2	9.2	8.4	6.3	13.6	8.4	11.7	11.3	15.4	7.2	8.9	14.7	7.5	5.5	12.0	13.7	10.9	7.2	7.3	8.0	8.4	7.9	9.3	10.4	7.1	8.3	10.3	13.5	5.8	9.9	23.0	9.5	7.9	11.3	9.6	10.2	12.4	8.6	9.6	10.3	10.9	6.0	9.1	10.4	6.7	7.1	27.0	8.9	22.8	11.7	4.6	9.9	9.2	8.2	7.6	11.4	12.2	9.3	9.2	8.9	6.0	3.7	9.9	6.5	18.4	4.3	8.3	16.5	4.3	3.5	3.2	4.9	2.9	13.5	6.5	3.6	6.9	2.2	4.7	9.6	4.2	11.0	3.4	7.2	9.4	3.1	4.2	3.7	5.9	7.6	6.6	4.6	3.9	5.9	8.5	5.6	11.5	7.4	8.4	4.3	9.2	6.5	6.4	9.3	15.6	8.1	5.2	9.6	13.8	7.0	3.9	7.9	7.6	7.0	4.7	6.0	5.7	3.0	9.0	7.6	12.6	9.0	8.0	9.0	9.6	3.3	9.3	12.2	8.4	8.8	7.9	5.9	7.5	7.7	11.4	7.6	7.2	8.9	12.1	9.2	6.5	8.8	7.4	6.0	8.4	13.6	11.3	15.4	8.4	7.9	10.3	13.5	11.3	8.9
ATP13A3	AFURS1	ENSG00000133657	"ATPase 13A3"	Q9H7F0	3	194402672-194498364	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029471	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"				Nucleoli	"Plasma membrane, Cytosol"	"HPA029471: AB_10600784"	"unprognostic (5.07e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.94e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.57e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (1.60e-4)"	"unprognostic (2.70e-2)"	"prognostic unfavourable (1.63e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.77e-1)"	27.1	14.4	9.0	20.8	12.7	17.5	22.8	15.3	13.8	12.1	13.4	10.8	17.2	11.4	16.2	13.2	12.4	11.3	17.1	37.8	9.6	8.1	29.7	56.9	22.1	11.6	10.1	8.3	13.2	11.4	37.6	10.6	28.9	10.6	11.8	12.6	12.9	16.7	15.9	11.8	7.7	15.0	12.1	9.0	17.1	16.3	8.8	8.4	18.9	37.1	12.0	12.7	17.8	16.1	1.9	2.4	2.3	2.3	2.2	4.7	1.0	49.9	5.7	10.2	9.7	11.6	18.1	24.8	17.2	18.7	18.7	34.0	31.3	12.2	19.7	51.1	24.7	17.0	9.7	17.1	43.5	65.7	8.5	10.9	7.6	6.7	20.1	35.4	28.6	8.3	7.7	38.8	25.3	9.7	12.5	39.9	22.7	8.5	14.2	7.1	9.7	9.9	13.0	21.9	11.8	15.8	16.0	15.6	8.3	18.2	19.0	12.8	36.3	24.8	12.6	22.8	19.0	45.3	32.0	26.4	47.5	35.1	45.4	21.0	15.8	1.8	1.7	2.3	1.8	2.3	2.2	1.9	1.7	2.8	2.4	1.1	2.5	2.5	0.3	2.2	0.9	1.6	4.7	1.0	9.0	12.7	15.3	13.8	9.6	8.1	10.1	8.3	10.6	8.4
ATP6AP1L		ENSG00000205464	"ATPase H+ transporting accessory protein 1 like"	Q52LC2	5	82279462-82386977	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"MOLT-4: 15.3"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	8	"dendritic cells: 1.3;NK-cells: 1.5;T-cells: 1.2"									HPA053771	Approved		Approved	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA053771: "	"unprognostic (1.64e-1)"	"unprognostic (8.15e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.43e-2)"	1.6	1.0	2.6	0.2	2.4	0.6	0.7	2.5	2.1	1.8	1.2			0.1	1.5	0.1	1.4	2.4	1.7	2.0	2.7	1.8	0.8	1.4	1.5	0.7	2.5		4.4	2.4	0.1	2.0	0.7		1.4	0.6		2.6	2.5	3.3	5.1	0.2	0.6	2.7	0.8	1.8	3.8			1.5		0.4	0.9	0.5	0.1	1.3	0.0	0.1	1.5	1.2	0.0	0.1	0.0	0.1	1.0	0.6	0.3	0.0	0.1	0.3	0.4	0.9	0.1	0.0	0.0	0.0	0.8	0.0	0.3	2.8	0.0	1.2	0.6	0.5	0.2	0.3	2.2	0.2	0.0	2.0	1.1	0.0	2.6	0.5	0.7	1.2	0.0	0.2	15.3	0.5	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.3	0.2	0.0	0.0	0.0	0.4	0.2	0.4	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.0	1.2	0.1	0.7	1.2	0.0	1.5	0.0	1.3	0.0	0.0										
ATP6V1G1	"ATP6G, ATP6G1, ATP6GL, ATP6J, DKFZp547P234, Vma10"	ENSG00000136888	"ATPase H+ transporting V1 subunit G1"	O75348	9	114587746-114598373	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004615, HPA042898"	Supported		Approved	Nucleoplasm,Nucleoli			150000	Nucleoli	Nucleoplasm	"CAB004615: AB_2258908, HPA042898: "	"unprognostic (3.85e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.84e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.47e-3)"	"unprognostic (9.40e-3)"	"unprognostic (4.13e-2)"	"prognostic favourable (1.73e-7)"	"unprognostic (2.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.92e-2)"	34.8	66.4	41.5	36.7	38.0	56.6	56.6	37.5	49.4	45.2	34.2	23.4	42.3	26.7	43.7	91.0	57.5	32.3	39.2	45.4	40.8	52.5	84.9	65.9	45.3	50.0	52.2	39.5	49.2	55.9	39.5	79.4	77.8	44.7	65.3	33.2	49.2	63.2	45.1	54.9	40.8	33.2	31.7	35.6	66.5	52.7	58.3	25.6	51.7	65.2	53.5	53.4	45.8	40.1	99.9	81.6	96.6	67.9	50.0	85.1	121.6	17.9	17.3	35.7	8.7	29.6	21.5	33.1	28.1	22.3	23.3	16.7	23.2	21.7	17.4	24.6	20.0	40.8	26.6	21.2	19.6	13.8	18.3	16.7	21.9	33.7	41.5	37.2	31.0	27.4	57.1	18.6	23.2	22.0	32.0	37.0	31.8	39.0	35.9	23.5	42.2	32.7	34.9	22.9	27.9	47.6	30.9	26.9	34.4	37.8	66.1	99.7	53.6	44.2	29.3	19.0	15.1	29.5	31.4	49.9	97.9	30.4	24.5	22.4	26.0	78.3	67.9	96.6	46.7	63.9	57.9	99.9	65.6	56.0	50.9	94.2	85.1	67.1	87.3	50.0	65.8	81.6	76.5	121.6	41.5	38.0	37.5	49.4	40.8	52.5	52.2	39.5	44.7	25.6
ATXN1	"ATX1, D6S504E, SCA1"	ENSG00000124788	"Ataxin 1"	P54253	6	16299112-16761491	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008335, HPA070756"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA008335: AB_1845129, HPA070756: "	"unprognostic (1.01e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.54e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.74e-2)"	"unprognostic (4.51e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.67e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.29e-3)"	8.1	9.1	17.7	11.9	25.1	5.5	9.1	33.7	29.5	14.8	13.5	12.9	10.3	8.2	20.5	9.8	11.1	11.0	12.1	11.8	18.0	11.0	9.1	10.1	14.8	11.6	21.1	17.7	10.7	10.3	18.4	11.6	10.3	16.4	14.2	8.5	9.8	8.4	14.0	26.3	12.0	8.3	19.1	16.1	11.4	10.3	8.1	25.6	4.6	11.8	12.5	7.4	11.7	11.3	0.4	0.8	4.4	1.7	0.1	2.5	0.8	3.3	2.0	0.7	0.0	3.5	4.8	4.6	3.7	8.6	2.2	2.6	2.1	2.1	0.1	5.0	7.1	3.2	0.2	2.3	3.3	1.9	3.6	0.5	3.2	6.7	5.6	3.1	5.5	3.7	4.4	4.7	4.0	4.6	0.0	4.1	1.9	1.7	0.2	3.6	0.7	3.3	0.2	4.5	3.0	3.1	5.8	0.2	1.9	3.4	4.3	7.0	2.8	5.4	7.0	3.2	4.9	3.7	3.3	24.1	13.8	0.1	2.0	3.2	7.7	0.7	1.7	0.4	2.5	1.3	1.9	0.4	1.7	2.4	0.8	0.1	0.2	1.5	4.4	0.1	0.7	0.4	1.3	0.8	17.7	25.1	33.7	29.5	18.0	11.0	21.1	17.7	16.4	25.6
ATXN3	"ATX3, JOS, MJD, SCA3"	ENSG00000066427	"Ataxin 3"	P54252	14	92044496-92106625	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB021976, HPA024123, HPA069338"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"				"Nucleoplasm, Nucleoli"	"Plasma membrane"	"CAB021976: , HPA024123: AB_1845133, HPA069338: "	"unprognostic (1.06e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.03e-2)"	"unprognostic (8.94e-3)"	"unprognostic (4.22e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.11e-1)"	17.8	10.3	10.2	9.1	11.6	14.3	12.8	18.7	12.1	16.0	11.8	12.2	11.9	6.4	17.9	12.4	17.7	9.5	11.2	10.4	9.0	9.9	9.9	16.0	12.3	11.6	16.3	9.5	14.0	10.3	11.9	17.2	11.7	13.8	15.8	11.7	8.6	11.4	10.2	6.1	21.0	8.7	20.6	16.5	12.6	9.0	14.8	14.3	16.2	11.5	12.0	15.6	15.4	13.6	9.8	14.5	11.4	18.8	7.0	8.5	5.3	5.6	11.1	10.0	9.3	14.6	14.3	19.6	6.4	10.4	8.2	11.4	8.0	15.7	11.5	12.8	10.5	9.8	7.7	14.0	18.1	13.1	2.3	4.9	5.4	11.7	12.1	8.6	8.8	11.6	12.5	14.3	15.0	12.6	6.5	8.6	12.4	21.9	9.0	7.8	7.1	9.2	7.2	18.5	6.5	10.5	12.8	3.4	6.0	15.5	6.6	8.8	12.3	6.0	6.7	8.1	11.9	5.2	3.4	7.5	12.5	10.6	6.0	8.5	4.7	11.4	13.4	9.4	5.9	14.5	7.0	7.1	6.9	6.5	14.5	9.8	7.6	8.5	11.3	7.0	18.8	8.4	6.8	5.3	10.2	11.6	18.7	12.1	9.0	9.9	16.3	9.5	13.8	14.3
ATXN7L2	"FLJ00381, MGC46534"	ENSG00000162650	"Ataxin 7 like 2"	Q5T6C5	1	109483479-109492804	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029827, HPA054952"	Uncertain		Approved	Nucleoli,Vesicles,Cytosol				Nucleoli	"Vesicles, Cytosol"	"HPA029827: AB_10602390, HPA054952: "	"unprognostic (4.53e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (7.65e-4)"	"unprognostic (3.90e-2)"	"unprognostic (4.61e-5)"	"unprognostic (2.40e-4)"	"unprognostic (1.75e-1)"	"unprognostic (3.53e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.77e-4)"	"unprognostic (2.85e-2)"	"prognostic unfavourable (1.19e-8)"	"unprognostic (3.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.94e-3)"	4.2	5.2	7.5	4.0	9.2	10.2	2.6	15.2	10.9	2.8	2.8	5.1	1.2	2.7	4.4	1.8	2.8	3.3	3.8	2.0	6.5	3.3	3.4	3.0	3.4	3.8	5.7	7.0	7.3	2.4	1.6	9.9	2.5	4.7	2.2	1.4	5.7	1.8	3.2	13.3	3.5	3.1	2.0	3.1	5.4	2.9	8.8	4.8	2.7	4.2	1.0	2.6	3.2	2.4	2.4	1.3	2.4	2.4	2.7	5.6	2.2	2.2	1.7	1.2	4.5	1.6	2.9	3.2	1.6	2.1	3.4	2.2	3.6	1.5	5.8	2.6	2.0	2.5	2.4	2.2	0.4	5.3	3.4	3.2	3.6	1.6	1.0	4.8	7.6	3.1	1.2	3.5	0.0	0.8	5.3	3.3	0.6	7.0	8.4	6.3	7.0	2.5	5.9	2.9	4.1	1.2	2.3	10.6	4.3	1.7	5.7	2.6	1.0	5.0	0.3	2.4	7.0	2.2	6.4	2.1	1.4	5.5	2.8	4.0	6.0	0.0	1.9	2.4	5.4	2.4	5.0	2.3	4.3	5.6	1.3	2.4	4.0	3.8	1.9	2.7	1.6	1.0	3.8	2.2	7.5	9.2	15.2	10.9	6.5	3.3	5.7	7.0	4.7	4.8
AXIN1	PPP1R49	ENSG00000103126	"Axin 1"	O15169	16	287440-352673	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB012987	Approved		Supported	Nucleoli,Vesicles				"Nucleoli, Vesicles"		"CAB012987: AB_2533178"	"unprognostic (3.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (3.38e-5)"	"unprognostic (1.23e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.03e-1)"	10.8	8.3	13.7	18.9	17.1	28.1	21.0	26.4	13.6	10.4	15.8	12.7	9.4	17.3	12.6	8.5	14.1	10.7	12.7	11.0	11.5	7.7	9.8	9.6	13.6	13.4	15.6	10.6	13.3	17.7	11.1	11.9	8.4	13.9	11.4	10.2	9.6	13.9	9.5	17.7	16.9	17.6	18.9	9.6	15.1	15.2	9.6	14.6	17.5	12.7	7.5	14.5	11.9	22.9	1.8	1.4	5.5	1.1	3.6	10.4	2.4	9.4	13.8	7.3	12.9	5.5	5.1	15.5	6.4	5.9	8.9	7.7	20.2	11.1	14.7	9.9	6.6	13.7	11.5	10.0	4.0	14.4	18.8	9.5	11.5	14.7	9.4	10.9	10.6	5.0	17.5	9.2	11.3	5.8	23.7	8.1	4.0	25.4	11.7	7.6	16.8	8.4	22.2	6.7	20.4	6.7	5.6	16.8	10.3	12.2	13.7	20.1	9.0	13.9	6.6	8.9	9.5	10.2	9.2	9.4	9.2	18.0	4.2	7.3	8.7	1.4	1.1	5.5	10.4	0.9	9.5	1.8	3.0	7.0	0.8	1.6	3.2	4.3	3.2	3.6	0.7	1.4	3.0	2.4	13.7	17.1	26.4	13.6	11.5	7.7	15.6	10.6	13.9	14.6
B3GNT4	"B3GN-T4, beta3Gn-T4"	ENSG00000176383	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4"	Q9C0J1	12	122203543-122208952	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 16.3;skin 1: 8.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 8.0;hTCEpi: 9.7;T-47d: 7.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA055261	Uncertain		Approved	Nucleoli,Mitochondria				Mitochondria	Nucleoli	"HPA055261: "	"unprognostic (1.67e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.82e-2)"	"unprognostic (3.69e-1)"	"prognostic unfavourable (3.52e-6)"	"unprognostic (1.24e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.97e-2)"	"unprognostic (9.47e-2)"	0.7	3.2	7.3	0.8	6.8	4.6	0.8	16.3	9.1	0.5	0.7	0.5	0.0	1.0	0.6	0.7	1.8	1.1	1.1	0.8	4.9	4.0	6.1	0.6	1.1	0.9	1.5	7.3	0.8	0.8	0.8	1.9	0.8	4.0	0.7	0.6	1.0	1.7	0.7	1.1	8.5	1.0	0.6	0.6	1.0	0.7	2.0	0.3	0.0	0.8	0.3	0.8	0.6	0.5	0.8	1.0	0.8	1.7	0.4	1.9	0.4	5.4	1.0	0.3	2.1	0.2	0.1	1.0	0.1	0.0	0.3	0.6	3.4	0.4	0.5	0.9	0.0	2.0	2.6	2.1	0.1	8.0	2.8	0.2	1.5	0.3	0.6	0.7	1.1	0.7	9.7	0.1	0.4	0.0	1.5	0.6	0.2	4.8	0.0	0.7	0.6	2.0	0.4	0.6	1.0	1.4	0.6	1.3	1.7	1.5	1.0	0.5	7.5	0.1	0.1	0.5	2.8	0.5	0.3	0.6	4.9	1.2	0.5	0.8	0.3	0.8	0.4	0.2	0.8	0.1	0.4	0.8	1.3	0.2	0.2	0.5	1.9	0.2	0.5	0.4	1.7	1.0	0.6	0.4	7.3	6.8	16.3	8.1	4.9	4.0	1.5	7.3	4.0	0.3
B3GNT5	"B3GN-T5, beta3Gn-T5"	ENSG00000176597	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5"	Q9BYG0	3	183253244-183298504	"Enzymes, Predicted intracellular proteins"		"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 80.2"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 25.8;hTCEpi: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 9.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 9.0"	"Region enriched"	"Detected in single"	12	"cerebellum: 16.5"	"Low region specificity"	"Detected in many"			HPA017292	Uncertain		Approved	Nucleoli				Nucleoli		"HPA017292: AB_1845237"	"unprognostic (2.17e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.08e-2)"	"prognostic unfavourable (5.09e-4)"	"unprognostic (7.10e-3)"	"unprognostic (7.78e-2)"	"unprognostic (8.48e-2)"	"prognostic unfavourable (7.23e-6)"	"unprognostic (4.20e-1)"	"prognostic unfavourable (1.30e-7)"	"unprognostic (1.18e-2)"	"unprognostic (2.71e-1)"	"unprognostic (3.53e-2)"	"unprognostic (8.10e-3)"	8.6	1.4	2.2	6.1	2.3	31.6	4.3	1.2	2.5	6.4	29.8	5.4	2.1	17.5	3.2	5.4	23.5	5.4	10.1	3.3	3.0	2.9	3.5	3.0	11.2	5.1	4.0	0.7	4.2	3.5	1.8	5.1	19.8	4.5	3.9	9.2	3.2	8.7	2.5	6.6	8.0	80.2	2.9	6.3	2.3	5.1	2.9	2.3	1.0	4.6	18.9	8.9	5.0	10.6	0.1	1.1	9.0	1.5	0.0	0.3	0.4	16.4	1.6	8.9	5.4	7.4	22.0	8.0	0.2	0.4	1.7	1.4	3.3	8.7	0.0	1.0	0.0	7.6	9.1	25.8	1.4	0.0	5.6	0.8	0.7	0.0	9.5	8.3	4.1	10.3	31.4	1.4	23.5	16.0	9.4	0.0	14.1	0.0	0.0	2.7	3.7	14.3	2.6	4.5	0.0	5.4	4.6	0.4	8.5	4.6	0.0	1.9	0.0	10.1	23.6	0.4	3.5	0.5	4.0	0.0	0.0	0.0	3.3	19.6	8.8	0.0	1.5	1.5	0.0	0.3	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.3	0.4	2.2	2.3	1.2	2.5	3.0	2.9	4.0	0.7	4.5	2.3
B3GNTL1	B3GNT8	ENSG00000175711	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1"	Q67FW5	17	82942155-83051810	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 17.6;HL-60: 18.3;THP-1: 17.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023585, HPA024547"	Supported		Approved	Nucleoli				Nucleoli		"HPA023585: AB_2061075, HPA024547: AB_1845240"	"unprognostic (1.51e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.61e-7)"	"unprognostic (9.95e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.80e-2)"	"unprognostic (4.17e-9)"	"unprognostic (2.02e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.39e-3)"	3.7	4.3	6.5	7.2	13.9	17.7	4.0	6.4	10.7	4.7	3.6	4.2	1.7	4.7	6.3	6.1	3.7	8.3	3.9	6.2	6.9	4.7	2.9	3.4	4.4	5.6	3.8	7.1	6.6	7.6	1.7	6.1	3.9	7.1	4.6	2.8	3.7	5.6	4.5	5.0	4.4	3.3	5.1	4.4	6.6	4.9	4.0	3.7	6.9	4.4	4.8	3.3	4.3	3.8	3.7	8.8	16.9	5.7	2.4	11.2	3.3	8.1	5.4	0.1	2.6	1.5	4.9	3.4	3.0	2.6	3.4	2.7	3.2	17.6	4.0	5.8	3.6	1.5	1.3	0.0	3.0	6.1	3.6	8.4	8.0	10.9	5.5	18.3	0.3	1.7	1.5	2.1	3.4	4.1	3.6	3.8	2.7	1.8	5.1	7.0	1.3	4.0	6.7	0.6	0.3	1.9	1.7	1.7	0.6	2.5	1.9	2.5	0.0	17.6	6.8	6.7	4.5	0.9	5.2	0.8	1.9	3.0	7.4	2.4	0.9	2.6	5.7	0.9	2.7	5.0	4.1	2.8	4.3	3.0	8.8	3.7	3.8	4.6	16.9	2.4	2.5	3.5	11.2	3.3	6.5	13.9	6.4	10.7	6.9	4.7	3.8	7.1	7.1	3.7
BAHCC1	"BAHD2, KIAA1447"	ENSG00000266074	"BAH domain and coiled-coil containing 1"		17	81395475-81466332	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"brain: 22.2"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 13.3;NB-4: 45.8;REH: 14.0"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in some"	5	"eosinophil: 1.4;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	8	"dendritic cells: 1.1;granulocytes: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023386, HPA076910"	Uncertain		Approved	Nucleoli				Nucleoli		"HPA023386: AB_1859537, HPA076910: "	"unprognostic (2.04e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.05e-2)"	"prognostic favourable (7.38e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.78e-2)"	5.9	4.8	5.0	3.0	8.3	8.1	3.6	22.2	7.4	5.1	3.1	10.6	1.1	6.0	4.5	2.3	2.5	3.8	5.6	2.2	4.8		2.8	1.1	4.4	1.1	8.5	5.7	6.0	4.3	5.3	3.2	1.6	4.9	4.4	1.5	9.5	6.1	3.8	6.2	4.4	5.5	4.0	3.2	4.9	3.6	4.4	10.4	9.6	2.5	1.6	0.5	3.7	4.4	0.0	1.1	1.4	0.1	0.0	0.0	0.0	1.7	2.9	2.2	7.1	0.8	1.2	1.0	1.3	1.1	0.7	0.4	0.5	0.7	0.0	1.9	1.4	1.7	1.0	0.8	0.1	0.0	3.3	2.3	0.7	0.9	0.7	10.7	2.3	2.0	0.3	0.6	0.6	0.7	1.6	0.0	0.3	1.0	13.3	45.8	0.1	2.0	14.0	1.5	0.0	0.9	0.1	10.0	1.6	1.6	0.0	5.7	0.3	8.6	0.9	3.9	0.5	2.1	0.6	0.0	0.0	0.0	0.0	5.0	0.7	0.1	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0										
BATF2	MGC20410	ENSG00000168062	"Basic leucine zipper ATF-like transcription factor 2"	Q8N1L9	11	64987943-64997045	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 12.2;BJ hTERT+ SV40 Large T+ RasG12V: 18.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 6.6;neutrophil: 9.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 9.6;monocytes: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA062496	Approved		Approved	Nucleoli				Nucleoli		"HPA062496: "	"unprognostic (5.29e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.31e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.08e-2)"	"unprognostic (6.92e-3)"	"unprognostic (1.03e-1)"	"prognostic favourable (9.39e-5)"	"prognostic unfavourable (2.12e-4)"	"unprognostic (1.28e-1)"	"unprognostic (9.09e-3)"	"unprognostic (2.34e-3)"	"unprognostic (3.17e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.12e-2)"	2.8	5.3	2.4	8.3	3.3	0.4	3.2	1.0	3.4	2.0	8.9	1.9	7.2	8.8	2.1	2.8	2.3	2.9	9.3	2.2	1.9	1.7	10.0	5.4	7.8	2.7	2.2	2.4	3.2	17.3	0.7	3.1	3.0	5.9	7.9	6.7	4.2	14.0	5.1	4.8	0.5	14.0	2.7	2.1	18.7	5.1	0.9	1.7	0.9	16.5	1.0	3.4	3.9	1.2	1.3	0.3	9.6	6.6	0.1	0.1	0.9	1.2	0.9	0.2	0.0	0.1	0.5	0.0	0.5	5.7	12.2	18.7	1.7	5.0	0.0	2.4	0.7	0.1	0.0	1.3	0.9	0.1	0.3	1.7	0.0	4.1	4.5	0.0	1.0	0.3	0.4	1.6	2.0	2.9	3.6	0.1	0.2	0.4	0.0	0.1	0.4	0.6	0.0	1.2	0.4	1.5	0.1	0.1	0.0	0.5	0.3	5.8	0.5	0.9	2.2	0.6	0.7	1.0	0.0	0.1	0.1	0.4	1.0	0.5	0.5	0.0	2.6	1.1	0.0	6.6	0.0	1.3	0.0	0.1	0.3	0.4	0.0	0.0	9.6	0.1	3.1	0.0	0.0	0.9	2.4	3.3	1.0	3.4	1.9	1.7	2.2	2.4	5.9	1.7
BCAS3	FLJ20128	ENSG00000141376	"BCAS3, microtubule associated cell migration factor"	Q9H6U6	17	60677453-61392838	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Angiogenesis, Transcription, Transcription regulation"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 43.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052409, HPA057289"	Approved		Approved	Nucleoli				Nucleoli		"HPA052409: , HPA057289: "	"unprognostic (2.84e-2)"	"prognostic favourable (2.04e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.52e-1)"	"unprognostic (5.52e-1)"	"unprognostic (3.60e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.47e-1)"	"prognostic favourable (1.23e-5)"	"unprognostic (2.55e-1)"	"prognostic favourable (1.73e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	12.1	15.9	13.9	8.3	24.1	8.8	11.6	21.5	30.8	12.9	11.4	32.2	12.6	7.1	20.6	18.6	14.3	21.1	11.3	11.7	15.8	14.3	17.1	18.3	13.6	8.5	19.2	18.6	11.9	13.5	26.5	16.9	14.7	24.3	17.1	9.3	16.1	13.6	14.3	20.3	17.0	8.4	13.6	16.3	10.8	11.7	20.2	20.0	16.6	13.7	7.6	13.9	17.0	11.9	9.1	6.9	26.8	8.0	11.7	12.9	6.4	3.3	8.1	4.2	14.0	8.6	7.3	4.9	3.5	4.8	3.6	4.6	5.5	7.4	1.3	6.0	5.8	2.6	2.4	2.9	4.7	3.0	9.4	3.2	4.6	4.9	4.8	1.6	2.7	8.6	3.4	3.0	5.5	4.2	2.7	6.6	3.2	43.2	4.6	1.2	4.4	9.3	5.7	5.7	6.0	3.0	12.6	6.2	5.3	7.1	2.1	5.0	7.7	2.4	3.9	4.8	4.1	2.0	1.6	15.4	12.7	5.6	5.7	1.2	3.7	15.8	7.8	11.7	12.1	6.7	9.8	9.1	8.4	9.2	6.9	8.4	9.3	7.5	26.8	11.7	8.0	4.9	12.9	6.4	13.9	24.1	21.5	30.8	15.8	14.3	19.2	18.6	24.3	20.0
BCKDHB		ENSG00000083123	"Branched chain keto acid dehydrogenase E1 subunit beta"	P21953	6	80106647-80346270	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 58.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031580, HPA031956"	Approved		Supported	Nucleoli,Mitochondria	"Intracellular and membrane"			Mitochondria	Nucleoli	"HPA031580: AB_10696054, HPA031956: "	"unprognostic (4.23e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.50e-3)"	"unprognostic (9.37e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.03e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.32e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.65e-2)"	"prognostic favourable (5.54e-9)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.49e-2)"	13.9	12.0	9.9	9.0	12.2	5.8	18.1	9.5	14.3	10.2	17.3	22.7	9.4	9.1	11.6	7.7	10.2	10.9	7.4	14.7	11.9	7.6	24.7	58.6	6.4	8.1	11.3	11.2	13.9	12.1	13.7	15.5	5.5	14.1	13.1	16.5	11.7	30.5	10.3	8.2	8.6	11.8	11.5	16.7	5.3	15.0	10.0	12.4	11.2	12.5	7.9	7.7	14.0	8.2	9.1	10.3	2.6	4.3	13.4	15.7	5.2	6.9	2.6	9.9	13.2	10.0	8.8	7.9	4.9	10.3	8.1	11.2	4.2	9.6	19.7	5.3	11.8	7.0	5.5	6.5	11.5	24.5	8.1	9.7	6.8	5.7	11.2	13.9	4.4	8.4	6.8	5.6	7.0	9.7	8.2	17.7	18.2	3.8	5.0	8.1	7.3	3.4	12.8	30.7	16.8	22.6	10.6	6.6	9.3	8.4	7.0	4.9	9.0	10.7	4.1	4.9	3.4	4.5	6.6	12.6	12.3	6.5	6.0	10.4	7.3	2.6	3.4	0.8	8.5	4.0	11.1	9.1	7.2	7.2	6.6	9.1	9.6	10.0	0.7	13.4	4.3	10.3	15.7	5.2	9.9	12.2	9.5	14.3	11.9	7.6	11.3	11.2	14.1	12.4
BLCAP	BC10	ENSG00000166619	"Bladder cancer associated protein"	P62952	20	37492472-37527931	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 102.5"	"Cell line enhanced"	"Detected in all"		"RT4: 70.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA047390			Approved	Nucleoli				Nucleoli		"HPA047390: "	"unprognostic (1.05e-2)"	"unprognostic (7.91e-3)"	"unprognostic (3.52e-2)"	"prognostic unfavourable (1.40e-4)"	"unprognostic (7.08e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.51e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.91e-3)"	"unprognostic (4.91e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.96e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.37e-2)"	"prognostic favourable (7.28e-5)"	18.9	16.7	31.6	12.9	89.5	10.7	16.4	23.2	40.1	14.3	15.6	13.3	11.4	17.6	9.8	19.9	18.5	50.5	17.9	23.5	26.5	44.4	21.3	23.8	12.2	12.5	22.5	28.3	15.1	7.9	15.4	34.4	26.1	27.6	18.9	18.8	13.4	17.7	21.1	102.5	30.3	18.9	13.4	13.4	14.2	12.4	12.2	10.6	8.5	14.0	27.3	17.8	20.2	12.7	48.0	20.5	26.6	22.2	17.0	28.4	18.7	26.4	7.8	9.2	9.5	17.8	13.7	13.0	12.7	12.4	11.3	9.3	27.2	21.6	13.8	12.8	17.7	51.4	6.8	52.7	11.8	2.8	6.1	4.5	17.4	25.2	11.4	8.9	6.0	17.4	56.8	10.9	20.7	15.8	4.3	10.4	22.8	14.9	7.4	7.1	7.3	22.0	7.0	34.4	9.2	13.0	70.9	8.4	10.2	15.2	44.3	10.3	14.6	8.6	15.0	29.5	7.5	10.3	5.4	5.7	7.0	6.6	12.2	8.2	5.2	26.6	22.2	25.9	18.7	21.5	20.4	37.5	21.4	19.8	20.5	48.0	28.4	22.0	23.2	17.0	19.3	8.8	20.6	18.7	31.6	89.5	23.2	40.1	26.5	44.4	22.5	28.3	27.6	10.6
BMI1	"PCGF4, RNF51"	ENSG00000168283	"BMI1 proto-oncogene, polycomb ring finger"	P35226	10	22321211-22331484	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 87.1;U-937: 102.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB011120, HPA030471, HPA030472"	Supported		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	"Nucleoli, Cytosol"	"CAB011120: , HPA030471: , HPA030472: AB_10601090"	"unprognostic (5.44e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.24e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.76e-3)"	"unprognostic (6.93e-2)"	"prognostic unfavourable (2.60e-8)"	"unprognostic (9.43e-2)"	"unprognostic (7.95e-2)"	"unprognostic (7.84e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.44e-2)"	"unprognostic (9.73e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.91e-3)"	"unprognostic (3.41e-2)"	19.7	23.5	28.0	17.0	35.0	13.3	26.5	26.1	33.7	21.6	22.3	26.3	11.6	14.1	23.9	22.8	16.0	17.0	17.4	15.1	28.3	24.2	19.2	25.5	16.7	17.9	42.3	27.7	18.8	18.6	40.0	37.6	20.6	24.8	25.5	16.0	16.5	15.7	20.3	28.5	10.3	14.6	26.3	34.8	24.6	16.5	24.3	40.7	12.9	17.6	10.6	18.8	21.5	25.9	5.0	1.8	13.0	3.4	6.2	8.4	2.4	12.7	6.2	7.1	2.2	12.5	10.1	7.2	8.6	3.9	6.6	7.8	6.5	16.0	6.5	5.9	7.8	4.5	10.3	6.1	8.2	87.1	12.8	18.0	5.3	7.3	7.5	6.6	10.0	6.5	10.6	7.2	8.0	4.6	17.8	11.1	8.7	5.1	17.8	1.9	1.6	14.8	13.3	10.2	6.2	6.2	4.2	6.0	11.9	5.7	7.5	9.6	6.7	26.7	9.8	7.4	22.2	17.7	11.6	13.7	17.8	14.4	10.5	102.3	4.8	13.0	1.5	2.5	6.1	3.4	8.4	5.0	6.4	5.8	1.0	2.6	5.5	5.2	0.6	6.2	2.1	1.8	4.3	2.4	28.0	35.0	26.1	33.7	28.3	24.2	42.3	27.7	24.8	40.7
BMP7	OP-1	ENSG00000101144	"Bone morphogenetic protein 7"	P18075	20	57168748-57266629	"Predicted intracellular proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 37.0;thyroid gland: 44.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 41.5;MCF7: 48.0;RPMI-8226: 18.4;SK-BR-3: 31.3;U-698: 56.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"basophil: 2.4"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA057757			Approved	Nucleoplasm,Nucleoli,Vesicles	"Secreted to blood"	247500		Vesicles	"Nucleoplasm, Nucleoli"	"HPA057757: "	"unprognostic (1.67e-1)"	"unprognostic (9.72e-3)"	"unprognostic (9.67e-2)"	"prognostic unfavourable (2.91e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.78e-2)"	"unprognostic (4.63e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.82e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.59e-1)"	1.5	7.2	16.8	2.4	17.5	0.7	2.1	3.8	19.7	9.2	2.3	23.6	6.0	2.7	1.9	17.7	17.2	10.0	1.2	8.5	13.9	9.9	4.5	0.7	1.8	1.6	14.3	11.2	0.8	1.0	0.8	1.9	24.4	12.2	5.0	2.4	37.0	2.6	10.3	1.0	15.5	2.4	1.0	13.8	1.3	4.1	1.4	13.4	1.8	44.3	5.7	4.9	7.8	7.0	0.1	0.1	2.4	0.0	0.0	0.1	0.0	0.0	0.1	5.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	1.6	41.5	10.6	0.0	12.0	1.2	0.0	0.0	0.1	4.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	48.0	0.0	0.0	3.0	0.0	0.0	0.0	18.4	0.0	0.0	0.1	4.5	1.3	31.3	0.1	0.2	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	56.7	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	16.8	17.5	3.8	12.5	13.9	9.9	14.3	11.2	12.2	13.4
BMS1	"BMS1L, KIAA0187"	ENSG00000165733	"BMS1, ribosome biogenesis factor"	Q14692	10	42782801-42834937	"Disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis"		"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036589, HPA043081"	Uncertain		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA036589: AB_10601460, HPA043081: "	"unprognostic (1.46e-2)"	"unprognostic (4.31e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.25e-3)"	"prognostic unfavourable (1.06e-6)"	"unprognostic (1.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.16e-3)"	"unprognostic (7.03e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.43e-1)"	"unprognostic (4.82e-2)"	17.8	15.3	10.4	15.8	19.7	17.4	16.2	22.5	20.6	15.5	12.9	13.7	11.2	11.8	23.1	13.4	17.8	14.0	10.0	14.4	10.8	13.3	17.8	16.8	14.1	17.2	12.6	15.4	17.5	16.2	24.7	28.0	15.3	22.8	14.1	15.4	12.3	18.8	14.0	29.9	18.1	13.8	14.7	15.0	18.3	13.5	14.8	13.4	20.7	14.0	17.2	19.2	14.4	15.9	9.8	8.4	3.4	9.1	6.2	11.6	5.6	16.6	14.2	13.8	15.7	10.5	8.7	13.4	14.0	14.8	16.5	14.3	19.5	13.1	8.8	10.0	12.0	14.6	22.5	18.0	21.8	12.9	15.7	11.8	11.0	16.6	9.0	31.9	11.2	7.7	9.2	17.8	17.4	12.5	20.7	9.6	11.7	14.0	17.7	10.6	17.5	15.1	16.3	14.5	9.5	9.2	14.7	10.6	11.3	12.2	13.6	11.5	16.5	9.2	15.1	7.8	27.9	15.5	22.7	7.7	9.5	26.0	11.3	23.7	5.9	3.4	5.1	2.9	8.6	9.1	10.2	9.8	10.6	9.3	8.4	7.4	11.6	10.0	0.7	6.2	7.4	4.4	7.5	5.6	10.4	19.7	22.5	20.6	10.8	13.3	12.6	15.4	22.8	13.4
BOP1	KIAA0124	ENSG00000261236	"Block of proliferation 1"	Q14137	8	144262102-144291370	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 66.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047869, HPA066764"	Approved		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA047869: , HPA066764: "	"unprognostic (6.92e-2)"	"unprognostic (5.03e-3)"	"unprognostic (6.78e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavourable (3.35e-5)"	"unprognostic (2.25e-2)"	"unprognostic (4.14e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.00e-2)"	"prognostic unfavourable (2.23e-7)"	"unprognostic (7.83e-2)"	"unprognostic (4.33e-1)"	"unprognostic (8.49e-2)"	"unprognostic (4.06e-3)"	4.8	4.3	5.7	7.7	5.9	7.8	6.4	6.3	6.9	2.0	3.9	1.6	2.0	5.1	2.7	1.5	6.8	2.6	4.8	5.1	5.5		2.8	6.2	2.3	6.6	4.1	6.7	2.7	17.5	5.1	2.2	3.2	4.3	2.9	1.5	1.5	5.8	3.0	19.0	7.4	4.5	4.9	2.0	4.8	4.4	8.3	3.3	6.3	3.9	6.7	4.5	3.5	6.9	5.2	6.4	2.5	4.7	3.5	5.7	2.5	12.4	24.3	3.3	14.3	1.9	2.2	12.4	8.6	1.8	8.7	5.5	18.4	7.2	15.1	14.7	3.3	10.0	6.1	10.2	2.0	13.3	24.5	19.0	14.7	13.9	4.6	8.4	10.5	4.5	5.1	7.3	6.6	5.4	19.1	5.1	3.3	31.5	22.5	10.7	8.2	66.9	17.3	5.0	23.0	3.6	8.3	18.8	7.5	9.2	11.9	5.8	8.8	8.0	10.2	8.0	24.7	10.7	24.6	4.8	3.0	12.6	5.9	13.6	10.5	0.0	4.7	2.5	4.4	4.7	4.8	5.2	4.9	5.7	6.4	4.5	4.4	4.1	0.2	3.5	4.0	4.1	4.2	2.5										
BPGM		ENSG00000172331	"Bisphosphoglycerate mutase"	P07738	7	134646808-134679813	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"	"Congenital erythrocytosis, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"placenta: 184.7"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 37.1;RT4: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016493, HPA028735"	Enhanced		Approved	Nucleoplasm,Nucleoli			69000000	Nucleoli	Nucleoplasm	"HPA016493: AB_1845414, HPA028735: AB_10600791"	"unprognostic (2.56e-1)"	"prognostic favourable (7.95e-4)"	"unprognostic (3.19e-1)"	"unprognostic (3.94e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.96e-1)"	"unprognostic (7.74e-2)"	"unprognostic (4.67e-3)"	"unprognostic (7.42e-2)"	"unprognostic (5.69e-2)"	"prognostic favourable (1.54e-8)"	"unprognostic (2.18e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.78e-2)"	6.1	7.3	13.6	4.5	11.1	37.7	6.9	11.7	11.6	7.1	6.9	9.1	6.1	4.3	5.4	10.2	14.6	4.7	6.9	7.3	12.5	14.2	19.1	8.1	8.0	5.2	13.9	7.8	5.7	5.4	16.5	14.4	184.7	12.4	7.5	5.4	6.7	10.6	10.3	17.7	5.5	6.0	6.6	15.9	8.6	6.8	7.4	8.8	8.5	7.5	22.2	13.3	24.9	9.5	11.6	10.2	28.2	12.8	9.8	14.5	12.8	4.4	5.4	7.2	9.7	8.3	4.9	7.2	13.4	16.2	5.2	7.8	2.1	6.0	5.4	4.0	7.5	3.6	7.6	7.4	9.2	37.1	6.7	3.1	5.0	2.5	5.7	5.9	4.1	4.8	6.7	9.8	5.3	18.9	9.0	6.8	12.3	2.1	9.6	8.2	7.4	5.2	7.3	5.1	3.9	11.8	59.6	6.2	10.4	6.2	7.5	6.7	4.9	3.8	14.3	8.3	2.0	11.1	10.8	11.3	12.9	6.8	14.4	5.7	14.2	28.2	9.8	27.6	14.5	12.8	10.4	11.6	9.5	12.7	10.2	10.5	13.2	13.4	18.0	9.8	12.5	6.7	12.0	12.8	13.6	11.1	11.7	11.6	12.5	14.2	13.9	7.8	12.4	8.8
BRF2	"BRFU, FLJ11052, TFIIIB50"	ENSG00000104221	"BRF2, RNA polymerase III transcription initiation factor subunit"	Q9HAW0	8	37843268-37849904	"Predicted intracellular proteins"	"Stress response, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019269, HPA023378"	Supported		Supported	Nucleoli				Nucleoli		"CAB019269: , HPA023378: AB_1845446"	"unprognostic (9.85e-3)"	"unprognostic (2.74e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.35e-2)"	"unprognostic (9.68e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.41e-2)"	12.6	10.3	8.4	8.3	9.9	19.0	12.1	9.8	17.9	12.8	11.0	8.7	9.7	7.5	14.7	10.4	9.2	12.9	8.6	17.0	9.9	8.6	8.7	8.8	9.0	11.6	10.2	10.7	20.2	16.2	8.4	11.1	12.9	9.5	14.8	8.5	11.4	10.6	13.3	32.4	11.9	8.1	12.4	7.4	11.0	9.5	13.1	9.9	21.7	10.7	10.7	9.0	11.5	19.0	12.8	8.3	10.2	8.8	16.6	19.1	10.2	9.6	7.5	7.4	9.8	10.3	7.6	8.7	11.6	9.1	15.5	10.7	9.7	7.0	11.8	17.0	7.1	10.1	9.5	7.2	7.7	7.5	9.6	14.7	6.3	7.8	10.7	5.8	8.8	10.1	9.5	15.5	6.6	5.0	17.9	10.7	5.0	5.7	18.3	8.4	12.7	9.6	11.4	8.6	6.1	5.6	6.5	6.3	8.3	5.5	8.0	13.0	17.0	12.8	6.7	8.3	11.1	17.9	11.9	13.3	17.8	14.0	11.4	8.9	14.6	10.2	8.8	9.5	12.7	7.8	12.7	12.7	13.3	12.9	6.9	12.8	19.1	15.3	3.6	16.6	7.2	8.3	11.5	10.2	8.4	9.9	9.8	17.9	9.9	8.6	10.2	10.7	9.5	9.9
BRIX1	"BRIX, BXDC2, FLJ11100"	ENSG00000113460	"BRX1, biogenesis of ribosomes"	Q8TDN6	5	34915376-34925996	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039614			Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA039614: AB_10963698"	"prognostic unfavourable (2.18e-4)"	"unprognostic (2.60e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (1.10e-5)"	"unprognostic (1.82e-1)"	"unprognostic (5.85e-3)"	"prognostic unfavourable (4.11e-8)"	"unprognostic (3.37e-2)"	"unprognostic (3.84e-3)"	"prognostic favourable (6.34e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavourable (3.07e-9)"	"unprognostic (1.95e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.09e-2)"	18.9	18.4	20.4	15.6	24.0	30.6	23.7	24.9	24.1	16.4	14.4	10.7	18.9	11.9	18.1	18.2	23.4	17.6	11.9	16.4	15.8	15.2	17.0	18.6	14.0	22.2	21.1	15.6	19.4	13.4	15.6	19.1	24.5	20.9	15.9	16.5	7.7	15.7	14.5	19.7	15.9	13.3	22.9	18.6	17.0	14.7	13.4	21.9	17.0	16.6	14.2	23.1	21.6	21.7	22.9	14.0	4.1	10.4	15.0	22.1	16.2	14.7	14.5	14.9	20.5	6.5	9.2	29.4	18.2	12.9	24.6	15.7	19.8	19.5	32.5	9.4	10.8	12.3	26.0	18.8	28.0	17.4	25.7	21.7	34.9	17.7	17.8	34.5	15.0	11.1	12.2	22.7	20.5	11.3	37.9	10.0	16.0	16.0	23.9	37.8	24.0	21.4	21.5	27.0	13.9	14.1	17.2	18.0	16.1	37.7	26.4	16.9	16.5	21.3	6.7	18.9	20.7	13.6	34.8	9.0	19.2	41.3	16.4	39.7	23.5	4.1	8.5	4.0	14.4	7.9	20.4	22.9	17.7	18.1	10.7	18.0	22.1	19.6	0.5	15.0	10.4	14.0	16.4	16.2	20.4	24.0	24.9	24.1	15.8	15.2	21.1	15.6	20.9	21.9
BRWD1	"C21orf107, DCAF19, FLJ11315, N143, WDR9"	ENSG00000185658	"Bromodomain and WD repeat domain containing 1"	Q9NSI6	21	39184176-39321559	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030943, HPA030944, HPA030945, CAB034184"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoli, Cytosol"	Nucleoplasm	"CAB034184: AB_2243666, HPA030943: , HPA030944: , HPA030945: AB_10670161"	"unprognostic (6.00e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.39e-3)"	"unprognostic (4.94e-2)"	"unprognostic (5.01e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.82e-3)"	"unprognostic (5.45e-2)"	"unprognostic (2.58e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.56e-2)"	10.9	16.7	33.0	15.4	36.8	13.4	16.3	15.5	40.2	12.3	12.0	14.3	10.5	8.8	13.0	21.1	10.2	11.8	9.9	12.9	29.1	32.9	13.9	21.8	10.0	12.9	24.3	17.7	16.2	17.2	12.8	12.0	15.2	13.4	13.2	11.5	13.0	9.3	11.8	14.6	11.9	9.6	13.1	16.1	9.6	9.9	17.2	10.5	22.4	17.7	9.3	13.2	12.1	11.6	8.5	7.2	11.6	6.1	10.2	11.1	3.8	10.2	4.1	10.1	5.6	6.5	9.8	10.4	5.9	7.0	4.6	5.4	3.9	7.0	33.0	6.2	8.0	5.1	9.4	6.8	7.3	7.6	7.8	22.4	7.2	7.1	8.2	12.3	6.3	6.7	11.3	6.3	16.0	6.8	16.5	16.6	6.4	7.9	8.4	14.6	10.6	5.8	14.9	7.9	10.4	5.6	6.6	8.0	10.3	12.6	15.3	8.8	12.9	17.3	7.5	6.1	2.9	3.5	4.4	18.5	12.7	16.1	7.3	13.2	4.8	4.4	5.2	11.6	10.7	6.1	8.3	8.5	9.2	11.0	7.2	6.3	11.1	9.0	5.7	10.2	3.8	6.8	10.3	3.8	33.0	36.8	15.5	40.0	29.1	32.9	24.3	17.7	13.4	10.5
BTBD16	"C10orf87, Em:AC061711.1, FLJ25359"	ENSG00000138152	"BTB domain containing 16"	Q32M84	10	122271306-122338162	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skin 1: 9.1;testis: 27.6;urinary bladder: 17.9"	"Cell line enriched"	"Detected in some"	8	"RT4: 26.9"	"Cancer enriched"	"Detected in many"	14	"urothelial cancer: 18.4"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	29	"T-reg: 2.8"	"Lineage enriched"	"Detected in single"	29	"T-cells: 2.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA040529, HPA057638"	Uncertain		Uncertain	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA040529: , HPA057638: "	"unprognostic (1.41e-4)"	"unprognostic (1.33e-1)"	"unprognostic (5.97e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (1.50e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.12e-2)"	"unprognostic (9.44e-3)"	0.3	0.0	0.6	0.3	0.5	0.0	0.5	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.6	0.3	0.3	0.2	0.3	0.3	0.9	0.4	0.3	4.4	0.3	0.3	1.2	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.3	0.4	0.3	0.3	9.1	0.3	0.3	2.3	0.3	0.0	27.6	0.3	0.3	0.3	0.3	0.3	17.9	0.3	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.1	3.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	26.9	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.6	0.5	0.3	0.3	0.9	0.4	1.2	0.3	0.3	0.3
BUD23	"MERM1, MGC19709, MGC2022, MGC5140, PP3381, WBMT, WBSCR22"	ENSG00000071462	"BUD23, rRNA methyltransferase and ribosome maturation factor"	O43709	7	73683025-73705161	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 112.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052185	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA052185: "	"unprognostic (2.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.62e-3)"	"unprognostic (8.54e-2)"	"prognostic unfavourable (9.92e-4)"	"unprognostic (1.17e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.20e-2)"	"unprognostic (6.71e-2)"	"unprognostic (4.20e-2)"	"prognostic unfavourable (1.46e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.13e-3)"	16.6	23.4	16.3	15.0	18.8	19.6	18.3	12.3	20.6	17.5	19.3	17.9	19.5	18.3	19.1	30.6	17.5	24.1	23.1	34.2	16.0	17.5	28.1	36.3	16.1	18.3	25.3	17.5	19.3	27.9	14.3	21.8	22.1	16.4	16.5	19.8	20.3	25.1	25.6	52.2	19.3	21.6	21.2	18.7	18.7	18.9	97.0	16.5	22.1	25.8	22.6	22.7	18.7	14.8	43.9	49.0	14.4	18.3	30.1	37.6	31.4	22.1	24.4	8.9	71.0	12.4	11.0	14.9	15.3	13.8	19.8	16.2	33.9	29.9	25.9	8.1	16.5	15.9	20.6	14.9	18.3	18.1	23.9	11.3	28.6	13.6	15.6	31.5	16.5	9.9	17.1	17.4	15.8	12.7	44.4	47.9	17.1	34.9	19.8	43.3	21.4	28.1	17.7	17.5	112.7	21.9	16.0	27.1	20.4	20.5	54.6	22.6	34.4	25.3	13.7	17.1	21.8	21.5	32.7	16.6	29.0	43.4	39.2	24.1	35.7	11.5	17.1	14.4	30.7	18.3	34.3	43.9	35.5	33.6	31.5	38.0	37.6	34.4	3.2	30.1	16.2	49.0	37.3	31.4	16.3	18.8	12.3	20.6	16.0	17.5	25.3	17.5	16.4	16.5
BYSL	Enp1	ENSG00000112578	"Bystin like"	Q13895	6	41921188-41933046	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031217, HPA031219"	Enhanced		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA031217: AB_10599488, HPA031219: AB_10601989"	"unprognostic (6.12e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.33e-3)"	"unprognostic (4.38e-2)"	"unprognostic (2.73e-3)"	"prognostic unfavourable (6.43e-4)"	"unprognostic (2.09e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavourable (2.15e-8)"	"unprognostic (4.39e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.79e-3)"	"unprognostic (5.99e-2)"	11.5	13.4	6.0	11.5	7.2	6.0	17.5	5.0	8.9	7.8	7.9	4.6	5.3	4.0	11.0	5.4	11.7	9.3	10.0	17.6	5.9	6.8	8.0	18.6	7.1	7.4	5.8	6.5	11.8	15.9	10.6	5.4	11.3	7.4	8.0	6.8	4.8	9.6	7.9	31.7	9.2	5.0	12.6	6.3	9.9	7.3	8.9	4.6	20.1	7.1	11.9	12.9	7.3	10.1	4.0	9.3	0.9	3.4	4.5	5.5	2.2	12.2	15.2	8.4	11.9	6.3	7.1	17.2	12.5	6.6	19.8	14.5	21.0	3.2	22.6	11.4	9.4	8.2	25.6	18.3	15.6	8.1	27.9	21.1	10.7	23.6	10.9	15.0	9.3	9.1	11.9	18.5	16.9	13.6	26.8	5.0	13.1	20.9	15.8	15.2	6.5	16.0	18.8	11.5	14.4	11.0	10.4	16.9	10.3	8.4	7.6	14.6	8.8	13.2	10.5	11.6	13.6	7.9	18.2	5.9	7.6	49.0	3.9	15.3	12.0	0.0	3.4	0.9	3.9	3.4	5.5	3.8	2.5	3.1	5.4	4.0	1.3	3.0	0.3	4.5	3.1	9.3	3.1	2.2	6.0	7.2	5.0	8.9	5.9	6.8	5.8	6.5	7.4	4.6
C10orf67	"bA215C7.4, C10orf115, LINC01552, MGC46732"	ENSG00000179133	"Chromosome 10 open reading frame 67"	Q8IYJ2	10	23201916-23344845	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 7.3;pituitary gland: 9.0;testis: 13.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 5.2;SiHa: 8.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 4.2"	"Low lineage specificity"	"Detected in many"											"HPA038130, HPA038131"	Approved		Approved	"Nucleoplasm,Nucleoli,Nuclear speckles"				Nucleoplasm	"Nucleoli, Nuclear speckles"	"HPA038130: , HPA038131: AB_10670658"	"unprognostic (4.76e-4)"	"unprognostic (2.38e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.92e-2)"	"unprognostic (9.67e-3)"	"unprognostic (1.91e-1)"		"unprognostic (1.54e-1)"	"unprognostic (1.78e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.46e-3)"	"unprognostic (3.98e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.84e-3)"	"unprognostic (9.58e-2)"	0.1	0.1	1.3	1.7	2.6	0.2	0.0	0.1	1.9	0.3	0.5	0.4	1.3	0.5	0.2	4.6	0.1	7.3	0.2	3.2	1.6	1.4	5.0	0.5	4.0	0.3	0.9	0.5	1.8	0.3	0.4	9.0	0.1	1.2	0.1	0.0	0.2	0.1	0.1	0.6	1.9	0.4	0.0	0.7	0.2	0.1	13.8	0.6	0.0	0.6	0.7	0.1	0.1	0.1	1.1	1.1	1.0	0.5	1.1	4.2	0.0	1.5	0.1	1.9	0.2	0.0	0.5	0.4	0.2	0.1	2.0	1.6	0.1	2.4	0.2	0.2	1.5	5.2	0.2	0.7	1.6	0.5	0.4	0.1	0.7	0.3	1.0	0.1	0.0	0.6	1.7	0.6	1.0	0.0	0.2	0.7	0.0	0.3	0.1	0.5	0.9	0.1	0.1	0.2	0.4	1.7	0.3	0.9	0.4	8.4	0.3	0.1	0.3	0.3	0.2	0.4	1.5	0.4	0.1	1.0	0.2	0.1	2.5	0.2	0.1	1.0	0.5	0.6	0.7	0.3	0.6	1.1	1.5	0.8	0.1	1.0	1.1	1.0	0.8	1.1	0.3	1.1	4.2	0.0	1.3	2.6	0.1	1.9	1.6	1.4	0.9	0.5	1.2	0.6
C11orf68	"BLES03, P5326"	ENSG00000175573	"Chromosome 11 open reading frame 68"	Q9H3H3	11	65916808-65919117	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045938	Uncertain		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA045938: AB_10961633"	"unprognostic (3.18e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.88e-2)"	"unprognostic (5.98e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.50e-3)"	"prognostic favourable (5.02e-6)"	"unprognostic (2.16e-1)"	"unprognostic (3.55e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.18e-1)"	20.1	13.1	23.5	11.0	23.5	6.9	15.4	44.0	42.9	24.5	19.7	20.0	16.6	13.6	26.3	33.0	19.0	25.3	16.4	24.5	22.9	18.8	13.7	12.1	15.4	17.3	18.3	23.7	32.9	17.6	20.6	11.0	19.5	18.6	23.3	12.9	14.8	24.2	27.5	37.0	19.6	13.1	22.2	15.5	19.0	14.1	21.5	18.5	23.0	21.5	13.1	16.4	22.3	23.1	6.6	3.6	12.6	5.2	4.9	7.5	2.8	20.4	9.2	5.7	6.2	20.3	19.7	4.9	16.4	25.2	21.1	12.9	3.4	23.4	4.2	11.5	24.7	6.7	4.4	10.1	11.4	6.5	4.4	5.0	6.2	8.9	16.2	4.0	6.7	18.1	15.2	15.2	16.9	15.7	6.6	10.6	38.1	9.3	5.2	9.6	5.7	46.4	7.8	6.5	11.8	11.1	4.0	3.9	6.1	6.3	8.4	15.9	10.9	3.8	16.9	33.7	16.5	45.7	8.3	7.1	3.1	3.5	19.9	3.0	26.2	8.7	3.5	4.9	7.4	5.2	5.2	4.2	4.8	6.1	2.6	6.6	7.4	7.5	12.6	4.9	2.6	3.6	5.6	2.8	23.5	23.5	44.0	42.9	22.9	18.8	18.3	23.7	18.6	18.5
C12orf43	FLJ12448	ENSG00000157895	"Chromosome 12 open reading frame 43"	Q96C57	12	121000486-121016502	"Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046148, HPA061739"	Uncertain		Supported	"Nucleoli,Golgi apparatus"				Nucleoli	"Golgi apparatus"	"HPA046148: AB_10965169, HPA061739: "	"unprognostic (1.51e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavourable (1.29e-6)"	"prognostic unfavourable (6.44e-4)"	"unprognostic (3.53e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-3)"	"unprognostic (9.70e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.36e-1)"	10.0	8.6	12.1	7.5	12.9	7.5	8.7	15.2	19.6	7.4	10.2	8.5	3.1	5.7	11.4	5.3	7.2	11.2	5.8	8.7	8.4	8.5	7.2	12.0	7.8	9.2	8.3	11.1	14.3	8.8	9.3	6.8	8.3	13.1	7.3	6.4	8.0	10.0	8.0	7.2	6.4	5.8	10.0	7.1	7.3	7.2	7.1	6.7	7.5	7.6	4.0	8.4	9.6	6.9	16.2	10.7	5.8	13.7	11.0	19.9	13.4	9.8	22.2	11.6	9.1	10.4	8.2	12.9	12.2	12.6	20.5	13.0	15.9	9.3	18.3	12.6	11.8	11.2	13.7	18.6	12.3	21.9	15.3	14.6	9.4	11.8	12.3	19.3	11.8	9.6	9.9	18.8	11.9	11.7	17.3	4.9	10.8	16.1	21.0	15.2	20.8	16.6	19.0	13.8	13.7	12.6	14.7	15.9	10.2	16.3	7.1	13.1	19.4	9.1	11.2	11.4	13.7	9.1	12.8	8.9	12.8	14.3	14.9	11.6	16.8	3.7	10.3	5.8	16.9	13.7	15.4	16.2	16.7	16.4	10.7	13.0	19.9	16.9	1.6	11.0	11.4	8.6	15.1	13.4	12.1	12.9	15.2	19.6	8.4	8.5	8.3	11.1	13.1	6.7
C14orf39	SIX6OS1	ENSG00000179008	"Chromosome 14 open reading frame 39"	Q8N1H7	14	60396469-60515543	"Plasma proteins, Predicted intracellular proteins"	"DNA recombination, Meiosis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 16.9;salivary gland: 6.7;testis: 14.9"	"Cell line enhanced"	"Detected in some"		"HEL: 5.4;HSkMC: 4.2;MOLT-4: 20.4;RH-30: 5.6;U-2 OS: 11.5"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA059518	Uncertain		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA059518: "	"unprognostic (6.17e-2)"	"unprognostic (1.73e-3)"		"unprognostic (3.00e-6)"	"unprognostic (2.78e-1)"	"unprognostic (6.97e-2)"		"unprognostic (7.55e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.78e-1)"		"unprognostic (7.46e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.09e-1)"	1.0	2.7	0.0	0.6	0.2	0.0	0.1	0.0	0.5	0.5	0.8	0.0	0.0	0.3	0.6	0.0	0.7	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.4	1.7	0.0	0.6	16.9	0.0	0.2	1.6	0.0	1.6	6.7	0.1	3.8	0.0	0.3	0.1	0.5	0.0	0.6	14.9	0.0	0.0	0.4	1.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.7	5.4	0.0	0.0	0.0	0.0	0.3	4.2	0.0	0.7	0.0	0.0	0.0	0.0	1.8	0.0	20.4	0.2	2.7	1.3	0.0	5.6	0.0	0.3	1.5	0.1	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	1.4	0.1	0.4	0.2	0.0
C15orf61	LOC145853	ENSG00000189227	"Chromosome 15 open reading frame 61"	A6NNL5	15	67521068-67530143	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 45.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062820			Approved	Nucleoli,Vesicles,Cytosol	"Secreted - unknown location"			"Nucleoli, Vesicles"	Cytosol	"HPA062820: "	"unprognostic (1.35e-1)"	"unprognostic (9.42e-3)"	"unprognostic (2.11e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.87e-3)"	"unprognostic (8.95e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.45e-2)"	"prognostic favourable (5.31e-5)"	"unprognostic (2.42e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.32e-2)"	9.9	10.0	10.8	4.7	18.1	11.0	17.9	14.5	17.2	5.5	6.0	2.4	5.6	7.5	6.3	5.9	5.5	5.2	5.1	21.0	8.7	7.2	8.4	6.4	7.2	7.5	6.9	10.9	7.9	20.7	8.8	10.9	5.8	7.3	7.2	6.4	5.9	7.0	6.4	45.8	8.4	5.0	7.0	5.8	5.0	6.6	25.2	5.5	3.6	7.7	16.9	3.7	4.6	8.0	7.2	7.2	10.7	6.6	5.1	9.8	5.0	4.3	4.6	1.2	5.1	5.4	7.9	3.3	1.9	3.4	3.6	2.8	3.5	3.1	3.6	4.1	2.1	5.1	4.6	1.3	2.9	2.1	10.9	3.9	3.5	4.6	3.5	4.7	3.2	8.1	3.6	1.2	4.3	1.6	4.3	8.1	1.1	2.4	3.8	7.7	2.0	5.9	5.2	2.6	13.2	2.5	3.0	6.9	5.2	3.3	3.2	5.8	2.8	7.3	1.7	4.8	7.3	5.9	4.9	7.7	11.1	8.8	2.0	9.3	2.4	8.6	6.6	10.7	7.0	5.2	8.0	7.2	9.2	6.9	6.9	5.6	9.8	7.9	0.8	5.1	4.4	7.2	5.6	5.0	10.8	18.1	14.5	17.2	8.7	7.2	6.9	10.9	7.3	5.5
C16orf58	FLJ13868	ENSG00000140688	"Chromosome 16 open reading frame 58"	Q96GQ5	16	31489471-31509309	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024406	Uncertain		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles,Cytosol"				"Nucleoli, Golgi apparatus, Vesicles"	"Nucleoplasm, Cytosol"	"HPA024406: AB_1845580"	"unprognostic (1.46e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.22e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.89e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.34e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.24e-2)"	13.5	17.7	15.9	15.3	22.3	11.0	15.7	17.9	30.8	22.6	17.5	16.6	34.2	18.6	24.2	21.4	16.8	21.0	20.0	16.7	12.9	15.3	19.1	51.0	13.9	15.7	13.8	16.4	29.5	49.1	30.7	27.6	23.1	13.1	22.0	11.6	22.9	36.9	26.7	4.8	14.1	22.2	15.6	9.1	12.9	19.7	11.9	14.3	15.1	26.4	14.2	19.3	15.9	17.4	8.9	12.0	8.8	9.8	10.8	11.3	8.4	11.4	15.2	9.5	16.5	22.1	14.8	17.6	13.7	23.5	10.7	12.8	4.6	20.2	9.8	29.2	20.2	16.0	9.5	12.7	5.0	14.3	9.4	10.0	8.6	11.4	32.1	11.7	12.0	17.8	13.8	14.1	29.0	10.3	14.7	17.0	10.4	21.6	5.4	7.8	7.4	10.0	12.4	14.3	29.7	12.2	7.1	10.4	16.0	10.3	27.2	21.4	23.5	17.3	8.9	18.7	10.5	12.0	8.9	24.8	14.4	7.4	23.9	18.0	25.7	3.8	6.9	8.8	10.3	9.8	9.6	8.9	10.7	10.2	12.0	8.5	10.8	9.3	1.2	10.8	9.6	11.0	11.3	8.4	15.9	22.3	17.9	30.8	12.9	15.3	13.8	16.4	13.1	14.3
C17orf97	"LIAT1, LOC400566"	ENSG00000187624	"Chromosome 17 open reading frame 97"	Q6ZQX7	17	410327-431062	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 53.2"	"Cell line enhanced"	"Detected in many"		"HaCaT: 9.0;U-2197: 12.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 2.7"	"Low lineage specificity"	"Detected in many"											HPA023583	Approved		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA023583: AB_1853122"	"unprognostic (6.62e-2)"	"unprognostic (9.12e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.07e-3)"	"unprognostic (7.73e-2)"	"unprognostic (6.51e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.12e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.98e-3)"	"unprognostic (7.70e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.19e-2)"	2.1	4.9	6.0	2.4	10.6	1.9	2.7	5.2	8.7	3.9	3.6	4.2	4.4	2.2	3.5	4.5	2.4	13.6	6.6	3.8	5.2	6.1	7.6	1.9	3.8	2.8	4.0	7.6	3.8	3.8	3.4	8.2	1.4	6.2	3.3	2.9	4.2	3.5	5.8	4.3	2.5	4.7	1.9	2.8	2.1	2.4	53.2	2.9	5.0	6.9	1.8	1.9	3.1	1.8	0.4	0.9	2.7	0.4	0.8	1.4	0.2	2.6	3.9	1.8	2.2	1.0	0.8	0.9	2.0	1.4	1.5	1.0	0.1	4.0	0.7	1.5	4.3	9.0	4.9	1.0	1.5	0.3	0.6	1.9	3.4	0.3	3.4	0.4	0.8	1.0	2.5	3.4	0.4	1.5	0.3	0.1	1.0	2.3	6.5	3.5	2.8	1.2	0.7	0.4	2.4	6.3	2.3	0.6	2.1	2.4	3.4	0.5	2.0	2.9	1.5	1.9	0.9	12.0	0.8	0.2	0.2	0.0	2.3	0.9	1.1	0.4	0.4	2.7	0.3	0.2	0.0	0.2	0.2	0.8	0.5	0.4	1.4	1.3	0.2	0.8	0.4	0.9	0.0	0.2	6.0	10.6	5.2	8.7	5.2	6.1	4.0	7.6	6.2	2.9
C17orf98	LOC388381	ENSG00000275489	"Chromosome 17 open reading frame 98"	A8MV24	17	38835088-38841455	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 10.7"	"Cell line enriched"	"Detected in some"	6	"hTCEpi: 7.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051696	Uncertain		Approved	"Nucleoli,Intermediate filaments"				"Intermediate filaments"	Nucleoli	"HPA051696: "	"unprognostic (2.30e-1)"			"unprognostic (3.25e-4)"	"unprognostic (1.46e-1)"					"unprognostic (3.01e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.14e-2)"	"unprognostic (8.69e-3)"	"unprognostic (2.56e-1)"	"unprognostic (7.58e-2)"	"unprognostic (9.02e-2)"		0.1	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.2	0.0	0.0		0.0	0.0	10.7			0.0		0.0	0.0		1.3	0.5	0.4	0.4	0.2	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.2	0.0	0.2	0.2	0.3	0.0	0.0	7.7	0.1	0.0	0.1	0.1	0.0	0.0	0.5	0.0	1.2	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	1.1	0.0	1.0	0.5	0.0	1.3	0.3	0.5	0.0	0.2	0.2	0.5	0.7	0.0										
C18orf21	"HsT3108, PNAS-124, PNAS-131"	ENSG00000141428	"Chromosome 18 open reading frame 21"	Q32NC0	18	35972083-35979286	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA065505, HPA067322"	Uncertain		Approved	"Nucleoli,Plasma membrane"				"Nucleoli, Plasma membrane"		"HPA065505: , HPA067322: "	"unprognostic (7.31e-2)"	"unprognostic (2.14e-3)"	"unprognostic (9.88e-2)"	"unprognostic (8.66e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (1.38e-6)"	"unprognostic (2.53e-3)"	"unprognostic (1.83e-2)"	"prognostic favourable (1.81e-6)"	"unprognostic (2.88e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.21e-2)"	"unprognostic (5.15e-3)"	"unprognostic (2.35e-3)"	"unprognostic (5.97e-2)"	14.1	16.1	13.4	16.7	12.5	53.0	18.4	23.1	25.8	13.0	12.8	7.9	17.6	15.2	15.0	17.7	15.0	12.9	11.7	15.2	12.4	12.5	14.0	14.5	11.3	17.1	11.7	14.7	16.4	22.0	12.9	16.9	14.8	13.0	13.4	12.3	8.1	16.5	17.8	28.7	13.6	14.1	15.8	10.6	17.2	16.7	28.7	11.7	22.9	14.8	21.4	15.7	17.8	14.8	18.5	15.1	40.6	16.5	16.5	21.7	10.6	13.3	9.0	19.7	13.6	12.7	19.2	13.3	18.3	17.4	22.0	22.4	7.7	9.1	10.7	19.6	13.4	13.6	13.7	14.1	24.4	16.1	14.0	11.1	10.8	17.2	18.3	33.8	13.9	18.6	22.9	19.4	19.7	17.9	18.0	17.3	14.4	14.8	22.3	23.4	16.5	9.9	15.1	16.8	20.7	14.9	14.6	12.6	18.9	12.2	9.8	29.2	14.3	15.3	12.7	21.7	10.4	8.0	16.1	24.3	21.5	23.4	11.1	17.6	11.4	40.6	16.5	18.3	14.6	16.5	14.6	18.5	15.9	13.7	15.1	16.1	12.3	16.0	14.9	16.5	15.3	14.6	21.7	10.6	13.4	12.5	23.1	25.8	12.4	12.5	11.7	14.7	13.0	11.7
C19orf53	"HSPC023, LYDG10"	ENSG00000104979	"Chromosome 19 open reading frame 53"	Q9UNZ5	19	13774168-13778462	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059928, HPA061291"	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA059928: , HPA061291: "	"unprognostic (3.94e-2)"	"unprognostic (2.70e-3)"	"unprognostic (6.53e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.93e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.60e-3)"	"unprognostic (5.21e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.85e-2)"	37.3	41.5	55.6	31.1	53.7	42.1	33.1	22.0	41.7	40.4	35.7	27.0	34.2	28.0	33.9	55.6	43.1	44.0	39.3	67.0	46.2	44.8	42.8	68.4	35.5	42.4	47.2	34.7	49.9	46.9	27.4	41.8	27.2	37.3	39.2	26.4	30.1	45.9	35.7	90.7	31.5	29.2	39.6	37.0	34.8	31.3	34.1	30.0	59.6	53.5	47.7	41.6	43.1	43.1	67.9	63.0	57.3	49.6	36.3	75.8	92.4	34.8	49.7	24.8	20.6	35.2	39.9	16.4	32.9	29.2	40.9	40.8	46.1	17.1	18.6	41.0	39.7	18.7	22.9	49.6	21.2	22.2	72.3	17.4	53.8	50.0	36.4	27.2	23.1	48.6	35.9	37.8	21.4	35.0	26.9	32.1	31.8	78.5	38.4	28.3	31.6	88.2	21.1	18.9	32.1	36.3	43.2	22.6	27.3	23.0	27.3	33.3	24.8	28.0	23.3	46.5	18.6	49.7	45.0	35.9	45.6	27.8	28.3	31.0	25.1	48.1	48.8	57.3	49.0	49.6	55.5	67.9	63.4	57.0	44.2	63.3	75.8	68.0	23.7	36.3	43.1	63.0	69.4	92.4	55.6	53.7	22.0	41.7	46.2	44.8	47.2	34.7	37.3	30.0
C1D	"LRP1, Rrp47, SUN-CoR, SUNCOR"	ENSG00000197223	"C1D nuclear receptor corepressor"	Q13901	2	68041130-68110948	"Predicted intracellular proteins"	"Apoptosis, rRNA processing, Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA037413, HPA037588"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA037413: , HPA037588: AB_10672907"	"unprognostic (1.84e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.71e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.49e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.24e-3)"	"unprognostic (6.18e-2)"	"unprognostic (2.50e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.01e-1)"	17.1	20.1	15.9	13.3	17.9	31.5	17.2	13.9	26.5	15.4	16.3	12.4	15.4	14.7	14.9	14.6	13.8	13.9	12.4	15.8	14.9	15.6	28.4	29.8	14.4	21.0	14.8	16.8	14.9	27.3	12.5	25.3	18.6	17.0	14.8	13.9	8.6	13.5	14.0	29.4	11.7	19.2	12.2	17.2	16.4	15.1	13.8	18.6	17.4	18.0	16.4	14.7	13.2	20.0	20.0	16.1	32.1	19.6	22.6	19.7	9.4	21.4	12.1	15.1	12.6	15.3	19.4	20.1	27.9	19.3	19.6	16.2	21.0	24.2	27.2	17.0	18.7	10.6	17.8	13.0	30.6	28.9	21.4	31.9	10.2	24.1	15.5	39.5	33.9	16.0	21.9	14.7	14.1	15.0	25.3	23.7	18.0	10.9	26.2	34.2	16.2	15.0	16.6	18.0	21.4	17.7	15.6	13.2	15.1	10.2	17.8	27.6	13.0	26.8	16.6	16.9	19.5	20.6	24.5	22.8	25.3	34.3	21.6	24.6	19.2	28.1	14.3	32.1	15.9	18.5	18.7	20.0	18.0	13.2	16.1	17.2	19.6	19.7	29.0	22.6	19.6	15.0	19.0	9.4	15.9	17.9	13.9	26.5	14.9	15.6	14.8	16.8	17.0	18.6
C1orf109	FLJ20508	ENSG00000116922	"Chromosome 1 open reading frame 109"	Q9NX04	1	37681570-37692249	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027110, HPA027127"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol				Cytosol	"Nucleoplasm, Nucleoli"	"HPA027110: AB_10611813, HPA027127: AB_1845628"	"unprognostic (1.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.71e-2)"	"unprognostic (7.13e-3)"	"prognostic unfavourable (1.76e-7)"	"unprognostic (1.93e-1)"	"unprognostic (1.48e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.79e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.96e-3)"	"unprognostic (1.69e-1)"	13.8	15.1	12.0	9.3	15.0	9.3	14.5	17.9	20.5	12.9	11.1	11.4	16.2	11.0	15.9	14.3	13.7	13.9	10.5	11.1	13.1	12.9	12.8	12.0	8.8	14.1	13.6	15.0	19.7	19.6	20.5	10.9	14.6	15.9	15.0	7.8	12.9	20.3	14.8	15.2	14.9	8.5	11.6	9.9	10.1	11.1	11.2	12.2	13.1	15.7	9.1	12.6	13.7	12.8	11.4	27.5	3.3	5.0	12.2	16.2	7.5	8.2	9.5	8.2	13.4	7.2	5.2	18.7	9.9	7.1	15.0	11.1	14.4	10.0	11.7	12.0	4.3	12.0	15.1	10.1	15.4	18.7	17.0	13.4	9.6	9.0	13.9	14.5	8.8	7.0	12.5	14.8	19.3	7.5	26.2	14.3	8.5	5.7	14.1	6.4	25.6	18.3	14.0	17.2	32.2	7.9	7.1	24.8	11.9	8.7	13.5	20.1	7.6	6.6	5.0	15.1	9.5	12.1	20.1	11.7	13.0	24.0	7.5	14.3	15.8	1.7	5.0	3.3	10.3	3.9	16.1	11.4	12.4	9.9	5.9	10.3	16.2	13.8	0.9	12.2	4.2	27.5	6.2	7.5	12.0	15.0	17.9	20.5	13.1	12.9	13.6	15.0	15.9	12.2
C1orf210	"MGC52423, TEMP"	ENSG00000253313	"Chromosome 1 open reading frame 210"	Q8IVY1	1	43281883-43285617	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 64.0"	"Cell line enhanced"	"Detected in some"		"A-431: 7.9;BEWO: 8.8;CACO-2: 8.2;CAPAN-2: 26.6;SK-BR-3: 9.3;T-47d: 10.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"basophil: 5.4"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 5.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA013788	Uncertain		Uncertain	Nucleoli				Nucleoli		"HPA013788: AB_1845637"	"unprognostic (1.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.01e-2)"	"prognostic favourable (0.00e+0)"	"unprognostic (7.57e-3)"	"unprognostic (3.94e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.61e-2)"	0.3	0.1	0.3	6.5	0.3	0.0	7.4	0.3	0.3	3.9	28.6	0.4	7.4	20.6	1.0	10.9	11.2	2.6	20.7	0.3	0.3	0.1	25.2	3.3	13.5	0.3	0.3	0.3	1.0	29.8	3.0	9.6	6.1	0.4	4.4	14.4	0.4	25.8	7.2	0.3	10.6	64.0	0.5	0.3	0.3	14.6	1.1	0.3	1.0	32.1	7.8	7.7	3.4	5.2	0.1	0.3	5.4	0.3	0.4	0.2	0.0	7.9	0.0	0.0	0.1	0.0	0.0	8.8	0.0	0.0	0.0	0.0	8.2	26.6	0.0	0.2	0.0	6.0	0.0	3.7	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.1	0.0	5.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.7	5.1	3.2	0.2	0.0	9.3	0.0	10.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.2	0.3	0.4	0.3	0.2	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.1	0.3	0.3	0.4	0.3
C22orf46	"CTA-216E10.6, FLJ23584"	ENSG00000184208	"Chromosome 22 open reading frame 46"	C9J442	22	41688939-41698136	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 19.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			HPA052741	Uncertain		Approved	Nucleoplasm,Nucleoli	"Secreted - unknown location"			Nucleoplasm	Nucleoli	"HPA052741: "	"unprognostic (3.76e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.45e-2)"	"prognostic favourable (4.70e-4)"	"unprognostic (1.56e-1)"	"unprognostic (6.02e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.38e-2)"	"unprognostic (3.32e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.62e-1)"	3.9	2.0	8.1	3.1	6.8	1.0	3.9	2.2	5.7	2.7	2.4			2.3	3.1	4.5	1.7	2.4	2.7	4.8	8.7	7.5	2.7	2.3	2.2	3.1	12.8		5.2	1.4	8.3	3.5	2.1		3.3	2.8		2.8	3.0	3.3	3.3	2.6	2.9	19.8	2.8	2.4	6.2			3.5		3.1	2.2	1.5	1.1	0.4	0.1	2.6	3.5	1.2	0.7	8.7	4.5	11.0	6.7	8.1	8.6	9.9	7.4	8.0	6.3	8.5	4.5	5.7	5.5	5.4	6.1	4.1	5.6	5.7	7.6	19.5	5.3	6.0	9.3	3.7	4.7	4.4	11.9	6.8	7.7	10.5	7.5	1.6	9.8	8.1	5.5	14.4	3.5	5.4	4.5	3.5	5.1	9.1	6.0	5.4	6.0	2.7	4.2	8.6	7.8	11.1	9.0	5.5	4.3	8.3	14.2	4.4	3.9	17.3	17.6	5.1	5.0	5.4	11.2	0.1	0.5	0.0	0.7	0.4	0.9	1.1	1.1	1.1	0.2	0.5	0.9	1.2	0.1	3.5	2.6	0.4	0.7	0.7										
C2CD2L	"KIAA0285, TMEM24"	ENSG00000172375	"C2CD2 like"	O14523	11	119102198-119118544	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 33.1"	"Cell line enhanced"	"Detected in all"		"HMC-1: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011044	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol"				"Nucleoplasm, Nucleoli"	"Nuclear membrane, Cytosol"	"HPA011044: "	"unprognostic (3.43e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.03e-3)"	"prognostic favourable (4.92e-4)"	"unprognostic (3.18e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.25e-3)"	"unprognostic (3.37e-3)"	"unprognostic (5.28e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.99e-3)"	"unprognostic (8.19e-2)"	"prognostic unfavourable (1.75e-4)"	"unprognostic (8.02e-2)"	"unprognostic (8.32e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.60e-1)"	5.2	7.0	15.9	7.3	33.1	14.7	4.8	18.2	31.2	5.8	10.3	7.5	8.3	18.7	4.1	6.1	9.4	10.9	6.3	7.9	15.8	13.6	6.3	7.3	8.3	8.5	9.1	12.6	3.9	7.5	7.8	14.2	4.8	11.7	4.8	8.8	5.6	8.7	7.0	8.3	12.5	19.4	6.1	7.3	9.2	5.5	2.6	9.1	7.0	5.5	6.7	6.6	6.6	5.3	0.4	1.1	5.7	4.2	1.7	1.6	1.1	3.3	2.5	3.5	7.1	4.5	1.9	2.2	5.1	4.5	5.1	4.3	4.0	3.5	5.1	13.4	3.5	7.6	4.3	2.2	2.0	8.0	3.6	20.0	3.2	2.9	6.0	5.7	29.2	2.2	4.5	9.5	3.5	3.2	8.3	9.1	4.7	8.9	6.4	13.8	1.3	6.8	4.1	3.1	5.8	5.0	2.1	10.7	6.1	2.1	11.5	3.2	20.2	7.7	3.8	4.7	1.6	5.6	8.9	4.0	2.4	2.0	2.9	9.9	5.2	1.1	3.0	5.7	0.6	3.2	1.0	0.4	1.4	1.4	1.1	0.1	1.6	0.8	1.0	1.7	4.2	0.7	1.6	1.1	15.9	33.1	18.2	31.2	15.8	13.6	9.1	12.6	11.7	9.1
C2orf68		ENSG00000168887	"Chromosome 2 open reading frame 68"	Q2NKX9	2	85606654-85612066	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051143	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria"				"Nucleoplasm, Nuclear membrane, Mitochondria"	Nucleoli	"HPA051143: "	"unprognostic (1.71e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.07e-2)"	"prognostic unfavourable (1.12e-6)"	"unprognostic (9.34e-2)"	"unprognostic (2.16e-1)"	"prognostic unfavourable (6.76e-6)"	"unprognostic (4.24e-3)"	"unprognostic (8.41e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavourable (1.11e-6)"	"unprognostic (1.18e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.70e-2)"	"unprognostic (8.81e-3)"	10.7	9.8	7.0	17.4	12.3	11.5	16.5	16.6	9.9	16.5	15.2	17.2	17.7	13.1	17.1	15.0	13.6	14.3	16.2	13.7	7.7	6.6	13.5	16.8	17.5	15.6	16.1	7.2	22.2	25.4	13.3	14.6	21.8	11.4	16.5	14.1	10.8	20.6	20.6	23.3	18.6	18.5	14.8	10.9	17.5	13.4	15.1	12.3	37.1	17.2	20.4	17.6	15.2	17.0	15.4	16.5	36.1	22.7	19.2	20.1	9.5	8.5	8.0	13.1	9.9	13.5	6.7	8.9	3.9	5.2	6.5	8.8	7.1	10.4	11.6	6.0	7.2	9.5	7.2	7.9	7.1	6.1	15.0	19.9	11.7	7.4	11.1	10.7	10.5	10.2	9.1	4.9	13.1	10.7	10.0	13.1	6.3	9.7	12.1	10.4	6.2	6.9	13.6	25.0	11.4	8.4	9.1	16.8	12.1	6.1	8.1	7.9	9.2	5.4	6.3	4.7	13.1	5.3	3.7	16.9	11.8	10.8	7.0	10.8	5.7	18.0	22.7	36.1	15.4	15.0	14.5	10.9	14.7	14.5	16.5	15.4	20.1	18.7	36.1	19.2	16.9	10.6	11.9	9.5	7.0	12.3	16.6	9.9	7.7	6.6	16.1	7.2	11.4	12.3
C7orf26	MGC2718	ENSG00000146576	"Chromosome 7 open reading frame 26"	Q96N11	7	6590017-6608726	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042899, HPA052175"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol"				Nucleoplasm	"Nucleoli, Intermediate filaments, Cytosol"	"HPA042899: , HPA052175: "	"unprognostic (4.85e-2)"	"unprognostic (6.87e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.22e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"prognostic favourable (6.95e-5)"	"unprognostic (4.72e-2)"	"unprognostic (2.26e-3)"	"unprognostic (4.41e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.55e-1)"	19.8	17.1	13.4	21.7	17.7	29.2	20.0	20.6	26.9	19.0	17.9	21.1	21.5	19.4	23.0	15.4	14.7	19.9	15.6	12.8	14.4	14.1	15.4	18.4	19.3	24.1	18.8	20.2	20.6	23.9	17.2	16.6	14.0	15.4	21.1	11.5	16.4	21.2	16.6	18.7	21.9	16.4	19.6	13.1	27.3	18.6	16.8	16.1	31.7	18.3	18.5	20.6	17.6	19.6	4.2	6.4	4.6	3.4	3.3	6.1	1.9	11.1	9.3	6.5	15.4	10.7	6.0	8.6	6.7	5.9	9.7	6.0	8.7	4.7	13.2	8.8	4.9	12.4	8.7	6.1	4.4	5.1	12.5	4.9	5.8	9.1	12.6	11.7	15.9	6.9	9.3	5.8	6.1	10.5	12.9	10.1	5.7	18.7	10.2	24.3	13.0	12.5	20.9	5.2	11.2	6.3	9.8	8.6	15.9	6.5	21.6	9.0	9.8	17.7	7.5	8.1	26.5	8.8	14.6	12.3	12.0	12.2	5.4	13.1	23.8	1.1	3.4	4.6	4.7	3.3	6.1	4.1	5.7	6.0	2.6	4.2	5.9	4.9	3.4	3.3	3.3	6.4	5.4	1.9	13.4	17.7	20.6	26.9	14.4	14.1	18.8	20.2	15.4	16.1
C7orf50	"MGC11257, YCR016W"	ENSG00000146540	"Chromosome 7 open reading frame 50"	Q9BRJ6	7	996986-1138260	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052281	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA052281: "	"unprognostic (1.64e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.57e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	"prognostic favourable (6.20e-6)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.33e-2)"	22.5	14.2	37.7	14.9	29.4	9.7	14.9	16.4	32.8	17.0	17.5	15.5	19.4	12.8	20.1	18.8	14.8	21.0	20.3	28.7	28.1	21.4	21.7	14.2	16.1	21.2	22.4	23.0	21.6	79.5	12.3	39.3	13.9	17.3	21.7	7.9	25.9	25.1	28.8	68.4	8.2	13.8	34.5	19.1	19.5	25.1	19.5	9.8	6.0	20.8	18.0	16.6	17.2	10.9	32.3	41.5	76.3	27.0	8.1	20.6	22.7	41.1	26.4	8.8	26.8	4.8	6.8	18.6	18.5	9.1	16.5	14.0	18.6	17.7	12.3	12.2	11.9	26.1	10.6	22.3	3.3	11.7	21.3	11.3	18.7	25.2	19.5	14.4	7.8	9.7	17.9	15.3	14.1	11.2	20.0	11.9	7.3	59.4	6.6	38.4	21.6	39.2	19.6	3.3	20.4	7.7	11.4	20.3	29.2	15.2	18.0	24.9	43.3	26.4	12.9	9.6	42.7	28.5	24.2	10.1	13.6	11.2	19.3	23.9	30.2	3.2	27.0	76.3	20.6	26.2	14.6	23.6	16.9	17.4	41.5	32.3	13.2	15.3	3.0	8.1	25.0	12.0	19.7	22.7	37.7	29.4	16.4	32.8	28.1	21.4	22.4	23.0	17.3	9.8
C8orf34	"vest-1, VEST1"	ENSG00000165084	"Chromosome 8 open reading frame 34"	Q49A92	8	68330722-68819022	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 15.3;parathyroid gland: 19.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.4;HEK 293: 5.7;LHCN-M2: 4.9;RH-30: 5.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044420, HPA053065"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus"				"Nucleoplasm, Nucleoli"	"Golgi apparatus"	"HPA044420: AB_10963791, HPA053065: "	"unprognostic (1.75e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.59e-3)"	"unprognostic (3.07e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.55e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.80e-4)"	"unprognostic (5.21e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.84e-4)"	"unprognostic (1.33e-1)"	4.2	0.9	7.4	0.8	10.6	1.1	1.5	9.6	8.4	4.0	0.7	9.6	0.2	0.7	1.5	2.5	2.1	15.3	3.2	1.6	8.9	7.0	1.0	0.7	8.3	0.8	3.7	5.0	1.4	2.1	19.9	2.7	0.9	10.4	3.9	0.9	3.5	1.4	2.2	0.9	1.8	0.8	1.7	3.2	0.8	1.7	1.4	6.7	0.0	1.0	1.1	0.7	1.2	1.1	1.8	2.0	2.9	0.7	1.3	1.8	0.5	0.3	0.0	0.8	0.4	1.2	2.2	0.2	1.4	4.4	0.7	0.6	0.3	0.4	0.2	0.9	1.2	0.3	0.3	0.8	0.2	0.1	5.7	0.7	1.0	0.4	0.2	0.1	0.5	0.1	0.6	0.8	1.5	0.1	0.3	1.0	4.9	0.6	0.1	0.5	2.5	0.1	0.2	5.3	0.1	0.6	0.4	1.1	0.1	0.3	0.3	0.0	2.5	0.2	0.1	1.0	0.6	3.3	0.2	0.8	0.0	0.1	0.4	0.3	0.8	2.1	0.7	1.2	1.4	0.3	1.1	1.0	1.2	1.1	0.3	1.8	1.5	1.8	2.9	1.3	0.5	2.0	0.8	0.5	7.4	10.6	9.6	8.4	8.9	7.0	3.7	5.0	10.4	6.7
C8orf59		ENSG00000176731	"Chromosome 8 open reading frame 59"	Q8N0T1	8	85214076-85220421	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044805, HPA071903"			Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA044805: , HPA071903: "	"unprognostic (1.61e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.51e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.82e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (2.03e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.84e-3)"	28.1	28.2	25.3	25.3	21.9	33.0	46.1	18.9	26.5	33.0	38.4	12.6	36.3	28.1	32.0	45.5	44.8	28.7	25.8	41.5	20.6	24.1	32.3	47.1	20.8	30.7	26.3	27.2	45.1	35.1	19.5	36.0	27.7	24.4	35.5	27.7	14.7	37.8	36.2	43.9	24.8	37.1	33.7	27.0	32.2	36.9	16.7	25.7	39.1	43.5	53.6	32.0	39.1	35.2	33.3	42.7	21.3	25.3	36.5	38.0	23.9	43.6	22.3	33.1	21.5	20.6	39.9	25.9	29.0	27.9	34.0	33.6	25.9	37.8	10.9	24.1	19.2	30.4	23.0	31.9	38.4	30.7	25.1	64.4	21.1	38.3	24.4	24.2	29.2	33.8	37.9	21.9	27.8	28.8	28.9	26.8	28.2	34.4	53.3	45.5	9.5	38.9	22.8	27.7	49.5	33.0	28.0	11.2	24.0	22.0	36.2	40.0	41.8	36.1	22.0	21.7	45.5	24.0	27.5	31.3	36.6	51.2	43.3	31.0	24.1	21.3	20.5	13.4	24.7	25.3	29.5	33.3	32.7	30.1	34.8	29.9	38.0	36.3	5.1	36.5	21.5	42.7	32.1	23.9	25.3	21.9	18.9	26.5	20.6	24.1	26.3	27.2	24.4	25.7
C9orf85	MGC61599	ENSG00000155621	"Chromosome 9 open reading frame 85"	Q96MD7	9	71911510-71986054	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050767, HPA076627"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"				"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA050767: , HPA076627: "	"unprognostic (7.81e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.60e-2)"	"unprognostic (4.02e-1)"	"unprognostic (6.18e-2)"	13.4	12.7	15.5	10.1	26.0	8.9	14.7	11.2	18.8	12.8	12.9	18.2	15.0	19.3	14.1	14.3	18.4	11.6	12.0	10.5	14.9	13.8	12.3	13.1	10.4	13.0	24.5	13.3	16.9	14.7	9.8	16.9	13.9	15.2	13.1	13.7	14.3	14.7	9.8	14.6	18.4	16.3	15.2	21.1	10.7	11.2	9.2	21.9	14.5	14.8	15.9	12.9	18.8	15.5	11.3	13.1	16.1	9.9	17.1	14.6	9.3	7.6	5.1	9.0	7.3	9.4	17.1	9.1	9.9	15.3	7.9	7.8	1.1	4.6	12.5	5.0	8.5	14.0	9.4	9.3	11.0	8.8	4.6	7.6	7.4	6.3	10.1	11.2	6.3	13.8	12.8	8.0	17.5	9.7	9.0	8.4	10.1	3.9	13.5	7.9	8.4	12.4	8.0	15.5	0.3	11.3	11.1	7.4	9.8	4.9	12.5	16.2	4.4	6.5	8.5	7.3	9.4	16.7	7.2	8.5	13.9	5.7	10.0	8.6	4.8	16.1	8.9	12.6	13.4	9.9	13.7	10.9	11.5	11.5	9.3	11.3	14.0	14.6	9.9	17.1	8.3	13.1	10.5	9.3	15.5	26.0	11.2	18.8	14.9	13.8	24.5	13.3	15.2	21.9
CA13	"CAXIII, FLJ37995, MGC59868"	ENSG00000185015	"Carbonic anhydrase 13"	Q8N1Q1	8	85220587-85284073	"Enzymes, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 56.7"	"Cell line enhanced"	"Detected in many"		"HEL: 16.1;RPTEC TERT1: 8.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA024689, CAB025567"	Enhanced		Uncertain	Nucleoplasm,Nucleoli,Vesicles			100000	Nucleoli	"Nucleoplasm, Vesicles"	"CAB025567: , HPA024689: AB_1846004"	"unprognostic (1.12e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.16e-5)"	"unprognostic (2.21e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.39e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.13e-1)"	"prognostic favourable (9.40e-4)"	"unprognostic (7.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.00e-1)"	2.6	2.6	2.0	1.9	3.1	0.5	2.9	2.4	2.4	3.2	18.2	0.8	0.0	14.2	1.8	1.7	6.7	1.4	25.6	5.8	1.6	1.9	10.4	17.1	9.5	2.4	2.0	0.1	2.2	1.6	9.3	6.5	1.0	5.7	2.6	3.7	1.9	7.0	1.0	1.9	7.1	56.7	1.9	5.2	2.2	7.0	0.9	0.9	0.4	10.3	3.9	5.6	2.9	5.2	0.8	2.1	3.2	2.5	0.5	0.5	1.0	0.3	0.4	0.9	0.1	0.6	0.7	0.4	1.1	1.1	0.1	3.1	7.5	5.8	0.4	0.5	1.3	2.4	2.3	3.0	0.2	1.6	1.0	16.1	2.1	6.9	1.6	0.2	0.7	2.4	0.5	0.2	1.3	1.7	4.1	3.2	2.7	0.1	0.3	0.2	0.5	0.5	0.2	2.4	0.2	8.7	0.3	0.3	0.1	0.5	0.0	1.6	0.6	0.8	1.6	3.0	4.3	0.1	1.6	1.3	0.6	2.0	6.3	2.3	2.8	3.2	2.5	1.3	0.4	0.7	0.2	0.2	0.2	0.1	2.1	0.8	0.3	0.5	0.9	0.5	0.8	0.9	0.1	1.0	2.0	3.1	2.4	2.4	1.6	1.9	2.0	0.1	5.7	0.9
CACHD1	"KIAA1573, VWCD1"	ENSG00000158966	"Cache domain containing 1"		1	64470792-64693058	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 21.6;NTERA-2: 29.6;U-2197: 15.2"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in some"	11	"naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017202	Uncertain		Uncertain	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA017202: AB_1852423"	"unprognostic (2.92e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.32e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.89e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.13e-1)"	5.4	7.6	6.5	0.5	8.4	0.0	4.7	1.2	4.3	7.3	0.8			0.2	6.1	5.2	1.6	8.5	2.1	1.2	3.5	4.2	3.3	0.4	4.7	0.4	2.3		14.2	3.7	5.5	4.5	5.5		4.0	1.0		4.4	4.3	0.8	3.0	0.9	5.3	0.6	1.7	3.3	0.5			2.4		0.2	2.1	4.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.9	21.6	3.2	8.6	3.0	0.0	3.0	4.0	5.1	4.9	12.5	0.1	0.0	8.9	4.9	1.6	12.0	2.5	5.2	2.3	6.5	4.5	1.3	0.0	0.0	1.9	0.0	2.6	1.8	0.6	3.3	2.8	0.0	0.0	0.0	0.3	0.3	0.0	29.6	2.2	2.3	2.2	0.0	0.0	0.6	0.5	11.3	6.6	0.0	2.6	0.8	0.3	1.9	0.5	3.8	15.2	2.7	0.0	0.0	0.0	0.4	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0										
CAMLG	"CAML, GET2"	ENSG00000164615	"Calcium modulating ligand"	P49069	5	134738501-134752160	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052636, HPA056472"	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles				Vesicles	"Nucleoplasm, Nucleoli"	"HPA052636: , HPA056472: "	"unprognostic (9.23e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.68e-2)"	"unprognostic (5.41e-3)"	"unprognostic (3.07e-1)"	"unprognostic (8.54e-2)"	"unprognostic (5.34e-3)"	"unprognostic (4.58e-2)"	"prognostic unfavourable (1.09e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.16e-1)"	24.2	29.0	37.6	14.3	32.4	22.7	29.3	28.2	39.3	33.3	32.7	15.5	20.2	26.1	31.7	45.2	21.4	23.0	21.8	22.3	32.4	38.3	20.1	19.7	18.9	18.4	36.2	22.7	53.0	25.7	14.8	21.9	14.0	22.4	27.5	14.3	21.7	15.9	26.2	32.5	19.7	22.2	30.4	26.0	15.1	17.7	36.6	14.0	21.1	21.6	18.5	19.3	40.3	20.0	25.0	16.1	32.1	23.3	16.6	28.6	17.4	9.5	7.4	12.8	23.7	28.4	44.0	5.7	13.6	19.8	10.2	19.3	13.6	14.6	39.1	20.0	9.5	12.4	10.5	16.6	14.5	18.2	19.4	10.4	13.6	11.1	20.9	5.5	32.9	35.6	18.1	12.5	21.6	19.2	6.5	18.2	15.1	10.7	14.5	23.2	6.5	7.5	16.3	16.9	15.1	17.5	9.4	18.9	13.3	9.8	6.2	32.6	17.2	11.5	18.4	9.9	6.1	15.1	12.3	17.2	18.5	15.0	16.7	17.3	5.4	32.1	15.2	32.1	18.3	17.3	24.6	25.0	26.4	22.9	16.1	22.4	27.8	26.8	27.6	16.6	23.3	14.7	28.6	17.4	37.6	32.4	28.2	39.3	32.4	38.3	36.2	22.7	22.4	14.0
CAPS2		ENSG00000180881	"Calcyphosine 2"	Q9BXY5	12	75275979-75390928	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 21.7"	"Cell line enhanced"	"Detected in many"		"A549: 5.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 1.8"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040004	Uncertain		Approved	Nucleoplasm,Nucleoli,Centrosome				Centrosome	"Nucleoplasm, Nucleoli"	"HPA040004: AB_10794758"	"unprognostic (1.38e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.26e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.02e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.69e-1)"	2.6	4.2	8.0	1.2	5.8	1.6	3.7	15.5	11.2	3.7	2.5	5.5	2.1	1.8	5.0	8.8	3.6	21.7	3.4	5.4	6.3	6.6	6.6	4.2	5.8	1.3	5.4	5.6	4.5	2.6	7.3	15.8	0.9	7.8	5.1	2.0	4.4	5.5	3.6	3.8	2.6	1.9	2.0	8.7	2.6	3.2	8.0	9.5	1.4	9.3	2.2	1.4	2.6	2.0	0.1	0.6	0.0	0.7	1.1	1.8	0.1	1.8	5.0	1.4	0.4	2.5	1.9	0.2	1.0	0.2	2.7	2.9	0.0	2.3	0.5	4.4	0.7	1.1	0.0	2.2	1.9	1.7	0.8	2.1	0.8	0.0	0.0	0.3	0.0	0.8	1.3	2.3	0.5	0.3	0.4	0.8	3.5	0.1	2.4	2.0	0.7	0.7	0.0	0.0	0.2	3.5	0.0	2.9	1.4	0.2	0.1	1.6	1.7	0.7	1.1	2.5	1.1	0.6	0.4	0.2	0.0	0.0	2.2	0.0	2.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.7	0.0	0.0	0.1	0.6	0.9	0.0	1.1	0.7	0.6	1.8	0.1	8.0	5.8	15.5	11.2	6.3	6.6	5.4	5.6	7.8	9.5
CASP8AP2	"CED-4, FLASH, FLJ11208, KIAA1315, RIP25"	ENSG00000118412	"Caspase 8 associated protein 2"		6	89829894-89874436	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053573			Approved	"Nucleoli,Nuclear bodies"				"Nucleoli, Nuclear bodies"		"HPA053573: "	"unprognostic (7.80e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.75e-4)"	"unprognostic (4.58e-1)"	"unprognostic (4.36e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavourable (1.88e-5)"	"unprognostic (2.35e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.53e-1)"	3.8	3.1	5.4	8.0	7.3	4.8	6.0	9.7	7.8	7.4	4.7	3.3	3.8	3.5	5.0	3.4	4.5	3.7	3.5	3.9	6.5		3.1	3.4	3.9	8.8	6.1	5.0	6.6	3.8	5.7	7.0	5.9	6.6	7.2	4.3	3.5	4.0	5.2	3.2	2.6	4.7	5.3	5.7	5.4	4.0	5.0	5.9	9.1	4.5	2.1	5.9	6.5	3.2	9.9	7.8	17.7	4.1	17.8	12.3	3.6	4.2	4.2	13.6	9.4	4.6	4.7	5.5	10.5	4.0	7.5	9.8	4.9	3.4	12.5	5.5	5.4	6.4	12.2	5.2	8.7	12.7	10.4	15.6	10.1	1.7	2.0	14.6	8.2	2.3	2.5	9.8	4.6	5.4	16.7	7.5	5.1	3.7	8.2	2.6	3.9	4.0	16.2	17.0	4.8	1.4	9.2	9.0	6.2	8.7	1.9	3.8	4.2	7.5	7.3	4.8	4.2	8.4	9.5	4.5	11.1	7.4	5.0	8.3	7.6	17.7	2.5	8.2	10.7	4.1	10.3	8.3	12.3	11.2	3.1	9.9	9.9	9.5	4.4	17.8	3.5	7.8	10.2	3.6										
CATSPERG	"C19orf15, DKFZp434A1022, FLJ46353"	ENSG00000099338	"Cation channel sperm associated auxiliary subunit gamma"	Q6ZRH7	19	38335775-38370943	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 35.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.1;HMC-1: 5.2;MCF7: 4.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 4.8;monocytes: 1.8"					"Low region specificity"	"Detected in all"			HPA052777			Approved	Nucleoplasm,Nucleoli,Cytosol	"Secreted in male reproductive system"			Nucleoli	"Nucleoplasm, Cytosol"	"HPA052777: "	"unprognostic (8.50e-5)"	"unprognostic (5.12e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.37e-4)"	"unprognostic (9.99e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.07e-3)"	0.9	0.8	2.9	0.8	7.7	1.1	1.3	4.3	5.8	1.2	1.1	6.5	1.9	1.2	1.2	1.8	0.9	1.4	0.9	0.8	3.9	1.0	1.0	1.0	1.1	1.0	7.4	2.2	1.3	1.0	1.0	1.2	0.8	5.2	1.3	1.0	0.4	2.0	1.1	1.0	2.0	1.1	0.9	3.2	0.9	1.0	35.7	6.5	2.2	1.3	0.0	1.0	0.9	3.3	0.1	0.6	4.8	1.8	0.2	0.5	0.2	0.2	0.4	0.2	1.8	0.8	0.0	4.1	0.2	0.0	0.0	0.0	1.3	0.8	0.3	0.0	0.0	0.6	0.5	0.1	0.0	0.9	0.2	0.1	0.2	0.0	0.1	0.3	5.2	0.0	0.8	0.0	0.5	0.1	0.0	1.3	0.0	4.2	0.0	0.0	0.0	0.8	0.1	0.0	0.8	1.9	0.1	0.4	0.5	0.4	0.9	0.2	0.4	0.0	0.3	0.0	1.0	0.6	0.0	0.7	0.9	0.0	0.2	0.2	0.0	0.3	0.8	1.8	0.4	0.9	0.2	0.0	0.1	0.2	0.6	0.1	0.5	0.2	4.8	0.2	1.8	0.4	0.3	0.2	2.9	7.7	4.3	5.8	3.9	1.0	7.4	2.2	5.2	6.5
CBS	HIP4	ENSG00000160200	Cystathionine-beta-synthase	P35520	21	43053191-43076943	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Cysteine biosynthesis"	"Allosteric enzyme, Lyase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"liver: 55.7;pancreas: 43.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 40.2;HAP1: 38.3;HHSteC: 51.8;MCF7: 44.3;RPMI-8226: 42.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	84	"neutrophil: 8.3"	"Lineage enriched"	"Detected in single"	84	"granulocytes: 8.3"									HPA001223	Supported		Approved	Nucleoli,Vesicles				Vesicles	Nucleoli	"HPA001223: AB_1846112"	"unprognostic (4.86e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.68e-4)"	"unprognostic (3.62e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.73e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-1)"	1.3	1.5	6.5	2.4	5.1	0.4	1.0	12.3	6.7	4.8	1.3	2.0	0.8	1.6	0.9	0.8	0.8	2.0	2.1	2.0	5.6	5.5	1.3	55.7	1.7	1.4	4.8	2.8	13.9	43.0	0.3	1.4	1.4	2.3	4.0	0.7	2.8	9.3	3.4	0.8	0.6	2.9	1.4	3.7	0.8	2.7	2.2	3.3	0.8	5.0	0.8	0.9	2.6	0.8	0.0	0.0	8.3	0.0	0.0	0.0	0.0	6.3	3.8	5.0	19.6	11.3	7.3	40.2	7.8	2.0	3.2	3.3	11.8	0.3	0.0	4.2	14.7	0.4	38.3	2.7	0.6	0.0	4.8	2.6	15.3	14.2	51.8	1.6	3.8	4.4	0.4	3.5	3.1	8.6	29.6	22.3	2.4	44.3	2.7	0.0	4.7	6.7	0.0	0.0	42.4	0.1	3.5	10.4	15.3	17.2	1.0	7.4	6.1	20.0	1.1	0.2	9.9	0.1	0.8	7.8	6.2	8.8	3.6	2.3	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	6.5	5.1	12.3	5.2	5.6	5.5	4.8	2.8	2.3	3.3
CBSL		ENSG00000274276	"Cystathionine-beta-synthase like"	P0DN79	21	6444869-6468040	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Cysteine biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.5;liver: 21.2;pancreas: 18.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 35.7;NTERA-2: 66.2;SH-SY5Y: 21.1;U-266/70: 20.9"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	47	"neutrophil: 4.6"	"Lineage enriched"	"Detected in single"	47	"granulocytes: 4.6"									HPA001223	Supported		Approved	Nucleoli,Vesicles			190000	Vesicles	Nucleoli	"HPA001223: AB_1846112"	"unprognostic (2.39e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.78e-3)"	"unprognostic (6.49e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.62e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.17e-3)"	"unprognostic (8.44e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.61e-1)"	0.0	0.0		0.0		0.0	0.0		11.5	1.8	0.0			0.4	0.0	0.0	0.0	0.3	0.0	1.0			0.0	21.2	0.0	0.0			1.6	18.5	0.0		0.0		1.8	0.0		0.0	3.5	0.0	0.0	0.8	0.0		0.0	0.0	0.0			5.0		0.0	0.3		0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	11.9	35.7	0.0	0.0	0.4	7.4	4.3	2.7	8.3	0.1	4.8	0.0	0.0	0.0	3.1	0.0	3.8	1.7	0.0	9.4	0.0	0.0	0.0	0.2	0.0	5.1	4.2	13.9	0.0	7.0	0.0	0.2	16.5	0.1	0.0	5.6	0.6	66.2	0.0	0.0	0.0	0.0	10.8	0.0	13.8	21.1	0.0	1.1	14.4	0.0	0.0	0.0	0.7	0.0	4.6	1.4	20.9	7.7	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0										
CC2D2B	"bA248J23.4, bA690P14.3, C10orf130, C10orf131"	ENSG00000188649	"Coiled-coil and C2 domain containing 2B"	Q6DHV5	10	95907603-96032684	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 10.6"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA044091, HPA072122"	Enhanced		Approved	Nucleoli				Nucleoli		"HPA044091: , HPA072122: "	"unprognostic (6.38e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.63e-1)"	"unprognostic (8.18e-3)"	"unprognostic (2.11e-3)"	"unprognostic (9.11e-4)"	"unprognostic (1.93e-2)"	"unprognostic (4.34e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.41e-1)"	0.5	1.7	1.0	1.7	1.0	1.7	0.6	0.3	3.1	0.8	0.8			0.6	2.3	0.2	0.8	1.3	2.0	0.8	0.6	0.6	0.6	0.3	0.9	1.1	0.9		0.8	0.2	0.0	0.4	0.7		0.9	0.0		0.5	0.1	1.6	2.6	0.9	1.2	0.7	1.4	0.6	10.6			4.0		0.0	1.0	1.1	4.1	1.0	1.8	1.0	0.8	2.9	0.5	1.1	3.9	3.8	7.1	0.2	0.4	4.1	3.8	0.4	0.6	0.1	4.1	0.8	5.0	3.0	0.0	2.7	0.3	0.2	0.0	4.9	8.6	9.1	3.3	3.1	0.0	9.6	0.6	0.6	0.0	0.4	0.1	0.3	7.8	2.9	0.9	2.4	4.4	3.2	8.3	6.5	11.4	3.4	4.2	0.7	1.3	7.0	3.7	4.2	1.1	2.7	6.9	4.3	3.3	4.4	4.4	3.0	5.5	2.6	10.8	0.1	3.3	9.8	2.8	0.0	1.0	0.2	1.9	0.3	2.9	3.4	1.4	1.1	0.9	4.1	1.3	0.4	1.8	0.8	0.8	1.0	0.8	0.5										
CCDC136	"DKFZP434G156, KIAA1793, NAG6"	ENSG00000128596	"Coiled-coil domain containing 136"	Q96JN2	7	128790757-128822132	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Fertilization, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 34.7;testis: 109.6"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 18.4;U-937: 27.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010647, HPA071015"	Enhanced		Uncertain	Nucleoli				Nucleoli		"HPA010647: AB_2259798, HPA071015: "	"unprognostic (2.07e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.29e-4)"	"unprognostic (4.65e-2)"	"unprognostic (4.52e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.43e-4)"	"unprognostic (2.58e-2)"	"unprognostic (8.44e-3)"	"unprognostic (4.35e-1)"	"unprognostic (1.18e-4)"	"unprognostic (5.27e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.93e-3)"	2.1	4.0	11.2	2.6	11.7	1.8	2.4	34.7	28.7	2.9	6.5	8.3	2.6	2.4	3.9	2.9	2.5	2.8	2.8	4.9	12.5	20.0	1.5	1.5	1.9	3.0	15.3	16.6	2.8	1.8	1.8	3.8	2.2	11.2	9.9	3.5	13.9	2.0	11.0	3.5	1.6	2.6	17.3	9.7	1.9	2.4	109.6	7.4	0.7	1.7	0.0	2.4	6.4	2.0	0.1	0.6	1.3	0.3	2.7	1.6	0.3	0.7	0.8	7.2	4.8	3.9	3.3	1.2	2.7	3.6	2.8	2.6	1.0	0.6	3.6	0.3	3.7	1.5	4.5	0.5	2.6	10.1	4.6	6.2	1.7	0.0	1.3	0.7	13.5	3.7	0.5	3.0	0.2	1.6	2.2	3.8	1.0	1.3	4.5	1.9	9.9	2.9	11.3	1.2	1.7	0.2	1.2	4.2	12.5	1.6	1.9	2.8	0.1	1.7	1.4	4.5	2.6	2.1	2.1	2.2	0.9	3.7	18.4	27.1	1.1	0.0	0.3	1.3	1.4	0.0	1.6	0.0	1.5	1.1	0.6	0.1	0.0	1.0	0.1	2.7	0.1	0.1	0.0	0.3	11.2	11.7	34.7	28.7	12.5	20.0	15.3	16.6	11.2	7.4
CCDC137	MGC16597	ENSG00000185298	"Coiled-coil domain containing 137"	Q6PK04	17	81666364-81673904	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052637, HPA053914"	Uncertain		Supported	Nucleoli				Nucleoli		"HPA052637: , HPA053914: "	"unprognostic (3.04e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavourable (1.35e-7)"	"prognostic unfavourable (8.32e-4)"	"unprognostic (2.21e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (1.16e-7)"	"unprognostic (4.26e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.39e-1)"	11.3	10.9	10.9	16.0	14.1	20.2	10.2	11.3	17.0	10.3	11.5	8.0	8.9	16.2	9.1	6.4	25.2	9.2	9.1	9.1	12.1	9.0	10.6	12.1	8.7	18.8	12.4	11.9	8.4	12.0	9.4	8.4	11.2	11.8	13.1	6.4	5.7	13.0	9.9	12.7	29.8	11.8	10.3	9.1	17.7	11.4	13.4	12.4	9.8	9.2	13.1	16.6	10.6	14.7	12.8	12.6	10.2	9.2	11.9	11.2	5.9	12.4	24.6	6.7	11.9	4.8	4.9	13.4	14.2	6.8	20.5	11.3	21.6	7.5	12.8	7.6	8.5	16.3	13.8	16.0	7.6	6.5	21.2	19.9	10.9	17.1	7.4	15.2	13.0	7.1	8.6	18.8	8.5	14.3	18.8	6.8	9.6	13.5	15.1	16.4	16.0	24.8	18.1	12.7	8.2	6.4	11.3	16.4	21.2	13.0	26.8	11.6	19.3	12.6	9.8	29.6	17.3	11.9	19.6	18.1	10.4	13.0	10.7	14.9	16.7	1.9	7.8	10.2	11.2	8.4	7.0	10.3	9.7	9.6	7.4	12.8	10.7	9.6	3.5	11.9	9.2	12.6	9.5	5.9	10.9	14.1	11.3	17.0	12.1	9.0	12.4	11.9	11.8	12.4
CCDC148	MGC125588	ENSG00000153237	"Coiled-coil domain containing 148"	Q8NFR7	2	158171081-158456753	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 5.9;testis: 6.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.0;HBF TERT88: 4.2;hTEC/SVTERT24-B: 2.7;RPTEC TERT1: 3.3;SCLC-21H: 4.1"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	9	"basophil: 1.9"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042626	Uncertain		Uncertain	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA042626: AB_10806244"	"unprognostic (1.88e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.94e-4)"	"unprognostic (3.29e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.35e-2)"	"prognostic favourable (2.54e-4)"	"unprognostic (6.57e-3)"	0.1	0.5	0.6	0.0	0.8	0.0	1.8	1.9	0.3	1.4	0.0			0.0	0.6	2.4	0.0	3.3	0.4	0.0	0.7	0.8	4.3	0.1	0.6	0.0	0.5		1.3	0.1	5.9	1.9	0.0		0.4	0.0		1.0	0.7	0.0	0.2	0.0	0.0	1.0	0.0	0.0	6.5			1.8		0.0	0.1	0.3	0.0	0.0	1.9	0.0	0.0	0.2	0.0	1.3	0.0	0.8	1.0	0.0	0.0	0.1	0.9	0.0	1.1	2.2	1.1	6.0	0.1	0.1	0.9	0.5	0.0	0.3	4.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.4	0.0	0.0	0.1	0.4	1.1	0.0	0.0	0.2	0.0	0.0	0.6	0.0	3.3	0.4	4.1	0.2	0.3	0.4	0.5	2.3	0.3	0.0	0.4	0.5	0.1	0.2	0.6	0.7	0.0	0.9	0.0	0.4	1.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CCDC149	DKFZp761B107	ENSG00000181982	"Coiled-coil domain containing 149"	Q6ZUS6	4	24806117-24980204	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 4.5"	"Lineage enriched"	"Detected in single"	6	"monocytes: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044158, HPA047913"	Uncertain		Approved	Nucleoli				Nucleoli		"HPA044158: , HPA047913: "	"unprognostic (1.68e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.09e-2)"	"prognostic favourable (6.63e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.11e-4)"	"unprognostic (9.71e-5)"	"unprognostic (2.68e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.82e-2)"	"unprognostic (8.59e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.80e-3)"	"unprognostic (8.87e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.80e-2)"	11.7	8.3	20.1	8.2	14.7	2.8	16.7	14.8	20.6	13.2	10.8	6.9	11.1	5.3	12.9	9.2	7.9	13.9	9.9	10.9	15.9	11.5	7.5	10.3	10.0	4.4	11.5	12.7	15.9	31.7	12.8	11.2	11.6	11.3	14.3	8.6	7.5	29.8	10.1	8.6	6.9	6.4	14.5	9.9	5.8	13.8	5.4	9.4	0.9	11.9	4.6	4.3	9.6	18.3	0.0	0.8	0.8	4.5	0.2	0.0	1.2	4.1	1.6	3.3	0.5	5.2	9.7	1.0	6.0	9.2	4.8	5.6	0.1	4.6	0.0	2.9	11.4	0.7	1.0	0.7	3.2	0.0	0.0	0.0	0.3	0.3	4.4	0.0	0.0	6.6	4.3	2.7	0.0	3.9	0.0	0.8	2.9	4.4	0.0	0.1	3.8	4.6	0.0	0.0	0.2	8.7	3.0	4.6	0.0	2.6	3.8	12.3	6.5	9.3	9.3	7.0	0.8	5.2	5.2	0.1	0.0	0.0	21.6	0.9	4.8	0.0	4.5	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.8	0.2	1.5	0.7	0.0	1.2	20.1	14.7	14.8	20.0	15.9	11.5	11.5	12.7	11.3	9.4
CCDC171	"bA536D16.1, bA778P13.1, C9orf93, Em:AL513423.1, FLJ39267, FLJ46740"	ENSG00000164989	"Coiled-coil domain containing 171"	Q6TFL3	9	15553086-16061663	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 9.4;HEL: 14.6"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA019803, HPA019806, HPA024133"	Uncertain		Uncertain	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA019803: AB_1845846, HPA019806: AB_1845847, HPA024133: AB_1845848"	"unprognostic (1.35e-2)"	"unprognostic (2.03e-4)"	"unprognostic (7.22e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.76e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.92e-3)"	"unprognostic (7.80e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.91e-3)"	2.5	2.5	5.8	5.5	7.5	4.0	3.6	8.2	7.8	4.1	2.4	1.1	6.9	1.9	11.6	5.8	2.4	4.6	3.4	2.6	4.9	4.1	2.8	1.3	2.5	2.4	3.4	7.6	6.3	3.4	4.2	7.8	7.3	6.6	3.4	2.5	2.0	1.9	7.4	2.4	4.9	2.2	7.1	6.1	1.5	3.1	20.4	3.3	20.2	4.3	1.4	2.2	2.5	2.8	1.6	0.7	5.1	0.6	0.4	1.8	0.2	1.7	0.9	2.1	2.1	1.2	2.6	1.4	1.4	1.1	1.4	1.5	0.6	0.8	9.4	0.7	0.8	0.4	0.9	1.3	1.5	2.0	0.9	14.6	1.5	1.3	1.8	2.1	1.9	1.5	2.6	1.1	2.1	0.6	0.4	2.6	1.6	0.7	4.0	1.9	1.7	2.1	4.8	1.6	0.3	1.0	1.4	3.1	1.5	2.8	1.0	3.5	1.1	1.5	1.1	2.8	1.6	0.8	0.9	1.4	1.7	6.2	1.2	1.2	2.0	5.1	0.6	0.0	0.8	0.6	1.8	0.7	0.7	0.7	0.7	1.6	0.5	0.9	0.5	0.4	0.4	0.7	0.6	0.2	5.8	7.5	8.2	7.8	4.9	4.1	3.4	7.6	6.6	3.3
CCDC175	C14orf38	ENSG00000151838	"Coiled-coil domain containing 175"	P0C221	14	59504539-59576831	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 17.1;pituitary gland: 6.6;testis: 8.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.5;SCLC-21H: 1.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"cerebellum: 17.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA004200	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA004200: AB_1078743"	"unprognostic (3.64e-3)"		"unprognostic (8.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-1)"					"unprognostic (3.83e-1)"			"unprognostic (2.02e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.27e-1)"			0.2	0.1	0.9	0.2	2.9	0.5	0.2	17.1	3.3	0.2	0.9	1.2	0.0	0.3	0.2	1.0	0.2	1.3	0.5	0.2	0.8	0.5	0.4	0.2	0.5	0.2	0.8	0.9	0.2	0.1	0.3	6.6	0.1	3.0	0.2	1.8	0.6	0.2	0.2	0.2	0.3	0.9	0.2	0.4	0.4	0.2	8.2	1.5	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.1	0.5	0.1	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.4	0.9	2.9	17.1	3.3	0.8	0.5	0.8	0.9	3.0	1.5
CCDC24	MGC45441	ENSG00000159214	"Coiled-coil domain containing 24"	Q8N4L8	1	43991359-43996528	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 14.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 6.8"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035424, HPA061710"	Uncertain		Approved	"Nucleoli,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoli, Cytosol"	"HPA035424: AB_2674619, HPA061710: "	"prognostic favourable (3.06e-5)"	"unprognostic (1.47e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.65e-2)"	"prognostic favourable (3.18e-4)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (1.92e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.00e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.74e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.84e-2)"	"unprognostic (2.15e-3)"	1.8	5.5	9.3	2.6	9.8	1.1	5.1	3.0	9.8	7.2	5.0	3.2	18.9	3.7	4.9	6.6	2.6	20.3	13.1	1.5	6.4	8.0	8.9	3.0	3.2	2.6	5.5	9.6	3.4	6.0	9.6	14.5	2.4	5.2	7.2	4.1	6.5	8.4	14.7	1.5	0.9	3.3	3.4	3.3	3.0	4.9	15.4	1.7	0.6	8.8	1.0	2.5	4.7	2.1	6.8	0.8	1.4	4.0	0.5	0.6	0.5	5.1	3.0	1.4	1.5	1.4	0.9	3.1	0.2	2.1	1.6	2.8	2.0	14.8	4.1	5.8	0.6	5.2	0.8	7.3	1.5	4.3	1.8	2.1	1.8	0.6	1.6	0.7	3.6	0.3	0.7	5.2	0.5	1.3	0.9	1.5	2.2	4.4	0.2	1.5	3.1	2.6	1.3	0.0	0.8	6.1	2.0	3.4	3.0	4.5	2.6	2.8	7.6	0.1	0.4	2.4	6.9	1.7	0.7	0.6	1.9	0.9	6.2	0.6	1.9	0.0	0.7	1.4	0.6	4.0	0.3	6.8	0.2	0.2	0.8	3.0	0.0	0.0	0.6	0.5	3.1	0.6	0.0	0.5	9.3	9.8	3.0	9.8	6.4	8.0	5.5	9.6	5.2	1.7
CCDC58	FLJ33273	ENSG00000160124	"Coiled-coil domain containing 58"	Q4VC31	3	122359591-122383231	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA047777, HPA051965"	Approved		Approved	"Nucleoli,Intermediate filaments,Mitochondria"				Mitochondria	"Nucleoli, Intermediate filaments"	"HPA047777: AB_2680152, HPA051965: AB_2681676"	"unprognostic (1.51e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (1.53e-4)"	"unprognostic (5.64e-2)"	"unprognostic (6.98e-3)"	"prognostic unfavourable (2.94e-5)"	"unprognostic (2.72e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.98e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.84e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.86e-1)"	"prognostic favourable (7.29e-4)"	9.5	13.3	8.7	6.8	8.1	7.1	9.2	6.9	12.6	8.2	13.3	7.1	12.4	10.6	7.3	12.4	14.0	5.8	7.7	12.4	7.2	7.0	21.9	23.3	5.4	10.0	8.6	5.3	8.8	9.3	3.1	7.7	6.7	8.5	8.2	14.4	6.5	7.2	6.9	35.2	6.9	10.2	6.3	7.2	8.6	9.1	8.7	9.3	5.5	8.8	24.5	9.6	8.7	7.1	13.9	18.3	1.7	10.2	11.4	16.1	4.6	34.5	11.0	21.0	13.4	7.8	11.0	27.0	13.3	14.4	32.2	31.8	30.9	17.6	25.4	23.0	10.1	24.2	34.0	22.7	38.7	8.7	12.0	29.9	7.8	37.4	13.1	44.4	10.7	9.0	11.8	19.7	21.7	14.8	33.8	11.1	16.9	17.2	28.3	31.8	40.2	20.8	18.8	24.9	31.2	22.2	18.4	21.2	10.4	15.4	16.4	36.9	16.3	29.3	8.5	18.1	23.2	7.6	26.4	8.8	11.7	54.8	20.6	21.6	15.9	0.4	5.0	1.7	10.2	10.2	12.0	13.9	13.6	13.4	10.3	13.5	16.1	14.9	0.9	11.4	8.5	18.3	10.5	4.6	8.7	8.1	6.9	12.6	7.2	7.0	8.6	5.3	8.5	9.3
CCDC59	"BR22, HSPC128, TAP26"	ENSG00000133773	"Coiled-coil domain containing 59"	Q9P031	12	82223681-82358805	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038555	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"				Nucleoli	"Nucleoplasm, Plasma membrane"	"HPA038555: AB_10669543"	"unprognostic (1.61e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavourable (1.39e-6)"	"unprognostic (5.73e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.02e-2)"	17.9	10.2	11.3	14.2	16.3	54.9	18.9	14.9	14.7	17.6	16.9	8.9	7.7	7.5	14.8	17.4	17.0	17.2	11.2	14.5	11.5	12.5	16.0	15.4	12.6	13.7	14.8	12.4	18.8	12.5	2.6	18.2	18.7	13.5	18.7	12.5	6.5	12.7	13.3	23.5	12.7	18.9	14.5	16.5	17.3	12.1	18.4	14.9	15.3	19.9	17.9	18.1	21.4	20.9	18.9	18.6	17.9	14.0	13.1	23.6	6.7	11.4	10.8	9.0	6.4	10.0	8.7	14.0	10.4	12.0	18.3	15.0	21.8	6.5	13.4	5.3	10.3	7.3	40.9	19.8	15.6	14.1	21.8	13.2	6.4	14.4	29.5	17.4	7.6	15.1	16.8	19.3	24.4	15.0	24.9	6.9	11.2	20.7	16.0	23.8	14.2	25.2	12.1	13.4	10.9	9.7	11.4	15.3	7.4	11.9	6.4	15.1	13.8	23.1	7.0	9.1	7.0	6.5	19.0	11.0	12.3	25.7	6.5	13.9	12.3	12.7	9.3	16.8	11.6	9.6	19.8	15.2	18.6	16.9	9.6	18.9	22.1	17.6	17.9	13.1	14.0	18.6	23.6	6.7	11.3	16.3	14.9	14.7	11.5	12.5	14.8	12.4	13.5	14.9
CCDC7	"BIOT2, C10orf68, FLJ13031, FLJ32762"	ENSG00000216937	"Coiled-coil domain containing 7"	Q96M83	10	32446140-32882874	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"testis: 65.5"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA075536			Approved	"Nucleoli,Mitotic spindle,Cytosol"				Nucleoli	"Mitotic spindle, Cytosol"	"HPA075536: "	"unprognostic (3.43e-3)"	"unprognostic (4.75e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.75e-3)"	"unprognostic (2.65e-5)"	"unprognostic (6.95e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.95e-5)"	"unprognostic (7.56e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	2.1	2.1	3.2	3.8	3.6	2.8	2.2	4.8	3.6	2.3	2.1	4.2	4.3	2.0	3.4	5.1	2.0	1.7	1.9	2.3	2.6	1.9	1.9	1.7	2.0	2.8	4.2	1.5	2.7	2.3	2.1	8.5	1.8	3.0	2.1	2.3	1.8	2.0	3.2	2.0	2.0	1.8	2.1	5.4	2.0	2.0	65.5	3.2	3.4	2.7	0.3	2.2	2.3	2.3	2.4	1.7	0.1	0.6	2.9	5.9	0.5	2.5	2.8	0.8	3.5	2.4	1.9	1.3	2.3	0.8	0.8	2.5	0.6	3.8	1.9	1.2	1.6	1.3	1.3	1.4	3.1	6.6	0.3	1.0	2.0	0.7	4.3	1.0	1.9	1.7	0.7	1.7	0.6	1.0	1.5	6.5	3.2	0.4	0.8	0.6	0.7	2.8	1.6	3.6	0.3	2.3	0.5	1.9	1.9	0.4	0.4	1.5	1.9	1.5	3.8	2.0	2.3	2.6	1.3	2.1	1.4	1.9	2.5	7.3	1.1	0.0	0.6	0.1	3.4	0.3	3.3	2.4	5.3	2.9	0.3	1.2	5.9	3.9	0.1	2.9	0.3	1.7	3.5	0.5	3.2	3.6	4.8	3.6	2.6	1.9	4.2	1.5	3.0	3.2
CCDC86	MGC2574	ENSG00000110104	"Coiled-coil domain containing 86"	Q9H6F5	11	60842071-60851081	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 200.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041117, HPA041540"	Enhanced		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA041117: AB_10794984, HPA041540: AB_10794299"	"unprognostic (2.93e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-3)"	"unprognostic (3.64e-1)"	"prognostic unfavourable (7.36e-5)"	"prognostic unfavourable (1.71e-4)"	"unprognostic (1.65e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.47e-1)"	"unprognostic (3.76e-2)"	"unprognostic (7.54e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.25e-2)"	13.5	12.4	7.3	8.6	11.0	6.1	11.2	3.3	11.2	5.8	6.7	7.9	3.4	7.4	8.4	5.0	9.3	7.4	8.3	9.3	6.7	6.4	8.1	11.4	5.4	8.2	10.0	6.0	11.3	13.6	200.8	12.7	7.3	8.5	11.9	4.7	6.7	6.4	6.2	20.2	10.4	6.2	7.3	6.7	9.3	7.7	47.8	8.7	10.2	7.9	12.6	6.5	8.6	6.5	6.9	20.0	5.0	19.5	4.2	8.5	6.7	20.9	28.6	7.1	20.4	5.7	9.5	9.7	14.1	11.0	26.0	14.0	24.3	14.1	25.7	27.0	7.6	19.7	23.9	17.0	12.0	9.0	26.4	13.1	12.7	33.9	19.1	20.4	22.4	10.9	13.0	24.0	15.2	19.2	41.7	13.2	12.7	24.8	30.6	31.1	28.6	41.1	21.0	10.6	64.6	9.0	8.9	16.0	10.3	9.1	21.0	16.5	21.2	8.2	12.5	25.9	15.9	35.1	30.5	11.2	16.5	27.8	21.2	22.1	31.3	2.6	9.1	5.0	6.5	19.5	6.9	6.9	6.9	6.0	20.0	6.5	8.5	7.4	0.7	4.2	6.3	11.2	6.2	6.7	7.3	11.0	3.3	11.2	6.7	6.4	10.0	6.0	8.5	8.7
CDCA7L	"JPO2, R1, RAM2"	ENSG00000164649	"Cell division cycle associated 7 like"	Q96GN5	7	21900900-21946084	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 47.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 11.8;memory B-cell: 28.6;naive B-cell: 38.5;naive CD4 T-cell: 9.7;plasmacytoid DC: 21.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in many"	5	"olfactory region: 22.0"	HPA027169	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA027169: AB_1856058"	"unprognostic (5.13e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (4.36e-6)"	"unprognostic (4.09e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavourable (1.98e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.83e-3)"	6.2	1.2	3.7	19.9	9.6	24.2	8.0	6.5	4.2	8.4	9.0	7.8	3.9	5.2	11.1	3.6	6.0	7.0	5.4	12.5	3.9	2.5	2.7	4.5	7.3	18.7	6.2	4.0	13.9	17.4	1.0	1.6	2.2	3.7	7.6	10.2	5.8	10.5	8.0	2.7	13.6	8.7	6.6	3.0	9.3	12.7	12.6	5.3	47.9	20.0	5.1	16.5	6.0	9.4	38.5	21.8	11.8	1.3	0.8	9.7	3.3	19.6	6.7	6.3	0.1	3.5	4.4	0.0	16.1	13.9	12.5	17.8	2.5	17.9	41.0	5.3	13.8	12.1	10.0	16.5	25.4	0.0	6.6	9.8	20.0	1.6	4.5	25.8	0.1	8.3	3.0	9.7	28.4	24.7	13.5	0.0	9.7	7.3	32.5	9.3	36.3	8.4	32.7	22.8	27.4	3.5	3.7	23.3	19.0	7.3	4.5	7.3	10.9	11.7	10.4	13.7	16.9	23.8	19.4	21.1	14.5	53.0	13.1	34.8	13.4	0.3	0.6	11.8	0.6	0.9	0.1	28.6	1.9	0.9	4.3	38.5	9.7	3.9	1.1	0.8	1.3	21.8	2.7	3.3	3.7	9.6	6.5	4.2	3.9	2.5	6.2	4.0	3.7	5.3
CDCA8	"BOR, DasraB, FLJ12042, MESRGP"	ENSG00000134690	"Cell division cycle associated 8"	Q53HL2	1	37692418-37709719	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 19.0;lymphoid tissue: 51.6;testis: 44.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA028120, HPA028258, HPA028783, CAB040294"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Cytokinetic bridge"				Nucleoli	"Nucleoplasm, Cytokinetic bridge"	"CAB040294: , HPA028120: AB_10670556, HPA028258: AB_10669864, HPA028783: AB_10671092"	"unprognostic (8.36e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.42e-2)"	"prognostic unfavourable (4.93e-10)"	"unprognostic (4.30e-3)"	"prognostic unfavourable (6.04e-4)"	"unprognostic (3.00e-1)"	"prognostic unfavourable (8.32e-4)"	"unprognostic (3.78e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (6.39e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.67e-1)"	1.2	1.4	0.9	12.9	1.7	19.0	1.7	0.8	1.6	1.8	6.0	1.1	0.7	5.3	1.4	1.3	9.6	0.7	2.4	0.8	0.9	0.9	1.3	1.5	2.0	12.2	1.8	1.3	0.9	1.0	0.1	0.8	3.7	1.3	1.0	7.7	0.7	2.1	1.0	0.9	4.0	5.4	1.6	1.2	5.4	3.5	44.7	1.7	51.6	0.9	6.5	14.6	1.6	2.9	2.8	1.8	4.5	5.0	6.3	8.9	2.5	28.0	12.3	23.2	16.7	1.0	2.0	15.6	21.2	10.7	37.5	26.6	19.1	21.1	34.1	8.6	13.5	16.0	26.6	14.1	39.9	22.7	11.9	30.7	13.1	15.1	0.2	29.5	15.9	0.7	1.0	21.1	18.7	16.5	25.9	36.7	27.0	12.5	27.2	18.1	26.8	17.0	26.5	31.7	19.5	8.5	11.8	20.7	9.1	23.3	11.0	14.3	16.1	11.2	9.9	18.5	19.6	10.5	33.1	25.0	32.4	46.5	8.7	27.5	21.1	0.0	1.1	1.8	2.5	2.2	4.5	2.8	5.7	3.3	1.0	2.5	1.9	3.8	4.5	6.3	5.0	1.8	8.9	2.5	0.9	1.7	0.8	1.6	0.9	0.9	1.8	1.3	1.3	1.7
CDK4	PSK-J3	ENSG00000135446	"Cyclin dependent kinase 4"	P11802	12	57747727-57756013	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"HBEC3-KT: 125.1;LHCN-M2: 138.1;RH-30: 434.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006024, CAB013116, CAB069405"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol"				Cytosol	"Nucleoplasm, Nuclear membrane, Nucleoli"	"CAB013116: AB_2536376, CAB069405: AB_1613464, HPA006024: "	"unprognostic (8.88e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.27e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (2.09e-7)"	"unprognostic (7.39e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.93e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavourable (3.15e-5)"	"unprognostic (3.32e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.57e-2)"	32.2	43.1	13.8	22.2	15.7	24.0	45.0	13.1	17.9	36.3	28.2	20.1	22.8	15.2	51.4	28.1	29.9	31.0	32.3	27.4	14.5	12.1	24.0	36.9	26.8	26.4	18.3	13.7	61.4	54.4	18.9	34.2	25.0	16.0	37.2	26.9	26.2	29.3	24.1	27.8	25.6	20.7	34.1	13.5	27.2	23.9	24.6	17.5	29.2	54.3	32.1	27.5	33.6	30.9	29.6	25.5	2.6	19.9	15.8	32.1	22.2	9.3	10.8	14.3	12.7	13.1	11.5	9.5	5.4	17.6	23.8	19.8	15.4	8.9	13.6	9.7	8.4	7.2	19.7	125.1	18.1	6.7	9.1	12.7	7.3	10.8	15.4	14.4	8.8	11.3	9.2	14.6	16.8	15.3	13.5	11.7	138.1	13.5	13.7	11.7	16.8	11.0	12.4	434.6	12.6	7.4	14.7	12.9	12.1	9.5	7.2	14.4	9.6	17.5	6.9	11.2	10.5	12.6	10.9	5.8	9.5	20.9	10.3	13.3	13.4	1.7	14.3	2.6	26.2	19.9	27.0	29.6	23.1	23.7	21.0	28.1	32.1	28.5	1.2	15.8	12.0	25.5	16.6	22.2	13.8	15.7	13.1	17.9	14.5	12.1	18.3	13.7	16.0	17.5
CDK5RAP3	"C53, FLJ13660, HSF-27, IC53, LZAP, MST016, OK/SW-cl.114"	ENSG00000108465	"CDK5 regulatory subunit associated protein 3"	Q96JB5	17	47967810-47981774	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022141, HPA022882, HPA027883"	Supported		Supported	Nucleoli,Vesicles,Cytosol				Cytosol	"Nucleoli, Vesicles"	"HPA022141: AB_1846426, HPA022882: AB_1846428, HPA027883: AB_10602797"	"unprognostic (4.27e-2)"	"unprognostic (1.01e-3)"	"unprognostic (9.95e-3)"	"unprognostic (6.65e-2)"	"unprognostic (5.98e-2)"	"unprognostic (7.19e-3)"	"unprognostic (3.84e-1)"	"unprognostic (4.44e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.92e-2)"	"prognostic unfavourable (3.61e-5)"	"unprognostic (8.35e-3)"	"unprognostic (2.30e-1)"	"unprognostic (9.58e-2)"	"prognostic favourable (7.31e-5)"	15.5	19.7	20.8	30.0	38.3	21.2	22.5	35.7	31.9	21.1	21.2	27.1	39.4	24.1	26.2	45.4	20.8	26.1	22.0	14.4	23.2	16.7	23.2	31.0	18.8	22.0	31.3	25.8	28.9	51.9	29.4	41.3	15.4	27.3	24.2	25.5	25.1	44.0	26.4	10.7	16.8	25.8	18.4	18.2	32.3	28.6	40.1	29.5	32.3	29.7	16.5	24.6	20.0	18.5	22.8	26.9	27.2	33.5	22.4	22.3	21.0	22.3	36.0	19.9	35.6	16.7	16.8	35.7	16.3	19.8	16.5	15.2	28.2	21.7	26.9	33.8	17.0	21.9	12.9	18.3	18.5	39.7	17.0	12.8	42.9	38.2	18.7	15.1	14.3	19.1	15.5	14.8	29.1	15.9	15.1	25.0	16.7	42.8	41.1	24.5	12.0	15.6	22.0	33.5	30.5	16.4	28.1	13.6	32.6	12.6	11.3	16.4	25.7	19.8	12.7	13.7	12.2	16.5	20.8	32.9	31.0	16.6	17.1	21.0	16.6	9.1	33.5	27.2	20.9	32.7	22.3	22.1	20.0	18.5	26.9	22.8	18.1	19.9	15.7	22.4	32.5	24.4	19.0	21.0	20.8	38.3	35.7	31.9	23.2	16.7	31.3	25.8	27.3	29.5
CDKN2A	"ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf"	ENSG00000147889	"Cyclin dependent kinase inhibitor 2A"	"P42771, Q8N726"	9	21967753-21995301	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, rRNA processing, Transcription, Transcription regulation, Ubl conjugation pathway"	DNA-binding	"Cancer-related genes, Disease mutation, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 22.6;pituitary gland: 39.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 50.0;HEK 293: 56.7;HeLa: 53.1;SK-MEL-30: 53.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 22.6"	"Group enriched"	"Detected in many"	8	"B-cells: 7.2;T-cells: 22.6"					"Low region specificity"	"Detected in many"			"CAB000093, CAB000445, CAB018232, HPA047838"	Enhanced		Supported	Nucleoli				Nucleoli		"CAB000093: AB_442119, CAB000445: , CAB018232: AB_785018, HPA047838: "	"unprognostic (3.41e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.00e-3)"	"prognostic unfavourable (1.82e-7)"	"unprognostic (5.22e-2)"	"prognostic favourable (5.19e-4)"	"prognostic unfavourable (2.17e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.56e-2)"	"prognostic unfavourable (5.76e-7)"	"unprognostic (9.41e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.55e-1)"	5.4	8.6	2.9	4.5	3.9	1.8	5.3	1.7	3.1	1.2	2.5	4.4	0.1	1.2	1.2	1.9	6.3	3.0	2.6	0.7	1.7	1.0	0.9	1.2	3.0	3.0	3.6	1.6	1.5	1.5	8.5	39.3	6.7	5.0	1.9	1.1	1.2	2.4	2.9	0.9	1.3	3.7	1.0	3.0	8.9	6.0	13.0	1.9	3.9	1.4	3.0	14.0	2.7	1.5	7.2	0.2	0.8	1.8	0.4	22.6	2.2	2.1	0.0	0.3	14.1	0.1	0.1	6.1	2.3	0.0	19.6	34.9	3.5	50.0	7.2	32.2	1.6	6.0	5.9	36.4	15.8	30.9	56.7	0.0	53.1	2.3	1.5	3.5	3.0	3.8	0.0	19.8	11.0	2.0	0.0	32.9	17.9	0.1	0.3	0.0	0.4	29.2	0.0	13.3	26.4	4.0	0.0	33.0	2.3	38.0	6.3	53.0	7.5	0.1	6.5	0.1	0.4	0.0	0.1	14.7	8.3	29.4	0.0	9.4	0.1	0.8	1.3	0.2	6.2	0.6	9.7	7.2	8.0	11.0	0.2	7.0	0.5	4.7	0.4	0.4	1.8	0.0	22.6	2.2	2.9	3.9	1.7	3.1	1.7	1.0	3.6	1.6	5.0	1.9
CDRT1	"FBXW10B, FBXW10P1, HREP, SM25H2"	ENSG00000241322	"CMT1A duplicated region transcript 1"	O95170	17	15565483-15619512	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"esophagus: 9.8;testis: 12.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 15.3;HaCaT: 28.1;HeLa: 9.5"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	5	"T-reg: 2.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.1"									"HPA013332, HPA047457"			Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA013332: AB_1848471, HPA047457: "	"unprognostic (2.25e-1)"	"unprognostic (2.78e-1)"	"unprognostic (7.03e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.45e-2)"	"unprognostic (5.93e-2)"	"unprognostic (5.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.31e-8)"	"unprognostic (1.55e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.86e-1)"	1.1	1.8	0.0	0.9	0.0	0.0	0.7	0.2	0.0	2.4	0.3			2.9	0.0	0.8	9.8	0.3	0.7	0.7	0.0	0.0	0.1	0.5	0.9	0.7	0.0		0.0	0.0	0.0	0.1	1.8		0.3	0.6		2.6	0.1	2.1	4.4	1.3	0.0	0.0	0.2	2.6	12.8			1.6		3.0	2.0	4.1	0.4	0.1	0.0	0.3	0.1	2.1	0.0	2.3	6.7	0.2	1.9	0.2	0.7	0.1	0.5	1.5	0.2	0.7	5.0	15.3	0.1	0.4	1.3	28.1	0.4	0.3	0.4	2.3	0.3	0.1	9.5	0.2	0.2	0.0	0.1	0.3	0.9	0.6	0.4	0.1	0.0	1.2	0.8	0.1	0.4	0.2	0.2	0.8	0.0	0.4	0.0	1.8	3.7	0.1	0.2	2.2	2.0	0.1	0.1	0.1	1.2	0.5	1.4	0.0	0.4	0.6	2.9	0.0	1.7	0.1	0.8	0.0	0.2	0.0	0.2	0.3	0.1	0.1	0.2	0.0	0.1	0.4	0.1	0.2	0.0	0.1	0.1	0.0	2.1	0.0										
CDV3	H41	ENSG00000091527	"CDV3 homolog"	Q9UKY7	3	133573730-133590261	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 150.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029761, HPA029762, HPA029763"	Enhanced		Enhanced	"Nucleoli,Plasma membrane,Cytosol"			220000	Cytosol	"Nucleoli, Plasma membrane"	"HPA029761: AB_10600193, HPA029762: AB_10611247, HPA029763: AB_10601679"	"unprognostic (1.17e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (5.21e-6)"	"unprognostic (1.20e-1)"	"unprognostic (3.30e-1)"	"unprognostic (8.45e-3)"	"unprognostic (3.29e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.87e-2)"	"unprognostic (7.59e-3)"	46.4	26.5	20.7	45.7	22.4	44.9	38.1	13.2	22.3	25.6	29.5	20.2	16.2	18.5	27.0	26.1	34.1	22.0	25.4	50.5	19.0	18.3	26.2	40.2	34.3	47.6	22.5	20.6	32.8	34.4	25.6	22.5	34.8	24.4	24.6	23.9	18.7	24.6	16.7	106.6	23.1	27.7	33.1	25.4	56.6	31.4	38.2	21.5	61.1	33.9	32.5	52.1	43.8	37.2	10.6	14.2	14.7	11.1	5.3	20.8	4.5	49.7	11.6	20.5	13.5	23.7	29.3	24.3	27.5	35.9	27.6	27.4	28.7	20.1	63.7	41.9	30.8	21.5	29.3	27.5	51.8	40.7	11.0	37.6	12.8	17.6	36.9	41.8	24.2	27.8	28.9	24.6	66.5	34.8	27.0	42.8	39.9	14.3	34.2	24.2	20.7	14.9	20.9	27.3	51.0	29.0	20.3	16.3	12.3	26.1	19.5	32.7	63.0	25.7	43.1	29.5	27.9	23.4	27.2	62.5	46.8	150.0	16.5	25.4	17.1	11.5	9.6	14.7	12.2	10.7	12.8	10.6	11.7	12.4	8.5	6.5	9.4	14.4	8.7	5.3	11.1	14.2	20.8	4.5	20.7	22.4	13.2	22.3	19.0	18.3	22.5	20.6	24.4	21.5
CEACAM19	CEAL1	ENSG00000186567	"Carcinoembryonic antigen related cell adhesion molecule 19"	Q7Z692	19	44662278-44684359	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 13.8;TIME: 17.8"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA014462, HPA052865"	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria				"Nucleoli, Mitochondria"	Nucleoplasm	"HPA014462: , HPA052865: "	"unprognostic (2.91e-1)"	"unprognostic (5.29e-3)"	"unprognostic (6.96e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.43e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.26e-9)"	"unprognostic (8.01e-3)"	"unprognostic (9.62e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.70e-1)"	1.6	2.9	1.1	0.8	1.9	1.0	2.4	4.3	1.7	3.1	2.4			2.7	2.7	1.4	2.4	4.3	2.1	4.1	1.2	1.8	3.3	4.3	3.8	0.6	0.6		4.0	4.7	1.2	3.9	1.8		4.1	3.3		2.9	3.0	12.5	10.8	2.9	3.0	0.9	1.8	2.0	3.0			3.4		1.7	1.0	4.4	1.7	0.5	1.7	1.0	1.0	0.7	0.6	4.3	8.8	1.3	0.9	3.1	3.6	3.3	2.4	3.6	0.8	1.6	0.3	1.0	0.1	0.8	3.3	5.3	2.2	0.9	0.7	1.2	5.0	0.1	4.7	1.4	3.2	0.2	0.8	1.1	8.8	2.2	5.4	2.1	0.3	0.2	1.2	1.0	0.0	0.5	0.8	1.0	0.0	1.6	0.2	13.8	1.0	1.7	0.4	0.9	0.9	0.8	1.2	0.3	17.8	0.3	6.1	1.3	0.7	0.1	0.3	0.0	0.4	1.7	1.4	1.7	1.0	0.6	0.6	0.4	0.3	0.5	0.3	0.6	0.2	1.7	0.4	0.7	1.6	1.0	0.5	0.5	0.3	0.6										
CENPBD1	MGC16385	ENSG00000177946	"CENPB DNA-binding domain containing 1"	B2RD01	16	89969773-89972832	"Predicted intracellular proteins"		DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEK 293: 7.6;K-562: 4.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA052759, HPA060522"	Uncertain		Approved	Nucleoli,Vesicles				"Nucleoli, Vesicles"		"HPA052759: , HPA060522: "	"unprognostic (2.63e-2)"	"unprognostic (2.22e-3)"	"unprognostic (4.43e-2)"	"unprognostic (3.48e-3)"	"unprognostic (7.76e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.86e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.44e-2)"	"prognostic favourable (5.27e-11)"	"unprognostic (2.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.59e-2)"	7.2	5.9	6.6	2.6	7.3	4.5	6.3	6.1	9.5	3.3	4.0	4.9	10.5	5.9	3.6	5.0	4.0	3.6	4.6	4.2	6.6	6.1	7.6	5.6	6.7	7.1	7.9	7.0	7.6	8.9	3.9	7.1	4.4	6.2	4.9	6.0	3.8	6.0	4.8	4.2	5.1	2.9	3.8	5.6	6.6	4.7	8.2	6.3	2.5	3.5	1.8	2.5	4.8	2.7	3.7	3.6	1.4	1.6	1.4	2.7	1.3	1.2	0.0	0.2	0.4	0.5	0.9	2.1	0.8	0.3	0.0	0.0	0.6	0.0	1.3	1.2	0.9	2.0	0.0	0.0	0.3	0.0	7.6	0.0	0.3	0.5	0.4	0.4	1.2	0.0	1.3	0.0	0.0	0.0	4.6	0.9	0.0	1.1	1.4	0.5	0.6	0.5	3.1	1.6	0.0	0.0	0.0	2.7	1.9	2.8	0.3	0.1	0.7	0.0	0.0	0.2	1.8	0.2	1.2	0.8	1.3	1.0	0.5	1.2	0.5	0.6	1.6	1.4	2.4	0.7	2.1	1.2	1.9	0.8	3.6	3.7	2.7	2.3	0.5	1.4	1.4	3.1	1.1	1.3	6.6	7.3	6.1	9.5	6.6	6.1	7.9	7.0	6.2	6.3
CENPH		ENSG00000153044	"Centromere protein H"	Q9H3R5	5	69189548-69210357	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 31.8;testis: 37.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA036494	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA036494: AB_10673354"	"unprognostic (1.49e-1)"	"prognostic favourable (6.86e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavourable (5.22e-5)"	"unprognostic (6.14e-3)"	"unprognostic (6.85e-2)"	"prognostic favourable (2.50e-4)"	"unprognostic (4.21e-2)"	"unprognostic (8.80e-2)"	"prognostic unfavourable (5.11e-15)"	"unprognostic (1.17e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.20e-1)"	4.0	1.9	2.9	15.2	3.1	19.1	5.5	2.1	3.0	3.9	4.7	1.2	0.7	4.2	2.9	3.1	7.7	2.5	2.8	4.4	2.7	2.1	1.9	2.2	3.6	11.1	2.6	3.7	3.6	1.6	1.6	2.7	6.8	1.8	2.4	5.5	1.6	3.0	1.5	3.6	6.0	4.0	2.4	2.6	6.2	2.5	37.3	1.8	31.8	1.8	10.2	12.2	3.1	4.3	12.1	6.1	2.5	3.6	7.5	9.8	4.2	18.1	5.6	26.4	20.6	1.7	5.5	14.0	8.9	9.6	20.0	21.7	7.7	23.2	39.1	10.8	5.3	13.6	17.2	20.7	25.7	11.8	11.9	9.1	9.6	7.6	0.6	13.1	9.4	2.1	4.3	13.0	14.4	6.7	16.1	15.6	15.4	10.1	42.2	18.8	22.9	4.9	26.3	34.8	30.1	6.3	6.7	18.2	24.3	9.8	6.7	7.9	9.3	8.9	3.2	10.0	16.8	13.2	22.2	19.3	29.1	31.3	15.3	26.6	18.8	0.6	1.8	2.5	4.5	3.0	7.3	11.8	7.6	5.7	2.8	12.1	9.8	8.3	0.4	7.5	3.6	6.1	8.7	4.2	2.9	3.1	2.1	3.0	2.7	2.1	2.6	3.7	1.8	1.8
CENPP	"CENP-P, RP11-19J3.3"	ENSG00000188312	"Centromere protein P"	Q6IPU0	9	92325484-92620533	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 30.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA021787, HPA058945"	Uncertain		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA021787: AB_1846524, HPA058945: "	"unprognostic (5.48e-2)"	"prognostic favourable (3.91e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.64e-2)"	"prognostic favourable (3.65e-4)"	"unprognostic (4.88e-5)"	"unprognostic (8.06e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.68e-3)"	"unprognostic (9.20e-8)"	"unprognostic (1.27e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.04e-1)"	5.0	5.1	6.8	8.9	8.8	15.5	4.9	14.9	7.4	6.0	3.8	3.5	1.4	4.5	6.4	4.1	8.4	3.6	4.6	4.3	5.4	4.6	3.5	3.2	3.5	7.8	6.1	4.5	4.6	7.5	7.8	9.4	5.3	6.8	4.8	4.5	5.5	5.0	2.8	11.8	30.0	3.2	4.8	4.4	5.4	3.0	8.7	6.5	14.8	3.0	7.4	9.1	4.4	8.0	6.7	4.8	4.1	10.3	5.1	8.2	4.0	7.9	5.0	7.0	5.1	2.9	3.2	6.7	8.4	4.7	10.4	8.4	2.3	4.5	10.0	3.9	2.6	9.5	6.8	4.6	9.8	14.3	8.0	10.3	4.5	3.2	1.5	20.9	9.9	3.4	2.6	10.1	6.5	5.2	11.0	14.6	7.9	5.0	29.4	6.3	5.7	9.4	10.0	11.5	11.2	1.6	8.0	15.7	5.5	9.5	6.1	3.0	3.2	6.5	2.5	10.2	5.0	15.4	11.9	9.7	11.4	13.2	11.4	10.5	9.2	3.0	3.2	4.1	4.9	10.3	8.2	6.7	5.3	4.1	3.6	5.7	5.0	4.8	0.8	5.1	5.1	4.8	5.7	4.0	6.8	8.8	14.9	7.4	5.4	4.6	6.1	4.5	6.8	6.5
CEP85	"CCDC21, DKFZP434L0117"	ENSG00000130695	"Centrosomal protein 85"	Q6P2H3	1	26234153-26279038	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 87.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 15.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028252	Approved		Supported	"Nucleoli,Golgi apparatus,Centrosome,Cytosol"				Nucleoli	"Golgi apparatus, Centrosome, Cytosol"	"HPA028252: AB_1846142"	"unprognostic (1.08e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.30e-3)"	"prognostic unfavourable (4.39e-6)"	"unprognostic (3.72e-2)"	"unprognostic (5.30e-2)"	"unprognostic (8.24e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.33e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.60e-2)"	2.1	2.7	4.8	3.8	11.0	12.4	3.1	7.7	8.8	2.4	3.7	15.5	4.6	3.5	2.6	3.3	5.6	2.7	2.6	19.4	5.5	4.0	3.8	3.7	3.2	5.3	20.4	4.9	2.4	3.3	4.4	4.7	3.6	7.8	3.0	4.5	4.0	3.5	2.5	87.8	8.4	3.3	2.9	10.4	4.3	3.7	26.8	13.5	12.1	5.4	5.5	6.6	3.0	3.8	2.4	3.8	15.6	5.0	2.1	3.4	2.8	13.4	6.7	10.8	11.4	3.0	2.8	21.1	6.8	3.2	9.5	10.1	8.6	12.6	12.8	9.3	2.8	11.9	12.0	5.7	9.5	9.4	10.4	18.1	13.1	9.0	3.1	16.5	20.0	1.4	5.6	7.9	5.8	4.2	24.3	17.9	6.9	4.8	15.8	20.0	10.4	11.1	16.1	12.5	11.9	4.7	2.0	18.3	8.4	9.6	8.0	8.0	7.3	11.8	4.9	7.7	12.9	9.0	10.5	14.1	20.6	16.0	4.8	29.1	14.6	3.4	4.6	15.6	3.0	4.4	2.5	2.4	2.0	2.3	3.8	1.3	1.8	3.4	0.5	2.1	5.0	1.3	3.2	2.8	4.8	11.0	7.7	8.8	5.5	4.0	20.4	4.9	7.8	13.5
CERCAM	"CEECAM1, CerCAM, GLT25D3"	ENSG00000167123	"Cerebral endothelial cell adhesion molecule"	Q5T4B2	9	128411751-128437351	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 78.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 55.3;ASC TERT1: 59.0;fHDF/TERT166: 50.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 5.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021657, HPA051595"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Intracellular and membrane"			"Nucleoplasm, Nucleoli"	"Cell Junctions"	"HPA021657: AB_1846507, HPA051595: "	"unprognostic (2.87e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.89e-3)"	"unprognostic (2.19e-1)"	"unprognostic (4.68e-3)"	"unprognostic (7.79e-3)"	"unprognostic (3.29e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (5.22e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavourable (3.33e-16)"	"unprognostic (1.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.05e-3)"	"prognostic unfavourable (3.30e-5)"	12.7	5.1	40.0	7.2	65.5	1.6	9.0	10.0	62.1	19.1	6.9	61.2	5.0	4.8	11.4	10.9	8.2	6.0	17.3	8.8	72.8	34.7	4.9	1.8	5.3	2.3	59.5	28.1	14.1	18.8	15.8	21.6	27.4	31.4	11.1	5.2	3.5	13.2	13.6	4.3	8.9	6.0	27.7	78.1	3.3	5.4	5.2	62.1	0.0	6.7	2.4	2.7	15.1	6.6	0.3	2.0	0.3	1.6	1.1	5.3	2.2	9.4	6.1	6.8	7.3	55.3	59.0	5.9	30.7	29.0	8.0	6.0	2.2	0.4	0.0	12.6	50.1	6.5	3.0	4.0	3.1	2.4	4.8	0.5	5.5	3.3	16.9	1.1	17.2	32.7	2.1	8.7	2.1	9.1	2.7	7.5	10.4	18.0	0.4	11.6	0.4	4.6	0.9	4.8	1.3	3.7	3.6	1.0	1.9	6.9	8.4	3.5	6.8	2.3	10.0	21.4	5.8	29.4	4.7	8.8	6.9	0.1	20.3	3.3	4.2	0.3	1.1	0.1	3.8	1.6	0.3	0.3	0.3	4.7	1.5	0.1	0.1	5.3	0.3	1.1	0.1	2.0	0.0	2.2	40.0	65.5	10.0	24.5	72.8	34.7	59.5	28.1	31.4	62.1
CERS5	"FLJ25304, LASS5, MGC45411, Trh4"	ENSG00000139624	"Ceramide synthase 5"	Q8N5B7	12	50129306-50167533	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026589	Approved		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA026589: AB_1852727"	"unprognostic (1.59e-2)"	"unprognostic (9.83e-2)"	"unprognostic (5.17e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.49e-3)"	"prognostic unfavourable (4.63e-5)"	"unprognostic (5.56e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.88e-3)"	"unprognostic (5.67e-2)"	"prognostic unfavourable (9.33e-11)"	"unprognostic (8.37e-2)"	"unprognostic (1.03e-1)"	"prognostic favourable (5.76e-5)"	"unprognostic (3.26e-1)"	18.0	13.2	18.3	13.3	21.6	10.9	18.0	38.3	19.6	21.1	15.0	17.5	8.9	6.3	22.6	20.9	14.1	17.7	14.9	9.9	16.7	11.6	16.0	7.8	14.7	15.1	13.9	19.1	22.5	13.8	23.9	22.4	19.7	14.3	15.6	11.5	14.9	14.6	16.2	5.0	21.5	12.2	21.8	10.3	15.7	13.3	11.6	14.4	12.7	15.5	7.0	14.9	18.4	18.3	21.0	26.1	33.5	35.1	29.0	26.3	22.3	9.3	10.4	23.0	6.5	12.9	10.8	19.5	20.6	17.8	19.8	18.8	24.5	14.7	14.1	17.2	29.1	8.7	10.1	7.9	19.6	22.1	10.3	11.8	8.8	14.8	25.6	11.9	16.0	18.6	12.0	16.3	15.2	18.0	8.8	13.1	24.8	16.2	10.4	32.5	14.8	10.1	13.6	15.1	10.0	25.6	12.0	7.0	11.4	17.4	8.2	27.5	11.2	13.8	17.1	17.0	11.4	12.8	8.9	12.8	12.1	11.3	13.5	8.3	7.8	24.8	19.0	28.1	26.0	25.5	22.9	17.9	22.9	22.4	18.2	21.0	17.9	24.3	33.5	29.0	35.1	26.1	26.3	22.3	18.3	21.6	38.3	19.6	16.7	11.6	13.9	19.1	14.3	14.4
CHD3	"Mi-2a, Mi2-ALPHA, ZFH"	ENSG00000170004	"Chromodomain helicase DNA binding protein 3"	Q12873	17	7884806-7912760	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043368, HPA076524"	Supported		Approved	"Nucleoplasm,Nucleoli,Centriolar satellite"				"Nucleoplasm, Nucleoli, Centriolar satellite"		"HPA043368: , HPA076524: "	"unprognostic (1.77e-2)"	"unprognostic (8.01e-2)"	"prognostic unfavourable (2.43e-4)"	"prognostic favourable (7.68e-5)"	"unprognostic (1.53e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.83e-2)"	"unprognostic (5.25e-3)"	"prognostic favourable (8.36e-4)"	"unprognostic (9.11e-2)"	"unprognostic (8.31e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.90e-3)"	"unprognostic (2.20e-3)"	10.4	12.9	31.7	24.3	26.0	18.7	12.5	12.1	28.3	41.1	21.1	4.1	22.5	8.2	46.3	16.1	15.1	25.0	20.0	8.7	30.4	14.2	15.2	2.3	13.1	19.0	8.4	28.4	27.3	15.1	28.5	21.0	8.0	10.7	32.9	11.1	20.7	19.4	23.0	3.3	16.2	14.0	23.3	6.9	14.6	15.8	11.3	5.1	40.6	19.7	7.5	17.7	20.6	28.9	1.6	4.0	4.1	3.5	2.7	7.8	3.6	12.1	30.4	17.8	23.6	21.7	18.2	9.5	14.2	19.1	12.1	12.9	5.9	10.3	34.3	10.8	20.9	16.5	33.4	15.0	15.2	17.4	19.4	16.6	39.4	0.7	11.6	4.7	32.7	24.0	8.0	16.2	10.9	22.3	11.1	0.5	11.2	12.0	13.1	5.5	2.8	11.2	38.4	21.7	5.2	12.0	29.7	12.1	16.4	35.3	13.8	6.9	15.8	7.8	27.9	26.2	20.6	6.3	20.4	2.5	0.4	19.4	13.3	13.5	22.3	0.6	2.7	4.1	7.0	1.7	5.5	1.5	6.7	6.6	2.1	1.6	7.8	5.1	2.1	2.7	3.5	4.0	3.6	3.6	31.7	26.0	12.1	28.3	30.4	14.2	8.4	28.4	10.7	5.1
CHD7	"CRG, FLJ20357, FLJ20361, KIAA1416"	ENSG00000171316	"Chromodomain helicase DNA binding protein 7"	Q9P2D1	8	60678778-60868028	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.1"	"Cell line enhanced"	"Detected in many"		"AF22: 25.8;SCLC-21H: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"B-cells: 12.2;granulocytes: 12.6;T-cells: 5.5"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 110.3"	HPA053075			Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA053075: "	"unprognostic (3.77e-2)"	"unprognostic (3.28e-3)"	"unprognostic (3.17e-2)"	"prognostic unfavourable (5.34e-5)"	"unprognostic (9.59e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.41e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.09e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.17e-1)"	3.9	2.2	7.0	7.9	11.2	25.1	4.1	47.1	9.0	2.3	5.7	13.4	3.1	5.9	2.6	3.2	5.1	3.2	3.1	4.1	8.1	4.3	3.6	3.6	4.7	7.0	8.1	3.3	1.4	6.4	12.4	9.9	5.6	9.9	2.9	5.5	6.4	5.7	2.8	10.3	5.7	6.6	2.4	7.5	6.1	4.5	4.3	12.2	1.6	5.4	2.2	7.3	2.9	5.9	12.2	0.6	12.6	0.6	0.0	5.5	0.4	3.8	1.9	25.8	4.5	0.0	0.0	8.1	0.2	0.0	0.9	0.8	4.8	3.6	7.5	0.4	0.0	2.3	13.2	3.8	0.8	2.8	7.1	17.6	3.2	6.3	1.1	5.3	3.3	0.5	2.9	0.0	4.3	3.8	1.3	6.7	0.6	3.9	8.3	6.0	17.7	0.9	17.3	6.1	2.4	2.0	4.4	23.6	11.7	0.7	2.9	7.2	5.2	5.0	4.4	0.2	4.2	0.2	2.1	7.1	4.1	11.7	1.5	0.6	6.6	10.4	0.3	12.6	2.6	0.1	3.3	8.0	2.9	0.9	0.1	12.2	5.5	2.0	7.1	0.0	0.6	0.6	0.2	0.4	7.0	11.2	47.1	6.5	8.1	4.3	8.1	3.3	9.9	12.2
CKAP5	"ch-TOG, KIAA0097, TOG, TOGp"	ENSG00000175216	"Cytoskeleton associated protein 5"	Q14008	11	46743048-46846308	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039377, HPA040375"	Supported		Approved	"Nucleoli,Plasma membrane,Centrosome"			460000	"Plasma membrane, Centrosome"	Nucleoli	"HPA039377: AB_10805477, HPA040375: AB_10794739"	"unprognostic (8.00e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.08e-2)"	"prognostic unfavourable (1.03e-6)"	"unprognostic (6.09e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.30e-3)"	"unprognostic (3.77e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.48e-1)"	"unprognostic (4.69e-2)"	13.7	25.5	20.6	11.5	25.7	18.6	12.5	34.6	32.9	11.3	14.6	16.5	7.3	10.2	13.7	10.4	11.7	9.5	10.1	16.6	19.2	19.3	9.7	37.7	8.5	14.1	18.8	21.1	23.8	7.9	20.0	20.8	13.8	33.0	13.5	15.0	9.1	8.7	12.0	26.3	10.7	9.9	16.1	22.5	8.8	12.9	25.4	22.2	28.6	8.0	10.8	14.7	12.6	9.7	8.6	8.4	6.0	8.7	11.7	10.0	3.6	25.9	25.1	53.9	23.1	12.8	20.1	12.5	29.8	18.1	28.4	30.2	20.4	8.8	28.3	10.5	20.0	29.5	38.6	16.9	35.7	25.5	29.5	47.2	20.1	19.6	9.5	36.0	19.8	10.2	9.0	15.9	34.5	21.4	33.3	26.6	23.4	17.9	30.6	9.3	29.0	20.2	32.5	57.4	24.8	9.1	16.0	25.1	21.4	40.5	14.5	14.8	26.7	9.8	18.4	27.6	24.4	46.7	43.9	15.1	32.6	40.8	17.3	17.1	27.0	5.4	5.7	6.0	9.0	8.7	8.8	8.6	6.7	10.0	8.4	8.0	8.2	8.5	0.9	11.7	7.8	5.4	7.5	3.6	20.6	25.7	34.6	31.2	19.2	19.3	18.8	21.1	33.0	22.2
CLDND1	"C3orf4, Z38"	ENSG00000080822	"Claudin domain containing 1"	Q9NY35	3	98497912-98523066	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 75.9;brain: 227.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029841	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA029841: AB_10600658"	"unprognostic (1.64e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.13e-2)"	"unprognostic (8.50e-2)"	"unprognostic (9.15e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.43e-3)"	"unprognostic (4.08e-2)"	"unprognostic (3.65e-2)"	"unprognostic (8.30e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.14e-1)"	"prognostic unfavourable (5.84e-6)"	"unprognostic (5.73e-3)"	"unprognostic (6.54e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.51e-1)"	14.7	12.4	61.6	10.7	76.1	11.7	14.1	11.9	77.1	14.1	10.4	100.5	3.3	10.0	16.9	12.6	22.6	10.9	14.3	15.9	85.4	52.3	11.0	14.0	12.2	13.6	133.4	28.9	19.1	5.8	7.0	6.7	20.5	72.7	14.6	13.6	4.9	6.8	15.7	9.7	17.6	9.4	18.5	227.4	11.5	7.5	28.5	95.4	4.3	11.5	4.7	14.8	14.7	11.1	19.9	19.7	28.1	18.6	49.5	75.9	28.6	17.9	7.3	23.0	14.1	27.8	21.7	12.5	14.3	19.6	20.1	27.8	14.8	18.4	9.0	19.3	13.7	24.4	17.6	10.8	35.2	21.2	7.5	18.8	5.2	13.3	22.2	16.9	18.7	25.3	58.5	15.7	16.8	21.8	9.3	27.8	28.2	9.4	12.4	11.2	20.0	15.6	8.4	30.9	11.5	18.7	8.2	8.3	22.9	19.7	6.6	28.2	6.6	14.3	20.1	26.2	24.2	17.8	18.5	36.8	15.7	14.5	43.8	16.3	33.4	28.1	18.6	19.8	21.7	10.7	40.8	19.9	40.9	39.8	19.7	16.4	16.6	16.9	13.8	49.5	10.5	12.7	75.9	28.6	61.6	76.1	11.9	38.8	85.4	52.3	133.4	28.9	72.7	95.4
CLN6	"FLJ20561, HsT18960, nclf"	ENSG00000128973	"CLN6, transmembrane ER protein"	Q9NWW5	15	68206992-68257211	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066046, HPA066759"	Approved		Approved	"Nucleoli,Endoplasmic reticulum,Vesicles"				"Endoplasmic reticulum"	"Nucleoli, Vesicles"	"HPA066046: , HPA066759: "	"unprognostic (1.01e-1)"	"unprognostic (1.54e-3)"	"unprognostic (7.01e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.85e-1)"	"prognostic favourable (4.87e-4)"	"unprognostic (1.22e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.78e-2)"	21.2	17.8	11.6	16.5	11.8	29.8	13.9	14.9	20.7	14.4	20.2	13.2	11.6	17.1	11.7	14.3	16.7	12.0	17.1	10.4	11.7	10.8	22.0	29.5	18.8	27.0	11.1	12.2	12.4	19.7	11.7	11.5	18.6	14.3	13.4	18.0	28.6	16.0	17.9	16.3	17.0	18.5	12.4	11.6	26.5	15.7	13.8	9.7	27.7	14.5	18.2	21.7	11.0	10.9	2.9	4.6	9.4	13.4	1.8	4.1	2.7	11.4	28.7	7.5	10.5	4.6	3.8	18.1	11.0	5.3	13.5	11.1	22.1	18.7	17.9	5.4	6.5	21.4	21.5	10.6	5.4	11.8	26.3	25.7	20.9	16.4	9.5	28.9	18.4	6.7	3.5	10.8	7.5	9.0	16.9	36.3	10.3	31.4	13.1	20.7	17.9	12.2	12.8	22.9	24.3	11.3	30.0	15.4	6.3	12.3	19.3	10.5	10.3	28.9	5.9	15.2	18.1	11.2	38.7	26.6	28.9	14.6	9.5	35.2	14.7	0.0	7.3	0.4	2.8	11.5	3.8	2.9	2.1	4.1	4.6	2.3	2.7	1.2	9.4	1.8	13.4	3.8	1.9	2.7	11.6	11.8	14.9	20.7	11.7	10.8	11.1	12.2	14.3	9.7
CMAS		ENSG00000111726	"Cytidine monophosphate N-acetylneuraminic acid synthetase"	Q8NFW8	12	22046174-22065674	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039905	Supported		Uncertain	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA039905: AB_10795237"	"unprognostic (5.54e-2)"	"unprognostic (4.10e-2)"	"unprognostic (4.25e-1)"	"unprognostic (5.39e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.44e-1)"	"unprognostic (7.53e-2)"	"prognostic unfavourable (7.19e-4)"	"unprognostic (2.27e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.03e-1)"	8.1	28.2	28.1	9.6	31.6	17.6	14.9	16.3	39.3	12.1	34.3	14.5	17.1	29.4	12.8	32.0	33.2	10.0	11.0	18.1	28.8	33.4	12.8	31.9	7.9	9.8	33.9	27.3	11.9	18.6	14.6	14.3	20.2	34.3	17.0	33.1	10.2	14.8	12.9	18.2	12.9	32.9	13.3	18.0	8.5	12.9	30.2	14.8	6.4	10.9	11.9	12.4	11.8	17.2	12.2	19.5	19.4	18.9	22.8	19.9	15.0	19.5	15.8	19.5	9.2	15.3	19.2	28.4	13.7	15.0	14.9	15.7	35.4	22.7	17.4	13.4	11.7	16.0	11.5	19.0	20.1	22.9	14.4	52.4	12.9	17.8	14.3	13.8	27.8	12.9	18.1	18.9	28.3	19.7	32.9	8.9	26.3	25.8	15.8	32.1	47.1	22.1	11.3	20.4	16.5	17.7	21.5	7.8	13.7	10.8	19.1	15.3	26.3	18.9	14.3	16.8	13.9	14.7	25.1	6.1	7.8	23.1	27.3	10.8	16.9	10.3	17.9	19.4	13.7	18.9	17.8	12.2	18.6	18.1	19.5	12.1	16.8	17.4	1.8	22.8	16.5	12.3	19.9	15.0	28.1	31.6	16.3	39.3	28.8	33.4	33.9	27.3	34.3	14.8
CMSS1	"C3orf26, MGC4308"	ENSG00000184220	"Cms1 ribosomal small subunit homolog (yeast)"	Q9BQ75	3	99817834-100181732	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042820	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli,Mitochondria"				Nucleoli	"Nucleoplasm, Nuclear membrane, Mitochondria"	"HPA042820: AB_10795763"	"unprognostic (1.50e-1)"	"unprognostic (8.28e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavourable (3.15e-6)"	"unprognostic (2.13e-2)"	"unprognostic (2.39e-3)"	"prognostic unfavourable (5.92e-10)"	"unprognostic (1.50e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.83e-2)"	"unprognostic (6.71e-2)"	"prognostic unfavourable (3.10e-4)"	"unprognostic (2.18e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.04e-2)"	21.4	34.1	23.7	15.1	24.5	17.7	20.6	24.1	27.4	13.4	12.9	9.4	8.2	8.3	19.6	10.7	12.0	13.3	10.5	16.6	24.0	22.2	17.1	17.5	10.8	15.8	15.3	22.3	21.1	26.4	20.7	25.9	11.7	19.2	15.1	12.4	9.3	12.4	14.5	58.2	11.5	9.3	13.8	15.7	12.9	11.0	28.1	13.5	13.6	14.9	14.4	14.7	18.8	15.7	23.5	26.1	1.6	10.9	11.2	19.0	7.9	28.5	12.9	12.8	18.4	9.1	10.7	13.2	13.3	7.2	24.0	20.0	16.0	9.6	30.9	23.4	7.1	17.3	17.7	15.1	31.7	16.0	16.9	24.4	9.2	13.0	16.3	33.3	13.4	7.3	14.7	17.9	29.9	16.5	15.0	20.1	17.3	19.7	26.6	31.1	18.7	32.5	12.0	20.7	33.1	14.8	7.0	36.1	15.2	13.3	10.9	30.3	13.1	20.8	4.7	19.0	54.0	11.0	27.0	14.4	28.6	60.1	12.3	36.9	31.7	0.3	4.7	0.8	10.0	10.9	14.2	23.2	14.8	13.5	9.9	23.5	18.7	19.0	1.6	11.2	9.7	26.1	13.7	7.9	23.7	24.5	24.1	27.4	24.0	22.2	15.3	22.3	19.2	13.5
COIL	"CLN80, p80-coilin"	ENSG00000121058	Coilin	P38432	17	56938187-56961054	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 58.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017524, HPA027885, HPA068537, CAB069400"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nuclear bodies"				Nucleoplasm	"Nucleoli, Nuclear bodies"	"CAB017524: AB_1121780, CAB069400: , HPA027885: , HPA068537: "	"unprognostic (1.01e-2)"	"unprognostic (3.05e-1)"	"prognostic favourable (1.77e-4)"	"unprognostic (1.90e-2)"	"unprognostic (3.19e-2)"	"unprognostic (4.13e-3)"	"prognostic unfavourable (1.28e-4)"	"unprognostic (1.64e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.00e-3)"	"unprognostic (2.50e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.92e-1)"	"unprognostic (3.36e-2)"	"unprognostic (7.71e-2)"	8.7	5.6	7.3	5.5	8.1	10.9	8.2	12.6	8.9	8.9	6.4	7.6	4.9	6.7	8.1	8.1	8.5	6.8	4.9	5.3	5.8	5.7	7.0	8.5	5.3	7.7	7.1	6.5	8.6	9.1	8.5	9.7	9.5	8.2	7.8	7.3	5.8	7.5	9.1	7.9	7.8	7.0	5.9	7.2	8.1	6.4	58.8	6.0	12.3	8.7	5.3	8.5	7.7	7.3	22.5	13.7	14.0	13.4	12.7	17.8	8.6	13.0	9.9	20.5	7.9	7.0	8.4	14.2	9.4	8.9	14.4	15.4	13.6	11.3	15.8	19.1	7.5	7.6	13.8	10.9	20.6	18.9	17.5	25.7	9.5	15.3	7.6	21.6	15.7	7.8	13.6	10.8	11.7	12.2	22.2	13.2	13.4	16.5	17.0	13.8	12.0	10.0	8.1	25.2	12.6	9.8	13.2	17.4	17.2	6.3	6.3	15.7	22.7	21.2	8.6	16.8	12.7	8.1	12.1	19.6	24.4	18.5	8.7	12.0	10.2	14.0	11.5	13.9	13.9	10.4	15.6	22.5	15.4	14.6	11.3	21.6	17.8	17.2	6.8	12.7	13.4	13.7	15.2	8.6	7.3	8.1	12.6	8.9	5.8	5.7	7.1	6.5	8.2	6.0
COMMD3-BMI1		ENSG00000269897	"COMMD3-BMI1 readthrough"		10	22316388-22329542	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA030471, HPA030472, HPA036584"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nucleoplasm, Nucleoli, Cytosol"	"HPA030471: , HPA030472: AB_10601090, HPA036584: AB_10670803"	"unprognostic (8.63e-2)"				"unprognostic (2.36e-2)"									"unprognostic (1.83e-2)"				8.5	12.4	4.5	6.6	9.1	2.8	6.9	5.1	8.5	9.7	11.9	4.7	8.3	4.9	4.0	5.9	9.4	8.3	4.3	14.3	4.7	4.1	5.5	6.9	8.0	5.0	6.6	4.7	4.3	11.4	5.7	8.7	4.7	5.7	5.0	2.8	4.2	8.3	14.6	22.8	4.8	7.6	7.0	7.3	7.3	7.6	23.4	6.6	12.3	3.7	7.6	6.4	12.0	5.4	25.0	30.3	25.7	25.8	18.8	21.6	26.6	3.8	13.8	4.8	0.5	5.6	3.8	0.7	3.9	4.3	2.1	5.5	7.6	1.5	1.9	5.7	13.0	1.8	5.1	8.4	0.7	15.2	1.7	5.2	2.9	3.3	17.1	0.4	2.4	6.7	4.8	7.6	4.0	5.3	1.0	5.4	0.6	3.7	15.6	0.5	0.5	4.3	4.4	5.3	4.2	2.1	4.7	0.5	1.7	7.4	1.8	1.6	3.4	3.8	7.0	1.7	5.4	0.3	1.0	11.6	14.0	6.1	2.6	11.6	1.7	25.7	25.8	17.2	15.1	23.5	16.6	25.0	16.1	14.7	30.3	21.9	11.0	12.2	3.8	18.8	17.8	29.2	21.6	26.6	4.5	9.1	5.1	8.5	4.7	4.1	6.6	4.7	5.7	6.6
COQ5	MGC4767	ENSG00000110871	"Coenzyme Q5, methyltransferase"	Q5HYK3	12	120503274-120534434	"Enzymes, Predicted intracellular proteins"	"Ubiquinone biosynthesis"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049487	Approved		Uncertain	Nucleoli,Mitochondria				Nucleoli	Mitochondria	"HPA049487: "	"unprognostic (1.46e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.30e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.37e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.02e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.88e-2)"	14.6	21.7	15.8	16.1	16.7	7.0	29.5	15.6	21.3	12.5	16.4	13.5	21.8	15.7	12.6	16.4	14.0	15.5	13.5	31.9	14.8	13.1	26.0	39.8	17.6	19.1	17.5	15.4	15.1	28.6	14.2	13.4	18.6	19.4	12.7	17.1	11.6	17.9	17.8	58.4	11.1	13.2	14.0	18.5	14.6	12.4	16.9	15.0	17.2	17.7	30.4	15.2	10.1	17.0	21.3	27.4	9.7	19.6	25.1	28.2	22.4	16.3	26.2	23.7	6.8	31.2	24.1	16.3	20.0	13.1	20.5	13.0	10.5	13.8	16.5	23.7	20.9	17.7	21.0	22.2	21.1	20.6	12.4	22.0	16.1	17.3	25.6	23.9	13.8	23.0	24.1	19.1	22.5	18.0	21.5	12.1	23.6	21.5	13.8	27.5	20.8	20.4	25.6	24.0	23.9	26.4	12.5	17.9	14.4	14.5	7.4	27.2	37.2	19.7	17.9	14.2	16.3	10.5	13.2	26.2	22.0	18.8	16.2	22.7	17.0	9.4	19.6	9.7	18.8	19.2	18.2	21.1	20.4	19.9	27.4	21.3	28.2	22.3	2.1	25.1	17.9	18.0	24.4	22.4	15.8	16.7	15.6	21.3	14.8	13.1	17.5	15.4	19.4	15.0
COX10		ENSG00000006695	"COX10, heme A:farnesyltransferase cytochrome c oxidase assembly factor"	Q12887	17	14069496-14208677	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Heme biosynthesis"	Transferase	"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 34.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032005, HPA032006"	Supported		Supported	Nucleoli,Mitochondria,Cytosol				Mitochondria	"Nucleoli, Cytosol"	"HPA032005: AB_10603560, HPA032006: AB_10670554"	"unprognostic (6.17e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.40e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.07e-1)"	"unprognostic (9.46e-3)"	"unprognostic (6.46e-2)"	"prognostic favourable (4.32e-6)"	"prognostic favourable (8.73e-4)"	"unprognostic (8.82e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.71e-2)"	5.5	6.9	5.3	5.7	6.5	7.0	5.4	6.5	7.2	4.4	11.8	4.1	2.9	9.7	5.1	3.6	9.4	4.8	3.5	18.9	5.8	3.8	10.0	9.3	5.2	8.4	4.5	2.8	4.9	9.6	7.2	6.4	6.6	5.7	5.2	10.1	5.5	6.7	4.8	34.9	6.0	10.9	7.2	4.0	4.6	7.7	15.5	4.9	5.9	5.2	9.6	7.4	7.2	5.8	11.9	13.6	4.0	14.1	8.8	17.5	9.8	8.6	16.6	6.9	9.9	6.9	6.3	15.7	10.5	7.4	19.2	13.3	14.5	6.4	20.4	8.3	10.5	16.7	14.1	13.5	15.5	11.0	14.1	12.1	13.4	16.0	12.2	12.5	11.4	9.1	17.0	12.0	15.3	10.1	16.4	7.0	8.4	10.7	10.6	8.2	10.5	8.6	8.9	23.4	14.4	12.1	16.2	5.2	8.8	10.8	14.4	13.0	8.1	7.1	8.3	8.4	7.0	8.5	13.2	8.5	11.9	9.2	12.6	13.0	10.3	3.0	10.6	4.0	9.9	14.1	10.4	11.9	11.6	10.3	13.6	8.2	12.6	11.9	1.2	8.8	11.9	4.6	17.5	9.8	5.3	6.5	6.5	7.2	5.8	3.8	4.5	2.8	5.7	4.9
COX7A2L	"COX7AR, COX7RP, EB1, SIG81"	ENSG00000115944	"Cytochrome c oxidase subunit 7A2 like"	O14548	2	42333546-42425088	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059124, CAB073545"			Enhanced	Nucleoli,Mitochondria				Mitochondria	Nucleoli	"CAB073545: , HPA059124: "	"unprognostic (3.90e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.45e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.27e-2)"	"prognostic unfavourable (4.13e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.76e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.02e-1)"	25.1	73.3	47.3	24.4	63.3	47.7	45.4	35.2	58.2	33.4	33.8	21.0	28.8	31.7	30.2	37.9	20.9	31.2	27.1	49.8	40.4	45.3	50.9	48.9	24.0	28.1	42.6	35.6	49.8	49.3	24.9	42.7	24.0	34.9	29.5	36.2	32.3	37.0	30.3	24.4	21.5	32.1	28.4	33.1	23.1	29.4	24.8	20.5	28.0	35.8	35.8	30.9	24.5	31.1	45.1	59.7	57.2	48.7	40.5	53.7	100.9	37.5	24.1	26.8	29.0	46.0	65.6	32.0	31.2	45.6	28.5	36.4	26.4	27.2	33.3	31.3	35.7	16.9	31.9	33.0	41.8	51.2	24.5	22.5	17.3	46.8	54.2	33.8	25.1	64.3	66.6	27.9	67.4	40.1	32.8	57.2	44.1	30.6	40.3	56.3	26.2	25.1	22.0	46.5	28.3	40.8	30.5	31.8	36.4	13.1	32.9	89.4	23.6	39.5	30.2	25.9	33.9	31.3	30.4	47.0	52.5	25.0	36.6	36.8	21.9	57.2	48.7	27.2	39.0	42.0	50.0	45.1	47.9	45.3	53.1	37.6	53.7	46.1	21.6	40.5	46.3	59.7	52.8	100.9	47.3	63.3	35.2	58.2	40.4	45.3	42.6	35.6	34.9	20.5
CPNE3		ENSG00000085719	"Copine 3"	O75131	8	86514427-86561498	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029552	Uncertain		Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol			52000	"Nucleoplasm, Cytosol"	"Nucleoli, Mitochondria"	"HPA029552: AB_10600703"	"unprognostic (5.63e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.95e-2)"	"unprognostic (4.22e-3)"	"unprognostic (9.92e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.40e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.64e-3)"	"unprognostic (2.77e-1)"	"prognostic favourable (5.07e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.13e-2)"	26.5	16.6	21.3	9.8	18.0	35.1	20.6	18.8	13.5	26.0	16.4	20.9	13.2	15.1	28.6	12.6	40.5	15.9	14.6	24.4	17.6	19.7	29.8	25.5	16.9	22.6	19.7	10.5	26.7	24.1	25.4	28.9	16.1	17.0	22.4	16.5	21.0	20.6	15.3	10.4	18.7	19.5	20.9	18.7	18.3	16.9	9.7	14.1	30.5	33.6	21.8	29.7	25.4	20.0	14.6	31.4	28.2	24.3	15.0	18.3	14.4	34.3	12.1	8.4	10.9	32.4	25.3	6.9	16.5	24.6	13.8	15.7	7.8	11.8	9.4	11.0	20.1	26.6	18.0	17.6	24.9	10.0	14.1	1.5	8.9	9.3	11.2	0.8	0.8	17.1	19.0	15.3	20.4	16.9	8.4	18.2	17.1	13.3	16.5	0.5	3.2	17.6	7.9	7.7	44.0	17.9	24.7	17.8	14.0	14.4	66.0	10.4	25.1	2.6	18.0	12.4	12.1	16.4	12.8	13.0	15.6	2.6	17.8	3.5	11.4	10.8	16.7	26.4	18.3	19.1	14.2	14.6	14.8	12.8	30.8	14.1	13.3	14.3	28.2	15.0	24.3	31.4	10.5	14.4	21.3	18.0	18.8	13.5	17.6	19.7	19.7	10.5	17.0	14.1
CPS1		ENSG00000021826	"Carbamoyl-phosphate synthase 1"	P31327	2	210477682-210679107	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Urea cycle"	"Allosteric enzyme, Ligase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"liver: 298.3"	"Cell line enhanced"	"Detected in many"		"HeLa: 88.4;SK-BR-3: 26.7"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 136.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB003781, HPA021400"	Enhanced		Supported	Nucleoli			2100000	Nucleoli		"CAB003781: , HPA021400: AB_1847197"	"unprognostic (1.67e-2)"	"unprognostic (3.72e-2)"	"unprognostic (4.02e-2)"	"unprognostic (7.21e-7)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-1)"	"prognostic favourable (6.93e-5)"	"unprognostic (1.23e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.94e-3)"	"unprognostic (2.38e-4)"	"unprognostic (5.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.74e-2)"	0.4	0.1	0.5	0.3	1.6	0.0	0.8	0.3	0.7	0.4	0.2	0.7	0.3	31.5	0.3	0.7	0.5	0.2	0.4	0.3	0.5	0.4	0.6	298.3	0.2	0.3	1.5	0.8	0.7	0.2	0.0	0.4	1.1	1.4	0.3	0.0	0.6	0.2	0.2	0.3	0.3	17.2	0.4	2.3	0.3	0.2	1.3	0.5	0.0	0.4	0.4	0.1	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.3	2.3	6.2	4.2	4.1	7.2	6.6	2.2	2.7	2.6	4.1	0.6	0.0	1.0	0.1	2.4	1.1	0.2	3.7	6.6	0.0	1.9	3.9	88.4	5.5	1.3	2.0	0.0	3.7	2.8	5.2	5.3	0.2	3.9	0.3	4.3	1.1	0.1	0.2	2.4	0.6	0.2	5.7	0.5	5.6	0.0	0.1	0.4	15.5	26.7	3.0	0.0	0.6	2.9	6.8	2.1	2.0	4.8	0.0	0.3	0.0	4.5	4.3	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.3	0.7	0.5	0.4	1.5	0.8	1.4	0.5
CPT2	"CPT1, CPTASE"	ENSG00000157184	"Carnitine palmitoyltransferase 2"	P23786	1	53196429-53214197	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028201, HPA028202, HPA028214"	Enhanced		Supported	Nucleoplasm,Nucleoli,Mitochondria				"Nucleoplasm, Nucleoli, Mitochondria"		"HPA028201: AB_10599177, HPA028202: AB_10599942, HPA028214: AB_10601958"	"unprognostic (2.43e-1)"	"unprognostic (2.27e-1)"	"prognostic favourable (5.27e-4)"	"unprognostic (6.48e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.34e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.97e-2)"	"prognostic favourable (1.46e-12)"	"unprognostic (4.00e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.95e-2)"	7.5	15.5	5.3	6.8	6.1	2.3	6.5	4.0	7.2	5.1	15.4	9.4	10.7	16.6	5.1	7.6	10.5	5.4	11.3	21.4	4.3	4.5	19.8	69.0	6.9	8.3	5.7	3.7	5.3	15.9	10.7	11.5	18.1	6.4	6.0	15.6	13.8	11.8	12.2	13.6	6.0	18.9	5.5	5.2	10.3	10.1	11.2	4.7	9.7	8.3	7.2	10.3	8.0	4.9	5.9	12.4	10.0	13.1	4.8	8.0	6.5	7.8	3.3	7.7	7.5	6.6	3.9	8.8	4.9	5.0	7.1	6.6	1.6	6.7	13.5	7.5	2.3	7.9	14.3	11.3	6.0	7.4	8.4	7.7	4.5	1.3	9.8	7.3	7.4	8.4	9.7	5.1	4.4	4.8	9.8	4.8	4.4	4.6	5.7	6.0	14.4	8.8	6.6	7.3	14.3	8.8	7.4	11.5	7.7	9.8	12.5	18.5	14.5	15.6	4.7	4.0	3.2	7.0	4.0	14.9	9.1	8.3	5.1	8.4	5.8	4.1	8.4	10.0	5.1	12.6	6.2	4.5	4.9	5.9	12.4	5.9	8.0	5.5	5.1	4.8	13.1	6.4	7.0	6.5	5.3	6.1	4.0	7.2	4.3	4.5	5.7	3.7	6.4	4.7
CRAMP1	"CRAMP1L, KIAA1426"	ENSG00000007545	"Cramped chromatin regulator homolog 1"	Q96RY5	16	1612325-1677908	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041752	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA041752: AB_10796459"	"unprognostic (3.67e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.25e-3)"	"unprognostic (5.78e-4)"	"unprognostic (4.17e-2)"	"unprognostic (8.53e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.93e-2)"	"unprognostic (3.86e-3)"	"prognostic favourable (4.93e-4)"	"unprognostic (8.57e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.33e-2)"	8.5	6.4	9.2	10.5	9.3	13.9	11.6	24.2	11.0	8.4	8.8	11.1	5.1	7.2	11.4	8.3	8.6	9.9	6.5	7.2	8.6	5.4	6.5	4.7	9.2	8.0	9.7	10.5	12.3	9.2	10.2	10.9	8.4	9.4	9.8	7.1	9.8	8.4	9.5	8.9	13.7	8.4	8.8	7.9	9.4	8.5	21.9	9.8	18.1	11.8	4.4	7.5	10.6	11.7	0.8	2.1	0.5	0.6	2.5	1.9	0.5	5.2	8.6	10.9	10.3	7.3	7.3	12.6	6.2	5.4	8.4	6.0	7.9	9.0	5.3	5.9	7.1	8.9	13.0	6.3	7.7	6.4	13.5	8.3	9.9	4.9	5.3	11.7	13.5	6.3	8.6	10.0	8.1	8.3	11.1	4.1	4.6	8.7	7.7	7.2	8.7	5.3	30.0	5.2	9.2	5.5	5.4	11.4	8.1	9.2	7.6	4.9	6.1	16.2	9.4	8.0	7.8	6.8	7.8	7.0	10.1	13.5	2.7	7.8	7.1	0.4	0.6	0.0	1.9	0.6	0.9	0.8	0.6	0.6	0.3	0.8	0.9	0.9	0.5	2.5	0.2	2.1	0.3	0.5	9.2	9.3	24.2	11.0	8.6	5.4	9.7	10.5	9.4	9.8
CRELD1	AVSD2	ENSG00000163703	"Cysteine rich with EGF like domains 1"	Q96HD1	3	9933822-9945413	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 48.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026964	Uncertain		Approved	Nucleoli,Cytosol	"Intracellular and membrane"		16000000	Cytosol	Nucleoli	"HPA026964: AB_10602210"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavourable (8.07e-4)"	"unprognostic (3.03e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.31e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.78e-2)"	21.8	22.9	31.6	15.3	32.4	7.3	27.3	52.2	45.1	9.9	22.4	12.0	17.1	12.5	15.1	17.8	13.1	20.1	15.8	50.2	25.6	24.9	16.6	23.5	15.8	11.0	17.2	30.7	19.7	15.2	21.9	32.4	15.1	27.2	25.4	11.4	10.0	19.4	32.2	24.4	11.6	13.1	19.5	19.4	11.9	14.8	11.1	22.3	5.9	45.7	7.4	8.2	17.8	15.6	10.5	13.7	11.5	12.5	13.4	14.3	10.4	2.8	5.3	8.7	4.5	14.7	9.6	48.1	10.6	3.2	2.6	5.0	5.1	8.7	3.5	23.4	7.4	1.9	4.2	7.7	1.8	6.9	3.9	3.2	6.9	12.0	29.4	1.1	12.3	9.8	14.2	6.6	6.0	12.1	3.8	4.2	2.5	6.9	2.0	8.6	2.3	3.6	2.1	1.3	8.3	11.3	5.0	3.5	11.2	4.9	4.6	9.5	11.7	6.9	8.4	5.1	8.2	6.7	2.5	4.8	6.2	6.5	11.4	3.6	5.4	11.5	11.4	9.4	14.2	11.6	14.3	8.9	10.5	13.7	8.2	10.5	14.2	12.7	1.8	13.4	12.5	13.7	8.0	10.4	31.6	32.4	52.2	45.1	25.6	24.9	17.2	30.7	27.2	22.3
CRIP2	"CRP2, ESP1"	ENSG00000182809	"Cysteine rich protein 2"	P52943	14	105472962-105480170	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"heart muscle: 180.3"	"Cell line enhanced"	"Detected in many"		"A549: 37.7;EFO-21: 38.6;HUVEC TERT2: 36.1;MCF7: 55.4;SK-BR-3: 43.4;T-47d: 37.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory CD4 T-cell: 24.0;T-reg: 29.2"	"Group enriched"	"Detected in many"	19	"B-cells: 17.9;T-cells: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042664	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"			490000	Nucleoli	"Nucleoplasm, Plasma membrane"	"HPA042664: AB_10797017"	"unprognostic (2.68e-1)"	"unprognostic (6.53e-3)"	"unprognostic (2.11e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.68e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.39e-2)"	"unprognostic (8.26e-3)"	22.8	11.5	27.5	9.1	24.6	1.6	16.9	3.6	30.3	20.2	10.1	9.4	33.7	7.9	15.3	30.6	25.6	29.5	24.5	180.3	22.6	18.7	20.0	6.9	28.5	9.3	13.5	16.9	12.5	12.6	4.3	20.4	29.1	10.4	14.6	3.8	8.8	18.4	28.0	10.7	28.4	9.1	24.9	10.3	13.0	11.3	10.9	7.8	1.0	17.8	23.8	13.3	23.8	17.5	17.9	0.9	0.2	0.5	1.2	29.2	3.4	0.4	37.7	5.5	15.0	0.9	3.9	1.6	1.7	0.4	0.5	0.1	1.1	7.0	0.0	38.6	12.3	21.6	0.7	9.2	0.0	0.2	0.2	0.0	23.7	14.3	4.0	0.0	3.2	1.9	0.8	0.9	5.1	36.1	0.0	0.3	5.4	55.4	0.1	0.1	1.5	22.7	0.0	0.7	1.6	25.4	0.1	8.4	20.9	2.4	43.4	0.3	37.2	0.0	14.0	12.5	5.9	0.3	7.0	0.1	0.1	0.1	3.6	0.0	25.2	0.0	0.5	0.0	2.4	0.2	2.3	14.4	24.0	5.3	0.9	17.9	5.9	1.6	0.2	1.2	0.1	0.1	29.2	3.4	27.5	24.6	3.6	30.3	22.6	18.7	13.5	16.9	10.4	7.8
CRISPLD2	"DKFZP434B044, LCRISP2, LGL1"	ENSG00000103196	"Cysteine rich secretory protein LCCL domain containing 2"	Q9H0B8	16	84819984-84920768	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 14.9;BEWO: 23.2;HHSteC: 55.4;HSkMC: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 36.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 36.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA030054, HPA030055"	Approved		Approved	Nucleoplasm,Nucleoli	"Secreted to blood"	219300000000		"Nucleoplasm, Nucleoli"		"HPA030054: , HPA030055: AB_10611821"	"unprognostic (8.91e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.58e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.87e-2)"	"prognostic unfavourable (1.97e-6)"	"unprognostic (7.35e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.15e-3)"	29.2	11.6	2.2	41.1	5.0	3.0	57.2	2.1	3.6	44.1	26.0	2.5	10.6	4.2	38.5	58.7	21.1	43.6	107.4	19.1	2.1	2.0	10.1	6.7	31.0	21.4	5.5	1.6	37.1	9.1	1.0	6.4	50.2	7.1	31.6	7.3	21.9	6.8	23.6	15.9	12.0	17.5	48.0	8.6	10.0	22.5	16.8	3.1	0.4	15.9	11.4	3.3	40.3	32.7	0.0	0.5	36.0	7.9	0.0	0.1	1.3	0.3	0.7	0.2	2.0	14.9	5.6	23.2	11.3	10.0	9.1	6.4	1.5	0.9	0.0	1.0	9.9	0.3	0.0	0.0	9.2	0.0	0.0	0.1	0.2	0.0	55.4	0.0	0.1	23.3	0.0	2.6	0.0	0.0	0.1	0.1	1.0	0.4	0.1	0.5	0.6	0.6	0.0	0.1	0.1	0.1	1.7	2.2	0.1	2.6	1.2	0.2	4.5	0.3	1.3	0.1	0.6	9.5	0.3	0.1	0.0	1.9	0.0	0.2	1.3	4.4	7.9	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	36.0	0.0	0.0	0.0	0.0	1.3	2.2	5.0	2.1	3.6	2.1	2.0	5.5	1.6	7.1	3.1
CRYL1	"GDH, lambda-CRY, MGC149525, MGC149526"	ENSG00000165475	"Crystallin lambda 1"	Q9Y2S2	13	20403666-20525873	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 104.0;liver: 80.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040403	Enhanced		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane"			210000	"Nucleoplasm, Nucleoli"	"Golgi apparatus, Plasma membrane"	"HPA040403: AB_10795632"	"unprognostic (1.84e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.25e-2)"	"prognostic favourable (1.76e-5)"	"unprognostic (3.10e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-3)"	"unprognostic (4.75e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.80e-2)"	"prognostic favourable (2.30e-9)"	"unprognostic (9.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.11e-1)"	9.8	8.9	21.5	8.8	22.9	3.5	7.0	10.4	17.4	11.8	35.1	26.7	18.9	61.0	9.2	18.0	7.4	9.3	16.1	9.3	18.8	19.8	104.0	80.8	6.8	5.9	24.5	12.3	7.3	15.4	5.3	10.4	5.6	16.8	11.2	16.5	17.2	13.1	20.1	5.4	4.1	45.7	8.0	32.0	6.5	12.0	2.7	16.4	3.2	11.9	5.6	5.5	8.6	5.9	9.3	25.7	1.8	24.3	6.0	15.6	17.5	3.4	3.0	2.6	19.0	14.5	16.8	2.6	4.9	8.8	2.1	1.7	1.1	3.2	0.0	9.3	6.7	0.8	2.5	4.4	2.2	8.3	2.1	6.1	0.3	23.7	8.3	1.9	5.5	9.9	2.8	1.6	10.0	23.0	0.4	2.4	5.6	12.5	5.2	3.1	0.1	4.6	2.7	1.7	0.4	18.3	7.4	1.8	2.2	2.9	1.4	21.8	9.4	7.8	22.0	2.7	1.2	6.5	3.0	3.4	0.7	0.0	5.1	3.4	10.9	1.8	21.8	1.4	10.5	24.3	8.5	9.3	14.0	10.0	25.7	9.1	11.0	10.2	0.7	6.0	20.1	2.8	15.6	17.5	21.5	22.9	10.4	17.4	18.8	19.8	24.5	12.3	16.8	16.4
CSRNP3	"FAM130A2, FLJ32093, PPP1R73, TAIP-2"	ENSG00000178662	"Cysteine and serine rich nuclear protein 3"	Q8WYN3	2	165469647-165689407	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 31.7;pituitary gland: 21.1"	"Cell line enhanced"	"Detected in some"		"AF22: 12.7;PC-3: 3.1;SCLC-21H: 9.3;SH-SY5Y: 7.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017905	Supported		Uncertain	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA017905: AB_1857757"	"unprognostic (2.85e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.61e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.82e-3)"	"unprognostic (7.41e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.08e-2)"	2.1	5.5	9.3	1.4	24.9	0.7	6.7	8.8	31.7	5.7	2.0	3.2	0.4	2.1	6.3	2.3	2.0	2.5	2.5	3.4	9.3	10.2	3.7	1.8	1.4	1.1	5.3	13.2	7.8	8.0	6.0	21.1	1.1	7.8	3.9	2.5	4.0	4.9	5.1	0.9	2.1	1.7	5.7	2.9	2.1	2.0	1.9	4.8	0.0	5.3	0.0	1.0	1.9	2.5	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.2	0.6	0.2	0.6	0.0	0.4	0.2	0.6	0.0	0.0	0.9	0.6	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	3.1	0.0	0.0	0.7	0.7	0.0	9.3	7.6	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.3	0.0	0.3	0.6	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.3	24.9	8.8	31.7	9.3	10.2	5.3	13.2	7.8	4.8
CSTB	"CST6, EPM1, PME, STFB"	ENSG00000160213	"Cystatin B"	P04080	21	43772511-43776445	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 365.3;lymphoid tissue: 130.6;tongue: 138.8"	"Cell line enhanced"	"Detected in all"		"RT4: 90.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017380, CAB047320, HPA058557"	Enhanced		Supported	Nucleoli,Cytosol			6100000	Cytosol	Nucleoli	"CAB047320: , HPA017380: AB_1847414, HPA058557: "	"unprognostic (1.69e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.05e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavourable (6.66e-5)"	"unprognostic (1.90e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (2.10e-4)"	"unprognostic (3.63e-1)"	"unprognostic (4.88e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.24e-1)"	21.1	7.5	5.6	6.1	5.9	3.2	13.6	3.0	5.3	57.8	8.8	4.4	3.9	5.6	6.1	6.4	365.3	6.0	7.2	6.5	4.6	5.0	9.6	17.3	17.2	11.2	5.3	4.9	7.8	5.0	3.2	7.6	5.2	5.8	7.1	7.2	7.8	65.2	6.2	4.8	9.4	7.5	6.3	5.1	7.4	10.4	4.1	4.1	8.6	11.6	138.8	130.6	14.0	81.5	11.4	43.2	25.4	69.1	7.7	22.3	21.3	57.8	17.5	5.8	7.3	30.9	25.4	14.4	12.5	14.5	7.9	7.9	13.5	32.5	4.7	9.7	19.5	10.4	13.3	14.0	5.0	19.4	15.8	13.1	13.5	15.6	27.6	3.2	10.9	26.9	14.6	21.8	10.8	11.0	9.7	25.8	11.6	14.6	4.1	10.1	14.0	30.2	6.8	3.3	53.1	22.7	90.4	5.5	4.9	16.5	8.8	35.2	8.2	8.1	16.9	13.2	6.9	12.3	7.9	6.4	11.2	8.7	57.4	15.2	9.2	16.8	28.2	16.9	14.5	45.9	13.3	11.4	18.6	15.0	43.2	9.7	13.2	13.0	25.4	7.7	69.1	5.3	22.3	21.3	5.6	5.9	3.0	5.3	4.6	5.0	5.3	4.9	5.8	4.1
CT45A1	"CT45-1, CT45.1"	ENSG00000268940	"Cancer/testis antigen family 45 member A1"	Q5HYN5	X	135713453-135723539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	17	"testis: 12.5"	"Group enriched"	"Detected in some"	7	"HMC-1: 68.4;Karpas-707: 31.7"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA044735: , HPA044757: , HPA046872: , HPA046987: "										"unprognostic (6.58e-3)"					"unprognostic (2.14e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.4	0.0	0.0	0.0	0.0	0.0	0.5	31.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	6.4	0.0	0.0	0.5	6.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT45A10		ENSG00000269586	"Cancer/testis antigen family 45 member A10"	P0DMU9	X	135881063-135889086	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	21	"testis: 14.1"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 32.5;K-562: 9.7;Karpas-707: 36.1;U-266/84: 30.3"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA044735: , HPA044757: , HPA046872: , HPA046987: "					"unprognostic (3.55e-1)"					"unprognostic (7.08e-3)"					"unprognostic (2.08e-1)"			0.0	0.0		0.0		0.0	0.0		0.6	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	14.1			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	32.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	9.7	36.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	7.1	30.3	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT45A2	"CT45-2, CT45.2"	ENSG00000271449	"Cancer/testis antigen family 45 member A2"	Q5DJT8	X	135811668-135820012	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	42	"testis: 4.2"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 32.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA044735: , HPA044757: , HPA046872: , HPA046987: "																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	4.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.0	0.0	0.0	0.0	0.0	0.0	3.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT45A3	"CT45-3, CT45-4, CT45.3, CT45.4, CT45A4"	ENSG00000269096	"Cancer/testis antigen family 45 member A3"	Q8NHU0	X	135759846-135768191	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	13	"testis: 15.6"	"Cell line enhanced"	"Detected in some"		"HMC-1: 29.2;T-47d: 17.1;U-266/84: 88.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA044735: , HPA044757: , HPA046872: , HPA046987: "																		0.0	0.0		0.0		0.0	0.0		0.5	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	1.1	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	15.6			0.0		0.0	0.0		0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	0.1	0.0	0.0	0.6	0.0	0.0	0.1	88.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT45A5	"CT45-5, CT45.5"	ENSG00000228836	"Cancer/testis antigen family 45 member A5"	P0DMU8	X	135777130-135785298	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	14	"testis: 10.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 17.9;Karpas-707: 12.5;U-266/84: 64.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA044735: , HPA044757: , HPA046872: , HPA046987: "																		0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.5			0.0		0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	17.9	0.0	0.0	0.0	0.0	0.0	1.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	2.4	0.0	0.0	0.9	64.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT45A6	"CT45-6, CT45.6"	ENSG00000278289	"Cancer/testis antigen family 45 member A6"	P0DMU7	X	135794706-135802656	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	5	"testis: 2.9"	"Cell line enriched"	"Detected in some"	9	"U-266/84: 46.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA044735: , HPA044757: , HPA046872: , HPA046987: "																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0	0.0	0.6	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	2.9			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT45A7		ENSG00000273696	"Cancer/testis antigen family 45 member A7"	P0DMV0	X	135829247-135837268	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	5	"testis: 4.1"	"Cell line enhanced"	"Detected in some"		"HMC-1: 4.0;Karpas-707: 3.4;PC-3: 1.0;THP-1: 1.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA044735: , HPA044757: , HPA046872: , HPA046987: "																		0.4	0.0		0.0		0.0	0.0		0.8	0.0	0.0			0.1	0.0	0.0	0.5	0.0	0.0	0.0			0.0	0.0	0.6	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.0	4.1			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.7	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT45A8		ENSG00000278085	"Cancer/testis antigen family 45 member A8"	P0DMV1	X	135846499-135854538	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	16	"testis: 3.9"	"Group enriched"	"Detected in some"	5	"AN3-CA: 13.8;HMC-1: 29.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA044735: , HPA044757: , HPA046872: , HPA046987: "																		0.0	0.0		0.0		0.0	0.0		0.2	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	3.9			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CT45A9		ENSG00000270946	"Cancer/testis antigen family 45 member A9"	P0DMV2	X	135863776-135871812	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	17	"testis: 4.0"	"Cell line enriched"	"Detected in some"	9	"HMC-1: 54.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044735, HPA044757, HPA046872, HPA046987"	Supported		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA044735: , HPA044757: , HPA046872: , HPA046987: "																		0.0	0.0		0.0		0.0	0.0		0.2	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	4.0			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CTSB		ENSG00000164733	"Cathepsin B"	P07858	8	11842524-11869448	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 297.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 237.0;fHDF/TERT166: 137.7"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 1446.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 53.1;classical monocyte: 127.4;intermediate monocyte: 97.0;myeloid DC: 68.0;non-classical monocyte: 54.7;plasmacytoid DC: 95.4"	"Group enriched"	"Detected in all"	5	"dendritic cells: 95.4;granulocytes: 53.1;monocytes: 127.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000457, HPA018156, HPA048998"	Enhanced		Supported	Nucleoli,Vesicles	"Secreted to blood"		130000000	Vesicles	Nucleoli	"CAB000457: , HPA018156: AB_1846069, HPA048998: "	"unprognostic (5.74e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.98e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.61e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.12e-2)"	"prognostic favourable (5.76e-4)"	"prognostic unfavourable (9.02e-4)"	227.9	42.1	19.6	67.2	24.4	14.7	67.6	14.9	31.4	76.7	49.1	30.1	22.7	29.9	53.2	44.8	54.2	52.4	43.6	120.7	18.3	23.7	95.6	167.8	94.3	175.1	29.1	16.5	44.2	31.6	13.8	21.6	68.7	24.8	42.6	27.9	33.8	63.7	33.6	41.3	22.8	51.2	51.1	35.9	116.4	26.7	21.5	20.4	18.1	297.0	25.9	38.4	56.8	62.2	7.9	95.4	53.1	127.4	5.3	17.1	108.5	6.4	29.1	3.7	16.0	65.8	74.1	11.6	121.4	237.0	42.5	50.4	13.9	37.9	0.1	17.6	137.7	35.4	5.1	33.5	26.9	3.1	5.0	9.4	3.4	34.1	67.0	2.1	7.0	81.1	45.7	38.4	34.4	83.1	7.8	21.5	35.3	5.1	0.8	3.4	3.1	9.8	3.3	3.8	16.4	12.9	10.1	1.6	9.5	14.0	7.6	63.3	12.3	6.3	115.1	72.3	24.5	23.1	22.6	21.4	15.5	0.5	82.9	8.1	33.8	53.1	127.4	16.3	5.2	97.0	7.2	7.9	17.1	5.8	68.0	6.1	9.6	4.1	18.5	5.3	54.7	95.4	13.4	108.5	19.6	24.4	14.9	28.0	18.3	23.7	29.1	16.5	24.8	20.4
CUL1		ENSG00000055130	"Cullin 1"	Q13616	7	148697914-148801036	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002676, HPA064584"	Supported		Supported	Nucleoplasm,Nucleoli			190000	Nucleoplasm	Nucleoli	"CAB002676: , HPA064584: "	"unprognostic (3.59e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.23e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.06e-3)"	"unprognostic (9.45e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.24e-3)"	26.0	20.9	21.2	20.4	22.4	22.3	27.5	27.5	26.2	23.9	25.8	19.5	22.5	16.7	30.2	23.7	22.7	21.2	18.7	25.7	21.1	21.8	16.9	35.2	20.5	26.5	21.7	16.7	25.0	17.9	24.9	30.7	32.0	21.0	23.9	18.8	22.7	19.6	25.0	58.9	20.5	21.2	37.7	26.3	21.9	22.4	65.6	23.7	16.9	24.5	24.6	24.5	26.1	28.8	16.8	24.1	13.4	17.1	22.1	20.8	16.1	30.7	23.9	23.5	36.3	18.5	20.8	29.8	25.4	30.0	25.7	24.5	25.4	21.5	42.2	20.4	25.1	20.8	33.5	23.7	30.3	27.5	28.5	24.9	16.9	24.6	21.7	28.2	23.7	17.0	23.3	18.8	19.1	28.0	38.4	32.6	28.0	29.4	24.5	32.3	44.0	22.9	29.8	20.7	40.6	21.1	22.5	33.8	24.8	29.6	35.3	20.0	11.6	22.4	21.5	18.4	6.4	37.2	29.2	30.6	21.2	41.8	37.4	31.5	27.1	13.4	15.2	12.0	16.1	17.1	18.6	16.8	16.7	18.6	24.1	14.4	20.8	16.7	2.1	22.1	14.5	5.5	15.9	16.1	21.2	22.4	27.5	26.2	21.1	21.8	21.7	16.7	21.0	23.7
CUTC	CGI-32	ENSG00000119929	"CutC copper transporter"	Q9NTM9	10	99702558-99756134	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 122.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038619	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Cytosol"	Nucleoli	"HPA038619: AB_10672649"	"unprognostic (1.25e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.67e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (3.81e-7)"	"unprognostic (1.00e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.97e-1)"	11.6	4.9	5.7	9.8	8.7	7.9	9.8	3.5	6.5	5.3	5.9	7.2	3.5	4.4	4.9	8.0	6.2	5.1	5.8	13.2	5.9	4.7	5.3	11.0	5.1	7.9	8.6	6.6	4.6	4.5	3.5	3.6	4.5	5.5	6.0	6.4	6.9	5.7	5.4	122.1	5.8	6.2	11.6	7.4	9.2	6.0	14.1	8.3	9.2	4.3	25.1	7.3	13.5	11.4	32.8	24.2	47.1	19.4	25.5	36.3	19.3	9.3	20.2	7.1	21.6	26.4	12.1	3.9	7.7	9.9	7.8	8.8	9.3	7.2	34.2	6.9	13.1	8.1	14.5	12.8	8.7	10.1	13.8	11.3	9.1	14.6	12.2	21.0	5.6	12.5	8.0	12.4	25.8	13.3	10.0	7.6	5.8	6.5	18.8	21.7	7.1	7.6	12.8	8.3	13.1	8.1	3.9	2.3	5.3	3.5	5.6	9.7	9.0	12.0	7.4	3.2	4.4	3.5	10.1	12.5	16.2	24.0	10.6	45.1	2.9	26.5	19.4	47.1	27.2	15.2	28.3	32.8	25.9	25.9	21.0	29.0	36.3	27.8	30.8	25.5	18.5	24.2	24.7	19.3	5.7	8.7	3.5	6.5	5.9	4.7	8.6	6.6	5.5	8.3
CUZD1	"ERG-1, UO-44"	ENSG00000138161	"CUB and zona pellucida like domains 1"	Q86UP6	10	122832149-122850793	"Predicted membrane proteins"	"Cell adhesion, Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	200	"pancreas: 650.6"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 7.1;LHCN-M2: 7.9"	"Cancer enriched"	"Detected in some"	54	"pancreatic cancer: 32.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.2"	"Group enriched"	"Detected in many"	6	"B-cells: 1.1;T-cells: 3.2"	"Low region specificity"	"Detected in single"							"HPA068479, HPA068660, HPA074117"	Enhanced		Approved	Nucleoli,Vesicles				Nucleoli	Vesicles	"HPA068479: AB_2685995, HPA068660: AB_2686015, HPA074117: "	"unprognostic (4.68e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.52e-5)"	"unprognostic (8.08e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.16e-4)"	"unprognostic (4.19e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.15e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.64e-3)"	"unprognostic (2.75e-3)"	"unprognostic (4.48e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.83e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	650.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.3	0.2	0.0	3.2	0.2	1.6	1.6	1.7	0.0	0.4	0.8	1.0	2.5	0.7	0.3	1.7	1.8	3.6	0.9	0.7	1.0	1.7	0.0	1.5	2.6	2.2	2.2	3.5	4.6	0.8	0.3	0.0	3.7	1.1	0.3	1.5	7.1	1.7	1.3	1.5	7.9	0.4	1.9	2.7	1.7	1.3	0.0	4.0	0.6	1.3	1.3	1.8	0.7	0.8	0.4	1.1	1.3	1.9	3.5	0.0	2.4	0.9	0.0	1.9	1.4	3.1	1.2	5.8	0.0	0.0	0.1	0.3	0.8	0.1	1.3	0.6	0.9	1.1	0.1	1.1	1.4	0.7	0.0	0.0	0.2	0.2	3.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
CYB561A3	CYBASC3	ENSG00000162144	"Cytochrome b561 family member A3"	Q8NBI2	11	61348745-61362299	"Predicted membrane proteins"	"Electron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 113.7;blood: 98.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"memory B-cell: 40.5;naive B-cell: 50.1;plasmacytoid DC: 98.8"	"Group enriched"	"Detected in all"	10	"B-cells: 50.1;dendritic cells: 98.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045674, HPA052548"	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol				"Nucleoli, Vesicles"	"Nucleoplasm, Cytosol"	"HPA045674: , HPA052548: AB_2681866"	"unprognostic (2.61e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.16e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.41e-3)"	"unprognostic (7.41e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.80e-3)"	10.0	113.7	4.0	22.5	6.4	7.1	7.5	4.7	6.9	6.6	10.9	10.9	14.4	6.1	10.9	9.9	8.8	11.0	11.0	5.7	5.1	4.1	9.7	30.6	12.4	21.7	8.3	3.5	14.5	17.9	9.0	6.6	21.0	6.8	9.2	9.6	10.7	10.9	8.1	10.2	24.8	15.8	7.6	5.6	24.0	8.5	8.0	7.0	16.8	10.0	8.4	33.3	10.7	7.3	50.1	98.8	3.8	7.4	3.3	3.8	8.7	18.0	30.5	4.9	14.1	23.2	15.4	4.1	9.1	13.9	11.0	11.0	8.3	20.2	35.2	16.4	16.0	25.3	4.6	25.4	6.7	23.5	10.4	6.0	20.6	5.6	10.9	8.3	15.8	21.6	35.9	23.9	11.0	16.3	19.8	21.1	18.5	19.4	15.7	3.6	9.1	17.5	19.0	4.7	26.3	12.7	17.9	6.0	10.0	18.6	26.9	21.0	21.8	9.7	10.9	13.0	6.7	12.6	13.1	13.2	17.4	19.7	17.8	14.6	16.3	1.6	7.4	3.8	3.8	6.0	3.4	40.5	2.7	3.4	7.4	50.1	2.8	3.0	2.5	3.3	6.4	98.8	2.6	8.7	4.0	6.4	4.7	6.9	5.1	4.1	8.3	3.5	6.8	7.0
CYB5D1	FLJ32499	ENSG00000182224	"Cytochrome b5 domain containing 1"	Q6P9G0	17	7857746-7862282	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA021632	Uncertain		Approved	"Nucleoli,Golgi apparatus"				"Nucleoli, Golgi apparatus"		"HPA021632: AB_1847368"	"unprognostic (1.99e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.10e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.04e-4)"	"unprognostic (2.38e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.27e-3)"	"unprognostic (1.79e-2)"	14.0	13.0	13.2	5.5	22.5	7.2	13.1	14.1	16.8	10.5	7.9	14.0	12.8	6.5	10.9	17.0	7.9	28.2	9.4	13.9	14.4	12.0	19.2	13.0	8.8	4.7	9.4	13.5	14.6	13.1	9.7	18.1	7.0	16.5	11.0	7.8	11.7	10.5	13.2	9.9	10.1	6.0	9.4	6.5	5.9	8.4	14.5	11.7	6.9	22.8	8.6	5.6	7.4	7.5	3.4	3.1	2.7	2.3	1.6	5.9	1.8	16.1	12.0	5.8	15.4	10.4	9.3	3.5	8.3	8.3	9.0	8.6	7.6	3.1	7.0	5.9	6.7	14.5	12.8	10.9	13.5	4.6	14.7	4.6	15.7	10.8	4.7	8.1	3.3	7.8	13.8	15.6	14.2	9.5	3.3	4.8	4.9	7.0	12.6	3.3	7.3	12.5	8.7	2.7	7.0	14.1	3.1	7.9	5.3	13.2	7.4	7.6	8.7	3.3	6.6	7.0	6.1	12.2	10.5	2.5	6.1	3.9	14.6	4.5	4.4	0.5	2.3	0.1	2.7	1.9	3.3	3.4	2.4	1.4	3.1	1.5	5.9	3.1	2.7	1.6	1.1	1.4	2.2	1.8	13.2	22.5	14.1	16.8	14.4	12.0	9.4	13.5	16.5	11.7
CYB5D2	MGC32124	ENSG00000167740	"Cytochrome b5 domain containing 2"	Q8WUJ1	17	4143168-4187310	"Predicted intracellular proteins, Predicted secreted proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042299	Approved		Approved	"Nuclear membrane,Nucleoli,Centrosome"	"Secreted - unknown location"			"Nuclear membrane"	"Nucleoli, Centrosome"	"HPA042299: AB_10793879"	"unprognostic (2.57e-2)"	"unprognostic (2.89e-2)"	"unprognostic (4.16e-2)"	"prognostic favourable (6.19e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.75e-2)"	"prognostic favourable (4.98e-6)"	"unprognostic (1.57e-1)"	"unprognostic (2.47e-1)"	"unprognostic (9.71e-3)"	"prognostic favourable (7.76e-5)"	"unprognostic (2.04e-1)"	"prognostic favourable (2.03e-10)"	"unprognostic (2.01e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.97e-1)"	13.1	17.3	18.7	5.1	26.4	3.6	15.0	20.6	27.5	15.0	8.1	21.8	14.6	13.3	13.9	27.1	9.8	17.4	14.5	10.3	17.8	21.6	22.9	25.3	8.6	7.4	19.7	26.1	19.5	17.0	28.5	18.5	9.9	19.1	12.0	6.8	17.3	17.5	16.8	12.2	11.7	10.3	7.8	21.7	7.9	12.3	54.1	17.1	4.8	20.6	7.1	6.8	12.0	8.6	9.4	13.0	14.7	12.7	5.9	12.5	9.0	7.8	10.5	6.1	6.4	39.3	11.6	2.5	7.6	16.4	5.5	5.7	3.1	5.2	2.5	6.9	8.8	11.1	2.5	3.5	2.2	8.3	12.6	2.4	6.6	5.2	7.1	1.0	4.8	15.1	8.4	3.0	6.0	10.0	2.5	15.5	4.2	9.6	3.6	1.6	2.2	5.7	4.4	5.4	6.2	12.8	4.1	4.9	4.1	8.5	5.0	11.2	13.2	1.5	13.5	8.1	2.1	7.5	3.9	3.0	2.2	1.9	10.0	2.2	3.1	0.6	12.7	14.7	7.2	10.4	8.1	9.4	11.4	8.8	12.0	9.4	10.8	9.7	11.7	5.9	9.4	13.0	12.5	9.0	18.7	26.4	20.6	27.5	17.8	21.6	19.7	26.1	19.1	17.1
CYB5R1	"humb5R2, NQO3A2"	ENSG00000159348	"Cytochrome b5 reductase 1"	Q9UHQ9	1	202961869-202967280	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 119.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010641, HPA014147"	Enhanced		Uncertain	Nucleoli,Mitochondria,Cytosol			860000	"Nucleoli, Mitochondria, Cytosol"		"HPA010641: AB_1078600, HPA014147: AB_1847370"	"unprognostic (6.36e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.16e-2)"	"prognostic favourable (1.14e-4)"	"unprognostic (1.86e-2)"	"unprognostic (4.34e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.03e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.69e-1)"	9.6	14.5	7.8	5.0	8.4	3.9	16.9	6.2	11.0	11.6	7.5	8.7	10.6	4.4	10.1	32.3	13.7	16.4	9.2	33.9	7.3	9.2	15.5	18.4	10.1	11.7	10.0	9.1	10.8	11.1	16.3	11.1	63.8	11.9	10.5	5.0	15.7	14.4	10.1	119.2	28.5	6.9	10.6	7.4	10.8	18.6	20.1	6.7	11.7	13.5	26.4	10.0	13.6	10.1	20.2	21.9	25.7	33.3	17.2	26.5	28.8	8.3	5.2	4.6	9.4	42.9	9.9	45.1	16.8	15.8	10.9	9.8	4.3	9.9	5.2	14.3	16.7	46.3	3.7	14.4	7.2	7.5	9.5	2.9	6.3	4.9	15.5	2.5	7.4	15.8	47.6	12.0	6.6	7.2	8.8	9.4	39.4	9.8	3.2	2.2	3.0	10.0	5.3	22.2	11.1	10.3	10.0	3.9	4.8	9.4	31.4	13.6	14.5	5.7	7.0	12.5	5.3	4.7	9.3	8.8	10.4	2.4	13.8	3.9	9.3	11.6	33.3	25.6	16.7	24.2	22.2	13.6	19.3	17.8	21.9	20.2	26.5	18.8	25.7	17.2	15.7	15.1	19.1	28.8	7.8	8.4	6.2	11.0	7.3	9.2	10.0	9.1	11.9	6.7
CYTH1	"B2-1, cytohesin-1, D17S811E, PSCD1"	ENSG00000108669	"Cytohesin 1"	Q15438	17	78674048-78782297	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 36.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047498			Uncertain	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA047498: "	"unprognostic (3.82e-3)"	"unprognostic (5.49e-2)"	"unprognostic (1.34e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.63e-1)"	"prognostic favourable (6.48e-4)"	"unprognostic (6.60e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.69e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.21e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.10e-1)"	17.4	12.4	20.7	28.5	36.0	34.4	12.0	17.7	27.5	10.1	17.4	64.1	5.0	13.2	7.7	6.5	25.9	10.2	15.5	10.3	21.5	16.0	11.5	16.0	25.7	42.3	44.4	27.4	5.9	16.0	7.5	8.4	15.8	32.1	15.2	19.9	10.1	17.3	5.3	17.5	15.9	21.4	10.0	31.2	31.8	24.8	7.9	45.2	19.3	15.2	9.2	50.1	14.4	12.1	24.7	19.1	45.9	20.0	21.8	39.4	31.3	9.1	6.4	6.4	5.5	4.4	5.6	6.2	4.3	3.8	5.3	6.2	4.0	10.2	6.8	4.3	5.6	8.1	3.1	11.2	4.3	14.2	8.6	2.7	8.1	7.3	3.1	5.6	27.5	2.7	9.3	6.0	6.2	17.0	4.5	26.3	6.2	4.6	36.2	5.0	1.6	5.7	9.6	7.1	23.8	5.8	6.4	3.7	13.5	7.6	14.8	6.0	7.2	6.6	8.0	4.2	6.2	6.6	4.4	30.6	14.0	24.9	3.1	5.6	4.4	45.9	16.2	31.4	39.4	20.0	28.6	24.7	32.8	31.8	13.7	23.0	36.5	30.7	33.8	21.8	17.6	19.1	24.5	31.3	20.7	36.0	17.7	27.5	21.5	16.0	44.4	27.4	32.1	45.2
DCAF13	"DKFZP564O0463, Gm83, HSPC064, Sof1, WDSOF1"	ENSG00000164934	"DDB1 and CUL4 associated factor 13"	Q9NV06	8	103414714-103443453	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Ubl conjugation pathway"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044504	Uncertain		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Centrosome,Cytosol"				"Nucleoplasm, Nucleoli"	"Cell Junctions, Centrosome, Cytosol"	"HPA044504: "	"prognostic unfavourable (4.06e-4)"	"unprognostic (4.39e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.46e-3)"	"unprognostic (3.57e-2)"	"unprognostic (7.86e-3)"	"prognostic unfavourable (8.05e-6)"	"unprognostic (5.92e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.31e-2)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.42e-2)"	"unprognostic (8.63e-2)"	18.4	20.5	13.8	18.1	15.7	10.6	20.2	11.3	14.3	16.0	16.7	13.0	12.9	13.1	18.1	16.7	24.0	15.3	10.7	15.9	12.4	11.8	35.2	26.5	12.4	18.4	16.5	12.1	20.9	28.9	15.7	34.6	21.2	16.2	16.4	18.5	7.4	15.9	11.3	21.1	13.7	16.8	15.3	13.9	20.4	14.7	25.3	15.0	26.4	17.1	22.6	24.3	16.9	15.5	28.6	26.4	10.3	22.1	24.0	27.2	20.2	27.5	24.8	23.2	23.6	16.9	19.6	17.4	20.6	15.8	19.6	20.1	24.4	27.0	38.4	35.3	21.5	20.8	31.4	26.3	38.0	36.6	22.3	53.1	14.9	27.7	19.3	21.7	22.9	15.9	18.2	28.8	48.0	27.2	35.6	16.9	29.8	22.5	41.1	22.8	35.5	38.8	26.8	28.2	39.6	28.5	23.1	29.6	28.1	12.9	20.2	23.3	31.1	14.9	17.8	20.0	32.1	25.7	27.5	18.7	32.5	54.3	26.9	47.5	25.5	8.6	18.6	10.3	18.4	22.1	25.2	28.6	19.8	19.7	26.4	22.1	19.8	20.2	2.0	24.0	16.0	13.7	27.2	20.2	13.8	15.7	11.3	14.3	12.4	11.8	16.5	12.1	16.2	15.0
DCTN3	DCTN-22	ENSG00000137100	"Dynactin subunit 3"	O75935	9	34613545-34620523	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044905	Approved		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA044905: AB_10960996"	"unprognostic (3.38e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.47e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.92e-3)"	"unprognostic (9.88e-2)"	"unprognostic (4.41e-2)"	"prognostic favourable (2.10e-5)"	"unprognostic (1.26e-3)"	"unprognostic (4.24e-3)"	"prognostic favourable (5.76e-11)"	"unprognostic (3.06e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.22e-1)"	"unprognostic (4.43e-2)"	26.4	32.5	42.4	16.2	49.1	46.5	30.4	33.7	58.3	25.7	23.3	20.7	22.2	21.4	24.6	25.5	33.7	31.7	23.1	42.8	36.3	37.4	32.8	32.4	21.1	21.9	35.8	48.4	32.6	33.7	29.8	36.3	23.0	37.4	27.4	20.6	27.5	32.4	28.6	69.1	37.9	18.3	28.0	26.2	19.4	23.7	16.2	22.0	42.6	32.4	37.1	29.2	22.5	24.9	28.5	44.6	62.3	45.9	29.9	56.0	46.8	34.0	28.6	26.6	27.8	23.7	33.1	11.0	29.1	27.2	40.6	32.0	18.3	12.8	15.7	18.3	38.3	13.6	24.1	30.5	26.0	49.2	30.3	10.4	50.6	15.7	25.6	27.4	31.9	29.1	26.4	28.0	18.4	26.7	12.4	32.6	35.3	28.0	34.5	74.0	8.0	46.2	17.4	14.4	21.5	19.5	12.1	8.8	22.7	21.6	19.9	11.1	26.6	31.5	24.2	25.6	20.7	29.0	28.2	22.0	28.5	10.4	40.3	16.0	52.0	62.3	44.0	59.3	35.2	44.2	32.0	28.5	37.8	37.2	44.0	28.3	29.9	35.7	38.4	29.9	45.9	44.6	56.0	46.8	42.4	49.1	33.7	58.3	36.3	37.4	35.8	48.4	37.4	22.0
DCTN6	WS-3	ENSG00000104671	"Dynactin subunit 6"	O00399	8	30156297-30183640	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024049, HPA024558"	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"				"Nucleoli, Cytosol"	"Plasma membrane"	"HPA024049: AB_1847524, HPA024558: AB_1847525"	"unprognostic (1.28e-1)"	"unprognostic (8.32e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.50e-2)"	"prognostic unfavourable (5.51e-4)"	"unprognostic (1.26e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.38e-2)"	"unprognostic (9.26e-2)"	"prognostic favourable (5.42e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.43e-1)"	29.5	34.6	41.4	15.6	39.4	23.3	32.6	23.6	43.6	21.0	20.6	27.4	15.4	14.2	24.1	27.2	24.1	18.0	20.0	44.5	37.7	35.2	32.8	27.5	20.3	15.3	42.3	36.3	26.3	19.5	31.0	27.7	32.7	41.4	21.9	22.5	16.5	20.3	23.7	20.4	17.5	15.6	26.0	46.2	16.8	19.3	13.9	30.3	15.4	33.7	18.2	17.9	25.7	18.8	7.4	19.8	9.5	15.9	10.2	11.2	6.9	18.9	18.2	23.0	12.1	21.0	28.9	14.8	25.8	29.9	25.2	26.4	11.8	12.6	14.1	27.7	27.0	14.1	15.9	21.8	29.7	11.3	12.4	20.2	15.6	18.5	16.2	11.4	17.2	24.4	31.2	18.0	19.3	22.5	22.6	15.6	26.7	14.4	21.1	16.4	18.8	11.6	11.3	17.3	12.3	35.8	18.6	37.8	21.4	15.0	18.5	25.6	17.8	16.2	21.6	13.7	47.8	11.2	18.3	6.6	7.4	18.2	25.2	13.1	23.8	9.5	14.1	4.9	8.6	15.9	9.8	7.4	7.8	10.1	16.8	5.5	9.0	11.2	4.5	10.2	15.1	19.8	8.7	6.9	41.4	39.4	23.6	43.6	37.7	35.2	42.3	36.3	41.4	30.3
DCUN1D5	"FLJ32431, MGC2714"	ENSG00000137692	"Defective in cullin neddylation 1 domain containing 5"	Q9BTE7	11	103062076-103092215	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050863	Approved		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA050863: "	"unprognostic (4.47e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.99e-1)"	"prognostic unfavourable (4.62e-4)"	"prognostic unfavourable (2.01e-7)"	"unprognostic (1.92e-3)"	"unprognostic (1.21e-2)"	"prognostic favourable (9.52e-5)"	"unprognostic (2.08e-2)"	"prognostic unfavourable (4.12e-4)"	"unprognostic (2.64e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.43e-3)"	20.9	18.3	18.9	17.2	24.5	13.4	19.1	22.5	28.8	12.9	13.5	15.9	11.5	11.4	15.9	13.7	26.5	12.9	10.6	24.2	20.3	16.6	14.4	19.0	13.9	21.5	15.6	21.0	12.2	17.7	14.5	17.0	17.3	23.6	15.4	13.9	9.9	15.6	13.5	38.7	14.0	11.3	18.4	17.5	15.7	16.0	24.0	21.0	19.4	13.2	24.2	21.3	14.4	14.7	14.4	17.3	11.8	13.1	20.5	17.0	13.4	22.0	12.2	13.5	20.7	11.0	14.0	15.0	21.9	11.9	18.1	18.6	46.9	25.8	10.6	38.7	15.5	21.0	28.4	27.7	18.6	18.7	19.1	28.5	10.5	18.2	18.7	40.8	14.8	12.2	24.6	24.2	25.1	22.3	46.5	0.0	17.1	19.9	26.9	31.9	26.3	31.3	11.5	21.6	27.0	13.7	22.7	18.3	19.5	20.4	20.9	18.2	24.5	17.1	18.1	14.7	17.8	26.0	19.5	9.0	14.2	35.5	10.4	40.1	15.2	11.8	11.1	10.2	13.8	13.1	16.3	14.4	16.3	14.2	13.7	14.1	14.0	16.3	4.0	20.5	10.0	17.3	17.0	13.4	18.9	24.5	22.5	28.8	20.3	16.6	15.6	21.0	23.6	21.0
DCXR	"DCR, KIDCR, SDR20C1"	ENSG00000169738	"Dicarbonyl and L-xylulose reductase"	Q7Z4W1	17	82035136-82037732	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Xylose metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 293.8"	"Cell line enhanced"	"Detected in all"		"Hep G2: 64.9;MCF7: 79.8"	"Cancer enhanced"	"Detected in all"		"liver cancer: 305.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023371, HPA023863"	Enhanced		Uncertain	Nucleoli,Microtubules			2700000	"Nucleoli, Microtubules"		"HPA023371: AB_1847530, HPA023863: AB_1847531"	"unprognostic (3.33e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.56e-2)"	"prognostic favourable (4.70e-4)"	"unprognostic (1.72e-1)"	"prognostic favourable (2.13e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.10e-2)"	12.7	6.1	12.8	4.3	12.1	5.7	12.2	9.0	15.1	9.9	9.5	8.4	18.1	7.8	4.4	62.7	11.7	6.1	4.8	11.8	9.8	9.7	50.8	293.8	10.5	5.3	14.4	7.3	8.1	13.0	6.7	7.2	9.0	13.4	22.3	5.4	7.8	19.3	14.0	22.5	8.6	6.8	3.6	8.4	4.4	14.9	8.7	9.7	8.3	15.6	12.6	9.1	7.5	6.4	32.8	52.7	25.3	33.1	35.2	43.7	35.8	8.9	12.3	5.7	10.3	23.0	5.8	15.2	4.6	6.0	12.7	8.7	21.8	3.9	18.5	9.0	6.4	10.6	10.4	9.2	4.4	3.9	26.7	17.7	9.2	64.9	24.7	13.6	21.8	8.4	11.5	4.0	14.6	7.1	20.2	13.5	6.7	79.8	11.4	32.7	6.6	13.1	10.5	7.7	24.2	9.4	12.7	15.9	9.4	6.4	55.0	8.0	41.2	13.5	3.6	6.7	8.4	9.0	8.6	13.9	10.2	8.7	5.7	15.0	4.9	13.9	33.1	25.3	24.7	30.6	23.6	28.6	30.8	23.6	52.7	32.8	43.7	31.9	16.5	35.2	28.0	42.5	33.1	35.8	12.8	12.1	9.0	15.1	9.8	9.7	14.4	7.3	13.4	9.7
DDA1	"C19orf58, MGC2594, PCIA1"	ENSG00000130311	"DET1 and DDB1 associated 1"	Q9BW61	19	17309518-17323301	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042134, HPA055272"	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA042134: AB_10794169, HPA055272: "	"unprognostic (1.30e-1)"	"unprognostic (6.35e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.49e-3)"	"unprognostic (5.38e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.15e-3)"	11.6	15.5	24.5	12.7	26.6	16.1	9.9	14.6	36.2	10.8	14.6	13.5	9.6	15.4	11.6	9.9	13.4	13.5	11.8	16.4	18.9	19.8	12.9	17.9	14.6	14.7	19.0	24.4	12.9	13.4	10.9	10.9	26.4	23.0	12.9	13.1	10.8	13.6	15.9	17.8	20.8	16.9	11.5	13.2	13.4	17.4	29.6	12.0	15.9	10.5	10.9	13.7	12.4	9.9	7.1	12.7	11.5	8.0	6.5	8.8	5.7	12.4	11.1	8.4	6.7	8.8	6.3	13.1	8.5	10.8	13.0	12.0	9.8	11.0	4.9	11.8	8.7	10.6	6.2	12.3	6.3	8.1	16.4	6.0	8.8	9.2	10.7	6.8	11.8	9.7	14.2	7.8	7.2	7.5	7.1	8.6	6.8	6.2	13.6	10.1	9.6	19.0	8.7	6.6	8.2	10.2	9.3	8.6	12.9	6.2	14.3	7.4	7.2	9.1	11.3	8.7	7.3	22.4	11.7	10.7	14.4	6.9	19.2	11.7	8.6	5.0	7.3	11.5	8.6	8.0	7.4	7.1	7.2	8.5	5.9	6.6	8.3	8.0	8.2	6.5	6.9	12.7	8.8	5.7	24.5	26.6	14.6	36.2	18.9	19.8	19.0	24.4	23.0	12.0
DDAH1	DDAH	ENSG00000153904	"Dimethylarginine dimethylaminohydrolase 1"	O94760	1	85318481-85578363	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 61.6"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 36.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.3;naive B-cell: 1.0"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006308	Enhanced		Approved	"Nucleoli,Plasma membrane,Cytosol"			140000	"Plasma membrane, Cytosol"	Nucleoli	"HPA006308: AB_1847532"	"unprognostic (1.44e-2)"	"unprognostic (2.43e-1)"	"prognostic favourable (5.99e-4)"	"unprognostic (6.82e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.56e-1)"	"prognostic favourable (5.21e-6)"	"unprognostic (5.37e-2)"	"unprognostic (9.06e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.56e-2)"	4.3	14.3	43.9	5.8	44.9	0.7	6.6	14.4	37.2	7.7	22.1	20.7	4.3	21.1	6.0	33.8	4.9	18.4	12.2	6.4	29.5	24.1	61.6	39.9	11.8	1.1	24.9	37.0	3.4	13.8	13.0	7.2	3.1	13.8	13.1	21.4	4.1	8.5	6.2	13.8	2.8	19.9	7.4	8.1	4.1	15.6	9.3	11.0	0.0	14.1	1.0	1.2	6.0	3.0	1.3	0.4	0.0	0.0	0.0	0.0	0.0	18.7	2.3	6.6	1.2	11.1	9.4	0.8	22.1	13.4	7.9	8.4	26.6	5.0	0.0	9.2	25.0	5.4	23.9	4.6	10.1	0.0	9.2	0.0	6.3	9.2	4.0	17.0	1.0	7.8	0.4	6.6	4.2	12.5	0.0	1.9	20.2	1.5	0.9	0.0	7.9	6.9	0.0	15.5	0.2	33.7	14.0	18.7	36.3	2.9	16.8	2.7	9.1	1.3	24.4	6.9	5.6	1.7	15.4	0.0	0.0	0.0	0.3	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	43.9	44.9	14.4	37.2	29.5	24.1	24.9	37.0	13.8	11.0
DDRGK1	"C20orf116, dJ1187M17.3, UFBP1"	ENSG00000198171	"DDRGK domain containing 1"	Q96HY6	20	3190350-3204685	"Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013373, HPA013705"	Approved		Supported	"Nucleoli,Endoplasmic reticulum"				"Endoplasmic reticulum"	Nucleoli	"HPA013373: AB_2091955, HPA013705: "	"unprognostic (2.99e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.54e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.10e-3)"	"unprognostic (8.16e-2)"	"unprognostic (5.44e-3)"	"unprognostic (7.29e-2)"	"prognostic favourable (2.01e-5)"	"unprognostic (6.80e-3)"	"unprognostic (1.43e-2)"	"unprognostic (2.48e-2)"	"unprognostic (6.90e-2)"	29.5	47.3	28.5	18.6	45.7	17.8	20.5	33.4	38.2	22.1	23.9	29.8	23.7	35.3	21.5	17.8	21.1	21.0	24.3	17.7	27.0	21.8	28.5	54.0	27.0	17.5	47.9	22.9	23.9	43.6	37.5	17.7	31.3	30.9	27.3	16.6	20.6	48.5	29.3	29.5	22.2	31.9	17.1	36.8	20.2	31.5	14.7	39.3	12.6	34.0	14.2	16.2	20.8	29.4	15.1	32.0	24.4	20.2	12.3	21.0	12.9	29.5	37.3	9.2	17.2	21.0	8.0	13.3	18.9	9.1	11.7	12.8	29.3	21.6	17.7	15.4	10.4	33.2	9.5	28.2	4.3	12.0	17.7	15.0	12.4	50.8	28.8	16.9	16.3	12.5	27.7	22.3	16.0	10.6	20.7	21.3	7.4	16.2	11.5	31.5	11.4	17.2	15.3	8.2	26.9	18.9	27.8	20.5	12.6	19.4	54.9	17.5	23.3	10.4	16.0	18.8	8.4	13.2	28.7	16.0	18.0	7.5	5.2	14.3	10.9	11.7	20.2	24.4	19.6	13.3	19.5	15.1	20.9	21.0	20.5	15.1	18.7	18.2	5.4	12.3	12.1	32.0	18.6	12.9	28.5	45.7	33.4	38.2	27.0	21.8	47.9	22.9	30.9	39.3
DDX10	"Dbp4, HRH-J8"	ENSG00000178105	"DEAD-box helicase 10"	Q13206	11	108665025-108940930	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004691	Approved		Approved	Nucleoli				Nucleoli		"HPA004691: AB_1078629"	"unprognostic (9.49e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.58e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavourable (2.52e-5)"	"unprognostic (2.86e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (5.75e-4)"	"unprognostic (1.00e-1)"	"prognostic favourable (2.14e-5)"	"unprognostic (5.20e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.64e-1)"	"unprognostic (2.43e-3)"	14.0	11.9	17.3	15.0	20.3	10.4	15.5	20.5	18.3	14.3	12.2	8.1	11.7	8.8	18.4	12.8	12.6	16.8	8.8	12.1	13.5	11.5	19.6	12.5	10.6	13.1	12.2	16.3	18.6	18.0	16.7	22.2	12.9	13.1	12.4	13.3	7.9	10.6	14.7	13.6	14.8	9.1	16.8	13.3	15.0	11.3	25.1	12.6	13.8	13.4	8.8	14.2	14.3	18.8	11.6	8.4	1.4	6.7	9.4	11.3	4.3	7.2	7.1	6.8	9.5	6.7	5.5	7.1	7.8	4.2	9.5	9.4	20.3	10.7	24.7	14.8	6.0	8.2	19.4	9.5	13.7	9.4	8.7	16.8	4.2	7.6	12.0	17.1	8.0	4.9	7.5	10.8	13.5	8.6	23.5	2.7	9.3	4.7	14.3	14.4	8.8	10.9	12.2	11.1	23.1	5.8	6.3	12.6	6.7	11.0	9.7	4.1	11.7	6.0	9.1	10.0	10.2	9.5	10.6	4.2	7.3	57.2	3.4	20.6	10.1	1.4	5.0	1.0	8.6	6.7	11.3	10.4	7.5	10.1	8.4	11.6	8.1	7.8	0.7	9.4	6.4	8.2	6.3	4.3	17.3	20.3	20.5	18.3	13.5	11.5	12.2	16.3	13.1	12.6
DDX18	"Has1, MrDb"	ENSG00000088205	"DEAD-box helicase 18"	Q9NVP1	2	117814650-117832379	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 88.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035400, HPA041056"	Approved		Supported	Nucleoli				Nucleoli		"HPA035400: AB_10672091, HPA041056: "	"unprognostic (1.44e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavourable (2.64e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.77e-3)"	"prognostic unfavourable (3.07e-4)"	"unprognostic (8.80e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.42e-2)"	"unprognostic (4.94e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.28e-2)"	"unprognostic (5.65e-2)"	35.3	21.3	20.5	28.7	26.0	17.4	31.2	27.1	25.6	31.2	27.9	16.7	21.6	20.9	32.0	22.9	27.8	28.5	21.3	22.9	19.6	19.1	32.0	40.3	24.1	35.0	25.5	22.9	36.3	29.5	21.0	25.9	25.0	25.0	25.0	30.3	11.5	24.2	26.6	37.0	24.9	26.3	28.3	30.8	46.5	26.2	22.9	31.1	40.7	31.3	23.9	37.6	37.6	23.7	22.2	20.5	9.4	18.5	17.2	23.6	16.3	21.5	9.8	14.7	13.2	8.7	7.9	24.2	12.8	10.1	17.7	15.7	24.1	14.3	31.8	21.0	10.6	16.8	28.5	16.6	26.2	16.2	19.9	30.4	9.2	24.2	12.2	40.5	15.9	8.2	15.3	22.5	22.8	10.6	33.1	13.8	13.5	13.4	22.1	21.2	36.8	14.8	19.3	22.9	27.9	11.7	12.8	14.1	24.0	14.9	16.4	16.6	10.4	22.4	8.1	15.9	23.4	11.1	23.0	15.9	19.8	88.2	11.7	19.2	7.1	6.2	13.8	9.4	16.2	17.3	20.6	22.2	19.3	18.5	12.5	19.1	23.6	20.7	3.6	17.2	18.5	20.5	15.0	16.3	20.5	26.0	27.1	25.6	19.6	19.1	25.5	22.9	25.0	31.1
DDX21	"GURDB, RH-II/GU"	ENSG00000165732	"DExD-box helicase 21"	Q9NR30	10	68956128-68985073	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, rRNA processing, Transcription"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036592, HPA036593"	Enhanced		Enhanced	Nucleoplasm,Nucleoli			14000	Nucleoli	Nucleoplasm	"HPA036592: AB_10673625, HPA036593: AB_2675208"	"unprognostic (3.04e-1)"	"unprognostic (6.81e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavourable (3.12e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.33e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.74e-3)"	37.5	16.0	10.0	26.6	13.3	46.8	24.4	8.0	11.8	18.5	20.1	7.2	16.2	13.3	18.7	13.7	28.3	20.1	17.6	19.1	11.4	8.0	25.1	48.0	25.9	24.4	14.9	7.2	30.2	27.9	15.6	20.7	22.8	18.3	14.0	17.6	5.9	18.0	17.8	61.2	22.5	18.5	19.0	20.4	43.5	19.0	12.9	13.3	27.1	18.1	24.1	25.8	33.2	22.4	12.6	11.5	17.1	17.3	7.7	15.0	6.2	32.8	19.5	11.4	35.2	10.3	13.6	24.1	22.6	18.3	29.2	24.9	63.1	22.5	49.6	13.9	18.7	29.3	43.9	28.2	39.2	15.4	30.9	34.7	13.9	26.2	22.1	82.5	33.0	14.0	36.7	34.9	58.4	21.2	66.0	24.8	20.5	15.0	32.3	18.0	31.2	41.7	28.9	18.7	24.3	19.4	17.7	23.6	25.3	20.3	45.1	26.3	25.5	17.3	21.8	17.2	24.3	23.0	39.6	28.6	37.8	73.2	14.3	62.6	11.6	5.0	9.7	17.1	8.4	15.0	15.0	12.6	10.9	11.0	11.5	10.4	10.3	11.3	4.5	7.7	17.3	10.8	7.9	6.2	10.0	13.3	8.0	11.8	11.4	8.0	14.9	7.2	18.3	13.3
DDX23	"prp28, PRPF28, SNRNP100, U5-100K"	ENSG00000174243	"DEAD-box helicase 23"	Q9BUQ8	12	48829764-48852842	"Enzymes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038680, HPA039037"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA038680: AB_10795401, HPA039037: "	"unprognostic (1.32e-3)"	"unprognostic (8.90e-2)"	"unprognostic (8.92e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (3.03e-5)"	"unprognostic (3.54e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.34e-2)"	"unprognostic (5.94e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.44e-1)"	26.1	26.5	29.5	35.6	34.2	19.4	27.2	32.8	35.6	26.7	32.8	23.3	27.5	27.9	31.0	22.3	31.0	31.1	25.2	25.1	29.8	20.3	25.2	37.7	27.7	35.2	26.5	25.3	36.2	30.4	32.2	28.1	34.4	25.0	29.9	32.6	24.7	31.1	27.0	44.4	30.6	32.3	29.4	24.1	40.0	30.6	24.9	32.0	46.8	28.2	29.8	38.9	28.9	47.9	12.0	11.5	19.6	13.3	11.2	19.8	10.6	21.6	49.4	23.5	24.9	23.5	16.3	25.0	26.8	20.6	30.5	19.4	48.1	28.9	27.3	29.5	22.2	19.6	50.9	24.4	26.1	42.8	27.0	36.2	42.1	21.7	12.7	36.5	33.0	15.7	22.0	32.3	19.4	24.9	47.9	24.5	22.1	30.0	34.6	34.7	34.9	23.5	37.0	27.8	21.7	18.0	30.5	29.0	16.9	26.9	30.8	11.2	30.1	33.6	22.3	23.1	16.9	11.3	21.2	18.5	25.8	33.0	19.6	25.8	12.6	17.1	11.1	19.6	19.5	13.3	19.8	12.0	14.5	17.6	10.8	11.4	14.0	16.9	11.9	11.2	8.9	11.5	13.1	10.6	29.5	34.2	32.8	35.6	29.8	20.3	26.5	25.3	25.0	32.0
DDX24		ENSG00000089737	"DEAD-box helicase 24"	Q9GZR7	14	94048291-94081245	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 103.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002554	Uncertain		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA002554: AB_1078631"	"unprognostic (7.48e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.06e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.60e-3)"	"unprognostic (4.13e-2)"	"prognostic favourable (3.06e-9)"	"prognostic unfavourable (2.89e-4)"	"unprognostic (6.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.66e-2)"	18.0	45.5	19.7	13.7	41.3	53.3	18.5	31.4	40.8	17.4	20.9	21.9	14.3	13.6	23.2	103.0	20.1	18.9	21.3	28.6	25.0	31.3	36.3	30.1	16.4	27.4	22.0	29.0	21.4	12.5	8.3	32.0	11.2	38.7	16.0	14.6	17.4	15.9	17.7	28.5	23.4	12.6	17.9	21.8	18.1	15.0	38.5	17.4	14.3	25.3	11.8	25.8	21.7	14.9	4.1	3.1	10.6	3.3	6.2	5.3	5.0	3.8	1.0	7.1	4.6	4.3	5.6	1.7	10.7	8.9	13.9	12.5	1.3	2.4	17.7	4.0	2.3	2.5	7.3	0.6	15.2	7.7	0.4	9.4	2.0	5.7	3.5	13.5	4.2	0.9	4.0	2.5	2.4	2.3	4.9	5.2	5.9	10.6	4.0	11.5	4.7	0.1	5.4	16.5	2.0	10.1	1.4	5.6	5.2	10.5	2.6	4.9	4.1	4.8	6.8	4.0	2.6	5.1	3.2	2.1	13.6	19.0	5.7	7.4	3.1	10.6	3.3	2.5	5.0	2.6	1.4	2.9	2.9	3.0	2.0	4.1	5.3	5.3	2.6	6.2	2.5	3.1	3.3	5.0	19.7	41.3	31.4	40.8	25.0	31.3	22.0	29.0	38.7	17.4
DDX27	"dJ686N3.1, DRS1"	ENSG00000124228	"DEAD-box helicase 27"	Q96GQ7	20	49219295-49244077	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047087	Uncertain		Approved	Nucleoli				Nucleoli		"HPA047087: AB_10964059"	"unprognostic (4.47e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavourable (1.44e-5)"	"unprognostic (2.82e-1)"	"unprognostic (7.12e-2)"	"prognostic unfavourable (6.70e-7)"	"unprognostic (2.28e-1)"	"unprognostic (9.53e-2)"	"unprognostic (2.74e-1)"	"unprognostic (7.18e-2)"	"unprognostic (5.84e-3)"	"prognostic unfavourable (1.73e-4)"	"unprognostic (1.26e-1)"	"unprognostic (4.32e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.27e-1)"	22.0	22.5	21.9	33.0	23.2	40.9	23.6	34.8	26.3	24.3	26.4	16.3	20.4	23.2	26.2	19.1	26.5	23.9	27.1	19.2	22.6	17.3	25.9	21.0	20.1	32.3	19.9	18.8	37.4	27.3	25.9	25.6	23.9	21.2	22.0	22.1	14.4	22.9	24.3	32.9	27.8	33.6	20.0	20.7	34.1	22.9	25.0	24.0	30.6	23.5	19.4	35.3	24.0	27.2	30.4	28.0	22.2	24.2	18.2	26.7	18.6	20.1	19.1	9.8	7.5	11.0	10.1	28.0	13.4	11.0	42.3	19.6	62.3	22.6	24.0	25.0	10.9	28.6	21.8	21.5	31.5	8.4	12.8	18.2	16.1	30.2	16.1	23.0	21.3	10.7	25.2	24.6	19.0	7.0	24.7	13.3	13.7	13.5	24.2	30.4	18.6	24.9	20.9	24.5	22.0	15.3	15.6	12.8	15.2	37.4	54.0	22.5	28.5	26.7	8.7	27.2	24.0	22.7	27.8	15.2	16.3	31.4	17.4	18.3	17.5	11.1	19.8	22.2	21.7	21.2	22.8	29.4	20.6	19.7	23.3	30.4	26.7	20.3	8.1	18.2	24.2	28.0	26.3	18.6	21.9	23.2	34.8	26.3	22.6	17.3	19.9	18.8	21.2	24.0
DDX28	"FLJ11282, MDDX28"	ENSG00000182810	"DEAD-box helicase 28"	Q9NUL7	16	68021274-68023442	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis"	"Helicase, Hydrolase, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041911, HPA053585"	Approved		Supported	Nucleoli,Mitochondria,Cytosol				"Mitochondria, Cytosol"	Nucleoli	"HPA041911: AB_10794161, HPA053585: "	"unprognostic (8.11e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.10e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.69e-2)"	"unprognostic (8.46e-2)"	"unprognostic (9.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.63e-2)"	"unprognostic (8.14e-3)"	"unprognostic (8.53e-2)"	"prognostic favourable (2.07e-10)"	"unprognostic (1.58e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.47e-1)"	9.8	12.7	6.2	6.7	8.3	19.7	7.1	6.0	12.9	8.3	7.2	6.4	6.8	5.2	7.5	7.3	9.7	7.1	7.0	9.2	5.2	5.9	8.9	12.4	5.8	18.4	6.4	5.1	8.6	13.3	6.8	4.6	17.1	6.6	6.1	6.0	7.8	6.3	5.2	16.2	9.9	7.9	5.3	3.0	11.1	7.0	11.5	2.7	14.6	10.2	7.3	10.6	8.0	4.8	17.8	18.0	22.9	19.1	17.0	22.9	16.6	6.1	9.1	4.5	5.4	6.3	3.5	10.5	4.2	6.2	10.6	7.6	8.8	9.8	23.0	6.5	5.2	11.1	6.4	10.2	6.3	3.1	10.5	8.3	4.8	9.1	8.5	13.0	9.0	6.8	11.1	8.7	8.0	5.9	14.8	3.6	4.7	13.7	13.6	18.3	11.0	6.8	13.4	4.2	24.6	7.4	7.1	9.4	6.3	17.1	4.9	9.3	9.4	14.3	4.2	4.7	4.0	6.7	6.9	8.1	9.8	22.1	5.8	10.1	6.3	17.7	19.1	22.9	15.7	18.8	17.3	12.6	14.6	16.9	18.0	17.8	22.9	16.9	6.3	17.0	18.5	9.0	13.8	16.6	6.2	8.3	6.0	12.9	5.2	5.9	6.4	5.1	6.6	2.7
DDX31	"FLJ13633, FLJ14578, FLJ23349, PPP1R25"	ENSG00000125485	"DEAD-box helicase 31"	Q9H8H2	9	132592997-132670401	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020891			Supported	"Nucleoli,Golgi apparatus,Vesicles"				Nucleoli	"Golgi apparatus, Vesicles"	"HPA020891: "	"unprognostic (5.71e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.91e-2)"	"unprognostic (5.79e-2)"	"unprognostic (9.94e-2)"	"prognostic unfavourable (1.68e-7)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.90e-2)"	"unprognostic (9.57e-3)"	"unprognostic (4.57e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.03e-1)"	6.8	6.9	8.2	15.3	11.2	6.0	12.3	18.4	8.5	7.5	6.6	9.4	12.6	5.0	8.9	8.8	9.8	8.8	7.5	5.4	6.3	6.3	8.4	9.2	12.0	15.1	9.1	5.7	16.9	17.3	10.0	8.8	5.8	9.8	9.2	8.0	7.4	12.7	12.6	12.9	14.0	7.2	12.7	12.9	8.7	6.8	15.2	8.3	6.8	22.7	10.8	13.8	7.2	12.6	5.0	4.5	1.9	2.7	3.1	6.9	3.0	7.1	13.2	6.5	8.9	7.9	7.2	12.7	7.6	7.5	12.1	9.2	14.7	14.7	17.8	7.0	7.1	20.0	20.3	8.9	9.7	10.9	7.5	9.6	11.8	7.7	9.6	17.1	7.9	6.3	12.2	12.3	17.4	7.9	17.7	7.0	10.0	15.3	11.9	9.3	16.0	13.6	12.6	11.5	20.5	11.0	6.8	11.7	8.3	14.0	12.4	10.6	26.0	5.0	6.6	20.5	9.3	11.6	11.8	3.4	10.7	13.9	7.4	10.9	15.4	0.0	1.9	1.9	5.7	2.7	4.7	4.2	5.5	4.4	4.5	5.0	6.9	5.1	0.3	3.1	1.9	2.8	3.6	3.0	8.2	11.2	18.4	8.5	6.3	6.3	9.1	5.7	9.8	8.3
DDX41	"ABS, MGC8828"	ENSG00000183258	"DEAD-box helicase 41"	Q9UJV9	5	177511577-177517469	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017911, HPA048803"	Supported		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA017911: AB_1847558, HPA048803: "	"unprognostic (2.52e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.47e-2)"	"prognostic unfavourable (2.21e-6)"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.75e-1)"	17.9	22.7	27.0	25.1	30.7	17.2	16.5	22.8	39.2	19.1	21.2	16.9	18.5	25.5	19.5	16.5	23.0	22.1	17.1	15.3	29.3	20.1	23.7	29.3	16.8	19.9	22.1	24.8	21.2	18.0	22.2	15.1	22.1	27.4	16.3	15.4	19.0	19.0	17.5	36.6	21.7	26.8	16.7	14.8	21.9	19.7	16.8	15.4	24.9	22.9	18.2	23.5	19.6	18.4	15.9	22.5	16.4	22.8	18.6	20.6	18.0	21.0	24.1	13.2	15.5	13.6	16.1	44.5	18.9	11.5	13.9	10.3	39.2	19.7	23.6	28.8	17.8	17.3	17.2	43.3	9.5	56.4	21.6	30.0	24.5	23.2	18.0	31.0	31.9	15.8	15.3	13.2	17.8	17.7	26.0	16.9	16.4	45.4	25.8	15.2	23.2	19.5	28.1	16.0	27.8	15.5	24.5	15.7	17.2	20.1	26.8	22.6	18.7	45.3	18.9	25.5	15.1	16.2	29.4	20.3	23.8	40.3	27.9	34.2	16.7	10.6	22.8	16.4	16.1	21.5	20.6	15.9	16.0	15.3	22.5	14.1	14.8	15.5	7.7	18.6	21.4	10.2	15.6	18.0	27.0	30.7	22.8	39.2	29.3	20.1	22.1	24.8	27.4	15.4
DDX47	"DKFZp564O176, FLJ30012, HQ0256, RRP3"	ENSG00000213782	"DEAD-box helicase 47"	Q9H0S4	12	12813316-12829981	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing, rRNA processing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014855	Approved		Supported	Nucleoli				Nucleoli		"HPA014855: AB_1847567"	"unprognostic (3.14e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.91e-2)"	"unprognostic (5.84e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.49e-3)"	"unprognostic (6.55e-9)"	"unprognostic (1.68e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.24e-1)"	"unprognostic (8.20e-6)"	29.3	24.1	19.9	21.6	25.6	31.0	29.1	27.4	26.9	26.7	26.2	28.2	21.4	16.0	33.7	21.0	28.9	27.5	17.9	22.6	20.0	19.4	29.6	38.1	23.2	26.1	28.2	19.9	33.7	31.0	25.8	23.8	27.6	25.1	29.2	24.2	25.5	27.1	27.7	40.6	28.1	20.4	34.1	21.4	25.6	28.0	26.8	29.8	29.7	39.4	27.9	33.7	35.7	26.7	22.0	25.0	3.5	19.1	16.6	26.0	14.0	39.6	17.2	16.9	13.7	16.6	16.4	28.8	17.1	19.6	36.5	34.2	25.9	25.6	20.4	6.7	23.1	25.9	24.2	19.7	41.1	28.8	17.3	18.7	12.8	14.7	14.1	21.2	12.0	15.8	18.7	21.6	17.9	28.0	18.0	4.6	19.9	14.2	17.2	14.7	74.0	10.5	19.1	32.8	12.3	22.2	28.6	7.4	18.8	20.7	13.3	17.0	5.4	16.1	12.5	14.7	35.8	9.4	25.6	6.5	11.8	37.0	15.7	11.1	16.9	3.3	14.4	3.5	21.8	19.1	26.0	22.0	19.4	20.1	25.0	21.2	25.8	24.2	1.7	16.6	18.2	14.7	18.7	14.0	19.9	25.6	27.4	26.9	20.0	19.4	28.2	19.9	25.1	29.8
DDX49	"Dbp8, FLJ10432"	ENSG00000105671	"DEAD-box helicase 49"	Q9Y6V7	19	18919675-18928633	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041870, HPA048093"	Enhanced		Approved	Nucleoli,Mitochondria				Mitochondria	Nucleoli	"HPA041870: , HPA048093: "	"unprognostic (3.51e-1)"	"prognostic favourable (2.01e-6)"	"unprognostic (2.28e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavourable (7.05e-4)"	"unprognostic (4.12e-2)"	"unprognostic (2.41e-3)"	"unprognostic (8.67e-2)"	"unprognostic (6.46e-3)"	"unprognostic (5.13e-2)"	"prognostic unfavourable (7.44e-5)"	"unprognostic (3.93e-2)"	"unprognostic (2.99e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.24e-1)"	14.8	16.8	17.6	17.3	16.9	28.3	18.0	17.0	30.7	15.3	15.8	19.0	14.8	19.5	15.6	13.2	23.4	16.5	12.2	18.2	19.2	12.9	15.5	25.6	13.0	19.3	15.7	14.8	15.7	26.8	13.0	11.1	23.3	16.2	15.5	10.3	13.5	24.3	15.8	27.2	23.6	18.7	12.7	16.8	16.7	15.7	19.7	16.3	23.4	18.8	16.6	18.7	16.4	15.6	8.2	25.0	13.5	19.5	14.1	14.0	9.7	15.8	16.5	6.7	21.0	9.8	7.9	25.2	10.1	6.9	17.9	14.5	18.8	16.1	20.8	30.9	10.0	13.7	14.9	13.9	5.1	6.3	39.6	10.2	17.9	16.3	23.3	26.2	14.2	15.8	13.4	14.2	15.1	8.1	19.2	14.9	6.3	35.5	18.9	12.2	21.8	40.3	21.0	11.2	22.5	9.6	10.0	23.6	24.3	13.3	13.2	16.1	13.6	12.6	10.4	8.7	9.9	31.5	16.5	19.6	23.4	19.0	11.1	30.2	13.6	10.5	17.7	13.5	12.8	19.5	10.6	8.1	9.7	9.6	25.0	8.2	9.7	10.2	7.9	14.1	12.6	11.2	14.0	9.7	17.6	16.9	17.0	30.7	19.2	12.9	15.7	14.8	16.2	16.3
DDX50	"GU2, GUB, MGC3199, RH-II/GuB"	ENSG00000107625	"DExD-box helicase 50"	Q9BQ39	10	68901278-68946847	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037388, HPA037389, HPA058196"	Approved		Enhanced	Nucleoli				Nucleoli		"HPA037388: AB_10671752, HPA037389: , HPA058196: "	"unprognostic (2.05e-1)"	"unprognostic (3.36e-1)"	"unprognostic (9.90e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.02e-1)"	25.0	17.8	16.7	25.5	19.2	14.7	24.8	20.8	17.0	26.5	25.3	13.1	24.0	12.9	30.0	22.6	24.0	23.0	17.5	20.3	15.7	15.0	18.6	16.1	16.4	24.5	17.6	15.0	35.3	24.1	24.9	35.2	23.0	16.1	30.0	18.1	12.6	19.5	25.0	26.6	18.3	17.4	31.9	18.3	22.0	19.9	25.6	17.3	33.0	26.1	21.5	25.7	35.4	27.2	14.2	10.3	10.7	12.2	13.8	20.2	10.9	19.3	12.5	22.2	27.5	18.9	24.7	14.2	20.7	22.8	18.7	17.7	28.0	16.9	25.2	12.5	18.2	17.4	21.5	15.2	23.4	22.1	16.3	13.5	12.4	12.2	19.1	28.1	16.9	19.0	15.9	17.8	49.8	15.0	24.1	15.4	23.0	15.5	26.8	27.0	12.9	28.1	23.3	25.3	4.5	14.7	11.6	15.5	21.4	15.2	17.8	22.8	20.7	18.3	13.0	14.6	17.1	16.5	28.1	20.9	18.8	21.4	15.7	29.4	8.5	5.5	7.8	10.7	15.0	12.2	18.3	13.6	18.5	15.4	10.3	14.2	20.2	17.7	2.7	13.8	9.6	10.2	16.1	10.9	16.7	19.2	20.8	17.0	15.7	15.0	17.6	15.0	16.1	17.3
DDX51		ENSG00000185163	"DEAD-box helicase 51"	Q8N8A6	12	132136594-132144335	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039503	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA039503: AB_10796328"	"unprognostic (2.84e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.84e-1)"	"unprognostic (8.66e-2)"	"unprognostic (4.00e-2)"	"prognostic unfavourable (4.73e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.88e-1)"	"unprognostic (3.05e-3)"	"unprognostic (5.31e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.65e-3)"	10.5	8.5	12.7	12.7	17.1	17.2	10.3	23.5	18.9	8.8	8.4	11.8	10.6	7.8	11.5	12.2	8.5	12.4	10.0	8.1	11.6	9.9	9.5	7.2	8.9	11.1	10.5	16.9	19.6	14.8	10.1	9.8	7.2	11.8	9.3	7.3	8.9	10.7	12.4	13.8	18.0	8.2	10.4	10.5	10.6	9.3	6.7	12.0	9.5	9.9	7.1	10.4	9.3	8.6	2.5	2.3	2.6	2.1	1.6	2.0	1.0	6.2	10.1	4.2	5.3	4.0	3.9	8.0	4.8	2.9	7.1	3.0	6.2	3.1	10.9	4.2	2.9	6.6	10.4	7.7	3.5	2.6	10.1	12.9	5.4	2.0	4.8	9.0	7.5	3.4	5.7	4.0	3.6	3.8	9.5	3.6	2.1	6.1	10.9	18.4	7.4	17.3	13.0	5.7	12.1	4.8	4.9	10.3	5.4	5.2	7.5	5.3	6.6	8.3	6.6	2.7	8.2	6.6	11.0	10.1	5.9	12.7	5.6	6.8	6.3	1.1	2.1	1.2	2.0	1.0	0.7	1.5	1.3	0.9	0.6	2.5	1.2	1.6	2.6	1.6	1.0	2.3	0.6	1.0	12.7	17.1	23.5	18.9	11.6	9.9	10.5	16.9	11.8	12.0
DDX52	ROK1	ENSG00000278053	"DExD-box helicase 52"	Q9Y2R4	17	37609739-37643464	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056173	Uncertain		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA056173: "	"unprognostic (1.05e-2)"	"unprognostic (1.85e-1)"	"prognostic favourable (9.41e-4)"	"unprognostic (4.26e-2)"	"unprognostic (9.96e-3)"	"unprognostic (6.77e-2)"	"prognostic unfavourable (2.44e-6)"	"unprognostic (5.10e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.95e-2)"	"unprognostic (5.58e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.28e-1)"	6.4	4.5	4.3	5.3	5.5	9.1	4.6	8.1	6.5	6.9	6.1	4.8	5.0	5.9	7.8	10.7	6.7	3.5	5.0	3.0	4.5		9.4	7.1	4.2	5.1	5.4	3.1	6.3	4.4	6.2	8.8	5.8	6.5	6.1	6.0	4.0	4.1	4.8	6.7	6.0	10.6	4.8	6.2	5.7	4.8	4.8	4.9	8.7	5.7	5.8	6.1	6.0	6.9	4.0	5.7	3.5	4.2	3.5	4.7	1.5	4.7	9.8	1.0	9.7	5.5	4.9	4.2	6.5	5.8	8.5	8.3	5.0	1.8	2.7	4.5	4.3	4.4	10.8	7.1	11.4	6.5	12.2	6.0	6.2	4.0	5.4	7.7	3.2	5.1	7.2	5.5	6.9	9.8	0.8	1.8	5.0	1.5	11.7	4.0	5.5	0.4	7.5	8.5	5.0	9.7	5.4	7.2	5.8	7.7	1.8	4.7	3.4	6.0	6.5	7.0	4.3	3.5	7.3	2.3	3.8	5.4	5.7	4.9	5.5	3.4	3.2	3.5	4.2	4.2	3.3	3.6	4.0	3.5	2.3	4.0	3.4	4.7	2.8	3.5	2.4	5.7	3.1	1.5										
DDX53	"CAGE, CT26"	ENSG00000184735	"DEAD-box helicase 53"	Q86TM3	X	22999961-23003589	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	33	"testis: 11.5"	"Cell line enhanced"	"Detected in some"		"K-562: 6.2;RPMI-8226: 3.2;U-2197: 2.1;U-266/84: 14.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA003186			Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA003186: AB_1078637"														"unprognostic (5.76e-1)"	"unprognostic (1.12e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.1	0.0	0.4	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DDX54	"APR-5, DP97, MGC2835"	ENSG00000123064	"DEAD-box helicase 54"	Q8TDD1	12	113157174-113185479	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028244, HPA070786"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"				"Nucleoplasm, Nucleoli, Golgi apparatus"		"HPA028244: AB_10603885, HPA070786: "	"unprognostic (1.61e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.57e-2)"	"unprognostic (6.39e-2)"	"prognostic unfavourable (1.39e-4)"	"unprognostic (2.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.24e-1)"	17.2	17.6	9.2	20.7	12.8	25.4	17.2	9.9	13.6	17.9	16.4	12.4	18.1	20.3	18.0	19.4	19.5	17.2	17.9	20.1	8.8	7.9	22.3	28.6	14.0	19.9	8.1	9.4	22.4	27.0	18.3	7.4	22.6	10.0	16.6	9.0	13.4	17.4	13.9	45.4	18.7	19.4	14.8	8.1	22.2	16.1	11.4	8.6	26.6	23.1	21.6	22.2	16.7	17.5	12.1	13.3	8.0	15.2	11.9	13.0	10.0	26.4	27.7	10.3	19.0	6.9	8.3	26.7	14.4	13.4	19.7	10.8	28.5	12.9	34.3	16.9	12.0	19.7	18.3	18.7	7.5	19.7	22.5	20.6	14.9	19.4	12.2	34.3	24.4	13.7	14.8	19.0	11.8	16.1	29.8	12.3	10.1	24.5	29.5	49.0	24.1	19.7	21.9	15.3	35.0	10.7	27.7	13.4	12.2	20.4	31.3	13.0	26.8	26.9	11.9	16.7	18.7	19.8	30.0	18.0	20.5	38.6	14.7	19.2	17.5	8.0	10.0	2.3	12.4	15.2	13.0	11.6	11.4	12.2	13.3	12.1	11.8	12.5	0.6	11.9	9.8	10.0	9.4	10.0	9.2	12.8	9.9	13.6	8.8	7.9	8.1	9.4	10.0	8.6
DDX55	KIAA1595	ENSG00000111364	"DEAD-box helicase 55"	Q8NHQ9	12	123602077-123620941	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039962, HPA044101"	Approved		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA039962: , HPA044101: "	"unprognostic (1.14e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (2.11e-9)"	"unprognostic (1.60e-1)"	"unprognostic (4.49e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.67e-3)"	"prognostic unfavourable (8.97e-12)"	"unprognostic (9.15e-3)"	"unprognostic (2.94e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.23e-3)"	15.0	13.5	12.3	16.4	14.0	27.7	16.3	21.4	13.9	13.0	13.2	15.7	16.2	12.0	14.7	13.2	14.2	15.0	11.8	8.8	11.4	10.9	10.2	17.8	11.2	19.9	15.6	10.3	17.5	25.9	13.8	20.3	12.3	14.4	14.4	14.5	11.9	15.2	12.6	12.6	21.4	12.9	11.9	10.5	18.8	11.6	11.2	14.8	16.9	12.2	12.5	16.5	11.9	23.1	13.4	12.8	7.3	10.0	12.2	15.7	8.5	10.0	14.2	10.9	11.0	9.4	7.5	16.5	12.4	4.6	11.1	7.7	16.1	7.3	14.8	10.0	5.4	12.3	16.6	9.2	13.0	11.1	15.1	20.0	15.7	11.9	7.1	24.6	15.8	6.2	9.8	13.1	15.3	7.9	20.4	7.9	7.8	10.3	24.1	33.5	16.9	14.2	18.2	11.7	9.7	7.8	17.4	13.0	10.8	10.1	13.1	16.9	23.4	16.0	8.1	9.6	12.6	15.6	15.3	14.6	18.0	26.9	9.1	17.7	16.3	2.8	9.2	7.3	12.0	10.0	12.7	13.4	11.6	12.5	7.5	11.3	15.7	14.7	5.6	12.2	5.9	12.8	9.1	8.5	12.3	14.0	21.4	13.9	11.4	10.9	15.6	10.3	14.4	14.8
DDX56	NOH61	ENSG00000136271	"DEAD-box helicase 56"	Q9NY93	7	44565417-44575051	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019749, CAB037320"	Uncertain		Supported	Nucleoli				Nucleoli		"CAB037320: , HPA019749: AB_1847579"	"unprognostic (3.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.08e-3)"	"unprognostic (2.12e-3)"	"prognostic unfavourable (1.38e-5)"	"unprognostic (5.17e-2)"	"unprognostic (2.76e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.01e-3)"	"prognostic unfavourable (8.41e-7)"	"unprognostic (2.60e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.90e-2)"	12.8	12.0	10.3	12.4	11.9	12.4	9.2	13.6	18.9	11.9	10.0	12.2	8.6	11.9	12.8	10.3	13.1	12.6	12.5	9.3	10.6	9.9	17.7	29.2	8.9	13.2	10.4	9.3	15.0	22.5	13.1	11.9	12.3	12.2	14.1	9.0	11.0	16.9	11.5	16.9	16.3	11.4	8.4	8.8	12.1	10.6	14.6	10.9	14.5	13.8	16.7	15.1	9.2	10.3	12.8	16.0	6.9	16.5	15.7	12.3	12.7	7.6	20.4	1.5	4.4	2.0	2.0	6.8	7.2	3.7	8.2	7.3	13.2	7.5	13.5	9.4	2.7	13.1	3.3	7.2	1.5	5.0	20.7	8.8	12.9	10.0	3.5	9.3	4.9	2.9	5.2	7.3	4.6	4.2	18.2	3.8	5.3	10.0	4.6	8.6	11.1	19.2	3.8	7.2	5.3	4.7	8.1	5.2	8.4	9.6	14.9	5.5	10.8	9.6	8.8	6.8	9.8	4.6	18.2	12.4	18.9	19.3	7.5	11.4	9.5	6.9	11.8	4.3	9.9	15.3	12.3	11.5	10.7	11.1	16.0	12.8	12.3	10.3	0.4	15.7	16.5	7.7	10.1	12.7	10.3	11.9	13.6	18.9	10.6	9.9	10.4	9.3	12.2	10.9
DEGS2	"C14orf66, DES2, FADS8"	ENSG00000168350	"Delta 4-desaturase, sphingolipid 2"	Q6QHC5	14	100143957-100160163	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 44.5;skin 1: 30.6"	"Cell line enriched"	"Detected in some"	20	"T-47d: 48.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 22.9"	"Cell type enhanced"	"Detected in many"		"memory B-cell: 11.9"	"Group enriched"	"Detected in many"	5	"B-cells: 11.9;granulocytes: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046644			Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA046644: "	"unprognostic (8.18e-2)"	"unprognostic (3.83e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.38e-1)"	"prognostic favourable (7.94e-7)"	"unprognostic (1.03e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.14e-1)"	"prognostic favourable (1.66e-4)"	0.4	0.3	2.0	2.3	4.6	0.5	5.8	22.9	6.4	5.3	20.2	1.8	0.6	20.8	3.4	4.6	20.9	1.9	13.3	0.3	2.0	1.5	8.7	17.2	2.6	0.8	2.4	1.4	0.8	13.0	0.3	1.6	0.6	2.7	2.5	4.2	0.8	4.5	2.3	0.5	30.6	44.5	0.7	1.9	0.5	17.9	0.7	0.7	0.0	2.4	7.3	11.1	7.1	5.2	11.9	0.7	6.4	0.5	0.2	1.8	0.8	0.0	0.1	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	1.8	0.1	0.1	0.0	0.0	0.1	0.0	1.6	0.0	0.7	2.4	0.0	0.0	1.4	0.0	48.0	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.7	0.5	6.4	1.8	0.0	0.0	11.9	0.1	0.8	0.7	5.9	0.0	1.2	0.2	0.2	0.0	0.1	0.0	0.8	2.0	4.6	22.9	6.4	2.0	1.5	2.4	1.4	2.7	0.7
DENND4A	"IRLB, MYCPBP"	ENSG00000174485	"DENN domain containing 4A"	Q7Z401	15	65658046-65792293	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065343	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA065343: "	"unprognostic (1.10e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.29e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.30e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.83e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.48e-1)"	13.7	15.7	9.5	13.9	11.3	32.9	9.5	26.7	12.6	10.0	9.6	12.2	6.8	6.9	11.5	6.6	8.0	9.3	13.2	8.2	10.7	8.5	9.8	19.1	12.8	20.8	12.1	9.7	16.3	19.9	17.9	21.2	9.9	11.6	8.1	8.2	14.6	9.5	7.2	15.3	7.6	10.2	12.5	16.6	13.6	10.2	9.0	11.9	16.9	12.7	5.6	20.1	13.4	10.1	9.3	3.1	6.8	3.6	4.4	8.0	1.9	4.8	4.6	2.4	2.4	7.2	8.0	3.0	5.0	6.7	3.3	5.0	2.6	3.8	24.8	3.5	7.3	9.0	4.7	4.4	5.9	27.5	5.4	23.6	5.9	4.9	4.2	8.0	8.4	5.3	5.0	4.6	9.8	9.0	7.1	15.4	3.8	2.6	3.7	4.3	0.7	3.4	1.8	8.5	21.4	3.9	9.3	3.9	3.6	4.9	3.4	4.4	3.3	20.4	9.6	4.7	5.2	8.4	6.9	8.4	9.3	9.3	6.6	17.4	3.8	3.1	3.6	6.8	5.3	1.5	8.0	7.8	4.6	6.7	3.1	9.3	4.9	4.7	1.9	4.4	1.2	1.2	4.2	1.9	9.5	11.3	26.7	12.6	10.7	8.5	12.1	9.7	11.6	11.9
DENND5B	MGC24039	ENSG00000170456	"DENN domain containing 5B"	Q6ZUT9	12	31382223-31591097	"Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 4.0;naive B-cell: 4.1;plasmacytoid DC: 2.2"	"Group enriched"	"Detected in many"	5	"B-cells: 4.1;dendritic cells: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038865	Approved		Approved	Nucleoli,Microtubules				Microtubules	Nucleoli	"HPA038865: "	"unprognostic (5.41e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.08e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.16e-2)"	"unprognostic (4.96e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.27e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.60e-2)"	6.0	9.5	9.9	9.3	16.6	3.1	5.9	24.5	17.8	6.5	8.1	7.9	2.7	12.4	9.7	3.4	3.9	6.0	6.2	14.4	9.3	12.4	10.7	17.0	4.6	9.3	8.7	10.9	30.5	7.9	6.0	12.8	6.9	16.0	4.7	6.3	7.7	3.2	5.0	10.9	2.8	14.6	10.2	6.4	8.9	6.8	20.3	8.4	0.4	4.6	3.2	11.1	6.6	7.3	4.1	2.2	0.6	0.3	0.4	0.2	0.2	1.7	17.6	13.0	4.9	4.7	5.9	2.0	4.3	4.7	10.9	7.9	11.8	7.1	6.5	7.2	9.3	0.5	2.5	1.2	11.0	0.0	5.5	0.1	13.8	7.0	4.3	5.8	0.1	3.6	3.9	7.3	12.1	10.0	2.5	13.3	6.8	1.6	3.4	6.2	13.2	3.1	3.3	18.0	0.1	9.3	2.3	4.1	6.3	10.8	1.2	9.4	1.8	3.3	10.4	4.1	10.5	7.3	9.0	7.1	7.8	6.6	7.0	0.7	6.9	0.3	0.3	0.3	0.2	0.1	0.1	4.0	0.1	0.1	0.6	4.1	0.1	0.1	0.6	0.4	0.2	2.2	0.0	0.2	9.9	16.6	24.5	17.8	9.3	12.4	8.7	10.9	16.0	8.4
DEPDC7		ENSG00000121690	"DEP domain containing 7"	Q96QD5	11	33015864-33033582	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 51.8;liver: 42.2"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 26.7;RH-30: 20.2;SiHa: 18.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 9.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA015800			Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA015800: AB_1847610"	"unprognostic (2.34e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.26e-2)"	"prognostic favourable (7.26e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.17e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.30e-2)"	"unprognostic (8.09e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.94e-2)"	0.6	0.5	2.0	1.4	4.1	0.9	2.0	0.5	2.6	1.7	15.3	4.3	1.2	14.1	1.2	1.4	3.1	0.8	3.1	0.9	2.6	1.4	10.9	42.2	0.7	0.4	4.0	1.5	1.3	2.7	3.5	0.8	1.2	2.8	1.4	3.1	1.2	1.7	1.0	3.3	3.4	51.8	1.0	3.2	0.5	2.2	15.6	3.3	1.8	0.6	2.0	0.9	0.9	2.4	0.0	4.4	9.0	0.7	3.0	3.1	0.6	4.5	2.5	3.7	1.6	1.9	1.9	2.4	8.0	2.7	4.9	6.6	6.5	0.4	0.0	1.8	7.9	4.6	5.3	1.9	5.8	0.0	7.4	1.2	7.8	9.2	1.6	4.3	5.5	2.3	2.9	2.8	2.1	0.0	2.9	0.0	26.7	0.5	0.0	7.0	2.4	0.0	0.0	20.2	0.0	1.6	0.6	0.8	2.1	18.4	3.3	15.9	0.8	2.3	0.0	3.2	5.3	17.1	5.1	0.0	0.0	0.0	1.1	0.0	15.6	4.0	0.7	9.0	0.3	0.2	0.0	0.0	0.6	0.3	4.4	0.0	2.9	3.1	0.0	3.0	0.0	1.8	0.0	0.6	2.0	4.1	0.5	2.6	2.6	1.4	4.0	1.5	2.8	3.3
DFFB	"CAD, CPAN, DFF-40, DFF40"	ENSG00000169598	"DNA fragmentation factor subunit beta"	O76075	1	3857267-3885429	"Predicted intracellular proteins"	Apoptosis	"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004328, HPA052904"	Approved		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"CAB004328: AB_626776, HPA052904: "	"unprognostic (2.98e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.52e-3)"	"unprognostic (6.12e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.82e-3)"	"unprognostic (4.07e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.86e-3)"	"unprognostic (3.39e-1)"	"unprognostic (2.27e-1)"	"prognostic favourable (6.29e-5)"	4.7	4.1	6.0	5.0	7.8	3.8	4.0	13.2	7.8	3.8	4.3	4.2	2.0	12.5	5.9	1.5	3.1	4.9	4.2	4.1	4.1	1.8	2.9	2.0	3.5	2.9	5.4	4.1	6.7	9.3	1.3	8.7	4.8	2.9	3.0	1.6	4.3	3.3	3.3	1.9	2.3	5.6	2.6	3.0	5.6	4.1	1.7	6.3	2.8	3.2	1.0	5.6	4.7	3.4	3.1	6.3	6.9	8.2	2.7	6.4	3.7	3.1	2.8	1.3	3.9	0.9	1.0	0.9	2.7	0.8	2.9	2.9	1.7	1.3	1.2	1.7	0.6	0.9	0.4	1.7	0.2	7.3	7.4	11.0	1.2	1.6	2.6	6.0	8.5	0.5	0.3	2.7	0.1	3.3	6.0	1.3	0.6	0.9	6.6	3.5	2.2	6.3	5.4	2.3	2.4	0.6	0.4	2.8	5.0	2.0	3.0	8.3	0.7	3.6	4.9	1.2	1.0	5.7	2.3	2.4	3.5	3.4	1.4	9.3	1.7	5.3	5.5	6.9	4.7	5.1	2.9	3.1	3.0	3.8	6.3	1.2	2.8	4.5	1.7	2.7	8.2	0.1	6.4	3.7	6.0	7.8	13.2	7.8	4.1	1.8	5.4	4.1	2.9	6.3
DGAT1	"ARGP1, DGAT"	ENSG00000185000	"Diacylglycerol O-acyltransferase 1"	O75907	8	144314584-144326910	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"intestine: 161.0"	"Cell line enhanced"	"Detected in many"		"Hep G2: 15.8;PC-3: 17.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB032853	Enhanced		Approved	"Nucleoli,Endoplasmic reticulum"				"Endoplasmic reticulum"	Nucleoli	"CAB032853: AB_2090798"	"unprognostic (9.24e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.67e-3)"	11.8	18.5	3.6	5.7	4.7	6.4	6.8	6.6	5.6	3.3	60.2	4.0	6.4	44.7	3.9	3.6	5.5	3.1	7.9	6.3	3.7	2.7	6.7	14.4	3.8	3.1	4.1	2.7	3.3	3.9	5.0	4.0	4.3	3.6	3.4	6.3	4.1	5.9	4.3	10.0	4.8	161.0	3.6	2.6	5.3	5.7	10.7	4.2	5.1	3.8	6.2	5.0	4.7	3.4	0.7	2.2	2.8	2.0	0.3	1.7	0.8	3.8	4.1	1.9	3.6	3.2	1.3	2.3	2.7	2.7	2.6	1.8	9.7	2.6	1.5	10.6	1.7	3.3	1.6	3.7	0.5	2.8	4.0	2.8	3.3	15.8	2.3	0.7	2.9	1.8	2.9	1.6	1.9	2.0	2.2	3.5	1.7	3.2	4.8	3.1	0.9	17.6	6.2	0.8	2.5	2.4	2.1	2.0	3.4	3.6	4.4	1.8	2.5	2.7	1.6	1.4	4.9	2.8	2.2	2.0	0.4	0.6	1.4	4.9	2.3	0.0	2.0	2.8	1.2	1.3	1.7	0.7	0.9	1.1	2.2	0.5	0.7	0.3	2.3	0.3	1.7	1.1	0.7	0.8	3.6	4.7	6.6	5.6	3.7	2.7	4.1	2.7	3.6	4.2
DHRS3	"RDH17, retSDR1, Rsdr1, SDR1, SDR16C1"	ENSG00000162496	"Dehydrogenase/reductase 3"	O75911	1	12567910-12617731	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 29.0;CAPAN-2: 59.3;SK-BR-3: 31.8;WM-115: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"gdT-cell: 33.5;MAIT T-cell: 24.2;memory CD4 T-cell: 18.3;memory CD8 T-cell: 15.7;myeloid DC: 8.6;naive CD4 T-cell: 31.6;naive CD8 T-cell: 19.7;NK-cell: 13.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 8.6;NK-cells: 13.8;T-cells: 33.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010844	Supported		Approved	Nucleoli,Mitochondria				"Nucleoli, Mitochondria"		"HPA010844: AB_1847653"	"unprognostic (7.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.25e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.76e-1)"	"prognostic favourable (2.65e-4)"	"unprognostic (5.48e-2)"	22.7	4.4	6.3	6.2	8.6	2.5	30.6	4.0	7.9	16.7	16.3	3.4	9.2	13.6	7.6	15.5	19.0	12.2	11.2	16.1	6.8	8.6	12.3	45.6	11.6	8.3	9.0	4.5	11.8	20.3	0.5	8.9	11.5	9.8	16.3	5.6	20.3	11.8	14.3	10.2	5.6	18.9	11.1	9.8	4.2	12.3	5.2	4.2	3.1	40.5	5.4	5.2	21.0	9.4	0.2	8.6	2.1	0.3	13.8	33.5	15.6	5.1	29.0	0.0	12.8	16.8	1.4	3.3	1.7	0.0	0.0	0.1	3.4	59.3	0.0	1.4	17.0	23.4	6.2	3.2	0.0	0.0	10.4	4.5	3.0	16.1	2.5	0.0	0.0	8.5	3.9	0.1	0.1	5.4	6.8	0.0	0.1	0.9	1.2	0.2	1.9	11.7	0.1	0.0	5.9	0.0	9.9	0.3	0.5	9.8	31.8	1.8	3.1	1.2	3.9	0.1	0.6	8.9	0.1	0.9	0.0	0.0	6.7	0.4	55.1	2.1	0.2	0.0	33.5	0.1	24.2	0.2	18.3	15.7	8.6	0.2	31.6	19.7	1.7	13.8	0.3	1.0	0.5	15.6	6.3	8.6	4.0	7.9	6.8	8.6	9.0	4.5	9.8	4.2
DHX33	"DDX33, DKFZp762F2011, FLJ21972"	ENSG00000005100	"DEAH-box helicase 33"	Q9H6R0	17	5440912-5469060	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073875	Supported		Supported	Nucleoli				Nucleoli		"HPA073875: "	"unprognostic (4.96e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (6.10e-4)"	"unprognostic (1.03e-1)"	"unprognostic (4.66e-1)"	"unprognostic (3.55e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.37e-2)"	10.0	10.4	11.6	11.0	14.6	7.0	12.9	15.8	22.0	9.0	8.7	14.1	8.6	8.6	12.4	7.9	11.2	11.2	9.2	7.7	9.7	7.0	8.2	13.4	8.0	10.1	11.0	13.2	11.1	12.1	16.5	7.3	11.5	10.3	10.0	10.7	11.3	10.4	10.8	13.9	12.5	8.7	11.1	8.0	11.1	9.6	10.1	11.7	8.4	9.5	9.4	10.3	9.6	9.5	3.7	3.4	2.6	3.5	3.0	2.5	0.7	10.3	15.3	9.8	17.5	4.1	8.4	12.2	10.2	6.4	15.8	12.8	9.6	4.5	25.3	7.2	8.4	12.3	19.9	16.0	20.2	8.1	19.1	10.0	12.5	16.2	8.2	13.4	9.1	7.0	9.8	16.8	23.1	11.7	13.3	12.6	8.6	7.3	13.5	7.3	21.7	7.8	18.2	14.4	13.7	7.2	8.0	8.6	12.4	10.7	9.2	15.8	7.2	7.0	10.8	10.9	11.5	8.6	21.6	4.7	5.0	13.0	7.8	16.0	15.6	0.6	3.5	1.8	2.2	1.4	2.1	2.5	2.5	1.4	1.4	3.7	2.5	2.4	2.6	3.0	1.3	3.4	1.8	0.7	11.6	14.6	15.8	22.0	9.7	7.0	11.0	13.2	10.3	11.7
DHX57	DDX57	ENSG00000163214	"DExH-box helicase 57"	Q6P158	2	38797729-38875934	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036160	Uncertain		Approved	"Nucleoli,Intermediate filaments,Microtubules,Cytosol"				"Intermediate filaments, Microtubules"	"Nucleoli, Cytosol"	"HPA036160: AB_10670711"	"unprognostic (6.78e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.03e-3)"	"unprognostic (3.25e-2)"	"unprognostic (3.43e-1)"	"prognostic unfavourable (3.32e-6)"	"unprognostic (1.75e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.77e-1)"	9.6	11.2	9.7	8.5	16.7	7.0	10.4	11.9	16.4	14.1	9.4	9.9	9.8	4.2	13.9	17.1	8.4	11.2	9.5	9.3	9.6	11.0	11.2	7.2	7.9	9.2	8.9	9.5	13.2	9.5	18.9	17.9	11.2	13.1	10.5	9.2	11.6	7.8	14.2	11.5	11.1	6.9	11.8	7.7	9.9	7.9	27.7	8.3	13.9	11.8	8.1	11.1	10.5	8.3	7.1	5.2	1.7	10.1	3.3	6.0	4.2	16.9	13.6	15.2	11.4	10.0	12.4	12.5	11.8	11.6	11.2	11.0	10.9	5.2	4.9	11.9	12.0	8.8	17.2	13.0	18.4	20.4	12.7	9.6	9.1	14.8	9.1	10.1	5.6	11.8	7.9	14.5	9.1	14.9	12.3	7.0	12.1	12.3	10.1	9.3	19.0	8.1	5.0	20.2	9.7	10.3	6.5	12.6	18.5	11.8	12.2	13.8	8.5	5.6	11.4	11.1	12.9	8.5	12.6	7.4	8.2	2.1	8.7	7.1	7.4	1.7	10.1	1.7	4.5	6.9	6.0	5.7	4.0	3.5	5.2	7.1	4.8	3.0	0.5	3.3	8.0	1.7	3.3	4.2	9.7	16.7	11.9	16.4	9.6	11.0	8.9	9.5	13.1	8.3
DIAPH2	"DIA, DIA2, POF, POF2"	ENSG00000147202	"Diaphanous related formin 2"	O60879	X	96684663-97604997	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Oogenesis"	"Developmental protein"	"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005647, CAB015461, CAB068183, CAB068184"	Enhanced		Supported	"Nucleoli,Endoplasmic reticulum,Vesicles"				"Endoplasmic reticulum, Vesicles"	Nucleoli	"CAB015461: AB_831223, CAB068183: , CAB068184: , HPA005647: AB_1078657"	"unprognostic (5.75e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavourable (2.16e-5)"	"unprognostic (1.58e-1)"	"unprognostic (6.48e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavourable (2.12e-4)"	"unprognostic (3.39e-2)"	"prognostic unfavourable (3.90e-4)"	"unprognostic (6.44e-2)"	"unprognostic (3.11e-2)"	"unprognostic (6.99e-3)"	"unprognostic (6.08e-3)"	25.3	5.7	8.2	16.5	13.6	19.9	12.0	1.6	4.6	17.8	18.5	2.9	15.1	5.5	10.7	9.1	16.3	10.4	12.6	13.0	6.6	3.0	6.1	15.7	16.8	6.9	4.1	4.4	14.2	6.6	8.7	5.5	37.2	7.1	16.0	11.4	4.7	9.4	17.2	19.9	9.3	12.0	18.5	7.3	9.8	9.9	12.3	5.1	9.4	7.5	12.0	4.9	19.8	26.9	2.7	4.3	5.7	5.8	1.4	2.8	1.0	0.0	4.0	1.9	3.9	11.0	18.4	0.0	6.9	7.3	3.7	7.9	3.3	7.6	11.3	5.5	5.9	0.0	10.3	1.1	4.9	0.3	5.9	0.0	4.8	3.5	9.2	14.5	5.2	9.2	3.7	5.0	15.7	7.2	0.0	9.3	6.9	3.2	5.4	5.9	15.3	5.9	0.0	10.4	0.0	2.1	6.0	0.0	4.0	0.0	2.0	5.5	1.7	8.0	9.1	8.1	3.7	6.6	4.4	0.1	0.0	9.5	6.8	14.8	4.7	0.0	5.8	5.7	2.3	5.4	1.8	2.7	2.4	2.8	4.3	2.4	1.6	1.5	0.6	1.4	4.5	4.1	1.3	1.0	8.2	13.6	1.6	4.6	6.6	3.0	4.1	4.4	7.1	5.1
DIMT1	"DIMT1L, HSA9761"	ENSG00000086189	"DIM1 dimethyladenosine transferase 1 homolog"	Q9UNQ2	5	62387254-62403939	"Enzymes, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042944	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA042944: "	"unprognostic (1.58e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.02e-3)"	"unprognostic (7.16e-2)"	"unprognostic (8.95e-3)"	"unprognostic (1.73e-2)"	"prognostic unfavourable (6.93e-4)"	"unprognostic (8.88e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.70e-1)"	"prognostic unfavourable (8.90e-12)"	"unprognostic (8.89e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.15e-2)"	16.7	14.0	18.9	16.7	17.0	10.6	18.9	11.5	23.5	18.6	11.8	12.4	11.8	11.0	16.2	11.9	20.1	14.2	15.3	19.7	19.1	17.0	11.9	16.3	11.7	22.5	18.8	8.5	17.8	28.4	8.9	13.4	16.7	12.3	18.8	9.5	10.0	16.1	18.3	17.9	12.2	11.9	24.6	20.2	22.1	10.2	10.7	9.8	16.3	19.0	19.0	19.2	21.7	13.2	7.9	7.7	5.0	5.6	7.0	13.2	6.1	14.4	8.7	15.9	20.8	11.8	15.7	15.9	18.6	7.0	14.4	15.3	14.1	15.5	29.8	17.0	13.8	11.3	10.7	11.0	18.3	21.2	18.7	20.5	11.4	11.7	14.2	16.8	15.8	13.6	8.9	14.0	13.7	12.5	20.7	13.8	14.6	14.5	24.7	25.9	15.4	18.4	16.0	16.1	41.1	13.0	13.4	17.9	15.6	15.9	14.9	15.9	12.0	15.8	13.8	9.9	10.4	14.0	25.4	18.2	18.9	26.9	15.1	30.2	14.6	5.0	3.1	2.3	7.7	5.6	11.7	7.9	10.4	9.3	5.0	6.6	13.2	11.0	0.8	7.0	4.3	7.7	9.3	6.1	18.9	17.0	11.5	14.7	19.1	17.0	18.8	8.5	12.3	9.8
DLG3	"KIAA1232, MRX90, NE-Dlg, NEDLG, PPP1R82, SAP-102, SAP102"	ENSG00000082458	"Discs large MAGUK scaffold protein 3"	Q92796	X	70444861-70505490	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 20.6;SK-BR-3: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 2.1;MAIT T-cell: 1.8;memory CD4 T-cell: 1.7;memory CD8 T-cell: 2.4;naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.8;NK-cell: 1.7;T-reg: 2.4"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.7;T-cells: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001733, HPA078130"	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA001733: AB_1078675, HPA078130: "	"prognostic unfavourable (1.69e-4)"	"unprognostic (1.87e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.98e-2)"	"prognostic favourable (1.72e-10)"	"unprognostic (3.36e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.97e-3)"	2.7	3.3	12.5	6.5	17.6	0.7	10.8	16.4	25.2	9.2	16.0	4.3	14.7	11.7	7.6	23.7	14.5	17.4	16.3	6.0	15.2	10.0	10.8	1.4	7.8	3.1	6.5	10.2	11.2	27.1	21.2	8.9	5.5	8.0	9.6	17.1	10.2	21.0	10.4	1.1	8.4	20.8	11.3	3.4	14.6	13.8	1.9	3.5	3.2	13.8	2.6	8.0	11.2	9.9	0.4	0.0	0.0	0.0	1.7	2.4	0.3	3.6	1.7	10.6	4.5	2.7	3.4	7.4	2.2	2.5	1.2	1.2	10.5	8.7	0.0	5.1	2.2	8.0	20.6	4.8	0.8	4.3	6.2	0.0	9.4	5.7	5.4	0.1	1.4	3.5	3.2	1.5	3.4	0.4	2.0	14.7	1.1	12.9	8.3	0.0	17.8	12.4	7.8	5.2	1.6	7.2	11.3	5.0	0.3	1.7	20.6	3.9	10.8	0.0	0.8	1.4	1.4	1.3	1.6	9.7	7.3	4.6	2.1	0.0	2.0	0.0	0.0	0.0	2.1	0.0	1.8	0.4	1.7	2.4	0.0	0.0	1.1	1.8	0.0	1.7	0.0	0.0	2.4	0.3	12.5	17.6	16.4	25.2	15.2	10.0	6.5	10.2	8.0	3.5
DLK2	"EGFL9, MGC2487"	ENSG00000171462	"Delta like non-canonical Notch ligand 2"	Q6UY11	6	43450352-43456632	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 19.3"	"Cell line enhanced"	"Detected in many"		"HaCaT: 16.2;HBEC3-KT: 8.8;hTCEpi: 26.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA061223, HPA068672, HPA070955"	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles				Nucleoplasm	"Nucleoli, Vesicles"	"HPA061223: , HPA068672: , HPA070955: "	"unprognostic (4.65e-5)"	"unprognostic (1.27e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.68e-4)"	"unprognostic (2.87e-1)"	"unprognostic (3.80e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.65e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.27e-12)"	"unprognostic (7.71e-4)"	"unprognostic (8.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.43e-2)"	1.0	1.1	4.5	1.4	7.9	1.7	4.3	12.2	8.2	2.2	0.7	0.9	6.4	1.1	1.4	3.8	10.5	1.1	0.9	1.8	4.1	4.6	0.7	0.7	1.1	1.7	1.5	4.8	1.7	1.5	0.4	0.5	1.3	0.9	10.4	0.5	0.3	12.4	13.0	0.7	19.3	1.0	0.6	1.5	1.5	1.1	1.1	1.2	1.3	0.8	4.7	3.9	2.2	5.3	0.8	1.8	1.0	0.5	2.5	3.2	0.3	5.1	1.8	0.5	7.7	0.0	0.4	1.7	1.9	2.1	2.1	1.0	1.8	0.2	0.9	1.2	0.3	16.2	5.4	8.8	0.4	1.0	2.0	0.4	0.9	2.7	0.5	0.3	1.1	0.9	26.6	0.6	5.0	0.0	0.4	0.7	0.8	1.9	0.4	0.4	0.7	1.9	1.0	0.9	0.5	0.3	1.8	5.7	0.5	0.6	0.2	0.3	0.5	1.6	0.5	0.8	2.5	0.6	3.7	1.2	0.3	1.7	0.1	0.7	0.5	0.9	0.4	0.4	0.7	0.3	3.2	0.6	2.2	2.2	0.1	0.8	0.9	0.4	1.0	2.5	0.5	1.8	0.3	0.3	4.5	7.9	12.2	8.2	4.1	4.6	1.5	4.8	0.9	1.2
DMXL1		ENSG00000172869	"Dmx like 1"	Q9Y485	5	119037772-119249138	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036431, HPA036432"	Approved		Supported	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA036431: AB_10669791, HPA036432: "	"unprognostic (2.47e-1)"	"unprognostic (4.84e-2)"	"unprognostic (7.87e-3)"	"unprognostic (3.51e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.80e-3)"	"unprognostic (2.80e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.88e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.26e-1)"	"prognostic favourable (5.16e-5)"	"unprognostic (4.04e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.12e-2)"	"unprognostic (5.18e-2)"	17.8	10.4	9.3	14.0	14.1	29.3	16.1	14.2	15.4	12.0	11.6	15.4	9.6	8.3	15.7	8.5	13.0	12.0	10.3	10.2	8.9	5.6	18.8	9.6	13.9	12.5	11.5	11.4	17.4	20.1	21.3	14.1	9.5	18.9	35.9	9.8	13.3	13.6	10.9	10.9	21.4	13.1	13.0	10.9	11.5	12.4	9.2	13.1	18.1	17.9	6.8	13.8	14.3	12.4	11.2	9.5	4.6	9.0	1.5	3.8	2.6	9.5	7.4	8.4	8.6	9.1	12.1	9.0	7.9	7.9	7.9	9.4	8.9	5.9	18.6	8.2	10.1	5.8	9.3	9.4	10.4	14.3	9.3	13.1	12.9	3.1	7.6	8.5	11.4	9.6	5.3	9.2	7.7	10.4	11.0	12.6	6.4	6.0	11.4	4.9	4.6	4.5	9.0	15.6	7.2	6.2	11.1	7.9	8.0	13.6	4.9	12.2	8.2	9.9	10.0	9.5	8.0	9.5	8.3	11.9	8.4	16.2	11.8	8.4	7.6	4.6	5.5	3.9	2.9	4.9	3.6	9.7	2.3	2.4	3.8	11.2	3.8	2.1	4.5	1.5	9.0	9.5	2.8	2.6	9.3	14.1	14.2	15.4	8.9	5.6	11.5	11.4	18.9	13.1
DNAJA2	"CPR3, DNAJ, DNJ3, HIRIP4"	ENSG00000069345	"DnaJ heat shock protein family (Hsp40) member A2"	O60884	16	46955362-46973788	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049789, HPA060538"	Approved		Approved	"Nucleoli,Intermediate filaments,Cytosol"			31000	"Nucleoli, Cytosol"	"Intermediate filaments"	"HPA049789: , HPA060538: "	"unprognostic (7.68e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.77e-2)"	"unprognostic (3.67e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavourable (2.81e-4)"	"unprognostic (1.03e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.41e-2)"	"unprognostic (2.12e-1)"	"prognostic favourable (1.19e-9)"	"unprognostic (9.22e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.69e-2)"	25.0	29.2	32.3	18.0	36.5	23.6	22.8	29.8	44.2	21.7	21.1	17.1	20.3	22.3	25.6	33.6	23.4	20.3	18.9	37.9	30.5	27.1	31.2	39.0	17.7	21.4	25.5	27.6	26.1	18.9	29.0	18.9	22.1	31.5	25.6	21.9	18.4	19.1	24.9	43.7	22.3	23.8	26.9	21.2	24.1	20.3	33.0	18.7	20.8	25.4	31.8	23.2	24.5	23.5	13.6	10.5	14.5	14.0	14.3	18.9	10.2	10.9	13.1	13.2	11.2	18.1	17.5	20.1	14.3	17.3	21.6	10.3	11.4	11.5	17.7	11.6	15.4	17.1	21.0	14.8	25.1	4.2	17.6	13.0	6.4	24.0	21.7	19.7	18.2	18.6	17.2	12.5	11.9	14.9	14.9	6.0	18.2	12.0	14.1	27.5	20.1	19.5	16.4	24.2	21.0	26.0	11.7	18.1	11.6	17.0	25.8	15.6	10.0	15.4	15.3	12.8	8.1	9.2	12.0	14.8	10.1	23.7	13.5	17.0	10.7	13.0	11.5	14.5	11.9	14.0	15.4	13.6	16.1	13.3	10.5	10.4	16.0	15.7	12.1	14.3	12.0	7.4	18.9	10.2	32.3	36.5	29.8	44.2	30.5	27.1	25.5	27.6	31.5	18.7
DNAL4	"dJ327J16, PIG27"	ENSG00000100246	"Dynein axonemal light chain 4"	O96015	22	38778508-38794198	"Disease related genes, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003647	Approved		Approved	Nucleoplasm,Nucleoli,Centrosome,Cytosol				Centrosome	"Nucleoplasm, Nucleoli, Cytosol"	"HPA003647: AB_1078712"	"unprognostic (8.45e-2)"	"unprognostic (8.15e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.14e-3)"	"unprognostic (3.74e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.46e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.07e-1)"	"prognostic favourable (1.20e-6)"	"unprognostic (1.60e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.83e-2)"	8.2	11.4	24.1	9.6	21.9	3.9	13.7	8.6	19.8	17.8	10.1	8.5	19.7	7.3	9.8	15.0	12.3	33.5	12.7	9.9	17.7	15.2	16.0	7.1	12.8	7.5	9.5	15.7	15.8	14.9	19.2	19.3	11.9	7.9	13.2	9.2	13.1	16.4	16.3	4.4	11.4	8.0	7.7	6.4	7.5	11.1	36.5	9.7	13.2	26.1	6.6	8.6	8.4	9.1	12.6	14.8	17.5	11.2	15.7	16.6	8.1	8.8	4.5	9.1	8.1	11.6	11.7	0.0	3.7	7.3	5.8	6.4	2.8	10.5	2.2	8.2	5.5	4.3	5.7	10.1	4.1	5.5	7.4	1.2	1.3	3.1	18.5	7.1	1.9	9.4	33.0	7.8	14.1	8.4	2.6	4.5	7.2	11.0	6.6	7.0	3.5	3.6	6.4	3.9	2.9	12.3	5.3	12.8	6.9	7.8	6.0	15.3	10.9	6.8	5.1	5.3	5.4	8.1	3.8	2.8	0.8	1.0	16.0	2.4	5.1	15.6	9.6	12.8	13.5	9.5	16.6	8.7	11.2	12.1	9.8	12.6	13.3	11.0	17.5	15.7	11.2	14.8	10.2	8.1	24.1	21.9	8.6	19.8	17.7	15.2	9.5	15.7	7.9	9.7
DNMBP	"ARHGEF36, KIAA1010, Tuba"	ENSG00000107554	"Dynamin binding protein"	Q6XZF7	10	99875577-100009919	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA037878, HPA058216"	Uncertain		Approved	"Nucleoli,Nuclear bodies,Golgi apparatus,Cytosol"				"Nucleoli, Golgi apparatus, Cytosol"	"Nuclear bodies"	"HPA037878: AB_10675622, HPA058216: "	"unprognostic (3.25e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.86e-1)"	"prognostic favourable (4.95e-6)"	"unprognostic (3.92e-2)"	"unprognostic (4.13e-1)"	"unprognostic (9.79e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.67e-3)"	"unprognostic (4.03e-2)"	"unprognostic (5.07e-3)"	"unprognostic (6.52e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.28e-1)"	"prognostic favourable (6.15e-4)"	11.0	4.8	3.7	8.3	3.6	5.8	8.4	9.2	4.4	13.0	24.9	3.2	23.0	14.5	15.6	11.1	8.2	9.2	10.2	6.0	3.1	2.6	11.1	8.6	6.6	4.5	2.3	3.0	13.8	22.3	24.6	5.0	8.5	3.5	11.6	13.8	8.5	7.2	23.3	10.2	20.0	38.3	15.9	3.1	6.2	15.3	8.6	2.3	30.4	7.1	8.8	7.7	17.4	16.8	4.3	0.8	1.6	2.7	5.3	1.7	1.2	10.8	8.9	8.1	12.8	14.9	12.5	1.9	19.6	19.0	9.5	9.2	6.0	16.5	11.3	8.4	15.0	8.6	9.4	11.3	13.4	0.6	2.9	1.6	10.1	4.2	7.7	1.1	0.8	5.9	2.5	11.7	10.4	22.7	1.5	0.0	19.2	1.3	1.9	2.1	7.8	5.4	2.3	8.3	0.5	16.2	9.4	1.4	1.8	3.2	0.8	2.4	0.7	1.0	27.4	7.1	6.8	5.7	12.8	0.9	0.7	15.9	6.8	3.6	5.3	0.0	1.8	0.4	1.7	2.7	1.6	3.0	0.4	1.2	0.8	4.3	0.4	0.8	1.6	5.3	2.7	0.6	0.0	1.2	3.7	3.6	9.2	4.4	3.1	2.6	2.3	3.0	3.5	2.3
DNTTIP1	"C20orf167, dJ447F3.4, Tdif1"	ENSG00000101457	"Deoxynucleotidyltransferase terminal interacting protein 1"	Q9H147	20	45791937-45811427	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 41.0"	"Group enriched"	"Detected in all"	7	"dendritic cells: 14.2;granulocytes: 41.0;monocytes: 16.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045496			Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA045496: "	"unprognostic (7.77e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.05e-2)"	"prognostic unfavourable (1.79e-5)"	"unprognostic (6.29e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.81e-3)"	"unprognostic (5.63e-2)"	"prognostic unfavourable (1.90e-6)"	"unprognostic (3.18e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.30e-1)"	15.2	16.3	15.8	19.0	18.0	31.6	16.0	15.5	19.9	16.4	24.2	15.4	20.5	14.0	23.3	21.3	18.8	20.6	18.6	20.6	14.6	15.3	15.6	18.7	18.2	17.7	14.5	17.6	20.1	24.1	18.2	17.8	18.3	15.1	23.5	32.0	16.1	21.0	21.6	45.0	21.8	19.6	32.6	13.8	21.2	20.7	36.9	11.8	25.2	21.1	19.4	21.7	30.1	16.1	3.2	14.2	41.0	16.6	1.0	3.4	4.5	20.4	10.9	11.3	10.7	8.7	9.4	11.8	7.7	12.5	25.0	22.7	34.6	33.6	8.5	25.3	11.2	15.5	9.9	16.5	16.7	4.6	12.4	9.2	11.5	22.0	17.7	18.0	15.4	9.4	15.6	16.3	15.8	14.6	8.5	8.7	14.8	27.2	14.7	27.9	7.6	74.6	11.9	14.0	8.8	12.5	9.8	10.6	9.6	15.7	12.8	16.1	12.7	28.9	8.5	15.0	11.2	14.5	18.4	9.5	6.1	10.5	32.8	11.6	12.8	4.8	16.6	21.6	1.4	6.9	1.4	3.2	1.9	2.4	14.2	2.7	3.4	1.6	41.0	1.0	4.2	5.5	2.7	4.5	15.8	18.0	15.5	19.9	14.6	15.3	14.5	17.6	15.1	11.8
DNTTIP2	"ERBP, HSU15552, TdIF2"	ENSG00000067334	"Deoxynucleotidyltransferase terminal interacting protein 2"	Q5QJE6	1	93866283-93879918	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044502, HPA053707"	Supported		Enhanced	Nucleoli				Nucleoli		"HPA044502: AB_10960277, HPA053707: "	"unprognostic (2.95e-3)"	"unprognostic (3.84e-2)"	"unprognostic (6.21e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.92e-2)"	"prognostic unfavourable (1.90e-6)"	"unprognostic (7.94e-2)"	"unprognostic (5.57e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (7.80e-5)"	"unprognostic (2.59e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.06e-2)"	14.0	8.5	10.7	7.3	11.4	27.6	10.9	12.0	12.5	12.4	9.4	5.8	7.9	6.1	9.4	14.1	15.1	9.7	9.7	11.4	9.4	10.3	14.5	15.1	12.1	10.7	10.4	10.5	15.9	8.3	9.9	12.1	15.5	17.7	13.0	8.1	4.6	9.0	7.3	24.6	11.7	11.7	11.0	13.2	16.2	9.0	12.0	10.9	15.9	16.2	12.6	10.7	17.3	15.5	11.1	7.2	15.8	11.6	11.9	11.6	8.0	12.4	6.0	6.7	7.1	6.5	5.8	10.3	8.4	6.0	10.1	8.7	6.6	5.6	16.7	11.2	8.8	7.0	10.8	10.0	14.4	10.1	6.1	13.7	9.8	9.6	6.7	15.3	4.9	6.4	11.0	10.8	9.1	7.2	16.1	5.8	13.6	5.4	10.7	10.0	13.0	9.7	6.2	14.3	6.4	10.3	9.7	8.1	7.3	8.8	13.2	9.1	5.6	11.1	6.8	8.2	8.6	9.3	14.0	6.1	8.1	13.7	4.8	12.1	5.4	10.9	7.9	15.8	9.6	11.6	11.6	11.1	8.9	8.7	7.2	10.5	8.2	10.4	12.1	11.9	10.7	5.0	8.8	8.0	10.7	11.4	12.0	12.5	9.4	10.3	10.4	10.5	17.7	10.9
DOC2A		ENSG00000149927	"Double C2 domain alpha"	Q14183	16	30005509-30023270	"Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 49.0;testis: 12.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 9.6;REH: 7.8;SCLC-21H: 26.1;U-937: 12.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"amygdala: 13.5;cerebral cortex: 30.8;hippocampal formation: 24.4"	HPA065676			Uncertain	"Nucleoplasm,Nucleoli,Cell Junctions"				"Cell Junctions"	"Nucleoplasm, Nucleoli"	"HPA065676: "	"unprognostic (1.46e-3)"	"unprognostic (3.39e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.66e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.13e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.61e-1)"	1.2	2.7	18.5	1.0	17.5	3.9	2.3	24.0	49.0	1.3	3.1	0.9	0.3	1.7	1.6	2.4	1.1	3.3	1.8	1.0	15.3	8.3	1.6	1.4	3.5	1.4	2.8	27.4	5.7	1.0	1.3	3.2	1.2	13.1	2.5	2.4	0.0	1.6	1.4	1.1	2.0	2.3	1.8	4.2	3.1	1.7	12.6	1.8	0.0	1.6	0.0	1.2	1.4	0.6	0.6	1.1	1.0	0.4	0.2	0.5	0.3	0.7	1.5	1.0	0.8	0.3	0.0	9.6	0.4	0.7	0.5	0.3	3.9	2.7	0.0	0.9	0.4	0.2	4.9	2.0	0.2	0.1	0.5	0.7	0.5	0.3	0.7	0.9	2.8	1.1	0.8	0.1	1.1	0.0	0.3	0.0	0.0	7.6	2.0	3.5	1.5	4.1	7.8	0.1	0.4	0.5	0.8	26.1	2.0	0.5	2.7	0.2	2.6	1.6	0.8	0.3	1.5	0.3	0.3	0.4	0.1	0.1	0.3	12.5	0.3	0.8	0.4	0.0	0.0	0.3	0.1	0.5	0.1	0.3	1.1	0.6	0.5	0.5	1.0	0.2	0.0	0.0	0.1	0.3	18.5	17.5	24.0	36.2	15.3	8.3	2.8	27.4	13.1	1.8
DOCK11	"ACG, FLJ32122, FLJ43653, ZIZ2"	ENSG00000147251	"Dedicator of cytokinesis 11"	Q5JSL3	X	118495898-118686163	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 27.2;HMC-1: 39.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059695	Uncertain		Approved	"Nuclear membrane,Nucleoli"				"Nuclear membrane, Nucleoli"		"HPA059695: "	"unprognostic (4.09e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.32e-1)"	"prognostic favourable (4.87e-4)"	"unprognostic (1.50e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.37e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.11e-2)"	"unprognostic (8.16e-3)"	27.3	6.9	5.0	15.9	15.0	23.5	30.6	1.4	3.1	7.6	11.6	1.5	4.2	2.5	7.9	8.2	7.8	7.0	7.3	6.7	4.4	3.3	7.4	2.6	11.7	27.5	5.4	2.0	3.5	1.7	2.4	15.9	10.0	3.9	6.0	4.8	1.4	4.4	4.1	2.5	4.4	9.7	9.6	7.8	13.8	7.3	3.7	5.3	19.7	9.4	3.6	13.8	9.3	13.3	5.2	4.6	13.1	7.3	7.6	11.3	2.1	0.0	2.4	2.0	1.8	27.2	11.6	5.3	2.8	6.0	2.3	6.0	0.3	0.0	7.4	0.2	10.0	0.1	3.5	0.0	2.0	9.1	3.1	16.1	2.6	0.0	8.8	9.7	39.1	8.1	0.1	2.4	2.7	0.0	4.9	13.4	1.4	1.6	5.8	12.9	2.1	3.8	3.9	5.2	0.2	0.0	0.5	0.7	4.8	8.4	7.8	2.7	0.9	8.2	0.1	1.8	0.6	10.7	1.2	4.1	6.2	6.9	4.0	15.6	0.9	6.3	4.2	7.5	8.8	6.1	5.5	4.9	7.4	7.0	4.6	5.2	6.7	8.3	13.1	7.6	7.3	3.7	11.3	2.1	5.0	15.0	1.4	3.1	4.4	3.3	5.4	2.0	3.9	5.3
DOCK4	"FLJ34238, KIAA0716"	ENSG00000128512	"Dedicator of cytokinesis 4"	Q8N1I0	7	111726110-112206411	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 18.7;HUVEC TERT2: 35.6;TIME: 30.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 6.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071516			Approved	"Nucleoli,Golgi apparatus,Plasma membrane,Cytosol"				"Nucleoli, Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA071516: "	"unprognostic (1.37e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.48e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.78e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.48e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.39e-2)"	10.7	6.5	16.5	10.0	28.2	2.3	6.8	11.7	28.2	9.1	4.4	21.0	2.0	2.8	7.9	4.4	4.4	8.7	7.9	6.9	22.2	10.1	7.3	13.9	25.5	3.7	18.2	12.4	14.2	5.0	4.7	4.0	10.8	12.2	6.5	4.9	1.7	4.4	3.9	6.7	3.5	3.2	10.7	20.3	3.2	3.1	3.5	21.8	0.0	5.8	2.7	3.6	5.7	5.2	0.2	0.3	6.4	1.2	0.1	0.1	0.2	0.0	1.6	4.0	3.2	3.3	4.9	2.3	0.4	4.4	0.8	1.3	0.0	0.0	0.3	3.3	1.0	0.1	0.6	3.8	3.4	1.2	6.6	0.1	2.7	5.6	2.4	0.5	0.2	2.6	0.4	18.7	9.7	35.6	0.0	10.1	1.7	0.4	0.8	0.2	2.1	6.9	0.2	2.9	1.6	2.7	0.1	0.9	3.1	2.5	2.0	2.4	0.3	0.1	30.7	3.1	1.5	6.0	1.3	0.4	0.1	0.3	0.3	0.7	6.9	0.2	0.7	0.1	0.0	1.2	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.1	6.4	0.1	0.2	0.3	0.0	0.2	16.5	28.2	11.7	18.2	22.2	10.1	18.2	12.4	12.2	21.8
DOHH	"HLRC1, MGC4293"	ENSG00000129932	"Deoxyhypusine hydroxylase"	Q9BU89	19	3490822-3500940	"Enzymes, Predicted intracellular proteins"	"Hypusine biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA041953, HPA076271"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				Cytosol	"Nucleoplasm, Nucleoli"	"HPA041953: AB_10795386, HPA076271: "	"unprognostic (1.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.63e-2)"	"prognostic favourable (2.24e-4)"	"unprognostic (3.66e-1)"	"unprognostic (2.01e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.26e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.13e-1)"	"prognostic favourable (3.58e-4)"	"unprognostic (9.87e-3)"	"unprognostic (1.14e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.76e-3)"	8.1	6.5	10.5	6.6	13.0	9.3	3.4	5.5	13.0	3.9	5.5	6.9	2.6	18.9	3.7	4.1	4.1	3.1	4.9	5.1	14.9	9.1	6.0	6.4	4.0	4.5	18.2	6.2	3.8	7.6	3.8	3.9	3.8	8.4	5.1	2.0	3.2	6.0	4.0	23.1	7.0	12.3	2.4	25.5	5.9	7.3	4.2	6.1	4.7	2.9	7.8	4.5	3.1	4.7	11.6	11.0	1.8	6.6	6.9	12.3	4.4	9.1	11.0	1.7	3.6	0.9	1.0	7.3	8.7	1.8	4.3	3.4	15.2	3.8	7.2	6.8	1.3	9.5	2.7	3.0	0.9	10.5	12.3	7.5	6.2	18.1	3.5	9.9	10.4	1.2	3.0	4.1	1.8	2.2	16.2	8.5	1.7	10.4	10.8	11.3	9.7	14.8	12.2	4.0	10.3	2.6	5.1	10.4	7.7	6.1	5.4	8.7	7.5	5.5	5.0	5.4	7.4	14.2	15.9	11.3	8.1	9.5	6.4	22.6	6.4	1.1	5.3	1.8	6.2	6.2	8.1	8.1	8.5	12.3	8.7	11.6	12.3	10.4	0.3	6.9	6.6	11.0	9.6	4.4	10.5	13.0	5.5	13.0	14.9	9.1	18.2	6.2	8.4	6.1
DOLK	"DK1, KIAA1094, TMEM15"	ENSG00000175283	"Dolichol kinase"	Q9UPQ8	9	128945530-128947619	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Kinase, Transferase"	"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066767, HPA068706"			Enhanced	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA066767: , HPA068706: "	"unprognostic (6.35e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.30e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.81e-3)"	"unprognostic (8.90e-3)"	"unprognostic (3.26e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.83e-2)"	"prognostic favourable (5.53e-4)"	"unprognostic (3.20e-2)"	"unprognostic (1.06e-1)"	"prognostic favourable (6.88e-5)"	"unprognostic (6.13e-3)"	11.0	20.2	7.9	7.8	13.8	1.4	9.5	7.0	18.6	9.8	8.6	14.9	7.1	8.8	12.4	16.8	10.9	10.8	10.8	12.0	7.6	9.9	17.5	22.0	10.6	10.6	8.1	6.7	13.2	16.9	19.2	8.0	19.5	16.3	12.3	8.0	14.2	15.5	12.8	7.9	11.4	10.9	11.1	5.9	11.6	12.4	22.4	6.0	12.5	11.0	11.9	12.1	10.4	7.3	9.4	14.2	5.6	16.4	9.8	13.7	9.0	5.1	19.1	6.8	10.0	20.1	10.6	9.2	10.7	17.4	13.2	9.8	15.0	8.1	2.8	5.7	15.5	36.4	9.2	13.4	6.8	4.7	8.1	3.5	13.1	10.8	20.3	3.8	6.3	14.6	12.4	14.2	7.8	12.8	8.5	4.5	14.2	25.2	3.1	3.2	8.7	11.9	3.1	9.0	11.1	11.8	7.7	6.2	7.0	14.2	11.7	6.3	20.5	5.0	10.6	11.9	4.3	14.9	8.8	4.3	10.7	2.8	11.2	3.5	9.0	2.3	13.5	5.6	10.2	13.3	9.1	9.4	9.2	11.2	14.2	9.2	12.1	12.3	2.1	9.8	16.4	8.1	13.7	9.0	7.9	13.8	7.0	18.6	7.6	9.9	8.1	6.7	16.3	6.0
DPH6	"ATPBD4, MGC14798"	ENSG00000134146	"Diphthamine biosynthesis 6"	Q7L8W6	15	35217345-35546193	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042976, HPA055496"	Approved		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA042976: AB_10964890, HPA055496: "	"unprognostic (9.78e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.94e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.49e-3)"	"unprognostic (7.92e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.65e-6)"	"unprognostic (9.70e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.44e-2)"	13.3	12.7	8.0	6.8	16.1	6.4	15.3	11.6	15.8	14.7	9.2	15.5	10.8	8.5	23.9	17.1	14.7	11.5	10.5	14.4	7.8	7.2	14.7	11.2	8.7	9.3	9.7	12.0	16.7	19.5	15.8	31.7	11.1	13.4	8.5	10.2	14.6	11.5	14.7	24.9	15.2	8.7	16.8	11.1	8.3	9.6	11.3	10.6	7.1	15.3	16.5	10.0	11.0	11.3	8.4	6.3	0.3	6.5	13.2	10.8	4.4	10.5	5.6	9.5	8.1	1.7	7.9	9.3	4.0	7.0	9.7	5.0	7.6	9.9	3.2	9.7	3.6	12.1	11.0	11.4	11.6	2.5	6.9	12.2	6.5	11.9	10.2	6.5	7.9	6.6	14.5	3.8	18.7	9.2	13.4	13.3	8.8	4.1	8.0	6.1	8.4	5.2	9.9	8.9	4.5	8.3	13.4	7.0	6.8	7.4	8.4	6.4	28.8	9.1	2.8	9.4	9.2	9.4	6.3	12.0	18.8	8.2	8.1	11.2	8.9	0.0	6.5	0.3	6.2	6.0	7.7	8.4	8.3	8.6	6.3	6.5	10.8	9.5	0.3	13.2	5.6	5.4	5.4	4.4	8.0	16.1	11.6	15.8	7.8	7.2	9.7	12.0	13.4	10.6
DPPA4	FLJ10713	ENSG00000121570	"Developmental pluripotency associated 4"	Q7L190	3	109326141-109337572	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 10.3;lymphoid tissue: 35.8"	"Group enriched"	"Detected in some"	5	"HAP1: 22.7;NTERA-2: 83.5"	"Cancer enriched"	"Detected in single"	218	"testis cancer: 59.0"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	11	"plasmacytoid DC: 10.3"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 10.3"									"CAB020678, HPA035249, HPA035250"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"CAB020678: , HPA035249: , HPA035250: "	"unprognostic (2.07e-2)"	"unprognostic (2.53e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.03e-8)"	"unprognostic (5.28e-2)"	"unprognostic (5.04e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.85e-2)"	0.1	0.1	0.2	0.3	1.0	8.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.6	0.1	0.2	1.3	0.6	0.8	0.3	0.0	0.0	0.0	0.0	2.2	4.2	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.7	0.0	8.1	0.0	35.8	0.1	0.0	1.0	0.4	0.1	0.9	10.3	0.0	0.0	0.7	0.2	0.1	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.2	0.2	0.0	0.7	0.0	10.3	0.0	0.1	0.2	1.0	0.1	0.3	0.6	0.1	0.3	0.0	0.4	0.0
DRGX	"DRG11, PRRXL1"	ENSG00000165606	"Dorsal root ganglia homeobox"	A6NNA5	10	49364181-49396016	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	8	"adrenal gland: 13.9;brain: 8.0"	"Cell line enhanced"	"Detected in some"		"RH-30: 8.1;SH-SY5Y: 36.6;U-2197: 13.2"	"Low cancer specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"cerebral cortex: 3.3;midbrain: 2.0;pons and medulla: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"pons and medulla: 4.1"	"Low region specificity"	"Detected in all"			HPA043978	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA043978: AB_10961154"		"unprognostic (1.42e-2)"	"unprognostic (5.68e-2)"		"unprognostic (3.92e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.58e-1)"		"unprognostic (4.54e-2)"	"unprognostic (3.74e-2)"			"unprognostic (8.91e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.09e-2)"		0.2	13.9	0.0	0.4	0.2	0.3	0.1	0.4	3.3	0.0	0.4	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.2	0.3	0.0	0.0	0.5	0.1	2.0	0.6	0.0	0.0	0.0	0.9	0.0	4.8	0.0	0.9	0.0	0.0	0.0	0.0	1.3	0.3	0.0	8.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	36.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	13.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	3.3	0.2	0.3	2.0	0.6	4.8	0.0
DRICH1	C22orf43	ENSG00000189269	"Aspartate rich 1"	Q6PGQ1	22	23608452-23632321	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 68.5"	"Cell line enriched"	"Detected in many"	5	"CACO-2: 15.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.0"	"Low lineage specificity"	"Detected in single"											HPA020446			Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA020446: AB_1853151"	"unprognostic (7.48e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.22e-4)"	"unprognostic (6.46e-2)"	"unprognostic (8.35e-4)"	"unprognostic (2.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.73e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.65e-2)"	"unprognostic (8.68e-3)"	"unprognostic (7.70e-4)"	"unprognostic (1.08e-3)"	0.5	0.5	0.5	0.5	0.5	1.3	0.8	1.0	0.5	0.5	0.5	0.5	0.5	0.1	1.3	9.7	0.5	0.6	0.5	0.5	0.5	0.3	1.2	0.5	0.5	0.7	0.5	0.5	1.3	0.9	8.3	0.8	0.5	0.5	0.7	0.2	0.5	0.5	0.6	0.5	1.3	0.6	0.5	0.5	0.8	0.4	68.5	0.5	0.5	1.0	0.5	0.5	0.5	0.5	0.0	0.0	0.4	0.6	0.0	1.0	0.0	0.7	0.8	2.1	0.6	2.6	0.6	1.9	0.0	0.0	0.1	0.1	15.3	0.6	1.0	0.1	0.6	1.5	3.0	0.1	0.4	0.2	1.4	0.5	1.2	0.6	0.9	0.3	2.3	1.2	1.3	0.4	0.0	0.4	1.2	0.3	0.2	0.7	0.2	0.7	0.2	0.8	1.6	0.1	0.0	0.4	1.6	0.9	0.7	0.0	1.3	1.1	0.2	0.1	0.4	0.0	2.7	2.4	0.2	1.0	1.4	0.1	2.5	0.6	0.2	0.0	0.3	0.0	1.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.5	0.5	1.0	0.5	0.5	0.3	0.5	0.5	0.5	0.5
DTD1	"bA379J5.3, bA555E18.1, C20orf88, DUEB, HARS2, MGC119131, MGC41905, pqn-68"	ENSG00000125821	"D-tyrosyl-tRNA deacylase 1"	Q8TEA8	20	18587893-18766644	"Enzymes, Predicted intracellular proteins"	"DNA replication"	"DNA-binding, Hydrolase, RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA040981	Uncertain		Uncertain	Nucleoli,Cytosol			180000	"Nucleoli, Cytosol"		"HPA040981: AB_10673268"	"unprognostic (3.32e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.27e-3)"	"unprognostic (9.67e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.09e-3)"	"unprognostic (2.42e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.59e-2)"	"unprognostic (8.53e-2)"	14.9	17.7	25.2	13.6	26.5	13.6	19.7	22.4	35.4	13.5	13.7	22.2	10.5	10.6	14.4	17.2	18.8	14.5	11.1	16.7	24.7	29.5	20.1	9.4	13.7	15.5	25.2	30.4	19.1	19.7	20.3	23.7	12.7	27.3	13.6	16.0	17.1	17.6	12.4	22.5	17.6	9.8	15.0	30.9	12.7	16.3	20.6	14.4	4.8	29.5	24.9	17.4	13.4	12.6	20.9	27.5	29.9	20.6	16.4	22.5	12.6	18.5	20.9	20.6	20.2	8.8	16.4	11.5	16.4	15.2	13.1	14.4	13.6	14.5	0.0	11.2	15.3	10.5	16.4	34.8	13.8	9.0	11.8	20.7	4.8	22.7	27.9	16.0	11.2	13.0	28.0	14.7	54.4	22.2	12.9	24.1	19.0	27.2	3.4	29.2	19.1	46.0	0.0	30.7	15.6	19.9	10.0	28.2	21.3	8.8	24.4	42.4	13.9	10.0	21.8	17.3	9.4	22.1	22.2	19.4	19.2	10.3	11.9	18.8	14.3	29.9	14.5	10.4	22.2	20.6	22.2	20.9	21.7	22.5	27.5	17.8	16.0	16.7	17.1	16.4	20.5	6.4	16.1	12.6	25.2	26.5	22.4	35.4	24.7	29.5	25.2	30.4	27.3	14.4
DTL	"CDT2, DCAF2, L2DTL, RAMP"	ENSG00000143476	"Denticleless E3 ubiquitin protein ligase homolog"	Q9NZJ0	1	212035553-212107400	"Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA replication, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 10.8;lymphoid tissue: 41.2;testis: 37.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory CD8 T-cell: 1.5;T-reg: 5.2"	"Lineage enriched"	"Detected in single"	7	"T-cells: 5.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA028016, HPA032023, HPA032031"	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA028016: AB_10611958, HPA032023: , HPA032031: "	"unprognostic (7.61e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.31e-2)"	"prognostic unfavourable (4.41e-5)"	"unprognostic (8.96e-3)"	"unprognostic (2.45e-3)"	"unprognostic (8.83e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.83e-2)"	"prognostic unfavourable (1.71e-9)"	"unprognostic (5.93e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.82e-1)"	1.3	0.7	0.4	5.4	0.6	10.8	1.3	0.4	0.5	1.2	2.8	0.3	0.1	1.7	1.0	0.6	4.0	0.4	1.5	0.6	0.4	0.4	0.8	1.0	1.6	4.4	0.4	0.1	0.6	0.5	0.6	0.7	5.4	0.2	0.6	4.2	0.2	1.1	0.1	0.4	1.6	3.3	1.4	0.4	4.6	1.1	37.2	0.1	41.2	0.9	5.7	7.5	0.9	1.6	0.7	0.3	0.0	0.4	0.6	5.2	0.7	12.5	10.7	18.4	9.2	1.1	2.3	9.0	15.8	9.8	14.9	22.3	6.6	11.1	9.5	5.9	6.0	9.8	24.2	13.3	21.6	11.5	11.6	15.2	14.1	8.1	0.0	19.9	9.5	1.0	0.4	24.2	12.9	6.8	18.1	19.4	17.2	5.0	26.6	9.1	21.2	12.4	21.1	32.4	18.4	4.2	8.7	11.5	18.0	15.0	14.4	6.5	12.2	9.1	3.7	15.0	11.2	15.4	17.7	7.1	11.1	22.0	7.6	13.2	14.5	0.0	0.0	0.0	0.6	0.4	0.0	0.7	0.8	1.5	0.3	0.1	0.0	0.3	0.0	0.6	0.0	0.0	5.2	0.7	0.4	0.6	0.4	0.5	0.4	0.4	0.4	0.1	0.2	0.1
DTWD1	"MDS009, MGC111207"	ENSG00000104047	"DTW domain containing 1"	Q8N5C7	15	49620980-49656232	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042214	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles				Nucleoli	"Nucleoplasm, Vesicles"	"HPA042214: "	"unprognostic (2.60e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.70e-4)"	"unprognostic (8.12e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.82e-1)"	"unprognostic (9.87e-2)"	"unprognostic (4.44e-3)"	"unprognostic (4.25e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.85e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.35e-1)"	19.1	12.6	15.7	11.3	27.5	4.2	17.5	16.7	16.0	24.5	20.1	10.9	9.4	6.9	25.2	15.8	11.7	17.0	19.9	12.0	11.5	9.3	10.3	9.9	11.6	10.4	12.9	12.2	21.6	28.5	8.7	22.1	11.2	11.9	19.2	11.2	11.6	18.0	14.2	10.7	10.8	8.9	22.4	11.7	9.4	15.6	8.2	13.1	12.1	15.5	11.8	8.7	21.5	17.2	8.6	21.6	5.4	11.9	11.1	11.5	5.2	4.4	5.2	9.6	5.1	19.1	37.4	7.6	12.9	12.9	17.2	12.7	1.6	3.6	7.0	9.7	16.1	8.0	6.8	6.8	16.7	4.7	4.8	6.1	10.6	6.2	12.8	7.9	5.3	18.0	9.1	10.7	13.2	7.0	11.3	7.5	18.0	8.9	5.3	6.4	6.0	7.1	7.7	19.8	27.7	5.5	3.1	8.6	6.5	15.6	5.3	12.0	5.3	11.5	4.6	20.4	8.1	11.4	14.3	6.0	9.1	4.2	17.9	22.7	12.6	5.4	8.6	4.2	6.5	9.8	8.9	8.6	9.6	10.4	10.8	8.6	11.5	10.6	2.1	11.1	11.9	21.6	7.5	5.2	15.7	27.5	16.7	16.0	11.5	9.3	12.9	12.2	11.9	13.1
DTX3	"FLJ34766, RNF154"	ENSG00000178498	"Deltex E3 ubiquitin ligase 3"	Q8N9I9	12	57604622-57609804	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"glioma: 54.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"NK-cells: 2.0;T-cells: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059654	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"				"Nucleoplasm, Nucleoli"	"Golgi apparatus"	"HPA059654: "	"unprognostic (2.31e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.91e-2)"	"prognostic favourable (9.87e-4)"	"unprognostic (1.84e-1)"	"unprognostic (4.26e-2)"	"prognostic favourable (1.44e-4)"	"unprognostic (8.62e-2)"	"unprognostic (5.44e-3)"	"unprognostic (7.99e-2)"	"unprognostic (8.81e-2)"	"unprognostic (9.51e-2)"	"unprognostic (3.48e-2)"	7.2	18.8	22.7	9.0	35.2	3.5	9.4	47.8	53.6	17.6	22.8	23.7	11.0	6.7	29.7	30.6	9.7	31.8	14.1	20.5	23.8	19.8	11.4	2.4	12.2	11.0	18.3	28.4	36.3	12.0	23.9	32.7	16.0	22.5	21.1	10.1	20.4	13.2	29.5	10.9	7.9	9.4	28.7	16.9	11.2	11.2	7.8	21.6	6.8	16.8	5.1	8.8	11.8	13.5	0.3	0.6	0.0	0.0	2.0	5.5	1.8	3.1	8.4	25.0	0.0	0.0	0.0	0.1	5.1	13.3	11.3	11.5	4.3	13.6	4.5	7.9	11.1	5.2	0.0	0.6	8.0	11.3	1.5	2.6	13.0	4.5	19.3	0.0	0.0	9.5	6.3	8.6	0.1	12.6	0.0	15.4	8.6	7.0	13.7	0.1	19.7	0.7	0.0	20.9	0.2	1.0	8.4	18.2	28.8	4.0	1.2	2.4	14.4	6.9	0.0	14.8	5.9	6.8	7.3	25.2	18.9	0.0	9.5	0.0	7.7	0.0	0.0	0.0	5.5	0.0	1.3	0.3	2.1	2.5	0.2	0.3	1.9	3.5	0.0	2.0	0.0	0.6	4.2	1.8	22.7	35.2	47.8	53.6	23.8	19.8	18.3	28.4	22.5	21.6
DUSP1	"CL100, HVH1, MKP-1, PTPN10"	ENSG00000120129	"Dual specificity phosphatase 1"	P28562	5	172768090-172771195	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle, Stress response"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 43.1;hTCEpi: 75.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 326.0"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 326.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069577			Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA069577: "	"unprognostic (1.51e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.73e-2)"	"unprognostic (8.17e-2)"	"unprognostic (4.64e-1)"	"unprognostic (1.58e-3)"	"unprognostic (4.18e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavourable (3.11e-5)"	"unprognostic (2.69e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.41e-3)"	158.4	78.0	12.4	68.5	14.0	89.7	91.8	17.4	14.9	81.4	37.1	32.4	48.5	9.4	55.4	71.6	82.7	94.8	138.8	49.2	12.5	11.4	29.8	115.4	135.0	43.5	30.6	9.7	69.4	34.4	26.6	40.8	93.7	29.3	67.1	34.2	61.0	38.1	192.8	54.8	116.1	27.6	65.0	29.5	36.1	53.6	45.9	18.7	10.8	90.4	104.1	46.9	69.0	109.7	2.4	11.5	326.0	31.8	4.5	9.8	14.0	2.1	5.4	1.7	2.3	37.5	22.0	2.9	34.9	10.2	23.5	9.5	5.9	2.5	0.7	10.2	24.5	0.9	1.6	8.6	11.0	19.1	4.6	0.4	11.9	2.5	43.1	0.2	0.8	21.0	75.3	10.6	17.3	7.3	1.7	13.7	15.1	2.5	1.1	1.0	1.5	1.6	40.5	3.2	6.3	16.7	1.1	7.4	3.1	9.4	16.1	1.2	1.3	0.4	19.2	16.7	8.3	16.2	2.6	2.8	1.6	0.6	14.8	0.3	0.6	33.3	24.6	69.8	3.9	25.0	9.8	2.4	3.5	4.0	11.5	2.1	1.7	1.9	326.0	4.5	31.8	0.6	2.8	14.0	12.4	14.0	17.4	14.9	12.5	11.4	30.6	9.7	29.3	18.7
DUX4		ENSG00000260596	"Double homeobox 4"	Q9UBX2	4	190173774-190185942	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"testis: 3.4"	"Cell line enhanced"	"Detected in some"		"A549: 2.4;U-2 OS: 3.6;U-266/70: 7.8;U-266/84: 10.1;U-698: 2.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA058451			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"				"Nucleoplasm, Nucleoli"	"Golgi apparatus, Cytosol"	"HPA058451: "																		0.0	0.4		0.0		0.0	0.0		0.5	0.0	0.0			1.0	0.1	0.0	0.0	0.9	0.0	0.0			0.0	0.0	0.5	0.1			0.1	0.5	0.3		0.0		1.1	0.0		0.5	0.1	0.0	0.3	0.0	0.0		0.0	0.3	3.4			0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	2.4	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.6	0.0	0.0	0.0	3.6	0.7	0.0	7.8	10.1	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0										
DYNC1I2	"DIC74, DNCI2"	ENSG00000077380	"Dynein cytoplasmic 1 intermediate chain 2"	Q13409	2	171687409-171748420	"Predicted intracellular proteins"	"Host-virus interaction, Transport"	"Motor protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033836, HPA040619, HPA053987"	Supported		Supported	"Nucleoli,Endoplasmic reticulum,Microtubules,Cytosol"			33000	"Endoplasmic reticulum, Cytosol"	"Nucleoli, Microtubules"	"CAB033836: AB_2093633, HPA040619: AB_2677045, HPA053987: AB_2682334"	"unprognostic (3.01e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.26e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.51e-3)"	"unprognostic (6.30e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.19e-1)"	"prognostic favourable (8.04e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-3)"	"unprognostic (6.42e-2)"	33.4	32.9	39.6	22.5	53.2	10.8	35.5	30.1	50.0	36.1	33.0	50.0	20.1	28.8	43.1	29.3	37.5	26.5	32.0	34.3	45.2	38.3	43.5	21.8	27.3	18.5	59.3	37.9	40.6	23.3	35.8	29.9	40.2	58.7	33.7	35.8	15.1	28.3	34.7	41.3	27.9	27.7	43.7	92.7	25.8	26.5	28.6	49.2	27.9	31.2	23.5	24.3	36.7	31.8	23.5	35.3	51.7	30.8	18.9	19.9	11.5	19.9	12.8	39.9	14.6	36.9	35.6	22.6	35.0	27.3	29.5	32.2	22.3	19.9	18.3	30.8	41.6	20.2	31.3	33.6	38.7	6.9	14.1	16.0	16.5	25.1	18.5	18.2	17.2	27.6	32.0	36.4	23.5	51.6	25.2	5.0	58.2	12.5	15.5	14.8	18.3	13.1	15.7	35.9	13.2	39.2	32.1	25.0	28.1	19.4	15.6	20.7	15.2	17.8	55.9	45.0	22.3	17.9	20.9	6.3	12.0	14.8	30.6	14.8	32.9	51.7	30.8	14.7	16.9	30.1	18.0	23.1	19.5	19.6	21.4	23.5	17.6	16.7	1.8	18.9	29.4	35.3	19.9	11.5	39.6	53.2	30.1	45.7	45.2	38.3	59.3	37.9	58.7	49.2
E2F5		ENSG00000133740	"E2F transcription factor 5"	Q15329	8	85177225-85217158	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cilium biogenesis/degradation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 27.0;Daudi: 53.1;U-698: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"memory B-cell: 13.3;naive B-cell: 7.6"	"Lineage enriched"	"Detected in many"	9	"B-cells: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055723, HPA065441"			Enhanced	Nucleoplasm,Nucleoli,Vesicles				Nucleoplasm	"Nucleoli, Vesicles"	"HPA055723: , HPA065441: "	"unprognostic (8.73e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.02e-3)"	"unprognostic (6.73e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.36e-5)"	"unprognostic (1.23e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavourable (1.89e-6)"	"unprognostic (2.88e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.95e-3)"	3.0	9.0	6.4	22.2	8.1	1.5	5.9	2.6	5.3	5.0	5.9	4.0	3.4	4.6	5.4	7.4	4.7	7.2	6.6	3.2	5.6	5.6	9.0	4.5	5.1	22.4	4.6	2.7	8.3	14.6	12.7	10.6	4.3	3.8	5.1	7.2	3.4	5.7	5.9	1.1	1.7	7.3	3.8	4.5	9.9	5.1	10.5	3.2	13.6	10.2	3.0	26.0	6.0	7.6	13.3	1.4	0.0	0.0	1.1	0.6	0.6	4.8	5.2	27.0	10.0	0.5	0.7	8.7	0.9	2.1	0.8	2.3	3.1	5.7	53.1	3.8	1.1	1.0	15.7	1.3	1.0	5.5	7.2	5.3	2.9	7.3	4.3	1.6	0.0	1.0	2.1	1.0	3.8	0.8	11.2	0.4	1.4	3.1	5.4	3.5	8.7	4.6	4.3	1.1	5.7	8.7	3.4	3.3	10.4	0.6	1.8	8.0	11.3	1.7	0.0	1.3	1.0	1.5	3.5	10.0	6.7	25.4	1.5	1.3	2.6	0.0	0.0	0.0	0.1	0.0	0.0	13.3	0.0	0.0	0.1	7.6	0.2	0.4	0.0	1.1	0.0	1.4	0.6	0.6	6.4	8.1	2.6	4.5	5.6	5.6	4.6	2.7	3.8	3.2
E2F8	FLJ23311	ENSG00000129173	"E2F transcription factor 8"	A0AVK6	11	19224063-19241620	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"T-reg: 2.9"	"Lineage enriched"	"Detected in single"	24	"T-cells: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA064882, HPA076614"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA064882: , HPA076614: "	"unprognostic (5.62e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.17e-2)"	"unprognostic (6.99e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.29e-5)"	"unprognostic (1.94e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.41e-1)"	"unprognostic (7.29e-4)"	"unprognostic (1.16e-2)"	"unprognostic (9.13e-8)"	"unprognostic (1.02e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.28e-3)"	1.0	0.4	0.4	7.2	0.2	11.5	0.3	0.2	0.4	1.6	3.6	0.2	0.2	3.3	1.2	1.4	8.2	0.9	2.0	3.4	0.2	0.2	0.4	0.5	0.8	6.1	0.2	0.2	0.7	0.3	0.0	0.2	4.0	0.2	0.6	4.8	1.2	1.8	0.9	11.5	2.6	4.6	0.7	0.2	2.4	5.1	4.7	0.2	30.3	0.3	8.0	12.5	3.4	2.1	0.0	0.1	0.0	0.0	0.0	2.9	0.4	14.2	4.3	4.4	6.1	0.2	0.6	18.9	7.9	2.2	9.3	10.1	14.7	4.7	14.1	3.3	2.5	12.6	10.8	1.0	8.5	9.5	8.7	4.9	2.4	4.0	0.0	7.5	11.9	0.2	0.0	1.9	0.6	13.1	10.3	13.7	3.7	6.9	14.6	9.3	4.1	6.0	15.9	8.3	9.6	4.0	9.7	3.8	4.3	3.5	7.0	0.8	4.8	8.0	2.5	4.5	5.6	11.0	7.1	4.7	9.5	17.9	5.7	14.7	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.4	0.4	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2
EBNA1BP2	"EBP2, NOBP, P40"	ENSG00000117395	"EBNA1 binding protein 2"	Q99848	1	43164175-43270936	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026512, HPA028277"	Approved		Enhanced	Nucleoli				Nucleoli		"HPA026512: AB_1847954, HPA028277: AB_10603664"	"unprognostic (9.30e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.03e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (4.22e-4)"	"unprognostic (7.64e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.11e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.10e-3)"	"unprognostic (3.04e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.33e-2)"	18.9	24.8	30.2	22.8	41.1	19.3	27.6	17.7	35.7	18.1	23.6	19.0	15.6	15.4	22.4	40.6	27.8	30.4	15.6	24.9	26.3	25.2	34.0	66.0	18.5	21.9	25.1	29.8	21.8	30.7	24.5	30.0	26.0	29.2	20.3	26.0	16.6	22.3	22.3	28.4	22.8	16.9	24.3	21.6	18.4	19.7	24.8	27.4	18.2	28.8	31.3	25.8	21.5	19.8	26.9	29.6	10.2	22.8	24.1	25.1	17.8	61.1	35.7	13.4	38.7	10.8	12.2	27.7	42.6	21.4	68.2	42.9	39.9	38.3	40.6	33.9	31.0	43.5	28.9	39.5	74.6	19.2	28.5	27.7	32.1	35.0	19.6	48.0	21.3	9.7	40.0	50.1	40.5	37.3	41.8	13.7	33.1	33.6	36.4	28.7	58.1	33.1	26.8	30.4	45.9	25.0	26.7	26.6	28.6	24.6	46.1	42.8	18.9	26.3	28.7	26.4	49.8	42.2	69.3	20.4	40.2	50.3	21.9	49.8	53.0	7.5	20.1	10.2	24.0	22.8	25.1	26.9	24.5	24.9	29.6	26.7	22.8	22.8	1.8	24.1	21.6	28.3	24.6	17.8	30.2	41.1	17.7	35.7	26.3	25.2	25.1	29.8	29.2	27.4
ECEL1	"DINE, XCE"	ENSG00000171551	"Endothelin converting enzyme like 1"	O95672	2	232479827-232487828	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.6;ovary: 57.1"	"Group enriched"	"Detected in some"	6	"AN3-CA: 29.4;HeLa: 15.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 12.9"	"Region enriched"	"Detected in many"	5	"hypothalamus: 28.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA067560, HPA069756, HPA077424"	Approved	Supported	Approved	"Nucleoplasm,Nuclear membrane,Nucleoli"				Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA067560: , HPA069756: , HPA077424: "	"unprognostic (1.21e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.39e-1)"	"unprognostic (4.62e-3)"	"unprognostic (2.80e-1)"	"unprognostic (9.96e-4)"	"unprognostic (7.56e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.89e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.24e-5)"	"unprognostic (3.09e-2)"	"unprognostic (3.68e-1)"	"unprognostic (7.84e-2)"	"unprognostic (5.45e-2)"	0.9	2.6	0.5	0.9	4.0	0.2	0.4	0.7	1.2	0.3	0.4	0.5	0.1	0.3	0.6	4.9	0.3	1.7	1.0	1.1	0.1	28.6	1.0	0.7	0.2	1.2	0.3	0.1	57.1	0.6	0.3	8.9	0.4	5.5	0.3	0.2	11.5	0.3	1.2	1.8	0.3	0.3	1.1	4.5	2.0	0.3	0.8	1.6	0.1	0.5	0.3	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	29.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.3	0.0	0.0	0.4	0.0	0.0	0.0	2.6	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.0	0.7	1.2	0.1	28.6	0.3	0.1	5.5	1.6
EDN1	ET1	ENSG00000078401	"Endothelin 1"	P05305	6	12290363-12297194	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 107.5;HUVEC TERT2: 71.2;T-47d: 22.0;TIME: 52.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"non-classical monocyte: 7.9"	"Lineage enriched"	"Detected in many"	6	"monocytes: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031976, CAB032500, CAB037291"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"	"Secreted to blood"	1085		"Nucleoli, Golgi apparatus"	Nucleoplasm	"CAB032500: AB_2096241, CAB037291: AB_259277, HPA031976: AB_10602489"	"unprognostic (1.51e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.72e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.92e-2)"	"unprognostic (4.19e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.02e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-1)"	35.7	1.5	8.4	6.2	30.8	3.6	19.2	3.2	22.0	8.2	9.2	4.2	1.1	9.0	7.2	15.3	10.8	8.6	11.9	5.2	19.0	6.2	5.7	2.8	25.1	6.7	10.9	5.5	4.3	8.2	1.6	1.0	16.0	25.1	5.4	12.9	6.9	9.7	8.5	25.6	8.2	6.7	9.7	13.5	10.2	6.8	4.8	5.6	0.2	2.9	3.8	2.1	5.3	4.1	0.2	0.2	1.2	7.9	0.0	0.2	0.0	1.5	9.0	0.1	0.0	0.0	0.0	0.0	2.8	2.5	2.4	2.0	11.6	1.3	0.0	107.5	1.1	0.8	0.0	1.6	1.7	0.1	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	1.0	0.4	0.3	71.2	0.0	0.0	9.0	0.2	0.0	0.0	0.1	0.1	0.0	0.8	0.0	5.6	1.4	0.1	0.0	0.2	8.5	0.0	22.0	0.1	52.7	6.0	4.8	0.1	3.6	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	7.9	0.1	0.0	0.0	8.4	30.8	3.2	22.0	19.0	6.2	10.9	5.5	25.1	5.6
EFCAB14	KIAA0494	ENSG00000159658	"EF-hand calcium binding domain 14"	O75071	1	46675159-46719064	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 107.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011224, HPA011938"	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol"			58000	Cytosol	"Nucleoli, Golgi apparatus"	"HPA011224: AB_1852314, HPA011938: AB_1852317"	"unprognostic (2.44e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.34e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.39e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.00e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.46e-1)"	29.4	17.4	29.4	14.3	29.5	6.7	22.5	16.2	24.8	25.3	26.0	40.6	15.6	17.2	23.7	27.3	30.0	22.0	19.7	20.2	27.2	20.5	27.8	24.9	24.0	16.4	31.0	15.2	25.2	16.0	107.1	17.2	25.2	27.3	24.4	24.0	23.0	19.9	24.9	24.7	20.4	26.9	22.5	36.1	24.0	36.4	21.9	30.6	28.7	30.1	13.2	20.2	25.7	20.0	16.6	16.0	30.3	21.1	17.1	28.5	18.3	14.3	8.2	7.0	11.1	33.5	21.1	16.1	15.5	23.0	17.2	17.8	9.8	9.7	11.5	16.3	21.1	17.4	12.0	17.2	23.5	21.9	7.7	14.4	9.1	4.0	11.5	18.6	28.4	18.6	28.7	13.7	11.4	21.0	8.9	16.5	17.8	5.6	12.2	8.4	10.0	9.3	9.3	19.6	10.1	18.2	29.1	3.6	5.0	19.2	27.2	14.6	12.2	16.2	19.3	14.8	7.2	17.1	15.7	16.9	23.5	9.3	18.9	16.0	10.9	15.6	18.6	30.3	23.6	21.1	28.5	16.6	20.6	20.2	16.0	16.2	18.0	19.5	12.5	17.1	18.3	12.9	17.8	18.3	29.4	29.5	16.2	24.8	27.2	20.5	31.0	15.2	27.3	30.6
EFCAB7	"KIAA1799, RP4-534K7.1"	ENSG00000203965	"EF-hand calcium binding domain 7"	A8K855	1	63523372-63572693	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 9.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029611, HPA029612, HPA029613"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"				"Nucleoplasm, Nucleoli"	"Plasma membrane, Cytosol"	"HPA029611: AB_10599972, HPA029612: AB_10600533, HPA029613: AB_10601004"	"unprognostic (8.81e-2)"	"unprognostic (5.24e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.64e-1)"	"prognostic favourable (3.65e-4)"	"unprognostic (1.70e-2)"	"unprognostic (6.53e-4)"	"unprognostic (2.99e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.97e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.73e-1)"	4.3	8.4	12.7	3.5	16.7	3.1	9.3	24.5	19.5	9.4	5.1	3.7	6.4	3.2	9.6	9.8	5.7	12.6	7.2	9.7	11.4	11.8	8.8	2.8	6.2	5.2	8.1	10.8	12.8	4.9	16.3	31.6	5.1	13.7	8.7	5.0	3.5	5.3	8.2	10.8	4.9	3.4	7.5	9.4	4.2	5.0	20.0	10.2	11.5	9.1	2.4	5.2	7.3	12.9	3.3	1.7	9.8	3.3	1.8	2.9	1.1	6.2	5.2	6.9	4.4	7.3	10.9	3.5	4.1	4.4	7.0	8.7	1.7	4.9	4.4	9.7	2.3	5.8	5.9	3.9	8.4	8.1	4.1	3.5	9.8	3.6	4.7	4.9	3.2	5.9	9.5	8.2	5.6	5.9	4.4	7.2	4.6	1.3	9.3	3.3	3.0	5.3	6.0	10.4	4.3	10.8	3.4	14.8	5.7	7.7	4.4	9.9	4.5	3.5	1.6	3.9	3.5	11.7	3.8	4.8	8.3	5.1	7.3	3.5	5.8	9.8	0.7	0.2	2.1	0.4	2.9	3.3	2.4	2.5	1.3	2.8	2.5	2.4	0.1	1.8	3.3	1.7	2.7	1.1	12.7	16.7	24.5	19.5	11.4	11.8	8.1	10.8	13.7	10.2
EFHB	"CFAP21, FLJ25200"	ENSG00000163576	"EF-hand domain family member B"	Q8N7U6	3	19879472-19947025	"Predicted intracellular proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 23.3;testis: 19.2"	"Cell line enriched"	"Detected in single"	33	"RPTEC TERT1: 21.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA078067			Approved	Nucleoli				Nucleoli		"HPA078067: "	"unprognostic (9.70e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.56e-3)"	"unprognostic (1.51e-5)"	"unprognostic (4.43e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.92e-2)"	"unprognostic (5.47e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.13e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.02e-1)"	1.1	1.5	3.9	0.7	6.0	0.7	1.8	0.7	4.3	2.0	0.7	6.5	0.0	0.6	2.0	7.8	1.0	23.3	1.3	0.8	6.3	4.7	1.8	0.7	3.9	0.7	4.4	2.2	5.5	0.5	0.5	1.6	1.0	9.5	1.0	1.0	2.3	0.6	1.3	0.7	1.1	0.6	1.6	3.1	1.2	0.6	19.2	6.0	0.0	1.2	0.0	0.8	0.7	0.6	1.3	0.6	1.1	0.8	0.4	2.2	0.4	0.0	0.5	0.2	0.2	0.1	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	21.0	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.8	0.1	2.2	0.1	0.1	0.8	0.3	0.4	0.0	1.3	0.5	0.3	1.1	0.4	0.3	0.6	0.0	0.4	3.9	6.0	0.7	3.8	6.3	4.7	4.4	2.2	9.5	6.0
EID3	"FLJ25832, NSE4B, NSMCE4B"	ENSG00000255150	"EP300 interacting inhibitor of differentiation 3"	Q8N140	12	104303739-104305205	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 69.1"	"Cell line enhanced"	"Detected in many"		"A549: 10.0;BJ: 9.3;BJ hTERT+: 7.6;BJ hTERT+ SV40 Large T+ RasG12V: 7.7;HeLa: 8.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.9;NK-cells: 6.6;T-cells: 9.5"	"Low region specificity"	"Detected in single"							HPA059367	Uncertain		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA059367: "	"unprognostic (1.25e-1)"	"unprognostic (5.41e-3)"	"unprognostic (5.82e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavourable (1.14e-4)"	"unprognostic (8.02e-2)"	"unprognostic (5.88e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.38e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (5.96e-5)"	"unprognostic (8.70e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.04e-3)"	"unprognostic (2.87e-2)"	1.7	1.7	2.0	2.9	2.7	3.0	1.7	4.0	2.6	1.6	1.8	1.5	0.2	0.6	2.1	1.9	1.3	1.8	1.8	1.2	1.9	1.9	1.2	0.9	1.8	3.7	1.2	2.3	3.4	1.7	0.9	5.3	1.1	2.2	2.7	0.6	1.7	1.3	4.1	1.5	1.6	1.6	1.6	1.2	1.9	1.4	69.1	1.6	2.3	1.0	0.4	2.5	1.5	1.3	2.9	0.5	0.7	1.5	6.6	9.5	2.6	0.3	10.0	0.3	1.0	2.2	2.3	1.9	9.3	7.6	4.5	7.7	0.2	0.5	0.1	0.1	2.1	0.2	0.3	0.8	6.6	0.6	0.1	1.8	8.4	1.5	3.3	0.1	0.5	3.1	0.0	2.8	0.6	0.7	0.1	0.6	2.8	0.1	3.3	1.4	0.5	2.0	0.2	0.0	0.1	2.5	0.3	0.1	0.0	6.2	0.4	0.2	0.0	0.0	1.4	0.1	0.3	2.2	0.4	0.4	0.2	0.1	0.2	0.0	0.9	0.0	0.3	0.5	5.2	1.5	5.5	2.7	6.6	6.2	0.3	2.9	9.5	5.7	0.7	6.6	0.9	0.5	7.6	2.6	2.0	2.7	4.0	2.6	1.9	1.9	1.2	2.3	2.2	1.6
EIF2S2	"EIF2, EIF2beta, PPP1R67"	ENSG00000125977	"Eukaryotic translation initiation factor 2 subunit beta"	P20042	20	34088298-34112332	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034415, HPA041262, HPA041332"	Approved		Supported	"Nucleoli,Endoplasmic reticulum"				"Endoplasmic reticulum"	Nucleoli	"CAB034415: AB_2095998, HPA041262: , HPA041332: "	"unprognostic (5.76e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavourable (8.74e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.47e-3)"	"prognostic unfavourable (3.23e-5)"	"unprognostic (9.36e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.55e-3)"	"unprognostic (3.04e-3)"	"unprognostic (1.25e-2)"	"prognostic unfavourable (9.64e-10)"	"unprognostic (2.52e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.12e-2)"	25.9	30.1	32.8	23.3	40.7	21.4	38.1	20.2	37.7	21.1	24.3	10.9	27.1	21.2	21.2	22.4	36.3	17.0	18.3	36.3	30.1	20.4	22.0	40.1	27.2	37.7	40.0	26.2	19.9	45.4	18.7	22.4	29.9	35.8	20.4	24.7	7.4	26.3	25.5	101.8	21.2	20.4	37.0	50.2	23.0	28.1	19.6	35.6	18.2	24.1	32.7	30.1	25.0	30.7	38.8	48.5	28.1	39.3	32.4	42.4	27.3	38.9	26.2	19.9	24.0	19.5	29.7	38.0	35.7	34.3	35.6	36.0	92.0	27.4	35.0	26.3	32.2	36.9	32.3	58.7	43.3	11.2	17.6	69.3	21.6	47.0	50.4	44.3	22.6	30.3	50.1	35.2	52.7	37.2	40.6	33.5	29.2	25.0	41.0	37.0	19.3	47.9	23.7	33.9	32.3	28.1	32.7	20.3	13.8	39.5	24.0	73.2	36.3	52.5	25.0	40.8	25.1	25.5	33.4	31.5	27.7	36.5	38.3	34.5	29.5	21.2	37.0	28.1	26.9	39.3	32.9	38.8	38.2	37.6	34.7	31.8	36.4	36.5	21.9	32.4	35.6	48.5	42.4	27.3	32.8	40.7	20.2	37.7	30.1	20.4	40.0	26.2	35.8	35.6
EIF3L	"EIF3EIP, EIF3S11, EIF3S6IP, HSPC021, HSPC025"	ENSG00000100129	"Eukaryotic translation initiation factor 3 subunit L"	Q9Y262	22	37848868-37889407	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003028	Approved		Approved	Nucleoplasm,Nucleoli			22000000	Nucleoli	Nucleoplasm	"HPA003028: AB_1078726"	"unprognostic (2.07e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.06e-3)"	"unprognostic (3.20e-1)"	"unprognostic (3.79e-3)"	"unprognostic (9.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.65e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.81e-3)"	"unprognostic (2.35e-1)"	"unprognostic (9.74e-2)"	"prognostic favourable (6.11e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.03e-3)"	30.9	18.4	17.4	17.5	19.8	26.4	55.1	34.4	19.3	40.7	29.1	16.1	16.7	20.8	36.1	18.9	33.4	24.2	14.0	15.5	15.0	15.6	23.7	36.1	18.4	31.3	14.0	13.4	63.4	78.8	20.2	26.8	27.9	17.7	38.7	23.8	21.5	39.6	31.0	40.3	30.6	25.2	35.8	15.6	24.7	22.7	19.6	11.4	44.0	54.8	32.3	31.0	38.6	22.0	33.6	58.1	9.8	35.9	25.0	42.5	55.2	16.8	9.6	27.1	19.6	26.2	58.7	19.5	16.2	39.0	26.1	35.8	15.9	12.5	58.1	4.5	18.9	10.8	29.8	22.4	30.8	7.6	49.7	20.5	14.0	7.5	16.4	54.3	17.6	31.6	25.6	19.3	29.2	32.4	17.0	15.9	30.2	6.6	14.4	25.2	15.4	25.3	16.6	37.2	17.0	19.9	10.2	19.7	30.6	16.0	18.8	21.8	14.3	21.9	15.6	16.3	19.8	9.9	12.9	9.5	15.5	23.7	15.3	24.1	13.3	9.8	35.9	9.6	20.7	35.4	34.6	33.6	30.0	25.0	58.1	27.5	42.5	31.8	4.8	25.0	29.1	28.4	29.1	55.2	17.4	19.8	34.4	19.3	15.0	15.6	14.0	13.4	17.7	11.4
EIPR1	"EIPR-1, TSSC1"	ENSG00000032389	"EARP complex and GARP complex interacting protein 1"	Q53HC9	2	3188925-3377882	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031231, HPA031232, HPA031233, HPA031234"	Approved		Supported	"Nucleoplasm,Nucleoli,Intermediate filaments"				"Nucleoplasm, Nucleoli"	"Intermediate filaments"	"HPA031231: AB_10669881, HPA031232: AB_10603222, HPA031233: AB_10670026, HPA031234: "	"unprognostic (2.16e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavourable (3.67e-7)"	"unprognostic (1.94e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.24e-2)"	"unprognostic (3.83e-2)"	7.3	12.3	20.1	17.3	24.4	14.2	9.0	26.0	22.9	8.3	11.9	12.1	10.0	10.7	7.7	18.4	14.5	12.0	7.9	10.3	17.7	19.3	12.4	11.4	7.9	15.2	15.1	14.5	5.8	11.6	14.2	20.8	8.0	13.6	7.7	10.9	10.5	9.9	7.4	10.9	9.2	9.3	9.4	12.4	12.0	9.3	9.9	11.5	14.5	20.4	15.5	15.3	11.1	7.7	15.7	23.4	13.9	13.3	16.3	16.9	14.0	11.1	20.9	11.2	12.6	7.1	9.6	25.3	11.7	12.1	14.1	10.8	13.9	14.1	19.4	20.7	11.8	11.4	8.7	16.8	7.8	15.1	16.5	17.2	13.0	32.2	13.5	16.8	21.5	8.7	15.3	14.2	18.5	17.8	19.1	13.5	12.9	20.7	15.5	24.5	12.9	16.7	18.2	11.8	26.1	17.4	15.4	24.4	28.3	8.2	13.8	12.7	12.8	15.7	12.4	11.3	5.9	9.3	15.6	15.5	37.5	16.1	13.4	17.5	10.4	13.9	11.8	9.4	16.1	13.3	16.3	13.9	13.4	16.8	21.3	15.7	14.7	15.8	5.0	16.3	11.9	23.4	16.9	14.0	20.1	24.4	26.0	22.9	17.7	19.3	15.1	14.5	13.6	11.5
ELAVL1	"Hua, HuR, MelG"	ENSG00000066044	"ELAV like RNA binding protein 1"	Q15717	19	7958579-8005659	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005256, HPA046298"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol			210000	Nucleoplasm	"Nucleoli, Cytosol"	"CAB005256: AB_2096342, HPA046298: "	"unprognostic (1.19e-1)"	"unprognostic (9.66e-3)"	"unprognostic (2.46e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.81e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.75e-2)"	"prognostic favourable (4.93e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (7.23e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.65e-2)"	19.7	23.8	28.0	22.4	34.1	17.2	22.4	35.4	28.0	23.1	21.4	21.2	19.6	17.9	27.5	19.7	24.4	25.7	16.9	25.2	23.6	17.6	20.8	21.4	19.4	26.5	27.5	22.2	25.7	20.4	29.4	25.4	23.3	26.5	20.4	20.2	19.7	21.2	23.0	27.6	19.2	18.4	30.4	17.7	21.9	19.7	46.7	26.5	40.4	20.6	18.7	30.7	23.4	32.2	17.1	17.6	24.3	14.7	23.2	19.6	9.4	35.6	23.7	39.8	29.9	15.6	15.7	22.4	26.6	22.4	39.7	31.1	34.2	20.8	43.0	37.5	29.2	24.9	44.3	30.5	33.6	38.4	41.2	37.7	17.4	31.8	22.9	35.7	30.2	19.4	18.3	27.6	16.8	30.3	38.7	32.3	27.3	26.5	59.6	28.8	35.5	30.2	67.1	26.0	28.3	25.2	26.4	28.6	20.9	25.2	25.5	20.1	29.1	28.2	22.7	37.2	26.1	34.4	45.8	33.0	31.8	45.2	20.8	43.0	32.0	16.4	13.0	24.3	12.2	11.7	12.9	14.0	17.8	19.6	17.6	17.1	16.1	12.4	3.8	23.2	14.7	8.8	13.5	9.4	28.0	34.1	35.4	28.0	23.6	17.6	27.5	22.2	26.5	26.5
ELL3	FLJ22637	ENSG00000128886	"Elongation factor for RNA polymerase II 3"	Q9HB65	15	43772600-43777543	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 13.3;lymphoid tissue: 24.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.8;U-698: 18.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"memory B-cell: 5.3;naive B-cell: 8.5"	"Lineage enriched"	"Detected in many"	7	"B-cells: 8.5"	"Region enriched"	"Detected in single"	11	"olfactory region: 2.4"	"Low region specificity"	"Detected in all"			HPA028938	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA028938: AB_10795352"	"unprognostic (2.59e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.52e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.24e-2)"	0.7	1.1	1.0	24.2	0.6	0.4	2.5	4.7	0.6	2.3	10.6	0.5	1.6	4.8	1.0	1.0	5.5	1.3	0.9	0.6	1.0	0.6	1.8	0.5	0.9	7.5	1.3	0.0	1.3	0.7	0.6	1.2	0.8	2.6	2.1	1.8	0.8	2.0	0.7	1.0	7.0	13.3	0.9	0.6	1.5	1.1	12.3	0.5	0.8	1.1	2.8	16.7	1.3	1.7	8.5	1.0	0.1	0.1	0.1	1.2	0.6	0.6	0.1	0.6	0.2	1.6	0.1	0.1	0.2	0.5	0.8	1.2	0.1	0.5	7.8	0.1	0.7	2.8	0.3	0.0	0.5	0.7	3.3	0.3	2.6	0.8	0.5	0.0	0.0	0.0	0.5	0.2	0.1	0.3	0.3	0.0	0.0	1.2	0.2	0.8	0.0	0.8	0.8	0.1	0.1	0.2	0.0	3.5	0.2	0.3	1.5	0.3	3.5	0.2	0.1	0.2	0.0	0.3	0.2	0.0	0.0	18.8	0.2	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.2	5.3	0.5	0.2	0.0	8.5	1.2	0.3	0.1	0.1	0.0	1.0	0.3	0.6	1.0	0.6	4.7	0.6	1.0	0.6	1.3	0.0	2.6	0.5
ELMOD2	MGC10084	ENSG00000179387	"ELMO domain containing 2"	Q8IZ81	4	140524158-140553770	"Predicted intracellular proteins"	"Antiviral defense"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047600	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoli, Cytosol"	Nucleoplasm	"HPA047600: "	"unprognostic (1.39e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.70e-3)"	"unprognostic (2.10e-3)"	"unprognostic (4.91e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.65e-1)"	"prognostic favourable (1.17e-8)"	"unprognostic (3.17e-1)"	"unprognostic (4.03e-1)"	"prognostic unfavourable (6.35e-4)"	"unprognostic (1.82e-2)"	11.6	20.8	9.2	11.9	14.0	8.5	16.7	14.0	10.6	13.8	17.9	10.4	24.7	14.4	15.4	15.8	13.9	13.9	10.9	18.0	10.4	11.2	20.6	19.3	14.5	13.9	13.6	9.2	13.0	17.2	20.2	24.1	17.3	13.6	15.5	15.2	12.1	13.5	21.2	8.4	10.5	31.0	12.4	14.4	11.6	12.1	9.1	12.3	18.2	19.6	10.5	11.2	12.1	11.6	6.0	10.6	17.0	7.8	7.8	8.6	4.8	6.5	7.3	14.9	11.4	15.7	18.1	9.6	15.5	14.8	8.6	10.4	7.1	14.0	10.7	6.9	9.7	6.0	14.1	9.8	10.7	10.4	8.4	8.8	5.8	9.3	14.2	13.4	7.8	12.4	16.4	7.3	7.6	9.4	11.3	17.7	14.8	4.8	14.5	4.6	7.9	6.0	17.1	11.5	6.9	12.5	10.5	7.1	26.4	10.2	10.4	11.1	10.2	5.6	9.4	19.9	7.2	9.3	16.0	18.6	26.4	13.6	14.5	10.6	15.0	2.6	7.2	8.7	7.5	7.8	8.6	3.8	6.9	8.3	6.1	6.0	7.1	7.0	17.0	7.8	5.9	10.6	8.0	4.8	9.2	14.0	14.0	10.6	10.4	11.2	13.6	9.2	13.6	12.3
ELOC	"SIII, TCEB1"	ENSG00000154582	"Elongin C"	Q15369	8	73939169-73972287	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078113			Approved	"Nucleoli,Vesicles,Cell Junctions"			250000	Vesicles	"Nucleoli, Cell Junctions"	"HPA078113: "	"prognostic unfavourable (6.48e-4)"	"unprognostic (1.60e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.46e-2)"	"unprognostic (8.02e-3)"	"unprognostic (5.84e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.99e-3)"	"unprognostic (4.02e-3)"	"unprognostic (3.33e-2)"	"unprognostic (2.77e-3)"	"unprognostic (3.84e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.95e-2)"	27.0	29.5	39.1	19.2	37.6	35.4	24.2	25.6	43.3	17.5	19.6	12.2	21.0	13.4	18.2	31.7	24.5	17.2	17.9	50.1	33.9	29.5	28.2	36.1	21.2	35.2	32.5	28.4	17.9	25.5	17.6	20.0	25.7	27.3	19.2	20.6	12.1	16.3	21.0	62.5	16.6	14.5	24.4	33.9	18.7	18.5	51.0	18.8	19.7	19.6	31.9	27.9	19.3	16.7	38.9	55.3	51.7	35.4	32.5	44.9	26.4	44.6	36.6	33.6	24.3	25.7	33.6	24.1	44.4	36.3	43.6	44.8	32.5	39.0	22.8	36.0	39.3	32.1	37.0	44.3	57.7	26.2	30.7	39.7	39.1	51.5	33.6	25.4	29.8	34.0	35.6	39.4	51.0	40.5	34.9	30.6	57.2	33.1	65.3	45.7	30.5	59.3	23.8	21.1	21.6	47.5	39.2	31.7	30.0	18.6	101.5	41.4	37.4	27.4	30.9	31.7	35.8	34.6	44.5	34.8	42.4	42.0	38.1	27.8	38.4	51.7	32.2	38.2	31.2	35.4	34.0	38.9	37.5	34.8	34.2	34.0	34.3	34.4	37.7	32.5	33.8	55.3	44.9	26.4	39.1	37.6	25.6	43.3	33.9	29.5	32.5	28.4	27.3	18.8
EMG1		ENSG00000126749	"EMG1, N1-specific pseudouridine methyltransferase"	Q92979	12	6970893-6979941	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, RNA-binding, rRNA-binding, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA039304, HPA039666"	Supported		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA039304: , HPA039666: AB_10672891"	"unprognostic (1.23e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (3.69e-4)"	"unprognostic (2.70e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (2.83e-6)"	"unprognostic (2.13e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.62e-1)"	8.1	10.1	4.9	12.4	6.6	7.3	8.8	3.6	6.3	5.8	7.5	4.8	11.5	7.5	6.9	9.9	8.1	5.8	7.4	11.6	5.0		7.2	8.3	6.4	8.8	6.4	4.2	8.9	9.4	2.7	5.6	12.6	6.2	7.2	6.8	5.1	8.6	11.4	14.9	5.6	6.7	6.3	5.5	7.7	6.0	4.8	6.1	9.0	8.7	9.5	10.8	7.5	8.7	33.3	20.5	7.7	29.6	20.8	30.1	28.5	16.8	16.8	6.5	8.0	5.1	3.7	27.1	12.6	5.6	10.0	6.8	33.0	18.1	17.0	4.7	7.7	12.4	5.9	14.4	11.3	12.3	9.6	23.6	16.6	30.4	6.6	23.9	15.3	6.0	8.6	14.5	16.6	4.3	11.6	3.8	9.4	19.9	12.4	14.7	53.9	8.8	17.2	13.2	13.5	6.3	21.4	3.8	11.4	13.2	13.9	12.0	3.8	17.8	9.1	10.5	13.6	8.5	28.5	4.6	5.2	29.6	11.2	10.4	16.6	4.4	16.6	7.7	24.0	23.8	24.8	30.7	25.5	26.3	18.8	33.3	30.1	27.7	2.3	20.8	29.6	20.5	24.1	28.5										
EMX1		ENSG00000135638	"Empty spiracles homeobox 1"	Q04741	2	72916260-72936071	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.8;kidney: 27.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.6;CACO-2: 5.6;HEK 293: 12.5;HMC-1: 2.5;RPTEC TERT1: 2.2"	"Cancer enhanced"	"Detected in some"		"renal cancer: 3.7"	"Region enhanced"	"Detected in many"		"cerebral cortex: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	13	"amygdala: 3.8;cerebral cortex: 11.1;hippocampal formation: 8.6"	"HPA006230, HPA006421"	Approved		Supported	Nucleoli				Nucleoli		"HPA006230: , HPA006421: AB_1078739"	"unprognostic (4.54e-2)"	"unprognostic (5.59e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.22e-6)"	"unprognostic (4.82e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.07e-1)"	"prognostic favourable (1.54e-6)"	"unprognostic (4.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.02e-2)"	0.2	0.3	5.2	0.2	3.1	0.1	0.1	0.1	14.8	0.1	0.5	0.0	0.8	1.4	0.1	6.0	0.2	0.1	0.1	0.2	5.0	0.4	27.4	0.2	0.1	0.2	0.4	1.5	0.2	0.4	4.8	0.2	0.1	0.0	0.2	0.2	0.0	0.6	0.2	0.2	0.2	1.1	0.1	0.1	0.1	0.3	2.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	3.6	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.5	0.0	0.0	1.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	3.1	0.1	14.8	5.0	0.4	0.4	1.5	0.0	0.0
EN1		ENSG00000163064	"Engrailed homeobox 1"	Q05925	2	118842171-118847678	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adipose tissue: 5.6;brain: 11.4;skeletal muscle: 20.1;skin 1: 10.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 14.1;ASC TERT1: 6.4;fHDF/TERT166: 11.1;HSkMC: 11.9;PC-3: 6.6;U-138 MG: 8.6;U-2197: 9.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 5.6"	"Group enriched"	"Detected in some"	10	"midbrain: 11.4;pons and medulla: 8.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"midbrain: 5.9"	"Region enriched"	"Detected in some"	5	"midbrain: 23.9"	"CAB014884, HPA073141"	Enhanced		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"CAB014884: , HPA073141: "	"unprognostic (5.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.84e-7)"	"unprognostic (1.87e-3)"	"unprognostic (1.90e-1)"		"unprognostic (1.95e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.46e-1)"	"unprognostic (3.38e-9)"	"unprognostic (2.15e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.30e-3)"	5.6	0.1	0.0	0.1	0.4	0.0	2.7	0.9	0.4	0.0	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	2.4	11.4	0.0	0.1	0.0	0.1	0.0	0.0	8.8	0.1	0.1	0.2	0.7	0.1	20.1	10.0	0.1	0.1	2.7	0.1	0.1	0.4	0.1	0.2	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.5	0.2	14.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.4	0.5	0.0	0.0	0.0	1.1	0.0	0.6	0.0	0.1	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	8.6	0.8	9.6	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.4	0.2	0.1	11.4	0.0	8.8	0.1
ENSA	"ARPP-19e, MGC4319, MGC78563, MGC8394"	ENSG00000143420	"Endosulfine alpha"	O43768	1	150600851-150629612	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	13	"U-698: 419.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051294	Uncertain		Approved	Nucleoplasm,Nucleoli,Microtubules,Cytosol			22000	"Nucleoplasm, Nucleoli"	"Microtubules, Cytosol"	"HPA051294: "	"unprognostic (6.27e-2)"	"prognostic favourable (8.24e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.64e-2)"	"unprognostic (8.07e-3)"	30.3	26.4	48.9	26.9	48.9	46.8	33.0	33.8	69.3	31.7	31.8	28.0	26.8	34.4	29.7	45.4	66.3	26.3	28.5	30.0	42.4	37.9	31.7	32.3	28.6	30.0	42.0	39.0	27.7	30.5	33.0	25.2	37.5	34.6	23.9	30.4	28.5	29.4	22.8	67.7	49.8	34.0	27.3	38.3	23.8	28.7	12.8	27.3	25.8	35.2	42.9	35.5	31.7	36.3	34.4	39.5	49.5	33.6	33.0	33.2	38.4	14.3	7.6	10.5	10.1	6.7	5.6	11.4	6.5	6.6	9.7	8.2	8.5	10.9	12.9	10.8	5.2	11.6	8.5	14.4	7.2	22.3	11.9	18.5	10.7	6.4	4.5	14.9	23.9	4.4	8.9	10.0	12.8	9.1	14.1	27.2	6.5	31.1	14.6	12.1	21.1	9.3	14.3	8.7	16.1	12.7	12.6	15.8	10.0	9.2	19.4	10.0	26.5	21.9	9.6	7.2	13.4	8.6	16.7	15.3	22.2	419.6	10.0	17.3	9.5	28.7	30.7	49.5	32.2	33.6	28.9	34.4	27.0	33.2	39.5	31.8	22.3	32.9	29.0	33.0	31.9	30.2	29.8	38.4	48.9	48.9	33.8	69.3	42.4	37.9	42.0	39.0	34.6	27.3
ERGIC2	"Erv41, PTX1"	ENSG00000087502	"ERGIC and golgi 2"	Q96RQ1	12	29337352-29381189	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049695	Approved		Supported	"Nucleoli,Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	Nucleoli	"HPA049695: "	"unprognostic (1.62e-2)"	"unprognostic (3.50e-2)"	"unprognostic (5.53e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.19e-3)"	"prognostic unfavourable (8.06e-6)"	"unprognostic (3.70e-2)"	"unprognostic (2.32e-2)"	"prognostic favourable (8.18e-4)"	"prognostic unfavourable (7.02e-6)"	"unprognostic (2.67e-1)"	"prognostic unfavourable (3.76e-6)"	"unprognostic (6.02e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.64e-1)"	26.6	21.0	24.4	21.9	32.8	5.5	29.9	28.1	36.1	25.4	22.7	14.6	25.8	21.2	23.1	33.1	32.5	16.6	21.2	33.7	25.3	22.6	27.7	36.2	18.6	18.9	29.8	24.2	24.9	32.6	27.3	40.1	40.9	31.2	29.5	21.4	12.1	28.8	23.8	29.2	15.6	24.3	31.4	31.0	25.6	21.1	32.8	30.7	25.7	28.6	21.6	25.8	33.4	20.6	27.0	39.0	59.2	30.1	22.1	40.8	27.5	24.6	22.7	18.6	12.5	26.9	31.7	45.4	40.2	33.9	25.2	27.3	29.9	41.7	13.6	40.1	31.9	25.9	17.7	26.6	40.4	29.1	19.1	22.1	32.5	17.3	15.8	30.7	18.7	22.4	21.4	31.8	32.2	19.5	18.0	38.7	33.6	13.3	15.3	33.3	26.2	64.2	14.2	51.3	27.6	21.4	36.2	7.1	11.6	20.5	23.3	23.8	45.0	25.2	21.6	34.4	29.3	45.4	43.3	28.5	36.0	27.2	28.7	23.0	27.8	24.2	17.0	22.1	29.7	25.3	35.8	27.0	38.1	34.8	17.8	22.3	38.4	32.3	59.2	22.1	30.1	39.0	40.8	27.5	24.4	32.8	28.1	36.1	25.3	22.6	29.8	24.2	31.2	30.7
ESF1	"bA526K24.1, C20orf6"	ENSG00000089048	"ESF1 nucleolar pre-rRNA processing protein homolog"	Q9H501	20	13714322-13784886	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047083, HPA050396"	Supported		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA047083: , HPA050396: "	"unprognostic (2.81e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (7.81e-9)"	"unprognostic (2.52e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.17e-3)"	"unprognostic (3.91e-2)"	"unprognostic (7.34e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.57e-1)"	12.4	10.5	13.5	9.7	19.7	7.1	11.9	17.0	17.4	10.8	8.8	6.9	9.2	7.7	11.2	11.5	11.9	9.2	9.1	9.7	17.2	11.6	10.8	14.6	7.0	10.3	16.8	17.5	14.1	8.7	12.9	20.0	11.9	17.2	12.2	10.7	4.2	8.9	8.6	29.9	11.3	7.5	12.9	28.9	10.7	8.1	14.3	17.9	9.2	11.5	12.1	10.1	11.2	9.2	13.8	14.6	2.0	10.6	11.5	12.4	3.7	13.2	12.6	11.7	5.9	9.0	10.8	6.5	14.2	8.7	10.3	8.8	13.4	12.5	17.4	7.2	6.7	20.4	17.4	14.2	18.4	4.6	8.2	22.9	5.1	31.4	12.5	27.5	6.3	8.7	10.1	17.0	13.8	7.8	31.8	7.9	11.7	11.7	20.8	16.5	11.2	7.6	13.6	29.1	12.7	7.2	11.7	11.5	7.1	11.4	18.0	17.6	9.1	12.1	10.5	15.9	11.0	11.6	26.1	8.0	19.4	21.4	6.7	12.1	14.5	1.8	6.9	2.0	8.7	8.6	10.0	13.6	10.0	9.3	6.9	13.8	12.4	11.3	0.4	11.5	10.6	14.6	7.5	3.7	13.5	19.7	17.0	17.4	17.2	11.6	16.8	17.5	17.2	17.9
ETV4	"E1A-F, E1AF, PEA3"	ENSG00000175832	"ETS variant 4"	P43268	17	43527844-43579620	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 38.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 45.0;Hep G2: 42.2;SK-MEL-30: 48.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005768	Approved		Supported	Nucleoli				Nucleoli		"HPA005768: AB_1848294"	"unprognostic (2.32e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.14e-3)"	"prognostic unfavourable (2.48e-4)"	"unprognostic (1.58e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.13e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.01e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.08e-2)"	"prognostic favourable (7.60e-4)"	"unprognostic (1.69e-1)"	0.6	2.4	1.4	0.9	1.4	0.0	6.8	1.6	8.3	3.6	3.3	0.4	1.3	5.7	3.4	2.2	9.9	2.4	38.4	2.6	1.8	1.3	7.8	1.4	2.5	0.4	2.3	1.1	1.2	23.8	19.3	19.7	11.6	2.7	4.7	1.6	1.7	4.9	4.5	1.3	6.7	3.8	1.2	1.8	0.5	3.6	1.3	0.5	0.3	6.6	15.0	12.1	3.1	5.3	0.2	0.0	1.3	0.2	0.0	0.6	0.1	5.9	16.7	20.5	45.0	0.8	5.3	4.5	1.9	5.3	3.8	3.9	9.4	8.5	0.0	1.1	1.0	10.9	0.6	10.0	3.4	0.2	0.1	0.5	2.6	42.2	1.1	11.4	5.3	0.9	0.3	14.5	9.0	8.1	11.7	0.0	7.8	2.3	0.0	20.2	29.6	28.0	24.4	2.4	14.3	8.4	4.3	0.0	18.3	0.5	1.1	48.7	0.2	3.4	3.7	2.7	13.4	4.0	5.4	1.8	11.2	0.0	4.9	2.2	15.8	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.1	0.0	0.0	0.0	0.2	0.6	1.3	0.0	0.0	0.0	0.0	0.1	1.4	1.4	1.6	3.6	1.8	1.3	2.3	1.1	2.7	0.5
ETV6	TEL	ENSG00000139083	"ETS variant 6"	P41212	12	11649854-11895402	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 38.9;NB-4: 20.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000264	Enhanced		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA000264: AB_1078763"	"unprognostic (4.03e-3)"	"unprognostic (3.08e-2)"	"unprognostic (7.54e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.35e-3)"	"unprognostic (2.74e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.16e-1)"	"unprognostic (9.46e-2)"	"prognostic unfavourable (9.38e-5)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (4.66e-8)"	"unprognostic (1.33e-2)"	"unprognostic (5.99e-2)"	"unprognostic (8.92e-2)"	"prognostic favourable (1.54e-5)"	17.2	8.9	5.1	20.0	7.6	32.8	20.4	1.6	9.1	10.5	14.5	6.0	9.8	7.2	10.8	14.2	11.3	8.9	15.3	6.7	5.6	3.8	9.2	9.6	16.0	13.4	6.0	3.1	10.5	10.4	8.4	8.7	7.7	7.4	14.9	11.0	8.0	41.9	12.4	6.9	23.9	14.6	25.0	9.4	17.8	9.7	4.7	5.7	30.6	10.0	10.0	19.9	19.0	15.8	2.9	6.2	11.4	7.1	2.4	2.2	1.3	2.5	3.5	3.2	5.5	2.4	2.3	3.8	1.9	3.2	2.5	3.0	0.2	12.2	2.1	1.9	3.2	3.3	1.4	5.8	3.0	38.9	0.7	13.7	1.9	1.3	3.0	14.4	15.0	4.5	3.6	2.4	5.1	7.5	1.0	7.3	2.2	1.6	8.1	20.7	5.1	0.9	2.3	3.0	5.6	5.7	16.2	0.6	3.2	3.8	3.7	3.5	1.2	9.1	8.5	5.6	4.8	1.8	4.0	3.2	2.4	1.2	3.6	0.1	6.4	5.6	5.7	6.6	1.5	6.6	2.0	2.9	2.2	1.4	4.1	2.3	1.3	0.8	11.4	2.4	7.1	6.2	1.4	1.3	5.1	7.6	1.6	9.1	5.6	3.8	6.0	3.1	7.4	5.7
EWSR1	EWS	ENSG00000182944	"EWS RNA binding protein 1"	Q01844	22	29268009-29300525	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Calmodulin-binding, Repressor, RNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004230, HPA051771, HPA062953"	Enhanced		Enhanced	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"CAB004230: AB_675526, HPA051771: AB_2681602, HPA062953: AB_2684910"	"unprognostic (1.96e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.15e-2)"	"prognostic unfavourable (1.27e-6)"	"unprognostic (1.33e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.71e-2)"	"unprognostic (7.04e-2)"	"unprognostic (9.30e-2)"	"prognostic unfavourable (1.21e-5)"	"unprognostic (7.33e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.50e-3)"	35.3	43.2	45.3	41.3	51.3	67.5	32.1	58.2	48.6	32.4	39.8	43.2	31.3	41.0	45.1	38.5	40.8	37.6	25.9	40.7	40.1	32.8	33.0	48.5	33.4	50.5	32.7	49.9	38.4	32.0	47.2	44.3	34.0	41.7	35.0	39.9	41.5	32.3	38.2	52.8	34.8	36.6	40.5	33.8	44.1	34.5	85.6	32.5	39.9	32.5	30.9	55.4	36.4	34.5	52.0	65.8	50.6	81.1	58.4	67.8	76.1	56.4	44.0	60.5	47.0	30.9	25.6	41.6	34.4	55.0	57.1	49.0	50.1	29.3	77.2	21.8	52.7	44.4	86.2	70.4	58.8	52.5	61.5	58.3	39.0	47.9	46.2	89.6	41.7	39.1	29.7	47.6	77.3	44.1	43.6	34.9	42.2	56.7	90.0	34.4	42.5	33.5	63.2	58.3	46.6	52.5	60.0	49.6	47.4	42.8	50.2	37.1	32.2	48.8	45.0	34.9	38.8	21.9	49.9	45.4	36.4	71.6	33.2	39.9	42.4	48.4	57.9	50.6	60.2	81.1	60.7	50.4	56.6	59.6	65.8	52.0	55.8	53.6	43.3	58.4	78.6	35.3	67.8	76.1	45.3	51.3	58.2	48.6	40.1	32.8	32.7	49.9	41.7	32.5
EXOC4	"KIAA1699, MGC27170, SEC8, SEC8L1, Sec8p"	ENSG00000131558	"Exocyst complex component 4"	Q96A65	7	133253073-134066589	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031443, HPA031444"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA031443: AB_10602496, HPA031444: "	"unprognostic (1.70e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.06e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (6.19e-4)"	"unprognostic (9.78e-3)"	"prognostic favourable (6.85e-5)"	"unprognostic (5.91e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.37e-1)"	"unprognostic (3.35e-2)"	21.2	23.7	18.5	17.7	22.3	10.5	19.4	25.7	24.4	20.8	17.0	19.7	22.2	11.2	25.8	20.6	21.5	24.2	16.8	16.5	14.7	15.4	15.6	15.2	16.5	12.6	14.2	19.3	27.7	26.5	28.5	31.2	16.4	22.0	16.9	18.8	19.3	20.5	18.8	50.7	24.4	13.7	20.8	18.7	17.9	16.3	17.2	17.3	34.7	22.9	18.3	22.1	26.3	20.6	8.3	16.3	8.1	12.7	18.4	12.4	10.4	17.7	14.6	20.2	19.9	23.7	24.7	7.0	13.0	21.7	11.8	15.6	8.4	25.0	13.3	9.4	24.4	11.3	10.8	17.7	19.7	20.2	12.9	10.7	15.4	8.9	26.1	14.0	11.7	24.0	22.2	16.8	31.2	20.1	15.4	13.3	21.9	11.6	25.5	15.5	15.1	13.7	11.4	17.9	23.9	19.1	15.9	15.8	24.9	19.5	18.0	20.8	11.9	13.2	21.8	13.2	6.9	13.9	14.1	21.1	12.8	12.8	38.9	16.5	20.1	8.1	12.0	6.9	11.8	12.7	10.5	8.3	12.3	12.4	16.3	8.0	10.1	10.4	4.0	18.4	10.5	7.3	12.4	10.4	18.5	22.3	25.7	24.4	14.7	15.4	14.2	19.3	22.0	17.3
EXOSC10	"p2, p3, p4, PM-Scl, PM/Scl-100, PMSCL2, RRP6, Rrp6p"	ENSG00000171824	"Exosome component 10"	Q01780	1	11066618-11099881	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, rRNA processing"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028470, HPA028484, CAB037141"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"CAB037141: AB_532315, HPA028470: AB_10599180, HPA028484: AB_10611250"	"unprognostic (1.23e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.37e-2)"	"prognostic unfavourable (2.49e-6)"	"unprognostic (3.36e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.49e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.68e-3)"	"unprognostic (3.43e-1)"	"unprognostic (9.03e-2)"	"prognostic favourable (5.27e-4)"	"unprognostic (1.33e-1)"	28.2	21.8	30.4	22.1	31.9	30.8	27.9	58.8	34.7	24.8	22.0	31.9	22.4	18.5	27.0	22.9	27.6	22.7	18.3	18.3	27.8	16.2	22.4	18.2	20.8	26.0	31.5	26.3	31.2	24.2	23.1	32.1	23.5	24.3	22.1	25.9	20.4	24.6	20.5	27.3	33.2	22.7	25.6	23.2	26.0	25.2	20.3	32.7	28.2	20.8	12.5	29.9	23.6	24.6	21.0	21.6	24.8	26.4	27.5	25.9	22.3	23.1	14.8	31.1	12.0	16.6	18.4	17.8	22.9	16.9	40.4	36.8	21.8	33.9	23.4	14.9	21.7	23.1	34.3	25.5	37.2	26.2	34.4	34.0	29.1	22.2	16.3	27.6	27.1	14.4	22.1	39.6	23.4	25.1	35.6	21.6	22.2	13.1	27.1	25.5	20.6	17.8	28.0	26.5	20.4	23.7	11.9	20.1	19.6	24.7	21.4	27.4	18.7	25.5	22.7	21.6	22.5	19.3	26.8	13.1	20.5	46.3	22.0	41.2	25.8	24.8	18.2	14.6	22.2	23.4	25.9	21.0	23.1	22.1	21.6	19.9	19.8	22.0	3.6	27.5	26.4	11.0	21.8	22.3	30.4	31.9	58.8	34.7	27.8	16.2	31.5	26.3	24.3	32.7
EXOSC2	"hRrp4p, p7, RRP4, Rrp4p"	ENSG00000130713	"Exosome component 2"	Q13868	9	130693721-130704894	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Deafness, Disease mutation, Dwarfism, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021756, HPA021790"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA021756: , HPA021790: AB_1848320"	"unprognostic (8.19e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (4.36e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.95e-2)"	"prognostic unfavourable (1.39e-5)"	"unprognostic (8.33e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.73e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.41e-1)"	13.0	14.2	14.4	18.6	17.0	12.7	17.9	22.7	18.0	16.1	14.3	15.8	13.6	11.0	18.7	10.1	16.6	19.0	11.7	12.5	15.8	12.5	14.3	18.4	11.1	16.7	18.5	17.3	22.1	25.0	19.6	12.6	13.1	13.9	13.9	17.4	14.6	14.1	13.7	22.3	13.1	11.5	18.7	12.3	14.0	13.4	8.4	17.6	17.3	14.2	15.7	21.3	15.8	13.9	11.0	10.4	5.6	7.9	16.8	11.7	7.7	13.7	28.2	16.9	14.9	6.1	6.9	12.3	20.7	10.0	20.8	16.1	22.7	12.0	27.4	11.4	11.1	25.2	26.9	20.7	23.0	16.2	13.1	21.9	27.6	15.8	11.5	33.0	14.5	8.8	7.8	29.1	34.1	14.7	23.8	11.9	14.4	24.5	23.2	9.2	20.9	18.3	18.3	31.0	29.9	9.7	12.8	10.4	11.6	24.2	18.5	10.9	19.2	11.9	8.9	20.5	15.9	18.2	29.2	6.1	24.0	41.6	14.6	19.3	16.0	1.5	7.7	5.6	10.9	7.9	11.2	11.0	11.0	9.2	10.4	10.4	11.7	10.0	2.0	16.8	5.4	6.8	9.9	7.7	14.4	17.0	22.7	18.0	15.8	12.5	18.5	17.3	13.9	17.6
EXOSC5	"hRrp46p, MGC12901, p12B, RRP41B, RRP46, Rrp46p"	ENSG00000077348	"Exosome component 5"	Q9NQT4	19	41386374-41397479	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053150, HPA055677"	Approved		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA053150: , HPA055677: "	"unprognostic (1.24e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.53e-3)"	"unprognostic (7.50e-3)"	"unprognostic (5.74e-2)"	"unprognostic (3.83e-3)"	"unprognostic (9.23e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.35e-2)"	"prognostic unfavourable (3.45e-7)"	"unprognostic (6.84e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.79e-2)"	"unprognostic (7.82e-2)"	9.1	14.3	12.6	12.3	16.6	13.1	11.1	7.6	21.3	8.8	12.1	10.8	9.0	10.0	8.1	6.0	14.6	13.6	6.4	11.6	12.0	10.3	7.9	25.1	5.7	17.0	13.4	9.9	13.2	46.9	3.2	4.9	6.5	10.3	9.5	6.6	6.3	14.0	8.1	30.9	18.5	9.5	6.6	14.0	12.7	9.8	7.5	11.8	16.8	15.1	15.7	12.2	11.3	8.6	22.9	36.8	3.3	23.7	17.1	21.1	13.5	17.8	33.5	4.7	13.8	3.0	3.8	11.0	7.6	3.6	12.4	10.3	19.5	13.2	27.9	19.7	3.7	6.8	9.3	8.5	3.9	17.8	32.1	12.4	12.6	14.8	9.6	22.4	12.3	4.7	19.1	10.0	9.6	5.8	16.6	20.1	4.1	23.4	19.3	15.8	16.6	16.6	18.3	12.9	25.1	5.0	12.8	18.1	13.6	10.9	18.3	18.5	8.5	27.7	4.6	13.1	11.0	8.3	23.3	31.7	40.5	30.3	10.2	32.3	11.1	3.3	21.7	0.6	13.2	23.7	15.8	21.1	14.4	13.3	34.1	22.9	21.1	18.5	1.5	17.1	14.0	36.8	11.1	13.5	12.6	16.6	7.6	21.3	12.0	10.3	13.4	9.9	10.3	11.8
EXOSC9	"p5, p6, PM/Scl-75, PMSCL1, RRP45, Rrp45p"	ENSG00000123737	"Exosome component 9"	Q06265	4	121801317-121817021	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041838, HPA048257, CAB070171"	Approved		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"CAB070171: AB_11026964, HPA041838: AB_10794492, HPA048257: "	"unprognostic (7.36e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavourable (1.04e-4)"	"unprognostic (7.89e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.25e-2)"	"unprognostic (9.85e-3)"	"prognostic unfavourable (6.49e-4)"	"unprognostic (3.28e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.21e-2)"	12.5	12.7	10.1	18.9	14.7	29.7	13.9	16.8	18.6	11.2	9.7	8.1	12.5	7.5	12.5	12.4	13.3	11.8	7.8	13.1	13.5	11.3	11.3	14.0	11.9	19.8	11.3	12.2	12.6	10.4	14.2	15.5	12.1	12.9	10.3	12.0	9.6	10.9	8.9	17.6	12.1	10.3	10.6	11.7	14.2	10.4	36.7	10.0	33.7	9.2	15.4	18.9	12.2	10.5	19.9	15.9	20.1	17.7	11.6	23.6	14.0	19.2	9.1	24.6	14.6	3.9	7.9	12.0	25.1	14.5	36.0	27.8	9.8	16.2	33.9	6.2	15.6	6.9	26.5	11.7	32.1	15.0	12.2	17.0	14.0	12.6	8.1	28.8	15.8	6.0	6.1	25.1	7.2	17.7	29.1	13.4	33.6	11.3	44.0	22.2	12.9	10.7	24.6	41.2	15.2	12.3	6.3	15.7	16.5	9.2	13.7	15.2	11.7	18.6	10.7	16.1	23.8	13.5	24.2	19.6	14.8	40.7	16.7	20.1	10.6	12.0	13.3	20.1	18.7	17.7	18.4	19.9	20.5	23.6	15.9	19.9	23.3	20.7	3.3	11.6	17.0	15.7	21.6	14.0	10.1	14.7	16.8	18.6	13.5	11.3	11.3	12.2	12.9	10.0
FAM102B	"DKFZp779B126, SYM-3B"	ENSG00000162636	"Family with sequence similarity 102 member B"	Q5T8I3	1	108560089-108644900	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 5.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028451	Uncertain		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA028451: AB_10602497"	"unprognostic (1.30e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.87e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.87e-3)"	"unprognostic (3.10e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.11e-2)"	"prognostic unfavourable (3.47e-6)"	"unprognostic (1.06e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.86e-1)"	11.6	5.2	11.8	10.4	11.4	19.0	11.3	23.3	20.0	8.5	13.8	3.8	6.6	11.4	7.5	8.2	6.5	6.7	15.7	9.2	15.6	14.3	4.6	5.1	8.1	8.8	12.6	19.0	10.5	5.8	12.1	7.3	6.0	11.4	8.5	15.7	5.5	13.5	9.6	2.3	4.2	11.5	11.4	10.2	8.6	7.9	8.8	5.0	9.4	6.7	4.3	8.4	16.4	18.0	0.9	2.7	5.7	2.3	0.7	1.4	0.5	3.6	2.6	5.2	2.8	9.5	5.7	3.4	2.1	2.9	3.3	5.7	0.9	3.6	4.0	2.0	5.5	7.1	17.8	0.7	4.3	2.6	2.6	5.6	20.1	0.4	2.4	7.2	10.7	3.0	0.8	4.9	0.3	2.1	13.5	22.3	7.8	14.7	4.6	5.2	4.1	13.1	10.6	13.3	0.8	0.9	4.2	17.1	5.0	8.5	14.8	4.4	3.1	11.8	0.4	5.4	10.2	4.6	8.1	4.0	0.9	3.7	7.9	5.7	2.8	5.7	1.1	1.0	1.0	2.3	0.6	0.9	1.0	1.4	2.7	0.9	0.7	0.5	1.0	0.7	0.9	0.5	0.8	0.5	11.8	11.4	23.3	20.0	15.6	14.3	12.6	19.0	11.4	5.0
FAM105A	"FLJ11127, NET20"	ENSG00000145569	"Family with sequence similarity 105 member A"	Q9NUU6	5	14581775-14615007	"Enzymes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 35.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 13.8;HMC-1: 43.3;THP-1: 12.0;U-937: 20.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046638	Uncertain		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA046638: "	"unprognostic (1.47e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.15e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.42e-1)"	"prognostic favourable (1.02e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.38e-2)"	"prognostic unfavourable (7.62e-4)"	"unprognostic (3.14e-1)"	"unprognostic (8.79e-3)"	5.1	3.5	4.0	7.9	4.9	35.4	5.2	3.1	5.1	6.3	15.4	9.0	4.5	8.3	3.0	5.6	2.9	3.1	4.1	3.0	3.9	4.3	5.2	1.9	28.8	16.7	6.1	3.8	4.0	13.3	1.9	8.7	6.7	7.9	12.6	17.3	10.3	3.1	13.5	1.3	2.6	13.7	3.3	10.8	13.2	5.4	4.4	4.1	3.5	27.2	3.0	6.2	7.1	5.8	0.1	26.7	6.9	26.2	14.1	9.6	16.2	0.0	0.6	1.2	0.0	0.2	0.0	5.2	1.5	1.4	0.4	0.7	1.9	1.3	0.0	0.8	0.7	0.1	2.6	1.2	0.6	0.8	3.6	3.4	13.8	0.3	1.3	0.0	43.3	0.1	0.3	0.2	0.0	0.0	0.0	5.4	0.1	1.0	0.0	1.2	1.9	9.2	0.3	0.5	1.5	0.0	10.4	4.5	5.0	0.7	0.4	0.0	0.4	12.0	0.0	0.6	3.4	0.2	1.1	0.0	0.0	0.0	0.7	20.5	0.2	0.0	26.2	0.1	4.5	12.4	6.0	0.1	5.7	6.1	26.7	0.1	7.8	7.5	6.9	14.1	9.4	19.7	9.6	16.2	4.0	4.9	3.1	5.1	3.9	4.3	6.1	3.8	7.9	4.1
FAM131A	"C3orf40, MGC21688"	ENSG00000175182	"Family with sequence similarity 131 member A"	Q6UXB0	3	184335926-184348421	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 54.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 31.7;basal ganglia: 23.9;cerebral cortex: 59.8;hippocampal formation: 86.5"	HPA042800	Uncertain		Approved	Nucleoli	"Secreted - unknown location"			Nucleoli		"HPA042800: AB_10797023"	"unprognostic (1.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavourable (2.22e-4)"	"unprognostic (2.88e-1)"	"unprognostic (4.84e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.54e-2)"	"unprognostic (7.02e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.28e-2)"	8.1	14.9	18.8	4.6	26.4	2.5	5.0	21.9	54.7	5.4	6.4	8.0	4.8	6.3	7.5	4.9	7.5	7.7	8.4	11.9	28.1	13.0	4.1	3.0	6.0	3.4	9.1	25.9	8.8	11.3	9.2	16.4	5.0	7.8	6.7	3.5	3.3	7.1	11.7	9.3	10.5	5.8	8.7	5.9	5.3	5.5	7.0	7.0	0.8	3.5	3.9	2.7	5.5	4.1	2.1	5.5	11.1	6.5	1.6	2.2	2.5	8.1	3.4	5.4	9.5	7.4	6.1	5.1	3.6	8.3	5.8	4.5	2.6	2.9	1.2	15.2	3.5	7.6	0.0	6.6	3.7	8.7	9.1	0.0	5.1	5.5	7.5	0.1	6.4	4.5	1.1	4.9	11.4	11.6	1.8	1.2	2.1	6.2	3.1	0.2	9.3	6.8	5.7	2.2	7.8	5.8	0.2	16.6	17.3	2.3	6.4	8.5	18.8	2.1	11.7	7.1	5.6	5.7	11.4	13.7	8.3	0.8	22.9	1.2	5.0	2.0	4.8	6.0	1.5	6.5	1.6	2.0	1.2	1.6	5.5	2.1	1.2	1.5	11.1	1.6	3.4	2.3	2.2	2.5	18.8	26.4	21.9	54.7	28.1	13.0	9.1	25.9	7.8	7.0
FAM131C	"C1orf117, FLJ36766"	ENSG00000185519	"Family with sequence similarity 131 member C"	Q96AQ9	1	16057769-16073632	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 41.1"	"Cell line enhanced"	"Detected in some"		"A549: 10.7;HEK 293: 6.9;PC-3: 7.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 41.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031046	Uncertain		Approved	"Nucleoli,Intermediate filaments,Cytosol"				"Nucleoli, Intermediate filaments, Cytosol"		"HPA031046: "	"unprognostic (4.69e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.26e-2)"	"unprognostic (2.46e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.67e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.68e-1)"	"prognostic favourable (9.33e-6)"	"unprognostic (1.93e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.44e-1)"	0.7	7.8	5.6	0.6	4.0	0.5	1.1	41.1	9.1	1.1	1.0	7.7	0.0	0.7	1.0	1.4	1.2	1.1	1.4	5.2	5.0	6.5	10.4	2.2	0.6	0.5	10.7	3.8	1.2	7.1	2.0	5.6	0.7	8.7	0.8	0.6	0.8	6.3	1.6	0.6	3.2	0.8	0.9	17.7	0.6	1.6	1.3	4.9	0.0	1.7	0.0	1.4	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	4.2	10.7	0.4	0.6	0.0	0.0	0.0	1.0	0.9	1.2	2.7	0.2	2.3	0.0	0.4	0.5	1.2	1.4	0.3	0.3	0.0	6.9	0.0	2.4	0.0	0.1	0.0	0.0	0.0	1.7	0.1	0.9	0.7	0.0	0.0	0.1	2.2	0.0	0.0	0.4	7.9	0.0	0.0	4.5	0.8	0.0	1.5	3.1	0.4	1.3	0.3	0.3	0.0	1.7	0.2	3.8	0.0	0.0	1.7	0.1	0.0	3.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	4.0	41.1	7.1	5.0	6.5	10.7	3.8	8.7	4.9
FAM133A	"CT115, FLJ37659, RP1-32F7.2"	ENSG00000179083	"Family with sequence similarity 133 member A"	Q8N9E0	X	93674013-93712274	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"brain: 14.8;pituitary gland: 8.2;testis: 16.1"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 21.8;U-2197: 11.3;U-266/70: 17.0;U-266/84: 37.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA066175, HPA069513"			Uncertain	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA066175: , HPA069513: "	"unprognostic (1.75e-1)"	"unprognostic (1.21e-1)"		"unprognostic (1.67e-3)"	"unprognostic (4.45e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.86e-3)"	"unprognostic (4.22e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.39e-2)"	"unprognostic (7.12e-4)"	"unprognostic (1.67e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.99e-3)"	0.5	3.0	4.7	0.4	14.8	0.3	0.8	2.3	7.7	1.7	0.5	0.5	0.0	0.4	1.0	0.8	0.4	1.1	0.7	2.2	2.5	4.5	0.4	0.4	0.5	0.4	2.3	4.4	1.4	0.4	0.4	8.2	0.4	3.7	0.4	0.5	0.2	0.4	0.5	0.3	0.6	0.5	0.8	4.5	0.5	0.4	16.1	2.6	0.0	0.9	0.0	0.3	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	21.8	0.0	0.0	0.0	0.0	0.5	5.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.4	0.5	11.3	0.4	17.0	37.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	14.8	2.3	7.3	2.5	4.5	2.3	4.4	3.7	2.6
FAM133B	MGC40405	ENSG00000234545	"Family with sequence similarity 133 member B"	Q5BKY9	7	92560793-92590394	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA066175, HPA069513"			Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA066175: , HPA069513: "	"unprognostic (5.54e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.87e-3)"	"unprognostic (8.56e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.73e-3)"	"unprognostic (9.01e-3)"	"unprognostic (3.16e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-2)"	10.5	11.7	18.5	11.1	23.6	32.1	15.1	25.7	23.3	13.6	10.4	8.2	12.0	11.9	13.0	22.5	11.4	10.4	9.2	9.2	13.8	9.1	11.2	14.3	11.2	14.1	15.3	13.2	15.1	13.6	13.4	21.3	12.9	18.0	12.0	11.7	7.5	11.4	10.5	17.1	12.8	10.8	15.7	18.5	12.1	10.6	7.3	17.3	15.9	12.5	7.5	12.8	10.6	12.0	22.5	23.2	9.8	11.7	10.7	17.0	5.9	12.8	6.7	18.8	28.8	11.0	11.8	11.3	14.6	15.8	14.3	17.5	10.7	14.4	21.1	14.2	9.9	10.4	14.8	9.2	22.0	11.8	19.4	17.1	9.8	21.4	11.6	18.8	14.8	7.8	9.8	11.0	13.7	8.4	22.4	26.8	15.3	15.7	29.5	29.3	25.7	8.6	21.4	18.9	17.5	14.3	13.8	18.3	17.7	12.6	16.0	17.0	14.9	13.8	9.7	16.5	26.2	19.2	16.3	7.0	7.4	37.8	9.9	24.8	21.2	9.5	11.7	9.8	10.7	10.5	13.9	22.5	13.6	13.2	9.6	18.8	17.0	14.4	4.9	10.7	7.8	23.2	14.3	5.9	18.5	23.6	25.7	23.3	13.8	9.1	15.3	13.2	18.0	17.3
FAM13A	"ARHGAP48, FAM13A1, KIAA0914"	ENSG00000138640	"Family with sequence similarity 13 member A"	O94988	4	88725955-89111398	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 32.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 5.7;monocytes: 6.5;T-cells: 5.2"	"Low region specificity"	"Detected in all"							"HPA038108, HPA038109"	Uncertain		Approved	"Nucleoli,Cell Junctions,Cytosol"				"Cell Junctions, Cytosol"	Nucleoli	"HPA038108: , HPA038109: AB_10672619"	"unprognostic (1.14e-1)"	"unprognostic (1.53e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.36e-2)"	"unprognostic (4.71e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.90e-2)"	"unprognostic (7.44e-2)"	"prognostic favourable (4.28e-4)"	58.6	10.8	9.1	11.0	9.3	6.5	19.0	17.9	18.5	15.5	41.0	3.7	7.4	30.5	10.9	12.0	9.3	14.8	10.7	8.8	9.6	5.7	14.0	22.9	13.3	5.3	10.0	6.8	17.8	23.5	45.5	11.2	20.7	11.4	15.9	9.3	11.5	13.3	8.0	8.4	17.5	30.5	15.6	19.4	4.9	13.4	11.1	12.9	3.2	20.4	16.1	4.0	30.4	23.8	0.1	5.7	1.4	6.5	0.7	5.2	2.6	2.4	3.7	5.5	7.2	32.2	13.3	9.1	5.7	6.9	2.2	2.1	3.1	5.7	0.1	2.3	4.0	1.5	8.1	4.1	5.1	0.3	5.6	4.0	5.1	0.4	9.4	3.3	0.5	12.7	3.3	5.7	2.1	3.8	10.5	0.4	4.9	0.1	0.3	1.5	6.8	3.8	5.5	9.4	2.1	4.2	12.0	14.0	3.7	1.4	4.4	5.4	3.1	0.1	1.4	6.4	3.5	3.1	3.2	1.9	1.1	0.0	9.5	0.3	3.3	0.1	6.5	0.1	1.8	3.2	1.3	0.1	4.7	0.6	5.7	0.1	5.2	1.3	1.4	0.7	1.0	1.9	2.5	2.6	9.1	9.3	17.9	18.5	9.6	5.7	10.0	6.8	11.4	12.9
FAM193B	"FLJ10404, IRIZIO, KIAA1931"	ENSG00000146067	"Family with sequence similarity 193 member B"	Q96PV7	5	177519788-177554541	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035847, HPA035848"	Approved		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA035847: , HPA035848: AB_10601320"	"unprognostic (6.58e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.95e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.15e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.78e-2)"	"prognostic unfavourable (3.71e-8)"	"unprognostic (1.08e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.15e-1)"	"prognostic favourable (1.30e-5)"	13.5	9.5	18.5	16.5	17.2	35.6	15.8	37.9	20.4	18.1	13.5	13.6	17.2	15.4	19.8	11.6	13.8	13.3	12.3	9.1	18.4	8.0	16.3	18.5	17.0	20.5	17.3	18.3	22.1	22.1	10.3	15.2	15.2	17.0	19.0	11.6	17.1	14.3	14.6	11.6	34.9	18.7	12.7	10.9	27.8	14.9	14.0	16.2	11.7	16.9	9.5	15.3	13.7	23.1	1.3	1.6	2.9	1.8	2.0	2.8	0.9	5.2	7.1	15.7	13.6	7.8	7.5	33.9	4.8	5.2	8.0	7.6	18.9	10.3	10.1	7.5	4.6	9.2	7.1	10.1	5.9	22.2	7.4	7.1	11.1	9.0	4.5	6.9	14.7	7.4	11.3	6.7	7.4	8.0	6.8	10.0	5.7	17.7	12.6	20.2	10.9	5.6	20.6	3.5	8.5	7.6	15.1	14.6	9.3	5.6	16.1	4.7	15.7	9.6	9.9	8.9	7.4	5.7	5.7	10.9	4.5	8.1	7.1	11.3	7.3	0.0	1.8	0.7	2.8	0.2	1.8	0.7	1.4	2.0	1.1	1.3	0.7	1.0	2.9	2.0	1.1	1.6	0.9	0.9	18.5	17.2	37.9	20.4	18.4	8.0	17.3	18.3	17.0	16.2
FAM204A	"bA319I23.1, C10orf84, FLJ13188"	ENSG00000165669	"Family with sequence similarity 204 member A"	Q9H8W3	10	118297930-118342328	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038182, HPA062025"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA038182: AB_10669519, HPA062025: "	"unprognostic (1.60e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.45e-2)"	"unprognostic (8.52e-3)"	"unprognostic (4.47e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.13e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (8.59e-4)"	"unprognostic (5.55e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.76e-3)"	31.2	17.5	30.0	18.5	31.6	40.3	28.1	18.9	37.8	24.9	26.8	20.0	19.6	17.9	27.4	29.5	26.1	19.2	19.2	29.5	25.4	21.7	25.0	24.8	21.4	22.4	23.4	25.9	26.2	21.4	19.1	31.3	19.1	30.4	21.1	21.6	19.4	21.9	20.7	36.3	17.1	18.5	34.0	31.2	24.1	20.8	39.9	20.9	19.8	26.0	21.9	23.0	32.8	18.4	27.4	32.4	36.6	35.1	17.5	27.2	28.7	21.4	9.7	16.0	22.3	16.0	17.5	9.1	17.0	32.1	24.7	22.4	11.4	20.1	15.3	10.6	18.3	18.6	13.4	17.8	22.5	24.0	16.6	12.7	10.0	10.0	23.9	32.8	18.1	12.0	21.8	18.1	38.1	21.0	13.2	18.1	20.4	12.0	20.1	30.6	11.3	8.7	17.3	31.0	11.2	22.3	11.0	10.3	16.3	11.7	10.9	25.0	17.4	23.8	14.6	13.0	12.2	11.5	25.8	13.0	11.5	22.0	25.4	35.6	13.1	29.8	31.7	36.6	21.7	34.4	22.7	27.4	24.6	19.8	32.4	20.2	21.3	24.7	17.6	17.5	35.1	23.5	27.2	28.7	30.0	31.6	18.9	37.8	25.4	21.7	23.4	25.9	30.4	20.9
FAM229B	"C6orf225, DKFZp586F0922, LOC619208"	ENSG00000203778	"Family with sequence similarity 229 member B"	Q4G0N7	6	112087599-112102790	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 118.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036068			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"				Nucleoplasm	"Nucleoli, Golgi apparatus"	"HPA036068: AB_10673495"	"unprognostic (1.65e-1)"	"unprognostic (9.41e-2)"	"unprognostic (4.29e-2)"	"unprognostic (4.67e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.74e-2)"	"prognostic favourable (8.76e-4)"	"unprognostic (3.74e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.06e-2)"	4.7	7.4	18.4	2.1	16.8	2.0	7.7	5.8	14.8	8.2	4.2	17.3	4.3	2.2	9.6	17.0	3.8	23.7	8.8	16.8	15.7	16.2	11.6	11.0	5.2	2.0	20.7	11.2	10.7	4.3	10.0	15.4	5.2	15.3	7.3	3.1	8.6	3.9	11.0	5.9	1.9	2.3	8.6	21.7	2.3	4.3	118.9	13.6	1.6	9.7	2.6	2.0	4.6	2.6	4.0	3.4	2.7	0.3	5.4	8.1	2.8	1.6	4.2	17.5	8.5	15.4	15.4	0.8	6.4	24.6	9.3	19.6	0.7	4.1	1.3	19.1	11.8	1.0	3.6	9.3	14.8	0.4	12.0	1.5	2.0	6.6	9.6	3.4	0.8	9.3	6.3	15.3	2.6	9.0	2.0	3.4	11.3	0.4	6.2	5.4	4.5	10.1	9.7	4.4	1.4	13.6	0.2	16.3	6.8	5.1	0.6	9.9	8.3	3.1	5.1	7.7	3.3	29.5	8.5	2.6	0.1	11.8	12.3	2.8	10.2	0.1	0.1	2.7	4.2	0.0	5.3	2.5	3.7	3.3	0.5	4.0	8.1	7.2	0.4	5.4	0.3	3.4	0.4	2.8	18.4	16.8	5.8	14.0	15.7	16.2	20.7	11.2	15.3	13.6
FAM32A	"DKFZP586O0120, OTAG-12"	ENSG00000105058	"Family with sequence similarity 32 member A"	Q9Y421	19	16185380-16192046	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA051712	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA051712: "	"unprognostic (3.20e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.23e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.31e-2)"	"unprognostic (3.23e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.49e-3)"	37.2	42.9	56.2	34.0	37.6	53.1	43.9	33.4	56.2	29.0	39.9	18.7	33.1	50.5	37.2	35.1	41.2	30.9	35.4	32.5	51.6	35.7	39.8	54.9	31.7	35.5	34.9	45.9	30.3	32.5	25.1	24.8	51.1	41.5	30.4	38.8	18.6	34.6	33.4	52.0	42.7	56.7	35.2	45.8	43.2	40.4	24.1	34.3	32.8	33.5	29.8	37.5	40.3	38.9	27.9	41.5	94.9	65.7	27.6	32.2	51.5	29.1	22.4	35.3	22.7	41.7	32.1	33.4	28.4	32.3	35.1	38.8	30.7	35.4	19.4	49.7	36.6	22.6	36.0	31.0	31.0	25.5	39.6	36.0	20.2	27.2	33.8	45.2	42.3	37.1	32.6	28.1	25.9	37.8	28.1	28.7	34.6	38.8	34.9	47.3	50.7	55.5	36.9	24.4	32.0	38.4	29.3	30.5	46.3	24.0	22.9	30.4	19.5	51.8	35.1	27.4	16.2	49.9	35.5	34.3	56.6	30.6	39.8	55.1	23.6	41.0	47.8	94.9	24.7	60.1	26.1	27.9	23.7	26.7	41.5	27.8	28.8	31.4	41.0	27.6	65.7	28.5	32.2	51.5	56.2	37.6	33.4	56.2	51.6	35.7	34.9	45.9	41.5	34.3
FAM3A	"2-19, DXS560S, XAP-7"	ENSG00000071889	"Family with sequence similarity 3 member A"	P98173	X	154506159-154516242	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 42.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025016, HPA035268, HPA056991"	Uncertain		Approved	Nucleoplasm,Nucleoli	"Secreted - unknown location"			Nucleoli	Nucleoplasm	"CAB025016: , HPA035268: , HPA056991: "	"unprognostic (1.60e-1)"	"unprognostic (2.72e-2)"	"prognostic unfavourable (1.76e-4)"	"unprognostic (3.19e-2)"	"unprognostic (4.73e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.04e-1)"	"unprognostic (9.71e-2)"	18.9	18.9	18.9	14.7	20.9	13.7	17.3	13.4	25.7	22.3	21.2	31.1	16.3	37.0	18.2	16.2	19.3	19.1	25.3	31.4	21.3	18.7	19.8	28.5	16.1	16.7	23.0	16.4	29.1	35.5	18.2	22.1	21.0	18.5	20.6	9.9	17.3	29.4	34.7	33.4	15.3	33.7	14.4	25.4	18.4	23.6	10.7	16.8	13.5	28.8	16.1	12.2	16.9	16.9	8.0	13.3	21.2	11.5	8.5	13.3	8.9	16.3	15.8	4.0	13.3	12.0	6.1	11.2	8.4	5.8	5.8	6.9	7.2	10.0	10.7	42.8	14.0	12.0	6.2	7.4	1.4	8.7	8.4	4.2	13.8	5.1	18.9	2.8	6.7	7.5	6.7	12.0	8.4	4.0	7.9	7.9	6.6	17.1	5.1	12.1	1.7	19.9	6.4	4.0	29.3	6.3	6.8	7.9	6.0	3.8	9.4	13.8	7.1	4.3	4.5	7.8	4.7	21.1	11.3	30.3	16.6	13.0	14.4	7.3	7.9	21.2	9.9	12.5	13.3	11.5	12.9	6.2	8.2	9.3	9.9	8.0	10.2	11.9	5.0	8.5	9.5	13.3	8.5	8.9	18.9	20.9	13.4	25.7	21.3	18.7	23.0	16.4	18.5	16.8
FAM98C	FLJ44669	ENSG00000130244	"Family with sequence similarity 98 member C"	Q17RN3	19	38403135-38409088	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040930, HPA041730"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA040930: AB_10795484, HPA041730: AB_10804114"	"unprognostic (3.01e-2)"	"unprognostic (6.44e-3)"	"unprognostic (5.15e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.18e-1)"	"unprognostic (8.10e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavourable (8.51e-5)"	"unprognostic (2.82e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.37e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.96e-1)"	"prognostic favourable (5.53e-4)"	10.8	8.9	18.3	9.3	16.9	11.0	9.8	17.0	19.9	8.7	14.2	12.8	9.0	19.6	9.9	7.2	14.3	13.8	9.1	11.6	16.0	13.1	9.1	13.4	8.7	9.5	12.3	16.9	10.2	22.4	10.6	8.1	7.6	13.0	12.5	7.0	8.2	17.7	9.5	2.5	17.0	22.2	6.8	12.7	10.1	19.2	5.4	9.7	5.3	11.8	7.7	11.2	9.4	9.5	6.0	3.2	12.6	3.4	3.3	5.6	1.6	11.7	12.8	1.5	7.4	1.6	5.6	6.5	6.8	5.8	6.8	7.2	2.1	8.6	10.7	7.7	4.0	5.7	2.9	4.9	1.1	17.2	6.0	3.5	2.1	4.9	7.3	3.0	6.4	5.3	10.3	3.4	6.3	4.0	9.6	11.8	4.0	13.0	4.3	2.3	1.1	13.8	8.9	3.1	6.3	8.2	6.2	2.6	7.6	6.9	12.2	4.0	9.3	9.4	5.1	3.1	8.3	9.4	8.2	12.7	6.4	4.5	7.9	7.0	4.9	0.0	2.3	12.6	3.1	3.3	4.2	2.6	5.6	4.6	3.2	6.0	4.3	3.4	2.0	3.3	3.4	1.2	4.4	1.6	18.3	16.9	17.0	19.9	16.0	13.1	12.3	16.9	13.0	9.7
FANCD2	"FA-D2, FACD, FAD, FANCD"	ENSG00000144554	"Fanconi anemia complementation group D2"	Q9BXW9	3	10026414-10101930	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 24.4;testis: 23.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016117, HPA063742"	Approved		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"				Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB016117: AB_2278211, HPA063742: "	"unprognostic (3.25e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.08e-5)"	"unprognostic (2.96e-2)"	"unprognostic (1.59e-3)"	"prognostic unfavourable (5.00e-5)"	"unprognostic (1.23e-2)"	"unprognostic (9.14e-2)"	"unprognostic (4.41e-10)"	"unprognostic (9.11e-3)"	"unprognostic (3.99e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.89e-2)"	2.0	1.3	0.8	10.3	2.6	12.2	2.4	1.6	2.7	1.7	2.9	1.1	1.0	2.2	2.2	1.8	4.7	2.4	2.5	1.1	0.8	0.9	2.3	1.0	2.4	9.5	1.3	1.2	3.5	3.5	0.6	1.1	5.3	1.4	2.2	4.9	1.6	3.3	0.4	3.0	3.3	6.2	1.2	2.0	7.3	2.4	23.3	1.6	24.4	1.6	5.6	14.6	2.2	2.4	6.8	3.7	5.3	2.6	2.1	2.9	1.0	8.5	9.1	17.5	4.9	0.9	1.3	45.3	7.9	3.5	11.4	9.3	6.8	8.5	16.8	3.7	2.6	7.5	18.0	6.1	11.4	8.0	12.2	23.0	14.0	6.5	0.1	17.0	14.4	0.4	1.0	12.8	7.1	6.8	14.0	19.3	8.5	9.9	14.2	6.5	21.1	6.4	15.5	14.2	11.9	3.9	9.7	4.9	9.6	9.7	7.6	3.1	11.6	10.8	3.9	9.4	10.8	5.7	11.4	8.2	16.0	28.5	5.4	17.5	16.1	5.3	1.4	3.7	1.5	1.0	1.3	4.9	2.0	1.2	0.9	6.8	2.5	1.9	3.3	2.1	2.6	3.7	2.9	1.0	0.8	2.6	1.6	2.7	0.8	0.9	1.3	1.2	1.4	1.6
FANCG	"FAG, XRCC9"	ENSG00000221829	"Fanconi anemia complementation group G"	O15287	9	35073835-35080016	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008105, HPA045335"	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoli	"CAB008105: AB_2231542, HPA045335: "	"unprognostic (9.41e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.83e-3)"	"prognostic unfavourable (2.02e-4)"	"unprognostic (8.92e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.27e-3)"	"unprognostic (9.01e-2)"	"unprognostic (5.62e-2)"	"prognostic unfavourable (2.38e-7)"	"unprognostic (1.14e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.10e-1)"	5.8	5.0	4.4	7.1	6.5	14.9	7.5	13.9	8.5	6.2	5.9	5.3	8.4	6.7	6.8	3.2	9.2	8.6	4.7	5.9	7.6	4.0	5.2	4.5	5.1	9.9	8.7	4.4	9.2	17.0	6.7	4.8	7.6	6.6	7.0	5.5	3.5	8.7	9.7	2.9	8.9	6.5	6.4	4.2	8.6	5.8	8.9	7.6	25.6	9.3	4.8	9.2	6.8	6.9	6.8	4.8	8.9	2.5	8.8	9.2	3.4	15.7	19.5	14.3	13.2	3.2	5.1	12.0	11.1	8.0	21.8	20.9	9.3	9.9	15.6	7.7	3.5	9.7	11.9	10.2	8.3	18.2	7.2	11.1	20.9	5.7	0.9	11.3	12.9	4.2	2.0	19.0	8.6	11.1	7.3	21.0	10.9	14.0	19.1	15.5	14.9	15.1	19.8	16.9	11.0	5.1	6.7	6.9	12.6	7.3	10.4	4.1	13.5	8.1	6.7	10.3	20.7	13.2	14.9	5.7	10.8	9.4	9.2	8.4	14.1	8.9	0.8	7.7	7.4	2.5	6.5	6.8	6.1	5.7	2.2	6.5	4.8	5.0	1.3	8.8	2.3	4.8	9.2	3.4	4.4	6.5	13.9	8.5	7.6	4.0	8.7	4.4	6.6	7.6
FAR2	"FLJ10462, MLSTD1, SDR10E2"	ENSG00000064763	"Fatty acyl-CoA reductase 2"	Q96K12	12	29149103-29340980	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 25.8;HUVEC TERT2: 30.2;NB-4: 25.9;SK-BR-3: 31.9;TIME: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 23.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015884	Approved		Approved	"Nucleoli,Golgi apparatus"				"Golgi apparatus"	Nucleoli	"HPA015884: AB_1853998"	"unprognostic (6.32e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.33e-3)"	"unprognostic (2.41e-1)"	"unprognostic (4.13e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.11e-2)"	"unprognostic (6.37e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.92e-1)"	"prognostic unfavourable (4.93e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.22e-3)"	9.4	7.2	9.8	6.9	17.4	12.0	7.6	5.1	18.2	4.6	25.7	3.2	6.1	13.3	6.2	29.4	6.0	3.7	4.2	5.4	12.8	10.9	4.0	3.1	8.6	6.7	9.4	10.4	2.1	2.6	1.0	2.9	19.2	6.6	2.8	22.3	4.1	4.8	1.7	4.5	8.7	14.0	6.0	5.1	12.3	3.7	8.4	5.9	7.2	3.5	4.5	2.3	6.6	4.3	0.9	4.0	23.7	11.5	1.8	7.6	4.4	0.9	1.7	1.7	0.4	2.5	9.9	0.7	7.5	8.8	2.1	2.0	2.9	10.1	1.3	2.0	1.0	0.5	4.6	0.0	0.5	0.6	11.5	25.8	4.1	0.9	5.3	10.3	8.6	2.8	0.0	3.2	4.0	30.2	2.2	1.0	0.3	0.3	6.6	25.9	7.0	19.7	5.5	2.9	1.1	9.3	2.6	3.0	2.7	1.7	31.9	12.7	1.5	9.7	24.5	5.6	1.7	2.0	3.3	1.6	1.6	0.6	8.9	13.6	4.8	1.3	11.5	23.7	2.7	6.9	1.8	0.9	4.5	3.2	4.0	0.7	1.5	1.7	20.7	1.8	3.7	1.5	7.6	4.4	9.8	17.4	5.1	18.2	12.8	10.9	9.4	10.4	6.6	5.9
FAU	"asr1, FLJ22986, Fub1, Fubi, MNSFbeta, RPS30, S30"	ENSG00000149806	"FAU, ubiquitin like and ribosomal protein S30 fusion"	"P35544, P62861"	11	65120628-65122473	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA059015	Supported		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA059015: "	"unprognostic (1.81e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.06e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.45e-2)"	79.7	95.0	90.6	84.9	76.2	186.7	95.4	50.9	80.9	103.6	134.8	77.6	63.4	77.8	84.0	80.5	115.2	100.0	87.2	133.9	70.0	58.9	88.0	162.9	77.5	182.6	78.9	40.8	176.0	202.8	27.5	56.1	73.2	46.6	123.5	53.0	67.8	97.3	76.7	190.8	86.8	93.8	97.5	72.4	130.9	79.2	53.6	53.2	126.8	121.5	83.6	149.5	122.0	136.6	291.3	169.7	90.9	119.0	116.3	253.8	346.5	78.1	51.5	45.5	72.1	44.6	66.6	62.4	44.6	43.5	62.6	39.7	58.2	78.5	93.1	121.2	38.4	69.1	42.2	59.5	26.1	68.3	64.6	75.1	54.1	79.9	82.0	89.0	82.8	82.1	99.1	53.7	73.2	48.2	70.0	110.4	33.1	97.7	102.7	179.6	125.2	85.8	100.0	36.4	182.7	57.6	44.2	63.4	63.6	34.7	100.3	139.4	89.7	123.4	45.6	56.6	65.3	87.3	71.3	120.1	114.1	158.5	68.6	69.3	64.0	90.9	119.0	70.6	128.9	107.0	176.1	291.3	212.1	165.5	132.1	281.7	253.8	198.1	78.9	116.3	92.8	169.7	153.8	346.5	90.6	76.2	50.9	80.9	70.0	58.9	78.9	40.8	46.6	53.2
FBXL2	"FBL2, FBL3"	ENSG00000153558	"F-box and leucine rich repeat protein 2"	Q9UKC9	3	33277025-33403662	"Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Calmodulin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 9.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061783			Approved	"Nucleoplasm,Nucleoli,Plasma membrane"				"Plasma membrane"	"Nucleoplasm, Nucleoli"	"HPA061783: "	"unprognostic (5.73e-2)"	"unprognostic (4.47e-2)"	"unprognostic (7.92e-2)"	"unprognostic (7.21e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.06e-1)"	"prognostic favourable (3.35e-4)"	"unprognostic (3.30e-3)"	"unprognostic (9.72e-2)"	"unprognostic (4.28e-2)"	"unprognostic (5.90e-2)"	3.2	5.2	8.0	2.2	15.0	1.9	4.1	7.2	18.1	3.7	2.9	4.1	1.8	3.2	5.2	8.2	2.3	6.0	3.0	2.7	8.7	11.3	5.5	1.4	4.6	1.8	6.6	13.4	4.5	3.5	7.7	16.1	5.5	13.1	4.3	1.5	6.4	3.1	6.5	1.5	2.9	2.0	3.5	4.5	2.3	2.5	4.3	2.8	0.0	8.6	0.6	1.5	2.6	2.5	1.3	0.9	2.8	1.0	0.9	1.1	0.1	4.0	1.1	1.7	1.9	2.4	4.0	0.6	3.2	2.6	2.9	4.3	0.8	4.9	0.2	1.0	2.1	1.1	1.4	3.6	2.0	0.4	2.0	0.7	3.4	0.8	2.9	0.3	0.8	1.6	2.6	1.8	1.4	5.2	1.0	0.4	9.9	0.4	0.8	0.7	1.2	1.0	0.1	1.0	0.1	7.4	1.2	2.1	2.1	1.4	0.8	2.4	2.3	1.2	4.0	1.5	1.4	1.1	1.8	0.4	0.2	0.2	1.3	0.3	1.0	1.5	1.0	0.7	0.9	0.5	0.7	0.5	0.7	0.9	0.3	1.3	1.1	1.1	2.8	0.9	0.7	0.9	0.4	0.1	8.0	15.0	7.2	18.1	8.7	11.3	6.6	13.4	13.1	2.8
FBXL22	"Fbl22, FLJ39626"	ENSG00000197361	"F-box and leucine rich repeat protein 22"	Q6P050	15	63597353-63602428	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 65.9;smooth muscle: 68.0"	"Cell line enhanced"	"Detected in many"		"MCF7: 7.9;SCLC-21H: 9.0;U-937: 5.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA047624, HPA054627"	Uncertain		Uncertain	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA047624: , HPA054627: "	"unprognostic (2.17e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.28e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.90e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.02e-2)"	1.9	0.4	0.4	5.5	0.4	0.0	1.1	0.6	0.7	31.4	26.0	0.0	20.8	1.4	65.9	7.6	11.9	10.5	31.1	10.3	0.4	0.4	0.6	0.4	0.7	0.2	0.4	0.3	7.1	0.4	0.0	0.4	1.0	0.2	20.1	2.9	1.9	3.3	24.0	2.2	0.7	4.1	68.0	0.4	0.4	6.3	4.2	0.0	0.0	0.6	1.0	0.4	38.2	4.8	1.5	4.3	0.5	0.2	2.0	2.9	0.5	1.2	2.1	0.3	1.3	0.7	0.9	0.1	0.4	0.1	0.5	0.0	1.4	1.6	0.5	1.1	0.2	1.3	0.7	0.4	0.0	1.3	0.9	0.4	1.5	3.5	0.2	0.5	0.2	0.5	0.3	0.1	0.7	0.2	0.0	1.9	0.0	7.9	1.2	1.0	2.5	0.8	1.1	0.0	3.8	0.3	0.4	9.0	0.3	1.0	1.8	0.3	3.2	0.9	1.3	0.6	1.7	0.8	0.4	1.2	2.0	1.3	0.9	5.6	1.3	0.4	0.1	0.0	1.2	0.1	1.6	1.5	1.3	1.4	0.0	1.2	2.9	1.0	0.5	2.0	0.2	4.3	0.1	0.5	0.4	0.4	0.6	0.4	0.4	0.4	0.4	0.3	0.2	0.0
FBXO36	"Fbx36, FLJ37592"	ENSG00000153832	"F-box protein 36"	Q8NEA4	2	229922302-230013109	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053865			Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA053865: "	"unprognostic (4.39e-3)"	"unprognostic (6.51e-2)"	"unprognostic (2.38e-2)"	"prognostic favourable (2.28e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.79e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.68e-1)"	4.0	7.8	8.9	1.9	12.6	1.9	7.3	4.1	12.2	6.7	2.8	11.9	4.7	3.2	5.4	8.9	3.8	21.7	3.9	2.9	8.3	9.1	10.3	3.7	4.9	2.1	8.1	6.9	6.8	3.7	11.7	11.7	3.6	10.1	6.4	3.0	9.3	5.0	5.8	2.0	6.1	3.2	3.9	8.9	2.1	3.7	14.0	5.2	2.7	14.8	2.8	2.7	2.9	3.3	2.8	3.6	0.8	1.7	2.7	4.5	1.2	1.2	2.5	3.0	1.2	1.5	9.2	6.0	1.6	4.2	2.2	3.9	0.8	4.0	0.1	0.8	2.8	1.0	1.4	0.8	3.9	0.3	0.9	0.5	0.9	1.5	5.9	1.0	0.4	9.7	6.8	4.3	3.3	2.3	1.7	0.7	2.6	5.1	2.1	2.4	7.9	2.9	2.6	0.8	0.6	4.0	1.0	2.9	3.7	2.6	2.1	1.0	4.4	1.8	1.7	3.7	1.4	6.0	0.6	2.7	2.2	0.9	4.6	0.5	2.7	0.1	1.7	0.1	2.5	1.3	2.1	2.8	1.9	1.7	3.6	2.0	4.5	2.5	0.8	2.7	0.9	1.7	3.5	1.2	8.9	12.6	4.1	12.2	8.3	9.1	8.1	6.9	10.1	5.2
FBXW11	"BTRC2, BTRCP2, Fbw11, Fbw1b, FBXW1B, Hos, KIAA0696"	ENSG00000072803	"F-box and WD repeat domain containing 11"	Q9UKB1	5	171861549-172006873	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Host-virus interaction, Ubl conjugation pathway, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062578, HPA072204"	Approved		Approved	Nucleoli,Vesicles				Nucleoli	Vesicles	"HPA062578: , HPA072204: "	"unprognostic (4.04e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.87e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.14e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.76e-1)"	15.0	17.1	28.1	11.5	29.4	7.9	17.2	29.7	34.4	17.5	11.2	24.7	9.4	10.2	19.2	10.7	20.0	22.7	14.5	30.3	28.9	26.3	19.5	16.5	14.0	14.0	28.8	20.1	21.8	24.1	37.8	15.8	11.2	23.3	16.2	13.3	12.4	11.6	18.1	24.5	11.0	10.3	21.6	30.6	13.6	15.8	11.3	21.2	12.0	17.5	7.0	17.0	12.9	16.0	9.0	8.2	19.1	7.0	12.9	6.2	5.5	16.2	16.7	24.9	21.7	19.6	19.9	12.7	17.5	25.1	21.9	27.6	17.0	11.0	14.9	21.6	22.4	10.7	17.9	26.4	36.6	19.7	17.7	12.1	17.4	13.1	17.8	13.4	17.3	14.4	18.4	17.6	28.9	18.3	7.5	15.1	26.6	12.2	9.3	7.0	9.5	18.6	13.8	20.9	10.1	16.9	13.8	10.4	18.4	15.4	13.1	32.3	16.4	14.4	15.8	21.7	10.8	13.1	17.2	15.4	17.4	10.4	15.2	12.9	16.5	19.1	7.0	6.5	5.7	4.7	6.2	8.7	4.9	5.7	6.9	9.0	4.7	5.8	6.7	12.9	5.1	8.2	5.3	5.5	28.1	29.4	29.7	29.9	28.9	26.3	28.8	20.1	23.3	21.2
FEN1	"FEN-1, MF1, RAD2"	ENSG00000168496	"Flap structure-specific endonuclease 1"	P39748	11	61792637-61797244	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 36.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002262, HPA006748"	Enhanced		Enhanced	Nucleoplasm,Nucleoli			38000	Nucleoplasm	Nucleoli	"CAB002262: AB_563729, HPA006748: AB_1848494"	"unprognostic (1.82e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.45e-2)"	"prognostic unfavourable (3.39e-6)"	"unprognostic (1.50e-2)"	"unprognostic (9.82e-2)"	"prognostic favourable (7.85e-4)"	"unprognostic (2.82e-3)"	"unprognostic (5.86e-2)"	"prognostic unfavourable (5.73e-6)"	"prognostic favourable (9.46e-4)"	"unprognostic (1.10e-1)"	"unprognostic (4.49e-3)"	"unprognostic (4.04e-2)"	4.8	9.6	7.9	14.6	8.5	23.9	7.4	16.9	14.9	4.9	11.0	8.5	5.0	8.1	5.0	6.6	13.3	4.2	7.0	4.6	8.6	8.5	4.9	9.3	5.0	22.5	8.3	9.8	3.9	6.3	5.2	7.9	11.2	12.6	4.7	12.0	7.3	9.3	4.6	11.2	6.8	8.2	6.4	7.1	12.3	7.2	16.2	5.9	36.3	3.5	10.6	25.5	6.1	4.2	11.5	18.1	14.5	9.4	13.3	18.0	7.3	31.0	28.6	31.4	16.9	3.1	3.9	20.0	27.5	15.7	33.7	38.4	25.0	23.4	44.9	21.5	11.7	32.9	44.2	24.1	34.6	23.6	24.3	23.7	39.1	25.4	2.4	36.8	24.5	2.7	3.3	31.1	8.3	13.1	35.8	32.5	28.0	39.1	51.2	33.1	34.5	28.1	35.2	36.4	46.3	13.4	29.5	35.8	29.7	18.3	24.1	15.8	34.9	25.9	8.8	30.0	37.9	38.2	27.7	25.7	39.9	46.6	20.9	24.7	25.8	14.5	5.0	10.2	12.4	9.4	13.1	11.5	10.0	11.8	5.8	11.5	11.2	11.3	2.1	13.3	8.8	18.1	18.0	7.3	7.9	8.5	16.9	14.9	8.6	8.5	8.3	9.8	12.6	5.9
FEZ2		ENSG00000171055	"Fasciculation and elongation protein zeta 2"	Q9UHY8	2	36531805-36646087	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 13.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035978	Uncertain		Approved	"Nucleoli,Golgi apparatus,Cytosol"				Nucleoli	"Golgi apparatus, Cytosol"	"HPA035978: AB_10672235"	"unprognostic (1.42e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.94e-3)"	"prognostic unfavourable (7.79e-6)"	"unprognostic (1.09e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.65e-2)"	"unprognostic (7.82e-3)"	"unprognostic (7.07e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.82e-1)"	31.7	23.4	28.7	12.0	25.3	8.1	18.6	20.1	31.2	18.3	17.2	28.0	6.0	13.1	20.4	13.1	20.4	13.1	14.6	28.5	26.1	22.6	21.4	18.4	16.5	13.1	27.6	21.6	18.3	6.8	14.2	8.5	29.6	29.3	15.6	18.4	19.0	9.7	22.1	51.0	9.1	18.7	26.9	33.8	17.8	12.2	12.6	25.4	9.4	14.8	12.2	12.1	15.5	13.5	1.7	13.6	4.7	3.5	3.1	1.5	0.7	15.3	9.2	12.6	5.3	24.9	33.0	9.9	39.1	20.0	24.0	15.2	6.4	5.0	9.5	24.0	50.6	6.1	10.6	13.5	26.2	2.2	5.8	7.7	3.3	10.6	11.9	7.7	1.9	31.6	11.6	14.8	17.8	34.2	8.3	3.0	44.2	5.4	4.7	6.7	6.6	14.5	3.1	11.4	3.2	19.0	15.0	0.3	11.4	9.6	7.9	9.3	2.8	9.7	39.7	15.0	8.0	8.2	22.7	2.2	2.6	6.5	14.9	5.4	21.1	2.4	3.5	4.7	1.5	3.3	1.0	1.7	1.1	0.8	3.6	1.0	1.3	0.5	4.0	3.1	1.9	13.6	1.3	0.7	28.7	25.3	20.1	28.8	26.1	22.6	27.6	21.6	29.3	25.4
FGF7	KGF	ENSG00000140285	"Fibroblast growth factor 7"	P21781	15	49423096-49488775	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 23.7;ASC TERT1: 21.8;fHDF/TERT166: 9.8;HSkMC: 22.2;RH-30: 17.6;U-138 MG: 12.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	9	"cerebellum: 9.7"					HPA043605	Uncertain		Approved	Nucleoplasm,Nucleoli	"Secreted in other tissues"			"Nucleoplasm, Nucleoli"		"HPA043605: AB_10960215"	"unprognostic (4.65e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.56e-2)"	"unprognostic (7.30e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.22e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.63e-3)"	39.7	2.7	0.6	9.9	0.6	0.0	16.5	0.6	2.4	73.3	22.2	0.0	10.1	1.1	13.1	16.1	25.2	14.1	25.4	19.1	0.6	0.6	5.9	1.2	44.8	5.5	2.1	0.0	43.7	2.5	2.9	2.8	9.1	0.8	42.5	4.5	2.7	6.4	8.1	25.6	3.6	4.2	38.3	1.4	1.0	6.6	12.7	0.0	0.0	23.2	24.7	2.9	72.2	32.4	0.2	0.1	1.6	0.2	0.3	0.5	0.0	0.1	0.0	0.1	0.1	23.7	21.8	0.0	7.2	4.4	0.0	0.0	0.0	0.1	0.0	0.1	9.8	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	2.0	0.1	0.0	22.2	0.4	1.9	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.1	0.1	0.0	17.6	0.0	0.0	0.0	0.9	0.3	0.2	0.0	0.0	0.1	0.1	0.1	12.0	0.2	0.4	0.0	0.2	0.1	0.0	3.3	0.0	0.2	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.3	0.0	0.2	0.5	0.2	0.0	0.3	0.2	0.1	0.4	0.0	0.6	0.6	0.6	0.6	0.6	0.6	2.1	0.0	0.8	0.0
FKBP15	"FKBP133, KIAA0674, PPP1R76, WAFL"	ENSG00000119321	"FK506 binding protein 15"	Q5T1M5	9	113161006-113221361	"Predicted intracellular proteins"	"Endocytosis, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007979	Approved		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA007979: AB_1848615"	"unprognostic (2.81e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (4.92e-4)"	"unprognostic (3.44e-2)"	"unprognostic (5.62e-3)"	19.8	17.8	16.7	25.3	21.9	19.2	19.4	18.6	21.6	16.9	15.3	25.4	14.2	15.1	18.1	17.0	18.8	16.7	14.4	16.4	16.2	13.1	15.7	17.2	26.7	30.9	22.6	15.4	18.6	17.5	34.7	22.1	24.4	19.2	17.2	18.7	17.6	20.0	22.3	19.2	22.3	18.2	20.5	23.5	36.5	15.9	6.8	20.9	25.1	18.7	13.4	23.3	18.6	18.3	2.8	8.5	5.7	20.5	3.7	3.4	4.5	12.3	12.7	8.5	8.3	18.5	16.4	11.6	15.4	23.4	17.3	15.5	8.0	12.9	20.6	7.5	19.5	27.0	10.3	15.1	16.0	15.7	6.9	7.9	13.8	7.6	15.0	16.8	20.8	16.4	15.3	19.1	19.9	16.9	9.7	12.6	17.7	18.9	12.6	8.9	8.9	10.1	11.4	18.0	7.4	12.6	11.4	7.6	7.5	18.7	14.3	9.0	17.2	6.3	19.6	18.7	7.0	18.5	15.9	10.9	11.9	9.5	19.5	9.7	15.2	1.8	11.6	1.6	3.4	14.6	2.8	2.0	2.1	2.1	8.5	2.8	2.5	1.9	5.7	3.7	20.5	3.5	2.2	4.5	16.7	21.9	18.6	21.6	16.2	13.1	22.6	15.4	19.2	20.9
FOXI1	"FKHL10, FREAC6"	ENSG00000168269	"Forkhead box I1"	Q12951	5	170105897-170109725	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 37.0;salivary gland: 12.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.4;HaCaT: 1.4;MCF7: 5.3;SCLC-21H: 1.1"	"Group enriched"	"Detected in many"	7	"breast cancer: 5.8;renal cancer: 23.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	48	"eosinophil: 4.7"	"Lineage enriched"	"Detected in single"	48	"granulocytes: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071469	Enhanced		Uncertain	Nucleoli,Vesicles				"Nucleoli, Vesicles"		"HPA071469: "	"unprognostic (3.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.48e-2)"		"unprognostic (8.06e-2)"		"unprognostic (7.47e-2)"		"unprognostic (2.73e-1)"	"unprognostic (1.52e-2)"	"unprognostic (9.71e-3)"	"unprognostic (4.88e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.34e-2)"		"unprognostic (2.22e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.1	0.0	0.0	7.5	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	37.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	3.3	0.0	0.0	12.4	3.7	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.1	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	1.4	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FOXM1	"FKHL16, HFH-11, HNF-3, INS-1, MPHOSPH2, MPP2, TGT3, trident"	ENSG00000111206	"Forkhead box M1"	Q08050	12	2857681-2877155	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 47.5;testis: 40.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			CAB017832	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"CAB017832: "	"unprognostic (3.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavourable (1.95e-6)"	"prognostic unfavourable (2.92e-4)"	"unprognostic (1.01e-2)"	"unprognostic (3.25e-2)"	"prognostic unfavourable (3.03e-5)"	"unprognostic (6.09e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (2.80e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.94e-1)"	1.7	1.7	1.0	9.3	0.9	13.8	2.4	0.4	1.2	2.0	6.5	0.4	1.1	6.0	1.2	2.1	13.5	0.4	4.1	1.2	0.8	0.6	1.3	1.6	2.8	6.6	0.8	0.3	0.8	0.6	0.0	0.5	3.9	0.9	0.9	8.2	0.6	2.6	1.1	0.7	3.7	7.1	4.4	1.2	5.0	3.2	40.1	0.4	47.5	0.6	11.4	11.6	2.0	3.7	0.7	0.6	1.0	0.6	0.4	1.9	0.1	28.6	29.1	22.6	20.7	3.4	4.5	28.8	18.7	18.5	38.1	34.5	36.7	25.7	18.5	4.0	26.8	22.3	33.8	17.2	37.3	34.6	18.1	20.9	27.9	15.7	0.5	16.8	17.1	2.3	1.9	35.3	24.9	26.8	11.7	41.7	29.9	26.9	22.8	8.0	49.8	21.7	16.6	34.3	9.7	9.0	18.4	12.7	20.2	24.0	20.1	11.0	19.7	18.8	10.7	30.9	47.0	36.1	65.0	5.5	9.1	26.8	14.3	16.1	32.7	0.4	0.6	0.1	0.4	0.2	0.4	0.7	0.5	0.4	0.2	0.7	0.9	0.3	1.0	0.4	0.1	0.6	1.9	0.1	1.0	0.9	0.4	1.2	0.8	0.6	0.8	0.3	0.9	0.4
FP565260.1		ENSG00000275464			21	5130871-5154734	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"blood: 17.2"	"Cell line enhanced"	"Detected in many"		"HEL: 37.5"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA024573	Uncertain		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA024573: AB_1855963"	"unprognostic (3.37e-3)"	"unprognostic (4.09e-2)"	"unprognostic (4.43e-1)"	"unprognostic (9.66e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.30e-3)"	"unprognostic (8.40e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.34e-3)"	"unprognostic (1.74e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.11e-1)"	3.0	3.0	1.1	3.0	2.2	3.3	1.4	1.1	6.8	1.7	1.9	7.2	1.1	2.8	1.6	2.6	1.9	2.4	4.8	2.9	3.2		1.8	1.1	1.8	4.2	2.4	1.1	1.9	2.0	2.5	1.1	2.3	2.9	1.8	2.7	1.1	1.7	1.1	6.8	1.8	2.2	3.4	1.1	2.8	1.4	1.4	1.1	1.1	1.7	1.1	2.3	2.4	1.1	8.9	6.6	5.0	12.9	7.4	17.2	7.5	11.6	8.7	5.9	9.1	2.6	1.9	3.5	0.0	0.0	0.0	0.0	0.0	7.5	0.0	5.4	3.9	7.7	16.4	7.2	0.0	2.5	5.3	37.5	4.6	4.5	4.1	17.2	11.2	7.1	8.8	10.1	7.9	7.7	20.9	4.1	2.5	10.3	12.6	11.8	23.3	11.0	19.8	5.5	10.3	5.3	9.3	5.7	10.3	9.6	14.6	5.5	12.2	9.3	3.7	4.5	11.4	0.1	12.1	4.9	5.3	23.6	8.0	22.7	6.2	2.6	5.5	5.0	15.0	9.7	17.2	8.7	9.1	11.0	6.6	8.9	9.2	12.6	3.3	7.4	12.9	4.4	6.0	7.5										
FPR1	"FMLP, FPR"	ENSG00000171051	"Formyl peptide receptor 1"	P21462	19	51745172-51804110	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 213.3;lymphoid tissue: 64.4"	"Cell line enriched"	"Detected in some"	5	"U-87 MG: 34.2"	"Cancer enhanced"	"Detected in all"		"glioma: 23.0"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 213.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 213.3"	"Not detected"	"Not detected"							"HPA046550, HPA061744"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"				"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA046550: , HPA061744: "	"unprognostic (5.54e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.48e-3)"	"unprognostic (4.59e-2)"	"unprognostic (8.34e-2)"	"prognostic unfavourable (2.21e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.70e-3)"	22.6	3.7	5.2	52.2	12.4	54.5	2.9	1.1	6.3	2.6	2.4	5.9	0.0	1.1	2.3	2.3	3.3	8.4	9.6	11.2	15.7	4.3	6.0	7.5	28.8	58.4	15.5	0.8	1.9	3.5	0.8	2.3	13.0	9.7	1.8	1.2	2.4	2.4	0.9	3.2	1.1	2.2	12.8	14.3	64.4	3.2	2.9	10.1	0.9	2.7	0.7	3.2	7.9	4.6	0.0	8.9	213.3	36.3	0.0	0.0	16.9	0.3	0.5	0.2	0.3	0.4	1.1	0.3	0.2	0.0	0.3	1.0	0.2	0.3	0.6	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.6	2.7	0.2	0.4	2.4	0.1	0.8	0.8	0.0	0.1	0.3	6.9	0.5	0.1	0.2	0.2	0.4	0.2	0.4	0.0	0.6	0.3	0.1	0.2	0.4	0.0	0.3	0.6	0.6	0.5	1.1	0.2	0.0	1.6	0.1	0.0	0.3	34.2	0.8	0.1	13.0	36.3	10.0	0.0	15.9	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	213.3	0.0	9.5	0.3	0.0	16.9	5.2	12.4	1.1	6.3	15.7	4.3	15.5	0.8	9.7	10.1
FRMD8	"FKSG44, FLJ90369"	ENSG00000126391	"FERM domain containing 8"	Q9BZ67	11	65386599-65413525	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"WM-115: 52.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002861, HPA005506"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA002861: AB_1078878, HPA005506: "	"unprognostic (1.54e-1)"	"unprognostic (4.07e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (9.94e-5)"	"unprognostic (9.12e-3)"	"unprognostic (1.51e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.90e-2)"	"unprognostic (6.41e-3)"	"unprognostic (4.19e-3)"	"unprognostic (1.47e-2)"	"unprognostic (7.36e-3)"	"unprognostic (3.34e-1)"	"unprognostic (2.91e-2)"	14.6	11.9	7.8	18.5	12.1	13.1	15.2	8.9	10.3	12.5	15.1	11.4	6.9	13.6	10.5	12.2	23.9	14.6	17.4	10.0	8.0	5.4	10.5	12.0	15.1	17.3	17.0	8.5	8.9	20.9	5.7	8.2	12.2	11.7	10.7	8.2	7.8	18.6	10.9	12.0	24.3	16.5	8.1	8.9	29.0	11.7	11.3	14.6	16.6	12.4	16.6	21.8	11.0	18.1	10.9	11.4	19.7	14.9	6.5	14.3	9.0	6.8	8.8	3.6	8.3	9.6	5.1	6.3	7.7	7.3	6.7	5.3	8.4	11.5	8.5	16.8	11.0	12.1	4.5	6.8	2.9	14.1	4.1	11.7	8.0	4.6	5.2	6.5	18.3	6.3	5.4	6.4	3.4	10.8	9.7	9.5	7.4	9.3	9.9	9.6	3.9	11.5	13.2	6.6	9.6	5.5	8.6	7.6	5.3	6.0	24.4	18.6	8.9	5.4	9.4	7.6	7.9	10.2	4.8	16.4	8.4	8.0	6.6	4.1	52.2	0.8	9.7	13.4	11.5	11.0	12.7	10.9	8.4	14.3	9.1	9.2	7.8	8.4	19.7	6.5	14.9	11.4	8.9	9.0	7.8	12.1	8.9	10.3	8.0	5.4	17.0	8.5	11.7	14.6
FTSJ3	SPB1	ENSG00000108592	"FtsJ RNA methyltransferase homolog 3"	Q8IY81	17	63819433-63830012	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055544, HPA062628"	Supported		Enhanced	Nucleoli				Nucleoli		"HPA055544: , HPA062628: "	"unprognostic (1.33e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.60e-2)"	"unprognostic (7.82e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavourable (1.44e-5)"	"unprognostic (1.27e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.10e-1)"	"unprognostic (3.43e-1)"	20.1	19.9	14.2	15.8	18.2	12.5	16.4	13.6	15.2	17.5	17.4	22.4	25.0	12.9	22.7	19.4	17.6	17.3	16.8	19.2	14.8	9.2	24.4	24.9	13.9	17.5	18.9	9.5	22.3	14.6	30.6	13.3	15.4	16.2	19.3	17.1	17.4	16.5	18.1	25.1	21.2	16.2	21.5	17.7	19.8	16.5	13.0	17.8	31.1	22.4	19.7	26.0	18.0	16.8	9.8	13.3	6.5	12.8	12.3	15.1	9.0	20.3	32.2	12.5	17.7	20.1	17.3	19.4	20.4	15.0	23.5	18.7	26.8	13.7	27.3	8.4	12.0	14.2	23.3	19.5	30.3	4.7	23.2	24.5	22.9	24.9	14.7	30.9	17.9	12.2	15.4	36.4	17.6	19.5	24.3	11.2	15.6	34.4	27.2	10.1	33.6	32.9	24.3	34.3	19.1	15.4	18.6	11.6	45.3	24.1	20.6	13.9	19.5	10.4	17.5	17.5	24.6	19.5	37.8	27.1	38.1	27.2	15.7	20.6	16.9	4.5	10.8	6.5	11.4	12.8	15.1	9.8	12.2	14.9	13.3	9.8	9.8	12.0	2.4	12.3	9.2	10.1	14.2	9.0	14.2	18.2	13.6	15.2	14.8	9.2	18.9	9.5	16.2	17.8
FXYD1	PLM	ENSG00000266964	"FXYD domain containing ion transport regulator 1"	O00168	19	35138808-35143109	"Predicted membrane proteins"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 134.1;liver: 137.1;skeletal muscle: 299.8"	"Cell line enhanced"	"Detected in some"		"ASC diff: 30.3;ASC TERT1: 8.8;HSkMC: 12.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 8.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 11.7"	"Group enriched"	"Detected in many"	5	"B-cells: 11.7;T-cells: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026873			Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Cytosol"	Nucleoli	"HPA026873: AB_1855471"	"unprognostic (5.58e-3)"	"unprognostic (6.60e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavourable (6.91e-4)"	"unprognostic (1.54e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.54e-3)"	"unprognostic (8.13e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavourable (7.59e-8)"	"unprognostic (9.97e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.92e-2)"	28.2	8.1	35.7	5.2	40.7	2.0	21.8	16.8	34.7	46.5	16.9	25.5	7.1	5.0	26.3	17.9	18.8	31.1	14.8	134.1	23.8	19.9	4.5	137.1	14.1	3.0	36.1	23.7	34.0	6.2	2.1	4.3	8.6	21.5	21.6	7.9	14.1	6.4	20.7	299.8	5.8	7.5	27.7	19.0	6.2	8.4	7.5	14.8	0.0	3.9	29.0	3.5	12.7	23.7	11.7	0.7	1.2	0.7	2.0	7.1	0.7	0.7	0.0	0.0	0.1	30.3	8.8	0.8	3.6	0.1	0.0	0.0	0.0	0.2	2.4	0.9	0.0	0.6	0.7	0.4	0.0	2.1	0.8	0.4	0.0	1.1	3.5	0.2	0.2	12.5	0.0	0.1	0.3	0.1	0.6	2.5	0.1	0.0	0.0	0.5	0.1	0.4	0.0	0.1	0.6	0.0	0.0	0.2	0.1	0.4	0.1	1.0	0.1	3.9	0.3	0.0	0.4	0.3	0.0	0.0	0.0	0.2	0.6	0.4	5.0	1.2	0.3	0.0	1.4	0.7	0.9	11.7	4.1	1.7	0.3	6.6	0.8	1.0	0.6	2.0	0.7	0.7	7.1	0.7	35.7	40.7	16.8	34.7	23.8	19.9	36.1	23.7	21.5	14.8
GALNT17	"GalNAc-T17, GalNAc-T19, GalNAc-T5L, GALNTL3, ppGalNAc-T17, WBSCR17"	ENSG00000185274	"Polypeptide N-acetylgalactosaminyltransferase 17"	Q6IS24	7	71132169-71713600	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.9"	"Cell line enhanced"	"Detected in some"		"AF22: 9.5;NTERA-2: 7.2;RPMI-8226: 7.9;SK-BR-3: 30.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA013624, HPA047986"	Approved		Uncertain	"Nucleoplasm,Nucleoli,Nuclear bodies,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"	"Nucleoli, Nuclear bodies"	"HPA013624: AB_1858787, HPA047986: "	"unprognostic (2.79e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.62e-1)"	"unprognostic (6.41e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.00e-1)"	"prognostic favourable (4.60e-4)"	"unprognostic (2.00e-1)"	"unprognostic (4.73e-1)"	"unprognostic (1.96e-2)"	"unprognostic (9.63e-3)"	"prognostic favourable (3.91e-4)"	"unprognostic (1.92e-1)"	"unprognostic (7.94e-3)"	1.8	7.8	8.2	2.1	13.9	0.5	1.2	25.7	42.9	2.3	4.9	1.7	1.9	0.8	7.9	4.6	8.9	4.4	2.7	19.4	13.2	4.6	2.3	0.6	3.5	0.5	2.1	12.0	22.3	9.4	0.6	4.1	0.7	4.5	9.1	1.4	1.2	1.7	8.3	1.9	0.8	1.5	12.3	1.2	3.3	1.1	3.8	0.8	0.3	9.4	0.0	1.8	10.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	7.9	0.0	0.0	0.5	0.0	0.0	30.4	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	13.9	25.7	22.5	13.2	4.6	2.1	12.0	4.5	0.8
GALNT5	GalNAc-T5	ENSG00000136542	"Polypeptide N-acetylgalactosaminyltransferase 5"	Q7Z7M9	2	157257598-157314211	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.2"	"Cell line enhanced"	"Detected in some"		"A-431: 23.1;BJ: 15.2;BJ hTERT+: 27.2;fHDF/TERT166: 31.7;HaCaT: 27.1;K-562: 15.7;LHCN-M2: 27.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	6	"cerebellum: 28.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA008963, HPA009035"	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles,Cytosol"			630000	"Nucleoli, Golgi apparatus, Cytosol"	Vesicles	"HPA008963: AB_1078942, HPA009035: AB_1078943"	"unprognostic (6.34e-3)"	"unprognostic (9.31e-2)"	"unprognostic (2.11e-2)"	"unprognostic (9.89e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.63e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.93e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.48e-3)"	0.4	0.2	0.2	1.5	0.2	0.5	1.1	28.2	0.2	7.5	12.0	0.7	0.0	2.3	0.5	0.5	9.0	0.2	17.1	0.9	0.4	0.2	0.3	0.2	15.5	0.0	0.2	0.0	0.3	1.5	0.0	6.8	0.1	4.4	1.6	16.1	0.3	18.9	0.2	0.2	0.5	8.4	0.8	0.3	0.3	15.2	0.5	0.0	0.1	0.3	12.2	11.7	2.3	6.6	0.2	0.1	0.2	0.1	0.1	0.5	0.0	23.1	2.5	0.0	0.0	1.0	8.1	0.0	15.2	27.2	0.2	0.6	1.0	13.4	0.0	0.0	31.7	27.1	0.4	5.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.1	0.0	0.5	0.0	15.7	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.1	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.5	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.2	0.2	28.2	0.2	0.4	0.2	0.2	0.0	4.4	0.0
GAS2		ENSG00000148935	"Growth arrest specific 2"	O43903	11	22625642-22813055	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell shape, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 37.2;lymphoid tissue: 19.6;pancreas: 22.7"	"Group enriched"	"Detected in some"	10	"Hep G2: 19.6;Karpas-707: 40.2;SCLC-21H: 11.7;U-266/84: 13.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.0"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058904	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Nucleoli"	"HPA058904: "	"unprognostic (5.48e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.30e-5)"	"prognostic favourable (6.13e-4)"	"unprognostic (5.85e-2)"	"unprognostic (4.22e-2)"	"unprognostic (7.94e-2)"	"unprognostic (3.58e-2)"	0.7	1.1	2.1	1.1	3.6	0.4	0.9	0.9	2.2	1.2	0.7	1.4	1.2	2.0	1.1	1.3	1.0	1.5	2.7	3.6	2.1	2.5	5.3	37.2	1.3	1.1	4.3	1.2	2.3	22.7	0.5	4.8	0.7	4.5	1.3	0.7	0.5	2.2	0.9	4.8	1.0	1.8	0.6	8.6	1.5	2.6	1.1	3.2	19.6	1.1	3.0	1.0	1.8	0.7	1.0	0.6	0.3	0.0	0.1	1.7	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.2	0.1	0.0	19.6	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	40.2	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.2	2.0	0.0	0.5	11.7	0.6	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.2	0.5	0.0	0.5	13.4	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.2	0.0	1.7	1.0	0.4	0.0	0.0	0.9	1.6	0.4	0.0	0.1	0.0	0.6	0.3	0.1	2.1	3.6	0.9	2.2	2.1	2.5	4.3	1.2	4.5	3.2
GCLC	"GCS, GLCL, GLCLC"	ENSG00000001084	"Glutamate-cysteine ligase catalytic subunit"	P48506	6	53497341-53616970	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glutathione biosynthesis"	Ligase	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.2"	"Cell line enhanced"	"Detected in all"		"A549: 54.7;Hep G2: 46.7;RT4: 50.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009569, HPA036359, HPA036360"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol			3600000	Nucleoplasm	"Nucleoli, Cytosol"	"CAB009569: AB_675582, HPA036359: AB_10672243, HPA036360: AB_10669789"	"unprognostic (8.41e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.60e-1)"	"unprognostic (7.50e-2)"	"unprognostic (9.94e-3)"	"unprognostic (4.67e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.23e-2)"	"prognostic favourable (3.83e-6)"	"unprognostic (3.78e-2)"	"unprognostic (8.91e-2)"	"prognostic unfavourable (8.24e-4)"	"unprognostic (2.30e-2)"	15.8	11.1	12.9	9.0	16.0	14.4	13.0	5.4	15.1	6.8	16.2	21.6	8.2	18.9	9.2	5.3	20.0	29.1	14.9	7.4	13.1	10.6	15.4	69.2	12.9	10.1	21.6	12.2	6.2	12.4	6.6	5.4	6.2	13.0	13.0	12.2	5.2	11.2	10.1	7.0	8.6	14.8	11.9	13.6	16.8	14.8	5.2	17.5	3.1	14.1	32.4	10.6	34.4	12.3	1.6	4.2	2.2	1.9	8.0	2.3	0.6	8.1	54.7	4.5	10.6	5.4	2.4	6.0	4.1	6.7	3.1	3.7	8.0	19.0	15.5	7.9	3.7	11.6	13.7	30.1	4.2	12.2	8.4	10.4	10.6	46.7	6.2	13.6	6.4	3.8	12.8	3.5	15.7	4.7	5.7	4.9	1.5	8.6	11.7	5.4	8.3	5.1	3.9	2.7	13.7	10.1	50.4	13.0	6.4	6.9	11.1	7.2	7.6	6.5	6.5	2.8	9.8	7.1	6.1	6.6	10.1	9.0	7.0	9.8	4.7	2.2	1.1	0.6	1.2	1.9	0.8	1.6	1.0	2.3	4.2	1.0	0.6	1.3	0.5	8.0	1.8	3.0	1.6	0.6	12.9	16.0	5.4	11.9	13.1	10.6	21.6	12.2	13.0	17.5
GDE1	MIR16	ENSG00000006007	"Glycerophosphodiester phosphodiesterase 1"	Q9NZC3	16	19501689-19522145	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074747			Approved	Nucleoplasm,Nucleoli,Vesicles				Nucleoli	"Nucleoplasm, Vesicles"	"HPA074747: "	"unprognostic (1.69e-1)"	"unprognostic (5.13e-2)"	"prognostic favourable (3.12e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavourable (7.52e-5)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.60e-3)"	"unprognostic (9.92e-2)"	"prognostic favourable (3.12e-5)"	"unprognostic (8.36e-2)"	"unprognostic (9.69e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.36e-2)"	20.3	18.5	30.6	11.7	34.3	17.5	23.9	13.5	32.2	18.1	31.0	24.5	23.0	22.7	15.0	22.6	19.0	13.4	17.5	40.7	31.1	17.5	21.1	21.3	22.1	13.1	29.2	20.6	9.9	28.3	35.3	13.9	15.5	20.8	21.4	32.5	12.5	20.4	24.9	42.4	18.5	20.8	27.2	25.3	10.1	22.8	14.8	23.8	9.6	17.9	21.7	12.7	22.8	12.4	4.6	7.4	23.9	12.4	3.7	7.4	4.6	14.6	17.6	9.7	11.5	46.8	17.4	13.9	15.1	26.0	11.8	14.7	10.0	26.2	11.0	19.5	22.0	12.7	13.5	17.8	14.4	11.9	20.8	9.2	17.3	21.6	28.4	12.1	8.6	18.3	28.9	12.6	14.8	15.8	5.1	11.4	12.8	26.4	10.5	11.2	11.3	13.7	15.2	17.8	15.9	29.2	22.5	11.3	10.3	14.7	17.6	13.9	18.0	14.5	16.6	10.0	9.0	13.2	9.2	10.7	10.1	7.6	15.4	18.0	8.9	23.9	11.8	6.4	5.7	10.5	7.3	4.6	6.8	6.6	7.4	3.7	3.6	5.7	19.8	3.7	12.4	4.6	7.4	4.6	30.6	34.3	13.5	32.2	31.1	17.5	29.2	20.6	20.8	23.8
GEMIN2	SIP1	ENSG00000092208	"Gem nuclear organelle associated protein 2"	O14893	14	39114223-39136973	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015426, HPA046570, HPA057114"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"	Nucleoli	"CAB015426: AB_629517, HPA046570: , HPA057114: "	"unprognostic (4.53e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.07e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavourable (3.88e-6)"	"unprognostic (8.62e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.99e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.78e-2)"	10.0	8.2	13.2	8.1	16.9	15.2	13.3	15.7	15.2	10.1	9.5	10.9	5.2	11.4	9.3	12.5	10.2	9.9	7.2	12.4	13.8	10.1	8.2	9.2	9.1	14.1	11.0	13.8	11.3	8.5	4.3	16.1	9.0	13.4	8.4	10.9	8.9	7.7	7.7	18.9	10.4	8.0	12.6	12.4	9.5	8.4	13.2	12.8	11.9	9.8	9.9	13.3	11.3	9.6	17.1	15.8	8.9	12.6	11.6	15.5	8.7	11.4	16.5	16.3	11.9	5.7	6.7	8.4	5.5	4.4	14.7	14.7	14.4	13.6	17.0	11.5	4.7	8.8	21.8	9.3	15.5	8.7	12.7	9.9	10.1	35.8	11.7	15.0	6.5	3.6	8.9	9.3	13.4	12.8	11.8	12.5	8.2	22.8	16.4	14.5	11.4	18.6	15.4	17.8	10.7	8.2	7.6	16.0	3.2	11.5	8.9	6.0	20.3	6.6	5.2	6.8	10.1	6.6	8.9	13.1	20.3	24.9	3.3	16.0	9.5	8.1	12.3	8.9	14.3	12.6	10.1	15.4	13.2	14.0	15.6	17.1	14.9	15.5	3.4	11.6	10.4	15.8	11.4	8.7	13.2	16.9	15.7	15.2	13.8	10.1	11.0	13.8	13.4	12.8
GET4	"C7orf20, CEE, CGI-20, H_NH1244M04.5, TRC35"	ENSG00000239857	"Golgi to ER traffic protein 4"	Q7L5D6	7	876552-896436	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019765	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Cytosol"	Nucleoli	"HPA019765: AB_1845750"	"unprognostic (2.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.66e-4)"	"unprognostic (9.86e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.93e-2)"	"unprognostic (9.47e-2)"	13.7	39.8	22.4	14.8	21.4	28.5	15.3	22.1	23.5	10.3	15.5	20.9	19.0	21.8	12.3	23.8	18.8	14.6	12.8	18.7	16.4	15.4	27.8	37.5	12.2	15.1	22.9	21.5	16.5	32.6	11.3	32.9	21.7	18.9	16.8	9.9	15.2	25.0	21.9	53.7	29.7	20.9	12.6	18.9	16.9	22.2	32.0	22.7	12.5	16.0	21.8	12.5	14.3	17.3	23.3	31.5	28.9	30.7	24.9	27.3	21.9	26.0	12.8	9.0	13.3	4.6	3.2	28.5	7.3	5.1	9.3	9.3	34.9	32.6	9.6	7.6	4.1	16.6	10.1	7.9	4.0	3.9	17.3	5.3	10.1	19.7	10.3	9.0	9.8	4.9	9.5	8.1	5.3	7.3	34.1	8.9	5.2	19.8	6.8	21.7	32.3	19.3	14.4	1.5	10.3	8.2	15.4	16.3	17.6	6.7	24.6	10.5	18.7	16.0	7.3	6.9	15.4	15.8	9.9	13.5	8.4	12.4	7.1	15.5	17.3	16.8	27.4	28.9	24.2	24.7	23.7	23.3	26.5	24.0	27.7	23.2	26.0	27.3	21.1	24.9	30.7	31.5	24.5	21.9	22.4	21.4	22.1	23.5	16.4	15.4	22.9	21.5	18.9	22.7
GFPT1	"GFA, GFAT, GFAT1, GFPT"	ENSG00000198380	"Glutamine--fructose-6-phosphate transaminase 1"	Q06210	2	69319769-69387254	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms"	"Aminotransferase, Transferase"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047240			Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA047240: "	"unprognostic (4.38e-3)"	"unprognostic (8.20e-2)"	"prognostic favourable (7.13e-5)"	"unprognostic (2.97e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.14e-1)"	"unprognostic (4.84e-2)"	"unprognostic (5.00e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.58e-1)"	16.7	11.4	6.4	12.7	7.8	5.6	18.3	7.8	10.1	16.8	27.0	6.4	41.2	14.5	10.1	18.7	11.6	9.5	19.4	11.3	6.0	9.8	17.8	49.1	14.1	4.7	6.5	5.7	11.1	34.9	13.9	39.6	36.5	7.0	17.2	27.5	7.7	39.7	34.0	9.2	6.1	28.2	8.7	6.2	8.2	24.6	13.9	4.8	8.5	35.2	7.7	18.1	10.6	16.2	5.6	4.1	5.9	3.4	4.1	6.8	3.0	9.5	6.6	8.5	5.3	24.0	16.5	18.5	18.2	17.0	8.6	11.0	21.2	8.7	8.6	6.7	16.9	4.6	10.7	5.6	14.3	7.8	4.1	10.0	4.9	21.8	28.4	6.8	4.0	10.4	27.3	16.7	32.0	8.0	8.3	14.0	16.8	5.6	7.2	7.1	11.1	5.5	7.2	17.8	4.4	14.0	7.6	5.3	3.0	6.8	12.6	24.4	5.0	4.3	12.2	7.7	10.3	13.2	8.7	10.0	6.7	6.5	12.5	4.6	8.8	5.9	2.8	3.4	6.8	3.2	6.5	5.6	6.1	6.6	3.6	3.4	6.1	5.6	1.3	4.1	3.4	4.1	4.3	3.0	6.4	7.8	7.8	10.1	6.0	9.8	6.5	5.7	7.0	4.8
GIN1	"FLJ20125, GIN-1, TGIN1, ZH2C2"	ENSG00000145723	"Gypsy retrotransposon integrase 1"	Q9NXP7	5	103086000-103120151	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037402, HPA061362"	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA037402: AB_10672790, HPA061362: "	"unprognostic (3.89e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.02e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.01e-2)"	"unprognostic (9.60e-3)"	"unprognostic (1.20e-1)"	"prognostic favourable (1.63e-4)"	"unprognostic (1.89e-1)"	"unprognostic (4.39e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.08e-2)"	6.0	9.3	5.0	5.7	9.5	1.4	8.0	15.0	9.6	9.0	7.0	6.5	6.1	4.9	7.0	5.6	7.2	6.4	3.7	12.7	5.8	5.1	7.9	8.3	5.6	6.6	14.0	4.2	11.0	6.0	8.4	17.4	5.1	9.4	8.3	6.7	3.6	6.1	7.6	14.6	4.5	5.9	5.8	11.4	6.9	6.3	9.3	10.8	8.6	9.1	6.1	6.7	9.4	9.5	4.6	3.3	4.8	7.1	3.7	8.3	2.8	5.4	5.8	7.4	5.4	3.5	9.1	6.0	7.3	5.0	5.5	4.9	3.5	7.0	3.3	6.9	2.8	6.4	6.9	10.2	7.4	4.1	5.5	4.7	5.7	3.9	7.3	4.2	3.1	3.6	11.4	5.0	10.3	4.3	4.2	4.8	8.6	3.9	5.8	2.8	6.3	9.2	5.2	8.5	8.4	7.2	4.5	6.0	4.4	4.8	4.0	6.9	11.8	6.4	3.5	5.6	3.4	6.0	5.5	5.8	4.7	4.7	7.1	6.7	4.5	0.4	2.7	4.8	3.4	3.4	3.9	4.6	4.6	5.0	3.3	3.8	5.6	5.6	3.8	3.7	7.1	3.2	8.3	2.8	5.0	9.5	15.0	9.6	5.8	5.1	14.0	4.2	9.4	10.8
GJC1	"CX45, GJA7"	ENSG00000182963	"Gap junction protein gamma 1"	P36383	17	44798448-44830816	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071788			Uncertain	"Nucleoli,Cell Junctions,Cytosol"				"Nucleoli, Cytosol"	"Cell Junctions"	"HPA071788: "	"unprognostic (1.84e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.02e-2)"	"unprognostic (4.01e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (3.55e-8)"	"unprognostic (5.18e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.52e-2)"	"prognostic unfavourable (7.83e-4)"	7.3	0.8	2.2	4.1	3.4	1.0	4.7	8.2	4.2	14.8	23.0	2.8	7.0	1.6	24.2	3.1	3.2	5.0	5.4	10.0	3.3	1.8	1.5	0.9	6.5	2.3	2.5	4.0	2.2	1.3	2.6	0.7	28.5	3.4	8.2	2.8	3.7	1.7	17.0	5.4	1.9	4.8	27.5	2.2	0.9	7.8	8.0	2.9	1.4	5.3	2.9	1.7	12.6	10.4	1.2	1.0	4.7	1.0	1.9	1.0	0.4	17.6	9.1	23.0	7.9	3.0	4.7	9.0	19.6	15.5	21.1	22.7	5.3	9.8	0.1	1.0	18.3	4.6	11.9	6.1	29.8	0.1	8.9	0.1	4.9	0.6	1.9	0.1	0.8	3.3	0.6	16.1	5.3	7.2	0.8	0.2	12.2	0.1	2.8	1.8	10.3	7.8	16.7	29.2	0.1	5.1	7.4	4.4	10.0	2.2	0.1	6.6	4.8	2.8	6.0	18.7	18.1	8.5	16.6	0.1	4.6	13.1	6.5	0.1	17.5	4.7	1.0	1.1	0.9	0.6	0.8	0.9	0.7	0.6	0.3	1.2	0.9	1.0	3.9	1.9	0.7	1.0	0.6	0.4	2.2	3.4	8.2	4.2	3.3	1.8	2.5	4.0	3.4	2.9
GLCCI1	"FAM117C, GIG18, TSSN1"	ENSG00000106415	"Glucocorticoid induced 1"	Q86VQ1	7	7968794-8094272	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 55.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 17.4;U-266/70: 40.5;U-698: 18.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001674, HPA005987"	Approved		Approved	Nucleoli				Nucleoli		"HPA001674: AB_1078971, HPA005987: AB_1078970"	"unprognostic (6.12e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.02e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.68e-3)"	"unprognostic (3.57e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.17e-3)"	"unprognostic (3.35e-1)"	"unprognostic (9.30e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.09e-1)"	"unprognostic (9.20e-3)"	4.6	4.3	5.6	19.1	12.5	7.6	4.1	26.6	8.0	5.4	4.9	3.4	0.9	5.7	3.4	1.8	3.0	2.8	3.9	2.2	3.7	4.1	3.9	3.8	18.4	13.8	3.1	5.6	5.1	2.3	8.0	6.5	9.3	4.4	3.2	4.7	3.1	6.3	2.0	3.0	7.5	5.6	2.5	3.2	9.2	6.4	14.2	3.7	55.7	20.7	1.9	15.9	7.7	3.3	3.1	2.4	3.7	0.4	4.7	4.5	0.7	2.3	0.3	3.9	0.9	1.2	1.7	0.8	2.0	2.8	1.2	1.1	1.2	0.8	6.4	0.5	1.6	0.4	3.5	1.0	1.5	3.2	2.7	1.9	4.9	0.8	1.9	3.0	2.8	0.8	1.3	0.7	2.6	1.0	6.9	17.4	2.0	1.3	1.3	3.0	9.6	2.3	6.8	2.9	3.4	1.1	2.7	6.4	12.6	3.0	3.8	0.2	4.5	7.8	0.8	2.2	0.9	1.9	1.0	40.5	12.9	18.3	2.3	3.2	1.6	3.7	0.1	1.5	2.7	0.4	2.5	1.8	2.8	2.0	0.1	3.1	1.6	1.8	1.2	4.7	0.1	2.4	4.5	0.7	5.6	12.5	26.6	8.0	3.7	4.1	3.1	5.6	4.4	3.7
GLE1	"GLE1L, hGLE1, LCCS1"	ENSG00000119392	"GLE1, RNA export mediator"	Q53GS7	9	128504700-128542288	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041689, HPA043538, HPA061560"	Supported		Supported	"Nuclear membrane,Nucleoli"				"Nuclear membrane"	Nucleoli	"HPA041689: , HPA043538: , HPA061560: "	"unprognostic (8.74e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.17e-1)"	"prognostic favourable (7.49e-4)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.00e-2)"	"prognostic favourable (7.04e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.99e-3)"	"unprognostic (5.64e-2)"	12.5	17.0	11.1	13.5	13.2	12.2	14.7	22.1	13.8	13.1	15.7	16.5	17.6	14.6	13.8	11.4	18.5	13.5	12.6	13.2	10.5	8.9	13.1	20.4	11.3	23.0	11.2	9.9	15.7	21.1	20.8	16.3	16.4	10.6	13.4	17.2	13.1	13.6	16.7	23.3	18.3	14.9	12.0	9.8	17.5	12.1	42.8	11.8	27.2	12.4	14.6	20.0	14.3	13.5	16.0	19.2	26.2	22.5	22.6	20.5	15.8	10.8	20.4	10.0	17.0	9.9	10.1	13.3	11.0	9.4	15.4	11.0	13.6	7.6	22.0	8.9	12.3	38.3	17.3	15.6	13.4	20.8	11.3	11.2	22.4	12.7	11.2	18.1	14.9	7.1	15.2	17.5	18.8	8.7	16.1	19.4	17.7	25.1	17.8	12.8	8.4	17.7	18.3	24.6	29.0	10.4	9.7	11.9	8.9	26.8	16.2	9.6	30.0	12.8	6.3	16.4	11.0	19.2	15.2	19.6	47.0	17.2	15.4	13.9	17.7	26.2	18.1	20.3	20.5	22.5	16.7	12.0	16.0	18.1	19.2	16.0	14.4	16.6	15.4	22.6	22.0	11.4	18.3	15.8	11.1	13.2	22.1	13.8	10.5	8.9	11.2	9.9	10.6	11.8
GLI2	"HPE9, THP1, THP2"	ENSG00000074047	"GLI family zinc finger 2"	P10070	2	120735623-120992653	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Disease mutation, Holoprosencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 23.3"	"Cell line enhanced"	"Detected in many"		"AF22: 19.2;NTERA-2: 11.7;U-2 OS: 19.9;WM-115: 16.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB008558, HPA074275"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"CAB008558: AB_2111910, HPA074275: "	"unprognostic (6.76e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.83e-3)"	"unprognostic (4.63e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.58e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.81e-2)"	"unprognostic (4.49e-10)"	"unprognostic (1.13e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.42e-3)"	2.1	1.6	3.6	2.9	5.3	0.2	2.3	3.1	3.4	8.0	4.4	1.9	1.5	0.9	8.6	2.6	3.9	5.8	8.8	3.3	3.7	1.0	1.7	0.8	2.9	0.7	1.3	1.5	23.3	0.8	0.7	2.6	1.7	3.6	6.2	1.4	5.9	1.8	2.4	1.6	3.7	3.2	4.5	1.6	2.0	3.9	5.4	2.1	1.7	1.6	4.7	2.6	4.3	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	19.2	3.8	2.1	4.1	0.0	7.3	1.6	3.2	2.1	0.0	0.6	0.0	0.8	3.6	0.3	5.3	0.0	1.6	0.0	3.4	0.5	4.7	0.0	4.6	0.0	1.5	2.1	0.0	10.4	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	11.7	5.9	0.0	2.1	1.2	0.0	0.0	0.8	3.3	3.4	0.0	0.5	0.0	0.2	5.8	0.0	19.9	2.0	0.0	0.0	0.0	0.0	7.2	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	5.3	3.1	3.4	3.7	1.0	1.3	1.5	3.6	2.1
GLOD4	"C17orf25, CGI-150, HC71"	ENSG00000167699	"Glyoxalase domain containing 4"	Q9HC38	17	757097-783390	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA021623, HPA023246, HPA023248"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol			3800000	Cytosol	"Nucleoplasm, Nucleoli"	"HPA021623: AB_1844365, HPA023246: AB_1844366, HPA023248: AB_1844367"	"unprognostic (2.82e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.88e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.13e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.96e-2)"	"prognostic favourable (2.18e-6)"	"unprognostic (6.21e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.02e-1)"	21.7	29.5	31.3	16.7	35.6	10.2	19.1	26.0	36.2	17.8	37.1	21.5	16.5	43.0	22.3	23.3	23.6	24.9	20.9	19.7	26.1	38.5	41.6	40.4	16.8	22.8	23.0	34.8	22.9	32.3	13.9	19.4	28.1	28.6	21.1	26.6	21.9	29.2	20.9	21.4	27.5	42.5	24.7	18.2	23.8	43.4	17.9	18.2	22.7	26.0	19.2	24.0	25.2	17.5	27.5	17.9	17.8	24.6	22.8	36.7	26.0	40.3	36.6	42.2	23.3	18.6	18.5	25.8	32.4	19.9	26.3	20.0	29.6	29.0	48.2	35.3	14.5	29.3	36.8	20.5	27.5	35.3	31.4	23.2	20.3	38.7	18.5	23.9	30.7	12.9	28.6	26.4	23.2	24.2	37.9	31.4	27.7	24.9	41.0	18.4	30.9	12.5	41.1	17.1	22.1	25.9	27.6	19.3	32.4	25.7	18.6	41.5	23.1	25.4	31.5	25.1	20.1	35.1	40.5	17.7	32.2	29.6	29.8	26.9	26.2	9.2	19.8	17.8	27.7	24.2	30.2	27.0	33.6	33.3	17.5	27.5	28.7	31.3	2.7	22.8	24.6	17.9	36.7	26.0	31.3	35.6	26.0	36.2	26.1	38.5	23.0	34.8	28.6	18.2
GMPR2		ENSG00000100938	"Guanosine monophosphate reductase 2"	Q9P2T1	14	24232422-24239242	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Purine metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000904, HPA067884, HPA068782"	Uncertain		Approved	Nucleoplasm,Nucleoli			160000	Nucleoplasm	Nucleoli	"HPA000904: AB_1078998, HPA067884: , HPA068782: "	"unprognostic (1.95e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.86e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.24e-1)"	"unprognostic (5.21e-3)"	"unprognostic (9.24e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.16e-1)"	"prognostic favourable (2.21e-5)"	"unprognostic (2.30e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.12e-2)"	18.9	44.2	19.6	14.6	24.2	11.5	26.2	13.6	31.7	22.5	21.1	25.1	20.3	21.3	18.8	26.3	17.8	28.7	23.4	15.0	20.1	21.9	39.1	26.3	19.0	18.1	23.0	21.2	26.1	26.9	49.1	22.4	22.7	26.0	20.3	21.6	21.9	22.6	23.7	16.1	14.4	21.7	18.2	20.3	25.5	21.2	10.6	19.1	21.6	43.0	11.2	21.0	21.8	17.6	7.5	14.4	32.3	14.0	7.6	14.9	11.0	9.0	10.4	14.1	9.2	16.3	23.1	12.8	10.7	19.1	15.1	19.3	12.2	7.2	12.1	9.8	15.7	12.6	15.5	23.2	21.5	11.4	11.4	9.5	6.5	44.5	15.3	15.6	15.0	21.7	16.7	7.9	16.5	24.4	5.5	11.5	15.2	16.9	15.4	14.0	10.9	13.5	11.7	9.5	10.0	20.7	15.0	10.0	14.1	7.7	16.9	14.4	14.7	12.5	12.5	7.1	5.7	9.4	7.8	25.5	24.4	7.9	5.9	11.9	6.9	9.0	14.0	7.2	10.1	11.2	10.7	7.5	10.2	11.2	14.4	7.1	9.1	10.2	32.3	7.6	11.3	6.5	14.9	11.0	19.6	24.2	13.6	31.7	20.1	21.9	23.0	21.2	26.0	19.1
GNAI1		ENSG00000127955	"G protein subunit alpha i1"	P63096	7	80133955-80219402	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transport"	Transducer	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"NK-cell: 20.0"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022449, HPA042141"	Approved		Supported	Nucleoplasm,Nucleoli,Centrosome			9000000	Centrosome	"Nucleoplasm, Nucleoli"	"CAB022449: , HPA042141: "	"unprognostic (2.29e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavourable (5.09e-4)"	"unprognostic (9.78e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.48e-1)"	"unprognostic (9.41e-3)"	"prognostic unfavourable (6.47e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.53e-1)"	33.2	23.4	17.2	5.4	26.2	1.5	14.4	14.4	33.7	9.4	10.5	36.9	3.0	6.9	10.0	3.0	16.6	9.0	8.6	5.7	23.8	18.3	25.9	13.1	10.3	3.4	40.3	21.9	14.3	5.4	2.5	7.3	30.4	26.2	10.1	9.0	2.8	4.9	9.5	4.2	32.4	5.3	12.2	49.7	5.7	8.3	11.1	32.0	0.9	11.1	3.2	4.6	15.5	9.0	0.1	3.7	2.1	1.5	20.0	2.3	0.7	2.9	20.5	18.8	0.1	23.4	15.0	8.6	12.5	15.1	11.1	13.7	0.0	3.2	0.1	4.0	13.4	3.0	10.4	12.8	14.7	0.1	9.6	17.6	18.1	1.2	23.7	2.2	3.8	16.1	32.4	5.9	17.1	7.4	1.4	0.0	20.7	0.5	0.1	0.1	5.4	7.4	8.2	7.2	8.8	33.1	9.9	13.8	9.5	13.4	0.2	10.6	2.5	0.4	13.1	24.8	17.5	5.7	4.7	0.1	0.0	0.1	6.5	1.3	11.0	2.1	0.7	0.7	0.1	0.7	0.0	0.0	0.3	0.2	3.7	0.1	2.3	0.9	0.3	20.0	1.5	0.3	0.2	0.7	17.2	26.2	14.4	25.5	23.8	18.3	40.3	21.9	26.2	32.0
GNAI3	87U6	ENSG00000065135	"G protein subunit alpha i3"	P08754	1	109548611-109618321	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	Transducer	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022099, HPA042141"	Approved		Approved	Nucleoplasm,Nucleoli,Centrosome			8400000	Centrosome	"Nucleoplasm, Nucleoli"	"CAB022099: , HPA042141: "	"unprognostic (2.19e-1)"	"unprognostic (1.64e-1)"	"prognostic favourable (1.62e-4)"	"unprognostic (1.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.45e-3)"	"prognostic unfavourable (5.30e-6)"	"unprognostic (2.56e-3)"	"unprognostic (2.18e-2)"	"prognostic favourable (4.59e-4)"	"unprognostic (1.83e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavourable (4.34e-4)"	"unprognostic (7.27e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.66e-2)"	25.2	13.0	12.3	15.5	11.3	26.4	15.8	12.8	10.7	19.0	14.7	10.3	14.3	12.1	19.7	15.7	34.8	12.5	13.2	9.3	12.3	9.4	18.1	25.8	13.2	23.8	13.1	8.3	18.4	13.7	10.7	11.0	22.4	11.5	17.2	13.8	8.0	16.2	14.4	8.6	27.9	17.0	15.9	12.9	21.6	12.1	14.0	12.0	22.2	12.9	25.2	20.6	20.0	20.4	6.1	9.6	16.8	13.1	5.8	7.2	9.3	13.9	4.9	9.5	5.6	9.1	10.9	7.8	10.6	8.5	10.8	10.8	7.5	4.9	7.5	7.1	11.3	7.4	8.9	10.8	15.1	8.4	5.5	6.5	8.5	6.4	7.8	10.2	6.0	8.1	9.2	12.4	8.6	12.9	8.5	7.4	10.7	9.5	7.8	8.3	9.5	5.8	5.6	22.4	4.8	12.0	10.7	6.1	10.7	7.4	8.4	11.6	6.5	9.0	11.7	9.1	12.5	13.6	12.0	7.9	8.9	8.7	15.1	10.1	14.1	8.5	9.1	16.6	6.8	13.1	7.2	6.1	6.7	6.5	9.6	5.0	5.6	6.4	16.8	5.8	12.3	4.3	6.9	9.3	12.3	11.3	12.8	10.7	12.3	9.4	13.1	8.3	11.5	12.0
GNL2	"HUMAUANTIG, Ngp-1, Nog2, Nug2"	ENSG00000134697	"G protein nucleolar 2"	Q13823	1	37566816-37595935	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027163, HPA060026"	Approved		Enhanced	Nucleoli				Nucleoli		"HPA027163: AB_10601655, HPA060026: "	"unprognostic (1.38e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.61e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (5.86e-9)"	"unprognostic (2.28e-1)"	"unprognostic (7.80e-2)"	"prognostic favourable (7.89e-4)"	"unprognostic (1.01e-2)"	"unprognostic (8.19e-2)"	"prognostic unfavourable (2.90e-11)"	"unprognostic (3.36e-2)"	"unprognostic (7.33e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.87e-1)"	24.1	17.4	13.8	24.1	15.0	30.7	21.9	11.2	14.2	15.9	15.7	11.7	16.8	12.4	20.2	18.3	21.8	16.4	14.8	17.9	12.5	11.3	18.0	26.9	18.7	19.6	21.2	11.5	19.6	17.4	15.2	21.6	24.5	15.8	16.4	18.7	10.1	19.4	18.9	40.3	22.2	16.3	17.4	15.0	21.8	17.8	21.4	15.2	24.3	17.1	27.5	22.2	20.5	19.8	18.4	25.2	14.4	22.7	20.7	17.4	12.2	19.3	10.0	19.4	20.3	15.6	18.0	31.6	29.5	20.5	27.3	27.9	27.3	22.9	31.8	19.3	21.8	18.3	31.7	24.1	37.8	18.0	24.8	31.9	20.1	21.9	20.9	41.9	22.9	11.3	22.1	37.2	44.7	19.6	42.3	22.9	26.4	17.1	22.5	25.3	50.9	19.6	24.1	35.3	36.1	22.8	21.2	23.8	22.0	22.3	22.5	21.9	16.1	24.5	15.8	18.5	26.1	39.1	40.9	21.5	19.3	55.4	21.3	33.8	23.6	10.3	17.1	14.4	15.3	22.7	17.4	18.4	14.3	16.5	25.2	13.5	15.1	14.5	1.8	20.7	20.7	18.5	16.9	12.2	13.8	15.0	11.2	14.2	12.5	11.3	21.2	11.5	15.8	15.2
GNL3	"C77032, E2IG3, MGC800, NS"	ENSG00000163938	"G protein nucleolar 3"	Q9BVP2	3	52681156-52694492	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020770, HPA036742, HPA036743"	Enhanced		Enhanced	"Nucleoli,Nuclear bodies"				Nucleoli	"Nuclear bodies"	"CAB020770: , HPA036742: AB_2675282, HPA036743: AB_2675283"	"unprognostic (4.40e-1)"	"unprognostic (9.30e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (2.93e-4)"	"unprognostic (1.46e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.67e-3)"	"prognostic unfavourable (6.11e-4)"	"prognostic unfavourable (5.69e-5)"	"unprognostic (1.33e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.06e-2)"	27.7	28.0	14.8	21.8	17.5	13.0	40.5	17.2	25.4	25.0	27.0	10.0	22.8	21.6	22.2	17.5	41.8	17.4	16.1	20.5	21.6	15.9	19.3	50.4	19.5	26.6	18.4	15.7	27.2	45.1	14.1	43.3	24.7	23.4	28.3	27.0	8.8	30.3	27.3	52.2	24.1	21.2	19.5	19.6	32.0	22.7	15.0	16.9	18.3	18.1	34.3	35.8	44.3	24.9	16.2	21.6	1.8	8.9	13.6	19.4	10.0	21.2	15.9	23.4	25.0	22.3	22.7	35.8	26.3	20.9	28.1	21.1	24.0	15.6	49.8	8.7	20.2	15.5	38.4	25.1	37.8	31.1	27.4	38.0	27.2	36.8	46.4	54.1	28.3	20.1	44.7	30.4	47.5	22.1	41.8	26.6	19.1	15.2	32.4	30.2	40.2	31.3	19.3	19.0	61.6	22.1	29.8	16.7	21.4	16.4	37.7	36.8	14.9	30.7	17.0	18.8	20.0	27.4	54.9	29.4	47.5	75.5	20.1	39.5	29.7	0.6	8.0	1.8	11.3	8.9	19.4	16.2	15.3	13.4	13.9	13.5	17.7	16.6	1.0	13.6	6.4	21.6	9.7	10.0	14.8	17.5	17.2	25.4	21.6	15.9	18.4	15.7	23.4	16.9
GNL3L	"FLJ10613, GNL3B"	ENSG00000130119	"G protein nucleolar 3 like"	Q9NVN8	X	54530211-54561071	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036314, HPA036315"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA036314: AB_10669986, HPA036315: AB_2675055"	"unprognostic (9.71e-3)"	"unprognostic (6.58e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.46e-2)"	"unprognostic (8.44e-2)"	"unprognostic (9.97e-2)"	"unprognostic (4.91e-3)"	"unprognostic (7.87e-2)"	"unprognostic (8.05e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.10e-1)"	12.7	12.9	10.3	16.1	12.3	19.2	12.5	8.6	13.1	10.8	10.2	14.8	10.5	8.5	15.2	10.2	16.3	11.0	10.1	15.3	8.1	8.0	12.0	12.5	13.0	15.5	13.0	10.8	13.2	17.5	15.9	16.9	12.0	10.2	10.6	13.3	12.3	13.3	12.4	24.0	13.2	13.5	15.0	11.5	17.6	11.7	5.9	13.9	20.5	18.0	12.0	18.6	13.7	13.1	17.2	11.4	20.2	15.2	21.8	17.7	11.5	11.1	27.7	5.7	11.8	5.9	4.0	10.6	6.7	4.9	7.5	6.0	23.4	9.2	15.7	12.9	9.6	10.9	19.2	8.4	10.4	10.8	9.9	15.7	22.2	11.0	4.5	24.4	15.5	5.8	4.0	17.6	10.6	8.1	10.3	15.8	7.5	21.7	13.8	5.1	16.6	15.6	14.9	13.1	15.2	5.7	17.7	9.4	5.6	21.8	13.5	6.3	17.8	6.2	11.5	13.7	13.7	13.2	11.3	11.9	15.2	20.2	7.1	20.2	15.2	18.9	14.2	15.1	17.7	12.6	16.1	15.0	16.2	15.4	11.4	17.2	12.4	13.0	20.2	21.8	15.2	9.6	8.6	11.5	10.3	12.3	8.6	13.1	8.1	8.0	13.0	10.8	10.2	13.9
GON7	C14orf142	ENSG00000170270	"GON7, KEOPS complex subunit"	Q9BXV9	14	93202894-93207094	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA051832	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA051832: "	"unprognostic (2.28e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.45e-3)"	"unprognostic (3.43e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (1.53e-5)"	"unprognostic (3.40e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.47e-3)"	"unprognostic (7.37e-2)"	"prognostic favourable (3.08e-4)"	"unprognostic (2.96e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.77e-1)"	7.3	15.5	11.4	8.7	13.2	5.4	11.0	11.3	13.4	14.6	14.2	4.9	21.5	12.5	6.8	20.5	7.5	33.8	9.8	18.6	10.9	13.6	21.1	14.7	10.1	13.7	10.4	11.3	7.6	11.5	9.5	14.8	6.1	13.2	8.7	12.9	7.6	9.4	12.1	13.2	5.1	17.4	6.4	8.2	10.3	9.3	8.9	9.5	13.6	14.6	9.5	11.8	8.3	8.8	14.2	14.8	10.7	10.8	10.6	17.6	8.8	5.0	6.9	7.2	7.4	6.4	7.7	5.7	6.4	6.0	9.4	10.8	4.4	7.9	15.8	4.9	4.1	7.2	7.9	5.7	11.2	9.2	6.2	4.1	10.0	10.5	4.8	15.7	7.8	4.7	5.3	7.2	5.9	7.0	9.7	10.6	8.4	17.0	10.6	13.7	4.7	13.5	15.2	9.2	8.2	9.2	6.6	11.8	8.0	5.8	7.5	10.6	9.7	11.1	4.6	4.8	5.8	8.5	5.1	11.7	26.2	14.9	10.0	9.6	5.8	10.7	9.7	8.1	9.6	10.8	12.5	14.2	11.0	10.1	12.3	9.8	10.4	11.4	3.5	10.6	9.8	14.8	17.6	8.8	11.4	13.2	11.3	13.4	10.9	13.6	10.4	11.3	13.2	9.5
GORAB	"FLJ11752, GO, NTKL-BP1, SCYL1BP1"	ENSG00000120370	"Golgin, RAB6 interacting"	Q5T7V8	1	170532129-170553446	"Disease related genes, Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027208, HPA027250, HPA027746"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"	"Intracellular and membrane"			"Golgi apparatus, Cytosol"	"Nucleoplasm, Nucleoli"	"HPA027208: AB_10599622, HPA027250: AB_10611253, HPA027746: "	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.75e-3)"	"prognostic favourable (1.39e-4)"	"prognostic unfavourable (5.26e-4)"	"unprognostic (8.48e-3)"	"unprognostic (2.94e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.77e-2)"	"prognostic unfavourable (7.83e-12)"	"unprognostic (2.52e-2)"	"unprognostic (2.83e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.70e-1)"	7.7	14.7	8.4	9.4	9.2	0.5	10.6	8.7	9.5	10.7	9.4	4.8	7.0	4.8	8.8	10.5	6.3	6.8	6.7	8.2	7.4	7.8	7.2	11.1	6.8	9.6	6.3	8.1	12.6	9.7	6.5	20.6	9.4	8.7	11.1	10.4	6.3	8.8	13.1	3.3	6.5	7.0	6.4	11.1	10.4	5.6	8.6	7.3	8.7	10.5	4.2	9.7	10.4	10.0	6.2	7.3	1.2	7.4	7.9	9.4	5.5	5.1	5.0	9.6	3.6	12.8	9.5	6.3	7.8	12.0	6.9	7.1	3.2	8.7	7.5	8.9	7.8	6.5	9.5	4.6	9.2	8.0	2.9	5.0	6.5	4.0	8.6	6.6	5.1	8.3	4.5	7.3	6.9	5.4	6.8	3.7	7.3	1.2	9.4	6.0	8.5	6.3	5.7	6.4	9.9	6.2	3.8	2.4	5.3	6.4	7.8	18.1	5.0	11.6	6.8	10.9	5.8	4.3	10.7	6.7	7.2	6.6	9.1	6.0	9.8	1.0	7.4	0.0	4.7	7.4	7.4	6.1	8.3	7.2	7.3	6.2	7.3	6.2	1.2	7.9	5.7	4.6	9.4	5.5	8.4	9.2	8.7	9.5	7.4	7.8	6.3	8.1	8.7	7.3
GPALPP1	"AD029, bA245H20.2, KIAA1704, LSR7"	ENSG00000133114	"GPALPP motifs containing 1"	Q8IXQ4	13	44989529-45037669	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038966, HPA058739"	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA038966: AB_10672656, HPA058739: "	"unprognostic (4.99e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.81e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.63e-2)"	"unprognostic (8.86e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.37e-2)"	"unprognostic (6.38e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.94e-2)"	15.6	17.9	19.8	13.8	28.1	16.4	15.0	27.6	24.9	18.1	15.0	15.0	14.5	13.7	18.3	15.5	14.4	13.8	12.5	14.4	19.4	15.3	13.9	13.7	12.7	19.1	14.2	23.3	20.9	12.2	9.1	17.8	19.7	16.8	14.9	15.0	10.8	12.7	16.0	15.0	10.3	14.4	17.6	14.3	16.1	15.3	13.9	19.9	19.4	19.6	12.6	18.8	15.6	15.8	10.4	13.0	11.1	8.5	10.1	10.6	5.1	8.8	7.6	14.3	8.9	6.8	11.3	10.0	12.7	10.4	14.7	14.1	13.2	16.3	20.2	8.5	10.2	14.8	14.1	10.2	16.6	17.3	16.6	15.2	9.8	9.4	11.0	21.6	7.5	8.9	7.3	9.6	8.7	11.7	13.2	4.4	10.8	9.8	20.5	14.9	9.8	7.1	20.0	11.8	8.6	8.3	8.8	5.8	10.0	10.7	6.3	8.1	6.6	17.2	13.4	7.9	5.7	9.3	9.5	6.0	7.4	20.3	8.5	13.3	10.2	2.6	8.5	11.1	9.0	7.1	7.6	8.7	9.5	7.6	10.7	10.4	10.6	9.6	4.0	10.1	6.5	13.0	7.8	5.1	19.8	28.1	27.6	24.9	19.4	15.3	14.2	23.3	16.8	19.9
GPATCH4	"DKFZP434F1735, FLJ20249, GPATC4"	ENSG00000160818	"G-patch domain containing 4"		1	156594487-156601496	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028323, HPA054319"	Approved		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA028323: AB_10601017, HPA054319: "	"unprognostic (2.80e-2)"	"unprognostic (4.61e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavourable (3.17e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.33e-3)"	"unprognostic (9.60e-2)"	"unprognostic (6.39e-3)"	"prognostic unfavourable (3.70e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.03e-2)"	"unprognostic (6.80e-2)"	18.2	13.3	14.7	16.9	27.7	9.4	15.1	6.9	22.5	10.0	12.1	8.3	3.9	9.7	13.8	10.0	14.0	11.6	7.2	11.9	12.6	12.1	18.0	23.1	10.0	15.7	15.3	12.4	15.3	12.9	19.6	16.2	10.0	24.2	12.6	14.6	5.7	11.5	11.9	47.1	10.9	10.0	15.1	10.2	16.6	12.5	8.8	13.2	8.0	10.3	19.0	19.1	12.5	10.1	16.6	10.1	0.3	11.2	10.7	15.9	7.6	17.1	23.6	10.0	14.3	9.2	7.0	12.9	21.2	8.5	16.6	9.7	24.1	13.0	41.2	17.6	14.8	12.0	22.6	18.7	18.4	12.2	22.4	24.6	23.1	18.4	8.3	54.8	15.9	8.0	15.8	31.4	27.8	11.6	40.2	10.4	13.4	31.9	22.5	13.3	43.6	24.9	22.5	17.0	28.5	11.4	20.3	15.7	23.7	20.3	44.7	13.1	14.6	26.7	17.7	15.8	21.5	16.4	37.9	19.0	20.9	53.2	14.3	28.5	23.9	0.0	5.4	0.1	13.3	10.5	13.4	16.6	13.5	14.7	10.1	16.6	15.4	15.9	0.3	10.7	11.2	6.4	8.5	7.6	14.7	27.7	6.9	22.5	12.6	12.1	15.3	12.4	24.2	13.2
GPR137	"C11orf4, GPR137A, TM7SF1L1"	ENSG00000173264	"G protein-coupled receptor 137"	Q96N19	11	64270062-64289500	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 64.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 15.7"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062871	Uncertain		Approved	"Nucleoplasm,Nucleoli,Actin filaments"				"Nucleoplasm, Nucleoli"	"Actin filaments"	"HPA062871: "	"unprognostic (2.25e-1)"	"unprognostic (4.21e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.29e-3)"	"unprognostic (6.37e-2)"	"prognostic unfavourable (5.34e-4)"	"unprognostic (5.68e-2)"	"unprognostic (1.83e-2)"	"unprognostic (7.61e-3)"	"prognostic favourable (6.18e-4)"	"unprognostic (4.95e-2)"	"unprognostic (8.66e-3)"	"unprognostic (3.67e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.41e-1)"	10.3	12.2	18.6	12.8	21.8	10.4	12.0	20.0	23.1	8.9	10.5	13.2	13.8	11.2	9.0	10.4	10.5	13.3	10.3	9.7	18.5	14.3	14.0	14.1	9.3	10.8	15.4	9.1	7.3	9.4	16.4	10.1	28.9	16.5	10.5	5.8	12.4	13.9	12.8	9.9	15.9	11.4	7.1	12.7	11.3	13.6	64.8	14.4	9.9	14.3	5.5	9.3	9.5	16.2	3.9	3.4	15.7	3.0	1.9	3.4	1.4	8.9	20.0	6.9	20.0	13.5	7.2	29.3	10.7	9.0	10.7	6.9	14.7	12.6	9.2	18.6	6.7	18.0	9.6	5.9	3.1	29.1	12.1	8.7	20.5	9.4	7.7	5.8	17.0	9.0	9.4	9.3	7.1	5.7	7.8	22.5	6.4	22.7	6.5	15.6	9.4	20.0	13.0	7.4	14.9	7.4	12.2	11.0	13.4	13.0	17.7	11.5	19.4	2.4	9.2	29.6	20.5	22.3	7.7	18.0	33.1	7.7	21.2	4.9	18.0	1.7	3.0	5.3	2.7	2.8	3.4	2.8	2.3	2.0	3.1	3.9	2.6	2.2	15.7	1.9	2.3	3.4	1.6	1.4	18.6	21.8	20.0	23.1	18.5	14.3	15.4	9.1	16.5	14.4
GPR157	FLJ12132	ENSG00000180758	"G protein-coupled receptor 157"	Q5UAW9	1	9100305-9129170	"G-protein coupled receptors, Predicted membrane proteins"	Differentiation	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 32.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 16.9;SK-BR-3: 33.2;U-266/70: 16.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA028697	Uncertain		Uncertain	"Nucleoli,Plasma membrane,Cell Junctions"				Nucleoli	"Plasma membrane, Cell Junctions"	"HPA028697: AB_10601810"	"unprognostic (2.83e-3)"	"unprognostic (1.13e-2)"	"unprognostic (5.91e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.13e-4)"	"unprognostic (7.11e-2)"	"unprognostic (7.52e-3)"	"unprognostic (3.60e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.13e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.04e-3)"	3.5	3.1	0.3	3.7	0.6	0.5	3.5	0.5	0.4	6.2	2.8	0.9	3.9	2.2	2.1	2.1	23.4	2.1	6.9	10.7	0.8	0.4	2.9	6.9	5.5	3.1	0.3	0.1	4.5	4.3	9.8	1.2	19.0	1.4	2.9	1.2	5.2	14.7	7.1	32.2	14.2	3.3	4.0	0.4	2.4	2.2	2.1	0.8	3.6	4.8	25.2	16.2	4.4	8.3	2.4	1.1	4.6	1.5	1.2	2.6	0.7	4.6	2.6	0.8	2.1	0.7	0.7	4.3	1.4	0.9	1.2	1.6	2.1	1.8	0.6	1.8	1.5	9.9	2.4	0.9	1.8	12.8	3.9	0.0	7.7	3.1	2.6	0.0	1.0	0.7	2.0	2.1	1.3	0.9	0.7	16.9	0.5	3.4	1.9	0.9	0.9	3.3	0.3	0.7	2.2	0.8	3.1	1.2	3.2	5.7	33.2	2.8	4.7	0.5	7.0	4.2	1.1	10.9	0.6	16.3	2.6	0.0	3.1	6.6	1.7	1.9	1.5	0.4	2.6	1.2	2.0	1.5	1.9	2.3	0.8	2.4	1.9	2.2	4.6	1.2	0.6	1.1	0.8	0.7	0.3	0.6	0.5	0.4	0.8	0.4	0.3	0.1	1.4	0.8
GPR161	RE2	ENSG00000143147	"G protein-coupled receptor 161"	Q8N6U8	1	168079543-168137667	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 27.1;smooth muscle: 21.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 23.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015576, HPA072047"	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA015576: AB_1849283, HPA072047: "	"unprognostic (1.45e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.04e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.57e-6)"	"unprognostic (3.93e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.34e-2)"	2.4	0.9	2.1	3.6	1.7	0.0	1.9	1.2	4.0	7.3	4.9	3.1	8.5	0.8	27.1	8.2	7.4	7.7	5.6	2.4	2.8	1.5	1.1	0.4	2.8	0.4	3.0	1.2	7.6	11.0	4.9	1.3	1.3	3.0	8.2	2.3	3.4	2.3	9.4	0.8	1.5	2.1	21.0	3.0	1.2	2.2	3.0	0.8	1.4	1.2	1.7	0.7	2.8	6.8	0.3	1.2	1.5	0.5	0.2	0.3	0.2	6.1	3.8	15.3	9.8	3.7	6.6	0.0	5.9	6.4	5.0	5.4	23.8	1.0	0.0	3.3	8.8	18.2	3.7	5.8	2.9	2.3	4.7	2.2	3.0	0.1	1.5	0.6	1.5	2.3	3.7	4.3	7.0	10.1	2.0	0.1	7.6	0.5	0.7	0.1	6.3	6.0	1.8	6.6	0.0	2.6	1.6	3.1	13.5	6.4	0.2	17.6	3.4	0.7	13.5	10.5	5.4	14.0	6.6	0.0	0.0	0.0	2.8	0.0	2.6	1.5	0.3	0.2	0.1	0.3	0.1	0.1	0.1	0.0	1.2	0.3	0.1	0.3	1.3	0.2	0.5	0.3	0.0	0.2	2.1	1.7	1.2	4.0	2.8	1.5	3.0	1.2	3.0	0.8
GPR65	"hTDAG8, TDAG8"	ENSG00000140030	"G protein-coupled receptor 65"	Q8IYL9	14	88005124-88014811	"G-protein coupled receptors, Predicted membrane proteins"	Apoptosis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 30.4;lymphoid tissue: 40.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 6.1;HEL: 6.6;HL-60: 7.9;HMC-1: 10.2;RH-30: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA072624, HPA077397"	Enhanced		Approved	Nucleoli,Vesicles,Cytosol				Vesicles	"Nucleoli, Cytosol"	"HPA072624: , HPA077397: "	"unprognostic (8.56e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.98e-3)"	"unprognostic (3.59e-3)"	"unprognostic (3.10e-1)"	"unprognostic (3.55e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (4.99e-4)"	"unprognostic (3.79e-1)"	"unprognostic (4.46e-3)"	"unprognostic (9.03e-2)"	"unprognostic (3.80e-1)"	9.8	3.1	1.8	12.1	6.4	15.2	2.3	0.7	3.0	1.9	2.4	0.9	0.9	2.3	2.2	2.2	2.3	2.2	4.1	2.3	6.0	2.1	4.0	6.9	10.6	13.1	8.2	0.0	1.7	1.8	0.8	6.2	3.6	6.3	2.9	2.3	1.2	2.6	0.9	0.9	1.2	7.7	3.3	15.7	40.8	2.5	1.5	6.2	12.5	1.8	2.3	8.9	4.8	2.3	4.3	5.9	19.1	13.7	21.3	30.4	9.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.6	0.0	0.0	0.3	7.9	10.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	1.1	0.0	0.0	0.2	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.1	14.6	9.1	19.1	16.5	12.8	30.4	4.3	8.4	12.6	5.9	4.0	4.4	9.7	6.9	21.3	13.7	2.7	4.0	9.4	1.8	6.4	0.7	3.0	6.0	2.1	8.2	0.0	6.3	6.2
GPRC5B	RAIG-2	ENSG00000167191	"G protein-coupled receptor class C group 5 member B"	Q9NZH0	16	19856691-19886167	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 108.0"	"Cell line enhanced"	"Detected in many"		"EFO-21: 38.4;HHSteC: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"naive CD4 T-cell: 6.5"	"Lineage enriched"	"Detected in many"	4	"T-cells: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015247	Enhanced		Supported	Nucleoplasm,Nucleoli,Vesicles				Vesicles	"Nucleoplasm, Nucleoli"	"HPA015247: AB_1849323"	"unprognostic (1.26e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavourable (9.27e-5)"	"unprognostic (2.60e-3)"	"unprognostic (3.28e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.27e-1)"	"prognostic favourable (6.30e-4)"	"unprognostic (4.73e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.42e-3)"	"unprognostic (6.78e-3)"	12.6	4.4	45.2	3.2	55.9	1.0	7.3	22.8	108.0	5.4	2.9	95.1	4.9	4.0	7.1	9.3	5.5	12.7	9.2	22.3	47.8	28.7	12.1	2.7	3.9	4.6	63.1	34.9	13.7	12.7	9.5	3.8	9.3	38.6	6.3	2.3	3.8	20.8	11.5	35.1	2.5	3.3	5.1	61.6	2.2	22.7	19.6	63.1	0.0	7.2	2.6	2.7	6.2	3.0	0.0	0.0	0.0	1.5	0.0	6.5	1.3	0.4	12.3	12.3	2.2	12.7	0.8	2.2	0.1	3.1	1.2	0.8	11.3	0.4	0.0	38.4	0.4	0.6	9.0	0.0	0.7	0.0	3.3	0.0	0.0	0.0	26.2	0.0	0.0	1.1	0.0	2.1	0.0	6.0	2.5	0.2	2.8	0.6	0.0	0.0	13.4	5.8	3.5	0.0	0.0	0.4	5.7	9.5	0.8	1.4	0.8	11.0	0.0	0.2	1.1	0.0	1.4	6.0	0.3	0.1	0.0	0.0	0.6	0.1	0.7	0.0	0.1	0.0	0.0	1.5	0.0	0.0	1.6	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.3	0.0	0.0	1.3	45.2	55.9	22.8	40.5	47.8	28.7	63.1	34.9	38.6	63.1
GPRIN3	"FLJ42625, GRIN3"	ENSG00000185477	"GPRIN family member 3"	Q6ZVF9	4	89236386-89308010	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.0"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 46.0;RPMI-8226: 11.8;SCLC-21H: 12.3;U-266/70: 7.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 41.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"basal ganglia: 53.1"	"HPA043148, HPA057666, HPA059092"	Enhanced		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA043148: , HPA057666: , HPA059092: "	"unprognostic (9.05e-2)"	"unprognostic (4.92e-2)"	"prognostic favourable (7.22e-5)"	"unprognostic (2.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.13e-1)"	"prognostic favourable (8.33e-4)"	"unprognostic (1.91e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.93e-1)"	"unprognostic (7.82e-4)"	7.0	1.8	4.0	11.5	9.1	8.9	3.2	41.0	5.0	3.5	7.2	2.8	0.0	8.4	2.3	1.7	1.8	2.1	5.6	5.4	3.6	4.1	5.5	2.8	11.2	12.7	4.1	3.1	4.8	7.0	1.1	12.4	1.4	6.5	2.1	9.8	6.4	2.9	1.0	2.1	1.6	7.0	2.0	6.0	12.9	4.7	1.1	6.2	5.3	2.9	1.4	10.5	4.5	2.4	0.3	1.5	0.1	2.2	2.9	6.6	1.4	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	46.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	11.8	0.1	0.0	12.3	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.1	5.5	0.0	0.2	0.0	0.0	0.1	0.5	0.0	4.8	1.7	6.6	0.3	4.7	3.7	1.5	0.1	1.9	1.9	0.1	2.9	2.2	0.0	5.3	1.4	4.0	9.1	41.0	5.0	3.6	4.1	4.1	3.1	6.5	6.2
GRAMD1B	"KIAA1201, LINC01059"	ENSG00000023171	"GRAM domain containing 1B"	Q3KR37	11	123358428-123627774	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 67.7;brain: 55.2;intestine: 21.7"	"Group enriched"	"Detected in many"	4	"A549: 21.8;HDLM-2: 57.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.5"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008557	Approved		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments"				Nucleoli	"Nucleoplasm, Intermediate filaments"	"HPA008557: AB_1079197"	"unprognostic (1.86e-1)"	"unprognostic (7.18e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.74e-3)"	"unprognostic (8.15e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.69e-3)"	"unprognostic (4.12e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.90e-2)"	"unprognostic (9.60e-2)"	"unprognostic (8.06e-2)"	"prognostic unfavourable (4.30e-7)"	"unprognostic (1.39e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.69e-1)"	1.4	67.7	15.5	3.1	16.0	11.8	1.1	55.2	25.0	1.2	3.1	5.1	5.9	21.7	1.2	6.6	0.9	2.9	8.1	4.3	13.6	7.5	10.4	1.3	1.9	3.6	6.8	15.1	7.6	2.0	0.6	6.7	5.0	14.4	1.1	1.2	11.9	1.3	2.5	1.8	0.8	15.6	1.3	4.1	2.7	7.8	10.6	5.1	3.4	3.7	0.0	2.7	1.5	0.8	0.1	11.5	0.6	2.0	2.6	2.7	0.7	0.0	21.8	1.2	0.0	0.1	0.2	3.6	7.2	5.2	1.6	0.6	0.9	0.1	1.3	3.8	3.6	0.0	2.3	0.0	1.7	57.6	2.0	0.0	9.8	0.2	0.0	7.5	0.0	0.4	0.0	2.8	0.0	0.6	0.0	0.0	1.3	0.1	1.2	2.5	2.8	8.2	3.9	3.5	2.3	0.1	0.0	7.2	5.9	1.7	0.1	0.0	0.2	4.2	4.3	8.7	1.4	1.5	0.3	0.0	0.0	0.0	1.8	7.9	0.4	0.0	2.0	0.6	0.7	1.0	0.4	0.0	2.7	2.1	3.0	0.1	0.3	0.3	0.2	2.6	1.0	11.5	1.1	0.7	15.5	16.0	55.2	25.0	13.6	7.5	6.8	15.1	14.4	5.1
GRAMD2A	GRAMD2	ENSG00000175318	"GRAM domain containing 2A"	Q8IUY3	15	72159807-72197785	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 24.6;placenta: 49.2"	"Group enriched"	"Detected in some"	12	"BEWO: 58.1;SK-BR-3: 26.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"myeloid DC: 2.3"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 2.3"	"Low region specificity"	"Detected in many"							HPA029435	Uncertain		Approved	"Nucleoli,Nuclear speckles,Cytosol"				"Nucleoli, Nuclear speckles"	Cytosol	"HPA029435: AB_10601811"	"unprognostic (5.70e-2)"	"unprognostic (7.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.51e-3)"	"unprognostic (2.95e-1)"	"unprognostic (9.96e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.77e-2)"	"unprognostic (4.45e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.33e-2)"	"prognostic unfavourable (7.01e-4)"	"unprognostic (7.29e-2)"	0.1	0.0	2.0	0.2	4.5	0.0	6.8	1.1	1.0	3.1	0.7	1.2	9.8	0.6	0.4	24.6	1.0	8.2	0.8	0.1	2.9	6.5	1.9	0.1	9.7	0.2	1.1	0.1	1.1	1.0	0.2	0.9	49.2	3.9	1.2	0.5	1.0	1.8	4.0	0.3	1.5	3.6	0.1	1.0	0.1	0.4	0.7	0.9	0.2	7.7	1.3	1.1	0.3	0.6	0.0	2.3	0.0	0.1	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	58.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.0	3.4	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	2.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	26.5	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	4.5	1.1	1.0	2.9	6.5	1.1	0.1	3.9	0.9
GRWD1	"GRWD, RRB1, WDR28"	ENSG00000105447	"Glutamate rich WD repeat containing 1"	Q9BQ67	19	48445773-48457022	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042643, HPA055680"	Approved		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA042643: AB_10795510, HPA055680: AB_2682884"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.46e-1)"	"unprognostic (7.77e-2)"	"prognostic unfavourable (2.16e-4)"	"unprognostic (1.71e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.69e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.07e-2)"	16.9	15.5	9.2	15.7	11.1	14.8	15.5	12.9	14.1	13.6	14.1	10.4	11.9	15.6	18.7	12.8	20.0	15.0	16.2	16.9	7.8	8.6	13.0	26.3	12.5	17.5	11.0	10.3	19.3	35.5	16.5	10.3	14.7	9.5	13.8	8.0	12.0	18.6	14.4	29.1	18.3	11.5	13.3	8.2	19.4	14.7	13.1	10.9	18.6	17.3	19.0	17.3	14.1	18.0	21.1	18.4	1.4	17.8	17.4	22.6	16.5	16.8	44.7	7.6	14.3	6.2	6.2	6.5	13.2	6.3	19.1	15.9	25.1	12.5	24.1	11.5	8.2	14.4	18.9	20.4	7.5	18.1	25.6	22.0	15.2	17.8	7.2	20.7	14.1	7.4	11.3	18.0	9.1	9.4	30.7	15.2	7.9	17.5	21.8	52.1	20.7	13.1	27.1	8.6	17.3	7.9	20.9	17.2	9.5	14.9	21.1	6.6	10.4	10.5	10.0	17.8	15.0	7.8	31.3	15.5	35.5	22.6	5.9	18.7	20.6	0.1	11.0	1.4	19.6	17.8	22.6	21.1	18.1	19.5	18.4	20.4	21.3	19.7	0.8	17.4	13.5	13.6	15.6	16.5	9.2	11.1	12.9	14.1	7.8	8.6	11.0	10.3	9.5	10.9
GSKIP	C14orf129	ENSG00000100744	"GSK3B interacting protein"	Q9P0R6	14	96363452-96387288	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 63.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043054, HPA046782"	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	Nucleoli	"HPA043054: , HPA046782: "	"unprognostic (3.48e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.23e-3)"	"unprognostic (1.11e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.16e-3)"	"unprognostic (6.82e-2)"	"unprognostic (2.84e-1)"	"unprognostic (8.74e-3)"	"unprognostic (4.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.30e-1)"	6.6	7.1	11.2	8.0	21.9	7.1	6.7	5.1	14.6	6.6	29.5	5.4	6.7	23.5	5.5	6.4	20.8	5.5	7.0	5.2	12.0	9.6	12.8	36.4	5.3	8.7	9.2	9.7	3.6	6.1	4.0	10.8	11.1	10.7	7.1	28.3	8.7	7.8	5.2	5.5	8.5	63.0	8.0	10.4	6.6	11.3	26.4	7.2	9.0	5.8	10.7	10.7	8.2	9.0	20.1	11.2	27.5	16.6	17.8	34.1	14.8	9.4	13.6	15.2	10.3	11.5	13.4	25.8	17.7	13.5	11.7	13.0	10.0	16.1	9.1	10.8	13.4	10.5	9.9	10.6	17.1	21.6	9.4	3.8	7.8	7.6	10.7	9.7	6.6	10.8	16.9	15.0	15.1	15.2	8.2	8.3	14.8	23.5	7.1	7.9	16.9	17.2	7.2	14.2	8.2	27.5	35.5	5.4	17.4	20.0	18.9	15.4	14.2	6.3	16.7	5.4	7.0	11.5	5.5	9.8	27.9	7.7	13.9	7.0	8.6	27.5	10.8	24.3	15.5	12.6	24.0	20.1	21.7	18.3	11.2	16.6	21.4	19.8	21.7	17.8	16.6	9.6	34.1	14.8	11.2	21.9	5.1	14.6	12.0	9.6	9.2	9.7	10.7	7.2
GTF3C1	TFIIIC220	ENSG00000077235	"General transcription factor IIIC subunit 1"	Q12789	16	27459555-27549913	"Predicted intracellular proteins, Predicted membrane proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"gdT-cell: 20.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051617	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA051617: "	"unprognostic (6.46e-2)"	"unprognostic (6.86e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.59e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.90e-2)"	"prognostic unfavourable (8.73e-4)"	"unprognostic (8.23e-2)"	"unprognostic (9.25e-3)"	"unprognostic (5.32e-2)"	"prognostic favourable (9.56e-4)"	"unprognostic (2.10e-1)"	"prognostic favourable (1.25e-4)"	"unprognostic (2.06e-1)"	"unprognostic (5.67e-2)"	"unprognostic (5.56e-3)"	"unprognostic (8.23e-3)"	13.6	18.4	19.4	12.1	25.9	17.3	10.6	25.3	31.2	17.3	12.8	21.0	18.8	11.0	19.0	12.0	39.3	19.9	16.5	23.7	15.8	16.2	16.9	13.2	14.1	13.5	14.3	19.1	20.7	24.0	33.8	33.2	13.5	15.8	35.4	12.4	22.3	15.3	16.9	29.5	41.5	11.7	19.3	12.8	14.2	15.7	24.4	17.1	25.2	35.8	18.8	21.0	12.3	20.7	1.9	4.2	2.1	2.1	7.8	20.6	3.6	12.7	28.2	20.8	24.2	18.7	15.1	11.8	13.9	15.7	19.4	16.6	21.1	12.1	14.1	20.6	17.0	14.4	26.3	17.7	16.0	6.3	25.2	11.6	23.9	30.0	10.5	13.3	15.5	18.5	13.5	23.8	10.5	19.2	14.3	11.6	15.2	31.5	14.7	16.0	27.9	13.5	27.5	25.7	14.4	12.2	13.4	26.3	17.6	14.0	11.9	8.6	21.4	10.1	20.3	19.6	11.8	12.3	14.2	12.4	11.1	14.3	8.1	14.8	14.3	1.0	2.1	2.1	20.6	1.9	15.2	1.9	2.4	10.3	2.7	1.6	2.5	6.7	1.6	7.8	2.0	4.2	2.5	3.6	19.4	25.9	25.3	31.2	15.8	16.2	14.3	19.1	15.8	17.1
GTPBP4	"CRFG, FLJ10686, FLJ10690, NGB, NOG1"	ENSG00000107937	"GTP binding protein 4"	Q9BZE4	10	988019-1019936	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039618, HPA056468"	Uncertain		Supported	"Nuclear membrane,Nucleoli"				Nucleoli	"Nuclear membrane"	"HPA039618: AB_10795292, HPA056468: "	"unprognostic (2.11e-3)"	"unprognostic (3.10e-3)"	"unprognostic (7.77e-3)"	"prognostic unfavourable (4.57e-4)"	"unprognostic (3.72e-2)"	"unprognostic (8.91e-3)"	"prognostic unfavourable (8.85e-12)"	"unprognostic (9.06e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (2.38e-5)"	"unprognostic (7.90e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.67e-2)"	19.0	24.6	11.3	13.9	14.9	24.8	14.2	11.6	15.0	11.0	10.5	12.2	10.3	9.6	14.8	10.1	12.2	15.8	8.9	11.9	14.1	11.8	11.8	14.0	9.5	13.8	14.0	10.1	16.3	22.8	12.7	18.3	13.8	15.3	11.1	12.2	8.9	10.3	9.9	24.8	11.4	11.0	14.4	18.1	13.5	12.7	22.9	12.2	14.2	11.9	16.3	16.3	11.6	10.4	10.5	11.3	10.7	14.2	15.8	14.2	7.7	21.0	17.2	14.5	12.7	10.2	12.3	10.4	19.8	6.9	24.3	20.7	25.4	16.4	30.5	6.0	15.7	16.7	28.6	18.1	28.4	15.0	17.8	33.5	12.4	15.4	16.2	14.5	18.1	15.9	15.4	26.6	18.6	13.2	34.2	12.7	22.2	19.4	22.2	13.7	21.1	11.8	22.1	12.7	21.1	14.4	13.4	7.3	21.9	13.0	16.7	22.9	23.9	14.5	11.4	11.5	6.4	27.7	23.9	16.4	31.5	38.4	13.0	15.4	9.5	10.7	8.4	3.0	11.6	14.2	13.6	10.5	11.0	11.7	11.3	9.9	12.2	11.8	1.4	15.8	10.8	7.4	14.2	7.7	11.3	14.9	11.6	15.0	14.1	11.8	14.0	10.1	15.3	12.2
GTSF1L	"C20orf65, dJ1028D15.4, FAM112A"	ENSG00000124196	"Gametocyte specific factor 1 like"	Q9H1H1	20	43726164-43726998	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 104.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.3;EFO-21: 1.2;REH: 3.9;U-698: 4.3"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"T-reg: 7.5"	"Lineage enriched"	"Detected in many"	5	"T-cells: 7.5"	"Low region specificity"	"Detected in some"							HPA054694	Enhanced		Uncertain	Nucleoli				Nucleoli		"HPA054694: "	"unprognostic (2.61e-2)"	"unprognostic (4.24e-6)"		"unprognostic (9.96e-3)"		"unprognostic (1.30e-4)"		"unprognostic (3.50e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.06e-2)"		"unprognostic (2.45e-7)"	"unprognostic (1.19e-1)"	"unprognostic (9.54e-2)"		"unprognostic (6.07e-3)"	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	104.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	7.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.9	4.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.7	1.0	0.0	1.4	0.6	0.8	0.0	0.0	0.0	0.0	7.5	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0
GYG2	GN-2	ENSG00000056998	"Glycogenin 2"	O15488	X	2828788-2882820	"Enzymes, Predicted intracellular proteins"	"Glycogen biosynthesis"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 76.7;brain: 21.2;breast: 30.4"	"Cell line enhanced"	"Detected in many"		"AF22: 17.7;BEWO: 12.8;CACO-2: 13.1;Hep G2: 14.2;NTERA-2: 17.4;SK-MEL-30: 37.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 42.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA005495, HPA064686"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoli, Cytosol"	Nucleoplasm	"HPA005495: AB_1079035, HPA064686: "	"unprognostic (4.45e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.41e-3)"	"unprognostic (8.50e-2)"	"unprognostic (2.07e-3)"	"unprognostic (5.16e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.43e-3)"	"unprognostic (6.74e-2)"	"prognostic favourable (3.01e-5)"	"unprognostic (9.76e-2)"	"unprognostic (6.10e-5)"	"unprognostic (1.78e-1)"	"unprognostic (5.05e-3)"	"unprognostic (5.41e-2)"	"unprognostic (6.60e-2)"	76.7	1.4	4.6	1.3	4.6	0.5	30.4	2.1	3.7	2.1	3.5	8.2	0.7	1.2	4.2	0.9	1.0	3.6	1.7	1.7	3.9	2.9	1.4	9.9	0.7	0.7	5.5	2.9	1.9	3.2	0.4	0.5	1.6	12.9	2.7	2.0	4.2	2.8	4.4	0.5	1.2	1.3	2.8	21.2	0.5	2.2	0.8	5.1	0.0	1.3	0.5	0.6	2.9	1.4	1.0	0.6	0.6	0.4	1.2	0.7	0.0	0.0	5.4	17.7	0.0	10.6	0.0	12.8	0.5	3.1	3.1	3.9	13.1	0.3	0.0	1.4	2.2	0.0	10.0	0.2	3.0	0.1	2.8	0.0	0.2	14.2	3.1	0.0	4.3	3.8	0.1	0.3	0.0	0.0	0.1	0.0	3.2	0.8	0.0	0.4	17.4	0.1	2.9	5.9	0.0	0.0	0.0	0.0	0.3	0.0	0.1	37.7	1.7	10.7	0.0	0.0	3.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.2	0.7	0.5	0.4	0.3	0.1	1.0	0.3	0.2	0.6	1.2	0.4	0.6	0.4	0.0	4.6	4.6	2.1	3.7	3.9	2.9	5.5	2.9	12.9	5.1
GZF1	"dJ322G13.2, ZBTB23, ZNF336"	ENSG00000125812	"GDNF inducible zinc finger protein 1"	Q9H116	20	23362182-23373063	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024520	Uncertain		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA024520: AB_10963938"	"unprognostic (3.11e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavourable (9.81e-7)"	"unprognostic (8.98e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.70e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.45e-1)"	7.6	25.8	12.3	7.1	12.5	35.7	6.6	14.1	17.2	8.8	7.1	14.9	8.0	5.4	9.0	7.6	6.1	8.2	7.5	15.6	11.5	10.6	9.2	8.7	7.1	6.5	13.0	10.4	11.4	7.8	12.0	9.8	8.4	12.9	8.3	5.9	7.1	7.7	11.2	10.0	5.8	5.6	10.7	12.4	6.7	6.6	16.5	13.0	7.4	9.6	5.3	6.3	9.3	9.8	3.2	4.4	3.4	4.5	1.3	3.2	2.4	5.5	9.8	6.3	6.3	7.4	7.3	5.1	6.8	6.3	7.0	6.6	7.4	4.5	11.3	6.0	5.8	9.9	7.2	9.2	8.0	1.9	4.7	10.5	4.0	10.0	9.7	6.2	6.4	7.3	6.8	7.5	11.6	4.7	7.1	17.7	10.0	7.3	9.6	7.8	4.7	13.5	6.4	15.1	7.8	5.3	5.6	9.7	5.6	6.0	10.8	14.2	7.1	9.1	6.0	11.4	6.6	8.6	7.2	14.5	5.9	10.0	3.3	28.6	6.1	0.0	4.5	2.0	2.0	2.7	1.5	3.2	3.0	3.1	4.4	1.6	3.0	3.2	3.4	1.3	3.2	3.7	0.9	2.4	12.3	12.5	14.1	17.2	11.5	10.6	13.0	10.4	12.9	13.0
H1FX	"H1X, MGC15959, MGC8350"	ENSG00000184897	"H1 histone family member X"	Q92522	3	129314771-129316277	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"bone marrow: 381.6;lymphoid tissue: 238.6"	"Cell line enhanced"	"Detected in all"		"U-266/70: 137.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB012235, HPA040099"	Supported		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"CAB012235: , HPA040099: "	"unprognostic (1.01e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.13e-2)"	"unprognostic (8.48e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.51e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.50e-2)"	23.1	13.1	11.9	19.0	14.5	381.6	33.7	29.0	22.9	30.9	21.0	9.6	13.4	21.1	26.0	19.6	34.5	25.1	24.0	27.5	11.3	11.2	12.9	24.9	30.9	44.2	6.7	16.3	39.0	22.4	18.4	20.5	15.0	6.9	26.2	7.8	18.4	32.3	16.3	30.8	40.5	26.0	19.1	9.6	29.9	29.0	14.2	6.3	238.6	21.9	18.1	20.5	35.6	25.0	5.7	10.8	15.9	5.3	4.8	8.3	2.2	19.6	10.4	19.8	8.5	2.0	2.4	18.8	8.6	6.3	10.3	10.9	6.2	10.8	2.5	9.6	3.0	19.8	8.3	5.5	1.6	18.0	16.1	7.5	8.1	8.5	8.5	8.6	2.0	4.8	7.6	4.1	9.5	5.9	11.5	44.8	1.4	20.6	40.1	17.2	18.5	11.8	28.9	8.4	23.4	3.1	4.1	31.6	36.6	9.1	4.6	26.2	17.9	17.6	5.8	8.0	41.9	7.8	7.2	137.4	52.5	21.2	6.5	8.2	8.7	0.4	5.3	15.9	4.3	3.7	4.0	4.4	6.7	5.1	7.4	5.7	8.3	4.3	1.2	4.8	3.3	10.8	5.1	2.2	11.9	14.5	29.0	22.9	11.3	11.2	6.7	16.3	6.9	6.3
HAP1	"HAP2, hHLP1, HIP5, HLP"	ENSG00000173805	"Huntingtin associated protein 1"	P54257	17	41717742-41734644	"Predicted intracellular proteins"	"Autophagy, Cilium biogenesis/degradation, Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 30.5;stomach 1: 23.3"	"Cell line enriched"	"Detected in some"	7	"REH: 45.1"	"Cancer enhanced"	"Detected in many"		"glioma: 6.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA076992	Enhanced		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA076992: "	"unprognostic (2.84e-3)"	"unprognostic (3.74e-3)"	"unprognostic (2.42e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.53e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.11e-2)"	"unprognostic (8.76e-2)"	"prognostic favourable (4.26e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.29e-2)"	0.7	3.2	11.7	1.1	16.2	0.8	2.0	5.6	13.1	4.8	1.3	3.8	2.2	5.2	4.6	3.5	0.9	2.8	3.1	0.6	10.1	30.5	1.1	1.2	1.4	0.9	6.6	6.6	1.0	2.2	0.5	6.8	3.1	15.5	1.6	1.4	0.4	3.4	3.0	1.0	1.6	2.5	1.7	8.3	3.3	23.3	3.4	2.2	0.0	7.2	0.0	1.0	0.9	1.2	1.2	0.8	2.6	0.6	1.5	1.0	0.1	0.1	1.5	0.7	1.5	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.9	0.1	0.1	0.5	0.1	6.2	3.2	0.2	0.0	0.0	1.6	0.0	0.8	0.0	0.1	0.0	0.3	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.8	0.4	45.1	0.0	1.7	0.3	0.5	0.2	0.0	0.3	0.2	0.0	1.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.6	0.6	0.5	0.6	0.3	0.4	0.5	0.5	0.6	0.2	1.2	0.8	1.0	2.6	1.5	0.6	0.8	0.8	0.1	11.7	16.2	5.6	9.3	10.1	30.5	6.6	6.6	15.5	2.2
HAUS7	"UCHL5IP, UIP1"	ENSG00000213397	"HAUS augmin like complex subunit 7"	Q99871	X	153447666-153495516	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003614			Approved	"Nucleoli,Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Centrosome, Cytosol"	Nucleoli	"HPA003614: AB_1080368"	"unprognostic (2.06e-1)"	"prognostic favourable (6.12e-4)"	"unprognostic (3.81e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.84e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.39e-1)"	"unprognostic (4.65e-3)"	"unprognostic (6.28e-2)"	"prognostic unfavourable (3.94e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.09e-2)"	13.1	9.4	16.1	10.3	16.4	9.4	7.9	9.1	19.3	12.7	9.3	8.9	20.3	7.9	10.8	17.1	7.0	9.9	15.1	11.9	20.3	9.1	13.3	11.9	9.4	12.1	12.0	16.5	9.3	4.3	3.1	6.4	12.6	11.1	11.8	6.2	7.8	8.5	17.4	7.2	46.9	7.4	12.1	8.9	16.4	8.8	6.1	18.4	14.2	10.8	8.8	9.8	7.5	11.8	20.2	22.3	10.1	31.1	16.7	18.5	15.8	13.7	22.2	9.8	19.1	3.5	4.8	13.7	9.5	5.4	11.0	19.7	16.1	7.7	13.2	30.7	6.5	11.7	14.1	9.6	8.6	15.8	23.2	9.6	20.6	12.0	3.1	15.8	13.9	7.3	2.5	9.8	6.2	7.8	12.0	6.8	6.5	26.5	14.8	19.1	6.1	22.2	13.9	16.2	19.9	3.5	8.7	10.9	8.3	5.2	11.3	3.9	4.5	7.6	5.0	9.5	19.0	22.2	17.4	9.9	26.2	51.5	5.1	28.4	13.1	4.7	26.2	10.1	17.0	31.1	17.8	20.2	18.5	17.1	22.3	16.6	18.4	16.7	3.4	16.7	27.1	12.6	15.5	15.8	16.1	16.4	9.1	19.3	20.3	9.1	12.0	16.5	11.1	18.4
HDDC2	"C6orf74, CGI-130, dJ167O5.2"	ENSG00000111906	"HD domain containing 2"	Q7Z4H3	6	125219962-125302078	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035677	Approved		Approved	Nucleoplasm,Nucleoli			19000	Nucleoli	Nucleoplasm	"HPA035677: AB_10603768"	"unprognostic (8.34e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.52e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.39e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.38e-2)"	"unprognostic (8.59e-3)"	"unprognostic (5.13e-2)"	"unprognostic (4.56e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.54e-2)"	17.5	29.8	50.5	12.0	36.1	11.3	21.1	26.4	31.7	14.8	15.2	11.1	31.6	12.4	12.9	25.2	19.6	17.2	12.4	34.7	41.1	37.0	31.3	8.9	13.4	18.8	45.0	18.9	18.3	22.9	16.3	15.6	11.5	23.4	15.7	16.9	19.3	54.8	42.0	42.8	13.5	16.1	19.0	25.8	12.2	14.4	25.7	16.8	12.9	24.3	35.4	18.2	17.7	11.2	27.3	15.4	4.4	14.2	23.6	33.9	17.7	8.4	23.6	14.7	60.2	11.9	16.5	20.5	11.4	17.4	12.4	12.8	37.1	10.2	39.2	24.6	21.6	8.4	20.6	16.7	15.8	15.4	48.3	18.1	13.2	36.4	27.3	23.4	13.4	23.0	25.7	17.6	40.5	8.8	68.4	16.9	26.6	47.0	18.1	24.7	17.3	19.2	27.3	11.7	8.2	28.8	10.8	28.8	14.0	13.9	27.1	24.9	15.9	39.8	5.4	12.5	13.7	19.1	22.9	20.2	13.9	32.4	17.9	42.4	25.4	4.4	14.2	2.5	22.9	12.2	18.7	27.3	25.3	31.0	14.7	22.0	31.4	33.9	3.2	23.6	11.1	15.4	21.5	17.7	50.5	36.1	26.4	31.7	41.1	37.0	45.0	18.9	23.4	16.8
HDHD3	"C9orf158, MGC12904"	ENSG00000119431	"Haloacid dehalogenase like hydrolase domain containing 3"	Q9BSH5	9	113373419-113376999	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 54.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020427, HPA024158, HPA024585"	Enhanced		Enhanced	Nucleoli,Vesicles				Nucleoli	Vesicles	"HPA020427: AB_1850561, HPA024158: AB_1850563, HPA024585: AB_1850565"	"unprognostic (1.30e-1)"	"prognostic favourable (2.72e-4)"	"unprognostic (3.01e-2)"	"unprognostic (1.31e-2)"	"unprognostic (8.24e-3)"	"unprognostic (1.57e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.87e-2)"	"prognostic favourable (3.54e-7)"	"unprognostic (2.16e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.19e-3)"	4.9	54.7	5.1	10.1	8.4	3.3	12.7	6.2	8.5	6.0	29.8	5.6	10.6	38.2	6.4	15.5	13.8	5.8	18.1	9.1	4.6	5.3	17.7	36.6	4.4	6.3	4.5	9.4	7.2	23.7	20.5	9.1	6.5	7.3	10.6	16.8	8.3	24.4	12.5	2.8	11.4	47.1	8.0	4.8	6.0	17.7	4.5	4.0	8.0	18.2	6.1	6.8	7.0	6.9	12.1	10.6	5.9	2.9	5.6	12.3	5.8	3.6	10.5	2.3	6.3	5.7	2.5	19.2	2.7	5.2	4.4	4.9	19.2	18.4	8.1	3.4	1.5	14.4	3.6	4.2	1.5	11.3	8.2	11.2	5.7	11.9	6.6	0.6	8.6	3.9	9.0	3.6	10.3	2.3	8.8	2.0	2.1	23.9	5.1	3.2	5.1	8.2	4.2	0.0	6.5	5.6	7.7	5.7	3.6	4.7	20.3	6.8	12.7	2.3	2.3	0.9	0.0	0.7	0.9	5.0	9.7	3.3	1.1	0.0	0.6	0.1	2.9	5.9	9.9	1.6	11.2	11.3	11.5	9.0	4.5	12.1	12.0	8.9	1.9	5.6	0.2	10.6	12.3	5.8	5.1	8.4	6.2	8.5	4.6	5.3	4.5	9.4	7.3	4.0
HEATR5B	"DKFZp686P15184, KIAA1414"	ENSG00000008869	"HEAT repeat containing 5B"	Q9P2D3	2	36968383-37084342	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042025, HPA055639"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA042025: AB_10959880, HPA055639: "	"unprognostic (3.11e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.07e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.70e-2)"	"unprognostic (7.75e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.33e-3)"	"unprognostic (8.26e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.80e-3)"	"unprognostic (8.69e-2)"	"unprognostic (4.18e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.95e-1)"	14.7	13.6	13.5	14.1	23.8	21.8	15.0	23.3	22.8	11.1	10.2	15.4	10.1	10.9	16.5	18.0	14.9	9.7	10.9	10.7	11.4	12.1	9.9	12.9	12.5	29.6	13.0	16.6	12.3	23.8	17.9	16.6	10.3	21.6	12.2	14.0	12.4	18.0	9.6	7.1	18.0	14.9	9.4	16.1	18.0	12.8	9.6	14.5	16.0	13.6	8.4	30.0	11.3	12.9	15.2	10.7	15.8	4.9	7.0	9.1	5.0	10.2	5.2	7.7	11.7	8.0	8.0	9.8	6.5	4.8	5.9	6.1	5.9	7.1	22.0	4.7	5.5	8.7	7.6	5.3	7.8	10.7	8.2	14.3	6.9	8.3	5.0	15.3	18.9	7.3	7.4	8.6	8.2	9.9	13.5	19.5	7.1	6.1	13.3	11.0	5.0	3.7	12.9	7.9	16.4	7.0	8.9	9.5	8.4	6.7	10.9	5.1	7.8	5.0	11.1	9.1	5.2	6.5	5.0	12.2	10.0	24.2	7.4	9.2	5.9	15.8	4.9	11.3	7.9	2.6	7.2	9.9	8.8	8.8	8.6	15.2	9.1	7.9	5.1	7.0	3.8	10.7	8.9	5.0	13.5	23.8	23.3	22.8	11.4	12.1	13.0	16.6	21.6	14.5
HECTD1	KIAA1131	ENSG00000092148	"HECT domain E3 ubiquitin protein ligase 1"	Q9ULT8	14	31100112-31207804	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002929, HPA054461"	Approved		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA002929: AB_1850574, HPA054461: "	"unprognostic (6.71e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.51e-1)"	"prognostic favourable (1.20e-6)"	"unprognostic (6.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.91e-3)"	22.0	22.3	14.2	21.0	16.8	22.0	18.5	22.3	18.9	19.4	17.9	15.2	20.2	11.5	17.6	15.7	30.4	16.1	15.2	26.2	13.5	14.3	18.0	35.2	15.0	14.1	14.5	14.5	18.2	15.1	34.8	20.5	27.0	18.8	16.8	15.5	16.8	18.9	16.4	88.5	24.3	16.3	15.6	13.7	16.4	18.8	18.9	14.4	16.7	24.8	23.0	18.6	18.6	22.3	10.6	9.3	12.6	8.6	8.9	8.1	3.3	28.4	17.8	15.7	9.8	49.6	26.0	15.0	17.4	17.6	15.6	13.5	13.3	15.4	22.3	18.5	31.8	19.3	20.8	15.7	23.7	13.6	8.5	22.8	14.7	53.1	23.1	23.7	16.8	22.8	21.8	17.5	27.5	28.6	16.4	10.4	24.2	23.3	9.2	10.1	11.9	16.2	17.0	18.1	9.7	24.3	29.5	11.6	13.6	25.5	17.7	15.4	18.6	15.3	28.6	18.1	14.2	13.0	14.7	11.4	16.1	25.2	8.6	12.0	15.2	12.6	8.6	11.3	7.1	7.1	8.1	7.2	8.0	6.3	9.3	10.6	6.7	6.6	4.4	8.9	5.3	7.8	8.0	3.3	14.2	16.8	22.3	18.9	13.5	14.3	14.5	14.5	18.8	14.4
HELZ	"DHRC, HUMORF5, KIAA0054"	ENSG00000198265	"Helicase with zinc finger"	P42694	17	67070438-67245989	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028276	Approved		Approved	"Nucleoli,Plasma membrane,Actin filaments"				Nucleoli	"Plasma membrane, Actin filaments"	"HPA028276: AB_10601814"	"unprognostic (3.16e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.56e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.83e-2)"	"unprognostic (4.71e-2)"	"unprognostic (5.85e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-1)"	17.9	12.9	11.2	14.3	14.3	17.7	12.6	24.3	17.7	14.4	14.0	11.6	12.9	7.9	17.0	13.0	9.1	11.1	11.5	11.1	12.0	9.7	11.8	17.3	14.8	14.6	10.7	6.2	20.5	13.9	34.1	33.5	19.2	16.5	11.9	10.9	12.2	12.4	10.9	18.9	9.0	15.6	12.2	13.5	17.3	11.7	16.4	12.7	34.1	15.3	8.8	13.9	15.3	11.9	4.8	4.4	4.3	4.9	4.0	11.0	3.2	7.5	7.6	9.2	9.5	11.7	6.5	14.2	6.7	6.7	8.8	9.7	11.0	6.0	15.6	5.6	9.0	8.0	17.6	8.5	14.2	6.0	5.5	19.9	8.3	9.0	5.6	16.4	12.2	7.7	8.2	8.7	11.1	13.6	13.8	10.0	7.4	9.6	21.1	5.7	5.6	7.3	14.3	16.8	6.8	7.1	10.7	9.3	8.5	10.6	8.9	11.6	10.5	10.2	12.2	11.4	13.1	6.2	6.0	8.2	9.6	11.8	5.6	10.2	11.8	3.6	4.9	4.3	8.8	4.5	11.0	2.9	5.4	5.3	4.4	4.8	3.3	4.5	3.7	4.0	2.9	3.6	4.8	3.2	11.2	14.3	24.3	17.7	12.0	9.7	10.7	6.2	16.5	12.7
HERPUD2	FLJ22313	ENSG00000122557	"HERPUD family member 2"	Q9BSE4	7	35632659-35695571	"Predicted intracellular proteins, Predicted membrane proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015630, HPA076087"	Approved		Approved	Nucleoli				Nucleoli		"HPA015630: AB_1850609, HPA076087: "	"unprognostic (1.85e-2)"	"unprognostic (5.31e-3)"	"unprognostic (2.76e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.30e-2)"	"unprognostic (7.95e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.42e-2)"	"unprognostic (6.54e-2)"	22.7	13.7	19.2	25.6	21.7	34.3	21.9	25.0	21.7	24.2	20.3	18.6	18.8	16.1	24.3	17.1	21.2	19.9	26.4	16.6	17.5	14.0	17.6	25.3	22.7	33.7	16.7	18.3	37.0	31.4	18.0	22.5	21.6	15.4	21.6	19.3	19.5	19.6	23.8	17.9	20.9	20.5	23.9	18.5	24.1	18.0	39.5	18.3	34.3	22.5	15.4	23.2	25.0	22.0	5.7	5.9	19.2	9.2	12.1	12.2	4.8	18.5	7.0	13.3	13.0	20.0	15.3	10.8	13.2	18.6	8.6	9.7	8.4	22.2	13.3	21.1	16.7	23.4	7.4	9.5	13.4	8.9	9.5	9.2	8.6	5.6	17.2	9.3	11.8	19.1	17.2	10.8	17.7	14.2	14.4	17.9	14.9	7.8	10.6	15.3	11.2	9.7	12.8	16.1	10.7	11.2	8.3	11.1	18.4	16.7	15.9	11.4	16.0	11.3	16.6	13.5	15.6	13.1	10.5	24.9	28.3	14.1	13.0	14.4	24.8	5.8	6.8	19.2	10.6	7.6	12.2	4.4	9.5	11.3	5.9	5.7	5.9	8.0	11.7	12.1	9.2	3.6	8.6	4.8	19.2	21.7	25.0	21.7	17.5	14.0	16.7	18.3	15.4	18.3
HES6	bHLHb41	ENSG00000144485	"Hes family bHLH transcription factor 6"	Q96HZ4	2	238238267-238240662	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 47.4"	"Cell line enhanced"	"Detected in many"		"NB-4: 50.4;SCLC-21H: 33.4;SK-MEL-30: 48.2;U-937: 25.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"eosinophil: 8.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061763			Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"				"Nucleoli, Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA061763: "	"unprognostic (1.35e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.40e-3)"	"unprognostic (7.46e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (2.79e-4)"	"prognostic favourable (9.18e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.35e-1)"	"unprognostic (6.30e-2)"	"unprognostic (5.13e-2)"	"unprognostic (8.50e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.49e-2)"	2.1	5.2	15.4	3.4	10.6	10.5	3.0	7.3	47.4	3.7	12.2	17.1	0.8	18.1	6.3	1.5	1.6	14.3	5.7	1.7	17.5	9.1	1.9	2.5	2.2	3.3	11.4	12.3	1.3	13.9	5.3	23.6	1.7	14.3	2.0	9.6	1.5	3.8	1.7	8.2	1.7	12.9	3.3	18.8	4.6	5.2	9.4	11.7	0.4	5.5	1.7	2.8	1.3	1.0	0.3	1.4	8.0	0.3	0.1	1.0	0.2	1.2	1.4	6.4	7.2	0.4	0.2	4.1	0.4	0.4	0.6	0.9	1.1	0.8	0.0	1.0	0.1	0.8	6.5	0.4	0.2	2.8	7.8	1.4	1.0	13.1	1.0	10.5	8.8	0.6	4.0	0.9	1.3	0.4	13.3	0.1	0.4	3.2	1.6	50.4	10.2	1.1	7.1	16.2	3.0	0.8	0.6	33.4	14.6	1.9	2.9	48.2	2.5	22.4	0.6	0.6	1.3	3.5	3.7	3.0	0.5	2.2	2.2	25.7	1.1	0.1	0.3	8.0	1.0	0.2	0.0	0.2	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.1	0.3	1.4	0.7	0.2	15.4	10.6	7.3	39.3	17.5	9.1	11.4	12.3	14.3	11.7
HES7	bHLHb37	ENSG00000179111	"Hes family bHLH transcription factor 7"	Q9BYE0	17	8120590-8124092	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.3;salivary gland: 10.5"	"Cell line enhanced"	"Detected in some"		"A-431: 6.6;Daudi: 7.0;HAP1: 9.0;HDLM-2: 7.1;HeLa: 13.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 9.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"cerebellum: 0.8"	HPA072105	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA072105: "	"unprognostic (1.98e-1)"	"unprognostic (7.91e-3)"	"unprognostic (1.16e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.99e-2)"		"unprognostic (2.84e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.22e-5)"	"unprognostic (2.99e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.55e-1)"	0.4	0.4	1.0	0.3	1.0	0.2	0.5	9.3	2.4	1.4	0.3	0.6	0.2	0.0	2.0	0.2	0.7	0.6	0.6	1.3	1.5	0.5	1.1	0.2	0.9	0.6	1.0	0.2	1.5	0.5	0.0	0.4	3.6	2.1	0.6	0.2	0.9	10.5	2.5	1.1	0.6	0.3	0.4	1.5	0.3	0.2	2.3	0.2	0.2	0.8	0.2	0.5	1.3	0.9	0.2	0.1	0.0	0.1	0.3	0.2	0.1	6.6	0.5	0.5	2.2	0.2	0.3	0.3	0.3	0.5	0.8	2.4	0.1	0.4	7.0	0.1	0.0	0.7	9.0	0.6	0.0	7.1	4.3	0.3	13.4	0.1	0.8	0.7	0.9	0.2	1.2	1.9	5.1	0.1	0.2	3.2	0.1	0.1	0.1	0.3	0.2	1.7	0.7	0.4	1.2	0.2	0.0	0.3	3.2	0.4	0.0	0.4	0.1	0.0	0.6	0.0	1.5	1.5	2.3	4.4	0.9	0.4	0.7	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.1	0.0	0.1	1.0	1.0	9.3	2.4	1.5	0.5	1.0	0.2	2.1	0.2
HINT3	FLJ33126	ENSG00000111911	"Histidine triad nucleotide binding protein 3"	Q9NQE9	6	125956781-125980244	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 65.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA027914	Approved		Approved	Nucleoli,Mitochondria,Cytosol				"Nucleoli, Mitochondria"	Cytosol	"HPA027914: AB_10602424"	"prognostic unfavourable (4.99e-4)"	"unprognostic (4.75e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.88e-3)"	"unprognostic (3.82e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.05e-1)"	"prognostic favourable (1.05e-6)"	"unprognostic (4.09e-2)"	"unprognostic (4.76e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.64e-1)"	11.4	16.3	27.4	8.0	23.3	7.2	15.6	19.4	24.3	13.1	13.1	24.8	10.6	10.4	11.5	12.6	15.2	11.4	10.9	19.0	28.1	23.0	15.1	18.5	13.9	7.0	28.7	17.0	10.4	12.8	16.3	13.4	12.1	20.7	20.5	12.1	10.3	16.0	16.2	65.8	11.6	10.5	15.2	40.8	6.8	16.0	21.9	17.0	7.7	15.9	16.8	7.4	16.1	8.8	11.0	11.1	15.0	13.2	7.9	9.9	7.0	6.9	5.5	7.7	15.9	3.0	8.3	9.5	7.5	10.9	5.8	6.0	13.5	3.8	15.1	14.0	5.0	10.4	9.8	6.3	6.8	14.2	12.6	6.3	8.3	11.3	14.2	9.9	10.7	6.5	14.1	5.8	14.8	8.7	19.6	10.2	5.7	10.5	7.9	7.2	2.6	5.3	6.7	5.3	5.0	12.0	12.7	15.4	9.5	6.8	9.8	35.1	9.9	15.3	6.1	4.0	5.6	18.9	10.6	14.8	16.9	9.6	11.2	9.5	5.1	14.4	13.2	11.4	7.2	8.4	7.8	11.0	9.2	7.5	11.1	10.4	9.9	8.7	15.0	7.9	10.8	6.9	9.1	7.0	27.4	23.3	19.4	24.3	28.1	23.0	28.7	17.0	20.7	17.0
HIST1H1C	"H1.2, H1c, H1F2, H1s-1"	ENSG00000187837	"Histone cluster 1 H1 family member c"	P16403	6	26055787-26056428	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 353.5"	"Cell line enhanced"	"Detected in many"		"K-562: 48.9;SiHa: 46.5;U-2 OS: 91.7;U-266/70: 101.7;U-266/84: 96.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 79.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 79.7"	"Low region specificity"	"Detected in all"							"CAB011507, HPA055907"	Supported		Supported	Nucleoplasm,Nucleoli			1800000	"Nucleoplasm, Nucleoli"		"CAB011507: AB_2117984, HPA055907: "	"unprognostic (4.43e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (1.12e-4)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (1.56e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.93e-2)"	"unprognostic (3.08e-1)"	"prognostic favourable (8.06e-5)"	25.1	17.4	10.1	32.1	10.2	94.7	36.0	23.8	12.8	29.8	23.3	8.1	14.3	15.0	24.7	21.0	48.6	16.6	27.4	37.6	9.3	7.3	23.8	43.1	31.4	37.2	8.2	8.7	34.4	46.6	2.3	5.8	29.1	6.9	44.3	21.2	26.5	22.0	9.5	69.1	21.0	21.1	22.9	12.5	28.4	25.6	33.7	5.4	353.5	21.7	28.5	39.7	38.8	28.0	14.9	5.9	79.7	3.2	3.3	8.6	4.2	5.7	4.2	3.1	3.3	8.0	1.6	0.1	2.9	4.8	13.8	14.7	2.2	4.2	0.4	16.8	3.8	2.5	1.0	2.2	3.9	5.6	3.6	2.4	4.6	2.5	2.3	1.1	5.8	11.2	3.1	1.8	3.0	2.1	48.9	36.8	6.8	2.6	2.9	2.6	1.7	6.4	1.5	1.4	18.7	8.1	4.2	8.0	2.7	46.5	8.0	3.2	9.9	1.7	0.9	6.3	91.7	1.8	1.3	101.7	96.6	4.4	4.6	38.1	2.1	35.8	2.6	79.7	3.8	2.6	4.8	9.8	6.3	4.1	5.6	14.9	5.8	4.4	43.0	3.3	3.2	5.9	8.6	4.2	10.1	10.2	23.8	12.8	9.3	7.3	8.2	8.7	6.9	5.4
HJURP	"DKFZp762E1312, FAKTS, hFLEG1, URLC9"	ENSG00000123485	"Holliday junction recognition protein"	Q8NCD3	2	233833416-233854566	"Predicted intracellular proteins"	"Cell cycle"	"Chaperone, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 27.4;lymphoid tissue: 51.1;testis: 20.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 1.2;monocytes: 1.3;T-cells: 4.2"					"Not detected"	"Not detected"			"HPA008436, HPA027261"	Uncertain		Enhanced	Nucleoplasm,Nucleoli,Mitochondria				"Nucleoplasm, Nucleoli"	Mitochondria	"HPA008436: AB_1850757, HPA027261: "	"unprognostic (5.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (3.37e-5)"	"prognostic unfavourable (2.46e-4)"	"prognostic unfavourable (6.49e-4)"	"unprognostic (9.48e-2)"	"prognostic unfavourable (7.72e-5)"	"unprognostic (7.60e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.42e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.74e-2)"	1.4	0.9	0.1	12.2	0.4	27.4	2.2	0.1	0.7	1.1	3.7	0.3	0.1	2.6	0.6	1.8	8.0	0.3	0.7	1.1	0.1	0.2	1.0	1.2	2.0	8.1	0.2	0.1	0.6	0.4	0.0	0.2	3.1	0.2	0.7	3.6	0.3	1.5	1.0	0.2	2.6	4.8	1.1	0.4	5.8	2.4	20.9	0.1	51.1	0.4	3.0	11.6	1.0	2.8	0.5	0.3	1.2	1.3	0.5	4.2	1.7	17.0	23.0	22.6	10.6	0.8	1.8	14.1	25.6	12.3	18.3	20.0	16.2	18.6	5.3	2.9	10.1	19.9	18.0	13.2	24.4	12.5	6.7	20.5	18.5	15.7	0.1	16.9	14.2	0.6	0.5	14.9	10.3	11.4	17.4	13.3	33.6	17.2	23.7	18.6	19.2	16.0	18.3	33.8	9.4	9.4	10.3	13.0	8.1	14.7	11.2	10.5	8.4	13.1	8.3	19.8	21.5	14.5	27.6	12.7	10.0	21.4	11.8	12.5	49.2	0.6	0.2	0.2	0.3	0.2	0.2	0.4	0.7	0.6	0.3	0.5	0.3	0.5	1.2	0.5	1.3	0.2	4.2	1.7	0.1	0.4	0.1	0.7	0.1	0.2	0.2	0.1	0.2	0.1
HMGA1	HMGIY	ENSG00000137309	"High mobility group AT-hook 1"	P17096	6	34236873-34246231	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 107.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB032200, HPA065612, HPA068442"	Enhanced		Approved	Nucleoplasm,Nucleoli			18000	Nucleoplasm	Nucleoli	"CAB032200: AB_2117771, HPA065612: , HPA068442: "	"unprognostic (1.81e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (7.13e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.20e-3)"	"prognostic unfavourable (1.29e-6)"	"prognostic unfavourable (3.36e-4)"	"unprognostic (8.54e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavourable (8.71e-4)"	"unprognostic (1.55e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.37e-1)"	"unprognostic (2.65e-2)"	15.8	3.5	14.8	35.7	13.5	55.4	13.0	13.8	19.0	26.1	22.0	5.9	7.7	42.3	8.6	7.2	79.4	15.1	17.8	13.0	11.7	12.6	14.6	6.9	16.0	46.1	10.7	8.7	3.9	13.0	4.1	5.1	31.8	12.5	8.7	21.2	9.9	22.0	6.9	33.7	38.3	36.0	3.8	8.4	31.6	24.2	32.6	7.2	107.3	12.5	39.6	72.7	13.0	29.6	26.6	33.4	12.8	10.1	7.3	22.4	11.0	120.4	47.7	24.5	17.1	11.4	84.6	107.0	48.7	55.7	37.8	21.1	31.2	84.5	56.8	24.6	19.9	25.9	28.8	86.9	30.1	12.4	19.3	17.4	16.1	41.7	24.2	62.2	20.1	36.2	9.7	68.4	35.8	114.1	70.1	2.9	52.6	12.2	53.9	76.6	119.2	80.9	80.2	0.5	62.7	25.6	11.1	42.8	18.1	5.1	24.7	45.0	9.9	66.8	98.9	19.7	62.2	28.6	45.6	23.4	36.2	73.4	41.7	26.0	98.3	6.2	10.1	12.8	10.2	10.1	13.3	26.6	18.7	16.0	30.7	16.4	22.4	17.7	2.6	7.3	9.4	33.4	21.0	11.0	14.8	13.5	13.8	19.0	11.7	12.6	10.7	8.7	12.5	7.2
HMGA2	"BABL, HMGIC, LIPO"	ENSG00000149948	"High mobility group AT-hook 2"	P52926	12	65824131-65966295	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cell division, DNA condensation, Growth regulation, Mitosis, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 25.3"	"Cell line enhanced"	"Detected in many"		"AF22: 66.0;NTERA-2: 38.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"CAB017809, HPA039076"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"CAB017809: , HPA039076: "	"unprognostic (2.39e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.68e-3)"	"unprognostic (5.21e-3)"	"prognostic unfavourable (4.79e-4)"	"unprognostic (4.05e-3)"	"unprognostic (6.17e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-6)"	"unprognostic (3.33e-2)"	"unprognostic (4.55e-5)"	"unprognostic (4.22e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavourable (2.86e-4)"	6.5	0.3	0.5	3.8	0.8	8.1	2.1	0.2	0.6	2.5	7.6	0.4	0.0	2.4	2.7	0.1	1.1	2.4	3.3	0.5	0.3	0.4	1.0	0.4	0.5	0.1	0.3	1.3	2.1	1.7	0.0	1.7	0.3	0.6	0.5	4.6	0.4	0.5	1.8	2.0	0.7	5.1	0.7	1.7	0.8	2.1	25.3	0.0	0.8	1.1	3.0	0.1	0.8	2.8	0.7	0.3	3.8	2.1	1.3	0.7	0.1	9.5	4.2	66.0	9.4	3.1	17.3	0.0	30.5	13.9	5.4	5.4	5.4	4.0	0.0	19.8	1.4	4.2	10.9	26.2	25.7	0.0	11.4	0.0	0.1	33.0	1.7	0.9	0.1	13.1	1.6	11.5	20.8	21.1	0.0	0.1	30.5	0.0	0.1	5.4	38.7	19.0	2.6	3.2	0.0	14.2	0.0	0.0	0.0	0.0	0.0	16.7	0.1	0.1	24.6	19.4	5.8	14.8	9.1	0.0	0.0	0.0	23.4	0.0	4.4	3.8	1.0	0.7	0.5	0.6	0.3	0.3	0.4	0.5	0.2	0.7	0.4	0.7	2.5	1.3	2.1	0.3	0.3	0.1	0.5	0.8	0.2	0.6	0.3	0.4	0.3	1.3	0.6	0.0
HMGB2	HMG2	ENSG00000164104	"High mobility group box 2"	P26583	4	173331695-173335125	"Plasma proteins, Predicted intracellular proteins"	"Chemotaxis, DNA recombination, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 95.9;bone marrow: 325.8;lymphoid tissue: 187.1"	"Cell line enhanced"	"Detected in all"		"MOLT-4: 168.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003506, CAB037206, HPA053314"	Enhanced		Supported	Nucleoplasm,Nucleoli	"Intracellular and membrane"		380000	Nucleoplasm	Nucleoli	"CAB037206: AB_1079071, HPA003506: AB_1079070, HPA053314: "	"unprognostic (2.82e-1)"	"unprognostic (8.52e-3)"	"unprognostic (2.56e-1)"	"unprognostic (8.37e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavourable (3.76e-5)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (3.13e-4)"	"unprognostic (4.41e-2)"	"prognostic unfavourable (7.04e-4)"	"unprognostic (9.65e-2)"	"prognostic unfavourable (7.60e-12)"	"unprognostic (1.60e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.21e-2)"	18.8	5.9	10.3	48.9	13.2	325.8	19.9	6.6	9.5	17.1	24.0	8.6	7.9	15.7	18.6	16.2	28.6	15.4	13.8	23.4	9.5	10.2	13.2	6.9	25.4	59.8	12.5	8.2	29.0	5.8	2.9	8.0	18.5	9.3	19.0	21.2	12.2	13.8	8.6	46.2	15.5	21.5	25.3	13.3	36.7	13.0	26.7	10.6	187.1	18.7	23.0	61.6	27.1	18.5	11.6	16.8	95.9	20.5	11.9	39.9	14.3	34.3	8.2	70.9	31.6	8.8	8.8	27.2	25.6	19.5	28.2	25.3	23.3	48.0	116.2	5.8	14.3	13.4	46.5	14.0	44.2	71.1	21.7	127.7	20.9	34.1	8.6	112.9	49.3	8.5	4.3	14.1	32.2	29.0	48.1	163.7	25.9	28.7	168.3	104.8	25.8	14.3	85.1	36.4	43.1	16.3	14.7	61.4	55.4	25.9	15.0	11.5	20.8	82.4	16.6	12.7	37.6	15.7	38.4	52.9	29.6	133.0	10.8	82.6	33.0	95.9	20.5	57.6	15.6	8.5	14.1	11.6	22.7	21.2	16.8	8.8	15.0	14.3	47.8	11.9	6.8	6.8	39.9	14.3	10.3	13.2	6.6	9.5	9.5	10.2	12.5	8.2	9.3	10.6
HMGB3	"HMG2A, HMG4, MGC90319"	ENSG00000029993	"High mobility group box 3"	O15347	X	150980509-150990775	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	DNA-binding	Microphthalmia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 54.3"	"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 107.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA062583	Enhanced		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA062583: "	"unprognostic (2.85e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.66e-3)"	"unprognostic (4.54e-3)"	"unprognostic (2.70e-2)"	"prognostic favourable (9.85e-5)"	"unprognostic (6.03e-2)"	"unprognostic (1.96e-2)"	"prognostic favourable (6.15e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	4.4	5.4	7.9	4.8	7.1	20.3	4.1	2.8	10.3	10.8	12.0	4.7	3.9	7.3	6.3	13.4	10.2	4.4	3.2	4.5	9.8	7.6	9.0	41.6	5.9	6.3	6.1	7.3	3.1	7.1	18.7	1.6	54.3	9.7	3.7	9.2	5.3	9.7	4.3	20.5	6.8	7.6	3.6	5.0	8.4	4.0	26.0	3.2	18.2	6.2	5.1	9.5	4.9	3.7	3.1	6.5	11.8	5.3	0.9	6.2	2.3	37.1	16.5	52.0	27.0	2.2	6.5	64.7	16.3	10.8	19.0	9.9	13.0	15.4	26.0	52.6	12.5	17.9	47.3	107.0	21.4	17.7	13.8	22.6	15.9	20.4	3.2	34.0	11.5	5.1	25.3	7.7	19.6	24.5	11.7	15.5	22.5	28.5	37.5	26.2	30.8	20.2	46.0	42.3	14.7	13.9	17.8	37.5	24.5	24.2	26.2	8.1	23.1	22.6	18.4	7.9	18.7	25.1	35.9	14.1	17.5	96.4	9.4	17.4	16.0	0.0	4.8	11.8	0.5	3.2	0.1	3.1	2.4	3.3	6.5	0.6	0.0	0.2	0.6	0.9	5.3	3.3	6.2	2.3	7.9	7.1	2.8	10.3	9.8	7.6	6.1	7.3	9.7	3.2
HMGN2	HMG17	ENSG00000198830	"High mobility group nucleosomal binding domain 2"	P05204	1	26472450-26475972	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB018371, HPA077364"	Supported		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"CAB018371: , HPA077364: "	"unprognostic (3.10e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.10e-3)"	"unprognostic (4.13e-2)"	"unprognostic (4.06e-1)"	"unprognostic (2.27e-2)"	"prognostic unfavourable (1.34e-4)"	"unprognostic (2.36e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.05e-3)"	"unprognostic (5.23e-3)"	"prognostic unfavourable (3.92e-4)"	"unprognostic (3.00e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.15e-1)"	30.6	34.9	36.0	52.4	32.3	169.1	37.6	30.8	39.1	51.3	43.4	30.3	53.6	30.0	46.1	60.6	44.1	50.1	51.6	37.6	30.5	32.0	35.9	37.1	62.9	100.2	32.7	30.5	64.7	59.4	16.7	52.7	49.6	26.0	48.0	49.9	42.5	58.9	51.9	41.1	33.9	41.3	68.1	40.4	50.0	33.2	29.9	31.1	104.6	48.6	52.5	83.2	43.7	38.7	60.4	81.4	157.4	73.6	38.6	83.4	103.5	82.5	28.7	83.1	34.9	7.7	17.9	32.4	40.9	23.6	80.1	61.8	29.5	77.4	93.0	39.1	33.2	47.7	104.7	40.6	68.2	57.2	74.2	99.8	34.0	28.8	14.5	211.2	58.3	18.8	21.3	43.8	25.9	37.2	78.9	44.7	41.9	60.9	150.6	96.0	69.5	53.3	104.8	130.4	56.9	25.2	22.6	82.9	51.4	122.9	34.6	45.2	56.7	100.2	27.7	40.0	74.7	76.5	68.1	54.6	74.1	103.5	25.7	222.3	79.2	30.3	59.9	157.4	34.2	69.0	32.0	60.4	46.8	41.4	60.9	59.1	51.5	41.7	53.1	38.6	73.6	81.4	83.4	103.5	36.0	32.3	30.8	39.1	30.5	32.0	32.7	30.5	26.0	31.1
HMGXB3	"HMGX3, KIAA0194, SMF"	ENSG00000113716	"HMG-box containing 3"	Q12766	5	150000046-150053142	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"parathyroid gland: 151.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005967			Approved	Nucleoli				Nucleoli		"HPA005967: AB_1080044"	"unprognostic (3.66e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.82e-2)"	"prognostic unfavourable (3.37e-5)"	"unprognostic (9.72e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.89e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.24e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-2)"	12.0	14.2	8.2	14.5	14.4	15.3	16.1	14.5	17.4	11.3	10.3	15.0	15.4	8.3	13.9	20.0	9.3	13.5	12.1	9.4	8.6	8.3	11.6	11.7	14.7	10.3	10.1	11.0	15.0	13.8	151.8	15.3	11.8	12.9	17.6	10.8	16.8	12.4	18.4	12.5	13.1	9.9	12.8	8.9	14.4	12.0	17.7	7.3	15.3	14.7	10.1	12.0	11.2	10.1	5.8	6.2	5.1	5.9	2.2	8.1	3.7	12.2	14.4	10.2	16.1	14.7	12.5	17.8	11.9	22.0	17.9	22.6	20.2	15.0	11.7	14.0	16.2	9.1	19.4	20.4	15.5	10.9	13.9	10.3	15.2	9.8	20.4	19.6	23.4	16.3	15.3	26.2	20.7	12.7	13.4	12.3	18.8	9.7	12.2	10.2	7.7	21.7	10.6	14.2	11.3	10.7	15.4	13.2	13.3	10.4	25.5	26.4	11.9	12.8	10.9	26.8	11.4	12.9	21.9	14.6	13.7	16.7	31.3	15.1	13.8	5.1	4.7	4.0	7.0	5.9	5.5	5.8	5.7	4.9	6.2	5.0	4.4	4.6	0.5	2.2	3.9	4.6	8.1	3.7	8.2	14.4	14.5	17.4	8.6	8.3	10.1	11.0	12.9	7.3
HOMEZ	KIAA1443	ENSG00000215271	"Homeobox and leucine zipper encoding"	Q8IX15	14	23272422-23299447	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036316, HPA036317"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA036316: AB_2675056, HPA036317: AB_10669787"	"unprognostic (3.70e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.93e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.37e-1)"	"prognostic favourable (2.41e-5)"	"unprognostic (2.23e-1)"	"unprognostic (1.77e-1)"	"prognostic favourable (1.17e-11)"	"unprognostic (2.62e-1)"	"unprognostic (2.00e-1)"	"prognostic favourable (1.75e-4)"	"unprognostic (3.23e-1)"	7.6	8.3	6.6	7.2	6.8	1.7	9.2	4.6	6.6	9.3	8.5	12.1	18.5	8.1	8.4	11.2	14.4	9.1	12.7	8.9	6.4	5.1	11.6	8.8	7.2	6.4	6.5	5.4	12.5	11.0	8.0	7.0	6.6	7.2	11.1	7.6	12.2	13.6	22.0	12.0	9.1	8.4	8.6	7.6	8.1	9.9	39.9	7.4	16.0	14.7	6.3	11.3	12.9	8.3	4.3	7.4	10.8	7.2	3.6	6.3	3.9	4.3	4.5	8.6	8.3	13.5	5.9	9.6	4.9	6.2	4.6	5.7	1.9	9.6	9.6	3.9	4.4	14.8	11.5	11.8	5.7	5.2	3.9	3.3	3.6	8.9	16.9	4.8	2.9	9.3	12.1	3.4	7.8	8.7	9.3	4.0	8.0	9.9	3.7	3.4	3.4	2.6	5.8	6.5	4.2	8.7	18.5	2.8	3.5	4.5	13.1	5.1	7.9	6.0	9.2	3.2	1.4	3.9	2.1	16.2	6.9	3.3	1.7	3.6	4.7	4.1	7.2	10.8	5.7	7.1	4.6	4.3	4.9	4.8	7.4	3.9	5.4	6.3	1.4	3.6	4.9	4.7	6.2	3.9	6.6	6.8	4.6	6.6	6.4	5.1	6.5	5.4	7.2	7.4
HORMAD1	"CT46, DKFZP434A1315"	ENSG00000143452	"HORMA domain containing 1"	Q86X24	1	150698060-150720888	"Predicted intracellular proteins"	"Differentiation, Meiosis, Oogenesis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"testis: 78.1"	"Cell line enhanced"	"Detected in some"		"A549: 5.6;HeLa: 4.4;hTCEpi: 19.3;SiHa: 5.9;THP-1: 11.1;U-2 OS: 3.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"classical monocyte: 1.2;neutrophil: 4.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.4;monocytes: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA028346, HPA037850"	Enhanced		Approved	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA028346: , HPA037850: AB_10696358"	"unprognostic (7.21e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.15e-2)"	"unprognostic (9.06e-2)"	"unprognostic (3.91e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-2)"	"unprognostic (5.17e-3)"	"unprognostic (3.79e-9)"	"unprognostic (3.32e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.49e-2)"	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.4	1.8	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	3.2	0.1	0.1	0.1	0.4	0.0	78.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.6	4.4	1.2	0.0	0.2	0.1	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.1	4.4	0.0	0.0	0.0	0.1	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.9	0.0	0.1	0.0	11.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	1.2	0.3	0.2	0.4	0.0	0.2	0.1	0.0	0.6	0.1	0.0	0.0	4.4	0.0	0.5	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
HOXD9	"HOX4, HOX4C"	ENSG00000128709	"Homeobox D9"	P28356	2	176122720-176124937	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 26.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 8.6;HEK 293: 12.0;RPTEC TERT1: 14.1;SH-SY5Y: 16.4;SK-MEL-30: 9.0;TIME: 12.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA068683			Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA068683: "	"unprognostic (1.89e-1)"	"unprognostic (9.41e-2)"	"prognostic unfavourable (8.25e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.03e-2)"	"prognostic favourable (9.58e-4)"	"prognostic unfavourable (1.08e-5)"	"unprognostic (6.62e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.56e-3)"	"unprognostic (6.71e-2)"	"unprognostic (4.77e-3)"	"unprognostic (8.38e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.44e-2)"	4.1	2.7	0.2	1.7	0.4	0.0	11.4	0.2	0.2	13.1	10.8	0.2	10.4	0.0	26.2	12.0	1.6	5.1	2.6	0.5	0.2	0.0	19.7	0.2	0.7	2.4	0.2	0.2	8.9	0.2	0.0	0.2	1.6	0.4	13.0	2.2	0.2	0.4	16.0	3.8	3.9	1.1	12.6	0.6	3.7	0.1	9.8	0.2	0.3	2.2	2.2	1.3	2.4	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	1.2	0.8	1.0	0.8	0.0	0.0	0.0	8.6	1.1	5.6	0.0	0.0	0.6	0.0	12.0	0.0	0.6	0.0	0.1	0.0	0.0	2.8	0.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	14.1	5.2	3.2	16.4	4.1	0.0	9.0	0.0	0.0	12.4	0.0	2.8	4.0	4.3	0.0	0.0	0.0	1.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.2	0.4	0.2
HS1BP3	"FLJ14249, HS1-BP3"	ENSG00000118960	"HCLS1 binding protein 3"	Q53T59	2	20560448-20651089	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035050	Approved		Approved	Nucleoli,Cytosol			32000	Nucleoli	Cytosol	"HPA035050: AB_10601816"	"unprognostic (4.52e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.67e-1)"	"unprognostic (4.39e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.45e-3)"	"prognostic unfavourable (2.97e-5)"	"unprognostic (2.06e-3)"	"unprognostic (1.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.53e-2)"	"unprognostic (8.00e-2)"	"prognostic favourable (2.30e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.20e-1)"	17.9	23.1	10.4	8.8	15.7	10.7	11.8	6.7	17.6	17.6	22.6	21.3	14.3	11.7	17.6	18.6	22.6	13.9	28.4	17.5	11.0	9.1	18.5	47.8	14.2	11.7	16.7	9.4	14.8	13.9	10.6	14.3	22.3	13.5	20.3	11.7	17.0	12.9	17.3	9.6	17.0	16.0	27.3	13.8	14.5	16.4	9.7	14.1	6.6	18.5	8.0	9.9	20.8	17.1	6.0	8.0	14.6	13.3	2.9	5.3	6.1	8.8	10.3	5.2	6.3	27.7	18.6	10.4	3.4	15.7	8.0	10.6	8.0	10.7	5.9	2.7	4.9	5.6	10.3	10.6	3.9	7.6	8.5	3.2	5.2	26.7	26.1	2.3	13.9	19.7	24.9	9.1	16.9	15.2	2.0	12.8	9.1	7.6	1.0	4.0	4.3	7.5	5.7	10.6	5.8	17.8	10.7	4.9	7.6	2.4	10.5	20.1	6.6	4.9	9.8	8.0	8.6	12.2	5.1	9.2	10.2	5.4	17.2	11.3	8.4	11.4	11.3	11.0	5.3	11.2	3.7	6.0	3.2	4.0	8.0	4.0	2.7	2.8	14.6	2.9	13.3	3.0	2.9	6.1	10.4	15.7	6.7	17.6	11.0	9.1	16.7	9.4	13.5	14.1
HSD3B1	"HSD3B, HSDB3, SDR11E1"	ENSG00000203857	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1"	P14060	1	119507198-119515054	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism, Steroidogenesis"	"Isomerase, Multifunctional enzyme, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"placenta: 231.4"	"Cell line enriched"	"Detected in some"	9	"CACO-2: 37.0"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA043261, HPA043264, HPA044028"	Supported		Approved	"Nucleoli,Endoplasmic reticulum,Cytokinetic bridge"				"Nucleoli, Endoplasmic reticulum"	"Cytokinetic bridge"	"HPA043261: , HPA043264: , HPA044028: "			"unprognostic (1.53e-1)"				"unprognostic (7.11e-2)"					"unprognostic (1.15e-1)"		"unprognostic (1.04e-1)"			"prognostic favourable (4.59e-5)"	0.1	0.6	0.0	0.0	0.3	0.0	0.7	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	231.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	4.5	11.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	37.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	4.1	0.4	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
HSD3B2	SDR11E2	ENSG00000203859	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"	P26439	1	119414931-119423035	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Steroidogenesis	"Isomerase, Multifunctional enzyme, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"adrenal gland: 223.2"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.5;SH-SY5Y: 1.4;SK-MEL-30: 5.1;TIME: 1.2;WM-115: 3.2"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Region enriched"	"Detected in single"	198	"basal ganglia: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA043261, HPA043264, HPA044028"	Supported		Uncertain	"Nucleoli,Endoplasmic reticulum,Cytokinetic bridge"				"Nucleoli, Endoplasmic reticulum"	"Cytokinetic bridge"	"HPA043261: , HPA043264: , HPA044028: "	"unprognostic (3.56e-1)"		"unprognostic (1.85e-1)"		"unprognostic (2.80e-1)"		"unprognostic (2.72e-2)"		"unprognostic (8.87e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.55e-1)"			0.0	223.2	0.0	0.8	19.8	0.0	0.0	0.0	0.0	0.0	0.5	43.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	3.6	0.2	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	1.5	1.4	0.0	0.0	5.1	0.0	0.0	1.2	0.2	0.1	0.1	0.7	0.0	0.0	0.0	0.8	0.0	3.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HSPB6	"FLJ32389, Hsp20, PPP1R91"	ENSG00000004776	"Heat shock protein family B (small) member 6"	O14558	19	35754569-35758079	"Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 356.8"	"Cell line enhanced"	"Detected in some"		"ASC diff: 184.7;ASC TERT1: 77.9;HHSteC: 62.6;HSkMC: 72.9"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 93.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB001974, HPA044153, HPA054811"	Enhanced		Supported	"Nucleoli,Golgi apparatus,Cytosol"	"Intracellular and membrane"		86000	Cytosol	"Nucleoli, Golgi apparatus"	"CAB001974: , HPA044153: , HPA054811: "	"unprognostic (3.19e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.21e-3)"	"unprognostic (7.02e-2)"	"unprognostic (9.67e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.02e-2)"	"prognostic unfavourable (1.93e-5)"	"unprognostic (3.32e-2)"	"unprognostic (6.65e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavourable (1.43e-6)"	95.3	39.5	3.9	18.3	8.1	1.1	40.5	1.1	6.1	49.7	48.4	3.8	18.6	5.7	42.6	57.4	24.6	33.3	80.6	132.0	4.4	2.4	6.2	3.5	8.7	7.2	5.4	2.8	53.4	5.8	1.7	1.2	12.7	8.1	42.1	8.7	18.2	8.6	35.8	356.8	2.5	14.3	128.2	10.2	1.9	32.4	22.6	4.9	0.0	11.0	153.5	16.4	121.6	23.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.2	0.2	184.7	77.9	0.1	8.2	0.1	0.5	0.9	0.1	0.0	0.0	0.0	24.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	62.6	0.0	0.0	72.9	0.0	1.9	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	1.7	0.0	0.1	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.9	8.1	1.1	6.1	4.4	2.4	5.4	2.8	8.1	4.9
HTD2		ENSG00000255154	"Hydroxyacyl-thioester dehydratase type 2"	P86397	3	58306262-58318574	"Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA066812			Supported	Nucleoli,Mitochondria				Mitochondria	Nucleoli	"HPA066812: "	"unprognostic (1.95e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.19e-3)"	"unprognostic (1.11e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.33e-2)"	7.9	8.9	9.0	6.6	13.9	6.9	9.4	17.0	11.5	7.4	9.2	6.4	7.1	11.3	8.6	8.5	9.4	7.8	7.1	15.9	7.9	9.3	12.1	16.2	6.9	8.2	8.5	10.7	11.0	12.9	8.8	14.2	6.7	7.8	9.6	10.1	9.7	9.2	9.4	35.2	7.2	9.7	12.6	6.0	9.7	8.6	9.8	6.4	6.8	10.7	19.8	9.2	7.8	8.1	23.9	21.6	23.7	20.4	21.3	26.5	13.5	8.0	6.1	9.4	6.7	8.0	9.0	12.1	11.5	8.7	14.3	12.6	13.4	6.1	16.0	3.4	8.3	7.1	15.8	10.4	14.8	8.9	11.0	9.6	13.6	11.3	8.7	12.6	9.1	11.1	10.7	15.2	9.2	12.5	9.4	15.2	9.0	4.7	8.1	6.4	12.2	14.0	5.7	6.0	11.4	9.6	11.9	5.9	8.8	7.1	6.6	13.1	8.9	11.1	7.3	12.2	8.6	11.0	14.0	11.6	20.9	12.5	9.8	9.4	7.4	13.5	17.3	23.7	18.7	20.4	20.1	23.9	18.7	23.5	17.5	23.8	26.5	20.2	18.4	21.3	16.7	21.6	13.4	13.5	9.0	13.9	17.0	11.5	7.9	9.3	8.5	10.7	7.8	6.4
IDH3G		ENSG00000067829	"Isocitrate dehydrogenase 3 (NAD(+)) gamma"	P51553	X	153785766-153794523	"Citric acid cycle related proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000425, HPA002017"	Supported		Approved	Nucleoli,Mitochondria				"Nucleoli, Mitochondria"		"HPA000425: AB_1079097, HPA002017: AB_1079096"	"unprognostic (4.24e-2)"	"unprognostic (1.43e-3)"	"unprognostic (5.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.96e-1)"	"prognostic favourable (5.73e-6)"	"unprognostic (1.50e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.46e-1)"	24.5	34.0	27.7	26.8	47.2	37.1	24.1	37.2	61.5	25.0	28.8	25.7	24.6	34.7	26.6	21.3	31.8	29.4	25.6	50.8	35.0	25.2	40.6	29.5	20.9	25.6	27.3	35.6	31.8	40.5	29.1	24.9	22.5	40.5	21.4	25.2	26.0	34.5	29.8	54.9	36.3	34.9	24.8	20.1	26.9	24.8	16.0	23.3	31.2	24.3	37.1	28.2	24.4	21.1	20.6	45.5	43.7	44.4	23.7	28.8	33.6	28.9	26.7	15.8	22.2	24.8	20.5	19.4	15.1	21.3	26.8	28.5	22.1	22.1	36.9	26.2	24.2	21.7	23.9	20.6	9.9	12.1	30.5	13.8	36.3	17.7	28.1	19.2	29.2	23.1	14.9	20.7	22.6	20.5	7.6	20.3	21.6	40.5	21.8	22.6	7.1	35.4	19.3	13.5	32.2	29.9	18.0	20.2	13.8	9.4	32.0	15.0	13.3	16.6	18.1	17.0	10.7	25.0	35.7	27.9	6.9	47.0	27.8	23.9	18.8	42.5	43.9	43.7	21.5	44.4	19.9	19.1	22.0	20.9	45.5	20.6	17.6	19.2	16.3	23.7	43.1	27.9	28.8	33.6	27.7	47.2	37.2	61.5	35.0	25.2	27.3	35.6	40.5	23.3
IER5		ENSG00000162783	"Immediate early response 5"	Q5VY09	1	181088712-181092899	"Predicted intracellular proteins"	"Stress response, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029894	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA029894: AB_10601433"	"unprognostic (1.18e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.55e-1)"	"prognostic favourable (2.42e-7)"	"unprognostic (1.00e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.63e-3)"	"prognostic unfavourable (1.18e-4)"	"unprognostic (2.81e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (2.36e-4)"	"unprognostic (1.26e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.09e-1)"	9.4	7.2	4.7	16.2	5.4	45.7	13.8	6.2	12.6	7.8	7.8	5.1	5.9	6.6	12.8	5.3	20.9	14.3	10.3	22.9	6.0	4.9	3.7	6.7	22.6	9.6	10.1	5.7	4.4	4.3	1.8	4.6	34.5	6.9	6.7	6.9	3.7	5.7	4.9	42.3	16.6	10.8	9.6	7.2	27.3	6.8	5.1	5.0	11.2	4.3	22.9	19.8	8.4	16.3	5.4	1.6	5.4	7.8	1.5	2.1	0.9	12.0	10.5	5.8	5.1	8.1	11.2	15.6	21.3	22.6	12.1	10.8	2.9	6.8	3.9	9.5	8.2	22.2	1.8	14.5	7.8	22.6	9.2	3.5	5.4	1.9	12.7	4.1	11.5	8.0	14.7	14.0	9.4	8.1	14.6	18.0	21.3	5.4	4.0	6.5	6.1	5.3	4.7	10.2	14.9	4.3	6.6	8.4	9.1	10.8	10.6	23.5	8.4	3.5	12.3	8.7	15.3	9.9	12.8	12.0	4.2	3.1	6.8	4.3	2.4	5.4	2.1	3.8	1.6	7.8	1.9	5.4	1.4	2.1	1.6	3.6	0.3	0.9	1.8	1.5	7.3	0.2	1.8	0.9	4.7	5.4	6.2	12.6	6.0	4.9	10.1	5.7	6.9	5.0
IFI16	"IFNGIP1, PYHIN2"	ENSG00000163565	"Interferon gamma inducible protein 16"	Q16666	1	158999968-159055155	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Autophagy, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA002134, CAB016293"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"CAB016293: AB_627775, HPA002134: AB_1079099"	"unprognostic (7.23e-3)"	"unprognostic (2.20e-2)"	"unprognostic (5.15e-2)"	"unprognostic (7.70e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.83e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.92e-3)"	"unprognostic (7.62e-2)"	"prognostic unfavourable (1.11e-16)"	"unprognostic (5.07e-2)"	"unprognostic (4.08e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.14e-1)"	64.2	21.0	10.9	42.5	18.0	10.2	34.8	6.7	11.4	28.5	18.6	9.6	7.8	7.5	32.5	21.8	32.8	25.0	33.4	24.8	16.5	7.5	13.3	10.2	32.1	51.0	19.5	6.3	32.6	5.5	3.2	7.0	21.4	18.0	23.0	15.2	10.9	33.6	11.2	14.6	23.7	21.6	29.1	32.2	63.2	11.8	14.2	16.0	81.8	19.1	24.2	41.8	30.9	27.6	28.9	20.8	51.2	21.0	27.9	24.6	16.9	6.9	0.5	2.4	0.1	16.8	55.6	0.0	14.8	39.7	41.7	55.5	0.0	8.9	40.9	12.8	9.0	20.3	0.3	15.0	16.7	12.6	0.1	10.5	3.1	0.0	31.4	3.6	0.7	52.3	26.9	21.3	30.4	43.8	0.2	30.0	23.1	0.0	48.0	3.3	6.4	5.4	22.7	15.4	47.2	5.8	2.6	1.1	0.0	19.4	0.1	42.1	0.0	4.2	24.7	10.7	5.1	30.2	6.2	28.0	13.1	38.4	30.8	11.8	25.8	2.5	21.0	0.1	18.9	20.5	16.9	27.6	18.1	19.3	20.8	28.9	11.5	14.6	51.2	27.9	18.5	15.6	24.6	16.9	10.9	18.0	6.7	11.4	16.5	7.5	19.5	6.3	18.0	16.0
IFI27L2	"FAM14A, TLH29"	ENSG00000119632	"Interferon alpha inducible protein 27 like 2"	Q9H2X8	14	94127779-94130253	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA049588			Approved	Nucleoli,Cytosol	"Intracellular and membrane"			Cytosol	Nucleoli	"HPA049588: "	"unprognostic (9.70e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.80e-2)"	"unprognostic (7.46e-3)"	"unprognostic (4.76e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.79e-3)"	"unprognostic (3.96e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.88e-1)"	"unprognostic (5.09e-2)"	"unprognostic (3.52e-2)"	11.4	39.9	38.6	18.3	23.8	17.0	18.8	15.2	24.7	19.9	16.0	23.5	8.7	11.6	15.8	9.6	24.5	21.9	20.8	38.9	29.7	32.4	13.2	3.7	16.5	21.5	37.1	22.8	25.9	13.2	11.7	20.6	5.4	27.4	10.6	9.7	20.4	7.2	12.5	4.0	16.0	13.5	15.5	35.7	17.0	15.7	9.1	22.9	13.8	8.5	16.0	22.5	12.0	17.2	31.5	29.6	19.8	38.7	6.0	30.5	31.9	8.3	5.9	1.7	11.9	8.6	22.1	1.0	15.6	16.1	11.8	13.9	1.6	3.8	3.7	17.1	16.8	10.3	1.2	20.8	4.8	24.9	0.9	5.7	5.8	0.5	14.5	6.7	15.7	20.0	7.7	7.0	4.3	7.8	0.5	56.9	12.2	15.7	3.9	4.1	2.1	6.7	0.1	5.5	4.9	18.0	3.2	3.1	4.7	0.4	0.1	10.0	19.3	11.2	7.6	7.9	4.8	10.6	4.3	23.2	19.2	1.2	25.2	14.9	5.1	19.8	38.7	7.1	25.6	25.9	16.4	31.5	24.4	28.1	29.6	27.4	17.6	23.0	5.7	6.0	18.8	24.6	30.5	31.9	38.6	23.8	15.2	22.8	29.7	32.4	37.1	22.8	27.4	22.9
ILF3	"DRBP76, MPHOSPH4, MPP4, NF90, NFAR-1"	ENSG00000129351	"Interleukin enhancer binding factor 3"	Q12906	19	10654261-10692417	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Transcription, Transcription regulation"	"DNA-binding, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001897	Supported		Supported	Nucleoplasm,Nucleoli,Mitochondria			1100000	"Nucleoplasm, Nucleoli, Mitochondria"		"HPA001897: AB_1078703"	"unprognostic (2.39e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.53e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.11e-3)"	"unprognostic (2.96e-1)"	"prognostic unfavourable (1.57e-4)"	"unprognostic (3.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.38e-2)"	"prognostic unfavourable (9.65e-4)"	"unprognostic (7.57e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.20e-2)"	31.0	39.0	29.6	45.5	26.8	88.2	34.5	48.3	35.2	34.2	30.2	30.8	35.2	30.3	45.4	31.7	40.5	41.9	32.5	34.0	25.5	20.0	28.1	25.6	34.1	44.9	24.7	27.8	52.8	36.8	34.9	34.9	31.8	32.3	34.9	27.3	35.5	35.1	46.2	50.1	37.7	37.2	33.2	33.3	44.5	32.6	54.3	28.0	58.6	43.4	32.4	41.1	38.5	32.1	18.7	18.7	11.5	14.3	15.4	19.4	8.0	45.4	37.0	60.0	54.9	13.0	17.9	34.9	29.1	24.7	48.9	38.3	42.4	26.4	56.8	29.0	26.1	40.8	64.8	39.3	44.1	36.3	57.7	73.7	32.7	39.5	18.7	53.0	36.8	16.9	17.6	38.8	43.5	41.7	62.9	44.7	28.4	37.4	87.9	85.3	72.0	40.7	64.8	57.2	39.3	19.4	48.3	66.3	48.2	37.5	29.8	21.6	25.2	34.1	33.4	40.1	38.2	41.5	57.4	38.4	52.4	69.0	22.4	56.7	43.2	11.5	13.4	7.1	19.4	10.4	16.1	14.7	15.9	17.3	16.8	18.7	15.7	16.0	2.1	15.4	14.3	18.7	15.0	8.0	29.6	26.8	48.3	35.2	25.5	20.0	24.7	27.8	32.3	28.0
IMP3	"BRMS2, C15orf12, FLJ10968, MRPS4"	ENSG00000177971	"IMP3, U3 small nucleolar ribonucleoprotein"	Q9NV31	15	75639085-75648706	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA060955, HPA061177"			Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA060955: , HPA061177: "	"unprognostic (6.01e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.04e-2)"	"unprognostic (7.64e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.44e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.22e-2)"	21.2	28.4	21.9	23.0	24.0	18.9	34.3	20.1	28.8	19.4	31.0	15.4	17.5	27.5	14.7	24.5	35.6	20.1	25.2	21.7	21.1	19.7	28.2	49.7	21.1	28.5	17.6	19.6	23.0	29.1	12.6	17.3	16.9	16.7	23.3	19.2	17.5	28.3	25.4	37.6	29.3	31.5	11.0	15.5	28.5	25.9	12.4	13.3	33.7	30.0	37.5	27.9	19.6	21.8	40.7	34.0	23.0	31.1	33.3	47.2	48.1	20.1	22.8	11.1	19.2	19.8	11.3	16.5	17.0	13.6	13.9	16.1	17.5	17.8	24.1	18.6	8.8	33.5	36.4	27.6	12.4	18.1	43.7	25.3	18.8	30.3	14.6	25.6	17.6	10.4	22.8	11.2	13.9	9.1	32.6	19.7	12.6	24.2	20.2	62.6	29.8	24.1	22.1	13.6	26.4	18.9	27.4	18.9	19.6	14.4	25.1	30.9	21.9	23.8	10.3	18.2	14.6	13.0	22.9	26.9	49.5	27.0	20.1	41.6	11.9	18.5	31.1	23.0	42.0	23.9	45.1	40.7	40.5	40.4	33.4	38.7	47.2	44.5	4.0	33.3	23.0	34.0	38.7	48.1	21.9	24.0	20.1	28.8	21.1	19.7	17.6	19.6	16.7	13.3
IMP4	"BXDC4, MGC19606"	ENSG00000136718	"IMP4, U3 small nucleolar ribonucleoprotein"	Q96G21	2	130342225-130347810	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066222, HPA066673"			Enhanced	Nucleoli				Nucleoli		"HPA066222: , HPA066673: "	"unprognostic (8.26e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.70e-3)"	"unprognostic (2.18e-3)"	"prognostic unfavourable (4.72e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.08e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.10e-2)"	19.0	15.7	13.1	19.5	15.7	17.9	14.2	6.6	25.1	9.4	12.2	11.7	9.2	15.6	11.1	7.4	20.1	9.2	12.7	30.5	11.8	10.1	13.5	29.1	10.6	22.2	14.9	12.7	9.0	36.3	2.6	7.4	10.5	15.4	9.5	3.4	7.1	26.0	12.5	52.3	10.8	15.5	12.5	8.5	11.2	16.4	9.1	13.7	8.5	12.0	10.9	11.5	17.1	9.7	34.8	31.6	7.0	26.8	26.6	25.4	26.7	19.3	17.7	0.8	14.8	2.9	3.5	13.8	11.8	5.6	8.4	8.8	38.0	12.3	51.8	18.5	5.6	11.7	1.6	12.4	0.3	11.8	13.3	15.8	5.0	32.0	15.7	14.9	11.4	5.8	7.6	15.1	6.8	8.4	17.7	16.0	2.2	35.9	11.1	6.3	13.4	23.4	15.5	6.2	26.4	3.7	13.7	9.1	10.2	9.0	27.5	9.8	10.5	10.7	9.4	15.9	15.1	16.8	24.4	16.2	20.0	42.9	12.2	9.5	22.4	2.4	25.5	7.0	25.4	26.8	22.6	34.8	22.4	21.9	29.3	30.7	22.4	22.2	2.9	26.6	25.1	31.6	21.5	26.7	13.1	15.7	6.6	25.1	11.8	10.1	14.9	12.7	15.4	13.7
INO80B	"hIes2, HMGA1L4, HMGIYL4, IES2, PAP-1BP, PAPA-1, ZNHIT4"	ENSG00000115274	"INO80 complex subunit B"	Q9C086	2	74455023-74457960	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA070644			Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA070644: "	"prognostic favourable (2.89e-4)"	"unprognostic (2.24e-2)"	"unprognostic (5.62e-2)"	"unprognostic (6.59e-3)"	"unprognostic (9.45e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.20e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-2)"	"unprognostic (7.52e-3)"	"unprognostic (2.18e-1)"	"prognostic unfavourable (1.56e-5)"	"prognostic favourable (8.44e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.18e-3)"	18.7	22.4	31.0	20.5	33.4	21.4	22.6	31.3	48.6	23.3	16.2	15.6	24.8	24.0	28.5	23.4	22.6	26.8	21.5	19.7	39.3	20.0	20.3	22.5	18.7	22.5	19.6	32.6	39.8	31.8	36.6	32.3	14.0	38.2	25.6	16.7	15.5	32.1	37.6	28.1	39.7	18.0	20.0	49.6	19.3	22.1	28.3	25.0	21.3	30.0	15.9	24.7	20.6	23.8	4.9	6.5	6.8	5.4	4.4	3.8	1.3	12.8	14.3	3.9	5.7	8.2	13.3	11.9	12.2	9.9	8.4	7.4	9.2	14.2	22.1	15.0	8.0	13.7	3.7	8.3	8.0	20.9	14.2	16.6	6.7	9.0	8.4	16.1	7.4	12.1	14.7	12.0	14.7	10.9	9.3	7.2	7.2	15.5	18.4	21.3	2.8	19.8	10.7	15.8	20.1	10.3	9.0	7.3	15.3	6.3	16.2	5.4	5.5	5.1	9.7	6.9	12.5	14.1	8.7	28.6	22.1	8.0	15.3	9.6	7.0	3.9	5.4	2.0	2.7	3.7	3.2	4.8	2.9	1.5	3.1	4.9	2.7	2.3	6.8	4.4	2.8	6.5	3.8	1.3	31.0	33.4	31.3	48.6	39.3	20.0	19.6	32.6	38.2	25.0
INO80E	"CCDC95, FLJ90652"	ENSG00000169592	"INO80 complex subunit E"	Q8NBZ0	16	29995294-30005793	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043146	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA043146: AB_10794923"	"unprognostic (5.61e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.75e-2)"	"unprognostic (3.38e-1)"	"unprognostic (5.73e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.74e-3)"	"unprognostic (5.21e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.98e-3)"	26.7	30.0	31.2	37.1	31.6	27.5	29.1	28.8	37.9	32.9	35.4	35.1	37.7	18.0	33.8	34.0	31.7	43.8	29.2	25.0	30.1	26.1	30.1	31.0	28.5	30.2	30.7	30.0	39.7	29.2	44.7	29.8	24.8	27.8	32.2	39.5	26.3	33.9	39.3	28.1	28.3	38.9	43.0	33.8	30.6	28.6	28.3	28.0	39.1	35.9	24.6	46.9	34.1	28.3	4.5	4.8	4.2	5.4	2.6	4.8	15.3	23.1	27.7	18.3	27.6	17.4	15.3	17.3	20.7	24.0	31.4	30.7	16.2	26.4	31.3	32.1	23.5	15.2	23.4	35.0	27.0	32.1	21.7	15.2	17.7	22.4	20.5	20.0	17.3	17.3	29.2	35.6	29.2	37.7	19.3	16.5	29.2	33.9	42.1	24.0	37.7	13.6	55.7	22.6	30.0	22.7	12.0	28.9	35.5	11.4	19.4	25.4	25.0	16.7	20.0	20.9	15.2	18.6	25.7	15.9	35.4	28.8	23.4	29.1	29.7	0.7	4.7	4.2	3.9	3.2	3.4	4.5	2.9	4.8	4.8	2.9	2.5	3.0	2.7	2.6	5.4	4.0	4.3	15.3	31.2	31.6	28.8	37.9	30.1	26.1	30.7	30.0	27.8	28.0
INPP5J	"INPP5, PIB5PA, PIPP"	ENSG00000185133	"Inositol polyphosphate-5-phosphatase J"	Q15735	22	31122731-31134696	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 65.2;thyroid gland: 71.2"	"Cell line enhanced"	"Detected in many"		"HL-60: 12.1;SK-BR-3: 26.2;T-47d: 16.5;U-698: 11.4"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 63.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 2.4"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034539			Approved	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA034539: AB_10670974"	"unprognostic (1.76e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.21e-3)"	"prognostic favourable (1.47e-5)"	"unprognostic (6.81e-2)"	"unprognostic (1.86e-2)"	"unprognostic (4.29e-4)"	"unprognostic (1.47e-1)"	"prognostic favourable (1.12e-7)"	"unprognostic (2.79e-3)"	"unprognostic (3.65e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.39e-2)"	0.8	0.9	4.6	0.8	6.3	0.5	3.7	27.4	13.4	1.5	6.4	0.8	16.7	7.9	1.3	0.8	1.0	1.0	1.0	9.5	7.4	2.0	9.5	0.5	1.5	0.7	2.3	4.6	0.8	5.3	65.2	3.7	0.5	5.5	3.5	2.2	5.6	15.5	19.2	1.6	1.7	21.7	1.2	0.9	0.6	3.8	1.6	1.1	0.0	71.2	0.0	0.7	1.1	0.9	0.3	2.4	0.0	0.4	0.0	0.0	0.2	1.3	1.3	0.8	1.4	0.2	0.1	0.7	0.5	0.5	2.6	2.6	0.7	0.8	0.0	0.6	0.2	1.5	1.6	0.7	1.1	0.0	4.2	0.0	5.5	0.2	0.5	12.1	0.1	0.1	0.8	2.2	0.2	0.1	1.1	1.8	0.0	4.0	0.1	0.0	1.4	0.2	0.0	0.3	2.8	1.1	1.6	6.4	4.8	1.0	26.2	0.3	16.5	1.0	0.0	0.1	4.8	0.5	0.3	0.0	2.0	11.4	0.4	0.0	2.0	0.0	0.4	0.0	0.0	0.3	0.0	0.3	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.2	4.6	6.3	27.4	13.4	7.4	2.0	2.3	4.6	5.5	1.1
INTS3	"C1orf60, FLJ21919, INT3, SOSS-A"	ENSG00000143624	"Integrator complex subunit 3"	Q68E01	1	153728067-153774808	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074391	Approved		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"			Nucleoli	Nucleoplasm	"HPA074391: "	"unprognostic (2.36e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.75e-3)"	"unprognostic (6.97e-3)"	"unprognostic (3.26e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.45e-1)"	"prognostic favourable (5.42e-4)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (1.34e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.18e-3)"	"unprognostic (8.29e-2)"	16.2	21.9	18.8	14.4	20.0	12.0	16.3	20.7	23.1	20.4	19.9	19.5	25.1	10.0	24.4	23.7	14.3	26.7	20.5	15.3	16.0	10.6	17.9	11.1	16.6	12.6	15.9	16.4	30.8	17.5	23.6	23.6	16.5	15.6	15.9	11.4	16.1	14.0	31.0	16.2	16.9	14.7	21.2	13.4	15.4	17.6	16.5	16.0	16.2	18.6	9.2	14.1	19.9	18.8	1.8	3.8	2.7	6.2	2.7	2.5	1.5	13.1	13.8	10.0	14.4	11.4	12.8	10.2	10.0	7.2	12.0	9.7	9.6	12.4	11.4	20.1	13.2	13.4	19.1	12.8	9.8	11.9	11.2	7.1	21.0	4.5	7.8	10.6	12.9	11.6	6.5	10.3	9.4	11.5	10.0	9.3	9.2	10.7	9.9	5.6	12.3	12.7	13.4	5.6	7.3	6.2	17.2	7.9	11.6	9.5	23.0	6.4	13.3	14.4	8.4	11.9	5.1	11.7	9.0	8.3	7.6	12.6	13.0	6.5	8.2	1.3	1.8	2.0	2.1	1.4	2.5	1.3	1.3	2.0	3.8	1.8	1.4	1.5	2.7	2.7	6.2	0.8	1.3	1.5	18.8	20.0	20.7	23.1	16.0	10.6	15.9	16.4	15.6	16.0
INTS4	"INT4, MGC16733, MST093"	ENSG00000149262	"Integrator complex subunit 4"	Q96HW7	11	77878720-77994678	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA042378	Uncertain		Supported	Nucleoli				Nucleoli		"HPA042378: AB_10797388"	"unprognostic (2.72e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.07e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavourable (9.44e-6)"	"unprognostic (2.04e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.20e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.20e-1)"	"prognostic favourable (9.66e-4)"	"unprognostic (9.39e-2)"	15.8	17.7	13.6	15.7	16.5	21.4	17.0	23.9	17.5	17.1	13.6	27.7	13.0	12.2	31.0	16.3	14.8	13.9	12.1	12.1	13.6	12.1	14.4	18.7	14.0	20.6	20.0	12.1	20.0	19.6	22.9	24.4	20.8	19.3	17.3	16.1	17.7	23.1	13.5	12.1	16.0	16.7	14.6	18.0	23.2	14.4	11.7	17.6	33.6	15.9	8.6	28.1	14.5	16.6	12.5	13.8	10.9	13.7	14.6	17.1	10.0	6.0	10.1	13.2	15.8	11.1	9.8	11.0	7.3	8.1	9.4	8.6	21.0	17.2	10.5	15.6	12.8	15.3	14.4	14.3	15.2	15.6	9.0	16.2	13.5	12.0	9.8	16.3	9.9	10.0	7.8	19.4	16.7	14.7	15.6	16.2	14.4	12.6	15.5	26.8	12.6	11.0	15.0	12.2	20.1	11.7	12.2	9.4	13.6	12.8	8.5	5.3	16.2	9.5	9.9	13.1	17.5	34.2	9.4	17.8	17.2	23.7	4.9	11.2	12.9	10.9	12.6	6.7	12.2	13.7	16.9	11.8	12.6	14.3	13.8	12.5	17.1	13.2	3.2	14.6	12.0	5.5	15.7	10.0	13.6	16.5	23.9	17.5	13.6	12.1	20.0	12.1	19.3	17.6
IPCEF1	"KIAA0403, PIP3-E"	ENSG00000074706	"Interaction protein for cytohesin exchange factors 1"	Q8WWN9	6	154154496-154356792	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	7	"blood: 30.1;bone marrow: 15.2;brain: 26.4;lymphoid tissue: 12.4;thyroid gland: 36.9"	"Group enriched"	"Detected in some"	5	"HMC-1: 19.3;THP-1: 9.8;U-937: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA028708, HPA028710"	Enhanced		Approved	"Nucleoli,Nuclear speckles,Plasma membrane,Cytoplasmic bodies"				"Nuclear speckles, Plasma membrane"	"Nucleoli, Cytoplasmic bodies"	"HPA028708: AB_10601916, HPA028710: "	"unprognostic (1.23e-2)"	"unprognostic (8.93e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.05e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.87e-2)"	"unprognostic (5.01e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.51e-4)"	1.3	0.7	5.3	6.9	12.9	15.2	1.9	20.0	26.4	3.4	1.6	5.5	0.0	1.1	1.7	1.8	1.9	2.5	3.2	1.0	3.8	4.6	3.4	2.4	2.0	12.4	3.9	14.1	1.3	1.4	0.4	1.3	2.0	5.5	1.3	1.6	0.0	1.4	0.8	0.7	1.2	2.9	1.3	4.2	6.4	2.6	1.5	4.9	10.0	36.9	0.0	11.7	2.4	1.1	0.0	7.1	30.1	6.3	6.0	13.5	5.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.1	19.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.1	1.0	0.4	0.2	0.2	0.5	0.9	2.1	0.3	0.3	0.0	0.1	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	10.2	0.0	1.4	6.3	30.1	6.1	2.8	13.1	0.0	7.7	5.8	7.1	0.0	13.5	7.9	19.3	6.0	3.4	0.2	9.9	5.3	5.3	12.9	20.0	26.4	3.8	4.6	3.9	14.1	5.5	4.9
IQGAP3		ENSG00000183856	"IQ motif containing GTPase activating protein 3"	Q86VI3	1	156525405-156572604	"Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.8;intestine: 13.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA030142, HPA030143"	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA030142: AB_10600108, HPA030143: AB_10601104"	"unprognostic (9.99e-3)"	"unprognostic (5.24e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.69e-3)"	"prognostic unfavourable (8.94e-6)"	"unprognostic (1.86e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.35e-3)"	"unprognostic (1.03e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (4.46e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.30e-2)"	"unprognostic (6.81e-2)"	3.2	1.2	0.3	5.4	0.3	14.8	0.6	0.3	0.8	1.4	10.1	0.4	1.3	7.0	1.1	3.7	9.8	0.3	1.8	1.8	0.4	0.2	1.5	1.1	2.6	1.4	0.3	0.3	0.5	0.4	0.0	0.3	6.5	0.8	0.8	5.5	0.4	1.8	0.3	0.5	3.8	13.0	2.9	1.5	1.5	5.1	6.8	0.3	12.2	0.4	3.1	7.3	0.9	3.1	0.2	0.9	0.5	0.3	0.6	2.6	0.0	23.5	11.3	10.7	7.5	0.6	1.7	5.2	17.5	11.7	17.2	15.4	13.0	21.7	2.1	6.5	10.2	22.4	7.2	9.0	15.4	0.0	6.5	3.1	22.4	6.4	0.1	3.8	0.0	0.5	1.0	14.4	21.2	9.9	6.3	3.4	12.5	12.3	2.2	5.5	7.7	11.4	7.5	12.0	2.4	4.3	8.0	6.7	10.5	15.9	18.7	6.4	14.9	10.3	6.5	15.6	18.6	12.7	20.5	1.6	0.8	1.0	5.2	6.1	17.6	0.5	0.2	0.2	0.1	0.1	0.2	0.2	0.2	0.1	0.6	0.1	0.1	0.1	0.2	0.6	0.3	0.9	2.6	0.0	0.3	0.3	0.3	0.8	0.4	0.2	0.3	0.3	0.8	0.3
IQSEC1	"ARF-GEP100, BRAG2, GEP100, KIAA0763"	ENSG00000144711	"IQ motif and Sec7 domain 1"	Q6DN90	3	12897220-13073117	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 34.2;U-266/84: 30.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038143, HPA038144"	Uncertain		Supported	Nucleoli,Vesicles				"Nucleoli, Vesicles"		"HPA038143: AB_10697241, HPA038144: "	"prognostic unfavourable (3.03e-5)"	"unprognostic (1.80e-1)"	"unprognostic (6.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (8.19e-3)"	"unprognostic (2.64e-3)"	"unprognostic (5.60e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.14e-2)"	"prognostic favourable (9.07e-4)"	"unprognostic (4.42e-1)"	"prognostic favourable (3.58e-6)"	"unprognostic (1.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.00e-3)"	"unprognostic (4.65e-2)"	17.8	14.1	27.8	12.3	27.0	32.5	7.1	31.9	41.5	9.5	6.7	18.5	3.5	4.8	8.0	4.7	6.1	8.5	7.4	16.0	25.0	17.8	7.0	11.5	12.4	14.8	16.4	24.8	12.3	13.0	25.7	7.8	13.4	36.7	11.6	4.8	17.0	9.3	10.0	21.0	6.2	7.7	8.4	10.6	20.6	6.9	5.6	15.5	2.6	6.3	4.3	14.0	7.8	5.9	6.2	6.8	12.9	4.0	1.8	3.6	2.3	4.9	6.7	6.0	6.8	5.1	7.1	34.2	5.6	4.6	3.7	2.9	4.6	4.4	10.5	6.4	10.5	2.8	4.6	2.9	2.8	7.1	9.7	6.2	4.0	19.6	5.6	0.1	2.6	7.0	5.4	7.6	4.3	3.4	17.5	11.2	2.5	15.8	3.9	6.6	6.3	13.8	5.3	2.0	15.1	2.2	6.4	5.3	9.7	4.0	14.1	3.3	6.0	4.3	9.2	4.1	10.4	3.5	0.7	22.3	30.6	4.1	7.7	3.1	3.3	5.0	3.8	4.8	3.6	4.0	2.7	6.2	2.4	2.7	1.9	6.1	2.4	3.0	12.9	1.8	3.9	6.8	1.7	2.3	27.8	27.0	31.9	41.5	25.0	17.8	16.4	24.8	36.7	15.5
IRAK4	NY-REN-64	ENSG00000198001	"Interleukin 1 receptor associated kinase 4"	Q9NWZ3	12	43758944-43789543	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 32.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016685, CAB022077"	Uncertain		Approved	Nucleoli,Microtubules,Cytosol				Microtubules	"Nucleoli, Cytosol"	"CAB016685: AB_1618505, CAB022077: "	"unprognostic (2.76e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.47e-2)"	"prognostic favourable (3.46e-5)"	"unprognostic (6.15e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.44e-2)"	"unprognostic (8.49e-2)"	"unprognostic (6.44e-3)"	"unprognostic (7.50e-2)"	"unprognostic (4.00e-3)"	"unprognostic (6.29e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.84e-1)"	"prognostic favourable (4.42e-5)"	18.0	9.4	5.1	15.0	10.4	10.3	11.3	3.7	6.0	10.3	12.2	9.1	12.5	10.2	13.0	14.1	15.0	9.4	10.8	7.6	6.7	5.2	13.3	11.8	12.0	24.0	13.2	3.9	9.3	20.1	9.1	16.1	14.0	9.8	10.5	10.0	11.9	11.9	15.1	4.1	15.2	15.0	11.8	13.0	25.0	12.3	7.1	11.7	30.3	17.0	7.7	18.9	11.1	10.7	5.1	5.8	16.9	6.0	8.8	7.7	4.7	5.3	3.9	2.8	3.7	10.1	17.0	4.0	7.5	5.3	6.0	5.5	3.3	5.1	9.1	7.4	6.2	4.4	3.1	4.8	8.6	13.0	2.9	8.7	3.0	2.1	5.8	12.0	10.7	9.0	7.8	7.6	4.4	8.8	8.0	6.8	16.4	2.9	10.4	6.8	1.0	4.6	6.9	3.4	4.8	4.6	5.1	2.0	1.9	3.6	4.7	3.6	5.9	10.7	7.8	7.4	1.4	9.0	5.1	8.4	10.8	7.9	7.6	32.4	4.0	16.9	4.6	9.4	7.4	5.4	7.7	4.0	6.1	6.3	4.5	5.1	5.5	5.9	9.3	8.8	6.0	5.8	7.5	4.7	5.1	10.4	3.7	6.0	6.7	5.2	13.2	3.9	9.8	11.7
IRX2		ENSG00000170561	"Iroquois homeobox 2"	Q9BZI1	5	2745845-2751662	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.9;breast: 27.9;lung: 32.8;salivary gland: 26.6"	"Cell line enhanced"	"Detected in many"		"AF22: 39.8;BEWO: 23.9;HaCaT: 13.5;hTCEpi: 26.2;SK-BR-3: 16.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"pons and medulla: 36.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"midbrain: 31.6;pons and medulla: 21.8;thalamus: 12.3"	"Low region specificity"	"Detected in all"			"HPA050895, HPA054669"	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA050895: AB_2616458, HPA054669: "	"unprognostic (9.79e-2)"	"unprognostic (1.93e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.50e-3)"	"unprognostic (8.12e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.33e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.07e-1)"	"prognostic favourable (8.84e-4)"	"unprognostic (2.62e-2)"	"unprognostic (3.98e-7)"	"unprognostic (4.40e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.97e-2)"	2.4	0.1	0.8	0.1	2.8	0.1	27.9	8.4	1.7	0.4	0.7	0.7	4.4	0.1	0.1	2.5	3.1	0.2	0.1	2.1	1.9	1.7	14.3	0.1	32.8	0.3	3.9	0.2	0.1	1.9	2.7	1.4	9.0	36.9	3.9	0.3	1.8	26.6	1.4	0.3	17.7	0.1	0.1	4.8	0.1	8.7	3.1	2.2	0.0	1.4	3.1	3.2	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	39.8	0.0	2.2	1.5	23.9	2.3	1.3	2.0	1.5	4.7	0.0	0.0	0.0	4.4	13.5	0.0	9.7	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	26.2	0.9	8.1	0.0	0.0	0.0	1.4	7.7	0.0	0.0	4.4	0.0	0.0	2.5	0.0	8.9	0.0	1.5	0.0	7.8	16.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.8	8.4	0.5	1.9	1.7	3.9	0.2	36.9	2.2
JADE3	"JADE-3, KIAA0215, PHF16"	ENSG00000102221	"Jade family PHD finger 3"	Q92613	X	46912276-47061242	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 36.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"memory B-cell: 4.8;naive B-cell: 3.7;plasmacytoid DC: 1.7"	"Group enriched"	"Detected in many"	9	"B-cells: 4.8;dendritic cells: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA006007, HPA064697"	Uncertain		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA006007: AB_1079605, HPA064697: "	"unprognostic (1.39e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.18e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.83e-3)"	"unprognostic (4.55e-2)"	"unprognostic (8.97e-3)"	"unprognostic (2.82e-1)"	"unprognostic (4.25e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.69e-1)"	"unprognostic (8.18e-2)"	"unprognostic (9.70e-2)"	4.9	12.6	3.5	2.7	5.1	1.5	6.2	3.3	4.9	5.7	4.5	7.1	14.0	1.9	9.5	16.3	4.7	4.3	3.2	5.2	3.9	3.3	3.7	7.7	4.3	4.1	9.2	1.4	7.2	8.7	3.0	2.1	15.9	4.7	5.4	3.2	2.1	4.3	12.2	3.3	3.8	3.5	6.0	8.5	9.8	4.7	14.5	8.4	8.4	4.2	1.4	7.5	7.6	13.1	4.8	1.7	0.0	0.3	0.2	0.2	0.4	6.3	5.7	9.4	6.5	3.5	2.6	36.2	3.8	3.2	4.3	4.8	6.5	5.6	0.0	2.7	2.8	2.5	11.4	3.1	6.2	17.1	7.5	5.0	6.5	6.3	5.7	3.8	2.7	2.0	4.3	3.0	9.8	8.0	3.4	3.0	3.3	6.6	13.7	4.6	7.4	4.9	14.2	10.6	8.9	3.6	5.9	8.2	7.3	11.0	10.2	6.0	6.7	4.0	5.0	4.5	8.0	6.4	2.5	2.3	2.0	12.2	1.2	3.2	4.4	0.0	0.1	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.1	3.7	0.0	0.0	0.0	0.2	0.3	1.7	0.0	0.4	3.5	5.1	3.3	4.9	3.9	3.3	9.2	1.4	4.7	8.4
JPT1	"ARM2, HN1, HN1A"	ENSG00000189159	"Jupiter microtubule associated homolog 1"	Q9UK76	17	75135248-75168281	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 109.4;testis: 101.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 109.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059729	Approved		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"				Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA059729: AB_2684114"	"unprognostic (1.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.31e-3)"	"unprognostic (3.57e-3)"	"unprognostic (6.71e-2)"	"unprognostic (2.51e-3)"	"prognostic unfavourable (1.58e-7)"	"unprognostic (3.58e-2)"	"unprognostic (1.37e-1)"	"prognostic favourable (4.91e-4)"	"unprognostic (1.25e-3)"	"unprognostic (8.24e-2)"	"prognostic unfavourable (1.77e-7)"	"unprognostic (1.83e-1)"	"unprognostic (8.99e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.51e-1)"	8.0	18.5	15.6	25.9	22.2	23.0	8.1	30.7	25.4	9.4	43.3	4.6	7.7	37.5	6.1	5.4	52.8	4.3	23.7	6.1	17.9	19.6	15.5	12.8	13.9	26.3	11.1	15.0	5.6	6.5	1.2	6.6	29.2	13.7	7.0	23.7	3.3	15.9	17.6	23.7	9.3	51.3	7.3	8.3	26.2	42.5	101.3	4.9	32.6	5.8	28.9	28.7	17.9	17.0	15.4	14.5	109.4	28.4	10.2	28.7	14.6	91.6	91.4	48.1	47.7	10.2	10.5	38.4	48.3	14.4	47.5	36.6	74.8	55.0	25.8	31.0	38.6	54.8	44.9	60.1	35.8	25.8	56.4	41.5	36.3	74.0	24.0	31.1	40.1	16.0	28.8	38.6	39.8	86.2	23.4	53.2	43.4	66.4	99.7	30.4	28.0	120.5	63.7	57.5	40.0	50.7	57.6	59.8	48.6	69.1	36.6	25.7	98.1	19.1	49.6	27.2	76.9	38.1	56.0	20.8	33.5	38.6	23.7	29.2	31.0	27.5	18.5	51.6	12.4	26.6	8.9	15.4	17.2	14.9	14.5	8.0	8.2	12.0	109.4	10.2	28.4	9.6	28.7	14.6	15.6	22.2	30.7	25.4	17.9	19.6	11.1	15.0	13.7	4.9
JRK	"jerky, JH8"	ENSG00000234616	"Jrk helix-turn-helix protein"		8	142657460-142681968	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052675			Approved	"Nucleoplasm,Nucleoli,Nuclear bodies"				"Nucleoplasm, Nucleoli"	"Nuclear bodies"	"HPA052675: "	"unprognostic (3.65e-2)"	"unprognostic (5.30e-2)"	"unprognostic (9.67e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.84e-2)"	"unprognostic (6.58e-6)"	"unprognostic (1.05e-1)"	"unprognostic (3.87e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.69e-2)"	2.6	3.3	6.4	4.0	6.5	1.6	3.7	11.1	7.1	2.8	2.8	6.1	6.8	2.9	5.4	3.6	3.1	4.7	2.6	3.7	4.4		2.9	0.7	2.6	5.3	5.2	5.2	9.6	4.6	5.6	4.4	3.0	4.3	4.5	2.8	5.4	4.1	4.5	6.2	6.5	3.2	4.9	3.5	4.8	4.3	6.1	5.3	4.3	4.2	2.6	6.1	2.6	7.9	4.5	2.3	3.3	2.3	2.0	4.4	1.2	5.4	5.9	6.9	5.6	6.7	9.9	4.3	8.5	3.6	10.5	6.0	5.3	11.4	9.4	3.7	7.0	7.4	6.1	5.3	5.3	7.2	10.4	9.4	18.8	6.1	2.8	7.2	6.6	6.3	4.7	6.7	3.8	5.9	10.0	4.2	8.8	9.4	8.3	4.0	5.9	8.4	11.0	4.4	5.2	3.6	9.4	12.8	8.5	15.7	6.4	3.7	6.3	4.5	6.9	8.2	17.6	8.0	4.7	5.5	6.1	5.6	6.2	9.1	7.9	3.3	2.3	2.9	3.1	1.6	1.8	1.4	3.5	3.1	2.3	4.5	4.4	3.5	2.5	2.0	0.8	2.2	2.0	1.2										
KAT6A	"MOZ, MYST3, RUNXBP2, ZC2HC6A, ZNF220"	ENSG00000083168	"Lysine acetyltransferase 6A"	Q92794	8	41929479-42051990	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Repressor, Transferase"	"Cancer-related genes, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017023, HPA063266, HPA065052"	Supported		Approved	"Nucleoli,Nuclear speckles,Cytosol"				"Nuclear speckles"	"Nucleoli, Cytosol"	"CAB017023: , HPA063266: , HPA065052: "	"unprognostic (3.51e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.27e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.95e-2)"	20.8	10.9	15.3	19.8	20.3	36.8	22.6	29.9	18.7	19.7	14.6	19.4	14.4	10.7	20.6	12.1	16.9	16.5	14.3	13.0	15.5	11.5	12.3	13.6	26.9	28.2	23.2	10.3	27.2	13.1	26.8	22.3	20.9	15.7	14.1	12.0	12.8	15.1	17.0	21.0	25.5	18.0	25.0	22.9	20.4	14.0	14.1	21.7	30.4	17.9	14.3	20.1	16.9	24.2	4.7	1.8	10.9	1.6	3.1	3.9	1.4	12.9	10.6	17.5	11.1	9.8	11.2	5.9	8.7	11.3	10.8	8.4	6.7	6.2	19.2	8.7	8.5	8.3	13.6	8.2	12.7	9.9	7.9	27.6	6.6	5.0	7.4	14.5	12.7	9.3	9.4	10.0	12.4	10.3	23.1	12.2	9.8	5.7	29.5	4.6	6.7	4.2	23.6	19.6	6.1	5.3	14.9	10.9	9.4	10.1	6.8	7.0	15.6	6.4	12.0	13.3	9.4	11.8	9.3	10.0	16.1	20.8	7.1	6.6	11.5	3.5	1.6	2.8	3.5	1.2	3.9	2.4	2.6	3.3	1.0	4.7	3.6	2.9	10.9	3.1	1.2	1.8	3.5	1.4	15.3	20.3	29.9	18.7	15.5	11.5	23.2	10.3	15.7	21.7
KCNB2	Kv2.2	ENSG00000182674	"Potassium voltage-gated channel subfamily B member 2"	Q92953	8	72537391-72938349	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.7;lymphoid tissue: 8.6;pituitary gland: 9.2"	"Group enriched"	"Detected in some"	5	"HaCaT: 3.2;HDLM-2: 3.0;HEK 293: 7.4;SCLC-21H: 6.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA065970			Approved	"Nucleoli,Plasma membrane,Midbody"				"Plasma membrane"	"Nucleoli, Midbody"	"HPA065970: "	"unprognostic (9.87e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.34e-1)"		"unprognostic (1.44e-2)"		"unprognostic (2.72e-1)"	"unprognostic (6.93e-5)"	"unprognostic (5.53e-3)"	"unprognostic (3.30e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.26e-1)"		0.8	1.9	3.8	0.6	5.3	0.4	0.7	0.3	9.7	0.5	0.7	0.0	0.0	1.2	0.4	0.4	1.1	2.1	0.5	0.4	7.1	3.1	0.5	0.4	0.6	0.5	0.9	7.8	0.4	2.4	0.4	9.2	0.5	3.2	0.7	0.7	4.2	0.5	0.5	0.4	0.4	1.6	0.5	1.6	8.6	2.4	1.7	0.4	0.9	0.4	0.0	0.9	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	3.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	5.3	0.3	9.7	7.1	3.1	0.9	7.8	3.2	0.4
KCNC4	"C1orf30, HKSHIIIC, Kv3.4"	ENSG00000116396	"Potassium voltage-gated channel subfamily C member 4"	Q03721	1	110211343-110283100	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 16.1;U-87 MG: 14.4;WM-115: 9.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014740			Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA014740: AB_1855580"	"unprognostic (9.16e-2)"	"unprognostic (1.92e-3)"	"unprognostic (2.06e-2)"	"unprognostic (3.72e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.68e-1)"	"unprognostic (7.48e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.25e-2)"	2.3	4.7	12.1	1.6	3.2	0.7	3.3	9.2	12.7	1.9	1.4	1.9	1.1	0.8	4.5	3.1	2.1	3.7	4.8	4.5	9.1	14.2	5.1	1.1	3.0	1.9	6.8	2.0	3.4	4.3	11.2	3.8	2.8	14.3	2.4	1.3	4.7	7.1	3.7	4.5	4.0	2.0	2.6	3.6	3.3	2.8	2.2	1.1	7.2	2.3	7.8	2.3	1.2	1.5	0.8	0.7	0.9	0.4	0.3	1.5	0.1	1.9	1.5	0.4	2.8	1.1	0.3	3.4	8.4	1.4	0.6	0.8	4.7	0.9	3.2	3.3	3.1	3.1	1.4	0.7	0.4	16.1	1.6	0.1	3.2	0.7	0.5	2.7	0.8	0.3	0.3	1.9	0.2	4.3	0.6	1.4	0.0	0.4	1.8	0.6	1.6	3.8	2.6	0.1	0.5	4.0	0.1	0.6	0.8	0.4	8.1	0.8	1.1	1.4	1.6	1.0	3.9	0.6	0.3	2.1	1.9	0.6	14.4	2.3	9.3	0.8	0.4	0.2	0.5	0.2	1.5	0.6	0.9	0.4	0.0	0.8	1.3	0.5	0.9	0.3	0.3	0.7	0.4	0.1	12.1	3.2	9.2	12.7	9.1	14.2	6.8	2.0	14.3	1.1
KCNJ14	"IRK4, Kir2.4"	ENSG00000182324	"Potassium voltage-gated channel subfamily J member 14"	Q9UNX9	19	48455509-48466980	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 22.9"	"Cell line enhanced"	"Detected in many"		"NB-4: 12.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA071765			Approved	Nucleoli				Nucleoli		"HPA071765: "	"unprognostic (1.38e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.33e-5)"	"unprognostic (5.77e-2)"	"unprognostic (9.41e-2)"	"unprognostic (5.26e-2)"	"unprognostic (7.05e-4)"	"unprognostic (7.83e-4)"	"unprognostic (1.26e-1)"	"unprognostic (6.48e-2)"	"unprognostic (4.43e-3)"	"unprognostic (4.92e-2)"	"unprognostic (5.02e-6)"	"unprognostic (1.47e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.82e-3)"	"unprognostic (4.41e-2)"	1.0	0.4	1.1	0.9	6.1	4.9	1.8	2.3	2.2	0.9	0.9	0.9	0.9	0.6	0.9	1.8	1.5	1.1	1.0	0.9	1.4	1.3	0.9	0.9	0.9	1.2	1.2	0.9	1.3	1.4	1.0	1.0	1.4	1.4	1.5	0.7	22.9	0.9	0.9	3.3	4.9	0.9	0.9	0.9	0.9	0.6	2.8	0.9	0.9	1.6	0.9	0.9	0.9	1.1	1.5	0.8	3.5	0.8	0.6	1.0	0.2	1.6	3.8	0.8	2.5	1.7	1.6	2.5	0.6	0.3	0.8	1.2	3.8	2.2	1.8	0.8	0.6	5.3	1.2	0.6	2.0	1.3	2.0	1.1	2.1	1.0	0.9	1.5	3.1	1.5	2.8	1.9	2.2	0.5	1.8	1.9	0.5	2.3	0.6	12.2	1.4	2.1	2.5	1.5	0.4	0.6	4.5	1.4	1.7	1.7	2.5	1.3	1.7	1.3	1.0	2.7	3.5	2.6	3.0	2.0	3.0	1.3	0.7	3.9	2.8	3.5	0.8	0.6	0.6	0.6	0.5	1.2	0.7	1.0	0.4	1.5	0.8	1.0	2.9	0.6	0.3	0.8	0.6	0.2	1.1	6.1	2.3	2.0	1.4	1.3	1.2	0.9	1.4	0.9
KCTD1	C18orf5	ENSG00000134504	"Potassium channel tetramerization domain containing 1"	Q719H9	18	26454910-26657401	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 35.6;HaCaT: 37.0;hTCEpi: 33.5;RPTEC TERT1: 32.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											"HPA057808, HPA062486"			Approved	"Nucleoplasm,Nucleoli,Cytokinetic bridge,Centriolar satellite"				Nucleoplasm	"Nucleoli, Cytokinetic bridge, Centriolar satellite"	"HPA057808: , HPA062486: "	"unprognostic (1.15e-3)"	"unprognostic (5.66e-2)"	"unprognostic (2.35e-4)"	"prognostic unfavourable (2.22e-4)"	"unprognostic (3.65e-3)"	"unprognostic (7.43e-2)"	"unprognostic (2.03e-3)"	"unprognostic (6.77e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.88e-3)"	"unprognostic (5.68e-3)"	"unprognostic (1.77e-2)"	"prognostic favourable (4.60e-8)"	"unprognostic (3.87e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.02e-2)"	3.9	11.8	15.9	2.1	37.3	0.7	22.2	13.7	29.0	12.6	5.0	6.9	6.2	3.2	10.0	15.8	32.8	33.8	5.8	12.9	16.7	6.7	20.1	2.6	4.0	2.0	6.6	18.4	11.1	5.2	7.4	6.1	17.2	6.8	15.3	7.3	8.4	12.5	16.4	2.8	39.3	2.2	8.7	6.0	2.9	7.0	4.1	10.7	5.7	13.6	20.1	11.7	8.5	18.3	0.3	0.7	0.7	0.3	0.0	1.8	0.2	5.4	19.0	35.6	3.8	20.9	3.4	4.5	4.6	7.0	7.4	7.3	1.8	6.3	1.1	17.7	9.8	37.0	6.8	10.0	6.9	1.0	3.2	1.1	4.2	3.0	3.9	0.6	1.8	5.7	33.5	2.1	13.9	6.9	0.4	0.5	5.2	7.8	5.4	1.7	3.6	8.7	2.9	2.1	0.8	32.6	8.2	3.7	14.1	6.7	9.2	3.1	8.3	1.5	3.7	8.2	2.6	1.6	5.1	1.7	1.4	0.1	3.1	3.7	12.2	0.0	0.1	0.7	0.8	0.1	1.6	0.0	1.8	0.6	0.7	0.3	0.7	0.5	0.0	0.0	0.3	0.3	0.0	0.2	15.9	37.3	13.7	29.0	16.7	6.7	6.6	18.4	6.8	10.7
KCTD6	"KCASH3, MGC27385"	ENSG00000168301	"Potassium channel tetramerization domain containing 6"	Q8NC69	3	58492114-58502360	"Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 36.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036100, HPA036101"	Uncertain		Approved	Nucleoli,Mitochondria				"Nucleoli, Mitochondria"		"HPA036100: AB_10673230, HPA036101: AB_2674941"	"unprognostic (8.63e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.37e-2)"	"unprognostic (5.71e-2)"	"unprognostic (9.00e-3)"	"unprognostic (2.45e-2)"	"prognostic unfavourable (4.57e-4)"	"unprognostic (3.19e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.67e-3)"	"unprognostic (9.36e-3)"	"unprognostic (7.48e-2)"	"prognostic favourable (8.63e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.44e-2)"	7.8	8.4	15.3	4.4	13.2	13.5	11.4	35.9	21.8	11.1	7.9	10.0	6.4	5.6	12.3	28.8	10.9	12.4	8.8	7.7	16.9	11.7	15.4	12.2	6.6	9.1	15.3	10.5	13.1	7.1	10.4	14.4	10.9	11.9	9.2	8.1	14.7	7.3	9.4	6.8	7.5	5.3	11.2	12.5	8.8	5.7	5.7	12.4	6.3	14.1	6.3	7.3	6.4	11.9	13.0	20.2	17.1	14.6	8.2	15.6	6.6	5.7	5.4	16.3	7.0	14.3	10.3	6.1	6.9	6.2	10.2	12.1	5.2	3.2	11.3	2.3	4.9	3.1	13.2	4.0	9.2	11.6	6.0	5.2	12.5	6.5	6.8	4.1	4.2	6.2	6.3	8.1	5.1	6.7	2.8	5.4	8.8	5.3	6.0	6.3	12.0	10.4	6.1	4.5	7.9	9.6	2.6	9.2	8.0	3.9	9.1	4.9	36.4	3.0	3.6	9.4	8.5	11.9	10.3	5.9	9.2	13.3	8.0	8.4	7.1	17.1	14.6	9.8	13.7	14.6	15.6	13.0	10.1	12.8	20.2	10.3	11.5	9.8	5.0	8.2	10.5	7.8	9.5	6.6	15.3	13.2	35.9	16.2	16.9	11.7	15.3	10.5	11.9	12.4
KDM6A	UTX	ENSG00000147050	"Lysine demethylase 6A"	O15550	X	44873177-45112602	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		"Chromatin regulator, Dioxygenase, Oxidoreductase"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000568, HPA001165, HPA002111"	Enhanced		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"			Nucleoplasm	Nucleoli	"HPA000568: AB_1858705, HPA001165: AB_1080541, HPA002111: AB_1858704"	"unprognostic (1.73e-3)"	"unprognostic (6.86e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.58e-3)"	"unprognostic (8.22e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.16e-2)"	12.3	12.1	16.5	17.6	24.5	47.9	21.4	26.1	22.0	16.9	11.8	16.7	12.0	13.1	22.6	11.3	15.4	16.9	15.2	9.1	18.2	6.5	11.6	13.5	19.7	15.1	28.8	11.3	23.8	14.9	21.3	20.2	13.3	18.3	10.3	11.3	10.3	16.1	12.6	15.1	21.3	17.6	13.5	14.9	18.1	15.0	17.7	26.1	19.1	14.5	6.9	13.6	14.9	22.8	5.5	7.1	15.7	7.5	6.2	7.9	3.5	8.9	7.8	11.6	11.7	8.3	8.6	24.9	7.0	5.0	8.4	8.8	18.4	7.7	5.9	3.8	6.5	19.3	14.8	12.3	7.8	8.5	15.9	7.3	9.9	6.8	5.9	3.9	20.7	4.6	10.2	13.8	14.5	6.5	10.1	14.6	5.2	5.8	8.1	11.5	9.7	9.0	9.0	11.1	1.0	4.8	16.8	10.0	5.4	22.3	11.2	9.5	10.8	0.1	5.5	8.0	6.2	8.0	3.6	9.2	11.1	8.9	5.6	4.1	4.6	15.7	3.8	3.5	5.3	7.5	6.0	5.5	7.2	7.9	7.1	3.8	7.0	6.3	7.3	6.2	7.2	3.8	5.6	3.5	16.5	24.5	26.1	22.0	18.2	6.5	28.8	11.3	18.3	26.1
KDM7A	"JHDM1D, KIAA1718"	ENSG00000006459	"Lysine demethylase 7A"	Q6ZMT4	7	140084746-140177035	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012114	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA012114: AB_1852429"	"unprognostic (1.55e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.52e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.00e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.84e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.18e-1)"	20.1	3.2	6.6	15.2	4.7	18.7	10.4	8.7	6.1	13.2	12.0	4.7	4.6	10.3	8.9	5.8	13.0	5.8	6.0	8.0	5.7	3.5	4.9	8.5	9.7	10.1	4.8	2.8	5.0	6.4	7.0	6.7	15.5	6.7	6.9	12.2	3.7	11.4	4.5	24.6	15.0	16.3	9.3	6.0	6.7	11.9	9.4	5.9	10.8	6.4	10.3	15.2	13.1	9.1	2.8	3.0	6.1	2.3	1.8	1.6	0.8	0.9	0.4	2.9	3.1	2.6	2.3	5.9	1.3	1.9	0.5	0.6	0.3	0.4	2.0	2.0	1.3	1.1	4.0	2.4	0.9	11.2	2.5	0.1	0.4	5.2	2.7	1.8	2.1	2.7	5.5	1.6	8.7	2.8	6.3	8.9	0.5	0.8	3.5	3.1	4.6	1.6	3.9	0.2	4.0	1.0	1.2	5.1	6.3	3.0	7.0	3.0	9.5	0.7	4.9	0.6	1.1	1.9	0.8	3.1	0.4	6.6	1.6	5.2	1.1	1.6	2.3	0.9	1.1	1.3	0.9	1.5	1.6	1.5	3.0	2.8	1.5	1.0	6.1	1.8	0.5	1.2	1.3	0.8	6.6	4.7	8.7	6.1	5.7	3.5	4.8	2.8	6.7	5.9
KIAA0319L	"AAVR, KIAA1837"	ENSG00000142687	"KIAA0319 like"	Q8IZA0	1	35433490-35557950	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 27.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072692	Supported		Supported	"Nucleoli,Golgi apparatus"			870000	"Golgi apparatus"	Nucleoli	"HPA072692: "	"unprognostic (1.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.87e-1)"	"prognostic unfavourable (5.92e-5)"	"unprognostic (3.41e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.79e-1)"	"prognostic favourable (1.27e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.84e-1)"	10.6	23.5	20.3	10.6	29.0	9.9	20.1	21.9	37.2	19.2	17.7	24.1	17.0	18.1	19.7	19.2	14.4	25.1	15.7	30.7	19.4	20.0	27.5	32.1	21.3	11.0	19.4	20.1	13.0	32.8	38.5	28.1	21.1	23.0	25.3	21.3	24.5	33.9	20.5	27.4	13.8	19.8	12.7	16.6	17.1	23.3	14.0	17.5	11.9	29.3	11.9	17.4	12.9	12.0	2.3	3.2	27.1	11.0	5.5	3.5	4.5	6.1	9.2	19.2	15.1	26.0	18.4	18.2	8.4	18.0	12.3	18.3	9.9	25.1	6.9	23.3	9.2	12.4	14.1	13.6	14.1	11.0	10.3	9.4	11.3	10.9	20.4	7.7	13.0	25.8	17.5	14.2	18.5	20.1	12.3	10.1	16.7	6.2	4.6	6.5	21.7	5.5	5.2	16.3	8.6	20.4	15.2	4.2	11.9	12.2	14.7	25.1	15.4	11.0	20.5	8.5	9.2	7.1	13.0	15.0	12.0	4.6	21.6	10.2	8.4	4.5	11.0	5.0	3.0	3.6	2.9	2.0	2.5	2.8	3.2	2.3	3.5	2.5	27.1	5.5	2.2	2.1	2.3	4.5	20.3	29.0	21.9	37.2	19.4	20.0	19.4	20.1	23.0	17.5
KIAA1551	"C12orf35, FLJ10652, FLJ20696, GET, UTA2-1"	ENSG00000174718	KIAA1551	Q9HCM1	12	31959370-31993107	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 58.8;lymphoid tissue: 56.3"	"Low cell line specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"testis cancer: 65.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"neutrophil: 58.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 58.8"					"Low region specificity"	"Detected in all"			"HPA013816, HPA015622"	Approved		Supported	"Nucleoli,Intermediate filaments,Cytosol"				Nucleoli	"Intermediate filaments, Cytosol"	"HPA013816: AB_1848661, HPA015622: AB_1848663"	"unprognostic (7.97e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.49e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.09e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.90e-2)"	"prognostic unfavourable (5.04e-9)"	"unprognostic (3.83e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.26e-3)"	12.4	5.8	4.7	28.8	6.1	9.0	10.3	8.7	7.0	15.7	17.5	2.7	7.1	10.7	11.2	10.3	12.3	19.0	8.9	6.2	4.8	3.5	8.1	14.2	17.0	56.3	7.5	4.1	38.3	7.0	3.6	8.0	17.5	5.4	11.6	6.5	3.5	8.6	5.5	5.4	6.7	30.0	8.5	8.1	39.1	8.8	8.7	5.9	48.5	10.0	7.6	27.6	17.3	13.9	9.6	3.3	58.8	4.5	8.0	13.2	5.0	2.9	5.3	9.2	3.5	4.2	5.0	13.7	3.6	3.6	2.6	2.8	20.0	19.6	14.3	9.0	3.0	4.0	12.6	2.4	3.7	10.5	1.7	20.0	2.6	2.6	8.2	14.4	32.4	2.7	3.7	2.9	4.8	20.2	11.4	22.8	2.7	1.4	20.2	6.0	19.6	2.2	9.4	8.8	6.2	2.6	5.5	3.7	3.3	4.7	2.4	2.5	8.4	16.0	12.7	2.7	4.4	4.7	3.8	13.9	14.7	17.6	1.5	8.1	3.0	12.5	3.9	3.9	12.5	4.4	11.8	9.6	11.2	11.6	3.3	7.5	13.2	12.6	58.8	8.0	4.5	2.0	10.2	5.0	4.7	6.1	8.7	7.0	4.8	3.5	7.5	4.1	5.4	5.9
KIAA1755	RP5-1054A22.3	ENSG00000149633	KIAA1755	Q5JYT7	20	38210488-38260772	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.2"	"Cell line enhanced"	"Detected in some"		"AF22: 39.9;ASC diff: 6.1;ASC TERT1: 9.2;WM-115: 10.1"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051064	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles"				Nucleoli	"Golgi apparatus, Vesicles"	"HPA051064: "	"unprognostic (3.98e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.79e-1)"	"unprognostic (3.01e-3)"	"unprognostic (1.77e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.42e-8)"	"unprognostic (1.41e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.53e-3)"	6.1	2.5	13.6	5.8	27.3	0.7	3.8	4.8	22.1	13.2	8.1	47.2	3.1	2.7	15.5	7.2	5.6	10.0	16.9	11.5	13.9	8.4	4.6	1.7	2.7	4.9	22.7	13.7	14.7	1.5	0.3	3.1	0.4	24.5	7.3	4.7	8.8	6.1	8.2	1.3	1.6	4.5	15.8	20.4	2.8	4.1	2.9	29.2	0.0	2.6	1.6	4.9	6.8	5.4	0.3	0.5	0.9	0.4	0.4	0.7	0.0	1.5	0.1	39.9	0.0	6.1	9.2	0.0	3.9	2.2	0.0	0.0	0.2	1.1	0.0	0.2	1.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.3	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.6	0.2	0.7	0.0	0.0	0.0	0.1	0.0	10.1	0.9	0.4	0.1	0.7	0.2	0.5	0.1	0.5	0.6	0.1	0.3	0.4	0.4	0.7	0.4	0.1	0.5	0.0	0.0	13.6	27.3	4.8	15.7	13.9	8.4	22.7	13.7	24.5	29.2
KIAA1841		ENSG00000162929	KIAA1841	Q6NSI8	2	61065871-61138034	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051240	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA051240: "	"unprognostic (1.01e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-2)"	"unprognostic (5.71e-8)"	"unprognostic (1.13e-1)"	"unprognostic (5.06e-3)"	"unprognostic (7.53e-2)"	"unprognostic (6.09e-2)"	"unprognostic (8.92e-2)"	"unprognostic (7.85e-6)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.25e-1)"	5.1	3.6	9.8	3.9	8.9	2.3	4.3	13.3	12.4	10.0	7.1	7.0	1.0	5.5	4.4	6.8	3.8	7.5	3.6	5.2	9.6	11.6	2.6	2.3	8.0	3.2	8.8	12.1	2.4	3.6	3.9	8.2	3.5	20.6	9.6	8.3	3.6	3.6	3.1	3.7	8.5	5.9	5.4	10.1	3.3	5.6	7.5	6.2	3.3	4.0	2.7	3.5	4.3	3.7	1.5	1.2	4.8	2.5	1.4	3.7	0.6	4.6	9.0	11.8	5.1	6.8	7.6	3.7	8.9	2.2	4.6	4.3	2.7	3.0	1.9	2.3	6.8	5.8	7.4	3.0	6.4	8.0	1.8	1.7	6.2	7.5	3.6	2.1	1.7	3.6	4.8	8.3	2.9	6.3	1.7	1.5	12.7	0.4	1.8	1.4	3.7	1.8	6.0	9.7	0.4	5.8	9.5	7.0	4.3	10.7	2.4	3.2	1.8	2.5	8.4	7.5	2.8	6.0	6.0	0.8	2.4	2.8	5.4	1.5	5.1	0.8	1.4	4.8	1.3	1.5	1.2	1.5	1.2	0.6	1.2	0.6	0.2	1.0	3.0	1.4	2.5	0.8	3.7	0.6	9.8	8.9	13.3	12.4	9.6	11.6	8.8	12.1	20.6	6.2
KIF2A	"HK2, KIF2"	ENSG00000068796	"Kinesin family member 2A"	O00139	5	62306162-62537249	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis"	"Developmental protein, Motor protein"	"Cancer-related genes, Disease mutation, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004715, HPA004716"	Approved		Enhanced	Nucleoplasm,Nucleoli,Centrosome			2100000	"Nucleoplasm, Nucleoli, Centrosome"		"HPA004715: , HPA004716: AB_1079211"	"unprognostic (2.40e-2)"	"unprognostic (3.43e-1)"	"prognostic favourable (1.70e-4)"	"unprognostic (2.74e-2)"	"unprognostic (1.43e-1)"	"prognostic favourable (5.45e-4)"	"prognostic unfavourable (3.17e-6)"	"unprognostic (8.77e-3)"	"unprognostic (4.69e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (3.81e-5)"	"unprognostic (3.53e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.58e-1)"	11.3	9.3	25.4	21.9	26.4	12.4	15.5	15.4	40.1	19.7	13.5	19.4	8.0	10.3	12.9	7.6	14.3	17.5	13.7	7.2	26.2	24.1	8.2	5.8	10.6	29.4	24.9	24.6	13.0	12.3	15.2	14.3	27.8	37.0	10.2	14.5	6.8	10.7	11.9	7.4	7.9	15.8	13.5	34.3	17.4	9.6	39.2	26.4	28.7	13.0	5.6	26.7	17.4	14.8	9.0	8.4	7.1	3.0	15.8	25.4	9.7	17.2	17.3	28.9	25.6	10.9	15.4	23.6	18.5	15.3	20.2	25.6	18.6	18.9	42.8	20.4	16.3	11.0	21.9	14.9	27.0	42.9	15.3	43.0	16.2	10.1	12.9	23.4	16.4	12.7	9.8	19.6	17.8	18.4	30.4	26.1	16.8	13.0	39.1	11.6	16.8	10.9	28.9	22.9	23.6	9.0	21.0	25.9	21.5	25.1	10.6	13.0	13.8	13.2	15.9	12.0	19.9	13.9	18.4	24.7	35.6	45.2	13.9	28.2	14.7	7.1	3.0	3.4	20.2	2.6	22.8	9.0	20.3	20.6	4.0	7.8	17.9	18.4	5.3	15.8	1.8	8.4	25.4	9.7	25.4	26.4	15.4	31.2	26.2	24.1	24.9	24.6	37.0	26.4
KIF2B		ENSG00000141200	"Kinesin family member 2B"	Q8N4N8	17	53822901-53825213	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	261	"testis: 103.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023081, HPA023103, HPA024795"	Uncertain		Supported	"Nucleoli,Microtubules,Cytokinetic bridge,Mitotic spindle"				"Microtubules, Cytokinetic bridge, Mitotic spindle"	Nucleoli	"HPA023081: AB_10600082, HPA023103: AB_10611254, HPA024795: AB_10602197"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	103.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KIF3B	"FLA8, KIAA0359, KLP-11"	ENSG00000101350	"Kinesin family member 3B"	O15066	20	32277664-32335011	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007119	Approved		Uncertain	"Nucleoplasm,Nucleoli,Golgi apparatus"				Nucleoplasm	"Nucleoli, Golgi apparatus"	"HPA007119: AB_1852498"	"unprognostic (1.74e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.01e-3)"	"unprognostic (9.30e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.18e-1)"	"prognostic favourable (1.44e-12)"	"unprognostic (2.41e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.11e-2)"	"unprognostic (4.42e-2)"	8.4	11.0	22.9	7.7	30.2	5.5	9.1	17.6	24.6	11.6	13.4	13.3	7.7	14.3	8.8	13.5	5.8	15.4	11.0	6.2	19.9	15.1	26.4	17.8	9.3	7.7	15.1	18.7	10.5	16.9	38.5	18.1	6.4	13.2	9.0	14.2	11.8	8.4	8.6	5.3	5.8	17.1	9.0	16.0	6.8	12.7	15.3	13.7	4.3	14.3	4.1	8.4	8.5	6.5	6.5	3.1	3.7	5.9	2.6	6.6	1.8	22.6	15.5	10.7	13.8	14.3	22.8	11.0	11.3	15.9	13.7	10.8	26.3	12.5	12.2	13.6	21.2	14.7	13.8	16.7	17.5	5.8	6.3	10.6	12.3	12.9	9.1	8.9	8.1	14.0	12.0	23.6	9.4	11.1	6.5	4.9	11.0	10.4	4.1	4.1	5.8	13.6	3.8	17.7	4.4	14.1	16.8	17.7	14.9	29.5	7.9	11.3	17.4	6.9	13.5	25.8	17.6	15.0	13.9	8.3	11.8	6.4	25.7	15.6	10.4	1.3	3.1	3.7	6.6	4.2	5.5	6.1	5.0	6.1	1.7	6.5	3.1	4.6	3.2	2.6	5.9	3.1	3.9	1.8	22.9	30.2	17.6	24.6	19.9	15.1	15.1	18.7	13.2	13.7
KLHDC4	DKFZp434G0522	ENSG00000104731	"Kelch domain containing 4"	Q8TBB5	16	87696485-87765992	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041665	Approved		Approved	Nucleoli				Nucleoli		"HPA041665: AB_10796352"	"unprognostic (2.96e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.28e-3)"	"unprognostic (3.54e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.61e-3)"	"unprognostic (6.40e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.87e-1)"	"prognostic favourable (1.14e-4)"	"unprognostic (3.84e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.88e-1)"	"prognostic favourable (1.69e-4)"	12.7	12.1	13.5	23.1	15.5	17.0	12.7	15.5	15.8	9.9	13.8	14.6	16.1	13.1	17.5	14.4	12.8	13.1	17.7	10.2	14.7	12.9	11.4	16.1	12.5	21.0	14.7	13.6	12.1	20.6	15.6	14.2	8.7	12.9	11.0	15.8	10.7	16.6	16.3	30.7	15.9	12.0	12.7	15.5	14.9	14.5	26.6	12.9	22.7	14.0	14.5	19.5	12.7	11.8	6.1	6.1	4.4	11.1	17.6	14.4	6.4	6.6	12.2	6.2	9.4	2.5	3.4	9.7	6.3	5.9	10.5	4.9	18.1	9.6	10.6	8.5	4.9	10.9	9.4	8.4	7.5	1.6	10.5	6.0	7.7	11.8	6.4	5.6	6.3	1.5	4.4	9.4	10.5	8.7	19.3	5.5	6.9	28.6	12.9	16.4	10.4	9.1	12.6	7.2	6.1	6.2	7.8	9.5	9.1	13.3	6.8	3.0	10.7	8.9	5.4	5.9	9.9	2.9	11.9	26.9	9.2	46.0	5.7	14.3	3.9	0.0	6.0	4.4	14.4	7.8	12.6	6.1	6.0	11.6	4.4	5.5	6.1	9.2	0.4	17.6	11.1	6.1	5.0	6.4	13.5	15.5	15.5	15.8	14.7	12.9	14.7	13.6	12.9	12.9
KLHDC9	KARCA1	ENSG00000162755	"Kelch domain containing 9"	Q8NEP7	1	161098361-161100346	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 24.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 4.9;HDLM-2: 3.5;HEK 293: 3.6;MCF7: 3.3;T-47d: 3.2;U-266/70: 3.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032058, HPA043197"	Uncertain		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA032058: AB_10601439, HPA043197: AB_2678359"	"unprognostic (1.79e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.87e-3)"	"unprognostic (6.31e-2)"	"prognostic favourable (4.20e-6)"	"unprognostic (1.81e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.51e-2)"	"unprognostic (6.36e-2)"	"unprognostic (6.88e-2)"	1.0	3.7	4.0	1.0	8.4	0.9	1.4	3.1	9.5	1.8	2.4	2.3	5.6	1.6	2.4	3.9	1.1	5.7	2.4	1.7	3.3	4.9	5.9	2.6	1.7	1.0	3.6	7.4	2.5	3.6	4.1	4.8	1.0	5.6	3.2	1.6	3.5	2.9	2.4	2.5	0.8	1.6	1.1	1.6	1.1	2.4	24.3	2.2	0.0	5.0	0.0	1.1	1.5	0.6	0.9	0.1	0.0	0.2	0.0	1.1	0.1	0.4	2.7	1.0	2.9	0.0	0.2	0.3	0.0	0.7	0.1	0.0	0.0	0.2	0.0	4.9	0.0	1.6	0.0	0.0	0.0	3.5	3.6	0.0	1.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.5	0.0	1.4	2.4	2.6	0.0	1.9	0.6	0.0	2.5	1.0	0.0	0.9	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	1.1	0.0	0.1	0.4	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	4.0	8.4	3.1	9.5	3.3	4.9	3.6	7.4	5.6	2.2
KLLN	killin	ENSG00000227268	"Killin, p53 regulated DNA replication inhibitor"	B2CW77	10	87859161-87863437	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 6.3;skeletal muscle: 7.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 8.7"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			HPA074502			Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA074502: "	"unprognostic (4.53e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.71e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.57e-2)"	"unprognostic (4.79e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.02e-4)"	"unprognostic (1.60e-1)"	1.7	1.5	1.2	0.8	1.9	0.6	1.4	2.0	1.4	1.3	1.6			0.7	1.2	2.0	0.6	2.9	0.6	0.7	1.0	1.8	1.7	1.7	0.5	1.3	1.1		0.7	0.6	1.3	1.9	0.9		0.6	1.6		0.4	0.8	7.4	0.4	0.7	0.8	0.9	1.7	0.9	2.4			1.3		1.4	0.9	0.9	1.7	1.4	6.3	1.6	1.7	1.2	0.5	1.4	1.6	2.0	1.4	1.0	0.6	1.5	1.2	1.6	0.9	1.2	1.0	4.4	3.4	0.6	0.5	1.7	1.2	1.3	0.7	0.9	0.5	1.1	2.6	1.1	1.1	2.4	0.9	1.1	1.5	1.2	1.5	0.5	0.8	8.7	0.9	2.9	6.6	2.7	0.8	0.8	4.3	0.3	4.2	0.8	1.4	0.8	1.7	1.5	1.1	0.2	2.8	2.0	0.5	1.0	0.5	1.7	0.6	5.1	5.2	4.9	1.7	4.8	1.0	3.1	1.0	1.5	0.7	1.4	1.1	1.2	0.9	0.9	0.8	1.7	1.2	1.1	6.3	1.7	1.6	1.4	0.7	0.5										
KNOP1	"101F10.1, C16orf88, FAM191A, TSG118"	ENSG00000103550	"Lysine rich nucleolar protein 1"	Q1ED39	16	19701934-19718235	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041079, HPA066169"	Uncertain		Enhanced	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA041079: AB_10962350, HPA066169: "	"unprognostic (6.55e-3)"	"unprognostic (3.96e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-2)"	"unprognostic (8.57e-3)"	"unprognostic (2.35e-1)"	"prognostic unfavourable (3.75e-6)"	"unprognostic (2.50e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.18e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.08e-1)"	6.9	7.1	13.9	7.6	34.7	3.9	13.8	11.1	23.7	7.1	9.5	20.9	8.5	8.2	8.5	10.9	10.1	8.1	7.3	6.9	17.0	10.5	6.2	7.6	5.5	9.4	33.1	9.1	12.8	19.6	17.2	6.4	10.3	18.1	8.1	11.1	4.9	13.9	9.8	15.2	15.0	8.2	5.8	21.2	6.4	9.3	10.0	33.2	4.9	7.3	5.8	7.5	8.4	7.7	7.0	5.2	1.6	8.0	4.5	12.8	4.4	12.2	18.9	21.1	15.9	5.2	4.9	10.8	7.6	4.2	7.3	7.4	13.3	10.7	14.6	31.1	4.6	11.4	16.3	10.4	7.1	9.8	11.4	8.6	10.7	17.4	9.5	13.4	6.8	3.1	14.9	9.5	7.9	7.7	26.4	6.6	6.8	16.0	11.9	11.2	40.9	7.5	25.6	11.3	17.0	7.7	11.7	18.9	16.0	9.5	12.2	12.4	14.2	9.2	8.8	11.4	11.8	7.0	10.0	9.8	20.1	18.4	6.2	10.4	11.1	0.4	3.5	1.6	4.8	8.0	7.2	6.6	6.9	4.8	4.2	7.0	12.8	7.2	1.0	4.5	7.0	5.2	4.4	4.4	13.9	34.7	11.1	23.7	17.0	10.5	33.1	9.1	18.1	33.2
KRCC1	FLJ22333	ENSG00000172086	"Lysine rich coiled-coil 1"	Q9NPI7	2	88027205-88055729	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA045618, HPA052666"	Approved		Approved	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA045618: AB_10960406, HPA052666: "	"unprognostic (7.37e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-3)"	22.5	15.0	23.1	30.6	27.3	5.7	25.9	23.5	20.4	23.3	29.9	15.8	19.9	20.7	17.8	29.1	26.4	18.4	16.5	21.4	27.0	15.7	21.5	28.1	23.4	22.3	30.3	15.2	20.3	19.4	24.8	23.8	17.3	23.8	24.0	29.7	12.1	20.8	37.9	23.0	16.7	28.9	24.7	28.2	22.0	17.5	10.0	29.9	20.2	26.9	14.5	20.5	22.1	20.2	18.3	12.7	37.2	11.6	14.8	16.5	8.0	11.5	7.1	11.2	8.1	27.0	32.0	8.3	18.3	20.4	9.8	9.6	0.6	15.5	16.4	6.6	11.5	6.0	2.5	3.8	11.1	17.1	3.5	3.1	1.8	1.1	19.7	4.7	2.2	16.0	19.1	6.5	14.0	11.0	4.4	8.2	21.1	9.8	5.4	6.6	8.5	4.7	11.1	2.0	1.7	14.7	6.3	8.7	8.8	6.9	9.7	21.3	6.8	19.5	15.3	11.6	0.8	19.0	5.7	18.6	12.9	13.1	12.5	12.7	27.3	24.7	11.0	37.2	10.1	11.6	11.7	18.3	12.4	12.3	12.7	16.9	14.2	11.2	17.9	14.8	10.0	11.2	16.5	8.0	23.1	27.3	23.5	20.4	27.0	15.7	30.3	15.2	23.8	29.9
KREMEN2	"KRM2, MGC10791"	ENSG00000131650	"Kringle containing transmembrane protein 2"	Q8NCW0	16	2963944-2968383	"Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 13.1;skin 1: 12.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 19.9;MCF7: 10.0;RPMI-8226: 18.7;T-47d: 10.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	7	"memory B-cell: 3.2;naive B-cell: 3.0;non-classical monocyte: 1.4"	"Group enriched"	"Detected in many"	6	"B-cells: 3.2;monocytes: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA003223	Uncertain		Approved	Nucleoli	"Intracellular and membrane"			Nucleoli		"HPA003223: AB_1079217"	"unprognostic (8.36e-2)"	"unprognostic (4.65e-1)"	"unprognostic (6.24e-3)"	"unprognostic (4.61e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.02e-3)"	"prognostic unfavourable (8.98e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.57e-2)"	"unprognostic (8.03e-2)"	"unprognostic (8.57e-2)"	"unprognostic (7.79e-12)"	"unprognostic (6.69e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.58e-3)"	0.2	0.1	1.6	2.0	0.7	1.7	0.2	0.2	3.0	1.8	0.4	0.2	4.5	0.3	0.3	0.8	3.8	0.6	0.3	0.2	1.9	0.3	0.2	0.2	0.2	0.8	0.7	0.2	0.2	0.4	0.0	0.2	0.2	0.3	1.6	0.0	1.9	1.6	0.2	0.6	12.5	0.6	0.2	1.7	0.9	0.5	2.1	0.2	13.1	0.2	1.8	6.8	0.2	0.6	3.2	0.3	0.0	1.4	0.0	0.0	0.0	1.2	0.8	0.3	7.1	0.0	0.0	1.0	0.4	0.0	0.0	0.0	2.9	1.1	5.2	1.4	0.0	5.9	0.9	0.5	0.0	0.8	0.8	0.3	1.7	1.7	0.0	0.4	19.9	0.2	0.0	0.0	0.1	0.0	2.1	2.1	0.0	10.0	1.2	2.3	2.0	1.5	3.1	8.2	18.7	0.0	0.2	2.1	1.2	1.4	3.2	3.2	10.1	1.9	0.1	0.6	8.7	0.7	0.4	3.7	0.8	3.1	0.3	0.9	0.5	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.6	0.7	0.2	2.3	1.9	0.3	0.7	0.2	0.3	0.2
KRI1	FLJ12949	ENSG00000129347	"KRI1 homolog"	Q8N9T8	19	10553078-10566037	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 56.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043110, HPA043574"	Approved		Enhanced	Nucleoli				Nucleoli		"HPA043110: , HPA043574: "	"unprognostic (6.38e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavourable (9.37e-4)"	"unprognostic (6.70e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.10e-3)"	"prognostic unfavourable (1.21e-4)"	"unprognostic (3.46e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.43e-2)"	"prognostic unfavourable (4.89e-10)"	"unprognostic (2.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.02e-1)"	14.7	12.5	10.4	23.6	20.6	19.1	14.3	27.8	19.6	14.5	13.4	16.6	12.4	12.7	15.9	17.6	17.2	14.3	15.0	12.1	13.1	10.3	11.9	13.3	12.4	25.2	16.7	9.8	17.2	19.5	21.0	18.3	10.9	14.9	15.6	9.8	20.3	14.7	18.2	23.0	25.3	16.8	15.0	17.2	23.0	12.7	14.6	18.6	46.8	15.6	10.9	21.3	15.8	15.9	8.5	14.1	2.5	4.9	8.5	11.2	3.9	12.0	6.2	8.0	11.5	4.3	4.8	5.5	11.2	5.3	7.1	6.6	8.9	4.4	17.9	13.3	4.5	9.5	9.7	8.8	8.0	19.4	22.1	56.7	12.0	5.8	7.9	22.2	20.6	5.8	7.2	10.2	10.5	4.5	15.8	18.2	6.1	10.8	22.8	33.0	12.7	14.9	9.6	10.4	8.8	6.0	10.7	13.1	6.1	13.2	7.8	8.2	9.7	16.3	5.4	9.2	7.8	24.8	23.3	13.0	15.0	12.9	7.7	18.0	13.7	1.3	4.5	2.5	11.2	4.9	10.3	7.1	7.5	9.0	5.8	8.5	8.4	9.0	0.8	8.5	2.5	14.1	5.4	3.9	10.4	20.6	27.8	19.6	13.1	10.3	16.7	9.8	14.9	18.6
KRR1	"HRB2, RIP-1"	ENSG00000111615	"KRR1, small subunit processome component homolog"	Q13601	12	75490861-75511636	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043433, HPA051690"	Approved		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA043433: AB_10960988, HPA051690: "	"unprognostic (2.77e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.71e-2)"	"unprognostic (6.01e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.12e-2)"	22.5	18.4	14.2	15.1	22.0	38.0	17.8	29.1	23.3	21.2	14.3	6.7	14.6	12.6	18.3	15.2	24.2	14.7	10.5	12.5	12.6	10.8	23.7	25.0	13.5	18.2	12.8	16.4	21.7	15.0	17.8	33.5	21.4	19.8	20.9	11.8	6.3	20.7	14.2	28.8	16.6	15.2	15.7	16.1	19.8	15.1	12.3	17.3	24.3	20.5	22.4	18.1	19.6	16.4	15.8	10.8	8.9	4.6	8.6	14.7	5.6	25.0	20.8	13.1	11.7	10.3	9.4	24.0	22.0	14.0	17.3	11.2	15.2	13.2	26.7	17.9	10.9	13.2	17.5	19.3	19.6	22.0	17.8	25.8	11.5	17.6	12.5	45.4	16.4	9.8	16.5	19.9	19.1	11.8	28.5	8.6	17.0	16.5	26.4	12.9	19.3	19.0	21.0	25.2	16.0	19.3	31.7	15.7	13.1	20.8	14.7	25.9	24.6	18.5	14.7	16.0	10.7	16.6	22.7	17.1	21.5	16.8	8.7	16.1	28.9	7.7	2.4	8.9	10.1	4.6	12.4	15.8	14.1	11.4	3.9	14.4	14.7	13.8	1.1	8.6	3.7	10.8	12.5	5.6	14.2	22.0	29.1	23.3	12.6	10.8	12.8	16.4	19.8	17.3
KYAT3	"CCBL2, KAT3, KATIII, RBM1, RP11-82K18.3"	ENSG00000137944	"Kynurenine aminotransferase 3"	Q6YP21	1	88935773-88992953	"Enzymes, Predicted intracellular proteins"		"Aminotransferase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026538, HPA027168"	Enhanced		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA026538: AB_1852076, HPA027168: AB_1852078"	"prognostic favourable (3.19e-5)"	"unprognostic (3.36e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.01e-2)"	"prognostic favourable (1.86e-4)"	"unprognostic (2.61e-1)"	"unprognostic (3.61e-3)"	"unprognostic (2.11e-1)"	"prognostic favourable (2.80e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.17e-1)"	"prognostic favourable (5.02e-6)"	"unprognostic (1.17e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.78e-1)"	22.2	26.8	16.6	13.2	19.3	10.6	27.5	14.9	23.5	23.7	17.5	20.0	13.0	19.4	24.1	21.2	27.2	18.9	17.8	13.2	18.6	14.2	27.3	23.8	17.1	17.6	16.9	22.2	27.4	28.6	27.0	19.5	21.9	23.4	19.0	19.6	19.5	21.0	20.7	10.4	22.0	17.2	22.1	14.8	20.7	23.5	15.6	17.2	15.5	24.5	13.4	20.2	25.2	17.7	9.6	17.0	9.2	12.7	11.5	16.7	8.2	20.4	4.3	20.9	7.0	7.5	21.0	18.2	12.6	23.7	16.1	21.0	6.2	7.2	13.5	9.6	9.3	5.8	5.9	9.7	24.7	7.9	8.4	12.1	4.1	10.3	24.6	16.9	3.3	17.7	9.8	11.0	20.0	15.6	15.5	7.1	15.1	6.7	18.0	8.2	12.5	3.8	18.4	14.7	7.2	33.9	20.9	15.3	18.6	16.7	22.3	10.9	12.3	4.1	10.4	6.8	4.5	21.6	9.1	9.6	4.8	9.0	3.3	7.5	5.7	5.6	12.7	7.1	9.1	7.9	12.6	9.6	11.8	10.5	17.0	9.3	12.4	10.4	9.2	11.5	10.2	6.3	16.7	8.2	16.6	19.3	14.9	23.5	18.6	14.2	16.9	22.2	23.4	17.2
L3MBTL3	KIAA1798	ENSG00000198945	"L3MBTL3, histone methyl-lysine binding protein"	Q96JM7	6	130013699-130141451	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 30.9;HUVEC TERT2: 30.1;TIME: 20.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044382, HPA053035"	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA044382: , HPA053035: "	"unprognostic (2.33e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.82e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.60e-2)"	8.8	16.7	5.2	16.4	8.2	7.5	7.5	2.4	7.7	17.1	5.6	3.6	9.3	3.1	17.5	14.1	5.7	7.4	6.0	4.1	5.4	5.8	6.1	6.4	7.4	11.4	5.2	5.9	12.1	3.8	8.1	17.0	6.5	5.7	10.3	5.7	4.8	5.8	7.5	5.3	4.3	7.6	9.9	5.4	18.5	4.6	7.5	3.9	25.5	10.2	4.3	12.8	10.4	11.6	10.7	10.8	3.9	14.1	1.7	4.2	0.6	0.8	3.1	7.3	1.1	5.0	6.8	1.5	3.6	7.5	1.5	2.7	3.7	3.9	1.3	5.3	4.7	3.1	4.2	6.5	2.3	2.8	4.2	8.5	1.5	0.9	2.6	5.0	30.9	4.2	4.7	1.7	5.0	30.1	6.1	3.4	3.7	0.3	10.6	0.8	3.4	1.6	4.0	2.0	0.0	4.8	1.2	0.2	1.0	1.4	0.3	2.9	7.6	4.4	20.5	2.4	3.4	0.4	2.3	0.6	0.0	2.2	1.2	2.1	2.5	3.9	3.5	3.5	2.7	4.0	2.7	7.6	2.7	3.8	1.3	10.7	2.4	3.0	3.7	1.7	14.1	10.8	4.2	0.6	5.2	8.2	2.4	7.7	5.4	5.8	5.2	5.9	5.7	3.9
LDB2	"CLIM1, LDB1"	ENSG00000169744	"LIM domain binding 2"	O43679	4	16501541-16898809	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 9.5;fHDF/TERT166: 9.6;HAP1: 17.6;HUVEC TERT2: 33.3;U-138 MG: 13.4"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"amygdala: 14.5;basal ganglia: 30.3;cerebral cortex: 45.3;hippocampal formation: 16.6;olfactory region: 21.7"	"Cell type enriched"	"Detected in single"	13	"NK-cell: 5.1"	"Lineage enriched"	"Detected in single"	13	"NK-cells: 5.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB017544, HPA068634"	Supported		Supported	"Nucleoplasm,Nucleoli,Plasma membrane"				"Nucleoplasm, Nucleoli"	"Plasma membrane"	"CAB017544: AB_2137013, HPA068634: "	"unprognostic (3.43e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.10e-2)"	"unprognostic (4.37e-1)"	"unprognostic (7.25e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.10e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.26e-3)"	"unprognostic (1.60e-1)"	"unprognostic (9.63e-2)"	"unprognostic (7.10e-3)"	27.9	9.5	14.5	4.6	30.3	0.4	26.8	1.1	45.3	27.1	6.8	2.7	8.0	4.0	54.9	14.4	9.5	15.6	18.3	18.5	16.6	4.8	14.9	15.0	31.3	6.9	5.5	21.7	11.9	4.6	15.2	5.6	33.7	3.4	10.4	5.4	15.4	6.1	8.6	7.5	5.4	6.8	32.8	4.2	32.9	6.7	6.4	3.4	0.7	17.8	7.5	3.0	14.7	13.3	0.2	0.0	0.3	0.0	5.1	0.0	0.6	0.0	0.0	9.5	0.0	5.5	9.1	0.0	5.2	4.0	0.6	1.4	0.0	0.0	0.0	0.0	9.6	0.0	17.6	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	5.1	0.0	6.5	0.0	33.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	4.4	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	8.7	13.4	0.0	0.6	0.0	4.3	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.1	0.0	0.0	0.0	0.6	14.5	30.3	1.1	45.3	16.6	4.8	5.5	21.7	3.4	3.4
LDOC1	"BCUR1, Mar7, Mart7, RTL7, SIRH7"	ENSG00000182195	"LDOC1, regulator of NFKB signaling"	O95751	X	141175745-141177125	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 29.2;MCF7: 39.3;PC-3: 49.3;U-251 MG: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 19.2"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 21.5"	"Low region specificity"	"Detected in all"			"HPA051768, HPA061842"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA051768: , HPA061842: "	"unprognostic (4.09e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.40e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.38e-3)"	"unprognostic (2.76e-2)"	21.1	24.2	24.4	5.9	31.8	2.0	9.9	18.3	51.2	24.2	5.5	21.0	11.0	5.1	17.3	12.1	10.0	30.3	10.4	6.7	27.3	25.6	15.6	3.1	9.7	5.5	23.2	23.3	31.8	18.3	13.0	54.9	1.8	30.2	23.1	3.5	13.5	47.9	36.4	3.8	17.9	5.2	12.5	19.5	9.3	7.8	6.6	16.6	1.8	22.6	3.7	5.7	11.2	9.9	8.2	4.8	8.2	0.0	19.2	8.9	3.0	0.0	29.2	4.5	12.5	7.9	9.6	0.0	7.0	8.7	9.5	13.4	0.0	11.5	0.0	5.5	11.4	13.7	4.9	10.2	6.8	0.0	9.1	0.0	15.8	0.0	3.0	0.0	2.7	16.9	5.3	8.2	4.4	8.1	0.2	0.0	8.5	39.3	0.0	0.0	4.7	49.3	0.0	4.1	0.0	11.7	6.9	0.0	3.9	0.0	6.1	0.0	7.8	0.0	14.5	0.0	9.5	0.0	29.3	0.0	0.0	0.0	4.9	0.0	0.0	8.2	0.0	0.1	4.3	0.0	3.1	3.3	8.9	3.3	0.8	8.2	7.9	5.1	0.2	19.2	0.0	4.8	8.1	3.0	24.4	31.8	18.3	47.4	27.3	25.6	23.2	23.3	30.2	16.6
LEKR1	FLJ16641	ENSG00000197980	"Leucine, glutamate and lysine rich 1"	Q6ZMV7	3	156825481-157046129	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 29.8"	"Cell line enhanced"	"Detected in many"		"A-431: 6.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA044039, HPA047774"	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA044039: AB_10794288, HPA047774: "	"unprognostic (5.42e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.98e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.66e-3)"	"unprognostic (3.50e-2)"	"unprognostic (5.99e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.80e-2)"	1.4	1.7	1.4	2.5	4.6	0.6	2.7	1.4	2.2	1.5	1.0	1.6	3.5	1.7	1.3	8.2	0.9	6.3	1.7	1.4	1.5	2.0	2.8	1.3	3.0	1.6	1.1	1.4	2.9	2.7	4.8	4.5	0.5	2.2	1.7	1.1	2.5	1.6	4.9	0.7	0.9	1.6	0.8	1.9	1.8	1.5	29.8	0.7	4.4	4.0	0.7	1.4	1.2	1.8	3.2	1.9	2.5	0.3	2.5	2.0	0.4	6.5	2.7	0.1	1.6	1.1	0.6	0.4	0.4	1.0	1.4	1.1	0.3	3.8	0.1	1.9	1.1	2.5	0.0	0.5	2.6	1.2	0.6	2.5	0.4	0.0	0.0	2.1	0.5	3.1	1.6	0.5	1.9	0.6	1.5	1.6	2.4	2.4	0.0	1.9	2.1	1.5	0.0	1.7	1.5	2.1	0.6	4.1	1.7	2.1	1.5	0.1	4.5	3.6	0.0	0.4	0.7	0.5	1.0	6.1	1.0	0.0	1.2	1.5	2.3	2.5	0.3	0.3	0.7	0.1	1.4	3.1	1.6	0.6	1.2	3.2	1.8	0.9	0.3	2.5	0.2	1.9	2.0	0.4	1.4	4.6	1.4	2.2	1.5	2.0	1.1	1.4	2.2	0.7
LEMD1	"CT50, LEMP-1"	ENSG00000186007	"LEM domain containing 1"	Q68G75	1	205381378-205457091	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 13.1;testis: 34.8"	"Cell line enriched"	"Detected in some"	6	"CAPAN-2: 29.2"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 10.6"	"Group enriched"	"Detected in some"	13	"cerebellum: 2.6;pons and medulla: 5.3"	"Cell type enhanced"	"Detected in single"		"NK-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045425			Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA045425: AB_10960538"	"unprognostic (1.78e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.20e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.48e-1)"		"unprognostic (2.72e-2)"	"unprognostic (1.01e-1)"	"prognostic favourable (1.26e-4)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (3.31e-1)"	"unprognostic (5.66e-6)"	"unprognostic (2.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.38e-2)"	0.2	0.2	0.2	0.0	0.3	0.0	0.3	2.6	0.2	0.4	1.4	0.0	3.8	0.6	1.0	13.1	1.0	1.5	0.7	0.2	0.2	0.3	0.9	0.2	0.4	0.0	0.3	0.0	0.6	0.6	0.0	0.6	4.7	5.3	0.3	0.0	0.3	3.2	0.4	0.2	0.3	1.4	0.1	0.2	0.2	0.3	34.8	0.0	0.0	4.8	2.2	2.6	0.2	0.3	0.0	0.0	0.0	0.0	1.5	0.7	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	29.2	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.2	0.3	2.6	0.2	0.2	0.3	0.3	0.0	5.3	0.0
LETMD1	"HCCR, HCCR-1, HCCR-2, HCCR1, HCCR2, SLC55A3"	ENSG00000050426	"LETM1 domain containing 1"	Q6P1Q0	12	51047962-51060424	"Predicted intracellular proteins, Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074361			Supported	Nucleoplasm,Nucleoli,Mitochondria				Mitochondria	"Nucleoplasm, Nucleoli"	"HPA074361: "	"unprognostic (2.16e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.48e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.86e-2)"	"unprognostic (6.57e-2)"	"prognostic favourable (3.26e-4)"	"unprognostic (4.07e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.58e-1)"	"prognostic favourable (3.16e-4)"	25.7	27.5	23.0	18.1	31.2	17.1	27.1	23.1	37.5	18.6	26.8	18.8	21.5	31.9	22.9	22.4	16.2	30.0	23.5	16.4	21.2	19.0	29.3	35.1	16.6	18.5	20.6	21.3	34.3	38.6	28.5	20.2	12.3	21.6	19.1	26.1	22.6	28.2	24.0	23.8	18.5	28.5	18.7	21.4	17.5	22.6	15.5	14.3	19.9	34.1	10.7	20.1	20.3	14.8	11.3	7.2	2.9	11.6	8.6	17.1	9.3	7.4	6.7	5.0	13.5	22.8	37.5	5.1	7.7	12.8	8.2	9.2	16.2	15.4	19.7	9.6	8.3	13.9	10.3	10.4	9.4	7.1	12.9	14.1	9.3	12.7	15.1	12.7	10.3	31.5	33.7	9.6	22.8	8.2	14.7	14.3	11.1	11.6	8.9	12.3	3.4	18.3	7.6	6.1	10.7	10.2	11.4	15.1	6.9	5.8	13.1	17.6	20.7	11.6	6.2	5.1	5.5	8.4	4.4	13.0	20.2	8.4	9.5	8.3	3.6	2.5	7.3	2.9	8.6	7.8	12.5	11.3	14.2	10.6	7.2	8.1	17.1	15.5	2.4	8.6	11.6	6.4	12.6	9.3	23.0	31.2	23.1	37.5	21.2	19.0	20.6	21.3	21.6	14.3
LEUTX		ENSG00000213921	"Leucine twenty homeobox"	A8MZ59	19	39776595-39786167	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"CACO-2: 1.0;HDLM-2: 2.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA041498	Uncertain		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA041498: AB_10796346"															"unprognostic (6.60e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.3		0.0	0.6		0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LHFPL6	"LHFP, MGC22429"	ENSG00000183722	"LHFPL tetraspan subfamily member 6"	Q9Y693	13	39342892-39603528	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 65.0;HSkMC: 47.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"myeloid DC: 9.4;plasmacytoid DC: 3.2"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058975	Approved		Approved	Nucleoli				Nucleoli		"HPA058975: "	"unprognostic (6.98e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.76e-1)"	"unprognostic (5.45e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavourable (1.20e-7)"	"unprognostic (4.41e-3)"	"unprognostic (5.25e-2)"	"unprognostic (7.75e-2)"	"prognostic unfavourable (2.30e-4)"	57.2	26.8	12.5	14.8	17.7	0.9	45.7	40.8	19.0	20.3	16.4	12.3	8.5	5.3	28.6	23.7	17.9	27.0	34.9	49.4	12.7	12.9	12.8	6.9	27.0	27.4	19.3	12.6	25.7	8.3	7.1	14.3	62.0	16.8	21.4	8.4	19.8	11.4	18.8	13.6	13.1	9.6	33.1	18.5	18.5	10.2	16.2	11.9	1.3	22.7	22.1	8.3	20.1	25.8	0.2	9.4	0.1	0.6	0.0	0.0	0.4	2.7	0.9	29.5	1.2	65.0	29.5	12.9	15.0	21.7	7.7	5.8	0.1	2.8	4.2	0.3	20.9	4.2	3.7	8.8	6.4	4.0	4.3	11.3	0.9	0.0	6.8	0.2	0.3	47.5	1.1	6.9	11.5	7.1	0.0	0.0	14.7	2.3	0.0	3.4	2.2	3.9	1.8	12.8	0.0	5.1	3.6	0.1	0.9	1.3	1.8	4.0	1.6	0.0	13.2	19.6	2.9	6.0	8.1	0.2	0.0	11.8	8.1	0.0	14.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	9.4	0.2	0.0	0.0	0.1	0.0	0.1	3.2	0.0	0.4	12.5	17.7	40.8	19.0	12.7	12.9	19.3	12.6	16.8	11.9
LHX8	Lhx7	ENSG00000162624	"LIM homeobox 8"	Q68G74	1	75128434-75161533	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 9.5;lymphoid tissue: 5.3;salivary gland: 6.1;tongue: 4.9"	"Group enriched"	"Detected in some"	6	"SCLC-21H: 23.3;U-266/70: 7.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"basal ganglia: 9.5;thalamus: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"basal ganglia: 9.9"	"Group enriched"	"Detected in some"	32	"basal ganglia: 15.3;hypothalamus: 4.4"	HPA071806			Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA071806: "	"unprognostic (2.28e-2)"					"unprognostic (6.23e-2)"		"unprognostic (3.85e-3)"					"unprognostic (1.52e-9)"		"unprognostic (1.64e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.06e-2)"	0.0	0.0	0.1	0.0	9.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.8	0.0	2.1	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.3	0.0	3.9	0.0	0.2	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.3	0.0	0.5	4.9	5.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.4	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.2	0.0	0.0	7.8	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.5	0.0	0.5	0.0	1.1	0.0	0.6	0.0	3.3
LIN28A	"CSDD1, FLJ12457, LIN-28, LIN28, ZCCHC1"	ENSG00000131914	"Lin-28 homolog A"	Q9H9Z2	1	26410778-26429722	"Predicted intracellular proteins"	"RNA-mediated gene silencing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 9.8"	"Cell line enriched"	"Detected in some"	10	"NTERA-2: 137.5"	"Cancer enriched"	"Detected in single"	261	"testis cancer: 101.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"CAB020785, HPA063074, HPA068814"	Enhanced		Supported	"Nucleoli,Cytosol,Rods & Rings"				Cytosol	"Nucleoli, Rods & Rings"	"CAB020785: , HPA063074: , HPA068814: "	"unprognostic (9.64e-3)"	"unprognostic (1.69e-1)"		"unprognostic (1.35e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.55e-1)"		"unprognostic (1.17e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.21e-1)"			"unprognostic (2.49e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.13e-1)"		"unprognostic (6.82e-2)"	0.1	0.0	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.5	0.5	0.1	0.1	0.1	0.2	0.3	9.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.3	0.6	2.3	0.5	1.0	0.8	0.1	0.0	0.0	13.5	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	137.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.5	0.7	0.7	0.3	0.4	1.0	0.5	0.6	0.2	1.3	0.8	0.7	2.2	1.0	0.3	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
LIN28B	"CSDD2, FLJ16517"	ENSG00000187772	"Lin-28 homolog B"	Q6ZN17	6	104936616-105083332	"Predicted intracellular proteins"	"RNA-mediated gene silencing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"placenta: 51.9"	"Cell line enhanced"	"Detected in some"		"AF22: 13.9;BEWO: 71.7;K-562: 23.2;NTERA-2: 12.6"	"Cancer enriched"	"Detected in single"	25	"testis cancer: 12.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA036630, HPA061745"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA036630: AB_10669911, HPA061745: AB_2684601"				"unprognostic (2.00e-4)"	"unprognostic (6.75e-2)"					"unprognostic (2.02e-1)"				"unprognostic (2.57e-2)"	"unprognostic (1.59e-2)"		"unprognostic (4.10e-2)"	0.1	0.1	1.2	0.0	0.8	0.3	0.0	0.1	1.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.3	0.0	0.1	0.1	0.1	0.5	0.8	0.0	0.0	0.0	1.0	51.9	1.2	0.0	0.0	0.4	0.1	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.1	5.8	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.7	0.7	2.1	0.4	0.2	0.5	0.3	0.0	0.9	13.9	2.8	0.0	0.0	71.7	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	6.7	9.9	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.2	0.3	0.0	0.0	1.4	1.6	12.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.3	0.0	0.0	1.1	0.0	2.9	0.3	0.0	1.5	0.0	0.0	4.2	5.9	0.0	0.0	0.0	0.0	1.6	0.4	0.2	0.5	0.4	0.3	0.5	0.3	0.1	0.2	0.7	0.1	0.2	2.1	0.2	0.4	0.7	0.2	0.3	1.2	0.8	0.1	1.3	0.9	1.3	0.5	0.8	1.2	0.4
LLPH	"C12orf31, hLLP, MGC14817"	ENSG00000139233	"LLP homolog, long-term synaptic facilitation"	Q9BRT6	12	66116555-66130768	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA048920, HPA058786"			Enhanced	Nucleoli				Nucleoli		"HPA048920: , HPA058786: "	"unprognostic (3.60e-3)"	"unprognostic (4.94e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.31e-2)"	"prognostic unfavourable (6.44e-7)"	"unprognostic (7.15e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.87e-2)"	"unprognostic (9.65e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.94e-2)"	20.4	38.1	16.4	20.4	16.9	40.9	17.9	10.9	20.0	16.4	20.2	11.2	19.7	16.4	17.2	17.1	21.3	14.4	13.4	19.9	15.7	13.9	27.8	31.3	14.5	21.4	20.6	16.7	18.2	16.2	11.1	18.0	24.3	17.3	18.1	18.6	9.9	15.9	14.5	47.3	13.9	27.9	21.0	26.7	29.7	18.6	20.0	17.6	23.8	22.9	23.5	21.6	23.6	22.4	23.6	24.6	34.9	34.7	20.0	29.4	21.1	26.9	21.8	13.5	16.6	15.7	15.5	16.7	31.7	20.5	23.5	19.9	18.9	11.4	31.4	26.1	21.0	23.2	21.0	19.2	31.9	27.4	18.0	33.1	15.8	16.8	19.0	57.5	23.3	15.7	19.8	20.0	21.5	20.2	28.6	22.5	27.5	29.0	25.7	38.8	28.9	23.2	21.9	24.8	22.5	23.1	32.7	13.5	16.8	20.5	21.8	33.4	28.0	31.4	21.8	18.5	26.5	22.5	28.7	17.5	27.1	46.4	24.2	27.1	28.0	22.2	25.6	26.4	23.7	29.0	27.0	23.6	27.6	25.5	24.6	21.7	23.9	25.2	34.9	20.0	34.7	21.2	29.4	21.1	16.4	16.9	10.9	20.0	15.7	13.9	20.6	16.7	17.3	17.6
LRCH1	"CHDC1, KIAA1016"	ENSG00000136141	"Leucine rich repeats and calponin homology domain containing 1"	Q9Y2L9	13	46553168-46753040	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 46.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021536	Approved		Approved	"Nucleoli,Actin filaments,Cytosol"				"Actin filaments, Cytosol"	Nucleoli	"HPA021536: AB_1853258"	"unprognostic (7.13e-3)"	"prognostic unfavourable (6.24e-4)"	"unprognostic (3.59e-2)"	"unprognostic (8.93e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.16e-2)"	"prognostic unfavourable (6.67e-4)"	"unprognostic (2.16e-1)"	"prognostic unfavourable (5.75e-4)"	"unprognostic (1.39e-2)"	"unprognostic (1.17e-1)"	"prognostic favourable (1.04e-4)"	"unprognostic (2.87e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.98e-2)"	17.9	5.0	6.5	20.3	5.9	7.2	15.2	46.4	7.2	17.5	14.6	4.6	11.5	7.0	24.6	9.8	10.6	11.9	14.1	8.0	6.3	5.9	13.8	10.9	14.3	13.5	6.6	4.9	9.5	5.1	5.2	13.1	24.1	8.0	12.8	9.3	8.4	11.3	14.5	5.3	18.1	12.0	20.9	8.5	13.7	14.6	5.0	6.0	31.7	7.8	6.4	13.7	16.6	18.3	6.2	2.3	1.8	2.0	5.1	3.6	1.8	4.6	6.7	6.1	6.3	4.5	8.6	15.7	8.0	10.5	10.0	9.5	15.1	8.0	15.0	2.2	7.5	6.8	4.6	8.1	14.5	15.4	4.3	13.4	2.7	7.0	5.6	8.7	23.0	5.4	6.4	9.2	11.3	8.6	2.6	4.5	7.3	9.0	9.3	10.9	3.4	3.6	5.1	6.6	4.0	18.6	4.9	9.7	9.7	4.5	4.5	12.0	3.4	11.7	8.1	5.9	4.0	7.3	7.6	0.8	2.3	6.7	6.9	7.6	7.1	1.5	2.0	1.8	3.6	1.6	2.1	5.3	2.7	2.6	1.9	6.2	2.1	2.1	0.7	5.1	1.2	2.3	1.9	1.8	6.5	5.9	46.4	7.2	6.3	5.9	6.6	4.9	8.0	6.0
LRCH2	KIAA1495	ENSG00000130224	"Leucine rich repeats and calponin homology domain containing 2"	Q5VUJ6	X	115110616-115234072	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 17.8;U-266/70: 11.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003233	Approved		Approved	"Nucleoli,Plasma membrane"				Nucleoli	"Plasma membrane"	"HPA003233: AB_2265929"	"unprognostic (9.74e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.14e-2)"	"unprognostic (4.22e-5)"	"unprognostic (2.88e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.29e-5)"	"unprognostic (1.09e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.16e-2)"	5.1	8.7	11.6	3.4	10.2	0.7	3.3	11.2	10.6	11.2	11.6	5.5	4.0	1.6	9.9	4.5	3.6	4.6	5.3	4.7	7.9	8.9	2.6	1.0	5.7	1.8	5.7	4.6	13.8	1.6	1.3	20.9	13.7	7.6	16.4	4.2	2.5	1.3	14.5	1.2	1.1	3.2	13.7	6.4	3.7	3.6	4.3	7.9	0.0	4.8	0.4	1.1	11.6	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	3.9	5.5	4.6	0.0	3.5	7.6	3.4	7.9	0.0	0.0	0.1	0.0	4.6	0.3	17.8	0.0	5.2	0.0	4.8	0.0	0.0	0.0	4.4	0.0	0.1	2.7	0.0	1.4	0.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	5.1	5.2	0.0	3.8	0.0	4.3	0.5	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	4.9	11.8	2.0	0.0	1.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	10.2	11.2	8.4	7.9	8.9	5.7	4.6	7.6	7.9
LRP10	"DKFZP564C1940, LRP9, MGC8675, MST087, MSTP087"	ENSG00000197324	"LDL receptor related protein 10"	Q7Z4F1	14	22871613-22881580	"Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 29.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 29.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000932			Approved	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA000932: AB_2281523"	"unprognostic (1.08e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.72e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.01e-2)"	"prognostic unfavourable (3.54e-7)"	"prognostic unfavourable (9.17e-4)"	"unprognostic (8.32e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.97e-2)"	"unprognostic (4.55e-2)"	"prognostic favourable (6.31e-5)"	"unprognostic (3.06e-2)"	"unprognostic (8.81e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.14e-2)"	33.1	20.1	12.7	26.0	13.1	23.7	37.2	5.8	10.3	32.0	52.4	16.2	41.0	31.7	39.0	46.8	66.1	27.1	65.1	27.7	13.6	6.0	46.5	63.3	34.1	30.0	14.2	8.1	30.7	36.6	31.4	11.7	32.0	14.4	36.9	19.0	22.6	36.1	41.1	21.2	32.9	65.9	32.0	11.2	26.1	37.9	19.1	12.9	20.7	46.9	34.1	36.2	43.3	42.8	3.8	2.3	29.7	2.6	2.4	6.3	3.4	15.4	18.8	4.1	10.8	56.5	32.8	14.1	24.4	46.5	15.4	21.4	5.7	54.9	8.1	12.2	55.0	22.1	2.7	27.9	6.1	13.2	2.9	2.8	10.3	4.0	25.2	6.4	25.8	35.8	32.7	23.1	12.0	28.1	3.4	31.3	20.7	17.8	1.8	1.9	0.9	25.4	4.0	4.2	8.0	16.5	27.5	0.3	4.5	13.5	26.0	10.6	13.6	4.6	29.3	23.8	6.8	12.3	10.0	14.7	8.7	3.7	12.3	2.6	10.1	5.9	2.2	15.8	5.1	2.3	5.0	3.8	6.3	6.0	2.3	2.7	5.5	3.1	29.7	2.4	2.6	1.9	6.0	3.4	12.7	13.1	5.8	10.3	13.6	6.0	14.2	8.1	14.4	12.9
LRP4	"CLSS, LRP-4, MEGF7, SOST2"	ENSG00000134569	"LDL receptor related protein 4"	O75096	11	46856868-46918642	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Endocytosis, Wnt signaling pathway"	"Developmental protein, Receptor"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.7;skin 1: 33.0"	"Cell line enhanced"	"Detected in many"		"AF22: 17.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011934, HPA012300"	Approved		Uncertain	Nucleoplasm,Nucleoli,Mitochondria				"Nucleoplasm, Nucleoli, Mitochondria"		"HPA011934: AB_1853286, HPA012300: AB_1853288"	"unprognostic (1.46e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.39e-2)"	"unprognostic (9.73e-3)"	"unprognostic (5.29e-4)"	"unprognostic (8.61e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.59e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.90e-3)"	"unprognostic (6.79e-2)"	1.2	1.9	16.0	1.3	20.3	0.5	2.1	7.3	23.7	3.0	5.4	11.6	0.6	3.9	2.1	1.3	2.4	2.0	2.5	7.2	20.4	5.8	1.2	0.7	3.4	0.5	9.6	12.6	5.4	2.7	9.3	3.3	3.1	14.5	2.7	4.1	1.3	2.1	3.0	4.4	33.0	5.3	2.0	9.7	4.2	9.6	1.6	19.0	0.0	2.9	1.0	0.8	1.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.6	17.3	5.2	10.8	2.9	4.0	0.7	1.5	2.3	2.6	2.2	0.0	0.0	1.1	8.9	3.1	9.6	5.9	1.8	0.0	8.1	0.8	3.0	5.3	2.3	0.1	1.5	3.7	3.4	3.6	0.9	2.0	0.7	0.0	1.3	0.6	0.1	0.2	9.4	0.7	1.2	5.9	0.0	0.2	2.2	0.0	11.4	0.9	0.0	2.8	0.2	0.4	0.1	4.7	2.9	5.3	1.6	0.0	0.0	0.3	3.5	0.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	20.3	7.3	17.3	20.4	5.8	9.6	12.6	14.5	19.0
LRRC10B		ENSG00000204950	"Leucine rich repeat containing 10B"	A6NIK2	11	61508800-61511018	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	7	"brain: 27.8;fallopian tube: 36.2;pituitary gland: 14.8"	"Group enriched"	"Detected in some"	5	"AF22: 11.9;RH-30: 12.8;SCLC-21H: 6.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 27.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"basal ganglia: 202.0"	"Group enriched"	"Detected in many"	5	"basal ganglia: 39.3;hippocampal formation: 35.0"	HPA047619	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA047619: "	"unprognostic (9.95e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.10e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.62e-1)"	"unprognostic (9.21e-3)"	"unprognostic (2.52e-2)"	"unprognostic (5.27e-4)"	"unprognostic (5.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.63e-2)"	2.4	1.6	4.8	0.9	27.8	0.5	1.9	0.2	5.8	3.4	1.6	1.2	1.0	0.9	2.2	3.7	1.1	36.2	0.8	1.2	5.2	1.9	0.9	0.6	3.7	0.5	1.1	4.3	3.0	1.5	2.1	14.8	1.2	1.2	0.9	1.0	0.0	1.1	1.2	0.7	0.5	0.9	2.5	0.2	0.6	1.0	2.4	8.3	0.9	0.8	0.2	0.5	0.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.3	0.0	0.0	12.8	0.0	0.0	0.0	6.7	0.6	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	27.8	0.2	5.8	5.2	1.9	1.1	4.3	1.2	8.3
LRRC23	"B7, LRPB7"	ENSG00000010626	"Leucine rich repeat containing 23"	Q53EV4	12	6873569-6914243	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"fallopian tube: 94.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA037766, HPA057533"	Enhanced		Supported	Nucleoli				Nucleoli		"HPA037766: AB_10672609, HPA057533: "	"prognostic favourable (6.02e-4)"	"unprognostic (7.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (4.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.68e-1)"	"unprognostic (6.25e-2)"	3.6	4.2	11.4	2.4	12.8	3.4	4.8	10.5	10.9	5.8	3.1	10.8	6.9	2.2	6.0	13.1	2.9	94.2	4.2	4.7	12.2	12.9	6.9	3.7	9.4	2.9	7.3	9.6	5.9	2.5	9.3	9.0	3.4	9.9	4.8	3.3	9.4	4.0	5.0	5.5	3.5	2.1	4.8	7.0	3.5	4.5	21.1	8.4	2.2	7.1	2.4	3.7	3.1	3.1	7.8	5.9	9.0	4.4	5.3	4.7	2.2	5.5	10.8	1.8	4.0	8.2	6.2	6.4	2.2	7.7	3.8	7.1	2.2	11.4	4.9	2.5	5.9	1.4	3.3	4.7	8.0	3.8	1.6	3.5	4.2	4.4	6.6	1.9	3.3	4.3	8.8	7.1	6.5	5.0	2.0	2.8	4.3	6.2	4.2	1.3	1.2	3.2	4.0	9.0	5.6	7.6	1.6	3.0	7.0	3.6	4.8	6.8	2.4	4.4	2.2	3.7	9.9	4.2	2.5	2.6	1.8	4.0	9.1	2.5	5.3	1.3	4.4	9.0	3.7	4.2	4.7	7.8	3.6	3.1	4.0	4.8	4.1	4.0	0.7	5.3	3.8	5.9	0.2	2.2	11.4	12.8	10.5	10.9	12.2	12.9	7.3	9.6	9.9	8.4
LRRC40	FLJ20331	ENSG00000066557	"Leucine rich repeat containing 40"	Q9H9A6	1	70144805-70205620	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA026564	Approved		Approved	Nucleoli				Nucleoli		"HPA026564: AB_2250054"	"unprognostic (9.39e-2)"	"unprognostic (1.01e-1)"	"prognostic favourable (4.54e-4)"	"unprognostic (6.42e-2)"	"unprognostic (6.65e-3)"	"unprognostic (3.94e-2)"	"unprognostic (7.69e-3)"	"unprognostic (9.90e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.50e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.95e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.12e-1)"	14.3	10.4	15.7	10.0	18.5	16.4	13.2	22.0	27.4	13.4	10.7	10.4	8.0	17.0	12.6	10.2	11.5	9.0	10.1	13.5	16.5	16.6	20.4	27.2	9.6	14.2	13.7	15.7	11.3	8.8	7.9	13.8	13.9	19.8	10.6	11.8	7.5	9.0	8.8	13.6	9.0	18.0	13.3	15.6	13.2	9.0	13.4	11.0	23.0	9.9	10.0	14.2	11.1	9.6	10.4	8.4	7.4	8.2	9.8	10.9	6.5	11.1	4.7	18.5	14.5	6.8	7.5	11.2	10.8	7.9	16.4	20.3	6.8	6.3	15.0	9.5	8.4	8.2	43.5	9.6	22.4	12.0	8.7	11.3	8.6	10.9	8.6	14.8	2.7	6.3	5.6	10.9	11.0	9.4	14.0	7.3	13.8	2.8	17.8	11.6	24.4	9.8	14.3	19.2	9.7	14.9	6.8	9.5	9.6	13.0	13.1	12.0	6.2	8.4	11.7	11.6	9.3	17.5	12.2	6.2	5.9	24.3	9.4	15.6	11.8	6.8	6.6	7.4	8.5	8.2	10.9	10.4	9.0	7.9	8.4	9.2	10.6	8.8	0.9	9.8	7.6	6.5	10.8	6.5	15.7	18.5	22.0	27.4	16.5	16.6	13.7	15.7	19.8	11.0
LRRC75A	"C17orf76, FAM211A, FLJ35696"	ENSG00000181350	"Leucine rich repeat containing 75A"	Q8NAA5	17	16441577-16492153	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 42.3"	"Cell line enhanced"	"Detected in some"		"HEL: 11.8;HUVEC TERT2: 3.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028528, HPA065840"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA028528: AB_10600755, HPA065840: "	"unprognostic (1.09e-1)"	"unprognostic (5.60e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.85e-5)"	"unprognostic (3.93e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.44e-1)"	"unprognostic (7.66e-3)"	"unprognostic (7.74e-2)"	"unprognostic (2.84e-1)"	"prognostic favourable (7.46e-5)"	"unprognostic (8.36e-2)"	"unprognostic (4.28e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.06e-1)"	1.0	8.9	5.2	2.8	3.7	1.7	0.6	0.7	6.3	2.2	26.3	1.5	1.4	15.0	1.9	0.5	0.4	0.9	0.5	0.4	4.1	2.4	0.8	0.2	1.6	1.9	1.6	3.2	1.8	1.6	3.7	4.1	1.5	2.1	1.1	10.4	1.9	0.3	1.7	0.4	0.4	42.3	3.0	0.8	6.4	1.3	8.5	0.4	0.5	1.2	0.0	1.9	1.3	0.7	0.8	0.0	0.3	0.6	0.3	0.6	0.2	1.1	1.0	1.2	0.8	0.3	0.5	0.1	0.3	0.8	2.7	2.2	1.1	0.3	0.0	0.8	0.1	0.4	0.3	0.2	0.1	0.4	0.9	11.8	0.6	0.0	0.4	0.2	0.9	0.0	0.0	0.6	0.0	3.8	0.5	0.2	0.0	1.9	1.9	0.8	0.2	0.1	0.6	0.7	0.1	0.5	0.2	2.3	0.6	0.0	0.2	2.8	0.2	0.1	0.0	0.3	1.4	0.9	1.5	1.5	0.3	0.2	0.1	0.7	1.0	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.6	0.3	0.3	0.6	0.0	0.0	0.2	5.2	3.7	0.7	6.3	4.1	2.4	1.6	3.2	2.1	0.4
LRWD1	"CENP-33, DKFZp434K1815, ORCA"	ENSG00000161036	"Leucine rich repeats and WD repeat domain containing 1"	Q9UFC0	7	102464929-102473168	"Predicted intracellular proteins"	"DNA replication"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"testis: 129.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021320	Enhanced		Supported	Nucleoplasm,Nucleoli,Vesicles				Nucleoli	"Nucleoplasm, Vesicles"	"HPA021320: AB_1853372"	"unprognostic (1.50e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.31e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.60e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.72e-3)"	"unprognostic (4.97e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.04e-2)"	"prognostic favourable (8.71e-5)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (1.25e-4)"	"unprognostic (1.46e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.82e-2)"	"unprognostic (9.20e-2)"	2.7	4.6	3.6	3.8	5.0	7.6	1.9	7.9	5.8	2.5	2.5	3.4	3.4	2.9	2.8	2.8	2.1	7.1	2.5	2.6	4.3	4.0	4.0	5.1	2.6	4.4	3.4	3.7	3.1	3.4	3.4	4.9	2.0	4.2	2.2	1.6	1.7	3.3	4.0	3.6	2.2	4.3	2.7	2.4	6.6	3.3	129.9	3.8	3.9	2.7	1.6	4.2	2.3	1.8	12.6	9.8	9.2	4.0	9.9	10.4	5.8	7.3	10.2	5.5	15.5	4.2	3.2	8.6	7.8	5.1	13.3	9.2	9.7	4.3	18.1	11.2	5.9	7.8	8.1	7.0	4.0	6.3	15.7	3.7	4.6	6.0	5.6	6.9	7.3	3.0	4.3	15.4	3.3	7.0	17.5	5.6	7.2	22.1	21.0	16.7	11.7	14.7	11.1	5.1	19.5	4.0	4.6	7.3	20.7	8.6	8.2	7.6	4.7	5.8	4.1	7.4	15.8	22.8	12.4	20.6	35.5	17.3	8.2	6.5	12.8	9.1	2.5	9.2	10.4	4.0	9.9	11.1	9.1	9.1	2.8	12.6	5.8	7.4	5.9	9.9	3.5	9.8	9.0	5.8	3.6	5.0	7.9	5.8	4.3	4.0	3.4	3.7	4.2	3.8
LSM3	"SMX4, USS2, YLR438C"	ENSG00000170860	"LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated"	P62310	3	14178358-14201119	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044966	Approved		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA044966: "	"unprognostic (3.84e-3)"	"unprognostic (7.00e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.94e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.73e-2)"	"unprognostic (8.07e-3)"	"unprognostic (4.93e-3)"	"unprognostic (5.57e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.89e-3)"	14.1	13.6	18.2	12.5	17.1	18.9	15.5	13.2	17.3	11.5	15.6	11.8	7.6	15.0	11.6	13.4	19.1	10.3	11.3	20.1	15.1	12.5	27.6	26.7	10.1	14.2	14.2	13.5	12.4	15.6	7.3	12.4	16.5	14.4	14.2	13.9	12.3	13.3	11.0	31.9	12.1	17.6	15.8	15.0	16.3	12.5	21.5	13.9	24.4	19.7	21.4	13.9	12.9	11.1	21.3	23.1	27.2	18.3	17.1	17.7	18.7	14.4	11.7	12.6	13.0	5.9	6.9	32.2	12.0	8.0	15.3	14.7	13.2	11.4	15.9	10.0	8.2	6.8	14.2	11.6	15.2	15.0	17.6	16.9	16.9	12.6	3.0	18.8	12.3	5.1	8.4	15.3	6.6	7.8	18.1	12.8	11.3	16.6	19.9	25.7	21.8	15.9	11.0	15.6	17.5	14.3	14.9	7.1	11.5	13.7	19.2	11.1	22.1	24.0	7.1	9.8	15.7	11.9	20.4	9.1	26.4	30.0	12.5	18.5	14.0	27.2	15.9	23.3	12.8	18.3	15.0	21.3	15.0	14.9	14.6	17.1	16.5	17.3	15.2	17.1	15.3	23.1	17.7	18.7	18.2	17.1	13.2	17.3	15.1	12.5	14.2	13.5	14.4	13.9
LURAP1L	"bA3L8.2, C9orf150, FLJ38505, MGC46502"	ENSG00000153714	"Leucine rich adaptor protein 1 like"	Q8IV03	9	12775021-12822131	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 48.7"	"Cell line enhanced"	"Detected in many"		"HHSteC: 44.4;hTERT-HME1: 35.5;T-47d: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"eosinophil: 1.2"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA024407	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA024407: AB_10603780"	"unprognostic (1.20e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.08e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.67e-2)"	"unprognostic (5.68e-3)"	"unprognostic (4.38e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.02e-2)"	10.6	7.2	2.9	7.9	9.2	0.1	13.0	23.4	5.5	11.5	13.7	7.1	2.9	4.0	5.0	7.9	8.5	4.1	14.7	3.5	3.5	3.3	4.1	48.7	17.8	5.3	7.7	4.0	4.5	19.9	0.2	7.3	21.0	5.9	8.0	9.6	4.7	21.6	7.3	2.4	8.8	6.6	13.2	8.1	11.0	9.9	3.7	7.9	0.9	8.6	2.8	5.3	10.3	9.4	0.0	0.1	1.2	0.0	0.0	0.0	1.6	0.9	3.1	0.0	1.0	4.8	6.7	0.0	1.6	8.9	2.2	2.4	0.0	1.1	0.0	0.6	8.5	1.3	0.0	0.1	1.6	0.0	0.3	0.4	2.9	1.6	44.4	0.0	0.0	2.6	4.2	7.9	35.5	1.4	0.0	11.6	1.2	0.7	0.0	0.0	0.0	3.4	0.0	0.6	0.0	8.7	0.5	6.8	0.6	1.9	1.2	1.5	51.0	0.1	0.5	1.9	0.3	4.9	1.2	0.0	0.0	0.0	3.3	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.9	9.2	23.4	5.5	3.5	3.3	7.7	4.0	5.9	7.9
LYAR	"ZC2HC2, ZLYAR"	ENSG00000145220	"Ly1 antibody reactive"	Q9NX58	4	4267701-4290169	"Predicted intracellular proteins, Transcription factors"	"Immunity, Innate immunity, rRNA processing, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 60.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035880, HPA035881"	Enhanced		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA035880: , HPA035881: AB_10669980"	"unprognostic (2.81e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.22e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavourable (3.20e-5)"	"unprognostic (1.08e-3)"	"unprognostic (2.92e-2)"	"prognostic favourable (8.82e-4)"	"unprognostic (5.05e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavourable (4.36e-10)"	"unprognostic (4.94e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.72e-1)"	11.1	5.7	6.8	11.9	10.1	10.9	8.2	7.3	8.0	6.6	6.9	4.3	4.1	5.7	6.9	5.5	11.2	7.1	5.4	10.1	7.0	4.6	5.0	9.9	7.7	13.8	10.9	4.5	11.1	6.3	4.4	15.6	7.1	8.4	7.8	6.8	3.7	5.4	6.4	15.1	5.9	6.2	9.1	7.9	18.2	5.8	60.2	12.0	10.0	6.3	11.9	10.9	10.1	10.4	7.3	7.1	8.9	12.9	10.7	32.8	10.3	13.1	6.9	6.2	9.0	5.4	6.2	10.6	12.0	4.1	12.5	8.6	21.6	17.3	35.3	8.7	5.1	8.4	23.1	12.5	16.4	6.3	17.0	35.4	6.6	24.2	9.2	40.8	9.6	4.8	8.0	14.3	24.5	10.8	47.3	11.8	8.7	13.3	13.8	52.6	30.8	22.6	21.3	11.3	17.0	5.6	9.2	14.7	6.3	6.5	7.1	12.2	7.4	12.2	10.0	12.5	9.9	16.2	37.7	8.4	12.6	56.4	8.5	34.5	10.1	8.9	9.7	8.5	28.6	9.6	32.8	7.3	18.9	30.8	7.1	5.7	8.9	19.0	2.8	10.7	12.9	5.3	8.8	10.3	6.8	10.1	7.3	8.0	7.0	4.6	10.9	4.5	8.4	12.0
LZTS1	FEZ1	ENSG00000061337	"Leucine zipper tumor suppressor 1"	Q9Y250	8	20246165-20303963	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 19.0;parathyroid gland: 64.9"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 35.9;U-698: 11.0;WM-115: 24.3"	"Cancer enhanced"	"Detected in all"		"melanoma: 59.2"	"Group enriched"	"Detected in many"	5	"amygdala: 13.3;basal ganglia: 19.0;cerebral cortex: 19.0;hippocampal formation: 8.9;olfactory region: 8.8"	"Cell type enhanced"	"Detected in single"		"gdT-cell: 2.2"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"amygdala: 47.8;basal ganglia: 76.8;cerebral cortex: 46.2;hippocampal formation: 41.3;olfactory region: 26.1"	"Group enriched"	"Detected in many"	10	"amygdala: 28.4;basal ganglia: 66.4;cerebral cortex: 45.3;hippocampal formation: 38.6;olfactory region: 47.4"	"HPA006294, HPA022046"	Approved		Approved	"Nucleoli,Plasma membrane"				"Plasma membrane"	Nucleoli	"HPA006294: AB_1079288, HPA022046: AB_1853455"	"unprognostic (7.76e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.49e-3)"	"prognostic unfavourable (3.03e-4)"	"unprognostic (6.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.29e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.06e-3)"	"unprognostic (6.81e-2)"	"unprognostic (3.63e-2)"	"prognostic unfavourable (9.28e-6)"	"unprognostic (3.35e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.82e-3)"	2.4	2.1	13.3	1.8	19.0	0.8	1.9	0.6	19.0	1.6	1.1	2.2	0.4	1.1	2.2	1.5	3.5	1.4	3.5	2.3	8.9	2.6	1.9	1.1	4.0	1.5	2.5	8.8	1.7	1.6	64.9	1.4	5.8	1.9	1.7	1.1	10.3	1.3	1.7	1.6	4.2	1.2	2.7	0.8	1.1	1.3	6.6	1.5	0.3	2.0	0.9	1.1	1.9	1.0	0.2	0.1	0.7	0.1	0.1	2.2	0.5	0.0	0.0	4.7	4.0	0.0	0.0	0.5	2.3	0.0	2.0	1.8	0.1	0.0	5.2	1.7	1.4	0.1	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.5	0.0	0.8	0.0	0.0	0.0	0.0	6.9	0.0	9.0	0.0	5.9	0.0	0.0	7.5	0.0	1.3	0.2	7.2	6.2	0.0	0.0	35.9	0.0	0.2	0.0	2.5	1.7	0.0	0.7	0.0	0.0	11.0	0.0	0.5	24.3	0.2	0.1	0.0	2.2	0.0	0.8	0.0	0.7	0.4	0.0	0.2	0.2	0.3	0.7	0.1	0.0	0.1	0.0	0.5	13.3	19.0	0.6	19.0	8.9	2.6	2.5	8.8	1.9	1.5
M1AP	"C2orf65, D6Mm5e, SPATA37"	ENSG00000159374	"Meiosis 1 associated protein"	Q8TC57	2	74557883-74648338	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 8.8;testis: 13.2"	"Group enriched"	"Detected in some"	9	"NTERA-2: 5.9;RT4: 5.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA045420, HPA059302"	Uncertain		Approved	Nucleoli,Mitochondria				Mitochondria	Nucleoli	"HPA045420: AB_10961177, HPA059302: "	"unprognostic (1.76e-1)"	"unprognostic (6.58e-3)"	"unprognostic (1.26e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.17e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.11e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.46e-1)"	0.7	0.6	5.2	0.2	1.5	3.7	3.7	1.2	3.4	4.6	0.2	0.3	1.0	0.2	2.1	0.5	0.3	4.6	0.5	0.1	0.9	1.8	1.5	0.1	0.6	0.1	0.5	1.6	0.3	0.4	1.7	8.8	1.2	0.9	0.2	0.0	2.0	1.5	1.0	0.1	0.2	0.2	0.2	0.7	0.4	0.7	13.2	0.2	1.0	3.6	0.0	0.5	0.9	0.5	0.0	0.9	0.2	1.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.5	0.2	0.5	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	5.9	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	5.2	1.5	1.2	3.4	0.9	1.8	0.5	1.6	0.9	0.2
MACROD2	"C20orf133, dJ631M13.5"	ENSG00000172264	"MACRO domain containing 2"	A1Z1Q3	20	13995369-16053197	"Predicted intracellular proteins"	"DNA damage"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.5"	"Cell line enhanced"	"Detected in many"		"EFO-21: 14.5;Karpas-707: 17.9;RT4: 7.9;SCLC-21H: 9.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 7.4;naive B-cell: 14.1;neutrophil: 3.8"	"Group enriched"	"Detected in many"	5	"B-cells: 14.1;granulocytes: 3.8"	"Low region specificity"	"Detected in all"							HPA049076	Enhanced		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA049076: "	"unprognostic (1.70e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.68e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.96e-2)"	"unprognostic (4.02e-1)"	"unprognostic (7.83e-2)"	"unprognostic (4.15e-5)"	"unprognostic (9.80e-2)"	"unprognostic (9.91e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.02e-2)"	2.8	5.1	15.2	3.0	47.5	2.0	4.2	20.8	13.6	6.4	2.7	3.7	2.0	1.4	12.1	3.9	2.3	10.3	4.1	1.9	10.5	8.2	5.6	2.7	15.7	5.5	7.6	8.9	4.5	4.2	5.4	12.0	1.8	10.5	7.1	2.1	4.0	2.4	14.9	3.1	3.9	1.8	5.8	6.9	6.9	3.4	7.9	9.9	0.0	4.1	0.1	7.2	10.6	3.1	14.1	0.5	3.8	1.8	0.3	0.6	0.5	1.0	0.6	2.7	0.9	0.9	0.8	0.5	0.5	2.0	1.1	0.6	1.0	0.7	1.9	14.5	1.4	1.4	0.4	0.6	1.8	0.9	0.8	1.1	1.1	1.8	3.5	0.3	0.3	1.6	1.1	0.0	0.8	1.1	1.3	17.9	3.0	0.4	0.5	0.7	0.9	0.4	1.1	0.5	3.4	2.1	7.9	9.9	4.3	1.5	0.1	0.7	1.0	1.6	0.8	1.5	3.0	0.2	0.1	1.5	0.4	1.8	0.9	1.0	1.8	0.3	0.6	0.6	0.4	1.3	0.4	7.4	0.3	0.4	0.5	14.1	0.4	0.6	3.8	0.3	1.8	0.2	0.2	0.5	15.2	47.5	20.8	12.8	10.5	8.2	7.6	8.9	10.5	9.9
MAD2L1BP	"CMT2, dJ261G23.1, KIAA0110"	ENSG00000124688	"MAD2L1 binding protein"	Q15013	6	43629540-43640952	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028729			Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"				Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA028729: "	"unprognostic (2.60e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.92e-2)"	"unprognostic (6.97e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.92e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.67e-3)"	"unprognostic (3.60e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.64e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.25e-3)"	12.1	16.6	11.0	13.3	14.4	35.7	13.8	16.5	24.4	12.2	21.3	10.1	6.3	18.1	12.9	14.1	17.0	13.4	13.2	19.2	11.9	12.1	18.3	18.9	11.4	18.2	11.0	12.6	11.3	18.5	11.5	12.8	12.6	14.0	12.6	22.0	13.6	24.2	11.3	25.1	11.9	22.0	12.4	9.8	17.5	16.8	17.6	7.9	29.0	18.9	13.9	19.9	14.3	13.2	27.9	27.6	39.7	22.2	26.8	39.8	21.4	19.1	8.9	14.0	15.5	12.2	13.3	8.5	11.5	18.7	25.6	24.0	18.1	7.8	14.9	6.6	13.5	12.6	21.7	16.0	19.8	13.7	16.9	18.4	9.8	15.5	13.2	10.8	11.2	13.4	19.7	19.0	11.7	19.1	23.6	8.1	17.7	18.0	9.6	20.1	8.6	11.5	11.2	10.9	14.1	18.2	15.4	16.7	16.9	8.3	12.8	54.2	15.0	28.9	10.4	13.7	11.5	9.0	18.3	10.4	8.8	35.0	12.5	18.3	15.0	39.7	22.2	25.0	25.7	22.1	25.8	27.9	30.8	28.4	27.6	25.6	32.3	29.0	18.6	26.8	19.9	18.3	39.8	21.4	11.0	14.4	16.5	24.4	11.9	12.1	11.0	12.6	14.0	7.9
MAD2L2	"FANCV, MAD2B, POLZ2, REV7"	ENSG00000116670	"Mitotic arrest deficient 2 like 2"	Q9UI95	1	11674480-11691650	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"		"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008110, HPA024176, HPA024612"	Approved		Approved	Nucleoli,Cytosol				Cytosol	Nucleoli	"CAB008110: AB_217976, HPA024176: , HPA024612: "	"unprognostic (1.26e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.09e-3)"	"unprognostic (1.54e-1)"	"unprognostic (9.27e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.36e-1)"	12.4	10.1	15.4	15.7	15.6	37.9	13.7	15.5	13.5	10.0	10.5	14.5	11.9	8.6	10.4	11.8	9.8	9.9	10.3	17.3	13.2	11.2	13.2	34.4	12.9	18.3	19.6	9.7	14.6	23.0	5.8	11.1	8.2	12.4	11.8	6.1	8.4	21.0	9.2	23.0	12.0	7.4	11.5	15.0	11.9	12.4	37.0	15.8	42.1	12.0	10.4	19.0	11.9	13.4	19.5	46.9	13.8	31.7	13.2	29.8	27.7	11.5	10.6	17.9	20.1	5.5	10.8	7.2	10.8	12.1	21.2	18.9	13.7	11.2	16.3	13.2	11.3	5.1	22.2	11.1	12.3	24.6	24.6	7.3	16.4	16.9	9.7	14.7	12.1	7.0	11.4	15.5	13.4	9.6	30.0	26.2	10.4	17.1	67.9	69.8	46.0	17.3	46.2	19.7	20.0	7.6	2.5	33.2	23.3	17.9	6.9	31.1	10.1	32.0	5.0	17.6	22.3	16.3	15.2	21.0	14.7	42.4	13.0	51.9	13.4	11.9	29.4	13.8	29.8	31.7	23.9	19.5	20.1	23.1	34.0	15.9	13.7	20.3	12.5	13.2	27.2	46.9	22.9	27.7	15.4	15.6	15.5	13.4	13.2	11.2	19.6	9.7	12.4	15.8
MAF1	DKFZp586G1123	ENSG00000179632	"MAF1 homolog, negative regulator of RNA polymerase III"	Q9H063	8	144104499-144107611	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024821, HPA058548"	Uncertain		Supported	Nucleoplasm,Nucleoli,Vesicles				Nucleoplasm	"Nucleoli, Vesicles"	"HPA024821: , HPA058548: "	"unprognostic (2.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.51e-2)"	"unprognostic (9.67e-2)"	"prognostic unfavourable (7.09e-4)"	"unprognostic (6.12e-2)"	"unprognostic (4.92e-2)"	"unprognostic (5.90e-3)"	"unprognostic (9.42e-2)"	"unprognostic (6.48e-2)"	"unprognostic (9.40e-3)"	"unprognostic (9.02e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.99e-2)"	26.8	23.2	17.5	18.4	17.5	43.6	35.7	20.5	26.3	27.3	47.2	23.7	22.8	19.5	33.0	22.5	34.4	26.1	33.6	72.5	17.3	15.5	24.1	21.4	21.2	28.2	19.7	18.6	36.3	39.8	25.2	20.8	23.8	14.9	36.8	18.9	23.8	28.7	32.3	114.3	18.7	29.8	50.9	17.2	27.7	28.9	30.2	16.2	35.5	40.4	38.7	22.8	35.2	46.7	48.0	39.9	45.1	34.5	33.2	46.2	32.6	23.9	38.6	17.9	17.9	49.1	24.5	14.6	18.9	31.3	29.6	30.2	14.1	26.7	26.7	32.2	31.6	14.8	24.3	26.7	21.8	23.5	29.4	29.1	26.6	22.1	33.1	12.3	20.0	21.6	31.4	23.7	44.7	31.8	22.5	18.2	17.6	57.2	46.0	22.8	13.4	103.8	18.4	25.1	28.4	18.5	18.1	26.2	21.8	25.1	32.7	30.5	22.2	19.0	19.1	13.8	31.6	24.3	23.7	22.0	16.7	12.5	22.9	23.1	9.1	15.8	34.5	45.1	28.5	26.8	32.3	40.1	41.0	46.2	39.9	48.0	44.2	41.4	19.9	33.2	27.0	29.8	29.2	32.6	17.5	17.5	20.5	26.3	17.3	15.5	19.7	18.6	14.9	16.2
MAFB	KRML	ENSG00000204103	"MAF bZIP transcription factor B"	Q9Y5Q3	20	40685848-40689240	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 87.6;parathyroid gland: 154.1"	"Cell line enhanced"	"Detected in some"		"HSkMC: 15.8;hTCEpi: 33.3;SCLC-21H: 9.1;SiHa: 8.2;U-138 MG: 9.0;U-2197: 13.1;U-87 MG: 8.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 27.4;non-classical monocyte: 36.7"	"Lineage enriched"	"Detected in many"	14	"monocytes: 36.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005653	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"				Nucleoplasm	"Nucleoli, Golgi apparatus, Cytosol"	"HPA005653: AB_1079293"	"unprognostic (1.55e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.16e-3)"	"prognostic unfavourable (5.64e-4)"	"unprognostic (9.16e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.57e-2)"	"unprognostic (6.09e-2)"	"unprognostic (5.45e-3)"	"unprognostic (9.92e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.21e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-2)"	38.3	7.9	3.2	13.0	4.0	17.0	19.5	1.0	9.7	10.6	6.9	3.0	1.2	3.3	5.6	8.9	16.8	7.0	9.2	12.4	3.6	2.3	10.9	14.0	21.9	28.9	4.7	3.4	7.0	6.1	154.1	2.3	9.4	5.0	7.6	3.3	5.6	10.4	2.7	11.0	41.6	7.6	5.5	7.7	87.6	4.7	7.5	3.8	6.9	18.2	20.5	11.4	8.2	10.9	0.0	2.5	0.7	36.7	0.0	0.0	2.5	0.0	0.0	0.0	1.4	0.8	0.1	0.2	0.2	0.0	0.1	0.0	0.2	0.1	0.0	1.0	0.2	2.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.1	0.5	0.0	0.1	15.8	33.3	0.1	1.1	0.2	0.0	0.0	0.0	0.5	0.1	3.8	1.4	0.0	0.0	0.0	0.0	0.3	0.2	9.1	0.7	8.2	0.8	2.0	0.8	0.1	0.2	9.0	0.1	13.1	0.0	0.0	0.0	0.0	8.7	0.3	0.0	0.1	7.3	0.0	0.0	27.4	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.7	0.0	36.7	0.0	0.0	2.5	3.2	4.0	1.0	9.7	3.6	2.3	4.7	3.4	5.0	3.8
MAGED2	"11B6, BCG1, HCA10, JCL-1, MAGE-D2, MAGED, MGC8386"	ENSG00000102316	"MAGE family member D2"	Q9UNF1	X	54807599-54816012	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Tumor antigen"	"Bartter syndrome, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031572, HPA031573"	Supported		Enhanced	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli, Cytosol"		"HPA031572: AB_10599819, HPA031573: AB_10602181"	"unprognostic (1.33e-1)"	"unprognostic (8.60e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.79e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.97e-1)"	"prognostic favourable (2.88e-4)"	"prognostic favourable (2.82e-4)"	"unprognostic (6.34e-2)"	"unprognostic (3.55e-3)"	"prognostic unfavourable (9.43e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.58e-1)"	22.1	38.4	26.9	14.8	26.5	8.2	50.2	24.4	43.0	55.7	27.3	27.8	21.4	16.2	41.1	31.8	21.9	45.9	28.5	40.7	23.8	38.2	42.7	17.3	24.0	13.5	30.3	36.0	79.7	23.5	34.5	57.6	58.6	57.1	63.9	16.4	43.1	32.0	53.7	25.6	16.5	17.6	41.6	24.7	17.5	22.5	21.8	18.3	23.4	45.1	17.3	22.0	31.9	29.2	17.1	11.7	43.1	37.0	28.5	35.5	32.5	5.5	10.3	61.7	18.8	29.4	40.0	11.4	23.1	41.2	18.3	32.6	10.2	14.2	7.7	60.6	46.4	7.6	17.5	17.4	13.2	13.8	14.5	16.1	12.2	20.0	25.2	4.1	12.4	52.4	7.3	18.6	9.4	34.8	3.9	9.5	35.0	15.4	9.1	6.9	22.8	12.3	6.1	22.1	11.0	25.1	4.2	9.7	25.1	9.2	10.7	53.4	44.0	7.0	29.9	15.6	24.4	23.3	6.5	6.1	5.1	5.6	22.8	10.8	79.7	43.1	9.1	35.5	35.5	22.4	27.3	16.3	29.4	33.1	11.7	17.1	29.7	34.1	3.4	28.5	37.0	7.2	29.2	32.5	26.9	26.5	24.4	43.0	23.8	38.2	30.3	36.0	57.1	18.3
MAGEH1	APR1	ENSG00000187601	"MAGE family member H1"	Q9H213	X	55452105-55453566	"Predicted membrane proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"epididymis: 207.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA011324	Uncertain		Approved	Nucleoli				Nucleoli		"HPA011324: AB_1853499"	"unprognostic (2.50e-1)"	"unprognostic (3.01e-1)"	"unprognostic (4.07e-2)"	"prognostic unfavourable (1.37e-4)"	"unprognostic (3.95e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.93e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.20e-3)"	"prognostic favourable (2.60e-4)"	"unprognostic (6.37e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.90e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.52e-1)"	8.3	13.2	21.5	7.6	21.6	3.0	8.1	19.9	29.7	13.5	7.5	14.4	13.8	5.2	13.3	207.1	5.2	19.2	8.3	10.2	22.8	32.1	11.4	8.7	10.2	9.0	19.8	20.6	16.1	11.9	9.0	22.5	9.2	17.9	20.8	5.9	11.4	8.9	19.6	5.7	5.6	6.3	11.8	17.2	8.1	9.3	18.2	15.3	10.8	12.4	5.2	7.5	8.5	10.0	9.4	14.0	9.5	8.5	8.3	26.0	9.4	0.0	2.5	14.8	0.0	23.9	14.5	0.2	16.0	14.8	4.4	11.9	0.0	3.3	0.0	22.0	16.0	2.2	5.6	6.0	7.0	18.4	0.9	4.9	0.0	2.0	7.9	0.2	6.4	12.0	0.5	2.5	1.8	6.7	2.7	19.8	4.8	9.5	13.1	4.2	4.2	3.0	8.3	1.8	10.4	8.0	0.0	0.1	11.2	0.0	4.3	6.6	2.1	3.7	7.8	6.1	7.1	3.7	0.8	11.8	14.8	2.0	11.4	6.9	7.7	5.0	4.4	9.5	11.3	6.8	10.1	9.4	18.7	12.9	6.7	8.8	26.0	16.1	0.6	8.3	8.5	14.0	24.7	9.4	21.5	21.6	19.9	28.4	22.8	32.1	19.8	20.6	17.9	15.3
MAK16	"MAK16L, RBM13"	ENSG00000198042	"MAK16 homolog"	Q9BXY0	8	33484750-33501260	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA044417, HPA050574"	Uncertain		Supported	Nucleoli,Vesicles				Nucleoli	Vesicles	"HPA044417: , HPA050574: AB_2681181"	"unprognostic (2.10e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (1.00e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (3.66e-4)"	"unprognostic (8.04e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.47e-1)"	22.3	11.0	10.6	14.9	15.3	13.5	15.2	11.5	17.6	13.2	11.5	12.5	8.3	9.1	20.8	9.1	15.2	13.6	11.3	13.1	10.5	13.4	17.9	20.0	10.5	17.3	11.4	10.3	24.8	15.7	10.4	19.2	13.1	19.2	14.2	11.3	8.9	10.6	10.3	25.2	12.4	10.8	19.7	13.1	17.3	11.9	9.5	7.1	20.3	14.8	14.3	17.4	16.8	11.3	3.8	4.0	0.9	9.4	5.7	6.2	3.3	5.9	8.4	5.9	13.5	7.0	8.4	8.8	10.8	7.1	11.8	11.1	12.5	5.3	21.1	10.7	9.5	7.9	19.7	12.0	15.9	4.5	5.5	19.9	6.0	11.0	10.4	8.0	12.2	8.7	11.1	15.3	18.0	8.6	24.7	12.3	9.8	7.0	28.5	9.7	31.2	5.9	10.2	8.9	9.5	10.0	10.2	15.1	12.0	6.6	9.4	13.0	6.5	8.5	7.6	11.1	8.7	14.3	12.3	6.1	6.7	21.8	6.9	17.2	11.8	0.0	3.2	0.9	4.8	6.8	5.4	3.2	4.7	4.1	3.9	3.8	6.0	6.2	0.7	5.7	9.4	4.0	3.6	3.3	10.6	15.3	11.5	17.6	10.5	13.4	11.4	10.3	19.2	7.1
MAP2K5	"HsT17454, MAPKK5, MEK5, PRKMK5"	ENSG00000137764	"Mitogen-activated protein kinase kinase 5"	Q13163	15	67542709-67807123	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022094, HPA027347, HPA027755"	Supported		Approved	Nucleoli,Microtubules				"Nucleoli, Microtubules"		"CAB022094: , HPA027347: AB_10599290, HPA027755: AB_10600883"	"unprognostic (4.54e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.16e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.41e-2)"	"prognostic favourable (8.03e-5)"	"unprognostic (1.68e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.99e-2)"	"unprognostic (2.73e-2)"	18.6	22.2	20.3	13.8	30.9	14.6	23.7	25.0	25.4	17.0	19.3	17.2	19.9	14.7	17.4	11.3	13.5	16.2	14.4	18.8	17.1	16.4	14.2	15.5	13.5	27.9	12.6	11.5	29.0	21.0	34.1	14.4	17.7	22.2	15.9	14.8	15.6	15.7	18.5	28.5	18.7	15.0	19.4	17.2	13.0	15.4	20.3	16.2	40.2	16.9	9.2	11.9	17.0	17.9	6.6	10.2	10.3	7.3	11.7	11.2	5.5	5.5	14.6	8.8	10.3	13.0	22.8	6.9	5.5	11.2	10.4	11.4	5.8	9.9	9.1	11.7	9.2	8.3	14.9	8.8	8.6	13.1	14.9	12.3	10.9	6.3	16.4	7.4	7.7	15.6	11.7	7.5	17.1	13.7	10.8	15.2	8.6	7.1	12.1	8.8	12.3	7.1	12.0	10.2	15.1	6.3	10.1	5.5	8.6	6.2	9.2	22.0	11.5	14.6	11.4	10.7	7.1	7.4	7.4	21.5	25.3	10.6	14.4	17.0	7.7	10.3	7.3	6.6	7.7	5.6	11.2	6.6	7.3	9.0	10.2	6.2	10.4	9.5	1.7	11.7	6.2	3.9	7.4	5.5	20.3	30.9	25.0	25.4	17.1	16.4	12.6	11.5	22.2	16.2
MAP3K9	"MEKK9, MLK1, PRKE1"	ENSG00000006432	"Mitogen-activated protein kinase kinase kinase 9"	P80192	14	70722526-70809534	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.1"	"Cell line enhanced"	"Detected in many"		"A-431: 17.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000942	Approved		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"			"Nucleoplasm, Nucleoli"		"HPA000942: AB_1079360"	"unprognostic (1.20e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.75e-5)"	"unprognostic (2.58e-1)"	"unprognostic (4.20e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.48e-2)"	"unprognostic (4.23e-6)"	"unprognostic (5.71e-3)"	"unprognostic (6.86e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.35e-1)"	0.5	2.2	5.8	2.0	9.2	1.4	2.8	20.1	16.5	2.4	3.1	1.8	0.4	3.0	1.1	3.4	10.1	2.2	1.5	1.2	5.7	7.1	3.1	2.4	3.9	2.6	5.9	5.9	1.4	4.3	6.8	4.7	2.8	12.8	2.0	3.1	3.1	3.2	1.3	1.9	7.8	2.9	0.7	1.6	1.9	3.4	10.1	1.8	0.6	5.3	3.2	6.8	2.0	3.9	2.3	0.5	1.3	0.2	1.1	1.4	0.3	17.7	8.2	1.6	2.0	0.0	0.0	5.5	0.3	0.2	1.7	1.5	5.9	6.8	3.6	2.4	0.1	8.4	5.2	10.0	1.8	2.4	1.5	0.2	2.9	3.9	0.2	0.4	0.8	0.1	5.5	1.2	10.4	0.0	1.3	0.8	0.4	7.1	2.8	0.4	3.5	3.8	1.0	3.1	0.7	3.9	8.2	11.3	2.4	5.1	6.1	1.0	5.5	0.6	0.0	0.0	7.2	0.0	2.8	1.9	4.3	1.9	2.7	0.3	1.0	0.5	0.2	0.8	0.6	0.1	0.1	1.0	0.6	1.0	0.0	2.3	1.0	0.7	1.3	1.1	0.2	0.5	1.4	0.3	5.8	9.2	20.1	16.5	5.7	7.1	5.9	5.9	12.8	1.8
MAPK13	"p38delta, PRKM13, SAPK4"	ENSG00000156711	"Mitogen-activated protein kinase 13"	O15264	6	36127809-36144524	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 45.7;RPMI-8226: 27.6;RT4: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 16.5;T-cells: 27.8"	"Region enhanced"	"Detected in some"		"cerebellum: 6.5"	"Region enriched"	"Detected in some"	15	"cerebellum: 59.9"	"HPA007667, CAB025854"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"CAB025854: , HPA007667: AB_1079867"	"unprognostic (6.36e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.13e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.30e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.21e-2)"	"prognostic favourable (9.00e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.41e-1)"	6.5	22.0	2.2	5.4	4.0	2.9	6.8	2.8	7.3	6.8	18.9	0.5	36.8	18.8	1.9	10.3	41.1	2.4	12.0	1.2	1.7	1.8	6.5	2.8	9.6	11.2	0.8	3.8	3.9	24.6	18.8	12.4	10.5	2.5	6.8	16.0	2.4	20.7	26.3	0.9	28.6	37.7	2.1	0.8	5.9	12.2	23.7	1.1	5.0	13.8	16.0	18.5	7.3	13.9	16.5	0.1	5.2	0.3	2.8	27.8	6.7	19.3	0.1	0.3	0.2	1.1	5.6	2.7	1.5	0.2	0.2	0.5	16.2	19.1	4.6	1.2	1.5	15.1	0.0	45.7	0.4	11.8	5.1	0.1	0.5	16.0	1.9	0.1	1.2	4.8	16.2	2.9	0.6	3.0	0.3	5.2	0.5	10.2	0.1	1.2	0.1	0.3	11.4	0.2	27.6	8.8	28.6	19.3	0.3	1.7	0.3	0.1	21.7	2.5	4.0	1.4	0.2	0.5	0.3	0.3	6.9	1.4	0.0	0.5	0.1	5.2	0.3	4.5	16.2	0.0	10.5	10.8	11.6	13.0	0.1	16.5	10.6	11.9	3.9	2.8	0.0	0.0	27.8	6.7	2.2	4.0	2.8	7.3	1.7	1.8	0.8	3.8	2.5	1.1
MAPKBP1	KIAA0596	ENSG00000137802	"Mitogen-activated protein kinase binding protein 1"	O60336	15	41774434-41827855	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030832, HPA030833"	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA030832: AB_10601869, HPA030833: "	"unprognostic (2.53e-1)"	"unprognostic (9.18e-2)"	"unprognostic (6.56e-2)"	"prognostic favourable (1.47e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (6.80e-4)"	"unprognostic (1.08e-3)"	"unprognostic (6.03e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-2)"	4.7	6.0	10.6	5.0	13.8	4.4	5.7	48.1	13.9	6.1	5.7	8.8	4.4	10.6	9.3	5.4	12.5	8.0	5.3	4.2	8.6	6.7	3.9	2.3	4.7	4.0	8.6	9.2	15.4	4.3	5.8	9.5	6.1	9.3	5.9	4.3	7.0	5.1	7.1	4.9	26.3	10.5	10.2	6.8	5.7	5.4	19.5	10.7	4.4	8.7	5.2	7.4	8.4	6.6	1.9	1.9	4.3	2.1	2.2	3.3	1.6	4.9	2.6	7.0	6.6	7.8	7.7	4.7	7.0	17.5	6.3	4.7	5.1	1.8	1.2	5.8	5.6	11.8	6.8	19.4	4.6	4.4	2.0	4.9	8.0	1.7	3.3	3.1	10.2	3.9	15.6	10.0	18.3	9.2	3.0	2.3	8.9	1.0	2.6	2.8	0.8	5.3	2.8	5.0	0.5	3.7	5.5	7.9	4.5	4.1	4.1	3.0	4.9	2.5	7.3	9.1	4.4	8.8	6.8	5.1	8.4	2.9	6.1	4.3	7.6	4.3	1.3	1.1	3.3	0.7	2.4	1.9	1.9	1.4	1.9	1.8	2.4	2.0	0.7	2.2	2.1	0.7	0.8	1.6	10.6	13.8	48.1	13.9	8.6	6.7	8.6	9.2	9.3	10.7
MBIP		ENSG00000151332	"MAP3K12 binding inhibitory protein 1"	Q9NS73	14	36298558-36320676	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 61.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003388	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol				Cytosol	"Nucleoplasm, Nucleoli"	"HPA003388: AB_1079322"	"unprognostic (8.79e-2)"	"unprognostic (9.92e-2)"	"unprognostic (5.07e-2)"	"unprognostic (8.66e-2)"	"unprognostic (9.85e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.71e-1)"	"prognostic favourable (1.52e-4)"	"unprognostic (5.24e-2)"	"prognostic favourable (1.14e-4)"	"unprognostic (4.65e-1)"	"unprognostic (9.27e-2)"	"prognostic favourable (1.25e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.09e-1)"	10.4	11.7	11.4	5.7	17.0	15.4	12.9	16.4	14.9	15.4	12.2	11.5	3.6	8.6	14.0	11.3	14.0	9.1	8.6	7.2	10.7	13.0	19.5	15.0	46.2	8.1	9.9	8.9	20.0	9.0	10.4	25.1	9.8	13.3	13.8	11.7	10.1	7.7	8.9	6.0	14.3	13.2	11.0	13.6	9.8	19.0	8.8	11.8	14.4	61.2	4.0	7.9	12.4	9.3	12.0	10.4	5.1	9.3	8.3	17.9	9.6	16.5	8.7	18.5	18.6	18.6	18.0	14.0	14.2	17.7	18.8	19.8	17.7	16.6	15.7	21.7	18.2	12.6	19.4	13.1	23.2	22.6	14.6	9.2	8.6	30.0	20.3	18.7	10.2	18.4	20.2	12.2	15.9	11.7	15.6	19.6	13.8	15.9	17.9	15.2	15.6	25.8	8.6	16.2	10.9	21.2	12.8	27.7	11.0	11.6	11.3	18.7	18.4	12.2	9.1	21.0	13.7	15.3	14.6	16.3	18.7	24.5	8.0	9.6	14.5	1.4	9.3	2.0	11.2	6.8	14.1	12.0	13.7	13.8	9.2	8.7	17.9	14.5	5.1	8.3	5.3	10.4	16.1	9.6	11.4	17.0	16.4	14.9	10.7	13.0	9.9	8.9	13.3	11.8
MCEE	GLOD2	ENSG00000124370	"Methylmalonyl-CoA epimerase"	Q96PE7	2	71109684-71130239	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035196			Approved	Nucleoli	"Intracellular and membrane"		16000	Nucleoli		"HPA035196: AB_10601871"	"unprognostic (7.65e-2)"	"unprognostic (8.20e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.35e-1)"	"prognostic favourable (4.76e-4)"	"prognostic favourable (5.78e-4)"	"unprognostic (4.86e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.43e-3)"	"unprognostic (8.59e-2)"	"unprognostic (9.40e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.51e-2)"	"unprognostic (5.38e-2)"	10.5	20.4	8.5	10.1	9.2	4.3	18.9	10.5	9.8	14.1	13.8	9.4	24.6	11.1	8.8	19.7	16.9	8.6	12.6	19.8	6.6	6.2	18.8	39.7	9.1	9.5	13.1	6.6	12.4	29.0	9.8	24.5	9.9	9.1	13.7	13.5	11.1	28.9	20.5	18.2	15.2	14.9	10.9	11.5	10.1	13.1	5.7	11.4	9.3	11.0	18.7	10.9	13.0	13.3	15.9	17.6	20.0	18.4	11.2	24.9	11.1	6.3	3.1	5.6	4.0	19.2	26.2	16.4	9.8	12.5	5.0	7.6	7.6	7.9	9.9	3.0	9.7	6.7	6.8	5.1	5.2	9.1	5.9	6.7	8.7	22.0	10.8	7.5	5.6	17.4	7.4	3.4	6.7	5.7	8.8	17.2	4.8	8.1	5.6	8.8	5.2	7.6	6.6	6.4	18.3	7.7	5.1	6.5	4.7	3.7	21.7	9.7	17.2	7.2	7.3	5.9	4.5	5.9	3.9	16.5	6.8	10.5	9.5	12.3	5.3	13.0	18.3	20.0	12.8	18.4	17.3	15.9	15.7	12.3	14.9	13.2	14.6	12.3	4.5	11.2	17.6	17.6	24.9	11.1	8.5	9.2	10.5	9.8	6.6	6.2	13.1	6.6	9.1	11.4
MCM10	"CNA43, DNA43, PRO2249"	ENSG00000065328	"Minichromosome maintenance 10 replication initiation factor"	Q7L590	10	13161554-13211104	"Predicted intracellular proteins"	"DNA damage, DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.8;lymphoid tissue: 31.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA045899, HPA071952"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA045899: AB_10960529, HPA071952: "	"unprognostic (9.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.41e-1)"	"unprognostic (6.58e-3)"	"unprognostic (1.78e-8)"	"unprognostic (2.42e-3)"	"unprognostic (3.51e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.78e-4)"	"unprognostic (7.81e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.87e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.05e-1)"	3.0	0.5	0.3	5.6	0.3	10.8	2.1	0.3	0.5	1.4	2.6	0.4	0.3	1.8	1.1	0.6	5.9	0.2	0.7	0.7	0.3	0.3	0.6	0.9	1.4	6.0	0.3	0.6	0.7	0.3	0.3	0.4	3.6	0.5	0.6	2.9	0.4	1.1	0.3	1.5	1.3	1.8	0.9	0.7	2.9	1.1	4.3	0.3	31.4	0.9	3.3	6.9	0.9	1.8	0.5	1.0	1.5	0.4	0.8	3.4	1.5	13.5	15.3	18.2	13.7	0.6	1.1	7.9	14.2	2.2	16.0	16.7	14.9	9.7	20.4	6.5	3.6	15.9	25.5	8.3	14.8	10.6	12.1	25.5	6.8	9.9	0.0	13.0	11.6	0.2	0.3	16.2	1.5	5.2	30.0	14.0	8.6	12.2	30.9	5.6	10.7	3.8	24.5	16.1	12.6	3.6	5.0	3.6	13.8	11.5	8.2	2.1	10.3	9.0	3.1	10.2	19.2	15.3	15.3	4.4	16.9	26.9	6.5	14.4	7.9	0.2	0.3	0.2	1.1	0.1	0.2	0.5	1.6	3.4	1.0	0.4	0.4	2.8	1.5	0.8	0.4	0.2	1.6	1.5	0.3	0.3	0.3	0.5	0.3	0.3	0.3	0.6	0.5	0.3
MCOLN3	"FLJ11006, TRP-ML3, TRPML3"	ENSG00000055732	"Mucolipin 3"	Q8TDD5	1	85018082-85048499	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 29.2;pituitary gland: 38.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 9.8;HAP1: 9.8;RH-30: 11.9;SK-MEL-30: 21.2"	"Cancer enriched"	"Detected in many"	6	"melanoma: 8.0"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.9"	"Lineage enriched"	"Detected in single"	29	"T-cells: 2.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory region: 1.7"	"HPA018106, HPA062137"	Enhanced		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA018106: AB_1853647, HPA062137: "	"unprognostic (5.91e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.21e-5)"	"unprognostic (2.25e-1)"	"unprognostic (8.80e-3)"	"unprognostic (3.97e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.45e-3)"	"unprognostic (3.09e-2)"	"unprognostic (7.32e-5)"	"unprognostic (6.36e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.11e-2)"	"unprognostic (6.43e-2)"	4.7	29.2	1.5	0.8	0.8	0.0	3.0	0.2	0.4	6.1	2.8	0.9	2.1	3.2	5.4	15.6	0.8	1.1	0.6	5.1	3.4	0.3	4.5	0.2	4.1	0.0	0.5	0.0	2.2	6.5	17.9	38.3	1.8	2.7	0.5	0.5	4.5	8.1	0.4	1.9	2.5	1.9	1.1	0.3	0.9	1.6	0.4	0.3	2.6	1.5	0.9	0.4	0.7	2.8	0.0	0.0	0.0	0.0	0.0	2.9	0.7	6.4	1.5	0.0	0.0	5.2	4.7	1.6	0.1	9.8	2.5	6.9	0.5	1.2	0.0	0.7	0.1	0.0	9.8	3.2	1.6	2.6	5.8	0.0	0.5	0.0	0.0	0.0	0.0	0.5	1.2	2.1	1.1	0.0	0.0	0.0	4.8	0.6	0.0	0.0	0.7	0.6	0.0	11.9	0.0	0.3	0.0	0.4	0.0	0.3	0.0	21.2	4.0	4.9	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.5	0.8	0.2	0.4	3.4	0.3	0.5	0.0	2.7	0.3
MDN1	"KIAA0301, Rea1"	ENSG00000112159	"Midasin AAA ATPase 1"	Q9NU22	6	89642499-89819723	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 26.6;NTERA-2: 25.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029666, HPA029667, HPA029668, HPA029669"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol"				"Nucleoli, Cytosol"	"Nucleoplasm, Intermediate filaments"	"HPA029666: AB_10600888, HPA029667: AB_10696207, HPA029668: AB_10669868, HPA029669: AB_10670429"	"unprognostic (2.00e-1)"	"unprognostic (4.46e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.14e-3)"	"unprognostic (3.46e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.54e-3)"	"unprognostic (6.28e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.09e-2)"	10.0	8.8	8.6	10.1	18.2	16.1	14.9	19.2	18.7	9.1	7.5	14.8	8.6	5.9	14.1	10.0	9.2	10.2	6.4	8.6	9.4	9.6	9.4	15.1	7.3	10.9	13.1	12.4	22.3	10.7	19.0	10.9	5.9	15.9	8.1	8.6	9.4	9.3	8.3	16.2	19.6	8.8	9.2	12.7	9.0	8.2	14.0	13.7	8.4	12.8	8.2	12.7	7.5	7.8	3.8	8.9	6.7	1.0	3.3	4.2	0.3	4.5	4.5	4.7	4.4	7.7	7.4	4.7	3.1	2.3	3.6	4.4	10.3	1.7	13.7	3.6	3.2	4.0	12.1	4.2	6.4	5.3	8.1	14.9	5.8	6.7	3.0	19.2	3.7	4.5	3.6	9.5	8.8	6.3	26.6	3.3	3.5	5.5	3.0	7.3	25.9	4.0	6.0	8.9	3.4	3.1	6.5	8.6	3.8	4.4	2.7	2.8	1.9	8.5	8.0	2.4	4.4	3.2	7.2	3.8	4.2	6.7	3.3	11.0	4.1	6.7	1.0	1.9	2.4	0.8	2.1	3.0	3.3	2.6	0.6	3.8	4.2	3.3	0.2	3.3	1.0	8.9	1.3	0.3	8.6	18.2	19.2	18.7	9.4	9.6	13.1	12.4	15.9	13.7
MED12L	"KIAA1635, TNRC11L, TRALP, TRALPUSH"	ENSG00000144893	"Mediator complex subunit 12 like"	Q86YW9	3	151085697-151437072	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 16.0;HEL: 17.3;MOLT-4: 8.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 5.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036807	Enhanced		Approved	Nucleoli				Nucleoli		"HPA036807: AB_10670242"	"unprognostic (1.01e-2)"	"unprognostic (5.82e-2)"	"unprognostic (5.12e-2)"	"unprognostic (8.14e-4)"	"unprognostic (2.03e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.23e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.36e-3)"	"unprognostic (3.84e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.92e-2)"	2.8	5.2	6.4	1.2	11.1	5.5	0.5	4.9	23.1	1.6	0.6	4.4	0.0	2.2	0.9	3.0	0.9	0.6	1.8	1.7	5.5	5.1	0.4	0.4	0.7	4.4	5.8	2.6	1.0	1.7	0.5	5.4	2.0	3.9	1.2	0.3	1.9	1.7	0.7	0.5	0.4	1.6	0.6	6.1	2.1	0.8	6.1	5.7	0.6	1.0	0.0	1.5	1.3	0.8	1.0	5.1	3.1	2.8	0.1	0.4	0.8	0.7	0.3	2.5	0.2	0.1	0.0	16.0	0.0	0.2	0.6	0.7	0.9	0.3	0.0	0.2	0.1	0.1	3.3	0.2	0.7	0.0	1.6	17.3	0.1	0.1	0.0	0.5	6.1	0.0	0.1	0.1	0.1	0.0	0.0	2.7	0.0	2.6	8.0	0.0	2.9	0.5	0.1	0.9	0.4	0.2	2.5	4.2	0.6	0.4	0.2	0.0	0.9	0.1	0.0	0.0	1.9	0.0	1.3	5.1	0.0	6.1	0.2	1.5	0.9	3.1	0.3	0.0	0.1	2.8	0.4	0.1	0.1	0.2	1.6	1.0	0.0	0.0	0.3	0.1	0.8	5.1	0.0	0.8	6.4	11.1	4.9	6.9	5.5	5.1	5.8	2.6	3.9	5.7
MED16	"DRIP92, THRAP5, TRAP95"	ENSG00000175221	"Mediator complex subunit 16"	Q9Y2X0	19	867630-893218	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030685, HPA046495"	Uncertain		Approved	Nucleoli				Nucleoli		"HPA030685: AB_10601872, HPA046495: "	"unprognostic (1.63e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.91e-1)"	"prognostic favourable (5.46e-4)"	"unprognostic (1.90e-1)"	"unprognostic (5.25e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.15e-2)"	"unprognostic (4.93e-3)"	"unprognostic (3.28e-1)"	"prognostic favourable (1.11e-5)"	"unprognostic (4.83e-2)"	"unprognostic (5.52e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.17e-2)"	17.8	19.8	17.0	24.2	21.1	16.1	15.9	16.8	34.5	21.8	20.4	21.4	12.5	20.5	20.7	14.9	21.0	20.3	21.9	14.0	16.0	15.4	19.4	29.5	16.2	19.4	13.4	16.3	28.6	46.1	18.9	18.8	21.9	14.7	20.6	8.5	19.4	24.4	15.6	31.1	24.6	24.4	14.9	11.2	22.3	27.0	20.1	14.0	27.0	21.6	16.1	21.6	20.5	18.9	30.3	20.8	24.7	17.0	19.2	40.3	25.4	14.2	12.4	12.4	8.3	5.3	5.6	13.6	9.6	9.6	14.8	11.4	16.0	13.6	14.8	11.9	8.9	11.2	4.7	12.0	2.5	18.2	14.9	14.7	9.2	14.7	10.3	13.8	13.4	9.8	6.0	9.1	6.0	10.9	17.2	34.1	8.7	21.3	22.3	16.4	19.3	16.1	23.4	8.9	18.7	9.9	22.8	15.4	15.0	13.5	9.2	10.9	10.6	11.1	10.9	15.4	15.4	23.2	11.1	25.8	9.2	13.4	19.6	13.2	11.0	24.7	15.7	19.0	27.6	17.0	25.0	30.3	30.3	31.5	20.8	23.1	25.8	23.8	22.2	19.2	16.9	13.6	40.3	25.4	17.0	21.1	16.8	34.5	16.0	15.4	13.4	16.3	14.7	14.0
MED21	"SRB7, SURB7"	ENSG00000152944	"Mediator complex subunit 21"	Q13503	12	27022546-27066343	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017177	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA017177: AB_1857665"	"unprognostic (3.02e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.01e-1)"	"unprognostic (4.78e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.54e-1)"	"prognostic favourable (3.74e-8)"	"unprognostic (3.18e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.42e-2)"	20.7	31.5	20.7	13.3	32.4	31.9	23.9	25.9	31.9	24.8	21.9	18.0	18.8	14.9	25.9	21.7	30.4	20.8	19.6	31.3	19.5	21.9	34.1	18.8	20.8	15.7	21.1	26.2	30.8	17.1	30.3	26.0	19.8	23.6	27.6	20.6	18.3	25.3	24.5	30.7	19.3	17.4	27.3	20.2	16.0	19.6	28.9	22.1	22.1	28.2	28.7	19.9	31.6	27.2	20.1	15.8	35.5	18.6	12.8	28.0	19.1	16.8	17.7	9.4	14.9	20.9	21.2	15.6	19.2	14.4	16.2	21.2	18.6	19.1	11.1	12.2	14.7	13.9	20.0	17.8	28.0	9.7	17.8	16.0	18.4	11.4	11.7	19.5	11.5	14.9	26.0	20.1	24.1	23.5	12.9	14.9	18.3	12.6	17.0	35.9	28.8	23.4	14.7	60.2	12.5	16.9	19.3	7.1	10.5	23.4	10.1	15.1	17.8	13.0	17.0	18.1	14.1	22.5	19.3	4.6	9.4	18.2	17.3	21.7	12.2	35.5	17.5	23.9	20.4	18.6	20.8	20.1	24.6	23.9	15.8	16.6	28.0	25.3	14.0	12.8	16.5	12.9	23.8	19.1	20.7	32.4	25.9	31.9	19.5	21.9	21.1	26.2	23.6	22.1
MED27	"CRSP34, CRSP8, MED3, TRAP37"	ENSG00000160563	"Mediator complex subunit 27"	Q6P2C8	9	131860107-132079908	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007002	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA007002: AB_1078574"	"unprognostic (8.81e-2)"	"prognostic favourable (1.59e-4)"	"unprognostic (2.42e-2)"	"unprognostic (2.21e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.59e-3)"	"unprognostic (5.93e-2)"	"unprognostic (7.45e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.60e-2)"	11.1	12.1	18.0	9.5	18.1	15.5	11.5	14.0	21.4	10.9	11.7	19.5	10.1	7.8	18.6	23.5	15.5	13.9	9.5	17.5	17.5	11.2	10.4	7.5	10.9	13.5	18.6	19.1	12.7	7.9	10.6	17.8	12.7	17.4	12.7	10.7	16.0	17.7	14.4	15.2	15.7	8.6	16.3	16.1	11.7	10.2	14.7	14.0	17.9	13.2	9.6	15.8	12.3	10.5	12.9	19.8	13.4	18.6	18.0	19.7	11.8	16.0	15.8	18.2	14.4	13.1	12.1	15.4	16.7	22.2	33.4	26.2	23.5	13.0	15.9	11.3	17.3	29.1	25.2	23.7	21.9	17.0	14.9	11.9	16.6	14.0	19.6	21.3	15.0	13.3	16.3	26.4	27.0	17.4	17.3	13.2	24.3	25.5	22.8	12.4	18.6	26.8	20.2	25.7	19.4	13.4	8.9	34.1	13.8	21.5	11.1	11.1	17.6	10.0	14.6	34.1	15.0	25.2	25.0	5.4	16.5	28.1	18.9	14.9	23.1	3.5	12.2	13.4	18.9	18.6	15.3	11.6	14.8	18.5	19.2	12.9	12.7	15.5	4.8	18.0	16.0	19.8	19.7	11.8	18.0	18.1	14.0	21.4	17.5	11.2	18.6	19.1	17.4	14.0
MESP1	"bHLHc5, MGC10676"	ENSG00000166823	"Mesoderm posterior bHLH transcription factor 1"	Q9BRJ9	15	89748661-89751310	"Predicted intracellular proteins, Transcription factors"	"Notch signaling pathway, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 14.1;prostate: 10.9"	"Cell line enhanced"	"Detected in some"		"A-431: 5.6;HDLM-2: 4.9;HEK 293: 4.9;PC-3: 9.3;SCLC-21H: 4.3"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 6.3;prostate cancer: 26.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA069981			Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA069981: "	"unprognostic (4.17e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.83e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.68e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.47e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.03e-2)"	14.1	1.6	6.8	1.4	4.3	1.1	3.8	7.3	8.8	2.5	1.9	1.1	0.1	1.3	1.0	1.0	0.9	1.0	2.9	3.9	4.9	5.0	1.3	1.2	1.1	1.1	3.3	4.3	1.0	1.2	1.1	1.1	0.8	2.4	10.9	1.0	1.3	3.0	1.2	7.0	0.9	1.1	0.9	1.4	0.9	1.0	1.4	1.9	0.0	1.0	2.2	0.9	0.9	0.4	0.0	0.1	0.0	0.1	0.0	0.8	0.1	5.6	2.1	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.3	0.1	0.0	0.3	0.0	2.2	0.0	0.0	0.4	0.0	0.0	4.9	4.9	0.2	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.8	1.4	0.0	9.3	0.2	0.0	1.3	0.1	0.0	4.3	0.1	1.1	1.8	1.1	0.1	0.7	0.0	0.0	0.3	3.4	1.1	2.2	0.7	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.1	6.8	4.3	7.3	8.8	4.9	5.0	3.3	4.3	2.4	1.9
METTL22	"C16orf68, FLJ12433, MGC2654"	ENSG00000067365	"Methyltransferase like 22"	Q9BUU2	16	8621683-8649654	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 12.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 12.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040803, HPA059882, HPA074173"	Uncertain		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA040803: AB_10795479, HPA059882: , HPA074173: "	"unprognostic (1.74e-1)"	"unprognostic (6.50e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-3)"	"unprognostic (3.82e-2)"	"prognostic unfavourable (2.79e-8)"	"unprognostic (1.78e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.90e-2)"	8.4	10.6	5.4	10.5	8.8	12.5	8.0	17.1	10.2	9.6	10.9	10.9	13.6	9.2	13.0	12.2	7.6	8.6	9.8	15.0	7.0	7.3	7.1	9.5	6.5	10.8	7.9	6.8	10.8	10.6	7.3	7.6	9.4	9.3	10.5	7.9	10.2	9.5	15.6	45.2	15.7	6.4	11.4	6.3	8.1	9.8	27.8	9.3	10.4	10.1	10.0	9.1	9.7	9.9	1.1	2.8	12.6	3.0	1.8	1.6	1.4	3.7	7.7	8.8	8.4	3.3	8.5	7.6	6.4	3.4	7.7	8.7	7.5	8.7	5.8	5.8	5.6	7.1	5.5	10.2	5.1	8.5	7.5	6.0	13.5	21.2	10.0	6.1	4.6	8.5	7.4	8.4	9.3	6.1	8.1	6.0	5.8	13.3	6.3	14.8	4.7	7.6	9.6	6.6	12.1	3.8	4.0	10.8	7.2	5.6	6.6	4.2	7.2	5.1	4.7	9.1	8.0	7.4	2.9	8.1	4.3	9.1	3.3	8.2	4.2	1.4	3.0	2.4	1.3	2.3	1.2	1.1	1.1	1.3	2.8	1.1	1.5	0.7	12.6	1.8	2.5	1.6	1.6	1.4	5.4	8.8	17.1	10.2	7.0	7.3	7.9	6.8	9.3	9.3
METTL5	HSPC133	ENSG00000138382	"Methyltransferase like 5"	Q9NRN9	2	169810081-169824931	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA038223	Uncertain		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA038223: AB_10672509"	"unprognostic (2.55e-2)"	"unprognostic (8.41e-2)"	"unprognostic (4.73e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.25e-3)"	"prognostic unfavourable (6.64e-5)"	"unprognostic (2.78e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.15e-2)"	"prognostic unfavourable (3.06e-8)"	"unprognostic (8.53e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.95e-2)"	"unprognostic (6.87e-3)"	28.9	25.2	30.1	15.8	29.3	17.6	31.2	18.1	30.2	19.8	28.6	14.2	14.9	17.7	18.8	40.4	29.0	17.9	17.3	38.2	25.6	28.5	27.8	29.2	15.8	19.4	25.6	20.8	16.6	32.5	18.0	24.2	22.3	30.2	25.3	26.5	11.9	27.9	20.9	50.1	19.6	24.9	38.4	26.5	17.8	25.1	14.1	23.9	18.1	26.1	33.9	22.3	31.6	26.5	28.6	21.9	15.0	14.1	18.8	29.1	15.1	23.9	13.3	19.3	21.4	17.7	26.6	31.8	20.3	19.2	24.8	20.0	41.3	28.4	30.7	24.9	16.6	25.1	26.3	42.6	35.0	23.6	18.9	46.3	10.9	45.0	24.2	58.0	22.9	19.5	57.2	31.4	38.7	23.0	43.0	25.8	31.5	23.2	27.8	47.1	26.1	25.3	28.2	18.1	47.5	42.6	22.1	23.5	17.6	13.1	20.7	35.3	19.5	26.2	15.7	27.1	22.1	16.9	26.0	25.2	38.0	51.0	22.6	28.4	24.4	15.0	11.7	9.0	19.0	14.1	29.1	28.6	26.3	25.2	14.2	24.1	27.5	24.9	3.5	18.8	12.9	21.9	24.9	15.1	30.1	29.3	18.1	30.2	25.6	28.5	25.6	20.8	30.2	23.9
MFSD1	"FLJ14153, UG0581B09"	ENSG00000118855	"Major facilitator superfamily domain containing 1"	Q9H3U5	3	158732198-158829719	"Predicted intracellular proteins, Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 45.3;granulocytes: 42.6;monocytes: 49.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057924, HPA065858"	Approved		Approved	Nucleoplasm,Nucleoli			14000	Nucleoplasm	Nucleoli	"HPA057924: , HPA065858: "	"unprognostic (9.94e-2)"	"unprognostic (3.12e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.16e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.92e-1)"	"prognostic favourable (5.60e-5)"	"unprognostic (1.62e-1)"	"unprognostic (6.33e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.57e-1)"	26.2	29.5	11.4	22.0	11.8	17.2	24.2	9.1	14.0	18.7	15.7	13.4	18.9	13.2	18.3	20.6	37.0	18.4	17.5	17.7	10.8	10.3	20.7	24.8	24.9	39.8	15.7	11.7	15.3	16.8	16.5	16.8	18.3	13.6	14.7	11.5	14.5	34.5	17.9	9.2	18.6	16.8	15.0	14.5	29.1	19.9	15.0	14.3	11.3	18.7	16.3	16.7	23.8	24.1	10.5	45.3	42.6	49.6	5.4	7.3	35.3	14.7	6.3	1.6	4.9	8.6	8.1	10.2	23.1	10.4	8.2	8.1	2.6	14.6	4.1	17.0	14.8	7.7	4.0	5.1	7.7	16.4	10.7	11.1	4.8	1.1	9.3	40.9	27.8	12.1	6.7	7.4	2.0	6.4	8.6	8.5	14.6	3.4	2.5	12.0	1.6	16.2	5.5	2.4	36.3	3.0	3.9	4.8	7.2	17.1	13.2	4.1	10.4	16.0	21.1	11.8	4.5	17.4	11.3	27.1	19.0	2.3	14.8	29.6	8.2	14.0	49.6	42.6	7.3	38.5	6.6	10.5	5.8	6.5	45.3	8.5	6.4	7.0	17.6	5.4	31.6	14.7	6.8	35.3	11.4	11.8	9.1	14.0	10.8	10.3	15.7	11.7	13.6	14.3
MFSD9	MGC11332	ENSG00000135953	"Major facilitator superfamily domain containing 9"	Q8NBP5	2	102715840-102736888	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055293, HPA061859"	Approved		Approved	Nucleoli				Nucleoli		"HPA055293: , HPA061859: "	"unprognostic (1.27e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.93e-2)"	"prognostic unfavourable (8.38e-4)"	"unprognostic (2.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.42e-2)"	"unprognostic (6.88e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.28e-2)"	4.3	4.1	3.0	3.5	3.1	6.2	6.2	12.9	5.2	4.6	8.4	2.4	11.0	11.6	2.8	3.8	7.2	2.7	4.1	3.8	2.3	2.8	7.2	16.2	3.0	4.5	2.3	1.5	3.3	16.8	6.3	10.7	3.4	4.8	3.4	7.9	5.1	9.0	6.8	2.2	4.4	16.0	4.0	2.7	4.8	6.7	2.7	1.7	10.0	5.0	3.9	6.3	5.5	3.5	3.0	4.4	6.4	3.2	4.1	4.3	3.0	3.9	3.2	3.5	6.3	4.1	1.8	8.7	2.6	2.4	3.8	3.9	9.9	6.0	3.2	4.2	1.8	6.2	4.9	2.6	2.7	12.9	5.0	5.7	3.6	13.0	3.6	4.5	7.7	2.1	6.4	2.6	1.3	2.5	3.5	2.0	1.8	3.8	4.3	6.9	3.4	3.7	3.5	5.5	3.3	6.7	13.4	6.8	5.0	2.5	7.8	7.7	3.3	6.5	1.9	3.0	5.6	4.2	3.4	4.7	3.7	2.4	2.8	9.6	3.6	3.7	1.2	6.4	4.3	3.2	3.3	3.0	3.4	3.1	2.6	2.7	3.7	3.8	5.0	4.1	1.9	4.4	2.2	3.0	3.0	3.1	12.9	5.2	2.3	2.8	2.3	1.5	4.8	1.7
MIF4GD	"AD023, MGC45027, MIFD, SLIP1"	ENSG00000125457	"MIF4G domain containing"	A9UHW6	17	75266228-75271227	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 67.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051222	Approved		Supported	"Nucleoli,Golgi apparatus,Cytosol"				Nucleoli	"Golgi apparatus, Cytosol"	"HPA051222: "	"unprognostic (1.05e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.82e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.15e-2)"	"prognostic favourable (2.70e-4)"	"unprognostic (2.18e-1)"	"unprognostic (9.20e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.31e-2)"	19.0	13.9	10.4	14.5	11.1	30.5	13.3	7.4	14.6	11.9	12.9	20.8	14.2	10.3	16.8	12.8	18.3	13.9	20.4	20.4	10.2	8.2	16.0	15.1	15.1	30.4	12.0	9.9	12.2	16.2	18.2	7.4	15.9	12.0	12.0	11.7	15.5	15.4	11.5	34.4	18.6	14.1	20.4	15.4	22.0	11.7	12.6	10.9	21.8	15.0	20.7	20.9	16.6	12.2	14.1	67.0	11.3	21.5	14.5	17.5	14.4	11.8	21.0	4.7	10.9	7.6	2.2	6.7	3.0	8.6	6.1	4.2	7.4	13.4	18.5	5.5	4.8	9.5	5.7	10.6	4.6	9.1	14.4	9.1	9.1	6.5	8.4	8.0	10.7	2.1	16.7	4.2	17.4	12.6	12.0	22.6	1.6	23.1	25.5	19.1	2.1	10.3	16.6	6.0	25.2	12.3	6.5	7.0	10.3	6.2	16.4	15.2	30.3	18.7	4.8	3.1	7.6	3.9	6.1	33.1	8.5	15.6	5.8	14.2	4.1	5.7	21.5	11.3	15.4	11.0	16.2	14.1	12.5	13.7	25.4	13.0	11.4	12.0	3.8	14.5	13.1	67.0	17.5	14.4	10.4	11.1	7.4	14.6	10.2	8.2	12.0	9.9	12.0	10.9
MIS18BP1	"C14orf106, FLJ11186, KIAA1903, KNL2, M18BP1"	ENSG00000129534	"MIS18 binding protein 1"	Q6P0N0	14	45203190-45253540	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA006504	Approved		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA006504: AB_1078317"	"unprognostic (2.12e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavourable (3.83e-4)"	"unprognostic (4.18e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.32e-3)"	"unprognostic (3.31e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.21e-1)"	10.3	5.2	5.1	22.5	5.7	26.3	14.1	1.8	5.7	9.0	11.8	2.3	7.6	6.0	9.8	9.5	10.2	8.6	5.7	5.3	5.1	2.8	5.0	4.3	14.3	23.9	4.5	4.1	12.5	7.1	1.8	5.2	9.5	6.7	7.9	7.6	1.9	12.5	10.2	3.0	8.4	10.7	7.3	10.2	22.5	6.9	9.5	3.1	38.4	7.1	8.2	15.5	8.2	7.7	13.1	14.7	23.6	22.6	4.5	4.8	4.0	20.6	7.8	16.2	7.1	5.0	7.2	12.0	14.4	7.6	12.0	14.9	4.1	20.1	28.6	6.3	7.1	14.5	9.5	7.2	22.6	15.1	6.0	17.1	9.6	5.3	3.3	39.4	16.0	5.1	3.0	7.1	6.7	14.6	7.5	6.8	11.6	7.6	16.4	17.4	12.3	9.8	19.7	6.6	11.0	6.1	8.6	11.4	5.0	5.8	9.8	5.2	11.7	22.6	7.9	6.4	19.5	7.8	6.3	6.1	8.1	13.3	3.6	16.5	8.9	23.6	14.2	16.2	3.9	13.2	4.1	13.1	3.6	3.2	9.6	12.9	2.4	2.5	8.5	4.5	22.6	14.7	4.8	4.0	5.1	5.7	1.8	5.7	5.1	2.8	4.5	4.1	6.7	3.1
MKI67	"MIB-, PPP1R105"	ENSG00000148773	"Marker of proliferation Ki-67"	P46013	10	128096659-128126385	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.2;lymphoid tissue: 81.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.4;T-reg: 1.3"	"Group enriched"	"Detected in many"	13	"NK-cells: 1.1;T-cells: 1.4"									"CAB000058, HPA000451, HPA001164, CAB068198"	Enhanced		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"CAB000058: AB_2142367, CAB068198: , HPA000451: AB_1079186, HPA001164: AB_1079187"	"unprognostic (2.54e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.37e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (3.61e-6)"	"unprognostic (7.16e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.73e-1)"	"prognostic unfavourable (9.47e-5)"	"unprognostic (2.45e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.61e-1)"	1.8	1.2	0.2	9.9	0.5	25.2	1.8	0.3	0.5	1.5	5.0	0.6	0.2	3.6	0.7	1.4	13.4	0.3	1.2	1.3	0.2	0.2	1.2	1.0	1.9	8.8	0.2	0.2	0.5	0.4	0.0	0.4	2.9	0.5	0.7	5.8	0.5	2.2	0.6	0.5	3.9	6.2	1.3	0.8	6.5	3.5	2.5	0.2	81.5	0.4	5.2	10.0	1.3	3.5	0.0	0.0	0.0	0.0	1.1	1.4	0.4	47.3	24.1	25.1	17.8	1.0	2.1	7.8	18.0	13.3	17.1	15.3	19.7	19.7	35.7	5.2	12.3	28.9	26.3	13.5	25.8	37.6	12.7	30.6	17.8	12.3	0.0	43.0	16.6	0.5	0.6	17.6	18.0	16.7	14.0	34.4	16.9	18.8	25.6	13.1	10.0	11.0	19.1	32.9	4.7	6.2	13.3	8.7	9.5	25.5	9.2	4.4	7.5	9.2	15.4	9.1	18.2	12.8	48.6	15.7	12.4	43.3	7.5	19.7	7.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1.4	1.0	0.0	1.1	0.0	0.0	1.3	0.4	0.2	0.5	0.3	0.5	0.2	0.2	0.2	0.2	0.5	0.2
MMP24	MT5-MMP	ENSG00000125966	"Matrix metallopeptidase 24"	Q9Y5R2	20	35226654-35277000	"Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 38.5"	"Cell line enhanced"	"Detected in some"		"A549: 19.6;CACO-2: 29.9;EFO-21: 8.8;RPTEC TERT1: 13.5;U-2 OS: 10.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 38.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 91.3"	"HPA049280, HPA078816"	Approved		Approved	"Nucleoli,Plasma membrane"	"Secreted to extracellular matrix"			"Nucleoli, Plasma membrane"		"HPA049280: , HPA078816: "	"unprognostic (1.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.51e-4)"	"unprognostic (2.47e-2)"	"unprognostic (7.61e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.82e-2)"	"unprognostic (9.20e-3)"	"unprognostic (7.12e-2)"	"prognostic favourable (8.17e-11)"	"unprognostic (3.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.90e-4)"	1.6	1.3	4.0	0.4	7.8	0.6	0.4	38.5	8.9	0.7	0.3	1.3	0.2	2.8	1.6	0.9	0.2	2.8	0.6	1.0	2.7	3.2	8.6	0.9	6.1	0.3	1.8	1.5	0.9	8.0	0.0	3.8	0.6	1.7	2.2	0.1	0.5	0.4	6.0	0.2	1.5	1.7	2.5	0.9	0.6	0.7	0.4	1.4	0.2	0.8	0.2	0.2	0.5	0.2	0.8	0.4	2.2	0.8	0.6	1.2	0.3	0.3	19.6	0.0	0.1	0.1	0.0	0.6	1.1	1.2	2.1	1.1	29.9	5.3	0.0	8.8	1.3	0.3	4.6	0.0	0.9	0.1	0.2	1.0	0.5	0.3	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.2	0.2	0.1	0.1	7.5	1.3	0.0	0.1	0.0	13.5	0.1	7.8	5.4	1.4	0.5	0.2	0.3	0.1	0.3	4.2	10.1	1.0	0.4	0.1	0.1	0.0	0.9	0.1	0.6	1.0	0.6	0.1	1.0	0.7	1.2	0.6	0.7	0.8	0.4	0.8	0.6	0.6	2.2	0.6	0.8	0.2	0.0	0.3	4.0	7.8	38.5	5.3	2.7	3.2	1.8	1.5	1.7	1.4
MNDA	PYHIN3	ENSG00000163563	"Myeloid cell nuclear differentiation antigen"	P41218	1	158831317-158849506	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 289.8;bone marrow: 83.3"	"Group enriched"	"Detected in some"	15	"NB-4: 35.9;THP-1: 67.7;U-937: 44.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 289.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 289.8"					"Low region specificity"	"Detected in all"			"HPA034532, HPA073215"	Enhanced		Supported	Nucleoplasm,Nucleoli			110000	"Nucleoplasm, Nucleoli"		"HPA034532: AB_10669677, HPA073215: "	"unprognostic (1.53e-2)"	"unprognostic (7.84e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.02e-1)"	17.6	6.3	5.4	24.4	7.9	83.3	3.0	1.4	5.8	2.1	2.1	3.2	0.2	1.1	1.7	3.4	2.3	4.7	8.4	6.3	4.9	3.2	3.9	4.2	31.3	32.2	10.7	2.6	3.4	2.4	1.1	2.2	9.9	6.8	2.6	2.5	5.0	3.6	1.2	2.0	1.9	3.6	6.2	18.6	57.3	2.6	4.0	6.3	5.5	2.1	1.4	4.2	9.1	4.9	1.6	29.7	289.8	60.9	0.1	0.1	40.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.4	0.0	7.1	60.9	11.1	0.1	25.4	0.1	1.6	0.0	0.1	29.7	0.6	0.0	0.0	289.8	0.1	12.0	0.4	0.0	40.2	5.4	7.9	1.4	5.8	4.9	3.2	10.7	2.6	6.8	6.3
MNX1	"HB9, HLXB9, HOXHB9, SCRA1"	ENSG00000130675	"Motor neuron and pancreas homeobox 1"	P50219	7	156994051-157010651	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"pancreas: 43.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.5;EFO-21: 11.1;HEK 293: 8.8;RPMI-8226: 24.2;SCLC-21H: 13.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071717			Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA071717: "	"unprognostic (2.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.72e-3)"	"unprognostic (8.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.07e-2)"	"unprognostic (5.06e-2)"	"unprognostic (8.62e-4)"	"unprognostic (1.00e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.23e-5)"	"unprognostic (1.67e-3)"	"unprognostic (5.80e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.08e-1)"	0.1	0.0	0.1	0.4	0.2	0.0	0.1	0.2	0.1	0.1	6.0	0.2	0.1	9.0	0.1	0.1	0.3	0.0	7.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	43.3	0.0	3.2	0.1	0.2	0.8	3.7	0.1	1.9	0.1	0.1	0.1	7.3	0.1	0.2	0.1	2.7	1.0	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	3.8	0.0	11.5	0.0	0.0	8.6	0.0	0.0	0.1	0.0	5.0	1.6	0.9	11.1	0.0	0.2	2.0	1.5	0.9	1.4	8.8	0.0	0.7	2.3	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	3.6	1.9	0.0	6.4	0.6	0.1	0.0	0.7	0.0	1.7	24.2	4.3	0.4	13.0	0.0	1.6	1.4	0.2	3.6	2.9	0.0	0.0	0.0	0.0	0.0	3.6	1.8	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.2	0.1
MOB1A	"C2orf6, FLJ10788, FLJ11595, Mats1, MOB1, Mob4B, MOBK1B, MOBKL1B"	ENSG00000114978	"MOB kinase activator 1A"	Q9H8S9	2	74152528-74178898	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047088, HPA071690"	Supported		Approved	Nucleoplasm,Nucleoli,Cytosol				Cytosol	"Nucleoplasm, Nucleoli"	"HPA047088: , HPA071690: "	"unprognostic (5.32e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.19e-2)"	"prognostic unfavourable (3.34e-4)"	"unprognostic (9.36e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.20e-3)"	"unprognostic (5.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.11e-3)"	32.2	18.0	12.2	41.5	16.3	36.6	36.2	10.8	11.3	24.5	21.5	12.6	16.1	19.7	27.1	19.8	28.9	22.0	19.9	20.9	11.0	10.4	34.7	21.4	28.4	65.1	14.7	6.9	28.4	12.6	13.8	11.5	20.9	15.9	21.0	20.7	14.3	18.1	18.8	12.8	22.9	30.2	31.6	21.8	51.1	18.7	17.9	12.8	57.0	25.4	16.9	42.4	29.2	24.6	22.3	22.2	32.3	42.8	20.6	15.9	25.2	20.7	11.9	15.0	16.1	24.7	27.0	17.7	16.7	22.5	21.8	21.6	16.2	15.1	42.6	14.3	20.9	17.4	19.1	19.1	33.2	29.9	11.4	38.4	8.2	17.1	19.7	33.2	62.1	22.8	18.7	17.4	14.8	22.8	16.4	15.8	21.1	11.2	41.6	28.3	13.9	9.8	28.7	51.5	22.6	18.7	26.0	7.6	9.9	23.7	17.6	15.2	14.0	15.8	21.6	28.4	15.0	19.8	26.4	11.8	10.4	32.7	19.1	28.4	15.1	30.8	24.0	32.3	14.8	39.0	15.9	22.3	13.3	15.7	22.2	17.2	12.3	14.6	24.0	20.6	42.8	15.5	13.4	25.2	12.2	16.3	10.8	11.3	11.0	10.4	14.7	6.9	15.9	12.8
MOB1B	"MOB4A, MOBKL1A"	ENSG00000173542	"MOB kinase activator 1B"	Q7L9L4	4	70902326-71022449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA047088, HPA071690"	Supported		Approved	Nucleoplasm,Nucleoli,Cytosol				Cytosol	"Nucleoplasm, Nucleoli"	"HPA047088: , HPA071690: "	"unprognostic (1.05e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.96e-1)"	"prognostic unfavourable (4.92e-4)"	"unprognostic (2.94e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.53e-3)"	9.8	10.1	15.7	17.8	13.0	30.9	11.1	10.4	20.0	10.5	9.7	17.3	4.8	6.1	13.9	8.6	9.9	11.8	9.1	11.1	19.8	10.6	29.3	8.3	20.6	13.4	15.5	18.6	13.8	11.0	18.0	10.9	11.2	12.8	12.7	8.5	8.0	11.1	8.6	10.8	11.2	8.4	14.1	17.4	10.6	10.1	7.6	15.4	52.3	14.4	8.2	12.8	10.8	9.8	0.6	5.3	2.5	3.1	0.7	1.4	1.2	3.8	3.1	11.9	9.7	6.5	8.3	9.8	11.7	6.4	6.6	5.8	4.1	7.4	21.6	5.6	10.4	2.7	7.4	9.8	16.0	11.4	2.6	33.8	3.6	3.2	6.5	7.3	6.8	6.8	5.4	7.3	6.0	7.7	20.7	7.1	10.4	4.1	22.8	4.6	3.9	4.2	7.3	11.6	2.9	10.9	6.8	4.2	8.0	5.0	2.2	15.7	5.3	4.8	9.2	18.3	9.4	8.2	4.7	4.6	1.5	9.2	6.4	5.4	8.4	0.8	3.1	2.5	1.3	1.6	1.1	0.5	0.6	0.6	4.0	0.6	0.8	0.7	0.4	0.7	0.9	5.3	1.4	1.2	15.7	13.0	10.4	20.0	19.8	10.6	15.5	18.6	12.8	15.4
MOB2	HCCA2	ENSG00000182208	"MOB kinase activator 2"	Q70IA6	11	1469457-1501247	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 57.3;urinary bladder: 51.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046313	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA046313: AB_10959882"	"unprognostic (5.02e-1)"	"unprognostic (5.71e-2)"	"unprognostic (6.24e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavourable (4.64e-4)"	"unprognostic (8.30e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.80e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.87e-1)"	"prognostic favourable (2.02e-4)"	"unprognostic (2.67e-1)"	"unprognostic (8.56e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.15e-1)"	9.2	4.2	2.4	17.0	2.5	3.0	12.1	2.5	3.2	14.9	30.9	1.8	6.7	2.5	12.5	8.7	17.3	13.8	26.8	8.1	2.8	1.9	3.2	3.0	4.1	8.2	2.1	2.1	8.6	5.8	6.8	1.8	4.2	2.9	21.2	6.7	4.3	12.9	20.1	7.1	9.4	10.6	57.3	2.5	3.7	9.9	4.2	2.0	2.0	4.3	3.2	4.4	51.8	21.2	10.6	10.8	11.2	12.5	11.6	17.3	9.0	13.9	15.2	9.4	7.6	23.6	16.6	8.7	11.0	16.1	21.3	16.8	9.7	19.2	10.3	8.5	25.9	17.1	14.6	24.8	13.0	13.8	21.8	7.8	5.5	12.3	15.9	10.2	12.3	13.4	29.8	11.3	13.4	22.5	12.6	10.7	10.8	9.9	13.2	17.4	11.6	14.2	9.6	9.7	10.7	17.7	13.4	17.6	18.8	13.7	17.2	13.3	7.9	10.3	18.5	13.0	6.6	4.2	7.0	10.6	10.3	10.7	9.0	9.9	9.9	8.2	8.6	11.2	17.3	8.7	14.6	8.2	14.9	13.8	10.8	10.6	12.5	10.5	7.1	11.6	12.5	6.9	12.8	9.0	2.4	2.5	2.5	2.5	2.8	1.9	2.1	2.1	2.9	2.0
MPHOSPH10	"CT90, MPP10, MPP10P, PPP1R106"	ENSG00000124383	"M-phase phosphoprotein 10"	O00566	2	71130314-71150101	"Predicted intracellular proteins, Predicted membrane proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035059, HPA035060, HPA049907"	Enhanced		Enhanced	Nucleoli				Nucleoli		"HPA035059: AB_2674436, HPA035060: AB_10601875, HPA049907: "	"unprognostic (3.20e-3)"	"unprognostic (1.59e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.41e-3)"	"unprognostic (6.13e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (3.89e-7)"	"unprognostic (1.24e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.23e-2)"	20.5	17.6	21.8	20.2	28.0	21.2	23.7	26.7	25.7	23.5	17.6	12.6	22.0	16.5	22.3	26.7	30.6	19.4	17.1	20.4	21.6	20.3	22.2	27.5	15.5	21.9	30.4	22.7	25.4	20.7	20.0	36.7	18.5	26.3	24.0	18.4	8.1	21.8	28.8	48.4	24.4	16.8	25.0	25.0	22.0	17.6	13.7	29.8	22.3	20.4	26.3	24.4	22.2	22.2	13.5	12.8	8.7	17.3	12.4	17.4	8.4	14.8	11.2	14.5	17.3	13.6	12.8	19.8	16.6	13.2	13.7	10.2	20.1	11.0	20.9	10.4	11.6	13.9	18.2	11.7	18.4	14.4	14.6	25.1	8.9	45.8	11.8	32.4	20.2	11.0	15.1	11.3	15.1	11.6	36.2	16.7	13.6	15.9	26.0	32.9	24.1	12.8	21.7	22.7	24.7	11.1	16.2	17.7	13.7	11.1	25.7	16.0	13.0	14.5	12.0	16.3	17.5	15.5	21.0	14.2	16.0	34.3	14.0	27.1	16.3	8.7	9.9	7.2	12.4	13.6	16.0	13.5	15.7	14.8	11.7	12.3	17.4	15.3	1.4	12.4	17.3	12.8	13.2	8.4	21.8	28.0	26.7	25.7	21.6	20.3	30.4	22.7	26.3	29.8
MPHOSPH6	MPP6	ENSG00000135698	"M-phase phosphoprotein 6"	Q99547	16	82147798-82170226	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003674, HPA026948"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"CAB003674: , HPA026948: AB_1854077"	"unprognostic (2.58e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.97e-3)"	"prognostic unfavourable (4.36e-5)"	"unprognostic (2.00e-2)"	"unprognostic (2.29e-3)"	"prognostic favourable (3.41e-5)"	"unprognostic (7.52e-2)"	"prognostic unfavourable (1.59e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.43e-2)"	13.7	15.5	32.0	17.5	25.1	12.3	54.1	37.1	32.6	18.5	16.0	9.3	7.0	9.9	18.9	17.1	26.5	11.9	12.3	9.4	25.4	22.2	12.0	11.5	13.6	16.1	17.5	21.9	10.4	7.2	13.6	43.5	17.4	24.0	11.3	18.7	10.8	18.1	10.3	15.4	28.4	11.0	16.8	31.7	12.7	11.2	9.9	17.9	10.8	8.7	12.9	18.2	19.6	18.5	18.6	24.6	19.4	25.2	17.1	28.3	15.6	19.3	10.6	23.7	11.6	11.6	16.3	13.1	20.9	25.1	18.3	8.9	17.0	11.4	16.0	12.7	11.4	20.4	22.6	21.7	24.6	11.8	14.8	12.8	8.8	30.6	11.5	31.9	19.9	10.3	19.5	10.8	31.3	20.9	30.1	4.5	27.8	15.7	24.5	37.7	21.7	14.7	30.4	11.0	10.5	16.5	20.4	16.3	7.0	35.2	15.7	15.0	27.5	19.9	16.4	17.2	17.1	15.1	14.8	6.7	16.2	63.5	15.5	26.2	21.7	13.0	22.0	19.4	22.3	25.2	28.3	18.6	23.1	23.2	24.6	14.6	24.8	23.6	2.7	17.1	17.4	14.7	23.0	15.6	32.0	25.1	37.1	32.6	25.4	22.2	17.5	21.9	24.0	17.9
MPND	FLJ14981	ENSG00000008382	"MPN domain containing"	Q8N594	19	4343527-4360086	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043274, HPA045475"	Approved		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA043274: AB_2678403, HPA045475: "	"unprognostic (3.16e-2)"	"prognostic favourable (2.99e-4)"	"unprognostic (4.85e-2)"	"prognostic favourable (6.12e-4)"	"unprognostic (8.60e-2)"	"unprognostic (5.37e-3)"	"unprognostic (3.16e-2)"	"prognostic favourable (1.55e-4)"	"unprognostic (1.23e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.94e-3)"	"unprognostic (5.18e-2)"	"prognostic favourable (7.04e-4)"	"unprognostic (2.22e-3)"	"unprognostic (3.22e-1)"	"unprognostic (5.44e-2)"	"unprognostic (9.04e-2)"	7.7	13.7	18.9	14.1	12.3	11.5	8.0	12.1	21.6	6.5	19.9	6.6	15.7	25.9	8.5	7.8	13.8	8.2	11.8	12.1	14.2	11.3	12.8	25.1	14.3	8.5	12.7	20.0	8.7	20.7	14.5	7.2	7.0	11.9	12.1	13.9	11.5	14.3	9.0	17.4	12.5	20.7	9.3	8.9	10.1	12.5	4.2	6.7	13.5	8.6	8.3	10.1	9.3	11.0	3.1	4.5	10.3	6.0	2.4	5.6	1.9	7.9	6.7	11.1	12.6	6.9	3.3	11.3	3.8	3.7	3.2	4.0	12.9	4.1	7.2	12.2	5.0	8.2	5.0	6.7	1.8	8.1	11.3	5.5	9.4	20.8	5.5	7.3	9.9	5.0	4.8	3.5	3.7	9.8	2.9	18.8	4.0	22.9	17.3	6.3	5.0	9.7	14.3	3.4	10.4	8.2	14.0	12.4	12.7	7.0	10.0	5.3	6.7	9.0	3.7	5.1	5.5	31.3	7.7	15.6	9.6	4.7	5.7	4.1	5.9	10.3	5.1	2.4	2.2	6.0	3.4	1.8	2.6	3.1	4.5	3.1	1.7	1.9	1.2	2.4	2.7	4.5	5.6	1.9	18.9	12.3	12.1	21.6	14.2	11.3	12.7	20.0	11.9	6.7
MPPED2	"239FB, C11orf8, D11S302E, dJ1024C24.1, dJ873F21.1, FAM1B, Hs.46638"	ENSG00000066382	"Metallophosphoesterase domain containing 2"	Q15777	11	30384493-30586872	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix, uterine: 31.0;thyroid gland: 30.0"	"Cell line enhanced"	"Detected in some"		"HaCaT: 19.4;HAP1: 11.5;RT4: 8.1;SH-SY5Y: 6.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 4.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062575			Approved	Nucleoli,Vesicles,Mitochondria				Nucleoli	"Vesicles, Mitochondria"	"HPA062575: "	"unprognostic (9.60e-3)"	"unprognostic (6.12e-3)"	"unprognostic (3.70e-3)"	"unprognostic (4.56e-2)"	"unprognostic (5.46e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.98e-4)"	"unprognostic (6.82e-2)"	"unprognostic (2.47e-7)"	"unprognostic (3.64e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.57e-2)"	2.9	7.0	6.3	1.7	19.3	1.1	5.5	4.6	8.9	31.0	4.2	1.8	4.4	1.5	8.3	7.9	1.6	11.1	1.9	4.6	8.5	9.7	12.2	1.2	1.1	0.9	7.0	6.7	1.2	2.5	5.0	10.7	2.5	11.2	15.6	1.4	7.1	12.1	10.1	5.7	1.0	1.4	5.1	4.6	3.1	1.9	3.8	3.4	9.1	30.0	1.2	1.0	4.7	4.9	1.3	0.7	0.3	0.2	2.0	4.8	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	11.5	0.0	0.0	0.0	2.1	0.0	0.2	0.2	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	3.2	0.0	0.0	3.1	0.2	0.0	8.1	0.1	6.1	0.0	0.0	3.1	1.8	0.0	0.1	0.0	1.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.1	0.3	0.2	0.0	0.9	0.0	4.8	0.0	0.0	0.6	0.4	1.3	1.3	0.2	0.2	2.0	0.0	0.7	0.1	0.2	6.3	19.3	4.6	8.8	8.5	9.7	7.0	6.7	11.2	3.4
MRPL40	"MRP-L22, NLVCF"	ENSG00000185608	"Mitochondrial ribosomal protein L40"	Q9NQ50	22	19431902-19436075	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 28.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006181	Uncertain		Supported	Nucleoli,Mitochondria				Mitochondria	Nucleoli	"HPA006181: AB_1079411"	"unprognostic (4.12e-2)"	"prognostic favourable (7.57e-4)"	"unprognostic (2.64e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.76e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.14e-2)"	4.0	6.6	5.5	2.5	6.6	1.3	3.9	5.1	5.4	4.3	2.6			2.9	3.0	5.0	3.7	5.0	2.9	11.8	4.6	4.7	6.1	10.3	2.2	3.0	5.1		4.7	7.0	6.4	4.9	2.5		4.6	2.2		8.7	4.2	14.8	3.6	2.3	2.4	5.0	2.7	3.1	2.8			8.2		2.8	3.7	2.5	28.1	21.6	10.3	15.1	10.9	16.4	16.6	13.2	9.2	2.2	8.4	13.7	12.7	7.0	10.0	11.6	14.1	17.6	10.8	7.7	11.6	10.4	11.0	13.1	13.9	15.9	11.8	11.7	21.2	10.5	6.5	13.3	20.2	14.9	7.0	13.1	15.4	10.3	18.5	9.4	42.4	11.0	13.6	10.1	7.8	8.9	3.6	12.5	7.3	14.5	5.3	16.7	5.5	7.6	7.0	15.3	12.9	19.1	11.4	8.7	11.7	18.8	17.3	7.4	9.6	10.6	14.2	16.9	12.2	10.2	13.5	5.9	13.8	10.3	13.0	15.1	14.0	28.1	13.2	13.5	15.0	25.5	16.4	14.3	1.6	10.9	12.0	21.6	15.0	16.6										
MRPS27	KIAA0264	ENSG00000113048	"Mitochondrial ribosomal protein S27"	Q92552	5	72219409-72320646	"Predicted intracellular proteins, Ribosomal proteins"	"Translation regulation"	"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA071751	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Mitochondria"				"Nucleoplasm, Mitochondria"	"Nucleoli, Plasma membrane"	"HPA071751: "	"unprognostic (3.05e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.14e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-2)"	"unprognostic (7.20e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.22e-3)"	"unprognostic (5.07e-2)"	"unprognostic (3.26e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.27e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.95e-2)"	26.9	32.3	19.0	20.9	26.8	13.6	26.1	24.6	31.8	25.1	21.0	20.1	21.8	16.5	28.6	23.7	33.6	26.3	18.0	43.6	18.9	17.5	25.1	30.9	14.9	27.4	18.1	21.7	33.9	25.1	24.5	23.7	17.5	23.5	26.2	26.4	25.5	31.0	26.5	43.7	23.9	17.5	25.0	17.5	22.2	20.9	12.1	12.6	34.2	32.1	26.7	32.4	25.9	21.0	19.6	23.3	6.1	14.1	21.5	21.5	16.1	16.3	22.0	19.6	32.3	25.8	33.3	25.2	15.8	22.7	30.1	24.3	27.3	23.3	42.5	22.2	18.4	18.3	38.0	56.1	32.7	16.0	23.5	21.8	26.5	30.1	25.7	19.1	17.0	31.1	23.7	31.5	35.4	32.0	21.8	12.9	24.9	19.7	28.5	23.2	22.6	13.8	30.4	32.6	43.5	27.8	17.6	30.3	16.2	26.5	21.9	19.6	33.6	23.3	18.1	12.3	18.2	17.3	28.3	13.1	19.6	30.0	21.2	31.5	19.4	6.1	12.1	4.1	14.0	14.1	20.6	19.6	17.4	17.0	23.3	16.5	20.3	21.5	1.8	21.5	11.3	8.9	17.8	16.1	19.0	26.8	24.6	31.8	18.9	17.5	18.1	21.7	23.5	12.6
MRPS31	IMOGN38	ENSG00000102738	"Mitochondrial ribosomal protein S31"	Q92665	13	40729135-40771173	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039083, HPA046344"	Uncertain		Supported	Nucleoli,Mitochondria				Mitochondria	Nucleoli	"HPA039083: , HPA046344: "	"unprognostic (9.62e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.96e-3)"	"unprognostic (1.84e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.92e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.54e-2)"	14.2	20.1	19.3	17.9	21.2	13.2	18.2	27.7	22.9	14.4	16.4	16.9	10.7	15.4	18.0	15.4	18.9	16.6	10.9	24.3	18.4	16.9	26.7	29.9	12.1	22.5	17.9	17.1	21.5	15.0	10.7	35.3	13.1	22.1	12.6	17.0	12.4	14.7	12.5	32.5	14.2	16.3	16.3	16.0	16.0	15.3	17.9	23.3	22.9	21.1	17.2	25.1	18.0	15.9	22.2	11.8	17.2	10.4	15.9	25.7	10.9	8.0	7.8	13.2	8.6	9.0	10.7	13.2	10.4	7.3	13.7	9.3	19.9	12.0	47.5	10.2	5.9	21.4	16.5	12.9	16.4	12.5	12.4	19.7	5.8	12.7	7.5	20.1	9.5	8.5	9.6	11.3	9.6	10.4	13.1	5.0	8.7	9.2	15.6	19.7	12.8	9.2	14.9	10.8	8.9	17.9	9.4	5.7	8.4	7.2	12.0	16.3	10.5	17.8	6.3	4.3	7.2	9.9	10.7	3.9	7.2	23.9	8.8	14.4	8.2	17.2	9.6	14.4	19.1	9.7	18.6	22.2	21.4	19.2	11.8	18.9	25.7	22.6	7.0	15.9	10.4	11.6	21.4	10.9	19.3	21.2	27.7	22.9	18.4	16.9	17.9	17.1	22.1	23.3
MRTO4	"C1orf33, dJ657E11.4, MRT4"	ENSG00000053372	"MRT4 homolog, ribosome maturation factor"	Q9UKD2	1	19251539-19260128	"Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026446	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli"				"Nucleoplasm, Nuclear membrane"	Nucleoli	"HPA026446: AB_10601441"	"unprognostic (3.99e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.94e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.22e-2)"	"prognostic unfavourable (1.56e-8)"	"unprognostic (7.46e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (4.11e-8)"	"unprognostic (5.87e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.23e-2)"	17.2	16.5	20.4	16.9	18.5	12.0	21.6	10.7	21.7	12.1	13.8	12.4	10.2	17.5	15.6	15.2	21.6	18.8	11.8	11.7	19.1	15.9	13.6	23.7	10.5	23.0	16.1	19.1	18.7	41.2	10.2	8.8	12.5	15.1	12.2	17.6	10.6	13.2	11.9	22.8	15.3	19.3	17.3	10.0	14.5	13.7	21.6	11.6	14.5	12.9	29.3	22.7	11.4	12.4	14.7	12.8	1.0	8.2	10.6	15.7	7.2	24.1	17.2	14.2	18.6	6.9	11.1	12.6	18.9	10.7	32.5	21.4	24.8	25.1	35.7	15.9	15.6	19.2	39.4	28.5	32.8	12.7	30.1	26.4	15.4	21.2	8.8	34.8	11.1	9.7	18.9	36.6	19.0	18.2	39.9	11.6	19.2	17.7	28.3	25.2	18.2	26.2	26.6	17.4	27.6	17.6	8.3	23.0	16.8	14.5	20.0	20.0	14.2	20.5	11.9	17.8	22.0	27.2	32.2	9.4	16.4	47.1	17.3	44.8	28.3	0.7	7.5	0.7	7.9	8.2	15.7	14.7	9.6	10.8	11.4	13.1	13.0	11.6	1.0	10.6	6.2	12.8	6.7	7.2	20.4	18.5	10.7	21.7	19.1	15.9	16.1	19.1	15.1	11.6
MS4A12	"FLJ20217, Ms4a10"	ENSG00000071203	"Membrane spanning 4-domains A12"	Q9NXJ0	11	60492778-60507430	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	41	"intestine: 64.7;lymphoid tissue: 28.6"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.5;LHCN-M2: 2.1;NTERA-2: 3.0;RH-30: 4.2;U-2 OS: 1.7"	"Cancer enriched"	"Detected in some"	8	"colorectal cancer: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA048616, HPA057657"	Enhanced		Approved	"Nucleoli,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoli, Endoplasmic reticulum, Golgi apparatus"	"HPA048616: , HPA057657: "			"unprognostic (2.64e-2)"						"unprognostic (2.33e-1)"			"unprognostic (1.49e-1)"		"unprognostic (3.26e-1)"	"unprognostic (2.83e-1)"	"unprognostic (9.20e-3)"		0.1	0.0	0.1	28.6	0.1	0.0	0.1	0.1	0.1	0.1	57.7	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	64.7	0.1	0.1	0.1	0.1	0.0	0.2	1.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	3.0	0.0	0.2	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.7	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
MTUS1	"ATBP, ATIP1, ATIP3, DKFZp586D1519, FLJ14295, ICIS, KIAA1288, MP44, MTSG1"	ENSG00000129422	"Microtubule associated scaffold protein 1"	Q9ULD2	8	17643795-17800917	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 29.1;AN3-CA: 25.6;HUVEC TERT2: 75.5;SK-MEL-30: 21.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 2.2;naive CD4 T-cell: 4.8;naive CD8 T-cell: 3.6"	"Lineage enriched"	"Detected in single"	21	"T-cells: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067903, HPA069795"			Enhanced	Nucleoli,Microtubules				"Nucleoli, Microtubules"		"HPA067903: , HPA069795: "	"unprognostic (3.20e-1)"	"unprognostic (3.29e-1)"	"prognostic favourable (1.05e-4)"	"unprognostic (2.50e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.44e-1)"	"unprognostic (9.73e-2)"	"unprognostic (7.93e-3)"	"unprognostic (3.33e-1)"	"prognostic favourable (2.76e-4)"	"unprognostic (2.04e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.53e-3)"	"unprognostic (2.43e-1)"	45.0	20.8	20.9	6.8	38.2	0.4	21.8	51.0	27.7	19.8	19.0	56.5	9.9	16.9	16.9	12.6	20.3	12.8	20.0	44.3	27.4	17.3	14.4	29.3	20.9	4.4	34.7	18.0	28.2	47.1	43.8	15.0	36.1	33.7	17.5	21.1	10.3	24.3	14.0	49.7	12.2	17.4	20.5	48.3	8.2	21.4	6.5	49.3	0.7	15.7	10.9	7.5	21.4	26.7	0.2	0.0	0.0	0.0	0.0	4.8	1.0	5.3	29.1	4.7	25.6	0.0	0.1	8.6	0.2	1.9	0.1	0.6	2.1	1.9	0.7	2.2	0.0	5.6	7.8	2.7	0.2	3.9	3.3	0.0	5.0	13.8	1.7	0.0	0.1	2.4	4.2	0.6	8.6	75.5	0.0	11.1	0.0	1.4	1.0	1.4	6.8	0.7	0.0	4.3	2.8	1.5	11.1	2.4	0.5	3.7	6.8	21.4	4.9	0.0	15.4	0.0	6.4	0.0	0.0	1.5	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	2.2	0.6	0.0	0.2	4.8	3.6	0.0	0.0	0.0	0.0	0.0	1.0	20.9	38.2	51.0	27.7	27.4	17.3	34.7	18.0	33.7	49.3
MTX2		ENSG00000128654	"Metaxin 2"	O75431	2	176269395-176338025	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031550, HPA031551, HPA031552"	Approved	Approved	Supported	Nucleoli,Mitochondria	"Intracellular and membrane"			Mitochondria	Nucleoli	"HPA031550: AB_10599733, HPA031551: AB_10601442, HPA031552: AB_10794616"	"unprognostic (2.61e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.54e-2)"	"prognostic unfavourable (5.06e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.80e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.33e-2)"	13.2	26.4	21.3	12.0	22.3	5.5	18.8	15.0	44.9	13.0	20.7	18.5	16.6	15.4	15.5	27.9	22.2	20.0	12.0	33.6	23.6	26.3	31.5	20.2	10.6	8.9	21.5	16.5	13.2	16.4	23.7	25.7	17.3	21.8	18.9	24.6	16.3	24.7	16.5	45.0	12.5	14.8	17.6	25.7	9.4	14.6	40.6	14.0	10.2	14.7	19.8	13.6	14.4	13.6	16.2	12.1	4.7	12.6	15.1	13.4	7.9	17.8	10.6	21.6	13.2	14.5	16.8	20.8	19.3	18.1	17.7	20.7	18.2	19.5	22.9	32.7	17.0	12.1	23.5	23.7	24.4	22.7	17.0	21.8	13.4	32.1	23.0	33.7	7.4	18.7	29.6	18.5	32.0	25.2	28.9	17.8	20.8	16.3	11.8	34.3	20.6	16.8	0.0	15.7	20.4	50.2	32.5	30.9	26.5	16.1	21.5	39.7	12.0	22.0	22.1	17.7	15.7	18.5	20.1	20.0	20.8	27.4	22.0	17.0	21.4	4.7	7.7	3.2	8.5	12.6	11.5	16.2	10.9	9.6	12.1	11.4	13.2	13.4	0.0	15.1	10.9	9.8	13.4	7.9	21.3	22.3	15.0	44.9	23.6	26.3	21.5	16.5	21.8	14.0
MXD3	"bHLHc13, MAD3"	ENSG00000213347	"MAX dimerization protein 3"	Q9BW11	5	177301461-177312757	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.1;lymphoid tissue: 59.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 14.1;monocytes: 8.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA070111			Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA070111: "	"unprognostic (2.78e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.63e-1)"	"unprognostic (8.26e-2)"	"unprognostic (6.18e-3)"	"prognostic unfavourable (3.60e-4)"	"unprognostic (3.32e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.33e-16)"	"unprognostic (8.55e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.22e-3)"	2.5	1.8	1.3	28.2	1.9	32.1	5.4	1.2	3.4	2.4	6.8	1.2	2.8	6.9	2.7	6.2	6.6	3.6	2.8	2.4	1.6	0.8	2.7	6.6	5.4	7.3	2.2	1.2	2.6	5.8	0.7	4.3	4.5	2.1	5.0	0.9	1.1	4.7	2.1	3.6	10.3	5.6	1.4	1.3	10.3	3.8	3.1	2.9	59.4	3.5	3.7	13.5	2.7	3.6	2.0	1.6	14.1	8.7	0.7	0.8	1.1	8.0	5.6	3.4	9.4	0.2	0.4	5.7	10.6	3.5	4.8	4.6	3.6	8.4	4.3	4.4	1.4	4.0	0.4	1.2	0.2	58.7	7.1	2.4	8.0	5.3	0.5	2.3	7.4	0.3	0.6	0.3	0.2	4.4	1.4	13.5	0.9	10.3	21.4	6.4	1.2	9.7	10.5	10.7	6.1	1.0	1.1	8.5	7.0	6.8	6.9	3.6	10.8	6.1	3.2	5.8	14.9	4.5	5.6	17.9	5.9	4.7	4.5	8.1	3.3	3.5	2.6	7.7	0.7	7.2	0.0	1.6	0.1	0.1	1.6	2.0	0.0	0.3	14.1	0.7	8.7	1.0	0.8	1.1	1.3	1.9	1.2	3.4	1.6	0.8	2.2	1.2	2.1	2.9
MXI1	"bHLHc11, MAD2, MXD2, MXI"	ENSG00000119950	"MAX interactor 1, dimerization protein"	P50539	10	110207605-110287365	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 29.5;SK-MEL-30: 53.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035319, HPA035320, HPA056762"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA035319: AB_10670588, HPA035320: , HPA056762: "	"unprognostic (1.77e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.26e-3)"	"prognostic unfavourable (9.17e-4)"	"prognostic unfavourable (1.02e-5)"	"unprognostic (3.05e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.96e-1)"	16.9	19.4	37.2	7.5	34.9	32.7	26.5	56.4	36.9	20.3	26.4	33.9	20.1	12.0	26.0	23.8	39.5	19.1	17.4	36.0	35.1	26.6	23.9	30.5	16.5	7.1	37.0	25.9	46.4	23.1	25.6	12.1	14.4	26.2	24.5	22.1	15.8	41.2	32.7	22.8	25.4	22.5	18.2	44.7	7.8	14.7	13.5	38.1	7.0	29.2	13.4	9.8	32.8	33.9	4.5	2.2	11.0	4.7	1.4	8.6	2.3	5.5	2.2	5.7	11.4	9.0	6.8	2.5	3.2	11.0	2.1	6.8	1.0	10.0	7.3	5.2	5.6	7.2	6.8	7.7	5.7	3.7	9.2	1.9	4.5	4.1	5.9	3.9	4.4	7.2	29.5	3.7	15.0	2.1	7.3	15.9	3.5	3.6	2.6	7.9	2.4	6.8	1.6	7.5	11.6	7.5	0.5	9.7	15.9	3.2	2.4	53.2	2.7	12.7	2.1	3.8	6.5	4.0	1.7	13.2	6.9	2.6	10.1	14.5	4.0	2.2	3.1	11.0	3.1	2.5	5.8	3.9	6.7	3.6	1.7	4.5	8.6	2.2	7.8	1.4	4.7	2.2	5.0	2.3	37.2	34.9	56.4	36.9	35.1	26.6	37.0	25.9	26.2	38.1
MXRA8	DKFZp586E2023	ENSG00000162576	"Matrix remodeling associated 8"	Q9BRK3	1	1352689-1361777	"Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 16.4;BJ: 49.0;BJ hTERT+: 23.0;fHDF/TERT166: 24.3;HSkMC: 19.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"naive CD8 T-cell: 9.8"	"Lineage enriched"	"Detected in single"	98	"T-cells: 9.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053958, HPA055780"	Uncertain		Approved	Nucleoli			450000	Nucleoli		"HPA053958: , HPA055780: "	"unprognostic (1.39e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.94e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.38e-2)"	"unprognostic (2.97e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavourable (3.43e-6)"	"prognostic unfavourable (9.93e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavourable (9.87e-4)"	45.6	5.3	2.3	11.4	4.6	1.1	25.2	3.9	3.8	34.8	14.3	4.8	6.2	6.5	34.0	16.3	13.7	14.4	20.5	12.7	3.6	1.1	7.6	3.5	13.4	5.6	2.6	2.6	30.4	3.7	1.6	6.0	25.0	5.4	23.4	2.3	36.6	8.4	12.3	15.5	10.9	8.6	22.0	4.5	9.5	8.7	16.4	2.9	0.3	13.9	11.8	4.5	22.3	17.8	0.0	0.0	0.0	0.0	0.0	9.8	0.3	1.3	0.3	0.4	0.3	5.9	16.4	14.8	49.0	23.0	5.8	6.9	2.6	1.1	0.5	0.2	24.3	1.0	0.3	0.0	1.1	1.0	0.4	0.4	0.8	4.1	15.4	0.0	0.5	19.5	0.0	2.1	0.0	0.0	5.7	0.4	7.3	0.1	0.1	0.1	4.8	1.6	0.2	0.1	0.1	0.0	0.2	1.1	3.1	0.1	0.4	0.0	3.8	0.2	0.4	0.2	8.2	7.6	0.1	1.1	0.1	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.3	9.8	0.0	0.0	0.0	0.0	0.0	0.3	2.3	4.6	3.9	2.7	3.6	1.1	2.6	2.6	5.4	2.9
MYBBP1A	"FLJ37886, P160, PAP2, Pol5"	ENSG00000132382	"MYB binding protein 1a"	Q9BQG0	17	4538897-4555631	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Ribosome biogenesis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005466	Supported		Supported	Nucleoli,Vesicles				Nucleoli	Vesicles	"HPA005466: AB_2667327"	"unprognostic (8.06e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.01e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.22e-1)"	"prognostic unfavourable (8.47e-4)"	"unprognostic (1.84e-1)"	"prognostic favourable (1.61e-4)"	"unprognostic (3.88e-3)"	"prognostic unfavourable (5.95e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavourable (8.12e-4)"	"unprognostic (9.70e-2)"	14.1	11.6	13.8	16.5	14.6	13.2	16.2	15.0	21.5	11.3	10.2	14.9	11.1	12.9	15.4	11.7	17.1	15.8	12.4	11.5	11.7	9.2	8.7	21.5	11.6	16.0	15.2	11.1	15.3	23.7	10.5	13.1	7.2	13.0	17.0	7.2	12.7	24.5	15.3	30.8	25.0	12.8	10.9	7.3	15.0	12.9	9.3	12.6	14.6	11.7	18.2	17.6	15.4	13.2	5.3	4.9	0.4	4.9	4.3	5.9	3.8	19.4	31.2	4.1	18.8	5.3	6.2	14.0	13.5	6.0	13.7	10.6	23.0	8.0	26.6	15.8	8.0	24.7	17.0	20.4	6.4	13.3	45.8	12.8	19.3	20.3	8.5	15.0	11.7	9.0	11.7	20.1	10.0	9.1	20.9	12.3	5.8	16.9	17.5	5.9	18.8	16.3	22.7	6.9	17.6	3.2	15.7	8.7	16.7	13.8	9.7	9.1	9.3	6.1	11.7	11.9	10.7	11.1	38.7	11.1	7.5	10.8	11.3	17.6	15.2	0.0	2.8	0.4	5.1	2.7	5.9	5.3	4.2	5.5	4.9	3.3	4.5	4.6	0.1	4.3	4.9	3.5	1.8	3.8	13.8	14.6	15.0	21.5	11.7	9.2	15.2	11.1	13.0	12.6
MYBPH		ENSG00000133055	"Myosin binding protein H"	Q13203	1	203167811-203175813	"Predicted intracellular proteins"	"Cell adhesion"	"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 53.8"	"Group enriched"	"Detected in some"	5	"CACO-2: 17.2;HSkMC: 33.7;THP-1: 8.4"	"Group enriched"	"Detected in many"	7	"glioma: 4.9;head and neck cancer: 20.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	6	"plasmacytoid DC: 6.1"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 6.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA061383	Enhanced		Approved	Nucleoplasm,Nucleoli,Mitochondria				"Nucleoplasm, Mitochondria"	Nucleoli	"HPA061383: "	"unprognostic (2.26e-4)"	"unprognostic (2.04e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.42e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.75e-1)"	"unprognostic (7.62e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.74e-1)"	0.8	0.1	1.1	0.8	0.8	0.3	0.4	0.4	0.6	0.1	0.1	0.0	0.0	0.1	0.4	4.4	3.9	0.2	0.1	0.2	0.4	0.3	1.1	1.5	0.2	0.3	1.3	0.0	0.1	0.2	0.1	0.6	0.3	1.0	4.2	0.1	0.0	8.8	0.1	53.8	0.2	0.1	0.1	0.4	0.4	0.1	0.2	2.1	0.9	3.9	12.7	2.0	0.3	0.8	0.0	6.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	4.3	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	33.7	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.5	0.0	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	6.1	0.0	0.1	1.1	0.8	0.4	0.6	0.4	0.3	1.3	0.0	1.0	2.1
MYCN	"bHLHe37, MYCNOT, N-myc, NMYC"	ENSG00000134323	"MYCN proto-oncogene, bHLH transcription factor"	P04198	2	15940564-15947007	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 16.8"	"Cell line enhanced"	"Detected in some"		"AF22: 12.7;BEWO: 68.9;HMC-1: 16.6;NTERA-2: 26.1;RH-30: 18.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 45.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA057420			Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA057420: "	"unprognostic (8.04e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.07e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.35e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.12e-3)"	"unprognostic (8.89e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.23e-1)"	0.9	1.9	5.1	1.8	5.5	1.6	1.2	1.4	8.4	3.1	1.2	12.1	0.0	3.0	1.9	0.8	1.3	1.4	2.6	2.3	7.0	4.7	6.0	1.5	1.6	2.9	6.0	2.2	10.3	0.7	0.4	0.7	16.8	6.8	0.6	1.3	1.1	6.6	0.7	1.0	2.4	1.7	0.9	8.9	0.9	8.5	6.5	4.0	5.7	5.1	2.3	3.5	2.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	68.9	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	26.1	0.0	0.0	18.2	3.5	0.0	0.8	0.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	5.5	1.4	7.0	7.0	4.7	6.0	2.2	6.8	4.0
MYL3	"CMH8, MLC1SB, MLC1V, VLC1"	ENSG00000160808	"Myosin light chain 3"	P08590	3	46857872-46882169	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"heart muscle: 398.1;skeletal muscle: 319.8"	"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 27.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 8.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA016564, CAB018662, HPA046859, HPA063034"	Enhanced		Approved	Nucleoli,Mitochondria			15000000	"Nucleoli, Mitochondria"		"CAB018662: AB_627952, HPA016564: AB_1854244, HPA046859: , HPA063034: "	"unprognostic (3.11e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.44e-2)"	"unprognostic (9.67e-3)"	"unprognostic (3.37e-2)"	"unprognostic (4.72e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.88e-2)"	"prognostic favourable (1.22e-8)"	"unprognostic (1.16e-3)"	"unprognostic (9.45e-3)"	"unprognostic (7.18e-5)"	"unprognostic (2.53e-3)"	0.9	0.2	0.5	0.2	0.4	0.0	0.6	0.2	0.4	0.5	0.1	0.3	0.0	0.0	0.2	10.1	10.5	0.1	0.2	398.1	0.7	0.4	2.3	0.1	0.2	0.1	0.7	0.3	0.3	0.1	0.0	0.0	0.3	0.3	1.6	0.0	0.3	5.5	0.0	319.8	0.1	0.0	0.1	0.8	0.4	0.0	0.1	0.4	0.0	1.1	30.1	3.1	0.2	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.9	1.6	0.3	0.1	0.0	0.1	5.8	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	27.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.2	0.4	0.7	0.4	0.7	0.3	0.3	0.4
MYL5		ENSG00000215375	"Myosin light chain 5"	Q02045	4	673580-682033	"Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 61.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			"HPA037381, HPA039262"	Uncertain		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA037381: AB_10672484, HPA039262: "	"unprognostic (6.30e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.77e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.91e-2)"	9.9	11.4	14.5	10.1	12.7	8.5	12.6	13.4	14.6	6.1	10.9	14.7	14.6	18.0	7.1	19.5	10.6	7.1	8.0	4.9	13.9	11.4	9.7	11.3	7.8	19.5	10.8	10.0	7.5	15.4	13.2	7.7	5.3	10.5	9.8	11.8	10.0	61.5	10.7	18.6	16.2	15.4	10.1	9.3	8.8	7.3	15.5	3.9	7.5	7.5	24.2	9.9	6.5	6.9	11.0	12.6	8.2	9.5	15.4	6.5	4.5	2.2	3.6	13.3	7.0	33.2	22.9	6.4	5.3	7.2	5.5	5.0	4.4	9.3	2.5	2.6	8.7	3.2	2.1	3.7	1.6	4.7	2.6	3.8	5.0	4.1	11.6	5.8	3.5	17.2	3.5	4.3	4.6	3.3	3.9	3.5	6.7	4.1	3.1	4.0	2.8	5.5	2.8	2.8	1.5	9.0	10.4	6.1	3.4	1.8	4.5	3.6	7.3	5.3	5.4	4.7	0.9	4.0	3.1	13.3	2.6	1.5	5.2	5.2	2.4	8.2	7.4	1.1	3.1	4.7	3.9	7.9	5.1	1.8	6.6	11.0	6.5	6.3	5.0	15.4	9.5	12.6	2.3	4.5	14.5	12.7	13.4	14.6	13.9	11.4	10.8	10.0	10.5	3.9
MYLK4	SgK085	ENSG00000145949	"Myosin light chain kinase family member 4"	Q86YV6	6	2663629-2750966	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	17	"skeletal muscle: 23.6;tongue: 63.6"	"Cell line enriched"	"Detected in some"	6	"HEL: 12.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA015860	Uncertain		Approved	"Nucleoli,Golgi apparatus,Vesicles"				"Golgi apparatus"	"Nucleoli, Vesicles"	"HPA015860: AB_2147922"	"unprognostic (1.75e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.99e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.63e-2)"	0.5	0.3	0.3	0.3	0.4	0.4	0.8	1.4	0.7	0.3	0.3	0.3	0.3	0.1	0.3	0.5	1.0	0.2	0.3	1.0	0.5	0.5	2.6	0.3	0.5	0.3	0.4	0.3	0.3	1.1	0.7	0.7	0.4	0.4	0.4	0.1	0.4	2.4	0.4	23.6	0.8	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	1.0	63.6	1.5	0.5	0.3	0.1	0.8	0.3	0.3	0.9	1.4	0.1	0.3	0.1	0.6	1.1	1.0	1.2	0.6	0.7	1.5	0.5	0.4	0.5	1.0	1.0	1.6	0.8	1.9	0.2	0.4	0.7	0.2	0.6	12.4	0.6	0.1	0.3	0.3	0.6	1.5	0.5	0.1	1.2	0.5	0.1	0.1	0.3	0.5	0.1	1.3	0.2	0.0	0.9	0.0	0.0	0.8	0.3	1.0	0.6	0.3	0.2	0.5	0.4	0.8	0.7	0.5	0.1	0.2	0.4	0.4	0.2	0.1	0.2	0.3	1.2	0.1	0.1	0.1	0.5	0.0	0.3	0.1	0.2	1.4	0.2	0.1	0.6	0.1	0.3	0.9	0.3	0.8	0.1	0.1	0.3	0.4	1.4	0.7	0.5	0.5	0.4	0.3	0.4	0.3
MYO10	KIAA0799	ENSG00000145555	"Myosin X"	Q9HD67	5	16661914-16936276	"Plasma proteins, Predicted intracellular proteins"	Transport	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HAP1: 38.8;SK-MEL-30: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 6.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015224, HPA024223"	Enhanced		Supported	"Nucleoli,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoli	"CAB015224: , HPA024223: AB_1854248"	"unprognostic (1.13e-2)"	"prognostic unfavourable (4.35e-4)"	"unprognostic (7.63e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.96e-2)"	"unprognostic (4.40e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.16e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.85e-1)"	"prognostic favourable (2.75e-4)"	"unprognostic (8.93e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.84e-1)"	10.5	3.4	28.1	5.1	30.1	3.0	8.0	8.9	39.7	6.3	15.3	17.3	6.6	19.5	5.7	4.3	7.7	3.8	7.7	3.7	26.2	10.9	13.3	7.1	14.5	1.6	14.6	15.3	12.1	22.0	10.4	16.2	22.0	10.6	5.4	15.8	19.7	9.8	7.4	6.6	13.4	14.6	4.3	11.1	10.9	24.2	12.4	18.5	0.5	28.6	3.3	2.3	6.6	7.1	0.9	0.5	1.1	6.0	0.5	0.6	0.3	13.1	20.9	8.7	4.1	6.4	3.5	8.0	23.6	16.7	6.6	5.4	13.2	2.2	0.4	16.2	10.7	7.0	38.8	15.5	12.3	0.0	3.9	0.0	34.9	3.7	23.6	0.1	0.4	7.1	6.8	15.9	19.0	22.0	0.0	1.3	6.4	2.6	0.0	0.1	22.5	7.6	5.3	2.2	13.9	6.6	10.2	1.1	0.6	5.1	2.6	45.3	1.7	2.1	26.6	16.0	5.9	0.2	12.9	0.2	0.1	0.1	7.9	2.5	15.9	1.0	0.6	0.5	0.3	1.5	0.4	0.3	0.4	0.3	0.5	0.9	0.6	0.6	1.1	0.5	6.0	0.4	0.3	0.3	28.1	30.1	8.9	20.7	26.2	10.9	14.6	15.3	10.6	18.5
MYRFL	"bcm1377, C12orf15, C12orf28, FLJ25056"	ENSG00000166268	"Myelin regulatory factor-like"	Q96LU7	12	69825304-69959097	"Predicted intracellular proteins, Predicted membrane proteins"		DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	15	"intestine: 56.1"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 6.8;SK-BR-3: 3.4;T-47d: 15.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"cerebellum: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA049340	Approved		Approved	Nucleoli	"Intracellular and membrane"			Nucleoli		"HPA049340: AB_2680719"	"unprognostic (2.95e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.45e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.08e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.96e-2)"	0.3	0.3	0.5	0.0	0.6	0.0	0.5	3.6	0.6	0.1	20.7	0.0	0.4	21.4	0.1	0.9	0.1	0.1	0.7	0.2	0.4	0.2	2.0	0.3	0.2	0.2	0.5	0.2	0.0	0.8	0.0	1.0	0.3	0.7	0.6	0.1	0.3	1.3	0.4	0.0	1.6	56.1	0.1	1.0	0.1	0.1	2.4	0.5	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.7	0.0	0.9	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	6.8	0.0	0.1	0.0	1.1	1.0	0.0	0.3	0.1	0.0	3.4	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.4	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	3.6	0.6	0.4	0.2	0.5	0.2	0.7	0.5
NAA10	"ARD1, ARD1A, DXS707, TE2"	ENSG00000102030	"N(alpha)-acetyltransferase 10, NatA catalytic subunit"	P41227	X	153929242-153935223	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006269, HPA030711"	Supported		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"CAB006269: AB_425759, HPA030711: "	"unprognostic (7.57e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.01e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavourable (3.29e-8)"	"unprognostic (1.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.29e-2)"	"unprognostic (7.48e-3)"	18.9	21.2	17.7	20.3	14.0	12.5	31.8	15.5	20.8	12.4	15.3	8.1	19.2	16.7	17.2	17.6	19.7	16.5	17.6	26.4	15.0	14.2	16.3	18.6	20.7	30.0	15.0	18.0	14.1	33.3	12.3	12.0	13.7	17.5	13.6	11.7	9.3	19.0	17.9	57.8	14.1	14.7	21.7	14.7	14.9	17.7	7.1	11.8	11.4	12.2	25.3	16.3	17.1	22.1	33.7	34.8	35.0	31.9	27.6	44.8	29.0	31.8	33.6	6.3	20.6	9.1	9.5	18.0	11.2	6.6	15.3	13.5	21.8	10.1	24.2	37.4	9.3	15.3	13.3	13.5	6.0	10.1	61.9	8.7	23.5	21.9	12.4	16.9	19.3	7.2	15.2	14.3	14.8	17.3	17.4	10.3	10.1	41.9	27.0	25.3	10.6	46.6	21.5	16.4	26.6	11.2	14.7	13.6	16.4	4.4	17.7	26.5	9.5	14.1	10.0	6.4	22.1	22.3	34.0	21.8	24.3	45.5	8.7	21.9	18.7	12.0	24.2	35.0	29.0	28.0	38.0	33.7	31.2	31.7	31.6	32.6	18.7	28.0	22.6	27.6	31.9	34.8	44.8	29.0	17.7	14.0	15.5	20.8	15.0	14.2	15.0	18.0	17.5	11.8
NACC2	"BEND9, BTBD14A, BTBD31, MGC23427"	ENSG00000148411	"NACC family member 2"	Q96BF6	9	136006537-136095285	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 25.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047924, HPA052962"	Approved		Approved	Nucleoli,Mitochondria				"Nucleoli, Mitochondria"		"HPA047924: , HPA052962: "	"unprognostic (1.13e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.90e-2)"	"unprognostic (8.73e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.23e-1)"	"prognostic favourable (8.28e-5)"	"prognostic favourable (8.63e-4)"	"unprognostic (1.71e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.12e-2)"	15.3	9.0	27.4	10.9	26.3	2.7	12.8	16.3	37.3	10.0	15.5	14.5	11.7	8.3	11.4	6.9	11.6	10.1	16.6	16.8	20.7	16.7	8.0	15.2	8.3	7.6	30.3	6.4	10.3	10.0	6.2	3.8	3.9	15.2	12.7	5.5	10.2	9.9	23.8	12.6	5.8	9.5	31.7	33.4	7.8	8.2	7.8	11.0	0.0	5.8	4.7	3.1	21.8	4.6	0.0	2.4	5.7	4.5	0.5	1.7	1.4	3.0	17.0	1.9	25.9	8.4	4.7	2.4	7.6	5.1	2.5	0.8	7.2	5.6	0.0	9.2	12.0	12.2	4.1	4.1	0.8	9.4	3.7	2.1	16.4	9.0	8.6	0.0	3.9	7.9	3.8	2.3	2.3	6.8	6.4	0.0	4.7	10.5	0.0	5.9	5.8	10.6	0.0	2.0	5.1	10.2	3.6	0.6	0.8	10.7	9.0	9.3	9.2	19.5	11.2	6.6	7.5	5.6	5.2	0.0	0.0	0.1	8.7	0.7	13.2	2.8	4.5	1.5	1.7	3.6	0.7	0.0	0.6	1.5	2.4	0.0	0.5	0.6	5.7	0.5	3.4	0.3	0.4	1.4	27.4	26.3	16.3	17.7	20.7	16.7	30.3	6.4	15.2	11.0
NARF	"DKFZp434G0420, FLJ10067, IOP2"	ENSG00000141562	"Nuclear prelamin A recognition factor"	Q9UHQ1	17	82458180-82490537	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053006			Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA053006: "	"unprognostic (1.84e-1)"	"prognostic favourable (1.15e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.14e-1)"	"unprognostic (6.52e-2)"	"unprognostic (6.62e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.42e-3)"	"unprognostic (3.80e-3)"	"prognostic unfavourable (1.48e-10)"	"unprognostic (3.57e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.83e-2)"	13.7	10.6	21.2	15.7	20.2	35.0	17.4	24.2	23.5	8.2	13.1	10.1	11.1	13.8	9.5	11.0	13.1	11.2	10.6	28.5	15.7	12.3	10.1	21.3	11.8	15.1	16.4	15.0	11.2	13.8	9.0	11.9	10.2	16.3	10.9	9.0	14.7	13.6	12.0	44.4	15.4	11.0	9.8	10.6	17.7	13.6	35.4	18.1	12.4	11.7	11.2	11.5	11.7	12.4	11.6	10.1	50.6	10.6	15.9	13.6	11.5	8.5	8.1	13.8	21.7	6.5	6.4	7.8	5.1	5.4	8.9	9.1	9.3	3.1	5.5	5.8	4.1	7.7	10.1	6.5	6.1	5.8	22.4	11.6	11.6	11.5	5.8	11.8	20.6	9.6	10.8	7.0	2.4	16.7	26.3	4.1	3.9	7.4	20.6	19.1	5.8	17.6	17.2	14.0	8.8	4.2	8.9	16.8	23.9	13.5	9.1	15.7	7.8	9.7	8.3	11.5	9.8	9.4	8.7	38.0	14.4	12.2	10.5	8.3	6.8	24.4	10.6	29.5	11.6	9.4	12.7	11.6	11.4	11.2	10.1	11.0	13.1	10.9	50.6	15.9	7.0	8.3	13.6	11.5	21.2	20.2	24.2	23.5	15.7	12.3	16.4	15.0	16.3	18.1
NAT10	"FLJ10774, FLJ12179, hALP, KIAA1709, Kre33, NET43"	ENSG00000135372	"N-acetyltransferase 10"	Q9H0A0	11	34105602-34147670	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB035546, HPA057576, HPA071628"	Approved		Enhanced	Nucleoli,Midbody				Nucleoli	Midbody	"CAB035546: , HPA057576: , HPA071628: "	"unprognostic (3.04e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavourable (1.07e-4)"	"prognostic unfavourable (9.61e-8)"	"unprognostic (1.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavourable (8.83e-5)"	"unprognostic (1.24e-1)"	"unprognostic (7.18e-2)"	"unprognostic (9.55e-2)"	"unprognostic (8.69e-2)"	18.5	22.8	20.5	21.9	27.5	23.6	20.8	21.9	29.9	18.1	17.6	24.3	16.4	13.7	30.6	19.8	25.2	21.7	14.7	16.4	17.2	18.6	15.9	21.8	15.1	28.7	16.9	19.8	26.4	24.9	31.5	23.1	20.1	23.4	19.5	21.7	23.0	22.5	17.8	23.4	31.0	16.6	21.5	15.1	23.6	18.0	30.9	16.9	31.2	18.3	19.4	35.3	17.8	19.7	10.4	12.8	2.2	11.1	11.8	13.7	6.9	12.2	17.3	9.3	19.7	11.2	10.0	10.8	12.2	9.0	15.5	12.4	19.4	7.1	39.4	9.1	10.3	18.7	34.9	18.6	19.9	10.9	22.4	17.9	14.2	18.1	10.2	44.7	13.0	10.1	12.8	10.1	28.6	11.8	38.9	13.8	12.9	23.3	36.4	20.3	13.3	20.9	27.4	31.5	16.4	8.9	21.5	13.8	10.5	16.4	17.5	7.3	17.5	12.3	9.5	13.9	11.0	20.3	22.6	15.1	18.1	37.6	14.0	18.6	13.7	0.5	6.6	2.2	10.3	11.1	13.7	10.4	11.1	11.7	12.8	9.6	11.5	11.2	0.8	11.8	9.7	9.7	9.6	6.9	20.5	27.5	21.9	29.9	17.2	18.6	16.9	19.8	23.4	16.9
NBAS	NAG	ENSG00000151779	"Neuroblastoma amplified sequence"	A2RRP1	2	15166909-15561330	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036817	Approved		Approved	"Nuclear membrane,Nucleoli,Golgi apparatus"				"Golgi apparatus"	"Nuclear membrane, Nucleoli"	"HPA036817: AB_10670925"	"unprognostic (1.72e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavourable (1.10e-4)"	"unprognostic (3.80e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.65e-1)"	"prognostic unfavourable (5.84e-5)"	16.8	18.1	23.2	16.3	30.9	21.9	22.5	21.5	28.3	21.9	17.1	20.6	17.4	13.3	27.1	23.4	14.1	18.7	13.5	21.6	20.9	21.5	19.1	16.9	15.4	16.3	19.3	20.8	24.1	28.6	34.1	35.5	16.2	24.9	16.9	17.7	16.8	22.9	19.0	26.5	23.4	20.5	21.0	18.1	18.1	19.0	31.4	16.7	23.8	20.1	14.6	20.0	14.4	15.2	5.3	6.0	3.2	8.7	9.4	9.9	3.6	5.4	7.2	8.0	5.5	20.9	23.0	8.2	10.1	11.1	7.9	8.0	7.2	7.9	7.0	2.3	15.3	6.6	8.6	12.7	9.4	6.9	5.5	26.6	6.4	20.1	21.5	6.9	13.6	15.1	10.1	10.4	17.5	16.2	20.6	8.0	12.0	6.7	5.7	15.5	6.9	6.9	6.0	14.0	8.3	16.3	7.4	4.7	7.7	8.6	7.1	12.7	5.0	6.3	14.0	10.0	6.2	7.1	7.3	12.0	10.2	9.9	17.8	8.1	8.9	1.4	5.7	3.2	7.6	3.9	9.5	5.3	5.9	9.9	5.2	5.1	5.9	6.1	1.0	9.4	8.7	6.0	6.9	3.6	23.2	30.9	21.5	28.3	20.9	21.5	19.3	20.8	24.9	16.7
NBEA	"BCL8B, FLJ10197, KIAA1544, LYST2"	ENSG00000172915	Neurobeachin	Q8NFP9	13	34942287-35673022	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	4	"SH-SY5Y: 41.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039730, HPA040385"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Nucleoli, Cytosol"	"HPA039730: AB_10794202, HPA040385: AB_10795523"	"unprognostic (1.80e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.89e-4)"	"unprognostic (3.59e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.75e-2)"	"unprognostic (6.95e-3)"	"unprognostic (5.01e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.45e-1)"	"prognostic favourable (7.86e-8)"	"unprognostic (2.28e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.46e-2)"	3.9	11.9	12.2	2.7	20.6	1.0	8.2	32.6	28.5	7.4	9.8	3.9	10.9	2.7	10.3	6.2	6.2	9.4	5.4	11.7	13.5	10.6	6.6	1.7	3.6	2.6	6.9	22.2	10.4	5.7	9.3	25.0	1.5	14.2	11.9	4.8	13.3	7.0	14.2	8.5	2.0	3.8	11.4	4.7	5.1	4.8	7.7	6.0	6.1	9.6	0.7	2.4	7.1	6.4	1.1	1.3	0.0	0.5	0.4	1.4	0.1	0.0	2.3	5.4	3.0	0.4	0.0	0.1	3.4	5.3	4.0	3.3	0.0	0.5	1.4	0.0	5.8	0.1	1.8	0.7	8.5	0.7	1.8	0.0	1.6	0.5	0.3	0.9	2.2	0.9	0.6	0.0	0.4	0.7	0.0	9.7	0.5	1.0	0.5	0.0	2.3	0.9	0.6	2.3	0.4	4.6	1.0	3.1	41.2	2.5	0.0	1.7	0.9	0.2	0.0	1.0	0.6	0.0	0.7	0.9	0.2	0.7	2.6	0.3	2.1	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.1	0.2	0.0	1.1	1.4	1.3	0.0	0.4	0.0	1.3	0.0	0.1	12.2	20.6	32.6	18.4	13.5	10.6	6.9	22.2	14.2	6.0
NCAPD2	"CAP-D2, CNAP1, hCAP-D2, KIAA0159"	ENSG00000010292	"Non-SMC condensin I complex subunit D2"	Q15021	12	6493356-6531955	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"lymphoid tissue: 84.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012423, HPA036947, HPA037363"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				Cytosol	"Nucleoplasm, Nucleoli"	"CAB012423: , HPA036947: AB_10671367, HPA037363: AB_10672483"	"unprognostic (1.51e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.84e-2)"	"prognostic unfavourable (1.79e-8)"	"unprognostic (2.73e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.41e-3)"	"unprognostic (4.53e-1)"	"prognostic unfavourable (1.13e-7)"	"unprognostic (4.80e-3)"	"unprognostic (1.18e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.75e-2)"	6.8	8.8	6.5	24.6	12.7	16.7	7.7	7.7	9.0	8.0	11.3	16.2	7.0	10.6	11.5	8.8	17.7	8.1	6.5	6.2	7.5	5.4	7.0	5.1	7.7	20.4	16.5	6.2	7.7	7.2	9.6	6.3	13.9	8.7	8.2	12.4	8.1	10.5	8.3	7.0	14.8	13.0	8.2	12.7	16.4	9.9	17.2	11.4	84.1	11.4	12.4	24.3	10.9	9.5	5.0	4.8	7.2	2.8	7.8	7.4	3.2	21.9	20.4	21.9	15.8	5.7	6.0	25.6	15.1	12.2	24.6	19.9	18.3	23.3	23.1	4.5	9.9	19.4	36.0	17.7	47.0	41.8	20.2	21.1	23.3	10.4	2.4	26.2	15.3	3.8	6.6	19.2	19.6	16.2	13.4	9.4	21.7	10.9	29.6	17.2	34.2	15.9	25.3	49.8	12.2	8.2	12.3	9.0	9.5	22.6	10.7	8.1	4.7	16.5	10.1	16.2	26.6	10.9	29.4	7.4	9.9	32.9	9.5	15.2	20.0	7.2	2.0	3.6	6.3	2.8	5.6	5.0	6.2	7.3	3.0	3.8	7.4	7.2	1.9	7.8	1.9	4.8	7.2	3.2	6.5	12.7	7.7	9.0	7.5	5.4	16.5	6.2	8.7	11.4
NCF2	"NOXA2, p67phox"	ENSG00000116701	"Neutrophil cytosolic factor 2"	P19878	1	183555563-183590876	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Chronic granulomatous disease, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 125.2;bone marrow: 53.0;lung: 39.5;lymphoid tissue: 45.4"	"Cell line enhanced"	"Detected in many"		"A-431: 13.1;HMC-1: 11.4;hTERT-HME1: 27.4;U-2 OS: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 125.2;neutrophil: 80.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002327, HPA006040, CAB022160"	Enhanced		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"CAB022160: , HPA002327: AB_1079550, HPA006040: AB_1854906"	"unprognostic (4.97e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.22e-3)"	"unprognostic (5.83e-3)"	"unprognostic (4.04e-2)"	"prognostic unfavourable (7.91e-6)"	"unprognostic (1.29e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.36e-2)"	15.3	3.1	2.0	23.0	4.5	53.0	3.9	0.7	2.8	2.9	2.8	3.7	0.2	2.3	1.8	6.1	4.1	5.2	7.2	6.4	2.0	1.8	2.9	5.4	39.5	42.7	6.8	0.4	3.5	4.2	0.6	1.9	11.5	3.8	3.4	3.7	4.2	4.4	0.8	3.5	7.1	3.8	5.8	5.5	45.4	2.6	3.9	3.2	4.2	2.0	5.6	5.5	7.3	3.5	1.4	24.3	125.2	45.7	0.2	1.0	22.7	13.1	0.4	0.0	0.0	0.0	0.0	0.1	1.0	1.2	1.8	0.8	0.1	0.4	1.6	2.3	0.4	7.4	0.0	9.7	1.6	8.2	0.0	0.0	3.3	3.0	0.0	1.0	11.4	0.0	2.1	1.7	27.4	0.0	0.0	2.9	3.0	0.1	0.1	0.5	0.2	0.7	3.5	1.1	9.9	0.4	0.1	0.0	0.0	0.1	0.0	0.4	1.4	4.6	0.6	0.0	26.6	0.0	2.4	0.5	0.7	0.2	0.2	5.2	0.0	15.5	45.7	125.2	0.1	34.4	0.1	1.4	0.4	0.1	24.3	0.8	0.2	0.1	80.6	0.2	29.7	1.3	1.0	22.7	2.0	4.5	0.7	2.8	2.0	1.8	6.8	0.4	3.8	3.2
NCKAP5	"ERIH1, ERIH2, NAP5"	ENSG00000176771	"NCK associated protein 5"	O14513	2	132671799-133568463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 18.3;lung: 19.2"	"Cell line enriched"	"Detected in some"	6	"AF22: 31.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"basophil: 3.1"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 3.1"	"Low region specificity"	"Detected in all"							"HPA034639, HPA044859"	Uncertain		Approved	"Nucleoli,Golgi apparatus,Plasma membrane,Cytosol"				Nucleoli	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA034639: AB_10669678, HPA044859: "	"unprognostic (2.54e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.13e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.06e-11)"	"unprognostic (4.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.03e-1)"	3.6	2.0	6.6	1.5	6.3	0.2	5.4	5.2	5.6	3.1	5.8	6.2	0.9	3.8	3.6	6.2	6.9	1.0	1.5	4.6	6.0	3.9	16.3	6.7	19.2	2.2	6.6	4.7	4.5	1.8	2.2	1.3	4.6	4.2	1.6	1.9	7.5	7.8	1.0	1.1	3.7	18.3	1.0	6.3	2.9	3.0	2.1	6.6	0.3	2.1	5.4	2.3	1.3	3.1	0.0	0.3	3.1	0.0	0.0	0.0	0.0	0.0	1.5	31.7	0.0	0.0	0.3	0.1	0.5	5.6	0.5	0.5	0.0	0.0	2.4	0.0	0.3	0.1	0.2	0.4	1.8	0.0	0.2	0.0	4.7	0.0	0.0	0.0	0.0	0.3	2.6	3.0	0.4	0.5	0.0	0.0	0.9	0.3	0.0	0.0	0.7	1.0	0.3	0.0	1.2	0.7	0.7	0.1	1.0	0.0	1.1	1.6	0.5	0.0	1.6	0.2	0.2	4.6	0.0	0.1	0.0	0.9	0.3	0.0	0.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	6.3	5.2	5.6	6.0	3.9	6.6	4.7	4.2	6.6
NCL	"C23, Nsr1"	ENSG00000115053	Nucleolin	P19338	2	231453531-231483641	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004210, HPA023981, HPA071110"	Supported		Enhanced	Nucleoplasm,Nucleoli			600000	"Nucleoplasm, Nucleoli"		"CAB004210: AB_670270, HPA023981: AB_1854688, HPA071110: "	"unprognostic (1.91e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (2.28e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.72e-3)"	"prognostic unfavourable (1.41e-6)"	"unprognostic (3.74e-2)"	"unprognostic (4.31e-3)"	"unprognostic (9.78e-2)"	"unprognostic (6.70e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.42e-2)"	71.2	68.2	59.6	67.7	77.0	96.6	71.0	72.8	69.2	72.1	63.0	79.2	46.0	48.1	80.3	63.7	85.2	65.7	45.9	55.9	57.7	53.3	66.7	94.7	55.6	78.4	67.4	51.8	93.9	77.5	94.8	83.4	69.5	79.8	64.6	75.4	47.1	58.1	51.8	120.6	70.3	56.9	70.9	88.4	80.2	59.4	41.7	76.4	118.9	67.8	82.6	105.5	79.9	60.6	40.8	41.3	20.4	36.4	52.6	53.9	40.8	62.2	58.2	70.7	51.7	41.7	45.4	72.7	70.5	47.8	66.5	58.9	96.1	44.8	82.8	60.7	54.3	61.1	141.3	94.6	114.1	48.3	59.3	138.0	55.3	129.6	45.8	157.2	52.3	43.0	54.9	83.0	87.5	69.7	122.9	28.4	58.5	84.6	137.7	97.6	105.2	41.8	102.8	127.4	72.6	48.8	82.7	61.2	43.7	47.1	54.1	62.2	40.7	79.7	59.2	53.3	55.2	62.3	92.5	53.8	52.8	178.1	38.8	102.7	55.2	9.5	27.9	20.4	47.4	33.2	53.9	40.8	41.7	42.6	41.3	38.9	46.6	42.1	6.0	52.6	36.4	35.5	34.4	40.8	59.6	77.0	72.8	69.2	57.7	53.3	67.4	51.8	79.8	76.4
NCOA4	"ARA70, DKFZp762E1112, ELE1, PTC3, RFG"	ENSG00000266412	"Nuclear receptor coactivator 4"	Q13772	10	46005088-46030714	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 100.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 30.2;granulocytes: 100.1;monocytes: 40.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051260, HPA065208"	Uncertain		Approved	"Nucleoli,Golgi apparatus,Cytosol"				Nucleoli	"Golgi apparatus, Cytosol"	"HPA051260: , HPA065208: "	"unprognostic (4.23e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.82e-1)"	"prognostic favourable (3.26e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.80e-1)"	"unprognostic (9.34e-2)"	"unprognostic (4.67e-2)"	"unprognostic (5.22e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.04e-2)"	"prognostic favourable (8.04e-6)"	"unprognostic (1.35e-1)"	"unprognostic (4.71e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.78e-1)"	18.5	6.9	5.5	9.5	10.0	17.4	10.0	5.5	11.3	10.8	22.5	13.6	5.9	27.0	9.9	9.4	17.0	6.3	9.0	16.6	5.7		20.8	40.9	11.6	11.6	8.7	7.1	11.0	9.1	9.3	9.6	28.4	13.5	14.7	12.4	9.9	12.6	8.5	15.5	6.8	36.4	11.2	9.7	23.8	8.9	6.4	8.1	26.8	13.2	13.9	16.3	13.0	6.4	7.3	30.2	100.1	40.4	13.4	10.9	53.9	31.3	13.3	15.6	16.0	41.4	37.6	39.1	28.8	46.7	28.5	27.9	20.4	23.2	35.4	34.7	47.1	32.0	16.3	31.7	31.7	25.0	16.8	23.9	18.3	58.5	29.1	60.8	53.4	36.5	31.8	24.2	40.7	41.8	26.0	21.4	38.7	14.0	29.5	22.8	9.4	7.8	17.5	22.7	21.2	34.1	26.7	15.7	10.6	29.1	33.3	28.8	24.0	29.9	38.5	17.6	21.2	18.6	19.4	15.9	17.0	35.2	22.0	51.2	9.3	69.1	40.4	70.7	10.0	26.8	10.9	7.3	9.4	9.5	30.2	6.6	10.2	8.6	100.1	13.4	30.4	9.3	10.8	53.9										
NDP	"EVR2, norrin"	ENSG00000124479	"NDP, norrin cystine knot growth factor"	Q00604	X	43948776-43973504	"Disease related genes, Predicted secreted proteins"	"Sensory transduction, Vision, Wnt signaling pathway"		"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 40.4"	"Cell line enriched"	"Detected in some"	17	"U-87 MG: 40.3"	"Cancer enhanced"	"Detected in many"		"glioma: 25.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"memory CD4 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003095			Supported	Nucleoplasm,Nucleoli,Vesicles	"Secreted to extracellular matrix"			Vesicles	"Nucleoplasm, Nucleoli"	"HPA003095: AB_1079457"	"unprognostic (1.12e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.55e-3)"	"unprognostic (6.84e-3)"	"unprognostic (1.51e-1)"		"unprognostic (9.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.87e-3)"	0.9	0.6	17.3	0.6	18.6	0.5	3.6	14.6	15.0	19.1	0.7	12.6	0.2	0.6	13.6	19.9	0.6	18.0	0.9	1.4	14.0	7.8	0.7	0.5	0.6	0.7	11.0	10.9	40.4	0.6	0.8	0.2	5.3	13.1	6.8	0.7	1.4	0.6	12.4	1.5	1.1	0.6	10.7	7.5	0.6	0.7	1.4	12.2	0.0	1.2	0.0	0.7	1.0	1.7	0.1	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.9	0.0	0.1	1.0	0.7	0.0	0.0	1.1	2.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.1	0.0	0.0	0.0	40.3	0.4	2.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.3	18.6	14.6	15.0	14.0	7.8	11.0	10.9	13.1	12.2
NEPRO	"C3orf17, DKFZP434F2021, NET17"	ENSG00000163608	"Nucleolus and neural progenitor protein"	Q6NW34	3	113002440-113019861	"Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069654			Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA069654: "	"unprognostic (8.45e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (1.13e-4)"	"unprognostic (2.29e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavourable (4.25e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.29e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.28e-2)"	15.1	12.3	12.6	12.9	19.8	15.9	15.5	22.8	21.3	14.4	12.8	15.3	11.6	12.3	15.4	19.0	12.7	12.8	13.0	14.0	13.2	12.5	12.4	10.3	11.3	19.3	14.2	13.7	14.8	16.5	13.4	18.2	12.4	15.6	12.4	9.8	11.5	13.5	15.1	28.1	18.2	13.6	16.0	17.5	17.5	14.2	19.1	12.8	21.9	20.0	16.4	15.5	17.5	10.9	3.8	3.4	2.9	3.0	7.9	6.4	2.7	9.9	8.3	13.3	10.0	4.4	8.0	7.1	9.6	6.1	5.3	3.6	7.6	6.6	13.3	5.3	3.1	10.6	9.7	4.3	7.5	2.6	6.1	20.3	7.4	5.6	8.0	12.9	7.5	12.5	7.8	4.4	11.2	4.6	6.9	10.7	3.9	6.4	11.0	7.6	13.9	10.7	9.1	10.6	6.9	6.1	8.9	9.2	13.6	5.5	6.9	15.9	8.0	11.1	9.4	7.5	7.4	2.7	6.8	10.6	8.1	15.6	12.0	10.2	5.3	2.9	2.3	2.7	4.4	3.0	4.5	3.8	5.1	3.7	3.4	3.1	6.4	6.3	1.5	7.9	1.2	2.4	2.2	2.7	12.6	19.8	22.8	21.3	13.2	12.5	14.2	13.7	15.6	12.8
NGDN	"C14orf120, CANu1, DKFZP564O092, LCP5, lpd-2, NGD"	ENSG00000129460	Neuroguidin	Q8NEJ9	14	23469688-23509862	"Predicted intracellular proteins"	"Translation regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA000944	Approved		Approved	Nucleoplasm,Nucleoli,Mitochondria				"Nucleoli, Mitochondria"	Nucleoplasm	"HPA000944: AB_1079483"	"unprognostic (2.63e-3)"	"unprognostic (7.65e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.51e-2)"	"unprognostic (3.14e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.72e-3)"	"unprognostic (5.64e-2)"	"unprognostic (3.87e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.36e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.70e-1)"	20.1	17.6	17.2	19.3	23.6	35.7	26.9	28.9	25.8	17.8	17.8	21.2	18.7	15.0	29.1	22.3	17.4	21.7	12.1	14.8	17.6	15.7	20.6	21.0	15.5	20.4	23.5	17.4	27.2	16.6	20.9	20.7	19.7	19.1	19.7	19.4	17.4	24.0	19.9	32.8	22.7	17.9	21.0	21.6	19.7	17.5	19.0	25.2	19.6	23.7	17.2	22.8	17.3	19.7	42.0	26.7	18.9	23.4	35.2	44.6	28.2	10.7	21.5	16.4	15.4	16.0	11.6	21.7	14.4	15.0	30.7	24.9	21.1	19.9	26.9	10.6	13.1	18.8	32.5	17.8	36.2	17.8	17.2	24.1	13.1	65.4	21.8	31.8	17.2	14.5	22.6	24.2	28.8	15.5	26.6	19.2	15.0	25.7	23.6	24.0	20.8	29.0	19.4	19.7	13.7	19.6	20.6	16.8	19.1	17.0	20.4	23.5	12.6	20.4	11.7	14.5	17.2	13.6	20.8	24.1	41.7	39.0	6.2	16.3	15.5	17.5	21.5	18.9	31.6	23.4	33.5	42.0	34.3	32.1	25.3	36.6	44.6	35.1	6.6	35.2	22.4	26.7	37.4	28.2	17.2	23.6	28.9	25.8	17.6	15.7	23.5	17.4	19.1	25.2
NIFK	"hNIFK, MKI67IP, Nopp34"	ENSG00000155438	"Nucleolar protein interacting with the FHA domain of MKI67"	Q9BYG3	2	121726945-121736923	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015382, HPA035735, HPA035736, CAB075728, CAB075729"	Supported		Enhanced	Nucleoli				Nucleoli		"CAB015382: AB_2142390, CAB075728: , CAB075729: , HPA035735: , HPA035736: "	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.49e-1)"	"prognostic unfavourable (5.57e-4)"	"unprognostic (1.21e-1)"	"unprognostic (4.15e-3)"	"prognostic unfavourable (2.92e-6)"	"unprognostic (7.74e-3)"	"unprognostic (4.63e-2)"	"unprognostic (3.21e-2)"	"unprognostic (6.02e-3)"	"unprognostic (9.50e-2)"	"prognostic unfavourable (5.01e-11)"	"unprognostic (1.72e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-1)"	25.1	18.7	18.4	22.1	19.0	19.9	28.1	14.3	20.8	24.0	17.3	14.8	9.8	16.5	21.4	17.4	28.2	20.3	16.6	15.4	16.1	15.1	24.2	40.1	14.7	30.8	15.8	15.2	32.8	33.7	12.9	28.9	19.8	18.5	21.2	19.7	10.2	16.5	14.2	35.5	22.8	17.9	20.9	18.3	28.1	19.2	18.7	18.0	31.3	23.6	21.3	29.5	26.1	21.0	28.1	25.9	12.5	23.5	27.1	32.9	24.6	28.5	8.6	18.7	18.4	16.5	22.9	22.5	22.5	20.3	28.4	31.1	25.3	14.6	39.4	28.2	17.5	18.6	40.3	30.5	42.6	23.9	21.3	38.7	12.2	23.7	23.2	35.6	21.4	23.0	35.2	37.6	50.4	20.4	43.5	19.6	24.6	14.1	27.3	35.4	45.9	31.2	26.2	21.1	48.3	25.2	17.9	23.5	24.3	14.2	28.3	49.2	13.6	30.7	11.7	19.5	32.0	22.1	32.0	23.0	34.6	43.8	15.2	35.3	27.2	12.5	19.8	9.3	22.9	23.5	32.1	27.0	28.2	26.2	25.9	28.1	32.9	30.8	1.3	27.1	20.9	22.6	23.5	24.6	18.4	19.0	14.3	20.8	16.1	15.1	15.8	15.2	18.5	18.0
NIN		ENSG00000100503	Ninein	Q8N4C6	14	50719763-50831121	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA005939, HPA070691"	Approved		Enhanced	Nucleoplasm,Nucleoli,Centrosome				Centrosome	"Nucleoplasm, Nucleoli"	"HPA005939: , HPA070691: "	"unprognostic (1.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.31e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.58e-2)"	"unprognostic (7.66e-3)"	13.0	6.1	15.1	24.9	10.3	34.8	9.7	12.6	14.0	8.0	9.2	7.6	4.5	5.0	11.8	6.1	11.8	8.2	7.6	16.4	11.7	4.9	6.7	5.2	10.7	30.2	7.6	10.0	11.0	5.4	9.1	12.3	20.2	7.1	6.5	7.7	6.2	8.2	5.1	16.9	10.9	8.3	12.0	7.1	18.2	9.3	4.6	9.0	16.4	7.8	5.1	25.8	11.7	10.3	6.8	6.3	18.4	2.3	1.5	6.0	1.3	12.2	8.7	18.1	15.4	7.0	11.2	7.6	10.5	9.1	8.9	7.5	5.6	6.5	28.8	7.2	14.1	12.9	14.5	6.6	18.7	13.9	4.5	10.6	5.3	5.3	4.1	18.4	30.6	7.7	5.3	15.5	6.4	14.1	2.6	11.8	13.4	13.4	13.9	7.4	2.5	9.6	15.8	33.5	2.0	8.0	13.9	8.4	9.5	13.2	4.0	11.3	7.5	16.4	20.5	22.6	31.4	8.6	11.6	9.5	4.8	19.9	5.9	15.0	12.2	12.6	2.3	18.4	3.3	1.7	3.5	6.8	2.2	6.0	1.5	5.5	4.4	3.8	8.3	1.5	1.5	6.3	1.9	1.3	15.1	10.3	12.6	14.0	11.7	4.9	7.6	10.0	7.1	9.0
NIP7	"CGI-37, FLJ10296, HSPC031, KD93"	ENSG00000132603	"NIP7, nucleolar pre-rRNA processing protein"	Q9Y221	16	69339430-69343111	"Predicted intracellular proteins"	"Ribosome biogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040856, HPA059850"	Supported		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA040856: , HPA059850: "	"unprognostic (2.14e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.76e-1)"	"unprognostic (8.02e-2)"	"unprognostic (6.47e-2)"	"prognostic unfavourable (1.52e-4)"	"unprognostic (1.04e-3)"	"unprognostic (1.37e-3)"	"unprognostic (5.72e-2)"	"unprognostic (3.86e-2)"	"prognostic unfavourable (6.69e-5)"	"unprognostic (6.99e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.33e-2)"	17.8	15.5	8.1	16.4	8.7	20.4	14.0	7.0	12.4	10.2	13.7	9.5	11.1	11.8	15.6	13.1	24.0	13.0	11.3	9.1	9.0	7.8	18.0	18.0	10.7	17.6	12.6	9.6	11.6	18.4	9.6	10.2	14.3	10.9	10.1	14.2	8.8	13.1	13.2	12.1	14.7	14.2	11.7	8.3	15.4	12.3	14.8	9.5	27.1	19.2	23.8	21.0	10.6	11.8	16.6	14.2	8.4	11.7	15.3	19.0	9.5	14.9	10.7	9.1	12.0	11.9	10.8	13.5	13.5	10.9	23.7	17.5	17.2	16.2	27.3	15.2	12.5	15.0	17.1	21.5	30.2	7.2	13.7	14.2	7.6	22.4	11.7	31.2	9.3	11.6	17.2	21.8	24.2	13.0	28.1	4.9	16.4	18.3	18.8	22.9	26.4	12.4	27.2	9.3	24.9	14.6	11.2	11.6	16.5	27.1	8.7	16.7	11.8	19.1	11.3	17.3	15.3	13.0	24.9	15.1	11.4	66.8	10.0	18.6	17.2	8.4	8.1	5.7	16.8	9.2	18.1	16.6	15.6	19.0	14.2	12.1	15.1	18.3	4.0	15.3	11.7	12.5	14.8	9.5	8.1	8.7	7.0	12.4	9.0	7.8	12.6	9.6	10.9	9.5
NKIRAS2	"DKFZP434N1526, kappaB-Ras2, KBRAS2"	ENSG00000168256	"NFKB inhibitor interacting Ras like 2"	Q9NYR9	17	42011382-42025644	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062861			Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA062861: "	"unprognostic (2.53e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.31e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (5.56e-4)"	"unprognostic (9.37e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.96e-2)"	"unprognostic (3.18e-2)"	"prognostic unfavourable (1.23e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.25e-2)"	"unprognostic (5.42e-3)"	15.3	10.9	6.7	11.5	8.4	12.5	12.9	9.2	10.3	12.0	14.6	11.0	10.3	8.7	15.4	12.5	22.0	10.5	14.1	27.5	6.1	5.6	14.0	16.1	11.7	10.4	8.5	3.6	14.9	10.7	8.4	9.0	30.8	7.2	12.5	9.9	14.6	12.3	11.1	31.5	16.1	15.6	15.7	8.3	12.4	11.3	17.1	6.0	17.7	9.5	15.4	19.1	14.5	12.7	8.2	23.0	21.0	25.5	12.0	7.4	10.4	9.0	15.6	24.1	12.5	17.0	11.4	14.3	15.5	11.7	24.3	18.2	17.1	12.8	15.1	24.4	15.6	19.2	19.5	11.6	12.4	12.5	21.3	13.5	14.6	12.5	26.6	17.9	11.1	16.9	20.6	16.1	12.4	29.4	19.0	15.2	13.7	8.9	34.5	11.1	14.2	12.0	27.3	27.7	14.1	15.7	9.3	28.9	37.8	11.3	34.2	15.3	21.7	21.7	21.2	15.3	16.5	16.4	17.2	20.1	32.4	12.4	10.3	10.7	21.5	21.0	25.5	20.5	7.0	20.5	6.9	7.8	7.1	7.0	20.5	8.2	7.4	7.1	14.4	12.0	21.5	23.0	6.0	10.4	6.7	8.4	9.2	10.3	6.1	5.6	8.5	3.6	7.2	6.0
NKRF	"ITBA4, NRF"	ENSG00000186416	"NFKB repressing factor"	O15226	X	119588337-119605895	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 34.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001476			Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA001476: AB_1079488"	"unprognostic (6.12e-3)"	"unprognostic (7.58e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.92e-2)"	"unprognostic (4.74e-3)"	"prognostic unfavourable (4.92e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.56e-3)"	"unprognostic (2.62e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.08e-3)"	3.8	7.9	14.5	6.2	24.3	7.6	6.5	11.4	34.9	4.9	4.0	4.4	1.1	4.7	4.8	5.6	5.6	5.2	4.1	3.8	15.4	14.0	6.9	6.9	4.1	9.7	8.1	24.6	7.4	3.9	8.3	6.5	7.5	25.7	4.9	4.5	2.9	4.6	4.3	4.8	6.4	4.4	4.7	6.0	6.4	4.0	1.9	3.5	7.4	5.4	1.4	9.7	5.2	4.8	3.8	2.7	2.8	2.2	1.3	5.5	1.7	10.8	11.1	6.6	7.6	5.7	5.8	10.0	6.6	5.4	9.0	9.7	11.8	9.4	19.4	11.7	5.7	12.8	27.4	10.2	11.0	9.7	18.7	10.2	13.2	7.8	5.4	19.7	7.9	6.1	8.4	10.4	12.2	9.1	11.0	8.2	8.0	16.8	12.6	15.8	14.6	12.5	9.9	9.4	19.9	11.9	8.1	10.8	9.0	9.3	14.5	9.8	6.1	12.0	7.4	5.8	6.2	12.2	16.6	6.7	8.1	20.5	5.9	22.2	6.4	2.8	1.3	1.5	3.3	2.2	3.1	3.7	3.6	3.7	1.3	3.8	5.5	4.8	0.2	1.3	1.1	2.7	4.3	1.7	14.5	24.3	11.4	34.9	15.4	14.0	8.1	24.6	25.7	3.5
NKX2-3	"CSX3, NKX2.3, NKX2C, NKX4-3"	ENSG00000119919	"NK2 homeobox 3"	Q8TAU0	10	99532933-99536524	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 12.5;intestine: 21.6;lymphoid tissue: 36.8"	"Cell line enhanced"	"Detected in some"		"HAP1: 2.1;NB-4: 4.7;REH: 6.0;THP-1: 1.5"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"memory CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"basal ganglia: 0.3"	HPA047561	Uncertain		Uncertain	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA047561: "		"unprognostic (5.70e-2)"	"unprognostic (2.95e-1)"			"unprognostic (2.70e-4)"	"unprognostic (6.34e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.83e-1)"	0.8	0.0	0.1	17.2	0.1	0.0	0.1	0.1	0.1	0.3	21.6	0.1	0.1	10.4	0.2	0.1	0.5	0.0	12.5	0.1	0.1	0.0	0.1	0.2	0.1	1.1	0.1	0.1	0.1	6.4	0.0	0.1	0.1	0.1	0.1	4.6	0.1	9.0	0.5	0.1	0.0	19.1	3.1	0.1	36.8	1.8	0.1	0.1	0.2	1.0	0.7	3.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	2.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.0	6.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	1.5	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
NLE1	"FLJ10458, NLE"	ENSG00000073536	"Notchless homolog 1"	Q9NVX2	17	35128753-35142315	"Predicted intracellular proteins"	"Notch signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 40.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018807	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA018807: AB_1848658"	"unprognostic (9.19e-2)"	"unprognostic (8.40e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (8.64e-8)"	"unprognostic (8.67e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (6.39e-4)"	6.3	6.9	7.0	8.2	7.6	6.4	11.4	7.6	9.1	5.6	5.8	5.4	3.3	5.1	10.0	5.5	7.9	10.0	8.3	4.8	6.0	6.4	4.8	6.9	4.5	9.1	5.6	7.7	16.3	40.3	5.1	4.2	6.1	5.4	9.2	5.3	6.2	9.1	7.5	8.8	7.6	5.1	10.2	5.1	8.3	6.8	7.2	6.4	10.0	10.0	6.6	8.3	6.3	5.4	6.4	4.5	0.4	3.2	2.4	9.1	3.0	8.1	19.9	6.7	11.9	4.2	6.2	10.7	7.3	6.9	13.1	10.9	13.7	7.9	18.1	10.2	6.1	10.9	15.1	18.8	9.1	2.9	23.6	8.1	9.5	17.1	5.6	15.6	6.5	7.0	10.1	13.6	20.8	8.5	21.8	6.6	7.7	11.2	23.9	12.7	12.6	8.8	19.3	11.7	19.9	7.7	7.9	13.8	8.4	7.0	7.1	8.7	17.4	11.3	7.5	7.1	10.0	6.8	24.5	5.2	4.0	15.1	5.0	12.9	13.6	0.1	3.0	0.0	5.7	3.2	9.1	4.8	5.4	6.0	4.5	6.4	7.4	5.1	0.4	2.4	1.6	1.0	3.0	3.0	7.0	7.6	7.6	9.1	6.0	6.4	5.6	7.7	5.4	6.4
NLK		ENSG00000087095	"Nemo like kinase"	Q9UBE8	17	28041737-28196381	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	32	"basophil: 17.6"	"Lineage enriched"	"Detected in single"	32	"granulocytes: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018192, HPA056511"	Approved		Supported	"Nucleoplasm,Nucleoli,Cell Junctions"				Nucleoplasm	"Nucleoli, Cell Junctions"	"HPA018192: AB_1854525, HPA056511: "	"unprognostic (7.19e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.54e-2)"	"unprognostic (5.64e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.59e-3)"	"unprognostic (2.72e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.92e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.57e-2)"	6.4	30.5	19.4	10.9	14.1	7.4	7.5	7.5	38.2	6.2	6.7	8.3	14.4	8.3	5.7	8.8	4.5	5.1	8.2	8.5	18.2	12.0	13.0	8.2	7.1	11.7	15.2	23.6	4.6	11.5	20.8	9.4	9.1	7.0	6.7	7.1	12.7	5.8	17.4	4.9	4.5	8.3	4.6	15.3	10.1	7.0	17.4	7.5	10.9	13.2	3.7	11.0	7.2	4.4	0.5	0.3	17.6	0.3	0.1	0.5	0.2	4.6	5.4	13.0	4.5	2.8	3.6	5.7	4.6	4.7	7.8	6.0	27.0	4.2	6.3	7.1	3.8	4.4	9.1	8.5	9.0	14.5	5.8	24.7	5.0	4.6	4.7	5.2	25.5	4.7	5.2	5.1	6.1	9.1	9.5	7.6	7.1	5.4	13.3	6.0	5.0	2.7	11.2	8.4	4.6	14.1	5.7	9.5	3.5	7.1	6.8	29.0	10.6	8.3	9.3	5.6	7.5	4.6	9.3	9.0	8.6	6.1	5.4	5.6	6.1	17.6	0.2	0.2	0.3	0.3	0.1	0.5	0.4	0.4	0.2	0.3	0.2	0.5	0.1	0.1	0.3	0.3	0.4	0.2	19.4	14.1	7.5	38.2	18.2	12.0	15.2	23.6	7.0	7.5
NMD3	CGI-07	ENSG00000169251	"NMD3 ribosome export adaptor"	Q96D46	3	161104696-161253532	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035019			Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA035019: AB_10600922"	"unprognostic (1.37e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.50e-2)"	"unprognostic (9.39e-3)"	"unprognostic (1.95e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (2.03e-5)"	"unprognostic (7.97e-2)"	"unprognostic (5.57e-2)"	"unprognostic (6.17e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.86e-3)"	26.8	15.7	16.2	10.7	16.5	34.7	20.3	26.6	21.8	23.1	14.4	13.2	10.9	10.8	23.4	17.7	22.9	14.3	14.2	24.1	15.5	13.6	25.7	46.7	19.4	12.5	16.7	18.2	27.9	29.0	13.4	27.5	20.1	21.6	21.7	13.5	14.1	19.7	13.3	31.8	15.5	16.3	22.1	16.3	17.1	25.3	12.1	13.1	19.6	21.7	21.3	15.0	32.1	16.0	12.1	13.2	15.9	11.8	22.8	18.7	13.6	21.7	12.7	12.5	12.8	15.7	21.7	17.3	24.9	18.9	18.6	21.8	21.4	18.0	27.7	31.9	17.4	14.3	20.0	18.3	29.2	28.7	12.2	28.5	11.2	13.4	17.4	34.2	17.3	18.1	13.6	13.2	43.6	20.2	20.8	15.4	22.0	49.7	15.5	13.1	15.7	20.3	19.1	18.2	28.0	17.8	49.4	20.0	12.5	14.2	34.8	20.6	25.9	15.7	17.6	14.9	10.7	17.1	30.0	25.3	17.1	28.4	18.6	22.4	20.3	15.9	10.8	5.7	11.8	11.8	18.3	12.1	13.9	14.5	13.2	10.4	18.7	14.5	2.5	22.8	7.3	7.4	17.1	13.6	16.2	16.5	26.6	21.8	15.5	13.6	16.7	18.2	21.6	13.1
NOC2L	"DKFZP564C186, NET15, NET7, NIR, PPP1R112"	ENSG00000188976	"NOC2 like nucleolar associated transcriptional repressor"	Q9Y3T9	1	944204-959309	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044258, HPA062195"	Approved		Enhanced	Nucleoli			420000	Nucleoli		"HPA044258: AB_10961284, HPA062195: "	"unprognostic (3.18e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.54e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.20e-3)"	"unprognostic (8.62e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.52e-1)"	17.7	15.6	13.4	20.5	17.8	23.8	18.2	23.7	27.4	15.0	15.3	15.6	13.5	16.8	19.0	13.5	27.7	18.3	21.8	23.0	15.3	15.3	15.2	36.6	14.0	19.3	18.7	19.0	16.9	26.8	20.8	15.3	15.9	16.7	16.6	11.1	14.0	22.0	16.5	40.0	32.4	14.6	14.7	13.6	17.5	16.4	21.1	18.0	22.7	19.8	29.5	21.8	17.5	18.0	14.3	20.2	11.3	29.0	18.8	18.4	16.0	27.6	27.6	4.9	32.0	9.0	8.0	18.1	20.6	9.7	28.9	15.9	36.5	27.1	31.2	29.4	13.7	25.4	36.6	30.9	12.3	19.5	41.7	16.5	35.6	31.6	20.3	36.3	16.2	13.1	8.7	31.8	21.2	14.0	46.5	14.4	12.7	43.7	23.3	21.9	28.2	32.7	29.2	20.6	37.7	13.3	11.6	34.6	34.0	27.4	41.4	25.3	18.5	19.9	16.0	17.3	24.7	18.9	35.2	24.8	26.7	56.3	21.5	51.5	14.4	7.2	17.0	11.3	14.2	25.7	18.4	14.3	13.8	13.6	20.2	11.9	14.3	11.1	1.6	18.8	29.0	13.0	10.9	16.0	13.4	17.8	23.7	27.4	15.3	15.3	18.7	19.0	16.7	18.0
NOC3L	"AD24, C10orf117, FAD24, FLJ12820"	ENSG00000173145	"NOC3 like DNA replication regulator"	Q8WTT2	10	94333226-94362959	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063958, HPA067638, HPA070981"			Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA063958: , HPA067638: , HPA070981: "	"unprognostic (1.29e-1)"	"unprognostic (2.25e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.58e-2)"	"unprognostic (6.49e-3)"	"unprognostic (3.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.93e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.30e-1)"	16.7	13.2	9.2	11.2	14.5	3.7	14.4	10.8	12.7	13.5	8.9	6.0	8.4	6.7	14.1	8.5	14.3	12.1	7.3	8.8	9.3	6.6	11.0	15.0	9.7	14.9	16.4	7.7	15.4	7.8	12.5	18.2	11.0	14.5	12.5	8.2	6.3	9.7	8.9	18.8	11.6	8.4	9.8	16.6	19.8	8.1	14.1	13.1	12.8	15.7	13.6	16.0	16.1	10.6	13.7	4.3	0.5	4.1	7.5	5.8	3.1	17.6	9.7	6.6	21.2	6.9	11.2	7.8	14.2	11.3	19.5	22.7	16.4	12.6	19.2	10.4	7.1	12.8	18.7	8.5	31.7	13.1	14.0	13.0	8.1	10.5	13.8	20.6	5.9	6.4	8.4	20.5	20.7	8.6	20.1	9.7	19.1	6.0	12.9	15.3	13.9	10.7	5.8	15.1	10.6	11.5	5.5	4.7	11.7	10.1	5.1	15.7	13.2	8.0	8.3	12.5	12.6	11.3	23.8	9.3	18.5	26.7	11.4	20.0	9.3	0.0	2.4	0.5	4.3	3.9	5.4	13.7	4.4	5.4	4.3	12.6	5.8	5.1	0.1	7.5	4.1	3.8	4.0	3.1	9.2	14.5	10.8	12.7	9.3	6.6	16.4	7.7	14.5	13.1
NOC4L	"MGC3162, NET49, Noc4, UTP19"	ENSG00000184967	"Nucleolar complex associated 4 homolog"	Q9BVI4	12	132144448-132152473	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053424			Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA053424: "	"unprognostic (9.44e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.79e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.36e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.61e-1)"	11.9	10.3	9.0	14.2	11.6	18.8	11.1	11.5	17.2	9.9	9.2	14.1	7.8	14.8	11.5	6.4	12.0	10.7	10.4	8.6	8.0	7.5	11.2	15.6	9.2	13.7	14.7	8.5	13.6	16.8	7.1	10.4	9.7	12.1	9.8	6.9	10.3	16.2	8.8	22.5	15.7	11.9	8.2	9.2	15.5	12.5	28.4	10.6	15.7	10.5	13.2	12.3	9.5	9.5	13.9	18.8	5.9	16.1	7.4	11.4	8.1	12.3	22.9	5.1	7.9	2.5	2.7	26.0	8.5	4.3	10.5	5.8	18.6	5.9	18.9	9.4	4.3	11.1	9.0	9.3	2.3	7.4	24.7	12.7	7.6	12.2	6.8	14.8	14.9	4.0	6.5	8.2	6.6	7.4	21.5	4.4	4.3	14.5	14.0	34.8	14.9	18.2	18.3	5.7	16.5	5.4	9.2	12.5	9.9	7.3	9.9	6.3	13.9	9.2	9.8	6.3	15.9	10.0	14.2	11.1	6.8	16.6	9.6	12.8	13.2	2.5	11.8	5.9	11.4	16.1	11.0	13.8	10.6	11.3	15.8	13.9	9.3	8.9	1.7	7.4	12.1	18.8	8.7	8.1	9.0	11.6	11.5	17.2	8.0	7.5	14.7	8.5	12.1	10.6
NOL10	"FLJ14075, PQBP5"	ENSG00000115761	"Nucleolar protein 10"	Q9BSC4	2	10570766-10689987	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035286, HPA043075"	Approved		Supported	Nucleoli				Nucleoli		"HPA035286: , HPA043075: AB_10794652"	"unprognostic (6.53e-3)"	"unprognostic (1.61e-1)"	"unprognostic (6.84e-2)"	"prognostic unfavourable (2.92e-5)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavourable (1.43e-7)"	"unprognostic (1.25e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.74e-2)"	"prognostic unfavourable (7.51e-5)"	"unprognostic (2.43e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.87e-2)"	18.6	22.4	13.5	18.7	16.1	20.5	17.7	20.4	16.9	14.7	15.5	16.2	19.6	13.1	21.5	19.1	20.9	11.8	15.7	15.7	11.6	11.8	18.2	21.9	13.8	17.5	17.4	12.5	15.2	25.8	17.0	21.4	19.8	16.2	15.2	17.6	14.4	19.8	15.5	27.5	19.4	13.5	15.2	17.0	15.3	17.2	18.4	15.4	16.4	16.8	21.3	18.9	14.6	18.2	8.1	7.4	3.6	8.5	7.0	9.7	4.4	11.4	18.5	10.9	19.4	13.0	14.3	21.6	19.5	15.2	20.7	16.3	21.9	14.7	26.8	12.1	17.3	14.9	25.7	23.5	26.1	18.7	20.1	25.9	11.7	25.8	17.3	29.8	14.4	12.8	17.4	23.0	23.0	14.8	34.1	17.1	20.4	20.7	19.7	21.4	30.3	17.6	18.4	30.0	24.9	14.6	15.7	19.0	20.6	14.6	24.1	17.0	12.6	11.7	14.6	20.2	25.0	20.8	31.7	22.8	35.8	30.9	17.0	29.6	24.9	2.5	6.1	3.6	6.8	8.5	9.6	8.1	7.1	7.7	7.4	6.3	5.5	7.6	0.8	7.0	8.3	5.3	9.7	4.4	13.5	16.1	20.4	16.9	11.6	11.8	17.4	12.5	16.2	15.4
NOL11	DKFZP586L0724	ENSG00000130935	"Nucleolar protein 11"	Q9H8H0	17	67717833-67744531	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022010	Supported		Supported	Nucleoli				Nucleoli		"HPA022010: AB_2267158"	"unprognostic (6.81e-2)"	"unprognostic (2.85e-2)"	"prognostic favourable (1.00e-6)"	"unprognostic (3.07e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.55e-2)"	"prognostic unfavourable (2.59e-6)"	"unprognostic (1.37e-2)"	"unprognostic (1.25e-3)"	"unprognostic (4.77e-3)"	"unprognostic (8.74e-2)"	"unprognostic (4.41e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.11e-1)"	17.3	15.1	12.2	14.3	13.4	17.0	14.5	19.8	11.6	15.2	12.9	10.2	11.9	10.3	17.2	11.7	18.1	13.9	10.4	12.8	9.5	7.6	18.9	22.1	10.4	17.5	14.4	5.4	19.5	16.9	18.4	17.0	19.8	10.8	14.6	13.9	10.4	14.1	10.7	26.8	13.8	13.8	13.6	11.1	16.6	14.4	10.6	14.3	32.1	13.6	16.4	20.1	14.5	13.4	9.7	7.0	7.4	5.8	10.0	14.7	7.8	14.5	17.0	14.3	9.3	6.8	8.1	15.6	10.1	8.8	22.6	18.5	16.1	11.2	24.8	7.9	11.0	11.4	34.8	16.8	33.2	7.0	27.6	16.3	10.3	14.3	7.9	21.7	10.7	6.3	10.6	16.9	11.6	21.0	27.2	7.6	17.9	14.3	26.6	9.1	15.7	23.8	18.4	30.0	17.4	10.2	17.3	11.8	10.9	9.4	26.5	12.3	18.0	12.2	7.2	19.7	13.3	6.7	21.0	4.8	12.3	26.7	8.4	15.2	11.7	7.4	5.2	3.6	8.5	5.8	8.8	8.8	8.9	10.2	7.0	9.7	14.7	10.8	0.8	10.0	5.3	5.3	9.6	7.8	12.2	13.4	19.8	11.6	9.5	7.6	14.4	5.4	10.8	14.3
NOL12	"MGC3731, Nop25, RRP17"	ENSG00000273899	"Nucleolar protein 12"	Q9UGY1	22	37681673-37693478	"Predicted intracellular proteins"		"RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 31.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003547	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles				Nucleoli	"Nucleoplasm, Vesicles"	"HPA003547: AB_10602012"	"unprognostic (3.37e-2)"	"prognostic favourable (6.80e-5)"	"unprognostic (2.65e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.89e-2)"	"unprognostic (3.23e-3)"	"prognostic favourable (9.41e-4)"	"unprognostic (9.96e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.18e-3)"	"unprognostic (4.60e-2)"	"prognostic unfavourable (2.56e-6)"	"unprognostic (1.34e-2)"	"unprognostic (8.40e-2)"	"unprognostic (4.65e-2)"	"prognostic favourable (3.24e-4)"	3.8	11.8	9.3	9.5	10.1	14.6	5.0	13.1	10.6	3.6	6.5	7.9	5.4	8.4	4.1	4.6	7.8	6.2	5.6	7.2	7.7		5.2	4.1	4.8	11.0	8.7	6.4	5.4	5.4	5.4	3.9	6.8	7.2	4.5	6.2	4.4	8.9	4.8	7.9	11.4	7.1	4.5	3.7	8.6	5.8	4.8	9.5	7.2	7.4	7.1	8.0	5.8	5.6	8.1	9.6	31.1	17.1	8.5	11.6	6.4	17.0	15.7	11.8	13.4	3.8	4.1	14.8	8.5	3.9	3.9	4.1	8.9	7.1	14.5	5.1	3.8	18.6	6.7	22.5	1.4	15.2	24.5	12.3	12.7	20.2	10.3	29.1	18.1	5.9	7.3	15.3	5.9	7.3	9.1	13.2	3.3	14.8	15.9	21.8	13.5	21.2	21.8	7.6	10.9	8.5	6.0	9.6	18.7	9.9	9.1	13.5	13.0	13.8	10.2	16.2	16.4	11.8	15.7	11.0	13.4	18.7	15.4	21.7	19.0	21.3	14.0	14.2	9.1	14.1	6.5	8.0	8.9	7.9	9.6	8.1	9.1	7.9	31.1	8.5	17.1	7.5	11.6	6.4										
NOL6	"bA311H10.1, FLJ21959, MGC14896, MGC14921, MGC20838, Nrap, UTP22"	ENSG00000165271	"Nucleolar protein 6"	Q9H6R4	9	33461441-33473930	"Predicted intracellular proteins, Predicted membrane proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055891, HPA061002"	Supported		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA055891: , HPA061002: "	"unprognostic (2.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.67e-1)"	"prognostic unfavourable (4.83e-5)"	"unprognostic (7.37e-3)"	"unprognostic (8.26e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (9.49e-4)"	"unprognostic (4.09e-1)"	15.3	14.9	13.3	17.7	19.7	21.0	14.9	16.8	30.8	16.0	11.4	14.6	9.0	10.3	15.3	11.9	21.1	12.8	18.2	13.1	12.4	10.6	13.8	41.6	13.5	15.8	10.1	11.4	20.5	20.5	22.7	18.2	15.4	19.2	17.5	14.8	12.5	15.5	15.5	23.4	23.5	11.3	17.0	7.3	17.6	13.0	19.0	7.8	13.8	13.2	19.7	20.9	12.4	14.5	4.2	7.1	0.3	8.4	3.9	6.0	3.4	15.5	22.5	8.6	19.4	13.5	9.3	14.7	17.4	13.1	20.4	17.2	24.8	5.7	27.2	8.0	19.5	10.9	24.9	25.0	21.6	17.2	10.3	14.0	26.2	13.7	13.3	31.8	20.5	10.2	20.8	27.0	26.1	13.3	22.7	10.5	16.2	13.7	17.8	32.0	31.0	20.6	15.4	8.5	14.1	15.8	18.7	10.2	14.0	14.5	18.8	6.2	7.6	18.6	14.9	12.6	17.0	15.8	30.3	10.0	13.9	23.0	11.1	16.9	14.4	0.0	4.0	0.3	5.4	8.4	6.0	4.2	4.1	5.2	7.1	3.6	5.1	4.8	0.2	3.9	7.9	3.8	4.0	3.4	13.3	19.7	16.8	30.8	12.4	10.6	10.1	11.4	19.2	7.8
NOL8	"C9orf34, FLJ20736, Nop132"	ENSG00000198000	"Nucleolar protein 8"	Q76FK4	9	92297358-92325636	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044440, HPA062922"	Uncertain		Supported	Nucleoli				Nucleoli		"HPA044440: AB_10963212, HPA062922: "	"unprognostic (3.44e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.73e-2)"	"prognostic unfavourable (1.50e-4)"	"unprognostic (1.85e-1)"	"unprognostic (6.16e-3)"	"unprognostic (5.17e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavourable (1.02e-5)"	"unprognostic (4.69e-2)"	"unprognostic (5.38e-2)"	"unprognostic (4.58e-1)"	"unprognostic (5.53e-2)"	15.8	11.5	11.6	14.6	20.0	8.5	13.6	15.9	15.9	15.1	13.2	7.3	12.1	6.4	16.4	11.1	14.1	13.0	9.4	9.4	13.7	8.2	10.6	8.9	9.5	13.6	17.9	8.4	17.5	11.1	25.3	23.6	11.8	13.4	14.0	11.0	5.2	11.0	13.2	15.0	12.9	10.7	14.6	19.5	15.7	10.6	7.7	17.8	18.7	15.2	11.2	15.1	16.3	16.2	13.6	12.2	13.6	14.7	12.6	17.5	6.6	7.9	13.0	6.0	12.1	13.7	11.7	8.3	9.2	7.2	9.8	9.5	4.6	8.4	25.3	8.1	9.7	16.7	21.5	12.8	10.9	15.8	9.7	18.0	13.0	10.4	9.2	29.9	13.7	12.2	9.5	11.0	15.5	12.1	27.2	7.8	11.3	12.9	20.8	10.5	10.2	12.4	12.6	17.8	10.3	5.1	5.4	11.3	5.5	12.6	11.0	7.7	4.5	9.4	11.8	9.1	5.9	12.9	9.6	7.9	17.7	13.7	8.5	17.2	11.8	13.6	8.3	11.3	12.5	11.1	17.5	13.6	11.9	12.0	12.2	12.6	14.6	12.5	3.2	12.6	14.7	10.3	13.2	6.6	11.6	20.0	15.9	15.9	13.7	8.2	17.9	8.4	13.4	17.8
NOL9	"FLJ23323, Grc3, NET6"	ENSG00000162408	"Nucleolar protein 9"	Q5SY16	1	6521347-6554535	"Predicted intracellular proteins"	"rRNA processing"	"Kinase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036347			Supported	"Nucleoli,Intermediate filaments"				Nucleoli	"Intermediate filaments"	"HPA036347: "	"unprognostic (3.03e-1)"	"unprognostic (4.93e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.14e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (3.69e-5)"	"unprognostic (2.48e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.32e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.65e-2)"	12.7	11.3	10.4	10.3	15.1	19.3	11.0	16.4	19.3	14.7	11.2	14.1	6.8	7.7	13.3	11.6	12.1	11.4	8.8	8.3	10.8	9.7	9.6	15.2	9.4	14.4	8.6	9.6	16.8	14.7	15.5	10.5	9.8	12.0	13.0	10.0	9.4	9.1	10.3	17.9	18.0	11.4	12.4	7.2	22.0	11.0	9.4	9.2	20.9	9.4	8.9	14.9	11.0	9.3	6.9	5.8	5.0	4.8	2.8	8.4	1.9	5.1	7.3	4.1	12.4	5.5	3.3	4.5	5.0	3.3	5.3	5.6	10.0	7.0	14.2	6.1	5.6	6.8	8.3	6.9	9.1	5.7	4.5	9.6	11.3	7.8	5.6	8.1	5.3	4.9	2.1	11.2	9.8	6.2	11.2	6.0	5.4	8.8	7.9	7.3	5.6	7.1	10.1	9.7	6.6	4.1	4.7	8.0	3.7	7.8	9.9	6.2	6.4	3.7	8.0	8.4	6.9	5.9	8.4	5.0	4.7	25.9	7.8	9.1	3.9	5.0	3.5	2.6	5.7	3.2	5.7	5.1	8.1	5.2	2.3	6.9	8.4	7.0	2.2	2.8	4.8	5.8	5.1	1.9	10.4	15.1	16.4	19.3	10.8	9.7	8.6	9.6	12.0	9.2
NOM1	"C7orf3, PPP1R113, SGD1"	ENSG00000146909	"Nucleolar protein with MIF4G domain 1"	Q5C9Z4	7	156949723-156973182	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019866, HPA051624"	Approved		Enhanced	Nucleoli				Nucleoli		"HPA019866: , HPA051624: "	"unprognostic (1.24e-1)"	"unprognostic (7.47e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.35e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.49e-1)"	12.3	10.9	10.8	16.9	14.2	15.3	11.1	13.0	15.9	9.7	11.4	9.9	11.1	8.9	12.8	9.0	12.9	11.4	8.1	8.3	11.2	6.4	8.4	12.2	9.9	13.4	11.9	11.7	13.9	14.5	11.1	8.4	10.3	11.4	9.6	10.0	9.3	10.5	12.5	21.0	15.5	10.5	12.0	10.0	12.1	10.6	13.9	11.9	9.9	9.9	9.8	12.4	11.4	17.0	5.0	2.8	2.5	2.8	2.6	3.4	0.9	9.0	7.8	5.8	8.5	5.8	6.1	7.9	9.0	4.5	7.4	6.0	8.4	7.7	15.9	9.1	7.3	7.4	10.3	11.0	9.1	7.2	9.0	13.3	6.5	7.7	4.7	23.1	8.1	4.4	5.4	6.6	8.6	6.2	20.0	8.6	6.6	11.8	14.6	19.3	13.9	8.4	10.5	8.7	12.2	4.7	10.8	7.1	8.6	8.2	6.6	6.2	3.2	12.5	10.0	8.0	2.6	14.8	11.6	11.1	7.9	14.6	10.2	16.7	7.5	2.5	2.8	1.5	2.1	1.9	1.2	3.8	2.7	2.9	2.8	5.0	3.4	1.8	1.3	2.6	2.1	2.8	1.0	0.9	10.8	14.2	13.0	15.9	11.2	6.4	11.9	11.7	11.4	11.9
NOP14	"C4orf9, NOL14, RES4-25, UTP2"	ENSG00000087269	"NOP14 nucleolar protein"	P78316	4	2937933-2963385	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039596, HPA055652"	Approved		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA039596: AB_2676590, HPA055652: "	"unprognostic (4.70e-2)"	"unprognostic (6.47e-2)"	"prognostic favourable (3.93e-5)"	"unprognostic (7.32e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavourable (9.10e-4)"	"unprognostic (2.41e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.77e-2)"	17.3	16.8	9.8	22.4	13.2	19.0	16.2	21.1	15.2	12.0	12.6	9.0	12.6	12.0	14.3	11.7	19.0	12.1	14.7	14.8	8.9	7.1	13.6	34.0	12.9	20.8	10.0	8.7	20.7	26.8	13.9	15.5	12.8	10.6	12.3	12.8	11.1	14.7	14.6	38.6	21.4	13.1	12.4	9.8	18.0	15.1	9.8	11.4	17.9	15.4	16.3	20.9	18.1	18.9	5.2	4.9	1.3	3.8	4.4	8.4	3.0	16.1	13.7	8.2	16.9	11.0	12.6	14.4	14.9	10.6	15.6	12.9	17.9	17.1	45.8	10.6	12.1	11.2	22.6	19.4	16.8	8.7	21.6	36.4	13.0	16.2	14.6	39.5	15.9	12.7	17.5	17.6	16.1	13.1	32.9	16.3	11.7	11.6	41.6	29.8	21.3	22.6	27.0	12.4	15.2	7.8	26.1	17.0	10.0	12.4	9.2	11.6	17.6	15.6	16.2	13.1	7.6	15.9	27.4	12.2	19.7	39.5	13.6	29.3	13.5	1.3	3.2	0.6	4.8	3.8	8.4	3.4	5.8	7.0	4.0	5.2	7.0	5.2	0.5	4.4	2.5	4.9	3.8	3.0	9.8	13.2	21.1	15.2	8.9	7.1	10.0	8.7	10.6	11.4
NOP16	"HSPC111, HSPC185, LOC51491"	ENSG00000048162	"NOP16 nucleolar protein"	Q9Y3C1	5	176383938-176388975	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036506, HPA058147"	Approved		Enhanced	Nucleoli				Nucleoli		"HPA036506: AB_10672223, HPA058147: AB_2683620"	"unprognostic (4.55e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.89e-1)"	"prognostic unfavourable (5.14e-4)"	"unprognostic (1.19e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (5.75e-6)"	"unprognostic (1.05e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.76e-1)"	17.1	12.8	11.0	15.3	12.7	13.2	13.5	6.1	10.4	8.5	13.3	4.9	8.4	12.0	9.5	8.1	23.2	9.6	9.9	18.2	8.0	8.2	18.2	34.3	8.7	15.0	11.0	8.8	10.9	16.2	5.8	7.2	9.5	14.8	9.1	11.8	3.2	8.8	7.7	50.2	15.6	9.5	8.7	6.8	14.7	11.2	12.2	9.5	9.4	11.3	29.3	17.1	11.1	12.2	26.8	30.3	2.7	26.6	24.1	22.6	13.7	17.5	26.9	6.7	28.5	9.9	10.4	26.0	14.6	8.6	21.2	18.4	36.8	17.8	29.3	20.0	10.8	16.6	31.3	48.4	14.8	37.3	25.6	15.1	19.8	31.2	19.9	30.9	17.9	10.7	21.8	19.4	24.1	15.5	29.6	15.1	15.3	51.2	23.7	42.8	23.6	34.2	19.8	9.4	31.2	19.8	15.0	20.1	17.0	8.6	34.8	19.4	15.5	22.7	14.0	16.2	16.6	15.1	36.4	19.4	22.9	32.6	12.7	42.4	13.9	2.1	16.8	2.7	17.4	26.6	22.6	25.1	19.6	18.7	24.9	26.8	21.5	22.5	1.7	24.1	13.0	30.3	13.6	13.7	11.0	12.7	6.1	10.4	8.0	8.2	11.0	8.8	14.8	9.5
NOP2	"NOL1, NOP120, NSUN1, p120"	ENSG00000111641	"NOP2 nucleolar protein"	P46087	12	6556863-6568691	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040119	Supported		Supported	Nucleoli				Nucleoli		"HPA040119: AB_10965321"	"unprognostic (2.88e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.15e-2)"	"unprognostic (8.74e-2)"	"unprognostic (6.47e-2)"	"prognostic unfavourable (1.12e-5)"	"unprognostic (6.38e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.53e-1)"	"prognostic unfavourable (2.35e-10)"	"unprognostic (1.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-3)"	16.5	12.7	14.8	21.7	17.1	30.9	15.3	14.8	14.9	10.8	12.8	6.9	7.3	14.0	15.2	11.4	19.5	15.0	11.2	12.8	11.9	8.7	12.8	31.2	14.0	25.9	14.7	8.9	14.5	21.5	12.1	15.1	12.3	13.8	17.4	14.7	9.0	21.3	9.4	32.6	19.1	15.7	14.7	8.9	23.1	13.4	19.4	13.2	24.7	16.8	18.5	27.2	11.5	17.1	12.6	16.5	3.3	11.5	11.9	20.3	10.9	16.1	26.0	7.1	24.3	9.1	7.8	38.6	14.7	9.5	17.4	15.0	31.7	16.5	34.5	4.0	7.2	20.0	27.2	16.2	16.9	40.7	25.5	33.8	24.8	18.3	12.2	33.3	19.5	7.9	16.0	21.0	32.8	11.7	23.7	5.5	13.8	20.0	17.8	29.0	59.4	14.5	25.4	20.7	16.9	12.7	22.3	5.5	10.9	23.0	25.1	12.1	4.1	16.0	11.0	12.0	16.1	15.5	33.7	7.7	11.2	51.5	11.0	19.1	20.8	1.4	8.2	0.9	14.8	11.5	20.3	12.6	14.1	16.6	16.5	10.1	17.3	17.6	3.3	11.9	10.0	14.5	9.7	10.9	14.8	17.1	14.8	14.9	11.9	8.7	14.7	8.9	13.8	13.2
NOP53	"GLTSCR2, PICT-1, PICT1"	ENSG00000105373	"NOP53 ribosome biogenesis factor"	Q9NZM5	19	47745522-47757058	"Predicted intracellular proteins"	"Host-virus interaction, Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 158.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 51.0;NK-cells: 20.5;T-cells: 52.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018999, HPA049600"	Approved		Supported	Nucleoli				Nucleoli		"HPA018999: AB_1849733, HPA049600: "	"unprognostic (2.08e-3)"	"unprognostic (1.84e-1)"	"unprognostic (4.02e-3)"	"prognostic favourable (2.35e-4)"	"unprognostic (1.76e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.89e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.32e-2)"	35.2	34.8	13.4	35.1	19.7	39.3	40.6	21.0	21.6	44.4	36.9	15.4	30.7	35.9	41.4	30.8	37.2	32.2	36.1	24.5	12.7	10.2	24.8	24.7	22.6	48.7	18.2	19.7	90.1	92.0	18.6	19.8	20.3	16.1	42.3	12.7	22.8	67.3	28.2	51.6	54.7	32.8	50.2	16.4	49.8	39.0	31.9	17.4	49.7	54.9	33.8	40.9	39.6	68.7	51.0	8.8	4.8	7.2	20.5	52.7	2.9	12.0	12.7	11.5	27.0	14.3	24.0	21.8	7.5	13.9	7.3	10.9	11.8	24.4	53.0	10.9	8.8	17.2	6.6	11.0	3.9	15.5	21.9	17.4	10.8	13.7	21.2	24.9	34.1	21.1	25.5	6.4	17.5	11.6	21.1	26.1	6.5	10.5	67.9	158.3	26.2	7.4	45.5	20.4	24.5	14.0	18.7	12.1	42.6	6.3	41.8	37.7	19.7	60.9	14.2	7.2	19.3	6.2	15.3	38.2	34.1	14.4	9.1	17.8	11.6	3.6	4.8	4.8	12.0	7.2	16.7	51.0	23.9	21.2	6.9	36.0	52.7	24.0	0.7	20.5	5.0	8.8	22.7	2.9	13.4	19.7	21.0	21.6	12.7	10.2	18.2	19.7	16.1	17.4
NOP9	C14orf21	ENSG00000196943	"NOP9 nucleolar protein"	Q86U38	14	24299862-24309124	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000850			Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA000850: AB_1078287"	"unprognostic (1.39e-1)"	"unprognostic (4.64e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.85e-1)"	"unprognostic (8.28e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.37e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.77e-2)"	"prognostic favourable (9.39e-6)"	"unprognostic (7.03e-3)"	"unprognostic (3.80e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.59e-2)"	12.0	12.9	11.3	11.4	11.4	14.4	10.0	13.3	17.5	11.3	14.4	16.8	9.6	16.5	11.1	10.1	16.6	10.3	13.8	19.4	10.9	10.6	9.7	14.2	9.5	15.1	13.7	10.0	13.3	13.3	20.1	8.9	11.6	10.9	10.8	12.3	13.0	12.5	11.5	29.7	13.5	12.4	12.3	12.3	18.8	10.9	13.0	10.7	11.8	11.2	18.3	14.9	12.1	9.4	1.6	2.1	1.8	5.2	0.4	1.6	1.4	5.1	10.2	8.3	10.4	7.2	6.2	8.3	9.1	6.8	10.8	8.5	7.6	9.0	13.1	5.2	8.3	13.3	16.4	11.3	11.3	8.3	6.2	9.6	14.1	17.5	5.8	22.0	11.0	6.2	8.9	7.9	7.4	10.0	8.1	6.5	7.5	8.8	10.1	8.3	3.7	13.1	12.8	5.0	8.4	6.6	11.7	8.4	6.4	12.8	15.0	2.8	6.3	5.8	10.2	7.3	6.0	6.0	8.6	9.2	8.1	9.9	4.0	10.1	5.7	1.4	2.3	1.8	1.5	2.4	1.6	1.2	1.4	0.7	2.1	1.6	1.0	1.0	0.5	0.4	5.2	1.1	1.2	1.4	11.3	11.4	13.3	17.5	10.9	10.6	13.7	10.0	10.9	10.7
NOVA1		ENSG00000139910	"NOVA alternative splicing regulator 1"	P51513	14	26443093-26597754	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 54.7"	"Cell line enhanced"	"Detected in many"		"AF22: 25.6;ASC diff: 13.9;HAP1: 12.5"	"Cancer enriched"	"Detected in many"	5	"glioma: 14.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004155	Uncertain		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA004155: AB_1079497"	"unprognostic (1.46e-1)"	"unprognostic (4.43e-3)"	"unprognostic (6.55e-3)"	"unprognostic (4.00e-2)"	"unprognostic (6.69e-3)"	"unprognostic (4.29e-2)"	"unprognostic (3.74e-3)"	"unprognostic (2.41e-1)"	"unprognostic (5.21e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.04e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.93e-3)"	"unprognostic (9.27e-4)"	"unprognostic (9.20e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.31e-4)"	17.8	6.7	17.5	3.4	17.4	1.3	32.9	54.7	49.2	12.2	6.3	13.3	5.0	2.5	9.4	6.9	4.0	6.2	6.2	3.0	17.1	25.1	7.0	2.2	2.7	4.4	19.2	17.8	6.3	2.7	4.4	14.1	1.3	26.4	5.4	6.5	4.0	2.8	17.5	6.9	3.1	3.4	9.9	22.5	2.1	3.3	10.3	14.9	0.0	4.1	2.7	5.2	5.6	9.4	0.3	0.3	0.6	0.4	2.2	0.5	0.0	0.0	6.0	25.6	0.0	13.9	7.5	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.4	0.4	0.1	12.5	0.1	0.0	0.0	1.0	0.0	0.0	0.2	5.2	0.0	1.2	9.3	0.0	1.9	1.9	5.4	0.0	0.0	4.1	0.0	5.2	0.1	7.5	6.1	0.7	8.5	0.1	3.5	4.9	8.1	4.7	0.0	0.0	0.0	0.7	0.0	0.0	3.6	4.1	3.1	0.7	0.0	0.0	0.0	5.0	0.0	3.7	0.6	0.0	0.2	0.3	0.1	0.3	0.2	0.2	0.2	0.1	0.3	0.2	0.5	0.6	2.2	0.4	0.3	0.4	0.0	17.5	17.4	54.7	26.9	17.1	25.1	19.2	17.8	26.4	14.9
NPM1	"B23, NPM"	ENSG00000181163	"Nucleophosmin 1"	P06748	5	171387116-171411137	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Host-virus interaction"	"Chaperone, RNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA011384, CAB012983"	Supported		Enhanced	Nucleoplasm,Nucleoli			810000	Nucleoli	Nucleoplasm	"CAB012983: AB_2533084, HPA011384: AB_1854692"	"unprognostic (1.84e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavourable (7.48e-4)"	"prognostic unfavourable (4.82e-6)"	"unprognostic (1.86e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (2.89e-6)"	"unprognostic (2.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.24e-2)"	56.8	44.7	29.9	61.1	33.6	76.0	67.0	37.7	34.6	113.5	57.8	24.8	39.3	36.7	78.2	50.5	81.6	65.0	44.0	48.5	28.8	31.6	64.9	78.8	59.5	128.1	36.1	27.9	177.4	102.0	27.1	57.9	65.2	36.1	87.2	49.3	29.5	47.3	48.2	67.9	42.7	52.8	92.4	43.2	85.9	54.0	56.7	31.3	111.3	112.6	66.5	82.1	116.8	65.7	85.3	54.1	12.3	29.1	59.0	126.6	91.4	118.4	80.2	97.5	138.1	59.6	108.9	145.4	107.8	98.5	146.1	131.6	191.5	83.7	317.2	85.7	62.3	69.5	135.3	245.1	190.4	98.7	107.3	111.9	78.7	141.0	88.4	225.3	92.8	96.0	86.4	99.1	195.6	109.0	136.0	73.0	106.0	147.1	147.0	160.3	122.0	98.6	132.0	107.6	162.6	124.6	83.6	76.9	61.8	64.4	105.4	195.1	129.3	100.0	68.0	48.9	107.8	56.2	181.5	58.5	106.3	190.8	73.9	183.5	97.4	12.3	26.9	8.4	45.7	29.1	84.6	85.3	85.1	66.2	54.1	62.8	126.6	99.0	4.0	59.0	23.1	48.7	73.2	91.4	29.9	33.6	37.7	34.6	28.8	31.6	36.1	27.9	36.1	31.3
NPM2		ENSG00000158806	"Nucleophosmin/nucleoplasmin 2"	Q86SE8	8	22024125-22036897	"Predicted intracellular proteins"	Fertilization	"Chaperone, Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.6;parathyroid gland: 40.2;thyroid gland: 23.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 13.1;HEL: 10.6;Hep G2: 23.4;THP-1: 8.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 10.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 4.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 4.1;T-cells: 2.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA041070	Enhanced		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA041070: "	"unprognostic (1.40e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.01e-1)"	"prognostic favourable (9.02e-4)"	"unprognostic (2.23e-1)"	"prognostic favourable (3.18e-6)"	"unprognostic (8.05e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.30e-1)"	0.8	15.6	14.4	0.5	11.4	1.3	2.3	20.4	27.6	1.9	1.4	0.8	0.3	2.4	4.9	1.3	1.4	2.8	2.2	1.5	13.0	13.8	2.9	1.3	2.0	1.0	14.9	15.7	0.8	7.4	40.2	7.8	0.9	7.2	4.7	1.4	3.7	3.1	1.8	0.8	2.0	1.4	4.0	3.0	7.5	2.0	3.1	2.4	0.1	23.2	0.0	0.8	1.4	0.8	0.4	0.0	4.1	0.0	0.0	2.2	0.1	2.8	0.4	0.1	0.2	0.7	0.0	1.2	0.3	0.4	1.8	3.7	1.2	2.7	0.0	0.9	0.0	13.1	0.3	0.0	1.1	0.1	0.3	10.6	0.7	23.4	2.4	1.4	1.0	0.4	1.8	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.1	2.8	0.5	0.3	0.2	1.0	0.6	4.4	0.0	2.8	0.2	0.0	0.0	3.5	0.5	8.3	0.0	0.0	0.2	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.9	0.0	2.2	0.0	0.9	2.1	0.0	0.4	0.3	0.4	0.0	0.0	0.0	0.0	1.4	0.1	14.4	11.4	20.4	27.6	13.0	13.8	14.9	15.7	7.2	2.4
NPM3		ENSG00000107833	"Nucleophosmin/nucleoplasmin 3"	O75607	10	101781325-101783413	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036295, HPA036296"	Approved		Approved	"Nucleoli,Actin filaments,Cytosol"				"Nucleoli, Actin filaments, Cytosol"		"HPA036295: AB_10671244, HPA036296: AB_10672083"	"unprognostic (3.41e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.06e-2)"	"prognostic unfavourable (1.42e-4)"	"unprognostic (1.00e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.69e-2)"	"unprognostic (9.58e-2)"	9.8	17.0	14.3	20.9	8.5	17.2	14.3	1.5	16.8	13.3	12.3	2.4	6.2	6.0	15.7	15.0	22.7	11.7	12.4	8.9	9.9	7.3	13.6	13.7	8.8	26.3	7.3	11.4	17.7	39.0	11.3	11.1	12.0	9.1	11.5	15.1	3.7	13.2	7.1	11.7	14.0	8.7	15.0	4.8	14.7	11.0	16.4	7.7	18.5	9.8	23.7	18.8	13.0	13.9	4.5	8.3	0.1	3.7	7.0	10.4	5.7	17.1	21.8	6.5	42.7	14.9	15.7	6.9	9.3	14.2	14.5	12.4	23.4	22.0	28.5	17.4	10.3	18.5	36.2	39.5	11.4	12.0	37.6	22.8	10.2	37.4	16.8	51.9	16.7	13.6	19.2	20.0	80.4	18.9	28.1	15.8	11.9	31.7	21.6	67.6	11.5	16.8	17.0	34.2	28.9	14.1	8.5	13.4	8.6	5.8	13.7	25.9	17.8	10.8	7.4	5.7	18.4	8.5	17.2	6.8	7.1	32.7	8.0	48.3	5.9	0.0	2.7	0.0	3.8	3.7	7.0	4.3	6.3	7.2	6.3	4.5	10.4	10.4	0.1	7.0	0.8	8.3	2.6	5.7	14.3	8.5	1.5	16.8	9.9	7.3	7.3	11.4	9.1	7.7
NPR1	"ANPa, ANPRA, GUCY2A, NPRA"	ENSG00000169418	"Natriuretic peptide receptor 1"	P16066	1	153678637-153693992	"Enzymes, FDA approved drug targets, Predicted membrane proteins"	"cGMP biosynthesis"	"Lyase, Receptor, Vasoactive"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 98.4"	"Cell line enriched"	"Detected in some"	6	"ASC diff: 59.1"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 39.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"olfactory region: 23.0"	"Region enhanced"	"Detected in many"		"olfactory region: 11.1"	HPA031087			Approved	"Nucleoplasm,Nucleoli,Plasma membrane"				Nucleoli	"Nucleoplasm, Plasma membrane"	"HPA031087: AB_10601975"	"unprognostic (2.54e-1)"	"unprognostic (3.03e-3)"	"unprognostic (6.31e-2)"	"prognostic unfavourable (3.97e-4)"	"unprognostic (1.55e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.27e-2)"	"prognostic favourable (2.49e-4)"	"unprognostic (1.27e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.74e-2)"	41.1	4.3	0.5	5.9	0.9	0.1	98.4	0.5	0.8	8.1	8.2	0.3	7.3	1.2	16.8	11.1	8.7	25.0	9.3	19.6	0.9	0.5	28.7	3.7	34.8	8.6	0.7	0.0	19.5	4.2	7.8	4.5	11.8	2.5	4.9	1.5	2.0	2.0	9.0	6.9	3.4	4.6	15.6	2.2	1.2	5.0	6.4	0.2	0.8	7.6	5.1	1.1	11.6	26.5	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	59.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	9.8	0.0	7.1	0.0	0.0	0.1	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.5	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	2.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.5	0.8	0.9	0.5	0.7	0.0	2.5	0.2
NRG2	"Don-1, HRG2, NTAK"	ENSG00000158458	"Neuregulin 2"	O14511	5	139846779-140043299	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.3"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 8.3;Karpas-707: 5.5;PC-3: 14.5;RPTEC TERT1: 7.4;SCLC-21H: 5.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.1"	"Lineage enriched"	"Detected in single"	4	"T-cells: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038935, HPA047973"	Approved		Supported	Nucleoplasm,Nucleoli	"Secreted to blood"			Nucleoplasm	Nucleoli	"HPA038935: AB_10672833, HPA047973: "	"unprognostic (8.66e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.96e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.26e-3)"	"unprognostic (4.00e-2)"	"unprognostic (7.79e-3)"	"unprognostic (3.64e-3)"	"unprognostic (9.54e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.07e-2)"	4.5	4.5	4.0	1.4	7.0	0.6	4.4	27.3	5.1	13.1	2.3	3.8	2.6	1.0	3.0	2.9	3.7	7.6	7.6	1.5	4.2	3.5	1.3	0.6	1.2	2.1	5.2	3.4	15.9	3.2	15.8	7.7	1.1	4.1	4.5	0.9	2.9	13.6	4.7	6.0	5.0	1.0	5.1	3.6	3.3	1.1	2.7	4.9	0.0	0.8	1.0	1.5	4.8	3.7	0.4	0.1	0.0	0.1	0.0	2.1	0.1	0.0	1.9	0.2	8.3	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.1	0.0	0.4	0.0	2.4	0.4	0.2	0.1	4.7	3.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.5	0.2	0.0	5.5	0.0	0.4	0.0	0.0	0.1	14.5	0.1	0.0	0.0	7.4	1.7	5.5	3.3	0.0	3.2	3.3	0.0	0.0	0.2	2.5	0.4	0.0	1.6	1.1	0.0	0.0	3.6	0.0	0.7	0.0	0.0	0.0	2.1	0.1	0.5	0.1	0.2	0.4	0.0	0.4	0.4	1.2	0.0	0.0	0.0	0.1	0.0	0.1	4.0	7.0	27.3	5.1	4.2	3.5	5.2	3.4	4.1	4.9
NRIP1	RIP140	ENSG00000180530	"Nuclear receptor interacting protein 1"	P48552	21	14961235-15065936	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 40.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 5.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029785, HPA046571, HPA060036"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA029785: , HPA046571: , HPA060036: "	"unprognostic (5.60e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.20e-3)"	"unprognostic (4.64e-3)"	"unprognostic (7.98e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.75e-3)"	"unprognostic (8.94e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.80e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.80e-1)"	29.0	15.0	10.8	12.6	7.5	19.6	18.4	20.8	10.5	23.1	21.2	6.7	8.5	14.5	16.6	13.4	13.1	18.8	9.0	11.8	9.3	5.8	16.0	22.7	9.3	8.9	5.9	7.3	14.4	15.8	8.3	11.2	16.8	7.2	13.9	15.8	12.7	10.3	7.7	36.5	7.6	30.3	17.3	12.9	17.0	8.4	6.8	7.7	22.1	7.3	12.4	5.9	13.0	14.9	2.6	1.7	0.5	1.4	1.2	5.6	0.7	9.6	20.4	16.1	0.0	8.1	5.2	5.7	11.5	5.1	7.6	5.8	3.8	7.6	0.0	6.5	10.9	5.0	1.0	6.8	15.4	0.0	4.4	14.5	7.1	11.7	4.8	7.2	3.2	6.4	9.5	7.9	9.3	5.6	10.3	8.0	5.0	5.4	3.3	0.0	6.5	6.1	40.9	12.6	0.3	4.4	16.6	1.4	0.0	9.5	5.0	3.8	12.2	5.5	9.7	6.2	4.2	9.6	4.6	3.8	0.0	0.0	13.6	0.0	3.1	0.0	1.4	0.5	1.0	0.8	5.6	0.9	1.0	1.1	1.7	2.6	1.7	0.6	0.3	1.2	1.4	1.7	0.5	0.7	10.8	7.5	20.8	10.5	9.3	5.8	5.9	7.3	7.2	7.7
NSA2	"FLJ94393, HCLG1, HUSSY-29, TINP1"	ENSG00000164346	"NSA2, ribosome biogenesis homolog"	O95478	5	74766991-74780113	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA043487	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA043487: "	"unprognostic (4.79e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.49e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.14e-3)"	"unprognostic (4.24e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.14e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.92e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.44e-1)"	25.4	32.6	17.4	26.8	29.3	28.3	24.0	14.0	29.4	31.8	25.8	8.0	18.0	26.2	26.5	22.6	27.9	22.9	13.5	27.7	20.8	13.6	27.4	35.4	27.0	42.5	16.7	19.1	54.2	31.2	13.5	35.4	25.4	20.3	27.8	20.6	10.4	33.8	17.9	51.1	17.3	22.2	23.1	28.5	28.5	24.3	44.5	15.7	26.4	27.2	21.7	26.1	36.7	26.1	17.0	11.1	4.4	11.9	13.1	19.3	6.1	20.3	11.1	13.8	18.5	8.6	15.8	21.0	14.6	7.6	9.3	7.4	18.4	20.0	16.5	31.1	8.0	12.6	10.8	16.1	13.2	11.2	16.8	8.6	21.7	21.1	8.0	14.9	20.2	10.4	15.2	12.4	9.2	7.7	8.5	13.9	9.9	15.4	25.1	37.6	9.1	9.7	18.0	16.1	31.0	11.7	22.5	14.8	19.3	8.8	17.1	39.3	16.0	42.6	8.9	7.1	21.7	13.5	41.8	13.9	18.5	26.9	18.0	26.5	10.7	4.4	7.2	4.2	10.5	11.9	15.1	17.0	16.0	15.8	11.1	12.4	19.3	19.1	1.3	13.1	8.8	10.4	15.8	6.1	17.4	29.3	14.0	29.4	20.8	13.6	16.7	19.1	20.3	15.7
NSMAF	"FAN, GRAMD5"	ENSG00000035681	"Neutral sphingomyelinase activation associated factor"	Q92636	8	58583504-58659844	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023067, HPA023148, HPA023151"	Uncertain		Approved	Nucleoli				Nucleoli		"HPA023067: AB_1854653, HPA023148: AB_10670028, HPA023151: AB_1854654"	"unprognostic (1.09e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.86e-3)"	"unprognostic (2.69e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.96e-3)"	"unprognostic (9.03e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.44e-1)"	"prognostic unfavourable (4.61e-9)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.69e-1)"	19.3	18.9	13.3	19.2	23.5	8.9	22.7	19.5	14.8	15.2	16.8	11.3	6.0	11.0	17.9	11.5	16.1	12.7	13.1	17.3	12.8	10.9	9.9	6.7	17.7	27.2	13.4	11.7	15.5	20.9	25.6	16.3	15.6	12.9	14.9	17.9	12.7	14.1	15.9	20.3	22.4	16.9	22.3	12.1	20.9	16.8	8.4	11.1	43.8	16.3	11.2	25.0	19.2	17.9	4.8	14.5	15.4	7.2	6.4	8.7	4.5	13.0	12.7	5.8	8.1	22.1	18.0	10.0	10.5	23.4	14.6	13.8	7.1	8.2	15.8	8.8	16.5	10.5	9.8	8.4	16.8	17.7	5.4	29.7	7.9	7.9	28.1	12.9	20.6	12.1	13.6	10.6	40.8	14.6	12.7	11.7	16.6	9.8	27.1	10.5	10.3	5.0	10.3	8.6	4.5	8.2	10.5	5.4	6.9	8.8	3.3	9.6	8.1	16.3	13.4	14.6	8.8	19.5	10.7	2.2	1.0	12.5	21.4	10.2	9.2	8.3	7.2	4.8	6.8	5.3	7.0	4.8	7.2	7.1	14.5	4.6	5.1	4.8	15.4	6.4	3.6	5.0	8.7	4.5	13.3	23.5	19.5	14.8	12.8	10.9	13.4	11.7	12.9	11.1
NSUN5	"FLJ10267, NOL1R, NSUN5A, p120(NOL1), WBSCR20, WBSCR20A, Ynl022cL"	ENSG00000130305	"NOP2/Sun RNA methyltransferase family member 5"	Q96P11	7	73302517-73308867	"Disease related genes, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, RNA-binding, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020536, HPA045590, HPA046867"	Approved		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA020536: AB_1858789, HPA045590: , HPA046867: "	"unprognostic (3.94e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavourable (2.48e-4)"	"unprognostic (1.92e-1)"	"prognostic unfavourable (3.96e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.85e-2)"	9.0	7.7	11.2	13.1	12.8	40.9	8.7	12.9	14.4	8.5	10.3	15.0	4.8	12.6	12.3	6.9	10.8	12.0	8.1	9.4	10.8	9.3	9.4	9.8	8.0	16.1	19.4	11.9	10.6	19.6	9.5	8.3	8.3	13.6	9.7	6.2	7.7	13.6	9.7	27.1	11.8	12.1	10.9	11.6	15.8	9.6	14.6	13.6	23.5	10.6	11.2	12.1	10.6	8.9	33.5	21.2	18.7	14.4	16.8	22.3	15.3	12.0	16.7	4.7	10.3	2.0	2.5	17.9	5.8	3.4	9.0	9.6	22.6	9.0	19.9	3.9	2.9	10.4	8.8	5.8	2.9	13.1	20.6	7.5	12.2	12.9	7.6	16.6	10.2	3.3	9.7	7.7	6.5	1.1	24.5	4.7	4.3	29.0	14.0	34.0	19.0	12.9	17.1	3.5	28.5	3.9	6.0	12.2	20.4	10.2	27.2	13.1	17.5	13.2	1.9	0.1	13.1	13.0	3.9	19.0	24.5	28.4	0.2	23.3	0.9	14.2	14.4	15.0	14.0	12.5	11.0	21.5	15.9	14.3	16.5	33.5	22.3	18.8	18.7	16.8	9.3	21.2	17.3	15.3	11.2	12.8	12.9	14.4	10.8	9.3	19.4	11.9	13.6	13.6
NTRK3	TRKC	ENSG00000140538	"Neurotrophic receptor tyrosine kinase 3"	Q16288	15	87859751-88256768	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.8"	"Cell line enriched"	"Detected in some"	8	"U-138 MG: 47.4"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009233, HPA027484, HPA048065"	Approved		Supported	"Nuclear membrane,Nucleoli"			11000000	Nucleoli	"Nuclear membrane"	"CAB009233: AB_632555, HPA027484: , HPA048065: "	"unprognostic (1.27e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.91e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.45e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.49e-3)"	20.8	7.4	22.0	2.5	28.1	1.5	6.2	30.4	41.8	7.0	4.0	8.4	1.3	2.0	12.4	6.7	3.4	9.5	3.9	5.5	22.0	11.1	5.1	2.0	5.7	3.1	11.2	18.7	5.1	2.9	1.6	7.9	2.8	14.7	6.8	4.7	8.0	11.5	8.7	1.9	2.9	2.5	7.7	13.7	4.1	3.0	13.8	13.7	0.0	2.5	0.7	4.3	7.1	4.8	0.7	0.4	1.3	0.5	0.5	0.8	0.0	0.0	5.9	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.4	0.9	0.0	0.5	0.0	0.0	0.0	1.4	0.0	0.1	1.2	0.5	0.4	0.3	0.1	0.2	0.4	0.3	0.3	0.1	0.7	0.4	0.4	1.3	0.5	0.1	0.4	0.8	0.0	22.0	28.1	30.4	28.9	22.0	11.1	11.2	18.7	14.7	13.7
NUB1	"BS4, NUB1L, NYREN18"	ENSG00000013374	"Negative regulator of ubiquitin like proteins 1"	Q9Y5A7	7	151341699-151378449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021220, HPA050722, HPA053648"	Approved		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA021220: , HPA050722: , HPA053648: "	"unprognostic (7.04e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.22e-2)"	"prognostic unfavourable (8.70e-4)"	"unprognostic (1.42e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.10e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.69e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.83e-3)"	20.1	17.3	17.1	22.1	15.5	13.2	20.5	20.5	20.0	22.2	25.0	17.6	17.3	30.9	24.4	17.6	18.1	19.8	17.0	16.5	14.8	12.9	17.1	18.9	21.2	28.7	14.3	15.4	25.4	21.7	28.0	26.4	23.7	18.5	21.6	15.3	16.2	19.8	15.7	30.3	16.9	38.3	20.8	19.8	26.5	17.7	56.0	16.0	32.3	26.5	15.9	19.8	25.3	22.3	21.1	18.9	28.9	24.0	24.5	24.7	17.1	26.6	12.1	16.4	9.6	17.1	20.9	13.6	21.5	19.8	16.4	18.9	11.8	23.6	28.8	28.5	13.4	13.5	9.7	14.0	10.5	25.4	16.5	10.4	11.6	7.5	23.9	24.2	13.6	13.3	16.4	11.7	11.1	10.7	27.3	0.8	13.1	14.3	42.8	18.5	25.6	16.0	23.8	17.0	4.3	12.1	13.2	15.4	25.6	40.3	17.3	20.5	11.9	14.0	21.6	13.9	4.9	18.5	20.3	28.1	21.4	25.3	28.1	20.9	22.7	10.4	15.7	20.7	20.9	20.3	24.7	21.1	18.3	21.1	13.6	19.9	20.4	19.0	28.9	24.5	24.0	18.9	14.3	17.1	17.1	15.5	20.5	20.0	14.8	12.9	14.3	15.4	18.5	16.0
NUCKS1	NUCKS	ENSG00000069275	"Nuclear casein kinase and cyclin dependent kinase substrate 1"	Q9H1E3	1	205712819-205750276	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062351, HPA063843"	Supported		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA062351: , HPA063843: "	"unprognostic (1.68e-1)"	"unprognostic (3.92e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavourable (1.41e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.93e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.82e-3)"	"unprognostic (7.45e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.57e-2)"	25.6	25.3	46.9	17.3	55.5	12.1	31.3	45.0	49.2	33.0	24.2	38.3	18.8	12.5	36.5	27.8	25.3	32.1	22.5	40.6	43.8	35.6	30.9	43.9	20.6	29.4	43.6	47.6	49.1	17.4	50.3	21.0	20.8	32.8	31.9	21.1	21.9	19.0	32.7	43.1	21.7	14.6	42.9	49.1	22.6	17.9	14.2	38.9	35.3	42.5	20.6	24.8	32.0	22.6	7.8	7.4	4.5	4.9	10.7	11.8	4.0	40.6	25.0	67.4	26.6	18.7	25.9	31.8	29.3	30.3	41.2	33.3	13.7	46.9	45.1	17.0	28.5	30.1	51.2	24.6	47.4	21.5	25.6	29.3	22.1	14.9	13.8	46.0	10.5	20.5	22.3	24.5	42.7	32.2	47.0	14.5	32.1	47.0	41.7	23.2	68.8	18.7	43.6	83.1	25.9	23.1	25.1	28.1	51.9	43.3	34.7	23.5	53.0	34.8	32.1	31.7	28.2	36.1	51.8	13.3	15.7	36.4	21.7	26.0	42.6	4.5	3.4	3.7	9.9	4.9	9.6	5.8	9.2	8.6	4.7	7.8	11.5	11.8	0.6	10.7	4.0	7.4	5.5	4.0	46.9	55.5	45.0	36.6	43.8	35.6	43.6	47.6	32.8	38.9
NUDT14	UGPP	ENSG00000183828	"Nudix hydrolase 14"	O95848	14	105172938-105181323	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046755, HPA058759"	Approved		Approved	Nucleoli,Microtubules				Microtubules	Nucleoli	"HPA046755: AB_10963433, HPA058759: "	"unprognostic (1.05e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.05e-3)"	"unprognostic (9.17e-3)"	"unprognostic (2.02e-1)"	"prognostic favourable (1.66e-4)"	"unprognostic (3.16e-3)"	"unprognostic (3.13e-1)"	"prognostic favourable (1.18e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.21e-3)"	"unprognostic (2.38e-1)"	18.2	12.6	22.4	5.0	16.0	3.1	14.3	2.5	23.4	6.5	11.0	7.9	5.9	16.7	4.7	11.7	7.1	12.6	9.8	20.9	15.4	13.5	16.7	11.2	12.6	9.4	16.1	14.8	4.0	26.0	4.7	27.6	4.8	11.2	10.5	4.6	14.7	16.7	9.9	28.7	6.2	13.8	3.1	13.2	6.3	12.7	8.9	7.8	3.1	17.9	9.2	5.7	4.9	4.7	5.8	15.1	1.7	27.3	6.1	5.8	8.9	8.2	11.3	1.0	4.4	1.3	1.6	18.1	2.3	3.1	3.8	5.5	8.0	8.8	0.6	11.6	1.2	10.4	0.5	6.3	0.3	4.3	8.3	1.8	4.9	5.5	9.7	2.2	22.3	2.3	8.0	0.9	0.7	7.5	2.8	1.4	1.3	24.0	0.2	0.0	5.9	15.8	4.3	10.4	4.8	4.1	23.8	15.7	2.3	4.1	0.1	9.6	8.9	10.7	17.6	6.4	2.8	4.5	2.3	0.7	0.4	1.0	9.3	2.5	2.3	1.7	18.5	0.5	5.8	17.4	3.6	5.8	4.6	3.8	15.1	4.0	4.5	5.2	0.6	6.1	27.3	7.3	2.5	8.9	22.4	16.0	2.5	23.4	15.4	13.5	16.1	14.8	11.2	7.8
NUDT16	FLJ31265	ENSG00000198585	"Nudix hydrolase 16"	Q96DE0	3	131381671-131388830	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 18.2;eosinophil: 18.8;intermediate monocyte: 21.9;myeloid DC: 13.6;neutrophil: 14.6;non-classical monocyte: 24.5"	"Group enriched"	"Detected in all"	4	"dendritic cells: 13.6;granulocytes: 18.8;monocytes: 24.5"					"Low region specificity"	"Detected in all"			"HPA060452, HPA062492"	Uncertain		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA060452: , HPA062492: "	"unprognostic (4.85e-3)"	"prognostic favourable (9.39e-5)"	"unprognostic (3.19e-3)"	"unprognostic (9.21e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.88e-2)"	"prognostic favourable (1.05e-7)"	"unprognostic (3.29e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.00e-2)"	"unprognostic (9.44e-2)"	25.9	13.4	22.1	13.1	22.0	8.7	13.1	13.5	20.5	11.1	32.8	23.9	13.9	20.2	11.7	11.6	8.7	14.0	13.6	22.2	21.1	19.6	25.9	23.1	16.2	31.1	27.7	16.9	23.0	18.3	32.9	9.7	7.6	20.1	13.4	18.4	13.6	11.7	13.6	20.3	6.8	37.5	18.5	30.4	22.2	13.8	9.5	21.6	2.2	17.1	11.5	9.1	12.4	8.4	4.3	13.6	18.8	24.5	3.7	4.3	6.7	12.7	6.8	11.2	5.8	22.6	20.5	5.2	10.4	9.6	7.0	7.3	10.4	5.7	2.1	9.1	9.6	9.3	9.9	6.5	11.3	6.3	7.2	5.4	8.7	10.0	14.5	9.1	9.9	18.3	5.8	4.6	12.7	10.9	6.1	11.1	6.8	13.2	0.0	2.4	8.7	10.1	7.1	8.1	16.0	7.0	10.3	5.5	9.7	6.2	6.3	9.5	13.8	7.2	10.7	11.5	5.0	21.0	8.0	11.0	10.8	0.3	7.4	7.0	6.3	2.2	18.2	18.8	2.6	21.9	2.7	4.3	2.7	2.4	13.6	4.2	2.4	2.4	14.6	3.7	24.5	1.8	4.3	6.7	22.1	22.0	13.5	20.5	21.1	19.6	27.7	16.9	20.1	21.6
NUDT19	RP2	ENSG00000213965	"Nudix hydrolase 19"	A8MXV4	19	32691961-32713796	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042761			Uncertain	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli, Cytosol"		"HPA042761: "	"unprognostic (1.20e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.35e-3)"	"unprognostic (6.61e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.18e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.23e-1)"	"prognostic favourable (1.35e-4)"	9.9	18.7	7.2	11.1	7.0	10.8	10.7	7.4	7.6	5.6	12.8	6.1	8.4	10.2	6.6	8.8	16.9	6.3	7.6	19.3	6.1	6.5	10.5	16.4	15.9	9.2	6.2	5.5	8.5	18.9	9.5	9.3	6.6	6.1	11.2	10.7	9.4	14.7	11.8	29.5	13.2	12.9	6.9	5.6	8.9	11.3	6.8	6.6	6.8	5.9	13.1	13.0	9.9	8.4	8.4	11.9	9.0	23.6	18.7	14.8	6.5	13.6	16.0	1.8	15.9	5.5	7.2	0.3	7.8	2.9	5.8	5.5	9.0	7.6	0.2	9.4	8.9	8.9	10.9	9.0	7.7	15.8	6.6	17.7	6.4	3.3	7.6	13.3	5.5	5.8	12.0	4.9	12.0	8.5	13.6	10.2	10.4	9.1	0.1	12.2	1.9	7.6	0.1	3.5	7.7	9.5	10.2	7.2	10.3	13.8	11.8	9.8	6.5	16.3	6.8	8.1	5.2	8.0	13.8	11.9	10.1	4.5	9.7	12.8	7.3	6.6	17.3	9.0	11.9	21.7	12.8	8.4	12.5	14.8	11.9	5.9	10.0	13.8	3.3	18.7	23.6	9.5	13.8	6.5	7.2	7.0	7.4	7.6	6.1	6.5	6.2	5.5	6.1	6.6
NUDT8	FLJ41567	ENSG00000167799	"Nudix hydrolase 8"	Q8WV74	11	67627938-67629930	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA041252, HPA041466"	Enhanced		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA041252: AB_10794551, HPA041466: AB_10793967"	"unprognostic (8.31e-2)"	"unprognostic (7.26e-3)"	"unprognostic (7.31e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.36e-3)"	"unprognostic (2.69e-1)"	"unprognostic (4.12e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.74e-1)"	"prognostic favourable (3.70e-4)"	"unprognostic (4.70e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.19e-1)"	5.5	2.0	3.0	4.1	4.1	2.1	10.8	4.1	2.7	3.9	8.1	3.5	10.1	10.6	1.7	4.8	22.0	2.4	5.9	32.5	2.6	3.0	16.0	21.4	3.8	4.3	4.9	2.3	2.2	7.7	4.3	1.3	2.5	5.9	4.2	4.2	2.0	28.3	8.2	38.2	12.4	12.2	2.4	4.1	1.9	6.9	1.4	2.3	2.0	13.6	25.0	15.3	1.6	4.7	7.1	11.8	1.0	11.2	8.1	3.4	2.1	10.3	4.2	1.6	2.7	1.5	1.9	2.6	2.1	1.0	0.9	0.9	3.4	2.7	10.8	3.4	1.6	5.1	1.9	1.3	0.1	10.5	4.5	0.6	1.8	10.5	0.4	3.4	5.2	1.2	2.6	1.1	0.3	1.9	3.0	9.7	0.7	17.3	5.7	4.9	0.9	8.6	3.5	0.8	67.9	2.7	1.8	0.8	1.1	0.5	6.0	2.1	3.3	1.4	0.5	2.3	3.3	14.7	0.4	6.9	4.6	2.1	1.6	4.6	1.3	0.0	1.0	1.0	3.1	3.9	2.6	3.3	1.8	3.4	4.3	7.1	1.6	1.9	0.0	8.1	11.2	11.8	1.1	2.1	3.0	4.1	4.1	2.7	2.6	3.0	4.9	2.3	5.9	2.3
NUFIP1	NUFIP	ENSG00000083635	"NUFIP1, FMR1 interacting protein 1"	Q9UHK0	13	44939249-44989483	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029958, HPA029959"	Approved		Enhanced	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA029958: AB_10598911, HPA029959: AB_10602308"	"unprognostic (2.01e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.98e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.91e-2)"	"unprognostic (9.74e-3)"	"unprognostic (4.52e-1)"	"unprognostic (3.95e-2)"	"unprognostic (3.73e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.31e-1)"	"unprognostic (5.24e-2)"	8.9	9.8	10.4	10.7	16.4	17.4	11.6	11.0	17.2	9.8	7.8	10.8	4.8	7.1	11.7	14.4	9.2	9.2	6.3	6.4	12.7	9.6	10.2	13.7	11.2	8.5	8.9	12.6	13.7	11.5	9.3	9.6	7.7	7.9	9.1	7.9	6.3	8.6	8.8	17.0	10.1	6.4	10.3	10.0	8.4	8.6	14.1	8.8	11.4	10.1	6.8	9.3	8.9	8.3	6.6	6.3	1.1	3.7	8.3	6.9	2.5	5.4	4.3	7.3	6.0	5.0	5.2	8.7	6.4	5.6	12.0	7.7	11.5	8.7	15.9	5.4	6.0	8.6	13.5	9.1	15.7	4.8	10.6	12.1	2.9	10.3	8.3	15.5	4.9	5.4	8.5	8.1	12.3	5.9	9.6	2.7	8.4	6.2	12.8	9.8	17.2	7.1	12.7	6.9	9.7	7.2	4.7	4.0	8.9	5.5	7.6	6.9	5.7	8.7	4.5	6.2	5.3	7.9	8.8	3.7	5.7	20.0	6.9	11.0	8.6	0.0	3.7	1.1	3.9	3.7	6.9	5.9	4.3	4.1	4.7	6.6	6.8	5.1	0.2	8.3	2.3	6.3	2.4	2.5	10.4	16.4	11.0	17.2	12.7	9.6	8.9	12.6	7.9	8.8
NUP188	KIAA0169	ENSG00000095319	"Nucleoporin 188"	Q5SRE5	9	128947699-129007096	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 60.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061750, HPA063942"	Approved		Uncertain	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA061750: , HPA063942: "	"unprognostic (4.64e-1)"	"unprognostic (6.91e-3)"	"unprognostic (2.36e-1)"	"prognostic favourable (5.20e-5)"	"unprognostic (9.50e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.81e-3)"	"unprognostic (3.53e-3)"	10.2	11.1	7.6	12.6	9.2	14.3	14.0	13.3	8.7	9.2	9.3	10.1	9.6	5.8	9.8	6.7	16.6	8.3	7.6	9.2	5.6	6.3	8.1	9.6	13.1	16.6	6.5	6.7	10.8	13.3	12.6	13.6	9.1	7.3	9.5	9.3	11.2	9.9	8.3	10.9	16.4	9.0	11.0	7.7	12.2	9.5	60.3	7.3	26.5	9.2	11.3	17.3	8.5	10.5	6.1	7.9	6.3	10.7	6.0	12.0	7.0	10.8	20.7	17.2	23.4	13.0	13.0	15.4	15.2	12.0	27.9	18.6	24.9	8.7	19.0	5.7	16.7	32.1	38.5	18.8	20.9	15.2	18.5	16.9	38.7	19.7	8.3	28.8	17.1	9.0	8.9	29.3	15.0	16.0	37.0	13.5	19.7	27.4	24.6	11.8	23.0	19.9	22.6	37.2	19.3	8.6	12.3	24.2	11.7	39.4	15.0	5.8	16.5	10.6	12.9	23.2	16.5	23.3	27.2	11.6	21.3	25.7	13.5	18.5	17.1	6.3	5.3	1.9	9.3	10.7	12.0	6.1	7.9	9.0	7.9	5.9	8.1	8.6	0.8	6.0	5.9	3.3	9.5	7.0	7.6	9.2	13.3	8.7	5.6	6.3	6.5	6.7	7.3	7.3
NVL	NVL2	ENSG00000143748	"Nuclear VCP-like"	O15381	1	224227334-224330387	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028207, HPA028219, HPA028224, HPA028654"	Supported		Enhanced	Nucleoli				Nucleoli		"HPA028207: AB_10601382, HPA028219: , HPA028224: , HPA028654: "	"unprognostic (1.50e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (5.77e-5)"	"prognostic favourable (2.95e-4)"	"unprognostic (4.43e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.42e-1)"	"prognostic unfavourable (4.10e-11)"	"unprognostic (1.67e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.37e-1)"	11.3	12.6	13.3	14.3	12.6	12.5	16.2	24.4	15.7	14.2	13.8	16.9	11.4	9.0	17.1	12.2	11.6	13.5	8.5	9.8	10.4	9.9	13.6	9.4	11.8	16.9	10.5	10.8	16.9	19.3	16.8	20.7	25.8	13.4	14.2	16.0	16.5	11.6	12.6	9.8	22.7	12.5	17.5	13.3	16.4	11.1	9.4	12.0	23.8	15.5	8.5	19.1	14.4	13.7	14.0	9.9	12.5	15.2	12.3	13.5	7.9	14.5	8.3	17.3	13.8	6.5	9.3	17.4	12.4	8.7	16.4	15.1	12.6	12.5	20.3	13.4	7.9	13.8	18.8	11.6	17.9	15.8	25.9	9.7	14.1	6.4	11.2	19.1	15.5	7.5	9.3	14.6	16.5	10.7	25.4	12.5	10.7	11.3	14.8	9.5	26.6	14.8	18.6	21.5	13.0	9.9	10.3	15.3	13.4	18.8	28.7	17.0	13.7	17.5	10.4	13.1	8.5	15.2	23.0	8.3	18.0	21.5	8.4	15.6	13.6	12.5	8.2	8.2	13.1	13.0	13.0	14.0	13.5	9.6	9.9	10.1	11.3	11.5	0.8	12.3	15.2	9.6	9.5	7.9	13.3	12.6	24.4	15.7	10.4	9.9	10.5	10.8	13.4	12.0
OARD1	"C6orf130, dJ34B21.3, MGC19570, TARG1"	ENSG00000124596	"O-acyl-ADP-ribose deacylase 1"	Q9Y530	6	41033627-41097787	"Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029036	Approved		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA029036: AB_10602336"	"unprognostic (2.33e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.62e-2)"	"unprognostic (7.06e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.99e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.15e-1)"	"prognostic favourable (1.13e-4)"	"unprognostic (4.78e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-1)"	14.6	19.1	19.1	15.8	19.3	15.3	19.3	13.2	20.2	13.6	17.4	18.8	30.3	19.1	12.6	26.6	15.8	20.1	15.9	13.5	19.1	18.6	27.8	35.4	16.2	24.8	21.4	19.6	22.5	25.3	21.6	22.4	13.8	20.9	16.8	20.4	17.6	15.9	24.2	16.7	14.9	17.9	15.8	21.4	16.2	22.7	44.7	20.9	21.4	24.6	14.2	20.7	16.0	14.1	27.6	16.5	23.4	16.2	27.4	24.4	13.2	14.3	9.3	20.1	13.5	11.6	13.3	11.9	8.8	12.6	10.5	11.7	13.9	10.6	19.9	9.8	5.4	10.6	12.4	11.9	15.7	17.5	6.7	24.1	9.8	26.0	10.9	16.5	15.8	10.4	17.5	10.2	34.9	7.3	30.5	17.1	11.3	21.4	26.9	19.4	18.9	6.1	12.5	17.5	19.3	20.8	7.9	21.1	14.1	8.3	8.4	28.9	14.8	15.3	7.5	11.0	13.0	7.0	15.2	22.5	22.4	44.2	9.1	16.8	9.3	20.4	13.8	23.4	17.2	14.2	21.6	27.6	19.7	17.0	16.5	25.8	24.4	23.2	13.4	27.4	16.2	16.0	21.8	13.2	19.1	19.3	13.2	20.2	19.1	18.6	21.4	19.6	20.9	20.9
OLFM1	"AMY, NOE1, NOELIN, OlfA"	ENSG00000130558	"Olfactomedin 1"	Q99784	9	135075422-135121179	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 159.5"	"Cell line enhanced"	"Detected in some"		"HeLa: 25.2;MCF7: 21.2;NTERA-2: 28.3;SCLC-21H: 40.8;SiHa: 33.8;T-47d: 52.4;U-2197: 22.8"	"Cancer enhanced"	"Detected in all"		"glioma: 18.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	38	"classical monocyte: 3.4;intermediate monocyte: 5.0;myeloid DC: 5.1;non-classical monocyte: 1.3"	"Group enriched"	"Detected in many"	51	"dendritic cells: 5.1;monocytes: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057444			Approved	Nucleoplasm,Nucleoli,Cytosol	"Secreted in brain"		130000000	Nucleoli	"Nucleoplasm, Cytosol"	"HPA057444: "	"unprognostic (6.77e-2)"	"prognostic favourable (7.14e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.76e-2)"	"prognostic unfavourable (6.58e-4)"	"unprognostic (3.08e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.69e-3)"	"unprognostic (2.67e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.87e-1)"	"unprognostic (9.46e-3)"	"unprognostic (4.60e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.20e-2)"	"unprognostic (7.53e-4)"	7.7	10.0	80.5	5.0	41.5	0.9	4.7	30.9	159.5	7.4	5.4	4.6	0.7	2.5	6.9	26.4	5.0	4.4	3.8	3.9	77.2	19.1	3.4	2.4	4.7	5.2	18.8	36.5	6.2	5.1	3.6	9.9	1.1	13.5	4.8	5.7	0.9	2.6	7.5	6.1	4.5	3.5	6.9	6.1	5.8	3.9	2.8	2.8	0.3	2.7	0.8	7.1	4.1	6.2	0.0	5.1	0.0	5.0	0.0	0.0	0.6	0.0	1.5	3.1	0.0	0.4	0.3	0.1	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.2	1.3	0.6	0.6	0.0	0.0	3.6	0.2	0.0	25.2	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	21.2	0.1	0.0	28.3	0.0	0.0	0.0	11.9	0.0	0.0	40.8	5.4	33.8	0.1	2.1	52.4	0.0	0.0	2.0	4.5	22.8	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.0	3.4	0.0	0.0	5.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.6	80.5	41.5	30.9	119.7	77.2	19.1	18.8	36.5	13.5	2.8
ORC4	"HsORC4, ORC4L, Orc4p"	ENSG00000115947	"Origin recognition complex subunit 4"	O43929	2	147930397-148021604	"Disease related genes, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015124, HPA064562"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"CAB015124: AB_2157883, HPA064562: "	"unprognostic (5.04e-2)"	"unprognostic (6.56e-2)"	"unprognostic (4.51e-2)"	"prognostic unfavourable (7.27e-4)"	"unprognostic (8.28e-2)"	"unprognostic (6.45e-2)"	"prognostic unfavourable (4.98e-8)"	"unprognostic (5.55e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.81e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.19e-1)"	"prognostic favourable (4.10e-6)"	"unprognostic (2.49e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.95e-3)"	11.5	14.3	19.0	11.4	20.5	19.6	17.3	29.8	27.2	13.6	14.6	11.0	12.0	13.9	14.8	13.5	13.1	17.3	11.9	13.8	18.1	22.3	24.5	15.5	10.9	11.9	18.1	18.1	21.2	12.1	18.9	29.5	14.3	30.9	14.9	16.8	12.7	15.2	14.6	16.0	11.6	15.6	13.8	18.1	11.0	10.9	17.3	11.8	20.4	19.0	12.7	13.6	13.3	12.6	16.1	18.1	21.5	19.1	20.2	16.6	13.1	12.2	10.7	21.0	11.5	8.2	8.1	22.9	14.0	11.8	17.7	17.8	26.4	12.5	15.9	15.4	8.2	12.5	23.8	13.8	18.5	11.1	20.2	21.9	11.6	17.8	10.9	13.8	8.3	6.8	16.8	19.3	7.7	11.9	20.8	8.4	11.5	13.0	10.7	11.3	23.9	15.7	11.8	14.2	14.3	19.6	25.5	19.9	15.6	12.6	13.9	16.8	10.7	6.7	8.6	13.5	13.3	9.8	12.8	8.4	19.7	15.0	11.0	10.8	8.2	21.5	15.0	19.8	16.2	19.1	16.6	16.1	15.8	16.6	18.1	15.4	16.6	16.3	21.1	20.2	14.8	9.2	16.0	13.1	19.0	20.5	29.8	27.2	18.1	22.3	18.1	18.1	30.9	11.8
OSBPL3	"KIAA0704, ORP-3, ORP3, OSBP3"	ENSG00000070882	"Oxysterol binding protein like 3"	Q9H4L5	7	24796539-24981634	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000691, HPA048401"	Enhanced		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA000691: AB_1854814, HPA048401: "	"unprognostic (3.57e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.11e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavourable (7.88e-4)"	"unprognostic (2.34e-1)"	"unprognostic (7.95e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.06e-2)"	3.7	2.2	3.9	18.2	9.5	3.8	6.6	1.2	16.0	12.1	6.1	6.2	0.7	9.8	3.8	3.7	10.2	6.2	10.4	5.3	4.3	4.3	14.4	1.9	9.0	10.9	4.2	7.4	8.4	3.9	23.1	4.2	6.3	3.1	4.3	6.7	3.7	6.9	2.9	6.7	12.8	10.4	4.0	6.7	10.2	8.7	3.5	4.1	13.9	16.8	7.2	14.7	12.4	9.6	3.7	3.5	6.3	2.1	8.1	9.8	2.4	14.4	3.9	2.9	5.4	6.6	13.4	6.6	16.4	18.3	7.7	12.2	9.8	19.2	8.0	2.3	17.5	12.7	8.8	12.3	11.9	4.8	3.6	1.9	5.8	7.3	9.4	5.4	43.0	6.5	10.3	10.0	12.1	11.5	10.0	11.2	13.0	0.0	3.3	6.7	5.7	5.1	2.7	8.1	3.3	7.7	10.3	0.6	6.1	11.1	8.0	2.4	4.1	0.5	13.6	3.4	6.8	18.5	12.2	7.8	11.3	20.2	7.4	9.0	37.9	6.3	2.1	1.5	9.8	1.8	8.4	3.7	6.2	6.3	3.5	1.7	2.1	4.2	0.4	8.1	1.2	2.5	9.8	2.4	3.9	9.5	1.2	16.0	4.3	4.3	4.2	7.4	3.1	4.1
OSCP1	"C1orf102, NOR1"	ENSG00000116885	"Organic solute carrier partner 1"	Q8WVF1	1	36415827-36450451	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 35.8;testis: 49.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028436, HPA052655"	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"				"Nucleoplasm, Nucleoli"	"Plasma membrane"	"HPA028436: AB_10600885, HPA052655: "	"unprognostic (3.46e-3)"	"unprognostic (7.57e-2)"	"unprognostic (4.67e-2)"	"prognostic favourable (6.88e-4)"	"unprognostic (1.28e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.52e-2)"	"unprognostic (5.52e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.87e-2)"	"prognostic favourable (2.18e-6)"	"unprognostic (1.20e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.20e-2)"	3.9	5.3	6.2	1.5	14.0	1.2	6.0	3.6	12.7	6.2	3.6	6.5	7.5	1.8	6.3	14.1	3.2	35.8	5.5	4.7	6.5	8.9	11.9	1.8	6.7	1.3	4.9	5.3	5.9	6.2	15.7	15.7	8.9	7.8	6.4	2.5	6.7	5.3	6.8	2.4	3.4	1.3	5.0	3.2	0.9	3.5	49.9	3.2	1.3	11.1	3.5	2.4	3.2	2.6	0.8	3.8	0.3	1.7	0.3	3.1	0.8	5.1	4.9	6.1	7.1	7.3	7.2	1.1	3.1	7.7	7.8	5.4	0.1	4.6	1.1	5.9	5.7	4.1	0.2	5.9	5.1	0.9	4.7	0.0	3.3	0.5	9.1	0.6	0.9	8.1	9.7	11.0	4.8	5.3	0.1	1.3	6.1	3.7	2.7	1.9	6.2	2.1	2.9	2.5	0.9	12.8	1.8	16.5	7.3	5.9	2.8	4.1	6.0	0.8	4.6	5.7	2.1	10.2	5.3	2.3	2.3	0.5	10.9	0.1	3.8	0.0	0.7	0.0	0.9	1.7	0.0	0.4	0.9	0.7	1.8	0.8	2.2	3.1	0.3	0.3	0.2	3.8	2.2	0.8	6.2	14.0	3.6	12.7	6.5	8.9	4.9	5.3	7.8	3.2
OSER1	"C20orf111, dJ1183I21.1, HSPC207, Osr1, Perit1"	ENSG00000132823	"Oxidative stress responsive serine rich 1"	Q9NX31	20	44196496-44210791	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045125	Approved		Approved	"Nucleoli,Nuclear speckles"				"Nucleoli, Nuclear speckles"		"HPA045125: AB_10961629"	"unprognostic (2.77e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.22e-1)"	"prognostic unfavourable (2.58e-5)"	"unprognostic (1.18e-1)"	"unprognostic (6.07e-2)"	"unprognostic (8.44e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.78e-2)"	"unprognostic (8.01e-3)"	"unprognostic (9.87e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.06e-1)"	18.7	11.8	11.9	18.4	13.3	62.5	20.0	17.8	13.3	19.1	17.2	13.0	13.0	15.1	17.5	17.6	23.5	14.2	13.7	16.9	12.4	10.0	15.0	16.3	17.7	16.9	16.3	10.9	21.4	10.9	19.3	12.5	31.7	13.1	22.6	14.1	12.4	17.0	13.2	46.3	22.3	18.9	23.5	16.9	18.2	14.7	47.4	13.3	15.1	19.0	15.4	17.4	29.6	16.7	28.4	14.6	74.3	21.9	15.1	17.6	19.8	20.5	16.1	11.6	9.2	31.3	22.3	13.6	19.0	28.6	29.9	27.5	38.5	21.3	20.6	18.8	17.3	28.0	13.2	17.4	25.2	6.9	8.7	6.6	34.6	26.1	18.1	11.4	11.1	26.4	29.4	19.6	36.0	13.6	9.8	25.4	16.4	30.7	9.1	13.9	10.6	16.5	12.8	19.8	14.2	14.9	14.1	11.8	11.8	27.1	35.9	24.0	18.3	10.2	11.9	24.7	19.0	14.7	16.3	17.3	18.4	20.0	17.5	8.5	12.8	50.2	16.8	27.7	12.7	15.7	13.7	28.4	14.8	12.5	14.6	26.9	17.6	15.9	74.3	15.1	21.9	9.5	17.1	19.8	11.9	13.3	17.8	13.3	12.4	10.0	16.3	10.9	13.1	13.3
OSGIN2	"C8orf1, hT41"	ENSG00000164823	"Oxidative stress induced growth inhibitor family member 2"	Q9Y236	8	89901859-89927888	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 56.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 17.0"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028515, HPA050595"	Approved		Approved	Nucleoli				Nucleoli		"HPA028515: AB_10602014, HPA050595: "	"unprognostic (3.29e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.42e-3)"	"unprognostic (3.26e-2)"	"prognostic unfavourable (3.91e-6)"	"prognostic unfavourable (2.93e-4)"	"unprognostic (2.32e-1)"	"unprognostic (2.22e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.25e-2)"	15.2	7.5	12.5	7.8	13.9	40.4	16.8	9.6	17.5	7.6	13.3	26.4	6.0	6.8	26.1	6.1	11.7	8.1	14.2	11.2	14.2	13.4	14.7	16.2	15.7	9.1	13.7	13.0	15.9	7.8	53.5	25.2	6.5	18.2	9.1	8.6	8.3	8.6	7.3	13.2	7.6	8.7	17.1	25.3	9.0	7.5	20.5	14.7	7.1	12.9	8.0	8.9	11.1	8.5	3.0	1.5	17.0	1.4	2.0	2.5	1.3	11.9	11.7	3.0	6.0	6.6	4.8	3.9	8.6	16.5	7.9	7.7	5.5	11.5	8.2	17.6	4.4	4.4	5.6	6.8	12.4	11.8	4.5	12.5	4.6	3.0	11.2	6.3	7.8	5.6	8.9	9.2	7.6	9.7	7.2	14.7	5.6	9.3	10.8	4.2	1.5	6.3	4.8	4.4	7.0	12.0	9.3	2.8	6.9	6.4	56.3	10.4	11.5	9.4	6.5	8.7	8.0	7.1	7.9	13.6	11.6	9.0	14.4	7.7	6.1	17.0	1.4	5.8	1.7	0.9	2.4	3.0	2.5	1.5	1.5	1.8	2.1	2.3	10.3	2.0	1.1	1.1	2.5	1.3	12.5	13.9	9.6	17.5	14.2	13.4	13.7	13.0	18.2	14.7
OSMR	OSMRB	ENSG00000145623	"Oncostatin M receptor"	Q99650	5	38845858-38945596	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Amyloidosis, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 38.9;HSkMC: 48.2;U-2197: 38.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017278	Approved		Approved	Nucleoli	"Intracellular and membrane"		21000000	Nucleoli		"HPA017278: AB_1854818"	"unprognostic (6.34e-3)"	"prognostic unfavourable (4.87e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.00e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.72e-3)"	"unprognostic (1.60e-3)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (3.96e-6)"	"unprognostic (1.88e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.75e-2)"	41.1	18.0	7.3	18.7	9.4	0.3	31.0	3.1	9.4	14.1	13.7	2.8	4.6	4.4	14.4	12.9	14.7	14.5	22.4	22.4	5.4	3.5	19.7	23.6	25.7	31.7	9.0	1.3	33.6	10.1	6.6	10.5	40.1	13.3	20.8	8.6	9.2	17.2	11.1	13.0	12.5	8.0	32.5	15.6	23.5	11.5	10.8	6.9	3.6	17.5	10.4	11.3	40.4	43.6	0.6	0.6	1.6	0.4	0.7	0.6	0.1	7.5	9.8	1.6	4.2	18.1	38.9	5.7	12.4	19.7	12.2	16.4	0.0	20.6	0.0	5.9	13.1	10.5	2.1	15.2	19.7	0.0	1.2	0.5	7.7	7.4	20.6	0.0	0.1	48.2	9.1	27.3	23.5	1.8	0.0	0.0	7.7	2.0	0.0	0.0	0.2	3.2	0.0	0.5	0.0	24.5	2.2	0.0	0.0	27.9	0.0	0.0	8.6	0.0	2.9	29.8	11.3	38.5	6.5	0.0	0.0	0.0	23.9	0.0	6.4	1.6	0.4	0.4	0.5	0.3	0.2	0.3	0.3	0.1	0.1	0.6	0.4	0.6	1.0	0.7	0.1	0.6	0.2	0.1	7.3	9.4	3.1	9.4	5.4	3.5	9.0	1.3	13.3	6.9
OTUD7A	"C15orf16, CEZANNE2, OTUD7"	ENSG00000169918	"OTU deubiquitinase 7A"	Q8TE49	15	31475398-31870789	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044554	Uncertain		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA044554: AB_10794895"	"unprognostic (3.61e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.24e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-11)"	"unprognostic (6.78e-2)"	"unprognostic (2.76e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.79e-1)"	2.6	2.0	12.4	1.7	13.9	5.9	1.5	13.2	17.0	1.8	3.4	16.0	0.0	1.5	1.9	1.9	1.9	2.0	2.3	2.1	10.0	4.6	2.3	1.0	1.5	3.5	20.4	7.1	2.0	2.5	4.6	1.7	0.9	10.5	1.2	3.1	0.7	1.6	2.0	1.8	3.2	2.1	2.9	9.1	2.2	2.3	8.2	17.4	0.0	2.3	0.0	2.4	1.9	1.3	0.1	3.2	0.3	1.4	0.1	0.7	0.4	3.6	4.1	4.5	6.0	0.4	1.3	3.2	2.5	1.3	3.9	1.9	2.5	3.2	2.9	2.2	0.9	4.6	4.8	2.0	3.2	5.9	6.6	3.7	8.3	2.0	0.3	4.0	5.7	0.0	0.2	3.8	4.3	3.5	6.0	5.4	1.8	2.9	3.1	3.9	2.0	2.0	5.6	3.0	1.4	1.6	3.9	10.9	6.0	3.4	3.0	1.0	2.5	4.3	2.3	5.3	5.2	3.0	6.2	3.3	2.4	3.0	2.9	5.8	4.5	0.0	0.4	0.3	0.6	0.5	0.3	0.0	0.3	0.7	0.2	0.1	0.2	0.2	0.0	0.1	1.4	3.2	0.0	0.4	12.4	13.9	13.2	13.8	10.0	4.6	20.4	7.1	10.5	17.4
P2RX6	"MGC129625, P2RXL1, P2X6, P2XM"	ENSG00000099957	"Purinergic receptor P2X 6"	O15547	22	21009808-21028830	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"skeletal muscle: 12.4"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 8.2;RH-30: 5.1;U-87 MG: 14.6"	"Cancer enhanced"	"Detected in some"		"melanoma: 2.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028776, HPA028777"	Approved		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA028776: , HPA028777: "	"unprognostic (1.81e-2)"	"unprognostic (5.15e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.79e-5)"	"unprognostic (1.70e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.88e-10)"	"unprognostic (2.81e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.39e-3)"	0.2	1.6	0.0	0.2	0.2	0.0	0.0	0.9	3.2	0.0	0.0			0.0	0.1	0.0	0.1	0.3	1.1	1.9	0.2	0.8	0.1	0.0	0.2	0.0	0.6		0.3	0.0	0.0	1.6	1.1		0.2	0.0		0.1	1.1	12.4	0.0	0.0	0.0	0.8	2.3	0.1	1.2			0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.8	0.3	0.1	0.0	1.0	0.1	2.0	0.8	1.5	0.0	0.0	0.0	1.4	0.5	1.7	0.0	0.1	0.1	0.3	0.0	2.2	0.8	0.0	3.6	0.0	3.0	0.4	0.0	1.5	0.1	0.0	2.4	0.7	8.2	0.0	0.0	0.4	0.0	0.0	0.0	5.1	0.2	0.0	0.0	0.2	3.8	1.5	0.1	0.7	0.0	0.0	0.0	2.6	0.5	0.0	0.0	0.3	0.0	0.0	14.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0										
P3H1	"GROS1, LEPRE1, LEPRECAN, MGC117314"	ENSG00000117385	"Prolyl 3-hydroxylase 1"	Q32P28	1	42746335-42767084	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 50.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA012113, HPA016980"	Approved		Approved	Nucleoli,Vesicles	"Intracellular and membrane"		13000	Vesicles	Nucleoli	"HPA012113: , HPA016980: AB_2669498"	"unprognostic (3.24e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.37e-2)"	"unprognostic (4.57e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (4.95e-7)"	"unprognostic (5.41e-2)"	"unprognostic (2.70e-3)"	"unprognostic (9.16e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.41e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.60e-3)"	11.9	11.2	7.1	8.6	6.3	5.2	9.7	6.4	5.3	14.0	7.1	6.0	7.7	2.6	13.8	11.1	6.4	8.8	12.1	8.8	3.8	2.9	7.9	19.9	10.8	10.1	6.1	3.3	13.1	6.8	5.8	15.2	36.1	4.6	7.8	5.7	10.5	6.4	6.5	4.3	7.2	6.6	19.7	3.4	13.3	6.6	13.1	4.7	10.2	7.4	5.3	7.8	11.4	8.5	3.1	16.2	11.0	16.2	11.7	7.9	6.1	2.2	5.8	13.0	30.4	30.8	23.6	5.3	26.8	34.9	19.4	33.1	2.9	4.9	3.3	21.5	50.5	2.0	5.5	6.8	13.4	4.9	6.9	7.8	9.2	8.3	17.9	7.8	9.0	20.1	4.6	19.5	8.4	27.3	4.4	4.2	12.9	1.2	5.0	4.4	14.2	4.2	5.0	19.2	4.5	10.2	1.2	2.7	4.6	16.3	0.4	11.5	0.9	32.8	22.2	14.5	12.8	11.5	10.6	3.8	4.3	3.0	16.6	10.6	20.1	3.5	13.2	11.0	6.0	14.0	6.4	3.1	4.6	5.1	16.2	2.6	3.9	3.9	1.2	11.7	16.2	7.6	7.9	6.1	7.1	6.3	6.4	5.3	3.8	2.9	6.1	3.3	4.6	4.7
P3H3	"GRCB, HSU47926, LEPREL2"	ENSG00000110811	"Prolyl 3-hydroxylase 3"	Q8IVL6	12	6828410-6839851	"Enzymes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 22.2;NTERA-2: 15.8;U-251 MG: 15.3"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.1;naive CD4 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	21	"T-cells: 2.1"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"cerebellum: 17.6"	HPA043695	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane, Cytosol"	Nucleoli	"HPA043695: AB_10797146"	"unprognostic (2.54e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.34e-2)"	"unprognostic (5.76e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.92e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.44e-1)"	"prognostic favourable (4.91e-4)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (1.64e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.77e-3)"	3.7	3.1	1.2	2.2	2.6	0.3	3.0	10.7	2.5	12.1	2.7	0.0	7.6	1.1	11.0	8.5	2.5	2.1	5.6	4.4	1.2		1.1	0.4	1.6	1.9	0.0	2.2	9.3	3.6	12.1	7.4	2.5	0.8	5.6	0.5	8.1	5.9	6.5	0.5	1.8	1.7	8.8	0.5	1.0	2.8	2.1	0.1	0.0	3.5	1.2	1.4	5.9	4.7	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.9	4.2	8.0	4.9	6.0	0.1	22.2	12.8	7.1	7.8	0.3	0.0	0.0	0.3	8.3	0.0	2.5	0.2	1.6	0.0	10.6	0.5	2.3	1.0	3.5	0.5	0.0	6.5	0.2	3.4	1.9	7.4	2.0	0.0	3.3	0.0	0.0	0.2	15.8	0.6	0.0	3.9	0.1	0.3	0.0	1.6	6.0	0.0	0.0	2.5	0.1	0.1	13.0	6.9	10.3	10.6	15.3	0.0	0.1	0.2	5.9	0.0	2.7	0.0	0.0	0.0	0.3	0.0	2.1	0.0	0.0	0.9	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.1	0.0										
PAFAH1B2		ENSG00000168092	"Platelet activating factor acetylhydrolase 1b catalytic subunit 2"	P68402	11	117144267-117176894	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051836	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"			1600000	Cytosol	"Nucleoli, Plasma membrane"	"HPA051836: "	"unprognostic (1.08e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.88e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.21e-3)"	"prognostic unfavourable (9.44e-4)"	"prognostic unfavourable (3.07e-4)"	"unprognostic (1.01e-1)"	"prognostic favourable (4.25e-4)"	"prognostic unfavourable (7.79e-5)"	"unprognostic (8.18e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.97e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.34e-1)"	21.5	34.1	30.6	19.2	29.7	33.5	32.3	43.5	41.3	21.6	20.2	33.3	12.7	21.1	23.4	22.8	23.3	20.8	19.3	26.2	31.9	36.8	24.6	22.5	20.5	17.7	39.3	31.6	23.6	23.0	23.1	24.2	26.9	39.6	22.2	19.6	17.3	19.3	17.4	14.1	20.8	18.0	19.9	51.6	18.3	21.4	29.9	26.3	15.1	30.9	10.8	20.4	25.9	20.3	26.8	21.6	36.8	35.7	18.9	31.4	26.9	14.8	17.0	19.7	28.3	22.0	15.4	15.3	25.0	21.9	13.9	12.7	31.0	32.8	16.1	35.9	29.9	23.9	28.5	32.3	18.4	14.3	11.0	41.3	15.6	19.9	19.7	14.2	15.8	17.0	25.6	27.8	35.1	22.8	21.9	12.3	21.3	9.5	13.7	21.0	18.0	13.4	15.4	22.3	17.6	21.3	23.3	21.9	29.1	28.8	21.8	9.5	24.3	12.3	36.4	25.5	16.9	12.4	17.7	3.9	5.9	21.6	10.3	27.4	21.4	32.1	30.8	26.7	24.2	33.3	28.2	26.8	28.0	25.3	21.6	25.4	29.3	31.4	36.8	18.9	35.7	15.8	19.5	26.9	30.6	29.7	43.5	37.8	31.9	36.8	39.3	31.6	39.6	26.3
PAK1IP1	"bA421M1.5, FLJ20624, hPIP1, MAK11, PIP1, WDR84"	ENSG00000111845	"PAK1 interacting protein 1"	Q9NWT1	6	10694695-10709782	"Predicted intracellular proteins"	"Ribosome biogenesis"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 48.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030111, HPA030112"	Supported		Supported	Nucleoli				Nucleoli		"HPA030111: , HPA030112: AB_10603125"	"unprognostic (9.41e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.17e-2)"	"prognostic unfavourable (1.35e-6)"	"unprognostic (7.23e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (7.02e-8)"	"unprognostic (8.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.10e-1)"	12.8	9.9	12.0	12.2	9.7	11.5	15.9	9.1	15.7	12.7	8.7	5.8	7.7	5.9	10.5	9.9	15.7	8.7	7.2	8.6	9.2	9.8	12.3	17.5	7.2	16.3	10.9	9.2	13.8	10.6	6.8	9.1	9.1	11.3	48.8	9.8	4.2	10.3	10.4	20.6	7.8	6.8	10.5	10.1	10.9	7.4	6.3	9.9	8.4	9.3	18.5	11.7	8.2	9.1	8.4	11.5	2.4	10.3	8.1	12.3	5.8	14.1	5.6	7.3	12.5	9.1	8.3	10.5	9.3	7.7	14.1	13.9	12.3	6.4	14.4	23.4	7.9	7.6	14.9	12.0	20.4	8.4	10.0	7.9	5.2	14.1	13.3	21.8	10.4	7.7	10.5	13.7	23.4	9.4	23.8	4.2	11.7	8.4	10.9	20.1	15.8	10.0	11.3	9.5	22.3	10.2	8.5	11.0	9.5	6.9	17.9	19.9	7.9	8.0	8.1	11.5	8.3	12.3	23.0	9.9	27.0	15.8	4.7	14.7	21.5	1.1	7.1	2.4	8.4	10.3	8.6	8.4	7.6	8.4	10.0	6.4	10.2	12.3	0.3	8.1	8.0	11.5	4.8	5.8	12.0	9.7	9.1	15.7	9.2	9.8	10.9	9.2	11.3	9.9
PAPSS1	"ATPSK1, PAPSS"	ENSG00000138801	"3'-phosphoadenosine 5'-phosphosulfate synthase 1"	O43252	4	107590276-107720452	"Enzymes, Predicted intracellular proteins"		"Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"basophil: 50.3;eosinophil: 62.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 62.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049781	Approved		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA049781: "	"unprognostic (1.36e-2)"	"unprognostic (5.03e-2)"	"prognostic favourable (9.14e-4)"	"prognostic favourable (8.58e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (2.70e-5)"	"unprognostic (1.58e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.76e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.38e-1)"	13.5	7.4	24.3	14.4	28.5	11.1	25.2	16.4	32.2	26.6	10.0	45.0	9.4	7.9	25.1	22.8	18.3	24.9	13.3	7.7	31.3	23.9	16.7	5.1	22.0	14.7	29.7	21.9	15.6	24.6	15.6	15.5	8.5	38.2	21.7	12.7	9.5	32.2	14.0	3.3	24.5	8.5	17.0	59.9	9.6	30.4	8.1	25.5	14.7	10.3	11.0	24.6	16.5	13.7	8.5	9.2	62.2	10.2	4.6	6.8	5.8	10.5	9.6	16.3	20.4	20.2	25.5	13.1	13.4	25.4	13.2	17.7	14.7	15.3	16.5	8.6	24.7	13.3	15.4	26.6	17.0	38.7	11.7	19.2	20.9	32.9	11.1	29.1	33.3	21.1	13.8	15.2	12.5	29.2	4.2	32.1	36.9	16.1	23.4	9.0	17.5	10.7	19.7	25.9	4.7	19.8	14.7	18.6	26.9	13.9	21.1	16.4	12.5	4.5	17.2	16.5	17.0	11.0	11.3	25.8	17.1	15.4	20.1	22.3	25.9	50.3	8.9	62.2	3.0	9.6	3.5	8.5	4.0	3.4	9.2	4.1	2.5	2.9	9.4	4.6	10.2	1.8	6.8	5.8	24.3	28.5	16.4	32.2	31.3	23.9	29.7	21.9	38.2	25.5
PAQR6	"FLJ22672, PRdelta"	ENSG00000160781	"Progestin and adipoQ receptor family member 6"	Q6TCH4	1	156243321-156248117	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	12	"brain: 138.1"	"Cell line enhanced"	"Detected in many"		"U-266/70: 20.7"	"Cancer enriched"	"Detected in all"	6	"glioma: 34.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"NK-cell: 10.5"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 10.5"									HPA073505			Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA073505: "	"unprognostic (1.64e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavourable (1.60e-5)"	"unprognostic (7.42e-2)"	"unprognostic (5.52e-2)"	"unprognostic (4.50e-3)"	"unprognostic (4.75e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.13e-1)"	"unprognostic (4.25e-3)"	"prognostic unfavourable (1.99e-4)"	"prognostic unfavourable (1.58e-8)"	"unprognostic (1.26e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.82e-2)"	"prognostic favourable (1.86e-4)"	2.1	3.6	42.5	2.2	38.0	7.6	2.2	8.7	71.6	2.0	2.7	102.9	0.0	2.8	2.3	2.9	2.5	2.2	2.9	2.0	48.1	37.6	2.0	2.1	2.1	2.1	82.7	16.1	1.6	1.6	2.4	1.2	2.2	72.5	3.5	2.3	0.0	3.2	3.0	2.1	11.5	3.0	2.0	138.1	2.3	3.1	2.5	46.0	0.0	2.0	0.0	2.0	2.5	0.3	0.8	1.6	0.0	0.0	10.5	1.2	0.1	1.7	2.0	3.3	3.4	0.6	0.5	8.1	0.2	0.5	0.0	0.2	0.9	6.3	3.2	1.5	0.5	5.7	0.0	0.7	0.4	1.9	2.7	2.0	1.7	0.9	0.3	0.6	5.3	1.6	2.6	2.4	2.4	0.2	1.5	9.4	0.5	6.7	0.2	1.0	3.7	0.9	1.4	0.7	1.5	2.3	10.6	2.8	5.7	0.7	0.7	3.8	10.7	1.1	0.5	1.0	5.3	1.7	0.5	20.7	4.5	2.0	0.2	7.4	0.9	0.0	0.0	0.0	0.4	0.0	1.2	0.8	0.6	0.2	0.0	0.1	0.0	0.0	0.0	10.5	0.0	1.6	0.1	0.1	42.5	38.0	8.7	34.4	48.1	37.6	82.7	16.1	72.5	46.0
PARP10	FLJ14464	ENSG00000178685	"Poly(ADP-ribose) polymerase family member 10"	Q53GL7	8	143977153-144012772	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 16.4"	"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"							"HPA028122, HPA052427"	Approved		Supported	"Nucleoli,Golgi apparatus,Cytosol"				Nucleoli	"Golgi apparatus, Cytosol"	"HPA028122: AB_10601979, HPA052427: "	"unprognostic (9.80e-3)"	"unprognostic (5.89e-2)"	"unprognostic (2.63e-3)"	"unprognostic (9.10e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.46e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.61e-1)"	"unprognostic (9.05e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.69e-3)"	"unprognostic (1.09e-3)"	"unprognostic (4.17e-2)"	"unprognostic (8.69e-2)"	"unprognostic (5.30e-3)"	14.2	18.8	8.8	27.4	9.5	15.7	18.6	5.3	8.7	14.4	16.5	9.3	20.7	20.5	20.3	18.3	15.8	18.0	21.8	6.4	8.9	4.1	20.5	19.1	21.4	23.6	10.4	6.8	22.4	15.3	9.3	14.2	10.4	9.2	17.7	3.8	12.7	27.7	14.9	12.5	14.3	21.8	9.6	8.9	31.1	13.1	15.8	9.8	27.8	15.4	10.4	21.6	8.8	12.9	2.4	16.4	3.2	2.8	1.9	4.6	2.4	8.4	0.8	0.6	1.5	4.2	3.8	4.6	1.4	1.8	9.5	10.7	0.4	14.8	10.5	20.2	4.5	3.2	0.2	5.0	0.4	23.7	0.0	11.6	4.9	5.3	4.1	4.5	14.0	2.4	5.0	4.7	1.9	1.4	0.2	8.4	1.8	10.3	15.7	7.9	0.5	6.8	14.8	1.7	14.1	3.9	10.7	0.5	0.5	9.8	1.0	18.6	11.0	6.8	6.5	4.9	7.4	8.2	5.2	14.3	8.4	2.4	7.1	15.4	2.6	0.0	1.9	3.2	4.6	2.8	3.0	1.2	2.2	3.7	2.3	2.4	1.6	2.3	1.1	1.9	2.7	16.4	1.6	2.4	8.8	9.5	5.3	8.7	8.9	4.1	10.4	6.8	9.2	9.8
PARP2	ADPRTL2	ENSG00000129484	"Poly(ADP-ribose) polymerase 2"	Q9UGN5	14	20343582-20357905	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052003	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA052003: "	"unprognostic (3.93e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.40e-2)"	"unprognostic (7.30e-2)"	"prognostic unfavourable (6.48e-4)"	"unprognostic (1.97e-2)"	"unprognostic (4.43e-2)"	"unprognostic (9.35e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.37e-3)"	"unprognostic (2.83e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.89e-2)"	11.5	16.6	23.6	8.9	28.5	20.9	15.2	36.7	31.3	12.0	11.7	16.8	9.3	11.2	18.8	16.8	10.7	14.7	8.9	14.0	19.2	17.8	14.0	15.0	12.0	11.8	16.6	30.8	20.2	11.8	11.6	14.6	11.3	22.1	11.3	12.9	10.8	10.5	12.9	25.9	15.1	10.8	14.6	13.9	11.4	11.6	20.4	17.4	6.0	11.7	13.9	15.2	9.3	10.4	6.7	5.6	1.8	5.0	6.9	12.3	4.9	20.2	14.8	22.8	17.1	7.6	7.2	16.6	22.5	12.3	28.6	35.5	13.9	19.4	15.0	10.2	7.1	19.0	30.3	10.3	33.9	12.0	14.8	13.7	17.9	23.3	6.8	28.3	7.9	5.0	8.8	17.8	19.7	14.7	14.5	20.5	19.6	12.5	14.5	12.2	12.5	23.1	18.2	31.0	9.7	11.4	10.6	15.8	10.9	25.1	14.0	6.6	12.9	9.6	10.0	17.5	26.5	12.0	18.2	19.2	24.5	19.9	7.3	12.6	19.3	1.8	5.0	0.5	9.5	4.5	12.3	6.7	8.9	8.3	5.4	4.6	9.6	9.3	0.1	6.9	2.5	5.6	5.2	4.9	23.6	28.5	36.7	31.3	19.2	17.8	16.6	30.8	22.1	17.4
PAX2		ENSG00000075891	"Paired box 2"	Q02962	10	100735603-100829941	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ductus deferens: 30.5;epididymis: 93.7;kidney: 43.1"	"Group enriched"	"Detected in some"	9	"AN3-CA: 14.2;EFO-21: 19.8;RPTEC TERT1: 14.1"	"Group enriched"	"Detected in some"	19	"endometrial cancer: 6.7;ovarian cancer: 7.0;renal cancer: 14.5"	"Group enriched"	"Detected in some"	6	"cerebellum: 1.0;pons and medulla: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"cerebellum: 1.5;pons and medulla: 3.5"	"Group enriched"	"Detected in some"	6	"cerebellum: 7.9;pons and medulla: 8.1"	"CAB013024, HPA047704, HPA070751"	Enhanced		Supported	"Nucleoli,Golgi apparatus"	"Intracellular and membrane"			Nucleoli	"Golgi apparatus"	"CAB013024: AB_2533990, HPA047704: , HPA070751: "	"unprognostic (3.98e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavourable (4.56e-4)"	"unprognostic (4.85e-2)"	"unprognostic (5.54e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-1)"		"unprognostic (1.24e-2)"	"unprognostic (6.59e-2)"	"unprognostic (9.18e-2)"	"unprognostic (3.30e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.34e-2)"	"unprognostic (8.26e-2)"	0.1	0.1	0.2	0.0	0.1	0.0	0.1	1.0	0.1	3.1	0.1	0.0	30.5	0.0	1.5	93.7	0.1	9.1	0.0	0.1	0.1	0.1	43.1	0.1	0.1	0.0	0.2	0.0	1.5	0.3	0.6	0.7	0.0	1.8	0.8	0.0	0.5	0.1	19.4	0.1	0.1	0.1	0.0	1.7	0.1	0.1	2.4	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	19.8	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	14.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.0	0.1	0.1	0.1	0.2	0.0	1.8	0.1
PBDC1	"CXorf26, MGC874"	ENSG00000102390	"Polysaccharide biosynthesis domain containing 1"	Q9BVG4	X	76172936-76178204	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003155	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol			88000	Nucleoplasm	"Nucleoli, Cytosol"	"HPA003155: AB_1078592"	"unprognostic (6.95e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.47e-3)"	"unprognostic (7.23e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.56e-3)"	"unprognostic (8.82e-3)"	"unprognostic (3.64e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.98e-2)"	"prognostic favourable (8.57e-4)"	"unprognostic (1.62e-1)"	24.9	25.4	12.7	15.1	14.3	28.9	17.1	15.3	14.9	21.3	31.5	10.0	14.8	28.5	21.3	18.4	26.9	15.1	14.2	14.7	12.5	12.5	36.3	39.1	16.6	17.0	17.6	8.8	23.1	16.1	15.2	22.8	21.9	15.0	22.3	20.9	10.3	18.0	14.3	19.2	19.5	48.9	22.3	22.7	23.8	17.8	8.4	14.6	21.1	22.5	21.2	18.2	20.8	17.6	28.1	24.0	17.0	27.8	27.1	30.6	17.1	12.1	17.8	15.2	10.4	19.5	19.5	13.1	21.6	18.6	20.0	17.2	17.0	16.9	16.7	14.6	21.8	17.6	25.4	24.2	26.1	12.3	16.1	12.3	10.0	25.4	30.7	36.2	18.1	15.5	20.0	27.3	23.3	25.3	17.4	8.3	24.3	14.3	17.0	26.5	42.3	27.9	14.6	16.0	2.1	29.1	22.6	8.9	11.5	9.6	15.9	0.1	9.7	13.7	21.8	14.9	15.0	17.7	19.8	14.7	25.8	9.9	16.6	12.7	11.7	6.7	17.6	17.0	30.6	25.6	22.2	28.1	27.5	29.7	22.5	23.7	28.2	26.9	3.3	27.1	27.8	24.0	22.5	17.1	12.7	14.3	15.3	14.9	12.5	12.5	17.6	8.8	15.0	14.6
PCDH1	pc42	ENSG00000156453	"Protocadherin 1"	Q08174	5	141853111-141879246	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 29.7;HaCaT: 37.1;HUVEC TERT2: 19.5;RT4: 25.4;TIME: 25.3;WM-115: 18.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.2;naive CD8 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047720, HPA050538"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"			270000	"Nucleoplasm, Cell Junctions"	Nucleoli	"HPA047720: AB_2680130, HPA050538: "	"unprognostic (4.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.61e-3)"	"unprognostic (5.03e-2)"	"unprognostic (4.16e-2)"	"prognostic unfavourable (4.96e-5)"	"unprognostic (1.98e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (3.61e-4)"	"unprognostic (2.43e-1)"	"prognostic favourable (7.55e-5)"	"unprognostic (2.05e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.91e-1)"	22.4	4.5	14.8	7.4	17.6	1.4	19.0	16.1	25.6	8.3	22.2	7.3	11.4	20.6	7.0	7.0	26.9	9.7	6.8	8.9	11.6	7.4	14.9	13.0	18.9	3.4	8.8	16.9	2.5	11.0	1.3	5.2	32.5	9.2	11.1	14.4	6.0	23.7	12.3	7.4	17.3	15.8	7.5	7.5	1.6	22.8	1.5	9.8	0.0	9.1	3.9	8.8	8.6	11.7	0.0	0.0	0.3	0.0	0.0	2.2	0.5	6.3	0.3	2.7	2.9	0.1	0.0	1.9	0.0	0.0	0.0	0.0	1.5	29.7	0.0	15.3	0.2	37.1	3.4	2.7	0.0	0.0	0.1	0.0	0.1	0.0	2.5	0.0	0.1	0.0	6.2	0.0	0.4	19.5	0.0	3.2	0.0	5.1	0.1	0.0	11.3	5.1	0.1	0.0	4.3	2.2	25.4	0.3	0.6	0.1	8.1	6.5	6.5	0.1	25.3	0.0	0.2	0.0	2.3	0.0	0.0	0.0	0.2	0.0	18.0	0.0	0.0	0.3	2.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.4	0.5	14.8	17.6	16.1	25.6	11.6	7.4	8.8	16.9	9.2	9.8
PCDHAC1		ENSG00000248383	"Protocadherin alpha subfamily C, 1"	Q9H158	5	140926369-141012344	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	12	"parathyroid gland: 33.3"	"Cell line enhanced"	"Detected in some"		"A549: 8.5;EFO-21: 3.6;hTCEpi: 11.0;PC-3: 6.2;SCLC-21H: 4.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA052775			Approved	Nucleoplasm,Nucleoli,Vesicles				"Nucleoplasm, Nucleoli"	Vesicles	"HPA052775: "	"unprognostic (2.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.32e-3)"	"unprognostic (9.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (9.63e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.04e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.29e-2)"	0.3	0.4	0.9	0.3	1.0	0.0	0.0	2.0	2.8	0.4	0.0			0.0	0.2	0.1	0.0	0.0	0.9	0.0	1.0	1.6	0.2	0.1	0.8	1.0	1.1		0.0	1.5	33.3	1.9	0.0		0.0	0.0		0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.8			0.8		0.4	0.0	0.0	0.2	0.1	0.5	0.2	0.2	0.1	0.0	0.0	8.5	1.2	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.6	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	11.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	6.2	0.0	0.0	0.0	0.5	0.4	4.9	2.3	0.0	0.6	0.0	0.5	0.0	0.0	0.6	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.5	0.2	0.2	0.1	0.0	0.0										
PCDHGA2	PCDH-GAMMA-A2	ENSG00000081853	"Protocadherin gamma subfamily A, 2"	Q9Y5H1	5	141338760-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.9;BJ: 5.4;fHDF/TERT166: 6.4;HSkMC: 5.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA008755, HPA010580, HPA038625"	Approved		Approved	"Nucleoplasm,Nucleoli,Vesicles,Plasma membrane,Focal adhesion sites,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Nucleoli, Focal adhesion sites, Cytosol"	"HPA008755: AB_1079577, HPA010580: , HPA038625: "	"unprognostic (2.43e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.54e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.32e-2)"	"unprognostic (8.45e-3)"	"unprognostic (9.68e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.23e-4)"	5.1	4.3	6.7	2.1	8.0	0.6	4.2	5.2	12.6	6.6	2.6	4.6	1.0	0.9	6.5	5.7	2.4	5.5	5.5	11.1	6.5	4.6	3.3	2.4	4.6	1.1	6.0	2.3	15.3	8.4	9.2	10.6	2.2	7.8	5.3	1.4	13.8	3.3	5.8	2.6	2.9	1.4	5.2	5.6	1.9	2.1	10.4	3.5	0.0	4.3	1.2	1.1	3.2	5.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.3	3.9	9.9	0.1	5.4	2.1	0.5	0.9	0.1	0.1	0.1	0.7	6.4	0.2	0.0	0.4	1.3	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	5.1	0.2	0.1	0.3	2.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.1	1.4	0.3	0.2	0.8	0.0	0.3	0.7	0.0	3.6	0.1	0.7	0.0	3.3	0.9	0.5	0.3	0.1	0.0	0.4	0.0	2.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	8.0	5.2	7.2	6.5	4.6	6.0	2.3	7.8	3.5
PCGF5	"MGC16202, RNF159"	ENSG00000180628	"Polycomb group ring finger 5"	Q86SE9	10	91163012-91284331	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA038349	Approved		Approved	Nucleoli				Nucleoli		"HPA038349: AB_10669523"	"unprognostic (1.34e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.25e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.35e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.43e-2)"	"unprognostic (3.89e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.49e-1)"	"prognostic favourable (4.98e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.56e-2)"	"prognostic favourable (6.90e-4)"	16.0	30.1	28.0	15.0	25.1	6.3	14.6	19.4	24.5	15.9	21.8	18.6	16.9	21.0	15.4	14.7	16.1	15.4	15.7	32.5	24.0	27.5	29.0	31.1	17.2	25.8	27.9	20.5	19.3	19.3	25.3	16.0	18.9	21.0	17.5	17.5	12.4	19.6	18.4	24.5	13.6	30.9	24.4	29.7	20.9	17.3	14.1	24.1	31.6	29.4	13.5	18.4	20.4	21.2	6.1	3.0	8.0	9.9	7.3	7.4	4.0	15.9	7.0	5.9	2.5	8.6	13.5	4.1	9.0	18.7	8.2	11.6	1.0	9.4	21.1	4.2	11.3	3.1	6.3	6.2	14.6	24.3	4.6	9.8	4.7	10.7	11.4	7.6	15.8	6.1	11.5	6.1	8.6	6.9	5.2	11.9	12.7	2.9	17.3	1.9	0.8	3.9	8.6	10.9	5.7	15.1	2.5	2.8	4.0	4.4	4.7	7.5	3.8	3.5	17.6	9.8	6.9	6.0	10.7	20.8	12.8	19.1	13.7	5.6	3.0	8.0	2.2	3.8	4.2	5.6	7.4	6.1	6.2	4.2	3.0	5.8	6.3	6.1	3.1	7.3	9.9	0.8	3.4	4.0	28.0	25.1	19.4	24.5	24.0	27.5	27.9	20.5	21.0	24.1
PCID2	FLJ11305	ENSG00000126226	"PCI domain containing 2"	Q5JVF3	13	113177539-113208715	"Predicted intracellular proteins"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069107, HPA073074"	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA069107: , HPA073074: "	"unprognostic (2.53e-2)"	"unprognostic (2.94e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (7.80e-5)"	"unprognostic (1.73e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavourable (4.24e-6)"	"unprognostic (1.41e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.45e-1)"	"unprognostic (6.28e-2)"	17.6	22.6	13.7	14.6	16.0	11.3	21.0	33.5	15.9	20.9	18.2	14.6	20.4	10.3	24.0	20.7	15.6	22.5	14.7	31.3	12.8	10.8	15.4	18.1	14.8	19.6	16.9	13.0	30.6	28.6	12.1	37.6	13.4	14.9	20.0	16.3	14.4	21.4	19.3	21.6	15.0	15.2	19.7	13.4	20.1	19.2	43.4	16.5	19.4	25.4	11.6	20.6	18.0	21.2	15.1	9.7	8.1	12.5	7.6	32.4	19.0	22.3	9.5	14.6	12.8	26.9	20.2	10.2	17.3	26.0	24.1	22.3	18.7	21.2	18.0	11.5	23.4	14.3	23.1	15.6	26.9	15.6	22.8	23.1	24.8	16.4	26.8	39.2	9.5	16.6	17.5	15.1	26.9	18.9	17.7	7.4	27.2	10.8	20.9	27.7	14.4	12.2	19.0	16.2	17.2	21.9	11.4	19.5	12.0	10.7	26.8	19.7	14.8	48.0	12.2	7.2	25.8	10.3	12.9	11.3	10.6	25.1	24.7	26.7	16.3	8.1	9.6	7.1	27.6	12.5	32.4	15.1	23.6	28.7	9.7	14.2	21.5	22.3	1.5	7.6	11.5	9.2	23.5	19.0	13.7	16.0	33.5	15.9	12.8	10.8	16.9	13.0	14.9	16.5
PCTP	STARD2	ENSG00000141179	"Phosphatidylcholine transfer protein"	Q9UKL6	17	55750979-55842830	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 56.4;liver: 53.2"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 56.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA022979	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA022979: "	"unprognostic (1.14e-1)"	"unprognostic (5.20e-2)"	"unprognostic (4.27e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.37e-2)"	"prognostic unfavourable (3.43e-6)"	"unprognostic (9.35e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.65e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.36e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.93e-1)"	"unprognostic (6.89e-3)"	"unprognostic (3.04e-1)"	8.2	5.6	4.9	8.2	8.2	5.1	8.4	3.1	5.3	6.2	11.9	3.0	29.8	9.3	5.2	15.8	6.6	4.9	10.1	12.1	5.1	4.7	17.0	53.2	11.6	7.8	6.2	4.9	5.2	7.5	4.2	5.3	19.4	5.5	7.5	12.7	5.3	7.1	32.1	10.8	4.1	9.8	8.3	5.0	10.0	12.5	8.0	3.9	3.0	5.7	5.8	5.2	8.1	9.9	2.0	12.1	56.4	15.3	6.2	2.7	6.5	8.6	7.9	6.0	2.2	8.1	7.9	15.5	3.4	4.5	5.4	5.3	8.9	11.2	2.4	26.5	5.3	4.8	3.5	5.7	4.9	38.3	8.0	21.4	2.4	16.7	7.2	8.1	17.0	6.5	7.6	3.2	5.9	10.5	15.3	8.6	5.9	7.5	6.4	6.6	6.5	7.1	3.3	8.7	1.9	5.7	6.4	3.0	6.8	1.7	3.7	14.3	10.0	14.1	7.6	6.2	4.4	6.9	4.4	24.6	7.7	1.5	5.7	13.5	10.7	15.1	15.3	56.4	2.5	12.6	1.5	2.0	1.6	2.5	12.1	1.4	0.9	2.2	15.9	6.2	13.2	0.9	2.7	6.5	4.9	8.2	3.1	5.3	5.1	4.7	6.2	4.9	5.5	3.9
PDCD11	"ALG-4, KIAA0185, RRP5"	ENSG00000148843	"Programmed cell death 11"	Q14690	10	103396648-103446292	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017924, CAB026472"	Approved		Supported	Nucleoli,Vesicles				Nucleoli	Vesicles	"CAB026472: , HPA017924: AB_10601045"	"unprognostic (1.34e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.94e-2)"	"prognostic unfavourable (2.79e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.25e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.28e-2)"	"unprognostic (5.59e-2)"	11.3	11.8	11.6	13.9	12.5	9.6	13.8	12.6	12.0	11.0	10.4	10.6	8.9	8.5	17.3	10.6	17.3	14.3	9.9	10.3	10.5	7.0	11.0	14.0	11.3	14.7	9.9	8.6	16.5	17.2	17.7	14.4	10.9	10.5	12.1	12.0	9.2	11.3	13.0	42.8	22.3	11.1	13.6	9.5	14.7	10.8	22.8	12.4	20.7	10.9	13.8	17.0	11.2	16.8	5.6	5.4	1.4	4.4	3.4	9.1	3.5	10.1	15.1	10.5	29.6	9.2	8.3	11.8	11.2	7.9	11.3	9.3	20.5	10.0	28.0	8.0	8.0	18.2	27.0	14.1	12.8	12.9	18.2	16.3	9.6	16.4	11.0	32.4	11.2	8.6	13.0	17.4	39.8	12.1	26.1	12.6	10.9	11.5	16.2	18.5	21.6	14.6	16.4	15.1	12.7	7.1	10.0	7.1	13.3	7.5	8.9	12.4	8.8	9.2	13.1	8.4	10.6	11.2	20.9	16.1	22.4	26.6	7.4	31.4	6.2	0.1	4.4	1.4	5.7	4.3	9.1	5.6	5.4	4.6	4.7	4.1	4.8	5.6	0.6	3.4	3.6	5.4	3.8	3.5	11.6	12.5	12.6	12.0	10.5	7.0	9.9	8.6	10.5	12.4
PDCD7	"ES18, HES18"	ENSG00000090470	"Programmed cell death 7"	Q8N8D1	15	65117379-65133836	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049388	Approved		Approved	"Nucleoli,Plasma membrane"				"Plasma membrane"	Nucleoli	"HPA049388: "	"unprognostic (7.71e-3)"	"unprognostic (3.25e-1)"	"unprognostic (4.09e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.68e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.18e-3)"	"unprognostic (8.18e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.36e-2)"	"prognostic unfavourable (1.00e-4)"	"unprognostic (5.29e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.62e-2)"	16.0	16.8	22.4	17.6	26.9	13.1	23.8	43.7	28.5	19.0	19.4	21.3	12.6	14.6	23.8	19.8	23.2	18.6	12.7	14.4	21.0	16.3	13.7	15.6	21.5	19.5	22.9	24.7	26.5	16.6	16.5	15.7	17.4	20.6	17.4	14.3	15.0	14.2	19.0	17.5	16.4	15.4	20.4	17.5	18.7	15.1	27.4	32.1	19.7	18.0	12.7	21.5	18.4	18.6	5.9	4.0	4.0	3.2	7.1	4.5	1.4	8.6	7.2	12.3	12.7	12.4	17.6	7.5	10.0	11.1	12.3	9.5	8.7	9.7	16.7	10.9	8.0	16.5	31.4	7.1	8.9	10.1	8.4	16.2	6.2	7.6	11.5	22.0	11.0	10.1	11.0	6.7	12.8	9.7	20.6	13.7	10.7	6.6	23.1	15.8	14.9	6.6	20.4	15.9	18.6	7.5	13.9	10.2	12.2	11.2	9.5	14.6	7.6	18.2	9.8	12.8	12.5	7.4	15.3	24.6	28.0	12.1	11.5	24.4	6.4	4.0	3.2	1.8	4.5	2.6	3.8	4.8	4.3	4.1	2.8	5.9	4.5	4.5	0.8	7.1	2.5	4.0	3.1	1.4	22.4	26.9	43.7	28.5	21.0	16.3	22.9	24.7	20.6	32.1
PDGFRL	PRLTS	ENSG00000104213	"Platelet derived growth factor receptor like"	Q15198	8	17576433-17644071	"Disease related genes, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 14.3"	"Group enriched"	"Detected in some"	5	"AN3-CA: 48.4;BJ hTERT+: 39.2;HSkMC: 21.4"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.4;neutrophil: 1.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA052801			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"	"Secreted - unknown location"			"Nucleoli, Golgi apparatus"	Nucleoplasm	"HPA052801: "	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.59e-2)"	"unprognostic (7.39e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.54e-2)"	"unprognostic (3.86e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.72e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.58e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.47e-3)"	"unprognostic (6.00e-3)"	7.7	0.4	0.5	0.1	0.9	0.0	14.3	0.6	0.5	8.0	1.3			0.0	3.6	2.0	0.3	5.8	2.6	1.2	0.3	0.4	0.4	0.3	0.7	0.0	0.4		11.6	1.6	2.3	2.0	1.5		0.9	0.0		1.4	1.1	3.3	1.8	0.6	6.3	0.5	0.2	1.0	0.9			8.3		0.0	0.9	2.0	0.0	0.9	1.4	1.4	0.0	0.0	0.1	0.0	4.4	0.2	48.4	1.5	0.6	3.1	0.9	39.2	1.8	7.8	0.2	0.0	0.0	0.2	0.6	0.0	2.6	0.2	0.9	0.0	2.9	0.0	1.4	1.0	3.7	0.0	0.0	21.4	0.0	2.2	0.0	3.2	0.0	0.6	0.2	3.1	0.0	0.1	2.4	0.6	0.0	0.0	0.1	0.2	2.8	0.1	0.3	0.3	0.3	0.8	0.1	0.0	0.5	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1										
PDK1		ENSG00000152256	"Pyruvate dehydrogenase kinase 1"	Q15118	2	172555373-172608669	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 31.3;U-87 MG: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 5.9;granulocytes: 16.0;T-cells: 15.8"	"Low region specificity"	"Detected in all"							"CAB017554, HPA027376, HPA059083"	Approved		Approved	Nucleoli,Mitochondria			22000	"Nucleoli, Mitochondria"		"CAB017554: AB_2161138, HPA027376: AB_1855139, HPA059083: "	"unprognostic (2.14e-1)"	"prognostic unfavourable (7.30e-5)"	"unprognostic (1.21e-1)"	"unprognostic (3.94e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.69e-3)"	"unprognostic (6.44e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.55e-1)"	"prognostic unfavourable (1.10e-8)"	"unprognostic (1.82e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.56e-2)"	"unprognostic (5.34e-2)"	9.9	16.2	6.8	11.0	10.5	13.4	16.7	7.1	15.6	7.3	15.3	3.3	2.9	15.5	5.4	8.0	11.2	4.4	5.8	27.6	6.9	5.2	6.8	14.2	6.1	21.4	7.2	5.2	19.5	7.2	3.4	7.5	7.9	7.2	6.5	13.1	7.6	14.1	7.6	9.6	24.7	8.4	5.2	10.7	14.2	12.5	11.0	6.7	10.3	5.1	5.0	20.8	18.0	9.8	5.9	2.3	16.0	2.2	1.4	15.8	6.2	14.1	0.6	3.7	9.1	1.5	2.3	5.2	12.5	10.1	6.3	13.4	3.6	3.0	13.5	6.9	3.8	6.2	2.5	7.8	20.1	2.7	5.0	16.4	3.3	4.2	2.7	8.1	6.1	2.9	2.8	4.3	7.3	3.3	3.4	9.3	8.3	1.4	5.1	10.2	8.9	3.9	5.4	6.0	21.7	3.2	4.6	6.9	7.9	3.2	3.8	4.7	2.4	3.4	3.8	10.0	3.2	5.2	3.3	31.3	18.1	11.1	32.0	5.9	2.0	12.2	2.2	16.0	2.5	1.5	3.0	4.7	4.2	2.8	2.3	5.9	15.8	9.6	8.5	1.4	1.9	0.4	8.0	6.2	6.8	10.5	7.1	15.6	6.9	5.2	7.2	5.2	7.2	6.7
PDK3		ENSG00000067992	"Pyruvate dehydrogenase kinase 3"	Q15120	X	24465221-24539837	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046583, HPA072492"	Approved		Supported	Nucleoli,Mitochondria				Mitochondria	Nucleoli	"HPA046583: , HPA072492: "	"unprognostic (5.41e-3)"	"unprognostic (5.43e-3)"	"unprognostic (5.35e-3)"	"unprognostic (3.40e-1)"	"unprognostic (4.05e-3)"	"unprognostic (5.38e-2)"	"prognostic unfavourable (2.76e-4)"	"unprognostic (1.51e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.28e-2)"	"unprognostic (9.43e-3)"	9.6	5.6	5.7	9.8	17.3	16.3	12.8	3.3	23.6	8.0	14.7	5.5	5.6	13.6	7.3	15.7	9.5	13.2	7.0	16.9	12.5	6.8	13.7	11.1	11.2	13.4	6.2	13.7	11.0	7.3	12.8	14.1	7.7	14.9	8.3	10.1	9.9	19.3	5.2	3.9	14.2	15.6	8.6	6.1	17.9	12.7	23.1	4.8	12.5	6.2	4.1	14.9	10.3	9.2	4.5	7.2	36.4	10.9	7.1	11.0	6.7	9.0	4.6	3.9	6.5	0.1	0.0	4.1	2.7	2.4	3.7	6.5	0.4	11.0	9.1	1.8	0.7	2.0	11.3	6.9	9.9	7.8	5.4	4.9	5.3	2.6	1.3	4.1	4.8	0.7	3.0	0.9	0.9	5.5	0.9	13.9	0.5	16.9	7.8	5.4	7.0	5.4	4.0	7.0	13.4	3.2	17.6	2.5	3.2	14.7	6.0	4.5	8.2	1.6	0.1	2.6	3.8	4.8	3.2	8.9	6.8	11.0	7.1	6.4	5.3	9.4	8.9	21.3	7.6	10.9	11.0	4.5	6.2	6.2	7.2	4.1	4.9	5.7	36.4	7.1	10.4	2.3	5.1	6.7	5.7	17.3	3.3	23.6	12.5	6.8	6.2	13.7	14.9	4.8
PELI1		ENSG00000197329	"Pellino E3 ubiquitin protein ligase 1"	Q96FA3	2	64092652-64144454	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 105.7"	"Cell line enhanced"	"Detected in many"		"CACO-2: 21.3;U-698: 53.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 33.9"	"Group enriched"	"Detected in all"	4	"granulocytes: 33.9;monocytes: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053182	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments"				"Nucleoplasm, Nucleoli, Intermediate filaments"		"HPA053182: "	"unprognostic (3.33e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.79e-2)"	"prognostic unfavourable (5.33e-4)"	"unprognostic (1.91e-2)"	"unprognostic (3.12e-3)"	"unprognostic (6.73e-3)"	"unprognostic (8.01e-3)"	"unprognostic (4.16e-2)"	"unprognostic (3.52e-3)"	"unprognostic (5.99e-3)"	"unprognostic (3.33e-1)"	"prognostic unfavourable (5.67e-6)"	"unprognostic (6.72e-2)"	"unprognostic (6.22e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.03e-1)"	15.7	5.1	10.0	15.1	20.5	105.7	22.3	15.1	8.9	9.9	14.5	11.0	3.3	9.9	14.5	7.1	26.4	8.0	14.9	11.6	11.3	6.8	6.7	8.6	20.1	16.8	15.6	5.2	4.8	6.2	11.0	14.8	13.7	10.8	7.6	11.8	6.0	12.3	8.5	4.5	17.5	17.3	8.4	15.0	17.8	10.2	7.8	12.8	19.9	6.3	10.2	19.3	14.1	14.8	3.9	2.3	33.9	9.2	1.3	5.0	2.5	1.2	1.0	13.7	9.1	1.6	1.2	3.1	1.7	2.0	1.6	2.6	21.3	1.5	17.5	4.3	0.6	2.1	4.1	3.8	3.2	4.3	3.3	1.6	0.6	3.4	4.8	1.7	3.1	1.6	3.0	2.4	8.2	9.0	0.9	4.4	1.3	0.1	3.7	2.5	8.9	0.6	4.7	4.7	9.9	6.6	3.9	6.3	8.8	1.3	2.0	4.7	1.1	1.2	6.4	1.5	2.2	1.5	2.5	10.1	0.9	53.0	0.8	1.5	4.0	5.1	6.5	6.3	0.4	6.1	0.7	3.9	2.2	0.9	2.3	2.4	2.7	1.1	33.9	1.3	9.2	0.2	5.0	2.5	10.0	20.5	15.1	8.8	11.3	6.8	15.6	5.2	10.8	12.8
PELI2		ENSG00000139946	"Pellino E3 ubiquitin protein ligase family member 2"	Q9HAT8	14	56117814-56301526	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 20.7;MOLT-4: 23.2;REH: 11.4;SCLC-21H: 10.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 21.4"	"Cell type enhanced"	"Detected in many"		"neutrophil: 9.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053182	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments"				"Nucleoplasm, Nucleoli, Intermediate filaments"		"HPA053182: "	"unprognostic (3.26e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.14e-1)"	"prognostic favourable (1.53e-6)"	"unprognostic (3.64e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.22e-1)"	12.3	3.3	5.2	5.6	4.6	16.5	8.7	21.4	6.5	7.5	9.4	5.4	9.7	11.1	9.3	7.1	4.7	5.9	11.5	3.4	4.6	4.5	9.7	3.1	7.3	4.8	5.2	3.9	16.0	38.9	1.7	5.5	3.3	4.4	8.2	4.2	9.2	7.6	12.4	3.8	6.5	12.6	17.7	5.8	6.6	14.1	10.0	4.2	38.2	4.9	3.4	2.6	13.3	14.9	0.9	2.0	9.0	3.0	0.5	0.8	1.1	0.0	1.9	5.5	0.0	3.1	4.6	0.1	0.7	2.5	0.5	0.0	0.1	0.4	0.1	2.6	1.5	0.5	4.2	0.0	0.2	1.3	1.5	4.7	8.5	0.0	2.6	0.7	20.7	2.9	0.2	0.0	0.0	1.0	3.5	0.1	0.6	0.0	23.2	0.2	9.0	0.7	11.4	0.3	1.0	2.2	9.3	10.9	0.0	0.5	0.0	6.1	0.0	3.8	0.3	1.6	2.8	0.5	2.6	0.4	0.0	0.6	2.9	3.2	1.6	1.4	3.0	3.5	0.5	1.6	0.8	0.2	0.6	0.3	2.0	0.9	0.4	0.3	9.0	0.5	1.2	0.5	0.0	1.1	5.2	4.6	21.4	4.4	4.6	4.5	5.2	3.9	4.4	4.2
PELI3	MGC35521	ENSG00000174516	"Pellino E3 ubiquitin protein ligase family member 3"	Q8N2H9	11	66466327-66477337	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033750, HPA038875, HPA062281"	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles				"Nucleoplasm, Vesicles"	Nucleoli	"CAB033750: AB_2161361, HPA038875: , HPA062281: "	"unprognostic (1.15e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.19e-3)"	"unprognostic (7.91e-3)"	"prognostic favourable (8.19e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.01e-2)"	6.7	9.5	14.5	3.8	17.0	1.8	7.4	19.6	33.1	7.4	8.3	6.7	6.4	4.8	10.3	9.1	10.6	8.2	10.1	7.7	17.4	13.5	4.6	3.2	7.1	4.3	13.0	12.5	15.3	9.9	21.5	8.3	3.8	15.8	11.5	2.9	6.4	10.4	22.3	10.8	11.2	4.7	11.3	6.2	5.0	5.8	6.2	7.8	0.3	8.5	2.7	3.4	9.0	11.8	3.3	3.3	1.3	6.8	1.2	3.1	1.4	15.3	6.5	5.3	4.1	8.5	3.3	4.2	4.9	6.4	4.7	4.0	9.5	3.5	3.8	4.9	5.4	8.2	3.5	6.2	1.9	7.5	3.0	1.0	5.4	2.8	5.4	0.8	7.5	3.1	7.0	4.8	1.7	0.9	1.8	6.1	2.0	9.4	3.1	2.4	3.3	6.7	10.7	3.9	4.0	2.6	4.9	6.4	3.5	2.5	7.1	16.7	8.3	4.2	2.7	4.2	6.4	18.1	4.1	5.6	3.2	2.0	8.7	2.5	3.4	1.3	2.5	0.4	2.5	1.8	2.0	2.8	2.1	3.1	3.3	3.3	2.2	1.8	0.1	1.2	6.8	1.0	2.4	1.4	14.5	17.0	19.6	33.1	17.4	13.5	13.0	12.5	15.8	7.8
PELP1	MNAR	ENSG00000141456	"Proline, glutamate and leucine rich protein 1"	Q8IZL8	17	4669774-4704337	"Predicted intracellular proteins"	Transcription	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053966, HPA056028, HPA060760"	Supported		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA053966: , HPA056028: , HPA060760: "	"unprognostic (8.81e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.81e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavourable (6.44e-4)"	"unprognostic (2.72e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.31e-2)"	"prognostic favourable (4.07e-5)"	"unprognostic (2.20e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.31e-1)"	"unprognostic (8.32e-2)"	"unprognostic (5.15e-2)"	14.0	12.3	19.8	13.8	22.0	10.5	10.9	22.9	28.0	12.6	11.8	25.5	8.4	12.9	14.3	9.8	17.4	17.3	11.4	18.2	19.9	18.8	9.6	10.6	11.2	17.2	20.2	18.6	21.0	18.9	18.2	17.0	12.4	18.3	13.8	8.6	13.8	16.5	14.7	38.2	17.2	11.6	12.2	18.7	13.6	12.4	21.3	18.1	17.0	14.5	12.3	13.3	11.2	10.6	3.8	3.5	5.8	3.4	3.8	4.5	1.9	15.7	34.6	13.7	21.6	10.7	7.9	30.8	11.4	8.0	15.9	17.0	33.7	11.7	38.0	17.6	9.0	24.3	25.5	17.9	9.0	19.6	36.4	16.9	17.4	27.1	13.8	13.6	22.8	9.7	11.1	19.6	16.5	11.8	20.3	16.7	8.7	21.6	25.6	16.1	22.5	11.6	27.1	12.1	18.7	11.1	12.0	13.8	18.4	19.7	14.5	14.7	17.5	9.2	11.8	12.3	17.4	18.6	22.0	9.0	15.4	15.8	13.9	14.1	15.8	0.9	2.4	5.8	3.1	3.1	3.1	2.6	3.0	2.4	2.4	3.8	3.3	4.5	1.4	3.8	3.4	3.5	2.0	1.9	19.8	22.0	22.9	28.0	19.9	18.8	20.2	18.6	18.3	18.1
PES1	"NOP7, PES"	ENSG00000100029	"Pescadillo ribosomal biogenesis factor 1"	O00541	22	30576625-30607083	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040210, HPA062439, HPA066670"	Supported		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA040210: AB_2676885, HPA062439: AB_2684764, HPA066670: AB_2685700"	"unprognostic (1.82e-1)"	"unprognostic (5.88e-2)"	"unprognostic (5.59e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.23e-3)"	"prognostic unfavourable (1.84e-9)"	"unprognostic (3.29e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.46e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.42e-1)"	24.4	28.1	26.0	26.1	30.1	28.2	29.6	19.0	31.8	19.7	21.9	27.2	18.1	20.4	28.0	21.3	31.2	28.0	22.7	18.1	26.3	18.5	24.2	34.9	19.8	30.0	27.2	26.6	30.5	49.0	31.3	17.0	20.2	23.6	24.2	19.2	18.6	22.2	22.1	34.1	32.3	19.8	22.9	24.3	26.4	25.2	34.5	27.2	21.2	25.3	23.1	24.9	21.8	22.6	14.4	17.8	3.9	19.4	12.4	16.2	16.3	34.2	39.2	14.4	30.7	16.7	16.4	22.3	22.8	18.8	39.0	30.5	45.4	14.8	46.6	20.4	25.9	23.9	44.5	40.8	28.8	19.9	42.8	22.5	22.5	39.0	41.6	54.4	23.8	23.1	25.7	40.5	40.9	25.1	37.1	19.0	23.6	43.2	26.4	55.2	28.1	28.7	33.7	25.2	45.5	21.4	23.8	25.0	26.0	22.5	25.8	30.2	18.1	28.0	19.8	45.9	34.8	23.2	38.1	24.2	20.6	47.6	32.1	25.0	29.3	3.9	15.8	3.9	13.3	19.4	16.2	14.4	12.4	12.7	17.8	13.8	14.2	12.7	0.6	12.4	13.9	15.4	9.5	16.3	26.0	30.1	19.0	31.8	26.3	18.5	27.2	26.6	23.6	27.2
PFDN1	PFD1	ENSG00000113068	"Prefoldin subunit 1"	O60925	5	140245039-140303121	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006499	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"			10000	"Plasma membrane, Cytosol"	Nucleoli	"HPA006499: AB_1079596"	"unprognostic (2.73e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.66e-3)"	"prognostic unfavourable (8.81e-5)"	"unprognostic (2.12e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.10e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.53e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.00e-1)"	36.1	24.8	39.5	18.8	38.8	26.4	25.8	28.5	48.7	23.1	27.0	29.3	15.8	20.9	28.2	29.6	26.8	22.5	18.6	46.7	38.2	34.7	32.7	20.2	24.2	21.6	38.8	35.3	20.6	18.1	26.5	19.9	26.9	45.6	24.3	23.0	19.8	23.1	24.4	69.5	20.9	22.0	32.1	37.1	23.1	19.2	19.6	24.1	23.7	24.4	28.7	25.5	23.0	19.2	38.9	36.3	45.6	46.4	39.5	45.1	37.2	38.5	18.1	32.4	18.6	21.2	21.8	31.3	52.8	26.3	40.7	45.3	38.6	24.7	26.0	53.4	28.1	14.4	23.4	51.9	47.9	27.5	23.6	23.1	18.6	24.9	24.9	47.5	18.1	23.2	27.6	34.5	36.4	44.6	20.7	17.1	34.1	17.2	32.3	32.6	21.4	27.2	22.8	46.1	19.1	45.4	17.7	18.3	19.4	39.6	34.8	30.2	23.7	28.1	57.3	28.7	28.5	16.9	47.2	16.6	42.7	67.5	29.0	31.4	33.3	43.2	31.1	45.6	33.4	46.4	35.3	38.9	38.4	38.4	36.3	35.9	38.5	34.6	5.1	39.5	44.1	33.9	45.1	37.2	39.5	38.8	28.5	48.7	38.2	34.7	38.8	35.3	45.6	24.1
PFKFB4		ENSG00000114268	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4"	Q16877	3	48517684-48562015	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 26.0"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 37.1;WM-115: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 6.5;eosinophil: 11.4;intermediate monocyte: 7.3;neutrophil: 21.6;non-classical monocyte: 12.2"	"Group enriched"	"Detected in many"	6	"granulocytes: 21.6;monocytes: 12.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047719, HPA066058"	Uncertain		Approved	Nucleoli				Nucleoli		"HPA047719: , HPA066058: "	"unprognostic (7.60e-2)"	"prognostic unfavourable (3.04e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.90e-3)"	"unprognostic (7.96e-2)"	"unprognostic (1.72e-6)"	"unprognostic (1.65e-1)"	"unprognostic (3.75e-2)"	"unprognostic (6.78e-2)"	"unprognostic (3.78e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavourable (3.91e-8)"	"unprognostic (2.04e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.35e-2)"	2.0	2.2	4.0	3.9	4.9	12.7	2.1	6.3	6.3	2.6	17.1	8.6	3.0	17.8	2.1	18.5	6.4	1.5	1.8	1.4	4.2	5.2	3.6	1.7	3.8	6.3	7.4	2.7	3.5	18.9	4.1	5.1	9.5	6.9	3.3	3.5	3.3	2.5	2.0	4.8	3.3	24.0	2.5	5.3	10.0	1.2	26.0	5.2	0.4	1.6	3.6	2.6	4.9	4.2	0.2	2.7	21.6	12.2	0.2	0.5	2.1	5.1	1.6	3.7	3.4	1.2	1.8	7.2	2.6	4.4	5.3	12.8	2.6	1.8	2.2	2.5	2.0	1.5	1.5	4.4	4.7	1.5	1.2	5.2	3.3	2.8	1.0	0.9	2.3	1.9	6.8	8.5	0.8	1.3	1.7	1.9	4.2	1.1	0.3	7.2	2.3	3.4	0.4	1.8	2.4	2.0	4.8	1.0	2.3	2.8	1.2	10.1	2.8	2.2	0.4	5.4	2.2	0.7	15.6	8.9	1.9	1.3	37.1	1.9	32.3	0.0	6.5	11.4	0.2	7.3	0.1	0.2	0.3	0.0	2.7	0.1	0.5	0.1	21.6	0.2	12.2	0.3	0.0	2.1	4.0	4.9	6.3	6.3	4.2	5.2	7.4	2.7	6.9	5.2
PGAM2	PGAM-M	ENSG00000164708	"Phosphoglycerate mutase 2"	P15259	7	44062727-44065587	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"heart muscle: 111.6;skeletal muscle: 379.1;tongue: 119.0"	"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 38.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 1.2;neutrophil: 1.1;plasmacytoid DC: 1.3;T-reg: 1.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.3;granulocytes: 1.2;T-cells: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA043801, HPA050314, HPA060173"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol			60000000	Nucleoplasm	"Nucleoli, Cytosol"	"HPA043801: , HPA050314: , HPA060173: "																		1.4	0.8	2.0	0.4	2.2	0.4	0.5	6.9	2.1	0.5	0.5	3.6	0.0	0.6	0.5	9.1	6.1	0.6	0.7	111.6	2.1	3.2	0.8	0.4	0.4	0.4	4.2	1.6	0.5	0.6	0.6	1.3	0.4	2.0	1.9	0.4	2.3	7.6	0.5	379.1	0.4	0.4	0.4	3.2	0.5	0.5	16.7	1.1	4.8	1.5	119.0	4.8	0.4	0.0	0.3	1.3	1.2	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	38.1	4.2	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.3	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	1.3	1.7	0.2	2.0	2.2	6.9	2.1	2.1	3.2	4.2	1.6	2.0	1.1
PGRMC1	HPR6.6	ENSG00000101856	"Progesterone receptor membrane component 1"	O00264	X	119236245-119244466	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 163.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002877, HPA064724"	Enhanced		Enhanced	"Nucleoli,Endoplasmic reticulum"			6000000	"Endoplasmic reticulum"	Nucleoli	"HPA002877: AB_1079602, HPA064724: "	"unprognostic (6.97e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.35e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavourable (3.02e-4)"	"unprognostic (1.58e-3)"	"unprognostic (9.28e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.06e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.11e-1)"	25.0	46.0	37.7	11.9	36.9	5.6	60.2	21.8	37.8	36.2	30.5	30.9	42.9	27.0	39.9	71.4	15.0	38.9	20.1	10.0	38.6	50.4	58.7	163.9	15.6	8.8	38.1	29.6	24.7	10.9	23.8	15.5	12.3	35.3	33.5	22.5	22.1	17.5	53.7	5.7	12.5	42.9	22.0	46.9	10.0	18.9	14.2	27.1	6.9	24.7	12.2	7.7	21.3	17.3	3.6	9.9	11.4	11.8	4.8	8.0	28.7	26.8	17.0	33.4	38.4	72.2	34.7	21.7	40.6	47.3	21.6	26.9	20.5	33.0	7.7	44.5	42.1	21.5	36.4	17.0	29.1	8.2	41.8	8.7	16.3	23.0	12.0	14.3	4.7	35.7	9.6	26.2	13.6	13.9	9.2	4.8	25.3	28.7	10.7	10.5	87.5	28.7	12.8	20.9	11.2	28.5	20.5	31.2	13.9	29.7	49.4	15.9	11.4	9.2	10.7	15.1	22.2	53.2	38.2	5.1	9.3	8.4	41.1	22.8	28.6	9.2	11.8	11.4	5.5	11.3	7.3	3.6	7.5	8.0	9.9	3.1	7.7	6.3	5.7	4.8	10.0	7.1	7.6	28.7	37.7	36.9	21.8	37.2	38.6	50.4	38.1	29.6	35.3	27.1
PHF2	"CENP-35, JHDM1E, KDM7C, KIAA0662"	ENSG00000197724	"PHD finger protein 2"	O75151	9	93576407-93679587	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010831	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA010831: AB_1855294"	"unprognostic (9.42e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavourable (9.34e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.89e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.49e-1)"	"prognostic favourable (1.12e-5)"	"unprognostic (1.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.19e-2)"	16.8	14.6	17.4	17.7	22.2	16.7	23.2	33.1	19.0	19.8	18.1	27.8	18.6	11.3	22.0	15.9	14.5	18.4	16.7	19.1	15.3	14.5	10.8	9.3	17.8	20.7	23.1	15.6	27.1	18.5	22.6	21.7	17.6	16.6	18.6	10.6	16.9	19.0	21.9	27.8	21.4	13.3	24.9	18.5	21.4	15.9	9.6	18.2	19.8	18.8	12.0	12.1	16.4	32.5	2.5	3.8	5.0	2.6	1.0	4.0	2.2	9.2	7.7	16.2	13.3	10.4	8.1	8.4	7.3	9.8	10.6	7.6	3.6	5.4	6.6	5.4	9.4	18.0	10.2	7.0	5.6	17.7	6.7	5.4	8.8	5.6	9.3	10.4	18.4	8.1	12.2	5.0	8.4	8.4	7.7	11.3	7.3	20.4	20.0	11.7	4.2	6.7	22.5	12.5	2.6	6.7	11.6	21.3	10.5	7.6	12.6	6.6	8.4	18.5	9.7	10.0	8.7	11.0	10.4	9.2	1.5	4.9	5.5	6.5	11.2	1.1	2.6	2.5	3.3	1.4	3.1	1.8	3.3	2.1	2.7	2.5	3.6	4.0	5.0	1.0	2.0	3.8	1.9	2.2	17.4	22.2	33.1	19.0	15.3	14.5	23.1	15.6	16.6	18.2
PHF6	"BFLS, BORJ, CENP-31, KIAA1823, MGC14797"	ENSG00000156531	"PHD finger protein 6"	Q8IWS0	X	134373253-134428791	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation, Epilepsy, Hypotrichosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001023	Enhanced		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA001023: AB_1079606"	"unprognostic (2.38e-3)"	"unprognostic (8.21e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.04e-3)"	"unprognostic (6.03e-3)"	"unprognostic (5.20e-3)"	"prognostic unfavourable (3.38e-4)"	"unprognostic (1.81e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (9.96e-4)"	"unprognostic (1.09e-1)"	"unprognostic (5.96e-2)"	"unprognostic (4.84e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.29e-2)"	7.4	19.3	10.2	14.1	12.2	6.5	9.7	18.2	13.5	8.7	8.0	11.6	20.3	7.8	9.0	30.1	11.5	7.3	6.1	7.2	11.0	11.1	9.9	7.5	8.4	20.4	12.5	9.3	30.7	10.4	24.1	18.1	8.2	13.3	8.6	9.5	5.4	11.3	16.8	6.2	7.4	10.2	8.1	17.1	17.8	8.1	8.3	14.4	30.2	11.8	6.0	25.0	8.9	9.8	18.4	11.0	5.3	7.4	9.6	9.9	5.0	11.3	9.4	41.3	16.9	7.7	9.9	7.8	11.4	9.1	12.2	15.2	5.6	11.8	18.2	26.2	6.9	10.2	28.8	12.9	20.6	14.8	13.4	17.6	16.1	6.4	8.3	17.5	9.8	6.5	9.8	13.3	16.6	17.0	12.9	9.0	14.9	7.4	28.2	8.7	12.6	12.7	27.9	15.1	13.8	13.0	13.7	14.3	16.9	8.7	8.1	11.9	7.5	9.7	12.9	11.4	8.2	14.3	17.4	4.6	10.7	24.6	7.5	20.9	14.2	5.3	6.1	3.7	7.9	6.0	8.5	18.4	8.2	7.1	8.8	12.8	9.9	8.2	2.5	9.6	7.4	11.0	8.3	5.0	10.2	12.2	18.2	13.5	11.0	11.1	12.5	9.3	13.3	14.4
PHLDA1	"DT1P1B11, PHRIP, TDAG51"	ENSG00000139289	"Pleckstrin homology like domain family A member 1"	Q8WV24	12	76025447-76033932	"Cancer-related genes, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"salivary gland: 142.4"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 43.3;RPTEC TERT1: 54.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 2.4;MAIT T-cell: 3.9;memory CD4 T-cell: 2.5;memory CD8 T-cell: 2.5;non-classical monocyte: 2.5;T-reg: 4.1"	"Group enriched"	"Detected in many"	7	"monocytes: 2.5;T-cells: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016160, HPA019000, HPA063520"	Enhanced		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"CAB016160: AB_628117, HPA019000: AB_1855309, HPA063520: "	"unprognostic (9.09e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.51e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.21e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.55e-3)"	13.2	15.9	9.4	8.4	12.1	9.0	13.5	6.4	15.7	11.5	4.5	11.1	4.8	3.4	7.1	3.1	33.3	5.1	20.0	9.6	8.2	7.9	13.8	33.2	14.2	3.0	8.4	5.6	10.8	8.8	2.6	6.0	7.1	10.0	4.8	5.5	24.9	142.4	6.5	3.3	6.3	7.0	7.6	9.7	14.6	10.8	2.3	10.1	2.5	18.0	13.2	19.9	17.0	17.8	0.3	0.1	0.4	2.5	0.3	4.1	0.6	13.5	16.3	12.8	7.0	6.0	12.4	0.9	11.5	31.1	5.2	7.3	9.0	16.6	0.0	3.5	4.8	7.0	0.3	19.3	11.3	2.0	0.2	0.3	0.8	15.2	8.7	0.3	3.5	3.8	14.2	21.8	43.3	12.5	1.1	0.4	26.8	1.7	0.0	1.7	4.6	25.2	0.0	3.3	0.4	54.9	30.8	0.9	2.4	2.0	0.1	37.4	8.2	0.1	11.6	17.9	1.7	20.8	11.3	0.2	0.0	0.0	30.2	0.2	22.3	0.3	0.1	0.2	2.4	0.2	3.9	0.3	2.5	2.5	0.0	0.2	0.5	0.6	0.4	0.3	2.5	0.1	4.1	0.6	9.4	12.1	6.4	7.7	8.2	7.9	8.4	5.6	10.0	10.1
PHLDA2	"BWR1C, HLDA2, IPL, TSSC3"	ENSG00000181649	"Pleckstrin homology like domain family A member 2"	Q53GA4	11	2928273-2929455	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"placenta: 163.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 82.0;PC-3: 66.6;SK-MEL-30: 52.3;WM-115: 71.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 8.2"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA003994			Uncertain	Nucleoli				Nucleoli		"HPA003994: AB_1855311"	"unprognostic (1.90e-1)"	"unprognostic (3.13e-2)"	"unprognostic (9.93e-3)"	"unprognostic (6.16e-2)"	"unprognostic (4.28e-2)"	"unprognostic (8.01e-3)"	"prognostic unfavourable (4.22e-5)"	"unprognostic (1.24e-3)"	"unprognostic (3.84e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavourable (2.63e-6)"	"unprognostic (2.83e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.59e-1)"	3.8	1.1	0.5	3.6	0.7	1.4	7.7	0.3	1.4	5.6	7.9	0.5	1.7	5.9	2.3	5.5	20.3	2.4	15.6	1.5	0.5	1.9	4.8	3.7	3.9	0.8	1.3	0.5	1.8	4.6	1.2	1.2	163.9	1.9	8.0	1.4	0.8	5.3	2.0	0.8	9.6	7.4	1.9	1.0	1.8	11.1	1.0	0.5	0.2	3.5	24.7	15.1	6.1	8.7	1.5	8.2	0.0	4.9	0.0	3.9	1.5	9.2	8.2	0.3	0.1	0.1	1.7	9.0	20.5	5.2	2.9	2.2	3.3	18.3	0.0	10.0	2.2	11.4	0.0	8.2	0.3	82.0	2.7	0.0	4.4	2.1	6.7	0.0	4.9	2.8	3.7	2.5	2.0	2.4	1.7	0.1	1.2	29.2	0.0	1.4	3.3	66.6	0.0	0.0	5.6	5.9	2.9	0.9	0.0	6.6	4.5	52.3	1.3	0.8	13.6	6.6	3.6	9.2	6.9	0.0	0.1	0.0	5.4	1.4	71.9	0.0	4.9	0.0	0.7	3.0	0.8	1.5	3.9	0.9	8.2	0.0	1.0	0.2	0.0	0.0	0.6	0.0	1.4	1.5	0.5	0.7	0.3	1.4	0.5	1.9	1.3	0.5	1.9	0.5
PHTF1	PHTF	ENSG00000116793	"Putative homeodomain transcription factor 1"	Q9UMS5	1	113696831-113759489	"Plasma proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059486			Approved	"Nucleoli,Nuclear bodies"				"Nuclear bodies"	Nucleoli	"HPA059486: "	"unprognostic (1.52e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.70e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavourable (1.21e-6)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.25e-1)"	6.5	10.4	11.5	7.9	8.6	19.5	11.8	31.6	15.1	7.1	5.4	4.0	7.6	4.5	6.6	9.6	3.4	13.1	8.8	8.2	10.1	12.4	8.9	10.1	10.8	11.9	8.2	12.9	4.0	8.2	15.3	20.9	8.5	10.4	5.8	6.5	8.2	5.2	6.9	5.5	2.4	4.9	8.4	6.4	10.5	8.0	33.8	6.6	3.4	6.1	2.4	7.7	8.1	6.3	3.0	4.5	6.0	2.6	4.3	5.7	1.7	12.7	6.7	19.1	10.1	9.5	8.6	5.0	11.8	15.7	10.6	17.4	7.3	10.4	3.7	16.8	8.1	7.1	7.2	4.7	12.2	15.2	7.2	8.9	14.1	8.4	7.9	10.9	12.6	7.2	1.3	14.1	3.1	19.5	5.3	17.0	12.8	19.0	0.1	11.0	15.1	10.9	11.5	28.7	7.3	17.0	5.6	13.4	12.4	13.2	6.5	7.0	2.6	8.8	20.5	8.3	11.5	15.3	11.4	23.8	24.2	6.9	20.5	9.5	22.6	3.0	2.6	4.9	3.0	1.3	2.3	3.0	3.7	3.7	4.5	1.6	0.1	2.6	6.0	4.3	1.7	3.0	5.7	1.7	11.5	8.6	31.6	15.1	10.1	12.4	8.2	12.9	10.4	6.6
PIGO	"DKFZp434M222, FLJ00135"	ENSG00000165282	"Phosphatidylinositol glycan anchor biosynthesis class O"	Q8TEQ8	9	35088688-35096601	"Disease related genes, Predicted membrane proteins"	"GPI-anchor biosynthesis"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014905			Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA014905: AB_1855369"	"unprognostic (1.41e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.03e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.98e-3)"	"unprognostic (4.14e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.54e-1)"	"prognostic favourable (3.05e-10)"	"unprognostic (1.89e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.23e-3)"	"unprognostic (3.81e-2)"	9.4	16.6	7.2	8.7	11.7	5.4	11.6	12.6	15.6	10.8	11.5	17.8	15.6	14.1	14.0	13.6	12.6	15.8	13.4	9.5	7.4	6.4	16.1	15.2	10.6	13.8	9.0	10.1	15.9	17.5	47.3	13.4	27.6	11.5	13.1	13.2	18.0	17.5	17.4	7.6	10.0	12.9	10.7	11.0	14.2	13.9	16.5	9.7	11.3	20.0	8.3	13.4	13.6	9.9	7.4	13.7	8.0	8.8	7.1	10.0	4.1	15.9	27.3	7.8	11.2	7.0	7.8	14.0	6.8	11.8	16.4	13.5	10.0	16.2	9.0	12.4	8.1	11.6	13.0	21.3	9.9	9.9	8.4	5.4	17.8	7.6	13.7	7.2	9.4	9.6	23.5	14.6	24.0	8.5	5.9	12.9	13.4	8.8	8.5	8.3	5.0	11.2	8.9	6.3	9.8	18.1	11.1	6.6	8.8	9.4	23.3	5.3	17.5	4.8	5.1	12.1	10.7	6.4	12.4	7.9	11.6	3.8	13.0	5.4	14.9	7.0	6.7	8.0	9.2	8.8	9.3	5.0	5.1	10.0	13.7	7.4	6.5	7.6	2.4	7.1	5.9	9.5	7.6	4.1	7.2	11.7	12.6	15.6	7.4	6.4	9.0	10.1	11.5	9.7
PIK3CB	PIK3C1	ENSG00000051382	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta"	P42338	3	138652699-138834938	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Autophagy, Cell adhesion, Endocytosis"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 41.2;HMC-1: 65.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031938, HPA042288, HPA064207"	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles,Midbody				Nucleoplasm	"Nucleoli, Vesicles, Midbody"	"CAB031938: AB_2165408, HPA042288: , HPA064207: "	"unprognostic (4.89e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.97e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.89e-2)"	"unprognostic (6.01e-2)"	"prognostic unfavourable (6.42e-4)"	"unprognostic (3.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (3.99e-5)"	"unprognostic (2.15e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.33e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.59e-2)"	12.5	9.9	10.6	9.7	20.6	17.4	11.5	29.9	25.0	12.4	14.6	11.9	11.7	13.7	9.6	6.9	15.2	10.9	8.7	12.7	12.2	14.2	22.6	9.3	9.5	9.1	11.9	15.2	8.8	20.3	20.2	10.9	18.1	24.1	13.4	15.7	12.2	14.9	15.9	33.4	19.6	16.4	8.3	12.5	9.9	11.0	6.4	10.7	14.4	37.4	7.1	11.9	13.4	11.0	4.6	9.1	11.3	7.8	1.3	6.5	2.6	22.6	9.8	4.2	3.5	3.9	5.2	28.7	5.3	5.1	5.4	5.8	10.5	8.6	9.1	14.5	5.2	9.7	5.5	8.4	9.7	11.6	6.2	41.2	6.7	6.3	4.0	10.0	65.3	4.4	6.5	3.8	7.7	8.1	15.7	6.8	6.7	10.3	5.8	7.0	6.0	9.2	4.2	4.4	6.5	8.3	12.5	3.7	2.7	14.7	6.4	18.9	16.0	23.9	8.5	3.5	4.4	7.5	7.4	11.5	7.5	8.3	8.5	9.7	4.8	7.0	7.8	11.3	4.0	4.5	2.7	4.6	5.2	3.0	9.1	4.1	6.5	4.4	10.0	1.3	4.3	1.4	2.2	2.6	10.6	20.6	29.9	25.0	12.2	14.2	11.9	15.2	24.1	10.7
PIM1	PIM	ENSG00000137193	"Pim-1 proto-oncogene, serine/threonine kinase"	P11309	6	37170203-37175426	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 34.8;HMC-1: 64.9;U-698: 116.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 64.6"	"Group enriched"	"Detected in all"	5	"granulocytes: 64.6;T-cells: 19.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003941, CAB017040"	Uncertain		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"CAB017040: , HPA003941: AB_1079618"	"unprognostic (1.25e-2)"	"unprognostic (4.77e-1)"	"unprognostic (3.61e-2)"	"prognostic unfavourable (9.73e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.65e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.14e-3)"	"unprognostic (8.16e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.26e-3)"	"unprognostic (2.90e-1)"	39.3	5.4	7.4	18.5	8.9	80.9	20.1	8.1	9.9	23.0	17.9	4.7	4.2	17.9	15.4	9.8	56.3	21.6	24.7	20.8	8.2	3.7	7.5	24.5	14.5	35.7	7.4	2.2	20.0	9.6	2.0	5.6	28.7	12.7	15.6	8.8	6.9	12.8	4.5	26.5	31.3	26.1	31.6	10.7	21.4	12.1	6.8	7.6	15.0	7.2	20.1	28.8	32.6	31.2	1.7	1.4	64.6	1.7	8.4	19.0	8.5	3.0	1.2	2.0	1.1	4.6	2.4	23.5	1.0	3.3	2.2	3.6	4.5	4.2	6.0	1.7	1.2	3.5	2.0	3.2	2.0	27.5	1.3	34.8	1.3	5.8	4.7	0.6	64.9	8.3	4.0	2.0	1.3	0.6	29.9	9.8	0.3	0.7	1.9	3.1	3.7	1.9	4.6	3.6	7.1	0.6	18.4	9.7	1.9	2.3	0.2	0.6	0.5	1.0	1.1	1.3	3.9	5.8	1.3	4.6	2.4	116.6	0.5	8.8	1.3	64.6	1.7	24.4	14.7	1.6	19.0	1.7	13.1	12.9	1.4	1.3	11.9	9.0	14.1	8.4	0.9	0.4	9.4	8.5	7.4	8.9	8.1	9.9	8.2	3.7	7.4	2.2	12.7	7.6
PIN4	"EPVH, PAR14, PAR17"	ENSG00000102309	"Peptidylprolyl cis/trans isomerase, NIMA-interacting 4"	Q9Y237	X	72181353-72302926	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 68.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054483, HPA064504"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA054483: , HPA064504: AB_2685274"	"unprognostic (2.47e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.77e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.14e-2)"	"prognostic favourable (6.37e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.92e-1)"	"prognostic favourable (2.58e-4)"	"unprognostic (3.34e-3)"	"prognostic favourable (2.66e-4)"	14.4	11.3	15.0	8.0	14.7	6.1	18.8	10.7	16.2	9.7	9.7	8.4	6.7	9.5	11.6	19.3	8.9	8.7	30.7	11.2	15.2	12.2	15.6	23.2	7.9	7.9	12.9	11.0	12.7	8.1	8.0	9.2	9.8	10.0	10.4	11.1	6.6	30.7	37.1	68.7	7.3	9.6	9.2	12.4	16.7	9.3	4.7	6.9	9.7	12.9	40.1	9.1	7.8	9.2	28.9	26.8	23.4	23.6	22.4	33.4	22.7	15.1	17.8	18.6	12.7	12.8	10.7	9.9	10.4	11.9	12.8	13.1	9.0	11.3	4.6	30.4	10.7	10.8	16.5	18.3	15.8	11.5	37.1	7.8	21.2	23.4	7.1	12.3	6.6	7.2	10.1	13.9	4.8	12.9	13.1	20.2	9.5	18.3	10.7	20.7	13.3	16.1	10.7	14.8	13.4	16.2	10.6	11.9	21.3	12.2	5.7	10.7	8.8	11.2	13.0	5.8	8.9	15.9	7.5	6.9	7.5	7.6	16.7	12.3	6.3	21.9	23.3	23.4	26.8	23.6	26.4	28.9	28.3	25.5	22.8	26.4	29.3	29.4	9.7	22.4	21.8	26.8	33.4	22.7	15.0	14.7	10.7	16.2	15.2	12.2	12.9	11.0	10.0	6.9
PINX1	"FLJ20565, Gno1, LPTL, LPTS, MGC8850, PinX1, Pxr1"	ENSG00000254093	"PIN2/TERF1 interacting telomerase inhibitor 1"	Q96BK5	8	10764963-10839884	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023139, HPA023146"	Uncertain		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA023139: AB_1855384, HPA023146: "	"unprognostic (4.01e-1)"	"prognostic favourable (2.45e-5)"	"unprognostic (7.80e-3)"	"unprognostic (3.35e-2)"	"unprognostic (4.10e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.40e-2)"	"unprognostic (9.73e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.37e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.08e-2)"	14.3	14.4	9.9	16.0	13.9	14.8	13.8	14.5	16.5	12.6	14.2	12.6	7.1	11.5	15.7	8.9	19.3	10.7	9.3	11.7	10.6	10.1	13.1	19.4	11.2	19.2	13.2	10.9	16.1	17.2	7.6	10.7	13.3	17.6	11.4	12.0	15.6	14.9	8.5	21.2	19.0	11.3	15.9	11.1	14.8	11.7	24.0	9.7	18.7	12.4	17.8	19.6	11.5	14.3	9.8	8.8	4.4	8.4	8.9	16.0	8.4	6.5	8.8	9.6	9.0	8.1	6.6	11.0	10.0	4.5	11.1	7.5	9.3	5.8	17.7	3.5	5.4	13.3	24.2	18.6	14.4	7.2	7.2	7.4	6.2	10.0	9.1	7.9	4.6	5.5	11.8	8.7	16.4	15.3	23.5	11.0	10.8	7.8	25.9	9.9	21.9	9.9	21.2	11.7	16.1	8.2	8.1	7.9	8.3	6.7	8.0	22.1	8.5	9.9	9.3	6.7	14.5	8.5	12.9	4.9	12.9	32.2	6.9	15.0	15.1	1.5	6.8	4.4	12.5	8.4	16.0	9.7	10.9	13.1	8.8	9.8	15.0	11.6	0.4	8.9	7.3	6.8	12.3	8.4	9.9	13.9	14.5	16.5	10.6	10.1	13.2	10.9	17.6	9.7
PITX1	"BFT, POTX, PTX1"	ENSG00000069011	"Paired like homeodomain 1"	P78337	5	135027735-135034813	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 119.4;lymphoid tissue: 60.8;tongue: 58.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 39.6;HeLa: 32.4;K-562: 31.6;T-47d: 47.1"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 73.6"	"Region enriched"	"Detected in single"	11	"pons and medulla: 1.0"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA008743	Approved		Approved	Nucleoli				Nucleoli		"HPA008743: AB_1855413"	"unprognostic (1.84e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.26e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.27e-1)"	"unprognostic (5.80e-14)"	"unprognostic (6.22e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.98e-3)"	"unprognostic (4.97e-3)"	0.3	0.3	0.0	4.7	0.0	0.3	0.2	0.0	0.2	14.8	2.8	0.0	0.0	5.6	0.5	1.2	119.4	0.3	1.9	0.2	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.0	0.2	0.2	0.2	32.9	1.3	1.0	8.8	1.1	10.8	33.0	0.2	8.6	0.5	3.2	18.6	0.0	0.2	7.4	0.4	0.0	0.0	0.4	58.8	60.8	18.2	28.9	0.3	0.3	1.4	0.4	0.4	1.1	0.2	16.9	10.4	0.0	14.0	0.5	0.2	4.3	3.4	4.9	1.6	0.6	39.6	10.0	19.0	5.4	0.2	5.7	2.3	8.1	0.1	0.2	14.8	4.7	32.4	10.9	5.1	1.7	0.0	0.4	5.9	0.0	1.9	0.0	31.6	0.0	0.5	5.2	0.1	3.8	0.0	9.3	5.6	0.3	0.3	0.2	5.3	6.5	0.0	14.8	8.0	0.0	47.1	1.1	0.6	1.8	4.7	1.0	5.2	0.0	0.0	12.5	2.4	0.1	0.0	1.4	0.3	0.1	0.9	0.3	0.5	0.3	0.6	1.1	0.2	0.3	0.3	1.0	0.7	0.4	0.4	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0
PJA1	"FLJ11830, RNF70"	ENSG00000181191	"Praja ring finger ubiquitin ligase 1"	Q8NG27	X	69160851-69165793	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 98.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 38.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000595	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA000595: AB_1079826"	"unprognostic (3.40e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.58e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.26e-3)"	"unprognostic (4.61e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.84e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.60e-1)"	"prognostic favourable (7.44e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.10e-1)"	12.6	9.9	21.6	5.5	35.7	2.6	7.9	13.4	23.7	12.2	5.8	8.9	19.3	4.7	9.2	98.7	5.7	10.2	7.1	7.5	18.4	23.4	7.5	4.4	7.4	5.9	14.9	16.7	16.2	6.0	27.1	12.5	10.7	11.7	9.9	5.3	7.2	6.4	20.3	4.7	7.1	4.4	9.8	12.0	5.9	6.5	13.7	9.5	3.0	13.8	2.9	7.4	7.8	7.9	11.2	4.3	2.7	4.5	14.8	17.8	9.0	10.4	8.0	25.1	17.5	8.8	9.3	7.5	7.0	8.4	6.6	8.9	6.5	9.9	1.6	10.9	11.0	9.1	38.5	13.6	8.3	7.8	13.7	3.1	6.6	4.3	11.0	1.8	6.0	9.7	9.1	11.2	6.7	7.4	2.9	1.1	6.7	5.6	0.8	3.5	17.1	13.1	7.5	11.2	2.5	10.6	8.8	18.6	12.1	11.2	1.9	8.5	3.1	2.6	6.7	5.7	9.2	16.9	3.2	0.0	0.1	3.8	6.2	5.1	7.6	2.7	3.3	1.0	15.5	4.5	17.8	8.7	13.7	14.2	3.6	11.2	14.4	16.6	1.1	14.8	2.9	4.3	8.3	9.0	21.6	35.7	13.4	23.7	18.4	23.4	14.9	16.7	11.7	9.5
PKMYT1	"MYT1, PPP1R126"	ENSG00000127564	"Protein kinase, membrane associated tyrosine/threonine 1"	Q99640	16	2968024-2980539	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 19.5;lymphoid tissue: 42.8;testis: 61.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	5	"T-reg: 4.4"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA068860			Supported	"Nucleoplasm,Nucleoli,Golgi apparatus"				"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA068860: "	"unprognostic (7.82e-2)"	"unprognostic (8.70e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavourable (8.33e-4)"	"prognostic unfavourable (3.37e-4)"	"unprognostic (4.52e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.95e-3)"	"unprognostic (0.00e+0)"	"unprognostic (1.09e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.91e-2)"	0.9	0.7	0.7	9.4	0.6	19.5	1.3	2.6	0.8	1.3	2.9	0.3	0.5	1.9	0.8	1.5	7.2	0.2	1.5	1.4	0.7	0.7	0.8	1.0	1.3	6.2	0.8	0.2	0.3	1.3	0.0	0.7	4.3	0.4	0.6	0.8	0.3	1.3	0.2	1.6	3.4	3.2	0.6	1.0	4.4	2.7	61.4	0.2	42.8	0.3	9.2	12.7	0.7	2.0	0.8	0.4	0.3	0.5	0.4	4.4	1.0	24.6	17.3	6.8	9.7	0.1	0.3	18.3	19.2	4.6	12.2	11.7	13.4	14.7	15.4	8.6	2.1	31.7	4.7	6.1	2.2	19.8	15.6	7.8	15.6	11.7	0.0	8.7	22.3	0.2	0.5	7.2	1.9	2.5	22.4	27.4	3.9	37.0	24.4	24.2	11.1	9.2	26.6	15.1	29.8	2.3	5.4	12.9	13.6	9.3	24.2	7.2	13.8	17.4	2.3	16.4	20.8	23.9	20.0	20.8	15.4	26.5	6.2	11.7	19.0	0.0	0.4	0.3	0.3	0.3	0.0	0.8	0.5	0.5	0.4	0.0	0.0	0.0	0.1	0.4	0.5	0.1	4.4	1.0	0.7	0.6	2.6	0.8	0.7	0.7	0.8	0.2	0.4	0.2
PLEK	P47	ENSG00000115956	Pleckstrin	P08567	2	68365173-68397453	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 80.4;bone marrow: 120.1;lymphoid tissue: 51.0"	"Cell line enhanced"	"Detected in some"		"HEL: 91.5;HMC-1: 35.0;NB-4: 30.8;THP-1: 35.8;U-266/84: 23.8;U-698: 24.4;U-937: 56.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA031838, HPA057341"	Enhanced		Approved	Nucleoli			970000000	Nucleoli		"HPA031838: AB_10602146, HPA057341: "	"unprognostic (2.57e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.87e-3)"	"unprognostic (4.52e-3)"	"unprognostic (3.52e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.67e-2)"	"unprognostic (3.40e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavourable (1.95e-4)"	"unprognostic (3.57e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.56e-1)"	27.8	3.6	3.0	21.7	7.7	120.1	4.6	1.0	3.0	1.8	4.2	7.0	0.4	2.4	2.4	7.5	3.5	5.5	4.9	4.9	2.6	2.4	3.8	6.5	17.0	36.6	6.4	0.8	4.3	2.8	0.7	2.0	8.5	5.0	4.0	4.5	2.7	3.5	0.8	2.3	1.7	8.0	5.0	8.6	51.0	3.2	5.7	3.7	8.2	3.8	2.7	25.7	7.3	2.0	22.9	66.9	80.4	50.8	33.2	44.7	65.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.5	0.0	0.0	0.0	20.6	35.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	30.8	0.0	0.0	0.2	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.8	0.0	0.0	0.0	0.0	0.0	1.3	23.8	24.4	0.0	56.8	0.0	24.8	39.7	57.2	44.7	49.2	23.5	22.9	8.2	32.2	32.1	13.5	2.3	25.3	80.4	33.2	50.8	66.9	0.8	65.9	3.0	7.7	1.0	3.0	2.6	2.4	6.4	0.8	5.0	3.7
PLEKHM1	KIAA0356	ENSG00000225190	"Pleckstrin homology and RUN domain containing M1"	Q9Y4G2	17	45435900-45490749	"Disease related genes, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"		"Disease mutation, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 9.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 9.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025018, HPA039473"	Approved		Supported	Nucleoli,Vesicles				Vesicles	Nucleoli	"HPA025018: AB_1855465, HPA039473: "	"unprognostic (1.52e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.29e-2)"	"prognostic favourable (1.28e-6)"	"unprognostic (8.71e-2)"	"unprognostic (3.06e-2)"	"prognostic unfavourable (3.25e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.93e-2)"	"unprognostic (4.02e-1)"	"unprognostic (3.93e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-1)"	8.0	3.6	2.5	3.6	4.5	10.9	5.3	7.6	5.6	6.1	4.1	2.6	0.9	2.2	2.9	2.0	17.2	3.7	3.8	3.9	4.2	1.7	1.7	3.1	4.5	7.3	10.5	2.9	2.5	4.2	3.5	3.6	2.8	4.7	2.6	3.0	3.4	7.6	2.7	6.3	5.8	3.4	2.5	5.3	4.5	3.0	2.4	3.4	6.7	3.8	6.5	10.4	5.2	6.7	2.4	1.3	9.8	1.4	1.3	1.4	0.9	5.8	8.5	1.5	2.8	6.0	2.9	5.3	1.7	3.9	3.0	3.1	2.6	3.2	3.0	5.1	5.6	1.5	3.5	2.1	0.9	11.8	4.1	0.0	3.1	3.5	6.3	0.0	4.4	11.3	6.7	4.8	7.9	9.0	2.9	3.5	4.7	3.6	5.8	1.1	0.9	6.0	2.6	3.1	2.7	4.4	9.0	2.6	2.4	3.0	2.3	3.2	5.2	2.5	10.3	7.3	2.7	5.5	3.0	3.6	3.8	1.2	4.1	1.5	3.0	3.8	1.4	1.3	1.4	1.0	0.8	2.4	1.0	1.1	1.3	1.0	0.7	0.6	9.8	1.3	1.3	1.0	1.2	0.9	2.5	4.5	7.6	5.6	4.2	1.7	10.5	2.9	4.7	3.4
PLOD2	LH2	ENSG00000152952	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2"	O00469	3	146069440-146163653	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 73.1"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 85.3;U-87 MG: 76.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB025898, HPA069126"	Approved		Uncertain	Nucleoli,Cytosol	"Intracellular and membrane"			"Nucleoli, Cytosol"		"CAB025898: , HPA069126: "	"unprognostic (8.68e-2)"	"prognostic unfavourable (1.97e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.29e-3)"	"prognostic unfavourable (7.64e-10)"	"prognostic unfavourable (1.42e-4)"	"unprognostic (2.97e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.27e-3)"	"unprognostic (2.24e-1)"	"prognostic unfavourable (4.99e-11)"	"prognostic unfavourable (2.83e-4)"	"unprognostic (6.07e-2)"	"unprognostic (4.06e-2)"	"unprognostic (4.41e-3)"	36.7	14.1	11.2	18.0	12.1	0.7	28.5	7.9	13.5	8.8	25.2	5.1	8.3	21.6	14.8	7.5	12.0	8.0	22.3	16.6	12.5	8.2	16.4	73.1	9.3	3.0	10.7	4.8	17.7	14.4	13.9	7.8	41.0	13.0	11.1	16.1	7.2	7.7	11.3	4.8	3.2	24.7	24.2	19.4	3.2	13.6	6.3	10.9	6.1	47.6	3.5	3.0	21.8	28.7	0.0	0.0	1.5	0.3	0.0	0.0	1.9	17.0	12.2	3.8	1.2	13.9	15.0	9.7	60.4	18.5	32.9	62.1	0.9	1.7	0.0	11.8	10.2	3.6	4.4	51.9	85.3	0.0	7.0	4.2	11.9	8.4	35.8	0.0	0.0	26.2	7.5	28.5	13.9	45.4	5.6	0.2	58.1	6.2	0.0	0.0	2.4	5.2	0.0	2.5	0.0	13.8	0.8	1.9	0.0	48.1	5.2	5.1	14.1	0.5	57.0	40.8	12.4	12.9	36.0	18.5	2.6	0.0	76.0	0.0	7.2	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.9	11.2	12.1	7.9	13.5	12.5	8.2	10.7	4.8	13.0	10.9
PLPP4	"DPPL2, PPAPDC1, PPAPDC1A"	ENSG00000203805	"Phospholipid phosphatase 4"	Q5VZY2	10	120456954-120589855	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 26.5;kidney: 12.6"	"Cell line enhanced"	"Detected in some"		"BJ: 15.1;fHDF/TERT166: 10.7;TIME: 12.0;U-138 MG: 9.6;U-251 MG: 46.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	22	"eosinophil: 2.2"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045188	Approved		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA045188: "	"unprognostic (8.19e-2)"	"unprognostic (2.94e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.90e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.62e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.40e-3)"	"unprognostic (3.49e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.21e-3)"	0.6	1.7	11.4	1.2	13.6	4.9	3.1	11.6	18.2	3.4	1.2	12.1	1.0	0.7	1.7	2.7	0.9	1.2	11.3	0.7	15.9	17.4	12.6	2.8	0.5	0.6	15.5	6.0	0.6	0.6	0.4	0.5	0.6	26.5	3.0	0.8	0.0	2.0	6.1	0.4	1.7	0.8	1.5	19.1	0.5	1.2	11.1	12.5	0.0	1.5	0.0	0.5	0.8	0.7	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	1.1	2.3	1.4	0.1	1.3	0.0	0.0	10.7	0.1	0.9	0.2	1.2	1.4	1.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	1.1	0.0	8.7	0.9	2.1	0.9	0.0	0.0	0.0	0.9	2.7	0.0	0.0	0.0	4.4	0.0	0.8	0.2	0.7	0.0	0.7	1.9	0.0	12.0	9.6	5.3	0.5	46.4	0.0	0.0	0.0	8.9	0.0	2.5	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	13.6	11.6	10.0	15.9	17.4	15.5	6.0	26.5	12.5
PNKP	PNK	ENSG00000039650	"Polynucleotide kinase 3'-phosphatase"	Q96T60	19	49859882-49878351	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Hydrolase, Kinase, Multifunctional enzyme, Transferase"	"Disease mutation, Epilepsy, Mental retardation, Neurodegeneration, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006782	Supported		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA006782: AB_1855496"	"prognostic favourable (9.18e-4)"	"unprognostic (1.87e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.55e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.68e-3)"	13.1	32.4	11.2	22.0	11.8	24.3	15.0	18.0	13.8	14.0	17.4	17.0	26.4	15.6	16.7	25.3	13.6	18.1	18.2	16.8	12.3	9.5	20.1	16.8	15.9	21.0	13.9	14.2	17.1	22.5	19.7	26.8	17.1	12.9	18.7	15.0	19.6	20.3	22.4	12.8	15.3	15.7	13.2	10.1	30.7	17.9	17.2	13.9	22.3	23.0	17.0	20.6	14.6	12.4	7.9	7.5	19.3	12.7	2.7	7.7	3.8	12.8	8.7	8.8	13.8	8.4	6.5	14.3	20.8	10.6	9.6	8.4	6.9	16.9	8.3	6.6	6.3	10.5	3.1	11.7	5.7	10.7	13.3	14.1	16.4	6.0	6.3	13.3	19.0	6.1	6.2	8.7	5.7	12.6	6.9	16.8	12.5	8.2	13.5	10.7	8.2	17.7	11.5	8.1	16.8	9.9	27.5	10.4	16.8	9.1	27.4	4.6	4.7	8.3	17.8	18.8	11.5	4.5	17.1	18.6	7.5	6.7	17.0	6.0	14.9	1.4	8.8	12.2	7.7	8.5	6.4	6.5	6.6	5.8	7.5	7.9	4.9	4.4	19.3	2.7	12.7	4.3	6.8	3.8	11.2	11.8	18.0	13.8	12.3	9.5	13.9	14.2	12.9	13.9
PNMA6A	"MGC15827, PNMA6C"	ENSG00000235961	"PNMA family member 6A"	P0CW24	X	153072482-153075018	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.3"	"Cell line enhanced"	"Detected in some"		"HHSteC: 7.9;HMC-1: 6.8;SK-MEL-30: 6.6;U-2 OS: 15.2;U-266/70: 5.8;U-698: 8.2"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in single"	15	"eosinophil: 5.3"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 5.3"									"HPA045007, HPA052115"	Uncertain		Uncertain	Nucleoli,Mitochondria				Mitochondria	Nucleoli	"HPA045007: , HPA052115: "	"unprognostic (2.14e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.33e-2)"	"unprognostic (4.12e-3)"	"unprognostic (4.39e-2)"	"unprognostic (3.44e-2)"	"unprognostic (9.27e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.76e-4)"	"unprognostic (5.75e-3)"	"prognostic favourable (1.93e-5)"	"unprognostic (4.61e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.04e-3)"	"unprognostic (3.22e-2)"	1.3	2.0	7.2	0.1	6.2	0.2	0.3	7.0	16.3	3.7	0.2			0.5	1.8	7.0	0.1	1.5	0.9	2.1	6.5	11.0	6.2	7.9	0.1	0.2	5.5		3.1	0.7	0.4	3.9	0.1		0.1	0.1		0.9	0.7	0.0	0.3	0.3	0.6	1.6	0.5	0.5	0.8			1.8		0.2	0.1	0.0	0.0	0.0	5.3	0.0	0.0	0.1	0.0	0.0	5.3	0.1	1.6	0.0	0.0	0.0	0.9	0.2	0.3	0.0	0.0	0.5	0.0	1.8	0.4	0.0	2.9	0.0	0.0	0.0	0.6	0.0	0.3	0.2	7.9	3.2	6.8	1.2	0.0	0.1	0.0	0.2	1.3	0.0	0.1	0.4	1.1	0.0	3.4	0.0	0.0	0.0	0.0	0.3	0.0	3.3	1.9	0.4	0.0	6.6	0.0	4.1	0.0	0.0	15.2	0.0	0.0	5.8	4.3	8.2	0.0	0.0	0.4	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0										
PNO1	"KHRBP1, RRP20"	ENSG00000115946	"Partner of NOB1 homolog"	Q9NRX1	2	68157844-68176238	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056928			Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA056928: "	"unprognostic (1.81e-3)"	"unprognostic (4.83e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavourable (1.12e-4)"	"unprognostic (5.88e-2)"	"unprognostic (1.66e-3)"	"prognostic unfavourable (3.04e-8)"	"unprognostic (5.82e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.13e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.74e-2)"	"unprognostic (7.66e-2)"	18.5	19.2	13.0	17.2	19.0	21.8	15.4	10.0	12.8	10.8	13.1	9.1	10.2	9.9	15.3	15.4	14.9	13.8	13.2	24.5	19.1	9.6	16.6	27.4	12.9	15.0	15.0	11.9	20.0	27.0	13.2	15.7	16.3	13.1	14.4	12.2	8.9	12.7	15.0	48.8	12.4	9.5	15.1	11.7	13.6	13.2	11.4	13.9	9.7	16.6	15.1	15.2	15.8	21.4	14.7	12.6	2.0	13.2	10.6	15.5	14.4	15.1	16.6	7.7	12.6	9.5	7.9	19.4	14.5	9.4	16.3	11.6	31.8	9.0	20.8	12.2	9.6	13.0	24.8	17.1	25.7	14.4	17.4	20.2	7.9	23.3	14.8	16.1	9.3	10.2	12.6	16.5	18.9	11.9	27.8	11.3	14.6	11.2	15.7	15.2	21.7	18.1	13.3	19.0	22.1	12.4	12.9	13.8	10.3	10.8	13.4	23.2	9.5	9.0	8.9	18.8	20.3	16.7	40.1	9.1	13.1	32.1	15.4	24.1	25.5	0.4	9.4	1.9	10.1	13.2	15.5	14.7	11.4	11.5	12.6	11.1	13.3	12.2	2.0	10.6	9.4	9.0	11.7	14.4	13.0	19.0	10.0	12.8	19.1	9.6	15.0	11.9	13.1	13.9
PNPLA3	"adiponutrin, ADPN, C22orf20, dJ796I17.1, FLJ22012, iPLA2epsilon"	ENSG00000100344	"Patatin like phospholipase domain containing 3"	Q9NST1	22	43923739-43964488	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Hydrolase, Transferase"	"Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"liver: 31.1;retina: 39.3"	"Cell line enhanced"	"Detected in many"		"AF22: 13.3;LHCN-M2: 15.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA058058	Approved		Approved	Nucleoli,Mitochondria,Cytosol				Nucleoli	"Mitochondria, Cytosol"	"HPA058058: "	"unprognostic (4.74e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.52e-3)"	"unprognostic (5.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.01e-1)"	2.8	0.4	0.5	0.7	1.0	0.3	4.0	0.3	2.4	0.8	1.3	0.4	0.0	1.0	0.5	1.9	0.4	1.1	0.5	0.9	0.8	0.6	4.6	31.1	1.4	0.4	0.3	1.8	0.5	0.2	0.6	0.2	0.4	2.2	0.2	0.2	39.3	0.9	0.2	2.2	5.3	0.6	0.2	0.5	0.6	0.3	0.5	0.3	0.0	0.2	0.0	0.3	0.2	0.4	1.2	0.7	1.8	0.6	0.9	0.8	0.0	3.9	1.2	13.3	5.4	3.8	4.2	0.4	2.4	1.4	3.3	7.1	3.8	7.0	0.0	2.0	4.0	3.3	8.3	3.9	2.7	0.0	0.7	0.2	3.1	7.1	6.1	0.0	0.2	4.8	3.0	10.4	0.5	0.4	0.0	0.0	15.0	0.6	0.2	0.0	9.1	0.0	0.0	7.2	0.1	1.4	0.2	1.2	0.1	2.7	1.0	3.7	4.2	4.5	0.4	1.3	4.0	0.1	0.1	0.0	0.0	0.0	11.4	0.0	4.7	1.5	0.6	0.4	0.5	0.4	0.3	0.7	0.4	0.3	0.2	1.2	0.6	0.8	1.8	0.9	0.3	0.7	0.2	0.0	0.5	1.0	0.3	2.4	0.8	0.6	0.3	1.8	2.2	0.3
PNRC1	"B4-2, PROL2, PRR2"	ENSG00000146278	"Proline rich nuclear receptor coactivator 1"	Q12796	6	89080751-89085160	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 53.8;hTCEpi: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029839, HPA066513"	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA029839: AB_10601247, HPA066513: "	"unprognostic (9.02e-3)"	"unprognostic (7.65e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.31e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.29e-2)"	"prognostic unfavourable (6.88e-6)"	"unprognostic (8.63e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.09e-2)"	70.5	58.1	21.3	46.1	28.3	105.4	48.1	30.8	31.8	55.9	51.5	30.3	27.0	23.6	60.3	30.9	45.4	73.6	45.0	48.5	20.8	17.9	32.9	97.9	59.5	87.1	23.1	22.3	83.4	41.3	31.3	29.5	38.8	20.4	56.6	26.0	46.5	35.5	40.8	154.1	49.0	32.4	63.6	31.1	46.9	38.2	35.5	20.8	91.2	38.4	30.8	45.4	113.2	41.0	9.6	7.3	37.5	7.1	6.9	10.4	3.8	2.9	2.8	6.0	10.2	24.6	41.6	4.2	3.8	26.6	7.1	16.8	2.4	8.2	6.3	18.6	4.6	10.0	3.2	5.7	11.0	7.9	9.9	1.1	16.4	7.6	53.8	5.9	14.8	29.8	57.2	4.8	22.1	11.7	0.9	19.6	7.9	2.8	1.5	31.1	1.7	6.1	7.0	7.4	5.0	16.8	5.2	3.8	10.9	9.8	13.5	9.9	6.7	29.7	11.1	5.7	3.4	3.9	1.4	30.8	15.1	2.1	11.4	5.1	3.5	10.3	6.6	36.7	7.5	7.1	7.8	8.3	8.9	7.8	4.2	9.6	10.4	10.4	37.5	6.9	6.3	7.3	7.1	3.8	21.3	28.3	30.8	31.8	20.8	17.9	23.1	22.3	20.4	20.8
POLE3	"CHARAC17, CHRAC17, p17, Ybl1"	ENSG00000148229	"DNA polymerase epsilon 3, accessory subunit"	Q9NRF9	9	113407235-113410672	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047945	Uncertain		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA047945: "	"unprognostic (9.55e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavourable (8.35e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.18e-1)"	16.9	23.9	18.2	22.0	18.5	56.3	19.3	36.0	25.0	17.0	17.6	15.8	12.5	15.1	18.2	16.5	27.8	17.6	17.0	17.9	16.1	14.8	14.3	29.5	15.8	29.0	15.1	18.5	15.4	20.8	13.1	8.4	21.2	20.0	15.9	20.3	12.4	17.9	16.3	48.3	24.7	17.3	16.9	16.9	26.8	17.2	29.9	15.9	35.0	16.3	27.3	32.4	18.8	16.7	34.9	33.5	34.3	34.4	28.0	44.0	47.7	15.7	19.7	13.9	20.8	7.9	7.1	12.2	21.1	10.8	23.9	18.9	18.2	14.4	57.4	13.1	12.3	27.1	27.0	23.2	22.1	10.9	16.3	29.8	20.4	18.6	8.5	61.7	18.0	8.1	16.0	20.7	26.8	16.5	41.5	32.1	16.6	40.1	42.3	33.2	17.9	35.7	43.4	57.9	32.2	10.4	15.1	30.1	17.4	30.6	19.4	16.5	29.0	27.8	13.6	17.8	24.1	22.4	36.0	16.8	54.9	77.4	16.2	36.5	21.2	25.4	34.0	34.3	35.5	34.4	44.0	34.9	34.0	33.7	33.2	33.5	36.9	34.3	7.2	28.0	26.6	33.5	39.0	47.7	18.2	18.5	36.0	25.0	16.1	14.8	15.1	18.5	20.0	15.9
POLR1B	"FLJ10816, FLJ21921, RPA2, Rpo1-2"	ENSG00000125630	"RNA polymerase I subunit B"	Q9H9Y6	2	112541915-112577150	"Enzymes, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037528			Supported	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA037528: AB_10671627"	"unprognostic (1.66e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (2.71e-5)"	"unprognostic (2.07e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (5.52e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.56e-2)"	8.8	11.0	6.4	10.6	6.8	4.9	15.7	8.0	8.2	7.6	7.0	7.7	8.6	5.8	9.3	7.4	12.8	9.2	9.2	6.1	5.7	6.1	11.3	20.5	8.0	11.3	6.8	3.7	11.3	25.2	20.7	11.5	7.2	5.2	7.7	8.5	7.3	10.0	8.3	14.7	9.2	8.0	7.9	4.8	11.4	8.1	15.7	5.0	9.6	15.7	11.5	14.6	8.9	11.8	9.4	11.0	2.5	6.3	10.2	17.1	7.3	9.4	9.9	6.3	13.0	6.8	6.6	11.8	7.1	5.4	12.0	10.5	22.2	5.6	22.7	10.6	4.7	13.3	26.4	14.5	13.9	10.2	13.3	13.1	9.9	16.7	7.2	20.9	9.1	6.2	10.5	12.5	19.3	9.3	23.7	8.2	6.3	8.3	9.4	13.6	30.6	19.7	14.2	10.4	24.1	8.3	9.0	15.9	14.8	6.5	16.5	9.0	7.6	7.4	8.4	7.4	10.9	6.8	10.4	11.1	18.3	19.6	5.6	13.4	6.2	0.2	6.0	2.5	8.3	6.3	17.1	9.4	8.4	8.9	11.0	9.3	10.3	10.4	0.4	10.2	4.8	2.6	11.3	7.3	6.4	6.8	8.0	8.2	5.7	6.1	6.8	3.7	5.2	5.0
POP1		ENSG00000104356	"POP1 homolog, ribonuclease P/MRP subunit"	Q99575	8	98117297-98159834	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066194			Supported	Nucleoli				Nucleoli		"HPA066194: "	"prognostic unfavourable (2.54e-4)"	"unprognostic (9.42e-2)"	"unprognostic (5.96e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.46e-2)"	"prognostic unfavourable (1.26e-6)"	"prognostic unfavourable (9.88e-4)"	"unprognostic (4.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.39e-2)"	"prognostic unfavourable (5.97e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.96e-1)"	6.1	5.5	7.8	9.0	9.7	3.7	5.8	14.3	10.2	4.3	5.4	5.2	2.7	4.3	6.0	4.2	9.1	6.6	3.9	5.0	5.7	4.7	10.5	6.4	5.2	9.1	4.1	7.6	8.4	5.8	7.6	11.1	3.5	7.4	5.0	13.8	6.2	5.1	4.2	5.7	8.2	5.1	5.2	4.0	8.8	5.7	11.8	6.2	8.8	5.0	5.6	11.3	4.3	5.0	10.5	7.7	10.9	7.4	4.1	9.8	2.5	12.6	7.6	8.3	7.7	2.9	2.1	5.5	10.9	9.2	11.4	8.5	7.8	8.2	8.9	15.7	7.9	8.5	24.2	10.8	12.3	6.4	10.2	17.8	6.1	5.3	1.3	9.4	11.2	1.7	2.0	12.6	5.0	8.8	9.7	8.1	10.6	10.1	13.6	4.8	6.3	10.6	11.3	4.9	6.4	8.3	6.8	20.0	4.7	5.0	8.5	3.8	11.6	3.5	12.0	10.0	7.2	12.6	21.5	8.1	7.6	19.2	7.8	10.2	8.7	10.9	6.7	4.6	9.8	7.4	7.8	6.2	7.1	6.5	6.2	10.5	9.3	8.6	0.9	4.1	3.4	7.7	5.9	2.5	7.8	9.7	14.3	10.2	5.7	4.7	4.1	7.6	7.4	6.2
POP5		ENSG00000167272	"POP5 homolog, ribonuclease P/MRP subunit"	Q969H6	12	120578764-120581398	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047598, HPA069204"	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA047598: , HPA069204: "	"unprognostic (1.50e-2)"	"prognostic favourable (2.68e-5)"	"unprognostic (1.55e-1)"	"unprognostic (3.61e-3)"	"unprognostic (3.81e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.34e-2)"	"unprognostic (5.75e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (4.85e-4)"	"unprognostic (3.07e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.68e-2)"	16.3	33.8	16.2	25.6	14.4	14.1	23.9	8.7	16.7	18.6	17.5	13.6	24.2	11.8	14.5	27.1	15.9	14.6	19.5	25.8	18.1	13.9	24.1	24.1	18.3	19.7	16.9	15.9	11.7	18.9	25.0	17.5	8.2	14.2	15.6	18.0	15.1	20.9	22.6	13.3	12.7	15.1	19.5	14.4	20.3	15.2	9.0	12.1	24.2	19.8	18.9	19.6	13.7	19.2	32.0	33.5	3.6	19.7	18.2	28.2	22.8	20.1	34.5	12.3	15.0	23.3	12.6	19.5	17.0	11.0	20.7	15.9	29.7	9.3	11.8	25.8	13.6	21.4	20.5	32.3	18.6	28.0	31.1	14.4	22.5	33.6	16.4	20.4	15.2	15.8	18.6	23.9	11.0	17.3	17.6	7.6	20.6	44.3	16.5	18.4	14.6	29.8	19.5	15.0	32.4	29.0	20.7	9.6	10.5	28.7	8.4	21.8	39.3	19.6	12.4	10.8	16.3	17.3	18.5	19.9	33.4	20.9	21.1	24.9	17.3	3.6	16.2	3.5	24.7	19.7	22.6	32.0	22.6	23.0	19.0	22.4	28.2	26.8	1.1	18.2	16.7	33.5	21.4	22.8	16.2	14.4	8.7	16.7	18.1	13.9	16.9	15.9	14.2	12.1
POP7	"RPP2, RPP20"	ENSG00000172336	"POP7 homolog, ribonuclease P/MRP subunit"	O75817	7	100706053-100707495	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021007	Uncertain		Supported	Nucleoli,Vesicles				"Nucleoli, Vesicles"		"HPA021007: AB_10963575"	"unprognostic (3.19e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.80e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (4.99e-5)"	"unprognostic (2.98e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.12e-2)"	"unprognostic (9.50e-2)"	"unprognostic (3.88e-1)"	"prognostic unfavourable (6.02e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.21e-2)"	"unprognostic (6.73e-2)"	12.3	16.6	20.5	15.1	21.0	25.3	16.1	25.1	33.2	11.3	14.7	8.7	14.0	17.5	13.9	12.5	20.4	13.4	13.9	19.6	18.3	18.1	13.1	31.4	11.7	18.2	16.8	22.0	13.2	21.2	6.6	11.5	18.1	13.3	16.0	8.1	10.0	24.2	15.8	46.4	22.6	17.6	12.3	12.9	12.3	15.5	7.0	9.4	11.0	11.6	20.5	11.8	11.5	12.5	32.1	30.4	46.4	35.6	42.1	37.0	32.0	24.3	24.2	9.8	17.3	5.2	5.0	19.2	13.8	6.5	15.3	15.2	35.4	15.8	19.8	23.3	6.0	15.5	14.3	16.2	7.6	17.9	43.2	8.9	15.8	34.0	8.8	13.6	10.9	5.8	6.1	15.7	15.5	8.5	31.5	17.7	8.0	69.0	34.1	46.7	30.1	33.5	25.8	10.4	33.5	9.1	13.4	19.7	20.0	11.1	34.4	16.3	11.3	13.8	8.3	21.3	25.6	41.8	27.1	7.5	20.4	35.4	13.4	23.5	23.1	46.4	35.6	38.2	32.4	34.1	29.4	32.1	32.5	31.6	30.4	26.4	29.9	31.1	21.9	42.1	35.3	27.9	37.0	32.0	20.5	21.0	25.1	33.2	18.3	18.1	16.8	22.0	13.3	9.4
POPDC3	"bA355M14.1, MGC22671, POP3"	ENSG00000132429	"Popeye domain containing 3"	Q9HBV1	6	105158280-105179995	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	5	"heart muscle: 23.9;skeletal muscle: 68.9"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 13.2;RH-30: 14.7;SH-SY5Y: 12.2;U-87 MG: 13.3;WM-115: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA012514			Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA012514: "	"unprognostic (2.17e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.14e-3)"	"unprognostic (7.74e-2)"	"prognostic unfavourable (4.43e-4)"	"unprognostic (2.24e-3)"	"prognostic unfavourable (5.79e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.12e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.83e-9)"	"unprognostic (6.25e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.33e-2)"	0.9	0.8	2.2	1.4	4.5	0.6	2.5	0.4	6.8	0.8	1.4	2.1	0.8	0.7	1.3	2.2	2.1	0.7	1.1	23.9	3.7	2.3	0.6	0.6	0.7	0.7	6.1	3.5	0.7	0.6	0.6	3.2	1.2	4.0	1.2	0.6	1.9	1.0	0.8	68.9	0.6	0.6	0.6	3.6	0.6	1.6	3.6	4.0	0.0	0.8	8.8	0.6	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.6	0.4	0.1	2.7	6.9	0.6	2.7	2.8	4.7	5.8	0.0	1.5	0.1	1.1	5.4	0.0	1.3	1.2	3.9	0.0	2.9	0.0	1.0	0.0	0.1	0.0	0.0	2.7	0.2	7.6	1.0	0.3	2.8	8.1	13.2	0.0	0.0	1.0	3.0	4.6	0.4	14.7	0.0	0.0	0.0	6.7	12.2	0.0	0.0	9.5	0.0	5.2	6.0	2.9	0.0	1.9	9.9	0.0	0.0	0.0	13.3	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	4.5	0.4	6.8	3.7	2.3	6.1	3.5	4.0	4.0
POU2F3	"Epoc-1, OCT11, PLA-1, Skn-1a"	ENSG00000137709	"POU class 2 homeobox 3"	Q9UKI9	11	120236640-120319944	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	5	"ductus deferens: 36.5;seminal vesicle: 13.2;skin 1: 38.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.1;SK-BR-3: 5.2;T-47d: 9.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA019652, HPA073468"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Plasma membrane,Cytosol"				Nucleoplasm	"Nucleoli, Nuclear bodies, Plasma membrane, Cytosol"	"HPA019652: AB_1855585, HPA073468: "	"unprognostic (1.75e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.41e-4)"	"unprognostic (2.60e-1)"	"unprognostic (4.46e-3)"	"unprognostic (8.56e-3)"	"unprognostic (9.34e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.69e-3)"	"unprognostic (1.70e-1)"	"prognostic favourable (8.14e-4)"	"unprognostic (1.45e-1)"	0.2	0.2	0.1	0.2	0.1	0.0	1.6	0.1	0.1	1.2	0.9	0.0	36.5	0.7	0.4	1.2	2.5	0.3	0.4	0.2	0.1	0.1	0.3	0.2	1.6	0.4	0.1	0.0	0.2	0.3	6.4	1.3	4.4	0.1	1.1	0.1	0.0	1.1	13.2	0.1	38.2	1.0	0.2	0.1	0.2	0.4	0.6	0.0	0.4	4.5	4.8	2.2	0.7	2.6	1.0	0.7	2.1	0.5	0.9	0.6	0.2	2.4	0.0	0.0	0.2	0.0	0.0	0.7	0.3	0.6	0.0	0.0	0.1	7.1	0.3	2.6	0.0	1.3	0.0	0.4	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.7	0.4	0.0	0.0	1.3	0.0	0.1	0.1	0.2	0.3	0.6	0.0	0.0	0.1	0.0	1.8	0.4	0.1	0.1	5.2	0.0	9.4	0.4	0.8	0.0	0.2	0.3	0.1	0.1	0.0	0.0	1.1	0.1	0.1	1.4	0.4	0.5	0.5	0.3	0.5	0.5	0.6	0.4	0.1	1.0	0.6	0.6	2.1	0.9	0.5	0.7	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
PPDPF	"C20orf149, dJ697K14.9, exdpf"	ENSG00000125534	"Pancreatic progenitor cell differentiation and proliferation factor"	Q9H3Y8	20	63520724-63522206	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 18.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA040929			Approved	Nucleoplasm,Nucleoli,Microtubules				"Nucleoplasm, Microtubules"	Nucleoli	"HPA040929: AB_10794155"	"unprognostic (3.75e-2)"	"unprognostic (5.39e-2)"	"unprognostic (4.37e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.20e-1)"	"prognostic favourable (3.91e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.09e-2)"	63.9	19.9	42.2	46.0	43.0	36.5	38.8	22.3	55.1	54.3	78.6	61.5	43.5	41.3	39.9	46.0	112.6	44.7	67.3	53.2	32.9	31.0	72.1	28.4	56.5	42.8	44.5	34.9	45.6	69.5	15.4	35.0	22.2	48.7	75.3	32.2	58.8	143.7	54.1	116.1	86.2	48.5	61.8	72.0	40.0	120.2	49.0	21.6	28.7	48.0	73.3	87.9	68.6	65.2	5.8	3.4	18.9	4.5	2.4	5.2	3.4	44.0	13.7	9.4	19.0	10.7	18.0	30.3	27.2	8.8	35.5	14.0	25.1	26.6	9.5	36.6	18.1	46.7	4.7	31.0	5.7	16.9	9.3	3.9	12.8	4.7	29.3	0.0	20.4	17.7	62.6	9.0	12.5	13.9	15.9	22.4	12.9	60.0	45.1	0.4	10.1	79.8	20.6	21.2	19.2	25.4	18.2	32.2	24.5	27.0	43.5	18.6	62.2	25.8	22.9	30.1	34.1	39.7	22.4	17.8	14.0	6.4	21.2	11.2	19.5	1.9	2.4	18.9	5.2	3.1	4.3	4.6	4.6	4.8	2.9	5.8	4.1	4.5	1.1	2.4	4.5	3.4	5.0	3.4	42.2	43.0	22.3	55.1	32.9	31.0	44.5	34.9	48.7	21.6
PPID	CYP-40	ENSG00000171497	"Peptidylprolyl isomerase D"	Q08752	4	158709134-158723396	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Protein transport, Transport"	"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019520, HPA019692"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoli, Cytosol"	Nucleoplasm	"HPA019520: AB_1847400, HPA019692: AB_1847401"	"unprognostic (4.26e-2)"	"unprognostic (2.03e-2)"	"unprognostic (8.91e-3)"	"unprognostic (8.17e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.62e-2)"	"unprognostic (4.72e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.66e-3)"	"unprognostic (8.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.09e-1)"	16.8	25.8	20.1	15.5	21.4	14.9	22.3	26.7	26.8	12.6	16.8	14.4	18.2	33.4	14.6	13.6	16.5	15.4	13.0	28.8	19.4	22.1	21.5	45.3	11.0	17.4	22.6	18.9	14.6	17.5	11.3	30.3	14.5	26.0	16.1	14.2	9.1	15.4	13.7	53.3	24.0	29.2	13.1	22.7	16.5	15.5	16.9	23.4	22.7	21.7	16.0	16.8	15.4	55.0	15.6	17.2	33.4	22.2	23.9	24.4	17.1	15.3	14.3	14.4	19.7	21.4	16.1	21.8	15.2	8.3	14.0	10.6	18.5	10.5	16.2	6.8	14.1	11.8	43.6	17.4	17.1	53.7	15.2	29.0	12.9	25.5	16.6	18.2	21.8	10.1	14.2	12.0	17.9	15.2	36.2	29.0	15.5	14.7	26.0	16.5	19.8	19.1	11.8	7.1	13.9	15.4	7.7	24.4	16.3	11.4	23.7	21.6	10.9	17.4	14.7	14.0	15.8	15.4	20.0	16.7	34.6	20.7	17.8	19.7	14.0	33.4	15.3	33.2	21.2	22.2	24.4	14.6	20.7	19.6	16.7	15.6	21.5	22.0	20.9	23.9	22.0	17.2	22.4	17.1	20.1	21.4	26.7	26.8	19.4	22.1	22.6	18.9	26.0	23.4
PPIL1	CYPL1	ENSG00000137168	"Peptidylprolyl isomerase like 1"	Q9Y3C6	6	36854827-36875024	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA062916			Approved	Nucleoli				Nucleoli		"HPA062916: "	"unprognostic (3.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.81e-2)"	"prognostic unfavourable (1.28e-5)"	"unprognostic (2.01e-1)"	"unprognostic (3.37e-2)"	"prognostic favourable (4.90e-4)"	"unprognostic (6.58e-2)"	"unprognostic (5.49e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.15e-2)"	9.0	17.2	15.9	11.1	23.1	7.3	12.3	16.6	18.7	11.1	10.2	13.0	5.7	8.7	13.7	11.7	13.1	17.5	7.5	29.7	13.2	19.8	17.6	34.3	7.5	13.4	15.0	15.5	13.2	36.7	10.6	19.4	16.0	15.3	11.2	13.2	11.0	12.0	12.5	11.7	5.6	8.2	17.4	15.8	10.3	8.5	14.0	11.0	10.2	23.5	13.4	17.4	12.2	8.1	7.7	6.6	1.1	4.4	5.0	15.0	6.9	14.1	11.2	29.6	19.7	4.0	8.4	16.0	14.4	9.6	21.7	18.1	19.6	9.4	21.7	18.3	10.1	11.5	35.0	24.0	24.9	18.1	29.2	25.8	7.3	25.9	13.2	22.0	10.8	6.3	11.4	16.7	31.3	19.4	48.3	10.6	15.7	13.4	26.1	10.1	19.6	15.2	21.1	25.9	19.5	12.9	10.0	31.5	16.6	9.6	10.3	18.9	15.0	18.7	11.8	16.8	15.5	12.8	24.0	11.6	30.3	39.7	5.3	40.8	31.9	1.1	3.2	0.8	11.2	4.4	15.0	7.7	9.3	10.7	6.6	6.2	10.5	12.3	0.9	5.0	2.1	5.6	6.8	6.9	15.9	23.1	16.6	18.7	13.2	19.8	15.0	15.5	15.3	11.0
PPM1B	"PP2CB, PP2CBETA, PPC2BETAX"	ENSG00000138032	"Protein phosphatase, Mg2+/Mn2+ dependent 1B"	O75688	2	44167969-44244384	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016745	Approved		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA016745: AB_1855622"	"unprognostic (5.49e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.96e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.75e-2)"	23.7	13.8	31.2	12.2	33.8	24.7	15.2	32.6	25.2	16.3	18.2	26.0	13.6	13.2	15.7	20.4	14.9	12.7	14.3	21.1	29.6	24.6	19.4	27.7	13.4	16.6	34.6	22.4	15.8	20.9	34.6	17.9	12.1	22.9	20.7	19.0	24.3	16.4	16.4	72.0	12.5	14.3	21.1	27.3	16.1	14.8	13.3	34.1	19.1	15.0	13.1	16.8	18.2	15.9	6.5	5.5	11.1	5.0	4.7	9.5	1.6	17.3	15.5	20.7	15.1	25.9	12.1	23.5	13.5	15.6	14.0	12.4	20.9	11.3	19.1	21.2	15.5	9.5	23.1	8.8	20.8	19.3	9.0	20.2	9.3	14.3	20.9	18.0	16.9	11.6	15.5	11.1	18.9	11.4	14.7	20.3	12.5	14.4	17.8	29.0	25.5	5.2	19.0	23.1	12.8	32.6	17.6	16.7	21.0	12.1	18.2	15.6	9.8	12.6	10.4	12.3	17.7	10.1	12.9	17.8	11.6	17.9	6.5	30.0	8.8	8.3	3.3	11.1	7.2	4.5	6.2	5.8	6.9	6.1	5.5	6.5	9.5	6.4	9.2	4.7	5.0	5.3	6.2	1.6	31.2	33.8	32.6	24.9	29.6	24.6	34.6	22.4	22.9	34.1
PPM1E	"CaMKP-N, KIAA1072, POPX1, PP2CH"	ENSG00000175175	"Protein phosphatase, Mg2+/Mn2+ dependent 1E"	Q8WY54	17	58755869-58985176	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 10.7;brain: 36.5;testis: 13.1"	"Cell line enhanced"	"Detected in some"		"AF22: 10.0;HAP1: 16.2;MOLT-4: 7.6;SCLC-21H: 7.5;SH-SY5Y: 15.5;THP-1: 6.9"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 3.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"basophil: 2.5"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018462, HPA019263"	Approved		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA018462: AB_1855623, HPA019263: AB_1855624"	"unprognostic (2.50e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.99e-2)"	"unprognostic (5.30e-1)"	"unprognostic (8.19e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.22e-2)"	"unprognostic (5.24e-2)"	"unprognostic (8.80e-5)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-7)"	"unprognostic (1.05e-4)"	"unprognostic (1.64e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.12e-2)"	0.7	10.7	15.0	0.8	7.5	0.7	0.7	11.9	23.3	1.0	0.7	3.6	0.0	0.8	1.1	2.2	0.7	3.3	0.8	2.3	36.5	5.4	1.9	2.4	1.0	0.9	3.2	9.2	1.0	1.7	0.8	3.4	0.6	10.5	3.2	0.7	3.5	0.8	0.7	0.6	0.7	1.0	1.3	2.7	0.8	1.4	13.1	2.0	0.0	0.8	0.0	1.0	0.6	0.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.5	0.0	0.0	0.7	0.0	0.0	0.8	1.1	0.0	0.0	6.3	0.1	0.1	0.0	16.2	0.0	0.4	0.1	4.8	0.0	0.1	0.0	1.1	0.5	2.1	0.3	1.3	0.0	0.0	0.0	1.6	0.0	0.0	2.8	7.6	0.0	2.8	0.8	0.0	1.3	0.0	0.0	0.0	7.5	15.5	0.2	0.0	1.0	0.0	6.9	0.0	0.0	1.9	0.0	2.3	0.0	0.1	4.3	0.2	0.0	2.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	7.5	11.9	14.0	36.5	5.4	3.2	9.2	10.5	2.0
PPP1R1C	Inhibitor-1-like	ENSG00000150722	"Protein phosphatase 1 regulatory inhibitor subunit 1C"	Q8WVI7	2	181954241-182131398	"Predicted intracellular proteins"	"Cell cycle, Cell division"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 7.5;heart muscle: 27.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.0;HAP1: 1.2;MOLT-4: 2.1;SiHa: 1.3;U-266/70: 2.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA055043			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"				Nucleoplasm	"Nucleoli, Golgi apparatus"	"HPA055043: "	"unprognostic (1.70e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.08e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.57e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.13e-1)"	"unprognostic (7.98e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.00e-3)"	"unprognostic (7.68e-2)"	"unprognostic (3.07e-2)"	"unprognostic (9.75e-3)"	0.2	0.1	0.7	0.1	3.5	0.1	0.2	3.5	1.8	0.1	0.2	3.0	0.0	0.2	0.2	0.1	0.3	0.2	0.5	27.8	1.5	1.1	0.2	1.2	0.3	0.2	0.8	0.6	0.1	0.6	0.1	0.4	0.2	7.5	1.4	0.2	0.5	0.5	0.2	4.3	0.2	0.7	0.1	2.5	0.2	0.4	0.6	1.3	0.0	0.2	3.3	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	2.1	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	1.3	0.2	0.3	0.2	0.0	0.0	0.0	0.6	0.0	0.0	2.0	0.0	0.2	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.5	3.5	1.8	1.5	1.1	0.8	0.6	7.5	1.3
PPP1R3D	PPP1R6	ENSG00000132825	"Protein phosphatase 1 regulatory subunit 3D"	O95685	20	59936668-59940297	"Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 6.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041146	Approved		Approved	Nucleoli,Vesicles,Mitochondria				"Vesicles, Mitochondria"	Nucleoli	"HPA041146: AB_10793870"	"unprognostic (2.50e-3)"	"unprognostic (3.55e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.23e-2)"	"unprognostic (5.87e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.39e-3)"	"unprognostic (5.54e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.48e-2)"	"prognostic favourable (9.14e-4)"	"unprognostic (4.71e-2)"	"unprognostic (1.47e-2)"	"unprognostic (5.71e-2)"	8.2	6.1	9.3	8.2	9.5	9.9	17.2	8.6	9.5	9.1	8.2	6.4	7.1	9.5	9.0	6.5	13.3	7.4	6.5	11.3	8.4	7.8	7.8	2.0	10.0	16.8	9.5	5.4	8.8	17.5	13.3	12.1	9.8	9.3	12.0	5.6	7.6	9.1	11.2	12.9	9.1	10.1	7.1	8.9	11.2	9.6	4.7	6.6	4.0	8.0	8.8	8.9	9.1	8.8	0.7	1.2	6.0	3.5	0.8	1.0	0.4	4.0	2.4	1.7	3.5	3.8	4.0	14.2	5.3	5.8	6.5	3.1	3.8	5.5	1.7	6.6	4.4	11.8	3.5	3.8	4.2	3.9	2.7	4.4	3.3	2.0	3.5	1.8	12.5	2.8	10.4	2.3	2.0	3.5	0.8	0.4	4.1	6.1	1.5	5.8	1.2	5.9	1.9	0.8	2.5	4.3	6.4	3.2	2.0	6.6	20.0	5.7	7.3	6.5	3.8	3.8	1.6	4.0	0.8	1.4	3.4	0.4	2.8	6.4	2.3	0.6	1.6	6.0	1.0	0.7	0.9	0.7	0.7	0.8	1.2	0.6	0.9	0.6	4.2	0.8	3.5	0.5	1.0	0.4	9.3	9.5	8.6	9.5	8.4	7.8	9.5	5.4	9.3	6.6
PPP1R7	sds22	ENSG00000115685	"Protein phosphatase 1 regulatory subunit 7"	Q15435	2	241149576-241183652	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034500, HPA034501"	Supported		Approved	Nucleoli			650000	Nucleoli		"HPA034500: AB_2674192, HPA034501: AB_10670965"	"unprognostic (1.63e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.62e-2)"	"unprognostic (4.38e-1)"	"unprognostic (8.07e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.51e-3)"	"unprognostic (1.23e-1)"	21.5	21.9	39.2	19.4	82.1	22.2	19.7	25.0	40.5	19.0	24.8	16.4	18.8	22.2	18.9	24.8	31.5	32.2	20.5	36.9	31.3	23.3	24.9	28.8	20.4	27.2	23.7	35.2	16.4	22.8	21.9	18.4	17.3	23.5	37.9	25.3	17.6	22.9	22.2	46.4	24.2	22.7	21.3	20.8	17.6	21.8	57.3	29.4	21.2	25.5	26.1	29.6	24.4	25.0	31.4	37.5	48.5	41.0	32.8	53.3	37.4	31.0	18.8	21.4	27.0	42.5	42.7	29.6	34.4	31.5	23.8	33.7	10.2	39.8	16.0	10.3	29.4	30.6	35.0	32.5	36.6	41.6	34.6	28.0	30.7	40.4	27.4	38.7	29.6	32.9	25.8	28.1	20.8	35.2	28.2	23.8	55.4	41.4	34.4	29.9	29.4	18.0	24.0	55.8	32.4	44.1	31.5	29.2	23.2	18.4	43.4	31.4	25.8	42.1	34.6	21.6	20.5	40.5	27.6	25.4	15.3	43.4	60.5	41.3	28.4	40.4	39.8	48.5	32.1	40.0	33.7	31.4	38.4	37.7	37.5	28.8	29.8	34.5	31.4	32.8	41.0	22.4	53.3	37.4	39.2	82.1	25.0	40.5	31.3	23.3	23.7	35.2	23.5	29.4
PRDM1	"BLIMP1, PRDI-BF1"	ENSG00000057657	"PR/SET domain 1"	O75626	6	106086320-106109939	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Immunity, Innate immunity, Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 49.9"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 66.9;RPMI-8226: 12.5;U-266/70: 25.1;U-266/84: 16.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"eosinophil: 5.6;gdT-cell: 12.6;MAIT T-cell: 19.3;memory CD4 T-cell: 12.0;memory CD8 T-cell: 11.6;naive CD8 T-cell: 6.8;neutrophil: 6.8;T-reg: 15.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.8;T-cells: 19.3"	"Region enriched"	"Detected in single"	6	"olfactory region: 4.4"	"Low region specificity"	"Detected in all"			HPA030033	Approved		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA030033: AB_10601050"	"unprognostic (9.60e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.56e-2)"	"prognostic unfavourable (9.81e-5)"	"unprognostic (1.52e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.45e-3)"	"unprognostic (7.90e-2)"	11.6	1.5	1.6	26.3	3.2	10.4	7.0	5.3	1.6	14.0	16.5	1.9	1.4	5.4	11.6	2.2	33.4	3.8	8.1	2.3	1.9	2.0	3.1	2.4	18.8	33.3	2.1	0.5	4.2	1.8	1.2	2.1	9.0	4.9	3.6	11.0	4.3	10.6	3.0	2.0	8.9	18.2	3.4	7.4	24.2	8.6	3.0	1.5	3.1	7.7	35.7	49.9	12.8	18.0	1.5	0.2	6.8	0.6	2.5	19.3	1.3	0.4	0.1	0.3	0.0	0.5	0.6	0.0	2.3	7.0	0.7	1.3	0.4	2.7	0.5	0.1	4.5	0.1	0.0	1.0	0.8	6.3	0.0	0.1	1.4	0.0	1.1	0.2	0.5	0.7	3.5	1.0	3.0	0.8	0.4	66.9	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	12.5	0.6	0.1	0.0	0.0	0.3	0.2	0.0	0.3	0.7	0.4	1.1	0.6	0.6	2.1	25.1	16.2	1.4	1.5	0.4	0.6	1.2	0.4	5.6	12.6	0.6	19.3	1.5	12.0	11.6	0.2	0.5	1.1	6.8	6.8	2.5	0.1	0.2	15.4	1.3	1.6	3.2	5.3	1.6	1.9	2.0	2.1	0.5	4.9	1.5
PRDM5	PFM2	ENSG00000138738	"PR/SET domain 5"	Q9NQX1	4	120684919-120922870	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 15.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	25	"eosinophil: 9.1;neutrophil: 6.7"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 9.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051406	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"	Nucleoli	"HPA051406: "	"unprognostic (7.74e-2)"	"unprognostic (8.45e-3)"	"unprognostic (3.15e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.20e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.28e-2)"	"unprognostic (4.52e-2)"	"unprognostic (5.09e-2)"	"unprognostic (8.71e-2)"	"unprognostic (6.29e-2)"	"unprognostic (4.13e-1)"	"unprognostic (3.00e-2)"	"unprognostic (4.91e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.56e-3)"	5.0	5.9	3.5	3.6	3.9	4.6	5.4	1.9	5.4	9.3	5.2	2.7	6.3	1.9	8.6	7.0	3.3	7.7	6.1	5.0	3.2	3.1	3.1	0.8	7.4	2.7	3.4	4.2	15.2	10.3	19.3	12.5	5.0	6.1	7.7	4.4	9.4	3.3	6.8	2.2	2.7	3.2	9.5	6.2	3.3	4.1	5.0	3.3	0.5	8.4	5.1	2.3	5.8	14.1	0.0	0.0	9.1	0.0	0.0	0.3	0.0	1.7	2.8	6.5	0.1	3.9	8.1	7.7	3.8	8.4	3.9	3.5	3.6	1.0	0.4	1.0	5.1	0.0	0.0	0.8	5.2	0.0	1.1	2.3	2.5	0.2	4.2	7.9	0.1	5.7	2.5	2.8	3.5	2.9	0.0	11.9	4.8	0.3	1.2	0.0	4.8	2.2	0.0	7.5	4.9	1.4	0.0	1.2	5.2	0.0	0.1	0.7	5.4	3.4	1.1	0.2	2.3	4.0	3.8	11.0	15.3	0.0	3.0	0.0	2.9	0.1	0.0	9.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	6.7	0.0	0.0	0.0	0.0	0.0	3.5	3.9	1.9	5.4	3.2	3.1	3.4	4.2	6.1	3.3
PRIMA1	PRIMA	ENSG00000175785	"Proline rich membrane anchor 1"	Q86XR5	14	93718298-93788481	"Predicted membrane proteins"	"Neurotransmitter degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 26.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 7.3;Hep G2: 4.7;NTERA-2: 3.0;SCLC-21H: 12.9;SH-SY5Y: 7.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 16.2"	"Low region specificity"	"Detected in all"			"HPA046671, HPA060047"	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoli, Cytosol"	"HPA046671: , HPA060047: "	"unprognostic (3.60e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.54e-2)"	"prognostic unfavourable (6.99e-5)"	"unprognostic (1.03e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.94e-2)"	"unprognostic (6.61e-3)"	"prognostic unfavourable (2.62e-7)"	"unprognostic (2.33e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.94e-4)"	"unprognostic (4.57e-3)"	4.6	6.0	4.2	5.9	16.7	0.4	2.4	4.5	8.2	7.7	26.2	21.7	4.2	4.6	7.9	7.9	13.7	10.7	3.3	4.8	5.8	3.3	1.2	0.7	1.0	0.7	20.2	4.0	6.9	1.2	0.6	0.3	2.2	15.5	8.6	7.6	9.9	4.6	10.2	0.7	2.1	11.6	14.9	24.3	0.7	12.1	1.8	14.7	0.0	1.3	0.9	4.4	4.7	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.3	0.0	0.0	0.2	0.4	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	3.0	0.0	0.0	0.0	0.3	0.0	0.0	12.9	7.3	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	16.7	4.5	8.2	5.8	3.3	20.2	4.0	15.5	14.7
PRMT6	"FLJ10559, HRMT1L6"	ENSG00000198890	"Protein arginine methyltransferase 6"	Q96LA8	1	107056679-107059294	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"MCF7: 81.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059424	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA059424: "	"unprognostic (5.17e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (3.05e-4)"	"unprognostic (2.68e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.13e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.73e-3)"	6.6	16.1	14.4	10.5	13.4	4.6	10.8	12.6	13.9	8.9	10.3	11.5	10.4	8.1	9.7	11.3	10.9	12.2	9.8	5.0	11.8	16.2	16.7	16.3	5.9	11.5	12.2	14.1	12.3	16.8	15.0	13.8	9.6	13.2	11.8	9.7	12.6	8.3	11.4	2.1	7.6	9.3	8.0	13.6	11.5	9.5	9.4	10.6	18.2	9.5	3.4	11.1	10.1	7.3	9.7	14.7	1.8	10.1	14.6	10.9	7.6	3.5	0.0	7.1	3.1	4.7	5.2	1.9	4.8	3.6	4.7	4.8	4.6	2.5	8.8	6.7	4.4	5.1	6.5	7.1	3.7	0.0	6.9	5.3	10.0	6.6	4.7	10.9	3.3	4.9	3.9	4.2	4.3	4.0	7.1	1.3	4.2	81.7	6.4	3.8	3.0	6.7	8.1	15.5	3.3	11.3	7.3	13.3	16.2	6.5	9.5	3.1	6.6	8.2	4.6	3.5	7.1	7.2	7.1	1.5	1.0	1.5	5.1	5.1	2.8	1.8	8.9	1.6	7.5	10.1	8.4	6.9	7.6	6.8	11.9	9.7	10.9	10.9	0.5	14.6	9.2	14.7	7.8	7.6	14.4	13.4	12.6	13.9	11.8	16.2	12.2	14.1	13.2	10.6
PRR19	MGC70924	ENSG00000188368	"Proline rich 19"	A6NJB7	19	42302098-42310821	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"testis: 25.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA070350			Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Mitochondria"				Nucleoli	"Nucleoplasm, Nuclear bodies, Mitochondria"	"HPA070350: "	"unprognostic (2.05e-1)"	"unprognostic (8.03e-3)"	"unprognostic (4.02e-2)"	"unprognostic (7.55e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.44e-5)"	"unprognostic (3.57e-1)"	"unprognostic (1.92e-2)"	"unprognostic (8.10e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.87e-3)"	"unprognostic (4.21e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.36e-2)"	0.5	1.0	2.2	1.3	5.8	3.5	0.8	2.6	2.9	1.0	0.5	0.7	0.6	0.7	0.8	0.8	1.0	0.9	1.1	0.3	1.8	1.6	0.7	0.9	0.6	0.9	0.9	0.8	0.9	0.5	1.0	0.8	1.2	1.7	0.9	0.5	0.6	1.0	0.8	0.6	1.3	0.8	0.7	1.6	0.7	0.6	25.8	1.0	1.3	0.8	0.3	0.9	0.8	0.5	3.1	2.3	2.8	2.2	2.6	2.9	1.3	3.9	6.0	3.3	4.4	0.2	0.3	3.5	2.3	1.8	5.3	5.1	2.5	3.7	0.7	6.9	1.9	1.3	1.5	1.7	1.2	2.6	1.5	4.1	3.5	1.4	1.2	1.1	2.5	1.8	2.3	3.5	0.7	0.9	2.2	2.0	2.4	9.2	3.9	2.0	3.5	0.0	1.5	0.6	0.4	1.8	3.4	7.5	3.0	3.2	2.3	0.9	3.0	1.4	1.2	3.5	5.2	0.9	3.1	0.4	1.4	1.2	3.8	2.9	3.6	2.8	2.2	0.6	2.4	1.8	0.8	3.1	1.7	2.3	2.3	2.2	2.3	1.3	2.4	2.6	0.7	1.5	2.9	1.3	2.2	5.8	2.6	2.9	1.8	1.6	0.9	0.8	1.7	1.0
PRR29	"C17orf72, DKFZp761M2312, FLJ11724"	ENSG00000224383	"Proline rich 29"	P0C7W0	17	63998351-64004304	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 17.9;fallopian tube: 48.7;testis: 23.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.7;REH: 6.8;RPMI-8226: 2.8;TIME: 5.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA051264			Uncertain	Nucleoli				Nucleoli		"HPA051264: "	"unprognostic (2.05e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.92e-3)"	"unprognostic (4.71e-3)"	"unprognostic (3.22e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.63e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.30e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.98e-3)"	0.9	0.5	3.3	0.8	7.6	0.6	0.9	0.1	2.1	4.0	0.5	8.3	0.4	0.6	1.0	17.9	0.6	48.7	1.0	0.7	5.6	5.5	0.6	0.6	7.3	0.7	1.6	0.8	8.1	0.5	0.9	5.8	0.7	15.2	0.6	0.4	0.2	0.9	0.9	0.6	0.5	0.5	0.6	1.1	2.5	0.5	23.5	1.0	0.0	2.5	0.0	0.7	1.0	0.0	1.0	0.7	3.1	1.8	1.0	3.0	1.6	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.2	0.0	0.0	0.4	0.0	6.7	0.0	0.7	0.0	0.0	0.1	0.4	0.2	0.0	0.0	2.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	1.0	0.0	0.0	0.0	2.3	0.0	0.2	0.2	6.8	0.1	2.8	0.5	0.0	0.4	2.0	0.0	0.3	0.4	1.0	0.0	5.5	0.2	2.3	0.7	0.2	0.7	0.1	0.5	0.9	0.3	0.0	3.1	0.9	0.0	2.0	1.8	0.4	0.7	1.7	1.0	0.7	1.0	3.0	1.7	0.8	1.0	1.7	0.1	1.1	1.6	3.3	7.6	0.1	2.1	5.6	5.5	1.6	0.8	15.2	1.0
PRRG2	PRGP2	ENSG00000126460	"Proline rich and Gla domain 2"	O14669	19	49580646-49591015	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 8.6;CAPAN-2: 12.0;RT4: 9.2;SK-BR-3: 10.8;T-47d: 11.6;U-266/84: 14.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA010702	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA010702: AB_1079693"	"unprognostic (2.25e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.60e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.67e-1)"	"prognostic favourable (3.82e-9)"	"unprognostic (4.89e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.58e-3)"	"unprognostic (3.68e-2)"	0.9	0.4	0.5	1.1	0.6	0.0	4.8	1.1	1.3	4.0	14.3	0.4	17.5	8.3	1.9	9.6	13.7	3.3	9.8	0.7	0.5	0.4	15.0	12.1	5.2	0.4	0.7	0.4	1.9	13.4	13.8	16.1	8.6	0.7	5.4	5.3	0.7	24.9	14.6	1.2	10.1	23.2	1.4	0.5	1.0	7.1	1.7	0.4	2.1	21.9	9.8	7.8	4.2	4.2	1.2	4.2	2.1	0.9	0.0	1.4	0.4	8.6	0.3	0.2	0.7	1.1	0.0	3.7	0.2	0.0	0.3	0.3	1.7	12.0	0.5	1.3	0.1	7.0	0.2	6.8	0.3	0.8	0.9	0.4	0.5	0.6	0.7	0.3	0.9	0.7	6.0	0.2	0.2	2.7	0.2	0.6	0.0	1.9	0.1	0.7	0.5	1.1	0.2	0.3	6.7	5.3	9.2	1.9	0.2	1.0	10.8	0.1	11.6	0.1	0.4	0.7	0.5	0.3	0.1	4.2	14.0	0.4	0.1	0.3	0.3	0.0	0.9	0.4	1.4	0.1	0.7	1.2	0.6	0.6	0.1	0.7	0.8	0.7	2.1	0.0	0.7	4.2	0.6	0.4	0.5	0.6	1.1	1.3	0.5	0.4	0.7	0.4	0.7	0.4
PSTK	"C10orf89, MGC35392"	ENSG00000179988	"Phosphoseryl-tRNA kinase"	Q8IV42	10	122954381-122997513	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037780, HPA037781"	Approved		Approved	"Nucleoli,Nuclear bodies,Actin filaments"				"Actin filaments"	"Nucleoli, Nuclear bodies"	"HPA037780: , HPA037781: AB_10670530"	"unprognostic (8.95e-3)"	"unprognostic (5.51e-3)"	"unprognostic (1.37e-1)"	"unprognostic (7.39e-4)"	"unprognostic (5.21e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.60e-2)"	"unprognostic (5.92e-4)"	"unprognostic (3.55e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.22e-3)"	"unprognostic (7.10e-3)"	"unprognostic (2.39e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.55e-4)"	2.8	5.6	7.0	2.5	8.8	12.5	8.8	4.3	10.4	5.8	4.3	10.5	4.7	4.6	5.4	11.4	3.7	5.6	3.5	4.7	7.5	7.3	5.5	10.6	2.8	4.0	8.8	8.7	3.8	5.4	4.2	7.2	3.7	9.3	5.6	4.3	3.8	4.3	3.6	6.8	3.8	3.8	5.4	8.7	2.9	3.0	11.1	8.6	2.9	6.8	1.4	3.6	4.8	3.2	6.5	7.4	6.3	5.5	6.6	10.0	6.0	5.4	3.8	2.0	1.0	2.5	4.7	2.6	2.0	5.2	4.6	5.5	5.6	4.8	5.5	5.0	3.7	2.9	1.0	4.6	5.3	2.9	10.2	3.7	0.9	4.4	6.0	7.6	4.6	5.2	8.0	4.1	7.9	3.2	5.1	8.5	6.7	8.1	2.6	4.7	4.7	5.5	5.5	3.6	5.0	6.9	3.3	2.2	2.4	4.6	5.2	7.6	2.4	0.6	3.8	3.6	3.4	1.4	5.2	3.1	1.7	7.5	3.3	5.2	1.4	0.0	5.5	6.3	8.9	3.3	10.0	6.5	6.9	8.4	7.4	5.8	9.2	9.4	0.6	6.6	3.9	7.0	4.2	6.0	7.0	8.8	4.3	10.4	7.5	7.3	8.8	8.7	9.3	8.6
PTMS	ParaT	ENSG00000159335	Parathymosin	P20962	12	6765516-6770952	"Predicted intracellular proteins"	Immunity			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 83.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 12.9;eosinophil: 3.3;plasmacytoid DC: 4.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 4.2;granulocytes: 12.9"									HPA038186	Approved		Approved	Nucleoplasm,Nucleoli			31000	Nucleoli	Nucleoplasm	"HPA038186: AB_10673042"	"unprognostic (3.11e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.16e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.69e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavourable (6.18e-5)"	"unprognostic (1.02e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.55e-2)"	47.0	24.7	45.4	23.5	54.9	7.5	79.3	54.0	40.3	46.0	58.1	7.9	32.4	17.8	71.3	24.9	43.7	36.5	30.8	21.8	31.7	20.0	43.4	155.3	50.7	19.4	11.1	28.6	72.9	18.3	45.8	21.0	26.3	17.9	58.7	19.1	26.6	22.7	58.1	22.6	29.9	24.4	62.5	17.7	20.8	28.3	16.1	15.3	9.5	28.3	29.8	13.0	44.4	81.6	0.1	4.2	12.9	0.3	0.2	1.3	0.3	6.0	26.9	46.2	43.3	25.0	21.0	16.7	26.5	29.7	24.2	20.8	17.0	24.9	2.3	19.9	48.1	12.7	26.8	24.6	9.6	83.3	36.4	2.9	15.8	5.8	28.3	0.7	7.1	19.9	10.0	17.4	35.8	27.0	21.1	6.1	22.0	15.3	1.1	4.9	44.0	29.1	0.5	12.1	5.0	19.0	1.2	14.2	46.0	29.0	10.9	22.7	9.9	3.0	36.6	33.3	46.3	4.6	24.1	5.3	2.5	3.1	25.9	2.0	24.2	12.9	0.3	3.3	1.3	0.1	0.6	0.1	0.1	1.2	0.3	0.0	0.0	0.2	1.0	0.2	0.0	4.2	0.5	0.3	45.4	54.9	54.0	40.3	31.7	20.0	11.1	28.6	17.9	15.3
PTPN11	"BPTP3, NS1, PTP2C, SH-PTP2, SHP-2, SHP2"	ENSG00000179295	"Protein tyrosine phosphatase, non-receptor type 11"	Q06124	12	112418351-112509913	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005377	Approved		Supported	"Nucleoplasm,Nucleoli,Actin filaments,Cytosol"			160000	Nucleoli	"Nucleoplasm, Actin filaments, Cytosol"	"CAB005377: AB_632401"	"unprognostic (2.18e-3)"	"unprognostic (1.73e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.80e-2)"	25.4	16.8	38.6	14.4	39.0	17.7	30.8	17.5	39.5	18.3	14.7	26.9	9.9	11.9	19.1	13.3	17.6	11.1	13.1	30.1	38.0	32.2	18.0	23.1	15.1	14.5	45.3	22.5	13.1	14.0	29.3	12.9	16.6	26.2	16.2	13.9	9.4	12.0	20.0	34.0	14.1	11.1	28.0	45.7	10.9	12.8	7.6	32.1	10.9	21.2	8.2	13.7	17.4	15.4	17.3	17.1	22.0	11.8	11.3	15.4	6.3	34.8	33.3	24.3	23.0	35.4	34.6	28.8	42.4	46.3	33.4	25.2	33.1	13.5	36.9	22.1	39.2	20.9	31.2	37.6	55.7	28.0	25.7	53.7	31.0	18.1	35.4	43.0	34.3	28.0	37.9	35.9	51.1	27.6	40.7	13.0	32.2	25.2	30.2	20.9	29.4	21.8	31.1	35.9	21.2	30.8	39.2	16.9	20.8	40.8	31.3	26.0	36.0	29.9	33.6	39.4	35.3	23.4	37.1	25.2	41.5	36.9	32.7	30.2	36.8	22.0	11.0	15.0	14.8	9.5	14.1	15.5	13.4	12.1	12.6	17.3	15.4	11.8	10.3	11.3	11.8	17.1	9.8	6.3	38.6	39.0	17.5	39.5	38.0	32.2	45.3	22.5	26.2	32.1
PTPN6	"HCP, HCPH, PTP-1C, SHP-1, SHP1"	ENSG00000111679	"Protein tyrosine phosphatase, non-receptor type 6"	P29350	12	6946468-6961316	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 107.1;lymphoid tissue: 69.0"	"Cell line enhanced"	"Detected in many"		"HEL: 28.1;HL-60: 24.9;HMC-1: 110.1;THP-1: 42.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001466, CAB004572, CAB072845"	Enhanced		Supported	Nucleoplasm,Nucleoli			7400000	Nucleoplasm	Nucleoli	"CAB004572: AB_628251, CAB072845: , HPA001466: AB_1855930"	"unprognostic (4.28e-3)"	"prognostic favourable (1.87e-4)"	"prognostic unfavourable (5.42e-4)"	"prognostic favourable (6.65e-4)"	"unprognostic (6.54e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.93e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.98e-3)"	"unprognostic (2.60e-2)"	"unprognostic (5.91e-2)"	"prognostic favourable (2.64e-8)"	6.6	8.8	2.4	42.9	4.4	27.7	4.6	1.2	2.7	2.8	7.0	5.1	4.7	7.5	3.7	8.8	7.0	5.0	9.8	2.9	3.1	2.3	7.0	6.8	25.4	58.1	5.2	1.8	2.3	6.7	2.7	5.6	7.7	3.9	5.6	5.2	3.6	10.6	7.0	1.3	6.1	21.0	2.6	4.9	69.0	6.6	1.5	3.3	31.4	6.3	4.1	50.7	8.5	4.2	63.9	38.0	107.1	103.2	22.2	28.2	63.2	2.8	5.5	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	2.9	6.4	2.0	1.5	0.0	3.3	0.0	3.8	0.0	1.2	1.1	28.1	0.6	2.4	0.0	24.9	110.1	0.0	2.8	0.0	1.2	0.0	0.0	0.2	0.0	6.0	9.0	14.6	1.5	0.9	8.2	0.0	14.2	3.0	5.4	0.5	0.0	0.9	4.5	0.0	1.4	42.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	10.9	0.1	54.4	35.9	107.1	28.2	71.3	18.2	62.3	13.7	21.0	38.0	63.9	15.8	19.9	66.7	22.2	103.2	10.0	14.4	63.2	2.4	4.4	1.2	2.7	3.1	2.3	5.2	1.8	3.9	3.3
PTTG1	"EAP1, HPTTG, PTTG, securin, TUTR1"	ENSG00000164611	"Pituitary tumor-transforming 1"	O95997	5	160421822-160428744	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, DNA damage, DNA repair, Mitosis"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 54.5;testis: 100.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 54.5"	"Lineage enriched"	"Detected in all"	7	"T-cells: 54.5"									"CAB008373, HPA008890, HPA045034"	Enhanced		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"CAB008373: AB_592493, HPA008890: AB_1079717, HPA045034: "	"unprognostic (6.48e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.46e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (1.62e-6)"	"unprognostic (7.50e-3)"	"unprognostic (5.24e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.13e-3)"	"unprognostic (6.70e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (7.17e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.23e-2)"	"unprognostic (3.35e-2)"	1.5	1.7	2.1	16.2	5.5	34.1	2.9	1.4	4.6	3.8	8.2	1.0	0.7	5.8	1.3	2.6	24.1	1.0	1.9	2.3	5.1	2.7	1.7	1.4	3.8	19.2	1.5	2.2	1.1	1.2	0.2	2.0	5.0	2.2	1.6	11.3	1.5	4.5	1.1	1.2	8.7	5.8	4.5	1.4	7.5	3.4	100.1	1.0	29.8	23.9	23.2	35.1	3.3	7.2	8.1	6.1	2.4	2.1	3.3	54.5	4.7	45.5	23.7	53.6	38.4	9.1	8.9	16.7	24.2	55.5	64.3	70.5	45.8	40.1	49.8	21.6	27.5	23.9	33.2	67.3	92.3	56.9	30.2	26.2	32.1	27.5	1.8	23.8	23.1	4.2	11.3	43.6	26.5	45.3	21.0	38.8	66.0	21.4	28.4	58.5	27.0	34.5	26.5	63.0	42.7	32.8	9.3	33.4	21.2	34.9	21.3	71.9	43.5	26.1	19.3	29.1	38.9	22.7	70.6	33.4	29.8	56.9	31.3	41.2	51.5	1.9	0.7	2.4	7.0	2.1	2.5	8.1	14.4	16.2	6.1	5.5	3.6	8.9	0.8	3.3	1.4	5.8	54.5	4.7	2.1	5.5	1.4	4.6	5.1	2.7	1.5	2.2	2.2	1.0
PTTG2		ENSG00000250254	"Pituitary tumor-transforming 2"	Q9NZH5	4	37960435-37961125	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.5;MOLT-4: 3.0;U-698: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.4;T-reg: 1.0"	"Low lineage specificity"	"Detected in many"											"HPA008890, HPA045034"	Uncertain		Approved	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA008890: AB_1079717, HPA045034: "	"unprognostic (3.29e-1)"	"unprognostic (4.41e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.74e-2)"	"unprognostic (9.58e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.74e-1)"		"unprognostic (7.07e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.32e-1)"	"unprognostic (8.60e-5)"	1.0	0.4	0.9	5.2	1.2	5.0	0.5	2.2	2.4	1.1	3.9	0.2	0.0	0.0	1.6	2.2	3.3	1.8	1.5	2.5	1.0	0.4	0.7	0.5	0.9	1.0	0.7	0.4	1.2	1.0	1.4	0.4	1.8	0.3	0.8	0.7	0.0	0.2	1.4	1.9	0.6	3.1	2.0	0.9	2.3	1.0	5.3	0.0	15.8	1.3	7.5	7.3	1.8	0.7	0.4	0.0	1.4	0.4	0.0	1.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.5	0.0	0.0	0.7	0.5	0.9	0.0	0.4	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	2.1	0.0	0.9	0.6	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.4	0.0	1.4	0.0	0.0	0.0	1.0	0.1	0.9	1.2	2.2	2.4	1.0	0.4	0.7	0.4	0.3	0.0
PUM3	"HA-8, hPUF-A, KIAA0020, PEN, PUF6, XTP5"	ENSG00000080608	"Pumilio RNA binding family member 3"	Q15397	9	2720469-2844241	"Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 71.7;HEL: 69.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002353	Approved		Supported	Nucleoli				Nucleoli		"HPA002353: AB_1852266"	"unprognostic (1.39e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.54e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (4.89e-5)"	"unprognostic (2.02e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavourable (1.74e-4)"	"unprognostic (2.44e-3)"	"unprognostic (8.44e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.11e-2)"	"unprognostic (8.43e-2)"	19.4	17.0	11.5	19.0	15.2	14.8	22.1	15.6	17.7	18.9	16.9	8.3	9.8	11.2	17.1	10.6	29.3	15.7	10.5	15.1	16.7	5.9	23.2	18.4	18.6	18.9	14.0	14.3	24.4	17.8	11.5	23.1	15.9	15.8	18.0	17.3	6.1	20.7	10.3	21.0	16.4	13.2	19.5	18.2	17.8	14.2	13.8	14.9	15.4	15.1	14.5	18.9	20.1	21.6	15.3	13.7	3.8	12.8	15.9	18.4	7.8	16.6	12.3	10.4	10.6	8.7	9.3	11.9	15.6	8.2	16.1	15.1	9.3	7.8	18.4	3.6	10.6	8.4	18.7	13.4	21.0	71.7	6.6	69.9	12.4	11.1	11.6	30.8	13.1	7.5	5.9	13.0	18.7	11.8	7.3	8.4	13.9	7.6	15.6	25.1	26.6	5.4	18.4	8.1	7.9	10.9	11.3	10.8	10.3	9.4	8.7	8.4	5.5	16.7	11.3	10.9	8.9	10.3	20.8	3.9	6.4	26.0	8.2	11.2	7.9	3.8	9.2	2.7	13.2	12.8	18.4	15.3	13.7	13.2	12.1	13.5	15.3	14.8	1.3	15.9	10.4	13.7	10.0	7.8	11.5	15.2	15.6	17.7	16.7	5.9	14.0	14.3	15.8	14.9
PURG	"PURG-A, PURG-B"	ENSG00000172733	"Purine rich element binding protein G"	Q9UJV8	8	30995802-31033715	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.7"	"Cell line enhanced"	"Detected in some"		"AF22: 8.8;HEK 293: 4.4;HUVEC TERT2: 4.3;NTERA-2: 6.9;SH-SY5Y: 8.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047746	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"				"Nucleoplasm, Plasma membrane"	Nucleoli	"HPA047746: "	"unprognostic (3.37e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.33e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.79e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.30e-2)"	1.3	1.9	11.0	1.2	10.3	0.6	0.9	14.7	13.5	2.4	1.0	2.4	0.5	1.0	5.6	2.6	1.5	1.6	3.0	1.6	9.4	6.2	1.7	0.7	1.4	1.3	4.9	7.3	1.6	0.7	0.6	3.9	1.5	6.2	1.9	1.1	1.7	1.6	2.6	1.0	0.9	1.0	5.0	4.5	2.5	1.3	8.1	6.4	0.0	0.8	0.0	1.0	1.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.2	0.1	0.0	0.0	0.2	0.4	0.7	1.8	0.0	0.0	0.2	0.0	0.0	0.0	2.9	0.0	1.1	0.0	4.4	1.6	0.0	0.2	0.0	0.0	0.2	1.3	0.0	1.3	0.0	4.3	0.4	0.5	0.2	0.0	0.9	0.0	6.9	0.3	2.2	1.2	0.0	0.0	0.0	1.2	8.3	0.0	0.0	0.0	0.0	0.0	2.7	3.0	3.7	0.0	0.4	0.3	0.0	0.2	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	10.3	14.7	8.9	9.4	6.2	4.9	7.3	6.2	6.4
PVALB	D22S749	ENSG00000100362	Parvalbumin	P20472	22	36800684-36819479	"Predicted intracellular proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 125.0;parathyroid gland: 137.5"	"Cell line enriched"	"Detected in single"	198	"RPMI-8226: 130.9"	"Group enriched"	"Detected in many"	10	"breast cancer: 14.2;renal cancer: 59.5;urothelial cancer: 12.3"	"Region enhanced"	"Detected in all"		"cerebellum: 125.0"	"Cell type enriched"	"Detected in single"	6	"neutrophil: 3.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.4"	"Region enriched"	"Detected in many"	5	"cerebellum: 2377.5"	"Low region specificity"	"Detected in many"			"CAB002515, HPA048536"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"				Nucleoplasm	"Nucleoli, Cell Junctions"	"CAB002515: AB_563948, HPA048536: "	"unprognostic (4.41e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.79e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.52e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.21e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.65e-2)"	"unprognostic (8.99e-3)"	0.9	0.8	1.2	0.9	3.9	0.8	4.3	125.0	47.2	0.8	0.8	6.6	0.0	0.8	1.1	0.9	0.8	0.8	0.9	0.8	4.5	9.4	16.7	1.8	1.2	1.2	28.6	2.5	0.8	0.8	137.5	0.2	1.2	22.9	0.9	0.9	27.3	1.2	1.0	5.0	0.8	0.8	0.9	12.6	1.2	0.9	1.1	1.2	0.0	0.9	0.0	1.4	1.2	1.0	0.0	0.5	3.4	0.4	0.0	0.3	12.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	130.9	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.4	0.0	0.0	0.5	0.3	12.2	1.2	3.9	125.0	47.2	4.5	9.4	28.6	2.5	22.9	1.2
PVRIG	"C7orf15, CD112R, MGC2463"	ENSG00000213413	"PVR related immunoglobulin domain containing"	Q6DKI7	7	100218241-100221490	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 51.7;lymphoid tissue: 21.0"	"Group enriched"	"Detected in some"	28	"Daudi: 37.2;MOLT-4: 40.5;U-698: 12.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	32	"gdT-cell: 43.5;MAIT T-cell: 51.7;memory B-cell: 24.8;memory CD4 T-cell: 28.9;memory CD8 T-cell: 42.9;naive B-cell: 19.3;naive CD4 T-cell: 32.6;naive CD8 T-cell: 32.2;NK-cell: 42.9;T-reg: 22.8"	"Group enriched"	"Detected in many"	37	"B-cells: 24.8;NK-cells: 42.9;T-cells: 51.7"					"Low region specificity"	"Detected in all"			HPA047497	Uncertain		Approved	"Nucleoli,Endoplasmic reticulum"				"Nucleoli, Endoplasmic reticulum"		"HPA047497: "	"unprognostic (1.63e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.21e-3)"	"unprognostic (5.13e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.58e-2)"	"unprognostic (5.55e-2)"	"unprognostic (9.29e-3)"	"unprognostic (3.17e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.71e-3)"	0.5	0.1	0.4	5.6	0.7	1.2	0.4	0.4	1.1	0.4	0.5	0.7	0.4	0.5	0.4	0.4	0.4	0.3	0.4	0.4	0.4	0.0	0.5	0.9	0.9	15.9	0.4	0.4	0.6	0.5	0.0	0.4	0.4	0.8	0.4	0.0	0.4	0.7	0.4	2.0	0.0	8.9	0.4	0.4	21.0	1.4	0.6	0.4	18.0	0.5	0.4	4.2	1.0	0.4	24.8	0.2	1.0	0.1	42.9	51.7	17.5	0.1	0.8	0.4	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	37.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	40.5	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.1	0.1	0.0	43.5	0.1	51.7	24.8	28.9	42.9	0.1	19.3	32.6	32.2	1.0	42.9	0.1	0.2	22.8	17.5	0.4	0.7	0.4	0.4	0.4	0.0	0.4	0.4	0.8	0.4
PWP1	IEF-SSP-9502	ENSG00000136045	"PWP1 homolog, endonuclein"	Q13610	12	107685732-107713167	"Predicted intracellular proteins"	"Ribosome biogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038708			Approved	"Nucleoli,Golgi apparatus"				Nucleoli	"Golgi apparatus"	"HPA038708: "	"unprognostic (7.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (9.65e-4)"	"prognostic unfavourable (1.40e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.89e-1)"	"prognostic unfavourable (2.26e-4)"	"unprognostic (2.00e-1)"	"unprognostic (6.95e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.10e-2)"	33.2	25.4	29.4	29.3	32.2	27.9	35.1	32.9	38.7	25.6	29.2	20.3	26.1	17.9	32.9	26.8	33.9	27.5	21.1	18.7	32.9	25.3	31.5	32.3	22.0	29.6	22.9	38.6	35.2	31.1	31.6	23.0	29.8	37.6	27.1	27.5	16.6	26.0	30.5	43.5	32.7	24.2	33.6	33.3	28.7	27.0	36.3	22.1	32.5	27.1	26.8	36.5	30.0	28.1	31.7	21.6	10.9	14.7	18.8	23.8	12.7	23.5	29.6	18.0	17.1	25.4	27.9	23.9	24.8	28.3	35.4	30.0	29.7	11.2	36.4	13.5	38.4	20.7	24.3	26.2	35.1	18.1	27.8	27.7	18.2	34.5	26.1	33.5	19.9	25.0	24.2	32.6	29.3	41.2	36.3	10.3	37.8	26.0	23.4	33.1	21.5	48.6	19.4	21.2	34.0	22.0	33.5	20.4	16.4	20.3	14.7	34.1	26.1	16.7	32.2	27.0	13.7	21.9	28.1	14.8	20.4	28.7	12.0	18.7	23.5	10.9	9.8	7.1	20.2	12.4	18.6	31.7	20.2	21.2	15.9	28.5	17.3	23.8	3.1	18.8	14.7	21.6	21.5	12.7	29.4	32.2	32.9	38.7	32.9	25.3	22.9	38.6	37.6	22.1
PWP2	"EHOC-17, PWP2H, UTP1"	ENSG00000241945	"PWP2, small subunit processome component"	Q15269	21	44107290-44131181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 30.5;Daudi: 26.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA024573	Uncertain		Supported	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA024573: AB_1855963"	"unprognostic (1.85e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.31e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.36e-4)"	"unprognostic (6.37e-5)"	"unprognostic (6.12e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.55e-1)"	6.1	6.1	11.3	7.7	14.6	3.6	6.3	9.7	12.8	4.0	9.0	9.6	2.4	4.4	7.8	9.2	8.2	5.9	4.8	4.6	6.8	4.8	6.9	8.7	5.0	7.9	15.4	5.7	5.0	12.8	1.4	4.0	7.6	8.9	8.1	1.8	4.9	8.2	5.2	8.0	14.7	5.6	2.2	6.4	8.8	10.6	5.3	17.2	3.6	4.8	8.6	16.8	5.0	5.7	6.8	2.6	2.9	4.3	3.4	6.9	5.0	1.1	0.4	0.3	1.2	3.5	3.6	9.2	11.8	6.2	15.7	10.6	30.5	0.5	26.4	0.4	0.0	1.3	0.5	8.9	9.1	6.4	19.0	3.1	5.5	7.0	2.3	2.3	0.9	0.2	0.0	10.9	0.0	0.5	10.1	10.6	5.2	0.3	0.1	0.7	0.3	1.1	1.5	0.1	13.6	0.0	0.4	9.2	1.6	0.6	1.0	7.4	0.0	1.0	6.0	6.4	1.1	14.2	1.4	14.3	17.0	1.2	0.4	2.8	9.1	0.2	2.2	2.9	6.0	3.1	6.6	6.8	4.9	6.9	1.6	4.1	4.9	6.1	1.2	3.4	4.3	2.6	3.5	5.0	11.3	14.6	9.7	12.8	6.8	4.8	15.4	5.7	8.9	17.2
PYCARD	"ASC, CARD5, TMS-1"	ENSG00000103490	"PYD and CARD domain containing"	Q9ULZ3	16	31201485-31203450	"Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 130.8"	"Cell line enhanced"	"Detected in many"		"MCF7: 33.9;NB-4: 53.4;THP-1: 39.4;U-937: 24.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 37.8;classical monocyte: 90.4;eosinophil: 71.4;intermediate monocyte: 87.5;myeloid DC: 66.8;neutrophil: 130.8;non-classical monocyte: 85.0;plasmacytoid DC: 61.0"	"Group enriched"	"Detected in all"	6	"dendritic cells: 66.8;granulocytes: 130.8;monocytes: 90.4"									"CAB006853, CAB015948, HPA049074, HPA054496"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol			1100000	Nucleoplasm	"Nucleoli, Cytosol"	"CAB006853: , CAB015948: , HPA049074: AB_2680621, HPA054496: AB_2682506"	"unprognostic (1.00e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.67e-3)"	"unprognostic (3.34e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.52e-3)"	"unprognostic (3.88e-2)"	"prognostic unfavourable (6.09e-7)"	"unprognostic (4.45e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.61e-2)"	"unprognostic (6.97e-2)"	11.6	4.4	3.6	16.7	4.6	22.4	8.6	3.6	3.3	8.2	26.8	6.8	4.1	38.7	5.4	7.9	20.7	6.8	8.5	6.6	2.4	2.6	5.6	6.8	15.0	32.8	6.4	1.8	6.6	6.1	1.3	3.2	6.6	4.0	9.7	4.4	4.7	9.6	5.6	3.5	31.2	29.9	3.5	6.4	34.1	13.3	3.7	3.3	20.6	5.5	22.3	26.3	7.9	11.8	17.1	66.8	130.8	90.4	16.0	16.0	53.1	5.6	13.3	0.1	0.0	1.3	3.0	0.1	2.8	3.9	1.8	1.2	0.0	7.1	2.3	0.0	2.7	15.7	0.6	10.5	0.0	17.0	0.0	2.2	1.6	4.3	4.6	19.8	15.7	3.9	5.5	0.8	0.1	3.8	9.7	3.6	0.5	33.9	0.0	53.4	3.6	0.0	17.2	0.0	7.4	0.1	5.5	0.1	0.0	2.4	0.0	2.7	3.3	39.4	2.5	0.1	0.2	2.3	0.0	0.1	0.0	0.0	1.3	24.4	0.0	37.8	90.4	71.4	15.1	87.5	9.5	17.1	12.7	15.5	66.8	15.2	8.9	12.3	130.8	16.0	85.0	61.0	16.0	53.1	3.6	4.6	3.6	3.3	2.4	2.6	6.4	1.8	4.0	3.3
PYM1	"PYM, WIBG"	ENSG00000170473	"PYM homolog 1, exon junction complex associated factor"	Q9BRP8	12	55901413-55932618	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012803, HPA039717, HPA046200"	Supported		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"				"Nucleoplasm, Nucleoli, Cytosol"	"Cell Junctions"	"CAB012803: AB_2269494, HPA039717: , HPA046200: AB_10965556"	"unprognostic (3.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (3.05e-4)"	"unprognostic (3.29e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.44e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.29e-1)"	"prognostic favourable (1.34e-4)"	17.5	21.4	16.2	21.2	14.8	13.2	20.3	16.3	17.1	15.2	21.2	14.2	27.1	21.8	16.1	30.8	46.7	16.3	21.5	13.6	14.0	14.7	19.4	31.3	14.4	28.6	14.7	14.0	13.3	24.8	15.3	19.8	21.5	12.8	20.7	21.5	18.3	22.9	24.5	18.2	27.2	29.9	16.3	13.2	25.5	15.8	21.1	14.1	26.3	22.5	31.2	39.1	16.5	19.9	29.5	35.9	21.6	27.2	14.4	53.6	24.1	17.4	13.9	20.4	11.3	12.4	16.2	33.5	12.8	15.5	12.2	10.3	20.3	20.8	21.9	19.6	12.4	13.7	15.7	27.5	9.8	16.9	11.7	17.8	11.9	25.0	15.2	20.6	16.3	14.5	17.8	13.7	20.6	12.9	15.2	24.4	14.2	26.2	13.2	36.8	35.6	7.3	11.9	8.1	25.1	24.9	24.8	13.8	15.9	16.4	22.1	11.5	26.9	43.7	10.0	7.4	10.4	11.4	9.3	12.9	19.5	33.8	12.6	14.3	11.4	3.9	24.5	21.6	18.7	27.2	22.9	29.5	34.0	26.1	35.9	25.2	22.6	22.6	5.8	14.4	18.5	19.6	53.6	24.1	16.2	14.8	16.3	17.1	14.0	14.7	14.7	14.0	12.8	14.1
RABGEF1	"rabex-5, RABEX5"	ENSG00000154710	"RAB guanine nucleotide exchange factor 1"	Q9UJ41	7	66682164-66811464	"Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA001407			Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA001407: AB_1856024"	"unprognostic (6.65e-2)"	"unprognostic (6.44e-4)"	"unprognostic (7.32e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (4.06e-5)"	"unprognostic (3.77e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.64e-4)"	"unprognostic (6.45e-2)"	"prognostic favourable (1.27e-4)"	"unprognostic (1.43e-1)"	"unprognostic (5.55e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.39e-1)"	18.4	15.2	13.0	14.7	14.4	59.2	12.0	22.4	16.8	16.9	14.1	12.6	9.4	9.1	16.4	9.5	20.6	12.0	13.5	10.8	13.5	15.6	14.9	17.2	10.5	10.6	12.8	12.1	14.7	13.2	13.3	10.2	18.8	13.5	13.1	11.0	13.8	10.6	16.1	12.1	21.9	15.5	15.3	11.9	15.3	11.9	21.5	9.8	13.1	22.3	20.7	18.2	19.1	16.3	15.7	10.4	18.1	13.5	15.4	10.9	7.6	20.2	6.1	5.3	8.9	14.4	20.2	5.3	17.8	22.9	18.8	17.9	5.6	13.2	9.9	7.0	25.8	8.5	7.3	9.7	26.3	6.7	5.8	5.3	7.1	5.6	11.5	9.1	7.5	10.0	12.5	24.3	26.9	4.9	9.7	7.2	18.7	10.2	6.0	12.6	7.0	8.8	5.4	9.3	7.4	16.4	9.3	6.1	9.5	8.3	18.3	9.6	10.5	5.7	6.4	30.6	6.4	18.7	13.9	9.4	12.2	11.7	14.2	10.1	9.7	18.1	7.8	9.4	8.6	6.9	9.3	11.2	8.1	10.9	7.3	15.7	8.8	8.2	15.1	15.4	13.5	10.4	6.7	7.6	13.0	14.4	22.4	16.8	13.5	15.6	12.8	12.1	13.5	9.8
RAC1	"p21-Rac1, Rac-1, TC-25"	ENSG00000136238	"Rac family small GTPase 1"	P63000	7	6374523-6403977	"Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB035994, HPA047820"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol			44000000	"Nucleoplasm, Cytosol"	Nucleoli	"CAB035994: , HPA047820: "	"unprognostic (8.66e-3)"	"unprognostic (2.47e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.88e-3)"	"unprognostic (4.06e-2)"	"prognostic unfavourable (1.74e-5)"	"prognostic unfavourable (4.59e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (4.57e-5)"	"unprognostic (3.63e-1)"	"prognostic unfavourable (2.11e-4)"	"unprognostic (1.95e-1)"	"unprognostic (2.11e-2)"	"unprognostic (4.13e-2)"	"unprognostic (8.72e-3)"	45.2	35.0	71.0	28.4	64.0	24.4	46.5	42.1	93.0	48.7	58.9	75.5	22.5	51.6	48.7	49.5	93.4	47.2	40.0	48.4	73.8	59.8	47.8	42.9	45.6	38.3	76.7	60.9	45.1	29.2	51.0	25.2	55.8	54.9	40.5	64.0	37.2	43.3	48.9	57.4	58.6	49.8	57.3	88.2	35.0	49.7	28.1	47.1	41.3	40.9	42.8	50.7	52.2	54.0	11.0	32.0	49.1	31.9	7.3	11.8	10.7	73.9	33.6	34.7	37.7	41.2	52.7	20.7	41.7	51.3	55.7	56.8	32.9	70.0	20.9	27.1	58.2	52.8	37.0	50.6	71.4	9.7	30.7	21.0	27.2	23.8	49.6	18.9	17.2	35.1	45.3	40.1	45.0	49.0	37.4	16.5	60.0	53.9	10.4	44.4	62.2	40.3	18.4	35.3	30.6	71.6	46.9	26.3	44.3	29.4	107.9	33.5	60.8	56.9	51.4	36.6	55.1	44.8	48.1	12.6	13.8	19.6	33.7	36.1	69.3	7.6	31.9	16.4	7.2	22.2	4.5	11.0	8.1	9.2	32.0	11.0	9.8	6.5	49.1	7.3	22.1	18.2	11.8	10.7	71.0	64.0	42.1	93.0	73.8	59.8	76.7	60.9	54.9	47.1
RAD51	"BRCC5, FANCR, HsRad51, HsT16930, RAD51A, RECA"	ENSG00000051180	"RAD51 recombinase"	Q06609	15	40694774-40732339	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.9;testis: 24.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB010381, HPA039310"	Enhanced		Supported	Nucleoli,Cytosol				Nucleoli	Cytosol	"CAB010381: AB_2253533, HPA039310: "	"prognostic unfavourable (7.94e-4)"	"unprognostic (7.20e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.72e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (9.33e-4)"	"unprognostic (3.40e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.53e-3)"	"unprognostic (0.00e+0)"	"unprognostic (2.26e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.94e-2)"	1.0	0.9	0.4	6.6	0.9	5.3	1.0	0.7	0.9	1.1	5.7	0.4	0.3	1.7	0.8	2.0	4.9	0.5	1.7	1.8	0.5	0.5	1.0	1.0	1.9	7.4	0.5	0.3	0.9	0.7	0.0	0.4	6.2	0.7	0.8	7.6	0.4	1.4	0.3	1.3	2.1	2.6	1.2	1.1	5.0	1.5	24.0	0.5	27.9	0.6	3.7	9.7	1.0	1.9	3.1	1.7	2.7	2.2	2.2	8.8	1.7	12.5	5.6	13.4	5.0	1.4	3.6	12.1	22.3	6.1	19.8	19.9	13.1	8.6	7.1	11.0	7.9	26.7	25.2	10.4	19.3	14.8	8.6	17.8	10.9	10.0	0.1	14.4	12.2	0.5	1.8	13.3	5.9	10.7	23.3	20.0	17.1	11.0	20.5	13.3	15.3	7.0	23.5	18.9	11.9	7.2	17.0	6.0	11.2	9.8	17.3	3.5	10.5	12.0	4.5	14.3	9.1	20.0	11.4	5.0	24.9	23.7	6.2	30.1	12.5	2.0	0.9	2.7	4.1	2.0	0.8	3.1	4.3	5.5	1.7	1.6	1.2	2.1	1.3	2.2	2.2	1.2	8.8	1.7	0.4	0.9	0.7	0.9	0.5	0.5	0.5	0.3	0.7	0.5
RASSF4	"AD037, MGC44914"	ENSG00000107551	"Ras association domain family member 4"	Q9H2L5	10	44959407-44995891	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 21.0;RH-30: 53.4;RPMI-8226: 17.4;U-937: 27.3;WM-115: 17.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 28.3;intermediate monocyte: 21.7;myeloid DC: 28.5;non-classical monocyte: 11.5"	"Group enriched"	"Detected in many"	9	"dendritic cells: 28.5;monocytes: 28.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA038834	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"				"Nucleoplasm, Nucleoli"	"Cell Junctions"	"HPA038834: AB_10795576"	"unprognostic (1.83e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.14e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.81e-2)"	"unprognostic (4.83e-2)"	"unprognostic (8.75e-3)"	"unprognostic (4.20e-1)"	"unprognostic (4.11e-3)"	"unprognostic (4.02e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.20e-2)"	23.4	5.9	16.7	17.0	25.5	6.0	8.4	12.5	36.5	3.6	8.2	26.7	12.1	11.2	2.6	14.9	4.3	3.3	9.0	29.1	16.6	15.1	37.2	10.5	9.7	14.1	34.5	9.7	3.0	11.5	2.2	8.4	10.4	19.4	4.5	5.3	8.4	14.0	9.9	7.6	2.9	10.8	7.0	21.8	12.6	4.3	5.7	31.5	1.2	23.0	2.9	7.4	8.3	3.9	0.0	28.5	0.9	28.3	2.2	3.0	13.8	0.4	0.1	1.9	3.8	6.0	0.3	1.3	0.2	0.3	0.6	1.1	1.5	0.1	0.0	0.7	0.2	0.0	0.8	0.9	0.9	11.9	0.0	0.0	0.0	12.4	6.3	0.8	0.0	4.4	0.0	0.6	0.0	0.9	0.0	21.0	0.9	0.0	0.9	13.6	0.3	0.4	2.5	53.4	17.4	0.1	0.3	0.3	0.2	0.0	0.1	0.6	0.3	10.4	0.2	0.1	1.2	1.0	2.0	0.2	0.2	0.0	6.3	27.3	17.7	0.0	28.3	0.0	3.0	21.7	0.0	0.0	0.2	1.3	28.5	0.0	0.2	1.0	0.9	2.2	11.5	0.7	0.1	13.8	16.7	25.5	12.5	18.2	16.6	15.1	34.5	9.7	19.4	31.5
RBBP5	"RBQ3, SWD1"	ENSG00000117222	"RB binding protein 5, histone lysine methyltransferase complex subunit"	Q15291	1	205086142-205122015	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049042, HPA058085"	Uncertain		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA049042: , HPA058085: "	"unprognostic (8.72e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.78e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.88e-2)"	12.9	17.0	13.7	10.9	23.1	13.5	13.0	20.9	23.3	13.7	11.2	16.4	6.7	11.3	16.4	12.8	11.9	12.6	9.9	10.4	13.2	12.9	20.6	17.3	10.5	16.5	13.5	12.5	16.2	16.8	15.9	21.5	10.3	15.0	11.8	13.2	12.7	14.6	12.0	18.8	14.9	12.7	11.6	10.5	14.0	10.7	9.5	13.7	22.5	17.4	8.9	19.8	11.7	16.7	8.6	6.1	19.1	7.7	7.7	9.6	3.3	10.5	11.2	10.8	12.8	15.1	8.7	11.8	10.0	8.6	12.9	12.9	11.8	12.8	16.5	7.7	7.3	12.2	18.0	6.7	15.4	14.0	9.7	13.8	11.4	9.5	9.8	17.2	11.3	7.0	8.7	12.0	10.3	10.3	26.5	17.0	10.7	9.7	16.6	7.3	17.6	18.7	14.9	23.1	20.6	9.0	7.7	17.0	13.7	14.2	15.0	12.8	16.2	9.8	7.8	10.7	11.5	15.7	13.2	8.3	11.5	20.3	9.5	10.8	16.4	19.1	5.2	7.5	8.6	6.3	9.2	8.6	8.1	8.8	5.4	7.1	8.0	9.6	11.9	7.7	7.7	6.1	8.1	3.3	13.7	23.1	20.9	23.3	13.2	12.9	13.5	12.5	15.0	13.7
RBL2	"p130, Rb2"	ENSG00000103479	"RB transcriptional corepressor like 2"	Q08999	16	53433977-53491649	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016547, HPA019703"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"CAB016547: AB_785011, HPA019703: AB_1856106"	"unprognostic (1.51e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.70e-1)"	"unprognostic (8.12e-2)"	"prognostic favourable (3.57e-5)"	"unprognostic (9.57e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.70e-2)"	"unprognostic (7.51e-2)"	27.8	20.6	15.7	22.2	20.0	11.1	25.5	24.1	18.7	26.3	23.7	24.7	25.6	15.4	30.0	20.2	21.5	25.1	19.5	19.9	15.5	11.7	23.8	34.2	24.0	31.6	25.8	13.7	29.3	30.7	55.3	22.6	12.4	15.8	28.2	18.9	20.2	26.2	30.5	28.3	20.8	24.6	26.1	17.9	27.2	24.9	28.6	22.8	54.4	31.0	10.3	31.6	36.5	26.8	9.1	8.0	20.2	9.8	26.2	35.1	24.5	12.6	8.6	11.5	10.6	30.2	29.2	5.4	9.3	13.3	11.6	4.0	5.6	15.9	18.5	14.1	15.7	15.9	8.6	14.4	18.5	6.6	11.9	8.3	8.7	10.4	13.0	11.5	26.1	18.5	17.7	7.9	11.3	17.9	6.7	11.6	12.9	3.7	22.9	15.5	4.7	7.8	16.7	21.0	21.2	11.4	12.9	9.4	7.8	21.1	9.3	9.1	12.0	15.2	14.8	14.4	7.7	11.9	6.9	17.9	10.5	21.7	18.0	14.4	9.9	16.4	8.2	20.2	21.2	5.9	23.7	8.7	23.8	24.3	8.0	9.1	35.1	29.6	15.7	26.2	9.8	4.9	17.5	24.5	15.7	20.0	24.1	18.7	15.5	11.7	25.8	13.7	15.8	22.8
RBM19	"DKFZp586F1023, KIAA0682, Mrd1"	ENSG00000122965	"RNA binding motif protein 19"	Q9Y4C8	12	113816738-113966371	"Plasma proteins, Predicted intracellular proteins"		"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038860, HPA058732"	Supported		Supported	Nucleoli				Nucleoli		"HPA038860: AB_10697400, HPA058732: "	"unprognostic (2.10e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (9.14e-2)"	"prognostic unfavourable (5.87e-7)"	"unprognostic (9.32e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.53e-3)"	"unprognostic (8.37e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.06e-2)"	15.4	18.4	19.9	23.5	26.1	23.8	17.1	25.0	26.7	13.7	15.4	27.5	16.0	14.7	17.7	15.1	15.7	15.1	13.0	14.3	19.4	12.6	16.5	15.7	15.2	22.1	22.4	16.2	25.5	21.3	22.0	16.6	16.9	19.4	19.0	15.8	16.0	16.1	16.2	20.0	16.3	16.5	19.6	14.5	19.1	16.7	17.3	26.3	16.8	26.7	14.4	21.5	17.1	21.7	8.1	6.7	1.4	11.9	7.9	9.1	4.8	7.0	14.2	8.5	16.6	8.6	6.9	13.0	12.8	10.1	14.5	10.7	19.0	10.0	12.7	8.0	10.8	10.1	20.0	12.3	11.5	22.9	11.7	27.2	14.0	18.2	6.5	20.5	13.0	8.5	8.2	17.7	6.5	10.5	29.2	5.2	8.9	10.6	11.5	15.5	18.6	12.2	15.4	8.2	11.0	9.9	13.8	10.2	8.2	11.4	16.7	7.8	18.3	5.9	11.9	9.6	11.8	8.2	7.8	9.5	7.1	12.7	12.9	14.7	12.1	0.0	4.9	1.4	9.1	8.8	6.9	8.1	6.4	7.4	6.7	7.0	5.2	7.1	0.3	7.9	11.9	4.6	5.5	4.8	19.9	26.1	25.0	26.7	19.4	12.6	22.4	16.2	19.4	26.3
RBM20		ENSG00000203867	"RNA binding motif protein 20"	Q5T481	10	110644397-110839469	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 45.9;skeletal muscle: 20.9"	"Cell line enhanced"	"Detected in some"		"HEK 293: 5.7;HEL: 4.8;K-562: 4.5;RH-30: 15.5;SH-SY5Y: 14.3;T-47d: 8.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"olfactory region: 4.6"	"Low region specificity"	"Detected in many"			"HPA035806, HPA070358"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytokinetic bridge"				"Golgi apparatus"	"Nucleoplasm, Nucleoli, Cytokinetic bridge"	"HPA035806: AB_10672097, HPA070358: "	"unprognostic (2.43e-1)"	"unprognostic (8.24e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.75e-2)"	"unprognostic (5.47e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.78e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.39e-3)"	"unprognostic (3.34e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.46e-2)"	1.7	0.1	0.4	0.6	1.9	0.1	2.2	0.5	1.5	0.9	2.6	1.3	0.0	0.2	2.5	7.5	3.6	1.9	2.3	45.9	0.6	0.2	1.1	0.1	0.5	0.1	0.3	1.3	2.4	13.7	0.9	1.2	1.4	1.4	1.0	0.5	4.3	6.3	0.7	20.9	0.7	1.0	2.1	0.6	0.1	0.6	0.9	1.4	0.0	0.7	3.4	0.5	1.8	3.2	0.1	0.2	0.0	0.0	0.0	0.5	0.0	0.0	1.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.3	5.7	4.8	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	4.5	0.0	0.2	0.0	0.0	0.0	0.4	1.3	0.0	15.5	0.0	0.0	0.0	0.1	14.3	0.1	0.0	0.6	8.7	0.0	0.0	0.2	0.5	0.0	0.0	0.4	0.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.4	1.9	0.5	1.5	0.6	0.2	0.3	1.3	1.4	1.4
RBM28	FLJ10377	ENSG00000106344	"RNA binding motif protein 28"	Q9NW13	7	128297685-128343908	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019058, HPA026672, HPA031519"	Enhanced		Supported	Nucleoli				Nucleoli		"HPA019058: AB_1856118, HPA026672: AB_1856119, HPA031519: "	"unprognostic (2.34e-1)"	"unprognostic (1.87e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavourable (2.94e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavourable (2.72e-11)"	"unprognostic (6.83e-2)"	"prognostic unfavourable (6.44e-4)"	"unprognostic (7.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.45e-3)"	"unprognostic (7.15e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.04e-1)"	22.1	17.7	16.3	18.4	25.1	14.2	17.5	26.5	25.3	12.8	13.7	19.7	9.6	13.2	17.1	9.9	15.1	12.5	10.9	24.4	18.1	8.6	12.0	18.8	13.2	17.9	26.5	16.2	19.7	15.7	16.5	18.4	14.5	17.3	13.1	12.7	12.3	13.0	13.0	33.5	17.3	11.2	14.2	25.4	13.8	14.1	18.4	24.4	11.7	16.1	12.2	15.6	13.8	18.9	14.5	14.3	9.8	11.5	12.3	13.7	5.5	18.4	20.4	12.3	35.2	8.8	5.6	16.9	17.0	7.0	15.4	16.8	16.9	16.2	24.5	9.3	7.7	12.5	18.1	14.4	20.1	12.2	17.3	24.6	14.3	15.5	7.8	30.9	22.1	6.4	9.4	20.5	12.4	14.2	45.9	14.4	12.0	14.9	22.1	17.7	23.5	16.0	17.6	14.8	23.5	7.5	12.5	13.8	16.8	21.9	36.7	11.6	9.4	9.5	13.6	22.5	11.7	19.8	20.6	14.8	12.6	42.5	14.7	26.2	24.1	3.5	11.5	4.4	13.7	8.9	9.4	12.8	11.6	12.2	11.5	14.5	10.5	12.0	9.8	12.3	7.8	14.3	7.1	5.5	16.3	25.1	26.5	25.3	18.1	8.6	26.5	16.2	17.3	24.4
RBM34	KIAA0117	ENSG00000188739	"RNA binding motif protein 34"	P42696	1	235131183-235161457	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA028606	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA028606: AB_10601494"	"unprognostic (4.53e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.32e-2)"	"unprognostic (6.57e-4)"	"unprognostic (2.98e-2)"	"unprognostic (5.65e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.69e-8)"	"unprognostic (8.50e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.73e-2)"	"unprognostic (7.09e-4)"	15.8	10.5	17.2	16.4	18.1	30.6	14.8	15.5	22.3	11.0	13.5	10.6	7.0	16.7	10.9	15.2	15.4	9.9	11.3	15.2	13.4	11.6	19.4	14.2	11.5	20.0	16.9	9.9	13.9	13.5	6.6	24.9	14.7	20.9	13.5	12.6	7.6	18.3	11.2	22.2	17.9	17.6	10.9	17.9	14.6	13.1	28.8	17.3	17.5	14.7	10.9	17.1	14.1	16.0	34.2	27.2	38.0	19.2	25.3	35.5	22.7	12.0	9.1	9.5	12.0	7.1	12.9	23.5	12.7	8.9	11.4	11.0	12.3	13.7	20.6	13.8	7.6	18.0	11.2	11.6	11.0	18.7	18.2	15.4	6.4	8.5	14.3	24.4	15.2	11.3	13.4	10.6	7.3	9.1	21.9	10.6	14.3	6.9	21.2	21.0	27.4	6.4	19.9	10.4	23.9	11.8	9.2	11.7	21.3	17.5	11.3	28.6	24.4	26.6	9.5	11.6	10.1	16.0	25.4	12.9	20.8	21.8	13.6	16.4	18.1	38.0	16.9	20.4	23.7	19.2	28.2	34.2	27.3	30.4	17.2	26.3	26.0	29.9	8.2	25.3	19.1	27.2	35.5	22.7	17.2	18.1	15.5	22.3	13.4	11.6	16.9	9.9	20.9	17.3
RBM43	"C2orf38, FLJ45645"	ENSG00000184898	"RNA binding motif protein 43"	Q6ZSC3	2	151247940-151261879	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 18.0;HSkMC: 16.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA038204	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA038204: AB_10669520"	"unprognostic (3.50e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.72e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.12e-2)"	"unprognostic (9.94e-2)"	10.7	14.8	5.2	7.6	6.4	6.0	7.9	1.6	4.9	14.4	8.1	5.4	7.4	3.1	14.6	14.6	8.4	13.6	7.2	4.4	6.0	4.8	7.8	7.0	14.3	13.6	4.5	5.3	17.6	6.8	8.7	7.8	6.0	4.3	14.4	4.7	14.3	6.2	8.9	4.5	6.2	6.3	11.5	5.6	8.4	5.9	6.5	4.1	11.0	13.4	3.6	6.9	20.5	6.6	3.2	1.1	5.9	4.6	5.3	4.9	1.2	2.9	1.8	3.0	4.0	8.2	18.0	2.0	3.4	7.8	4.3	6.2	0.1	4.8	2.3	1.3	6.0	1.5	0.9	3.9	2.2	3.4	2.1	5.4	0.7	0.2	8.0	6.6	1.9	16.2	4.3	3.4	2.5	9.0	2.2	2.5	5.8	2.9	3.8	3.2	1.1	3.5	2.6	3.5	1.3	7.2	2.5	1.1	3.6	3.2	2.4	6.3	3.5	4.3	5.1	3.2	2.9	2.7	1.4	0.9	0.6	0.0	8.4	2.7	1.9	1.9	1.7	5.9	2.8	2.1	4.6	2.8	3.9	3.5	1.1	3.2	4.9	3.4	2.0	5.3	4.6	0.5	1.9	1.2	5.2	6.4	1.6	4.9	6.0	4.8	4.5	5.3	4.3	4.1
RBMX2	"CGI-79, Snu17"	ENSG00000134597	"RNA binding motif protein, X-linked 2"	Q9Y388	X	130401969-130413343	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026609	Approved		Approved	"Nuclear membrane,Nucleoli"				"Nuclear membrane"	Nucleoli	"HPA026609: AB_1846601"	"unprognostic (2.54e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.80e-3)"	"unprognostic (3.32e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavourable (7.04e-4)"	"prognostic favourable (9.15e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.86e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (8.44e-9)"	"unprognostic (1.06e-1)"	"unprognostic (4.78e-2)"	"unprognostic (3.08e-2)"	"unprognostic (5.63e-3)"	19.4	16.7	22.3	16.7	20.0	17.1	25.0	22.7	22.9	25.1	19.9	18.9	19.1	17.0	29.4	29.5	18.7	19.8	18.8	17.8	21.0	18.7	17.7	21.1	16.9	21.2	18.6	22.1	28.2	21.9	17.9	24.4	17.3	21.0	23.0	20.0	16.3	20.5	23.7	21.0	21.4	15.9	23.0	18.9	21.1	18.4	10.8	19.0	26.4	23.0	17.9	26.7	27.2	20.2	12.6	10.5	11.0	9.5	9.4	19.3	5.4	13.8	14.5	14.6	15.1	14.6	27.4	14.9	13.0	13.4	14.9	16.2	10.8	17.0	13.4	31.4	9.9	15.1	23.3	12.0	21.7	12.2	20.7	12.0	13.4	11.3	13.2	18.5	14.3	19.8	17.3	16.6	23.2	16.6	10.4	11.7	16.6	24.1	21.2	23.1	11.0	23.7	16.4	14.5	18.1	15.1	11.1	17.1	20.4	8.2	17.6	23.0	11.4	13.7	10.8	12.0	9.8	28.0	27.2	15.5	16.9	19.1	14.6	30.3	15.2	11.0	9.4	10.8	11.1	9.5	11.1	12.4	13.8	14.0	7.8	12.6	15.1	14.2	8.0	9.4	9.4	10.5	19.3	5.4	22.3	20.0	22.7	22.9	21.0	18.7	18.6	22.1	21.0	19.0
RDM1	"MGC33977, RAD52B"	ENSG00000278023	"RAD52 motif containing 1"	Q8NG50	17	35918066-35930773	"Predicted intracellular proteins, Predicted membrane proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 5.7;lymphoid tissue: 6.2;testis: 24.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 10.6;T-47d: 17.4"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"memory CD8 T-cell: 5.7"	"Group enriched"	"Detected in many"	14	"NK-cells: 1.5;T-cells: 5.7"	"Low region specificity"	"Detected in all"							"HPA024794, HPA067546"	Enhanced		Supported	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA024794: AB_1856039, HPA067546: "	"unprognostic (9.36e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.00e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.06e-4)"	"unprognostic (5.95e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.06e-8)"	"unprognostic (1.58e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.53e-1)"	0.0	0.0	0.9	0.9	1.2	0.6	0.0	0.0	1.8	0.0	0.9	0.1	0.0	1.3	0.2	0.7	0.3	0.1	0.3	0.0	1.0		0.1	0.0	0.1	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.2	0.2	1.7	0.0	0.0	0.0	0.0	1.1	1.5	0.1	0.2	0.1	1.1	24.0	0.0	6.2	0.3	0.0	2.8	0.0	0.0	0.1	0.2	0.0	0.0	1.5	5.7	0.3	6.0	7.1	1.3	2.5	0.1	0.0	2.1	1.4	0.1	0.8	1.3	10.6	6.0	6.6	2.9	0.4	0.9	4.1	1.7	4.1	1.5	8.3	4.2	1.8	0.0	0.0	0.2	3.0	0.0	0.8	0.5	0.4	0.1	1.8	0.0	0.6	2.4	2.3	2.3	0.9	2.6	0.8	0.0	0.0	1.6	3.4	4.8	0.8	1.9	1.8	2.6	17.4	0.4	0.0	0.1	2.1	0.0	0.4	5.5	2.0	2.3	3.4	2.4	1.1	0.0	0.0	0.0	1.4	0.0	2.3	0.1	1.6	5.7	0.2	0.0	0.0	0.7	0.0	1.5	0.0	0.0	1.5	0.3										
RETSAT	FLJ20296	ENSG00000042445	"Retinol saturase"	Q6NUM9	2	85342088-85354620	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 86.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 64.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007961, HPA046513"	Uncertain		Uncertain	Nucleoli				Nucleoli		"HPA007961: AB_1079802, HPA046513: "	"unprognostic (6.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-1)"	"prognostic favourable (4.23e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.59e-1)"	"prognostic favourable (1.95e-10)"	"unprognostic (2.73e-2)"	"unprognostic (5.34e-1)"	"unprognostic (8.24e-3)"	"unprognostic (9.90e-2)"	65.7	24.8	7.7	9.8	9.1	0.9	35.6	5.6	9.3	7.4	46.5	12.4	12.7	49.0	6.8	12.3	16.7	5.0	17.7	7.3	7.4	5.7	20.6	51.9	7.2	5.1	10.2	7.7	5.5	11.5	13.1	3.5	5.7	8.9	10.1	22.6	10.0	12.5	7.6	24.3	14.3	86.1	7.0	12.7	4.0	18.2	9.2	10.1	3.5	27.2	13.9	9.3	9.9	9.0	3.8	5.6	5.3	10.0	6.5	9.2	4.1	15.9	9.3	5.4	12.5	64.5	12.1	7.0	11.7	14.5	7.1	10.0	6.4	11.2	5.6	9.7	9.3	13.4	7.2	20.4	7.0	6.9	5.0	2.7	7.6	15.7	15.5	5.3	6.2	15.8	28.0	9.1	12.2	11.8	2.9	13.5	13.2	3.4	3.8	2.8	1.7	11.4	2.5	10.7	7.3	12.6	9.4	2.6	4.4	9.8	18.8	31.8	8.8	0.9	9.2	8.0	4.4	7.5	6.1	7.3	6.8	2.2	9.9	6.4	5.5	0.0	5.1	2.4	7.0	5.5	9.2	3.8	5.6	8.8	5.6	2.5	3.8	4.0	5.3	6.5	10.0	4.0	5.8	4.1	7.7	9.1	5.6	9.3	7.4	5.7	10.2	7.7	8.9	10.1
REXO2	"CGI-114, DKFZP566E144, SFN"	ENSG00000076043	"RNA exonuclease 2"	Q9Y3B8	11	114439386-114450279	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038450, HPA038451"	Enhanced		Supported	"Nucleoli,Focal adhesion sites,Mitochondria"			390000	Mitochondria	"Nucleoli, Focal adhesion sites"	"HPA038450: AB_10672516, HPA038451: AB_10697391"	"unprognostic (3.26e-3)"	"unprognostic (2.36e-2)"	"prognostic favourable (6.51e-4)"	"unprognostic (6.84e-3)"	"unprognostic (5.80e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.78e-1)"	"unprognostic (8.18e-3)"	"unprognostic (2.49e-2)"	"unprognostic (2.17e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.73e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.69e-2)"	"prognostic unfavourable (6.70e-4)"	21.8	31.1	13.5	15.8	14.2	16.2	30.0	14.9	12.6	31.4	36.0	11.2	24.0	8.4	38.4	24.8	33.5	17.7	23.9	64.3	13.3	10.5	35.7	28.6	20.1	13.9	17.0	13.1	28.5	27.7	61.2	24.9	45.0	15.3	32.0	17.7	11.6	61.6	22.8	27.8	22.7	15.8	44.6	15.7	18.6	31.5	29.6	14.5	9.9	20.0	25.2	15.2	34.9	40.6	15.5	28.6	19.0	7.9	18.1	30.5	12.2	27.4	16.0	6.2	16.6	49.9	53.0	14.8	46.5	36.4	23.5	30.0	41.9	47.0	15.1	46.9	41.1	17.5	13.9	41.2	38.9	14.6	10.8	16.6	22.1	26.0	65.6	12.1	5.3	36.6	39.5	29.7	31.6	42.0	30.7	9.3	52.6	6.5	8.8	15.2	19.1	28.3	7.8	20.2	54.9	33.7	22.3	11.0	6.9	21.4	16.5	19.6	33.6	6.3	39.7	30.3	36.3	23.3	28.5	7.3	8.7	25.5	20.9	28.6	16.1	19.0	6.0	8.8	14.3	7.9	16.5	15.5	21.6	17.9	7.8	11.7	19.9	16.1	1.5	18.1	7.9	28.6	30.5	12.2	13.5	14.2	14.9	12.6	13.3	10.5	17.0	13.1	15.3	14.5
REXO4	"hPMC2, XPMC2H"	ENSG00000148300	"REX4 homolog, 3'-5' exonuclease"	Q9GZR2	9	133406059-133418096	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047006	Uncertain		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA047006: "	"unprognostic (2.69e-2)"	"unprognostic (3.76e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.77e-2)"	"unprognostic (6.52e-2)"	"prognostic unfavourable (4.76e-6)"	"unprognostic (2.15e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.55e-2)"	"prognostic favourable (2.65e-4)"	"unprognostic (2.25e-2)"	"unprognostic (2.86e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.20e-1)"	9.9	13.7	16.9	15.1	18.4	10.9	14.5	21.6	18.3	12.7	11.9	11.9	13.2	13.8	14.5	10.7	15.5	13.5	11.2	14.6	13.8	11.8	12.0	19.3	9.7	18.3	18.0	13.2	22.2	21.4	13.3	14.6	14.1	15.4	13.7	10.1	8.8	14.9	13.1	36.4	15.1	13.5	11.9	16.1	16.9	13.0	18.7	18.4	15.0	15.2	9.1	16.3	12.5	21.3	5.5	3.6	3.3	2.5	7.2	5.2	1.8	5.7	13.5	6.3	9.3	6.6	6.9	11.3	10.0	5.7	10.6	7.0	16.0	7.5	18.9	6.8	5.4	15.8	13.2	10.5	6.1	12.2	12.3	10.2	14.3	12.5	8.3	23.3	10.0	6.4	8.9	11.1	15.3	7.7	22.4	8.3	6.7	16.7	16.3	14.0	12.8	19.5	11.6	10.4	18.8	6.7	5.5	18.2	9.9	10.6	12.4	11.4	15.2	9.4	6.7	19.4	10.1	9.2	12.2	5.5	6.7	13.0	7.2	13.5	11.5	0.7	2.5	3.3	3.9	2.5	4.3	4.7	4.0	4.0	2.0	5.5	5.1	5.2	0.1	7.2	2.0	3.6	3.4	1.8	16.9	18.4	21.6	18.3	13.8	11.8	18.0	13.2	15.4	18.4
REXO5	NEF-sp	ENSG00000005189	"RNA exonuclease 5"	Q96IC2	16	20806429-20849668	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"blood: 33.9;testis: 119.4"	"Cell line enhanced"	"Detected in many"		"K-562: 24.1;U-266/70: 24.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	15	"basophil: 33.9"	"Lineage enriched"	"Detected in single"	39	"granulocytes: 33.9"					"Low region specificity"	"Detected in all"			"HPA040755, HPA040868"	Enhanced		Approved	"Nuclear membrane,Nucleoli,Endoplasmic reticulum"				"Nuclear membrane"	"Nucleoli, Endoplasmic reticulum"	"HPA040755: AB_10965790, HPA040868: AB_10963549"	"unprognostic (2.39e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.24e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.42e-4)"	"unprognostic (1.01e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.93e-2)"	0.8	0.7	0.7	1.4	1.9	2.6	1.0	1.0	1.0	0.4	0.6	0.6	0.2	0.7	0.9	0.8	0.6	1.1	0.7	1.1	0.6	0.5	0.5	0.5	0.6	0.7	0.4	1.2	0.8	0.6	3.3	0.4	0.4	0.6	1.4	0.8	0.7	0.8	0.7	0.4	0.6	0.6	0.7	0.3	0.3	1.6	119.4	0.4	4.1	0.3	0.5	0.9	0.8	0.6	0.0	0.3	33.9	0.2	0.8	0.7	0.1	6.3	3.5	5.7	2.5	2.3	4.8	1.9	4.2	4.7	4.7	5.3	2.6	5.5	3.9	6.8	3.6	3.2	4.3	1.9	5.0	4.0	3.1	6.4	5.4	3.6	0.5	9.5	9.4	2.2	0.8	5.5	7.2	1.6	24.1	17.3	11.5	8.2	1.5	7.2	3.1	3.7	7.7	10.6	6.9	1.4	2.1	5.1	5.7	4.0	5.4	1.3	9.2	8.1	0.8	3.5	3.1	4.6	5.1	24.9	16.8	1.5	7.3	12.3	3.3	33.9	0.2	2.2	0.1	0.0	0.2	0.0	0.2	0.2	0.3	0.0	0.0	0.1	0.1	0.8	0.1	0.1	0.7	0.1	0.7	1.9	1.0	1.0	0.6	0.5	0.4	1.2	0.6	0.4
RGCC	"bA157L14.2, C13orf15, RGC-32, RGC32"	ENSG00000102760	"Regulator of cell cycle"	Q9H4X1	13	41457559-41470882	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 109.9;lung: 120.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 15.0;BJ hTERT+: 78.9;Daudi: 25.7;U-698: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 46.2"	"Lineage enriched"	"Detected in many"	26	"T-cells: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035638, HPA063701"	Enhanced		Supported	Nucleoplasm,Nucleoli	"Intracellular and membrane"		390000	Nucleoplasm	Nucleoli	"HPA035638: AB_10670152, HPA063701: "	"unprognostic (1.39e-3)"	"unprognostic (4.61e-2)"	"prognostic unfavourable (5.60e-4)"	"unprognostic (2.28e-1)"	"unprognostic (4.27e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.49e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.42e-3)"	58.6	6.7	26.7	8.8	33.1	109.9	27.7	21.6	22.7	12.8	5.6	36.1	4.2	5.7	8.7	3.1	5.4	7.6	14.3	15.1	32.1	16.8	11.0	8.3	120.1	10.8	41.7	15.2	1.8	13.4	8.7	7.1	70.6	21.1	10.7	3.6	16.1	33.2	6.8	12.7	10.8	4.9	11.3	22.2	7.3	8.0	7.1	34.8	15.2	26.9	5.8	6.9	9.5	8.7	1.7	1.7	0.2	0.2	0.1	46.2	2.8	0.2	0.1	8.8	0.0	1.7	15.0	0.3	0.2	78.9	0.0	0.3	10.9	0.1	25.7	0.2	1.0	0.2	0.3	0.5	0.1	2.6	1.2	0.0	1.9	0.8	0.8	0.9	0.3	1.1	1.7	0.3	11.0	9.0	1.9	0.0	0.2	0.0	5.7	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.2	4.9	6.0	0.0	0.9	0.5	0.1	0.0	0.0	27.0	0.0	0.6	0.2	0.0	0.2	0.0	1.6	0.1	1.6	1.2	13.8	4.4	1.7	1.7	46.2	10.5	0.2	0.1	0.0	0.5	23.1	2.8	26.7	33.1	21.6	21.7	32.1	16.8	41.7	15.2	21.1	34.8
RGS12		ENSG00000159788	"Regulator of G protein signaling 12"	O14924	4	3293028-3439913	"Plasma proteins, Predicted intracellular proteins"	Transcription	"GTPase activation, Repressor, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 37.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054646, HPA067421"			Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA054646: , HPA067421: "	"unprognostic (2.08e-1)"	"unprognostic (1.71e-3)"	"unprognostic (7.50e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.65e-1)"	"prognostic favourable (7.03e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.13e-1)"	"prognostic favourable (8.43e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.60e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.11e-2)"	4.7	4.4	20.7	4.1	22.0	2.3	4.4	10.2	37.2	5.4	2.9	10.2	1.5	5.3	6.4	5.6	13.5	7.5	4.4	4.7	13.4	5.6	4.4	6.7	6.5	3.4	12.3	16.3	8.9	3.1	3.1	6.1	4.1	9.4	6.8	2.2	3.1	6.5	5.7	6.8	20.6	4.6	3.0	18.9	4.1	3.2	5.5	9.9	4.3	3.8	3.4	3.6	5.5	7.9	1.0	1.5	1.6	3.9	0.4	1.3	0.7	3.9	5.0	10.1	7.3	3.4	2.7	4.2	4.3	3.4	4.4	3.3	4.0	2.4	0.9	2.7	3.7	3.9	2.0	13.6	1.4	0.1	1.6	0.4	2.8	9.8	3.1	0.3	5.6	2.3	9.3	2.3	3.1	9.7	4.6	0.2	4.0	3.4	0.7	10.6	4.8	4.8	10.0	3.9	3.2	2.3	11.8	11.4	11.8	2.7	1.9	9.0	4.6	6.7	7.3	8.6	5.6	1.7	4.5	5.0	3.9	2.2	5.1	5.9	6.1	1.0	1.2	0.3	0.9	3.9	0.3	0.2	0.8	0.5	1.5	1.0	1.3	0.5	1.6	0.4	3.7	0.8	0.6	0.7	20.7	22.0	10.2	37.2	13.4	5.6	12.3	16.3	9.4	9.9
RGS6		ENSG00000182732	"Regulator of G protein signaling 6"	P49758	14	71932439-72566529	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.8"	"Group enriched"	"Detected in some"	7	"HEL: 8.1;Karpas-707: 29.3"	"Group enriched"	"Detected in some"	7	"glioma: 3.1;thyroid cancer: 1.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.6;T-reg: 1.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003067	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles				Nucleoplasm	"Nucleoli, Vesicles"	"HPA003067: AB_1079807"	"unprognostic (7.18e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.85e-2)"	"unprognostic (5.61e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.24e-4)"	"unprognostic (7.83e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.06e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.06e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.68e-2)"	6.9	0.8	8.6	1.1	11.1	2.0	4.9	4.0	18.0	7.9	1.8	2.8	0.3	0.8	2.7	4.2	1.0	3.6	1.9	15.7	3.7	7.5	3.3	0.6	1.7	0.5	15.4	9.3	2.3	0.6	10.9	2.6	4.6	20.8	0.7	1.8	1.3	1.3	2.5	1.7	1.4	1.4	2.2	5.2	1.5	0.8	13.9	2.4	0.0	8.5	0.3	1.0	1.1	1.3	0.5	0.4	1.6	0.2	0.6	1.2	4.1	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	8.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	29.3	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.6	0.6	0.0	0.4	1.2	4.1	8.6	11.1	4.0	18.0	3.7	7.5	15.4	9.3	20.8	2.4
RHOJ	"ARHJ, FLJ14445, RASL7B, TCL"	ENSG00000126785	"Ras homolog family member J"	Q9H4E5	14	63204114-63293219	"Predicted intracellular proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 15.2;HUVEC TERT2: 88.4;TIME: 23.5;WM-115: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003050	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"				"Plasma membrane"	"Nucleoplasm, Nucleoli"	"HPA003050: AB_1079812"	"unprognostic (7.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.42e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.42e-2)"	"unprognostic (7.07e-2)"	"prognostic unfavourable (1.31e-4)"	"unprognostic (3.50e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.06e-3)"	17.0	2.9	11.4	6.4	12.0	0.2	14.3	7.3	15.8	15.1	12.0	3.4	7.9	5.8	22.8	14.7	12.4	15.6	20.0	13.0	11.3	4.6	7.3	4.0	18.6	7.0	8.0	9.8	11.9	3.6	3.3	6.5	7.3	6.8	15.9	8.8	14.8	7.2	11.8	5.8	6.0	8.4	25.3	5.4	9.4	9.4	4.7	8.5	0.0	13.1	13.9	3.9	16.9	9.2	1.2	0.9	2.6	0.8	1.4	0.6	0.1	0.0	0.0	15.2	0.0	0.0	0.0	0.0	2.5	10.2	0.9	1.5	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	88.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	23.5	0.0	0.2	0.1	1.4	0.0	0.0	0.0	0.0	0.0	25.4	1.0	0.8	0.6	0.5	0.4	0.3	0.7	0.4	0.4	0.2	1.2	0.6	0.6	2.6	1.4	0.2	0.9	0.2	0.1	11.4	12.0	7.3	15.8	11.3	4.6	8.0	9.8	6.8	8.5
RIMS3	"NIM3, RIM3"	ENSG00000117016	"Regulating synaptic membrane exocytosis 3"	Q9UJD0	1	40620679-40665657	"Predicted intracellular proteins"	"Exocytosis, Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 47.7"	"Cell line enhanced"	"Detected in many"		"Daudi: 37.0;SH-SY5Y: 17.5;U-87 MG: 16.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"MAIT T-cell: 1.8;plasmacytoid DC: 4.6"	"Group enriched"	"Detected in many"	9	"dendritic cells: 4.6;T-cells: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055285			Approved	Nucleoli,Mitochondria				Mitochondria	Nucleoli	"HPA055285: "	"unprognostic (3.51e-3)"	"unprognostic (7.18e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.44e-4)"	"unprognostic (3.70e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.44e-5)"	"unprognostic (2.41e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.19e-2)"	1.3	7.2	13.6	2.2	19.2	3.7	3.1	21.5	47.7	1.4	3.4	3.4	0.0	1.1	3.0	2.2	2.9	2.1	1.3	1.5	7.8	17.4	1.4	0.7	3.1	2.0	7.4	22.3	2.5	1.1	4.0	0.5	3.8	4.9	3.2	3.8	2.0	2.0	4.1	0.6	2.7	1.7	4.8	3.4	1.7	2.5	3.1	4.4	0.7	2.8	0.0	2.8	1.7	1.0	0.1	4.6	0.1	0.3	0.1	1.8	0.1	1.9	0.7	2.8	3.0	0.1	0.0	0.4	0.0	0.0	0.5	0.6	0.3	0.6	37.0	0.0	0.0	0.3	1.9	0.3	0.3	6.4	0.9	2.1	0.2	1.0	0.1	0.3	1.7	0.0	1.5	0.1	0.1	0.1	1.8	1.4	0.0	3.3	5.4	0.2	1.8	0.2	2.5	2.6	6.8	0.5	0.5	9.9	17.5	0.4	1.8	1.2	0.4	10.3	0.0	0.3	3.0	0.0	0.5	0.3	2.7	8.1	16.1	0.6	0.3	0.1	0.0	0.0	0.1	0.0	1.8	0.0	0.5	0.2	0.2	0.1	0.0	0.2	0.0	0.1	0.3	4.6	0.4	0.1	13.6	19.2	21.5	47.7	7.8	17.4	7.4	22.3	4.9	4.4
RIN2	RASSF4	ENSG00000132669	"Ras and Rab interactor 2"	Q8WYP3	20	19886521-20002457	"Disease related genes, Predicted intracellular proteins"	Endocytosis	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"PC-3: 24.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"dendritic cells: 1.2;granulocytes: 2.2;monocytes: 3.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034641	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol"				Cytosol	"Nucleoli, Golgi apparatus"	"HPA034641: AB_10671230"	"unprognostic (8.23e-3)"	"unprognostic (8.09e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.12e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.49e-1)"	"unprognostic (6.27e-2)"	"prognostic favourable (8.34e-6)"	"unprognostic (3.10e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.02e-3)"	"unprognostic (3.63e-2)"	19.2	6.7	9.9	6.1	8.7	4.0	24.4	4.3	10.2	11.7	21.6	9.5	7.6	10.5	12.7	6.6	11.1	9.7	14.7	13.7	10.0	6.2	12.2	4.6	26.8	4.3	8.3	4.4	12.7	5.1	4.2	4.9	16.7	9.3	8.0	10.4	16.5	12.0	11.3	10.9	6.6	23.4	13.2	7.7	17.5	6.5	3.5	9.9	0.3	13.1	5.5	3.7	9.9	15.6	0.3	1.2	2.2	3.3	0.1	0.3	0.4	3.4	11.2	2.1	6.7	12.3	7.5	6.9	2.7	11.5	2.9	1.7	5.3	3.1	0.0	12.2	7.0	12.4	0.1	17.8	3.3	1.4	0.0	0.0	1.9	0.4	2.7	0.0	0.0	11.0	3.0	5.6	6.2	15.9	0.0	0.2	8.8	2.5	0.0	0.2	0.3	24.8	0.0	7.4	1.8	3.8	4.8	1.8	0.4	2.7	11.0	0.0	1.0	0.9	17.2	6.2	1.4	3.7	4.6	0.0	0.0	0.0	4.0	0.0	0.9	0.6	3.3	0.2	0.2	2.7	0.2	0.2	0.2	0.2	1.2	0.3	0.3	0.3	2.2	0.1	2.8	0.6	0.1	0.4	9.9	8.7	4.3	10.2	10.0	6.2	8.3	4.4	9.3	9.9
RIOK1	"AD034, bA288G3.1, FLJ30006, RRP10"	ENSG00000124784	"RIO kinase 1"	Q9BRS2	6	7389496-7418037	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis"	"Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017866, HPA051446"	Enhanced		Approved	"Nucleoli,Nuclear speckles,Cytosol"				"Nucleoli, Nuclear speckles"	Cytosol	"HPA017866: , HPA051446: "	"unprognostic (2.33e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (3.41e-5)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (4.43e-4)"	"unprognostic (3.45e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavourable (5.85e-5)"	"unprognostic (2.33e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.12e-3)"	"unprognostic (2.59e-2)"	13.8	10.6	7.7	13.2	13.0	17.5	13.1	12.2	13.5	12.7	11.6	7.3	4.0	7.3	15.4	6.0	15.6	12.3	8.5	11.8	8.0	8.1	8.7	11.7	10.1	14.2	11.6	9.4	13.8	15.3	7.7	17.8	13.9	13.3	10.7	9.6	7.2	10.2	10.3	18.8	12.5	9.9	15.5	9.4	14.4	10.3	21.3	9.2	19.2	10.1	14.7	16.8	10.9	12.6	15.4	14.9	7.7	11.1	18.6	15.0	8.2	7.5	4.4	7.1	16.7	11.1	9.1	10.9	9.5	6.4	8.9	7.4	12.8	3.9	19.7	16.9	7.7	7.7	17.9	7.6	11.4	13.0	19.3	10.5	7.1	13.7	9.4	30.2	13.8	6.7	10.6	9.6	19.8	7.8	26.8	4.6	8.3	9.9	20.5	14.3	15.3	10.4	15.8	9.3	21.4	5.0	7.4	23.7	11.7	8.0	4.8	13.8	7.3	10.0	7.8	9.8	7.4	6.4	14.3	6.4	12.1	29.3	3.0	15.6	14.9	7.7	8.5	5.9	11.5	11.1	13.8	15.2	11.9	12.1	14.9	15.4	13.7	15.0	1.7	18.6	9.7	12.4	11.3	8.2	7.7	13.0	12.2	13.5	8.0	8.1	11.6	9.4	13.3	9.2
RIOX1	"C14orf169, FLJ21802, JMJD9, MAPJD, NO66"	ENSG00000170468	"Ribosomal oxygenase 1"	Q9H6W3	14	73490964-73493392	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003730			Supported	Nucleoli				Nucleoli		"HPA003730: "	"unprognostic (4.70e-3)"	"unprognostic (1.94e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.51e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.35e-3)"	"unprognostic (4.55e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.97e-3)"	"unprognostic (8.62e-2)"	3.9	2.4	4.3	5.2	5.6	8.0	4.0	7.6	8.0	5.3	4.1	6.7	3.6	4.1	4.5	5.7	3.9	4.7	3.3	5.3	3.4		4.1	5.1	4.1	8.4	5.8	4.9	4.5	6.1	5.2	3.2	2.8	4.6	4.0	4.1	4.7	5.0	5.0	2.8	4.0	3.4	4.8	2.1	5.0	3.9	10.5	5.2	17.3	4.5	3.6	7.5	3.7	4.4	3.5	5.2	5.1	3.8	4.9	7.4	1.3	10.3	9.4	6.1	9.4	7.9	4.5	11.7	7.1	5.2	7.3	6.6	8.1	5.3	17.7	5.2	6.1	12.3	11.6	7.0	6.1	11.2	12.8	11.1	5.6	5.3	4.4	0.0	14.9	4.8	6.5	7.0	3.2	6.6	8.0	6.6	6.5	16.3	19.3	12.6	6.7	15.9	15.4	9.5	5.3	7.2	7.8	12.7	9.2	11.8	21.2	7.5	21.1	11.1	9.4	0.0	12.2	6.3	0.0	9.1	9.7	6.2	3.2	9.2	7.2	0.2	2.2	5.1	6.4	3.8	7.4	3.5	6.5	5.1	3.0	2.7	6.0	4.4	0.9	4.9	2.3	5.2	2.8	1.3										
RIOX2	"FLJ14393, JMJD10, mdig, MINA, MINA53, NO52"	ENSG00000170854	"Ribosomal oxygenase 2"	Q8IUF8	3	97941818-97972457	"Predicted intracellular proteins"	"Ribosome biogenesis, Transcription, Transcription regulation"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007603, HPA008080, CAB013458"	Supported		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"CAB013458: AB_2533432, HPA007603: AB_1853957, HPA008080: AB_1853960"	"prognostic unfavourable (4.41e-4)"	"unprognostic (8.64e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.53e-3)"	"unprognostic (1.64e-3)"	"unprognostic (8.68e-2)"	"unprognostic (9.68e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.56e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.76e-1)"	13.9	9.6	12.7	13.6	16.7	2.2	14.1	8.1	11.1	9.8	11.0	12.2	14.5	8.1	10.7	11.3	20.4	11.3	12.1	8.2	10.9	12.6	13.1	14.2	9.1	13.1	13.9	11.9	14.2	22.5	13.8	15.0	27.1	14.1	11.2	13.9	10.2	20.3	11.3	27.1	14.9	8.3	11.2	14.7	12.1	10.5	6.6	11.2	6.3	48.4	12.8	15.6	14.7	12.5	13.1	21.8	1.6	11.1	8.2	13.6	9.1	20.2	12.2	4.3	9.4	10.3	15.7	11.5	9.9	7.6	11.7	9.6	8.2	10.7	27.1	11.4	11.2	11.8	13.8	14.1	18.4	51.3	6.4	8.5	5.3	9.8	16.6	17.4	4.0	12.0	19.1	8.9	21.9	11.8	11.8	12.1	11.8	5.9	13.8	5.7	9.4	16.2	0.0	14.7	27.0	11.8	11.9	23.3	8.4	10.6	14.6	16.5	13.0	7.3	9.5	11.7	12.9	6.3	20.4	17.9	9.2	27.2	13.7	17.4	12.5	1.6	10.9	0.6	8.7	9.4	13.3	13.1	13.6	10.6	13.4	10.3	13.2	10.8	0.7	8.2	11.1	21.8	12.0	9.1	12.7	16.7	8.1	11.1	10.9	12.6	13.9	11.9	14.1	11.2
RLF	"Zn-15L, ZNF292L"	ENSG00000117000	"Rearranged L-myc fusion"	Q13129	1	40161373-40240921	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054653, HPA057300"	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA054653: , HPA057300: "	"unprognostic (1.71e-1)"	"unprognostic (2.24e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.88e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavourable (1.75e-4)"	"unprognostic (5.84e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.60e-2)"	"unprognostic (9.38e-2)"	"prognostic unfavourable (7.68e-6)"	"unprognostic (1.86e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.69e-2)"	14.8	8.1	12.6	11.3	12.6	44.5	13.9	20.8	17.1	12.4	11.1	11.6	7.1	8.6	14.1	8.6	12.4	9.9	11.2	12.3	11.0	8.3	8.7	12.7	12.8	11.8	12.8	11.8	14.6	9.4	12.5	15.1	11.9	15.4	13.2	9.2	10.2	9.4	9.9	13.4	17.7	9.9	14.3	14.1	10.1	9.3	15.9	11.8	14.9	10.0	8.4	13.5	18.1	14.8	4.1	3.5	10.1	4.1	4.1	4.9	2.4	12.3	4.7	9.4	9.8	8.4	6.9	11.2	4.6	7.0	8.0	10.7	9.7	6.6	12.4	6.1	5.9	11.7	11.9	8.2	14.7	5.8	8.0	10.2	5.8	5.9	6.7	8.4	6.2	6.8	8.7	8.6	9.7	5.5	15.4	7.6	7.3	3.9	7.1	5.1	12.6	5.5	5.5	15.5	7.2	5.1	12.6	6.7	9.4	8.7	11.7	8.3	5.5	30.6	4.6	9.5	10.2	7.8	8.6	7.0	6.5	11.6	8.2	7.9	5.9	10.1	2.8	5.5	3.7	3.9	4.9	4.1	3.7	3.8	3.5	4.1	4.8	4.0	6.3	4.1	4.1	1.6	3.3	2.4	12.6	12.6	20.8	17.1	11.0	8.3	12.8	11.8	15.4	11.8
RNF115	"CL469780, ZNF364"	ENSG00000265491	"Ring finger protein 115"	Q9Y4L5	1	145738868-145824077	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019130	Approved		Approved	Nucleoli,Mitochondria				"Nucleoli, Mitochondria"		"HPA019130: AB_1859220"	"unprognostic (3.44e-2)"	"unprognostic (2.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavourable (2.95e-4)"	"unprognostic (2.29e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.64e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.23e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.08e-1)"	7.2	5.2	6.8	4.8	6.8	6.4	7.7	16.2	7.0	6.3	3.4	4.6	5.7	3.5	8.9	5.0	5.8	4.3	4.8	23.5	5.8		5.6	5.1	3.9	5.6	4.7	6.2	4.7	4.5	5.8	5.9	3.5	5.2	6.5	3.8	7.3	3.6	5.6	27.6	3.8	3.1	10.9	4.5	4.2	3.8	3.4	4.5	6.0	5.0	5.4	4.5	4.1	6.3	2.7	2.4	9.0	2.2	3.2	3.2	1.4	11.1	4.6	5.7	4.2	10.4	13.7	4.6	8.4	15.7	6.2	7.6	5.0	4.1	7.8	9.6	12.0	7.8	6.3	5.8	6.8	7.8	4.1	6.2	5.9	4.6	6.6	9.7	14.5	7.9	5.1	6.3	7.6	8.0	6.1	12.8	11.3	8.4	7.1	6.2	7.2	9.8	6.8	5.7	6.5	12.2	3.8	5.7	7.9	6.8	8.5	6.2	9.3	9.3	9.8	9.1	7.1	5.4	8.9	10.8	10.2	8.3	4.6	6.6	5.7	9.0	2.2	3.2	3.2	1.5	2.7	2.7	2.2	3.2	1.8	2.4	2.3	3.1	1.7	3.2	1.6	2.4	2.0	1.4										
RNF125	FLJ20456	ENSG00000101695	"Ring finger protein 125"	Q96EQ8	18	32018372-32073213	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	4	"HMC-1: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041514	Uncertain		Supported	"Nucleoli,Golgi apparatus"				"Golgi apparatus"	Nucleoli	"HPA041514: AB_10795596"	"unprognostic (2.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.93e-1)"	"unprognostic (5.03e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.30e-3)"	"unprognostic (6.15e-2)"	"unprognostic (4.21e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.35e-2)"	"prognostic unfavourable (4.06e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.07e-3)"	21.9	2.3	4.1	9.1	5.7	18.2	20.4	1.2	6.6	5.0	8.9	12.2	3.3	12.3	7.2	5.5	3.9	4.3	6.0	5.4	6.1	4.1	2.1	14.1	10.3	13.5	7.7	3.1	2.4	4.2	2.5	1.3	4.4	7.0	3.1	7.8	1.6	5.0	1.9	4.4	6.0	26.0	4.1	12.0	7.4	4.2	3.3	8.3	14.8	3.2	2.9	7.2	4.5	6.2	2.1	3.4	9.0	3.8	11.7	12.5	5.1	0.7	0.1	0.1	0.2	0.3	0.5	0.6	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.8	0.0	0.5	0.9	0.7	0.1	3.9	1.6	0.2	0.2	0.2	0.1	5.1	31.8	1.0	1.5	0.0	1.7	0.3	0.1	1.1	0.0	1.1	1.3	4.8	2.6	0.9	5.4	0.3	0.1	0.3	0.3	0.5	0.2	0.1	0.1	7.8	0.8	2.5	0.1	0.1	0.5	0.1	0.0	3.7	0.1	0.1	0.4	6.8	4.2	9.0	3.8	3.3	12.5	2.0	8.2	2.0	10.1	10.5	3.4	2.1	8.2	10.6	1.5	11.7	1.9	3.4	10.0	5.1	4.1	5.7	1.2	6.6	6.1	4.1	7.7	3.1	7.0	8.3
RNF144B	"bA528A10.3, IBRDC2, P53RFP"	ENSG00000137393	"Ring finger protein 144B"	Q7Z419	6	18387350-18468874	"Enzymes, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 54.7;hTCEpi: 17.4;HUVEC TERT2: 16.1;TIME: 16.1;U-698: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 28.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 7.9;granulocytes: 15.6;monocytes: 28.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046013, HPA054127, HPA072469"	Uncertain		Approved	Nucleoli,Mitochondria				Nucleoli	Mitochondria	"CAB046013: AB_11126028, HPA054127: , HPA072469: "	"unprognostic (2.24e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.48e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.87e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.21e-1)"	16.3	2.0	4.6	11.1	6.8	15.7	21.1	5.1	7.5	8.0	4.2	2.8	4.6	1.5	6.8	7.5	9.4	9.0	6.8	8.7	5.3	4.3	13.8	11.4	39.0	11.1	8.3	2.3	4.2	3.7	3.0	2.3	11.1	8.8	12.8	2.3	8.3	16.9	6.2	36.8	19.2	3.7	4.9	9.2	37.1	4.3	3.3	6.9	5.8	32.9	11.4	12.2	7.3	6.6	2.0	7.9	15.6	28.8	0.2	0.7	2.6	1.3	0.2	0.1	0.0	0.0	0.6	2.9	1.5	1.6	3.2	3.5	0.0	0.1	54.7	15.0	0.6	4.7	0.0	4.6	4.6	0.2	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.8	17.4	1.2	3.9	16.1	0.0	0.0	0.8	0.5	0.4	0.0	0.4	0.3	0.2	0.5	3.3	9.8	3.0	0.5	0.0	0.3	7.0	5.2	8.2	0.1	16.1	2.5	0.5	0.2	0.3	0.0	0.0	46.0	0.3	0.1	0.2	0.1	9.1	5.1	0.2	16.4	0.7	2.0	0.3	0.3	5.6	1.6	0.7	0.4	15.6	0.2	28.8	7.9	0.2	2.6	4.6	6.8	5.1	7.5	5.3	4.3	8.3	2.3	8.8	6.9
RNF215		ENSG00000099999	"Ring finger protein 215"	Q9Y6U7	22	30368811-30421771	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029427, HPA056498"	Approved		Approved	Nucleoli,Microtubules				Microtubules	Nucleoli	"HPA029427: , HPA056498: "	"unprognostic (1.24e-2)"	"unprognostic (3.20e-1)"	"unprognostic (3.67e-4)"	"unprognostic (8.68e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavourable (6.37e-10)"	"unprognostic (2.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.78e-2)"	9.8	7.1	17.5	7.3	12.6	8.0	8.0	20.7	24.5	10.1	7.8	7.3	11.9	10.4	14.0	13.0	6.4	10.6	13.3	7.7	11.3	14.4	8.5	8.0	6.9	6.5	10.4	15.2	10.8	15.4	12.6	7.9	9.0	10.7	12.3	5.2	11.2	8.8	11.8	7.4	7.9	5.5	10.9	8.1	8.8	6.9	10.0	5.5	2.2	10.3	1.6	5.0	7.9	8.0	4.8	3.5	3.5	2.1	6.1	4.8	0.9	4.5	9.6	10.1	16.3	9.9	10.4	10.0	7.8	7.1	7.8	4.9	2.6	5.1	1.8	14.2	6.3	5.7	6.1	9.0	6.4	10.6	7.4	3.2	10.4	3.4	13.6	2.4	13.0	14.1	11.1	13.5	7.3	9.2	2.6	8.8	9.4	7.3	1.7	5.7	3.1	10.7	8.2	5.8	7.2	10.3	7.0	4.4	11.4	7.8	5.8	5.8	5.3	2.7	12.7	21.4	9.5	6.1	4.6	9.4	2.3	2.4	12.6	1.8	8.2	1.9	2.1	3.5	2.5	1.9	2.5	2.7	2.6	2.0	1.1	4.8	4.8	4.3	1.6	6.1	1.7	3.5	1.3	0.9	17.5	12.6	20.7	24.5	11.3	14.4	10.4	15.2	10.7	5.5
RNFT1	PTD016	ENSG00000189050	"Ring finger protein, transmembrane 1"	Q5M7Z0	17	59952240-59964761	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 45.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA013739			Approved	Nucleoli				Nucleoli		"HPA013739: AB_1856382"	"unprognostic (1.61e-1)"	"unprognostic (2.83e-1)"	"prognostic favourable (6.57e-4)"	"unprognostic (3.04e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.08e-2)"	"prognostic favourable (7.48e-4)"	"unprognostic (5.42e-2)"	"unprognostic (3.45e-1)"	"unprognostic (8.26e-3)"	"unprognostic (9.44e-3)"	"unprognostic (1.19e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.05e-1)"	"prognostic favourable (2.57e-4)"	"unprognostic (2.60e-1)"	7.9	6.2	2.8	5.3	4.3	3.8	4.2	5.1	3.7	3.1	4.0	2.4	3.7	5.3	2.7	8.1	4.6	3.2	3.1	4.1	3.1	2.2	4.7	12.0	5.0	4.4	2.9	3.1	3.5	7.5	4.7	6.1	4.4	3.4	4.5	4.8	4.2	5.1	3.0	6.7	2.7	7.6	3.0	3.4	4.1	3.9	45.5	3.0	5.9	6.1	4.3	6.0	5.1	3.7	9.5	10.1	20.2	17.1	8.9	7.7	7.9	4.8	2.2	2.3	3.1	7.6	5.7	4.5	6.2	3.3	4.8	6.0	6.9	1.9	7.2	10.4	5.1	5.6	7.2	4.7	8.4	6.8	7.8	6.0	5.8	6.2	5.6	9.3	9.3	6.3	2.5	4.5	2.0	4.9	17.3	4.4	4.1	6.2	3.8	4.5	0.9	5.1	5.2	17.4	4.1	3.9	3.4	1.4	2.7	8.9	2.1	12.3	10.2	17.8	3.5	9.4	8.4	5.5	5.2	6.5	18.0	4.2	6.5	5.2	4.7	17.3	11.8	20.2	5.6	13.9	7.7	9.5	5.2	6.3	10.1	6.1	6.8	6.1	5.7	8.9	17.1	6.7	6.5	7.9	2.8	4.3	5.1	3.7	3.1	2.2	2.9	3.1	3.4	3.0
RNPEPL1		ENSG00000142327	"Arginyl aminopeptidase like 1"	Q9HAU8	2	240565804-240581372	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036772	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA036772: AB_10670848"	"unprognostic (3.92e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.24e-3)"	"prognostic favourable (7.43e-4)"	"prognostic unfavourable (5.06e-4)"	"unprognostic (3.72e-3)"	"unprognostic (9.10e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.10e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.31e-2)"	"unprognostic (9.86e-2)"	17.2	13.7	10.1	13.7	8.8	17.2	48.4	7.2	10.5	11.0	21.0	9.5	11.8	18.6	8.0	8.9	22.1	8.0	22.3	28.3	9.2	6.0	18.2	26.7	32.2	54.1	12.9	8.2	7.1	40.0	7.7	4.3	10.1	8.1	14.9	9.1	7.0	21.5	13.5	26.5	22.5	31.0	11.4	9.7	25.7	20.0	5.9	7.6	23.1	8.8	16.7	12.1	14.4	18.8	7.0	7.6	22.4	9.1	7.6	12.4	5.4	6.8	11.5	2.5	6.8	9.4	9.8	8.7	4.4	11.0	5.0	6.2	3.1	20.2	2.0	2.3	11.1	7.5	2.9	8.2	0.5	12.0	4.0	4.5	3.7	18.6	23.7	2.9	8.2	11.6	13.4	2.6	5.1	17.0	3.3	13.4	3.3	9.7	3.7	11.1	3.4	4.6	7.8	3.8	16.6	20.2	9.5	2.4	5.1	3.0	10.3	20.0	7.2	13.6	11.6	5.4	5.6	7.5	5.0	12.7	1.9	2.3	11.1	8.3	8.1	5.8	9.1	22.4	12.4	7.8	10.6	7.0	9.6	11.1	6.4	6.8	5.4	8.1	16.0	7.6	7.6	7.6	11.1	5.4	10.1	8.8	7.2	10.5	9.2	6.0	12.9	8.2	8.1	7.6
RPAP2	"C1orf82, FLJ13150, Rtr1"	ENSG00000122484	"RNA polymerase II associated protein 2"	Q8IXW5	1	92298965-92402056	"Enzymes, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046443	Approved		Supported	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA046443: "	"unprognostic (1.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.71e-2)"	"unprognostic (4.12e-2)"	"unprognostic (4.96e-3)"	"unprognostic (5.73e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.29e-2)"	"unprognostic (8.01e-3)"	"unprognostic (4.09e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.09e-2)"	"unprognostic (7.02e-4)"	"unprognostic (1.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.62e-3)"	"unprognostic (4.10e-2)"	6.8	7.0	7.8	7.3	10.5	12.0	7.6	27.2	11.6	8.4	6.3	7.1	7.2	6.6	11.1	11.5	5.6	6.3	5.5	5.9	8.1	8.6	8.1	10.6	5.2	8.2	7.7	6.7	8.2	8.6	9.4	16.1	6.7	11.7	7.6	5.8	6.4	7.2	7.1	10.5	10.7	6.3	7.4	9.9	7.6	6.4	6.7	8.7	12.8	9.4	6.5	6.3	6.6	7.6	4.4	3.5	4.9	2.4	4.0	4.8	1.2	6.2	3.8	6.7	6.1	5.5	7.1	5.7	4.9	3.4	3.2	2.7	2.7	2.8	9.3	8.5	3.6	4.3	5.5	3.2	5.0	6.3	4.0	5.7	6.9	3.6	3.3	9.8	5.7	3.6	3.9	4.2	4.1	3.4	5.8	6.2	4.9	3.2	8.3	6.2	5.2	4.3	6.2	8.9	4.0	4.2	5.6	6.2	4.6	8.0	7.3	4.0	3.9	7.5	6.0	4.9	6.2	5.6	6.9	6.0	7.0	4.9	3.4	6.2	3.3	4.8	2.4	1.9	4.1	1.7	4.8	3.4	3.2	3.5	1.8	4.4	3.5	3.8	4.9	4.0	1.9	3.5	2.8	1.2	7.8	10.5	27.2	11.6	8.1	8.6	7.7	6.7	11.7	8.7
RPF1	BXDC5	ENSG00000117133	"Ribosome production factor 1 homolog"	Q9H9Y2	1	84479259-84497790	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024642	Supported		Supported	Nucleoli				Nucleoli		"HPA024642: AB_1856428"	"unprognostic (1.56e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.63e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (1.60e-5)"	"unprognostic (2.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.71e-1)"	20.9	20.4	21.3	25.1	36.2	42.7	26.3	14.8	24.7	21.3	24.8	12.8	18.8	18.8	25.5	27.4	26.0	20.8	18.2	39.8	17.9	16.5	33.1	33.8	21.3	27.2	16.7	15.1	23.9	21.3	16.8	25.7	19.8	16.0	23.7	24.0	14.1	20.8	26.2	56.8	22.1	22.7	20.8	16.6	33.9	22.8	31.0	20.3	31.8	29.3	27.9	30.2	30.0	23.1	36.9	23.1	29.2	26.0	31.8	33.9	26.1	19.0	13.4	17.0	14.2	13.3	17.7	19.2	19.6	17.4	25.7	22.9	10.1	8.2	14.7	22.2	15.5	14.5	25.5	20.2	28.4	21.1	26.8	36.9	15.1	17.5	18.5	35.5	12.1	14.1	30.1	26.8	19.1	20.5	35.6	18.9	22.4	9.9	33.3	23.9	42.4	30.0	21.5	27.3	11.8	24.4	22.4	21.4	20.0	11.4	24.5	46.8	13.8	24.3	14.0	19.4	19.3	30.5	40.5	13.1	15.4	32.4	9.1	32.0	17.3	29.2	21.3	19.6	26.6	24.6	29.3	36.9	30.4	26.9	22.5	31.0	33.8	33.9	8.9	31.8	26.0	23.1	31.3	26.1	21.3	36.2	14.8	24.7	17.9	16.5	16.7	15.1	16.0	20.3
RPF2	"bA397G5.4, BXDC1, FLJ21087"	ENSG00000197498	"Ribosome production factor 2 homolog"	Q9H7B2	6	110982015-111028263	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 81.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035475	Supported		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA035475: AB_10669861"	"unprognostic (2.85e-3)"	"unprognostic (2.19e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.90e-3)"	"unprognostic (4.45e-1)"	"prognostic unfavourable (2.04e-4)"	"prognostic unfavourable (2.25e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.43e-2)"	"unprognostic (9.16e-2)"	"prognostic unfavourable (2.07e-6)"	"unprognostic (2.39e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.86e-1)"	21.1	17.1	13.9	14.1	19.2	15.4	20.7	16.7	17.3	14.5	13.8	9.0	10.3	10.3	15.4	12.1	19.2	15.8	14.4	19.6	16.5	11.0	18.8	30.7	12.2	15.3	16.8	11.3	20.9	25.9	13.7	21.6	15.5	19.3	15.5	14.1	9.5	14.0	11.5	46.3	16.7	10.6	19.8	17.4	16.3	14.2	18.1	18.7	10.0	20.4	29.3	15.8	22.1	15.1	10.3	9.3	0.8	7.7	11.1	12.4	6.1	7.9	3.8	4.3	17.0	7.6	11.9	11.3	11.4	6.8	10.1	10.1	15.4	5.7	18.6	10.9	5.7	9.1	14.3	10.8	22.9	7.9	13.1	12.2	4.8	8.9	9.1	18.4	5.9	7.2	8.7	14.0	28.7	8.0	32.3	10.3	12.6	7.7	13.6	19.4	12.5	6.9	13.1	8.2	13.3	9.7	7.9	7.3	9.5	5.0	6.7	18.7	6.1	15.7	5.2	8.3	7.4	81.5	30.4	4.4	6.8	23.2	11.1	23.3	16.7	0.3	6.9	0.8	5.9	7.7	12.4	10.3	8.4	7.7	8.1	7.8	11.1	10.5	0.2	11.1	4.9	9.3	7.3	6.1	13.9	19.2	16.7	17.3	16.5	11.0	16.8	11.3	19.3	18.7
RPL10A	"Csa-19, L10A, NEDD6"	ENSG00000198755	"Ribosomal protein L10a"	P62906	6	35468408-35470785	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053803	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"			360000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA053803: "	"unprognostic (5.47e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.37e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.34e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavourable (3.77e-4)"	"unprognostic (2.21e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.72e-2)"	55.0	41.7	35.5	80.8	28.0	79.0	96.9	25.3	37.6	71.5	76.4	22.8	62.3	35.0	91.2	62.5	88.7	91.0	72.6	45.2	28.1	23.1	45.4	71.1	44.8	94.0	28.5	38.0	155.3	141.2	18.6	35.6	56.6	25.6	86.5	55.2	34.7	104.5	66.1	98.5	92.9	47.2	56.8	27.3	51.4	55.5	33.2	20.1	70.6	62.0	121.6	76.5	77.4	86.4	165.3	104.4	8.5	62.8	101.1	186.5	235.1	65.8	68.0	77.4	72.7	116.0	211.6	87.7	68.3	140.6	96.3	76.8	98.4	63.8	197.7	63.0	92.5	58.5	104.2	155.8	80.1	68.5	91.8	75.9	63.0	137.4	171.8	110.6	63.3	245.9	182.7	70.6	237.0	141.0	89.4	97.8	109.2	116.4	116.7	134.5	81.2	60.1	92.4	74.6	153.0	121.7	109.0	54.6	80.0	42.0	96.6	192.8	104.5	201.8	81.3	31.5	56.9	41.8	85.9	61.8	100.6	130.6	39.5	129.1	56.3	8.5	62.8	5.9	82.7	61.2	146.9	165.3	137.8	106.1	104.4	146.8	186.5	145.8	6.1	101.1	52.4	98.5	104.4	235.1	35.5	28.0	25.3	37.6	28.1	23.1	28.5	38.0	25.6	20.1
RPL13	"BBC1, D16S444E, L13"	ENSG00000167526	"Ribosomal protein L13"	P26373	16	89560657-89566828	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051702	Approved		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"			53000	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA051702: "	"unprognostic (5.41e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.14e-2)"	"prognostic favourable (6.26e-4)"	"unprognostic (1.57e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.57e-2)"	"prognostic unfavourable (6.64e-4)"	"unprognostic (4.34e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.30e-2)"	82.5	56.0	46.7	105.0	38.4	112.7	150.9	37.7	44.0	114.5	114.9	31.3	76.9	65.5	118.4	85.4	144.0	98.4	101.6	85.2	38.6	32.1	60.8	118.3	90.4	385.1	38.8	37.4	231.3	255.8	36.5	57.5	66.0	27.0	136.2	44.4	43.0	267.3	87.6	197.4	137.7	66.7	90.2	44.8	104.7	71.1	106.5	24.6	135.0	102.4	129.6	98.6	109.3	156.8	277.8	163.1	26.9	96.9	120.7	299.0	355.4	66.8	74.4	52.9	85.7	95.2	158.6	110.8	42.3	91.7	88.4	35.9	112.3	103.8	94.1	87.4	71.7	93.1	62.8	111.2	44.1	26.3	174.3	32.0	41.5	148.9	203.8	38.9	39.1	192.1	237.1	56.6	142.9	92.1	97.8	53.7	67.9	209.5	106.4	305.2	108.1	79.1	158.7	56.0	132.2	107.3	56.2	74.6	109.1	58.6	76.5	126.9	150.5	231.1	53.7	57.1	61.7	50.3	57.9	81.4	76.5	96.0	74.6	137.3	60.0	26.9	96.9	15.3	129.1	74.9	239.2	252.5	234.3	176.5	116.8	277.8	299.0	230.2	10.7	120.7	56.7	163.1	163.7	355.4	46.7	38.4	37.7	44.0	38.6	32.1	38.8	37.4	27.0	24.6
RPL13A	"L13A, TSTA1"	ENSG00000142541	"Ribosomal protein L13a"	P40429	19	49487554-49492308	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Translation regulation"	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA038751	Approved		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA038751: AB_10962004"	"unprognostic (2.35e-3)"	"unprognostic (2.15e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.95e-3)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (9.97e-4)"	"unprognostic (1.21e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavourable (1.44e-5)"	"unprognostic (7.81e-2)"	"unprognostic (7.85e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.87e-1)"	85.4	87.0	45.7	114.3	46.9	132.5	106.4	38.9	41.2	103.8	145.5	38.8	89.2	84.1	129.4	80.7	117.7	83.5	119.9	112.5	37.2	31.2	65.4	113.9	71.8	265.3	41.5	37.0	203.8	334.9	21.8	54.2	76.7	44.1	114.3	46.8	65.4	169.0	95.4	216.0	122.9	77.0	121.1	44.2	121.4	87.8	54.5	27.8	124.0	119.8	147.0	115.0	112.7	196.5	284.6	144.9	40.5	81.3	148.0	268.3	354.3	119.8	147.3	70.1	204.6	133.7	211.9	83.5	104.9	129.9	75.6	82.1	124.9	92.1	304.0	84.4	78.4	79.5	87.4	151.7	44.8	85.1	205.9	153.4	95.9	178.0	163.0	230.4	122.0	245.0	253.4	53.6	182.2	121.9	132.1	114.7	87.0	104.2	161.0	234.1	135.5	132.6	156.6	160.0	132.5	102.7	203.6	120.2	158.1	54.8	244.2	231.7	107.7	265.9	150.1	95.5	103.1	59.2	138.0	116.1	157.4	137.2	59.7	158.0	87.6	40.5	81.3	20.7	132.2	70.3	194.3	284.6	226.2	180.3	126.7	264.8	268.3	212.3	13.6	148.0	60.4	144.9	165.3	354.3	45.7	46.9	38.9	41.2	37.2	31.2	41.5	37.0	44.1	27.8
RPL18	L18	ENSG00000063177	"Ribosomal protein L18"	Q07020	19	48615328-48619536	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"NB-4: 548.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046572	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"			100000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA046572: "	"unprognostic (2.12e-2)"	"unprognostic (1.86e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.48e-3)"	"unprognostic (4.76e-2)"	"unprognostic (3.21e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.15e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavourable (1.21e-4)"	"unprognostic (2.40e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.27e-2)"	56.2	57.3	50.3	79.1	40.8	122.4	84.9	35.2	51.1	89.8	76.6	44.8	60.8	66.1	100.6	56.1	129.6	78.2	99.2	43.4	38.3	33.1	56.4	101.9	62.1	194.1	40.3	27.0	206.5	260.5	19.8	57.1	74.8	26.8	100.5	39.6	54.6	136.7	62.3	78.8	108.6	60.5	69.1	39.7	88.7	64.0	45.8	28.6	114.9	115.8	116.5	122.2	91.2	90.5	137.1	84.5	19.0	57.5	71.1	144.1	148.6	57.1	89.2	32.9	57.0	33.5	66.1	48.0	26.3	43.8	54.5	45.9	80.4	53.2	83.7	27.6	25.1	47.4	29.8	59.7	20.8	35.6	103.8	30.3	41.7	76.8	67.8	42.1	47.3	77.9	87.7	29.2	39.4	53.6	42.7	73.7	34.2	72.6	66.2	548.2	52.3	44.5	69.4	26.4	75.8	44.1	70.7	46.7	60.9	23.7	83.6	79.3	47.1	82.1	30.5	40.5	45.0	25.0	60.2	61.3	71.4	49.9	25.4	65.1	47.6	19.0	57.5	12.2	65.7	47.6	115.3	130.3	116.4	88.1	79.2	137.1	144.1	113.9	8.6	71.1	37.3	84.5	89.6	148.6	50.3	40.8	35.2	51.1	38.3	33.1	40.3	27.0	26.8	28.6
RPL18A	L18A	ENSG00000105640	"Ribosomal protein L18a"	Q02543	19	17859876-17864153	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 430.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA055259	Approved		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA055259: "	"unprognostic (3.40e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.79e-3)"	"unprognostic (6.46e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.71e-2)"	"prognostic unfavourable (1.48e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.36e-1)"	48.8	33.8	24.9	42.2	43.0	85.7	53.6	27.8	61.1	49.9	46.0	26.5	28.1	40.4	47.8	36.4	65.5	56.5	38.9	31.5	22.6	16.2	50.0	85.9	34.8	83.7	22.3	26.1	109.2	106.6	9.3	30.5	46.9	30.9	41.8	26.8	30.4	99.8	31.6	157.7	90.1	43.3	36.6	21.9	57.6	50.1	67.3	17.6	59.5	65.3	107.9	54.0	45.0	57.1	395.8	193.6	24.8	110.7	126.0	278.4	430.5	126.2	98.4	65.8	92.7	98.8	162.8	166.6	77.5	98.6	102.7	97.9	135.8	127.2	191.2	179.9	66.7	95.2	77.5	165.1	35.9	97.7	208.8	89.3	94.7	154.6	171.1	128.4	97.8	203.2	217.7	56.8	122.4	112.2	113.4	124.0	64.8	197.0	173.7	169.6	154.7	151.8	156.3	69.8	226.6	93.7	120.2	95.3	143.0	27.5	192.2	240.0	91.2	249.6	86.0	63.6	74.1	127.0	130.0	166.3	151.2	123.4	83.6	205.6	78.9	24.8	110.4	16.5	134.8	110.7	234.6	368.3	232.2	167.1	166.6	395.8	278.4	212.5	11.3	126.0	85.6	193.6	195.9	430.5	24.9	43.0	27.8	61.1	22.6	16.2	22.3	26.1	30.9	17.6
RPL19	"DKFZp779D216, FLJ27452, L19, MGC71997"	ENSG00000108298	"Ribosomal protein L19"	P84098	17	39200283-39204727	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	7	"SK-BR-3: 937.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043014, HPA051987"	Approved		Enhanced	Nucleoli,Cytosol			100000	"Nucleoli, Cytosol"		"HPA043014: AB_10965840, HPA051987: "	"unprognostic (4.07e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.46e-2)"	"unprognostic (4.25e-2)"	"unprognostic (6.40e-2)"	"unprognostic (9.70e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.46e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (6.87e-5)"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.60e-2)"	72.3	57.7	51.3	56.7	56.9	122.5	94.7	41.8	88.6	72.2	64.5	42.2	62.7	48.7	67.0	56.7	77.7	78.1	65.9	87.3	49.2	37.0	62.3	124.4	70.7	229.5	50.5	53.0	156.4	124.4	33.1	51.7	57.3	58.7	60.0	52.5	48.1	113.8	67.6	91.4	95.8	58.8	57.5	57.1	74.4	66.1	45.2	34.1	53.0	63.3	94.9	103.4	63.1	75.9	208.2	143.4	40.4	108.7	116.2	236.3	325.8	47.0	64.0	46.4	56.3	85.0	107.5	48.1	44.3	90.4	91.7	73.8	69.7	44.5	115.2	78.0	63.2	80.0	69.8	91.6	47.3	46.7	122.5	41.1	47.8	90.7	132.6	100.6	56.9	119.7	100.6	70.6	127.9	79.1	71.4	67.4	63.3	46.4	133.2	140.6	47.5	47.7	79.0	66.1	115.1	82.7	59.0	56.5	62.8	26.6	937.7	138.3	90.8	128.1	46.5	35.9	48.5	54.6	81.4	89.0	88.1	84.7	48.7	76.8	46.1	36.7	108.7	40.4	116.1	90.3	180.1	208.2	187.2	146.8	143.4	193.1	236.3	190.8	17.1	116.2	72.6	132.4	146.2	325.8	51.3	56.9	41.8	88.6	49.2	37.0	50.5	53.0	58.7	34.1
RPL22	"EAP, L22"	ENSG00000116251	"Ribosomal protein L22"	P35268	1	6181269-6209389	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Heparin-binding, Ribonucleoprotein, Ribosomal protein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068294			Approved	Nucleoplasm,Nucleoli			320000	Nucleoli	Nucleoplasm	"HPA068294: "	"unprognostic (3.16e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.40e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.46e-3)"	"unprognostic (3.83e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.98e-1)"	75.5	71.5	54.3	79.7	42.8	124.7	75.0	46.7	39.5	95.8	73.9	39.2	53.9	66.5	133.6	63.9	103.9	59.1	61.8	50.8	47.4	38.6	58.8	90.2	55.3	142.6	50.6	39.7	163.1	154.8	30.4	57.0	49.8	37.4	90.8	46.4	57.0	140.3	66.8	114.0	79.7	62.6	106.6	58.3	79.1	62.0	38.2	35.0	95.3	91.0	112.8	81.1	101.5	91.9	75.6	62.3	11.0	38.9	42.2	98.8	73.9	88.0	25.1	53.5	54.6	37.7	59.3	42.3	76.9	30.9	28.3	24.2	49.8	76.6	136.7	63.3	28.5	50.9	40.2	40.0	37.3	66.9	65.4	132.8	57.2	61.7	37.4	175.7	53.3	52.3	33.1	25.2	52.2	35.3	109.4	82.8	32.5	38.8	76.8	143.4	33.3	55.7	74.1	111.0	105.8	41.4	30.6	74.0	67.9	62.6	181.4	140.8	58.4	139.3	86.3	40.4	44.5	53.3	72.2	66.7	91.4	206.8	26.7	181.7	25.0	11.0	38.9	8.8	38.0	34.3	66.9	75.6	71.1	52.3	59.8	72.4	98.8	78.1	2.9	42.2	27.8	62.3	54.0	73.9	54.3	42.8	46.7	39.5	47.4	38.6	50.6	39.7	37.4	35.0
RPL22L1		ENSG00000163584	"Ribosomal protein L22 like 1"	Q6P5R6	3	170864875-170870483	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 100.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA048060, HPA056207, HPA068294"	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA048060: , HPA056207: , HPA068294: "	"unprognostic (1.99e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.97e-1)"	"prognostic favourable (8.60e-5)"	"unprognostic (1.17e-3)"	"unprognostic (4.52e-2)"	"prognostic unfavourable (5.13e-12)"	"unprognostic (5.12e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.96e-2)"	17.2	14.6	8.9	28.1	9.5	36.0	21.5	6.0	9.3	14.3	15.7	5.3	6.6	8.4	12.2	12.3	33.6	15.3	11.8	11.3	7.4	8.5	11.4	64.3	18.8	31.4	10.1	5.7	18.6	71.6	1.9	12.1	10.5	10.7	14.7	15.7	6.4	15.7	14.0	17.7	19.4	13.7	12.2	11.5	37.5	17.4	9.7	8.9	17.9	15.2	32.5	27.8	18.9	15.9	24.1	24.2	1.9	7.6	13.1	13.8	3.5	15.5	17.5	5.7	66.3	17.0	100.0	17.5	15.8	36.5	12.9	8.4	7.5	3.6	48.1	3.6	14.7	4.0	14.1	40.4	7.2	2.9	2.5	4.3	2.1	16.8	68.7	8.9	6.4	72.6	82.5	4.1	43.8	43.7	3.0	3.1	70.5	19.7	64.5	5.0	89.3	3.2	86.6	2.0	7.4	31.9	34.7	0.9	4.8	1.6	7.9	6.8	11.1	7.8	20.2	2.4	19.0	4.9	22.0	5.0	3.4	7.6	45.0	5.4	51.1	1.0	4.8	1.9	6.8	5.7	13.8	24.1	10.0	9.0	5.1	17.9	6.7	7.4	1.0	13.1	7.6	24.2	6.3	3.5	8.9	9.5	6.0	8.1	7.4	8.5	10.1	5.7	10.7	8.9
RPL26	L26	ENSG00000161970	"Ribosomal protein L26"	P61254	17	8377516-8383250	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 586.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA030449, CAB037301"	Supported		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	Nucleoli	"CAB037301: AB_796168, HPA030449: AB_10602125"	"unprognostic (2.02e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.76e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.59e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.15e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.38e-1)"	122.5	64.5	70.2	102.5	49.8	132.2	170.4	44.4	52.4	127.6	131.6	34.8	68.1	53.1	76.4	97.0	161.2	87.6	98.6	68.1	54.8	42.5	100.6	138.3	97.5	117.5	61.6	32.6	183.0	586.0	32.2	41.1	82.2	47.7	129.0	84.0	41.5	95.3	87.4	170.8	106.3	98.6	103.6	62.9	129.0	75.9	53.0	45.1	104.9	131.6	145.8	107.9	154.7	127.6	154.9	120.8	25.1	92.1	93.0	158.2	165.0	101.9	93.8	92.3	109.2	174.4	287.2	90.3	88.6	131.8	120.3	90.9	99.1	52.5	178.2	101.9	104.9	113.3	117.4	181.5	141.7	66.5	211.4	69.5	103.6	114.3	203.9	103.2	90.2	244.7	363.4	99.6	299.5	148.1	78.7	53.7	126.3	70.1	113.8	141.3	86.8	62.3	113.7	93.8	110.8	161.7	76.6	38.4	82.0	47.7	89.2	204.8	91.2	138.3	92.8	48.7	60.8	67.1	155.0	43.2	50.4	77.9	79.7	146.9	72.1	25.1	92.1	18.2	89.9	78.3	130.5	154.9	134.3	116.8	120.8	140.1	158.2	136.0	10.9	93.0	69.5	104.5	111.3	165.0	70.2	49.8	44.4	52.4	54.8	42.5	61.6	32.6	47.7	45.1
RPL26L1	RPL26P1	ENSG00000037241	"Ribosomal protein L26 like 1"	Q9UNX3	5	172958729-172969771	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 73.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA030449	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA030449: AB_10602125"	"unprognostic (3.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.39e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (2.49e-4)"	"unprognostic (2.04e-3)"	"unprognostic (2.45e-1)"	"unprognostic (7.51e-2)"	"unprognostic (5.86e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.14e-3)"	11.2	23.0	17.9	14.7	17.9	18.0	15.2	10.5	21.1	13.1	12.8	8.2	14.4	13.5	14.5	21.6	18.1	14.7	11.9	19.5	20.7	16.8	20.0	25.9	10.5	16.7	16.2	18.0	14.1	25.5	9.1	15.4	14.2	16.3	12.1	14.6	11.5	18.4	16.7	19.0	9.7	10.8	14.0	12.8	13.3	12.2	73.6	11.8	20.0	16.2	18.2	14.9	13.1	11.9	19.7	40.0	17.5	36.2	14.6	21.7	20.9	29.6	26.9	24.4	33.5	16.9	17.9	31.7	28.4	16.7	41.1	36.7	32.8	32.0	22.4	73.0	38.9	19.3	40.2	56.4	38.0	28.5	52.3	16.5	31.6	40.1	33.3	24.0	14.7	22.3	23.9	42.3	29.7	23.5	22.6	18.9	29.2	65.9	29.3	38.0	15.5	42.9	21.4	37.8	29.7	23.9	18.7	24.6	15.1	26.0	23.9	37.7	29.3	25.9	24.7	47.0	26.1	27.4	21.3	16.9	26.3	41.8	37.0	30.2	27.8	7.8	36.2	15.5	14.3	31.4	18.3	19.7	17.4	19.6	40.0	15.1	14.5	18.4	17.5	14.6	26.8	27.5	21.7	20.9	17.9	17.9	10.5	21.1	20.7	16.8	16.2	18.0	16.3	11.8
RPL29	"HIP, HUMRPL29, L29, RPL29P10"	ENSG00000162244	"Ribosomal protein L29"	P47914	3	51993600-51995942	"Predicted intracellular proteins, Ribosomal proteins"		"Heparin-binding, Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 434.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA069064	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA069064: "	"unprognostic (3.77e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.32e-3)"	"unprognostic (2.89e-3)"	"unprognostic (5.46e-2)"	"unprognostic (6.79e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.99e-2)"	"unprognostic (6.25e-2)"	"unprognostic (7.56e-2)"	91.6	61.7	42.5	64.6	33.0	110.2	111.0	30.1	39.7	102.4	98.1	30.3	57.1	53.6	59.6	72.8	124.7	76.0	68.7	72.1	33.8	26.0	55.7	122.9	64.8	219.4	36.0	26.0	150.1	434.1	16.3	34.3	50.7	26.3	91.1	41.2	38.9	103.7	54.8	160.8	102.5	73.8	80.2	38.1	83.9	59.7	58.7	25.2	85.9	83.3	123.3	92.4	88.5	87.1	137.9	98.1	32.8	80.0	74.8	132.2	202.9	69.2	90.1	69.5	105.9	123.9	194.9	98.1	77.5	95.8	106.5	88.7	107.2	106.5	193.8	33.8	78.7	63.1	100.2	164.9	51.0	78.8	136.3	100.3	116.5	178.9	147.0	145.5	96.8	238.2	234.6	78.5	139.9	119.2	78.2	148.9	78.5	158.2	126.2	189.2	115.4	153.0	58.7	76.6	187.9	136.2	144.9	56.2	109.7	58.0	133.9	132.4	100.2	248.9	103.3	59.8	80.4	92.2	115.5	97.1	137.7	137.8	79.1	174.5	79.0	32.8	80.0	22.6	68.8	61.7	115.0	137.9	112.2	87.6	98.1	128.2	132.2	109.9	10.8	74.8	48.4	82.8	100.8	202.9	42.5	33.0	30.1	39.7	33.8	26.0	36.0	26.0	26.3	25.2
RPL3	L3	ENSG00000100316	"Ribosomal protein L3"	P39023	22	39312882-39320389	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003365, HPA055361"	Uncertain		Supported	Nucleoli,Cytosol			120000	"Nucleoli, Cytosol"		"HPA003365: AB_1079841, HPA055361: "	"unprognostic (9.79e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.68e-3)"	"unprognostic (5.44e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.63e-1)"	"unprognostic (5.81e-2)"	"unprognostic (5.87e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.32e-2)"	71.7	71.8	51.3	72.3	50.3	107.0	134.5	50.8	49.3	102.2	94.4	42.7	78.1	63.1	207.5	79.6	126.9	101.6	96.2	54.5	41.4	38.8	66.6	102.5	74.5	205.9	47.4	57.7	217.8	453.1	50.9	75.0	74.5	58.0	138.7	57.0	74.8	216.3	68.5	48.9	118.1	62.6	115.6	50.7	84.3	74.4	76.4	23.3	105.5	158.5	82.3	109.8	119.9	105.7	198.9	114.8	18.9	56.4	150.3	249.0	326.4	86.4	80.1	91.6	101.3	117.3	254.3	123.5	67.0	127.6	67.1	60.3	100.6	66.1	357.7	92.9	80.7	57.6	97.7	143.3	44.7	60.8	96.3	90.0	95.8	150.5	173.2	127.9	76.0	245.7	194.2	58.0	206.7	130.4	101.3	124.4	96.9	111.3	129.8	186.2	95.8	55.9	104.3	88.9	179.5	123.9	128.2	83.9	99.1	42.0	137.6	219.3	103.7	208.6	129.2	45.1	71.3	47.2	76.3	95.6	72.2	158.4	101.6	113.1	50.9	18.9	56.4	11.9	132.5	51.7	205.6	198.9	192.1	153.7	101.2	175.8	249.0	195.2	8.1	150.3	44.5	114.8	126.1	326.4	51.3	50.3	50.8	49.3	41.4	38.8	47.4	57.7	58.0	23.3
RPL34	L34	ENSG00000109475	"Ribosomal protein L34"	P49207	4	108620566-108630412	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 400.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035139	Uncertain		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA035139: AB_10602925"	"unprognostic (1.49e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.97e-2)"	"prognostic favourable (2.76e-5)"	"unprognostic (2.45e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.22e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.72e-3)"	"unprognostic (6.17e-2)"	"unprognostic (8.96e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.19e-2)"	68.5	52.6	65.9	77.6	63.7	118.0	165.2	43.7	52.9	82.0	70.1	25.5	57.5	47.3	106.0	111.1	76.4	75.2	61.9	59.2	53.7	41.4	60.2	98.4	56.1	110.1	54.6	49.7	157.4	305.1	17.8	68.3	63.8	59.0	74.3	61.0	35.2	129.9	60.2	87.1	77.6	57.6	87.5	57.5	70.8	60.3	43.2	32.2	63.3	82.2	109.5	95.4	67.6	102.3	300.5	153.8	56.2	116.4	134.2	331.0	400.6	58.6	42.9	77.9	110.7	169.1	267.7	76.7	90.7	115.2	74.8	62.7	108.6	104.4	178.5	54.6	88.1	41.9	83.7	141.4	98.3	65.8	134.1	74.5	90.1	166.2	142.4	186.8	83.5	238.0	202.1	61.1	139.0	134.5	130.5	102.5	123.2	114.0	114.4	228.2	89.3	86.8	105.2	83.7	108.1	156.2	99.0	83.6	107.1	37.0	216.2	127.0	71.9	170.9	99.3	51.3	69.6	53.6	80.1	76.6	99.9	143.9	69.9	116.8	62.7	56.2	116.4	35.6	122.0	86.8	207.8	300.5	247.8	165.5	121.2	257.1	331.0	244.9	24.9	134.2	74.9	153.8	176.2	400.6	65.9	63.7	43.7	52.9	53.7	41.4	54.6	49.7	59.0	32.2
RPL4	L4	ENSG00000174444	"Ribosomal protein L4"	P36578	15	66498015-66524532	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA034600	Uncertain		Supported	"Nucleoli,Nuclear bodies,Endoplasmic reticulum,Cytosol"			830000	"Endoplasmic reticulum, Cytosol"	"Nucleoli, Nuclear bodies"	"HPA034600: AB_10601483"	"unprognostic (1.51e-2)"	"unprognostic (3.77e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.68e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (5.20e-5)"	"unprognostic (1.27e-1)"	"unprognostic (5.60e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.27e-1)"	63.6	33.4	37.0	59.0	40.4	70.6	88.2	34.5	42.2	73.6	60.5	33.5	42.3	18.8	67.3	49.8	81.3	65.7	39.4	38.8	31.7	26.4	53.2	84.5	46.1	103.9	35.1	26.3	139.1	159.9	33.1	42.0	52.0	34.1	67.6	50.9	35.9	66.2	51.0	87.2	77.1	36.4	67.3	47.9	60.3	46.3	42.8	20.0	81.3	66.1	91.7	102.8	74.2	55.9	72.5	58.7	5.9	40.9	45.0	97.0	135.7	44.2	89.4	37.8	63.7	170.4	309.9	66.8	54.1	111.7	83.8	65.1	98.8	77.7	175.4	61.7	128.8	80.6	270.2	209.1	92.7	48.4	162.0	107.5	80.1	82.0	240.2	112.6	53.9	304.0	272.6	91.0	363.9	133.9	98.4	69.0	125.2	73.0	75.0	50.1	82.7	64.0	84.1	86.3	170.2	115.1	87.9	67.3	70.4	33.3	94.9	133.6	70.1	162.8	78.4	43.8	66.2	40.7	85.9	67.9	105.2	117.3	53.9	151.6	49.3	3.5	40.9	5.9	38.2	36.2	71.1	72.5	74.6	53.7	58.7	60.5	97.0	75.7	2.7	45.0	33.5	37.4	57.0	135.7	37.0	40.4	34.5	42.2	31.7	26.4	35.1	26.3	34.1	20.0
RPL5	"L5, PPP1R135"	ENSG00000122406	"Ribosomal protein L5"	P46777	1	92831983-92841924	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"	"Cancer-related genes, Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA043717, HPA054444"	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"			130000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA043717: AB_10964719, HPA054444: "	"unprognostic (5.81e-3)"	"unprognostic (3.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.44e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-3)"	"unprognostic (9.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavourable (6.81e-5)"	"unprognostic (2.26e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.97e-1)"	119.4	80.3	50.0	70.0	50.1	113.8	140.5	46.9	46.8	158.6	111.4	45.0	75.1	61.7	135.2	114.6	159.4	100.5	73.1	73.0	43.5	43.1	99.7	114.9	89.9	148.2	54.5	36.2	296.8	306.5	40.8	90.3	90.2	44.3	175.4	78.8	64.3	121.5	73.2	109.1	97.8	95.3	153.4	61.9	130.1	90.0	68.8	45.7	156.6	210.0	97.7	118.9	191.2	146.6	104.5	85.2	12.8	45.9	72.4	143.0	142.1	116.8	50.2	89.5	75.5	116.4	235.3	143.6	69.9	93.6	87.1	62.4	133.0	51.1	220.5	112.3	78.5	74.7	102.6	131.0	111.3	69.8	140.4	114.4	83.6	122.4	139.7	175.1	48.2	192.4	206.7	77.3	170.2	120.2	141.6	116.3	99.7	66.3	139.4	198.6	138.2	94.9	128.1	173.4	142.4	105.6	97.3	76.3	91.3	45.5	127.1	203.3	70.0	240.9	73.0	44.0	80.4	83.1	126.0	72.0	68.3	149.2	29.8	151.0	29.8	12.8	45.9	7.2	60.9	44.8	122.1	104.5	111.5	91.6	85.2	88.4	143.0	123.9	4.4	72.4	38.3	71.1	83.2	142.1	50.0	50.1	46.9	46.8	43.5	43.1	54.5	36.2	44.3	45.7
RPL7	"humL7-1, L7"	ENSG00000147604	"Ribosomal protein L7"	P18124	8	73290267-73295789	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 536.3"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 627.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA058373	Approved		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"			170000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA058373: "	"unprognostic (3.75e-1)"	"unprognostic (3.60e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.41e-2)"	"unprognostic (8.31e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.63e-2)"	"unprognostic (9.89e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.31e-1)"	54.7	36.5	54.6	37.9	49.3	67.6	86.9	55.9	54.1	57.5	46.2	36.4	41.0	33.6	54.9	50.6	59.5	50.6	26.5	36.7	32.1	22.0	46.4	67.6	40.3	53.3	55.9	20.5	125.8	87.5	22.9	67.7	33.4	55.0	43.6	44.9	44.1	51.8	36.6	61.9	72.7	37.0	49.5	46.9	46.5	51.2	135.1	54.9	33.7	42.6	69.0	66.6	50.8	58.5	338.1	231.5	66.1	171.7	205.0	464.0	536.3	98.1	71.3	76.7	92.3	156.6	200.7	75.5	107.9	86.8	73.7	58.3	85.7	102.8	292.0	88.3	87.0	94.2	101.2	137.7	115.1	78.5	84.0	159.8	93.3	88.2	94.1	112.6	82.0	187.8	162.8	68.2	213.6	119.5	142.4	110.8	104.6	83.3	178.7	172.3	89.4	76.7	120.9	87.9	113.8	114.9	98.5	106.2	77.4	50.7	627.9	151.0	158.7	148.1	112.1	56.7	86.8	72.1	99.6	64.1	90.8	188.4	59.3	139.9	93.1	66.1	171.7	41.1	179.1	138.9	322.3	338.1	314.4	232.5	231.5	282.6	464.0	327.0	22.3	205.0	118.6	192.4	237.0	536.3	54.6	49.3	55.9	54.1	32.1	22.0	55.9	20.5	55.0	54.9
RPL7A	"L7A, SURF3, TRUP"	ENSG00000148303	"Ribosomal protein L7a"	P62424	9	133348214-133351426	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA046794			Approved	Nucleoli,Vesicles			160000	Nucleoli	Vesicles	"HPA046794: "	"unprognostic (5.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.07e-3)"	"unprognostic (4.17e-3)"	"unprognostic (7.95e-2)"	"prognostic unfavourable (8.99e-4)"	"unprognostic (1.98e-1)"	"unprognostic (8.88e-2)"	"prognostic unfavourable (3.60e-5)"	"unprognostic (4.91e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.92e-2)"	"unprognostic (9.89e-2)"	58.8	72.8	34.9	64.0	39.6	78.6	96.3	33.1	43.2	70.1	66.6	27.6	66.9	38.9	137.4	81.5	96.0	94.8	74.4	48.2	29.5	25.7	51.0	59.3	48.1	159.6	32.7	45.2	164.9	193.1	29.1	50.6	42.4	34.1	90.1	67.6	47.3	204.8	70.0	85.2	91.9	48.6	91.0	35.5	68.1	61.4	78.2	24.0	80.5	77.9	70.1	93.2	75.1	109.7	79.7	56.4	12.1	35.8	50.2	80.4	94.0	45.2	69.0	78.9	78.5	138.7	230.3	75.3	57.1	116.9	103.0	57.6	104.8	59.8	142.1	35.3	99.6	111.1	116.5	137.2	83.2	60.3	65.9	50.0	102.6	101.9	92.0	118.3	59.3	231.6	205.4	74.5	129.3	130.7	95.6	75.0	118.2	153.8	91.7	123.8	85.7	68.1	80.7	98.9	180.8	132.7	58.1	74.1	65.4	46.7	120.5	72.9	131.3	125.4	71.4	68.1	49.0	61.2	67.7	29.3	58.3	87.3	53.1	82.7	52.8	12.1	35.8	7.7	52.2	33.6	77.3	79.7	71.2	64.3	56.4	71.8	80.4	73.5	5.5	50.2	29.3	56.1	54.6	94.0	34.9	39.6	33.1	43.2	29.5	25.7	32.7	45.2	34.1	24.0
RPL7L1	dJ475N16.4	ENSG00000146223	"Ribosomal protein L7 like 1"	Q6DKI1	6	42879618-42889925	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA046049, HPA050478"			Approved	Nucleoli,Mitochondria				"Nucleoli, Mitochondria"		"HPA046049: AB_10964167, HPA050478: "	"unprognostic (1.03e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.97e-2)"	"unprognostic (7.73e-3)"	"unprognostic (4.26e-2)"	"prognostic unfavourable (8.53e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.31e-3)"	"unprognostic (4.58e-2)"	17.5	22.1	19.9	14.4	27.5	9.0	19.9	20.5	35.9	14.8	14.2	16.9	16.4	11.9	15.7	17.4	18.9	17.2	10.2	14.4	17.6	16.5	18.8	23.5	11.9	16.5	14.9	20.4	17.4	16.9	22.9	22.4	15.1	17.9	17.0	17.0	13.2	17.4	14.4	19.9	16.3	12.8	16.5	13.9	15.4	13.7	33.0	14.5	25.1	17.8	15.6	20.3	13.7	13.3	15.4	12.5	10.2	13.6	16.4	18.6	10.6	35.4	11.3	20.1	32.2	19.0	24.6	13.7	28.4	20.7	27.6	22.9	28.0	13.6	53.3	25.8	23.9	17.0	45.6	34.5	45.9	27.9	34.3	28.4	15.9	25.3	20.9	43.7	22.0	25.1	26.6	36.1	35.0	27.0	54.8	18.5	25.1	26.1	24.9	28.4	20.3	16.7	28.6	22.6	33.7	21.5	22.5	38.5	23.5	24.3	18.6	29.8	24.9	42.4	25.8	26.8	22.3	21.1	49.0	23.2	36.3	81.1	14.9	41.6	27.8	5.6	11.4	10.2	14.9	13.6	18.6	13.3	14.6	15.5	10.8	15.4	15.5	14.9	2.6	16.4	11.9	12.5	12.0	10.6	19.9	27.5	20.5	35.9	17.6	16.5	14.9	20.4	17.9	14.5
RPL8	L8	ENSG00000161016	"Ribosomal protein L8"	P62917	8	144789765-144792587	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 322.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045095, HPA050165"	Enhanced		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"			240000000	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA045095: AB_2679213, HPA050165: AB_2681038"	"unprognostic (2.52e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.84e-2)"	"prognostic unfavourable (7.22e-4)"	"unprognostic (4.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.13e-2)"	65.9	45.5	32.1	53.7	34.7	120.1	115.2	31.0	61.9	63.9	78.4	26.4	51.1	95.2	106.4	57.1	76.0	51.2	68.9	78.7	27.2	23.6	48.2	62.6	54.5	169.4	29.0	28.8	125.7	349.6	11.8	45.2	38.4	28.8	61.3	15.7	45.6	174.7	57.3	202.1	89.0	82.8	84.9	29.2	79.7	96.4	48.9	17.0	61.2	73.2	103.2	72.8	64.7	100.0	174.8	117.5	31.1	82.7	77.9	136.8	251.3	120.4	142.3	10.2	44.2	11.4	26.0	97.8	87.3	16.5	26.7	19.0	124.2	65.2	162.1	126.4	10.3	73.0	13.3	30.4	4.9	70.4	161.9	96.2	109.6	87.5	28.6	63.0	52.5	28.0	34.7	12.0	20.6	19.6	129.5	37.6	11.3	322.1	89.9	85.4	95.0	161.3	88.2	58.9	152.4	14.2	91.4	62.3	104.0	83.8	45.7	119.9	105.8	61.0	78.4	35.5	135.2	74.1	104.9	68.8	58.7	140.2	70.7	104.8	48.6	24.1	80.3	31.1	70.5	82.7	117.9	166.8	119.3	86.9	117.5	174.8	136.8	105.0	9.8	77.9	78.5	64.5	113.8	251.3	32.1	34.7	31.0	61.9	27.2	23.6	29.0	28.8	28.8	17.0
RPL9	L9	ENSG00000163682	"Ribosomal protein L9"	P32969	4	39452521-39458949	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003372	Approved	Approved	Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"			24000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA003372: AB_1079843"	"unprognostic (1.08e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.06e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.58e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.50e-2)"	"unprognostic (7.85e-2)"	"prognostic unfavourable (7.34e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-2)"	52.6	35.2	42.2	73.9	44.4	179.1	202.3	35.7	51.6	63.0	59.8	34.5	42.2	69.8	50.4	226.8	49.9	48.1	69.7	58.2	42.3	27.6	47.4	73.2	35.8	48.7	34.7	51.7	158.5	126.2	37.4	44.7	38.7	42.5	47.8	59.1	31.7	93.7	71.4	66.3	62.9	38.8	49.5	34.0	45.2	46.5	56.9	25.9	36.0	63.2	70.1	59.0	46.0	56.6	118.3	72.5	26.2	41.4	63.0	145.0	148.9	3.2	2.8	122.4	2.8	6.6	9.0	4.7	57.6	87.0	71.9	54.6	8.0	65.4	142.9	6.6	57.9	65.1	5.4	6.2	78.7	52.0	115.0	4.5	24.1	7.8	8.5	9.3	37.8	11.9	180.9	4.4	82.7	5.4	109.2	66.7	5.0	4.3	77.5	9.8	109.2	3.8	71.6	122.7	4.9	89.4	3.7	4.6	48.8	1.9	47.3	7.3	104.4	6.7	4.1	3.0	4.6	83.7	7.9	102.5	143.9	124.1	83.1	86.9	3.3	26.2	41.4	12.3	52.1	40.1	101.2	118.3	102.2	71.4	57.2	103.8	145.0	111.7	6.9	63.0	31.2	72.5	77.0	148.9	42.2	44.4	35.7	51.6	42.3	27.6	34.7	51.7	42.5	25.9
RPP30	TSG15	ENSG00000148688	"Ribonuclease P/MRP subunit p30"	P78346	10	90871716-90908553	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037578	Approved		Approved	"Nucleoplasm,Nucleoli,Microtubule ends,Cytosol"				"Nucleoplasm, Nucleoli"	"Microtubule ends, Cytosol"	"HPA037578: AB_10696939"	"unprognostic (1.55e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.08e-1)"	"unprognostic (5.64e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavourable (1.01e-6)"	"unprognostic (1.98e-1)"	"unprognostic (9.84e-3)"	"unprognostic (3.43e-2)"	"unprognostic (2.10e-2)"	24.2	19.0	20.9	16.8	20.3	27.2	22.3	26.0	24.0	18.9	19.0	16.2	16.3	11.5	25.2	18.6	23.8	19.2	16.0	26.6	19.8	16.8	20.6	18.4	17.1	23.2	18.5	20.4	23.9	17.7	37.7	23.6	23.6	19.3	18.8	19.3	18.7	19.2	16.5	35.9	23.5	16.4	20.6	19.2	21.3	19.2	32.0	21.6	31.2	18.1	24.0	26.3	21.7	18.9	19.4	22.2	16.2	19.5	14.2	20.3	16.2	28.0	18.7	19.6	23.6	12.8	13.8	6.9	20.1	18.1	33.7	35.4	31.6	22.6	16.6	15.4	12.8	19.7	26.1	17.8	34.7	26.6	18.0	11.1	12.0	24.9	12.1	22.5	14.1	11.3	11.6	25.3	28.8	19.1	22.1	15.2	22.2	17.3	26.1	30.7	12.1	21.3	14.6	16.7	17.4	12.7	13.3	10.6	10.7	11.7	8.5	23.6	23.0	14.3	10.8	16.8	16.8	9.5	41.4	10.3	26.3	35.6	21.1	12.2	12.9	4.3	19.5	16.2	17.1	18.7	18.6	19.4	19.6	18.7	22.2	16.7	17.0	18.5	2.2	14.2	15.3	20.7	20.3	16.2	20.9	20.3	26.0	24.0	19.8	16.8	18.5	20.4	19.3	21.6
RPP38		ENSG00000152464	"Ribonuclease P/MRP subunit p38"	P78345	10	15097180-15139818	"Enzymes, Predicted intracellular proteins, Ribosomal proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045128, HPA050398"	Approved		Supported	Nucleoli				Nucleoli		"HPA045128: , HPA050398: "	"unprognostic (1.75e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (1.46e-4)"	"unprognostic (1.41e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.57e-3)"	"unprognostic (3.42e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavourable (6.25e-4)"	"unprognostic (6.13e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.11e-2)"	"prognostic favourable (2.89e-6)"	13.1	12.2	12.4	10.7	13.6	9.7	18.3	22.4	12.4	13.6	16.7	12.0	15.8	14.4	15.7	16.1	15.2	18.2	10.3	10.0	11.6	10.2	17.4	21.6	12.5	16.3	15.0	10.0	14.4	16.8	11.3	16.0	17.4	12.7	18.4	15.7	11.7	17.1	14.9	20.9	14.8	17.9	14.3	11.5	16.7	13.5	38.6	12.7	18.8	19.8	13.9	18.5	13.4	13.6	31.0	25.7	23.4	24.5	18.6	31.4	20.2	20.9	15.9	8.7	11.2	11.8	12.2	15.4	10.2	7.7	16.0	16.5	16.0	22.1	17.6	11.0	9.5	19.7	17.5	17.7	14.8	13.4	15.9	18.1	9.7	14.0	25.4	10.2	15.3	14.5	24.5	13.1	11.6	12.8	20.9	12.6	12.2	17.3	18.2	11.2	10.1	7.8	15.0	8.8	21.9	20.5	8.3	8.3	10.5	14.1	24.5	28.2	21.9	16.5	11.0	7.4	12.9	15.6	13.4	17.5	18.7	24.0	14.5	12.5	7.0	8.5	24.5	23.4	25.6	23.7	25.1	28.8	26.2	31.4	25.3	31.0	30.6	27.8	8.3	18.6	18.6	25.7	22.0	20.2	12.4	13.6	22.4	12.4	11.6	10.2	15.0	10.0	12.7	12.7
RPS11	S11	ENSG00000142534	"Ribosomal protein S11"	P62280	19	49496365-49499689	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049719	Uncertain		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA049719: "	"unprognostic (1.49e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.89e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.47e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (3.50e-7)"	"unprognostic (5.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.71e-3)"	103.0	76.8	80.6	187.8	68.7	161.8	165.7	50.4	75.3	138.6	134.1	43.2	105.8	67.0	149.4	132.4	142.8	132.3	133.0	135.9	63.2	53.5	84.3	105.7	101.9	354.2	71.5	64.2	242.4	490.0	41.7	89.7	72.2	63.4	116.6	103.4	72.7	193.2	104.0	223.4	140.8	88.1	198.4	69.9	132.6	96.3	67.2	48.3	137.3	119.0	190.7	169.5	145.6	230.6	232.4	173.3	45.1	96.7	91.3	161.6	231.8	110.2	171.9	130.6	201.7	188.9	286.0	87.5	93.8	185.4	133.7	128.2	119.0	92.1	270.6	58.6	127.7	74.3	154.0	185.9	131.9	115.3	267.3	163.6	113.1	171.0	176.5	289.0	121.6	283.7	303.3	89.3	230.0	192.9	161.5	144.3	144.2	123.2	134.8	217.7	120.6	177.3	130.1	165.4	143.9	191.9	260.5	139.6	186.3	63.9	215.3	139.5	70.0	300.6	110.4	106.2	95.5	51.5	123.4	144.4	219.6	192.4	44.2	199.1	90.6	45.1	96.7	29.9	95.6	82.8	127.6	232.4	137.5	110.9	144.1	221.1	161.6	135.7	25.9	91.3	70.6	173.3	109.8	231.8	80.6	68.7	50.4	75.3	63.2	53.5	71.5	64.2	63.4	48.3
RPS17	"MGC72007, RPS17L, RPS17L1, RPS17L2, S17"	ENSG00000182774	"Ribosomal protein S17"	P08708	15	82536750-82540564	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 146.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA055060	Approved		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"			39000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA055060: "	"unprognostic (3.37e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.06e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavourable (1.78e-4)"	"unprognostic (2.83e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.31e-1)"	40.1	37.3	23.9	41.5	28.0	78.5	93.7	20.5	39.7	41.3	35.4	18.0	32.7	12.0	34.4	69.6	58.2	48.5	36.3	36.2	24.9	16.0	33.0	56.8	30.4	75.5	22.2	22.4	100.0	160.7	8.0	28.1	28.7	29.1	32.2	54.1	21.2	64.2	38.1	47.5	60.8	33.0	54.2	26.6	40.9	38.1	29.3	19.2	36.1	38.5	85.2	82.2	34.1	55.8	42.1	34.6	12.5	19.7	26.5	48.5	63.4	10.2	74.1	23.9	15.5	40.5	56.4	18.6	5.6	10.4	17.7	16.3	105.6	33.8	14.7	10.5	22.6	32.5	57.7	57.2	32.0	8.9	146.2	2.6	76.6	70.9	55.3	12.9	14.1	72.5	105.7	21.9	75.0	37.5	10.0	39.1	27.3	82.5	16.6	45.7	36.0	59.2	11.1	6.1	26.3	52.9	93.5	17.4	11.2	2.2	31.4	30.9	38.2	39.9	9.7	27.7	20.2	17.1	12.3	11.8	18.2	12.8	22.6	33.5	15.1	12.5	19.7	4.5	16.6	17.2	43.6	39.9	41.3	26.8	27.2	42.1	48.5	42.4	2.5	26.5	14.8	34.6	23.7	63.4	23.9	28.0	20.5	39.7	24.9	16.0	22.2	22.4	29.1	19.2
RPS19BP1	"FLJ21770, MGC52010"	ENSG00000187051	"Ribosomal protein S19 binding protein 1"	Q86WX3	22	39529093-39532855	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042874	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoli, Cytosol"	Nucleoplasm	"HPA042874: AB_10793988"	"unprognostic (2.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.79e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (3.71e-4)"	"unprognostic (1.65e-1)"	"unprognostic (5.68e-2)"	"unprognostic (8.31e-2)"	"unprognostic (7.00e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.32e-2)"	32.8	38.8	38.9	29.5	30.6	36.9	47.5	24.2	34.7	26.4	28.0	19.2	40.6	31.4	18.8	25.2	24.1	18.0	25.0	30.5	38.9	28.4	30.8	40.7	22.5	29.4	40.3	27.0	23.4	45.0	15.4	18.8	21.9	31.9	31.6	14.4	19.2	65.2	35.4	55.0	19.8	30.9	28.5	31.1	27.1	32.6	28.8	24.6	16.3	40.8	28.0	23.7	24.3	54.5	64.2	73.5	67.3	57.7	42.8	60.3	50.5	21.2	26.3	12.6	17.8	14.2	9.3	26.6	24.4	19.9	21.4	17.0	29.0	14.0	26.6	25.5	14.4	17.2	19.9	25.0	7.4	38.2	63.5	25.5	22.3	25.6	20.9	37.3	33.3	13.9	18.9	18.3	22.5	14.5	28.5	19.2	13.5	23.5	17.8	37.2	22.0	50.3	28.4	16.5	39.9	22.3	21.0	28.2	15.8	19.8	31.5	43.8	22.7	30.2	17.2	17.8	40.7	19.9	31.8	33.5	30.7	41.2	24.2	25.9	41.6	42.1	57.7	67.3	53.4	52.1	49.2	62.0	54.4	55.2	46.3	64.2	53.2	54.1	63.4	42.8	42.0	73.5	60.3	50.5	38.9	30.6	24.2	34.7	38.9	28.4	40.3	27.0	31.9	24.6
RPS26	S26	ENSG00000197728	"Ribosomal protein S26"	P62854	12	56041351-56044676	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043961, HPA055803"	Uncertain		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA043961: AB_10963579, HPA055803: "	"unprognostic (1.59e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.36e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.74e-1)"	"unprognostic (7.84e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.99e-2)"	36.5	66.6	33.3	29.0	48.8	39.2	49.7	23.8	73.7	44.5	45.6	34.9	20.5	20.0	35.9	50.4	49.9	43.5	28.4	39.8	25.8	24.8	61.8	154.3	29.5	56.0	31.4	26.2	75.8	80.4	25.6	29.7	28.7	45.1	35.4	49.1	28.5	38.0	41.1	62.2	50.9	57.5	36.9	30.0	51.6	40.3	47.0	32.5	47.3	58.4	60.0	78.4	46.7	41.2	93.0	69.8	29.8	42.8	63.6	107.4	108.8	52.8	65.1	74.2	27.5	102.8	152.5	74.4	53.9	80.1	89.9	52.6	99.9	24.0	118.0	34.1	56.9	24.9	83.3	46.4	61.6	46.6	133.6	62.3	43.4	59.6	94.9	40.4	34.2	92.3	148.7	47.4	54.0	68.2	42.4	39.4	72.7	82.0	30.3	73.5	72.8	147.4	41.3	22.3	72.6	75.1	53.6	27.9	48.2	21.1	46.6	30.6	41.2	45.3	22.1	22.4	45.8	28.5	43.2	33.9	64.9	63.7	24.8	80.8	28.6	29.8	41.4	27.1	74.6	42.8	83.8	93.0	97.8	81.8	55.3	79.8	107.4	99.3	17.0	63.6	38.2	69.8	101.7	108.8	33.3	48.8	23.8	73.7	25.8	24.8	31.4	26.2	45.1	32.5
RPS27	"MPS-1, MPS1, S27"	ENSG00000177954	"Ribosomal protein S27"	P42677	1	153990755-153992155	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 778.4;lymphoid tissue: 769.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA066851			Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA066851: "	"prognostic favourable (9.69e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.62e-2)"	"unprognostic (5.88e-3)"	"unprognostic (2.05e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.81e-2)"	"prognostic unfavourable (4.86e-7)"	"unprognostic (1.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.81e-2)"	120.7	72.5	74.9	188.7	118.6	186.7	268.2	51.3	91.4	172.5	114.2	35.9	136.4	58.1	169.0	135.6	107.5	129.0	144.1	176.5	59.6	50.1	98.6	102.5	167.8	769.0	92.1	76.0	317.8	227.2	44.6	91.5	67.5	71.2	117.6	113.6	63.5	248.2	116.1	243.8	160.1	115.9	254.3	65.6	159.3	111.5	119.0	81.9	118.2	113.0	224.0	270.9	162.9	286.0	720.2	296.5	132.9	139.9	324.1	750.5	778.4	104.0	122.0	161.3	87.8	379.9	374.5	100.0	126.2	302.5	170.0	153.7	244.4	115.1	236.9	106.0	182.0	104.8	142.1	208.9	143.7	115.1	183.2	93.3	161.8	158.5	251.8	207.4	123.1	363.6	410.9	135.2	249.1	139.3	113.9	128.9	161.3	261.5	223.2	131.3	195.4	178.0	143.0	118.2	184.3	157.0	210.8	85.8	191.2	72.3	254.7	219.3	141.9	416.9	82.3	58.8	97.3	93.6	126.1	258.9	263.9	287.2	102.0	116.5	80.6	132.9	139.9	68.1	393.0	138.9	473.7	720.2	594.4	502.0	179.5	637.3	750.5	579.6	32.4	324.1	127.0	296.5	397.8	778.4	74.9	118.6	51.3	91.4	59.6	50.1	92.1	76.0	71.2	81.9
RPS27A	"S27A, Uba80, UBCEP80"	ENSG00000143947	"Ribosomal protein S27a"	P62979	2	55231903-55235853	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033319, HPA041344, HPA049132, HPA054087"	Supported		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Nucleoli, Endoplasmic reticulum, Cytosol"		"CAB033319: AB_793618, HPA041344: , HPA049132: , HPA054087: "	"unprognostic (7.32e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.20e-3)"	"unprognostic (2.16e-1)"	"unprognostic (9.75e-2)"	"prognostic unfavourable (2.26e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavourable (2.60e-6)"	"unprognostic (1.09e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.60e-1)"	54.1	45.0	46.8	66.0	85.5	111.5	120.1	33.3	77.9	74.5	60.0	21.4	43.0	37.3	66.0	57.8	68.3	61.4	51.2	47.1	57.0	32.7	71.1	172.7	43.9	84.3	42.4	68.3	167.1	88.9	20.7	53.7	57.1	52.1	57.7	52.5	25.3	70.5	46.9	101.9	69.1	52.5	46.3	40.4	77.1	58.9	48.6	36.4	62.8	64.0	144.0	82.1	52.1	71.1	194.8	130.9	42.2	62.9	122.8	253.3	267.6	104.8	61.0	66.9	111.2	93.4	178.5	127.9	82.7	95.2	90.9	57.6	113.8	119.1	146.9	139.9	78.9	99.7	96.6	113.1	106.3	124.5	111.8	135.3	65.6	152.2	135.9	201.7	92.7	160.5	225.1	61.0	166.4	123.2	120.6	134.9	103.8	82.1	117.9	243.0	160.7	78.2	112.5	170.5	173.6	102.8	100.4	88.5	70.2	56.8	247.2	184.4	109.9	172.3	117.3	83.4	126.9	74.3	140.0	121.5	84.2	95.5	119.3	171.7	83.0	42.2	62.9	24.1	129.3	59.1	183.5	194.8	197.3	154.8	91.1	179.3	253.3	206.8	14.4	122.8	52.5	130.9	120.7	267.6	46.8	85.5	33.3	77.9	57.0	32.7	42.4	68.3	52.1	36.4
RPS27L		ENSG00000185088	"Ribosomal protein S27 like"	Q71UM5	15	63125872-63158021	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066851			Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA066851: "	"unprognostic (4.62e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.38e-1)"	"prognostic favourable (9.08e-6)"	"unprognostic (1.75e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.98e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.19e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.97e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.97e-3)"	"unprognostic (5.10e-3)"	46.8	64.2	21.3	19.8	29.7	18.2	53.6	16.3	23.4	29.4	58.5	15.5	30.4	46.0	30.2	49.3	40.4	27.0	38.3	47.1	22.8	22.2	61.0	75.2	31.7	23.4	32.6	19.2	26.5	65.9	19.2	38.8	35.6	43.9	56.2	55.3	18.3	99.8	46.0	47.1	18.1	80.4	54.8	39.9	28.2	41.9	15.7	27.3	19.4	53.9	25.7	19.8	55.0	36.3	34.5	30.9	51.5	47.6	27.2	75.4	38.3	17.1	48.0	43.5	11.7	63.7	75.5	43.6	54.2	38.7	11.9	29.2	8.8	23.9	16.1	19.4	51.8	6.6	14.7	26.7	20.1	11.9	19.9	13.3	40.5	62.7	73.4	10.5	36.9	59.0	35.9	26.9	20.5	67.5	12.2	16.2	99.3	23.7	13.5	16.5	12.8	14.0	10.6	20.9	18.2	33.5	34.7	6.3	9.6	19.7	8.3	38.3	18.4	24.5	71.4	63.3	59.6	13.6	24.0	18.3	15.6	14.3	67.1	29.2	57.0	51.5	34.3	40.0	27.5	35.9	33.9	34.5	41.6	32.0	30.9	26.9	32.9	33.1	11.4	27.2	47.6	30.8	75.4	38.3	21.3	29.7	16.3	23.4	22.8	22.2	32.6	19.2	43.9	27.3
RPS3A	"MFTL, S3A"	ENSG00000145425	"Ribosomal protein S3A"	P61247	4	151099573-151104652	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	Differentiation	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 440.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047100, HPA053454"	Approved		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"			63000	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA047100: AB_2679931, HPA053454: AB_2682156"	"unprognostic (6.24e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.46e-2)"	"prognostic unfavourable (6.56e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.81e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.39e-1)"	71.7	46.9	48.4	69.2	47.7	124.7	160.3	40.4	43.5	114.1	98.4	30.4	61.9	45.0	75.3	84.4	142.8	73.3	53.9	51.1	36.8	33.3	72.8	94.2	79.4	102.5	42.6	43.5	179.5	143.8	18.1	49.3	70.5	38.0	113.3	62.4	39.0	113.8	48.5	116.8	97.1	73.5	62.0	43.1	94.2	64.2	61.9	30.7	120.4	126.8	111.6	90.6	111.4	86.3	211.6	187.7	44.3	92.8	142.9	282.7	440.7	79.4	58.5	111.6	109.6	143.6	281.1	113.9	84.8	130.9	120.2	74.4	113.0	116.2	360.7	42.4	92.4	52.8	113.1	141.5	114.2	79.4	109.4	77.9	72.3	130.5	166.3	184.8	80.8	208.5	292.1	73.9	196.6	142.5	125.2	188.9	142.6	118.7	199.5	219.6	104.7	45.3	146.2	108.9	120.6	139.1	96.6	107.3	106.2	38.1	139.5	186.6	93.3	224.7	86.5	58.8	77.8	64.8	93.2	146.9	236.3	220.8	75.5	135.0	69.6	44.3	92.8	27.2	120.6	74.5	203.9	211.6	203.1	157.9	156.5	185.7	282.7	226.9	15.1	142.9	62.1	187.7	145.5	440.7	48.4	47.7	40.4	43.5	36.8	33.3	42.6	43.5	38.0	30.7
RPS6KA3	"CLS, HU-3, MRX19, RSK, RSK2"	ENSG00000177189	"Ribosomal protein S6 kinase A3"	P51812	X	20149911-20267519	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 67.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003221, CAB003853, CAB013520"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"CAB003853: AB_562343, CAB013520: AB_2533378, HPA003221: AB_1853553"	"unprognostic (1.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-1)"	19.7	12.5	9.9	23.0	12.5	8.2	16.5	15.2	12.1	11.4	23.2	4.4	22.1	13.7	12.4	10.1	13.6	12.7	15.7	21.3	9.7	8.8	14.1	25.8	21.6	34.0	9.9	10.0	12.7	14.0	36.6	9.8	11.0	10.2	14.5	18.8	7.7	14.3	11.3	45.2	11.7	23.7	16.1	11.7	25.8	11.8	4.8	9.7	29.4	13.5	15.0	18.2	20.3	19.0	4.2	8.6	12.5	6.9	8.3	11.3	2.7	12.6	22.2	8.4	4.3	8.2	14.5	2.5	11.0	16.8	8.2	11.3	25.1	16.4	8.3	3.8	11.5	9.0	9.6	9.3	15.3	7.0	7.6	9.8	14.0	67.5	8.4	19.0	10.2	9.2	7.5	12.9	16.3	29.8	6.4	23.9	8.6	6.0	12.3	5.8	6.0	13.4	6.6	17.8	9.6	7.1	10.6	3.9	3.8	14.8	4.5	16.0	0.0	5.7	16.6	9.0	6.3	28.5	6.2	19.1	11.6	9.3	17.0	9.5	21.2	12.5	4.7	9.5	6.3	6.9	11.3	2.9	7.3	6.9	7.0	4.2	5.0	6.0	7.5	8.3	6.9	8.6	3.5	2.7	9.9	12.5	15.2	12.1	9.7	8.8	9.9	10.0	10.2	9.7
RPS6KA6	RSK4	ENSG00000072133	"Ribosomal protein S6 kinase A6"	Q9UK32	X	84058346-84187907	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 20.7"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 10.8;PC-3: 11.7;RH-30: 14.4;SH-SY5Y: 11.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002852, HPA003904"	Uncertain		Supported	Nucleoplasm,Nucleoli,Mitochondria				"Nucleoplasm, Mitochondria"	Nucleoli	"HPA002852: AB_1079854, HPA003904: AB_1079853"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.12e-9)"	"unprognostic (4.44e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.49e-3)"	0.7	2.9	5.9	1.0	12.2	0.0	2.3	4.7	5.1	3.1	4.5	1.1	20.7	1.7	2.7	4.0	1.5	4.0	1.9	1.2	5.1	2.9	9.2	0.9	0.8	0.2	1.5	3.3	4.9	3.4	13.5	9.1	0.5	4.4	4.3	3.7	1.5	3.0	15.0	1.4	2.3	2.0	1.7	1.0	0.6	2.4	2.6	2.7	0.8	14.5	0.9	0.6	3.3	2.3	1.2	0.8	2.4	0.5	0.7	2.8	0.1	0.0	3.6	3.5	0.0	3.4	3.4	0.0	7.5	4.0	3.4	2.8	2.7	3.0	0.0	0.0	4.1	0.1	9.0	6.0	7.9	0.0	4.5	0.0	0.1	0.0	3.0	0.0	0.0	1.9	0.0	0.0	3.7	0.8	0.0	0.1	2.7	0.0	1.3	0.1	10.8	11.7	0.0	14.4	0.0	0.5	8.3	0.0	11.5	0.0	4.2	0.0	1.9	0.0	0.0	0.1	4.3	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	2.4	0.4	0.5	0.5	0.3	0.4	1.2	0.4	0.7	0.8	0.6	0.4	0.4	1.1	0.7	0.5	0.4	2.8	0.1	5.9	12.2	4.7	5.1	5.1	2.9	1.5	3.3	4.4	2.7
RRN3	"DKFZp566E104, TIF-IA"	ENSG00000085721	"RRN3 homolog, RNA polymerase I transcription factor"	Q9NYV6	16	15060022-15094317	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049837	Supported		Supported	Nucleoli				Nucleoli		"HPA049837: "	"unprognostic (1.83e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.74e-3)"	"unprognostic (3.67e-2)"	"unprognostic (4.50e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.25e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.27e-1)"	7.8	6.0	4.3	4.0	5.7	10.0	7.2	9.2	6.3	4.9	5.1			5.0	6.3	5.4	4.5	5.9	4.7	5.5	3.9	5.0	5.5	10.1	4.3	5.9	3.7		8.4	5.8	8.9	5.8	4.9		6.6	6.5		4.6	4.8	15.2	5.3	5.0	5.1	3.9	6.2	5.3	4.9			6.2		6.3	6.6	4.9	10.7	8.2	12.3	7.0	10.0	14.2	9.5	7.6	10.2	8.0	6.8	9.5	8.2	5.8	9.7	6.5	9.5	9.1	9.4	11.2	13.5	15.5	8.6	7.5	14.9	9.9	13.8	10.8	10.1	29.6	13.6	18.0	13.8	11.0	34.6	8.5	13.7	13.4	15.2	6.7	8.2	11.7	13.1	12.0	10.6	14.1	9.0	8.5	23.3	11.1	14.9	7.9	10.0	16.9	11.9	10.4	12.3	10.7	15.9	9.9	6.8	11.3	5.3	7.9	9.8	9.4	13.4	19.0	6.7	13.3	14.5	12.3	6.4	5.9	11.2	6.6	13.3	10.7	9.8	11.0	8.2	7.7	14.2	11.0	1.0	10.0	7.0	5.2	9.4	9.5										
RRNAD1	"C1orf66, CGI-41, METTL25B"	ENSG00000143303	"Ribosomal RNA adenine dimethylase domain containing 1"	Q96FB5	1	156728442-156736960	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047426	Approved		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA047426: "	"unprognostic (2.12e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (5.60e-5)"	"unprognostic (2.00e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.03e-3)"	14.1	19.4	12.4	22.6	19.0	8.7	19.1	15.3	18.8	17.6	25.7	20.8	31.2	22.5	20.3	22.9	18.4	24.4	20.2	12.5	13.3	10.9	15.9	25.8	14.5	14.4	19.9	14.5	24.5	29.2	24.3	18.8	20.5	16.1	21.8	14.8	20.2	22.5	24.5	21.9	23.9	26.6	12.9	14.7	18.5	19.3	25.9	17.7	11.9	30.3	13.5	15.9	21.7	27.9	4.9	5.9	7.0	4.0	6.5	8.6	2.9	5.9	11.8	8.7	8.5	23.6	10.8	13.3	4.5	13.8	7.8	5.9	6.3	27.5	10.2	13.5	7.1	25.5	12.2	10.6	3.1	20.1	10.2	6.1	11.1	4.7	14.8	9.0	16.8	16.7	20.3	7.7	14.8	6.5	14.6	22.9	4.1	14.4	4.6	10.7	10.1	3.6	7.6	5.8	23.5	9.2	6.4	11.4	16.4	8.0	16.4	9.7	21.7	19.5	6.2	4.8	6.0	7.5	6.0	26.8	26.2	12.5	5.4	10.2	5.8	6.7	3.3	4.7	6.8	2.5	6.9	3.4	6.6	4.8	5.9	4.9	5.3	6.0	7.0	6.5	4.0	2.2	8.6	2.9	12.4	19.0	15.3	18.8	13.3	10.9	19.9	14.5	16.1	17.7
RRP1	"D21S2056E, NNP-1, Nop52, RRP1A"	ENSG00000160214	"Ribosomal RNA processing 1"	P56182	21	43789513-43805293	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016818, HPA018166"	Approved		Enhanced	Nucleoli				Nucleoli		"HPA016818: AB_1854561, HPA018166: AB_1854562"	"unprognostic (5.38e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.53e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.69e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.63e-3)"	"unprognostic (9.42e-2)"	"unprognostic (6.94e-2)"	"unprognostic (5.25e-2)"	"prognostic unfavourable (6.29e-5)"	"unprognostic (1.13e-1)"	"unprognostic (9.21e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.88e-1)"	12.0	10.6	12.1	12.8	15.6	9.7	9.4	11.4	20.0	8.6	8.9	18.0	6.0	10.6	10.0	9.1	19.8	10.9	9.3	8.5	14.3	11.3	8.3	16.6	7.3	15.1	16.3	14.4	14.8	16.6	9.4	7.6	10.3	14.9	9.4	6.7	9.9	14.7	9.8	15.6	20.1	9.7	7.4	11.5	11.1	11.9	13.8	15.6	10.5	9.6	11.4	14.7	8.9	9.8	10.9	8.8	1.5	4.3	10.4	12.3	6.0	16.2	8.8	6.0	10.1	3.3	3.7	11.7	8.3	4.9	11.6	8.2	22.9	9.7	15.7	6.9	4.5	8.3	11.2	8.1	5.3	7.8	21.9	22.4	8.1	14.0	6.8	14.1	8.1	5.0	7.6	11.6	9.2	6.1	29.2	11.8	5.4	19.2	12.2	19.4	20.2	13.1	22.7	4.8	28.9	5.9	9.0	14.3	8.6	8.7	9.3	10.9	9.8	9.7	7.0	7.8	8.8	8.2	14.4	14.8	12.7	16.3	11.8	23.7	10.1	0.1	4.3	1.5	9.7	4.0	12.3	9.6	10.1	9.9	8.8	10.9	11.2	7.4	0.9	10.4	1.9	7.5	5.8	6.0	12.1	15.6	11.4	20.0	14.3	11.3	16.3	14.4	14.9	15.6
RRP12	KIAA0690	ENSG00000052749	"Ribosomal RNA processing 12 homolog"	Q5JTH9	10	97356358-97426076	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 62.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 19.3"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049945, HPA074403"			Supported	"Nucleoli,Vesicles,Plasma membrane,Cytosol"				Nucleoli	"Vesicles, Plasma membrane, Cytosol"	"HPA049945: , HPA074403: "	"unprognostic (2.79e-1)"	"unprognostic (7.65e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (3.12e-8)"	"unprognostic (2.64e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavourable (2.54e-5)"	"unprognostic (2.58e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.81e-2)"	"unprognostic (6.99e-3)"	7.1	8.4	5.9	7.4	11.9	62.6	4.6	3.8	15.7	4.1	4.0	5.4	2.9	5.2	6.4	3.9	7.1	6.4	6.4	8.4	4.4	7.2	4.4	9.3	5.6	6.0	5.9	6.1	6.0	16.4	9.6	10.6	3.9	9.6	5.5	3.6	4.1	6.6	3.9	31.7	8.2	3.8	5.3	3.2	7.1	5.3	13.9	6.1	4.6	4.9	7.2	5.4	4.2	4.3	3.4	4.3	19.3	11.1	1.2	2.4	3.7	15.8	21.1	5.6	12.1	4.3	5.1	12.4	10.0	6.0	10.4	8.1	22.9	14.7	17.4	13.0	6.3	20.4	15.4	11.6	7.0	9.4	18.5	13.4	7.9	17.8	7.2	20.9	17.7	5.3	16.4	25.6	23.7	5.8	19.2	11.7	5.9	20.5	14.1	13.5	24.2	14.3	15.6	7.7	17.2	7.2	8.8	7.6	16.2	8.0	7.7	10.0	18.6	10.9	7.6	7.0	12.0	15.6	31.5	23.9	20.8	20.5	10.0	26.9	7.4	0.2	7.3	4.6	2.0	9.3	2.4	2.9	1.2	1.6	4.3	3.4	1.9	2.1	19.3	1.2	11.1	3.6	0.8	3.7	5.9	11.9	3.8	15.7	4.4	7.2	5.9	6.1	9.6	6.1
RRP15	"CGI-115, KIAA0507"	ENSG00000067533	"Ribosomal RNA processing 15 homolog"	Q9Y3B9	1	218285287-218337983	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024639	Approved		Approved	Nucleoplasm,Nucleoli,Mitochondria				Nucleoli	"Nucleoplasm, Mitochondria"	"HPA024639: AB_1844368"	"unprognostic (2.68e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.33e-2)"	"prognostic unfavourable (4.26e-5)"	"unprognostic (7.87e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.65e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.77e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.23e-2)"	10.3	7.2	8.9	8.0	9.9	8.5	11.6	11.6	10.4	8.4	8.0	5.5	5.4	5.3	10.1	7.1	8.7	8.9	5.0	11.4	8.6	6.3	9.3	10.7	7.5	8.3	8.0	5.0	9.8	8.4	12.1	10.0	8.7	8.6	7.8	7.2	5.8	7.9	6.4	33.5	8.5	6.8	11.8	9.4	10.3	7.6	6.3	9.0	6.5	8.9	10.5	8.3	8.5	9.4	5.1	3.3	0.6	2.4	3.1	5.7	1.6	8.0	6.1	6.8	4.9	5.0	6.9	5.9	8.3	6.3	8.7	6.3	11.8	7.5	11.7	11.4	6.4	7.4	11.6	11.0	14.6	4.7	8.7	9.1	5.7	6.5	10.3	14.0	4.9	4.7	6.8	11.3	15.2	5.6	18.5	3.8	9.7	7.4	9.2	6.8	13.5	12.7	6.5	4.2	11.5	7.0	7.5	7.9	11.5	7.1	13.2	12.2	9.5	10.1	7.8	7.1	6.5	12.4	15.3	4.7	7.2	12.2	8.0	6.9	11.1	0.6	1.6	0.2	3.5	2.4	4.8	4.7	4.2	2.9	2.4	5.1	5.7	5.5	0.5	3.1	2.1	3.3	2.5	1.6	8.9	9.9	11.6	10.4	8.6	6.3	8.0	5.0	8.6	9.0
RRP1B	"KIAA0179, Nnp1, PPP1R136, RRP1"	ENSG00000160208	"Ribosomal RNA processing 1B"	Q14684	21	43659548-43696079	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA017893, HPA020324"	Supported		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA017893: AB_1852274, HPA020324: AB_1852276"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.03e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.08e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (2.95e-9)"	"unprognostic (1.45e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.24e-2)"	12.7	10.3	10.7	20.0	13.7	7.6	14.5	13.9	12.5	13.1	11.1	11.5	9.4	9.5	16.1	9.2	15.7	14.0	12.2	8.4	9.5	8.6	7.5	17.7	10.4	22.8	13.1	7.5	20.0	20.6	11.8	11.4	8.4	10.3	11.3	10.9	15.0	13.9	12.8	21.6	14.1	11.1	12.9	9.9	16.9	11.8	32.5	12.6	25.6	9.6	12.6	20.5	13.5	14.1	6.0	3.2	2.1	2.7	5.8	9.8	5.3	16.6	9.9	10.6	15.9	6.9	7.4	8.7	8.8	6.3	9.8	8.1	22.4	7.3	32.7	5.8	6.9	7.5	26.0	15.2	11.7	11.0	20.7	19.3	11.4	14.0	9.5	30.1	7.7	7.6	9.7	11.7	13.6	10.9	30.2	9.6	8.6	8.7	23.9	9.1	36.0	11.0	31.5	10.7	22.9	7.1	8.0	21.0	11.2	16.5	12.2	12.2	8.0	9.4	9.6	3.0	9.6	7.9	16.0	13.1	16.7	39.1	9.6	32.5	9.9	2.1	2.6	0.7	7.2	2.7	8.5	6.0	9.1	8.6	3.2	5.3	8.6	9.8	0.1	5.8	2.3	2.6	7.0	5.3	10.7	13.7	13.9	12.5	9.5	8.6	13.1	7.5	10.3	12.6
RRP36	"C6orf153, dJ20C7.4"	ENSG00000124541	"Ribosomal RNA processing 36"	Q96EU6	6	43021645-43034156	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029904, HPA029905"	Uncertain		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA029904: AB_10611817, HPA029905: "	"unprognostic (1.76e-1)"	"unprognostic (4.47e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (5.95e-4)"	"unprognostic (2.61e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavourable (2.48e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.09e-2)"	25.0	29.7	21.0	24.9	27.2	23.3	57.7	18.0	42.1	21.3	22.4	16.0	24.9	19.4	23.8	24.7	31.9	20.6	20.1	31.3	22.7	21.4	25.2	32.7	24.1	46.5	21.1	28.0	17.3	37.4	37.0	28.8	23.4	27.3	24.6	23.8	19.5	23.5	36.4	61.9	28.4	21.4	28.3	28.5	29.4	25.7	23.9	15.8	25.0	22.6	30.9	31.8	23.7	28.2	6.5	9.7	4.0	4.6	3.1	7.7	1.2	42.6	24.1	24.0	35.0	25.9	24.3	20.2	33.8	30.7	43.4	42.7	43.7	18.6	19.8	27.6	35.1	22.9	40.0	41.0	48.1	25.0	40.7	31.7	26.7	46.6	30.1	26.3	24.7	24.5	25.1	51.8	22.2	35.2	38.3	21.6	40.1	45.0	31.6	28.8	26.6	25.0	29.9	23.7	22.8	26.5	40.3	30.7	26.9	24.9	22.9	38.6	31.5	32.5	28.2	40.1	30.6	26.4	53.0	20.3	30.5	52.8	17.5	33.3	37.2	3.9	3.6	3.1	5.9	4.6	4.7	6.5	4.2	7.0	3.7	2.6	3.9	7.7	4.0	3.1	3.6	9.7	2.1	1.2	21.0	27.2	18.0	42.1	22.7	21.4	21.1	28.0	27.3	15.8
RRP7A	"CGI-96, Rrp7"	ENSG00000189306	"Ribosomal RNA processing 7 homolog A"	Q9Y3A4	22	42509968-42519802	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001586, HPA046768"	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"				"Nucleoplasm, Nucleoli"	"Cell Junctions"	"HPA001586: AB_1078506, HPA046768: "	"unprognostic (8.46e-2)"	"unprognostic (3.30e-3)"	"unprognostic (5.96e-2)"	"unprognostic (3.21e-3)"	"unprognostic (9.71e-3)"	"unprognostic (2.92e-1)"	"prognostic unfavourable (1.21e-5)"	"unprognostic (6.73e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.22e-2)"	"unprognostic (9.53e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.71e-2)"	10.4	12.9	19.9	15.4	26.6	16.5	13.5	18.5	20.9	12.8	12.2	15.1	9.4	10.2	12.0	47.3	15.1	18.9	12.0	11.1	17.5	14.8	14.0	18.1	11.3	21.5	14.8	9.3	21.2	12.0	16.6	10.3	17.7	17.4	17.8	10.8	12.6	15.2	14.6	13.5	14.9	13.3	11.9	11.7	15.6	12.0	11.2	18.6	17.4	11.6	8.7	16.4	10.7	11.0	26.2	30.5	17.4	27.5	15.2	18.4	20.3	12.8	18.1	10.0	11.7	6.4	4.3	20.2	11.0	6.6	14.2	12.1	23.1	7.4	21.4	5.6	7.8	14.3	11.4	15.2	6.1	5.4	23.4	11.7	12.7	12.4	6.1	27.9	10.1	5.4	7.7	19.2	9.8	8.6	16.4	6.2	8.4	26.1	26.8	11.4	8.3	13.2	46.7	10.2	9.5	7.4	15.8	5.4	3.9	8.0	23.2	10.6	9.5	12.6	6.4	10.9	14.0	8.3	11.1	9.5	7.1	25.3	9.0	10.7	15.5	10.0	23.5	17.4	18.4	26.4	17.7	20.5	16.1	16.8	18.1	26.2	17.7	16.5	4.7	15.2	27.5	30.5	13.5	20.3	19.9	26.6	18.5	20.9	17.5	14.8	14.8	9.3	17.4	18.6
RRP8	"KIAA0409, NML"	ENSG00000132275	"Ribosomal RNA processing 8"	O43159	11	6595075-6603620	"Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038487, HPA057562"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA038487: AB_10672518, HPA057562: "	"unprognostic (9.01e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavourable (3.10e-7)"	"unprognostic (4.64e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.23e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.87e-2)"	13.8	11.9	13.9	15.8	14.8	32.1	17.9	18.1	15.3	15.9	24.9	16.1	10.5	14.0	15.5	21.3	13.8	11.9	15.4	16.2	16.0	10.3	13.3	24.7	14.3	16.0	18.4	13.6	12.4	12.7	12.0	12.3	12.8	14.2	19.8	14.4	11.8	10.9	19.7	18.6	15.5	12.8	19.5	11.0	17.7	15.1	12.3	18.6	11.8	14.2	9.7	16.6	20.2	13.9	13.3	14.4	20.3	12.0	14.4	13.8	10.2	10.2	10.2	4.1	5.3	8.6	7.5	5.8	5.3	6.6	12.3	11.6	10.5	12.0	14.4	5.2	5.0	10.4	11.7	9.3	13.1	6.9	16.8	6.8	12.3	11.8	9.8	12.3	9.5	6.4	12.2	5.8	10.7	12.6	13.4	8.4	9.7	12.7	11.9	18.4	10.1	9.3	10.7	3.3	3.2	11.5	8.2	6.3	7.4	7.6	15.5	8.6	8.4	10.8	6.5	11.7	5.4	11.3	10.2	9.4	8.5	13.7	9.9	12.4	7.5	20.3	11.0	10.7	13.7	11.8	13.2	10.9	13.5	12.6	14.4	13.3	13.3	13.8	4.4	14.4	12.0	11.0	12.6	10.2	13.9	14.8	18.1	15.3	16.0	10.3	18.4	13.6	14.2	18.6
RRS1	KIAA0112	ENSG00000179041	"Ribosome biogenesis regulator homolog"	Q15050	8	66429028-66430733	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055549, HPA060937"	Approved		Enhanced	Nucleoli				Nucleoli		"HPA055549: AB_2682846, HPA060937: AB_2684390"	"unprognostic (7.68e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.72e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.84e-3)"	"unprognostic (4.93e-3)"	"unprognostic (2.82e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.46e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.29e-2)"	"unprognostic (8.35e-3)"	12.0	11.2	8.7	14.1	12.4	7.0	9.9	8.5	9.8	8.5	9.6	7.1	7.2	10.3	13.4	6.6	12.2	11.2	9.8	9.6	8.5	7.5	9.5	18.0	6.7	14.6	11.5	7.9	19.0	41.4	8.3	5.8	7.6	11.1	9.0	7.1	6.4	9.8	9.7	31.7	10.2	7.7	14.0	7.8	9.5	12.0	4.9	9.9	8.6	7.5	19.2	11.5	13.7	13.1	6.8	15.2	0.6	11.8	11.2	17.8	6.8	22.7	28.8	5.9	12.4	6.4	5.2	9.6	14.4	6.4	11.2	8.3	12.8	15.2	31.0	5.0	7.6	21.4	14.5	16.4	12.4	17.0	24.4	24.6	8.7	22.8	9.5	14.6	13.1	6.8	13.3	12.3	16.4	7.2	21.5	13.2	8.1	26.4	29.0	26.6	38.5	33.9	6.2	7.6	12.9	15.6	18.8	8.1	17.9	7.0	11.7	16.0	20.1	13.0	12.4	20.8	18.6	17.4	33.1	23.7	21.2	23.9	9.7	23.1	14.0	0.0	8.9	0.6	10.0	11.8	17.8	6.8	12.7	11.7	15.2	6.7	11.9	13.6	0.3	11.2	7.2	7.1	9.1	6.8	8.7	12.4	8.5	9.8	8.5	7.5	11.5	7.9	11.1	9.9
RSL1D1	"CSIG, DKFZP564M182, L12, PBK1, UTP30"	ENSG00000171490	"Ribosomal L1 domain containing 1"	O76021	16	11833850-11851585	"Predicted intracellular proteins, Ribosomal proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043483	Supported		Enhanced	Nucleoli				Nucleoli		"HPA043483: "	"unprognostic (4.46e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.88e-2)"	"unprognostic (7.77e-2)"	"prognostic unfavourable (2.95e-4)"	"prognostic unfavourable (1.38e-4)"	"unprognostic (6.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (3.24e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.68e-2)"	31.5	16.8	11.6	15.8	15.0	18.6	36.1	16.3	16.2	26.6	21.5	11.5	12.6	14.9	20.6	14.0	28.6	21.8	14.2	17.3	11.2	11.4	17.9	24.0	15.9	29.4	14.2	11.7	58.1	32.7	14.9	20.7	22.0	15.0	30.2	18.1	14.7	18.1	17.0	66.9	21.2	23.2	25.6	15.7	25.2	17.8	19.9	12.6	25.2	27.8	19.8	28.7	37.8	20.8	32.2	31.0	3.0	30.2	28.5	49.0	53.4	21.0	20.1	16.9	21.1	22.2	40.1	20.1	19.7	22.1	25.6	26.2	19.4	20.0	53.1	32.7	16.3	15.0	45.2	29.9	41.7	20.7	24.3	26.1	19.8	44.2	41.5	37.0	17.5	29.2	42.5	26.4	61.5	24.8	45.8	24.7	31.3	23.4	28.9	21.5	43.2	20.9	30.2	31.1	56.2	22.9	18.6	23.7	19.4	37.1	28.3	26.3	24.4	28.8	15.1	17.1	19.1	16.1	28.3	19.9	28.5	61.9	18.5	39.0	22.7	3.0	30.2	2.9	18.2	28.6	33.2	32.2	33.6	23.4	31.0	27.0	49.0	35.0	1.6	28.5	26.1	19.1	23.4	53.4	11.6	15.0	16.3	16.2	11.2	11.4	14.2	11.7	15.0	12.6
RSL24D1	"C15orf15, HRP-L30-iso, L30, RPL24, RPL24L"	ENSG00000137876	"Ribosomal L24 domain containing 1"	Q9UHA3	15	55180806-55197067	"Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA062724, HPA063392"	Enhanced		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA062724: AB_2684850, HPA063392: AB_2685002"	"unprognostic (3.40e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.83e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.56e-3)"	"unprognostic (1.34e-1)"	"unprognostic (6.19e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.44e-1)"	"unprognostic (4.54e-2)"	"unprognostic (4.95e-1)"	"unprognostic (2.41e-1)"	27.7	24.3	26.7	23.4	28.8	76.1	47.8	35.7	29.9	40.6	32.2	10.0	25.6	18.1	34.5	26.6	34.2	26.4	21.4	25.3	25.1	25.3	24.3	26.7	27.0	35.8	25.4	25.8	54.7	37.8	15.0	23.2	22.4	24.1	44.3	20.5	11.2	25.8	21.3	47.2	19.3	21.1	50.4	27.5	28.6	28.8	24.2	20.6	39.5	43.1	36.9	27.4	61.9	49.6	29.1	27.0	11.4	24.1	22.7	45.1	47.7	15.8	16.2	17.8	23.4	14.0	26.4	14.4	16.9	18.9	14.2	18.1	15.4	9.8	49.6	15.2	12.1	19.5	23.4	19.4	19.0	24.1	14.5	25.3	13.0	19.1	32.2	47.7	16.6	22.3	41.3	14.2	41.2	17.6	47.9	36.0	16.4	16.2	26.1	42.1	22.0	14.5	20.8	22.3	74.7	21.2	14.8	25.3	30.3	7.8	21.9	54.5	21.0	70.7	12.2	11.7	13.7	13.6	24.0	34.7	53.0	49.3	18.2	47.3	19.5	11.4	23.8	11.4	19.6	23.4	31.1	29.1	29.5	24.3	27.0	22.5	45.1	34.0	6.0	22.7	24.1	21.1	32.4	47.7	26.7	28.8	35.7	29.9	25.1	25.3	25.4	25.8	24.1	20.6
RSPH14	RTDR1	ENSG00000100218	"Radial spoke head 14 homolog"	Q9UHP6	22	23059415-23145021	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 15.3;testis: 24.8"	"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 7.0;SCLC-21H: 4.6;U-266/70: 8.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 10.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA018420, HPA050425"	Approved		Uncertain	Nucleoli				Nucleoli		"HPA018420: AB_1856496, HPA050425: "	"unprognostic (8.81e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.80e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-2)"	"unprognostic (8.31e-2)"	"unprognostic (7.28e-2)"	"prognostic favourable (4.04e-4)"	"unprognostic (5.18e-2)"	"unprognostic (4.40e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.73e-2)"	0.8	3.0	4.8	0.5	6.8	0.4	0.5	1.2	8.8	1.4	0.7	2.6	0.9	0.4	1.3	4.9	0.6	15.3	1.8	0.3	4.7	4.7	9.3	0.3	1.8	0.5	2.9	3.3	5.5	0.6	0.9	3.1	0.4	6.4	1.1	0.5	1.0	1.0	2.4	0.9	1.6	0.4	0.6	1.6	0.4	0.8	24.8	1.6	0.0	2.7	0.0	0.5	0.6	0.3	0.1	0.0	10.8	2.0	0.2	0.3	0.6	0.4	4.0	3.6	3.4	0.0	1.6	0.2	0.0	0.8	0.7	0.6	0.7	1.2	0.8	1.3	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.4	0.2	1.5	0.2	0.2	1.8	0.0	0.4	0.6	0.0	0.0	0.1	1.7	0.0	0.5	0.8	0.6	0.0	0.1	0.2	0.1	3.7	7.0	0.0	4.6	2.2	0.1	0.1	0.2	0.7	0.8	0.0	3.1	0.8	0.2	0.0	8.1	3.1	2.3	2.6	0.4	1.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.2	10.8	0.2	2.0	0.0	0.1	0.6	4.8	6.8	1.2	8.8	4.7	4.7	2.9	3.3	6.4	1.6
RTF2	"C20orf43, CDAO5, HSPC164, RTFDC1"	ENSG00000022277	"Replication termination factor 2"	Q9BY42	20	56468585-56519449	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053986	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA053986: "	"unprognostic (1.65e-1)"	"unprognostic (1.94e-3)"	"unprognostic (2.01e-1)"	"prognostic unfavourable (6.35e-4)"	"unprognostic (3.54e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavourable (1.31e-4)"	"unprognostic (8.90e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.98e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.58e-1)"	"unprognostic (8.48e-3)"	33.4	34.2	43.5	29.1	43.9	52.6	28.9	27.4	48.7	28.8	29.4	53.0	20.1	28.0	31.4	24.1	30.5	31.6	23.2	38.7	40.6	35.6	31.8	30.3	24.2	29.7	49.6	35.7	35.2	27.5	26.0	29.3	30.5	46.6	28.5	26.0	26.0	25.8	31.7	74.6	27.9	29.8	34.1	59.7	30.2	25.3	29.1	45.2	31.4	29.1	28.9	34.4	29.0	23.9	20.0	35.1	91.6	31.8	29.4	23.0	33.2	28.5	20.5	20.8	20.3	26.0	23.3	19.4	44.6	33.7	64.4	37.0	41.9	27.8	24.5	52.9	36.1	32.1	20.8	34.3	44.6	11.4	16.1	30.6	22.4	32.3	29.9	43.5	42.3	20.6	35.7	28.7	25.0	27.6	23.6	25.6	31.5	54.5	36.4	37.1	15.4	39.1	25.0	56.7	32.2	26.8	18.8	21.5	23.3	46.8	79.4	41.9	36.8	41.6	29.5	55.1	35.7	29.9	36.0	21.4	24.6	34.8	43.4	29.6	30.0	39.2	31.8	84.1	20.9	29.6	17.6	18.6	18.0	20.3	35.1	20.0	20.5	18.8	91.6	29.4	28.8	29.9	23.0	33.2	43.5	43.9	27.4	48.7	40.6	35.6	49.6	35.7	46.6	45.2
S100A13		ENSG00000189171	"S100 calcium binding protein A13"	Q99584	1	153618787-153631360	"Predicted intracellular proteins, Predicted secreted proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 99.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 19.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 8.4;NK-cells: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019592, CAB025494"	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"	"Secreted in other tissues"			"Plasma membrane, Cytosol"	"Nucleoplasm, Nucleoli"	"CAB025494: , HPA019592: AB_10601499"	"unprognostic (1.50e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.77e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.75e-3)"	"unprognostic (9.93e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.83e-3)"	"prognostic unfavourable (1.97e-4)"	"unprognostic (3.43e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.72e-2)"	38.2	20.9	49.6	13.8	48.3	1.2	61.8	11.5	28.2	39.1	32.3	25.0	13.9	9.4	23.5	25.0	19.9	34.5	32.0	56.3	30.3	32.0	28.0	20.2	23.3	12.7	54.2	32.7	29.9	13.9	45.9	9.7	21.6	37.7	23.0	19.3	21.1	19.8	21.7	73.8	14.1	13.7	27.2	38.9	13.7	11.9	10.3	28.5	2.4	79.0	28.2	14.6	21.1	16.0	2.6	8.4	3.0	1.5	19.4	0.9	0.8	22.1	18.6	21.5	13.6	19.0	55.8	7.7	30.8	48.9	18.7	21.5	18.0	24.8	0.5	58.6	52.3	21.2	8.9	19.2	16.5	0.0	8.3	1.4	23.3	15.3	12.6	0.6	4.8	44.8	7.3	16.7	18.1	42.2	7.1	0.0	58.0	78.7	0.0	0.4	17.3	56.1	3.5	22.3	0.1	99.4	17.0	6.6	0.2	66.0	34.0	66.6	27.7	0.8	59.7	12.9	7.2	17.2	37.1	0.2	0.5	1.0	23.1	0.3	7.5	3.0	1.5	0.1	0.3	0.7	0.6	2.6	0.3	0.2	5.0	1.6	0.5	0.3	0.2	19.4	0.9	8.4	0.9	0.8	49.6	48.3	11.5	28.2	30.3	32.0	54.2	32.7	37.7	28.5
S100A2	"CAN19, S100L"	ENSG00000196754	"S100 calcium binding protein A2"	P29034	1	153561108-153567890	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 224.8;tongue: 246.5"	"Group enriched"	"Detected in some"	5	"HBEC3-KT: 656.0;RT4: 256.5"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 1229.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 11.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 11.9"					"Not detected"	"Not detected"			"CAB002600, CAB047340, HPA062451"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"			130000	"Nucleoplasm, Cytosol"	"Nucleoli, Plasma membrane"	"CAB002600: , CAB047340: , HPA062451: "	"unprognostic (8.47e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.21e-4)"	"unprognostic (9.00e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.23e-2)"	"prognostic unfavourable (2.04e-4)"	"unprognostic (3.52e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-1)"	0.4	0.0	0.4	0.5	0.4	0.0	2.1	0.4	0.5	16.9	0.4	0.4	0.9	0.0	1.8	1.9	224.8	0.5	0.4	0.4	0.4	0.0	16.6	0.4	1.6	0.4	0.4	0.4	0.4	0.4	0.0	0.5	0.6	0.6	3.3	0.0	0.4	23.3	2.1	0.7	27.5	0.4	1.5	0.5	0.4	0.0	0.5	0.4	0.7	1.0	246.5	48.4	36.2	43.8	0.5	2.6	11.9	0.6	0.0	2.9	0.7	24.8	0.2	0.0	0.0	0.3	0.1	0.0	0.3	0.3	0.2	0.2	0.0	0.8	0.0	13.2	0.5	61.7	0.0	656.0	0.3	0.1	0.1	0.1	1.7	0.1	0.1	0.0	0.0	0.2	87.4	0.7	99.7	0.4	0.0	0.0	1.4	0.1	0.0	0.0	0.0	4.8	0.0	15.6	0.0	15.5	256.5	0.5	0.0	1.0	0.1	0.2	0.1	0.1	0.1	0.3	21.7	2.9	8.4	0.0	0.0	0.1	0.8	0.0	0.7	11.9	0.5	0.0	2.9	0.0	1.8	0.5	2.0	1.6	0.4	0.0	0.6	0.5	5.0	0.0	0.6	2.6	1.8	0.7	0.4	0.4	0.4	0.5	0.4	0.0	0.4	0.4	0.6	0.4
SALL1	"Hsal1, TBS, ZNF794"	ENSG00000103449	"Spalt like transcription factor 1"	Q9NSC2	16	51135975-51151367	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	Deafness	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.9;kidney: 26.8;liver: 32.0"	"Cell line enhanced"	"Detected in some"		"AF22: 14.8;BJ hTERT+: 12.7;NTERA-2: 24.1;RPTEC TERT1: 20.4;U-87 MG: 23.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"olfactory region: 64.6"	"Low region specificity"	"Detected in many"			"HPA049829, HPA074673"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear speckles,Cytosol"				Nucleoplasm	"Nucleoli, Nuclear speckles, Cytosol"	"HPA049829: , HPA074673: "	"unprognostic (9.91e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.82e-6)"	"prognostic favourable (1.28e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.96e-1)"	"prognostic favourable (1.91e-7)"	"unprognostic (1.86e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.76e-1)"	0.8	0.7	12.2	1.2	14.5	0.7	0.9	1.7	18.9	16.1	3.1	31.9	0.0	1.6	17.8	1.5	0.8	10.4	1.1	1.2	13.6	5.5	26.8	32.0	0.6	0.6	21.8	9.1	5.2	1.6	0.9	4.3	4.3	17.6	1.3	3.2	0.0	0.9	2.3	0.6	0.7	1.4	9.4	19.7	0.7	3.0	2.2	19.4	0.0	23.7	0.0	0.6	2.2	4.8	1.0	1.9	2.3	3.1	0.1	1.1	1.1	0.0	0.8	14.8	0.1	0.4	0.3	0.0	4.9	12.7	0.3	0.7	0.0	0.0	0.0	5.7	6.9	0.0	9.2	0.0	0.4	0.0	5.6	0.0	0.0	8.9	0.3	0.0	4.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	0.0	1.8	0.9	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	23.5	0.0	4.9	0.6	3.1	2.3	0.7	2.0	0.7	1.0	1.0	0.9	1.9	0.8	0.6	0.6	1.8	0.1	1.5	1.9	1.1	1.1	12.2	14.5	1.7	10.3	13.6	5.5	21.8	9.1	17.6	19.4
SAMD15	"C14orf174, FAM15A, FLJ35963"	ENSG00000100583	"Sterile alpha motif domain containing 15"	Q9P1V8	14	77376689-77391497	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 29.1;testis: 22.1"	"Cell line enhanced"	"Detected in many"		"MCF7: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in many"			"HPA030673, HPA030677"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli"				"Nucleoplasm, Nuclear membrane, Nucleoli"		"HPA030673: AB_10600655, HPA030677: AB_10599938"	"unprognostic (1.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.38e-2)"	"unprognostic (3.70e-3)"	"unprognostic (5.20e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.83e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.53e-3)"	"unprognostic (6.87e-3)"	"unprognostic (9.90e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.76e-2)"	0.8	1.3	5.3	0.5	6.7	0.9	1.5	0.8	3.3	1.2	0.7	2.2	3.1	0.6	1.5	7.5	0.7	6.2	1.5	0.6	3.7	2.9	6.0	0.6	1.8	1.9	1.4	3.1	3.2	2.7	5.2	29.1	0.5	7.9	1.3	0.5	4.4	0.8	1.1	0.5	0.8	0.6	0.6	1.5	0.7	0.7	22.1	2.3	0.1	6.9	0.0	1.8	1.9	0.7	0.6	0.2	2.3	0.5	0.6	0.4	0.1	3.5	4.8	1.9	4.0	0.5	2.1	1.8	1.4	1.3	3.9	3.5	3.5	3.2	3.9	1.6	1.4	3.4	1.4	2.0	5.4	0.3	0.7	0.6	1.4	0.9	0.2	0.7	4.2	1.9	1.3	3.3	0.4	2.6	0.4	1.2	1.6	10.6	0.9	0.4	0.8	1.5	1.7	1.8	0.2	6.8	1.9	4.2	2.6	5.0	0.8	0.7	6.3	1.2	1.0	3.7	2.2	3.8	1.9	0.6	3.2	2.6	4.6	0.2	1.8	0.7	0.5	1.2	0.2	0.1	0.1	0.2	0.2	0.1	0.2	0.6	0.3	0.4	2.3	0.6	0.5	0.1	0.4	0.1	5.3	6.7	0.8	3.3	3.7	2.9	1.4	3.1	7.9	2.3
SAPCD2	"C9orf140, p42.3"	ENSG00000186193	"Suppressor APC domain containing 2"	Q86UD0	9	137062124-137070588	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.4"	"Cell line enhanced"	"Detected in many"		"MCF7: 38.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.7"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA044154	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				Cytosol	"Nucleoplasm, Nucleoli"	"HPA044154: AB_10959464"	"unprognostic (3.68e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.42e-8)"	"prognostic unfavourable (5.88e-4)"	"unprognostic (8.33e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.83e-7)"	"unprognostic (4.37e-3)"	"unprognostic (4.62e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.35e-2)"	1.0	0.4	11.5	10.5	7.0	3.3	2.6	1.4	14.4	2.5	6.2	10.1	0.0	7.6	1.0	0.4	7.8	0.8	5.4	0.4	9.6	7.5	1.2	0.4	2.7	4.7	8.0	3.8	0.3	0.8	0.3	0.4	1.8	5.4	5.4	3.5	0.0	7.3	0.4	0.4	5.4	7.7	1.0	7.0	2.7	4.6	1.5	2.7	9.2	0.6	3.5	10.0	1.0	1.9	0.5	0.8	0.5	1.7	0.0	0.4	0.4	16.4	8.9	3.5	10.5	0.1	0.2	19.0	2.7	1.8	2.9	1.3	16.9	7.6	17.2	8.9	1.3	23.5	11.1	3.1	0.6	11.9	12.8	7.5	9.9	18.9	0.0	8.5	13.1	0.0	0.5	1.0	1.9	4.7	10.4	7.8	0.8	38.9	2.4	23.1	6.6	20.4	26.4	13.5	19.2	3.6	4.8	18.5	10.9	10.5	29.4	4.0	23.7	16.3	3.0	2.6	9.1	8.0	13.4	2.7	7.8	8.3	6.2	10.2	8.4	0.2	1.7	0.0	0.0	0.5	0.4	0.5	0.3	0.0	0.8	0.2	0.1	0.0	0.5	0.0	0.8	0.2	0.3	0.4	11.5	7.0	1.4	6.1	9.6	7.5	8.0	3.8	5.4	2.7
SCML2		ENSG00000102098	"Scm polycomb group protein like 2"	Q9UQR0	X	18239314-18354727	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 20.0;REH: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"plasmacytoid DC: 7.0"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 7.0"					"Low region specificity"	"Detected in all"			"HPA001662, HPA064713"	Enhanced		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA001662: AB_1079879, HPA064713: "	"unprognostic (5.15e-2)"	"unprognostic (2.57e-2)"	"unprognostic (7.93e-2)"	"unprognostic (7.26e-5)"	"unprognostic (1.24e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.95e-5)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.15e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.35e-4)"	"unprognostic (3.30e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.31e-3)"	2.4	7.7	3.1	2.1	4.1	8.6	3.1	3.4	3.8	3.7	3.7	3.7	2.0	2.1	4.9	2.5	2.3	2.9	2.8	2.0	2.3	2.0	1.5	2.6	1.3	2.0	3.6	0.5	9.5	3.9	3.2	8.0	7.1	2.3	2.9	2.3	3.6	10.0	2.2	2.0	3.4	2.0	6.5	2.2	2.3	1.7	19.0	4.2	12.5	4.3	2.3	2.1	2.7	4.2	0.8	7.0	0.2	0.2	0.9	0.7	0.2	0.9	3.3	11.8	3.0	0.9	1.5	3.5	2.0	1.4	4.0	4.5	4.8	0.7	0.0	0.4	0.9	0.0	16.5	0.2	4.9	0.0	13.5	0.0	3.0	2.1	0.5	10.3	2.7	0.6	0.6	2.9	3.4	0.2	7.7	0.0	2.8	1.5	16.5	5.5	20.0	4.2	17.8	5.9	2.4	0.0	0.2	7.2	8.4	3.5	3.3	0.0	4.2	4.6	0.3	3.6	2.6	8.0	1.8	0.0	9.4	16.5	1.2	7.1	2.7	0.0	0.2	0.2	0.7	0.2	0.7	0.2	0.3	0.2	0.9	0.8	0.2	0.1	0.2	0.9	0.1	7.0	0.0	0.2	3.1	4.1	3.4	3.8	2.3	2.0	3.6	0.5	2.3	4.2
SCN5A	"CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1"	ENSG00000183873	"Sodium voltage-gated channel alpha subunit 5"	Q14524	3	38548057-38649673	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Calmodulin-binding, Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Cardiomyopathy, Disease mutation, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"heart muscle: 67.3"	"Group enriched"	"Detected in some"	4	"LHCN-M2: 21.5;RH-30: 17.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"amygdala: 3.2;basal ganglia: 10.5;hypothalamus: 7.0"	"Low region specificity"	"Detected in many"			HPA063346			Supported	"Nucleoplasm,Nucleoli,Plasma membrane"				"Plasma membrane"	"Nucleoplasm, Nucleoli"	"HPA063346: "	"unprognostic (9.29e-4)"	"unprognostic (4.05e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (8.48e-2)"	"unprognostic (7.12e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.16e-4)"	"unprognostic (4.85e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.95e-3)"	0.3	0.2	1.3	0.2	0.3	0.4	0.6	0.1	2.3	2.0	0.4	0.0	0.4	0.3	0.9	0.8	0.2	0.4	0.3	67.3	0.5	0.7	0.1	0.1	0.2	0.1	0.1	0.3	0.6	0.2	0.1	0.8	0.3	0.0	1.3	0.2	1.2	0.3	1.6	5.5	0.2	0.3	0.4	0.1	0.2	0.2	0.5	0.0	0.0	0.3	0.1	0.1	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.1	0.8	0.3	0.0	0.1	0.3	2.7	0.0	0.0	0.0	0.8	2.7	0.0	0.3	0.0	1.1	0.7	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.5	0.0	3.5	0.0	0.0	21.5	1.0	0.0	0.0	2.0	0.0	0.0	17.9	0.0	0.0	2.4	0.3	2.3	0.0	0.0	0.0	0.0	0.0	4.3	0.0	4.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.1	2.3	0.5	0.7	0.1	0.3	0.0	0.0
SDAD1	FLJ10498	ENSG00000198301	"SDA1 domain containing 1"	Q9NVU7	4	75940950-75990962	"Predicted intracellular proteins"	"Protein transport, Ribosome biogenesis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA035949	Uncertain		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA035949: AB_10673225"	"unprognostic (8.82e-3)"	"unprognostic (3.39e-3)"	"unprognostic (7.62e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.74e-2)"	"prognostic unfavourable (1.32e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.98e-2)"	"prognostic favourable (2.13e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.62e-1)"	17.0	17.9	19.6	16.5	30.2	7.3	21.5	17.6	26.7	19.9	17.9	9.6	14.0	14.0	26.2	23.2	19.5	18.9	10.6	16.4	18.2	15.4	21.9	23.9	14.6	22.8	16.4	19.1	22.7	26.9	20.4	30.6	17.5	22.6	18.5	18.6	9.4	18.3	20.8	32.3	19.6	16.1	24.9	16.2	23.5	18.1	24.1	19.9	21.5	25.8	17.1	22.9	21.3	17.5	13.2	10.3	5.6	16.8	15.4	17.8	10.5	14.4	5.9	14.5	19.3	17.2	15.6	15.2	20.6	17.9	17.3	15.0	18.0	20.8	22.8	15.5	18.9	15.0	22.0	19.9	21.7	20.0	11.6	19.5	12.9	14.9	16.3	32.9	22.2	13.5	22.6	18.2	20.1	15.0	34.7	18.8	17.6	16.0	33.4	11.6	23.5	9.0	20.3	27.2	19.1	16.5	16.2	21.9	18.2	14.1	28.8	23.3	13.2	19.4	14.2	18.6	18.8	22.2	17.1	17.3	18.0	31.1	20.9	14.9	22.9	5.6	9.9	2.7	14.2	12.7	17.7	12.1	17.4	16.1	10.3	13.2	17.8	14.9	1.6	15.4	16.8	9.0	14.7	10.5	19.6	30.2	17.6	26.7	18.2	15.4	16.4	19.1	22.6	19.9
SDHA	"FP, SDH2, SDHF"	ENSG00000073578	"Succinate dehydrogenase complex flavoprotein subunit A"	P31040	5	218241-256700	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Cardiomyopathy, Disease mutation, FDA approved drug targets, Leigh syndrome, Primary mitochondrial disease, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 100.1;skeletal muscle: 114.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034929, HPA041981, HPA064582"	Enhanced		Supported	Nucleoli,Mitochondria			780000	Mitochondria	Nucleoli	"CAB034929: AB_2183443, HPA041981: AB_2677779, HPA064582: AB_2685293"	"prognostic unfavourable (6.00e-4)"	"unprognostic (1.93e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.24e-1)"	"prognostic favourable (9.53e-8)"	"unprognostic (1.11e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.79e-1)"	17.6	31.4	15.3	11.5	20.3	10.6	12.8	18.8	29.0	10.2	29.4	17.3	10.0	44.3	11.3	12.1	15.3	12.6	14.8	100.1	15.8	14.5	36.5	55.4	10.7	11.7	19.6	19.3	14.5	14.7	23.2	9.5	9.2	29.7	10.7	24.6	14.5	17.3	12.0	114.0	11.5	39.9	16.5	13.2	13.9	21.2	14.6	14.8	15.7	12.5	39.6	12.5	13.2	11.1	28.3	31.9	29.1	29.2	27.1	48.9	32.4	18.4	29.9	12.3	20.1	21.2	15.9	33.4	14.2	18.1	24.5	25.0	32.4	25.1	22.8	45.0	16.2	23.9	21.7	29.0	14.5	48.6	19.9	11.6	82.6	42.0	13.1	14.4	15.1	15.8	18.7	18.3	9.7	26.5	18.6	19.0	11.5	28.2	19.1	39.0	4.2	37.9	24.7	17.9	44.2	52.2	24.5	13.6	7.8	67.0	43.3	17.6	26.3	18.3	19.2	18.2	17.9	10.8	11.7	20.2	8.6	16.8	17.6	20.9	11.5	17.8	24.4	29.1	36.4	29.2	32.1	28.3	34.8	35.1	31.9	24.5	34.5	31.7	5.9	27.1	24.1	20.5	48.9	32.4	15.3	20.3	18.8	29.0	15.8	14.5	19.6	19.3	29.7	14.8
SDHAF2	"C11orf79, FLJ20487, PGL2, SDH5"	ENSG00000167985	"Succinate dehydrogenase complex assembly factor 2"	Q9NX18	11	61430042-61447529	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		Chaperone	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039464, HPA039732"	Supported		Approved	Nucleoli,Mitochondria,Cytosol				"Mitochondria, Cytosol"	Nucleoli	"HPA039464: AB_10962146, HPA039732: AB_10962868"	"unprognostic (5.31e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.98e-3)"	"unprognostic (9.06e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.09e-3)"	"unprognostic (4.21e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.48e-2)"	23.7	33.0	22.2	22.4	27.2	34.1	24.8	19.9	33.8	20.5	22.1	23.4	21.0	22.3	23.3	33.5	25.3	25.8	21.1	32.5	20.8	26.9	26.8	39.1	19.9	36.7	24.3	25.0	25.7	22.7	23.3	38.4	26.7	25.2	26.1	24.9	32.0	28.1	21.5	31.4	22.9	27.9	26.6	20.8	32.2	24.3	19.2	21.1	36.1	27.0	20.2	30.9	24.0	19.2	31.3	23.2	44.6	25.4	32.7	43.7	26.7	15.3	22.0	13.1	9.1	19.0	15.5	10.2	11.9	17.2	16.1	12.4	20.6	16.5	15.4	21.8	17.1	16.6	17.0	16.9	17.3	22.8	16.1	13.3	18.1	29.6	19.8	15.6	18.5	19.2	20.7	17.5	17.1	25.9	15.2	19.9	19.4	33.8	15.9	35.5	20.2	32.4	17.2	16.9	28.5	22.9	22.7	14.0	17.5	16.3	19.1	33.0	29.7	18.7	16.1	16.4	13.3	19.4	14.1	12.3	19.0	19.6	15.9	13.9	17.1	41.9	25.4	44.6	32.4	22.8	38.4	31.3	35.9	34.7	20.3	29.9	39.5	38.4	37.0	32.7	17.9	23.2	43.7	26.7	22.2	27.2	19.9	33.8	20.8	26.9	24.3	25.0	25.2	21.1
SELENBP1	"hSBP, hSP56, LPSB"	ENSG00000143416	"Selenium binding protein 1"	Q13228	1	151364302-151372733	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein transport, Transport"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 112.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 38.1;HEL: 28.3;HSkMC: 19.6;SK-BR-3: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"myeloid DC: 4.8"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 4.8"					"Low region specificity"	"Detected in all"			"HPA005741, CAB008366, HPA011731"	Enhanced		Supported	Nucleoli			57000000	Nucleoli		"CAB008366: AB_592677, HPA005741: AB_1856662, HPA011731: AB_1856663"	"unprognostic (1.51e-1)"	"unprognostic (7.01e-2)"	"unprognostic (8.52e-3)"	"unprognostic (6.25e-3)"	"unprognostic (6.28e-2)"	"prognostic favourable (6.63e-4)"	"unprognostic (1.08e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.78e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.86e-2)"	"unprognostic (6.86e-3)"	27.9	5.1	17.2	28.9	16.4	17.6	18.4	6.5	11.9	15.1	105.1	10.4	15.8	17.2	13.5	23.1	11.0	32.4	28.8	11.7	18.5	5.1	20.8	56.3	64.9	5.6	10.9	14.9	13.2	7.2	1.4	4.1	5.6	11.3	19.1	112.3	27.9	14.5	15.4	15.9	6.4	29.1	22.9	6.5	13.0	29.1	4.1	13.0	0.0	52.9	18.3	6.0	15.8	8.1	0.0	4.8	0.0	1.1	0.0	0.0	5.5	0.0	4.2	7.9	0.4	38.1	15.2	2.0	1.5	0.7	0.8	1.6	4.3	1.3	0.0	7.3	2.6	0.0	0.0	0.1	0.6	0.0	3.6	28.3	14.2	6.8	8.0	0.0	0.0	19.6	0.2	1.3	0.0	4.8	2.8	0.0	2.0	3.1	0.0	0.0	6.3	8.0	0.0	0.4	0.1	1.7	0.0	0.1	0.1	0.0	68.0	0.0	11.7	0.4	0.4	0.0	0.2	4.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.5	17.2	16.4	6.5	11.9	18.5	5.1	10.9	14.9	11.3	13.0
SELENOF	SEP15	ENSG00000183291	"Selenoprotein F"		1	86862445-86914424	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054937			Approved	Nucleoli,Cytosol	"Intracellular and membrane"			Nucleoli	Cytosol	"HPA054937: "	"unprognostic (6.15e-2)"	"unprognostic (6.98e-3)"	"prognostic favourable (6.53e-4)"	"unprognostic (6.20e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (8.17e-4)"	"prognostic unfavourable (1.98e-5)"	"unprognostic (1.65e-1)"	"unprognostic (6.51e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.24e-3)"	"unprognostic (1.34e-2)"	41.5	48.9	34.7	32.4	33.2	27.1	41.4	20.4	33.9	44.3	37.0	28.9	42.7	32.9	34.9	62.0	36.9	36.8	36.1	31.4	33.4	35.8	68.4	85.3	47.8	45.4	36.0	25.1	47.6	38.5	20.6	46.9	65.6	34.3	41.5	37.4	30.8	35.8	33.7	22.0	21.7	51.1	30.2	45.0	58.7	32.3	36.4	29.0	57.0	100.7	22.8	33.7	40.0	29.7	68.9	57.5	44.3	41.8	26.8	41.3	51.1	38.5	26.5	22.1	24.5	72.6	86.4	36.2	48.7	55.7	45.8	46.7	37.4	47.0	47.6	62.5	43.1	24.3	25.0	27.1	54.0	44.4	35.3	48.5	25.3	35.4	45.9	63.3	33.1	55.4	43.0	30.5	46.0	38.5	44.8	49.8	44.4	17.3	46.0	42.6	32.5	36.7	38.5	41.0	46.5	63.5	39.9	28.8	23.8	48.4	44.2	64.1	19.3	55.2	40.1	33.6	25.0	64.6	53.1	30.0	30.4	48.8	19.6	52.4	39.3	44.3	40.0	36.8	32.8	38.4	41.3	56.7	35.8	34.7	39.0	68.9	37.1	37.5	36.7	26.8	41.8	57.5	38.3	51.1	34.7	33.2	20.4	33.9	33.4	35.8	36.0	25.1	34.3	29.0
SELENOH	"C11orf31, SELH"	ENSG00000211450	"Selenoprotein H"	Q8IZQ5	11	57741250-57743554	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048362	Uncertain		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA048362: "	"unprognostic (1.12e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavourable (4.30e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.23e-2)"	"prognostic favourable (1.80e-4)"	"unprognostic (1.58e-1)"	"unprognostic (7.56e-2)"	"unprognostic (4.12e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.60e-1)"	27.5	49.3	34.8	35.6	49.9	36.2	30.4	17.0	52.5	23.6	30.6	14.8	23.3	38.5	22.1	38.1	36.3	26.9	28.7	32.7	29.7	31.9	33.8	49.5	26.4	40.1	29.3	40.0	28.4	41.5	9.7	30.7	28.9	22.2	32.8	16.2	22.8	48.2	26.0	52.7	21.1	37.8	15.5	19.5	49.3	36.8	30.8	18.7	44.4	43.2	25.4	35.5	21.6	23.3	61.7	83.7	39.6	71.7	29.9	53.1	71.6	31.8	23.3	25.2	14.5	3.8	12.3	4.6	12.9	10.9	11.0	6.5	6.3	16.2	15.4	36.0	7.1	14.2	11.7	15.6	7.4	22.3	25.3	20.3	14.8	15.3	22.6	30.0	39.9	12.9	13.3	13.0	12.2	19.1	19.4	14.5	13.1	30.6	25.9	46.1	44.6	30.6	33.0	24.3	29.2	10.5	14.8	13.5	27.7	11.3	10.6	33.0	29.2	22.5	19.1	12.5	27.5	24.6	18.5	73.1	52.4	10.1	26.9	23.9	29.6	39.6	71.7	34.5	29.9	71.0	28.2	59.7	39.7	31.3	71.2	61.7	53.1	37.6	5.4	29.9	65.4	83.7	29.4	71.6	34.8	49.9	17.0	52.5	29.7	31.9	29.3	40.0	22.2	18.7
SENP3	"DKFZP586K0919, DKFZp762A152, SMT3IP1, SSP3, Ulp1"	ENSG00000161956	"SUMO1/sentrin/SMT3 specific peptidase 3"	Q9H4L4	17	7561875-7571969	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA060290	Supported		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA060290: "	"unprognostic (5.68e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.82e-1)"	"unprognostic (7.37e-2)"	"unprognostic (3.72e-2)"	"prognostic favourable (6.22e-5)"	"unprognostic (2.71e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.56e-2)"	16.3	16.0	22.3	20.9	23.4	16.6	18.0	29.2	38.4	15.9	22.5	18.4	16.8	16.2	18.6	22.7	18.6	19.9	17.0	26.1	21.0	19.2	17.5	15.1	18.7	18.8	20.0	23.3	19.6	17.8	29.5	17.3	23.6	17.2	16.0	20.5	17.3	18.6	21.9	22.0	20.8	17.6	23.1	15.3	18.9	17.2	28.8	16.4	18.9	19.0	14.2	23.4	16.8	32.8	0.8	0.7	1.1	0.7	1.1	1.7	0.3	26.2	31.8	18.9	29.2	21.4	15.7	19.7	19.3	19.8	33.6	31.6	19.0	11.5	31.4	19.1	25.3	25.3	40.6	30.1	28.3	22.1	37.1	16.3	27.0	19.4	29.0	15.0	20.8	20.1	30.8	38.3	37.6	26.9	20.8	8.8	25.9	17.6	36.3	11.4	23.4	19.4	33.3	17.7	18.1	22.4	15.4	18.9	24.4	19.3	18.7	20.5	15.7	9.8	14.1	19.3	16.8	18.3	41.3	13.0	13.5	19.9	19.5	15.9	28.5	0.1	0.7	0.2	0.4	0.4	0.1	0.4	0.2	1.3	0.1	0.8	1.7	0.5	1.1	1.1	0.1	0.7	0.3	0.3	22.3	23.4	29.2	38.4	21.0	19.2	20.0	23.3	17.2	16.4
SENP5	MGC27076	ENSG00000119231	"SUMO1/sentrin specific peptidase 5"	Q96HI0	3	196867856-196934714	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006684			Supported	"Nucleoli,Plasma membrane"				Nucleoli	"Plasma membrane"	"HPA006684: "	"unprognostic (4.07e-2)"	"unprognostic (4.91e-3)"	"unprognostic (7.63e-2)"	"prognostic unfavourable (4.04e-4)"	"unprognostic (4.13e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (4.15e-4)"	"unprognostic (2.95e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.89e-1)"	"unprognostic (9.57e-3)"	"prognostic unfavourable (2.14e-5)"	"unprognostic (2.02e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.62e-2)"	"unprognostic (6.71e-2)"	13.8	13.5	20.0	15.3	20.0	25.7	16.1	28.3	23.8	15.0	15.1	16.1	14.5	11.3	14.6	16.2	16.3	12.9	14.4	15.9	18.9	21.7	13.6	19.5	15.2	15.9	19.4	18.4	17.5	15.7	19.8	21.5	17.8	23.5	15.1	14.0	12.0	13.2	15.9	17.8	16.4	13.0	16.8	18.2	17.1	14.0	36.6	16.4	19.3	14.1	9.2	21.1	14.9	20.1	8.9	7.8	15.8	8.7	7.6	8.9	4.2	13.1	6.0	9.6	8.6	8.1	9.8	7.6	8.4	9.0	9.1	14.7	10.4	5.2	12.3	23.4	9.2	9.1	9.9	4.5	14.9	6.6	6.5	16.7	8.9	7.3	9.5	13.7	7.9	8.4	12.1	9.3	9.9	8.9	11.0	19.1	10.6	11.3	12.9	8.1	7.4	11.9	8.3	7.7	8.3	4.5	7.5	6.0	8.0	9.4	10.6	10.3	17.8	10.5	10.0	8.9	9.2	12.2	17.1	20.4	35.7	26.5	12.0	11.1	10.1	15.8	7.6	7.1	8.9	8.1	8.1	8.9	8.6	8.8	5.0	8.5	8.0	8.6	14.9	7.6	8.7	7.8	6.9	4.2	20.0	20.0	28.3	23.8	18.9	21.7	19.4	18.4	23.5	16.4
SEPT7	"CDC10, CDC3, SEPT7A"	ENSG00000122545	"Septin 7"	Q16181	7	35800932-35907105	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023309, HPA029524"	Enhanced		Enhanced	"Nucleoli,Actin filaments,Midbody,Cytosol"			16000000	"Actin filaments"	"Nucleoli, Midbody, Cytosol"	"HPA023309: AB_10600093, HPA029524: AB_10601573"	"unprognostic (7.91e-3)"	"unprognostic (6.89e-3)"	"unprognostic (9.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavourable (2.37e-4)"	"unprognostic (2.00e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.56e-2)"	"unprognostic (7.66e-2)"	"prognostic unfavourable (2.78e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.43e-3)"	35.5	28.5	89.0	26.8	77.8	31.9	29.5	41.9	81.5	35.1	28.7	54.3	11.5	15.7	37.8	36.2	31.7	25.4	34.2	47.5	86.4	58.1	24.3	21.5	28.3	38.8	79.6	66.2	42.8	11.2	22.9	31.9	41.0	72.0	28.4	28.2	9.6	14.9	29.9	21.7	29.1	20.1	42.6	76.8	29.5	18.1	19.3	98.2	33.0	22.6	17.3	41.4	36.9	24.0	40.4	24.0	47.3	24.8	69.1	56.8	48.6	36.6	17.7	45.1	29.6	50.8	52.6	23.1	47.3	43.7	40.4	34.8	27.4	28.5	34.7	32.2	48.1	27.9	31.8	31.5	57.7	23.7	16.7	27.9	24.7	14.8	29.7	33.6	30.9	34.1	24.7	31.7	31.3	42.1	21.9	27.5	65.5	17.1	33.9	56.5	48.3	25.0	35.1	42.9	19.9	39.1	27.4	24.2	42.5	33.0	42.6	28.3	31.4	37.3	35.5	40.8	48.4	25.0	52.0	32.4	29.5	87.6	26.1	56.3	86.1	47.3	20.7	34.9	55.4	24.0	56.8	40.4	39.6	50.5	24.0	37.4	35.6	44.9	39.3	69.1	24.8	17.2	34.2	48.6	89.0	77.8	41.9	81.5	86.4	58.1	79.6	66.2	72.0	98.2
SERF2	"4F5REL, FAM2C, H4F5rel, HsT17089"	ENSG00000140264	"Small EDRK-rich factor 2"	P84101	15	43777087-43802589	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056613			Uncertain	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA056613: "	"unprognostic (3.29e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.13e-3)"	"prognostic favourable (5.33e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.91e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.42e-2)"	78.4	109.1	61.4	103.2	58.1	110.6	115.0	33.0	45.9	71.2	107.6	45.1	99.7	59.2	65.1	121.7	109.6	60.0	128.9	166.4	56.1	48.2	97.5	153.1	79.7	81.4	72.9	42.6	51.8	125.4	23.5	62.5	102.9	89.4	84.7	87.6	63.0	134.3	106.7	98.7	59.9	86.4	68.5	66.7	79.5	79.5	65.5	45.8	77.0	122.5	116.7	82.9	84.8	116.3	146.1	259.3	225.7	218.7	91.4	142.8	413.5	34.5	57.7	43.0	58.6	149.8	110.4	33.2	61.8	77.5	40.3	51.6	74.0	34.8	18.0	51.2	106.0	46.1	33.6	46.4	20.2	49.2	39.8	43.4	83.9	141.8	73.4	40.5	93.9	104.2	60.2	32.6	35.0	58.6	44.7	118.9	78.9	106.2	51.7	95.8	36.7	67.2	53.0	28.5	82.5	109.8	126.8	32.3	34.7	33.1	139.3	31.6	116.6	173.3	49.6	68.9	35.2	103.5	45.2	43.9	58.8	124.8	74.4	73.6	71.4	127.3	218.7	225.7	113.6	194.5	103.1	142.2	125.7	116.0	185.9	146.1	116.7	118.3	129.1	91.4	166.0	259.3	142.8	413.5	61.4	58.1	33.0	45.9	56.1	48.2	72.9	42.6	89.4	45.8
SERTAD3	RBT1	ENSG00000167565	"SERTA domain containing 3"	Q9UJW9	19	40440844-40444705	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068262			Approved	Nucleoli				Nucleoli		"HPA068262: "	"unprognostic (1.56e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.55e-3)"	"unprognostic (6.50e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.51e-3)"	"unprognostic (7.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.80e-2)"	"unprognostic (8.74e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.66e-3)"	28.3	13.0	5.7	16.8	7.1	10.8	18.6	3.7	6.9	29.3	31.5	13.0	22.0	12.3	24.6	22.2	29.6	18.8	24.9	21.1	5.8	5.7	21.4	19.6	23.6	12.3	8.8	4.5	33.1	8.0	8.8	14.1	49.1	6.6	24.8	14.2	13.6	15.7	25.1	32.1	13.5	25.2	18.9	7.9	21.4	18.6	16.6	6.8	7.8	25.6	24.2	17.3	31.8	18.3	14.4	24.8	28.7	20.6	7.8	7.7	12.2	15.4	30.0	10.5	13.7	11.8	18.2	14.5	12.6	17.1	18.0	15.6	10.8	12.1	7.5	5.7	16.2	5.6	10.6	12.3	10.2	8.4	4.7	5.0	9.8	9.2	13.9	1.2	15.9	16.0	16.9	11.2	8.2	14.6	14.9	5.1	14.2	23.1	3.0	6.1	5.5	7.4	4.6	6.5	6.1	14.3	12.2	1.5	6.5	10.7	18.7	9.5	16.4	12.5	12.2	15.5	12.4	11.9	9.9	8.7	4.5	6.4	12.3	5.4	6.8	12.2	20.6	22.0	7.1	20.4	7.1	14.4	7.7	7.6	23.0	12.7	5.7	6.8	28.7	7.8	17.1	24.8	6.0	12.2	5.7	7.1	3.7	6.9	5.8	5.7	8.8	4.5	6.6	6.8
SETD7	"KIAA1717, KMT7, SET7, SET7/9, Set9"	ENSG00000145391	"SET domain containing lysine methyltransferase 7"	Q8WTS6	4	139495941-139606699	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058111	Enhanced		Enhanced	Nucleoli				Nucleoli		"HPA058111: "	"prognostic unfavourable (8.28e-4)"	"unprognostic (7.07e-2)"	"unprognostic (4.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.92e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.44e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.17e-1)"	"unprognostic (6.92e-2)"	"unprognostic (6.56e-3)"	26.1	13.2	12.0	9.6	12.3	5.7	26.3	10.2	16.2	27.9	17.7	17.9	11.0	4.8	23.8	12.0	18.3	13.8	16.9	25.2	13.0	10.0	7.2	30.7	12.1	6.9	18.0	10.1	13.3	13.8	26.8	9.3	12.0	15.4	22.8	10.2	12.4	13.7	13.9	56.4	14.2	9.9	33.3	19.0	11.8	17.7	10.6	16.5	2.9	10.3	15.2	9.9	24.2	30.1	2.3	6.8	1.8	5.6	0.5	5.6	1.6	8.9	11.5	4.4	2.6	26.1	22.5	9.7	21.2	22.0	10.8	9.2	6.8	12.2	20.8	8.4	35.6	4.5	14.6	16.7	17.7	10.2	10.3	2.9	15.0	0.2	12.9	9.9	4.4	19.5	19.6	17.2	18.4	13.7	1.7	32.3	13.8	14.9	6.5	1.5	2.1	7.6	6.1	15.3	11.9	10.5	8.2	17.2	5.7	14.1	20.9	5.0	8.3	9.1	22.2	19.2	13.6	22.9	17.5	28.0	26.8	13.2	22.1	10.0	9.2	1.0	5.6	0.5	0.6	3.2	4.1	1.8	1.8	1.8	6.8	2.3	0.8	0.5	1.8	0.5	4.8	3.5	5.6	1.6	12.0	12.3	10.2	16.2	13.0	10.0	18.0	10.1	15.4	16.5
SETMAR	metnase	ENSG00000170364	"SET domain and mariner transposase fusion gene"	Q53H47	3	4303304-4317567	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator, DNA-binding, Endonuclease, Hydrolase, Methyltransferase, Multifunctional enzyme, Nuclease, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA057999			Supported	Nucleoli				Nucleoli		"HPA057999: "	"unprognostic (1.59e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.24e-3)"	"unprognostic (4.89e-2)"	"unprognostic (7.73e-2)"	"unprognostic (4.73e-2)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.19e-1)"	"prognostic favourable (6.61e-6)"	"unprognostic (5.42e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.26e-3)"	14.1	6.2	7.3	7.2	9.2	3.7	14.2	6.9	8.5	12.5	6.5	6.2	5.2	4.3	19.4	7.6	7.2	12.5	8.2	6.3	6.6	4.3	10.1	5.3	5.1	6.5	9.1	8.7	19.4	9.8	5.7	7.4	5.6	6.5	13.9	6.9	5.7	11.9	10.0	7.7	7.3	5.7	16.8	7.2	5.0	6.0	7.3	10.8	13.1	11.5	8.3	4.4	11.3	13.3	3.8	1.6	1.9	3.3	0.5	5.3	1.5	2.9	2.7	8.1	1.7	19.4	6.5	8.2	3.3	1.0	3.2	3.1	2.8	2.3	7.9	3.5	1.8	2.6	7.1	5.0	3.6	5.3	6.1	9.8	4.8	4.5	2.2	4.6	4.2	7.6	3.8	2.4	0.8	4.7	6.5	3.0	5.0	4.1	6.9	2.9	7.9	4.6	8.1	8.0	3.2	3.0	4.1	6.4	9.5	4.0	5.0	4.2	4.7	2.7	3.1	4.9	6.8	4.1	4.3	3.9	9.4	19.5	1.7	5.3	4.0	1.9	1.1	1.3	2.3	3.3	2.0	2.9	2.7	2.9	1.0	3.8	4.5	5.3	0.2	0.5	1.9	1.6	1.7	1.5	7.3	9.2	6.9	8.5	6.6	4.3	9.1	8.7	6.5	10.8
SF3B3	"KIAA0017, RSE1, SAP130, SF3b130"	ENSG00000189091	"Splicing factor 3b subunit 3"	Q15393	16	70523788-70577670	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041134, HPA042986"	Supported		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA041134: , HPA042986: AB_10960386"	"unprognostic (3.39e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.67e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.76e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.73e-1)"	23.8	21.1	11.8	22.1	23.2	24.7	22.4	24.9	26.9	23.4	20.6	20.9	15.6	17.1	27.5	13.9	31.8	22.1	15.6	20.1	14.0	12.8	17.0	19.0	18.4	28.5	16.9	15.0	33.3	22.5	34.0	26.8	19.9	16.5	18.4	16.4	20.2	22.6	17.3	30.9	28.9	18.8	20.1	15.4	21.0	17.9	15.5	15.9	47.7	25.1	17.2	31.9	23.7	25.0	23.2	21.4	16.4	18.8	21.0	25.9	19.7	18.4	19.4	25.2	17.6	12.5	11.6	19.0	17.5	15.0	22.9	18.6	19.8	14.8	24.8	14.2	13.7	21.8	26.5	15.0	37.0	8.0	18.6	19.3	15.9	20.9	8.5	27.1	22.8	11.0	10.9	25.5	18.9	13.7	26.3	8.9	18.2	22.8	23.8	13.4	23.1	11.2	42.1	19.6	27.8	7.4	25.5	21.9	16.2	57.1	9.1	8.8	19.6	13.5	14.0	17.0	18.6	13.1	18.4	10.0	21.9	66.5	11.3	17.4	15.8	11.5	15.8	16.4	23.1	18.8	25.4	18.6	21.8	24.2	21.4	23.2	25.9	22.0	5.4	21.0	17.9	12.0	24.0	19.7	11.8	23.2	24.9	26.9	14.0	12.8	16.9	15.0	16.5	15.9
SFN	YWHAS	ENSG00000175793	Stratifin	P31947	1	26863138-26864457	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 256.2;lymphoid tissue: 107.4;skin 1: 123.8;tongue: 256.0"	"Cell line enhanced"	"Detected in many"		"A-431: 68.6;HaCaT: 108.3;HBEC3-KT: 166.7;hTCEpi: 111.9"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 2526.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"basophil: 7.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 7.1"	"Low region specificity"	"Detected in some"							"CAB006268, HPA011105, CAB040552, HPA061603"	Enhanced		Supported	Nucleoli,Cytosol	"Secreted in other tissues"		54000000	Cytosol	Nucleoli	"CAB006268: AB_425459, CAB040552: , HPA011105: AB_1844339, HPA061603: "	"unprognostic (5.70e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.37e-2)"	"prognostic favourable (1.92e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavourable (5.68e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.96e-1)"	"prognostic unfavourable (6.01e-4)"	"unprognostic (3.83e-1)"	"prognostic unfavourable (7.45e-6)"	"unprognostic (7.90e-3)"	"unprognostic (3.25e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.06e-2)"	0.4	0.0	0.5	3.1	0.5	0.0	3.8	0.4	0.7	37.5	10.7	0.5	0.5	5.9	3.3	0.7	256.2	0.0	6.0	0.3	0.6	0.1	1.2	0.5	8.2	0.3	0.4	0.3	0.3	0.3	0.0	0.3	3.4	0.8	5.9	4.0	0.3	25.5	0.4	0.4	123.8	13.2	0.5	0.7	0.3	6.6	0.4	0.4	3.1	0.4	256.0	107.4	9.1	47.7	0.0	0.0	7.1	0.0	0.0	0.6	0.0	68.6	11.6	0.0	0.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	4.2	36.2	0.6	3.0	0.0	108.3	0.0	166.7	0.0	16.4	0.5	0.0	11.6	12.2	0.0	0.0	0.1	0.0	111.9	0.0	29.3	0.0	0.1	0.4	0.0	14.6	0.0	0.0	0.2	19.3	0.0	0.0	3.8	25.9	15.8	0.0	0.0	16.6	2.9	0.1	7.7	0.1	0.0	0.0	31.7	0.0	0.4	0.1	0.5	0.3	0.1	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.5	0.5	0.4	0.7	0.6	0.1	0.4	0.3	0.8	0.4
SFRP1	"FRP, FRP-1, SARP2"	ENSG00000104332	"Secreted frizzled related protein 1"	Q8N474	8	41261958-41309497	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 105.4;BJ hTERT+ SV40 Large T+: 30.5;HBF TERT88: 43.2;hTCEpi: 39.4;NTERA-2: 31.5;RPTEC TERT1: 64.8;WM-115: 42.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB008116, HPA064870"	Approved		Approved	Nucleoli,Cytosol	"Secreted in other tissues"		1600000	Nucleoli	Cytosol	"CAB008116: AB_2187070, HPA064870: "	"unprognostic (1.23e-3)"	"unprognostic (7.01e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.59e-1)"	"unprognostic (7.13e-2)"	"prognostic favourable (1.55e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.15e-2)"	"unprognostic (4.67e-3)"	"unprognostic (3.52e-3)"	"unprognostic (4.74e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.57e-1)"	"prognostic unfavourable (3.12e-4)"	20.1	3.4	4.6	2.4	7.5	0.3	73.2	10.8	5.6	58.4	6.1	15.2	8.0	3.0	35.6	19.3	9.7	25.9	15.5	43.9	7.8	2.5	30.6	1.5	1.8	0.9	4.5	6.7	12.5	1.5	0.6	0.7	9.9	24.1	12.8	7.8	19.3	73.2	27.1	1.9	20.8	5.4	21.4	2.8	5.0	11.0	11.1	13.7	0.0	3.3	18.4	5.1	10.9	41.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	11.6	0.3	10.6	0.6	2.2	20.0	105.4	30.5	29.1	0.0	2.6	0.0	0.1	0.1	0.1	1.6	8.0	43.2	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.1	1.8	39.4	3.0	3.0	0.9	0.0	0.0	0.5	0.0	0.0	0.0	31.5	0.0	0.0	2.4	0.0	64.8	0.0	0.6	2.8	0.8	0.0	6.1	0.0	0.3	0.2	0.0	3.1	0.0	2.7	0.0	0.0	0.0	0.0	0.0	42.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	7.5	10.8	5.6	7.8	2.5	4.5	6.7	24.1	13.7
SGF29	"CCDC101, FLJ32446, TDRD29"	ENSG00000176476	"SAGA complex associated factor 29"	Q96ES7	16	28553915-28591790	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA052590, HPA053608"	Enhanced		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA052590: , HPA053608: "	"unprognostic (1.38e-2)"	"prognostic favourable (4.77e-4)"	"unprognostic (1.73e-1)"	"unprognostic (2.46e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.48e-1)"	"prognostic favourable (3.37e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.41e-1)"	"prognostic favourable (2.99e-4)"	"unprognostic (2.96e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.42e-3)"	11.1	11.4	7.9	11.8	12.5	9.9	15.5	20.9	11.0	19.5	17.1	10.6	16.9	11.6	21.4	10.2	9.0	17.6	11.1	10.7	7.9	6.8	9.8	12.9	11.1	17.2	16.5	7.1	31.5	17.7	8.6	9.4	8.4	10.8	13.1	6.9	12.1	14.8	20.0	36.1	12.2	13.4	21.4	13.4	11.6	13.5	35.6	14.4	17.6	19.5	9.0	10.4	17.1	25.1	25.4	27.6	18.8	18.2	19.5	36.1	20.4	6.9	11.9	9.1	5.9	6.3	6.2	16.6	4.7	5.4	12.5	11.8	13.6	6.3	21.2	11.9	3.7	8.3	7.0	8.3	3.5	6.8	13.2	13.1	7.3	18.1	15.5	11.7	14.8	6.6	11.4	7.4	7.6	4.6	11.0	10.8	4.4	23.4	13.3	23.1	12.6	11.6	20.8	5.9	18.3	6.2	10.6	14.8	6.8	7.4	14.1	7.9	11.6	9.7	3.2	8.7	7.4	5.0	8.3	12.6	18.3	12.3	6.2	19.9	6.9	5.0	18.2	18.8	22.3	15.6	26.9	22.2	31.2	27.2	18.3	25.4	36.1	27.8	5.6	19.5	12.5	27.6	29.6	20.4	7.9	12.5	20.9	11.0	7.9	6.8	16.5	7.1	10.8	14.4
SH3TC1	FLJ20356	ENSG00000125089	"SH3 domain and tetratricopeptide repeats 1"	Q8TE82	4	8182072-8241803	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 15.0;MOLT-4: 26.0;SK-MEL-30: 14.9;U-2197: 11.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 14.5"	"Group enriched"	"Detected in many"	5	"B-cells: 6.5;dendritic cells: 14.5;monocytes: 8.6"	"Low region specificity"	"Detected in many"							"HPA038132, HPA056807"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA038132: AB_10673041, HPA056807: "	"unprognostic (2.46e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.46e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.77e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.29e-2)"	16.8	4.2	3.7	12.7	7.6	7.5	8.5	0.9	4.0	5.7	3.2	8.6	3.3	1.9	3.2	7.9	9.7	3.9	10.0	4.5	6.6	3.5	19.9	11.2	10.1	14.2	7.4	1.0	2.8	8.6	1.1	3.3	5.8	7.2	5.9	2.4	6.4	5.9	6.0	2.0	3.3	5.6	4.1	9.6	17.0	9.6	1.7	5.8	24.4	5.6	3.8	14.5	9.9	6.3	6.5	14.5	1.0	8.6	0.4	2.0	2.6	2.1	3.4	0.1	0.0	0.0	0.3	2.5	0.2	0.2	0.3	0.4	1.7	1.3	3.0	3.0	0.0	1.3	0.0	6.4	0.0	7.9	0.1	0.0	2.7	2.8	2.6	0.0	0.4	0.1	8.0	0.1	6.5	15.0	0.4	4.2	0.3	2.4	26.0	2.1	0.1	2.8	1.7	0.8	0.8	0.3	0.4	0.2	1.4	0.9	0.3	14.9	0.0	0.5	6.1	0.0	1.7	11.3	0.2	0.1	0.6	2.6	0.1	1.2	2.0	0.0	7.5	1.0	0.7	6.9	0.7	4.2	1.5	0.9	6.2	6.5	0.7	0.6	0.2	0.4	8.6	14.5	2.0	2.6	3.7	7.6	0.9	4.0	6.6	3.5	7.4	1.0	7.2	5.8
SIPA1	SPA1	ENSG00000213445	"Signal-induced proliferation-associated 1"	Q96FS4	11	65638097-65650930	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 47.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020833, HPA039867"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane"				Nucleoli	"Nucleoplasm, Golgi apparatus, Plasma membrane"	"CAB020833: , HPA039867: "	"unprognostic (6.10e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (9.42e-4)"	"unprognostic (1.35e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.44e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.86e-2)"	"prognostic unfavourable (3.52e-6)"	"unprognostic (1.60e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.49e-1)"	10.5	9.1	7.5	27.1	12.0	29.8	10.0	2.6	8.7	8.9	10.8	9.4	2.9	7.7	10.9	3.0	7.6	9.0	9.9	8.0	8.4	4.6	9.5	7.8	17.6	33.2	11.5	4.7	7.7	4.6	2.7	4.2	11.9	10.3	8.6	3.9	8.2	8.7	6.8	5.4	4.2	17.2	9.0	14.3	47.1	8.1	3.0	10.5	25.3	7.7	4.6	32.7	8.5	7.8	6.6	2.8	14.1	5.2	5.8	7.4	3.0	0.7	6.2	4.4	9.5	2.6	5.4	10.5	7.1	6.0	5.5	5.4	1.9	6.8	9.8	16.0	3.5	3.6	1.6	2.3	1.8	10.6	3.9	23.9	9.1	3.3	4.6	9.6	10.3	5.5	1.1	7.7	1.0	16.2	13.5	4.5	2.7	2.7	3.8	16.5	3.0	5.7	17.5	2.4	8.7	2.1	0.5	1.7	10.1	3.5	6.1	14.5	4.6	14.9	22.7	6.9	13.9	7.5	1.4	6.8	5.3	22.0	9.4	15.4	19.8	4.0	4.1	10.2	7.4	4.8	5.5	5.3	3.7	4.8	2.8	6.6	2.9	4.4	14.1	5.8	5.2	2.7	3.5	3.0	7.5	12.0	2.6	8.7	8.4	4.6	11.5	4.7	10.3	10.5
SIRT2	SIR2L	ENSG00000068903	"Sirtuin 2"	Q8IXJ6	19	38878555-38899862	"Cancer-related genes, Predicted intracellular proteins"	"Autophagy, Cell cycle, Cell division, Differentiation, Immunity, Innate immunity, Meiosis, Mitosis, Neurogenesis, Transcription, Transcription regulation"	Transferase	"Cancer-related genes, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 86.6;skeletal muscle: 108.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004573, HPA011165"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"CAB004573: AB_2188600, HPA011165: AB_1856900"	"unprognostic (2.15e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavourable (7.20e-7)"	"unprognostic (3.75e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.73e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.70e-1)"	14.1	11.0	30.2	8.1	36.0	10.7	9.1	14.3	38.8	11.0	8.4	78.1	4.0	9.3	9.7	7.8	17.1	12.9	10.7	20.3	36.9	23.5	9.0	12.0	10.8	8.8	52.3	20.5	17.3	9.5	10.1	6.2	7.7	40.8	9.8	7.6	5.8	14.9	11.2	108.7	13.7	9.3	12.8	86.6	9.9	9.0	7.9	46.3	3.2	10.1	23.4	8.9	10.6	7.1	13.2	21.5	28.0	33.0	16.6	23.5	22.1	8.1	5.1	4.4	11.0	25.3	17.4	3.0	6.0	10.7	9.4	12.2	9.2	5.2	2.8	13.1	11.2	4.4	8.0	12.9	5.7	13.0	8.3	5.5	5.8	5.5	17.8	3.8	12.2	18.1	15.6	7.7	9.2	16.4	5.2	22.6	14.3	4.6	7.7	3.0	0.7	7.2	10.2	12.4	7.8	7.5	7.3	11.1	5.0	7.0	9.4	6.6	4.2	9.9	15.6	12.7	2.8	19.6	8.9	9.3	4.5	6.5	10.2	9.6	11.7	19.5	27.3	28.0	23.5	33.0	14.6	12.2	11.4	16.1	21.1	13.2	7.5	12.5	20.7	16.6	25.8	21.5	15.5	22.1	30.2	36.0	14.3	38.8	36.9	23.5	52.3	20.5	40.8	46.3
SIX1	DFNA23	ENSG00000126778	"SIX homeobox 1"	Q15475	14	60643415-60658259	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 39.1;salivary gland: 55.1;skeletal muscle: 59.0"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 52.7;RH-30: 28.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"olfactory region: 1.2;pons and medulla: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001893, CAB058690"	Enhanced		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"CAB058690: , HPA001893: AB_1079991"	"unprognostic (3.62e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.09e-2)"	"prognostic unfavourable (8.92e-6)"	"unprognostic (1.33e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.04e-3)"	"prognostic favourable (3.94e-4)"	"unprognostic (1.40e-1)"	"unprognostic (9.15e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.06e-8)"	"unprognostic (8.61e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.86e-1)"	7.1	0.4	0.3	0.1	0.5	0.1	4.7	0.3	0.6	7.4	0.2	0.2	0.0	0.1	0.2	2.1	1.3	0.5	0.4	0.4	0.3	0.3	0.3	0.2	1.8	0.3	0.4	1.2	0.3	0.3	16.8	39.1	0.1	4.5	8.7	0.1	2.0	55.1	0.2	59.0	0.4	0.2	0.7	0.5	0.2	0.5	1.6	0.0	6.5	2.4	22.5	3.0	1.4	9.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	8.2	1.9	0.2	11.7	6.8	8.0	0.1	2.0	4.5	2.3	2.0	0.0	3.7	0.0	1.1	0.4	2.7	3.9	3.6	0.8	0.0	9.4	0.9	0.8	2.7	0.0	0.0	0.1	6.0	1.7	1.6	0.3	0.1	2.6	0.0	52.7	1.3	0.0	0.2	0.0	4.7	0.0	28.8	0.0	2.2	6.4	1.1	0.1	2.3	0.1	2.4	1.3	0.2	6.7	3.1	3.2	3.6	2.9	0.2	0.0	0.0	0.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.5	0.3	0.3	0.4	1.2	4.5	0.0
SLBP	HBP	ENSG00000163950	"Stem-loop binding protein"	Q14493	4	1692800-1712555	"Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019254, HPA061670"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA019254: AB_1856951, HPA061670: AB_2684581"	"unprognostic (1.81e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.09e-3)"	"prognostic unfavourable (2.29e-5)"	"unprognostic (5.53e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.81e-3)"	"unprognostic (9.55e-3)"	"unprognostic (4.58e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.07e-2)"	19.8	18.1	26.9	30.4	28.0	60.7	27.5	23.8	30.0	19.3	19.3	14.2	20.7	16.3	20.4	21.9	25.0	19.0	15.8	17.9	25.1	26.5	23.7	21.2	18.7	43.9	19.9	24.0	23.1	17.8	13.0	19.5	27.7	16.0	20.0	21.3	17.9	24.7	21.2	15.1	24.7	17.0	20.5	17.1	26.1	18.2	50.6	12.4	52.4	24.9	17.7	42.8	23.7	26.6	24.4	24.1	45.3	29.8	19.8	36.1	30.4	28.8	11.9	17.1	18.0	15.2	17.4	17.8	25.4	21.7	30.9	31.3	24.5	33.7	38.2	15.2	21.0	17.7	34.4	23.0	36.2	15.6	18.6	47.8	14.8	24.6	18.8	44.2	23.4	12.0	18.5	23.5	15.6	17.5	34.2	37.7	37.8	10.4	68.0	40.3	21.3	21.1	51.3	28.0	24.1	29.7	22.0	19.5	15.0	21.5	14.0	15.0	23.2	29.2	14.8	25.9	14.9	27.3	39.5	22.0	39.9	91.2	24.3	37.9	25.5	9.3	29.8	21.8	23.6	22.3	21.4	24.4	30.8	33.2	24.1	18.0	26.5	25.1	45.3	19.8	19.8	19.1	36.1	30.4	26.9	28.0	23.8	30.0	25.1	26.5	19.9	24.0	16.0	12.4
SLC1A3	"EA6, EAAT1, GLAST"	ENSG00000079215	"Solute carrier family 1 member 3"	P43003	5	36606355-36688334	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 188.6"	"Cell line enhanced"	"Detected in many"		"AF22: 21.2;CACO-2: 34.1;HaCaT: 25.8"	"Cancer enriched"	"Detected in all"	21	"glioma: 168.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"classical monocyte: 4.3;intermediate monocyte: 2.1;myeloid DC: 3.4"	"Group enriched"	"Detected in many"	39	"dendritic cells: 3.4;monocytes: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002573, HPA037467, HPA037468"	Enhanced	Supported	Approved	Nucleoli,Mitochondria				Mitochondria	Nucleoli	"CAB002573: AB_564088, HPA037467: AB_10795027, HPA037468: AB_10671371"	"unprognostic (1.23e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.17e-3)"	"unprognostic (3.28e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-2)"	17.3	10.3	76.1	5.9	70.6	3.1	6.3	45.8	188.6	6.9	3.2	26.3	0.0	2.1	2.8	2.3	7.2	5.4	5.9	12.0	57.9	27.3	3.1	3.6	4.7	8.6	32.7	39.6	8.6	4.0	2.6	3.7	12.7	28.5	3.3	2.6	1.9	3.0	4.4	7.6	5.5	2.3	4.1	29.4	5.8	2.9	2.7	33.6	0.0	2.6	0.7	4.5	4.8	1.2	0.0	3.4	0.0	4.3	0.0	0.0	0.8	0.4	0.1	21.2	1.8	2.1	5.9	13.5	0.0	0.0	0.8	1.8	34.1	1.7	0.0	10.3	0.3	25.8	6.2	2.8	0.9	0.3	12.7	0.0	0.1	0.0	0.4	0.4	0.1	10.9	12.8	5.2	2.1	0.0	0.0	0.1	3.6	0.0	0.0	0.0	2.5	2.1	0.0	0.1	0.0	0.0	1.3	1.8	0.0	2.1	6.2	0.3	0.0	1.0	0.0	1.9	3.1	0.0	7.5	0.0	0.0	0.0	8.6	14.3	4.8	0.0	4.3	0.0	0.0	2.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.8	76.1	70.6	45.8	57.8	57.9	27.3	32.7	39.6	28.5	33.6
SLC30A3	ZNT3	ENSG00000115194	"Solute carrier family 30 member 3"	Q99726	2	27253684-27275817	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 28.7;epididymis: 41.0;testis: 19.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 8.8;Hep G2: 11.7;REH: 18.9;RH-30: 9.8"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	9	"amygdala: 15.8;basal ganglia: 11.4;cerebral cortex: 28.7;hippocampal formation: 10.2;olfactory region: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 135.1;basal ganglia: 48.1;cerebral cortex: 108.9;hippocampal formation: 75.6"	"Group enriched"	"Detected in many"	7	"amygdala: 43.9;cerebral cortex: 117.8;hippocampal formation: 91.9"	"HPA060505, HPA067637, CAB079044"	Enhanced	Approved	Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol				Vesicles	"Nucleoplasm, Nucleoli, Cytosol"	"CAB079044: , HPA060505: , HPA067637: "	"unprognostic (2.05e-4)"	"unprognostic (1.17e-1)"	"unprognostic (6.84e-4)"	"unprognostic (5.26e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.65e-12)"	"unprognostic (3.23e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.63e-4)"	0.5	1.9	15.8	0.5	11.4	0.5	0.4	0.4	28.7	0.5	0.5	0.0	1.9	0.4	0.5	41.0	0.4	0.7	0.4	5.0	10.2	0.8	0.4	0.5	0.5	0.8	1.1	12.1	0.5	0.4	0.6	0.4	0.4	1.6	0.6	0.5	0.7	0.4	0.9	0.4	0.4	0.5	0.5	0.7	0.5	0.4	19.5	0.0	0.0	0.4	0.0	0.4	0.5	0.4	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.3	1.1	0.0	1.5	0.0	0.2	0.1	0.0	0.0	1.0	1.0	0.3	0.4	0.0	0.0	0.0	0.2	8.8	0.0	0.2	0.0	1.0	5.0	0.2	11.7	0.2	0.1	2.0	0.0	0.0	0.5	0.0	0.7	1.4	0.0	0.1	3.8	0.0	0.3	1.4	0.0	18.9	9.8	1.0	0.0	0.0	0.0	0.6	2.3	0.0	0.0	0.0	0.7	0.0	0.2	4.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	15.8	11.4	0.4	28.7	10.2	0.8	1.1	12.1	1.6	0.0
SLC35F3	FLJ37712	ENSG00000183780	"Solute carrier family 35 member F3"	Q8IY50	1	233904933-234324516	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.0"	"Cell line enriched"	"Detected in some"	7	"HDLM-2: 48.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	49	"plasmacytoid DC: 7.1"	"Lineage enriched"	"Detected in single"	69	"dendritic cells: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051327, HPA061582"	Uncertain		Approved	"Nucleoli,Golgi apparatus"				"Golgi apparatus"	Nucleoli	"HPA051327: , HPA061582: "	"unprognostic (1.11e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.69e-5)"	"unprognostic (3.38e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.86e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.57e-3)"	"unprognostic (7.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.62e-1)"	"unprognostic (3.58e-1)"	0.8	3.5	4.6	1.3	26.0	0.7	6.8	25.1	16.7	1.4	0.8	0.5	0.0	0.8	1.0	2.5	1.6	1.7	0.8	0.6	5.4	4.6	1.6	0.6	1.2	2.4	4.8	6.6	0.6	3.6	4.6	2.8	0.7	4.1	2.0	0.8	0.0	6.6	1.1	1.1	0.8	0.9	1.1	4.8	1.0	2.5	1.1	4.3	0.5	1.9	0.3	1.9	0.8	0.6	0.0	7.1	0.0	0.1	0.0	0.0	0.0	1.4	3.8	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.2	0.0	3.5	0.0	48.3	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.3	0.0	0.0	0.0	3.6	0.0	2.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	7.1	0.0	0.0	4.6	26.0	25.1	11.6	5.4	4.6	4.8	6.6	4.1	4.3
SLC6A13	GAT2	ENSG00000010379	"Solute carrier family 6 member 13"	Q9NSD5	12	220621-262873	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"kidney: 77.6;retina: 95.9"	"Cell line enriched"	"Detected in some"	7	"RPTEC TERT1: 10.1"	"Cancer enriched"	"Detected in some"	18	"renal cancer: 32.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036449, HPA052726"			Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol				Mitochondria	"Nucleoplasm, Nucleoli, Cytosol"	"HPA036449: , HPA052726: "	"unprognostic (8.45e-3)"	"unprognostic (4.20e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.64e-5)"	"unprognostic (1.13e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.21e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.91e-1)"	0.6	0.5	3.0	0.4	5.8	0.5	0.5	2.1	5.8	0.5	0.5	2.5	0.0	1.8	0.5	0.9	0.4	4.2	0.5	1.0	3.1	2.4	77.6	13.2	0.9	0.5	3.4	4.1	0.5	0.4	0.4	1.0	0.5	4.8	0.5	0.5	95.9	0.5	0.5	0.6	0.6	0.8	0.4	5.7	0.5	0.5	1.1	2.1	0.0	4.9	0.0	0.5	0.5	0.0	0.4	0.0	0.0	0.0	0.6	0.9	0.3	0.0	0.0	0.1	0.3	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.6	0.0	0.0	0.0	1.3	0.2	0.1	0.0	0.0	0.0	0.4	0.4	0.5	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.1	10.1	0.1	0.1	0.0	0.1	0.0	0.9	0.0	0.0	0.3	0.2	1.0	0.0	0.4	1.4	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.3	3.0	5.8	2.1	5.8	3.1	2.4	3.4	4.1	4.8	2.1
SLC6A15	"FLJ10316, hv7-3, NTT73, SBAT1, V7-3"	ENSG00000072041	"Solute carrier family 6 member 15"	Q9H2J7	12	84859488-84913615	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 30.4;ASC TERT1: 18.8;hTERT-HME1: 43.0;SCLC-21H: 29.3;SK-MEL-30: 21.6"	"Cancer enhanced"	"Detected in some"		"melanoma: 7.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008609	Uncertain		Approved	Nucleoli,Vesicles				Nucleoli	Vesicles	"HPA008609: AB_1857190"	"unprognostic (1.01e-4)"	"unprognostic (9.02e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.65e-6)"	"unprognostic (1.25e-2)"	"unprognostic (2.92e-1)"		"unprognostic (7.65e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.05e-2)"	"unprognostic (7.69e-4)"	"unprognostic (2.57e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.63e-3)"	1.4	4.5	18.0	2.2	16.2	1.0	2.3	17.8	31.0	1.7	2.2	5.4	0.0	1.4	2.8	1.1	6.7	1.2	1.3	1.0	10.9	18.2	1.5	1.0	1.3	1.1	10.3	16.9	2.1	1.0	1.0	5.6	8.9	14.7	1.8	1.8	9.2	1.4	1.5	1.0	4.9	2.1	1.6	4.9	1.1	1.3	3.6	12.8	0.0	2.0	1.8	1.8	1.1	1.5	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	3.6	0.0	30.4	18.8	0.0	0.0	6.4	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.0	8.1	0.0	0.0	9.3	0.0	1.5	0.0	11.2	0.0	0.2	10.5	15.7	4.1	43.0	0.1	0.0	0.0	7.7	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	29.3	7.6	0.0	9.7	21.6	0.0	0.0	0.0	4.6	2.5	0.0	0.0	0.0	0.0	0.0	8.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	18.0	16.2	17.8	18.6	10.9	18.2	10.3	16.9	14.7	12.8
SLC6A17		ENSG00000197106	"Solute carrier family 6 member 17"	Q9H1V8	1	110150486-110202202	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 53.5"	"Cell line enriched"	"Detected in some"	5	"SK-MEL-30: 27.6"	"Cancer enriched"	"Detected in some"	9	"melanoma: 17.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007663, HPA008044"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"				"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA007663: AB_1857194, HPA008044: AB_1857192"	"unprognostic (1.13e-1)"	"unprognostic (1.37e-3)"	"unprognostic (5.52e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.11e-3)"	"unprognostic (3.87e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.68e-3)"	1.4	7.8	9.3	1.2	18.3	1.1	1.3	21.8	53.5	1.0	1.1	2.3	0.0	1.0	1.0	2.1	1.3	1.0	1.1	1.0	11.2	14.9	2.1	0.9	1.0	0.9	6.0	16.2	1.0	2.6	1.0	12.4	1.8	19.5	1.0	1.0	2.6	1.2	1.0	1.0	7.6	1.1	1.1	1.8	1.0	1.8	2.4	0.7	0.0	1.3	0.0	0.9	1.0	0.1	0.3	0.0	0.8	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	4.2	0.4	1.6	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.6	4.7	1.4	27.6	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	5.6	0.0	2.5	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	9.3	18.3	21.8	37.3	11.2	14.9	6.0	16.2	19.5	0.7
SLC7A10	asc-1	ENSG00000130876	"Solute carrier family 7 member 10"	Q9NS82	19	33208664-33225850	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 40.9;brain: 13.6;breast: 15.6"	"Group enriched"	"Detected in some"	5	"BEWO: 4.2;HHSteC: 2.5;HSkMC: 3.6;THP-1: 8.2;U-2 OS: 2.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041884, HPA057036"	Uncertain		Uncertain	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA041884: AB_10794494, HPA057036: "	"unprognostic (1.85e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.79e-6)"	"unprognostic (1.16e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.98e-3)"	"unprognostic (4.64e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.28e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.34e-3)"	"unprognostic (8.91e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.18e-2)"	40.9	1.0	9.8	1.9	13.6	1.0	15.6	2.4	12.1	1.0	2.2	0.8	0.0	1.0	1.0	1.0	1.0	1.0	1.0	1.1	4.7	6.2	1.3	1.0	1.0	1.2	7.6	5.0	1.0	1.2	1.0	0.0	1.2	9.0	1.0	1.0	8.4	2.3	1.0	1.0	1.1	1.0	1.1	0.8	1.0	1.0	1.4	1.8	0.0	1.4	0.0	1.4	1.0	1.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.2	8.2	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	9.8	13.6	2.4	12.1	4.7	6.2	7.6	5.0	9.0	1.8
SMAD2	"JV18-1, MADH2, MADR2"	ENSG00000175387	"SMAD family member 2"	Q15796	18	47808957-47931146	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025507, HPA067203, CAB073546"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli, Cytosol"		"CAB025507: , CAB073546: , HPA067203: "	"unprognostic (1.55e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.82e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (9.44e-5)"	"unprognostic (1.91e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.41e-3)"	"unprognostic (6.46e-2)"	"unprognostic (4.91e-2)"	"unprognostic (9.20e-3)"	"unprognostic (2.68e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.20e-2)"	"unprognostic (6.28e-2)"	38.5	39.2	29.0	26.2	25.9	19.6	31.4	19.5	28.9	28.8	34.2	29.4	28.9	21.5	26.6	26.3	33.5	28.8	25.7	31.1	26.1	27.1	26.4	20.9	28.3	23.8	30.9	24.3	36.6	28.1	25.7	24.4	34.8	28.6	27.8	29.8	31.7	29.7	28.7	33.9	28.0	26.4	34.6	35.4	34.1	26.3	29.2	26.2	60.7	46.1	23.6	31.5	35.1	35.7	12.0	21.8	28.9	24.7	24.5	25.9	19.7	22.4	32.2	19.7	19.0	31.5	38.5	22.5	24.5	29.4	25.6	29.9	12.3	21.5	34.9	17.6	31.0	24.8	22.1	27.3	34.3	37.9	11.3	29.6	48.7	19.9	36.7	41.1	30.3	28.4	35.3	21.9	50.7	28.2	13.7	29.3	31.4	14.6	28.2	19.8	9.6	7.7	20.6	28.7	23.8	57.4	38.7	18.2	21.4	29.5	20.2	24.0	15.3	27.4	31.5	38.0	21.9	10.3	17.8	28.7	27.5	30.4	26.3	28.1	27.7	28.9	22.6	25.0	16.9	24.7	21.2	12.0	23.1	20.9	21.8	9.4	25.8	19.8	22.7	24.5	20.8	15.5	25.9	19.7	29.0	25.9	19.5	28.9	26.1	27.1	30.9	24.3	28.6	26.2
SMC2	"CAP-E, hCAP-E, SMC2L1"	ENSG00000136824	"Structural maintenance of chromosomes 2"	O95347	9	104094260-104141417	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 56.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071309	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA071309: "	"unprognostic (1.51e-1)"	"unprognostic (2.01e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.57e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.47e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.56e-3)"	"unprognostic (8.02e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.32e-2)"	7.4	6.1	6.6	10.1	10.5	15.2	6.1	8.1	9.1	7.9	7.5	4.0	5.1	7.0	6.1	5.2	11.4	5.1	3.6	7.1	6.5	6.8	8.6	5.7	5.5	14.2	8.2	5.2	6.0	4.1	5.2	6.5	7.5	10.7	5.2	8.5	3.0	5.9	4.7	4.2	6.8	6.9	5.4	8.6	13.7	5.9	12.3	8.7	56.1	7.2	12.9	14.7	6.1	6.3	8.9	5.1	12.0	8.3	8.0	7.4	2.8	18.1	14.0	15.8	14.6	3.3	4.9	14.8	16.8	8.0	15.1	12.8	12.1	14.1	34.7	8.2	8.6	30.8	22.9	10.9	20.5	22.0	9.6	20.9	22.5	7.8	0.9	12.6	21.1	3.2	2.2	20.4	8.3	10.6	16.8	28.6	13.6	8.8	32.9	6.5	13.7	11.0	22.1	45.3	13.0	6.5	6.6	15.0	11.6	20.0	9.4	4.9	18.9	8.6	8.4	18.4	19.4	25.4	21.0	10.5	35.2	20.4	11.9	18.6	22.2	12.0	2.8	2.8	6.2	7.1	7.0	8.5	5.7	6.2	3.0	8.9	6.7	7.4	0.4	8.0	8.3	5.1	6.9	2.8	6.6	10.5	8.1	9.1	6.5	6.8	8.2	5.2	10.7	8.7
SMG6	"C17orf31, EST1A, KIAA0732, SMG-6"	ENSG00000070366	"SMG6, nonsense mediated mRNA decay factor"	Q86US8	17	2059839-2303771	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042932	Approved		Supported	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA042932: AB_10964261"	"unprognostic (5.22e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.30e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.33e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.63e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.31e-1)"	"prognostic favourable (1.30e-6)"	"unprognostic (1.90e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.08e-2)"	12.7	16.6	18.1	18.9	17.6	11.9	10.9	19.1	18.4	15.0	10.6	15.1	13.2	9.0	26.2	11.9	16.1	22.2	16.7	16.4	12.8	15.9	11.5	7.3	11.5	10.7	13.4	16.1	38.7	9.3	16.2	17.2	10.1	14.5	14.5	9.5	18.6	10.4	13.3	14.0	15.3	10.3	18.9	12.8	9.0	9.7	39.2	11.5	22.3	11.6	8.4	16.8	12.7	12.4	2.0	3.3	4.8	3.6	4.6	4.3	1.5	8.4	13.0	18.8	12.1	20.3	16.5	9.7	13.7	15.1	15.6	13.3	15.8	4.3	8.9	4.9	20.1	12.4	13.7	11.7	16.4	8.9	8.6	8.7	6.9	7.7	11.6	4.6	6.3	23.3	8.6	12.6	11.2	14.2	7.1	10.9	11.6	6.7	11.6	3.7	6.0	6.8	12.1	12.0	3.5	9.0	7.8	3.2	9.6	14.3	4.2	5.9	6.5	3.4	18.6	14.4	7.9	15.2	14.3	9.5	5.7	4.2	11.5	5.2	8.3	4.8	1.8	2.0	3.7	0.8	3.7	1.2	3.1	3.5	1.0	2.0	4.3	2.9	1.4	4.6	3.6	3.3	1.8	1.5	18.1	17.6	19.1	18.4	12.8	15.9	13.4	16.1	14.5	11.5
SMIM20	"C4orf52, MITRAC7, PNX"	ENSG00000250317	"Small integral membrane protein 20"	Q8N5G0	4	25861830-25929874	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016552	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Cytosol"	Nucleoli	"HPA016552: AB_1859536"	"unprognostic (1.18e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.20e-3)"	"unprognostic (7.01e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.86e-1)"	"prognostic favourable (8.97e-5)"	"unprognostic (5.51e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.12e-3)"	14.9	20.5	21.8	15.6	26.7	7.1	25.0	11.4	28.0	12.9	16.4	8.3	12.8	24.1	13.7	46.4	11.9	15.1	22.5	33.7	17.9	16.2	27.1	22.7	18.5	26.0	19.2	14.3	19.5	50.0	8.7	10.0	9.5	22.8	13.6	16.1	11.3	20.4	15.7	51.3	6.9	23.8	24.0	22.6	12.7	18.8	17.7	13.5	9.3	21.3	15.3	14.5	14.5	15.9	27.1	21.4	13.3	20.3	18.1	31.1	18.2	12.7	10.7	14.4	13.9	16.0	34.8	19.2	12.4	15.2	10.7	13.7	9.5	22.7	21.0	21.7	13.8	3.7	16.7	15.9	15.1	11.9	13.3	12.1	7.8	18.0	27.1	14.4	8.1	24.6	32.0	13.7	20.8	8.2	19.3	6.9	13.2	8.2	15.6	24.5	27.2	16.0	12.9	18.8	13.5	23.9	9.4	18.6	17.3	8.0	5.6	27.4	11.6	20.5	13.7	11.7	13.8	13.1	15.8	13.6	11.2	22.0	17.7	15.3	14.7	13.3	18.2	8.4	15.7	20.3	20.5	27.1	22.7	19.7	20.5	26.8	31.1	24.7	9.2	18.1	15.2	21.4	23.2	18.2	21.8	26.7	11.4	28.0	17.9	16.2	19.2	14.3	22.8	13.5
SMKR1		ENSG00000240204	"Small lysine rich protein 1"	H3BMG3	7	129502479-129512932	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	10	"testis: 65.7"	"Cell line enhanced"	"Detected in many"		"MCF7: 12.6;SCLC-21H: 22.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"B-cells: 2.9;NK-cells: 1.3;T-cells: 3.7"					"Low region specificity"	"Detected in all"			HPA078358			Approved	Nucleoli				Nucleoli		"HPA078358: "	"unprognostic (5.08e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.13e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.02e-1)"	"unprognostic (9.24e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.72e-6)"	"unprognostic (1.67e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.40e-2)"	"unprognostic (3.67e-2)"	0.3	1.0	3.1	0.5	6.3	0.3	1.5	0.8	3.3	0.6	0.3	0.1	0.0	0.5	0.4	1.7	0.4	4.6	0.4	0.2	2.7	2.2	0.7	0.2	0.5	0.7	1.1	2.7	0.3	2.6	2.9	2.7	0.9	1.0	0.5	0.4	0.0	0.3	0.4	0.2	0.5	0.4	0.3	0.5	0.3	0.5	65.7	0.7	0.0	0.7	0.1	0.7	0.2	0.0	2.9	0.0	0.2	0.0	1.3	3.7	0.4	8.6	8.4	0.2	7.4	0.0	0.0	0.0	0.0	0.2	0.7	0.7	0.0	2.3	0.0	0.8	0.5	1.0	1.5	0.0	1.1	8.0	0.9	0.0	1.7	0.0	1.6	0.1	5.6	0.0	3.7	2.3	1.5	0.3	0.5	0.2	0.4	12.6	1.6	0.8	1.1	7.5	0.8	0.0	1.8	3.1	0.0	22.1	6.0	6.3	0.7	0.5	1.9	1.1	0.1	0.0	0.2	4.9	1.8	2.1	2.7	0.1	3.0	0.3	0.6	0.0	0.0	0.0	3.7	0.0	1.7	2.9	0.7	1.9	0.0	1.5	1.5	1.4	0.2	1.3	0.0	0.0	0.0	0.4	3.1	6.3	0.8	3.3	2.7	2.2	1.1	2.7	1.0	0.7
SMPDL3A	"ASM3A, ASML3a, FLJ20177, yR36GH4.1"	ENSG00000172594	"Sphingomyelin phosphodiesterase acid like 3A"	Q92484	6	122789049-122809720	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 23.8;hTCEpi: 19.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	10	"basophil: 31.2"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 31.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030148	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria	"Secreted to blood"		22000000	"Nucleoplasm, Nucleoli, Mitochondria"		"HPA030148: AB_10601591"	"unprognostic (2.60e-1)"	"unprognostic (1.22e-1)"	"prognostic favourable (6.11e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.30e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.44e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	8.8	15.9	4.0	8.3	5.4	8.1	24.9	9.7	9.9	35.3	46.7	3.8	8.0	19.2	10.0	9.8	9.6	5.1	8.5	11.9	4.5	4.1	20.1	36.9	13.0	29.1	4.7	5.6	6.2	24.6	16.1	7.0	23.2	6.5	19.6	28.5	7.6	9.5	13.7	56.1	32.1	63.6	10.9	4.9	37.7	13.1	3.8	3.2	3.3	7.2	18.0	7.6	18.7	24.3	0.1	0.4	31.2	3.2	0.0	0.0	0.5	0.1	1.3	3.2	1.5	23.8	10.8	10.3	5.4	14.5	1.6	3.5	1.7	1.4	0.0	0.8	3.4	2.5	0.9	2.7	1.3	0.0	2.8	1.2	5.4	4.5	15.3	0.0	0.1	13.1	19.5	1.5	2.8	2.8	1.9	0.0	6.6	4.7	0.0	0.1	0.5	4.2	0.0	5.7	0.2	7.9	2.1	2.4	0.0	0.7	9.7	13.6	1.6	0.7	5.6	3.2	1.9	0.3	3.5	0.0	0.0	0.0	4.6	2.5	7.1	31.2	1.7	0.4	0.0	1.9	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	3.2	0.0	0.0	0.5	4.0	5.4	9.7	9.9	4.5	4.1	4.7	5.6	6.5	3.2
SNAPC1	"PTFgamma, SNAP43"	ENSG00000023608	"Small nuclear RNA activating complex polypeptide 1"	Q16533	14	61762357-61796428	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 42.5;U-2 OS: 56.4;U-251 MG: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA067076, HPA072276"			Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA067076: , HPA072276: "	"unprognostic (7.40e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.94e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.01e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.26e-1)"	9.9	12.3	7.5	8.6	10.3	7.0	8.4	12.1	8.0	14.4	6.8	5.6	11.6	4.9	10.3	15.8	9.2	8.7	10.4	11.2	7.8	7.6	8.7	7.0	10.5	9.7	11.8	5.4	12.1	5.0	8.8	27.2	11.3	14.2	10.3	4.2	5.7	7.2	19.8	5.6	8.7	5.2	6.9	14.5	9.5	5.4	24.9	9.4	9.1	9.8	8.2	8.9	17.4	14.3	12.0	9.3	7.5	7.0	9.6	13.1	5.1	14.9	2.9	2.9	6.1	3.2	3.8	3.4	12.7	8.4	14.6	8.7	1.0	3.1	3.1	16.9	5.4	4.7	2.8	3.8	24.1	3.4	2.0	1.8	1.5	2.1	8.6	1.9	4.1	3.6	2.6	12.3	42.5	5.5	2.0	2.9	13.9	1.9	4.7	3.1	2.8	9.7	3.6	7.7	1.1	11.9	2.3	2.1	5.0	8.3	1.5	10.0	3.0	3.1	8.5	16.1	56.4	10.4	38.8	1.9	2.0	2.7	10.9	2.5	9.5	7.5	7.0	5.8	6.4	5.9	8.3	12.0	8.1	5.5	7.0	12.0	13.1	8.5	7.1	9.6	4.9	9.3	8.7	5.1	7.5	10.3	12.1	8.0	7.8	7.6	11.8	5.4	14.2	9.4
SNAPC3	"MGC132011, MGC33124, PTFbeta, SNAP50"	ENSG00000164975	"Small nuclear RNA activating complex polypeptide 3"	Q92966	9	15422704-15465953	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA053145, HPA066031"			Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"	Nucleoli	"HPA053145: , HPA066031: "	"unprognostic (2.62e-1)"	"unprognostic (4.26e-1)"	"unprognostic (5.42e-3)"	"unprognostic (2.09e-1)"	"unprognostic (4.93e-3)"	"unprognostic (6.08e-2)"	"unprognostic (5.60e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.36e-3)"	"unprognostic (3.07e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.09e-2)"	9.8	18.5	18.7	10.3	21.1	4.6	10.4	26.3	21.2	17.9	13.2	10.4	10.3	11.6	16.5	15.5	12.6	10.8	10.8	17.5	18.0	14.0	12.3	8.6	10.0	11.2	15.2	16.3	17.4	11.1	12.8	18.4	16.7	21.8	13.3	14.6	9.6	10.5	11.3	19.3	13.7	14.2	12.8	15.2	12.8	10.5	14.7	15.9	11.9	11.3	6.8	10.8	12.9	15.1	12.2	7.7	5.0	21.2	5.0	8.2	5.5	4.1	5.3	11.2	4.2	9.0	9.4	6.5	6.5	2.8	3.8	4.5	2.5	1.8	2.9	2.5	4.0	2.5	5.9	3.0	4.7	13.5	6.9	10.4	11.1	3.4	4.5	2.3	8.1	6.1	6.1	2.7	3.1	7.0	2.9	4.8	8.7	1.3	2.8	7.4	3.6	13.9	5.7	1.3	1.6	6.6	2.5	11.9	8.5	2.2	2.0	1.5	4.8	4.8	5.8	6.4	2.5	2.7	8.1	6.3	7.5	3.6	4.1	3.1	2.9	3.4	10.1	5.0	5.7	16.7	5.5	9.9	5.7	5.1	7.7	12.2	8.2	7.9	1.2	5.0	21.2	6.3	7.9	5.5	18.7	21.1	26.3	21.2	18.0	14.0	15.2	16.3	21.8	15.9
SNAPIN	"BLOC1S7, BORCS3, SNAPAP"	ENSG00000143553	"SNAP associated protein"	O95295	1	153658654-153661830	"Predicted intracellular proteins, Transporters"	"Exocytosis, Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046974	Approved		Approved	"Nucleoli,Golgi apparatus"			15000	"Golgi apparatus"	Nucleoli	"HPA046974: AB_10962506"	"unprognostic (3.65e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.47e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.86e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (5.42e-4)"	"unprognostic (2.31e-1)"	"unprognostic (4.73e-1)"	"unprognostic (1.31e-3)"	"unprognostic (4.89e-2)"	21.8	32.5	20.2	14.5	25.9	8.4	30.2	12.1	26.3	17.5	19.2	18.5	17.2	9.1	19.7	25.0	20.7	20.4	21.4	38.1	17.4	17.7	21.8	22.1	15.7	26.1	21.6	17.8	17.9	22.9	18.0	10.8	14.5	20.5	17.9	14.7	15.6	14.1	22.6	56.9	16.1	13.2	24.9	22.1	19.4	16.0	16.5	20.8	18.1	19.9	29.8	21.7	19.6	13.9	42.4	50.8	44.6	49.9	35.4	42.8	42.8	20.1	24.7	21.0	12.7	26.9	18.0	13.6	17.1	19.0	24.2	18.5	17.5	16.1	14.5	34.5	17.3	26.9	17.2	22.3	17.0	19.3	23.8	16.0	19.0	8.4	27.8	15.7	10.2	21.6	16.7	18.1	20.7	22.7	13.5	11.2	24.2	32.5	17.9	9.2	11.4	26.6	17.0	18.3	38.2	26.8	19.4	16.1	28.2	19.7	22.9	22.3	34.8	16.7	19.9	11.3	17.2	22.3	16.0	27.2	29.7	22.1	21.5	9.8	14.6	27.6	49.9	44.6	30.9	49.1	35.0	42.4	31.4	31.0	50.8	36.9	34.8	31.8	10.4	35.4	39.0	38.1	42.8	42.8	20.2	25.9	12.1	26.3	17.4	17.7	21.6	17.8	20.5	20.8
SNORC	"ASCL830, C2orf82, UNQ830"	ENSG00000182600	"Secondary ossification center associated regulator of chondrocyte maturation"	Q6UX34	2	232857270-232878708	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 27.9;breast: 19.6"	"Cell line enriched"	"Detected in some"	14	"Hep G2: 35.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	18	"basophil: 6.3"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 6.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA052824	Uncertain		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"			"Nucleoplasm, Nucleoli"		"HPA052824: "	"unprognostic (4.58e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavourable (3.56e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.06e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.23e-3)"	"unprognostic (3.52e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.30e-7)"	"unprognostic (1.83e-3)"	"unprognostic (8.15e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.33e-2)"	1.4	1.5	4.8	0.8	6.4	1.5	19.6	2.8	9.0	0.3	2.4	9.3	0.0	2.7	0.7	2.0	0.3	0.4	0.3	0.4	8.8	7.8	1.2	2.1	1.3	1.7	11.9	7.0	0.5	4.2	0.7	0.3	0.9	9.1	3.0	1.1	0.0	3.2	0.6	2.8	10.8	2.0	0.6	27.9	1.4	1.3	6.2	7.4	0.0	0.9	0.0	0.5	0.5	0.0	0.0	0.0	6.3	0.0	0.0	0.3	0.0	0.5	0.0	0.2	0.8	0.6	1.0	1.5	0.1	0.0	0.2	0.4	0.0	0.1	0.0	0.4	0.1	0.3	0.0	0.0	0.0	0.4	1.3	0.3	0.2	35.5	0.5	0.0	1.0	0.0	0.8	0.2	0.5	0.9	0.1	0.1	0.1	0.1	0.1	0.3	0.0	1.4	0.2	0.3	0.2	0.0	0.5	0.1	0.5	0.2	0.0	1.3	0.0	1.6	0.5	0.1	0.5	0.5	0.4	2.3	2.5	0.1	0.0	0.8	0.2	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	6.4	2.8	9.0	8.8	7.8	11.9	7.0	9.1	7.4
SNRNP35	U1SNRNPBP	ENSG00000184209	"Small nuclear ribonucleoprotein U11/U12 subunit 35"	Q16560	12	123457641-123473154	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059145, HPA067031"	Supported		Approved	Nucleoli				Nucleoli		"HPA059145: , HPA067031: "	"unprognostic (3.80e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.78e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.56e-3)"	"unprognostic (7.24e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.31e-3)"	15.3	15.4	18.7	14.1	20.5	14.1	17.7	25.4	23.1	14.1	15.2	22.8	14.8	14.3	16.0	15.1	17.1	14.8	11.4	22.4	18.5	18.1	16.3	19.3	16.4	16.8	21.2	18.5	13.6	12.9	20.9	19.6	15.6	20.4	16.3	17.1	17.5	21.8	12.9	64.0	24.1	15.0	15.6	20.3	21.0	15.1	14.5	23.6	14.1	20.2	23.7	17.7	12.4	14.2	35.1	24.8	37.5	24.7	23.3	40.4	19.1	12.1	13.1	15.7	8.0	11.4	10.7	13.8	10.7	15.7	11.3	8.2	8.1	8.4	24.2	7.9	15.4	12.6	13.4	19.1	9.7	17.7	10.8	11.3	11.7	18.4	8.0	11.6	18.2	13.0	13.4	10.1	9.7	15.3	14.5	4.9	15.7	25.7	12.4	26.2	10.9	12.4	9.6	6.9	12.8	25.8	24.7	13.4	19.9	9.5	20.1	14.6	24.2	15.7	17.7	7.5	13.7	9.4	9.5	12.3	12.4	14.2	12.3	11.4	10.3	37.0	24.4	37.5	24.3	24.7	24.0	35.1	30.8	27.3	24.6	30.7	24.4	25.9	36.7	23.3	22.7	24.8	40.4	19.1	18.7	20.5	25.4	23.1	18.5	18.1	21.2	18.5	20.4	23.6
SNX10		ENSG00000086300	"Sorting nexin 10"	Q9Y5X0	7	26291895-26374329	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"		"Disease mutation, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 67.6;brain: 39.0;liver: 37.4"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 26.6;U-937: 21.8;WM-115: 75.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 67.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015605, HPA064782"	Approved		Supported	Nucleoplasm,Nucleoli,Microtubules				"Nucleoplasm, Microtubules"	Nucleoli	"HPA015605: AB_1857342, HPA064782: "	"unprognostic (6.42e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.45e-1)"	"unprognostic (7.62e-2)"	"prognostic unfavourable (1.16e-4)"	"unprognostic (6.92e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.51e-2)"	"unprognostic (4.87e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.56e-1)"	"prognostic unfavourable (8.06e-5)"	"unprognostic (1.12e-2)"	"unprognostic (3.21e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.50e-1)"	17.7	8.7	20.2	18.6	17.9	20.9	6.7	13.2	39.0	2.9	3.3	2.1	0.1	2.5	5.4	0.8	1.8	1.9	5.2	1.3	22.2	32.7	21.3	37.4	22.4	18.0	27.8	20.8	1.0	5.0	0.6	3.0	8.9	36.2	2.2	3.9	1.8	1.4	1.5	0.9	1.0	3.6	5.4	15.4	22.1	2.3	3.0	2.1	3.8	1.9	0.1	13.6	6.3	1.8	16.3	20.1	67.6	30.9	9.0	5.6	11.6	13.6	1.2	0.0	2.6	0.0	0.0	14.9	0.0	1.0	0.0	0.0	0.1	4.6	6.0	10.7	0.0	0.4	3.4	0.9	0.0	8.2	3.2	0.6	0.1	9.0	0.0	12.7	2.3	0.1	1.4	0.0	1.1	0.2	0.3	0.0	0.0	2.4	5.3	13.4	3.9	1.3	0.0	0.0	0.3	26.6	2.9	5.8	1.8	2.9	2.2	15.5	3.9	18.2	0.0	0.0	3.2	0.0	3.4	4.6	3.7	4.0	0.1	21.8	75.8	8.2	29.2	0.7	4.0	30.9	3.8	16.3	2.8	3.4	20.1	14.5	1.5	2.6	67.6	9.0	30.1	7.4	5.6	11.6	20.2	17.9	13.2	39.0	22.2	32.7	27.8	20.8	36.2	2.1
SNX15		ENSG00000110025	"Sorting nexin 15"	Q9NRS6	11	65027408-65040572	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038955	Approved		Supported	"Nucleoli,Vesicles,Plasma membrane,Cytosol"				"Nucleoli, Cytosol"	"Vesicles, Plasma membrane"	"HPA038955: AB_10672834"	"unprognostic (2.00e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.93e-1)"	"unprognostic (9.61e-4)"	"unprognostic (2.79e-1)"	"unprognostic (4.06e-3)"	"unprognostic (4.45e-3)"	"unprognostic (4.74e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.55e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.79e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.68e-4)"	17.9	13.6	17.1	12.7	18.3	11.6	23.5	25.7	21.9	13.2	22.7	16.7	9.5	19.7	14.2	8.9	15.9	11.4	13.9	15.1	16.2	14.3	15.7	9.8	14.1	14.7	16.3	14.5	18.3	17.7	13.7	8.4	9.5	13.4	15.1	11.6	11.2	15.6	15.4	25.2	17.2	20.4	15.0	17.6	11.3	13.5	7.6	15.8	12.4	14.4	10.1	11.5	14.9	12.5	7.7	8.0	10.9	18.3	3.2	7.1	5.7	17.4	12.9	8.4	8.2	10.1	7.5	4.7	1.7	7.9	13.8	12.7	10.1	13.7	17.8	9.9	9.9	9.8	9.8	8.7	3.8	26.7	8.1	8.9	10.6	16.9	11.0	4.6	14.4	6.3	13.0	14.6	8.4	8.2	15.0	11.4	7.2	10.5	16.3	20.7	9.0	12.8	13.5	5.0	19.1	10.2	3.8	15.2	11.4	14.9	13.5	12.9	13.6	10.7	16.1	14.0	13.4	14.1	7.4	12.3	21.0	17.0	13.7	7.3	4.8	7.8	11.3	10.9	6.9	13.6	5.6	7.7	7.1	6.1	8.0	6.1	5.2	4.7	1.6	3.2	18.3	5.5	6.7	5.7	17.1	18.3	25.7	21.9	16.2	14.3	16.3	14.5	13.4	15.8
SNX30	ATG24A	ENSG00000148158	"Sorting nexin family member 30"	Q5VWJ9	9	112750838-112881671	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019346	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli, Cytosol"		"HPA019346: AB_2286395"	"unprognostic (1.67e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.69e-1)"	"unprognostic (8.05e-3)"	"unprognostic (2.04e-3)"	"unprognostic (4.48e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.48e-1)"	"prognostic favourable (1.01e-7)"	"unprognostic (4.48e-3)"	"unprognostic (1.18e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.41e-2)"	4.9	4.4	12.2	7.7	12.6	8.3	7.7	18.1	18.5	10.9	11.1	25.6	3.6	7.9	6.4	4.1	5.3	3.8	5.4	3.4	14.2	12.0	23.7	5.2	23.4	8.8	14.8	12.8	6.9	5.2	6.9	6.3	5.1	14.7	4.1	11.7	4.9	7.1	4.3	2.6	5.7	8.9	7.5	20.3	7.4	4.7	12.7	11.8	2.3	3.1	2.6	8.7	5.4	4.6	0.7	4.2	1.5	5.1	0.8	1.7	1.6	6.0	3.7	6.5	5.1	8.2	7.5	5.5	5.2	10.8	4.4	4.2	13.3	1.4	10.0	4.4	13.3	7.2	7.9	3.0	6.8	3.2	3.7	3.0	3.4	5.4	5.9	3.1	5.5	6.1	4.3	6.7	5.0	3.7	4.8	5.7	5.9	4.2	2.0	3.6	7.2	4.0	4.3	15.2	2.5	8.5	10.5	9.7	3.1	6.7	9.3	12.9	6.9	5.5	4.2	6.5	7.0	19.1	4.4	14.9	13.7	4.8	8.4	2.9	12.7	0.0	5.1	1.5	0.8	2.0	1.7	0.0	0.8	1.0	4.2	0.7	0.7	0.6	0.7	0.8	2.1	0.7	1.6	1.6	12.2	12.6	18.1	18.5	14.2	12.0	14.8	12.8	14.7	11.8
SOGA1	"C20orf117, dJ132F21.1, FLJ44670, KIAA0889, SOGA"	ENSG00000149639	"Suppressor of glucose, autophagy associated 1"	O94964	20	36777442-36863686	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 55.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043992	Approved		Approved	Nucleoli,Cytosol	"Secreted to blood"			"Nucleoli, Cytosol"		"HPA043992: "	"unprognostic (2.34e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (8.28e-5)"	"unprognostic (1.09e-3)"	"unprognostic (2.85e-1)"	"prognostic unfavourable (4.49e-4)"	"unprognostic (6.99e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.45e-3)"	6.2	11.4	10.8	4.5	10.6	1.4	6.0	55.5	12.5	11.3	8.3	20.5	7.2	2.5	8.8	5.3	7.2	9.4	9.9	6.7	9.9	7.5	4.7	1.3	6.1	3.0	12.7	8.9	12.6	3.7	11.5	4.4	7.9	8.7	10.7	3.9	6.7	4.4	12.3	2.9	11.0	4.6	14.1	7.9	5.3	5.3	14.8	14.7	0.9	16.0	4.7	4.1	8.0	10.5	1.0	2.1	1.4	0.7	0.7	0.2	0.2	7.4	10.2	12.4	13.3	7.2	6.6	3.2	6.6	7.1	9.3	5.6	4.1	1.2	3.3	2.4	11.5	10.1	9.9	6.1	9.8	0.5	1.9	5.3	9.5	5.4	3.8	1.2	5.2	3.7	7.5	8.9	6.4	6.1	3.7	0.7	10.2	7.2	3.7	2.8	3.1	7.9	8.9	11.5	1.2	5.5	2.2	14.8	9.2	13.6	15.0	4.3	19.1	8.0	9.2	23.5	4.6	11.5	14.3	1.4	0.3	3.3	10.0	1.6	14.8	1.4	0.7	0.2	0.1	0.4	0.2	1.0	0.1	0.1	0.4	1.0	0.2	0.2	1.4	0.7	0.3	2.1	0.1	0.2	10.8	10.6	55.5	12.0	9.9	7.5	12.7	8.9	8.7	14.7
SOX15	"SOX20, SOX26, SOX27"	ENSG00000129194	"SRY-box 15"	O60248	17	7588178-7590170	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 62.7;lymphoid tissue: 38.7;skin 1: 30.0;tongue: 59.0"	"Group enriched"	"Detected in some"	7	"A-431: 40.8;HaCaT: 45.9;HBEC3-KT: 18.3;hTCEpi: 18.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 67.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 7.1;non-classical monocyte: 10.8"	"Lineage enriched"	"Detected in many"	4	"monocytes: 10.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA067196, HPA074049"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles"				Nucleoplasm	"Nucleoli, Golgi apparatus, Vesicles"	"HPA067196: , HPA074049: "	"unprognostic (5.79e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.81e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.97e-1)"	1.0	0.8	4.6	1.0	4.1	2.1	1.3	7.2	5.0	7.5	2.6	1.1	1.0	0.7	4.4	1.7	62.7	3.7	1.0	2.9	3.1	4.1	1.3	1.0	1.5	1.0	2.6	1.0	7.0	1.0	0.1	2.0	2.0	3.5	4.1	0.6	1.4	3.4	7.0	1.9	30.0	1.0	1.6	1.4	1.0	0.7	1.3	1.0	1.8	1.0	59.0	38.7	3.6	7.8	0.0	2.4	0.2	10.8	0.0	0.0	0.5	40.8	1.0	0.6	0.3	0.0	0.1	3.2	0.4	0.1	0.3	0.6	0.8	0.2	0.1	0.4	0.0	45.9	0.0	18.3	0.1	1.1	1.2	0.1	0.5	0.1	0.0	0.0	0.9	0.0	18.2	0.2	4.1	0.0	0.9	0.3	0.0	0.3	0.2	0.5	1.2	0.2	0.5	0.6	0.3	0.8	0.2	0.3	0.7	0.5	0.1	0.2	0.3	0.3	0.5	0.4	0.8	0.5	1.4	0.3	0.4	0.5	1.5	0.5	1.0	0.2	2.4	0.0	0.0	7.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	10.8	1.2	0.0	0.5	4.6	4.1	7.2	4.4	3.1	4.1	2.6	1.0	3.5	1.0
SP5		ENSG00000204335	"Sp5 transcription factor"	Q6BEB4	2	170715351-170718078	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"Hep G2: 50.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"Low region specificity"	"Detected in many"			HPA074123			Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA074123: "	"unprognostic (1.16e-2)"	"unprognostic (6.99e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.52e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.60e-2)"	"unprognostic (4.77e-1)"	"unprognostic (8.97e-3)"	"unprognostic (1.79e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.06e-8)"	"unprognostic (8.05e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.17e-1)"	8.7	1.8	0.5	2.5	0.6	0.1	7.4	1.6	1.0	11.4	3.9	1.4	3.2	3.1	7.2	3.0	1.9	3.0	5.1	0.8	0.6	1.4	0.8	5.9	4.6	3.1	0.2	0.8	1.5	0.5	0.1	0.1	2.1	0.4	7.2	1.0	3.8	2.1	0.9	0.7	6.6	3.1	3.1	0.1	0.2	7.3	2.4	0.0	0.2	0.1	0.8	6.5	3.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.6	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.0	1.4	0.1	0.1	0.0	50.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	1.6	1.0	0.6	1.4	0.2	0.8	0.4	0.0
SPATA17	IQCH	ENSG00000162814	"Spermatogenesis associated 17"	Q96L03	1	217631324-217871696	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 48.0"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 4.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA030099	Enhanced		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA030099: AB_2270988"	"unprognostic (4.72e-2)"	"unprognostic (7.58e-3)"	"unprognostic (4.30e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.80e-2)"	"unprognostic (3.24e-4)"	"unprognostic (2.07e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.82e-1)"	0.5	0.6	1.4	0.3	5.2	2.4	0.9	0.5	1.2	1.0	0.5	2.7	2.9	0.6	0.7	9.7	0.5	6.8	0.8	1.1	2.3	2.2	2.8	0.4	3.0	0.3	0.8	1.6	3.3	0.6	3.0	10.8	0.4	11.1	0.7	0.3	1.2	0.6	1.2	2.9	1.0	0.7	0.2	0.7	0.4	0.6	48.0	1.4	0.0	3.1	0.3	0.2	0.5	0.5	1.3	0.6	2.3	0.6	0.6	1.0	0.1	0.6	1.2	1.2	1.2	0.3	2.0	0.9	0.4	0.7	0.6	0.3	0.8	3.2	0.6	1.0	0.4	2.2	0.8	1.1	0.7	0.6	1.2	0.5	1.5	0.7	0.6	0.3	0.5	0.7	2.3	1.2	1.2	0.1	0.7	1.3	0.6	2.5	0.4	1.0	2.3	1.2	0.4	0.4	0.4	2.3	0.9	4.7	1.8	0.7	0.7	0.6	1.4	0.6	0.6	0.8	0.6	0.9	0.5	1.2	0.7	0.3	1.9	0.5	1.0	2.3	0.5	0.5	0.9	0.5	0.8	0.7	0.7	0.7	0.3	1.3	0.9	1.0	1.5	0.6	0.6	0.6	0.3	0.1	1.4	5.2	0.5	1.2	2.3	2.2	0.8	1.6	11.1	1.4
SPATA5L1	"FLJ12286, MGC5347"	ENSG00000171763	"Spermatogenesis associated 5 like 1"	Q9BVQ7	15	45402331-45421419	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA043679	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA043679: AB_10964179"	"unprognostic (6.22e-2)"	"unprognostic (3.34e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.57e-2)"	"unprognostic (9.67e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.69e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.97e-2)"	"prognostic unfavourable (7.88e-4)"	"unprognostic (5.40e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.72e-2)"	"unprognostic (4.80e-2)"	9.0	8.7	10.7	12.3	10.7	11.1	9.5	21.3	8.2	10.3	9.9	10.0	10.2	12.1	9.8	8.4	17.5	8.8	8.3	9.6	9.6	5.9	10.8	14.8	11.2	14.1	13.5	5.8	12.9	12.0	7.6	7.6	10.6	8.9	9.9	10.2	7.2	9.4	12.8	15.9	16.1	13.2	9.4	7.1	8.6	8.2	12.1	12.0	9.9	11.2	12.3	10.9	10.2	11.9	3.6	3.3	4.8	6.4	3.3	4.7	0.7	7.2	5.6	7.5	5.5	6.2	6.1	9.1	6.5	5.9	7.0	6.9	12.7	4.7	5.3	7.2	4.2	16.7	11.1	8.1	7.9	7.2	6.2	6.9	8.9	9.9	7.0	9.2	3.0	5.0	9.3	5.8	7.7	5.6	11.1	8.6	7.9	4.8	6.3	17.7	5.3	7.2	7.1	10.5	4.9	8.8	7.2	10.3	5.2	5.3	11.7	5.8	10.3	16.9	3.4	3.5	5.2	21.0	13.7	7.3	14.5	8.2	8.9	15.2	6.2	0.1	2.8	4.8	4.1	2.6	1.5	1.9	2.8	4.7	3.3	3.6	2.9	3.0	4.2	3.3	6.4	2.5	2.6	0.7	10.7	10.7	21.3	8.2	9.6	5.9	13.5	5.8	8.9	12.0
SPATS2L	"DNAPTP6, SGNP"	ENSG00000196141	"Spermatogenesis associated serine rich 2 like"	Q9NUQ6	2	200305881-200482263	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 76.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055427, HPA066310"	Uncertain		Enhanced	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA055427: , HPA066310: "	"unprognostic (1.13e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.39e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (7.43e-4)"	"unprognostic (3.95e-1)"	"unprognostic (7.84e-3)"	"unprognostic (3.71e-2)"	"unprognostic (5.67e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.99e-1)"	25.0	13.5	22.4	14.3	20.1	4.2	46.1	15.7	25.7	33.1	34.5	14.5	27.2	34.3	20.4	20.7	28.0	34.8	46.9	46.4	18.4	18.8	37.7	44.9	22.4	14.7	21.9	20.9	30.0	24.3	17.1	24.7	26.9	20.3	27.3	34.6	14.9	63.4	28.8	26.5	15.6	44.6	20.6	23.4	22.1	42.2	11.5	16.7	14.3	21.6	17.5	12.3	25.4	46.5	2.2	9.8	22.9	3.3	4.2	17.0	1.6	27.1	15.7	18.5	2.3	12.4	15.9	6.9	48.7	16.3	31.7	23.8	42.4	29.9	0.1	11.3	30.9	27.0	5.6	28.4	20.9	16.3	7.8	0.2	14.3	50.8	22.3	4.6	2.0	19.5	28.3	21.2	20.3	12.3	6.3	19.6	42.1	8.3	0.7	1.3	4.5	36.2	0.1	65.9	1.9	76.5	22.2	0.5	5.2	12.7	7.1	19.8	3.8	6.5	20.4	21.1	21.3	6.5	27.7	5.8	5.6	0.3	18.0	2.2	29.6	22.9	3.1	4.2	3.6	3.3	8.3	1.6	3.9	3.6	9.8	2.2	1.7	2.0	3.1	4.2	2.5	7.6	17.0	1.6	22.4	20.1	15.7	25.7	18.4	18.8	21.9	20.9	20.3	16.7
SPC24	"FLJ90806, SPBC24"	ENSG00000161888	"SPC24, NDC80 kinetochore complex component"	Q8NBT2	19	11131520-11155808	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 58.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA051234	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA051234: "	"unprognostic (1.57e-1)"	"prognostic favourable (3.59e-4)"	"unprognostic (6.79e-2)"	"unprognostic (1.07e-3)"	"unprognostic (4.04e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavourable (1.46e-4)"	"unprognostic (1.21e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavourable (1.22e-4)"	"unprognostic (6.12e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.62e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.82e-2)"	2.8	3.2	1.1	9.0	1.0	19.4	3.8	0.4	1.9	2.8	4.0	0.8	0.9	3.5	2.2	2.8	8.4	1.4	2.4	8.2	1.0	0.4	1.8	2.6	4.2	4.9	0.6	1.0	1.1	1.0	0.1	1.0	5.9	0.6	1.4	3.5	0.8	2.4	1.5	2.7	3.2	4.4	6.7	0.7	5.5	4.0	13.3	0.7	58.0	0.9	12.8	12.2	2.3	3.2	1.9	1.3	7.2	1.4	4.2	3.7	0.7	26.0	9.8	13.6	11.1	1.9	3.6	6.2	15.3	5.7	14.5	16.5	10.3	8.9	20.7	17.5	6.8	14.2	10.6	10.9	10.8	10.9	9.1	27.8	22.9	15.3	0.4	19.4	12.5	0.7	0.4	10.3	4.8	12.8	14.8	43.7	10.1	17.2	26.6	11.8	9.6	15.9	21.3	20.9	6.7	4.3	8.6	14.3	10.3	13.4	8.4	3.5	8.2	7.1	12.0	13.8	14.6	18.4	18.3	26.7	13.7	19.9	10.1	19.3	11.1	4.1	1.4	1.5	1.4	1.2	1.2	1.9	2.3	3.4	0.5	1.9	2.7	1.7	7.2	4.2	1.3	1.3	3.7	0.7	1.1	1.0	0.4	1.9	1.0	0.4	0.6	1.0	0.6	0.7
SPDEF	"bA375E1.3, PDEF"	ENSG00000124664	"SAM pointed domain containing ETS transcription factor"	O95238	6	34537802-34556333	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 55.8;salivary gland: 98.0"	"Group enriched"	"Detected in some"	5	"MCF7: 68.4;SK-BR-3: 47.3;T-47d: 37.8"	"Group enriched"	"Detected in many"	10	"breast cancer: 103.4;endometrial cancer: 78.1;prostate cancer: 388.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	8	"midbrain: 2.1"	HPA055707			Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA055707: "	"unprognostic (2.98e-1)"	"unprognostic (9.68e-2)"	"unprognostic (2.84e-1)"	"prognostic favourable (9.26e-9)"	"unprognostic (1.57e-1)"	"unprognostic (7.10e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.39e-3)"	"unprognostic (3.48e-3)"	"unprognostic (2.92e-1)"	"unprognostic (6.16e-11)"	"unprognostic (8.04e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.12e-2)"	0.1	0.0	0.4	2.4	0.2	0.0	28.5	0.3	0.7	12.0	6.5	0.2	0.3	4.4	4.0	0.3	0.9	2.4	16.1	0.1	0.4	0.3	0.1	0.1	5.5	0.1	0.3	0.1	0.6	1.3	0.0	0.1	0.2	0.1	55.8	4.0	0.2	98.0	4.5	0.1	3.0	7.8	0.1	0.1	0.1	10.8	0.1	0.1	0.2	0.1	7.8	22.9	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.4	0.0	0.1	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	47.3	0.0	37.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.7	0.4	0.3	0.3	0.1	0.1	0.1
SPG11	"FLJ21439, KIAA1840"	ENSG00000104133	"SPG11, spatacsin vesicle trafficking associated"	Q96JI7	15	44562696-44663678	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040412, HPA040947"	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoli	"HPA040412: AB_10795418, HPA040947: AB_10796232"	"unprognostic (1.10e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.99e-1)"	"unprognostic (9.31e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.26e-3)"	"unprognostic (2.58e-2)"	"unprognostic (9.19e-2)"	"prognostic favourable (6.28e-5)"	"unprognostic (8.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.72e-1)"	"unprognostic (6.06e-2)"	23.8	24.6	16.6	26.4	22.2	25.8	23.4	21.2	21.2	20.8	26.0	31.7	25.8	17.9	18.6	28.1	22.9	19.0	20.2	19.3	16.1	15.2	22.0	25.1	22.6	26.9	26.3	15.6	20.5	25.5	33.4	25.9	15.7	22.1	22.3	21.6	18.7	22.7	26.6	19.0	31.8	26.2	21.5	22.1	39.2	22.8	22.1	23.1	35.8	30.9	12.6	26.0	23.0	19.4	12.8	7.1	13.6	13.0	6.7	8.3	3.8	8.1	5.5	14.2	13.8	22.2	21.9	10.2	8.6	11.1	8.4	10.8	6.7	7.9	6.0	10.8	11.4	18.7	9.8	13.2	8.3	18.0	6.0	13.8	13.1	10.1	15.7	13.7	12.7	16.7	15.1	6.9	19.9	11.9	17.5	15.5	11.9	7.1	6.1	12.7	7.5	7.6	8.1	11.9	6.5	17.9	21.4	9.3	10.9	9.4	15.0	8.0	14.2	18.8	12.9	11.2	5.6	13.9	10.3	15.5	13.7	12.0	11.5	18.2	11.4	6.0	8.8	12.3	7.8	10.2	8.3	10.9	6.5	5.8	6.9	12.8	5.4	6.4	13.6	6.7	13.0	7.1	6.6	3.8	16.6	22.2	21.2	21.2	16.1	15.2	26.3	15.6	22.1	23.1
SPIN4	"FLJ44984, TDRD28"	ENSG00000186767	"Spindlin family member 4"	Q56A73	X	63347228-63351344	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 27.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA044559	Uncertain		Approved	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA044559: AB_10794171"	"unprognostic (9.66e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.22e-4)"	"unprognostic (3.30e-3)"	"unprognostic (9.44e-3)"	"unprognostic (8.62e-2)"	"unprognostic (3.65e-3)"	"unprognostic (9.39e-2)"	"prognostic unfavourable (3.56e-6)"	"unprognostic (1.74e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.09e-2)"	3.9	3.2	4.2	5.1	4.4	13.8	13.7	2.3	5.4	5.1	5.9	6.7	2.0	3.5	6.7	4.7	16.8	3.9	3.5	3.2	4.7	6.1	3.3	2.4	16.8	7.6	4.5	2.3	6.6	4.2	4.8	4.7	12.3	5.2	7.2	6.9	4.8	27.4	2.9	1.2	3.5	4.9	5.8	5.2	5.9	3.9	3.4	3.5	11.2	5.6	6.4	11.8	4.3	8.2	1.2	1.4	3.7	2.1	6.0	1.5	0.8	16.1	4.1	9.7	7.8	2.1	3.0	7.0	8.1	3.4	4.7	5.7	2.7	16.1	0.0	3.6	3.8	5.4	12.5	5.9	8.7	6.9	3.9	20.8	5.6	2.5	0.9	17.9	16.3	1.4	2.1	7.9	4.3	5.2	6.3	20.3	10.8	5.4	5.9	9.7	10.0	6.1	8.4	20.9	4.4	3.5	4.3	0.0	5.4	14.5	4.2	1.5	9.2	8.6	2.2	9.6	10.8	15.9	5.0	4.5	5.2	10.7	5.1	14.8	5.6	1.7	1.8	3.7	1.5	2.1	0.7	1.2	0.8	0.9	1.4	1.1	0.5	1.0	0.0	6.0	1.7	0.0	0.5	0.8	4.2	4.4	2.3	5.4	4.7	6.1	4.5	2.3	5.2	3.5
SPOCD1	"FLJ25348, PPP1R146"	ENSG00000134668	"SPOC domain containing 1"	Q6ZMY3	1	31790422-31816051	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 28.9;urinary bladder: 13.7"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 18.6;hTEC/SVTERT24-B: 19.3;RT4: 32.6;TIME: 16.9;U-87 MG: 32.1"	"Group enriched"	"Detected in many"	7	"glioma: 13.9;urothelial cancer: 5.6"	"Region enhanced"	"Detected in many"		"pons and medulla: 8.2"	"Cell type enriched"	"Detected in single"	15	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.9"					"Low region specificity"	"Detected in some"			"HPA031713, HPA031714, HPA031715"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol				Cytosol	"Nucleoplasm, Nucleoli"	"HPA031713: AB_10604099, HPA031714: , HPA031715: "	"unprognostic (7.78e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.60e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.00e-1)"	"unprognostic (0.00e+0)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.54e-2)"	"prognostic favourable (4.05e-5)"	28.9	0.5	1.8	5.1	1.6	0.3	1.6	0.4	3.9	2.0	0.7	1.5	0.1	1.6	2.4	2.8	0.3	2.1	1.6	0.4	1.2	1.6	0.5	0.2	12.9	0.9	2.6	0.3	1.8	0.1	0.1	1.6	3.5	8.2	1.8	0.9	1.8	0.1	0.3	0.4	0.1	0.9	2.4	3.1	1.9	1.1	11.9	0.6	0.1	0.4	0.8	0.2	13.7	2.1	0.0	0.0	1.9	0.1	0.0	0.0	7.3	10.6	0.3	0.0	0.0	0.2	1.5	0.5	13.9	18.6	13.5	9.0	0.2	0.6	0.1	1.9	15.6	1.4	0.0	0.2	4.3	0.0	0.0	0.0	1.9	0.0	0.6	0.0	0.2	6.8	0.2	19.3	0.6	9.1	0.2	0.2	7.9	0.0	0.1	0.0	0.2	0.3	0.0	1.4	0.0	0.0	32.6	0.0	0.0	0.3	0.0	0.9	8.0	0.0	16.9	14.2	1.4	9.2	5.2	0.0	0.1	0.0	32.1	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	7.3	1.8	1.6	0.4	0.6	1.2	1.6	2.6	0.3	8.2	0.6
SPON1	"f-spondin, KIAA0762"	ENSG00000262655	"Spondin 1"	Q9HCB6	11	13962689-14267884	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 40.2"	"Group enriched"	"Detected in some"	35	"EFO-21: 41.0;RPTEC TERT1: 115.2"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 199.1"					"Cell type enriched"	"Detected in some"	5	"MAIT T-cell: 7.3"	"Lineage enriched"	"Detected in single"	74	"T-cells: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038584, HPA077546"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Actin filaments,Microtubule ends,Cytokinetic bridge"	"Secreted to blood"	11500000	27000000	"Nucleoli, Microtubule ends"	"Nucleoplasm, Actin filaments, Cytokinetic bridge"	"HPA038584: AB_10697394, HPA077546: "	"unprognostic (1.66e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.93e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.07e-1)"	"prognostic favourable (3.12e-4)"	"unprognostic (7.22e-3)"	"unprognostic (7.89e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavourable (1.88e-4)"	16.8	5.1	8.3	5.2	12.5	0.0	3.3	4.8	10.7	15.7	9.7	7.6	0.0	9.6	12.0	4.6	5.3	20.3	40.2	4.9	7.2		5.4	0.1	8.1	0.7	5.1	8.8	12.0	0.8	0.0	2.0	12.3	7.5	7.2	15.0	8.5	0.9	2.5	0.0	1.6	12.4	15.7	3.2	1.8	3.9	0.8	5.7	0.0	0.8	0.6	0.0	15.6	9.9	0.0	0.0	0.0	0.0	0.0	7.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	41.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	115.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	7.3	0.0	1.3	0.7	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.3										
SPRY3	HSPRY3	ENSG00000168939	"Sprouty RTK signaling antagonist 3"	O43610	X	155767812-155782459	"Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.4;EFO-21: 4.1"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB013505	Uncertain		Approved	Nucleoli,Cytosol				Cytosol	Nucleoli	"CAB013505: "	"unprognostic (3.70e-2)"	"unprognostic (4.39e-1)"	"unprognostic (5.24e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.52e-4)"	"unprognostic (1.21e-2)"	"unprognostic (9.60e-2)"	"unprognostic (5.26e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.44e-2)"	"unprognostic (3.49e-2)"	1.6	2.1	1.3	0.4	1.8	2.8	1.2	7.5	1.5	1.3	0.8			1.2	1.5	5.8	0.8	1.1	0.8	0.9	1.3	1.5	0.9	0.7	0.9	0.3	1.1		2.8	0.4	1.3	1.1	1.9		0.9	1.4		1.1	1.2	1.2	0.4	1.1	1.2	1.2	1.4	0.7	0.1			1.0		0.5	0.8	0.7	0.0	0.5	0.4	0.5	0.2	0.2	0.0	0.5	0.2	2.3	8.4	1.7	0.8	0.0	2.0	1.3	0.6	1.0	0.2	1.4	0.0	4.1	1.1	0.3	0.9	0.6	0.6	0.2	0.4	1.0	2.1	0.1	0.7	0.4	0.4	2.0	1.1	0.8	0.5	1.3	0.1	0.6	1.6	0.3	0.2	0.3	0.8	0.0	0.5	0.2	2.0	0.9	0.7	0.6	0.6	1.0	0.0	0.5	0.5	0.6	2.1	0.6	0.9	0.3	0.6	0.6	0.1	1.8	2.0	1.0	1.1	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.1	0.5	0.0	0.0										
SPTBN4	"KIAA1642, SPTBN3"	ENSG00000160460	"Spectrin beta, non-erythrocytic 4"	Q9H254	19	40466241-40576464	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Deafness, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 36.3"	"Cell line enhanced"	"Detected in some"		"K-562: 3.5;Karpas-707: 5.0;SCLC-21H: 7.9;SH-SY5Y: 4.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054481	Enhanced		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA054481: "	"unprognostic (1.97e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.65e-4)"	"unprognostic (3.72e-4)"	"unprognostic (7.79e-3)"	"unprognostic (9.77e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.50e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.78e-4)"	"unprognostic (4.54e-1)"	"unprognostic (2.55e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.02e-1)"	3.1	5.9	13.4	1.2	15.3	1.2	1.2	36.3	27.1	1.4	1.3	1.8	0.0	1.7	2.3	1.3	1.6	2.0	1.8	3.3	9.8	10.8	1.9	1.3	1.2	1.0	7.5	13.0	4.1	3.0	3.3	8.0	1.0	10.4	2.8	1.1	2.6	2.2	2.0	5.1	1.3	1.5	1.8	2.8	1.3	2.5	3.5	3.7	0.0	1.6	0.0	1.0	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.5	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.4	2.3	1.9	0.4	0.0	0.0	0.0	0.0	0.4	2.3	0.5	0.0	0.0	0.3	0.0	0.8	0.3	0.0	0.0	0.0	0.0	3.5	5.0	0.0	1.3	0.0	0.0	0.2	0.8	0.5	0.0	1.1	0.0	0.0	7.9	4.8	0.1	0.2	0.0	0.7	0.0	0.0	0.0	1.4	0.8	0.0	0.2	0.3	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	15.3	36.3	22.7	9.8	10.8	7.5	13.0	10.4	3.7
SPTY2D1	"DKFZp686I068, FLJ39441, Spt2"	ENSG00000179119	"SPT2 chromatin protein domain containing 1"	Q68D10	11	18606401-18634791	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039372, HPA040177, HPA047957"	Approved		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA039372: , HPA040177: , HPA047957: "	"unprognostic (8.43e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavourable (2.59e-4)"	"unprognostic (2.03e-1)"	"prognostic favourable (2.07e-4)"	"unprognostic (1.33e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.33e-1)"	14.0	12.7	6.2	9.7	9.2	33.6	11.9	10.9	10.9	13.7	10.9	6.9	9.9	8.3	11.9	8.6	15.5	12.5	12.2	9.9	5.8	6.5	14.9	25.1	9.7	8.7	6.0	6.8	16.7	16.9	13.6	14.0	15.3	8.5	12.5	9.7	7.9	13.3	13.9	16.3	12.5	13.7	9.3	7.6	15.0	11.0	7.1	5.5	17.7	12.8	8.0	13.3	12.5	11.8	2.7	3.4	7.8	5.7	7.3	8.7	3.3	8.1	8.1	6.4	9.0	10.8	11.3	9.9	12.1	13.3	10.1	12.2	7.2	3.6	18.3	6.8	11.3	8.5	10.6	9.5	14.5	9.6	10.0	7.3	4.9	6.6	10.4	15.5	14.6	9.3	9.9	6.4	13.1	11.0	10.2	29.1	11.2	8.8	10.3	6.2	5.8	9.0	9.5	17.9	7.8	10.5	11.7	6.2	8.8	10.8	12.5	8.4	7.8	6.6	9.7	9.9	8.4	19.2	7.4	10.2	12.6	14.3	11.8	8.6	8.3	7.8	4.1	5.8	5.7	5.7	8.7	2.6	5.6	5.7	3.4	2.7	5.2	5.6	6.0	7.3	5.4	2.9	6.0	3.3	6.2	9.2	10.9	10.9	5.8	6.5	6.0	6.8	8.5	5.5
SREK1IP1	"FLJ36754, P18SRP, SFRS12IP1"	ENSG00000153006	"SREK1 interacting protein 1"	Q8N9Q2	5	64718144-64768685	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA045677, HPA062853"	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA045677: AB_10964635, HPA062853: "	"unprognostic (1.19e-1)"	"unprognostic (3.61e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavourable (9.03e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.13e-1)"	"unprognostic (8.60e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.20e-2)"	"prognostic unfavourable (9.68e-4)"	"unprognostic (2.67e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.99e-1)"	16.3	12.1	12.2	10.9	16.5	8.3	13.8	13.9	12.8	17.0	16.1	4.1	10.8	8.6	12.5	12.4	25.3	10.8	11.6	13.1	12.3	10.7	18.0	13.1	13.2	12.1	10.6	9.5	14.6	11.7	10.8	20.5	20.2	11.9	15.5	10.4	4.7	10.3	15.0	15.7	18.7	15.2	12.6	15.5	19.0	10.9	11.7	11.5	19.2	13.9	17.9	12.3	24.1	14.6	4.0	8.2	3.8	4.1	4.1	4.7	2.1	6.9	3.5	9.1	7.0	8.2	13.6	5.5	10.6	8.5	7.3	9.7	6.6	7.7	7.2	10.9	8.5	4.6	8.3	16.0	12.8	8.6	10.1	7.9	6.6	5.9	8.5	8.4	8.0	8.9	15.2	10.1	13.2	10.7	7.0	4.5	8.6	2.5	15.1	8.6	4.7	4.9	7.2	7.5	11.6	12.4	5.6	4.0	5.9	6.7	4.8	10.1	6.1	16.4	10.8	5.3	3.2	6.4	11.0	6.6	11.3	6.5	10.2	13.3	7.2	3.8	4.1	1.7	4.5	3.0	4.7	3.9	4.6	4.2	3.4	4.0	4.5	4.7	1.6	4.1	1.9	8.2	4.0	2.1	12.2	16.5	13.9	12.8	12.3	10.7	10.6	9.5	11.9	11.5
SRFBP1	"BUD22, FLJ25286, p49, Rlb1, STRAP"	ENSG00000151304	"Serum response factor binding protein 1"	Q8NEF9	5	121961961-122075570	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042737, HPA058150"	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles				"Nucleoplasm, Nucleoli"	Vesicles	"HPA042737: AB_10796583, HPA058150: "	"unprognostic (8.94e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.61e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.07e-3)"	"unprognostic (2.03e-1)"	"unprognostic (8.96e-3)"	"unprognostic (6.31e-3)"	"prognostic unfavourable (5.31e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.45e-2)"	21.8	9.4	11.6	11.1	15.2	10.1	17.2	15.0	14.8	12.7	10.2	6.1	8.5	9.1	13.0	12.1	14.2	11.1	9.6	10.7	11.8	8.0	14.3	12.6	11.2	12.5	13.1	11.9	17.1	10.6	15.5	20.2	11.5	14.2	12.8	10.9	5.1	13.0	9.5	19.7	10.7	9.5	11.3	16.0	15.4	10.1	9.3	14.9	12.5	15.6	13.8	11.6	14.4	17.5	10.3	9.6	2.6	12.8	7.4	11.5	4.3	10.8	8.0	7.4	11.6	8.5	7.9	12.3	10.4	7.6	11.5	13.5	6.5	10.8	13.7	12.2	6.5	8.0	12.0	14.2	21.5	19.4	6.8	13.1	5.8	6.6	9.1	15.1	11.0	9.5	11.0	14.4	14.3	12.4	12.0	11.2	12.0	4.9	10.4	4.8	10.8	5.3	10.8	17.4	14.3	12.6	11.2	7.6	7.1	9.6	9.5	17.9	9.7	9.1	9.0	17.8	10.9	12.6	15.1	6.0	11.2	15.8	10.2	12.3	15.6	0.6	7.3	2.6	6.6	12.8	8.4	10.3	7.3	7.2	9.6	8.9	8.6	11.5	1.2	7.4	10.1	9.1	6.7	4.3	11.6	15.2	15.0	14.8	11.8	8.0	13.1	11.9	14.2	14.9
SRP14	"ALURBP, MGC14326"	ENSG00000140319	"Signal recognition particle 14"	P37108	15	40035739-40039188	"Plasma proteins, Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053738, HPA065118"			Approved	Nucleoplasm,Nucleoli			400000	Nucleoli	Nucleoplasm	"HPA053738: , HPA065118: "	"unprognostic (2.52e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.20e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.39e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"prognostic favourable (5.31e-4)"	"unprognostic (2.20e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.41e-3)"	"unprognostic (4.94e-2)"	63.0	81.2	100.0	46.0	102.8	85.9	75.4	65.4	91.3	87.8	62.6	67.9	54.7	50.7	83.0	115.7	75.6	87.8	64.2	114.2	80.7	95.4	107.2	79.6	52.2	60.8	103.5	86.3	99.1	59.1	69.6	82.3	68.8	84.3	84.1	65.0	61.0	71.3	66.4	107.5	44.4	65.7	67.2	86.5	67.5	56.0	43.4	68.9	58.7	98.9	56.6	65.0	80.9	72.7	78.7	151.5	111.2	69.3	63.6	96.4	135.1	24.7	31.1	75.4	56.3	56.5	51.3	36.8	45.7	48.5	39.7	40.8	55.9	21.2	20.8	47.6	55.4	40.2	59.9	47.5	37.6	49.7	42.8	49.7	99.3	65.4	43.3	44.2	40.6	53.2	54.4	32.8	40.3	66.6	51.9	38.3	63.4	37.6	65.2	52.1	41.1	56.4	44.8	34.4	35.0	85.5	74.0	55.0	49.0	46.1	45.8	29.9	62.9	82.0	57.3	46.2	31.4	43.5	33.3	31.2	87.0	51.6	44.9	48.2	42.8	76.2	69.3	111.2	68.5	62.5	66.4	78.7	77.7	76.3	74.5	66.1	75.4	72.8	60.7	63.6	56.5	151.5	96.4	135.1	100.0	102.8	65.4	91.3	80.7	95.4	103.5	86.3	84.3	68.9
SRP54		ENSG00000100883	"Signal recognition particle 54"	P61011	14	34981957-35029567	"Plasma proteins, Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA048977, HPA062044"	Approved		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA048977: , HPA062044: "	"unprognostic (1.22e-3)"	"unprognostic (6.04e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.88e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.06e-3)"	"unprognostic (6.44e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.50e-3)"	18.4	27.5	18.6	21.3	21.0	13.6	22.5	18.2	26.0	24.6	19.2	23.2	31.2	19.3	24.1	25.5	22.6	18.0	17.1	21.8	18.7	22.5	34.4	67.8	19.4	24.0	23.7	17.1	21.1	43.2	30.1	47.1	26.4	29.4	23.2	21.7	19.2	48.1	31.2	28.4	19.6	24.4	20.0	22.3	23.5	22.3	30.8	19.4	32.3	23.6	22.5	27.9	23.9	17.6	20.5	23.4	26.3	30.1	29.5	33.4	19.7	20.3	22.0	21.1	19.8	21.8	22.5	25.4	29.2	26.6	30.2	38.8	26.5	22.9	29.7	29.8	27.8	21.5	28.9	23.0	43.9	29.5	14.5	24.0	21.0	62.1	33.9	25.6	24.3	18.8	22.7	22.2	39.6	30.4	21.2	32.5	31.4	33.8	27.4	14.4	16.2	21.4	21.9	25.8	23.7	36.0	31.1	20.1	21.6	20.9	27.2	26.6	36.1	17.8	23.0	18.4	19.8	21.9	20.1	28.2	37.8	37.2	13.1	16.5	21.9	15.9	19.8	26.3	23.6	24.0	29.3	20.5	23.6	26.0	23.4	18.6	22.3	21.7	19.3	29.5	30.1	16.0	33.4	19.7	18.6	21.0	18.2	26.0	18.7	22.5	23.7	17.1	29.4	19.4
SRSF5	"HRS, SFRS5, SRP40"	ENSG00000100650	"Serine and arginine rich splicing factor 5"	Q13243	14	69726900-69772005	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043484, HPA056523"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA043484: AB_10797143, HPA056523: "	"unprognostic (2.08e-3)"	"prognostic favourable (7.91e-4)"	"unprognostic (1.89e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.30e-3)"	"unprognostic (1.07e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.00e-2)"	66.6	60.1	67.1	60.9	74.4	131.5	70.3	111.7	88.8	54.3	63.3	67.8	77.1	42.6	71.3	74.6	66.3	79.3	50.1	48.5	66.2	43.0	40.5	60.8	69.4	63.3	86.4	62.1	76.6	41.0	56.4	124.8	59.2	74.0	59.0	54.7	69.2	68.5	75.6	76.0	78.1	74.1	59.7	68.6	66.5	62.0	35.3	75.6	47.8	70.8	52.3	69.1	69.6	55.8	41.2	37.4	60.8	45.1	30.8	38.2	24.4	69.2	20.2	49.6	22.3	30.7	26.5	27.5	33.4	36.0	27.3	29.0	25.4	44.5	71.8	17.7	45.3	33.1	37.5	47.7	32.3	61.3	20.6	54.1	54.3	27.8	35.7	50.4	41.0	55.1	30.4	31.5	33.8	37.8	37.5	42.8	16.9	56.2	57.9	34.2	29.1	18.7	49.7	23.6	27.6	34.7	85.3	25.9	37.0	56.7	34.4	43.1	37.4	42.5	46.6	16.0	42.9	17.4	31.2	41.7	27.2	116.1	37.7	43.0	22.0	39.0	24.1	37.2	37.3	43.4	38.2	41.2	33.2	33.4	26.2	40.6	33.2	31.5	60.8	30.8	45.1	37.4	27.4	24.4	67.1	74.4	111.7	88.8	66.2	43.0	86.4	62.1	74.0	75.6
SRSF9	"SFRS9, SRp30c"	ENSG00000111786	"Serine and arginine rich splicing factor 9"	Q13242	12	120461668-120469793	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049849	Supported		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA049849: "	"unprognostic (3.80e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.50e-3)"	"prognostic unfavourable (9.85e-7)"	"unprognostic (9.65e-3)"	"prognostic unfavourable (7.80e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.19e-3)"	"unprognostic (9.57e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.60e-1)"	25.8	50.7	29.5	37.9	28.5	33.8	31.2	24.9	30.6	31.5	36.4	21.7	35.5	29.8	26.7	37.4	53.6	32.6	42.3	20.7	26.7	27.9	37.2	42.5	27.2	41.4	31.6	25.3	37.1	68.5	34.9	36.5	49.3	27.9	33.1	35.8	29.3	33.9	30.4	17.0	32.4	31.0	25.1	23.8	39.6	33.0	52.5	25.0	53.1	43.7	36.8	51.0	26.5	35.7	22.1	18.7	28.8	15.4	15.7	14.8	5.1	54.8	38.4	59.0	38.0	27.0	27.1	63.2	37.8	34.0	48.5	41.8	46.1	25.9	53.6	44.2	31.6	32.9	53.1	53.7	53.6	40.1	54.5	45.7	25.8	45.0	34.9	56.2	41.8	28.7	34.7	42.1	36.8	44.1	57.3	16.2	41.7	76.9	55.4	109.9	73.9	33.6	62.0	24.8	51.7	42.0	70.2	52.4	37.4	44.3	23.6	43.6	71.0	49.7	38.4	36.1	42.8	27.1	40.8	50.0	37.4	67.0	38.0	42.5	37.6	12.3	10.7	28.8	14.8	11.7	11.2	22.1	11.7	13.0	13.9	17.7	11.5	12.8	12.2	15.7	15.4	18.7	11.9	5.1	29.5	28.5	24.9	30.6	26.7	27.9	31.6	25.3	27.9	25.0
SS18L2	KIAA-iso	ENSG00000008324	"SS18 like 2"	Q9UHA2	3	42581840-42595114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047377	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria				"Nucleoli, Mitochondria"	Nucleoplasm	"HPA047377: "	"unprognostic (4.09e-3)"	"unprognostic (1.90e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.64e-2)"	"prognostic favourable (7.03e-4)"	"unprognostic (6.55e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.24e-3)"	12.7	11.6	24.5	17.8	26.4	29.9	20.8	25.2	23.8	14.0	14.8	14.4	9.1	19.4	9.1	20.6	16.6	10.6	11.8	10.8	23.5	20.6	15.8	26.2	11.9	34.8	20.5	15.9	13.5	29.0	10.9	16.1	10.7	17.4	22.2	15.5	11.3	18.6	10.8	10.1	14.9	19.3	8.4	24.0	19.7	15.6	6.4	14.9	20.4	18.7	14.7	32.0	16.0	11.1	48.0	30.0	32.8	25.9	31.0	53.5	32.9	15.8	7.3	14.6	13.2	18.8	15.3	9.1	10.3	11.8	15.4	17.4	13.9	14.5	21.7	9.5	7.0	8.9	17.5	14.4	17.0	10.8	20.4	23.5	14.2	23.3	13.6	30.7	18.6	12.0	9.3	12.4	11.6	16.8	21.2	32.7	12.4	15.0	21.5	38.1	23.1	17.9	11.4	10.7	30.1	17.0	20.0	8.2	11.8	8.7	13.7	13.9	18.0	28.7	9.8	9.1	14.8	21.7	18.7	23.8	37.6	36.8	13.3	33.7	8.6	19.0	23.5	32.8	38.4	25.9	51.6	48.0	50.5	45.3	24.9	40.8	43.9	44.1	31.1	31.0	19.2	30.0	53.5	32.9	24.5	26.4	25.2	23.8	23.5	20.6	20.5	15.9	17.4	14.9
SSX1	CT5.1	ENSG00000126752	"SSX family member 1"	Q16384	X	48255317-48267444	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	14	"testis: 12.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 28.1;Karpas-707: 40.8;U-2197: 9.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045683	Supported		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA045683: "					"unprognostic (2.25e-1)"		"unprognostic (3.51e-3)"		"unprognostic (2.36e-1)"	"unprognostic (4.32e-3)"				"unprognostic (3.38e-1)"	"unprognostic (5.41e-2)"	"unprognostic (6.94e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.9	0.4	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	40.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	9.5	0.0	0.0	2.0	0.0	2.3	0.0	0.0	0.9	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX2	"CT5.2a, HD21, HOM-MEL-40, MGC119055, MGC15364, MGC3884, SSX"	ENSG00000241476	"SSX family member 2"	Q16385	X	52696896-52707189	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	57	"testis: 24.1"	"Cell line enhanced"	"Detected in some"		"PC-3: 3.1;U-2197: 1.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045683, CAB046020"	Enhanced		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"CAB046020: AB_2194010, HPA045683: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1			0.4		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.0	0.2	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.6	0.1	0.6	1.9	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0										
SSX2B	CT5.2b	ENSG00000268447	"SSX family member 2B"	Q16385	X	52751132-52790305	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	24	"testis: 13.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.8;HMC-1: 5.3;PC-3: 5.1;T-47d: 2.2;U-2197: 3.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045683	Supported		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA045683: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.9	0.0	0.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.5	0.1	0.0	0.0	0.2	5.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.7	0.0	2.2	0.0	1.0	0.0	0.5	3.2	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0										
SSX3	CT5.3	ENSG00000165584	"SSX family member 3"	Q99909	X	48346428-48356707	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 18.0"	"Cell line enriched"	"Detected in some"	4	"Karpas-707: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											HPA045683	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA045683: "															"unprognostic (1.86e-1)"	"unprognostic (2.13e-2)"		0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	1.6	0.2	0.4	0.4	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.1	0.4	0.0	0.0	0.4	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	1.6	0.5	0.2	0.2	0.0	0.0	1.6	0.2	0.8	0.3	0.1	0.2	0.8	0.3	0.4	0.0	0.9	0.4	0.4	0.2	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SSX4	CT5.4	ENSG00000268009	"SSX family member 4"	O60224	X	48383516-48393347	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	14	"testis: 6.8"	"Group enriched"	"Detected in some"	10	"BEWO: 3.5;Karpas-707: 8.6;U-266/70: 5.1;U-266/84: 9.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045683	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA045683: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.3	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	8.6	0.0	0.0	0.0	0.0	0.3	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	5.1	9.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0										
SSX4B	OTTHUMT00000056510	ENSG00000269791	"SSX family member 4B"	O60224	X	48402078-48411910	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	14	"testis: 6.7"	"Group enriched"	"Detected in some"	10	"BEWO: 3.5;Karpas-707: 8.6;U-266/70: 5.1;U-266/84: 9.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045683	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA045683: "																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.1	0.0	0.4	0.0	0.3			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	6.7			0.0		0.0	0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	8.6	0.0	0.0	0.0	0.0	0.3	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	5.1	9.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0										
SSX5		ENSG00000165583	"SSX family member 5"	O60225	X	48186220-48196763	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"testis: 4.3;thyroid gland: 2.9"	"Cell line enriched"	"Detected in some"	4	"BEWO: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045683	Uncertain		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA045683: "									"unprognostic (1.20e-1)"						"unprognostic (2.96e-1)"	"unprognostic (1.23e-1)"		0.4	0.0	0.1	0.1	0.4	1.0	0.1	0.1	0.1	0.1	1.2	0.1	0.1	0.0	0.5	0.2	0.1	0.8	0.1	0.8	0.1	0.1	0.1	0.1	0.2	0.3	0.1	0.1	0.3	0.1	1.6	0.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.6	0.2	0.1	0.1	0.8	0.0	4.3	0.1	0.1	2.9	0.1	0.1	0.1	0.1	0.5	0.2	0.9	0.2	0.6	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.6	1.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.2	0.4	0.3	0.4	0.1	0.5	0.1	0.4	0.9	0.6	0.0	0.2	0.2	0.0	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
SSX7		ENSG00000187754	"SSX family member 7"	Q7RTT5	X	52644090-52654900	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in some"			"Cell line enhanced"	"Detected in some"		"HEL: 1.7;HMC-1: 7.9;RT4: 4.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"											HPA045683	Uncertain		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA045683: "																"unprognostic (1.29e-1)"		0.1	0.2	0.2	0.4	0.1	0.7	0.1	0.1	1.0	0.1	0.2			0.6	0.2	0.0	1.5	0.3	0.5	0.1	0.1	0.2	0.1	0.1	0.5	0.3	0.1		0.8	0.1	0.0	0.1	0.0		0.1	0.0		1.8	0.0	0.1	1.5	0.1	0.0	0.1	0.6	0.4	1.0			0.4		0.0	0.2	0.1	0.0	0.2	1.0	0.7	0.3	0.4	0.0	0.4	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.9	0.0	0.1	0.1	0.5	0.3	1.7	0.7	0.3	0.0	0.0	7.9	0.0	0.2	0.2	0.0	0.1	0.2	1.4	0.1	1.0	0.7	0.2	0.0	0.0	0.4	0.5	0.0	0.0	4.2	0.3	0.0	0.1	0.0	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.3	0.4	0.6	0.1	0.0	0.1	0.1	0.1	0.5	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.0	0.3	0.7	0.1	0.0	0.0										
STEAP3	"dudlin-2, STMP3, TSAP6"	ENSG00000115107	"STEAP3 metalloreductase"	Q658P3	2	119223831-119265652	"Disease related genes, Predicted membrane proteins"	"Apoptosis, Cell cycle, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"liver: 82.3;parathyroid gland: 47.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 36.9;U-87 MG: 47.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"classical monocyte: 4.0;intermediate monocyte: 4.3;myeloid DC: 7.0;NK-cell: 2.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 7.0;monocytes: 4.3;NK-cells: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA050510	Approved		Approved	Nucleoli,Cytosol			28000	Cytosol	Nucleoli	"HPA050510: "	"unprognostic (6.51e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.94e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.04e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.08e-3)"	"unprognostic (6.95e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (2.82e-1)"	"unprognostic (4.45e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.82e-2)"	8.1	2.8	2.5	1.2	4.2	5.1	9.2	3.0	2.2	6.4	6.1	3.0	3.7	7.9	1.3	3.1	5.1	4.0	2.8	6.6	2.9	1.4	3.4	82.3	3.9	4.9	3.9	0.4	5.2	9.0	47.4	5.1	4.3	6.1	4.8	2.4	2.1	12.6	9.1	10.9	3.0	9.8	0.9	6.4	1.0	6.7	1.5	3.2	0.2	3.3	6.9	4.0	4.2	3.7	0.8	7.0	0.7	4.3	2.1	0.2	1.5	6.5	7.9	0.0	2.7	3.9	36.9	7.0	2.1	2.3	4.2	3.8	6.0	9.0	0.0	15.9	11.9	11.2	3.4	6.9	4.7	0.0	11.2	12.8	7.1	11.7	9.7	3.1	2.4	21.8	12.2	24.7	8.9	3.6	6.2	1.3	11.7	6.2	0.0	1.8	10.8	16.5	0.0	4.6	5.6	5.1	16.7	13.3	2.4	5.8	20.2	1.5	4.0	4.2	15.3	26.0	15.3	5.5	11.4	0.0	0.0	0.0	47.8	8.1	5.4	0.0	4.0	0.7	0.2	4.3	0.0	0.8	0.0	0.0	7.0	0.2	0.0	0.0	0.1	2.1	0.6	0.3	0.0	1.5	2.5	4.2	3.0	2.2	2.9	1.4	3.9	0.4	6.1	3.2
STK24	"MST-3, MST3, MST3B, STE20, STK3"	ENSG00000102572	"Serine/threonine kinase 24"	Q9Y6E0	13	98445185-98577940	"Enzymes, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026435, HPA026502"	Enhanced		Supported	Nucleoli,Cytosol			2800000	"Nucleoli, Cytosol"		"HPA026435: AB_1854151, HPA026502: AB_1854152"	"unprognostic (3.49e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.25e-2)"	"unprognostic (9.67e-3)"	"prognostic unfavourable (6.23e-6)"	"unprognostic (5.45e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (5.81e-4)"	"unprognostic (9.62e-2)"	"prognostic favourable (6.91e-5)"	"unprognostic (3.10e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.12e-2)"	28.6	14.2	15.0	29.7	16.9	19.1	34.8	12.2	21.0	36.3	37.4	12.1	23.0	31.9	24.6	26.5	68.4	20.4	41.3	30.0	14.7	12.8	30.5	14.2	23.9	31.2	10.6	10.1	20.0	20.6	12.4	13.9	38.4	14.7	28.3	28.8	36.8	30.8	21.6	18.8	60.6	67.9	34.8	9.2	31.7	30.2	22.1	7.6	38.2	28.2	41.6	48.5	39.2	45.4	8.1	11.2	11.4	13.4	1.5	13.7	6.7	36.0	11.2	20.0	18.5	30.8	18.4	28.4	16.9	23.8	23.7	23.2	32.9	49.0	25.7	8.6	21.1	32.7	18.5	37.2	22.7	64.0	9.5	27.4	14.4	18.8	43.5	27.6	19.5	11.9	59.5	18.6	54.8	20.3	9.9	17.8	15.5	15.7	20.6	11.4	17.9	8.5	26.1	12.3	13.9	22.8	32.6	11.7	16.8	10.7	17.2	22.8	20.8	26.9	27.4	15.1	11.0	12.3	19.4	17.4	9.1	9.6	23.5	16.7	24.8	5.8	13.4	6.1	6.1	10.6	7.2	6.6	11.4	8.7	11.2	8.1	7.8	6.1	11.4	1.5	12.7	7.5	13.7	6.7	15.0	16.9	12.2	21.0	14.7	12.8	10.6	10.1	14.7	7.6
STK33		ENSG00000130413	"Serine/threonine kinase 33"	Q9BYT3	11	8391868-8594289	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 34.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 14.1;HEK 293: 12.0;Karpas-707: 13.2;SCLC-21H: 14.8;U-251 MG: 14.9;U-266/84: 12.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 7.1;naive B-cell: 4.4"	"Lineage enriched"	"Detected in many"	5	"B-cells: 7.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015742, HPA056855"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA015742: AB_1857592, HPA056855: "	"unprognostic (2.57e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.76e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.85e-4)"	"unprognostic (1.23e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.33e-3)"	"unprognostic (9.46e-2)"	"prognostic favourable (4.89e-6)"	"unprognostic (2.39e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.90e-2)"	0.9	6.1	4.7	1.6	7.5	1.1	0.6	6.1	4.4	5.4	5.3	6.8	7.7	2.6	9.6	15.3	2.3	30.7	4.5	11.4	6.6	6.1	7.7	0.4	5.3	2.3	4.9	2.7	10.3	4.6	20.4	29.9	0.3	17.7	5.3	1.3	14.8	1.6	8.9	2.6	0.3	2.5	7.0	6.7	1.2	4.4	34.4	4.6	4.5	14.6	1.5	1.8	3.7	1.4	7.1	0.7	0.0	0.0	0.2	1.4	0.3	0.0	2.0	9.8	0.0	0.0	0.0	0.0	1.7	1.9	4.2	3.9	1.2	0.0	14.1	7.4	0.3	0.0	4.3	1.3	3.7	0.0	12.0	0.0	2.6	3.3	1.6	7.8	0.0	0.4	0.0	0.1	0.0	0.3	0.0	13.2	0.1	0.0	0.3	0.0	7.0	0.0	5.3	1.3	8.9	3.8	0.0	14.8	3.9	0.0	0.0	0.1	0.0	0.8	0.0	0.0	6.7	0.1	14.9	3.1	12.5	0.2	4.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	7.1	0.0	1.4	0.0	4.4	0.0	1.1	0.0	0.2	0.0	0.7	0.2	0.3	4.7	7.5	6.1	4.4	6.6	6.1	4.9	2.7	17.7	4.6
STON2	"STN2, STNB2"	ENSG00000140022	"Stonin 2"	Q8WXE9	14	81260656-81436465	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 42.8;HMC-1: 24.3;Karpas-707: 22.0;RT4: 17.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4;intermediate monocyte: 3.6"	"Lineage enriched"	"Detected in single"	4	"monocytes: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA003086	Enhanced		Supported	Nucleoli,Cytosol			9800	Cytosol	Nucleoli	"HPA003086: AB_2302748"	"unprognostic (5.28e-2)"	"unprognostic (9.83e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (4.96e-4)"	"unprognostic (2.50e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.30e-1)"	"unprognostic (9.88e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.37e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.44e-1)"	6.1	1.2	26.8	1.5	23.5	5.6	11.5	2.0	22.4	4.3	5.3	18.1	1.6	4.7	1.8	6.7	11.3	13.6	7.1	4.0	26.1	11.6	17.5	3.7	5.0	1.3	10.3	11.5	3.7	1.3	0.6	7.9	4.3	9.6	2.6	6.1	7.9	4.6	3.8	9.5	9.2	4.9	2.2	4.5	18.7	6.8	4.0	15.9	0.3	13.1	4.9	3.4	6.8	6.6	0.0	0.5	0.8	3.6	0.0	0.1	3.2	1.7	1.3	4.7	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.1	4.2	1.5	0.0	2.2	0.0	11.8	6.5	14.7	0.0	0.2	2.3	42.8	7.9	1.6	0.0	0.0	24.3	0.6	13.0	0.0	4.4	0.0	15.7	22.0	0.4	2.6	2.1	0.0	4.7	1.1	0.0	6.9	1.3	3.1	17.7	11.5	0.7	5.2	0.2	0.0	0.6	0.1	0.1	0.9	3.6	3.9	1.0	2.5	4.5	0.0	3.2	0.1	1.1	0.0	2.4	0.0	0.1	3.6	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.8	0.0	1.2	0.0	0.0	3.2	26.8	23.5	2.0	17.5	26.1	11.6	10.3	11.5	9.6	15.9
STX17	FLJ20651	ENSG00000136874	"Syntaxin 17"	P56962	9	99906633-99970341	"Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001204	Approved		Uncertain	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA001204: AB_1080118"	"unprognostic (1.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.67e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.70e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.08e-1)"	"prognostic favourable (1.62e-5)"	"unprognostic (9.48e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.28e-1)"	15.1	15.8	13.5	16.4	16.3	13.6	16.1	10.8	17.8	19.4	18.5	14.2	29.3	13.4	21.7	25.2	19.9	12.0	14.9	14.5	13.8	13.2	14.3	26.0	13.2	11.9	15.4	14.2	18.2	17.8	25.5	37.1	17.6	14.1	18.2	14.6	16.3	20.6	28.7	28.5	20.6	18.9	20.4	19.1	13.3	15.0	12.0	10.4	17.0	21.8	18.3	15.9	18.8	17.8	7.4	4.9	15.5	8.1	14.3	10.4	4.5	10.6	9.7	10.0	11.9	11.4	11.6	19.9	8.2	12.2	9.2	7.9	12.2	14.4	20.9	8.2	8.7	12.3	8.3	11.5	7.4	18.3	6.8	13.5	12.8	7.4	13.2	19.8	4.9	11.4	13.3	10.0	15.1	10.8	18.6	11.6	6.9	13.1	11.7	5.4	8.8	7.9	10.1	17.7	9.6	12.3	12.5	5.8	10.3	16.5	12.7	8.1	12.6	5.4	8.5	6.2	8.8	9.9	6.6	16.5	20.1	4.2	8.7	8.3	6.7	15.5	4.2	7.3	7.4	4.5	10.3	7.4	9.1	8.2	4.9	5.9	10.4	9.8	4.3	14.3	8.1	3.1	4.9	4.5	13.5	16.3	10.8	17.8	13.8	13.2	15.4	14.2	14.1	10.4
SUB1	"p14, p15, PC4"	ENSG00000113387	"SUB1 homolog, transcriptional regulator"	P53999	5	32531633-32604079	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 162.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA001311, CAB015351"	Supported		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"CAB015351: AB_2197157, HPA001311: AB_1080123"	"unprognostic (5.19e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavourable (5.25e-6)"	"unprognostic (8.31e-2)"	"prognostic unfavourable (2.79e-4)"	"unprognostic (3.46e-3)"	"unprognostic (5.04e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.45e-1)"	54.4	40.8	64.1	50.9	69.8	87.6	52.3	28.2	82.4	48.9	44.4	21.5	23.2	36.2	36.8	36.3	52.7	27.4	31.3	46.9	79.3	53.5	54.7	60.7	36.3	58.4	45.8	57.5	30.7	26.9	26.5	49.0	47.0	51.6	34.5	46.0	17.4	32.3	29.1	39.6	26.8	47.5	33.2	39.6	67.2	38.7	28.1	29.8	72.4	42.2	54.2	54.6	39.8	29.7	61.1	69.4	92.0	24.6	25.9	59.5	49.2	21.6	18.0	35.8	33.4	21.8	38.7	22.5	38.0	27.7	34.4	31.8	26.0	34.4	11.0	26.5	26.2	14.8	30.0	31.1	46.4	45.9	27.5	37.0	43.9	49.2	30.9	64.3	50.7	27.1	26.9	36.5	26.1	25.7	42.9	162.4	30.3	19.3	60.7	102.8	23.5	36.8	27.0	46.7	70.3	34.2	19.7	19.4	16.1	58.8	27.7	26.9	30.7	59.9	26.5	37.3	40.5	31.4	28.5	63.5	109.5	19.2	34.3	69.9	22.7	92.0	23.9	54.9	31.5	24.6	28.4	61.1	41.4	41.2	46.8	35.1	32.9	37.6	29.2	25.9	21.9	69.4	59.5	49.2	64.1	69.8	28.2	82.4	79.3	53.5	45.8	57.5	51.6	29.8
SUMO1	"GMP1, OFC10, PIC1, SMT3C, SMT3H3, SUMO-1, UBL1"	ENSG00000116030	"Small ubiquitin-like modifier 1"	P63165	2	202206180-202238608	"Disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004269, HPA056956"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Nuclear bodies"				"Nucleoplasm, Nuclear membrane"	"Nucleoli, Nuclear bodies"	"CAB004269: AB_628300, HPA056956: "	"unprognostic (7.15e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.89e-1)"	"unprognostic (9.56e-3)"	"unprognostic (1.76e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.78e-3)"	"prognostic favourable (7.93e-4)"	"unprognostic (7.06e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.31e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.19e-1)"	27.1	37.8	44.4	21.6	37.9	41.8	31.6	47.7	49.2	26.9	29.7	19.9	27.2	26.2	24.7	33.4	26.9	24.7	26.6	28.3	38.0	39.6	43.5	62.6	24.6	28.7	34.6	40.6	23.4	29.8	26.6	28.7	30.4	32.3	28.8	31.2	21.6	35.6	24.5	42.4	21.6	33.2	27.6	29.6	25.1	26.4	28.7	27.1	32.2	38.4	28.1	33.6	26.9	23.1	74.8	63.0	77.0	63.7	65.8	89.0	94.0	33.6	17.1	62.3	33.1	34.7	37.1	27.8	35.9	45.3	44.8	59.4	36.8	42.9	23.0	33.3	41.3	24.7	51.0	49.8	70.4	21.5	39.1	42.6	33.6	43.1	25.1	48.0	40.6	28.5	48.2	35.0	26.7	41.6	39.2	37.6	47.8	28.6	60.4	79.9	74.9	36.3	39.2	34.9	40.6	54.2	28.0	43.4	47.3	29.3	28.4	47.9	25.5	46.0	29.1	33.1	33.3	30.2	31.6	32.8	64.5	58.5	36.8	34.2	28.9	56.6	63.7	77.0	51.1	62.6	53.5	74.8	63.7	59.8	63.0	58.4	60.2	62.8	73.6	65.8	62.8	52.9	89.0	94.0	44.4	37.9	47.7	49.2	38.0	39.6	34.6	40.6	32.3	27.1
SURF2		ENSG00000148291	"Surfeit 2"	Q15527	9	133356552-133361169	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 50.1"	"Cell line enhanced"	"Detected in all"		"MCF7: 43.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044340, HPA052213"	Approved		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA044340: , HPA052213: "	"unprognostic (1.53e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.24e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.46e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-1)"	8.3	9.2	15.8	9.0	13.2	8.2	10.7	13.1	14.5	5.7	8.8	7.4	10.8	13.2	6.4	12.0	11.0	10.7	11.2	8.9	13.4	11.0	14.3	12.0	6.5	12.1	13.1	8.7	9.0	17.5	7.1	11.3	5.9	10.3	7.7	5.7	7.7	14.2	8.8	11.5	14.8	11.4	6.9	9.4	8.6	9.3	50.1	6.6	10.6	10.1	14.9	9.8	6.5	8.3	17.5	15.6	13.1	16.2	13.2	26.9	14.1	7.1	12.4	5.2	6.5	3.8	3.0	11.0	3.6	3.2	5.9	3.0	17.0	6.0	7.2	5.3	2.4	19.7	8.3	9.0	2.7	6.9	11.4	5.6	14.2	6.3	7.7	9.3	4.3	3.6	10.6	8.3	12.3	2.7	8.9	4.9	4.0	43.2	9.5	6.2	16.4	24.0	10.7	7.8	16.8	5.0	8.2	19.5	9.9	8.2	13.6	10.9	14.5	4.4	5.1	8.9	9.0	9.1	13.0	6.2	12.2	7.7	5.7	5.5	8.9	13.1	16.2	12.0	17.8	16.2	23.1	15.6	21.9	20.2	13.8	17.5	20.8	19.7	7.1	13.2	11.6	15.6	26.9	14.1	15.8	13.2	13.1	14.5	13.4	11.0	13.1	8.7	10.3	6.6
SURF6	"FLJ30322, RRP14"	ENSG00000148296	"Surfeit 6"	O75683	9	133328774-133336398	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023608, HPA074622"	Approved		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA023608: AB_1857671, HPA074622: "	"unprognostic (5.27e-3)"	"unprognostic (8.67e-3)"	"unprognostic (5.41e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.18e-3)"	"unprognostic (9.32e-3)"	"prognostic favourable (7.31e-5)"	"unprognostic (1.50e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.66e-1)"	14.8	16.8	19.9	15.0	22.7	16.2	15.7	16.4	25.8	13.9	16.2	14.0	11.9	21.7	18.6	10.9	17.4	18.5	15.9	13.9	19.1	17.9	14.5	16.2	12.6	17.6	19.6	22.9	27.4	23.1	16.5	11.8	12.5	24.6	15.8	13.1	11.6	18.3	19.5	47.3	17.8	22.3	18.0	23.6	18.8	13.6	16.5	19.8	8.6	14.4	11.1	13.5	15.3	19.1	7.7	8.9	3.9	4.7	4.6	8.5	3.6	4.1	6.6	5.1	7.6	3.2	2.9	8.4	6.7	3.9	6.0	3.7	10.3	7.2	12.2	5.2	3.7	12.7	6.5	7.0	2.2	8.1	7.4	8.4	7.5	6.1	5.8	14.1	7.3	4.2	6.3	6.3	5.8	3.1	18.2	6.6	5.3	10.9	11.4	11.6	14.8	11.9	12.1	7.1	12.3	5.2	4.0	10.7	9.1	6.5	10.8	5.8	9.4	8.0	6.3	13.7	7.2	6.9	9.0	4.9	6.9	15.8	5.1	9.7	8.0	3.9	4.7	1.9	6.8	4.4	7.0	7.1	6.2	6.1	4.9	7.7	8.5	7.0	1.3	4.6	3.7	8.9	5.0	3.6	19.9	22.7	16.4	25.8	19.1	17.9	19.6	22.9	24.6	19.8
SUZ12	"CHET9, JJAZ1, KIAA0160"	ENSG00000178691	"SUZ12 polycomb repressive complex 2 subunit"	Q15022	17	31937018-32001045	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057436	Approved		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"				"Nucleoplasm, Nucleoli, Nuclear bodies"		"HPA057436: "	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.65e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.66e-3)"	"unprognostic (8.05e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.31e-1)"	10.1	10.8	13.4	15.4	10.4	25.5	33.5	16.0	13.8	11.2	11.4	7.5	13.6	10.1	12.5	8.1	12.3	9.8	7.7	9.7	9.1	7.6	10.9	11.5	10.6	19.9	9.3	9.9	10.0	10.1	15.5	10.4	15.3	9.5	10.7	10.9	6.9	10.1	9.6	8.7	9.9	12.2	9.6	7.7	15.2	10.7	17.1	12.5	31.8	12.0	6.5	18.9	10.8	19.5	5.5	4.6	4.1	2.6	4.4	5.5	1.2	14.0	12.5	11.8	13.5	6.8	8.8	12.1	13.7	12.1	16.9	20.5	9.4	7.9	30.8	10.6	8.5	12.5	17.5	7.9	27.5	10.8	17.0	21.3	10.6	6.8	8.0	33.5	21.9	6.1	8.9	16.8	12.9	10.3	20.5	42.8	14.5	4.9	39.8	19.5	6.7	7.6	23.8	30.2	24.9	9.9	13.8	15.1	11.8	22.1	7.2	13.2	20.8	28.0	7.6	13.4	12.2	16.1	21.1	23.4	29.1	38.1	9.8	20.7	12.1	1.4	1.9	3.8	3.8	2.6	3.0	5.5	4.1	4.0	1.4	4.4	3.9	5.5	4.1	4.4	1.8	4.6	4.2	1.2	13.4	10.4	16.0	13.8	9.1	7.6	9.3	9.9	9.5	12.5
SYCE3	C22orf41	ENSG00000217442	"Synaptonemal complex central element protein 3"	A1L190	22	50551112-50562905	"Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 61.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.7;Karpas-707: 7.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 8.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 8.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA047813			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"				"Nucleoplasm, Nucleoli, Golgi apparatus"		"HPA047813: "	"unprognostic (2.55e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.68e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.43e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.20e-2)"	0.4	0.4	0.7	0.5	0.9	0.1	0.7	0.2	0.6	0.2	0.4	0.5	0.4	0.1	0.2	1.1	0.2	0.8	0.6	0.1	0.5	0.7	1.0	0.8	0.4	0.9	0.9	0.3	0.1	0.2	0.2	0.4	0.4	0.7	0.1	0.0	0.2	0.7	0.1	0.0	0.2	0.0	0.5	0.7	0.1	0.2	61.5	0.4	0.0	1.1	0.2	0.3	0.7	0.0	0.5	1.9	8.0	1.3	0.0	0.3	0.3	0.3	0.7	0.1	0.3	0.6	0.5	0.4	0.5	0.0	0.0	0.0	0.0	8.7	0.4	3.2	0.0	0.0	0.9	1.0	0.0	0.0	0.5	0.0	0.6	0.0	3.9	0.0	1.6	2.3	2.0	0.3	1.4	0.0	0.0	7.3	0.4	3.3	0.0	0.0	0.3	0.0	0.0	0.0	3.8	1.2	2.6	0.8	2.3	0.0	2.2	1.4	2.1	1.7	0.0	0.7	0.8	0.0	0.1	1.9	0.4	1.1	0.9	0.3	0.2	0.0	1.3	1.5	0.0	1.1	0.3	0.0	0.0	0.0	1.9	0.5	0.0	0.2	8.0	0.0	0.9	0.0	0.0	0.3	0.7	0.9	0.2	0.6	0.5	0.7	0.9	0.3	0.7	0.4
SYDE2	FLJ13815	ENSG00000097096	"Synapse defective Rho GTPase homolog 2"	Q5VT97	1	85156873-85201046	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.1;SK-BR-3: 8.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027138, HPA058378"	Uncertain		Approved	"Nucleoli,Golgi apparatus"				"Nucleoli, Golgi apparatus"		"HPA027138: AB_1857686, HPA058378: "	"unprognostic (1.68e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.43e-3)"	"unprognostic (2.50e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.84e-3)"	"unprognostic (6.47e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.88e-2)"	"unprognostic (4.05e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.57e-1)"	"unprognostic (8.76e-2)"	"unprognostic (7.51e-2)"	"unprognostic (6.69e-2)"	2.5	1.8	1.1	2.6	1.7	0.6	3.8	0.6	2.2	3.5	11.4	0.5	2.0	2.5	3.8	2.6	5.6	2.3	7.7	5.4	2.8	0.9	4.7	6.4	9.1	3.4	0.9	2.4	3.3	9.9	8.4	5.1	5.0	0.9	5.0	2.6	7.2	3.9	2.5	2.4	1.9	9.2	13.3	0.9	1.0	6.0	3.3	1.0	0.6	5.2	1.0	0.8	6.0	9.6	0.3	0.1	1.4	0.1	0.3	0.7	0.2	2.2	0.6	0.7	0.8	2.5	0.7	16.1	2.5	1.6	1.5	2.3	4.2	0.7	0.0	0.8	1.6	4.2	8.0	1.0	2.4	0.9	2.2	2.0	1.7	1.4	2.9	1.3	0.5	1.1	1.3	1.1	1.1	0.3	2.5	0.0	1.1	3.0	1.2	0.2	4.1	0.9	0.0	4.3	0.5	1.1	5.6	0.1	0.0	1.8	8.7	2.6	2.0	1.7	0.3	1.9	4.2	0.0	2.5	0.0	0.3	0.8	0.2	0.8	1.7	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.3	0.7	0.3	1.4	0.3	0.0	0.1	0.0	0.2	1.1	1.7	0.6	2.2	2.8	0.9	0.9	2.4	0.9	1.0
TACSTD2	"EGP-1, GA733-1, M1S1, TROP2"	ENSG00000184292	"Tumor associated calcium signal transducer 2"	P09758	1	58575423-58577773	"Disease related genes, Predicted membrane proteins"	"Sensory transduction, Vision"	"Tumor antigen"	"Amyloidosis, Corneal dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.9;salivary gland: 56.4"	"Cell line enhanced"	"Detected in some"		"A-431: 74.1;CAPAN-2: 100.5;HaCaT: 100.7;RT4: 34.8"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"eosinophil: 12.4"	"Group enriched"	"Detected in many"	65	"dendritic cells: 3.7;granulocytes: 12.4;monocytes: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043104, HPA055067, CAB072852"	Enhanced		Supported	"Nucleoli,Vesicles,Plasma membrane"				"Plasma membrane"	"Nucleoli, Vesicles"	"CAB072852: , HPA043104: AB_10960710, HPA055067: AB_2682687"	"unprognostic (1.80e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.67e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-2)"	"unprognostic (7.91e-2)"	"prognostic favourable (3.99e-4)"	"unprognostic (7.10e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.91e-3)"	"unprognostic (2.50e-1)"	0.0	0.0	0.0	0.0	0.0	0.7	17.1	0.0	0.0	23.1	0.0			0.0	1.7	2.6	103.9	2.7	0.9	0.0	0.0	0.0	10.4	0.0	8.0	0.0	0.0		0.0	9.0	0.0	0.0	1.5		15.7	0.0		56.4	12.6	0.0	42.1	0.0	0.0	0.0	0.0	7.3	0.0			0.1		20.6	17.7	36.1	0.0	3.7	12.4	3.2	0.0	0.0	1.8	74.1	0.0	0.0	0.1	0.0	0.0	28.4	0.0	0.0	0.0	0.0	0.0	100.5	0.0	9.7	6.3	100.7	0.0	18.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	27.6	0.0	1.1	4.2	0.0	0.1	0.0	15.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	13.5	34.8	0.0	0.0	3.2	26.8	0.1	17.5	0.1	4.5	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	12.4	0.0	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.8										
TAF13	"TAF2K, TAFII18"	ENSG00000197780	"TATA-box binding protein associated factor 13"	Q15543	1	109062486-109076002	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044492	Approved		Enhanced	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA044492: AB_10962871"	"unprognostic (8.54e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.33e-2)"	"prognostic unfavourable (8.74e-6)"	"unprognostic (1.73e-2)"	"unprognostic (2.18e-1)"	"prognostic favourable (2.42e-5)"	"unprognostic (1.85e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.61e-3)"	"unprognostic (7.22e-3)"	23.5	13.4	24.6	14.3	23.4	27.7	14.7	14.0	33.7	18.0	16.6	19.5	15.3	10.0	13.9	14.7	22.1	9.9	18.0	19.2	25.3	26.9	22.3	21.0	11.5	8.6	32.2	22.6	6.6	15.9	14.6	21.2	21.0	35.8	16.9	18.2	7.7	14.5	11.7	40.9	13.0	12.8	22.2	36.1	7.7	14.0	10.3	20.7	4.1	18.2	16.6	14.8	16.4	11.0	1.3	3.0	7.9	4.6	0.5	2.3	0.8	20.2	5.3	8.2	11.9	23.6	22.1	13.6	48.3	20.4	19.7	19.9	8.5	4.6	7.7	18.5	32.1	8.6	14.3	17.4	29.7	13.2	3.2	7.8	12.9	8.7	18.7	13.7	11.9	19.7	20.9	33.0	18.0	16.8	14.9	7.6	26.6	11.7	7.1	3.7	16.3	11.1	5.6	14.7	3.1	23.2	17.7	8.5	10.7	23.7	15.4	17.4	5.2	9.8	21.9	32.6	12.4	23.0	26.4	9.2	23.3	10.4	34.6	7.2	48.3	2.6	4.6	3.7	1.7	3.3	1.5	1.2	1.1	1.7	1.5	1.3	1.1	1.6	7.9	0.5	2.8	3.0	2.3	0.8	24.6	23.4	14.0	33.7	25.3	26.9	32.2	22.6	35.8	20.7
TAF1B	"RAF1B, RAFI63, SL1, TAFI63"	ENSG00000115750	"TATA-box binding protein associated factor, RNA polymerase I subunit B"	Q53T94	2	9843354-9934416	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071254			Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA071254: "	"unprognostic (1.12e-1)"	"unprognostic (1.74e-1)"	"prognostic favourable (8.58e-5)"	"unprognostic (1.44e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (6.94e-7)"	"unprognostic (9.17e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.98e-1)"	"prognostic favourable (8.55e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.49e-2)"	13.4	11.7	10.2	10.7	11.1	7.8	12.1	14.0	12.7	12.3	7.4	8.4	15.9	7.1	19.2	14.5	16.5	13.6	9.7	8.5	9.3	11.7	17.9	9.9	11.5	13.9	9.2	9.5	12.7	8.9	22.6	19.5	20.2	10.7	12.6	8.1	11.6	10.1	20.1	7.2	11.3	7.5	11.1	8.5	13.9	8.4	17.1	9.2	23.3	14.9	10.9	15.8	9.9	14.4	9.8	11.3	4.9	13.1	8.5	12.9	4.6	12.0	12.0	16.7	5.1	8.4	12.9	26.9	13.2	13.2	14.4	12.5	11.1	9.8	14.2	7.0	10.7	6.9	14.5	16.3	16.1	13.8	15.8	15.3	5.1	14.9	10.9	12.0	17.1	10.1	9.6	10.6	15.7	21.6	10.2	15.1	14.5	8.0	9.0	10.2	20.1	8.8	5.4	14.1	4.4	14.7	10.8	7.1	18.2	11.4	15.3	11.6	5.3	9.6	10.0	17.4	20.5	17.0	18.2	7.4	8.8	20.2	10.5	13.9	14.9	2.6	8.4	4.9	11.5	13.1	10.9	9.5	9.5	12.9	11.3	9.8	6.3	9.4	0.4	8.5	10.0	9.4	9.4	4.6	10.2	11.1	14.0	12.7	9.3	11.7	9.2	9.5	10.7	9.2
TAF1D	"JOSD3, MGC5306, TAF(I)41"	ENSG00000166012	"TATA-box binding protein associated factor, RNA polymerase I subunit D"	Q9H5J8	11	93729948-93784391	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA030703, HPA055935, HPA060385"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Mitotic spindle,Centriolar satellite"				Nucleoplasm	"Nucleoli, Mitotic spindle, Centriolar satellite"	"HPA030703: , HPA055935: , HPA060385: "	"unprognostic (9.91e-3)"	"unprognostic (4.38e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.40e-3)"	"unprognostic (6.46e-2)"	"unprognostic (3.68e-3)"	"unprognostic (9.70e-2)"	"unprognostic (5.24e-3)"	"unprognostic (3.55e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.09e-2)"	"prognostic unfavourable (3.17e-7)"	"unprognostic (1.95e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.37e-2)"	13.9	10.6	12.5	19.9	18.4	14.2	12.9	17.3	20.1	15.1	14.7	4.3	17.3	16.8	15.2	9.7	16.0	11.5	18.1	11.1	12.0	7.6	13.6	18.7	15.8	19.0	14.4	13.6	20.9	30.5	9.3	24.3	18.5	13.6	16.4	13.4	3.9	12.3	11.4	31.5	14.5	17.8	18.1	22.1	18.4	13.0	8.0	13.6	13.1	13.2	12.9	12.2	28.1	17.1	24.1	14.3	22.3	9.2	9.0	16.3	2.7	3.8	3.0	4.1	4.1	4.1	16.0	7.5	4.4	3.2	5.6	4.0	10.5	10.6	9.4	8.4	4.2	11.6	4.8	6.9	6.2	2.5	2.0	9.6	17.3	6.2	4.0	8.7	5.2	4.4	7.4	4.5	7.3	7.0	6.5	18.6	7.7	1.2	7.3	16.8	3.2	2.4	3.5	4.7	8.0	6.5	6.2	2.9	6.2	2.6	9.5	3.0	11.8	2.2	6.8	8.4	5.6	12.7	6.4	8.3	9.4	7.9	3.1	9.3	2.8	17.4	9.2	14.8	10.0	6.5	10.0	19.5	13.8	10.9	6.2	24.1	16.3	13.6	22.3	9.0	5.2	14.3	9.4	2.7	12.5	18.4	17.3	20.1	12.0	7.6	14.4	13.6	13.6	13.6
TANK	"I-TRAF, TRAF2"	ENSG00000136560	"TRAF family member associated NFKB activator"	Q92844	2	161136908-161236221	"Predicted intracellular proteins"	"DNA damage, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010345, HPA037675, HPA037676"	Approved		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"CAB010345: AB_2199871, HPA037675: , HPA037676: "	"unprognostic (1.14e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.27e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (2.90e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.98e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.58e-1)"	"prognostic unfavourable (2.78e-6)"	"unprognostic (2.13e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.30e-2)"	35.9	23.6	17.2	32.0	21.1	43.0	34.2	17.7	16.8	19.6	22.3	11.7	18.0	15.8	20.6	21.8	23.2	20.9	25.1	18.4	16.2	17.2	22.7	37.2	35.4	28.8	20.1	12.7	19.7	15.4	17.0	33.3	41.7	18.2	26.0	21.5	15.7	21.9	15.5	49.5	21.4	22.6	32.2	21.3	42.1	18.2	13.5	19.1	29.2	29.0	25.1	29.0	37.3	38.6	22.4	20.7	54.0	27.9	13.3	28.1	14.7	11.9	7.6	10.1	11.5	29.4	38.8	14.5	17.1	27.1	12.5	18.9	9.3	15.7	17.0	12.5	20.3	8.6	6.2	13.4	19.0	39.3	6.5	9.2	7.4	23.8	24.0	15.1	10.3	31.1	21.6	18.9	14.8	32.1	9.1	22.4	24.0	9.0	9.1	15.3	5.8	6.9	5.3	14.8	11.0	28.4	19.5	8.6	10.0	11.1	13.2	18.5	5.5	18.6	33.7	15.8	9.7	8.0	10.2	15.2	13.9	25.7	21.0	12.0	12.0	28.1	21.6	26.4	12.1	25.1	18.5	22.1	19.5	17.5	20.7	22.4	12.9	13.2	54.0	13.3	27.9	12.1	28.1	14.7	17.2	21.1	17.7	16.8	16.2	17.2	20.1	12.7	18.2	19.1
TAOK2	"KIAA0881, MAP3K17, PSK, PSK1, TAO1, TAO2"	ENSG00000149930	"TAO kinase 2"	Q9UL54	16	29973641-29992261	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010650	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Cytosol"	Nucleoli	"HPA010650: AB_1080204"	"unprognostic (7.30e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavourable (2.51e-4)"	"prognostic favourable (3.87e-5)"	"unprognostic (8.46e-2)"	"unprognostic (2.14e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.60e-1)"	"prognostic favourable (4.78e-4)"	"unprognostic (3.85e-3)"	"prognostic favourable (3.66e-4)"	"unprognostic (7.42e-3)"	"unprognostic (3.17e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.37e-1)"	27.8	24.1	26.2	15.1	26.7	12.3	17.7	29.2	30.6	13.5	13.6	21.5	11.8	18.5	16.8	13.0	12.4	14.1	15.1	17.6	25.0	18.2	13.9	10.4	23.0	14.4	22.1	22.7	15.8	16.3	26.2	18.7	22.5	20.7	13.6	9.6	15.0	17.1	15.9	22.8	20.0	19.3	14.8	14.9	26.3	16.0	21.2	20.2	14.0	15.9	9.8	11.5	12.8	18.0	2.6	3.3	4.8	2.8	2.0	3.2	2.0	11.2	21.5	11.8	18.5	13.8	9.3	18.1	20.6	11.0	14.0	13.1	17.2	15.0	12.2	17.5	14.8	17.5	10.7	10.4	7.5	18.9	22.7	13.1	21.7	17.2	10.1	12.8	25.2	10.9	9.0	14.8	6.0	23.3	11.7	12.4	13.3	20.7	14.9	18.3	11.4	14.5	27.7	17.1	11.3	8.8	10.6	13.9	11.1	11.8	15.8	6.1	19.8	14.6	32.5	24.1	11.2	17.1	11.9	18.1	11.6	11.5	14.8	14.8	17.5	1.3	2.8	1.5	2.9	2.7	3.1	2.0	2.9	2.6	1.8	2.6	1.6	1.4	4.8	2.0	1.4	3.3	3.2	2.0	26.2	26.7	29.2	30.6	25.0	18.2	22.1	22.7	20.7	20.2
TAS2R5	T2R5	ENSG00000127366	"Taste 2 receptor member 5"	Q9NYW4	7	141790217-141791367	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skin 1: 8.8"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 10.4"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA053742			Approved	"Nucleoplasm,Nucleoli,Cytoplasmic bodies"				"Nucleoplasm, Nucleoli"	"Cytoplasmic bodies"	"HPA053742: "	"unprognostic (5.48e-3)"	"unprognostic (3.90e-3)"	"unprognostic (6.07e-2)"	"unprognostic (8.00e-3)"	"unprognostic (7.56e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.13e-5)"	"unprognostic (1.13e-2)"	"unprognostic (8.29e-7)"	"unprognostic (1.29e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.39e-2)"	1.0	1.0	0.4	1.4	1.1	0.2	3.2	4.9	0.7	2.5	0.9			0.8	2.8	6.1	1.1	3.0	0.8	0.8	0.6	0.7	1.0	0.5	1.1	1.2	0.4		4.6	1.5	0.1	2.9	1.0		1.7	1.2		1.6	1.0	2.6	8.8	1.7	1.2	1.2	1.9	0.7	1.4			1.7		1.2	1.3	2.4	1.0	0.6	0.5	0.2	0.4	1.4	0.1	0.5	0.2	1.4	0.6	0.9	2.7	1.7	0.6	0.6	0.5	0.9	2.0	0.4	1.1	0.9	0.2	0.3	1.5	0.8	0.3	0.6	1.7	0.3	1.2	2.7	0.9	1.7	1.3	2.3	10.4	1.2	2.8	1.0	2.6	0.3	0.1	1.7	0.6	3.9	1.3	0.3	0.2	0.1	2.8	0.4	0.7	2.0	1.2	0.3	0.4	0.2	0.1	0.4	0.3	0.9	0.6	0.6	1.2	1.9	0.4	1.4	0.8	0.8	0.5	0.5	0.2	0.0	1.0	0.0	0.0	0.9	0.3	0.4	0.0	1.0	0.9	1.4	0.0	0.4	0.0	0.6	1.3	0.1										
TBC1D1	"KIAA1108, TBC, TBC1"	ENSG00000065882	"TBC1 domain family member 1"	Q86TI0	4	37891087-38139175	"Predicted intracellular proteins, Transporters"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041816, HPA058158"	Approved		Approved	Nucleoli				Nucleoli		"HPA041816: AB_10796784, HPA058158: "	"unprognostic (3.77e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (5.22e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.42e-2)"	"prognostic favourable (1.47e-8)"	"unprognostic (1.49e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.21e-1)"	13.6	3.7	9.3	19.8	8.3	19.0	9.8	9.5	8.4	36.0	48.9	7.1	24.5	10.2	63.4	16.5	14.9	22.9	30.6	24.0	7.5	6.0	29.0	8.8	13.3	16.6	7.0	7.6	16.1	9.4	55.9	8.0	32.4	7.4	18.0	9.8	18.2	8.3	28.1	41.9	5.6	15.1	31.6	7.4	21.2	18.1	15.6	5.4	30.4	26.1	23.1	13.3	27.2	26.8	6.0	4.8	14.0	16.7	6.2	4.3	2.2	5.7	6.5	12.0	12.9	4.3	12.1	10.4	15.6	26.3	14.8	15.1	3.7	18.8	29.4	3.9	10.4	0.3	9.1	11.3	22.8	2.3	5.1	11.3	4.5	7.8	6.9	20.9	13.0	14.6	2.3	9.1	6.3	22.7	13.8	5.1	15.3	4.4	29.0	19.8	6.8	6.0	25.9	19.5	8.5	12.2	10.6	10.5	9.4	5.8	5.4	6.5	5.2	16.2	15.5	19.6	22.3	4.9	22.6	12.5	15.3	77.4	8.5	19.2	17.3	1.9	5.0	14.0	2.6	15.6	4.3	4.8	2.6	2.2	4.8	6.0	2.4	3.0	13.9	6.2	16.7	4.2	2.1	2.2	9.3	8.3	9.5	8.4	7.5	6.0	7.0	7.6	7.4	5.4
TBC1D13	FLJ10743	ENSG00000107021	"TBC1 domain family member 13"	Q9NVG8	9	128787204-128810432	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045865	Approved		Approved	Nucleoli				Nucleoli		"HPA045865: AB_10965700"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.16e-2)"	"unprognostic (4.23e-2)"	"unprognostic (4.29e-2)"	"prognostic favourable (3.14e-6)"	"unprognostic (1.82e-2)"	"prognostic favourable (1.58e-7)"	"unprognostic (1.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.68e-1)"	12.5	17.4	23.0	8.3	20.8	12.1	10.1	12.0	24.7	9.8	10.7	17.3	8.4	11.7	13.3	14.2	8.4	14.7	10.9	13.4	17.8	18.5	26.0	8.9	10.5	11.0	13.9	12.7	19.3	11.3	30.2	9.7	9.5	14.9	11.6	8.2	12.5	16.9	14.3	16.6	11.6	13.0	12.6	8.7	12.0	11.2	8.1	13.3	8.6	14.1	7.6	11.2	11.2	8.5	5.0	9.0	15.7	2.8	3.4	5.6	3.4	6.2	15.0	15.8	15.7	20.5	9.9	15.3	15.0	12.8	15.6	10.1	16.2	8.4	10.5	10.4	17.7	16.9	9.6	11.9	9.2	8.2	10.9	11.2	17.5	14.8	12.7	16.8	22.9	13.8	14.1	13.4	8.1	20.0	17.1	7.1	18.5	13.4	10.1	10.0	14.9	22.6	11.5	14.6	23.7	11.4	8.1	15.9	11.1	20.8	13.4	8.8	14.2	15.8	15.7	19.5	12.3	15.8	12.1	9.1	11.7	10.3	14.3	10.1	14.0	15.7	2.7	4.6	4.9	2.8	4.9	5.0	3.8	4.7	3.1	4.0	3.3	5.6	2.2	3.4	2.1	9.0	2.8	3.4	23.0	20.8	12.0	24.7	17.8	18.5	13.9	12.7	14.9	13.3
TBCA		ENSG00000171530	"Tubulin folding cofactor A"	O75347	5	77691166-77868780	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036487	Approved		Supported	Nucleoli,Microtubules			1000000	Microtubules	Nucleoli	"HPA036487: AB_10669794"	"unprognostic (2.03e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.78e-2)"	"unprognostic (4.95e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.68e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.78e-3)"	"unprognostic (7.63e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.55e-1)"	"unprognostic (7.44e-2)"	40.5	77.3	50.0	32.5	66.7	41.2	108.9	46.8	86.9	33.0	35.7	22.1	34.1	31.8	37.5	78.5	44.4	43.0	27.1	76.7	69.2	56.5	57.7	85.1	59.8	69.6	51.0	50.8	62.3	80.7	24.0	57.9	36.7	77.9	39.1	33.2	30.6	37.3	36.8	43.4	24.6	31.0	62.4	117.9	30.3	38.9	31.2	29.0	26.7	39.8	35.2	40.7	33.3	35.4	53.6	63.1	20.9	39.2	30.9	57.8	34.8	60.8	42.4	77.9	76.8	34.7	49.4	42.6	51.8	44.6	56.5	65.0	58.0	67.2	94.1	94.9	29.0	37.9	48.2	66.1	55.9	43.8	77.1	44.7	45.6	63.8	50.9	38.7	37.3	49.6	52.2	40.2	62.2	48.2	46.6	59.0	50.7	54.0	81.2	92.9	47.8	38.9	55.0	65.1	100.6	54.6	54.5	75.2	49.0	49.7	35.2	93.0	50.0	98.0	44.9	29.1	32.3	51.0	81.2	48.8	47.1	82.2	66.2	66.8	57.6	13.9	34.9	18.2	35.9	36.7	40.4	53.6	43.0	42.4	42.4	49.0	41.3	52.0	20.9	30.9	39.2	63.1	57.8	34.8	50.0	66.7	46.8	86.9	69.2	56.5	51.0	50.8	77.9	29.0
TBL1X	"EBI, TBL1"	ENSG00000101849	"Transducin beta like 1 X-linked"	O60907	X	9463295-9741037	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Activator	Deafness	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 17.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 17.3"									"CAB005363, HPA067703"	Approved		Approved	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"CAB005363: AB_2240272, HPA067703: "	"prognostic unfavourable (8.50e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.21e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.27e-1)"	"prognostic favourable (1.32e-4)"	"unprognostic (2.66e-1)"	"prognostic favourable (4.58e-4)"	"unprognostic (6.71e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.53e-1)"	6.5	7.1	10.1	6.0	12.3	4.5	8.1	3.3	8.1	21.4	7.9	13.2	18.0	2.1	33.0	26.4	8.3	12.4	6.7	5.2	8.6	9.0	12.5	11.0	5.2	9.5	7.6	6.0	13.8	11.3	21.0	24.3	14.5	7.5	24.7	4.1	9.8	5.5	33.0	4.9	5.8	4.2	22.4	9.0	5.7	7.0	9.9	8.5	14.7	9.4	3.4	7.1	15.3	24.5	3.2	3.1	17.3	4.2	0.3	3.1	1.7	0.0	13.5	8.6	23.0	8.0	8.4	8.5	5.2	11.6	10.0	10.5	10.1	9.3	14.4	0.3	10.3	3.1	18.8	4.1	14.7	5.9	9.3	9.0	16.5	11.9	11.4	3.2	32.5	7.5	4.7	10.4	5.5	9.2	15.8	25.1	5.7	11.4	7.8	12.2	17.1	14.6	17.6	6.8	17.6	13.6	7.7	11.1	5.0	12.5	3.1	7.5	6.1	7.1	13.3	3.5	8.7	0.3	2.0	15.3	11.9	11.4	12.9	7.9	3.3	4.4	4.2	4.9	2.1	2.6	1.7	2.0	1.6	1.9	3.1	3.2	3.1	2.8	17.3	0.3	1.7	0.3	2.5	1.7	10.1	12.3	3.3	8.1	8.6	9.0	7.6	6.0	7.5	8.5
TBL3	"SAZD, UTP13"	ENSG00000183751	"Transducin beta like 3"	Q12788	16	1972037-1982933	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042562, HPA055695"	Enhanced	Supported	Enhanced	Nucleoli				Nucleoli		"HPA042562: AB_10964911, HPA055695: "	"unprognostic (1.96e-1)"	"unprognostic (5.49e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.67e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.03e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.32e-2)"	"prognostic favourable (7.33e-4)"	"unprognostic (3.65e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.77e-1)"	8.9	7.9	6.0	9.5	8.3	6.0	5.8	16.3	9.6	6.2	6.8	8.8	6.8	7.7	7.1	6.3	9.4	5.4	6.0	7.5	6.6	6.1	7.2	8.7	6.9	7.2	7.0	7.3	7.7	8.9	10.5	5.5	7.3	5.7	5.7	3.6	5.6	10.5	6.0	18.2	9.5	7.8	5.9	4.8	6.7	9.5	20.5	6.5	9.5	7.2	11.5	9.3	5.1	5.4	8.5	11.2	5.8	12.0	14.8	12.1	8.5	5.5	10.7	3.0	5.8	2.9	2.3	9.7	5.1	3.3	4.4	3.6	13.7	10.7	7.3	12.1	3.9	15.0	4.8	6.0	2.3	5.4	6.8	4.6	5.4	5.2	3.3	8.0	4.4	2.4	4.5	5.5	3.3	5.5	9.3	5.5	2.6	8.9	10.2	4.5	7.0	4.4	17.8	5.5	12.3	2.2	2.1	6.9	5.4	4.6	11.9	4.4	9.0	5.4	8.6	6.1	7.3	5.4	9.9	9.9	4.3	11.6	3.6	5.1	7.0	4.8	10.2	5.8	12.1	12.0	10.7	7.5	8.9	11.8	11.2	8.5	11.4	8.6	2.5	14.8	11.7	5.7	9.6	8.5	6.0	8.3	16.3	9.6	6.6	6.1	7.0	7.3	5.7	6.5
TBPL1	"STUD, TLF, TLP, TRF2"	ENSG00000028839	"TATA-box binding protein like 1"	P62380	6	133952170-133990432	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 71.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071810, HPA071813"	Enhanced		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA071810: , HPA071813: "	"unprognostic (2.21e-3)"	"unprognostic (1.95e-2)"	"unprognostic (5.11e-2)"	"unprognostic (6.67e-3)"	"prognostic favourable (7.22e-4)"	"unprognostic (5.16e-3)"	"prognostic unfavourable (7.91e-5)"	"unprognostic (1.19e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.66e-2)"	"prognostic favourable (7.23e-4)"	"unprognostic (2.56e-1)"	"prognostic unfavourable (4.14e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.82e-1)"	"unprognostic (8.16e-2)"	7.1	7.7	10.8	8.9	11.7	19.3	12.2	16.4	16.6	7.3	7.3	5.2	7.8	8.1	7.9	5.6	7.1	8.5	7.4	7.9	15.9	14.2	5.7	8.5	6.6	12.0	10.0	11.8	8.3	6.0	4.7	8.2	9.2	11.1	8.0	9.3	4.6	5.7	9.2	4.4	5.9	7.7	7.2	8.5	7.6	7.2	71.2	8.0	11.7	10.7	5.0	10.2	9.2	12.0	27.8	14.7	43.1	14.9	21.1	30.8	25.3	6.2	7.6	17.6	11.4	13.5	13.9	9.9	11.8	12.6	15.9	20.9	9.0	5.0	19.4	8.2	9.4	8.2	11.2	12.8	19.2	14.8	13.9	34.1	4.6	9.8	13.7	17.8	13.3	8.6	13.1	17.7	19.3	15.0	49.2	13.4	11.3	14.2	14.9	10.7	19.6	10.0	10.4	10.6	7.4	9.3	5.6	22.9	22.8	7.0	9.2	14.6	4.2	7.2	13.5	9.1	13.3	20.1	13.0	10.8	11.7	12.6	15.3	11.7	10.9	43.1	13.7	32.7	28.5	13.8	30.8	27.8	24.1	29.9	12.4	25.0	23.4	27.3	31.4	21.1	14.9	14.7	24.6	25.3	10.8	11.7	16.4	16.6	15.9	14.2	10.0	11.8	11.1	8.0
TCEA1	"GTF2S, SII, TCEA, TF2S, TFIIS"	ENSG00000187735	"Transcription elongation factor A1"	P23193	8	53966552-54022529	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043786	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA043786: AB_10959468"	"unprognostic (5.35e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (3.75e-5)"	"unprognostic (3.80e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.05e-2)"	26.7	25.3	30.7	40.5	31.5	29.6	31.1	26.1	27.4	26.0	28.3	21.9	26.6	20.3	27.3	20.9	27.5	23.6	24.7	21.4	27.8	24.2	26.5	56.8	22.3	39.2	29.7	17.6	28.5	38.4	32.2	28.7	21.1	27.1	31.3	22.5	20.6	25.4	25.4	21.8	22.8	22.4	38.9	36.8	30.0	26.1	17.3	31.3	39.9	54.6	18.6	46.9	39.6	37.3	60.0	31.9	20.5	17.8	25.2	40.1	17.8	26.8	27.2	24.3	25.0	17.3	21.5	17.4	21.3	25.0	25.2	28.2	15.5	22.5	65.9	24.3	24.4	20.7	30.7	19.5	36.8	37.7	15.4	49.8	13.3	22.9	54.3	19.5	21.5	15.4	52.8	23.7	104.8	21.5	31.6	57.3	22.9	12.7	40.4	13.7	39.6	8.1	31.3	8.5	11.8	34.8	18.3	22.8	16.6	17.6	15.5	57.2	22.4	21.9	19.0	18.6	17.1	20.8	19.1	35.4	22.1	44.7	32.7	22.4	26.1	18.1	17.8	20.5	30.1	16.8	28.6	60.0	31.4	27.7	22.1	44.4	28.0	29.1	6.4	25.2	15.6	31.9	40.1	17.8	30.7	31.5	26.1	27.4	27.8	24.2	29.7	17.6	27.1	31.3
TCHHL1	"S100A17, THHL1"	ENSG00000182898	"Trichohyalin like 1"	Q5QJ38	1	152084144-152089064	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"epididymis: 1.7;skin 1: 3.8;tongue: 7.0"	"Cell line enriched"	"Detected in single"	59	"SK-BR-3: 10.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			"HPA042579, HPA063483"	Enhanced		Approved	"Nuclear membrane,Nucleoli"				"Nuclear membrane, Nucleoli"		"HPA042579: AB_10794283, HPA063483: AB_2685021"						"unprognostic (8.21e-2)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TENM2	"KIAA1127, ODZ2, Ten-M2"	ENSG00000145934	"Teneurin transmembrane protein 2"	Q9NT68	5	167284799-168264157	"Predicted membrane proteins"	"Cell adhesion, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 15.1;heart muscle: 24.7"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 26.1;HBEC3-KT: 17.1;HDLM-2: 16.7;U-138 MG: 30.6;U-2 OS: 26.6;U-251 MG: 19.6"	"Cancer enriched"	"Detected in many"	6	"head and neck cancer: 15.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 15.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"HPA038018, HPA038420, HPA068691"	Uncertain		Approved	Nucleoli				Nucleoli		"HPA038018: , HPA038420: AB_10674682, HPA068691: "	"unprognostic (6.00e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.94e-2)"	"unprognostic (9.16e-3)"	"unprognostic (3.88e-3)"	"unprognostic (3.81e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.68e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.69e-5)"	"unprognostic (3.47e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.16e-4)"	"prognostic unfavourable (7.52e-4)"	0.2	0.4	2.5	0.0	3.5	0.0	1.8	0.5	15.1	0.6	0.3	0.0	0.0	0.3	0.2	0.4	1.4	0.2	0.3	24.7	6.5	0.9	2.7	1.2	0.3	0.0	0.5	1.7	0.7	0.2	0.0	0.4	0.0	2.3	2.2	0.0	0.2	0.3	1.0	0.2	2.3	0.2	0.0	0.6	0.2	0.3	1.2	0.4	0.0	0.4	0.0	0.9	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.7	0.0	0.0	0.0	0.0	26.1	0.0	0.0	17.1	0.3	16.7	0.0	0.0	0.1	0.0	0.8	0.0	0.0	1.2	3.0	0.1	2.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	3.9	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	1.5	0.0	0.0	30.6	26.6	0.0	19.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.5	0.5	15.1	6.5	0.9	0.5	1.7	2.3	0.4
TERB2	"C15orf43, MGC33951"	ENSG00000167014	"Telomere repeat binding bouquet formation protein 2"	Q8NHR7	15	44956702-44979229	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"testis: 51.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.5"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041780			Uncertain	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA041780: AB_10796460"							"unprognostic (1.42e-3)"					"unprognostic (4.19e-2)"		"unprognostic (1.29e-1)"	"unprognostic (3.62e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TEX264	"FLJ13935, ZSIG11"	ENSG00000164081	"Testis expressed 264"	Q9Y6I9	3	51662693-51704323	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005002, HPA017739"	Enhanced		Approved	Nucleoli,Cytosol	"Secreted - unknown location"			"Nucleoli, Cytosol"		"CAB005002: AB_425976, HPA017739: AB_1857910"	"unprognostic (2.80e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.79e-3)"	"unprognostic (8.11e-2)"	"unprognostic (8.26e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.06e-3)"	"unprognostic (2.30e-1)"	"unprognostic (5.19e-2)"	"prognostic favourable (5.67e-4)"	"unprognostic (1.83e-1)"	"prognostic favourable (7.95e-9)"	"unprognostic (4.99e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.17e-1)"	"unprognostic (4.67e-2)"	15.7	34.6	15.1	15.3	18.7	9.0	20.0	8.6	22.8	17.5	21.3	15.0	36.0	18.7	20.1	25.5	17.7	21.9	24.8	19.0	14.6	15.6	35.9	30.7	17.0	22.6	15.7	17.9	15.8	29.0	29.9	12.3	24.5	12.2	20.3	16.7	22.6	43.6	44.3	16.3	29.5	20.8	16.6	15.8	18.6	19.0	90.8	11.5	16.6	33.9	18.5	15.9	16.7	16.3	33.1	34.5	24.7	36.7	22.8	50.7	41.1	11.7	21.6	3.8	19.9	40.4	19.7	7.9	10.1	24.0	16.9	17.1	11.6	28.0	17.0	7.4	14.5	11.5	11.0	20.5	8.2	13.6	17.5	16.2	13.5	15.3	36.1	10.2	18.2	25.9	32.7	19.1	19.6	12.3	8.5	29.6	17.3	13.6	16.2	23.6	4.2	24.3	7.9	5.1	32.0	26.6	16.4	5.6	9.1	12.4	34.3	15.6	16.7	21.5	9.0	17.0	7.1	17.8	13.4	20.7	22.3	8.3	20.9	21.4	16.9	24.7	36.7	21.7	41.9	36.7	41.9	32.2	43.5	39.7	34.5	33.1	36.5	37.0	7.7	22.8	34.7	30.5	50.7	41.1	15.1	18.7	8.6	22.8	14.6	15.6	15.7	17.9	12.2	11.5
TFF3	"HITF, ITF"	ENSG00000160180	"Trefoil factor 3"		21	42311667-42315651	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"gallbladder: 230.9;thyroid gland: 258.3"	"Cell line enhanced"	"Detected in some"		"MCF7: 32.1;SCLC-21H: 9.8;T-47d: 15.0;TIME: 41.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	30	"eosinophil: 9.5"	"Lineage enriched"	"Detected in single"	63	"granulocytes: 9.5"	"Region enriched"	"Detected in single"	20	"cerebellum: 1.7"	"Region enriched"	"Detected in single"	8	"olfactory region: 1.0"	"CAB020681, HPA035464"	Enhanced		Approved	Nucleoplasm,Nucleoli	"Secreted to blood"	2090000		Nucleoplasm	Nucleoli	"CAB020681: , HPA035464: "	"unprognostic (2.84e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.07e-1)"	"prognostic favourable (5.60e-6)"	"unprognostic (1.28e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.71e-1)"	"unprognostic (6.90e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.86e-2)"	2.2	1.2	0.2	16.8	0.2	0.0	4.3	0.2	0.2	45.1	66.3	0.2	0.5	40.8	2.8	1.2	5.1	8.0	230.9	0.7	0.2	0.3	1.0	0.6	12.6	0.6	0.4	0.2	2.0	4.8	0.0	0.5	0.5	0.2	3.6	63.3	0.3	54.8	0.7	0.6	1.6	70.6	1.5	0.5	5.0	1.1	0.4	0.2	0.3	258.3	14.4	72.6	1.1	1.6	0.0	0.0	9.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	32.1	0.0	0.5	0.1	4.8	0.0	3.6	0.4	0.0	0.0	9.8	0.1	0.0	1.0	0.0	15.0	0.0	41.7	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.3	0.4	0.2	0.2	0.2
TGDS	"SDR2E1, TDPGD"	ENSG00000088451	"TDP-glucose 4,6-dehydratase"	O95455	13	94574051-94596257	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039927, HPA040857"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA039927: AB_10795238, HPA040857: AB_10794867"	"unprognostic (4.07e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavourable (2.48e-4)"	"unprognostic (5.51e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.09e-1)"	11.1	12.2	7.9	11.4	11.8	5.8	13.4	8.0	7.8	11.9	9.0	9.0	13.4	11.1	13.7	13.2	10.3	10.5	8.7	7.7	7.0	7.0	11.8	31.9	7.8	12.5	11.8	6.8	13.9	14.1	6.2	24.3	10.8	10.1	10.5	10.6	15.4	12.5	12.7	7.6	7.9	11.1	10.3	12.6	11.9	9.8	7.2	12.6	27.1	15.8	8.9	12.5	10.9	9.2	9.9	8.0	10.5	7.0	10.4	17.4	6.7	7.2	3.0	5.1	4.6	7.6	6.1	6.4	6.6	6.4	6.3	6.1	8.4	7.1	11.2	6.7	4.6	4.6	9.0	5.2	6.5	8.9	3.6	9.0	3.6	7.8	9.6	30.8	6.2	7.1	4.2	3.5	10.1	5.8	8.8	3.9	5.6	4.4	8.4	15.9	6.7	3.9	7.2	5.2	6.6	7.9	3.2	7.3	4.0	5.0	10.5	18.6	4.7	16.7	5.3	2.5	6.6	3.9	5.5	8.9	4.8	41.2	6.9	11.4	6.8	10.5	5.3	9.6	9.6	6.2	14.5	9.9	11.3	10.5	8.0	7.3	17.4	12.4	1.5	10.4	7.0	7.1	12.5	6.7	7.9	11.8	8.0	7.8	7.0	7.0	11.8	6.8	10.1	12.6
THAP3		ENSG00000041988	"THAP domain containing 3"	Q8WTV1	1	6624866-6635586	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067114	Approved		Approved	Nucleoplasm,Nucleoli,Mitochondria				Nucleoplasm	"Nucleoli, Mitochondria"	"HPA067114: "	"unprognostic (1.82e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavourable (1.33e-4)"	"unprognostic (2.89e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.70e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.50e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.26e-3)"	14.2	17.2	16.4	11.4	16.8	12.9	31.4	21.5	20.3	16.5	16.6	13.8	11.8	12.0	15.2	13.6	11.8	16.3	11.9	19.0	16.0	14.5	17.2	17.3	10.8	15.5	18.1	14.1	23.7	28.8	12.1	14.2	11.4	17.6	17.0	7.2	11.5	24.8	16.7	20.9	14.2	11.4	12.7	13.0	15.3	12.0	11.9	16.3	11.6	22.6	9.0	12.9	17.2	21.6	22.2	18.0	10.6	14.7	17.0	22.0	15.0	9.8	9.3	8.5	12.3	14.1	12.7	8.2	8.9	11.7	23.8	14.9	12.5	6.2	8.7	12.0	9.8	7.8	13.5	7.9	8.3	15.0	22.1	10.0	12.5	11.1	17.7	7.1	10.4	11.9	10.2	14.9	13.2	10.2	10.1	11.2	8.7	6.8	12.2	16.0	7.3	15.8	11.8	10.3	12.5	10.6	2.3	11.2	12.7	10.9	15.0	20.6	9.6	12.8	9.2	12.6	7.6	8.6	13.8	12.7	13.5	11.4	10.7	15.2	7.1	10.2	14.7	10.6	20.1	11.7	20.2	17.1	19.7	20.8	18.0	22.2	22.0	18.5	9.0	17.0	9.1	16.4	19.3	15.0	16.4	16.8	21.5	20.3	16.0	14.5	18.1	14.1	17.6	16.3
THTPA	THTPASE	ENSG00000259431	"Thiamine triphosphatase"	Q9BU02	14	23555988-23560271	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028876	Approved		Uncertain	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA028876: AB_10600731"	"unprognostic (3.50e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.13e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.50e-1)"	"prognostic favourable (1.70e-9)"	"unprognostic (3.47e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.40e-2)"	14.9	19.5	27.7	12.2	23.3	7.6	12.9	16.4	24.3	12.3	14.0	20.7	15.9	15.7	13.3	18.4	10.1	17.7	16.8	16.3	23.3	17.4	16.3	12.1	10.7	10.7	21.9	13.3	15.4	12.7	25.0	12.4	7.6	16.1	18.8	12.3	17.1	18.0	23.5	21.9	7.4	11.7	13.7	19.5	11.3	11.6	18.8	14.3	14.1	15.9	12.3	11.2	9.9	7.9	14.3	17.0	11.1	14.4	6.9	11.6	8.7	2.7	17.2	8.5	9.1	19.4	11.0	4.7	8.0	7.1	8.0	7.9	3.5	11.4	5.2	7.1	9.6	8.5	8.9	10.0	5.9	11.0	9.6	7.1	12.1	9.4	9.8	6.5	6.4	14.8	7.4	12.1	9.0	9.5	5.3	11.5	11.5	8.2	10.2	2.7	3.0	14.6	7.0	5.7	9.5	14.0	5.5	16.3	7.8	7.9	16.3	4.7	10.9	3.2	7.5	5.2	5.6	10.8	4.7	13.6	8.2	2.9	5.5	2.9	8.0	11.1	14.4	7.3	9.6	10.6	9.5	9.6	6.9	7.5	13.2	14.3	11.6	9.9	1.5	6.9	13.4	17.0	5.4	8.7	27.7	23.3	16.4	24.3	23.3	17.4	21.9	13.3	16.1	14.3
THUMPD3	DKFZP434F091	ENSG00000134077	"THUMP domain containing 3"	Q9BV44	3	9362842-9386791	"Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036170, HPA036171"	Approved		Enhanced	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA036170: AB_10671836, HPA036171: "	"unprognostic (2.13e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.74e-3)"	"unprognostic (4.25e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (1.25e-7)"	"unprognostic (6.54e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.19e-2)"	"prognostic favourable (1.03e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.53e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.59e-2)"	17.4	17.2	13.3	12.9	14.8	22.2	14.2	13.4	19.6	15.2	14.4	13.8	12.5	12.8	14.0	15.8	16.5	12.3	10.9	19.3	12.3	13.9	20.7	23.9	11.1	13.5	18.3	11.0	14.3	14.8	22.2	27.8	14.4	23.2	15.9	15.1	14.0	16.1	14.9	29.4	13.4	14.9	12.3	15.8	14.5	12.5	42.8	14.8	22.3	18.2	17.5	13.2	16.2	11.7	13.9	15.4	12.5	19.3	11.7	22.3	10.1	12.5	17.2	12.0	6.2	15.9	15.3	48.4	15.4	12.7	15.7	12.0	12.9	13.4	12.9	12.1	13.9	8.3	21.9	15.8	16.0	14.4	12.7	16.3	17.4	11.2	15.5	20.7	11.7	12.2	17.8	18.6	19.4	10.3	25.4	18.9	20.7	17.9	24.3	8.9	23.1	16.7	15.5	20.6	18.5	10.4	19.1	5.0	16.2	12.8	9.2	13.7	14.9	13.4	7.3	15.1	13.1	18.2	16.9	24.1	56.2	41.7	18.3	19.4	21.7	10.6	13.2	12.5	16.2	17.4	21.1	12.3	14.1	16.8	15.0	13.9	22.3	16.8	2.7	11.7	19.3	15.4	13.2	10.1	13.3	14.8	13.4	19.6	12.3	13.9	18.3	11.0	23.2	14.8
TICAM1	"MGC35334, PRVTIRB, TICAM-1, TRIF"	ENSG00000127666	"Toll like receptor adaptor molecule 1"	Q8IUC6	19	4815932-4831704	"Disease related genes, Predicted intracellular proteins"	"Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Inflammatory response, Innate immunity"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042460	Uncertain		Uncertain	"Nucleoplasm,Nucleoli,Plasma membrane"				"Nucleoplasm, Nucleoli"	"Plasma membrane"	"HPA042460: AB_10806240"	"unprognostic (2.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.86e-2)"	"prognostic favourable (4.81e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.88e-2)"	"unprognostic (7.60e-3)"	"prognostic unfavourable (3.48e-4)"	"unprognostic (9.86e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.30e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.53e-2)"	"unprognostic (6.48e-2)"	10.5	6.9	7.3	9.4	9.5	18.2	9.4	5.9	15.8	10.2	15.4	7.0	3.4	20.3	8.3	5.2	35.6	8.0	11.4	7.7	5.9	5.4	11.0	15.2	14.1	9.0	6.4	6.1	8.0	14.8	4.2	7.8	6.8	7.1	8.2	5.2	6.1	11.8	5.7	15.3	15.8	21.3	5.2	6.5	11.6	15.2	2.8	6.5	4.4	8.5	12.1	21.7	9.3	13.3	5.3	5.0	7.8	9.1	1.5	3.1	5.4	21.1	4.2	0.0	3.6	3.2	4.1	1.9	7.0	7.2	5.6	6.3	4.2	7.6	14.4	4.0	8.0	14.4	2.0	7.3	2.2	15.4	3.9	3.6	8.4	4.1	8.8	1.3	9.4	6.6	9.2	7.0	5.1	5.8	7.7	3.1	3.0	7.9	3.6	0.7	0.6	16.8	8.0	0.9	9.3	5.0	6.7	2.9	5.4	4.3	12.9	7.1	5.8	3.0	11.5	6.9	4.7	17.4	10.5	12.5	11.0	10.0	8.0	4.9	5.3	7.8	5.3	2.3	2.6	7.8	2.4	5.3	2.6	3.0	5.0	4.0	1.7	1.0	1.6	1.5	9.1	3.6	3.1	5.4	7.3	9.5	5.9	15.8	5.9	5.4	6.4	6.1	7.1	6.5
TIFA	"MGC20791, T2BP, T6BP, TIFAA"	ENSG00000145365	"TRAF interacting protein with forkhead associated domain"	Q96CG3	4	112274542-112285903	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 45.1;U-698: 38.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA045889	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA045889: AB_10963785"	"unprognostic (2.41e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.86e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.14e-2)"	"unprognostic (4.60e-3)"	"unprognostic (5.26e-2)"	"unprognostic (6.44e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.49e-3)"	5.7	6.4	3.3	16.7	3.8	19.2	7.4	6.1	4.5	7.0	3.9	2.0	8.4	3.4	3.6	2.3	14.3	4.0	4.2	7.9	4.7	2.1	4.1	14.6	6.7	22.9	5.4	1.6	9.2	32.2	4.1	3.3	7.4	3.9	6.6	3.7	5.4	21.3	4.5	4.0	9.0	8.7	4.7	4.0	20.3	7.1	3.0	4.8	12.5	14.8	7.8	23.2	7.2	7.3	23.2	7.0	11.3	3.8	9.1	17.7	6.1	6.8	1.7	2.6	4.3	3.2	2.6	5.2	5.5	10.4	3.5	6.0	0.9	6.2	21.1	4.5	2.1	2.0	3.5	4.2	7.4	17.1	2.1	2.1	4.2	1.9	2.1	6.6	2.9	3.5	2.3	3.7	4.1	5.5	2.1	45.1	4.6	3.4	11.6	3.6	0.5	2.2	20.1	6.5	14.0	7.7	4.7	6.0	6.2	4.4	9.3	2.1	4.0	9.5	4.1	5.5	6.6	4.6	4.3	28.2	25.9	38.9	5.2	4.4	4.1	2.9	3.8	2.0	6.3	2.7	10.3	21.2	11.7	11.0	7.0	23.2	5.4	6.6	11.3	9.1	3.2	6.5	17.7	6.1	3.3	3.8	6.1	4.5	4.7	2.1	5.4	1.6	3.9	4.8
TIGD1	EEYORE	ENSG00000221944	"Tigger transposable element derived 1"	Q96MW7	2	232547968-232550592	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA041717	Approved		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies"				Nucleoli	"Nucleoplasm, Nuclear bodies"	"HPA041717: "	"unprognostic (2.48e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.40e-2)"	"unprognostic (6.86e-2)"	"prognostic unfavourable (4.41e-5)"	"unprognostic (3.77e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.21e-3)"	3.9	5.9	13.3	9.2	15.3	19.4	8.9	10.1	11.7	5.4	5.1	10.7	2.0	5.9	8.5	10.1	5.6	7.4	6.9	4.9	13.8	8.2	10.1	5.0	6.9	12.5	9.1	8.0	13.2	5.8	6.3	21.2	6.5	8.6	8.3	6.7	8.3	7.3	7.9	7.5	13.6	6.8	4.3	8.8	11.1	8.1	9.7	10.8	14.2	9.6	4.8	10.6	5.5	5.9	7.1	3.8	7.0	4.8	4.5	9.8	1.9	6.9	5.2	11.3	16.7	4.2	5.5	8.5	5.0	2.8	6.1	6.9	6.5	7.8	11.5	3.8	3.7	6.6	9.3	2.8	9.4	7.0	8.1	10.2	15.2	7.4	2.6	8.5	6.8	6.1	2.7	6.4	4.0	3.8	8.0	12.2	5.3	10.4	10.5	17.3	6.7	6.3	9.7	10.1	5.2	3.6	8.2	13.5	13.5	5.4	4.8	5.2	7.1	8.3	6.5	10.2	10.4	6.4	5.1	10.8	7.5	10.7	5.9	8.6	6.3	4.0	4.8	5.3	6.7	4.3	6.1	4.9	6.5	4.3	3.4	7.1	9.8	7.7	7.0	4.5	4.8	3.8	4.5	1.9	13.3	15.3	10.1	11.7	13.8	8.2	9.1	8.0	8.6	10.8
TLCD2		ENSG00000185561	"TLC domain containing 2"	A6NGC4	17	1702790-1710438	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 6.5;ASC TERT1: 7.6;SiHa: 8.1;T-47d: 6.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 4.1;neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046063	Uncertain		Approved	Nucleoli,Vesicles				Vesicles	Nucleoli	"HPA046063: "	"unprognostic (1.78e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.64e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.04e-2)"	"unprognostic (7.94e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.56e-1)"	"prognostic unfavourable (4.36e-5)"	"unprognostic (3.77e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.44e-2)"	11.3	9.2	0.5	4.7	1.4	1.7	18.4	0.1	1.5	2.7	9.6	0.3	1.7	7.9	1.8	3.1	6.8	2.7	5.6	4.0	0.6	0.4	2.3	14.8	4.6	0.5	1.2	0.4	4.6	1.2	1.5	0.9	1.6	1.9	4.1	5.4	3.0	2.9	3.6	2.2	2.2	18.4	4.3	1.3	1.1	4.5	0.8	0.5	0.3	2.6	1.2	2.7	4.8	6.3	0.7	0.4	4.1	0.4	0.6	0.5	0.1	0.7	1.4	0.8	2.4	6.5	7.6	0.5	1.3	1.2	0.7	0.5	4.6	2.1	0.1	1.3	2.1	6.2	1.0	0.6	0.5	0.2	1.0	0.6	2.0	0.4	3.7	0.0	1.6	6.1	2.2	0.8	1.5	0.5	0.5	0.3	0.6	1.3	0.0	0.3	0.1	0.4	0.1	3.7	0.1	0.4	2.2	0.1	0.3	8.1	0.7	1.2	6.5	0.6	1.7	0.4	2.0	1.4	0.3	0.1	0.0	0.1	0.4	0.2	1.0	4.1	0.4	0.6	0.4	0.2	0.2	0.4	0.5	0.2	0.1	0.7	0.4	0.4	2.7	0.6	0.2	0.4	0.2	0.1	0.5	1.4	0.1	1.5	0.6	0.4	1.2	0.4	1.9	0.5
TLDC1	KIAA1609	ENSG00000140950	"TBC/LysM-associated domain containing 1"	Q6P9B6	16	84476421-84554033	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 28.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041020	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				Cytosol	"Nucleoplasm, Nucleoli"	"HPA041020: AB_10794184"	"unprognostic (8.35e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.39e-3)"	"unprognostic (5.97e-4)"	"prognostic unfavourable (1.03e-5)"	"unprognostic (3.94e-1)"	"unprognostic (2.85e-2)"	"prognostic unfavourable (7.05e-5)"	"unprognostic (2.92e-2)"	"unprognostic (6.78e-3)"	"unprognostic (9.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.16e-2)"	5.5	4.9	7.6	7.1	10.7	1.8	7.3	8.1	11.5	8.1	7.1	6.3	5.2	6.0	14.0	8.8	24.4	6.9	6.5	4.7	6.3	4.5	7.6	5.1	6.4	6.1	5.0	9.4	8.7	5.2	11.3	4.4	15.8	10.7	7.8	7.8	12.9	7.7	6.1	4.5	11.0	9.3	10.7	4.0	5.4	6.8	8.1	3.4	8.3	7.6	6.5	10.0	10.4	12.1	3.3	2.7	13.6	3.5	3.1	8.7	2.6	14.4	10.2	9.0	4.8	4.1	7.2	4.2	10.7	9.6	11.0	3.2	5.8	17.5	2.0	5.8	20.6	16.1	2.5	28.7	14.6	1.0	2.1	1.6	5.0	5.0	5.1	1.2	5.0	5.0	12.5	10.3	13.6	4.6	2.6	2.5	7.4	3.4	1.1	1.2	2.7	3.5	4.5	2.3	0.6	9.8	8.1	2.9	2.1	9.7	6.9	4.8	10.0	1.9	11.2	7.8	3.5	4.1	4.4	2.0	3.4	5.3	4.6	0.6	2.6	13.6	3.1	4.4	3.8	2.7	3.7	3.3	6.8	5.5	2.7	2.7	7.6	4.7	3.1	3.1	3.5	0.8	8.7	2.6	7.6	10.7	8.1	11.5	6.3	4.5	5.0	9.4	10.7	3.4
TMA16	"C4orf43, FLJ11184"	ENSG00000198498	"Translation machinery associated 16 homolog"	Q96EY4	4	163494442-163520539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041571, HPA052688"	Uncertain		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA041571: AB_10794381, HPA052688: "	"unprognostic (6.02e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.92e-3)"	"prognostic unfavourable (2.70e-5)"	"prognostic unfavourable (4.40e-4)"	"unprognostic (2.30e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.69e-2)"	"prognostic unfavourable (7.70e-4)"	"unprognostic (6.98e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.56e-2)"	16.1	13.1	7.1	25.3	9.6	10.2	16.0	8.9	11.5	17.5	11.5	8.9	11.8	9.4	18.5	17.7	16.1	12.8	13.5	12.0	8.7	7.4	13.5	16.8	10.2	22.1	7.6	8.8	16.0	19.3	7.2	12.4	12.6	9.9	11.6	11.0	8.8	16.9	12.2	17.2	15.1	9.8	13.1	11.1	21.1	13.0	30.0	8.5	28.2	10.6	15.0	18.3	15.6	13.5	21.4	28.2	3.3	21.9	13.5	14.0	7.4	15.5	8.2	13.2	12.0	5.5	9.5	13.6	18.2	9.1	9.9	8.4	7.9	21.3	34.5	7.6	9.6	7.9	15.4	13.0	12.6	17.8	13.2	48.1	7.8	12.5	12.3	38.0	14.9	6.1	11.8	8.4	10.5	10.9	16.8	25.4	10.9	14.0	22.8	19.7	14.7	12.0	21.8	12.5	21.7	7.9	7.6	7.7	11.3	11.5	15.4	13.7	9.3	14.8	19.1	8.0	15.1	7.5	19.2	18.4	23.6	40.2	15.7	20.3	23.8	3.3	14.5	1.3	7.7	21.9	11.4	21.4	14.0	9.9	16.5	19.9	13.2	11.1	0.5	13.5	17.7	28.2	11.5	7.4	7.1	9.6	8.9	11.5	8.7	7.4	7.6	8.8	9.9	8.5
TMA7	"CCDC72, HSPC016"	ENSG00000232112	"Translation machinery associated 7 homolog"	Q9Y2S6	3	48440257-48444208	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 204.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047397			Approved	"Nucleoplasm,Nucleoli,Nuclear bodies"				Nucleoli	"Nucleoplasm, Nuclear bodies"	"HPA047397: "	"unprognostic (1.26e-3)"	"unprognostic (1.21e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.55e-2)"	"prognostic favourable (8.33e-4)"	"unprognostic (1.14e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.31e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.64e-3)"	38.7	54.0	76.1	41.7	82.7	72.5	49.8	41.7	55.8	35.3	49.0	22.6	44.7	37.8	28.4	72.6	43.0	30.5	40.3	49.8	61.4	61.6	50.3	50.3	36.6	50.3	63.6	46.0	41.7	59.5	21.6	45.4	28.7	53.3	36.9	47.0	39.2	39.6	37.4	107.4	28.4	41.1	36.5	57.4	41.5	39.0	35.0	41.0	37.9	38.3	67.6	56.6	29.9	37.7	125.7	139.0	192.1	98.7	79.4	146.7	204.3	63.8	46.4	75.3	53.9	62.5	61.0	51.9	52.9	41.7	50.7	50.4	37.7	46.4	41.8	37.8	46.0	25.0	65.6	59.6	56.7	51.4	55.9	78.8	100.0	96.0	48.6	89.4	52.9	55.8	64.1	47.8	46.7	64.0	42.1	44.8	72.3	66.2	104.0	121.7	100.3	74.9	29.8	47.2	70.8	87.1	86.6	24.8	63.0	59.5	43.6	79.5	42.0	132.9	47.8	43.0	77.4	66.5	103.1	74.7	110.1	100.8	55.2	86.5	44.5	141.0	98.7	192.1	110.7	89.8	119.5	125.7	146.7	132.9	104.9	100.5	146.3	140.0	188.5	79.4	87.7	139.0	143.8	204.3	76.1	82.7	41.7	55.8	61.4	61.6	63.6	46.0	53.3	41.0
TMEM108	"CT124, MGC3040"	ENSG00000144868	"Transmembrane protein 108"	Q6UXF1	3	133038391-133397792	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 25.6"	"Cell line enhanced"	"Detected in some"		"HMC-1: 11.6;LHCN-M2: 6.5;SCLC-21H: 10.0;SH-SY5Y: 44.3"	"Cancer enhanced"	"Detected in many"		"glioma: 4.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063350	Enhanced		Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane, Cytosol"	"Nucleoli, Vesicles"	"HPA063350: "	"unprognostic (4.75e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.06e-4)"	"unprognostic (2.08e-1)"	"unprognostic (7.27e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.61e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.36e-2)"	2.2	15.1	12.7	2.2	13.8	0.7	2.4	15.6	21.7	3.2	1.8	7.5	0.2	1.1	3.7	1.3	12.7	2.4	1.6	8.4	10.0	8.1	1.0	0.6	12.1	2.5	5.3	13.7	0.8	1.0	6.1	2.8	9.1	4.9	4.0	2.2	16.1	1.8	3.2	25.6	2.2	2.0	10.4	4.4	2.0	2.2	16.8	4.3	0.0	4.1	1.5	3.3	12.0	1.3	0.8	0.4	1.0	0.4	0.6	0.8	0.6	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.3	0.4	0.8	3.9	0.0	0.0	0.0	0.0	11.6	0.1	0.0	0.0	0.0	0.6	0.0	0.0	6.5	0.3	0.0	0.1	1.8	0.0	0.0	2.2	0.0	0.5	0.0	10.0	44.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.6	0.0	0.3	0.8	0.0	1.7	1.0	0.3	0.2	0.5	0.3	0.3	0.3	0.2	0.5	0.0	0.8	0.3	0.4	0.9	0.6	0.4	0.4	0.8	0.6	12.7	13.8	15.6	21.7	10.0	8.1	5.3	13.7	4.9	4.3
TMEM151A	"MGC33486, TMEM151"	ENSG00000179292	"Transmembrane protein 151A"	Q8N4L1	11	66291870-66296664	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 48.5"	"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 18.2"	"Cancer enhanced"	"Detected in some"		"glioma: 4.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041035	Uncertain		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA041035: AB_10794404"	"unprognostic (1.20e-1)"	"unprognostic (8.24e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (7.60e-2)"	"unprognostic (9.48e-3)"	"unprognostic (8.57e-2)"	"unprognostic (8.73e-4)"	"unprognostic (2.41e-3)"	"unprognostic (2.02e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.69e-3)"	"unprognostic (2.80e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.67e-2)"	1.4	3.8	12.4	1.5	16.8	1.4	1.4	5.9	48.5	1.4	1.5	41.8	0.0	1.5	1.4	1.4	1.4	1.4	2.8	1.6	22.7	14.3	1.4	1.4	1.4	1.4	21.2	13.1	1.5	2.4	1.8	3.3	1.4	22.2	1.4	1.4	1.0	1.5	1.4	1.4	1.4	1.5	1.4	43.2	1.4	3.9	1.6	13.6	0.0	1.4	0.0	1.4	1.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.6	0.0	1.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	18.2	4.1	0.5	0.0	0.3	0.1	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.4	16.8	5.9	31.1	22.7	14.3	21.2	13.1	22.2	13.6
TMEM178B	DKFZp547G036	ENSG00000261115	"Transmembrane protein 178B"	H3BS89	7	141074232-141480380	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.4;parathyroid gland: 20.6;pituitary gland: 18.5"	"Cell line enhanced"	"Detected in many"		"HAP1: 6.9;HDLM-2: 6.3;NTERA-2: 5.9;RPTEC TERT1: 9.6;SCLC-21H: 7.6;WM-115: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA048771	Uncertain		Approved	Nucleoli,Vesicles				Vesicles	Nucleoli	"HPA048771: "	"unprognostic (7.33e-3)"	"unprognostic (2.02e-2)"	"unprognostic (2.83e-2)"	"unprognostic (7.79e-4)"	"unprognostic (1.94e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.69e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.17e-4)"	"unprognostic (1.05e-1)"	"prognostic favourable (4.10e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.35e-3)"	"unprognostic (8.98e-2)"	0.9	1.7	5.2	0.7	7.4	0.1	0.7	3.2	13.4	0.5	0.8	1.0	2.3	0.1	1.1	0.6	1.8	0.3	0.7	11.6	4.8	5.8	2.9	0.6	0.4	1.5	4.9	1.0	0.2	2.6	20.6	18.5	0.1	1.8	2.8	0.4	0.5	4.4	0.8	4.5	0.2	1.2	1.3	2.4	0.8	0.5	0.8	0.4	1.0	9.5	0.1	3.3	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.6	0.3	1.8	0.1	2.7	0.8	1.0	0.0	0.0	2.2	2.3	0.2	0.0	6.9	0.0	2.3	6.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	5.9	0.0	0.4	1.1	2.9	9.6	2.7	7.6	4.6	0.1	0.3	1.0	1.0	0.0	0.0	0.1	1.1	3.1	0.0	0.1	0.0	0.0	0.5	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	7.4	3.2	9.6	4.8	5.8	4.9	1.0	1.8	0.4
TMEM187	"CXorf12, DXS9878E, ITBA1"	ENSG00000177854	"Transmembrane protein 187"	Q14656	X	153972327-153983195	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA038134	Uncertain		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA038134: AB_10669517"	"unprognostic (1.51e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.08e-1)"	"unprognostic (7.88e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.09e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.33e-2)"	"unprognostic (7.41e-2)"	"prognostic favourable (9.14e-8)"	"unprognostic (6.73e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.04e-2)"	8.8	13.0	9.2	6.8	10.2	3.4	10.5	13.2	9.0	7.6	9.0	10.5	13.9	6.8	8.8	9.3	9.5	12.0	6.8	8.1	9.6	6.0	7.6	10.2	7.7	10.2	10.4	9.0	10.9	24.4	7.5	13.0	7.3	11.0	10.3	4.5	6.7	14.1	10.1	8.5	10.7	10.9	6.8	8.0	10.0	8.0	5.9	8.7	8.4	10.8	2.9	9.9	7.9	7.4	13.4	19.6	17.8	9.8	10.1	22.5	10.9	8.3	9.5	2.1	7.6	8.2	7.4	1.1	3.4	1.7	1.0	3.4	1.9	14.4	1.3	19.7	2.7	7.6	2.9	5.0	0.8	10.7	3.9	2.3	5.0	3.1	7.0	1.1	2.6	8.3	7.6	2.9	4.3	2.6	2.0	10.8	4.3	9.0	4.4	1.5	1.5	10.6	4.1	1.1	13.9	5.3	2.7	2.8	2.8	5.0	4.2	3.6	8.0	2.7	4.8	1.7	1.8	6.9	1.9	7.6	5.1	1.7	5.1	5.0	0.9	17.8	9.8	11.9	14.7	7.3	14.7	9.7	18.1	15.9	7.4	13.4	22.5	13.9	9.5	10.1	6.9	19.6	17.6	10.9	9.2	10.2	13.2	9.0	9.6	6.0	10.4	9.0	11.0	8.7
TMEM217	"C6orf128, dJ355M6.2"	ENSG00000172738	"Transmembrane protein 217"	Q8N7C4	6	37212180-37258155	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	6	"testis: 20.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 3.6;HEL: 4.7;hTEC/SVTERT24-B: 3.3;HUVEC TERT2: 4.9;TIME: 12.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"HPA045432, HPA071187"			Supported	Nucleoli				Nucleoli		"HPA045432: , HPA071187: "	"unprognostic (7.78e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.29e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.23e-4)"	"unprognostic (8.22e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.62e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.33e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.59e-1)"	0.3	2.7	0.4	0.4	1.4	1.3	0.3	0.4	1.1	0.3	0.3	1.6	0.0	0.4	0.2	1.1	1.4	0.4	0.7	0.4	0.3	0.4	0.9	0.5	0.5	0.1	0.9	1.0	1.1	3.1	0.6	2.3	0.2	1.0	0.4	0.3	1.1	1.5	0.1	1.0	0.5	0.4	0.5	1.6	0.2	0.2	20.1	0.9	0.0	0.5	0.0	0.3	0.4	0.3	0.1	0.4	0.2	0.0	0.0	0.6	0.1	0.1	0.0	0.3	0.0	0.2	1.2	0.0	0.3	2.7	1.0	3.6	0.7	0.5	0.1	0.2	0.0	0.5	0.3	0.3	1.0	0.1	0.2	4.7	0.0	0.1	0.3	0.0	2.7	0.5	0.7	3.3	0.2	4.9	1.3	0.0	0.5	0.0	0.1	0.4	0.2	0.0	0.2	0.0	0.0	1.2	0.2	0.0	0.0	0.5	0.0	0.2	0.0	0.1	12.8	0.2	0.1	0.0	0.2	0.1	0.2	0.5	0.0	0.9	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.4	0.0	0.1	0.4	1.4	0.4	1.1	0.3	0.4	0.9	1.0	1.0	0.9
TMEM35B	ZMYM6NB	ENSG00000243749	"Transmembrane protein 35B"	Q8NCS4	1	34981535-34985353	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 42.3;CAPAN-2: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051024	Uncertain		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA051024: "	"unprognostic (3.34e-3)"	"unprognostic (2.77e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.12e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.32e-1)"	"unprognostic (9.41e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.49e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.07e-1)"	23.1	20.6	6.4	10.7	8.0	5.3	24.4	5.7	7.9	23.7	13.8	9.3	12.6	7.4	22.3	19.0	15.2	19.7	26.1	17.6	6.4	5.8	27.5	24.4	25.3	28.0	9.9	7.6	20.0	20.5	9.2	14.6	29.5	9.6	29.6	12.6	26.6	14.2	17.4	10.5	7.2	16.0	18.3	10.2	19.0	12.9	21.4	7.8	17.9	48.7	9.8	18.4	22.0	19.1	24.9	37.3	29.4	26.8	36.4	53.1	38.4	9.0	6.9	1.7	2.7	42.3	25.1	3.4	9.9	16.5	7.1	9.6	6.8	40.0	4.6	15.3	10.1	9.8	3.0	8.4	5.8	17.0	4.6	9.6	3.6	8.0	23.3	6.4	10.1	24.9	7.9	6.3	13.4	13.7	6.2	13.2	12.3	5.5	4.7	6.4	7.5	4.9	6.3	13.6	1.4	18.9	8.9	4.2	1.4	15.0	0.2	13.2	3.7	9.7	14.0	9.5	8.8	8.3	5.6	7.6	4.3	3.1	9.5	10.4	7.9	29.4	24.5	25.4	47.3	26.8	50.7	24.9	52.3	51.9	16.8	21.0	46.1	46.3	7.6	36.4	21.9	37.3	53.1	38.4	6.4	8.0	5.7	7.9	6.4	5.8	9.9	7.6	9.6	7.8
TMEM42	MGC29956	ENSG00000169964	"Transmembrane protein 42"	Q69YG0	3	44861869-44865670	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 16.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052569	Uncertain		Uncertain	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA052569: "	"prognostic favourable (5.23e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.93e-2)"	"unprognostic (6.99e-3)"	"unprognostic (1.64e-2)"	"unprognostic (9.16e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-1)"	"prognostic favourable (1.10e-5)"	"unprognostic (1.31e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.19e-1)"	11.1	14.6	18.6	5.7	26.1	4.6	13.4	7.8	17.3	12.7	8.5	17.7	8.5	6.1	10.4	25.9	7.2	16.8	8.9	10.2	18.4	19.7	12.9	19.1	9.7	9.3	19.1	14.1	17.1	17.5	12.7	16.5	8.9	16.4	12.7	8.5	8.5	10.9	12.7	16.6	8.6	6.2	9.2	19.8	8.7	9.9	20.0	15.5	11.6	17.1	6.5	9.1	7.5	8.7	13.9	11.8	4.2	10.2	9.1	15.9	9.2	4.0	4.1	1.2	2.3	15.9	12.5	0.1	3.4	4.8	4.1	4.1	0.8	8.0	2.8	6.6	6.5	2.7	0.3	5.2	4.2	4.3	0.0	1.7	5.3	4.3	16.9	2.0	0.1	13.0	13.2	4.3	9.5	7.0	0.1	5.7	6.2	3.2	1.7	3.4	2.2	1.9	1.4	0.6	0.6	9.0	1.6	1.3	1.7	4.1	1.4	1.6	3.0	3.5	4.6	3.6	0.4	5.3	3.7	2.0	1.5	0.8	7.3	2.4	1.6	3.7	8.6	4.2	7.8	7.7	8.2	13.9	11.6	7.2	10.6	11.9	15.9	12.6	1.6	9.1	10.2	11.8	9.2	9.2	18.6	26.1	7.8	17.3	18.4	19.7	19.1	14.1	16.4	15.5
TMPRSS15	"ENTK, MGC133046, PRSS7"	ENSG00000154646	"Transmembrane serine protease 15"	P98073	21	18269116-18485879	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	67	"intestine: 154.6"	"Group enriched"	"Detected in some"	20	"U-138 MG: 19.8;U-87 MG: 55.3"	"Group enriched"	"Detected in some"	12	"liver cancer: 0.7;pancreatic cancer: 1.5;stomach cancer: 1.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"olfactory region: 9.3"	"HPA015611, HPA034857, HPA072934"	Enhanced		Approved	"Nucleoli,Plasma membrane"				"Plasma membrane"	Nucleoli	"HPA015611: AB_1855791, HPA034857: , HPA072934: "					"unprognostic (9.26e-2)"	"unprognostic (4.14e-1)"		"unprognostic (3.52e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.20e-2)"	"unprognostic (4.70e-2)"		"unprognostic (6.35e-2)"	"unprognostic (5.92e-2)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	80.5	0.0	0.0	154.6	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	42.4	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.5	0.1	0.6	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.1	0.0	0.3	0.0	0.0	55.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.1	0.5	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0
TMX1	"PDIA11, TMX, TXNDC, TXNDC1"	ENSG00000139921	"Thioredoxin related transmembrane protein 1"	Q9H3N1	14	51240162-51257546	"Predicted membrane proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003085	Approved		Supported	"Nucleoli,Endoplasmic reticulum"			740000	"Endoplasmic reticulum"	Nucleoli	"HPA003085: AB_1080424"	"unprognostic (1.83e-1)"	"unprognostic (7.42e-2)"	"unprognostic (6.97e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.12e-2)"	"prognostic unfavourable (1.29e-6)"	"unprognostic (3.70e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.44e-3)"	"unprognostic (5.07e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.21e-3)"	21.8	24.2	13.6	18.5	18.3	15.5	19.7	14.1	12.3	14.4	20.7	17.2	27.0	17.7	17.5	19.2	25.0	13.3	15.0	11.3	13.5	11.9	24.9	29.2	20.0	25.3	22.6	9.2	15.5	23.9	18.4	19.0	21.9	16.3	14.2	21.2	13.3	21.0	27.9	12.5	16.7	23.4	17.0	24.9	29.1	18.1	12.9	17.9	37.5	23.5	17.6	17.4	20.2	19.9	9.4	17.0	9.6	17.5	12.6	12.5	13.3	13.6	12.6	17.5	9.4	14.0	11.0	18.8	17.2	13.9	17.4	22.3	12.7	25.2	19.5	16.2	11.5	13.5	30.9	11.3	31.7	19.6	10.6	14.2	11.0	12.5	12.2	32.6	14.4	13.1	10.4	11.7	8.6	15.4	11.7	13.5	16.5	16.8	14.5	17.6	19.9	15.8	15.4	31.6	11.7	16.8	17.8	11.1	8.2	13.7	9.2	12.3	13.5	14.6	9.9	18.4	17.1	13.0	15.6	11.8	11.9	16.0	8.1	18.6	17.2	9.6	15.4	7.2	10.2	17.5	12.5	9.4	10.9	10.5	16.2	7.4	10.8	12.0	5.7	12.6	12.6	17.0	12.1	13.3	13.6	18.3	14.1	12.3	13.5	11.9	22.6	9.2	16.3	17.9
TNFAIP1	"B12, B61, BTBD34, EDP1, MGC2317"	ENSG00000109079	"TNF alpha induced protein 1"	Q13829	17	28335602-28347009	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 51.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013333, HPA014641"	Uncertain		Approved	Nucleoli				Nucleoli		"HPA013333: AB_1858160, HPA014641: AB_1858159"	"unprognostic (4.42e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.32e-2)"	"prognostic unfavourable (7.48e-5)"	"unprognostic (2.29e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.31e-2)"	"unprognostic (8.27e-3)"	"unprognostic (1.43e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.49e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.09e-1)"	"unprognostic (7.02e-2)"	23.1	20.4	17.5	13.3	20.9	5.4	20.7	17.5	32.2	17.2	13.5	17.7	12.6	12.9	17.3	12.1	29.2	12.9	21.1	28.6	14.6	11.4	22.9	69.9	27.8	11.7	15.0	16.5	15.2	30.3	19.5	12.7	43.2	14.2	14.3	12.4	19.2	17.5	15.8	14.8	19.5	16.2	22.1	13.9	40.4	16.8	13.3	14.3	12.5	17.7	18.5	14.7	19.8	15.6	7.2	10.9	11.0	9.6	11.2	10.0	5.8	13.0	19.5	12.9	9.2	11.0	9.7	12.5	15.7	19.4	19.2	15.2	51.5	8.1	2.9	10.9	20.6	15.5	6.9	27.0	14.9	7.3	9.4	2.3	19.5	7.8	14.8	4.1	4.0	12.5	31.5	15.2	11.9	22.3	5.9	4.1	8.9	8.3	7.5	2.6	3.1	6.9	3.3	16.6	4.6	28.2	14.2	9.5	10.3	19.7	33.1	8.5	13.9	3.6	23.8	14.3	14.2	11.1	12.0	6.7	5.7	2.9	11.4	3.1	9.2	2.2	8.6	11.0	8.6	8.6	10.0	7.2	6.3	7.6	10.9	5.4	6.2	7.2	2.9	11.2	9.6	5.7	5.4	5.8	17.5	20.9	17.5	32.2	14.6	11.4	15.0	16.5	14.2	14.3
TNFRSF9	"4-1BB, CD137, ILA"	ENSG00000049249	"TNF receptor superfamily member 9"	Q07011	1	7915894-7943165	"Cancer-related genes, CD markers, Predicted membrane proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 13.5;lymphoid tissue: 18.3"	"Cell line enriched"	"Detected in some"	8	"HDLM-2: 45.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"memory CD8 T-cell: 8.0;neutrophil: 6.6;NK-cell: 4.1;T-reg: 13.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.6;NK-cells: 4.1;T-cells: 13.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA071425			Approved	"Nucleoli,Plasma membrane"				"Plasma membrane"	Nucleoli	"HPA071425: "	"unprognostic (7.23e-2)"	"unprognostic (1.72e-2)"	"unprognostic (8.26e-3)"	"unprognostic (1.32e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.19e-4)"	"unprognostic (9.47e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.02e-1)"	"prognostic unfavourable (2.69e-8)"	"unprognostic (1.64e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (9.55e-2)"	0.8	1.0	0.3	11.0	0.3	1.9	0.5	0.2	0.3	0.4	0.5	0.1	0.1	0.6	0.3	0.1	0.6	0.8	1.6	1.8	0.3	1.0	0.7	0.7	2.1	10.8	0.3	0.1	0.3	0.6	0.0	0.5	0.2	0.5	0.4	0.7	0.3	2.1	0.1	0.3	0.5	2.3	0.1	0.3	7.9	0.7	0.5	0.1	18.3	0.7	0.9	17.5	1.4	0.4	0.5	1.1	6.6	1.5	4.1	13.5	1.1	1.2	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.9	0.3	0.1	0.4	0.0	0.1	0.0	0.2	0.4	45.9	0.1	0.2	0.2	0.0	0.9	0.0	0.5	0.1	0.3	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.2	0.2	0.2	1.5	0.1	0.2	0.1	0.1	0.1	5.7	0.2	0.0	1.1	1.5	0.2	1.5	0.4	0.2	0.2	1.0	8.0	1.1	0.5	0.3	1.6	6.6	4.1	0.1	0.3	13.5	1.1	0.3	0.3	0.2	0.3	0.3	1.0	0.3	0.1	0.5	0.1
TNNI1		ENSG00000159173	"Troponin I1, slow skeletal type"	P19237	1	201403768-201429866	"Predicted intracellular proteins"		"Actin-binding, Muscle protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skeletal muscle: 559.6"	"Cell line enriched"	"Detected in some"	9	"RH-30: 103.8"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 9.6;prostate cancer: 3.4"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028190	Approved		Uncertain	Nucleoplasm,Nucleoli			25000	Nucleoplasm	Nucleoli	"HPA028190: AB_10600831"	"unprognostic (2.82e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.31e-2)"	"prognostic unfavourable (9.27e-4)"	"unprognostic (1.93e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.25e-1)"	"unprognostic (3.81e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.59e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.71e-1)"	1.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	22.9	9.5	0.0	0.1	6.6	0.1	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.0	0.0	0.0	6.8	0.0	559.6	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	2.7	83.8	10.7	0.0	0.1	0.2	0.6	1.7	0.4	0.4	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	103.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.4	0.3	0.3	0.3	0.1	0.2	0.2	0.2	0.6	0.2	0.3	0.5	1.7	0.4	0.3	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
TNNT2	"CMD1D, CMH2, CMPD2"	ENSG00000118194	"Troponin T2, cardiac type"	P45379	1	201359008-201377762	"Candidate cardiovascular disease genes, Disease related genes, Predicted intracellular proteins"		"Muscle protein"	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	241	"heart muscle: 679.2"	"Cell line enriched"	"Detected in some"	26	"RH-30: 185.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 5.7"	"CAB015371, HPA015774, HPA017888"	Enhanced		Uncertain	"Nucleoplasm,Nucleoli,Focal adhesion sites"			50000	"Nucleoplasm, Nucleoli"	"Focal adhesion sites"	"CAB015371: AB_630390, HPA015774: AB_1858354, HPA017888: AB_1858355"	"unprognostic (1.45e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.33e-4)"	"unprognostic (1.85e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.63e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.76e-2)"	"unprognostic (9.98e-2)"	0.1	0.3	0.1	0.1	0.7	0.0	0.8	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.2	679.2	0.9	0.0	1.9	0.0	0.7	0.3	0.1	1.1	0.1	0.3	0.0	0.2	0.7	0.1	0.7	0.0	0.0	0.2	0.1	2.0	1.3	0.0	2.8	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.1	0.0	0.0	0.4	0.0	0.0	185.3	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	2.1	0.9	0.0	0.1	1.1	0.1	0.0
TNPO2	"FLJ12155, IPO3, KPNB2B, TRN2"	ENSG00000105576	"Transportin 2"	O14787	19	12699194-12724011	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046446, HPA071498"	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"CAB046446: AB_10603392, HPA071498: "	"unprognostic (1.88e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavourable (7.16e-5)"	"unprognostic (2.25e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.63e-2)"	"prognostic favourable (8.18e-4)"	"unprognostic (2.76e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.50e-3)"	"unprognostic (7.63e-2)"	21.7	19.8	37.1	16.0	35.7	17.8	13.5	33.1	44.7	17.9	13.9	23.2	12.7	13.4	20.7	20.9	22.9	22.4	15.9	20.0	31.1	24.9	14.3	10.1	13.7	16.6	24.8	36.6	32.9	16.0	26.6	19.1	16.1	22.2	16.8	15.9	18.2	15.1	20.0	15.2	36.6	12.5	23.3	25.2	15.3	12.9	24.1	20.9	14.9	17.8	9.9	17.8	18.9	14.7	1.6	4.3	2.6	1.2	0.4	3.3	0.7	17.4	13.3	20.6	26.3	12.5	16.6	13.4	20.2	13.4	29.3	20.7	18.2	9.5	11.9	15.8	17.0	23.4	36.5	20.0	16.4	14.7	29.2	18.3	21.0	22.1	14.2	32.3	17.7	14.8	15.8	19.4	20.7	13.7	28.5	11.4	16.2	30.3	27.0	22.3	23.9	40.4	26.1	16.1	21.8	17.4	12.8	50.5	25.1	16.4	20.9	10.0	14.6	11.5	13.7	45.0	11.9	24.0	29.6	22.7	21.8	20.3	13.4	29.4	15.9	0.6	0.9	0.3	2.1	0.8	3.0	1.5	1.5	1.7	1.2	1.6	2.7	3.3	2.6	0.4	1.2	4.3	0.5	0.7	37.1	35.7	33.1	42.1	31.1	24.9	24.8	36.6	22.2	20.9
TOP2A	TOP2	ENSG00000131747	"DNA topoisomerase II alpha"	P11388	17	40388516-40417950	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 146.3;testis: 36.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 5.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002448, HPA006458, HPA026773"	Enhanced	Approved	Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"CAB002448: AB_564035, HPA006458: AB_1858189, HPA026773: AB_1858190"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.28e-3)"	"unprognostic (9.42e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (5.92e-6)"	"prognostic unfavourable (4.99e-4)"	"unprognostic (6.21e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavourable (3.83e-5)"	"unprognostic (5.03e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (7.46e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.29e-1)"	2.7	2.0	0.4	20.0	0.5	14.6	4.1	0.4	0.5	3.0	6.9	0.5	0.5	7.0	2.0	3.4	18.2	0.7	2.4	2.3	0.6	0.5	1.4	1.9	5.5	15.4	0.6	0.4	1.2	1.1	0.0	0.4	10.7	0.6	1.2	8.0	0.6	3.2	0.3	0.6	5.9	9.2	2.6	1.8	7.3	4.5	36.8	0.3	146.3	0.9	11.8	16.7	3.2	5.7	1.3	0.3	0.3	0.3	3.2	5.7	1.1	33.7	44.9	57.2	26.1	2.8	5.8	12.7	46.4	25.0	42.7	37.9	21.0	25.9	54.5	23.6	15.7	53.8	43.9	18.5	57.4	29.1	29.3	36.0	28.7	35.1	0.2	50.4	38.3	1.2	1.5	30.0	30.6	22.4	38.9	37.4	46.1	11.7	58.4	33.9	23.7	17.9	49.6	88.8	22.6	10.3	21.6	33.8	24.3	37.4	46.7	14.7	39.2	23.2	14.7	28.2	39.7	32.5	44.5	21.5	24.3	47.6	15.9	34.8	46.9	0.3	0.0	0.0	0.6	0.0	0.0	1.3	0.9	0.9	0.3	0.4	0.2	0.1	0.3	3.2	0.3	0.0	5.7	1.1	0.4	0.5	0.4	0.5	0.6	0.5	0.6	0.4	0.6	0.3
TOX4	"C14orf92, KIAA0737, LCP1"	ENSG00000092203	"TOX high mobility group box family member 4"	O94842	14	21476597-21499175	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017880, HPA027551"	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles				Nucleoplasm	"Nucleoli, Vesicles"	"HPA017880: AB_1845573, HPA027551: AB_10601701"	"unprognostic (9.56e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.46e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavourable (3.46e-4)"	"unprognostic (8.05e-3)"	"unprognostic (2.58e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.94e-1)"	"prognostic favourable (8.38e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.48e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.48e-3)"	16.5	15.1	18.0	13.4	24.7	18.8	16.9	19.9	29.8	19.8	17.3	21.0	10.9	12.7	18.9	16.2	21.8	15.6	14.7	19.2	17.0	18.4	14.3	15.8	15.8	13.7	19.3	15.9	17.0	17.0	23.2	15.5	21.3	25.3	15.6	15.9	16.0	19.7	19.2	46.0	20.2	20.0	20.5	17.3	14.7	16.9	18.0	13.3	19.5	17.7	16.6	21.6	18.2	14.4	18.4	23.7	34.1	19.9	19.1	21.4	17.6	12.9	13.8	11.5	10.9	16.7	16.1	15.4	12.6	24.9	26.9	26.0	13.3	15.8	7.9	8.9	20.7	15.8	18.8	19.4	34.5	13.9	7.6	8.8	9.4	18.4	21.7	16.2	14.5	20.9	20.1	21.0	20.3	19.0	10.8	13.6	19.1	11.1	16.0	9.0	6.5	21.8	14.4	11.9	9.1	12.5	16.5	10.7	10.9	12.4	13.3	10.9	12.6	6.2	12.4	13.6	12.9	12.2	11.0	17.9	19.4	17.7	6.6	7.9	14.4	25.2	19.6	27.0	17.3	19.9	18.6	17.0	15.3	16.2	17.7	18.4	16.4	17.9	34.1	19.1	17.7	23.7	21.4	17.6	18.0	24.7	19.9	29.8	17.0	18.4	19.3	15.9	25.3	13.3
TPCN2	TPC2	ENSG00000162341	"Two pore segment channel 2"	Q8NHX9	11	69048897-69162440	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA016561, HPA027080"	Supported		Approved	Nucleoli				Nucleoli		"HPA016561: AB_1858207, HPA027080: AB_10600917"	"unprognostic (1.29e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (2.96e-4)"	"unprognostic (7.60e-2)"	"unprognostic (7.04e-2)"	"unprognostic (3.59e-1)"	"prognostic unfavourable (1.49e-4)"	"unprognostic (4.15e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.24e-3)"	"unprognostic (5.01e-2)"	"unprognostic (4.88e-2)"	11.0	6.2	6.3	8.7	11.1	9.2	9.4	14.5	14.0	18.0	18.0	9.2	11.3	15.0	22.4	12.4	11.2	13.8	12.1	7.5	6.2	4.9	11.6	15.7	8.7	10.4	6.0	7.7	12.1	6.8	6.4	7.2	7.1	8.8	13.1	7.4	20.7	8.1	17.8	8.1	16.1	13.7	15.6	6.0	10.9	11.4	8.5	4.9	6.4	7.3	7.4	10.1	11.0	11.2	2.0	7.5	7.1	9.9	6.9	3.2	3.6	3.4	8.8	2.7	4.1	2.6	2.0	11.6	3.8	4.7	4.6	2.8	7.5	10.8	4.4	5.6	4.8	7.9	2.2	4.4	1.4	2.8	2.3	6.0	9.4	2.5	2.4	4.3	8.2	3.3	2.3	2.4	2.5	3.2	2.9	20.9	2.9	8.0	3.6	10.2	3.1	3.1	3.4	2.2	5.5	4.7	5.5	2.4	3.1	4.4	10.1	15.5	6.5	5.7	2.9	3.1	4.7	5.8	3.5	5.5	2.2	2.2	5.1	4.5	6.7	4.3	9.8	2.9	1.0	9.8	0.9	2.0	2.1	2.1	7.5	1.5	1.7	2.0	7.1	6.9	9.9	3.2	3.2	3.6	6.3	11.1	14.5	14.0	6.2	4.9	6.0	7.7	8.8	4.9
TRA2A	"AWMS1, htra-2-alpha, tra2a"	ENSG00000164548	"Transformer 2 alpha homolog"	Q13595	7	23504780-23532041	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054018	Uncertain		Supported	Nucleoplasm,Nucleoli,Vesicles				Nucleoli	"Nucleoplasm, Vesicles"	"HPA054018: "	"unprognostic (2.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.24e-1)"	"unprognostic (6.77e-3)"	"unprognostic (8.05e-2)"	"unprognostic (3.41e-2)"	"prognostic unfavourable (2.07e-5)"	"unprognostic (1.28e-2)"	"unprognostic (2.50e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.87e-3)"	"unprognostic (6.04e-2)"	"prognostic unfavourable (1.79e-6)"	"unprognostic (1.46e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.36e-3)"	23.4	29.4	27.8	29.5	34.1	70.6	27.4	38.1	27.5	30.3	22.9	29.0	31.6	19.8	32.7	34.5	29.4	25.9	17.6	18.7	28.6	29.3	21.3	21.8	28.6	32.2	35.8	18.5	36.8	27.4	14.9	46.6	24.4	28.2	26.4	30.1	23.7	21.9	26.7	15.7	31.6	22.6	35.2	30.4	33.8	21.1	25.9	37.3	35.6	24.7	20.5	38.0	25.0	31.8	15.5	23.9	20.4	23.0	14.7	21.7	8.2	19.0	21.1	32.7	51.2	17.6	11.1	21.2	24.2	11.5	24.3	20.1	17.3	26.2	35.9	14.0	17.9	31.6	39.2	22.6	30.7	21.6	22.9	22.0	23.3	27.3	18.4	25.6	20.7	13.1	15.7	18.4	23.1	27.7	42.7	17.6	27.6	18.6	31.0	43.1	29.3	21.8	35.4	25.8	21.5	28.2	27.5	28.4	23.1	22.7	26.3	16.2	20.6	28.9	24.9	19.5	27.9	17.8	28.1	19.8	24.7	29.5	16.7	35.0	25.9	11.5	14.9	18.5	21.7	23.0	18.7	15.5	20.3	19.8	16.8	14.4	17.7	20.9	20.4	14.7	20.4	23.9	20.0	8.2	27.8	34.1	38.1	27.5	28.6	29.3	35.8	18.5	28.2	37.3
TRAF6	RNF85	ENSG00000175104	"TNF receptor associated factor 6"	Q9Y4K3	11	36487027-36510272	"Enzymes, Predicted intracellular proteins"	"DNA damage, Immunity, Osteogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004605, HPA019805, HPA020599"	Approved		Supported	Nucleoli,Mitochondria				Mitochondria	Nucleoli	"CAB004605: AB_628391, HPA019805: AB_1858231, HPA020599: AB_1858232"	"unprognostic (2.48e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.83e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.22e-2)"	"prognostic favourable (1.36e-4)"	"unprognostic (2.82e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.07e-1)"	13.0	11.0	12.9	8.5	17.0	31.8	11.9	18.1	15.0	10.6	10.7	13.6	8.2	9.5	12.9	9.8	12.4	11.5	9.4	13.9	9.8	7.1	11.2	12.3	15.2	9.2	14.8	10.6	14.6	11.3	11.0	11.9	10.3	12.7	9.6	10.5	10.5	11.0	9.3	13.9	12.7	12.5	12.1	10.1	13.0	10.3	15.0	12.8	18.5	15.6	6.7	10.8	11.3	13.0	10.6	7.7	27.7	11.4	9.6	13.1	8.5	5.1	6.5	12.6	7.1	11.9	8.7	5.5	7.8	8.4	7.2	9.5	5.7	3.5	6.8	4.8	8.2	9.7	10.0	7.9	12.0	11.1	11.7	6.5	5.1	5.1	7.7	7.2	8.0	8.1	11.1	3.9	11.8	10.1	9.7	7.4	9.0	6.3	11.5	3.9	6.8	6.0	7.6	17.1	3.8	8.7	10.7	2.1	11.1	7.8	7.6	5.5	8.7	7.0	8.0	10.3	9.1	9.4	9.4	8.7	7.3	7.3	5.8	5.2	7.7	27.7	8.0	20.9	11.9	11.4	11.7	10.6	10.3	11.6	7.7	8.1	10.0	13.1	11.1	9.6	8.2	4.5	8.0	8.5	12.9	17.0	18.1	15.0	9.8	7.1	14.8	10.6	12.7	12.8
TRDMT1	"DNMT2, RNMT1"	ENSG00000107614	"TRNA aspartic acid methyltransferase 1"	O14717	10	17142254-17202054	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009468, HPA036945, HPA036946"	Approved		Approved	Nucleoplasm,Nucleoli,Centrosome				Nucleoli	"Nucleoplasm, Centrosome"	"CAB009468: AB_2208432, HPA036945: , HPA036946: "	"unprognostic (4.55e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.49e-6)"	"unprognostic (7.07e-2)"	"unprognostic (3.87e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.27e-4)"	"unprognostic (3.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.64e-2)"	6.1	4.4	4.4	8.5	7.7	4.0	6.3	14.0	6.2	5.3	3.8	4.2	4.7	4.1	7.5	14.4	3.9	6.8	5.1	5.0	4.9	4.5	6.7	2.7	5.3	5.3	4.3	2.9	9.6	5.0	12.8	12.6	5.1	6.2	5.0	3.6	8.0	5.6	3.8	4.3	4.4	5.0	5.4	5.1	5.9	4.2	4.2	6.1	19.9	11.5	3.3	5.7	4.0	5.2	6.1	10.5	5.2	4.4	3.5	8.0	3.6	5.1	2.5	10.0	2.6	3.8	2.2	0.0	4.4	3.2	4.7	5.5	4.2	4.3	3.5	0.6	5.0	2.6	6.7	4.2	5.4	7.4	4.3	5.2	3.8	2.5	3.4	3.4	3.9	3.0	2.6	3.2	2.3	6.1	6.5	3.9	7.7	1.6	17.0	0.8	6.3	2.9	3.7	7.8	2.2	2.5	2.8	2.7	3.4	0.0	1.9	3.4	4.8	3.1	3.6	3.4	7.2	6.3	5.1	5.0	4.7	8.9	4.3	4.8	3.4	5.2	4.4	2.4	3.9	2.5	7.2	5.4	6.6	4.9	5.5	6.1	8.0	5.8	2.8	3.5	1.4	10.5	2.2	3.6	4.4	7.7	14.0	6.2	4.9	4.5	4.3	2.9	6.2	6.1
TRIM27	"RFP, RNF76"	ENSG00000204713	"Tripartite motif containing 27"	P14373	6	28903002-28923989	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transport, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048684, HPA053408"	Approved		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA048684: , HPA053408: "	"unprognostic (1.57e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.12e-3)"	"unprognostic (4.76e-3)"	"unprognostic (1.16e-2)"	"prognostic unfavourable (3.50e-6)"	"unprognostic (1.27e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.47e-1)"	"prognostic favourable (2.71e-4)"	11.5	10.6	8.8	25.5	9.7	7.9	9.3	10.1	12.2	11.2	10.2	8.7	20.2	23.8	12.1	13.2	7.8	12.1	11.4	8.1	8.2	9.6	10.1	22.5	10.4	17.4	12.6	8.3	14.7	31.0	7.4	13.9	13.7	10.6	13.7	4.6	7.7	17.0	25.2	12.2	9.7	19.4	9.2	8.4	18.6	18.5	9.2	9.2	16.7	12.5	7.9	12.1	9.9	11.8	12.5	12.5	13.8	13.9	11.2	15.9	13.8	3.3	2.3	0.9	6.0	0.8	1.7	0.6	4.6	1.1	1.4	1.7	1.7	1.4	7.7	7.9	1.3	7.4	1.1	2.7	0.1	3.0	12.9	10.8	0.5	2.3	1.3	4.5	1.7	1.3	1.6	1.2	0.5	1.2	10.5	3.3	0.4	1.3	6.3	2.4	0.0	7.3	9.0	6.9	14.2	1.1	1.1	3.2	12.9	5.5	3.4	7.3	3.3	3.5	3.9	3.4	7.1	6.2	2.7	12.0	14.4	12.0	1.8	11.5	5.2	12.6	13.8	8.8	12.7	13.9	15.9	12.5	12.6	14.4	12.5	10.5	11.8	12.1	13.8	11.2	12.1	9.8	10.4	13.8	8.8	9.7	10.1	12.2	8.2	9.6	12.6	8.3	10.6	9.2
TRIM34	RNF21	ENSG00000258659	"Tripartite motif containing 34"	Q9BYJ4	11	5619764-5644398	"Predicted intracellular proteins"	"Antiviral defense"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.2;SK-BR-3: 17.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA077996			Approved	Nucleoli,Centrosome				Centrosome	Nucleoli	"HPA077996: "	"unprognostic (8.66e-3)"	"unprognostic (9.94e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.88e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.74e-1)"	"unprognostic (9.16e-3)"	"unprognostic (8.16e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.40e-1)"	"unprognostic (6.76e-2)"	15.9	14.6	2.7	12.2	2.9	1.4	7.3	0.9	3.4	9.3	7.9	6.0	8.5	6.6	15.7	10.6	8.7	7.8	5.6	4.1	3.6	2.2	7.1	4.4	7.9	11.7	2.6	3.9	11.4	5.5	4.5	5.5	8.7	4.7	9.5	6.8	7.8	10.2	6.3	2.0	6.2	14.2	5.8	6.2	16.6	6.1	4.6	4.3	12.5	7.0	5.0	14.3	10.0	7.8	12.8	15.9	15.2	15.9	5.9	9.5	7.8	2.2	1.3	0.5	0.2	5.2	8.1	16.2	3.4	10.0	8.9	8.7	1.0	7.9	8.0	1.6	4.6	3.7	0.3	7.4	4.5	10.4	0.3	4.2	0.4	0.4	2.3	4.6	3.0	8.5	6.4	4.5	1.4	11.5	0.2	0.6	4.2	1.0	4.2	2.7	0.0	0.7	6.2	0.3	0.5	5.4	6.1	0.0	0.0	0.1	17.3	2.5	3.0	2.2	9.2	2.3	0.5	0.9	1.2	0.9	1.0	3.1	6.7	0.6	1.1	8.7	14.3	3.6	5.6	15.9	6.1	12.6	5.4	6.9	15.9	12.8	6.8	5.7	15.2	5.9	13.5	8.1	9.5	7.8	2.7	2.9	0.9	3.4	3.6	2.2	2.6	3.9	4.7	4.3
TRIM41	"MGC1127, RINCK"	ENSG00000146063	"Tripartite motif containing 41"	Q8WV44	5	181222499-181235809	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 43.7"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 38.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024204	Approved		Supported	"Nucleoli,Nuclear bodies"				"Nucleoli, Nuclear bodies"		"HPA024204: AB_1858299"	"unprognostic (1.13e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.93e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.56e-2)"	"unprognostic (7.24e-2)"	"unprognostic (8.66e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.07e-1)"	"unprognostic (5.17e-3)"	"unprognostic (2.45e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (4.22e-4)"	"unprognostic (2.68e-2)"	10.0	8.3	25.5	9.4	24.3	9.3	5.4	7.3	17.0	6.9	6.5	19.8	8.8	11.2	6.1	8.3	7.3	8.4	7.0	9.8	26.9	20.4	10.7	7.6	6.9	6.0	37.3	12.5	5.9	12.3	18.8	7.6	7.3	17.0	7.0	4.0	7.8	8.3	8.4	30.0	9.0	9.0	5.3	43.7	7.5	9.5	19.1	18.3	10.6	11.3	7.2	7.2	5.8	5.2	2.2	2.4	3.9	2.3	1.9	4.3	1.4	4.6	12.1	4.5	7.5	5.4	5.4	10.6	6.8	3.7	5.0	4.7	10.2	7.0	7.8	11.1	4.6	8.8	4.7	16.3	2.7	38.5	14.9	8.9	11.9	5.8	5.2	6.5	6.1	4.7	8.4	6.2	2.2	2.8	11.1	9.7	2.8	16.6	9.8	7.3	4.2	5.8	9.3	6.9	10.2	2.9	7.4	7.0	6.6	6.3	7.4	9.5	14.8	7.4	5.9	6.9	4.7	4.1	5.1	21.4	13.5	11.1	7.2	7.7	5.8	0.9	1.4	2.2	2.4	1.1	3.6	1.9	2.5	4.3	1.6	2.2	2.6	3.1	3.9	1.9	2.3	2.4	3.2	1.4	25.5	24.3	7.3	17.0	26.9	20.4	37.3	12.5	17.0	18.3
TRIM51	"SPRYD5, TRIM51A"	ENSG00000124900	"Tripartite motif-containing 51"	Q9BSJ1	11	55883297-55891810	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"blood: 11.0"	"Group enriched"	"Detected in some"	124	"SK-MEL-30: 35.2;WM-115: 9.0"	"Cancer enriched"	"Detected in single"	50	"melanoma: 4.3"					"Cell type enriched"	"Detected in single"	111	"basophil: 11.0"	"Lineage enriched"	"Detected in single"	111	"granulocytes: 11.0"									"HPA044988, HPA077883"	Uncertain		Approved	Nucleoli,Vesicles				Vesicles	Nucleoli	"HPA044988: , HPA077883: "									"unprognostic (9.60e-2)"									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.8	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3			0.0		0.0	0.1	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TRIM52	RNF102	ENSG00000183718	"Tripartite motif containing 52"	Q96A61	5	181254417-181261139	"Predicted intracellular proteins"	"Antiviral defense, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA054565, HPA056819"	Approved		Approved	"Nucleoli,Intermediate filaments"				Nucleoli	"Intermediate filaments"	"HPA054565: , HPA056819: "	"unprognostic (1.21e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-2)"	"unprognostic (5.23e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.98e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.24e-3)"	"unprognostic (7.48e-3)"	"prognostic unfavourable (3.46e-4)"	"unprognostic (2.96e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.33e-2)"	"prognostic favourable (4.07e-4)"	9.2	13.0	17.8	15.3	19.7	10.9	11.5	42.3	24.2	10.9	10.9	9.8	15.4	11.8	12.1	14.3	6.6	10.3	8.2	9.1	15.0	10.5	11.2	9.7	11.0	18.8	18.0	12.0	17.7	14.6	15.3	19.4	8.6	16.2	13.8	10.2	8.1	14.0	15.6	9.8	14.5	12.6	8.3	14.0	16.9	11.3	11.7	20.8	15.3	16.8	5.0	13.9	10.3	15.1	5.4	2.7	5.6	2.5	5.5	11.2	3.7	3.5	4.2	6.8	8.7	12.4	7.9	6.1	4.0	3.5	3.9	3.4	6.0	6.7	7.8	4.3	4.3	6.7	3.7	5.3	4.6	13.4	7.7	3.0	15.9	5.0	3.0	9.1	7.0	7.9	4.5	4.2	2.4	4.6	3.2	18.6	4.0	6.8	5.0	8.4	2.4	5.4	6.0	3.7	5.3	3.2	4.8	7.8	6.3	5.7	4.1	3.6	7.7	6.3	5.5	7.8	4.1	3.6	3.7	13.7	6.6	5.4	8.9	8.1	3.0	5.0	2.5	5.6	8.4	2.2	9.3	5.4	9.0	9.2	2.0	4.2	11.2	8.9	2.6	5.5	2.0	2.7	5.9	3.7	17.8	19.7	42.3	24.2	15.0	10.5	18.0	12.0	16.2	20.8
TRIM6-TRIM34		ENSG00000258588	"TRIM6-TRIM34 readthrough"		11	5596725-5644398	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	6	"kidney: 30.3;salivary gland: 9.5;testis: 8.0"	"Cell line enriched"	"Detected in some"	7	"A549: 9.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA077996			Uncertain	Nucleoli,Centrosome				Centrosome	Nucleoli	"HPA077996: "																		0.9	0.7	0.4	0.6	0.4	0.1	0.9	0.4	0.4	1.4	0.4	0.0	0.7	0.8	1.5	1.6	1.9	0.7	0.2	1.4	0.4	0.3	30.3	0.4	0.7	0.1	0.3	0.0	1.7	2.7	1.1	0.4	1.4	0.3	1.5	0.2	2.2	9.5	1.9	0.4	0.4	0.6	1.9	0.4	1.1	0.4	8.0	0.0	0.0	1.7	0.0	1.5	1.1	0.5	0.5	1.5	1.3	0.8	0.9	0.2	0.2	0.0	9.9	0.0	0.0	0.2	0.8	1.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.7	0.6	0.6	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.1	0.2	0.2	0.1	0.4	0.0	0.1	1.5	0.5	0.1	0.1	1.3	0.9	0.4	0.3	0.0	0.2	0.4	0.4	0.4	0.4	0.4	0.3	0.3	0.0	0.3	0.0
TRMT10A	"MGC27034, RG9MTD2, TRM10"	ENSG00000145331	"TRNA methyltransferase 10A"	Q8TBZ6	4	99546709-99564032	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Diabetes mellitus, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047601, HPA058241"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Actin filaments,Cytosol"				"Nucleoli, Actin filaments"	"Nucleoplasm, Cytosol"	"HPA047601: , HPA058241: "	"unprognostic (5.24e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.96e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.51e-1)"	"unprognostic (7.49e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavourable (2.14e-4)"	"unprognostic (1.68e-2)"	7.0	8.9	6.5	7.5	8.9	3.3	13.1	6.1	8.7	4.6	6.0	9.3	7.5	7.3	5.5	7.2	9.2	10.1	6.1	5.0	7.9	6.7	9.1	16.8	4.9	7.4	9.2	6.1	6.6	12.4	6.7	12.2	10.0	9.7	7.4	6.9	2.5	7.3	4.7	9.3	6.5	10.4	5.1	10.5	7.0	7.6	16.7	10.1	10.7	10.8	5.1	8.0	7.2	10.8	8.8	10.0	9.2	7.6	5.8	7.1	4.0	6.6	4.7	9.2	4.7	5.5	7.7	6.7	8.1	3.1	5.7	4.3	3.9	8.3	9.2	3.1	4.8	3.9	10.7	5.1	8.8	11.7	4.7	6.3	4.1	6.4	5.2	16.0	6.8	4.9	13.2	5.7	12.5	5.8	14.6	8.3	4.8	7.7	13.5	3.3	5.5	4.6	7.8	8.8	5.9	7.7	5.5	5.8	5.0	4.4	24.6	8.1	8.0	6.9	4.2	5.8	6.0	4.7	9.2	5.8	9.7	8.4	4.4	9.4	4.1	4.0	7.6	3.7	3.8	7.1	3.1	6.3	6.5	6.4	10.0	8.8	6.7	6.2	9.2	5.8	6.2	5.6	7.1	4.0	6.5	8.9	6.1	8.7	7.9	6.7	9.2	6.1	9.7	10.1
TRMT1L	C1orf25	ENSG00000121486	"TRNA methyltransferase 1 like"	Q7Z2T5	1	185118098-185157072	"Predicted intracellular proteins"	"Behavior, tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026728	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA026728: AB_1845641"	"unprognostic (1.07e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.55e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.44e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.26e-1)"	7.6	12.9	9.4	10.1	12.8	5.9	8.9	14.2	11.3	10.5	10.0	9.6	9.6	9.6	9.3	11.3	10.5	12.6	8.2	13.2	10.3	10.6	15.3	16.0	10.3	11.1	11.2	9.1	13.7	8.3	18.0	26.9	9.7	11.9	11.7	8.5	5.2	7.6	10.0	27.4	5.5	8.7	8.5	12.4	12.8	8.4	29.4	12.8	16.5	12.4	7.6	13.0	11.8	12.2	16.2	12.1	19.0	15.8	11.0	12.7	8.1	8.0	14.8	10.2	7.6	15.1	13.9	14.5	7.8	7.0	10.7	11.2	13.4	15.5	8.8	19.5	5.3	10.4	17.1	10.2	10.5	10.4	7.4	8.4	11.2	13.6	10.5	12.4	14.0	6.7	13.9	10.9	11.0	11.7	22.0	12.1	12.7	6.8	9.4	7.2	16.9	3.1	11.1	14.7	14.0	10.3	8.9	9.1	8.1	15.2	14.8	10.5	15.1	7.0	11.2	9.8	7.8	6.7	10.4	19.5	26.1	14.0	6.4	11.0	9.4	16.8	9.8	19.0	7.4	13.4	7.9	11.7	9.7	8.9	12.1	16.2	12.2	9.5	11.1	11.0	15.8	5.1	12.7	8.1	9.4	12.8	14.2	11.3	10.3	10.6	11.2	9.1	11.9	12.8
TRMT5	"KIAA1393, TRM5"	ENSG00000126814	"TRNA methyltransferase 5"	Q32P41	14	60971451-60981358	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000943	Supported		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA000943: AB_1080388"	"unprognostic (1.58e-2)"	"unprognostic (3.62e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.11e-2)"	"unprognostic (7.70e-3)"	"unprognostic (2.26e-2)"	"unprognostic (7.82e-3)"	"unprognostic (4.50e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-1)"	15.8	10.1	7.9	13.8	12.1	5.4	12.9	9.3	11.8	10.9	8.6	5.7	11.9	7.5	12.0	10.9	11.1	10.0	6.7	6.8	7.7	7.1	12.5	13.9	6.6	7.3	6.7	8.3	17.1	11.1	15.9	13.1	10.8	9.0	10.6	8.1	4.8	11.5	9.9	14.8	9.7	7.4	9.2	6.3	8.6	8.1	24.9	5.9	12.4	10.4	12.1	7.2	13.3	9.0	7.2	7.4	0.9	7.5	2.0	6.0	3.7	28.3	7.3	10.7	14.9	9.4	14.2	11.7	10.7	8.2	11.5	9.1	5.3	17.0	14.6	11.9	7.7	13.1	13.4	15.4	15.1	14.4	6.8	10.7	4.9	5.9	15.4	18.9	6.0	11.2	15.0	10.4	15.4	10.0	13.9	5.2	16.8	10.7	9.7	9.5	9.8	12.0	3.1	24.8	12.3	9.7	9.6	13.1	13.0	11.9	11.9	9.4	19.9	11.4	9.4	13.3	16.1	9.4	10.1	3.2	6.0	6.9	9.3	4.1	12.4	0.1	4.6	0.9	3.5	7.5	5.0	7.2	5.2	5.2	4.2	4.9	5.6	5.1	0.4	2.0	7.5	7.4	6.0	3.7	7.9	12.1	9.3	11.8	7.7	7.1	6.7	8.3	9.0	5.9
TSEN15	C1orf19	ENSG00000198860	"TRNA splicing endonuclease subunit 15"	Q8WW01	1	184051651-184123978	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, tRNA processing"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA029237	Approved		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA029237: AB_10671361"	"unprognostic (4.54e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.72e-3)"	"unprognostic (8.04e-3)"	"prognostic unfavourable (2.07e-5)"	"unprognostic (1.82e-2)"	"unprognostic (4.11e-2)"	"prognostic favourable (4.59e-4)"	"unprognostic (3.82e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (3.66e-10)"	"unprognostic (1.62e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.20e-1)"	14.2	17.5	20.6	13.2	22.1	16.2	17.3	14.0	34.0	16.4	16.8	25.4	7.8	11.2	16.7	24.5	12.7	13.9	12.3	17.2	22.1	19.0	12.8	14.2	15.9	16.3	27.6	16.6	15.0	19.2	13.0	13.4	16.0	20.7	16.3	11.8	13.2	13.9	14.5	31.8	13.7	10.3	15.0	34.5	13.4	13.9	12.4	24.2	20.8	19.4	15.4	15.2	13.7	12.5	14.0	20.2	15.9	14.2	28.2	21.9	17.6	22.5	7.5	9.8	12.1	8.2	7.8	28.0	10.8	19.5	16.4	16.2	7.1	9.9	14.7	11.9	12.1	10.4	10.6	9.1	16.8	21.5	6.8	6.7	5.7	9.3	15.1	26.2	9.4	5.3	17.7	7.2	15.0	9.1	14.8	41.2	14.5	10.9	26.1	13.3	21.0	8.6	16.5	16.4	31.0	10.4	7.6	10.2	15.1	14.1	11.3	27.3	14.3	16.5	4.6	10.9	24.6	7.4	17.3	56.0	38.3	22.4	10.4	14.7	23.7	15.9	9.8	13.5	20.4	14.2	17.6	14.0	19.3	20.9	20.2	10.4	15.0	20.4	1.8	28.2	13.0	18.1	21.9	17.6	20.6	22.1	14.0	34.0	22.1	19.0	27.6	16.6	20.7	24.2
TSG101	"TSG10, VPS23"	ENSG00000074319	"Tumor susceptibility 101"	Q99816	11	18468336-18527232	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Growth regulation, Host-virus interaction, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004283, HPA006161"	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"			14000	Cytosol	"Nucleoli, Plasma membrane"	"CAB004283: AB_671392, HPA006161: AB_1080408"	"unprognostic (1.42e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.72e-3)"	"prognostic unfavourable (3.74e-6)"	"unprognostic (5.67e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.00e-2)"	"unprognostic (4.15e-3)"	"unprognostic (4.27e-2)"	"prognostic favourable (5.52e-6)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.02e-3)"	"unprognostic (1.06e-1)"	24.7	30.5	18.4	14.2	25.5	23.5	27.6	22.7	25.9	22.5	23.1	23.7	21.6	20.5	25.8	27.7	34.3	23.9	18.4	31.8	17.7	20.6	33.4	29.0	20.1	23.4	21.6	21.4	23.2	39.5	33.2	23.5	38.5	24.6	21.9	28.4	19.4	25.4	22.4	44.5	27.3	25.7	23.1	21.7	20.5	23.0	33.7	20.2	27.5	32.3	37.1	25.5	24.2	25.5	20.5	18.2	42.3	29.2	14.3	22.0	22.2	14.3	23.7	21.0	14.6	24.9	26.0	19.5	22.3	30.1	27.3	27.0	16.2	7.6	19.4	13.7	24.8	22.0	20.9	20.2	30.4	27.2	25.5	12.0	12.5	23.8	32.0	18.0	20.8	22.4	41.1	14.2	38.8	22.4	19.5	16.5	33.0	25.9	11.4	19.6	12.9	24.0	10.3	21.2	16.1	18.3	20.5	15.0	26.9	21.4	18.0	28.5	17.9	18.1	12.0	18.3	11.2	38.2	16.5	10.6	20.4	15.4	18.9	10.0	23.4	42.3	19.5	40.7	14.9	21.7	15.0	20.5	14.4	15.9	18.2	18.0	15.4	16.4	34.5	14.3	29.2	15.4	22.0	22.2	18.4	25.5	22.7	25.9	17.7	20.6	21.6	21.4	24.6	20.2
TSPYL1	TSPYL	ENSG00000189241	"TSPY like 1"	Q9H0U9	6	116276578-116279903	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031970, HPA031971"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA031970: AB_2674092, HPA031971: AB_10602484"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.11e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.76e-1)"	"unprognostic (9.18e-3)"	"prognostic favourable (5.40e-4)"	"unprognostic (5.12e-1)"	"prognostic favourable (1.48e-13)"	"unprognostic (1.61e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.47e-1)"	14.0	34.1	38.3	9.8	67.2	18.5	14.4	49.1	64.5	15.2	12.8	9.8	20.1	14.7	13.9	21.4	15.4	20.3	12.9	21.4	34.6	36.6	31.5	23.5	12.9	11.8	21.8	49.8	22.9	17.6	41.3	17.2	9.7	31.1	27.1	11.3	13.3	17.2	22.6	61.6	11.2	12.9	17.1	11.5	15.6	15.3	12.9	12.2	9.8	25.0	15.5	15.2	14.6	12.9	30.7	24.6	52.9	29.4	17.4	36.2	17.0	13.0	12.8	16.5	30.1	29.3	19.4	13.9	20.9	20.9	19.2	22.1	16.5	9.5	27.9	26.3	24.1	23.1	13.0	35.7	20.6	11.3	33.8	11.2	18.9	29.9	18.6	18.3	6.8	22.6	28.0	19.8	19.3	18.2	19.7	21.7	26.7	28.6	12.2	10.8	8.2	12.0	11.3	14.3	15.2	33.2	25.4	14.5	14.3	17.4	23.4	10.0	30.7	22.9	22.0	12.9	11.6	10.4	22.6	11.9	12.9	15.3	21.5	11.9	8.4	52.9	17.8	27.2	24.2	27.7	36.2	25.9	31.7	26.7	14.3	30.7	31.3	30.4	13.5	17.4	29.4	24.6	23.7	17.0	38.3	67.2	49.1	64.5	34.6	36.6	21.8	49.8	31.1	12.2
TSPYL6		ENSG00000178021	"TSPY like 6"	Q8N831	2	54253184-54256272	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	54	"testis: 41.1"	"Cell line enriched"	"Detected in single"	131	"K-562: 13.1"	"Cancer enriched"	"Detected in single"	27	"testis cancer: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA034699, HPA034700"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA034699: , HPA034700: AB_10670159"	"unprognostic (8.21e-2)"				"unprognostic (4.25e-1)"			"unprognostic (1.06e-2)"		"unprognostic (1.00e-1)"			"unprognostic (5.54e-6)"	"unprognostic (4.50e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.73e-1)"		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	41.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0
TSR2	"DT1P1A10, RP1-112K5.2, WGG1"	ENSG00000158526	"TSR2, ribosome maturation factor"	Q969E8	X	54440401-54445487	"Disease related genes, Predicted intracellular proteins"	"rRNA processing"		"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030514	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"				"Nucleoplasm, Nucleoli"	"Cell Junctions, Cytosol"	"HPA030514: AB_10603457"	"unprognostic (1.05e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.91e-2)"	"unprognostic (7.15e-3)"	"unprognostic (8.29e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.94e-2)"	"unprognostic (6.19e-2)"	"prognostic favourable (1.21e-6)"	"unprognostic (2.27e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.80e-3)"	20.8	25.0	52.9	13.8	53.1	15.3	19.2	27.6	44.3	18.2	17.2	30.8	16.9	13.9	18.4	33.9	16.2	21.1	14.8	22.2	45.3	46.2	26.5	23.7	17.5	14.9	53.8	34.4	22.9	17.2	30.7	19.0	19.8	31.0	20.8	20.6	19.0	16.6	25.4	35.5	17.2	14.7	19.7	54.3	18.1	16.5	8.4	27.5	10.2	23.9	10.8	22.0	17.7	16.8	39.6	15.4	28.7	21.2	24.7	41.4	21.1	20.4	26.2	19.2	17.4	17.3	12.5	17.1	20.3	16.5	18.9	16.3	24.7	22.4	22.4	14.1	17.7	21.2	46.9	28.1	25.3	29.1	23.2	18.2	19.6	19.2	10.7	31.5	19.1	11.6	15.4	26.4	27.3	13.2	18.5	16.8	19.2	37.5	24.0	24.8	30.5	29.8	21.6	35.7	18.9	20.1	18.2	24.2	16.8	38.6	19.3	21.5	39.3	11.0	17.9	13.9	24.5	29.2	17.3	18.0	27.1	26.8	20.5	25.1	20.8	24.5	15.3	28.7	35.1	20.5	28.8	38.7	33.3	31.8	13.9	39.6	41.4	31.7	9.4	24.7	21.2	15.4	35.5	21.1	52.9	53.1	27.6	44.3	45.3	46.2	53.8	34.4	31.0	27.5
TSSK3	"SPOGA3, STK22C"	ENSG00000162526	"Testis specific serine kinase 3"	Q96PN8	1	32351521-32364312	"Enzymes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"testis: 68.1"	"Cell line enhanced"	"Detected in many"		"HeLa: 9.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037516			Approved	"Nucleoplasm,Nucleoli,Nuclear bodies"				"Nucleoplasm, Nucleoli"	"Nuclear bodies"	"HPA037516: "	"unprognostic (5.71e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.69e-2)"	"unprognostic (2.02e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.68e-3)"	1.1	2.0	0.8	1.7	0.8	8.2	1.1	3.9	0.8	1.3	0.9	0.8	1.4	2.5	1.8	2.9	0.8	1.3	1.0	0.9	0.8	0.0	0.9	1.3	1.4	2.4	0.8	0.8	2.0	1.2	0.0	0.8	0.8	1.0	1.0	0.0	0.8	1.4	0.8	1.7	3.4	2.9	0.8	0.8	3.4	1.2	68.1	0.8	0.8	1.3	0.8	0.8	0.9	1.1	0.6	0.1	0.1	0.7	0.3	2.3	0.1	2.3	2.3	6.0	3.6	0.0	1.2	5.4	0.7	1.1	0.0	0.0	0.5	1.2	1.2	0.9	0.0	3.7	0.0	0.0	0.0	3.5	7.2	2.7	9.8	3.7	4.4	1.1	3.4	0.1	0.9	0.0	1.3	0.0	3.1	5.8	0.0	0.6	1.4	1.5	1.5	1.2	1.9	1.7	4.4	0.0	1.9	1.8	3.8	0.8	2.8	4.1	1.9	2.7	2.9	2.1	3.4	3.0	2.4	8.5	2.8	1.8	3.7	3.9	0.5	0.0	0.1	0.0	1.1	0.7	0.0	0.0	0.2	0.0	0.1	0.6	2.3	0.9	0.1	0.3	0.5	0.0	0.0	0.1	0.8	0.8	3.9	0.8	0.8	0.0	0.8	0.8	1.0	0.8
TTC27	FLJ20272	ENSG00000018699	"Tetratricopeptide repeat domain 27"	Q6P3X3	2	32628032-32821051	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031246	Approved		Approved	Nucleoli,Mitochondria			11000	Mitochondria	Nucleoli	"HPA031246: AB_10603139"	"unprognostic (3.10e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.21e-3)"	"unprognostic (6.28e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavourable (1.42e-5)"	"unprognostic (7.68e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (7.32e-4)"	"unprognostic (1.37e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	18.4	18.2	7.0	18.8	11.5	9.9	17.8	8.6	10.7	16.4	11.9	16.1	12.0	8.2	25.1	13.6	17.5	14.7	8.5	14.3	8.2	6.9	11.0	15.7	10.8	13.6	12.5	8.1	18.6	17.7	15.7	19.4	11.9	8.9	14.7	13.1	13.2	17.2	14.7	18.7	16.8	11.0	15.3	11.0	19.3	13.4	17.4	10.3	16.4	14.9	15.5	20.4	14.6	14.6	9.6	9.6	0.3	9.0	8.4	12.5	5.7	21.7	10.6	7.4	5.7	6.2	12.6	3.7	9.1	7.5	14.0	12.4	16.3	13.3	19.1	8.2	13.6	11.0	11.8	14.1	20.7	9.1	14.5	21.7	5.8	22.2	12.0	20.6	11.4	8.3	13.1	17.0	18.5	12.7	29.7	5.6	12.5	8.7	16.3	7.2	13.5	11.1	10.9	16.0	16.7	10.8	12.8	6.1	8.8	7.5	7.1	8.4	8.7	5.0	10.6	9.0	9.9	10.6	15.5	8.2	2.0	21.7	9.7	16.2	9.5	0.0	4.5	0.0	9.1	9.0	10.0	9.3	10.0	8.9	9.6	9.6	12.5	9.8	0.3	8.4	6.1	4.7	8.7	5.7	7.0	11.5	8.6	10.7	8.2	6.9	12.5	8.1	8.9	10.3
TTC28	KIAA1043	ENSG00000100154	"Tetratricopeptide repeat domain 28"	Q96AY4	22	27978014-28679865	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 2.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003099			Approved	Nucleoli,Mitochondria				"Nucleoli, Mitochondria"		"HPA003099: AB_1079195"	"unprognostic (9.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.98e-1)"	"unprognostic (8.55e-3)"	"unprognostic (4.83e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.25e-1)"	"prognostic favourable (4.30e-4)"	"unprognostic (3.91e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.10e-2)"	"prognostic favourable (5.65e-5)"	"unprognostic (5.54e-3)"	"unprognostic (1.85e-1)"	"prognostic unfavourable (1.21e-4)"	"unprognostic (4.36e-1)"	4.6	3.0	1.4	1.1	2.0	0.0	4.2	0.6	1.3	6.0	4.1			1.4	7.6	6.5	3.0	5.7	3.7	2.8	1.2	1.0	2.8	2.1	4.7	0.5	0.9		11.8	2.7	3.2	2.4	5.4		3.3	1.3		3.7	4.4	2.6	1.6	2.1	5.3	1.0	1.6	3.1	5.0			4.3		0.2	4.3	3.4	1.0	2.5	0.4	0.2	0.9	0.6	0.5	0.0	5.2	13.6	5.8	8.1	12.1	0.3	3.9	7.3	5.6	4.9	0.4	0.0	0.0	5.5	11.5	0.8	8.7	0.2	3.0	0.5	5.8	0.8	6.6	4.9	3.7	0.1	5.4	12.1	0.3	3.7	2.5	10.2	3.4	0.4	1.3	1.8	0.1	0.4	2.4	3.4	5.3	3.4	0.1	2.7	0.1	3.8	8.4	5.5	0.2	3.6	2.7	0.5	9.5	6.7	3.3	4.3	2.9	1.8	0.2	0.1	2.4	0.1	2.8	0.4	0.2	0.1	0.5	0.1	0.3	0.3	0.4	0.3	0.3	1.0	0.6	0.5	0.4	0.9	0.2	2.5	0.1	0.5										
TTC3	"DCRR1, RNF105, TPRD, TPRDI, TPRDII, TPRDIII"	ENSG00000182670	"Tetratricopeptide repeat domain 3"	P53804	21	37073226-37203112	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016810, HPA023964, HPA036304"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA016810: AB_1858434, HPA023964: AB_1858435, HPA036304: "	"unprognostic (3.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.52e-2)"	"unprognostic (9.29e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.74e-2)"	22.9	22.1	34.0	18.7	36.5	12.0	23.4	39.2	40.0	34.9	20.6	15.9	26.7	13.0	21.6	33.3	15.3	19.5	19.0	21.5	29.1	16.5	21.4	17.0	15.4	14.3	17.7	27.5	34.5	25.8	27.4	50.4	15.2	34.7	28.9	19.9	16.1	24.5	25.4	21.6	16.1	16.8	21.6	21.7	13.6	21.3	19.5	19.9	19.7	35.4	11.1	15.1	23.3	18.9	10.6	12.8	4.8	5.7	9.1	18.6	3.8	21.4	7.6	35.7	6.7	34.5	50.2	12.4	23.6	29.4	10.7	14.5	10.1	10.8	18.5	8.2	39.5	7.0	10.7	14.5	15.1	19.6	7.7	37.4	11.5	13.1	12.6	20.8	12.1	25.9	9.0	10.8	9.7	15.8	22.5	21.8	20.0	16.6	20.2	5.4	10.1	13.0	27.1	17.1	9.7	12.4	16.6	27.3	20.8	29.3	16.8	15.2	19.0	8.2	20.5	15.3	6.1	18.7	8.8	21.9	15.7	18.5	25.2	20.9	11.5	2.9	4.4	4.8	9.1	4.8	13.6	9.5	10.6	12.3	7.9	10.6	18.6	11.3	0.7	9.1	5.7	12.8	7.2	3.8	34.0	36.5	39.2	40.0	29.1	16.5	17.7	27.5	34.7	19.9
TTF1		ENSG00000125482	"Transcription termination factor 1"	Q15361	9	132375548-132406851	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Transcription termination"	"DNA replication inhibitor, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA054837	Supported		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA054837: "	"unprognostic (7.07e-2)"	"unprognostic (5.62e-3)"	"unprognostic (9.12e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavourable (1.40e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.21e-3)"	"unprognostic (3.08e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.95e-3)"	"unprognostic (2.09e-2)"	"unprognostic (5.93e-3)"	"unprognostic (8.38e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.71e-2)"	10.3	6.6	9.9	12.6	14.6	18.0	12.5	15.0	13.4	10.3	12.1	8.5	13.8	6.2	11.9	12.1	8.5	9.6	6.8	16.6	9.8	8.5	8.3	6.2	8.9	12.2	10.4	11.3	11.8	8.7	8.7	15.4	8.3	14.1	13.4	8.8	6.8	9.0	10.1	18.0	9.3	8.6	9.5	13.5	9.7	8.7	11.6	12.7	15.1	16.9	7.0	12.3	13.4	11.5	12.3	10.2	19.4	6.3	7.3	9.1	3.0	7.4	7.1	10.1	9.2	5.6	7.3	9.2	8.4	6.5	9.8	7.1	7.2	8.2	12.2	7.1	6.2	17.9	11.1	6.5	10.6	7.9	7.7	5.6	10.6	5.5	5.6	14.9	9.2	4.4	7.7	8.5	6.3	8.4	11.2	10.8	7.6	11.1	34.4	9.1	18.5	10.9	22.0	13.9	14.5	7.8	6.1	8.9	15.4	11.7	8.9	5.9	11.0	7.9	7.9	16.0	9.8	13.5	9.8	5.1	14.4	14.9	9.0	12.2	15.3	11.3	5.4	10.3	6.5	5.2	8.3	11.2	8.2	7.4	3.3	12.3	9.1	6.9	19.4	7.3	6.3	10.2	8.4	3.0	9.9	14.6	15.0	13.4	9.8	8.5	10.4	11.3	14.1	12.7
TTK	"CT96, MPH1, MPS1, MPS1L1"	ENSG00000112742	"TTK protein kinase"	P33981	6	80003887-80042527	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 58.3;testis: 31.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 4.0"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB010166, CAB013229"	Enhanced		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"CAB010166: AB_632567, CAB013229: AB_2533230"	"unprognostic (4.27e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavourable (1.44e-5)"	"unprognostic (7.97e-2)"	"unprognostic (4.78e-2)"	"prognostic unfavourable (3.84e-10)"	"unprognostic (1.56e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.02e-3)"	"prognostic unfavourable (2.54e-4)"	"unprognostic (1.54e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.51e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	1.1	1.4	0.3	3.2	0.4	13.9	1.0	0.3	0.4	1.0	2.7	0.2	0.2	2.2	0.5	1.0	6.5	0.3	0.4	1.5	0.4	0.3	0.9	0.6	1.2	4.6	0.4	0.2	0.4	0.5	0.0	0.3	3.0	0.6	0.6	3.6	0.3	1.2	0.6	0.3	2.0	2.8	0.7	0.8	2.1	1.8	31.7	0.2	58.3	0.5	2.6	5.4	0.8	1.8	1.7	0.0	1.1	0.0	1.1	4.0	0.8	13.3	8.0	24.0	19.7	1.1	3.5	13.6	15.5	9.6	22.7	27.8	10.9	10.2	19.8	12.1	6.6	17.4	21.2	9.5	31.7	18.0	17.1	18.3	10.7	8.9	0.0	21.5	12.0	0.4	1.0	15.9	10.2	12.8	20.0	20.5	19.3	9.9	12.3	15.6	14.2	9.7	11.0	43.9	8.2	5.7	8.6	16.6	9.7	9.1	9.9	5.6	9.3	16.4	5.3	10.2	10.2	6.6	24.8	4.6	15.5	11.0	3.6	20.1	8.7	0.0	0.0	1.1	0.6	0.0	0.6	0.9	1.0	1.6	0.0	1.7	0.3	0.5	0.3	1.1	0.0	0.0	4.0	0.8	0.3	0.4	0.3	0.4	0.4	0.3	0.4	0.2	0.6	0.2
TTLL1	C22orf7	ENSG00000100271	"Tubulin tyrosine ligase like 1"	O95922	22	43039644-43089428	"Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048392	Approved		Approved	Nucleoli,Mitochondria				Nucleoli	Mitochondria	"HPA048392: "	"unprognostic (1.02e-1)"	"unprognostic (4.06e-3)"	"unprognostic (1.51e-1)"	"prognostic favourable (1.85e-4)"	"unprognostic (6.18e-3)"	"unprognostic (4.27e-3)"	"prognostic unfavourable (2.34e-5)"	"unprognostic (8.22e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.29e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.82e-1)"	"prognostic favourable (1.68e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.38e-2)"	4.0	7.3	16.5	3.6	12.0	2.9	6.8	12.8	16.6	7.6	4.6	8.8	0.9	2.5	7.1	12.5	5.7	14.6	5.7	12.5	13.9	12.6	6.1	2.1	5.3	4.9	9.2	14.1	8.3	4.2	8.5	9.8	3.9	13.2	7.7	4.6	6.8	4.7	6.0	4.4	5.8	2.9	5.9	10.0	4.5	5.4	14.0	8.4	4.7	10.3	1.8	4.8	5.4	4.6	4.7	10.4	7.0	6.5	9.9	14.1	6.2	0.8	1.5	12.8	9.7	14.5	12.9	0.6	4.3	4.8	2.5	4.2	0.1	1.9	0.9	3.1	7.9	0.6	1.1	1.1	2.5	1.1	2.1	1.3	0.7	1.2	10.4	3.2	1.7	10.6	16.6	1.6	4.1	8.1	0.3	8.3	9.2	4.2	3.0	5.2	1.7	0.9	7.4	7.2	0.7	4.6	1.1	3.2	6.1	3.4	1.7	11.8	5.1	5.4	7.8	2.7	1.8	6.2	0.6	2.9	0.8	0.3	6.8	5.9	4.8	5.2	5.9	7.0	13.0	6.5	12.2	3.1	11.4	14.1	10.4	4.7	9.7	12.2	1.7	9.9	4.9	6.7	6.9	6.2	16.5	12.0	12.8	16.6	13.9	12.6	9.2	14.1	13.2	8.4
TTLL2	"C6orf104, dJ366N23.3, NYD-TSPG"	ENSG00000120440	"Tubulin tyrosine ligase like 2"	Q9BWV7	6	167325086-167359503	"Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	37	"testis: 54.1"	"Cell line enriched"	"Detected in some"	5	"CACO-2: 6.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"							HPA027985			Approved	"Nuclear membrane,Nucleoli"				"Nuclear membrane, Nucleoli"		"HPA027985: AB_2211832"	"unprognostic (5.98e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.29e-2)"	"unprognostic (9.47e-4)"		"unprognostic (7.57e-2)"	"unprognostic (2.63e-4)"	"unprognostic (3.50e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.94e-1)"	"unprognostic (8.02e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	54.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.2	0.8	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0
TUB	rd5	ENSG00000166402	"Tubby bipartite transcription factor"	P50607	11	8019244-8106112	"Disease related genes, Predicted intracellular proteins"	"Phagocytosis, Sensory transduction"		Obesity	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.4"	"Cell line enhanced"	"Detected in many"		"HEK 293: 17.8;HeLa: 23.9;SCLC-21H: 27.1;SH-SY5Y: 20.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017997, HPA049019"	Uncertain		Approved	"Nucleoli,Centriolar satellite"	"Intracellular and membrane"			"Centriolar satellite"	Nucleoli	"HPA017997: AB_1858449, HPA049019: "	"unprognostic (2.53e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.06e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.53e-1)"	"unprognostic (9.71e-2)"	"unprognostic (5.08e-2)"	"prognostic favourable (2.85e-4)"	"unprognostic (4.18e-1)"	"prognostic favourable (2.35e-5)"	"unprognostic (8.37e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.39e-2)"	5.0	18.3	18.9	2.8	16.1	0.7	4.5	12.4	36.4	18.2	4.2	6.3	2.8	2.5	24.3	10.7	3.6	20.8	5.5	10.2	20.5	17.9	11.7	1.0	3.4	2.2	25.1	22.6	17.9	5.1	11.0	18.4	4.6	17.7	8.7	2.9	11.3	5.6	9.0	3.1	6.5	2.4	12.0	9.2	2.1	2.4	5.1	9.1	0.5	10.5	2.9	1.3	5.2	8.7	0.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	4.8	7.0	8.7	6.5	2.2	0.0	4.7	1.2	5.1	6.7	0.0	0.0	0.0	0.4	6.3	0.0	13.0	1.0	4.5	0.0	17.8	0.0	23.9	2.8	1.0	0.0	0.1	3.4	1.1	2.3	0.0	0.4	0.0	0.0	2.3	0.6	0.0	0.0	4.8	0.0	6.4	0.1	0.0	0.0	0.2	27.1	20.2	3.4	0.0	1.3	0.7	0.1	0.0	2.8	6.8	0.4	2.0	0.0	0.0	0.0	2.4	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.6	0.4	0.2	1.2	0.0	0.7	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	18.9	16.1	12.4	36.4	20.5	17.9	25.1	22.6	17.7	9.1
TULP3	TUBL3	ENSG00000078246	"Tubby like protein 3"	O75386	12	2877223-2941140	"Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015285, HPA018496"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Plasma membrane"	"Secreted - unknown location"			"Nucleoplasm, Nucleoli"	"Plasma membrane"	"HPA015285: AB_1858460, HPA018496: "	"unprognostic (5.33e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.80e-2)"	"prognostic favourable (2.99e-4)"	"unprognostic (2.45e-1)"	"unprognostic (1.78e-2)"	"prognostic unfavourable (7.97e-5)"	"unprognostic (2.44e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.37e-1)"	"prognostic unfavourable (7.18e-4)"	"unprognostic (7.52e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.19e-2)"	14.0	12.0	8.1	6.9	12.9	2.4	13.0	21.2	11.1	22.7	13.6	19.6	12.6	5.3	27.7	11.7	14.1	20.9	11.5	12.7	12.1	5.3	12.1	6.5	9.5	7.2	11.0	7.7	37.1	6.8	13.5	15.4	12.7	10.9	12.5	8.1	17.2	9.8	14.0	9.9	19.8	7.0	17.5	9.7	7.3	11.7	13.2	13.8	4.4	13.3	6.3	9.2	11.6	28.4	3.5	2.8	0.6	1.5	4.8	6.3	1.7	9.2	7.9	15.0	12.5	15.2	22.7	14.2	14.6	24.5	15.8	17.5	10.0	8.6	6.9	2.2	21.5	7.8	8.9	9.4	18.3	8.9	6.6	4.1	9.8	6.4	19.6	4.4	4.8	13.3	11.1	23.8	32.7	12.1	3.9	6.5	13.2	8.3	6.5	3.9	20.3	5.8	6.9	14.7	2.5	9.9	7.8	3.8	10.1	12.7	7.6	8.3	9.5	4.3	9.7	11.6	14.1	23.6	14.1	2.0	2.4	6.0	11.7	2.4	17.7	0.0	1.5	0.5	4.0	1.5	6.3	2.9	3.1	4.0	1.3	3.5	3.8	5.2	0.6	4.8	0.8	2.8	5.5	1.7	8.1	12.9	21.2	11.1	12.1	5.3	11.0	7.7	10.9	13.8
TWIST2	"bHLHa39, Dermo-1, DERMO1"	ENSG00000233608	"Twist family bHLH transcription factor 2"	Q8WVJ9	2	238848032-238910543	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 34.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 32.8;ASC TERT1: 20.9;BJ: 26.6;BJ hTERT+: 83.9;fHDF/TERT166: 38.0;U-2197: 32.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	21	"eosinophil: 11.2"	"Lineage enriched"	"Detected in single"	52	"granulocytes: 11.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA062870			Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA062870: "	"unprognostic (1.62e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.53e-4)"	"unprognostic (1.83e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-9)"	"unprognostic (1.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.48e-2)"	25.8	1.3	0.2	4.7	0.6	0.6	21.7	0.1	0.4	34.6	8.4	0.4	4.3	0.6	14.3	6.2	9.1	7.4	5.8	4.3	0.6	0.2	0.7	0.3	4.2	0.9	1.1	0.0	15.6	0.7	0.0	2.1	9.1	0.4	13.1	1.9	3.9	2.2	7.1	4.3	9.7	2.3	12.4	1.7	1.2	3.3	4.6	0.5	0.0	4.0	6.4	3.4	15.9	18.6	0.2	0.0	11.2	0.1	0.0	0.0	0.0	0.0	1.8	0.1	0.0	32.8	20.9	0.0	26.6	83.9	12.4	18.7	0.0	0.0	0.0	0.8	38.0	0.2	0.3	2.1	9.1	0.0	2.8	0.0	1.6	0.1	5.6	0.0	0.6	4.8	1.1	6.0	5.0	1.6	0.0	0.0	1.6	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.3	4.6	0.5	0.9	32.5	0.3	0.0	0.0	0.0	0.1	0.8	1.7	0.0	0.1	11.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.3	0.6	0.2	1.1	0.0	0.4	0.5
TYW1	"FLJ10900, MGC23001, MGC60291, RSAFD1, TYW1A, YPL207W"	ENSG00000198874	"TRNA-yW synthesizing protein 1 homolog"	Q9NV66	7	66995173-67239519	"Enzymes, Predicted membrane proteins"	"tRNA processing"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA013568, HPA014118, HPA015535, HPA043136, HPA047029, HPA047052, HPA052097"	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA013568: , HPA014118: , HPA015535: AB_1856487, HPA043136: , HPA047029: , HPA047052: , HPA052097: "	"unprognostic (1.53e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (1.73e-4)"	"unprognostic (4.86e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.79e-2)"	15.4	19.1	10.2	12.3	15.4	11.9	15.1	14.9	15.3	18.8	12.9	21.2	18.2	14.1	22.7	15.3	12.0	15.5	10.8	12.9	10.8	9.8	15.2	17.7	11.1	15.5	14.1	10.8	19.4	23.9	22.9	28.0	13.2	14.5	14.9	16.5	17.8	15.3	14.7	26.2	14.4	12.8	14.0	13.9	15.1	12.6	13.7	13.4	19.7	19.0	13.6	23.3	15.3	15.2	9.6	8.3	3.6	9.1	11.2	11.8	5.3	10.5	13.5	8.3	17.1	12.4	8.6	9.6	11.3	8.6	9.0	8.4	15.4	13.8	18.4	17.4	10.4	12.5	17.1	13.9	13.0	14.4	13.1	7.9	11.2	10.4	12.3	18.3	10.6	8.8	14.1	12.1	18.7	8.1	20.9	11.1	10.2	10.4	11.5	15.3	14.5	12.1	13.1	11.6	23.1	12.2	10.7	12.7	12.6	13.6	26.4	11.3	18.0	13.0	9.5	10.3	7.4	8.2	15.4	11.2	15.8	22.2	8.4	17.2	14.2	2.0	7.0	3.6	8.6	7.8	11.7	8.5	9.4	9.8	8.3	9.6	11.5	11.8	2.0	11.2	9.1	6.6	6.8	5.3	10.2	15.4	14.9	15.3	10.8	9.8	14.1	10.8	14.5	13.4
TYW1B	"LINC00069, MGC87315, NCRNA00069, RSAFD2"	ENSG00000277149	"TRNA-yW synthesizing protein 1 homolog B"		7	72558744-72828198	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA013568, HPA014118, HPA043136, HPA047029, HPA047052, HPA052097"	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA013568: , HPA014118: , HPA043136: , HPA047029: , HPA047052: , HPA052097: "	"unprognostic (2.61e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.91e-2)"	"unprognostic (6.22e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.19e-2)"	"unprognostic (8.96e-3)"	"unprognostic (5.78e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.33e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.90e-2)"	2.7	1.6	1.8	4.5	3.8	4.4	4.2	6.0	3.3	5.6	2.9	5.8	7.4	1.5	6.0	5.2	3.4	4.1	1.5	2.3	1.9		3.1	7.9	2.9	2.4	3.9	1.7	10.1	5.7	2.0	11.6	3.0	3.4	4.1	4.4	4.7	4.1	5.9	4.4	2.5	2.9	3.6	4.7	3.0	3.1	7.2	3.8	6.0	5.9	1.8	6.0	3.1	1.1	7.5	5.4	5.7	3.5	2.4	3.0	0.9	2.3	2.4	1.0	2.0	1.6	0.5	1.1	1.2	0.5	1.0	1.1	7.9	4.1	7.2	0.7	0.8	1.1	1.9	0.8	1.3	7.7	2.3	0.7	1.2	4.6	0.8	7.3	2.0	3.7	0.6	1.3	0.8	0.7	9.8	7.6	1.0	0.9	2.3	3.7	1.8	4.5	1.4	5.4	2.6	1.1	0.8	1.8	0.9	1.5	8.2	4.3	2.1	2.6	3.1	1.8	4.3	9.5	1.4	6.6	8.0	8.2	0.5	2.0	9.5	4.0	3.5	5.7	3.0	1.8	2.8	7.5	2.0	1.8	1.4	5.2	2.3	2.7	4.3	2.4	1.7	5.4	2.0	0.9										
UBE2R2	"CDC34B, FLJ20419, MGC10481, UBC3B"	ENSG00000107341	"Ubiquitin conjugating enzyme E2 R2"	Q712K3	9	33817567-33920404	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 21.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061000			Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA061000: "	"unprognostic (1.51e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.55e-2)"	"unprognostic (5.15e-2)"	"prognostic unfavourable (4.37e-4)"	"unprognostic (1.82e-3)"	"unprognostic (4.61e-3)"	"unprognostic (3.05e-3)"	"unprognostic (2.22e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.43e-1)"	26.1	19.7	29.4	19.7	26.8	13.9	39.3	23.7	32.3	25.6	24.1	27.9	16.3	28.0	26.1	18.4	25.3	22.3	21.8	29.2	25.5	20.3	22.1	34.5	23.0	27.1	30.5	23.2	29.8	44.5	15.7	13.9	24.6	21.6	21.0	21.4	19.3	18.7	20.8	56.1	28.1	25.7	28.5	24.2	21.6	20.8	34.5	29.6	36.7	19.5	22.5	25.7	35.8	30.5	3.3	4.2	21.9	11.6	5.0	2.1	2.4	16.3	18.0	34.6	15.0	19.1	31.2	10.6	14.6	20.3	17.1	17.1	14.4	12.3	14.0	6.0	20.3	7.3	18.1	16.6	18.8	23.0	9.6	12.0	19.8	18.3	27.2	14.3	13.1	26.4	24.7	14.0	26.5	28.7	11.3	15.1	16.9	9.5	26.9	37.6	19.7	14.9	25.0	10.5	7.2	18.1	12.4	16.2	19.5	17.0	15.2	10.9	13.4	17.4	21.4	16.5	15.0	11.4	13.5	9.6	9.0	19.5	15.8	8.3	35.5	12.4	7.5	4.1	2.0	7.5	1.3	3.1	1.9	1.6	4.2	3.3	1.9	1.7	21.9	5.0	11.6	2.6	2.1	2.4	29.4	26.8	23.7	32.3	25.5	20.3	30.5	23.2	21.6	29.6
UBE2T	"FANCT, HSPC150"	ENSG00000077152	"Ubiquitin conjugating enzyme E2 T"	Q9NPD8	1	202331657-202341980	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 46.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA002831			Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA002831: AB_1080445"	"unprognostic (2.38e-3)"	"unprognostic (6.37e-2)"	"unprognostic (5.27e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.13e-3)"	"prognostic unfavourable (4.79e-6)"	"unprognostic (1.71e-2)"	"unprognostic (2.32e-2)"	"prognostic favourable (6.90e-6)"	"unprognostic (6.28e-3)"	"unprognostic (2.85e-2)"	"prognostic unfavourable (2.22e-16)"	"unprognostic (5.37e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.86e-2)"	1.9	4.2	9.6	8.5	12.2	20.8	3.9	4.4	13.5	3.5	11.2	0.7	17.2	7.5	4.3	4.1	10.3	2.9	3.0	8.8	8.8	11.2	4.5	2.8	3.1	15.2	8.7	8.2	1.3	0.9	2.4	3.1	8.7	8.2	2.2	13.9	1.9	2.8	7.0	13.1	4.5	6.9	8.1	3.4	6.7	4.0	16.0	1.8	46.8	2.6	12.8	15.3	6.3	4.5	9.0	3.6	1.7	8.6	1.1	11.1	2.9	30.3	29.0	43.2	20.4	4.0	7.4	24.7	33.2	18.6	38.0	26.8	20.6	37.3	35.4	13.2	12.1	24.8	39.9	19.5	34.3	32.1	22.8	21.6	15.8	23.5	1.8	25.9	26.4	2.6	4.7	29.9	12.4	22.0	27.3	29.3	29.7	28.3	46.3	33.0	16.7	14.8	35.9	46.0	30.8	14.5	14.6	34.0	34.7	23.2	28.6	11.1	30.1	16.4	10.8	17.1	27.4	29.9	39.4	14.9	29.0	45.1	17.0	27.0	35.5	0.0	0.8	1.7	3.7	2.4	2.8	9.0	5.0	3.9	1.7	6.3	7.3	8.0	0.0	1.1	8.6	3.6	11.1	2.9	9.6	12.2	4.4	13.5	8.8	11.2	8.7	8.2	8.2	1.8
UBE2W	"FLJ11011, UBC-16"	ENSG00000104343	"Ubiquitin conjugating enzyme E2 W"	Q96B02	8	73780097-73878910	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045161, HPA073181"	Uncertain		Approved	Nucleoli				Nucleoli		"HPA045161: AB_10960706, HPA073181: "	"unprognostic (5.36e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.17e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.01e-2)"	"unprognostic (4.38e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.18e-1)"	15.2	14.2	13.5	13.3	21.8	17.5	13.4	18.9	24.4	12.0	9.8	11.3	11.0	7.9	13.4	10.5	16.6	9.4	15.2	14.8	19.0	12.3	21.9	23.4	13.6	11.6	11.6	13.0	11.8	12.7	18.4	20.9	13.6	18.4	12.0	11.5	9.5	12.2	10.6	16.4	10.6	8.5	12.8	12.6	13.6	10.0	16.4	12.3	14.7	17.1	4.8	12.9	16.8	12.8	5.0	8.1	23.0	9.4	4.7	4.3	4.8	8.5	5.6	6.9	7.5	12.1	12.4	6.0	9.4	10.4	9.1	9.5	4.6	9.6	4.0	7.8	9.8	8.7	10.2	9.6	15.2	6.4	6.2	8.1	5.8	7.1	8.2	4.4	11.5	9.7	10.8	10.6	19.0	11.0	4.0	8.6	13.8	6.8	9.6	4.8	5.3	11.1	2.9	7.1	3.4	16.9	9.4	5.1	5.6	7.5	24.5	11.3	11.5	7.9	9.8	11.0	8.4	8.3	6.9	7.3	7.5	2.9	9.6	7.1	9.4	12.9	9.4	11.5	3.5	8.8	4.3	5.0	3.6	2.6	6.3	4.3	3.2	3.8	23.0	4.7	9.4	8.1	4.0	4.8	13.5	21.8	18.9	24.4	19.0	12.3	11.6	13.0	18.4	12.3
UBFD1	"FLJ38870, FLJ42145, UBPH"	ENSG00000103353	"Ubiquitin family domain containing 1"	O14562	16	23557362-23574389	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051746			Approved	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA051746: "	"unprognostic (2.70e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.45e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.86e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.86e-1)"	"unprognostic (8.28e-2)"	"unprognostic (8.06e-2)"	"unprognostic (6.20e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.11e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.46e-1)"	10.2	16.2	11.9	8.9	13.0	7.1	10.0	23.1	19.5	11.7	9.2	9.4	15.2	6.1	16.4	14.9	9.6	13.9	11.8	21.2	11.3	17.6	12.3	15.4	7.6	8.7	13.0	11.8	14.5	17.5	28.5	17.2	16.5	13.6	12.5	9.4	12.3	12.3	12.6	52.8	7.6	7.0	14.6	7.4	9.1	8.1	27.6	7.0	16.2	16.4	11.1	11.7	10.9	12.9	2.8	4.1	1.0	1.9	3.0	4.0	1.1	6.4	14.6	20.8	15.0	24.0	29.8	19.5	20.0	16.4	15.9	15.0	11.1	11.1	14.3	31.2	24.4	8.9	32.8	13.3	20.6	23.7	19.3	7.4	13.2	24.1	12.8	7.8	14.4	21.2	10.0	15.5	14.6	15.4	18.8	7.9	17.5	13.4	11.1	14.1	49.7	6.5	20.3	12.8	11.8	14.9	5.5	20.7	19.0	6.6	12.9	11.7	17.7	11.5	16.2	9.0	10.4	9.6	10.4	11.9	11.9	8.7	16.4	9.3	13.6	0.0	1.3	1.0	4.0	1.9	2.3	1.6	2.8	3.9	3.0	2.8	1.7	2.3	0.0	3.0	1.0	4.1	2.3	1.1	11.9	13.0	23.1	19.5	11.3	17.6	13.0	11.8	13.6	7.0
UBLCP1	"CPUB1, MGC10067"	ENSG00000164332	"Ubiquitin like domain containing CTD phosphatase 1"	Q8WVY7	5	159263081-159286040	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039615	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA039615: AB_10674425"	"unprognostic (1.25e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.04e-3)"	"unprognostic (3.45e-2)"	"unprognostic (7.08e-2)"	"unprognostic (6.82e-2)"	"prognostic unfavourable (4.46e-5)"	"unprognostic (4.01e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.51e-2)"	17.1	16.0	16.7	18.4	19.7	16.7	16.3	20.2	33.0	18.5	12.5	12.2	11.4	9.8	22.5	13.1	22.2	14.7	14.5	13.1	20.9	19.1	17.5	14.4	17.8	24.1	19.7	22.7	16.8	12.6	18.0	23.9	19.6	36.7	14.7	14.7	10.9	15.4	17.6	15.3	14.2	13.8	19.5	20.4	22.2	13.3	24.2	15.4	26.8	14.4	16.1	30.1	18.8	16.8	11.9	10.8	21.9	13.9	25.5	19.2	8.2	14.5	10.6	22.0	23.8	22.9	21.2	13.0	15.9	24.2	16.3	21.8	8.6	10.1	13.0	17.6	19.8	11.1	13.6	30.5	28.5	25.9	13.3	10.0	9.3	7.8	28.9	22.6	15.8	18.7	28.7	14.8	29.6	15.5	13.7	17.6	22.7	4.7	12.2	6.9	15.2	6.4	15.5	21.5	15.2	16.1	11.2	11.7	15.5	16.0	10.7	37.4	11.3	15.1	16.5	16.8	14.1	8.7	20.0	14.1	14.2	19.8	17.8	15.6	24.9	21.9	6.5	16.1	16.6	13.5	18.6	11.9	15.8	17.3	8.5	10.9	18.5	19.2	19.4	25.5	13.9	10.8	16.9	8.2	16.7	19.7	20.2	33.0	20.9	19.1	19.7	22.7	36.7	15.4
UBR3	"DKFZp434P117, FLJ37422, KIAA2024, ZNF650"	ENSG00000144357	"Ubiquitin protein ligase E3 component n-recognin 3 (putative)"	Q6ZT12	2	169827458-170084131	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 76.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035390	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA035390: AB_10670699"	"unprognostic (1.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.19e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.18e-1)"	11.9	15.5	10.9	6.1	18.3	5.4	9.6	15.5	18.9	9.9	10.0	9.8	9.1	6.7	11.5	7.1	10.7	8.1	7.8	23.1	10.3	7.2	12.9	16.9	9.2	5.6	11.9	14.0	8.9	9.8	20.9	14.9	7.2	14.7	11.2	7.3	8.0	11.1	9.2	76.3	11.5	8.4	9.6	10.2	6.9	9.2	7.9	11.4	6.3	14.9	10.9	6.0	12.8	8.7	2.0	2.8	1.9	2.1	2.4	4.3	1.2	8.8	7.5	8.0	10.6	16.0	12.7	6.8	16.0	9.3	9.3	7.5	11.5	5.6	10.0	13.9	12.4	11.7	9.5	8.1	11.6	10.4	8.2	36.6	8.0	12.2	8.0	12.1	11.9	7.6	7.6	12.1	8.1	9.1	19.0	10.9	15.7	8.3	7.8	5.9	6.3	6.3	7.5	13.2	10.6	6.7	12.5	15.8	8.6	11.2	10.4	6.5	6.8	6.8	11.5	14.0	5.7	10.9	10.0	8.9	6.9	9.2	11.5	7.1	7.7	0.0	2.1	1.7	3.2	1.8	4.2	2.0	1.9	2.7	2.8	1.2	3.3	4.3	1.9	2.4	1.6	2.4	3.1	1.2	10.9	18.3	15.5	18.6	10.3	7.2	11.9	14.0	14.7	11.4
UBXN11	"SOC, SOCI, UBXD5"	ENSG00000158062	"UBX domain protein 11"	Q5T124	1	26281328-26318363	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 32.4;intermediate monocyte: 28.1;myeloid DC: 16.6;non-classical monocyte: 22.5"	"Group enriched"	"Detected in all"	4	"dendritic cells: 16.6;monocytes: 32.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA028600, HPA031357"	Approved		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA028600: AB_10604001, HPA031357: "	"unprognostic (1.78e-3)"	"prognostic favourable (2.54e-5)"	"unprognostic (8.18e-2)"	"prognostic favourable (1.90e-4)"	"unprognostic (2.53e-1)"	"prognostic favourable (4.90e-4)"	"prognostic unfavourable (5.90e-6)"	"unprognostic (8.41e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.89e-2)"	"unprognostic (5.59e-3)"	"unprognostic (5.00e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.31e-2)"	5.4	7.6	16.6	10.2	25.7	18.9	5.6	7.0	21.5	8.6	4.6	7.9	9.0	4.2	6.7	23.8	4.3	35.4	8.4	5.9	17.0	15.0	9.3	3.7	12.0	8.2	9.8	12.3	9.7	8.2	8.4	18.3	5.2	12.7	5.4	3.5	13.6	8.3	8.3	6.2	6.0	4.4	5.0	5.6	11.7	4.8	27.4	8.5	6.2	15.7	2.7	5.7	6.1	3.9	5.3	16.6	2.4	32.4	1.9	5.7	13.2	17.1	7.8	3.9	7.8	2.8	2.1	13.5	3.8	6.0	10.7	7.8	3.0	15.3	10.1	5.8	2.4	9.4	2.4	6.2	2.7	5.0	9.2	1.7	11.1	7.4	5.1	7.3	3.4	3.3	6.7	18.0	4.6	2.9	6.5	7.0	3.6	7.7	4.1	3.5	7.8	6.0	8.6	2.8	9.0	5.9	2.5	18.4	4.4	9.5	8.9	6.6	6.9	7.1	2.8	6.2	9.3	9.2	5.7	6.7	18.8	11.4	7.6	10.1	5.0	0.7	32.4	1.5	3.4	28.1	4.1	4.4	5.0	3.9	16.6	5.3	5.7	3.6	2.4	1.9	22.5	2.5	4.1	13.2	16.6	25.7	7.0	21.5	17.0	15.0	9.8	12.3	12.7	8.5
UBXN8	"D8S2298E, REP8, UBXD6"	ENSG00000104691	"UBX domain protein 8"	O00124	8	30732247-30767006	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 30.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017725, HPA077538"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Endoplasmic reticulum"	"Intracellular and membrane"			"Endoplasmic reticulum"	"Nucleoplasm, Nucleoli"	"HPA017725: AB_1847462, HPA077538: "	"unprognostic (3.00e-2)"	"unprognostic (2.30e-1)"	"prognostic favourable (6.13e-4)"	"unprognostic (7.71e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.06e-2)"	"prognostic unfavourable (5.25e-5)"	"unprognostic (2.49e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.88e-2)"	5.0	5.3	3.9	1.4	4.8	1.4	4.3	1.5	9.2	3.0	3.5	4.0	6.7	3.1	3.8	14.3	4.1	3.6	3.8	2.8	5.7		8.2	21.5	2.1	3.9	7.6	4.0	30.6	10.3	6.2	3.5	6.2	6.2	4.8	4.7	1.6	1.8	6.1	1.7	4.1	2.9	2.9	7.1	5.7	3.3	11.5	6.1	0.9	9.1	2.8	2.3	2.9	3.7	6.0	8.2	1.0	6.1	3.3	8.4	3.4	7.6	7.7	5.6	5.8	9.1	12.2	6.2	13.7	8.0	7.5	9.2	12.2	2.7	12.2	11.3	11.1	6.8	1.1	7.6	11.6	6.4	12.5	34.3	6.3	14.9	13.6	7.8	19.4	9.5	7.9	12.0	5.9	6.5	33.4	9.2	16.5	7.2	7.9	6.0	10.8	5.8	9.5	5.4	8.5	12.8	10.0	3.2	8.1	3.8	11.3	24.7	8.4	13.6	8.3	8.5	3.7	3.8	12.7	4.0	12.5	9.2	7.6	12.6	12.1	0.0	6.0	0.7	8.4	6.1	7.3	6.0	4.5	8.0	6.7	2.9	4.4	7.4	1.0	3.3	3.0	8.2	4.3	3.4										
UFD1	UFD1L	ENSG00000070010	"Ubiquitin recognition factor in ER associated degradation 1"	Q92890	22	19449910-19479215	"Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 130.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030286, HPA030287"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Cytosol"	Nucleoli	"HPA030286: , HPA030287: AB_10601830"	"unprognostic (2.52e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.61e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.70e-2)"	"prognostic unfavourable (2.59e-4)"	"unprognostic (9.79e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.02e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavourable (4.50e-8)"	"unprognostic (1.45e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-2)"	27.8	28.0	22.7	24.3	38.0	38.7	23.9	25.3	30.4	21.1	28.9	23.3	24.7	21.7	32.8	40.3	31.6	21.3	21.7	35.6	21.9	22.9	28.0	46.6	24.6	34.8	44.3	15.9	22.4	34.7	22.5	22.6	31.6	33.0	21.7	27.7	21.9	26.7	24.4	57.9	27.3	24.7	28.3	39.7	26.7	26.2	31.8	29.9	37.8	27.8	26.9	31.7	23.9	23.7	27.7	35.3	53.5	42.8	31.1	67.6	37.5	31.4	22.9	19.6	29.6	16.1	11.3	15.1	26.0	26.0	36.0	33.4	25.4	13.7	22.0	20.3	21.8	27.3	22.9	22.8	31.5	40.5	24.2	23.2	16.2	20.0	15.3	36.8	31.7	10.4	23.5	30.7	15.1	28.9	130.1	42.5	21.9	45.7	23.6	22.5	14.0	19.5	28.7	46.3	8.5	22.1	29.7	16.1	18.1	20.4	22.2	20.4	13.3	17.7	31.3	30.5	41.4	25.3	27.9	18.2	36.1	28.7	25.6	18.8	27.7	39.8	29.0	47.8	36.1	42.8	34.7	27.7	41.6	37.3	25.5	23.9	35.9	35.1	53.5	31.1	41.1	35.3	67.6	37.5	22.7	38.0	25.3	30.4	21.9	22.9	44.3	15.9	33.0	29.9
UPF3B	"HUPF3B, MRX62, RENT3B, UPF3BP1, UPF3BP2, UPF3BP3, UPF3X"	ENSG00000125351	"UPF3B, regulator of nonsense mediated mRNA decay"	Q9BZI7	X	119805311-119852998	"Disease related genes, Predicted intracellular proteins"	"mRNA transport, Nonsense-mediated mRNA decay, Transport"	RNA-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001592, HPA001800, HPA001882"	Approved		Enhanced	Nucleoplasm,Nucleoli,Cytosol				Cytosol	"Nucleoplasm, Nucleoli"	"HPA001592: , HPA001800: AB_1080476, HPA001882: AB_1080474"	"unprognostic (1.79e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.64e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (1.52e-6)"	"unprognostic (6.61e-2)"	"prognostic unfavourable (5.39e-4)"	"unprognostic (5.74e-2)"	"unprognostic (4.51e-2)"	"unprognostic (8.63e-3)"	"prognostic unfavourable (1.44e-7)"	"unprognostic (8.67e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.95e-2)"	9.7	10.3	19.4	11.5	21.9	14.5	10.8	34.1	24.0	10.2	13.0	9.3	12.8	14.2	14.6	13.5	13.0	8.8	8.4	7.8	16.9	17.5	10.0	12.4	9.0	17.2	16.5	21.7	14.8	8.7	14.3	26.7	10.5	17.2	12.4	13.2	9.1	9.7	14.4	14.5	18.6	11.1	14.2	21.7	12.9	9.9	15.0	21.0	9.9	12.5	11.5	18.3	12.6	12.9	17.5	10.0	7.1	5.9	7.9	8.1	2.7	11.6	7.1	14.8	12.0	6.7	4.4	9.5	11.3	6.3	8.8	7.8	13.3	8.4	21.1	9.6	4.7	11.2	19.1	6.7	11.3	12.0	14.0	19.5	23.5	6.9	7.7	21.1	9.7	3.8	5.1	15.1	18.5	8.2	18.8	17.6	7.3	14.2	14.8	26.5	28.5	19.4	14.5	16.9	15.4	7.2	5.9	19.7	13.6	23.0	9.3	16.8	4.9	12.3	7.1	9.2	7.1	14.7	23.8	9.7	10.8	28.5	7.4	31.0	10.7	7.1	5.3	6.8	7.5	5.1	5.7	13.8	7.0	5.9	3.8	17.5	7.6	8.1	5.9	7.9	5.9	10.0	7.8	2.7	19.4	21.9	34.1	24.0	16.9	17.5	16.5	21.7	17.2	21.0
URB2	"KIAA0133, NET10, NPA2"	ENSG00000135763	"URB2 ribosome biogenesis 2 homolog (S. cerevisiae)"	Q14146	1	229626234-229660199	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008902, HPA046788"	Uncertain		Enhanced	Nucleoli				Nucleoli		"HPA008902: AB_2213805, HPA046788: "	"unprognostic (1.26e-1)"	"unprognostic (4.03e-3)"	"unprognostic (2.16e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.62e-3)"	"unprognostic (7.81e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.45e-1)"	9.8	6.2	7.0	7.2	7.8	7.6	6.5	5.8	11.0	4.7	5.0	9.5	2.9	4.3	7.4	3.8	8.0	6.9	5.2	4.9	5.3	3.7	4.3	10.4	4.9	12.0	8.2	7.7	7.2	13.7	6.5	9.9	6.5	8.0	5.0	4.9	6.4	5.8	3.8	14.0	5.8	5.3	6.6	5.8	8.4	5.8	15.6	7.2	10.3	4.6	6.2	9.0	5.5	4.8	2.7	2.7	0.5	3.9	1.9	5.6	2.9	7.3	11.0	7.2	9.6	4.5	3.8	22.0	5.8	3.6	9.1	6.9	10.9	5.8	15.2	6.8	4.1	10.1	17.8	7.1	8.3	7.4	16.9	9.4	9.3	6.4	4.3	13.8	8.2	3.7	5.2	9.0	7.0	4.3	20.0	7.1	5.6	5.8	15.3	6.8	24.1	7.3	17.2	10.2	15.2	4.0	9.3	10.8	13.2	6.9	7.2	5.8	8.1	7.9	4.7	7.5	9.4	9.4	16.6	7.9	7.6	22.8	4.0	10.4	13.5	0.2	1.9	0.5	3.0	3.9	5.6	2.0	2.8	3.6	2.7	2.7	4.3	3.3	0.2	1.9	1.3	1.6	3.1	2.9	7.0	7.8	5.8	11.0	5.3	3.7	8.2	7.7	8.0	7.2
USF3	KIAA2018	ENSG00000176542	"Upstream transcription factor family member 3"	Q68DE3	3	113648385-113696646	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029243, HPA029245"	Uncertain		Uncertain	Nucleoplasm,Nucleoli,Centrosome				"Nucleoplasm, Nucleoli"	Centrosome	"HPA029243: AB_10611114, HPA029245: AB_10600443"	"unprognostic (2.80e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.21e-2)"	"unprognostic (7.80e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.30e-1)"	"prognostic favourable (1.74e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.55e-2)"	9.0	5.1	8.8	11.0	7.3	13.8	11.4	13.9	7.5	7.2	12.2	5.3	5.4	4.8	5.8	13.3	7.0	6.3	5.3	8.1	7.6	5.5	12.7	24.0	6.1	9.2	6.3	5.6	6.9	10.8	14.4	8.9	4.9	6.5	6.2	6.7	6.4	8.3	5.4	28.7	11.4	14.7	8.3	11.2	12.0	7.3	4.8	6.9	13.3	7.1	11.5	8.9	6.1	6.0	5.9	5.1	6.9	3.7	2.6	3.1	1.4	5.2	3.9	4.9	4.6	12.0	4.6	3.3	2.1	3.4	2.1	2.0	3.7	2.2	9.2	3.8	5.3	3.3	5.3	4.2	3.9	2.8	2.1	6.6	2.5	6.0	3.6	11.9	7.3	6.7	7.6	3.8	4.4	4.9	3.1	4.9	4.4	7.3	6.6	6.7	3.6	4.0	2.8	3.8	3.6	7.4	7.3	2.3	3.5	5.1	2.8	6.0	3.9	8.9	6.7	3.3	7.1	1.8	3.0	5.7	3.2	11.0	3.7	5.0	2.4	4.1	2.4	3.5	3.1	2.8	2.3	2.2	2.2	2.3	1.7	5.9	2.7	2.8	6.9	2.6	3.7	5.1	1.1	1.4	8.8	7.3	13.9	7.5	7.6	5.5	6.3	5.6	6.5	6.9
USP36	"FLJ12851, KIAA1453"	ENSG00000055483	"Ubiquitin specific peptidase 36"	Q9P275	17	78787381-78841441	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012082, HPA012395, HPA052860"	Uncertain	Supported	Enhanced	"Nucleoli,Nuclear speckles"				Nucleoli	"Nuclear speckles"	"HPA012082: AB_1858682, HPA012395: , HPA052860: "	"unprognostic (1.94e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (5.18e-5)"	"unprognostic (9.35e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.78e-1)"	26.3	23.4	12.9	21.3	16.0	36.5	28.1	28.3	17.4	17.2	16.4	25.4	19.2	12.3	25.1	22.2	14.6	18.0	21.9	17.4	10.4	11.2	15.9	16.4	20.0	17.2	17.5	16.0	41.3	33.6	19.6	30.0	23.4	14.6	21.0	15.1	20.4	21.8	45.5	19.5	29.3	15.1	25.2	14.5	18.2	17.3	20.8	13.7	12.8	19.3	11.2	22.2	24.6	18.1	6.7	12.4	8.9	5.3	5.6	8.8	2.5	15.7	19.1	5.6	10.4	12.1	13.5	10.8	13.0	13.2	12.5	8.4	18.5	8.0	20.2	6.6	11.5	11.6	13.2	9.6	22.4	4.8	20.0	18.4	27.8	19.2	12.4	20.1	10.1	11.7	16.0	17.8	39.9	10.8	14.6	21.3	10.3	12.1	18.3	20.4	8.7	15.3	14.1	12.3	13.5	7.9	16.6	16.6	10.1	9.3	43.5	23.6	11.2	12.8	9.2	29.5	13.7	17.1	22.9	15.8	6.2	24.8	11.6	15.8	9.2	8.9	3.9	3.1	7.6	5.3	8.8	6.4	7.2	6.4	2.3	6.7	8.0	7.7	5.7	5.6	3.3	12.4	4.8	2.5	12.9	16.0	28.3	17.4	10.4	11.2	17.5	16.0	14.6	13.7
USP37	KIAA1594	ENSG00000135913	"Ubiquitin specific peptidase 37"	Q86T82	2	218450251-218568361	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045160	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA045160: AB_10795620"	"unprognostic (7.00e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.83e-2)"	"unprognostic (9.19e-4)"	"unprognostic (1.83e-1)"	"prognostic favourable (2.85e-4)"	"unprognostic (2.18e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.66e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.87e-1)"	"unprognostic (6.69e-2)"	"unprognostic (6.41e-3)"	10.4	8.4	9.2	9.7	10.5	19.2	9.0	16.2	10.0	8.3	6.6	10.4	8.0	5.8	9.6	15.8	8.2	7.8	7.0	6.9	7.4	5.5	6.1	7.4	8.1	10.5	8.7	7.8	15.3	6.9	10.7	17.1	8.5	8.7	7.3	7.0	7.4	9.7	9.6	11.1	9.9	7.2	8.1	10.2	7.0	6.6	22.2	10.5	13.4	9.8	5.4	9.4	10.5	9.1	7.4	6.1	7.4	4.8	5.9	9.0	2.5	7.3	5.4	11.4	8.8	3.0	3.7	9.7	5.6	4.1	9.9	11.1	10.2	5.9	6.7	6.2	4.4	7.1	12.5	6.3	10.9	9.2	6.6	18.2	10.9	6.7	3.4	11.8	9.1	2.0	3.8	10.3	7.5	4.2	13.1	13.0	6.2	5.5	15.2	8.1	9.8	4.7	12.3	17.1	6.2	3.4	8.8	12.5	6.8	9.0	4.5	5.7	5.2	8.4	5.3	11.1	9.8	6.2	7.4	8.9	7.8	13.8	6.0	8.8	7.5	6.5	4.2	7.4	7.0	4.8	7.3	5.4	5.8	5.9	4.4	7.4	9.0	5.7	3.5	5.9	4.4	6.1	7.3	2.5	9.2	10.5	16.2	10.0	7.4	5.5	8.7	7.8	8.7	10.5
USP46	FLJ12552	ENSG00000109189	"Ubiquitin specific peptidase 46"	P62068	4	52590972-52659335	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Behavior, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA007288, CAB076369, CAB076370"	Uncertain		Approved	Nucleoli				Nucleoli		"CAB076369: , CAB076370: , HPA007288: AB_1080531"	"unprognostic (1.15e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.28e-1)"	4.7	9.5	26.0	3.5	20.9	2.8	7.0	23.7	29.4	8.9	4.2	12.8	5.2	4.8	7.2	6.2	12.4	7.8	5.8	28.9	21.9	19.0	10.8	3.1	4.4	3.7	19.1	13.9	12.3	5.6	12.2	5.3	10.6	12.7	7.7	4.6	5.3	8.0	7.8	13.7	8.0	4.5	5.5	18.9	3.5	6.3	12.2	15.0	1.0	10.0	4.3	5.8	7.3	5.7	1.4	4.4	2.0	1.4	1.2	3.9	1.0	5.3	3.8	12.3	9.1	13.5	16.9	13.6	8.8	7.1	6.5	5.5	7.6	4.2	3.5	10.4	8.7	3.1	21.4	10.2	12.0	3.1	7.5	5.5	3.6	8.5	13.5	7.3	6.5	14.4	9.6	6.7	6.3	9.6	5.4	5.0	13.8	4.9	3.1	3.8	9.1	4.6	7.9	9.0	0.7	14.0	9.9	7.4	8.9	4.3	14.7	8.5	5.4	5.5	8.9	6.4	14.0	7.5	13.2	5.2	2.4	2.8	9.9	4.4	7.9	2.0	1.4	0.3	2.3	1.2	1.7	1.4	3.9	2.0	2.8	1.2	0.9	0.8	0.3	1.2	0.9	4.4	1.2	1.0	26.0	20.9	23.7	24.3	21.9	19.0	19.1	13.9	12.7	15.0
UTP14A	"NY-CO-16, SDCCAG16, Utp14"	ENSG00000156697	"UTP14A, small subunit processome component"	Q9BVJ6	X	129906121-129929761	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA047217, HPA054023"	Uncertain		Supported	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA047217: , HPA054023: "	"unprognostic (6.75e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.84e-3)"	"unprognostic (2.95e-1)"	"prognostic unfavourable (7.67e-4)"	"unprognostic (3.00e-3)"	"unprognostic (8.24e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.28e-2)"	"unprognostic (6.99e-3)"	"prognostic unfavourable (8.12e-8)"	"unprognostic (4.77e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.06e-2)"	"unprognostic (9.99e-2)"	15.1	11.4	8.2	13.3	11.2	10.2	15.8	12.7	13.8	13.3	13.4	8.4	8.5	8.5	17.6	13.9	16.9	13.9	9.0	10.0	7.1	7.2	13.2	14.9	10.7	14.8	7.6	9.8	17.4	22.7	13.1	13.8	12.5	10.6	13.5	14.7	8.6	13.2	10.6	19.6	11.8	11.0	15.3	7.7	16.1	13.3	4.3	7.7	20.7	12.4	16.3	19.5	16.0	13.5	11.1	11.8	16.2	14.3	15.5	14.6	7.7	14.2	15.9	8.6	22.5	14.4	14.7	14.4	15.8	12.1	15.9	12.7	16.2	14.1	33.8	31.9	11.4	18.3	34.2	17.2	19.6	11.2	17.0	19.3	13.6	12.3	16.3	27.2	14.8	18.0	15.2	21.6	22.9	12.5	19.1	10.6	13.7	23.4	19.6	20.8	17.8	17.9	15.4	12.9	23.1	11.0	10.9	9.0	23.6	9.0	16.6	18.6	8.9	15.9	10.8	7.0	9.2	19.6	30.3	13.3	15.4	30.1	10.6	33.8	15.8	16.2	8.0	4.0	12.7	14.3	14.6	11.1	10.7	11.8	11.8	10.9	13.5	12.4	1.0	15.5	12.0	9.4	14.4	7.7	8.2	11.2	12.7	13.8	7.1	7.2	7.6	9.8	10.6	7.7
UTP14C	"2700066J21Rik, KIAA0266"	ENSG00000253797	"UTP14C, small subunit processome component"	Q5TAP6	13	52024691-52033600	"Predicted intracellular proteins"	"Differentiation, Meiosis, Ribosome biogenesis, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA047217, HPA054023"	Uncertain		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA047217: , HPA054023: "	"unprognostic (7.89e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.47e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.30e-1)"	"unprognostic (7.16e-2)"	"prognostic unfavourable (7.52e-4)"	"unprognostic (7.35e-2)"	"unprognostic (1.23e-1)"	"prognostic favourable (1.46e-5)"	"unprognostic (2.44e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.04e-2)"	4.8	4.8	5.3	3.4	5.9	0.5	6.2	6.6	5.9	6.8	5.3			4.6	6.7	4.6	3.6	5.2	3.9	5.5	5.1	5.2	8.0	7.9	4.5	3.5	5.5		6.1	5.8	8.9	4.8	6.6		7.1	5.9		5.7	5.5	5.3	2.9	4.5	5.3	6.2	4.4	5.7	2.3			9.1		3.8	4.6	4.2	4.1	5.8	6.7	4.8	3.5	6.8	3.1	4.3	6.9	14.3	11.2	14.7	10.6	11.0	12.4	9.7	8.4	7.8	6.8	9.1	10.6	3.4	11.8	10.1	12.6	6.9	11.2	10.8	9.0	20.4	4.9	6.6	10.0	18.1	14.2	9.3	13.2	6.4	12.6	6.9	11.8	5.4	12.6	3.2	11.0	10.1	13.0	5.0	10.9	10.0	4.6	14.3	7.0	4.7	9.6	7.4	11.1	8.5	10.0	14.4	10.4	7.8	8.2	8.7	8.5	5.5	7.9	12.9	4.2	6.8	14.6	6.7	3.7	5.4	4.6	4.8	3.9	3.0	4.9	3.7	4.4	4.1	6.8	6.7	2.4	3.5	3.9	5.8	5.2	3.1										
UTP15	"FLJ12787, FLJ23637, NET21"	ENSG00000164338	"UTP15, small subunit processome component"	Q8TED0	5	73565443-73583377	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044697			Supported	"Nucleoli,Endoplasmic reticulum"				"Nucleoli, Endoplasmic reticulum"		"HPA044697: "	"unprognostic (8.96e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.87e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.27e-2)"	"unprognostic (9.66e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.22e-1)"	17.1	11.8	6.5	9.4	11.7	38.6	13.2	8.7	12.5	7.5	8.6	10.4	9.3	7.0	11.3	8.7	13.6	10.4	6.7	8.8	12.9	5.6	9.3	12.9	10.2	12.1	11.0	8.0	11.0	9.7	11.8	16.4	8.8	12.5	10.1	10.9	7.5	10.9	6.6	14.5	18.3	10.7	9.9	10.3	11.4	11.9	10.1	10.0	11.4	10.3	13.2	12.8	9.5	9.4	8.3	9.0	4.6	8.0	8.8	10.8	5.4	10.7	11.7	7.9	23.9	6.9	8.2	15.0	12.8	7.5	14.6	16.2	13.0	14.4	24.3	13.0	8.7	9.1	13.5	23.9	22.6	11.9	9.8	11.2	12.4	10.6	8.5	10.1	9.2	8.3	10.8	16.5	18.5	10.0	17.0	13.4	12.3	13.6	15.4	7.2	10.7	6.7	12.3	12.2	23.5	8.7	14.7	8.2	8.8	11.6	9.5	13.5	12.2	7.5	8.1	8.7	12.0	10.1	25.0	9.9	13.1	31.4	13.7	17.5	12.6	2.5	7.0	4.6	9.7	8.0	9.7	8.3	9.8	10.6	9.0	7.2	10.5	10.8	3.8	8.8	7.3	6.5	7.9	5.4	6.5	11.7	8.7	12.5	12.9	5.6	11.0	8.0	12.5	10.0
UTP18	"CGI-48, WDR50"	ENSG00000011260	"UTP18, small subunit processome component"	Q9Y5J1	17	51260528-51297936	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052378	Approved		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"				Nucleoli	"Nucleoplasm, Nuclear membrane"	"HPA052378: "	"unprognostic (1.36e-2)"	"unprognostic (1.00e-1)"	"prognostic favourable (3.33e-4)"	"unprognostic (2.62e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.99e-2)"	"prognostic unfavourable (1.99e-4)"	"unprognostic (2.47e-2)"	"unprognostic (8.37e-3)"	"unprognostic (1.10e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.75e-2)"	"unprognostic (3.11e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.72e-3)"	"unprognostic (1.93e-2)"	15.6	16.1	14.4	18.0	20.5	26.9	20.2	23.3	20.9	15.0	13.6	14.5	12.4	13.6	13.0	13.4	17.7	14.0	11.1	8.9	14.2	13.9	17.1	16.9	14.0	22.9	17.0	20.5	19.4	18.1	17.3	19.4	28.3	16.1	13.1	15.0	12.8	14.9	11.9	19.1	25.7	13.0	10.2	14.4	22.0	13.5	42.5	16.9	21.6	19.1	15.6	25.3	15.2	17.9	26.1	26.4	12.4	22.9	17.4	28.1	24.9	26.3	26.2	16.7	15.3	11.0	16.6	43.7	14.6	12.1	25.6	24.7	16.4	14.8	33.5	20.9	10.9	14.4	27.1	15.6	38.2	21.8	35.3	35.1	15.9	28.5	15.1	37.1	17.3	10.6	12.1	21.7	17.7	15.3	28.5	15.4	19.2	16.3	33.3	25.3	23.9	27.8	30.3	38.1	26.2	18.7	17.6	18.6	23.7	17.0	20.3	33.1	25.0	19.0	13.3	26.5	22.2	21.7	30.3	29.9	55.1	38.8	16.4	25.9	18.8	6.8	22.9	12.4	20.5	21.6	24.9	26.1	25.8	24.7	26.4	24.4	28.1	26.2	4.0	17.4	21.1	16.6	25.7	24.9	14.4	20.5	23.3	20.9	14.2	13.9	17.0	20.5	16.1	16.9
UTP20	"1A6/DRIM, DRIM"	ENSG00000120800	"UTP20, small subunit processome component"	O75691	12	101280109-101386616	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049341			Supported	"Nucleoli,Plasma membrane"				Nucleoli	"Plasma membrane"	"HPA049341: "	"unprognostic (3.04e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (1.15e-5)"	"unprognostic (8.34e-2)"	"unprognostic (4.30e-2)"	"unprognostic (8.15e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.22e-2)"	"prognostic favourable (8.87e-4)"	"unprognostic (2.88e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.30e-2)"	"unprognostic (6.92e-3)"	14.7	11.9	8.4	10.7	9.7	8.3	15.3	8.4	9.6	14.1	8.0	11.8	7.0	5.0	12.5	8.4	10.9	10.3	5.8	8.3	6.7	5.8	8.0	12.0	12.0	17.8	9.0	6.3	16.3	14.2	17.9	9.5	9.7	8.2	8.8	10.1	9.9	13.8	8.5	13.1	10.8	8.0	9.4	7.1	11.3	8.6	12.6	9.7	11.9	9.8	11.0	12.9	9.4	13.8	3.1	2.8	0.1	1.1	2.0	2.8	0.6	4.4	11.2	8.5	3.9	7.6	8.9	10.4	7.7	6.1	12.4	6.9	12.8	3.2	11.9	4.1	8.6	9.3	18.7	8.0	16.1	5.3	7.6	12.6	6.0	9.5	4.3	20.9	5.8	5.8	4.2	17.2	5.9	8.5	19.8	2.4	9.0	5.8	9.0	5.9	22.2	11.7	10.3	13.9	9.3	5.2	13.6	9.8	6.6	14.5	9.2	8.7	9.7	4.7	9.6	14.7	7.2	10.2	15.0	4.5	6.7	20.0	8.0	9.6	22.4	0.1	0.8	0.1	1.9	1.1	1.9	3.1	2.1	2.4	1.4	2.4	2.3	2.8	0.1	2.0	0.7	2.8	1.8	0.6	8.4	9.7	8.4	9.6	6.7	5.8	9.0	6.3	8.2	9.7
UTP23	"C8orf53, MGC14595"	ENSG00000147679	"UTP23, small subunit processome component"	Q9BRU9	8	116766503-116849463	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044418	Uncertain		Approved	Nucleoli				Nucleoli		"HPA044418: AB_10961139"	"prognostic unfavourable (5.18e-5)"	"unprognostic (2.30e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.64e-1)"	"unprognostic (7.23e-2)"	"unprognostic (9.45e-3)"	"unprognostic (7.73e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.34e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.15e-3)"	"unprognostic (9.27e-2)"	14.5	11.9	16.9	13.1	21.4	39.5	13.6	25.2	20.0	12.3	12.3	9.3	9.3	8.5	15.6	10.1	11.4	12.9	10.5	11.6	14.4	10.0	9.7	11.6	12.4	18.8	15.4	15.5	20.0	12.7	9.7	15.8	12.8	13.3	13.8	8.3	6.8	11.7	13.4	11.7	11.3	11.5	12.7	13.0	13.2	11.0	8.9	16.2	13.1	16.4	8.7	12.0	13.7	13.7	27.4	23.3	24.2	21.7	16.3	33.3	15.9	10.9	11.9	6.5	5.8	9.3	11.4	4.9	10.8	6.3	7.2	7.9	12.4	7.3	16.2	10.6	5.2	7.9	8.9	5.8	9.5	16.0	17.3	20.0	9.1	8.2	9.1	10.0	9.5	9.0	7.1	7.1	9.6	7.7	13.0	12.4	7.5	20.0	24.5	6.0	5.8	22.3	13.8	7.0	14.0	4.4	10.1	11.9	9.5	7.0	28.4	9.9	12.6	7.6	8.6	7.8	10.6	17.8	14.5	15.0	22.8	19.9	9.8	13.1	8.7	24.2	16.3	20.6	26.8	16.8	23.2	27.4	24.4	21.1	14.1	27.3	33.3	23.2	16.2	16.3	21.7	23.3	26.4	15.9	16.9	21.4	25.2	20.0	14.4	10.0	15.4	15.5	13.3	16.2
UTP3	"CRLZ1, DKFZp761F222, FLJ23256, SAS10"	ENSG00000132467	"UTP3, small subunit processome component"	Q9NQZ2	4	70688479-70690551	"Predicted intracellular proteins"		"Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035655, HPA041453"	Approved		Supported	Nucleoli,Vesicles				Nucleoli	Vesicles	"HPA035655: AB_10601832, HPA041453: "	"unprognostic (2.44e-2)"	"unprognostic (9.70e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.79e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.44e-3)"	"prognostic favourable (3.16e-4)"	"unprognostic (4.45e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.24e-2)"	19.9	23.4	17.6	21.3	17.9	14.5	17.1	20.1	20.3	15.7	16.1	12.1	12.1	14.3	19.4	14.2	23.5	19.4	13.3	18.9	17.0	12.1	24.5	27.5	16.4	26.7	15.5	16.2	17.2	17.0	16.4	21.2	22.9	18.4	14.5	15.2	9.9	16.0	16.7	18.1	20.1	22.8	18.2	14.7	38.7	19.5	11.5	20.3	33.3	16.5	21.6	27.2	15.5	17.6	7.3	13.6	6.3	12.7	6.5	8.6	5.2	12.0	11.8	15.9	13.2	22.7	17.2	13.7	25.2	16.3	14.5	14.1	15.4	16.2	53.4	15.9	21.5	10.2	23.3	34.5	21.1	16.5	13.3	20.3	15.9	16.5	24.7	30.6	18.1	23.2	20.8	17.7	17.5	19.4	23.1	18.0	23.4	25.1	28.3	17.2	11.1	17.3	12.2	21.9	21.8	26.1	19.6	13.4	18.3	10.7	24.5	15.6	13.5	12.4	21.5	14.8	25.1	14.0	16.1	26.4	19.4	38.8	18.0	15.1	12.9	6.3	11.1	5.5	7.0	12.7	7.3	7.3	5.8	7.8	13.5	6.8	8.6	7.2	0.9	6.5	10.8	13.6	7.0	5.2	17.6	17.9	20.1	20.3	17.0	12.1	15.5	16.2	18.4	20.3
UTP6	"C17orf40, HCA66"	ENSG00000108651	"UTP6, small subunit processome component"	Q9NYH9	17	31860899-31901765	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025936, HPA055806"	Supported		Enhanced	Nucleoli				Nucleoli		"HPA025936: AB_1845588, HPA055806: "	"unprognostic (1.55e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.61e-3)"	"unprognostic (2.54e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavourable (1.86e-5)"	"unprognostic (5.68e-2)"	"unprognostic (9.78e-3)"	"unprognostic (5.50e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavourable (1.16e-6)"	"unprognostic (1.63e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.96e-2)"	"unprognostic (4.76e-2)"	19.3	17.9	18.7	16.9	19.3	19.0	26.4	28.7	19.3	17.7	19.5	18.0	12.5	10.8	23.4	30.4	15.7	13.3	10.7	13.0	19.5	17.0	16.7	20.7	15.4	23.3	16.2	16.1	19.5	17.0	14.1	26.0	21.4	16.2	19.9	15.9	15.0	15.9	15.0	17.0	25.3	15.2	17.0	18.8	23.1	16.4	18.5	19.1	23.2	17.1	18.5	28.1	16.0	15.5	15.4	19.7	13.1	10.9	5.7	8.0	7.0	8.3	5.5	7.7	4.4	8.0	5.3	9.4	7.2	4.1	11.0	8.5	19.6	4.4	12.6	9.1	6.6	11.0	10.9	9.0	10.2	3.2	16.4	7.8	12.3	17.8	8.8	12.0	8.1	8.1	9.0	10.8	7.9	7.0	13.8	7.2	8.7	6.8	11.2	32.0	10.2	8.6	11.7	11.0	12.3	11.3	7.7	5.1	7.7	7.6	5.4	12.1	13.3	22.5	7.3	16.6	12.5	8.7	14.5	8.1	14.5	18.3	11.4	8.4	8.9	10.6	10.8	6.7	7.6	10.9	7.3	12.7	8.0	8.0	13.6	15.4	7.1	8.0	13.1	5.7	9.7	19.7	7.7	7.0	18.7	19.3	28.7	19.3	19.5	17.0	16.2	16.1	16.2	19.1
UTY	"KDM6AL, KDM6C"	ENSG00000183878	"Ubiquitously transcribed tetratricopeptide repeat containing, Y-linked"	O14607	Y	13248379-13480673	"Predicted intracellular proteins"		"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 37.7"	"Cell line enhanced"	"Detected in many"		"HEL: 14.7;U-266/84: 11.3;U-698: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA000568, HPA001165"	Supported		Approved	Nucleoplasm,Nucleoli	"Intracellular and membrane"			Nucleoplasm	Nucleoli	"HPA000568: AB_1858705, HPA001165: AB_1080541"			"unprognostic (7.52e-2)"		"unprognostic (6.60e-2)"	"unprognostic (4.04e-6)"	"unprognostic (6.47e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.00e-2)"		"unprognostic (9.17e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.46e-2)"	5.3	5.1	3.0	15.4	10.3	9.0	5.1	6.1	11.0	0.4	8.4	18.0	18.4	4.3	0.4	16.5	7.2	0.4	6.5	4.7	3.5	3.4	5.0	6.9	11.9	19.0	3.3	0.0	0.5	15.1	0.4	6.3	5.9	13.0	14.0	10.6	16.8	10.9	16.1	9.3	7.4	10.1	18.6	4.8	17.4	5.7	6.7	0.0	37.7	6.3	10.3	22.0	7.2	0.0	6.1	4.8	6.6	3.8	9.9	6.7	1.3	0.0	1.8	0.0	0.0	0.0	0.0	6.5	3.3	5.6	3.7	5.6	0.0	0.0	8.9	0.0	3.7	0.0	0.0	0.0	5.2	4.9	0.0	14.7	0.1	0.0	4.9	0.0	0.0	5.9	5.9	0.0	0.0	0.0	0.0	0.0	4.1	0.0	5.0	0.1	0.0	0.0	0.0	2.3	3.9	4.0	6.0	3.7	0.0	0.0	0.0	10.5	0.0	3.2	4.3	6.5	0.0	0.0	2.3	10.0	11.3	14.7	0.6	0.0	0.0	1.8	2.8	5.8	4.7	3.4	6.7	5.0	4.6	3.6	3.0	6.1	6.5	4.7	6.6	9.9	3.8	4.8	5.3	1.3	3.0	10.3	6.1	11.0	3.5	3.4	3.3	0.0	13.0	0.0
VASN	SLITL2	ENSG00000168140	Vasorin	Q6EMK4	16	4371848-4383528	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	12	"U-2197: 123.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011246, HPA016992"	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria	"Secreted - unknown location"		2400000000	Mitochondria	"Nucleoplasm, Nucleoli"	"HPA011246: AB_1858720, HPA016992: "	"unprognostic (2.20e-1)"	"unprognostic (2.75e-1)"	"unprognostic (9.22e-2)"	"prognostic unfavourable (6.24e-5)"	"unprognostic (2.35e-3)"	"unprognostic (8.91e-3)"	"unprognostic (3.15e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.82e-3)"	"unprognostic (4.23e-2)"	"unprognostic (4.95e-3)"	"unprognostic (5.27e-2)"	22.4	10.2	4.9	7.7	6.7	3.8	28.6	1.6	6.5	19.9	5.1	5.6	6.4	5.1	14.3	13.6	16.2	9.9	10.2	12.9	4.4	1.8	21.6	14.1	17.2	5.2	2.7	2.9	21.0	9.8	1.7	5.9	30.2	4.8	12.9	2.0	33.6	7.9	13.1	7.0	16.0	4.0	9.4	3.6	7.9	6.5	14.7	3.5	0.0	15.2	5.5	8.2	16.6	19.0	0.3	0.2	0.4	0.0	0.0	0.2	0.0	0.3	0.5	0.0	0.0	2.7	3.1	1.1	5.2	5.1	1.6	2.6	0.3	0.5	0.0	1.9	3.4	0.0	0.0	0.1	0.2	1.1	0.1	0.1	1.4	1.6	9.9	0.0	0.0	3.2	0.0	3.9	0.1	0.0	0.2	0.0	0.2	1.8	0.0	0.4	0.3	0.4	0.0	0.0	0.0	0.4	0.0	0.1	0.9	2.4	4.1	0.0	0.9	0.2	0.0	4.8	1.2	123.8	0.6	0.0	0.0	0.0	1.4	0.0	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.9	6.7	1.6	6.5	4.4	1.8	2.7	2.9	4.8	3.5
VAX1		ENSG00000148704	"Ventral anterior homeobox 1"	Q5SQQ9	10	117128521-117138301	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	10	"brain: 21.8"	"Group enriched"	"Detected in some"	7	"A-431: 7.5;WM-115: 5.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 21.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"basal ganglia: 5.8;hypothalamus: 3.8;olfactory region: 1.8"	"Low region specificity"	"Detected in many"			HPA028946	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA028946: AB_10602679"		"unprognostic (1.08e-2)"		"unprognostic (1.92e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.96e-2)"		"unprognostic (5.77e-3)"	"unprognostic (2.19e-1)"			"unprognostic (1.17e-1)"		"unprognostic (5.72e-2)"	"unprognostic (2.09e-1)"		"unprognostic (2.99e-1)"	0.4	0.4	1.4	0.4	21.8	0.4	0.4	0.0	7.0	0.5	0.5	9.5	0.0	0.4	0.4	0.4	0.5	0.4	0.5	0.4	1.5	5.2	0.4	0.4	0.4	0.4	0.7	4.3	0.4	0.4	0.7	0.5	0.4	1.2	0.4	0.5	0.0	0.4	0.5	0.7	0.4	0.5	0.4	1.3	0.4	0.4	2.1	2.9	0.0	0.4	0.0	0.4	0.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.5	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	21.8	0.0	7.0	1.5	5.2	0.7	4.3	1.2	2.9
VEPH1	"FLJ12604, KIAA1692"	ENSG00000197415	"Ventricular zone expressed PH domain containing 1"	Q14D04	3	157259742-157533619	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 38.1;pituitary gland: 70.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.3;HUVEC TERT2: 64.8;TIME: 38.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"cerebellum: 2.2;pons and medulla: 5.5"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA026645	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli, Cytosol"		"HPA026645: AB_1858741"	"unprognostic (4.35e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.58e-1)"	"unprognostic (5.17e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.87e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.75e-3)"	"unprognostic (3.57e-3)"	"unprognostic (1.99e-2)"	"prognostic favourable (7.75e-9)"	"unprognostic (2.03e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.15e-4)"	"unprognostic (7.49e-2)"	0.5	16.0	0.3	0.2	0.3	1.1	1.4	2.2	3.5	1.9	0.4	0.7	2.0	0.2	0.4	12.1	0.2	3.4	1.1	0.4	0.8	0.5	20.7	0.6	38.1	0.1	0.7	0.1	1.1	8.6	0.7	70.3	1.6	5.5	1.2	0.3	17.7	6.9	4.9	0.2	0.7	0.2	0.1	0.3	2.3	0.6	1.7	0.2	0.1	1.1	0.5	0.6	0.5	0.8	0.0	0.0	1.5	0.7	0.0	0.0	5.1	1.8	0.2	4.2	0.0	2.5	9.3	0.0	11.0	24.3	3.2	4.8	0.3	1.7	0.0	4.3	11.8	0.0	0.1	0.2	18.2	0.0	0.0	1.8	0.2	0.0	0.8	0.0	0.0	2.7	0.1	13.9	2.8	64.8	0.6	0.0	8.8	0.2	0.0	0.0	1.7	1.6	0.0	0.3	0.0	1.6	0.9	0.1	0.0	0.3	0.5	4.3	18.8	0.0	38.5	13.0	0.4	4.5	15.0	0.0	0.0	0.0	10.4	0.0	3.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.1	0.3	0.3	2.2	0.4	0.8	0.5	0.7	0.1	5.5	0.2
VGLL3	VGL-3	ENSG00000206538	"Vestigial like family member 3"	A8MV65	3	86876388-86991119	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"placenta: 195.7"	"Cell line enriched"	"Detected in many"	4	"U-2197: 103.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 7.9"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054983	Approved		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA054983: "	"unprognostic (9.08e-2)"	"unprognostic (4.47e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.73e-8)"	"unprognostic (3.85e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.42e-3)"	"unprognostic (1.05e-1)"	22.5	1.0	0.5	3.4	0.5	0.2	8.6	0.2	0.3	6.3	6.2	0.4	3.3	0.6	8.2	7.8	6.1	5.2	6.8	4.3	1.0	0.7	1.8	0.6	16.1	3.6	0.6	0.3	10.6	2.7	0.7	0.4	195.7	0.8	8.0	1.6	2.8	1.9	3.1	7.5	4.0	2.1	11.9	0.8	2.4	2.9	8.0	0.3	0.1	3.4	1.9	1.0	12.2	9.2	1.1	0.6	2.3	0.5	0.8	0.7	0.1	1.5	2.5	13.9	0.0	18.6	23.2	0.2	9.6	6.7	8.2	10.3	2.9	0.6	0.0	0.0	15.0	1.3	0.9	0.9	11.3	5.4	0.0	0.7	0.9	0.0	8.5	0.1	0.0	17.7	1.5	12.0	5.4	1.2	0.0	0.0	10.2	0.0	0.1	0.0	0.2	0.0	0.0	18.4	0.0	0.0	1.6	0.0	0.0	4.1	0.1	0.0	0.0	0.0	0.5	18.3	2.7	103.9	0.3	0.0	0.0	0.0	3.4	0.0	0.7	2.3	0.5	0.7	0.4	0.3	0.4	0.5	0.5	0.3	0.2	1.1	0.6	0.7	2.0	0.8	0.4	0.6	0.5	0.1	0.5	0.5	0.2	0.3	1.0	0.7	0.6	0.3	0.8	0.3
VMP1	"EPG3, TANGO5, TMEM49"	ENSG00000062716	"Vacuole membrane protein 1"	Q96GC9	17	59707192-59842255	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Autophagy, Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"blood: 193.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 193.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 193.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030773, HPA064780"	Approved		Approved	"Nucleoli,Endoplasmic reticulum"				"Endoplasmic reticulum"	Nucleoli	"HPA030773: AB_10602248, HPA064780: "	"unprognostic (2.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.09e-2)"	"prognostic unfavourable (1.56e-5)"	"unprognostic (3.14e-2)"	"unprognostic (3.17e-1)"	"prognostic unfavourable (8.02e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.98e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.21e-2)"	"prognostic unfavourable (2.77e-8)"	"unprognostic (1.88e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.96e-3)"	22.0	37.8	20.4	21.9	24.9	13.0	18.6	20.0	28.7	18.2	32.0	27.8	16.7	40.5	18.3	15.4	22.9	14.4	25.2	19.6	21.7	22.3	22.9	43.0	22.4	20.1	23.1	15.6	16.5	22.9	19.0	20.1	27.9	29.8	17.3	29.3	20.0	17.8	13.9	19.8	19.2	39.7	14.3	26.4	36.6	19.0	17.6	16.2	14.4	18.1	12.5	16.8	19.5	17.6	3.3	10.9	193.2	39.9	3.8	4.1	24.7	20.4	41.2	13.4	20.7	28.7	17.7	21.6	32.6	23.3	20.4	27.4	27.0	29.5	11.8	48.8	22.0	25.5	15.5	18.7	25.4	30.2	19.5	15.1	23.6	28.4	28.0	17.1	18.6	27.0	16.0	26.2	22.3	21.6	19.8	20.9	21.0	56.4	15.9	9.0	15.1	21.3	8.8	23.5	24.3	25.2	23.9	9.6	21.9	18.6	15.8	21.6	32.8	14.7	30.4	27.4	26.2	21.7	26.9	32.4	37.2	16.4	30.2	10.5	27.6	7.0	35.1	4.4	3.8	24.4	4.0	3.3	3.7	4.0	10.9	2.8	3.5	3.8	193.2	3.8	39.9	3.6	4.1	24.7	20.4	24.9	20.0	28.7	21.7	22.3	23.1	15.6	29.8	16.2
VPS51	"ANG2, ANG3, C11orf2, C11orf3, FFR"	ENSG00000149823	"VPS51, GARP complex subunit"	Q9UID3	11	65089324-65111860	"Predicted intracellular proteins"	"Lipid transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA039650, HPA061447"	Uncertain		Approved	"Nucleoli,Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	Nucleoli	"HPA039650: AB_10673147, HPA061447: "	"unprognostic (2.36e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.64e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.56e-1)"	"prognostic favourable (2.41e-9)"	"unprognostic (7.77e-3)"	"unprognostic (4.63e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.18e-1)"	22.1	19.5	17.5	19.4	24.3	30.3	21.7	29.8	33.8	23.4	30.9	16.9	22.4	31.2	27.7	15.5	22.9	20.9	25.0	27.7	15.9	13.0	18.5	24.7	16.6	35.0	14.5	19.2	53.2	77.6	22.9	14.5	21.7	15.9	22.0	15.7	17.2	54.2	18.4	39.4	32.0	27.7	24.4	13.2	20.5	30.3	17.5	12.6	36.5	34.7	24.4	21.9	24.6	22.4	15.6	14.8	9.9	10.5	21.8	19.8	10.5	21.7	24.0	11.8	14.4	5.3	13.1	22.0	8.6	17.6	17.5	13.0	17.4	28.8	38.0	24.7	16.6	18.7	12.4	19.3	6.4	22.1	18.8	22.6	24.4	16.7	17.3	24.4	20.7	22.6	13.2	13.0	10.8	19.2	23.0	27.3	7.1	29.6	32.7	24.4	19.1	18.4	20.4	5.7	45.8	11.9	24.4	19.7	27.1	6.4	36.6	21.3	29.8	12.2	15.5	11.9	10.4	14.7	12.3	34.9	27.0	21.3	13.2	8.9	8.4	7.0	10.0	9.9	13.3	10.5	15.5	15.3	18.5	19.8	14.8	15.6	16.9	14.7	6.3	21.8	10.3	13.4	11.9	10.5	17.5	24.3	29.8	33.8	15.9	13.0	14.5	19.2	15.9	12.6
VSIG4	Z39IG	ENSG00000155659	"V-set and immunoglobulin domain containing 4"	Q9Y279	X	66021738-66040125	"Plasma proteins, Predicted membrane proteins"	"Complement alternate pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.2;HMC-1: 1.1;NB-4: 3.1;SH-SY5Y: 1.0;U-937: 2.7"	"Cancer enhanced"	"Detected in all"		"glioma: 88.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	26	"classical monocyte: 13.9;intermediate monocyte: 8.1;myeloid DC: 13.1"	"Group enriched"	"Detected in many"	30	"dendritic cells: 13.1;monocytes: 13.9"					"Low region specificity"	"Detected in many"			"HPA003903, CAB026000"	Enhanced		Uncertain	"Nucleoli,Plasma membrane,Cytosol"			41000000	"Plasma membrane, Cytosol"	Nucleoli	"CAB026000: , HPA003903: AB_1858776"	"unprognostic (6.87e-3)"	"unprognostic (4.79e-2)"	"prognostic unfavourable (1.34e-4)"	"unprognostic (3.19e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.77e-1)"	"prognostic unfavourable (1.95e-6)"	"unprognostic (3.70e-2)"	"unprognostic (5.45e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.47e-2)"	67.1	28.1	15.9	17.6	16.6	2.6	19.0	1.8	10.4	6.3	18.0	5.6	1.0	9.2	6.1	14.2	9.3	28.7	15.5	15.9	11.5	3.5	18.5	22.9	61.4	37.0	17.9	3.4	8.2	8.2	3.7	7.9	52.4	12.0	10.9	12.6	8.1	11.3	4.0	10.5	4.0	14.6	39.9	16.7	28.5	9.4	13.5	17.8	0.0	10.7	1.7	1.8	14.4	9.0	0.1	13.1	0.4	13.9	0.0	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.1	3.1	0.2	0.0	0.4	0.0	0.5	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.0	0.8	2.7	0.0	0.0	13.9	0.0	0.0	8.1	0.0	0.0	0.0	0.2	13.1	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.0	3.3	15.9	16.6	1.8	10.1	11.5	3.5	17.9	3.4	12.0	17.8
VWA5A	"BCSC-1, LOH11CR2A"	ENSG00000110002	"Von Willebrand factor A domain containing 5A"	O00534	11	124115362-124147721	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 27.7;HEL: 20.0;HHSteC: 15.5;HUVEC TERT2: 18.4;RPTEC TERT1: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 25.6"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA037813, HPA037814, HPA061500"	Uncertain		Enhanced	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA037813: AB_10672727, HPA037814: AB_10672287, HPA061500: "	"unprognostic (2.69e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.48e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.53e-2)"	"unprognostic (2.38e-2)"	"prognostic favourable (1.55e-5)"	"unprognostic (4.54e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.65e-1)"	14.8	20.2	13.8	7.5	13.4	1.6	16.0	2.3	9.3	15.5	23.9	7.5	10.0	16.7	16.6	17.0	12.6	9.9	19.9	6.5	14.1	24.6	16.0	4.3	19.4	6.8	12.5	6.6	9.6	15.3	5.5	34.2	25.9	15.2	22.5	28.4	10.3	31.2	13.2	3.0	17.9	24.0	13.6	15.0	6.0	17.8	6.3	7.6	3.9	13.7	7.1	9.8	14.9	11.8	4.5	4.8	25.6	5.3	4.3	7.5	3.6	0.0	0.2	3.6	0.2	3.8	3.5	1.3	0.5	0.2	0.3	0.1	0.2	27.7	0.0	3.4	0.5	0.1	0.7	6.3	0.0	9.4	0.0	20.0	5.0	0.6	15.5	0.2	9.4	10.5	0.7	0.6	2.1	18.4	1.0	3.4	1.1	0.0	0.4	0.3	5.6	0.7	0.0	12.3	0.1	20.2	0.2	3.1	0.3	0.5	0.2	1.0	2.5	0.9	0.4	0.1	2.6	0.1	0.0	1.2	1.1	0.0	11.5	0.4	0.2	25.6	4.8	0.5	2.9	3.3	0.7	4.5	3.2	1.7	4.8	2.3	4.1	2.6	0.3	4.3	5.3	2.6	7.5	3.6	13.8	13.4	2.3	9.3	14.1	24.6	12.5	6.6	15.2	7.6
WASHC2A	"bA56A21.1, bA98I6.1, FAM21A, FAM21B, FLJ10824"	ENSG00000099290	"WASH complex subunit 2A"	Q641Q2	10	50067888-50133506	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA047844, HPA060975, HPA061022"	Supported		Supported	Nucleoli,Vesicles,Cytosol				Vesicles	"Nucleoli, Cytosol"	"HPA047844: , HPA060975: , HPA061022: "	"unprognostic (2.46e-1)"	"unprognostic (1.11e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.75e-1)"	"unprognostic (6.51e-3)"	"prognostic unfavourable (6.75e-5)"	"unprognostic (4.60e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.40e-2)"	24.0	21.0	15.8	31.4	19.3	24.7	27.1	22.5	18.3	19.1	21.2	16.2	12.6	19.4	22.8	15.3	15.7	15.5	14.4	42.9	17.6	13.9	26.1	12.1	20.7	20.2	15.3	15.8	22.5	14.0	21.2	27.0	17.7	22.0	16.7	23.0	13.1	17.5	16.5	15.5	19.2	21.3	16.8	14.6	27.4	16.2	9.4	14.8	27.0	21.4	9.8	20.2	18.4	27.4	6.6	9.0	11.7	13.9	9.0	12.5	8.8	10.9	5.3	9.1	10.6	37.1	20.8	7.4	12.9	27.4	19.2	20.6	12.4	16.5	9.7	8.1	19.2	12.0	13.1	10.9	19.0	9.2	9.5	6.9	10.7	12.4	25.9	11.7	12.0	21.3	13.7	21.0	13.3	14.5	11.2	9.8	23.1	7.8	6.4	19.2	7.4	25.2	9.8	13.2	5.7	13.2	12.7	3.1	9.8	12.0	11.2	17.2	13.8	8.1	21.3	9.8	8.3	27.8	10.6	10.1	20.1	8.3	21.6	21.6	3.9	1.2	10.7	11.7	12.0	13.9	12.5	6.6	10.2	11.0	9.0	6.5	10.2	7.4	5.1	9.0	8.2	5.3	10.4	8.8	15.8	19.3	22.5	18.3	17.6	13.9	15.3	15.8	22.0	14.8
WASHC2C	"Em:AC012044.3, FAM21C, KIAA0592"	ENSG00000172661	"WASH complex subunit 2C"	Q9Y4E1	10	45727200-45792961	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA047844, HPA060975, HPA061022"	Supported		Supported	Nucleoli,Vesicles,Cytosol				Vesicles	"Nucleoli, Cytosol"	"HPA047844: , HPA060975: , HPA061022: "	"unprognostic (7.50e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.51e-2)"	"unprognostic (5.98e-3)"	"prognostic unfavourable (1.35e-5)"	"prognostic favourable (4.69e-4)"	"unprognostic (1.26e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.00e-2)"	17.2	15.8	10.0	33.6	15.7	30.1	27.2	24.9	17.1	16.7	15.8	10.7	15.9	12.2	18.3	17.0	12.3	13.2	13.6	23.2	14.2	10.2	20.6	12.8	17.3	14.8	16.0	8.4	20.2	10.1	22.7	16.5	13.4	16.2	13.4	18.5	13.0	15.3	24.0	17.1	14.8	17.0	15.8	14.0	15.5	12.5	10.1	15.3	19.4	14.9	13.2	14.6	19.3	14.8	10.7	11.4	17.2	20.3	12.2	13.4	11.6	11.1	12.0	9.8	11.1	25.5	22.6	5.9	13.1	21.6	15.5	14.9	7.3	10.9	9.2	8.9	19.3	10.1	10.9	6.0	15.6	8.5	9.1	9.5	14.9	5.6	27.1	9.5	11.8	21.3	14.6	16.8	12.6	15.9	15.1	7.3	19.0	5.8	6.3	16.4	7.1	1.8	7.9	14.4	4.7	11.5	17.5	4.8	10.8	15.2	7.7	18.4	10.4	9.6	26.7	8.1	8.7	21.3	8.7	10.3	15.9	9.1	11.4	22.9	4.3	12.5	16.9	11.0	13.0	18.2	12.5	10.7	10.8	13.4	11.4	9.6	10.8	9.7	17.2	12.2	20.3	8.4	10.1	11.6	10.0	15.7	24.9	17.1	14.2	10.2	16.0	8.4	16.2	15.3
WASL	"N-WASP, NWASP, WASPB"	ENSG00000106299	"Wiskott-Aldrich syndrome like"	O00401	7	123681935-123749067	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 44.3;U-2197: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005399, HPA005750"	Supported		Approved	Nucleoli,Cytosol				Cytosol	Nucleoli	"CAB005399: AB_2288632, HPA005750: AB_1854729"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (5.30e-5)"	"unprognostic (7.32e-2)"	"prognostic favourable (4.51e-8)"	"unprognostic (9.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (5.14e-1)"	17.9	19.3	25.6	11.6	29.5	3.8	20.7	21.0	39.3	23.7	31.2	17.0	8.9	27.4	21.0	14.6	22.5	14.8	21.7	15.4	35.2	22.5	33.3	34.5	15.3	5.5	18.8	23.0	27.8	21.9	36.7	16.9	25.4	28.6	19.9	28.8	18.0	16.9	19.5	21.6	14.4	30.2	18.2	16.6	12.1	22.0	17.3	15.0	10.0	26.7	12.0	9.7	23.7	21.1	4.6	4.5	4.9	6.2	6.2	4.3	1.5	10.7	7.9	8.8	7.5	13.8	14.4	11.4	7.5	12.5	5.5	7.2	6.5	13.6	1.1	6.0	11.3	8.1	16.2	8.2	8.6	1.8	6.4	0.9	6.6	7.0	15.1	1.4	0.9	11.5	15.5	8.2	14.0	9.5	4.8	2.1	13.2	6.5	1.8	1.9	16.4	7.3	1.1	7.1	2.4	11.7	44.3	10.8	15.9	10.3	31.1	20.1	6.0	1.4	10.8	14.9	4.2	42.0	7.3	2.4	0.8	2.4	12.9	1.2	11.9	4.9	4.1	1.8	4.3	4.1	3.6	4.6	2.8	2.6	3.5	3.2	3.6	3.8	1.8	6.2	6.2	4.5	1.4	1.5	25.6	29.5	21.0	39.3	35.2	22.5	18.8	23.0	28.6	15.0
WDCP	"C2orf44, FLJ21945"	ENSG00000163026	"WD repeat and coiled coil containing"	Q9H6R7	2	24029340-24049575	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041054	Approved		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA041054: AB_10796566"	"unprognostic (1.07e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavourable (6.53e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (5.14e-8)"	"unprognostic (7.69e-2)"	"unprognostic (9.01e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.76e-2)"	"unprognostic (3.00e-1)"	11.7	9.6	8.3	7.6	9.4	2.4	9.2	14.6	9.8	9.6	9.3	11.5	8.4	5.3	10.7	8.0	7.4	7.2	5.6	6.8	7.1	6.9	7.5	8.9	5.4	12.4	8.3	4.8	11.6	7.7	11.2	9.4	8.5	8.7	8.7	6.2	7.8	7.1	12.9	13.8	5.9	7.5	7.4	8.0	9.4	7.0	12.5	9.2	17.9	8.9	5.5	13.7	9.4	6.4	4.9	4.3	1.5	3.8	5.0	7.8	4.2	7.2	11.1	12.3	8.5	8.5	6.8	4.4	8.8	4.7	9.2	8.8	10.1	3.3	19.0	3.8	4.5	5.3	17.4	6.0	9.6	11.4	10.0	11.5	5.5	10.5	5.8	10.5	8.0	4.0	4.7	9.4	4.7	8.7	16.0	5.3	9.6	3.3	13.7	6.3	14.8	8.7	15.1	20.8	7.6	4.3	3.6	9.5	13.1	4.3	4.2	5.4	3.3	4.7	8.2	7.4	8.2	4.4	8.0	8.7	10.9	26.8	4.8	11.3	5.7	0.0	2.4	1.5	7.5	3.8	7.8	4.9	5.0	5.5	4.3	4.7	6.8	7.5	0.7	5.0	2.6	1.6	7.1	4.2	8.3	9.4	14.6	9.8	7.1	6.9	8.3	4.8	8.7	9.2
WDFY3	"ALFY, KIAA0993, ZFYVE25"	ENSG00000163625	"WD repeat and FYVE domain containing 3"	Q8IZQ1	4	84669610-84966391	"Disease related genes, Predicted intracellular proteins"	Autophagy	"Developmental protein"	"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 31.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.3"	"Group enriched"	"Detected in many"	23	"dendritic cells: 1.1;granulocytes: 4.3;monocytes: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042734, HPA048572"	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"				Cytosol	"Nucleoli, Plasma membrane"	"HPA042734: , HPA048572: "	"unprognostic (7.14e-2)"	"unprognostic (6.02e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.33e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.12e-2)"	"prognostic favourable (3.64e-5)"	"prognostic unfavourable (9.35e-4)"	"unprognostic (2.79e-1)"	"unprognostic (4.41e-2)"	"unprognostic (4.95e-2)"	10.1	15.2	17.2	7.5	18.7	13.1	9.0	17.9	18.6	9.6	8.3	17.6	4.8	3.6	11.5	6.9	9.4	9.3	9.0	7.3	17.3	6.5	21.3	5.8	7.9	2.4	22.8	9.5	14.7	9.0	24.0	14.6	11.8	17.0	9.2	5.9	8.6	9.8	8.1	13.7	10.9	5.6	8.7	14.8	7.5	7.8	8.0	21.4	0.4	12.1	3.2	2.6	14.2	6.6	0.0	1.1	4.3	1.5	0.0	0.0	0.3	6.3	4.4	8.0	4.4	14.2	11.1	5.0	6.1	6.5	6.4	5.8	4.9	5.3	0.0	6.4	10.2	3.2	8.5	6.7	8.2	4.4	2.7	4.0	4.8	2.9	5.3	3.1	7.6	8.1	6.1	8.4	8.5	20.4	4.1	19.6	11.8	4.6	3.0	0.7	4.1	2.2	4.5	6.4	0.9	11.1	8.5	9.4	4.4	7.6	8.4	4.2	4.3	7.8	31.0	8.5	8.5	4.7	7.7	0.0	0.0	0.0	5.8	2.7	9.3	0.0	1.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	4.3	0.0	0.5	0.0	0.0	0.3	17.2	18.7	17.9	18.6	17.3	6.5	22.8	9.5	17.0	21.4
WDR12	"FLJ10881, YTM1"	ENSG00000138442	"WD repeat domain 12"	Q9GZL7	2	202874782-203014798	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036389	Uncertain		Approved	"Nucleoli,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoli	"HPA036389: AB_10670716"	"unprognostic (1.08e-2)"	"unprognostic (3.59e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.59e-3)"	"unprognostic (1.24e-2)"	"unprognostic (9.40e-3)"	"prognostic unfavourable (2.57e-6)"	"unprognostic (1.52e-1)"	"unprognostic (6.14e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.69e-3)"	"unprognostic (4.48e-2)"	5.8	9.7	7.2	5.5	16.1	6.7	7.6	11.5	15.2	5.9	6.2	6.5	3.7	8.9	7.1	7.0	8.0	6.7	5.0	8.4	6.8	8.6	11.1	8.7	4.2	6.4	7.4	8.9	7.3	5.7	6.7	8.0	6.6	12.6	4.9	8.7	6.7	5.4	5.2	11.0	7.7	6.0	7.4	6.2	5.3	5.6	17.1	8.2	9.6	7.1	5.1	7.5	5.8	5.6	5.4	6.9	3.6	5.0	3.6	5.9	3.0	4.3	4.6	5.3	10.0	10.0	8.6	9.7	6.6	5.3	8.2	8.0	11.6	6.1	7.9	6.1	5.3	5.5	14.3	10.6	13.2	4.0	8.9	13.4	7.4	13.7	6.5	17.4	8.2	7.8	7.7	9.7	19.4	8.5	20.9	5.2	9.0	5.0	11.9	10.2	12.1	11.7	8.7	8.3	12.4	9.0	5.2	9.3	8.2	5.2	6.8	8.1	4.0	11.5	6.8	7.4	6.0	6.1	7.3	6.8	10.3	13.3	7.3	11.9	7.3	3.6	4.7	2.0	4.2	5.0	5.9	5.3	4.0	4.3	6.0	5.4	5.2	5.0	2.1	3.6	4.5	6.9	4.3	3.0	7.2	16.1	11.5	15.2	6.8	8.6	7.4	8.9	12.6	8.2
WDR3	"DIP2, FLJ12796, UTP12"	ENSG00000065183	"WD repeat domain 3"	Q9UNX4	1	117929720-117966542	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027509, HPA054354, HPA072915"			Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA027509: AB_10601808, HPA054354: , HPA072915: "	"unprognostic (6.77e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.91e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavourable (7.33e-5)"	"unprognostic (1.29e-1)"	"unprognostic (9.52e-2)"	"unprognostic (6.04e-2)"	"prognostic unfavourable (8.82e-4)"	"unprognostic (8.90e-3)"	"unprognostic (7.47e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.65e-2)"	12.5	13.5	7.7	10.6	10.7	3.3	12.2	8.4	9.7	10.5	7.7	6.8	9.7	7.3	12.6	6.5	13.3	10.5	4.6	8.7	7.1	6.4	8.5	14.8	7.3	15.5	6.9	6.2	12.1	21.4	16.3	14.8	8.4	8.3	8.4	10.8	6.6	9.8	8.1	25.4	10.5	6.8	11.7	6.2	8.5	9.3	14.9	6.9	15.2	11.1	9.5	15.2	10.2	9.1	8.7	11.9	0.5	6.6	7.9	12.4	6.3	15.0	9.6	9.6	14.5	10.4	8.6	11.1	10.5	6.9	12.3	10.8	10.0	5.0	17.8	14.5	7.8	10.1	23.7	12.1	19.6	14.6	12.3	16.7	10.2	8.1	8.6	31.3	8.9	8.4	8.7	15.5	23.6	11.7	20.3	8.8	10.7	8.7	14.9	7.2	34.4	15.3	14.2	33.2	13.5	6.1	10.0	14.8	13.5	12.0	14.9	17.0	5.9	13.1	10.3	9.2	14.7	16.8	23.5	12.9	15.1	27.9	13.5	20.2	23.8	0.1	6.0	0.5	8.8	6.1	11.4	8.7	8.0	10.3	11.9	7.9	12.4	11.3	0.5	7.9	6.6	6.6	10.7	6.3	7.7	10.7	8.4	9.7	7.1	6.4	6.9	6.2	8.3	6.9
WDR36	"GLC1G, TA-WDRP, UTP21"	ENSG00000134987	"WD repeat domain 36"	Q8NI36	5	111091716-111130502	"Disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Sensory transduction, Vision"		"Disease mutation, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037796, HPA037797"	Supported		Supported	Nucleoli				Nucleoli		"HPA037796: , HPA037797: AB_10672725"	"unprognostic (2.14e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.64e-1)"	"unprognostic (9.79e-2)"	"unprognostic (7.10e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavourable (1.18e-4)"	"unprognostic (4.91e-2)"	30.6	12.3	8.2	15.4	12.2	17.5	15.2	14.5	14.6	15.9	12.2	9.3	10.2	9.6	19.0	11.8	18.4	13.9	11.5	11.7	8.2	9.7	14.8	24.6	12.4	18.7	8.8	11.1	20.6	15.0	14.8	19.1	15.3	13.5	15.0	12.8	9.3	13.6	11.0	17.0	15.2	13.7	14.5	8.9	21.7	12.2	11.3	9.4	24.3	16.7	12.9	18.4	13.8	14.7	6.7	9.9	2.5	10.1	6.0	9.4	6.4	10.0	11.3	8.0	20.8	12.6	17.6	13.3	8.4	8.7	12.7	18.8	13.1	12.0	30.2	11.0	6.8	11.1	16.4	19.8	22.3	10.8	9.1	16.6	11.2	10.1	13.2	15.1	30.5	10.0	10.9	22.3	22.3	14.8	19.8	15.4	13.6	8.4	19.8	11.5	10.3	10.0	16.3	18.5	23.4	8.8	13.2	14.2	10.7	11.3	8.2	12.4	9.4	10.2	10.3	16.6	10.9	12.2	17.5	12.5	11.7	32.6	12.8	20.2	13.3	0.2	6.4	2.5	7.8	8.6	9.2	6.7	6.7	8.7	9.9	5.9	9.4	7.8	0.4	6.0	10.1	4.3	9.0	6.4	8.2	12.2	14.5	14.6	8.2	9.7	8.8	11.1	13.5	9.4
WDR55	"FLJ20195, FLJ21702"	ENSG00000120314	"WD repeat domain 55"	Q9H6Y2	5	140664676-140674124	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043470, HPA048143, HPA075133"	Uncertain		Enhanced	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA043470: AB_2678495, HPA048143: , HPA075133: "	"prognostic unfavourable (1.51e-4)"	"unprognostic (1.35e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavourable (8.88e-6)"	"unprognostic (9.96e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.51e-2)"	17.9	12.4	7.6	17.8	8.8	18.1	12.9	13.0	12.7	9.5	16.6	11.4	16.9	14.9	12.0	11.0	18.8	10.9	20.2	9.6	7.7	9.1	15.3	29.9	12.7	15.0	12.6	8.5	12.0	16.2	11.4	13.2	13.9	10.6	12.8	17.5	8.9	16.7	14.8	18.2	15.8	20.8	11.1	8.9	18.8	14.9	8.0	8.5	12.5	12.0	14.0	21.4	13.5	11.0	10.4	11.3	10.4	18.9	11.3	14.3	10.2	7.8	10.8	5.3	21.0	8.2	6.6	14.7	7.8	9.6	8.4	9.6	18.5	10.8	7.4	10.5	10.2	9.8	7.1	13.7	6.5	6.8	5.8	8.4	8.8	7.5	7.9	8.8	15.9	7.8	8.0	11.5	6.1	8.9	5.8	5.8	9.2	11.2	8.1	7.9	5.5	9.5	6.9	7.6	6.9	9.9	11.9	5.2	6.9	10.7	31.5	11.9	22.3	9.4	7.9	11.0	5.7	12.5	10.6	9.7	7.5	5.8	14.2	11.7	6.4	6.9	11.7	8.6	13.9	18.9	14.3	10.4	12.9	11.8	11.3	8.8	10.5	10.7	10.4	11.3	15.4	8.4	14.1	10.2	7.6	8.8	13.0	12.7	7.7	9.1	12.6	8.5	10.6	8.5
WDR74	FLJ10439	ENSG00000133316	"WD repeat domain 74"	Q6RFH5	11	62832342-62841809	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 77.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA037795, HPA038419"	Uncertain		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA037795: AB_10671380, HPA038419: AB_2676006"	"unprognostic (5.52e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.97e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.46e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.29e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.35e-1)"	14.2	13.2	12.6	19.7	13.8	77.4	14.2	14.6	21.5	12.5	12.5	10.9	8.7	10.8	14.1	10.2	16.1	15.1	12.8	12.6	12.2	11.9	15.5	19.7	10.0	18.1	15.4	16.5	17.4	20.6	9.4	8.0	11.9	13.6	12.5	11.2	8.0	16.5	9.8	42.1	19.8	10.6	11.5	9.5	18.0	13.4	23.5	16.6	16.0	20.0	19.1	16.0	12.4	14.0	39.1	44.8	15.9	34.8	26.8	16.7	11.9	16.2	19.5	7.7	12.7	6.3	8.7	23.7	9.1	9.9	19.9	13.3	28.6	19.9	28.6	26.0	7.5	21.7	23.5	18.2	15.6	18.2	17.3	14.4	21.6	24.7	18.6	28.6	9.5	8.4	20.5	12.6	42.2	9.7	31.4	8.5	9.0	31.2	27.3	45.5	31.2	26.1	27.9	13.1	49.8	14.1	9.3	17.1	19.2	10.5	21.8	29.4	15.3	22.1	6.9	11.6	14.0	26.1	22.9	21.2	29.4	34.7	12.9	17.5	15.1	8.7	34.8	3.2	11.7	16.9	14.7	18.6	12.1	11.0	29.2	39.1	16.7	14.8	15.9	26.8	11.3	44.8	13.7	11.9	12.6	13.8	14.6	21.5	12.2	11.9	15.4	16.5	13.6	16.6
WDR82	"MST107, MSTP107, PRO2730, PRO34047, SWD2, TMEM113, WDR82A"	ENSG00000164091	"WD repeat domain 82"	Q6UXN9	3	52254421-52288020	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040427			Supported	Nucleoli				Nucleoli		"HPA040427: "	"unprognostic (7.43e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.92e-3)"	"unprognostic (9.32e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.26e-1)"	27.5	28.4	33.8	31.5	38.4	33.1	27.9	58.7	42.9	36.8	29.0	24.1	23.4	23.3	40.3	23.5	34.1	32.0	30.3	34.5	32.0	36.6	21.3	22.5	24.8	39.3	26.9	35.8	40.6	19.5	29.1	19.9	29.8	27.9	30.2	28.1	28.2	26.0	36.6	49.8	29.2	24.9	37.1	26.4	34.1	22.8	25.4	25.2	63.5	28.7	29.7	40.7	31.7	37.0	7.9	5.6	12.5	9.6	7.4	17.0	7.9	14.3	17.4	32.8	24.5	31.3	26.1	16.5	24.6	20.5	24.3	20.2	20.2	14.4	38.2	9.6	26.2	13.1	44.9	26.3	28.5	27.7	17.2	49.0	22.1	20.7	21.8	46.0	25.9	26.1	26.1	28.5	26.2	25.5	21.8	27.6	23.4	14.5	35.6	18.2	29.7	33.7	18.4	21.9	28.4	25.3	26.5	7.8	33.0	26.3	8.0	15.1	15.0	18.6	26.1	22.9	26.1	23.8	28.2	27.0	39.4	38.8	19.5	35.1	24.9	6.8	6.4	8.2	14.1	6.4	17.0	7.9	12.9	13.7	5.6	6.1	15.1	15.2	12.5	7.4	9.6	5.4	10.8	7.9	33.8	38.4	58.7	42.9	32.0	36.6	26.9	35.8	27.9	25.2
WDSUB1	"FLJ36175, UBOX6, WDSAM1"	ENSG00000196151	"WD repeat, sterile alpha motif and U-box domain containing 1"	Q8N9V3	2	159235793-159286799	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036840, HPA058172"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA036840: AB_10670926, HPA058172: "	"unprognostic (1.37e-2)"	"prognostic favourable (3.35e-4)"	"unprognostic (2.56e-1)"	"unprognostic (7.33e-3)"	"unprognostic (3.44e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavourable (2.67e-4)"	"unprognostic (2.76e-3)"	"unprognostic (4.90e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.46e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.87e-2)"	10.3	14.2	9.7	6.6	12.7	10.9	14.8	18.9	14.0	10.3	8.5	8.9	10.6	5.8	9.8	22.1	11.1	11.8	9.9	11.5	9.7	10.6	27.7	8.2	10.7	16.1	11.5	7.0	16.4	15.5	19.4	23.8	15.7	9.2	11.3	9.2	16.0	11.8	8.7	7.7	8.2	7.7	9.9	9.5	10.5	9.0	7.7	10.2	8.5	22.2	6.1	9.2	10.0	15.0	9.8	10.3	2.8	9.3	16.2	13.0	6.2	6.6	4.9	4.5	7.1	8.2	9.5	15.3	5.2	10.2	9.5	16.7	10.7	10.8	8.8	5.5	7.8	4.0	12.6	4.7	13.4	3.4	10.5	9.1	5.7	10.7	10.0	7.7	12.6	5.5	17.6	11.6	9.6	7.8	12.0	6.7	8.9	6.8	5.5	14.2	6.1	10.7	8.7	6.6	4.8	10.9	9.5	8.4	5.5	5.4	7.0	12.0	5.4	13.5	3.2	6.7	5.0	9.4	4.9	3.4	5.7	8.1	11.9	9.6	4.2	2.7	9.3	2.8	13.0	7.0	9.8	9.8	5.2	8.1	10.3	8.9	6.3	7.4	0.6	16.2	6.3	9.7	2.6	6.2	9.7	12.7	18.9	14.0	9.7	10.6	11.5	7.0	9.2	10.2
WEE1	WEE1A	ENSG00000166483	"WEE1 G2 checkpoint kinase"	P30291	11	9573681-9593457	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB004619, HPA068845"	Approved		Approved	Nucleoli				Nucleoli		"CAB004619: AB_628447, HPA068845: "	"unprognostic (6.04e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.09e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.21e-3)"	"unprognostic (3.73e-1)"	"prognostic unfavourable (5.19e-4)"	"unprognostic (1.07e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.80e-1)"	6.9	3.5	2.0	26.1	2.1	6.6	27.4	5.3	1.6	12.8	18.0	2.5	15.4	3.7	21.9	14.3	22.1	12.4	20.2	23.0	2.0	2.2	6.8	19.3	10.2	10.9	1.8	1.2	11.1	4.4	4.9	6.1	42.7	4.7	17.0	4.7	5.9	12.8	17.8	12.0	33.3	10.4	22.9	2.4	8.0	12.5	28.3	2.0	35.9	12.0	26.8	26.4	19.8	14.7	8.5	0.1	6.4	0.0	2.1	7.8	0.6	14.2	5.5	21.2	11.7	18.6	9.3	42.0	17.6	13.6	9.9	9.8	10.1	17.5	33.4	6.6	7.7	17.3	14.5	6.8	12.7	11.9	11.9	13.1	8.9	6.7	2.0	19.8	13.1	3.1	7.4	4.6	16.4	6.1	21.3	23.3	17.2	3.4	20.2	10.7	31.9	6.3	19.5	16.6	7.2	7.8	30.1	7.9	10.5	11.9	14.1	8.6	8.9	9.5	7.0	17.8	12.5	7.2	14.1	5.5	16.3	44.2	7.6	10.9	12.5	0.0	0.0	6.4	2.0	0.0	0.2	8.5	2.0	3.3	0.1	3.6	0.1	1.6	0.1	2.1	0.0	0.1	7.8	0.6	2.0	2.1	5.3	1.6	2.0	2.2	1.8	1.2	4.7	2.0
XDH	"XO, XOR"	ENSG00000158125	"Xanthine dehydrogenase"	P47989	2	31334321-31414715	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 78.6;liver: 32.5"	"Cell line enhanced"	"Detected in some"		"BJ: 6.1;HBEC3-KT: 15.0;hTERT-HME1: 23.9;U-251 MG: 6.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062641, HPA069323"	Supported		Uncertain	Nucleoplasm,Nucleoli	"Intracellular and membrane"			Nucleoplasm	Nucleoli	"HPA062641: , HPA069323: "	"unprognostic (8.58e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.08e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.38e-3)"	"unprognostic (7.48e-3)"	"unprognostic (3.55e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.24e-6)"	"unprognostic (2.25e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.54e-1)"	"prognostic favourable (8.73e-6)"	0.2	0.2	0.2	2.4	0.2	0.0	17.8	0.2	0.2	2.6	17.9	0.1	0.0	20.1	0.3	6.3	9.3	0.2	1.8	0.2	0.1	0.2	0.4	32.5	0.2	0.0	0.2	0.0	0.2	0.4	0.0	1.5	3.7	0.1	1.2	4.2	0.1	20.9	0.0	0.7	1.0	78.6	0.1	0.2	0.2	1.3	0.2	0.0	0.2	0.3	2.4	6.1	1.8	1.1	0.7	0.3	1.0	0.6	0.7	0.5	0.0	1.5	0.3	0.0	0.0	0.0	0.1	0.1	6.1	3.5	0.7	1.1	0.2	1.7	0.0	1.2	0.2	3.2	0.0	15.0	0.8	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.3	0.9	23.9	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.3	0.1	0.0	1.1	3.3	4.4	3.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.9	1.9	0.1	6.5	1.9	0.1	0.0	0.2	0.0	0.0	0.5	0.6	0.2	0.2	0.2	0.4	0.1	0.3	0.3	0.0	0.7	0.2	0.5	1.0	0.7	0.2	0.3	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.0	0.1	0.0
XPO6	"FLJ22519, KIAA0370, RANBP20"	ENSG00000169180	"Exportin 6"	Q96QU8	16	28097979-28211920	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	7	"neutrophil: 56.4"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 56.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038246	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"				"Nucleoplasm, Nucleoli"	"Plasma membrane, Cytosol"	"HPA038246: AB_10674550"	"unprognostic (1.17e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (3.68e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.01e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.36e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavourable (8.80e-4)"	18.4	14.1	24.3	32.0	25.0	47.9	17.7	16.0	30.6	12.4	17.7	30.4	9.9	13.4	13.5	12.0	16.8	14.1	14.9	9.6	27.5	23.9	13.3	19.1	20.6	54.6	25.6	16.9	15.3	13.2	22.0	18.0	25.9	21.7	14.1	17.0	16.3	19.4	13.1	8.3	18.8	18.3	16.3	23.8	50.4	14.8	28.9	19.8	37.1	18.0	7.8	31.8	17.2	13.2	5.2	2.6	56.4	4.4	2.7	6.5	2.0	28.4	20.4	18.0	19.3	12.5	19.9	20.7	35.2	31.9	41.3	41.8	28.6	20.4	20.2	30.4	32.0	18.6	42.7	27.0	50.2	45.5	26.5	22.1	28.8	31.8	29.6	30.8	24.9	15.6	20.1	36.6	36.3	23.7	40.2	10.2	27.9	31.9	37.0	36.8	30.5	19.5	34.8	21.4	33.5	15.3	14.5	35.2	19.1	17.4	29.1	15.4	20.9	20.4	25.1	34.9	23.4	29.7	29.3	23.9	30.2	30.0	26.6	32.2	29.4	4.7	2.7	8.4	4.1	3.0	4.4	5.2	4.7	4.4	2.0	3.9	5.2	6.5	56.4	2.7	4.4	2.6	3.8	2.0	24.3	25.0	16.0	30.6	27.5	23.9	25.6	16.9	21.7	19.8
XRN2		ENSG00000088930	"5'-3' exoribonuclease 2"	Q9H0D6	20	21303304-21389827	"Predicted intracellular proteins"	"mRNA processing, Transcription, Transcription regulation, Transcription termination"	"DNA-binding, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047118, HPA050485"	Supported		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA047118: , HPA050485: "	"unprognostic (9.38e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (3.54e-5)"	"unprognostic (7.26e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.31e-1)"	42.9	35.1	12.5	24.5	17.7	38.3	30.4	18.0	16.4	26.8	22.8	18.6	23.3	14.4	38.6	25.2	22.1	30.6	21.8	19.3	13.7	10.3	31.4	35.3	27.5	33.4	17.4	12.1	32.1	26.4	30.0	35.3	26.5	15.9	25.7	20.1	19.1	27.6	25.0	36.8	23.0	21.6	24.1	18.6	40.9	23.2	27.4	18.3	41.1	31.3	20.4	30.6	33.1	21.7	16.0	30.6	35.0	33.9	21.7	24.6	23.8	27.2	32.4	35.8	27.4	26.8	33.0	35.4	25.1	32.8	33.5	39.1	21.6	31.3	26.8	15.0	26.2	32.4	40.2	42.2	43.0	12.1	20.3	34.6	12.2	40.7	23.6	31.1	30.3	31.2	21.4	36.8	32.4	28.7	27.8	23.1	31.0	21.3	45.8	20.6	27.8	21.9	33.6	60.8	22.8	28.5	28.9	27.8	36.1	29.2	36.1	26.8	20.2	37.1	26.4	33.7	25.3	7.6	31.6	20.4	26.2	28.8	13.0	14.6	25.3	15.1	33.9	23.8	18.6	27.2	24.6	16.0	20.4	20.2	30.6	15.1	21.8	21.0	35.0	21.7	32.7	13.2	24.0	23.8	12.5	17.7	18.0	16.4	13.7	10.3	17.4	12.1	15.9	18.3
YAP1	YAP65	ENSG00000137693	"Yes associated protein 1"	P46937	11	102110461-102233423	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009370, HPA038885, CAB069915, HPA070359"	Enhanced		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"CAB009370: AB_2273277, CAB069915: AB_922796, HPA038885: , HPA070359: "	"unprognostic (9.56e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.66e-3)"	"unprognostic (3.73e-1)"	"prognostic unfavourable (2.03e-4)"	"unprognostic (9.26e-2)"	"unprognostic (4.80e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-2)"	27.1	15.8	11.6	12.1	10.0	0.0	34.9	7.0	9.5	37.5	21.3	7.0	40.1	9.8	51.7	33.3	36.9	25.5	34.6	18.8	12.5	6.0	17.3	32.1	26.2	7.6	9.3	6.1	41.1	8.9	18.9	6.4	34.0	15.0	34.8	11.4	21.7	22.2	35.2	27.8	23.4	15.1	58.2	17.2	7.6	18.2	15.6	9.7	2.6	34.0	25.7	12.6	42.3	41.1	0.1	0.0	0.0	0.0	0.0	0.3	0.2	11.6	10.9	30.5	14.9	33.3	31.8	25.5	27.5	31.5	26.8	22.1	27.2	28.4	0.0	22.7	35.9	20.7	15.1	39.2	28.5	3.4	5.3	0.0	14.9	18.5	25.5	0.0	0.5	25.4	25.8	29.4	48.0	8.3	0.0	0.0	30.3	5.6	0.5	0.0	14.4	10.4	0.0	17.2	0.0	19.8	20.9	0.1	1.0	32.4	12.2	9.2	22.1	0.1	9.1	38.2	15.0	19.1	11.5	0.0	0.0	0.1	11.1	0.0	27.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	11.6	10.0	7.0	9.5	12.5	6.0	9.3	6.1	15.0	9.7
YWHAB	YWHAA	ENSG00000166913	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta"	P31946	20	44885676-44908532	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003759, HPA007925, HPA011212, HPA061603"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol			210000000	Cytosol	"Nucleoplasm, Nucleoli"	"CAB003759: AB_289588, HPA007925: AB_1844340, HPA011212: AB_1844334, HPA061603: "	"prognostic unfavourable (9.18e-4)"	"unprognostic (1.48e-1)"	"unprognostic (9.06e-2)"	"prognostic unfavourable (5.46e-4)"	"unprognostic (3.80e-1)"	"prognostic unfavourable (6.14e-4)"	"prognostic unfavourable (1.91e-6)"	"prognostic unfavourable (6.01e-4)"	"unprognostic (8.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.35e-1)"	"prognostic favourable (2.52e-5)"	"unprognostic (6.72e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.60e-3)"	"unprognostic (8.59e-2)"	39.3	38.6	65.5	39.4	79.2	28.6	33.0	60.1	87.9	34.0	47.5	27.7	28.7	37.9	35.2	26.4	48.1	30.2	29.6	40.3	68.7	63.4	47.3	36.5	37.4	46.8	49.8	76.2	25.8	18.9	41.1	18.4	36.7	50.1	31.4	53.4	22.9	30.7	43.2	28.3	38.4	39.3	43.3	38.4	53.7	36.7	16.8	33.6	48.2	36.1	31.8	60.2	41.2	34.9	30.9	41.9	37.3	58.4	26.8	43.5	26.6	51.8	39.3	31.7	30.4	52.8	46.7	43.0	47.2	46.0	58.2	51.1	81.8	58.8	55.4	49.5	62.3	55.2	44.7	87.8	69.6	21.2	27.3	41.2	34.6	48.5	35.0	66.7	39.9	36.5	65.7	45.6	58.9	58.2	44.4	26.8	59.7	61.3	52.0	55.0	29.9	61.2	40.9	46.0	43.0	62.3	58.0	33.9	36.1	80.0	85.6	55.1	62.3	64.2	66.0	90.5	46.5	51.0	48.0	17.9	32.6	50.8	66.1	44.7	46.0	34.8	40.1	34.4	29.7	52.2	30.2	30.9	37.7	36.3	41.9	28.6	30.8	36.6	37.3	26.8	58.4	26.5	43.5	26.6	65.5	79.2	60.1	87.9	68.7	63.4	49.8	76.2	50.1	33.6
YWHAE	FLJ45465	ENSG00000108953	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon"	P62258	17	1344272-1400378	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008445, CAB016200, CAB021109, CAB047350, HPA061603"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol			160000000	Cytosol	"Nucleoplasm, Nucleoli"	"CAB016200: AB_626619, CAB021109: AB_10060396, CAB047350: , HPA008445: AB_1844336, HPA061603: "	"unprognostic (1.29e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.99e-2)"	"prognostic favourable (6.48e-6)"	"unprognostic (1.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.73e-2)"	"unprognostic (4.77e-3)"	"unprognostic (4.53e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.92e-3)"	"unprognostic (8.33e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.24e-2)"	"unprognostic (8.94e-2)"	55.2	54.3	107.5	35.3	87.1	32.7	37.3	71.5	118.4	28.4	40.2	60.9	23.8	40.2	35.9	54.1	43.1	44.2	23.4	57.7	92.3	81.9	64.5	50.9	32.8	25.4	94.1	77.9	40.2	40.2	41.0	37.9	45.1	73.7	35.0	42.5	27.9	42.4	27.7	135.9	36.8	36.2	32.2	101.1	26.2	38.5	46.0	53.6	30.9	47.5	36.5	37.2	31.6	32.1	19.2	41.5	17.2	36.2	15.0	23.3	31.5	77.8	58.2	70.5	59.3	31.2	36.1	67.8	50.4	29.7	45.0	34.9	104.0	32.0	52.9	59.2	41.7	54.1	59.7	50.9	63.8	36.5	111.3	36.9	48.6	44.5	37.3	35.3	37.8	32.7	37.6	45.0	69.0	54.1	42.3	38.2	57.8	37.9	46.7	28.2	64.6	37.8	56.8	33.3	37.5	45.8	45.1	39.3	59.7	60.6	24.9	39.4	47.2	32.7	51.1	43.7	37.1	55.1	88.9	24.0	44.3	44.4	52.4	42.3	63.1	17.2	31.8	8.6	12.4	36.2	15.6	19.2	18.7	13.9	41.5	16.1	17.0	14.3	10.8	15.0	30.9	28.8	23.3	31.5	107.5	87.1	71.5	90.2	92.3	81.9	94.1	77.9	73.7	53.6
YWHAG	PPP1R170	ENSG00000170027	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma"	P61981	7	76326794-76359031	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 117.8;skeletal muscle: 91.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB013274, CAB018389, HPA026918, HPA061603"	Approved	Approved	Supported	Nucleoplasm,Nucleoli,Cytosol			160000000	Cytosol	"Nucleoplasm, Nucleoli"	"CAB013274: , CAB018389: AB_2217962, HPA026918: AB_10610566, HPA061603: "	"unprognostic (3.71e-2)"	"prognostic unfavourable (4.53e-4)"	"unprognostic (3.88e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.40e-3)"	"unprognostic (8.98e-3)"	"prognostic unfavourable (5.34e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (7.44e-4)"	"unprognostic (3.03e-2)"	"prognostic unfavourable (4.01e-4)"	"unprognostic (9.31e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.70e-1)"	52.4	31.2	46.3	17.7	54.6	7.3	17.2	36.2	117.8	13.4	14.2	13.3	4.6	14.4	15.0	7.0	18.6	9.0	17.0	33.1	50.2	56.2	15.9	22.0	12.9	12.1	45.9	49.8	13.3	18.0	14.8	7.8	16.6	74.6	14.7	14.0	8.6	10.0	13.3	91.8	11.7	12.5	20.2	22.8	12.7	11.2	8.9	13.5	6.8	8.8	13.8	14.3	14.7	13.2	3.1	5.9	3.2	5.0	1.1	3.3	1.7	37.1	46.7	41.4	52.5	42.4	24.5	18.7	43.2	21.4	26.8	29.2	29.3	40.0	52.4	14.9	38.3	34.8	51.8	47.7	37.8	35.5	22.6	49.6	32.0	32.5	38.7	60.5	48.6	26.8	45.8	31.3	64.9	42.6	68.1	59.3	40.0	35.0	43.2	44.7	45.9	32.8	50.7	41.9	57.9	42.1	25.4	22.2	61.7	47.9	61.4	30.6	42.7	36.7	44.9	52.4	30.5	46.4	57.7	19.7	36.9	80.7	47.1	57.3	55.8	3.2	5.0	1.1	2.1	4.6	3.3	3.1	2.4	2.6	5.2	1.8	1.8	2.0	1.1	1.1	3.8	5.9	2.0	1.7	46.3	54.6	36.2	88.9	50.2	56.2	45.9	49.8	74.6	13.5
YWHAH	YWHA1	ENSG00000128245	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta"	Q04917	22	31944461-31957603	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"brain: 154.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025918, HPA061603"	Uncertain		Approved	Nucleoli,Cytosol			130000000	Cytosol	Nucleoli	"CAB025918: , HPA061603: "	"unprognostic (3.77e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (1.59e-5)"	"unprognostic (8.62e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.60e-2)"	"unprognostic (7.00e-2)"	"unprognostic (6.81e-2)"	21.5	18.6	87.9	20.6	47.4	16.3	19.3	41.9	154.3	13.7	24.4	10.0	4.3	17.2	13.1	14.1	14.0	16.4	18.6	15.2	78.8	59.1	11.7	11.5	25.0	13.5	35.5	101.6	10.0	16.7	5.2	10.4	22.4	49.5	12.3	20.1	6.8	9.9	15.6	13.9	9.9	17.4	25.9	19.4	12.8	26.9	3.7	9.1	6.3	10.5	5.5	15.1	18.5	10.6	8.1	16.6	14.9	14.4	17.7	12.8	9.6	67.9	27.2	30.4	17.7	18.5	17.1	19.3	66.1	32.7	38.1	43.6	28.8	23.7	40.1	16.1	60.6	32.9	36.4	36.3	36.0	35.5	31.7	23.7	21.4	25.7	18.7	76.3	26.5	15.5	19.4	32.1	22.9	31.1	32.7	29.4	29.0	27.4	23.1	35.1	36.2	29.8	33.2	41.9	21.3	24.0	29.4	65.4	21.5	37.6	26.3	23.5	15.0	18.9	49.7	38.5	38.5	28.2	41.9	16.4	25.3	50.2	27.9	30.8	33.8	7.8	14.4	14.9	5.7	11.8	8.1	8.1	7.0	8.1	16.6	7.6	2.8	3.6	8.7	17.7	12.2	4.5	12.8	9.6	87.9	47.4	41.9	126.3	78.8	59.1	35.5	101.6	49.5	9.1
YWHAQ	"14-3-3, HS1"	ENSG00000134308	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta"	P27348	2	9583972-9631014	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA007925, CAB010286, HPA061603"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol			120000000	Cytosol	"Nucleoplasm, Nucleoli"	"CAB010286: AB_2218221, HPA007925: AB_1844340, HPA061603: "	"unprognostic (2.65e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavourable (8.20e-4)"	"unprognostic (1.53e-1)"	"unprognostic (5.78e-3)"	"prognostic unfavourable (9.83e-6)"	"unprognostic (4.90e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.51e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.74e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.39e-3)"	40.5	47.3	77.8	32.1	60.8	48.0	50.8	88.5	82.5	52.2	44.0	82.5	25.0	37.9	60.5	48.2	57.6	45.3	40.0	68.5	73.7	76.2	45.9	37.2	35.0	38.2	74.3	54.8	55.9	64.4	39.2	39.0	39.3	69.8	54.2	44.1	31.2	38.9	48.8	17.6	33.3	36.5	57.9	72.2	29.8	36.9	44.3	63.5	58.8	45.4	56.7	43.3	47.7	46.3	31.5	30.9	24.8	28.9	51.4	58.4	60.9	42.7	64.5	58.5	56.5	46.1	63.8	55.0	58.8	57.9	61.8	51.9	48.5	37.7	55.4	30.7	84.2	40.3	64.9	64.1	79.8	136.3	52.8	51.8	42.1	51.8	35.3	49.8	31.4	43.1	37.7	67.4	44.0	69.3	50.8	33.5	75.9	29.8	88.2	50.9	99.3	74.4	64.6	75.9	67.8	68.0	38.3	55.7	94.4	53.5	55.5	42.5	34.5	25.7	63.1	77.7	55.1	67.2	89.6	34.2	46.8	73.1	66.4	52.1	64.4	17.1	22.2	24.8	47.8	28.9	58.4	31.5	45.1	50.8	30.9	28.8	24.7	39.9	6.8	51.4	27.2	15.7	43.1	60.9	77.8	60.8	88.5	69.0	73.7	76.2	74.3	54.8	69.8	63.5
YWHAZ	"14-3-3-zeta, KCIP-1, YWHAD"	ENSG00000164924	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta"	P63104	8	100916525-100953388	"Plasma proteins, Predicted intracellular proteins, Transporters"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB005065, HPA061603"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol			760000000	Cytosol	"Nucleoplasm, Nucleoli"	"CAB005065: AB_2218378, HPA061603: "	"unprognostic (4.70e-3)"	"unprognostic (7.38e-3)"	"unprognostic (8.09e-2)"	"prognostic unfavourable (3.91e-4)"	"unprognostic (1.83e-3)"	"unprognostic (2.00e-2)"	"prognostic unfavourable (2.28e-5)"	"prognostic unfavourable (3.93e-4)"	"unprognostic (1.65e-1)"	"unprognostic (3.72e-1)"	"prognostic unfavourable (1.20e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (2.03e-6)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-1)"	54.6	40.9	89.9	51.8	104.6	70.8	39.6	55.8	117.7	52.4	69.6	38.7	25.3	47.4	43.5	37.6	141.8	38.3	51.9	29.1	81.7	67.0	44.1	32.9	40.7	60.0	50.1	66.7	46.4	27.5	37.8	25.2	69.0	78.2	42.5	70.3	31.7	55.2	47.2	19.7	63.0	71.4	53.5	43.8	56.3	51.5	34.1	31.5	89.4	46.0	74.9	83.2	53.6	70.2	58.6	57.2	129.4	77.9	57.0	78.4	104.9	138.9	67.6	129.0	37.0	32.1	40.8	63.9	65.3	85.0	88.5	86.2	47.0	91.2	62.5	70.9	103.7	60.5	81.1	93.1	134.8	55.3	32.0	59.0	51.2	30.4	42.3	24.6	67.7	37.8	126.9	73.1	116.5	79.4	67.0	61.3	75.6	50.5	101.6	43.7	43.6	70.9	43.3	37.6	42.9	85.1	78.5	72.2	51.5	49.7	49.3	103.4	71.4	29.1	64.6	44.9	65.9	54.1	58.5	39.1	46.4	76.7	74.3	46.5	183.7	129.4	45.0	81.2	69.1	66.5	70.3	58.6	59.0	66.5	57.2	48.0	44.8	56.4	74.6	57.0	77.9	35.4	78.4	104.9	89.9	104.6	55.8	117.7	81.7	67.0	50.1	66.7	78.2	31.5
Z82206.1		ENSG00000225528			22	39960397-39964718	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	14	"blood: 8.1;bone marrow: 4.1;lymphoid tissue: 2.3"	"Cell line enhanced"	"Detected in some"		"HEL: 4.0;K-562: 15.9;MOLT-4: 2.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA047397			Approved	"Nucleoplasm,Nucleoli,Nuclear bodies"				Nucleoli	"Nucleoplasm, Nuclear bodies"	"HPA047397: "	"unprognostic (8.48e-4)"	"unprognostic (2.95e-6)"	"unprognostic (3.67e-1)"	"unprognostic (5.90e-2)"	"unprognostic (4.27e-1)"	"unprognostic (6.95e-3)"	"unprognostic (3.74e-1)"	"unprognostic (5.41e-4)"	"unprognostic (2.33e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.18e-3)"	"unprognostic (8.77e-2)"	"unprognostic (6.53e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.58e-3)"	0.0	0.0		0.5		4.1	0.1		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.2	0.0			0.0	0.0	0.3	2.3			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.3	0.0	0.0	0.1		1.0	0.1	0.0			0.0		1.1	0.3		3.6	3.0	5.7	2.2	2.2	8.1	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	4.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	1.8	4.4	5.2	2.2	4.5	3.6	6.5	5.7	2.7	3.2	6.7	8.1	4.3	2.2	1.9	3.0	4.2	7.6										
ZBED9	"Buster4, FLJ31087, KIAA1925, SCAND3, ZFP38-L, ZNF305P2, ZNF452"	ENSG00000232040	"Zinc finger BED-type containing 9"	Q6R2W3	6	28570535-28616212	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 13.2;testis: 17.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 7.7;hTCEpi: 7.0;K-562: 12.3;U-266/84: 5.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA007246	Uncertain		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"				Nucleoli	"Nucleoplasm, Golgi apparatus"	"HPA007246: AB_1080727"	"unprognostic (1.01e-1)"	"unprognostic (5.16e-5)"	"unprognostic (1.88e-1)"	"unprognostic (1.27e-4)"	"unprognostic (3.96e-2)"	"unprognostic (9.46e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.73e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.34e-3)"	"unprognostic (8.21e-3)"	"unprognostic (4.31e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.66e-3)"	"unprognostic (3.92e-2)"	"unprognostic (1.59e-1)"	0.8	1.8	2.6	0.4	7.2	0.4	2.3	9.5	4.7	2.3	1.1	0.3	9.3	0.7	1.6	7.5	1.0	3.1	0.7	1.2	2.4	2.3	2.3	3.2	1.9	0.5	1.3	2.9	4.1	3.4	3.2	6.9	3.0	3.5	3.4	1.5	0.8	2.4	13.2	0.5	0.7	0.8	1.1	0.8	0.6	1.0	17.6	0.7	0.0	4.1	0.0	0.6	1.4	1.2	0.5	0.7	1.1	0.7	0.4	1.4	0.2	1.8	1.8	1.8	0.0	0.0	0.0	2.2	0.4	0.0	0.4	1.1	0.0	1.2	0.0	7.7	0.1	1.0	0.0	2.1	0.4	0.0	5.1	0.4	1.2	1.8	1.2	0.0	0.0	1.1	7.0	0.1	3.5	0.0	12.3	0.0	0.1	1.3	0.0	0.1	1.8	0.9	0.6	0.8	0.1	2.0	2.1	2.0	4.8	0.0	1.9	0.0	0.0	0.6	0.0	0.0	2.2	0.0	1.2	0.0	5.9	0.0	0.0	0.0	0.0	0.6	0.3	0.3	0.3	0.4	0.1	0.2	0.4	0.4	0.2	0.5	1.4	1.0	1.1	0.4	0.7	0.7	0.1	0.2	2.6	7.2	9.5	4.7	2.4	2.3	1.3	2.9	3.5	0.7
ZBTB43	"FLJ22470, KIAA0414, ZBTB22B, ZNF-X, ZNF297B"	ENSG00000169155	"Zinc finger and BTB domain containing 43"	O43298	9	126805006-126838210	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 51.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016825	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA016825: AB_1858959"	"unprognostic (1.18e-1)"	"unprognostic (2.66e-1)"	"unprognostic (7.02e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.14e-1)"	"unprognostic (5.41e-3)"	"prognostic favourable (8.73e-4)"	"unprognostic (6.76e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.13e-2)"	6.6	6.2	7.8	4.9	12.1	51.7	6.6	10.6	13.6	5.8	5.6	9.5	3.0	5.6	6.6	5.2	10.3	5.3	5.9	9.5	7.9	5.7	5.1	9.0	9.3	6.0	8.6	7.1	7.1	5.9	9.6	9.3	8.2	8.1	5.1	6.6	7.5	7.4	4.4	34.7	14.6	6.7	6.0	8.5	5.7	7.4	15.7	9.3	5.3	6.2	7.1	10.1	5.5	7.0	6.1	5.2	10.6	6.3	9.0	10.7	4.3	4.5	3.5	6.4	5.9	5.4	7.8	6.7	6.4	6.0	4.8	4.3	8.5	3.2	6.3	3.1	6.1	13.3	5.6	6.0	6.0	6.0	3.7	4.4	10.4	3.6	7.3	6.1	8.4	9.5	15.2	7.8	19.5	3.7	7.5	14.8	7.1	4.9	5.3	3.9	5.8	6.0	4.6	20.7	5.2	5.3	5.3	5.7	5.3	6.6	6.2	5.7	5.8	3.9	3.5	5.8	5.6	6.5	5.2	15.9	11.3	2.5	7.2	5.2	4.7	10.6	6.3	5.3	10.7	6.3	10.2	6.1	5.8	6.2	5.2	5.1	6.4	7.3	3.5	9.0	4.8	2.8	8.2	4.3	7.8	12.1	10.6	13.6	7.9	5.7	8.6	7.1	8.1	9.3
ZC3H14	"FLJ11806, NY-REN-37, UKp68"	ENSG00000100722	"Zinc finger CCCH-type containing 14"	Q6PJT7	14	88562909-88627596	"Disease related genes, Predicted intracellular proteins"		RNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 73.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049798, HPA053510"	Enhanced		Enhanced	"Nucleoli,Nuclear speckles"				"Nuclear speckles"	Nucleoli	"HPA049798: AB_2680888, HPA053510: AB_2682174"	"unprognostic (5.80e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.47e-3)"	"unprognostic (9.57e-2)"	"unprognostic (7.21e-3)"	"unprognostic (2.77e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.50e-2)"	"prognostic favourable (7.08e-4)"	"unprognostic (2.09e-1)"	"unprognostic (8.23e-2)"	"unprognostic (3.71e-1)"	"unprognostic (4.25e-2)"	13.5	12.6	16.2	10.8	16.4	9.7	13.3	23.4	19.6	14.0	15.3	14.3	17.5	10.6	17.2	15.5	12.4	15.8	10.4	12.3	14.8	8.4	15.2	24.9	13.9	9.1	16.1	16.3	17.1	19.4	19.3	24.1	14.8	16.0	14.9	16.6	11.3	18.0	16.3	15.4	13.6	15.2	14.8	11.2	9.4	12.7	73.1	14.1	9.3	19.4	8.2	11.4	16.2	12.8	13.3	17.4	21.7	21.1	18.5	17.7	13.3	16.1	31.1	28.5	22.5	22.7	22.0	28.9	24.8	22.5	35.2	31.1	22.1	25.4	22.5	17.9	25.2	19.9	20.2	23.1	48.0	18.9	15.2	11.0	22.2	18.0	22.8	24.0	14.4	17.6	27.2	27.4	27.5	22.9	21.4	10.4	31.8	34.3	21.7	13.3	18.1	27.4	19.0	36.5	9.8	23.7	29.0	21.4	19.2	30.9	35.4	17.3	32.3	15.8	16.8	42.8	26.2	18.0	24.6	13.3	11.5	25.1	21.0	11.8	19.6	12.9	16.0	21.7	15.9	20.0	17.7	13.3	15.5	17.5	17.4	12.0	14.7	14.7	2.9	18.5	21.1	9.5	13.2	13.3	16.2	16.4	23.4	19.6	14.8	8.4	16.1	16.3	16.0	14.1
ZCCHC10	FLJ20094	ENSG00000155329	"Zinc finger CCHC-type containing 10"	Q8TBK6	5	132996985-133026604	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA038944	Approved		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA038944: AB_10673601"	"unprognostic (1.09e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.77e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.23e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.30e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.89e-3)"	18.6	17.3	14.5	18.2	14.1	30.6	16.4	18.1	20.6	17.4	24.1	10.5	15.4	18.3	18.7	15.4	26.9	14.9	14.2	17.3	13.7	12.4	19.6	23.5	21.0	26.0	11.9	15.2	17.3	17.7	9.8	27.4	23.0	15.3	16.1	22.1	10.0	17.9	16.8	31.5	14.0	21.7	14.0	17.5	23.6	17.8	20.3	14.1	25.6	13.9	22.4	26.5	17.8	17.3	48.1	27.2	16.5	28.0	22.9	27.7	18.8	11.7	12.3	16.3	13.5	8.2	7.4	21.4	12.4	9.7	15.9	18.5	31.0	14.7	32.8	19.1	8.3	15.0	19.9	15.9	17.3	19.3	26.4	19.0	15.1	23.0	12.1	16.3	22.3	6.7	18.3	9.7	15.8	15.7	20.5	18.2	12.0	15.4	25.4	18.9	17.7	12.9	22.9	19.3	14.3	14.6	17.0	12.8	10.8	19.9	8.1	22.9	18.0	21.2	16.0	13.7	16.2	8.9	17.9	15.4	24.4	46.1	11.1	29.2	16.1	16.5	28.0	16.4	19.7	25.3	20.6	39.7	24.1	23.5	27.2	48.1	21.2	21.8	14.6	22.9	25.3	24.0	27.7	18.8	14.5	14.1	18.1	20.6	13.7	12.4	11.9	15.2	15.3	14.1
ZCCHC11	"KIAA0191, PAPD3, TUT4"	ENSG00000134744	"Zinc finger CCHC-type containing 11"	Q5TAX3	1	52408282-52553487	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027412, HPA027973"	Supported		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA027412: AB_1852281, HPA027973: AB_10603242"	"unprognostic (2.74e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.85e-3)"	"prognostic unfavourable (9.00e-4)"	"unprognostic (2.64e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.84e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.11e-2)"	"unprognostic (5.35e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.33e-1)"	13.8	19.1	18.4	25.6	19.0	20.5	18.7	50.9	21.3	22.4	13.3	11.8	16.1	7.7	22.1	22.0	11.5	16.8	14.0	13.5	17.8	16.5	14.2	17.7	13.3	27.4	15.4	14.6	28.3	17.6	34.4	56.0	18.8	16.3	16.1	10.5	12.1	12.6	20.6	44.6	28.1	17.1	20.3	26.6	20.9	12.3	24.9	21.1	31.9	23.9	14.6	25.1	18.3	17.0	23.2	26.0	26.7	4.3	10.3	15.0	2.2	10.4	9.9	24.4	16.5	9.6	12.3	16.9	9.3	13.6	13.6	15.7	10.2	5.5	22.3	11.0	12.9	8.7	18.3	9.8	17.3	18.2	16.7	23.5	12.8	21.2	15.9	25.4	13.4	14.5	21.9	14.5	18.0	9.4	19.1	11.2	11.3	0.1	25.3	18.2	17.7	12.6	22.5	24.8	17.4	14.6	8.6	13.1	13.0	14.3	6.1	13.9	8.5	13.4	7.9	10.6	14.3	9.7	11.3	24.5	32.1	32.1	7.0	13.9	7.6	26.7	4.3	13.8	11.8	1.7	8.8	19.1	12.4	9.5	2.1	23.2	15.0	9.9	16.2	10.3	1.4	26.0	9.3	2.2	18.4	19.0	50.9	21.3	17.8	16.5	15.4	14.6	16.3	21.1
ZCCHC2	"C18orf49, FLJ20222, FLJ20281, KIAA1744"	ENSG00000141664	"Zinc finger CCHC-type containing 2"	Q9C0B9	18	62523007-62587709	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"salivary gland: 99.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040943	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoli, Cytosol"	Nucleoplasm	"HPA040943: AB_10795496"	"unprognostic (9.32e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.84e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-1)"	12.6	5.0	6.8	7.0	7.5	22.8	16.0	8.0	6.8	7.5	8.5	6.0	5.3	6.8	6.9	7.1	6.5	7.4	9.0	8.5	5.3	5.7	5.8	23.0	10.1	7.6	8.1	5.7	8.8	6.3	7.8	8.5	8.2	5.5	8.1	5.8	4.5	99.1	5.9	16.8	11.3	7.5	7.6	5.6	8.9	6.5	13.4	8.9	10.8	7.8	4.3	6.4	11.0	19.3	1.6	1.0	4.9	1.6	0.6	2.0	0.4	5.8	5.1	4.4	8.7	13.5	5.8	8.4	3.4	5.1	8.1	8.1	2.7	3.6	16.6	4.5	5.6	10.0	14.2	7.5	3.4	11.4	6.7	4.4	11.8	18.6	4.6	8.3	6.4	5.7	9.7	5.1	9.6	15.2	4.6	5.6	2.6	4.8	5.4	3.5	2.8	5.1	7.2	4.7	0.1	5.6	6.0	5.6	3.5	5.7	12.8	5.0	4.5	6.6	6.4	8.0	5.5	3.1	4.8	2.2	4.2	7.1	6.0	3.5	2.9	0.0	1.0	2.4	1.7	1.6	1.2	0.5	1.1	1.5	0.3	1.6	2.0	1.3	4.9	0.6	0.3	1.0	1.2	0.4	6.8	7.5	8.0	6.8	5.3	5.7	8.1	5.7	5.5	8.9
ZCCHC7	"AIR1, FLJ22611"	ENSG00000147905	"Zinc finger CCHC-type containing 7"	Q8N3Z6	9	37120539-37358149	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020600, HPA021088, HPA029522"	Uncertain		Enhanced	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA020600: AB_1858985, HPA021088: AB_1858986, HPA029522: AB_10601029"	"unprognostic (1.19e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.21e-3)"	"unprognostic (2.78e-1)"	"unprognostic (4.27e-3)"	"unprognostic (3.18e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.29e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.58e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.49e-2)"	15.2	12.7	9.9	28.4	11.3	16.2	16.8	16.5	12.1	16.1	13.4	10.2	20.0	11.3	19.2	14.9	11.5	13.1	12.4	10.2	10.1	10.3	10.0	11.1	10.9	27.5	11.8	8.4	21.9	19.8	8.6	30.7	10.2	11.2	13.5	14.2	9.8	14.3	19.2	9.9	12.7	13.9	14.0	11.8	18.4	11.8	14.3	12.4	19.9	16.1	12.3	29.3	19.2	12.9	29.7	7.5	10.9	8.5	10.1	11.4	5.2	7.2	4.9	6.8	7.3	7.2	11.1	6.4	7.1	8.3	5.5	7.7	4.8	3.5	25.8	3.9	5.5	3.0	6.6	6.7	8.0	11.8	4.6	7.4	8.0	4.2	11.1	12.6	7.4	7.6	10.5	5.8	22.7	6.4	20.2	9.0	4.9	3.4	9.7	7.0	7.3	7.3	46.8	4.5	6.5	6.9	2.9	7.7	5.6	5.0	6.1	6.5	4.4	8.2	5.7	4.1	5.2	5.9	4.3	3.1	5.7	30.7	6.6	8.2	7.5	4.7	4.4	10.9	7.8	5.0	7.7	18.1	8.9	8.8	4.0	29.7	11.4	10.4	8.8	10.1	8.5	7.5	7.4	5.2	9.9	11.3	16.5	12.1	10.1	10.3	11.8	8.4	11.2	12.4
ZCCHC9	"DKFZp761J139, PPP1R41"	ENSG00000131732	"Zinc finger CCHC-type containing 9"	Q8N567	5	81301590-81313297	"Predicted intracellular proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038404	Uncertain		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA038404: AB_10672744"	"unprognostic (1.55e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.29e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.68e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.06e-1)"	14.4	12.9	11.7	16.1	10.5	8.9	15.2	14.3	11.5	21.1	19.7	7.4	14.5	13.9	18.4	16.4	21.4	13.9	14.3	11.9	10.0	10.7	23.0	36.3	10.7	16.2	11.1	10.1	19.6	13.8	10.9	22.6	23.0	10.4	23.1	14.6	13.6	12.2	18.1	14.4	15.2	27.7	22.5	12.2	18.0	14.5	14.8	10.0	17.9	19.6	19.1	16.4	26.8	23.5	14.9	17.5	12.8	16.2	11.6	19.1	7.3	10.2	7.2	17.8	9.4	15.5	14.7	24.1	15.4	18.4	11.9	16.6	15.9	14.2	9.5	6.4	7.7	7.6	14.1	14.1	19.1	21.2	13.3	9.8	8.1	18.6	18.2	12.4	8.1	11.3	12.4	10.1	25.5	10.0	16.3	9.3	12.2	13.9	20.4	18.6	12.9	9.3	12.2	23.0	13.9	9.3	10.3	8.7	8.3	12.2	7.4	55.0	9.2	20.0	6.8	7.5	9.2	13.3	16.8	13.4	13.7	14.5	13.3	18.1	16.0	12.8	12.3	11.9	12.8	16.2	16.3	14.9	17.2	15.5	14.8	13.2	16.7	17.1	12.0	11.6	14.0	17.5	19.1	7.3	11.7	10.5	14.3	11.5	10.0	10.7	11.1	10.1	10.4	10.0
ZDHHC14	"FLJ20984, NEW1CP"	ENSG00000175048	"Zinc finger DHHC-type containing 14"	Q8IZN3	6	157381133-157678146	"Enzymes, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 32.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063754	Approved		Approved	Nucleoli,Mitochondria				Nucleoli	Mitochondria	"HPA063754: "	"unprognostic (1.66e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.63e-1)"	"prognostic favourable (6.93e-4)"	"unprognostic (3.94e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.63e-1)"	6.4	3.9	9.0	4.4	10.8	4.8	3.6	15.6	16.2	7.4	5.3	22.1	2.9	6.2	22.6	2.6	4.2	4.8	5.3	11.1	10.6	8.8	6.9	8.7	6.4	4.8	15.8	7.1	3.3	5.7	12.7	3.7	5.1	15.3	7.9	4.0	9.1	4.6	3.8	4.7	3.3	8.6	13.7	22.0	6.4	8.1	6.3	11.8	0.7	3.8	1.5	5.7	5.3	5.0	1.5	4.2	0.0	0.1	0.4	0.9	0.4	1.7	1.8	0.5	2.5	1.4	1.0	5.8	2.7	2.5	1.9	1.7	2.2	1.2	4.2	0.9	2.1	0.8	1.4	1.4	1.7	32.7	2.1	8.2	0.6	1.0	1.9	1.1	1.8	0.7	1.5	2.0	0.8	2.9	6.6	3.1	1.1	1.1	0.7	2.7	1.0	2.1	0.1	0.3	2.5	3.9	0.7	4.2	1.2	3.1	2.0	2.3	0.3	1.3	4.0	2.9	2.1	5.6	3.4	0.7	0.8	0.6	1.0	2.9	3.1	0.0	0.1	0.0	0.5	0.0	0.9	1.5	0.4	0.4	0.0	0.8	0.0	0.3	0.0	0.4	0.0	4.2	0.0	0.4	9.0	10.8	15.6	16.2	10.6	8.8	15.8	7.1	15.3	11.8
ZEB2	"KIAA0569, SIP-1, SIP1, ZFHX1B"	ENSG00000169554	"Zinc finger E-box binding homeobox 2"	O60315	2	144364364-144524583	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease mutation, Epilepsy, Hirschsprung disease, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 76.6"	"Cell line enhanced"	"Detected in many"		"HEL: 38.4;THP-1: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003456	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA003456: AB_10603840"	"unprognostic (1.02e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.77e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavourable (6.04e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.32e-2)"	30.2	23.7	48.0	27.8	42.4	55.5	16.6	6.7	36.6	29.4	12.3	72.9	3.4	11.3	15.6	11.1	14.4	11.1	22.6	22.5	52.5	28.8	9.9	11.6	20.7	19.6	54.4	26.4	37.5	3.6	5.0	3.1	31.5	37.6	10.9	16.3	15.7	5.7	12.5	9.6	7.7	12.8	17.2	76.6	32.6	9.3	8.2	38.7	1.9	8.3	7.5	12.4	21.5	14.8	5.0	12.7	9.7	21.6	3.6	10.7	7.4	0.4	0.5	22.1	0.0	26.4	13.5	0.0	9.1	9.2	10.2	9.9	0.0	0.2	1.6	0.0	9.8	0.1	3.7	0.0	12.8	9.4	2.6	38.4	1.6	0.0	5.9	6.6	30.5	11.0	0.2	12.6	6.1	7.7	10.7	1.1	12.0	0.0	0.0	20.1	3.2	0.5	11.3	15.2	0.0	0.1	0.2	0.1	5.8	1.1	0.0	23.9	0.0	45.7	11.9	11.7	0.2	22.8	2.8	12.5	0.0	1.9	17.6	19.9	31.6	9.7	21.6	5.7	10.7	20.8	1.0	4.4	1.4	5.3	12.7	5.0	1.1	4.0	7.5	3.6	19.5	10.2	0.3	7.4	48.0	42.4	6.7	35.6	52.5	28.8	54.4	26.4	37.6	38.7
ZFAND2B	AIRAPL	ENSG00000158552	"Zinc finger AN1-type containing 2B"	Q8WV99	2	219195237-219209651	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035159, HPA035160"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA035159: , HPA035160: AB_10670697"	"unprognostic (3.71e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.77e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.20e-1)"	"prognostic favourable (9.38e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.32e-1)"	"unprognostic (6.21e-2)"	"unprognostic (7.02e-2)"	13.4	12.9	16.4	14.6	16.9	23.8	13.5	22.3	24.6	14.8	30.0	20.2	15.9	30.5	15.3	14.2	22.2	13.1	22.2	11.6	16.2	13.3	20.0	28.5	15.2	27.3	18.8	17.9	14.1	29.1	18.6	18.0	22.2	15.6	14.7	18.5	11.3	17.3	14.2	15.9	23.4	34.7	24.5	17.5	22.6	21.8	9.5	13.9	23.0	30.0	12.9	19.3	14.7	16.6	29.1	20.5	36.6	27.8	30.7	32.5	25.4	10.4	7.1	8.2	11.5	8.7	9.2	11.4	10.6	12.5	15.3	15.2	16.0	9.0	8.5	11.3	18.1	7.2	7.6	13.5	12.2	13.1	11.8	19.4	11.8	13.8	17.9	10.3	22.5	7.6	29.7	15.1	36.0	10.2	11.3	24.2	14.9	18.1	17.0	21.7	4.2	8.2	10.6	4.9	14.6	14.5	8.9	17.9	8.1	5.1	8.7	11.8	7.4	21.9	10.8	15.5	14.5	17.8	15.1	10.0	3.2	15.3	15.2	20.5	12.0	17.7	21.7	28.6	32.1	27.8	28.0	25.4	29.3	31.3	16.4	29.1	26.7	32.5	36.6	30.7	21.9	20.5	30.2	25.4	16.4	16.9	22.3	24.6	16.2	13.3	18.8	17.9	15.6	13.9
ZFP41	"FLJ00028, FLJ38705, ZNF753"	ENSG00000181638	"ZFP41 zinc finger protein"		8	143246821-143262705	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA047232, HPA056268"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"				Nucleoli	"Nucleoplasm, Plasma membrane"	"HPA047232: , HPA056268: "	"unprognostic (9.16e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.45e-2)"	"prognostic unfavourable (3.46e-5)"	"unprognostic (4.92e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.53e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.44e-2)"	"unprognostic (3.20e-1)"	7.8	6.6	10.3	6.5	9.0	4.1	5.6	12.6	13.7	8.0	8.8	10.7	6.5	9.4	12.5	6.8	5.7	9.2	5.6	6.3	10.8	14.3	6.5	5.8	6.3	6.7	10.7	7.4	13.1	9.1	11.4	10.2	3.5	9.6	7.7	4.5	8.9	12.6	9.1	8.1	12.1	9.1	7.3	7.4	8.5	7.2	10.6	8.6	4.6	8.0	4.6	6.7	6.7	10.0	0.9	3.7	0.1	0.9	0.7	2.2	0.8	7.1	11.3	4.9	6.6	5.7	4.5	5.8	4.3	2.3	8.5	5.8	5.6	5.9	3.9	6.4	5.6	5.8	5.4	5.6	4.2	6.2	6.5	5.0	5.5	4.3	8.0	1.9	3.1	4.7	8.0	5.4	8.1	3.9	10.5	3.9	4.0	12.7	5.2	2.1	7.3	11.3	2.8	4.0	1.4	3.7	6.4	6.3	8.7	12.1	3.3	6.4	8.5	3.9	4.1	6.4	11.5	5.0	6.8	6.3	4.7	1.9	5.7	4.8	8.4	0.0	0.6	0.1	1.3	0.9	2.2	0.4	1.1	0.9	0.5	0.9	1.9	1.2	0.0	0.7	0.1	3.7	0.9	0.8	10.3	9.0	12.6	13.7	10.8	14.3	10.7	7.4	9.6	8.6
ZFX	ZNF926	ENSG00000005889	"Zinc finger protein, X-linked"	P17010	X	24149173-24216255	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA001748, HPA003877, HPA071863"	Supported		Approved	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA001748: AB_1080650, HPA003877: AB_1080648, HPA071863: "	"unprognostic (2.60e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.99e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.22e-3)"	"unprognostic (2.39e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.95e-2)"	20.3	8.8	10.8	8.2	11.7	25.9	23.5	22.1	12.6	18.5	12.2	7.2	8.4	6.6	18.5	11.0	10.6	15.8	7.2	17.8	10.1	6.6	16.6	11.3	9.7	12.7	13.1	9.6	20.2	11.8	20.2	17.9	23.2	10.4	16.4	6.5	7.0	9.4	13.1	24.1	8.9	11.8	15.7	11.3	12.4	10.1	5.4	14.7	16.4	13.9	8.9	10.6	12.5	25.3	11.9	9.6	16.6	10.3	9.9	10.7	7.0	8.0	10.9	11.3	13.1	15.3	10.7	5.9	7.6	7.2	8.8	9.2	6.7	6.0	9.3	10.3	11.7	10.3	12.9	14.1	11.8	9.0	16.0	8.2	33.8	3.9	6.4	10.8	14.5	9.3	4.5	17.1	22.3	11.0	9.7	10.1	6.3	4.4	7.7	8.0	6.5	8.4	10.6	9.0	8.0	5.2	13.0	6.0	9.0	23.0	9.2	7.4	5.8	5.7	10.8	7.8	4.6	10.8	5.3	5.7	7.5	9.3	6.1	4.6	9.0	11.2	8.7	13.5	10.6	10.3	10.7	8.4	9.9	10.6	9.6	11.9	9.9	9.4	16.6	9.9	9.4	6.9	5.7	7.0	10.8	11.7	22.1	12.6	10.1	6.6	13.1	9.6	10.4	14.7
ZFY	ZNF911	ENSG00000067646	"Zinc finger protein, Y-linked"	P08048	Y	2935281-2982506	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA001748, HPA071863"	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA001748: AB_1080650, HPA071863: "			"unprognostic (1.07e-1)"		"unprognostic (7.43e-2)"	"prognostic favourable (3.58e-5)"	"unprognostic (1.07e-1)"	"unprognostic (7.52e-2)"	"unprognostic (2.75e-2)"		"unprognostic (2.94e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.91e-1)"		"unprognostic (2.54e-2)"	4.1	2.9	2.8	6.8	4.3	9.6	3.4	6.8	5.3	0.0	5.4	2.8	14.1	3.2	0.0	9.1	7.2	0.0	7.0	6.1	3.0	3.0	2.7	13.1	10.1	10.9	2.6	0.0	0.0	10.0	0.1	3.3	5.8	4.5	10.6	8.0	3.5	15.8	10.2	7.0	2.9	6.3	5.8	3.3	9.1	4.7	10.5	0.0	12.6	7.2	5.7	5.8	6.1	0.0	5.8	5.9	4.7	4.7	6.2	7.0	2.7	0.0	3.5	0.0	0.0	0.0	0.0	6.4	9.0	8.7	7.7	7.5	0.0	0.0	6.9	0.0	9.3	0.0	0.0	0.0	10.3	10.4	0.0	12.7	0.1	4.6	6.8	0.0	0.0	7.5	6.1	0.0	0.0	0.0	0.0	0.0	8.7	0.0	5.2	0.0	2.8	0.0	0.0	5.6	2.6	5.2	11.7	6.1	0.0	0.0	0.0	9.0	0.0	4.1	7.8	7.5	0.0	0.0	4.5	4.9	0.0	11.6	1.0	0.0	0.0	0.0	4.7	4.7	5.0	3.9	7.0	4.3	5.5	2.8	5.9	5.8	6.3	3.0	3.2	6.2	3.3	4.3	3.1	2.7	2.8	4.3	6.8	5.3	3.0	3.0	2.6	0.0	4.5	0.0
ZMAT4	FLJ13842	ENSG00000165061	"Zinc finger matrin-type 4"	Q9H898	8	40530590-40897833	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 11.5;brain: 21.6;thyroid gland: 29.1"	"Group enriched"	"Detected in some"	5	"AF22: 20.6;U-2197: 12.8"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.9"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	115	"NK-cell: 11.5"	"Lineage enriched"	"Detected in single"	115	"NK-cells: 11.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA069813, HPA071585"	Enhanced		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA069813: , HPA071585: "	"unprognostic (1.25e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.83e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.42e-1)"		"unprognostic (1.07e-1)"		"unprognostic (9.73e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.46e-4)"	"unprognostic (5.44e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (3.51e-4)"	"unprognostic (4.79e-3)"	0.8	2.0	4.4	0.9	15.3	0.8	0.9	0.6	20.4	3.3	1.0	0.9	0.0	0.7	1.4	1.0	0.7	0.9	1.0	1.5	6.1	4.0	1.2	0.7	0.8	0.9	3.3	7.8	1.6	0.7	0.7	5.3	1.0	21.6	1.6	1.2	1.4	0.8	1.5	0.7	0.7	0.8	0.8	1.0	1.3	1.0	2.9	3.9	0.0	29.1	0.0	0.9	0.8	0.2	0.0	0.0	0.0	0.0	11.5	0.0	0.1	0.0	1.2	20.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.1	0.0	0.0	0.2	0.0	0.0	1.1	0.3	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.6	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.1	4.4	15.3	0.6	20.4	6.1	4.0	3.3	7.8	21.6	3.9
ZMYM4	"KIAA0425, MYM, ZNF198L3, ZNF262"	ENSG00000146463	"Zinc finger MYM-type containing 4"	Q5VZL5	1	35268967-35422058	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051301, HPA054802"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA051301: , HPA054802: "	"unprognostic (8.95e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (9.75e-9)"	"unprognostic (9.76e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.44e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavourable (8.10e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.04e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.21e-1)"	16.6	15.9	17.9	17.3	22.1	13.6	19.7	28.1	24.7	22.0	14.8	17.1	18.3	10.2	19.8	18.2	15.0	17.9	15.7	13.1	17.6	19.0	15.8	14.4	14.1	15.0	15.8	14.6	27.0	15.7	26.1	22.6	19.6	22.2	21.0	13.6	18.2	18.0	26.8	15.9	12.9	12.5	16.6	15.2	16.0	15.4	36.3	13.6	26.7	21.6	13.0	18.8	17.2	14.7	4.2	9.8	3.5	8.2	9.6	4.4	2.5	12.7	10.4	31.9	16.1	9.3	20.3	11.8	15.2	23.0	18.6	24.3	11.2	12.8	23.8	9.4	19.0	8.3	22.1	11.2	26.9	13.4	15.3	29.0	12.1	9.5	17.0	24.8	13.2	15.3	10.1	18.0	17.1	20.6	31.6	6.5	22.5	7.7	21.0	13.8	26.6	9.9	23.6	20.5	11.5	13.3	16.9	18.4	17.9	18.3	13.4	20.8	10.9	18.9	24.8	17.3	18.0	7.6	16.3	7.2	13.3	18.3	12.5	19.0	16.5	2.4	5.0	3.5	4.3	7.1	4.4	4.2	4.2	3.8	4.8	3.7	4.1	3.9	1.0	9.6	8.2	9.8	3.1	2.5	17.9	22.1	28.1	24.7	17.6	19.0	15.8	14.6	22.2	13.6
ZNF106	"SH3BP3, ZFP106, ZNF474"	ENSG00000103994	"Zinc finger protein 106"	Q9H2Y7	15	42412823-42491123	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 64.8;skeletal muscle: 111.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 48.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054267	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA054267: "	"unprognostic (2.15e-2)"	"unprognostic (3.31e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.32e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.76e-3)"	"unprognostic (8.71e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.36e-1)"	"unprognostic (4.09e-3)"	14.9	5.4	8.8	6.6	10.4	9.0	10.3	6.3	9.1	7.1	7.8	4.5	4.5	3.9	7.4	6.3	12.7	5.4	6.1	64.8	9.2	6.3	6.4	3.7	7.8	6.0	7.6	6.4	6.6	4.4	8.4	7.1	5.0	11.9	7.8	5.6	11.3	6.0	5.7	111.1	4.3	5.9	10.9	8.0	6.3	6.0	5.7	7.2	3.4	5.7	46.9	6.8	7.0	17.7	8.3	10.8	48.5	19.6	3.9	5.1	4.5	14.1	8.2	14.4	15.9	36.4	32.1	8.8	11.5	11.0	10.1	10.8	19.3	4.1	9.5	10.3	14.1	16.2	14.9	11.8	15.5	15.4	7.2	18.2	19.2	6.9	10.5	21.8	10.9	24.1	7.9	15.3	17.1	16.2	21.6	1.3	16.4	5.6	8.3	5.3	6.1	8.4	8.0	26.2	5.2	5.3	16.0	9.2	4.9	23.3	11.0	13.0	10.1	14.2	24.4	10.9	16.8	14.4	16.8	7.9	15.2	35.6	9.7	17.4	18.8	19.9	19.6	7.6	5.1	15.9	4.5	6.7	4.2	4.2	10.5	8.3	3.8	3.4	48.5	3.9	18.5	10.8	3.8	4.5	8.8	10.4	6.3	9.1	9.2	6.3	7.6	6.4	11.9	7.2
ZNF121	"D19S204, ZHC32, ZNF20"	ENSG00000197961	"Zinc finger protein 121"	P58317	19	9560353-9584533	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA054961	Uncertain		Approved	Nucleoplasm,Nucleoli,Centrosome				"Nucleoplasm, Centrosome"	Nucleoli	"HPA054961: "	"unprognostic (3.06e-1)"	"unprognostic (9.38e-3)"	"unprognostic (9.51e-2)"	"unprognostic (7.49e-2)"	"unprognostic (3.07e-2)"	"unprognostic (3.91e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.80e-3)"	"prognostic favourable (6.59e-5)"	"unprognostic (9.36e-2)"	"unprognostic (1.76e-3)"	"prognostic unfavourable (1.01e-4)"	"unprognostic (8.75e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.06e-1)"	"prognostic favourable (5.75e-5)"	13.8	8.9	10.4	11.0	12.3	21.0	14.0	16.1	11.8	10.6	8.9	6.2	12.5	6.7	9.4	10.0	16.5	12.4	7.6	10.3	10.3	5.0	9.2	13.2	14.6	13.0	13.6	6.3	13.8	12.5	22.3	20.2	8.3	11.0	11.8	10.6	5.3	14.1	13.7	9.4	18.6	12.3	12.3	14.8	12.4	11.1	6.2	13.0	12.2	11.3	10.4	12.1	15.8	12.7	6.0	4.6	2.9	4.5	7.1	6.8	1.8	7.6	4.9	5.9	12.3	2.7	3.3	9.1	2.6	2.4	4.0	5.0	8.5	3.4	8.7	7.6	2.1	7.6	12.1	7.0	5.6	4.2	19.6	27.2	12.2	7.6	3.4	13.4	13.6	4.5	6.2	3.9	10.3	2.9	9.7	14.8	2.9	6.4	9.9	30.9	14.6	8.6	6.4	8.1	6.0	3.8	32.5	10.6	5.4	5.2	5.2	3.0	4.2	4.3	4.2	12.7	7.1	4.3	6.8	15.7	8.6	10.3	3.4	7.9	4.3	2.9	3.6	2.1	5.5	4.4	6.8	4.0	4.9	5.1	4.1	6.0	6.1	6.8	2.8	7.1	4.5	4.6	4.3	1.8	10.4	12.3	16.1	11.8	10.3	5.0	13.6	6.3	11.0	13.0
ZNF136	pHZ-20	ENSG00000196646	"Zinc finger protein 136"	P52737	19	12163064-12189881	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA054120			Approved	Nucleoli				Nucleoli		"HPA054120: "	"unprognostic (1.40e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.68e-3)"	"unprognostic (2.36e-1)"	"unprognostic (9.39e-3)"	"unprognostic (5.97e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.33e-2)"	"unprognostic (5.46e-3)"	"prognostic favourable (4.75e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-2)"	12.6	10.8	7.2	15.3	11.0	20.5	13.0	19.6	12.4	13.2	9.5	7.1	10.5	4.5	13.3	13.0	5.9	11.6	8.2	8.0	7.3	7.2	9.4	6.0	11.1	12.7	7.5	11.3	19.0	7.5	13.0	16.8	10.6	10.2	13.0	8.6	8.3	10.1	8.9	9.9	10.4	9.4	12.9	12.5	11.7	10.0	10.2	6.8	16.0	14.4	3.6	10.7	12.6	11.3	9.7	5.1	13.5	4.1	8.7	10.0	4.0	2.1	1.2	7.3	7.6	4.1	4.6	4.4	4.0	4.3	3.9	4.1	1.4	0.7	9.9	5.2	2.9	2.2	3.4	2.4	4.9	4.9	4.6	5.6	3.6	2.4	3.1	11.9	10.1	5.0	4.4	3.6	4.6	2.7	4.2	16.1	4.9	2.9	8.2	4.8	8.6	4.5	6.5	9.3	3.8	4.1	7.6	7.6	7.2	5.0	1.2	4.2	3.2	6.3	5.7	9.5	3.3	4.0	3.5	10.9	19.0	11.3	3.6	4.6	4.9	13.5	3.9	9.0	7.9	3.7	9.4	9.0	8.9	8.5	4.2	9.7	10.0	8.4	11.6	8.7	4.1	5.1	5.9	4.0	7.2	11.0	19.6	12.4	7.3	7.2	7.5	11.3	10.2	6.8
ZNF146	OZF	ENSG00000167635	"Zinc finger protein 146"	Q15072	19	36214602-36238774	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003358	Supported		Supported	Nucleoli				Nucleoli		"HPA003358: AB_1080674"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.35e-3)"	"unprognostic (2.11e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.42e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.92e-1)"	20.6	17.2	24.5	23.5	40.4	8.6	33.0	25.7	27.9	28.9	20.7	28.4	23.5	17.9	30.0	18.2	22.3	23.0	18.0	21.5	25.6	20.0	21.1	25.0	18.1	25.0	46.4	23.7	33.7	20.3	32.5	45.2	25.1	32.0	25.2	25.5	13.4	19.6	23.9	38.3	21.1	17.7	26.2	30.9	19.9	19.2	9.9	36.3	33.6	27.1	24.0	28.3	25.8	20.5	13.7	9.8	5.9	14.6	10.2	18.3	10.3	21.6	30.3	25.9	24.9	19.2	21.6	13.8	19.2	17.8	18.6	18.5	13.7	15.9	21.1	31.0	17.7	10.1	32.9	22.4	33.7	32.7	18.3	35.3	11.7	16.4	22.4	55.4	24.5	17.6	34.8	17.9	51.1	23.0	37.4	23.3	22.3	14.2	25.7	13.1	35.0	18.5	29.8	26.1	18.1	22.6	21.4	32.9	20.8	23.7	30.1	20.3	13.4	28.4	17.5	21.0	25.2	16.4	33.5	16.3	19.2	30.2	14.8	27.5	26.7	4.9	8.2	5.9	12.2	9.9	17.4	13.7	14.1	12.2	9.8	12.1	18.3	16.6	2.0	10.2	14.6	4.9	12.1	10.3	24.5	40.4	25.7	27.9	25.6	20.0	46.4	23.7	32.0	36.3
ZNF16	KOX9	ENSG00000170631	"Zinc finger protein 16"	P17020	8	144930358-144950888	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cell division, Transcription, Transcription regulation"	"Activator, DNA-binding, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA035782, HPA061835"	Uncertain		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA035782: AB_10603243, HPA061835: "	"unprognostic (4.11e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.69e-1)"	"prognostic favourable (2.39e-4)"	"unprognostic (7.53e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.96e-1)"	"unprognostic (9.75e-2)"	"unprognostic (4.17e-3)"	8.1	6.0	8.9	7.1	9.0	3.4	9.7	8.1	10.1	9.7	10.1	7.8	7.1	7.2	13.8	11.1	9.4	11.2	13.3	6.5	7.5	4.9	8.5	5.9	5.7	5.0	6.4	7.5	17.4	12.1	15.9	7.0	6.0	6.5	8.9	7.3	7.7	7.4	9.2	12.4	14.0	10.8	10.3	4.9	6.4	7.7	10.9	5.3	6.7	10.8	5.3	6.8	9.1	10.1	5.6	6.4	3.5	4.0	12.2	7.8	4.1	4.8	4.3	8.5	4.7	7.4	10.3	6.2	4.4	9.9	8.9	8.1	3.3	5.0	7.7	5.9	5.7	3.9	6.0	9.8	8.1	3.3	5.0	8.8	4.8	4.8	12.3	3.2	5.2	12.5	10.0	5.7	15.0	4.9	6.0	5.2	7.1	6.6	6.3	3.2	5.3	9.8	8.0	5.0	4.9	7.6	7.3	7.2	5.3	9.3	5.7	7.6	10.6	6.0	5.2	4.0	8.6	4.7	4.9	3.8	3.2	7.1	4.7	4.4	6.4	3.5	4.0	2.7	6.9	3.7	7.8	4.1	5.5	6.3	6.4	5.6	5.6	5.1	0.5	12.2	3.7	3.5	7.2	4.1	8.9	9.0	8.1	10.1	7.5	4.9	6.4	7.5	6.5	5.3
ZNF202	"ZKSCAN10, ZSCAN42"	ENSG00000166261	"Zinc finger protein 202"	O95125	11	123724177-123741675	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059229			Approved	"Nucleoli,Nuclear bodies"				Nucleoli	"Nuclear bodies"	"HPA059229: "	"unprognostic (3.12e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (2.52e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.80e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavourable (9.93e-7)"	"unprognostic (2.61e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.35e-2)"	7.2	6.5	9.2	16.1	11.6	6.0	10.4	11.9	10.9	9.5	8.2	9.2	8.1	5.6	13.1	13.9	8.8	9.7	6.1	6.2	7.3	5.5	6.6	7.3	7.8	10.6	10.5	6.4	15.1	14.1	11.1	11.5	8.2	7.0	10.6	11.0	7.2	9.2	8.6	8.5	10.9	8.9	12.3	7.0	14.1	8.0	24.0	7.8	8.9	10.3	5.4	11.7	9.1	10.5	4.1	3.6	0.1	3.6	3.0	5.6	3.0	4.0	5.9	10.6	12.8	5.0	7.2	8.4	6.2	5.3	6.1	5.3	6.5	10.8	12.2	6.0	5.0	10.3	10.8	7.3	8.5	5.1	6.4	20.1	3.8	7.0	6.7	12.3	6.2	5.3	15.1	6.8	20.7	7.0	11.3	8.0	7.7	4.3	10.6	16.2	17.0	9.2	13.3	7.0	4.5	5.7	7.7	7.7	8.8	5.5	6.8	4.4	11.4	8.6	5.7	11.5	6.9	8.1	6.4	5.5	3.7	8.3	3.1	13.6	7.5	0.0	2.1	0.1	3.8	3.6	3.4	3.4	4.8	4.9	3.6	4.1	5.6	5.0	0.0	3.0	1.5	2.3	4.0	3.0	9.2	11.6	11.9	10.9	7.3	5.5	10.5	6.4	7.0	7.8
ZNF275		ENSG00000063587	"Zinc finger protein 275"	Q9NSD4	X	153334155-153360110	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 38.6"	"Cell line enhanced"	"Detected in many"		"U-266/70: 35.4;U-698: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000566	Approved		Approved	Nucleoli				Nucleoli		"HPA000566: AB_1080700"	"unprognostic (6.96e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.11e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.59e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.33e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.14e-2)"	6.5	38.6	5.9	3.4	5.9	2.2	11.5	5.9	6.9	5.8	3.5	7.0	20.4	2.8	5.9	12.6	2.5	5.4	4.9	3.0	6.8	6.9	3.8	8.5	3.3	7.0	8.8	5.3	30.3	8.5	5.8	6.9	2.1	6.2	5.1	3.2	3.8	6.3	27.9	3.1	2.5	4.5	5.6	10.7	6.8	4.1	10.5	6.5	3.9	4.7	1.7	5.3	4.0	2.6	4.5	2.7	0.7	1.7	2.8	5.0	2.0	5.8	2.6	5.2	3.6	5.9	5.9	2.6	4.1	6.8	2.7	4.0	2.7	1.3	10.1	8.5	7.7	1.0	5.9	3.7	3.9	2.3	4.7	3.3	2.5	3.8	8.0	4.1	3.0	6.9	2.7	2.3	4.2	3.2	5.0	0.0	4.7	4.3	4.8	3.4	2.3	4.2	5.9	5.5	3.5	2.0	3.9	2.6	3.6	2.1	0.2	5.0	0.9	7.3	3.5	4.0	4.8	6.6	5.3	35.4	9.4	20.2	3.6	8.3	2.8	0.7	1.7	0.2	3.7	1.5	4.4	4.5	3.4	3.3	1.6	4.4	5.0	4.2	0.1	2.8	1.4	2.7	4.6	2.0	5.9	5.9	5.9	6.5	6.8	6.9	8.8	5.3	6.2	6.5
ZNF276	"CENP-Z, CENPZ, MGC45417, ZADT, ZFP276, ZNF477"	ENSG00000158805	"Zinc finger protein 276"	Q8N554	16	89720400-89740903	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021309, HPA022255"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoli, Plasma membrane"	"HPA021309: AB_1859024, HPA022255: AB_1859025"	"unprognostic (1.45e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.17e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.95e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.36e-3)"	"prognostic unfavourable (3.37e-4)"	"unprognostic (2.65e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.62e-3)"	9.7	9.8	9.0	18.6	13.1	25.5	7.9	20.2	12.3	10.8	11.1	30.6	9.4	16.0	9.0	8.4	14.5	11.4	9.5	6.7	9.8	7.3	8.4	10.1	9.6	21.7	21.3	11.2	13.5	10.9	11.0	11.6	7.4	12.6	10.2	8.8	8.1	11.3	11.4	11.4	18.5	15.3	6.8	9.9	22.2	12.2	6.4	18.4	11.1	10.1	8.1	15.1	9.5	10.3	2.9	2.0	4.5	1.9	5.0	10.1	2.4	5.0	4.2	3.4	8.9	2.8	3.9	6.1	3.4	2.1	3.2	1.2	5.4	5.3	6.6	4.4	3.6	9.2	4.3	3.8	2.3	4.1	23.2	5.9	7.9	2.1	5.4	5.7	7.8	5.3	5.1	4.3	3.5	4.8	10.8	5.7	1.4	7.0	7.3	13.1	2.5	9.5	11.7	3.8	4.4	4.0	2.9	9.3	7.8	7.5	6.8	4.2	9.2	8.3	5.4	5.3	7.2	4.1	2.9	20.5	6.6	3.5	4.2	9.5	5.2	4.3	1.7	2.8	10.1	1.9	4.8	2.0	5.5	7.6	1.8	2.9	5.6	7.2	4.5	5.0	1.2	2.0	4.0	2.4	9.0	13.1	20.2	11.3	9.8	7.3	21.3	11.2	12.6	18.4
ZNF286A	"KIAA1874, ZNF286"	ENSG00000187607	"Zinc finger protein 286A"	Q9HBT8	17	15699577-15720787	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA021594			Approved	Nucleoli				Nucleoli		"HPA021594: "	"unprognostic (2.09e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.47e-4)"	"unprognostic (4.66e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.29e-4)"	"unprognostic (5.60e-2)"	"unprognostic (1.66e-3)"	"unprognostic (4.95e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.94e-2)"	3.7	5.9	6.6	5.5	9.5	2.0	6.0	8.2	7.8	9.7	5.3	6.5	10.0	2.5	11.3	10.0	7.6	6.6	6.6	11.5	7.6	6.5	6.1	3.2	3.5	7.0	8.7	4.7	14.3	2.9	9.8	15.9	4.0	9.4	7.1	3.5	7.1	4.7	8.3	3.8	4.0	3.5	8.4	10.7	4.5	3.4	14.2	9.0	5.2	8.0	3.8	6.0	6.9	6.0	6.4	2.7	1.0	3.6	6.0	9.8	2.5	15.4	17.5	25.6	12.3	7.5	10.8	8.1	7.2	6.4	12.0	9.7	10.5	5.5	13.9	6.0	6.1	13.7	18.0	8.5	15.1	10.2	14.0	9.5	17.9	9.0	7.4	4.6	4.6	10.1	5.5	11.4	11.5	15.8	8.2	2.7	16.9	4.2	20.3	4.3	23.6	4.1	15.1	37.1	6.8	8.7	6.0	8.1	18.3	15.7	6.8	5.5	6.3	2.7	7.0	7.5	8.1	6.6	11.0	6.1	9.5	0.0	9.2	0.1	8.4	0.8	1.6	1.0	6.9	1.9	7.1	4.0	7.9	7.0	2.5	6.4	9.2	9.8	1.0	6.0	3.6	2.7	9.5	2.5	6.6	9.5	8.2	7.8	7.6	6.5	8.7	4.7	9.4	9.0
ZNF300		ENSG00000145908	"Zinc finger protein 300"	Q96RE9	5	150894392-150904983	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 17.2;HeLa: 18.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 3.8"	"Low lineage specificity"	"Detected in all"											"HPA028975, HPA051777"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"				"Nucleoplasm, Nucleoli"	"Nuclear bodies"	"HPA028975: , HPA051777: "	"unprognostic (5.06e-2)"	"unprognostic (1.05e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.23e-3)"	"unprognostic (4.21e-2)"	"unprognostic (3.23e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.85e-3)"	"prognostic unfavourable (3.21e-6)"	"unprognostic (3.62e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.50e-2)"	4.5	1.3	4.8	4.0	12.0	3.6	7.2	12.5	6.4	7.4	4.3	5.4	4.1	4.1	11.7	5.3	7.5	5.4	5.4	4.0	7.5	3.2	7.3	1.5	3.0	4.4	8.2	2.4	16.6	7.3	1.0	7.3	2.4	7.4	7.0	4.4	3.6	3.8	3.9	1.5	6.9	5.8	6.4	9.2	5.1	7.1	14.9	9.1	1.5	9.3	2.7	4.4	5.5	6.2	3.8	1.2	1.1	1.5	1.7	1.0	0.8	1.2	2.8	17.2	0.0	1.5	3.6	0.0	4.2	3.3	3.7	5.4	1.4	2.1	0.0	3.7	3.5	2.5	0.0	9.6	5.8	0.0	5.6	0.0	18.9	2.2	3.1	0.1	0.0	5.5	3.0	7.7	9.1	6.3	0.0	9.1	3.6	0.0	0.0	0.8	16.5	0.0	0.0	2.5	4.9	2.7	3.1	9.7	16.1	9.9	8.6	5.7	5.7	0.0	2.7	5.0	2.1	3.6	7.6	0.3	0.1	0.0	0.5	0.1	10.3	0.0	0.6	1.1	0.7	1.5	0.1	0.9	1.0	0.0	1.2	3.8	0.7	0.4	0.2	1.7	0.1	0.1	0.0	0.8	4.8	12.0	12.5	6.4	7.5	3.2	8.2	2.4	7.4	9.1
ZNF324B	FLJ45850	ENSG00000249471	"Zinc finger protein 324B"	Q6AW86	19	58451604-58457833	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"NK-cell: 8.3"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 8.3"									HPA023400	Uncertain		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA023400: AB_1859195"	"unprognostic (2.75e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.27e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.21e-1)"	"prognostic favourable (2.83e-4)"	"unprognostic (5.58e-2)"	"unprognostic (2.43e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.94e-2)"	7.4	6.2	6.9	8.3	12.4	5.0	9.0	11.4	12.6	8.7	5.9	7.6	9.8	5.9	8.5	5.0	8.4	9.0	6.8	4.7	6.6	5.5	6.2	6.6	7.3	6.8	9.1	7.0	10.2	10.1	8.0	8.4	4.8	8.8	7.5	6.1	8.4	8.9	8.5	8.2	11.2	6.0	7.4	5.3	10.3	8.0	11.3	9.3	9.4	8.0	6.0	6.4	9.3	6.9	1.1	0.6	1.3	1.0	8.3	1.3	0.7	4.2	7.1	3.9	6.4	2.8	2.4	2.8	3.8	2.8	3.1	2.3	2.5	1.8	5.8	2.4	2.2	3.6	5.1	3.5	2.4	5.8	28.8	5.0	5.3	1.0	2.9	8.1	7.4	2.4	3.6	3.5	3.0	2.2	7.2	3.5	3.2	2.8	6.0	1.9	2.1	4.1	5.7	5.1	3.4	2.0	8.5	9.3	5.3	3.6	5.9	0.9	2.2	2.3	2.6	7.5	1.9	4.0	6.1	7.7	6.9	4.3	3.0	3.5	2.9	0.0	1.0	0.1	1.3	0.6	0.9	0.5	0.6	0.9	0.6	1.1	1.3	0.9	1.3	8.3	0.4	0.6	0.4	0.7	6.9	12.4	11.4	12.6	6.6	5.5	9.1	7.0	8.8	9.3
ZNF330	"HSA6591, NOA36"	ENSG00000109445	"Zinc finger protein 330"	Q9Y3S2	4	141220887-141234697	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 80.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA015705, HPA056325"	Uncertain		Supported	Nucleoli				Nucleoli		"HPA015705: AB_1859199, HPA056325: "	"unprognostic (1.90e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.12e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.32e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavourable (3.66e-6)"	"prognostic favourable (7.27e-6)"	"unprognostic (3.24e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.30e-2)"	21.7	15.9	8.9	12.2	13.7	16.2	13.8	17.5	11.2	14.9	17.4	9.8	14.2	9.5	19.0	15.6	13.6	14.0	10.5	80.7	9.0	9.5	14.9	26.7	15.2	13.4	13.7	8.6	14.9	16.5	13.2	15.1	10.4	12.7	12.2	12.3	22.3	44.9	11.4	34.7	10.9	12.6	18.9	14.1	16.0	14.2	14.2	13.3	14.3	23.5	15.4	13.5	18.7	16.0	16.3	21.9	12.2	20.8	14.6	19.3	11.8	7.6	9.5	11.5	9.1	20.6	18.6	16.2	20.7	12.0	13.4	12.7	12.8	14.8	33.0	12.7	13.0	6.2	20.3	13.4	20.5	15.2	13.3	15.3	14.6	17.9	22.1	38.5	12.4	18.6	15.8	12.5	18.4	13.9	31.0	22.5	17.0	17.4	29.7	18.1	10.2	18.1	24.3	16.5	20.9	14.3	8.6	20.1	9.3	7.2	16.7	20.3	8.3	10.5	14.8	17.1	11.6	10.2	14.7	37.7	27.1	31.3	14.3	24.1	12.1	9.7	20.8	12.2	12.9	17.5	17.8	16.3	16.4	16.6	21.9	13.4	18.0	16.2	3.2	14.6	13.5	15.0	19.3	11.8	8.9	13.7	17.5	11.2	9.0	9.5	13.7	8.6	12.7	13.3
ZNF354A	"EZNF, HKL1, KID-1, KID1, TCF17"	ENSG00000169131	"Zinc finger protein 354A"	O60765	5	178694605-178730702	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 29.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052043	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA052043: "	"unprognostic (2.79e-1)"	"unprognostic (3.44e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.66e-3)"	"prognostic favourable (8.28e-4)"	"unprognostic (4.06e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavourable (3.45e-6)"	"unprognostic (8.71e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-2)"	14.0	7.0	13.0	12.1	13.6	14.2	14.2	13.3	14.4	12.6	15.0	6.7	11.4	7.1	13.7	13.3	10.4	11.7	9.8	14.5	13.2	9.3	18.0	6.2	10.8	12.7	16.7	16.1	10.9	15.0	11.7	14.1	14.0	13.4	13.3	10.0	7.1	8.8	15.1	11.9	12.3	10.6	13.6	12.9	17.1	10.4	14.0	14.4	13.1	15.1	8.6	14.2	17.0	25.1	5.7	5.3	15.0	5.8	6.0	6.4	3.6	4.2	3.3	7.0	18.5	12.2	9.9	29.0	4.9	6.6	6.9	7.4	4.9	7.2	5.7	6.5	4.5	8.5	2.6	21.0	10.6	7.6	8.0	1.7	4.2	0.6	9.3	0.0	4.8	7.7	13.5	6.0	12.4	6.5	1.4	0.0	9.9	8.6	8.5	5.7	6.1	8.7	6.4	1.2	3.6	6.4	4.3	7.7	8.4	6.2	7.1	9.5	5.8	8.4	5.0	7.8	5.1	4.4	4.2	1.9	3.9	3.6	0.2	1.3	9.7	4.4	5.8	14.5	5.1	3.8	6.4	5.7	4.6	5.7	5.3	3.6	5.3	3.8	15.0	6.0	3.9	1.9	4.1	3.6	13.0	13.6	13.3	14.4	13.2	9.3	16.7	16.1	13.4	14.4
ZNF362	"FLJ25476, lin-29, RN"	ENSG00000160094	"Zinc finger protein 362"	Q5T0B9	1	33256545-33300719	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059239	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA059239: "	"unprognostic (8.31e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.90e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.34e-2)"	"unprognostic (4.02e-3)"	"unprognostic (2.02e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.67e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.66e-1)"	21.6	14.0	18.1	12.0	17.2	8.9	21.7	24.5	30.5	18.6	17.3	13.8	9.6	11.0	23.7	23.8	14.2	20.1	20.7	28.0	15.4	13.8	16.8	8.8	18.7	26.3	12.8	15.6	23.3	19.9	16.4	19.1	17.9	12.3	20.4	8.8	27.4	22.8	21.7	26.1	23.5	11.6	28.1	13.1	22.6	14.0	8.5	10.3	17.9	17.4	14.1	15.3	20.1	15.4	6.0	8.3	6.0	4.6	4.2	4.7	2.5	3.3	5.4	23.4	9.3	6.2	4.3	15.4	4.6	5.5	5.8	6.1	5.5	11.3	1.7	10.2	5.8	11.1	5.4	2.6	2.4	9.9	4.9	8.4	3.2	6.7	5.5	4.0	6.9	9.3	6.5	2.5	2.2	7.8	0.9	2.9	4.4	8.0	12.9	6.6	13.9	5.1	21.0	5.6	0.7	4.6	5.3	8.3	25.1	13.2	4.2	20.7	4.0	10.3	11.3	3.5	4.7	8.2	3.0	8.8	8.1	1.8	2.8	3.6	10.2	3.8	4.6	6.0	4.7	4.1	3.4	3.0	3.5	4.1	3.3	6.0	3.1	2.9	3.5	4.2	4.5	8.3	2.6	2.5	18.1	17.2	24.5	30.5	15.4	13.8	12.8	15.6	12.3	10.3
ZNF397	"MGC13250, ZNF47, ZSCAN15"	ENSG00000186812	"Zinc finger protein 397"	Q8NF99	18	35241030-35267133	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026087	Uncertain		Approved	"Nucleoli,Plasma membrane,Microtubules,Cytosol"				"Nucleoli, Plasma membrane, Cytosol"	Microtubules	"HPA026087: AB_1859243"	"unprognostic (1.97e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.09e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.28e-2)"	"prognostic favourable (9.44e-4)"	"unprognostic (2.46e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.09e-3)"	15.1	17.7	20.3	16.8	31.1	5.7	20.6	23.9	26.4	16.2	15.0	27.9	16.7	13.3	22.7	16.5	13.4	15.2	12.9	14.6	20.2	13.8	14.9	12.7	13.6	18.8	34.8	19.3	23.6	17.1	25.3	24.8	14.7	25.6	18.4	18.0	13.8	17.5	16.3	15.0	17.2	15.9	18.9	30.5	19.0	16.7	11.9	35.1	22.0	20.2	8.3	19.2	17.3	16.8	13.3	8.1	12.4	9.4	4.8	9.4	2.2	2.9	5.8	13.8	12.5	15.3	13.0	6.6	6.1	6.1	3.0	4.0	2.1	4.2	15.1	5.5	4.8	8.1	8.9	6.6	4.3	9.5	5.5	0.6	7.6	6.1	5.1	7.2	5.5	5.8	9.0	3.6	10.6	1.9	8.8	10.6	7.8	6.4	12.1	5.6	11.9	2.3	12.8	4.0	10.7	6.3	7.9	15.0	12.9	9.9	5.3	5.9	9.2	5.4	3.0	10.2	5.7	3.4	2.7	17.2	6.4	8.8	9.0	5.1	9.6	9.4	5.1	8.4	6.6	8.0	4.8	10.3	6.3	5.3	3.6	13.3	9.4	6.5	12.4	4.8	9.4	8.1	3.2	2.2	20.3	31.1	23.9	26.4	20.2	13.8	34.8	19.3	25.6	35.1
ZNF404		ENSG00000176222	"Zinc finger protein 404"	Q494X3	19	43872363-43901385	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 8.4;U-2 OS: 30.8"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA032014, HPA063607"	Uncertain		Supported	"Nucleoli,Intermediate filaments"				Nucleoli	"Intermediate filaments"	"HPA032014: AB_10602591, HPA063607: "	"unprognostic (3.76e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.92e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.68e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.03e-5)"	"unprognostic (1.46e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.80e-3)"	0.9	2.2	4.6	0.7	4.8	0.1	2.6	5.8	4.8	1.5	2.5			0.2	2.0	10.9	1.2	3.7	2.2	6.0	4.6	4.4	1.5	1.0	1.8	3.1	6.0		7.5	0.8	2.6	8.2	2.6		4.6	1.6		2.6	2.2	1.5	2.9	1.0	1.8	7.0	3.9	1.9	3.4			2.6		1.2	1.5	1.1	1.9	0.9	1.9	0.4	2.1	1.9	0.6	2.2	0.3	2.3	0.3	5.9	8.4	1.4	3.1	1.5	2.0	2.8	0.2	0.8	0.0	3.3	1.5	0.3	0.4	1.6	2.7	0.3	2.3	0.8	0.0	0.9	2.1	0.2	0.6	5.0	3.8	1.5	1.4	1.7	0.1	0.0	1.8	0.2	0.0	0.0	1.9	0.5	0.0	1.3	0.4	1.9	1.5	1.2	1.0	1.3	0.6	1.6	0.1	0.9	0.7	2.9	30.8	2.5	1.8	4.0	5.2	0.0	4.1	0.0	1.6	0.0	0.3	1.9	0.7	0.0	0.8	0.9	1.4	0.0	0.4	1.9	1.9	1.5	0.0	2.1	0.4	0.9	1.3	0.6										
ZNF428	"C19orf37, MGC51082, Zfp428"	ENSG00000131116	"Zinc finger protein 428"	Q96B54	19	43607219-43619874	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042596, HPA048072"	Uncertain		Approved	Nucleoli,Mitochondria				Mitochondria	Nucleoli	"HPA042596: , HPA048072: "	"unprognostic (2.45e-3)"	"unprognostic (5.51e-2)"	"unprognostic (6.68e-3)"	"unprognostic (6.31e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.67e-2)"	"prognostic favourable (3.60e-5)"	"unprognostic (3.85e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.74e-2)"	18.8	31.2	36.8	15.8	37.6	18.9	9.2	25.9	48.8	13.7	14.2	14.4	8.8	17.0	18.8	14.9	8.8	13.0	18.4	19.9	31.3	28.7	17.4	15.5	13.1	15.5	27.0	31.1	19.2	19.4	9.8	19.2	12.7	18.0	20.1	6.3	14.8	21.7	13.2	37.7	6.6	13.7	17.2	22.2	16.8	16.6	19.7	17.0	17.8	16.6	8.7	8.9	10.0	11.4	7.8	7.1	9.4	3.2	3.1	8.5	1.0	11.0	8.9	13.9	23.0	5.4	3.9	6.6	8.4	3.9	5.9	6.3	5.5	7.4	18.7	19.3	6.4	2.7	5.6	1.5	1.9	15.8	23.6	20.5	9.3	9.2	10.5	16.0	17.0	7.2	3.5	5.2	2.8	8.3	21.4	11.8	6.1	11.7	39.5	28.7	9.3	6.2	39.4	6.4	13.7	7.1	6.7	26.8	31.3	12.2	7.5	18.8	4.6	23.1	16.3	7.1	20.3	6.8	12.8	13.3	15.9	32.8	10.3	16.4	15.7	2.5	2.5	9.4	7.8	1.4	4.4	5.2	7.1	7.4	2.7	7.8	8.5	3.7	1.3	3.1	3.2	7.1	4.1	1.0	36.8	37.6	25.9	48.8	31.3	28.7	27.0	31.1	18.0	17.0
ZNF444	"EZF2, FLJ11137, ZSCAN17"	ENSG00000167685	"Zinc finger protein 444"	Q8N0Y2	19	56132599-56160893	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 50.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056895, HPA065203"	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA056895: , HPA065203: "	"unprognostic (1.58e-1)"	"unprognostic (3.34e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (2.61e-4)"	"unprognostic (4.70e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.32e-1)"	"prognostic favourable (1.87e-4)"	9.4	13.4	15.0	7.1	21.0	3.7	8.3	14.9	20.1	9.0	14.8	12.8	14.3	13.6	10.5	9.9	6.6	11.9	11.2	10.5	13.5	13.3	9.9	37.4	10.9	6.1	12.3	11.0	12.5	25.3	8.5	12.2	12.5	8.0	14.3	5.3	10.4	14.1	25.6	17.2	11.5	11.3	7.5	10.3	8.6	17.2	9.2	10.4	28.1	16.6	2.8	8.2	10.4	6.8	4.3	3.5	3.5	1.7	3.7	7.1	1.8	4.6	9.0	8.3	7.2	3.5	3.6	5.3	5.9	3.9	5.1	5.6	9.8	5.3	8.2	5.3	3.4	4.3	5.1	4.0	2.2	7.1	50.4	8.1	6.0	17.6	5.8	3.6	7.5	4.2	3.7	4.2	3.2	4.5	10.4	3.7	3.6	6.0	11.6	10.1	8.9	16.4	13.5	5.3	4.3	5.6	4.4	8.9	12.1	3.0	10.1	4.4	10.0	6.6	5.8	9.2	7.9	1.9	6.5	8.9	7.6	6.2	5.8	4.9	5.9	3.1	1.7	3.5	4.1	1.4	4.5	2.0	6.9	6.9	2.1	4.3	7.1	4.6	0.2	3.7	1.0	3.5	4.2	1.8	15.0	21.0	14.9	20.1	13.5	13.3	12.3	11.0	8.0	10.4
ZNF461	"GIOT-1, MGC33911"	ENSG00000197808	"Zinc finger protein 461"	Q8TAF7	19	36637192-36666853	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA021139	Uncertain		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"				"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA021139: AB_10961418"	"unprognostic (8.37e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (3.64e-4)"	"unprognostic (2.08e-2)"	"unprognostic (6.32e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.11e-1)"	"unprognostic (7.01e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.21e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.86e-2)"	"unprognostic (5.11e-3)"	6.0	8.7	8.1	5.6	12.3	6.3	7.2	13.5	12.0	7.1	5.9	8.5	4.7	1.5	10.2	7.1	5.2	7.6	5.8	5.0	6.9	7.5	6.8	5.1	5.4	6.9	7.0	8.6	10.8	4.0	7.9	12.1	8.7	8.7	6.7	4.7	5.7	4.8	6.3	4.1	5.9	5.4	8.5	7.4	7.9	5.4	8.1	9.2	5.9	10.6	3.1	7.6	6.2	7.3	3.3	2.3	1.0	2.3	2.2	6.2	1.6	2.8	5.3	4.0	5.1	2.8	6.2	2.4	3.1	3.5	4.8	6.8	0.9	1.3	0.4	6.6	4.3	0.5	2.8	3.4	5.2	5.4	3.9	4.6	0.7	1.9	4.5	3.9	5.5	3.9	6.2	1.5	4.3	3.0	0.2	0.4	4.8	3.1	6.0	1.0	2.2	2.0	0.4	3.8	0.9	1.5	6.6	4.6	6.6	0.2	2.3	4.1	2.4	1.5	3.0	2.9	3.8	1.9	3.7	8.7	12.8	1.6	0.0	0.7	3.8	0.0	0.8	1.0	2.5	2.3	3.1	2.8	4.1	6.2	2.3	3.3	3.1	2.2	0.1	2.2	0.4	0.7	3.5	1.6	8.1	12.3	13.5	12.0	6.9	7.5	7.0	8.6	8.7	9.2
ZNF483	"KIAA1962, ZKSCAN16, ZSCAN48"	ENSG00000173258	"Zinc finger protein 483"	Q8TF39	9	111525159-111577844	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.3;pituitary gland: 40.4"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 11.5;SCLC-21H: 6.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055041			Approved	Nucleoli				Nucleoli		"HPA055041: "	"unprognostic (4.33e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.11e-2)"	"unprognostic (5.95e-3)"	"unprognostic (9.18e-5)"	"unprognostic (2.02e-1)"	"unprognostic (9.50e-2)"	"unprognostic (4.44e-3)"	"unprognostic (5.49e-2)"	"unprognostic (5.19e-4)"	"unprognostic (7.19e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.30e-2)"	"unprognostic (6.17e-2)"	3.2	10.1	13.9	2.1	30.5	7.7	5.6	35.9	36.3	6.1	4.0	8.6	2.9	2.0	10.0	11.9	2.4	7.0	4.9	4.7	18.1	7.3	5.1	2.5	3.9	3.4	9.5	23.0	12.6	4.3	13.6	40.4	1.8	24.4	7.2	2.4	5.9	3.2	7.7	2.3	3.5	2.9	5.5	9.8	4.8	3.9	11.8	10.3	0.0	12.5	0.0	3.1	4.7	4.8	2.5	1.0	4.6	1.0	2.1	6.5	1.5	0.3	3.2	3.1	4.7	0.4	0.6	1.0	0.4	1.5	3.1	2.9	0.3	1.5	0.5	0.5	1.3	0.9	1.5	1.6	1.9	0.2	1.8	1.6	4.4	2.5	0.9	0.6	0.4	1.2	0.6	1.7	0.9	2.9	1.3	0.8	0.7	3.0	0.2	0.8	11.5	1.1	0.3	4.8	0.4	1.2	1.3	6.7	3.2	1.2	0.6	0.8	1.9	0.4	0.5	0.9	1.6	1.4	2.2	0.7	1.9	0.4	1.0	0.5	0.7	4.6	1.0	0.6	4.8	0.5	2.7	1.5	3.3	2.3	0.3	2.5	5.9	6.5	3.4	2.1	0.7	1.0	1.6	1.5	13.9	30.5	35.9	36.3	18.1	7.3	9.5	23.0	24.4	10.3
ZNF507	KIAA1084	ENSG00000168813	"Zinc finger protein 507"	Q8TCN5	19	32345594-32387667	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030964, HPA049728"	Uncertain		Supported	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA030964: AB_10670562, HPA049728: "	"unprognostic (3.39e-1)"	"unprognostic (3.78e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.24e-2)"	"unprognostic (4.28e-3)"	"unprognostic (7.24e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.46e-2)"	10.9	8.7	11.3	16.0	13.1	13.5	12.0	18.4	16.4	12.0	11.4	9.0	10.2	10.0	12.4	9.8	9.6	12.2	10.3	10.1	9.4	8.1	9.0	11.1	8.2	10.5	12.3	10.3	18.6	10.9	13.6	15.7	16.9	11.1	10.7	9.9	6.8	11.0	9.6	21.0	8.6	14.7	11.9	12.9	9.6	9.7	28.3	13.0	17.1	18.7	10.0	10.5	11.0	20.1	4.0	0.4	2.3	1.4	2.0	4.7	1.4	9.1	18.2	13.6	8.4	8.9	14.0	11.0	8.2	8.1	7.6	8.5	10.5	7.2	13.6	10.2	7.9	5.3	19.8	10.2	14.7	10.5	17.9	13.9	8.8	7.1	10.7	11.6	7.6	8.8	7.8	9.7	15.8	10.2	20.5	11.0	8.0	5.7	12.4	3.8	14.6	5.8	13.0	15.8	5.5	4.6	10.2	11.2	9.7	10.9	7.4	9.0	5.8	8.4	10.8	12.2	13.1	7.1	10.6	10.7	12.4	14.1	8.6	8.6	11.0	0.4	0.1	2.3	4.1	0.0	4.7	2.5	3.1	2.8	0.0	4.0	4.2	3.4	2.0	2.0	1.4	0.4	2.4	1.4	11.3	13.1	18.4	16.4	9.4	8.1	12.3	10.3	11.1	13.0
ZNF519	"FLJ36809, HsT2362"	ENSG00000175322	"Zinc finger protein 519"	Q8TB69	18	14057457-14132490	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA028982	Uncertain		Approved	Nucleoli				Nucleoli		"HPA028982: AB_10610705"	"unprognostic (1.85e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.16e-5)"	"unprognostic (1.40e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.65e-4)"	1.8	1.4	2.8	1.9	7.6	1.4	2.8	13.7	14.4	5.7	4.6	0.7	0.8	1.2	7.0	2.6	3.4	4.5	1.8	1.9	3.4	1.6	0.8	1.0	2.7	6.6	1.7	4.0	8.7	1.2	1.1	1.5	1.2	3.0	2.6	2.6	2.0	1.6	2.7	1.0	2.0	2.1	6.0	2.1	2.2	1.4	3.0	2.5	1.1	2.0	0.9	1.9	4.3	3.8	1.7	0.1	0.0	0.6	0.5	3.5	0.7	1.3	0.3	5.9	6.2	0.8	1.2	1.6	1.6	0.9	3.5	3.1	2.6	1.2	3.1	1.6	1.2	0.9	4.8	1.2	4.0	1.8	3.3	5.4	1.7	1.1	0.2	11.1	2.4	0.6	1.5	2.8	1.2	0.6	2.7	4.6	2.0	1.8	6.7	4.4	2.6	1.4	7.2	5.7	3.8	0.9	1.8	9.1	2.4	2.3	0.7	1.8	0.7	3.0	0.4	5.6	7.5	2.5	1.8	1.8	1.2	4.5	1.8	4.3	4.7	0.0	0.3	0.0	1.1	0.6	1.8	1.7	1.4	1.5	0.1	0.8	3.5	2.2	0.0	0.5	0.5	0.1	2.0	0.7	2.8	7.6	13.7	14.4	3.4	1.6	1.7	4.0	3.0	2.5
ZNF554	FLJ34817	ENSG00000172006	"Zinc finger protein 554"	Q86TJ5	19	2819874-2835773	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA060247, HPA063358"	Uncertain		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA060247: , HPA063358: "	"unprognostic (3.81e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.58e-3)"	"unprognostic (5.05e-2)"	"unprognostic (7.36e-5)"	"unprognostic (1.65e-1)"	"prognostic favourable (9.31e-4)"	"unprognostic (1.82e-1)"	"unprognostic (3.37e-3)"	"prognostic favourable (4.69e-4)"	"unprognostic (1.57e-1)"	"prognostic favourable (1.99e-5)"	"unprognostic (1.75e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.79e-2)"	"prognostic favourable (5.00e-4)"	4.1	4.4	7.9	2.0	9.1	1.9	5.1	12.2	14.1	6.0	4.6	7.7	5.6	6.1	6.8	4.5	4.0	6.4	5.6	7.3	8.2	8.4	6.6	8.6	5.0	3.9	6.2	6.9	8.2	5.0	9.8	8.4	25.9	6.0	5.7	4.3	7.7	7.6	5.4	8.9	7.4	4.7	5.6	4.2	3.7	4.2	4.0	6.5	5.1	7.9	4.7	6.0	4.5	4.1	2.3	3.6	0.6	0.6	1.8	1.8	0.7	3.7	0.1	3.3	3.6	2.3	3.0	4.2	2.4	2.6	5.0	2.3	0.3	1.0	3.5	2.3	1.9	1.8	0.3	1.9	0.7	0.0	1.7	1.0	1.2	1.5	1.8	0.5	0.8	2.4	4.4	1.4	2.0	0.4	3.6	2.0	1.6	0.7	1.7	0.4	1.6	1.1	1.9	2.2	0.9	3.2	3.0	3.0	5.4	2.7	0.5	4.0	1.3	1.8	0.0	0.4	0.9	1.4	0.9	6.6	7.3	0.7	1.9	1.7	1.0	0.2	0.3	0.6	0.4	0.1	1.5	0.8	0.7	0.9	0.0	2.3	1.8	0.3	0.2	1.8	0.6	3.6	0.3	0.7	7.9	9.1	12.2	11.2	8.2	8.4	6.2	6.9	6.0	6.5
ZNF57	ZNF424	ENSG00000171970	"Zinc finger protein 57"	Q68EA5	19	2900898-2918476	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA061915			Approved	Nucleoli				Nucleoli		"HPA061915: "	"unprognostic (3.59e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.91e-2)"	"unprognostic (8.86e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.07e-2)"	"unprognostic (7.66e-2)"	"prognostic favourable (6.26e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.04e-2)"	"prognostic favourable (7.72e-4)"	"unprognostic (2.34e-3)"	"prognostic favourable (4.11e-9)"	"unprognostic (6.26e-3)"	"unprognostic (2.82e-2)"	"unprognostic (7.35e-2)"	"unprognostic (6.49e-3)"	3.6	2.9	3.6	3.2	4.7	4.0	7.3	17.2	5.7	6.2	15.7	2.3	5.1	7.8	5.6	4.2	11.0	4.7	4.0	4.2	3.3	2.7	9.2	3.9	4.9	2.9	2.6	3.2	5.4	7.4	3.9	4.1	5.8	4.2	6.1	10.1	3.6	5.5	8.7	7.4	18.6	18.5	2.1	2.4	3.6	11.7	26.4	3.9	2.9	5.4	7.0	6.6	5.0	7.9	4.9	3.6	1.4	5.8	6.3	8.4	4.1	6.8	3.2	4.5	6.6	4.3	3.8	7.6	2.9	2.3	4.7	4.9	6.7	2.7	5.8	3.8	2.4	8.1	7.1	10.1	5.9	0.0	3.7	3.4	3.8	8.8	3.3	0.0	6.4	3.0	11.3	4.1	9.0	3.5	6.0	0.1	3.7	6.9	8.8	3.8	2.9	5.7	8.2	13.8	1.3	6.4	11.3	2.3	3.4	4.3	8.1	2.8	5.0	5.6	2.8	3.3	3.2	7.4	4.1	1.2	6.6	2.9	2.7	0.9	2.5	0.0	3.3	1.4	6.5	5.8	5.4	4.9	7.1	6.7	3.6	4.9	8.4	7.4	1.2	6.3	3.1	3.4	7.1	4.1	3.6	4.7	17.2	5.7	3.3	2.7	2.6	3.2	4.2	3.9
ZNF571	HSPC059	ENSG00000180479	"Zinc finger protein 571"	Q7Z3V5	19	37554782-37594790	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 61.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA054762			Approved	"Nucleoplasm,Nucleoli,Plasma membrane"				"Nucleoplasm, Nucleoli"	"Plasma membrane"	"HPA054762: "	"unprognostic (1.16e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.19e-1)"	"unprognostic (9.03e-4)"	"unprognostic (5.77e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.90e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.71e-4)"	6.5	6.7	8.6	3.2	12.9	6.1	12.5	12.5	12.8	5.9	4.2	9.8	4.4	2.3	6.7	8.7	3.9	6.0	4.5	4.2	10.4	7.2	6.4	4.2	4.1	4.4	15.3	9.4	8.5	3.8	11.5	12.2	4.8	13.4	7.1	3.4	5.1	3.6	4.5	3.5	7.1	3.7	7.7	14.3	4.8	3.5	8.5	15.8	3.7	61.8	3.3	5.0	6.6	5.3	9.4	4.1	4.9	1.3	3.7	8.4	3.2	1.8	1.0	6.3	9.1	4.7	4.7	2.0	2.7	4.4	6.6	8.2	1.9	1.7	9.6	8.6	2.8	2.4	2.0	2.9	11.0	2.1	7.9	5.1	2.7	1.1	5.4	1.9	5.8	2.6	5.2	6.3	5.7	1.3	2.4	0.8	5.3	1.7	9.5	2.1	15.8	3.5	4.8	3.0	5.0	9.0	11.6	13.6	9.5	6.4	2.1	3.2	9.7	1.3	0.8	3.0	3.9	3.2	6.9	7.7	15.8	13.2	0.5	0.8	6.5	1.8	0.8	4.9	6.7	1.3	6.1	8.7	6.3	6.5	2.7	9.4	7.8	8.4	1.5	3.7	1.2	4.1	4.2	3.2	8.6	12.9	12.5	12.8	10.4	7.2	15.3	9.4	13.4	15.8
ZNF577	MGC4400	ENSG00000161551	"Zinc finger protein 577"	Q9BSK1	19	51804816-51890950	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA041499, HPA046761"	Uncertain		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA041499: , HPA046761: "	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.17e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.51e-3)"	"unprognostic (2.81e-3)"	"unprognostic (2.72e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.02e-2)"	"prognostic favourable (2.03e-4)"	7.9	6.8	13.4	5.8	15.5	4.2	13.9	14.6	12.1	10.2	10.9	9.9	15.5	5.1	12.3	11.1	6.3	10.0	8.9	8.0	14.8	5.6	11.0	5.5	6.8	5.6	7.6	8.7	27.2	7.1	17.4	7.5	10.1	9.9	17.4	7.6	17.2	12.9	16.1	9.4	22.3	8.1	14.4	11.0	10.1	7.1	22.5	14.9	3.8	16.3	5.2	6.3	8.8	10.2	9.4	3.2	7.1	4.0	4.6	4.6	1.8	1.2	0.1	6.6	8.1	11.4	12.4	0.0	7.7	2.9	3.0	6.1	0.8	1.0	1.3	0.8	3.5	2.1	2.6	1.6	1.6	0.0	7.6	12.7	0.1	1.1	8.9	2.8	4.3	9.7	5.0	4.4	1.3	1.5	2.8	0.0	3.8	0.0	7.8	3.6	7.6	0.2	3.4	3.3	2.3	4.9	2.9	2.7	1.4	1.9	0.9	6.5	1.3	3.1	1.0	5.6	7.7	1.6	2.8	5.4	0.0	1.7	1.5	0.5	8.9	7.1	2.6	5.7	1.7	4.0	4.6	9.4	3.0	3.6	2.8	5.1	3.8	2.4	1.2	4.6	3.0	3.2	1.4	1.8	13.4	15.5	14.6	12.1	14.8	5.6	7.6	8.7	9.9	14.9
ZNF583	FLJ31030	ENSG00000198440	"Zinc finger protein 583"	Q96ND8	19	56397966-56436035	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023805, HPA023957"	Uncertain		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA023805: , HPA023957: "	"unprognostic (9.89e-3)"	"unprognostic (5.52e-3)"	"unprognostic (8.14e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.69e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.79e-2)"	"unprognostic (8.43e-3)"	"unprognostic (5.00e-2)"	"unprognostic (9.54e-5)"	"unprognostic (2.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.54e-2)"	7.2	5.9	7.9	3.9	9.3	2.3	4.7	11.6	12.4	5.6	4.6	5.6	3.7	3.2	6.1	5.5	3.6	5.8	5.4	5.0	7.7	7.3	6.6	5.9	6.6	4.5	7.5	6.3	11.2	5.9	7.3	8.4	4.7	8.3	6.0	3.5	3.3	2.6	4.7	4.8	2.1	3.1	6.2	7.6	5.4	3.9	15.8	7.6	5.0	7.9	2.1	4.1	4.4	5.7	6.3	3.5	9.4	4.7	9.2	7.4	2.8	0.0	1.9	4.6	0.0	3.3	2.6	0.0	5.7	5.8	2.6	2.2	0.2	0.6	4.3	2.8	5.2	0.2	1.8	1.8	2.9	2.0	10.0	5.6	0.0	1.0	3.7	4.6	5.1	3.7	2.8	3.8	1.9	2.6	2.1	1.6	8.6	0.0	5.7	1.6	1.1	1.9	2.9	8.8	3.2	2.1	4.2	2.6	4.0	0.0	0.5	1.5	2.9	6.0	1.7	13.8	3.7	2.6	11.2	5.9	10.8	6.7	0.3	1.2	4.9	9.4	2.2	4.7	4.9	3.2	7.2	6.3	4.0	4.5	2.5	5.5	7.4	4.4	1.0	9.2	4.7	3.5	4.9	2.8	7.9	9.3	11.6	12.4	7.7	7.3	7.5	6.3	8.3	7.6
ZNF593	ZT86	ENSG00000142684	"Zinc finger protein 593"	O00488	1	26169871-26170873	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 59.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA054363, HPA059387"	Supported		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA054363: , HPA059387: "	"unprognostic (1.23e-2)"	"unprognostic (8.97e-2)"	"unprognostic (7.13e-2)"	"unprognostic (7.42e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.96e-2)"	"unprognostic (5.06e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.79e-2)"	11.7	11.5	9.4	10.7	9.4	15.7	18.3	7.2	12.1	9.0	11.7	7.0	12.1	11.4	8.7	9.0	10.9	8.4	11.3	14.5	8.9	10.0	13.5	30.8	7.7	16.8	10.0	7.0	11.6	36.2	9.7	9.3	12.7	10.9	10.4	5.8	5.9	15.9	12.0	59.3	9.8	11.0	6.5	7.3	13.0	15.2	9.3	8.3	5.4	15.1	17.2	9.2	10.6	10.1	23.5	26.8	0.7	25.0	16.1	21.7	14.1	20.0	11.0	3.8	13.3	3.7	4.8	20.1	8.9	4.5	10.4	10.0	16.9	12.2	23.4	16.5	5.6	13.1	12.9	11.6	3.8	14.0	41.2	15.9	9.0	25.6	15.9	21.9	14.0	8.8	11.4	11.5	12.1	8.7	23.9	9.1	6.1	15.3	8.9	40.8	15.0	39.3	11.2	6.6	23.6	7.4	8.8	10.1	11.0	10.8	27.2	34.0	11.3	12.4	9.0	10.0	11.9	21.0	16.6	17.9	18.0	25.3	11.8	45.6	12.8	0.1	15.7	0.2	14.2	25.0	13.3	23.5	20.1	14.0	21.7	22.7	15.0	14.3	0.7	16.1	25.0	26.8	21.7	14.1	9.4	9.4	7.2	12.1	8.9	10.0	10.0	7.0	10.9	8.3
ZNF596		ENSG00000172748	"Zinc finger protein 596"	Q8TC21	8	232137-264703	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 13.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA055463	Uncertain		Approved	Nucleoli,Mitochondria				"Nucleoli, Mitochondria"		"HPA055463: AB_2682821"	"unprognostic (3.30e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.07e-3)"	"unprognostic (9.68e-3)"	"unprognostic (2.10e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.84e-1)"	"unprognostic (1.70e-5)"	"unprognostic (6.37e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.51e-1)"	"unprognostic (4.53e-1)"	4.9	6.2	6.3	9.9	7.4	2.6	8.5	18.2	10.1	6.7	4.4	8.3	8.3	4.3	10.4	11.9	4.7	6.7	6.3	5.1	7.5	7.0	6.1	5.3	4.8	5.3	6.8	7.3	7.8	7.1	13.5	10.9	5.5	6.2	6.1	5.3	6.6	4.2	9.4	10.2	6.7	4.1	7.7	7.8	6.8	5.4	22.4	7.8	7.4	9.2	4.2	4.4	4.5	4.8	6.8	4.4	6.4	5.0	2.9	7.3	2.6	1.8	1.1	5.4	13.8	2.8	2.6	4.6	4.1	1.9	1.6	2.9	1.3	2.2	1.7	1.3	3.4	3.6	1.5	3.2	2.1	1.4	2.1	3.9	3.3	1.3	3.1	1.7	1.8	6.1	0.5	1.9	2.9	1.3	2.3	5.9	9.6	5.8	4.2	1.6	2.8	1.3	1.9	1.2	3.2	5.4	3.2	3.1	8.1	2.8	1.4	2.0	4.1	5.0	3.2	4.0	1.1	0.3	1.8	2.1	5.2	2.2	4.8	1.4	2.5	6.4	2.8	4.5	4.8	2.3	6.7	6.4	5.2	4.2	3.6	6.8	6.2	7.3	3.1	2.9	5.0	4.4	5.6	2.6	6.3	7.4	18.2	10.1	7.5	7.0	6.8	7.3	6.2	7.8
ZNF597	"FLJ33071, HIT-4"	ENSG00000167981	"Zinc finger protein 597"	Q96LX8	16	3432422-3443542	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 11.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.3"	"Low region specificity"	"Detected in all"							HPA001556	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA001556: AB_1080740"	"unprognostic (1.98e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.15e-3)"	"unprognostic (2.88e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.84e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.75e-3)"	"unprognostic (4.73e-2)"	"unprognostic (7.26e-2)"	"unprognostic (4.58e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.99e-3)"	6.7	6.7	4.5	4.6	8.5	5.0	5.9	5.2	8.7	4.7	4.2	7.3	2.4	3.8	5.6	6.8	4.0	5.9	6.0	5.4	4.8	4.4	5.2	5.4	7.4	6.1	4.5	4.5	7.2	5.2	4.5	7.7	7.9	8.9	4.8	3.2	5.8	4.6	4.9	3.6	4.4	5.1	4.1	4.6	5.4	4.8	13.2	5.4	5.4	6.4	2.6	5.6	5.7	4.6	1.4	1.1	11.3	2.2	0.9	2.2	0.8	0.0	1.8	2.2	5.3	1.7	2.6	8.6	2.5	3.1	2.5	3.1	0.0	3.3	4.3	2.5	2.9	1.4	5.1	2.3	3.2	2.6	2.0	7.5	4.8	3.1	2.5	4.4	4.5	3.3	3.6	2.8	3.1	6.8	1.6	2.9	2.8	1.4	3.1	4.6	7.3	0.0	2.0	6.6	3.0	2.0	7.0	2.9	4.1	5.1	2.6	1.9	2.2	6.7	4.4	4.1	2.1	0.0	2.4	3.8	4.0	0.5	0.0	2.5	2.5	3.8	1.1	11.3	1.3	2.2	2.2	1.4	1.0	1.1	1.1	1.1	1.9	1.4	0.3	0.9	1.0	0.5	1.6	0.8	4.5	8.5	5.2	8.7	4.8	4.4	4.5	4.5	8.9	5.4
ZNF615	FLJ33710	ENSG00000197619	"Zinc finger protein 615"	Q8N8J6	19	51991332-52008230	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA052422	Uncertain		Approved	Nucleoli,Mitochondria				Mitochondria	Nucleoli	"HPA052422: "	"unprognostic (2.20e-1)"	"unprognostic (4.66e-2)"	"unprognostic (4.56e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.08e-3)"	"unprognostic (7.28e-2)"	"unprognostic (5.23e-2)"	"unprognostic (3.68e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.44e-2)"	"unprognostic (4.41e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.16e-3)"	"unprognostic (3.03e-1)"	"unprognostic (1.82e-1)"	"prognostic favourable (2.98e-4)"	10.2	7.4	11.9	6.0	16.4	7.5	10.1	20.7	12.2	8.2	8.8	7.3	6.9	5.2	12.0	7.8	6.5	9.8	7.6	8.5	8.5	7.1	9.5	6.1	7.6	6.2	11.7	9.8	15.7	7.5	16.6	17.8	8.3	9.9	26.9	5.8	8.0	7.7	11.0	7.2	7.2	6.0	9.6	12.8	7.9	6.7	5.5	13.6	7.3	11.7	3.8	6.1	11.1	8.8	4.7	4.8	6.9	4.4	12.0	7.8	3.8	1.3	5.2	5.8	11.8	10.6	7.7	4.4	3.9	6.6	5.4	5.6	1.1	1.4	2.1	2.2	4.7	1.4	4.0	2.6	5.0	0.3	8.9	6.7	5.2	4.0	8.3	0.0	4.0	6.6	2.8	8.6	9.1	2.9	0.0	0.0	4.1	0.4	0.0	3.5	6.0	8.8	4.2	9.1	3.7	3.7	9.1	5.2	4.5	4.8	4.5	3.2	6.5	3.3	5.2	5.1	5.9	3.3	2.8	4.0	10.5	2.6	3.0	0.0	8.2	6.9	3.0	5.8	3.7	4.4	7.8	3.9	6.6	5.3	4.8	4.7	6.6	4.3	4.1	12.0	2.7	2.9	5.7	3.8	11.9	16.4	20.7	12.2	8.5	7.1	11.7	9.8	9.9	13.6
ZNF622	"MGC17552, MGC2485, ZPR9"	ENSG00000173545	"Zinc finger protein 622"	Q969S3	5	16451519-16465792	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036514, HPA036515"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"	"Nucleoplasm, Nucleoli"	"HPA036514: , HPA036515: AB_10672224"	"unprognostic (6.29e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.00e-2)"	"unprognostic (6.53e-2)"	"unprognostic (8.24e-3)"	"unprognostic (4.71e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.69e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	14.3	10.8	18.3	12.1	19.4	28.8	14.8	20.5	20.3	12.6	19.5	14.5	9.5	15.5	14.4	16.9	13.6	13.2	12.3	38.6	13.8	14.6	14.8	18.8	12.8	14.5	16.8	15.5	15.1	45.9	12.5	15.0	16.0	17.2	13.1	19.8	10.9	17.5	12.8	29.0	18.6	19.6	12.6	12.8	12.4	15.9	14.1	17.3	14.0	16.7	11.9	15.4	13.7	14.9	50.4	45.6	55.4	45.9	39.1	56.9	47.2	11.0	24.2	7.6	15.6	18.6	15.9	27.6	19.9	15.1	16.3	20.8	28.7	10.3	13.0	26.9	15.7	14.6	12.2	15.5	13.1	17.4	16.5	11.8	42.9	20.5	26.8	22.9	14.2	24.5	19.7	15.1	14.3	11.3	15.9	12.9	17.8	18.6	12.0	22.4	13.4	23.9	9.5	9.2	11.0	15.0	16.6	10.5	11.8	27.8	20.9	32.2	11.6	17.8	15.4	18.2	13.9	17.6	12.6	18.6	16.6	18.1	15.8	19.9	12.6	45.2	41.6	52.9	49.1	43.4	51.2	50.4	49.5	53.7	45.6	47.0	56.9	47.7	55.4	39.1	45.9	37.0	50.1	47.2	18.3	19.4	20.5	20.3	13.8	14.6	16.8	15.5	17.2	17.3
ZNF627	FLJ90365	ENSG00000198551	"Zinc finger protein 627"	Q7L945	19	11559374-11619135	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA049770, HPA073463"	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA049770: , HPA073463: "	"unprognostic (1.81e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.14e-2)"	"unprognostic (7.89e-3)"	"prognostic favourable (8.12e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.67e-2)"	"prognostic favourable (6.93e-7)"	"unprognostic (2.10e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.91e-1)"	"unprognostic (6.39e-3)"	10.3	8.4	9.9	10.1	11.1	10.5	17.5	15.6	12.8	13.8	9.2	11.1	15.4	8.1	16.7	14.6	7.9	19.4	10.1	8.4	9.2	10.0	15.4	11.0	9.6	10.3	12.3	10.0	20.9	19.7	9.3	17.8	9.8	10.3	13.4	11.0	12.5	11.6	14.8	7.7	10.1	8.5	14.1	9.6	9.9	9.2	12.1	11.8	17.4	19.9	7.8	11.3	11.9	13.8	10.2	8.0	13.4	5.6	7.9	8.9	4.8	4.7	3.9	12.8	15.7	5.8	6.1	7.2	7.1	8.4	8.1	8.2	3.3	3.3	3.5	7.1	5.5	4.3	5.1	6.9	9.1	6.3	2.3	10.0	2.5	6.3	11.0	5.6	5.8	7.3	9.9	5.5	12.2	8.9	9.4	5.1	10.6	9.9	9.0	5.7	9.4	8.6	10.0	9.7	4.8	9.2	7.5	17.8	12.8	9.3	5.2	9.8	9.2	16.0	7.8	8.7	4.0	4.9	4.9	7.3	7.0	3.9	4.0	9.3	7.1	13.4	4.9	7.8	5.4	5.6	6.4	10.2	6.6	6.6	8.0	6.9	8.9	7.9	2.6	7.9	5.3	3.1	3.6	4.8	9.9	11.1	15.6	12.8	9.2	10.0	12.3	10.0	10.3	11.8
ZNF668	FLJ13479	ENSG00000167394	"Zinc finger protein 668"	Q96K58	16	31060843-31074320	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043048	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA043048: AB_10962503"	"unprognostic (2.71e-2)"	"unprognostic (4.95e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.27e-1)"	"unprognostic (7.20e-3)"	"unprognostic (6.73e-5)"	"unprognostic (4.03e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.71e-3)"	"prognostic unfavourable (6.24e-4)"	"unprognostic (1.72e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.83e-3)"	"unprognostic (7.25e-2)"	7.1	8.2	8.2	8.9	10.0	18.5	5.9	11.1	15.4	8.3	10.2	6.6	5.1	11.8	9.4	5.6	8.0	6.1	9.6	5.1	8.6	7.4	5.9	6.9	7.3	8.6	7.6	5.2	5.7	10.6	4.6	6.7	10.1	9.2	8.1	4.2	4.9	7.2	7.6	12.6	9.0	10.3	9.5	6.5	8.6	8.8	10.0	6.1	16.9	5.4	8.8	7.5	6.6	6.5	5.6	7.3	8.6	4.8	8.4	13.9	5.4	3.7	12.7	2.8	7.0	3.0	3.1	9.8	10.5	7.7	5.2	4.4	5.7	5.1	5.9	8.4	6.1	6.7	1.9	5.6	1.3	7.5	8.3	3.6	7.9	9.2	3.7	5.7	9.1	3.8	2.3	9.1	1.8	3.8	6.8	3.8	9.5	12.5	12.1	12.4	10.2	10.7	16.1	21.4	8.6	2.8	8.2	10.0	11.7	6.6	9.4	3.2	7.1	8.4	6.4	13.1	5.5	9.9	4.5	6.3	10.2	8.4	8.7	6.0	8.5	7.6	4.8	8.6	13.9	4.7	9.2	5.6	4.1	8.4	7.3	4.4	4.5	5.6	1.7	8.4	3.8	3.9	4.3	5.4	8.2	10.0	11.1	15.4	8.6	7.4	7.6	5.2	9.2	6.1
ZNF678	MGC42493	ENSG00000181450	"Zinc finger protein 678"	Q5SXM1	1	227563543-227677443	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA028507	Uncertain		Approved	Nucleoli,Mitochondria,Cytosol				"Mitochondria, Cytosol"	Nucleoli	"HPA028507: AB_10603567"	"unprognostic (1.76e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.42e-3)"	"unprognostic (3.92e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.54e-6)"	"unprognostic (1.39e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.88e-4)"	9.0	7.6	8.2	6.6	16.2	7.1	8.8	19.4	10.8	9.3	7.2	6.7	7.1	5.4	9.2	6.2	6.1	7.7	7.4	7.4	8.9	6.3	6.4	5.3	7.8	9.8	12.7	8.2	9.9	12.6	7.2	19.4	9.7	8.9	10.6	10.8	4.6	7.6	6.3	6.2	5.2	6.6	7.5	14.2	9.5	7.6	8.7	15.5	12.0	12.7	5.1	9.1	8.2	9.4	6.6	3.2	7.1	1.1	2.2	3.2	1.5	2.0	3.2	11.8	13.4	1.4	3.4	7.1	2.7	2.7	4.0	4.3	2.5	2.5	8.2	7.1	1.2	3.9	6.9	1.8	6.7	3.4	13.2	3.9	2.5	1.6	2.6	6.5	10.5	2.9	3.3	2.4	5.3	3.8	9.7	13.0	4.4	1.7	9.0	2.3	10.3	5.4	7.0	7.6	3.2	3.0	6.4	5.0	9.8	4.1	4.8	2.0	6.7	8.3	2.5	5.1	4.8	4.5	5.5	4.2	9.5	9.0	2.1	1.2	5.2	7.1	1.1	1.3	2.5	0.3	3.0	6.6	2.5	1.4	2.1	4.5	2.2	3.2	0.2	2.2	0.7	3.2	2.7	1.5	8.2	16.2	19.4	10.8	8.9	6.3	12.7	8.2	8.9	15.5
ZNF691	Zfp691	ENSG00000164011	"Zinc finger protein 691"	Q5VV52	1	42846573-42852477	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062527	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles				Nucleoplasm	"Nucleoli, Vesicles"	"HPA062527: "	"unprognostic (4.34e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.32e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.50e-2)"	"prognostic unfavourable (7.33e-6)"	"unprognostic (1.40e-3)"	"unprognostic (2.65e-3)"	"unprognostic (5.12e-2)"	"prognostic favourable (6.25e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.05e-1)"	7.8	14.6	13.6	11.2	15.5	2.9	15.6	10.8	14.4	12.9	12.6	18.3	14.1	8.8	16.9	21.8	9.1	14.2	8.4	11.4	11.9	9.8	14.2	24.1	9.9	16.0	12.2	12.1	18.6	13.4	19.2	17.3	12.7	12.3	16.8	10.2	12.3	15.2	18.5	10.9	12.8	10.6	13.5	11.9	17.7	10.8	13.9	14.8	17.9	19.3	6.4	16.8	11.8	10.0	20.5	12.5	18.2	11.2	18.4	19.3	12.8	4.5	6.4	13.1	10.8	11.8	9.1	1.7	5.5	6.7	9.0	9.0	4.5	6.8	11.3	8.6	5.1	8.1	12.5	7.2	7.8	20.2	12.7	11.8	17.6	8.1	8.8	4.5	2.5	7.8	8.9	11.2	9.3	9.1	11.4	4.9	8.7	3.6	13.4	6.0	19.5	4.8	9.2	16.4	7.7	8.3	4.4	9.4	9.3	5.6	10.2	9.4	5.6	15.5	4.7	9.0	9.5	5.0	5.9	11.9	9.4	3.3	6.3	5.5	7.5	18.2	11.2	16.0	12.2	9.7	15.7	15.9	16.4	16.4	11.1	20.5	15.8	15.7	6.3	18.4	10.0	12.5	19.3	12.8	13.6	15.5	10.8	14.4	11.9	9.8	12.2	12.1	12.3	14.8
ZNF692	"AREBP, FLJ20531, Zfp692"	ENSG00000171163	"Zinc finger protein 692"	Q9BU19	1	248850006-248859144	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059337, HPA062792"	Uncertain		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA059337: , HPA062792: "	"unprognostic (4.86e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.85e-3)"	"unprognostic (5.66e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.50e-2)"	"prognostic favourable (4.09e-4)"	"unprognostic (5.65e-3)"	"prognostic unfavourable (7.72e-9)"	"unprognostic (5.32e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.59e-1)"	"prognostic favourable (8.35e-5)"	5.6	8.7	15.3	7.9	25.0	11.1	10.7	27.7	22.3	11.6	8.1	16.5	17.8	8.3	13.6	15.1	9.7	13.1	9.4	7.4	20.1	11.6	9.7	8.6	6.9	9.8	30.4	14.3	17.2	12.2	18.4	13.8	8.1	21.2	14.9	7.0	7.7	21.9	11.1	11.5	19.6	8.9	9.2	18.3	10.0	8.7	22.9	25.7	6.6	11.3	9.2	7.8	9.1	8.8	4.6	4.4	4.8	2.1	10.6	6.4	2.8	4.8	5.1	4.3	10.7	3.7	1.9	18.6	4.1	1.4	4.7	3.0	5.8	7.0	6.0	8.5	2.0	6.9	6.5	6.2	3.4	8.9	4.3	7.0	10.8	1.6	2.8	7.9	5.7	2.4	7.9	4.8	12.8	4.3	14.5	4.4	2.1	3.4	4.0	16.3	8.7	11.1	13.6	2.7	12.0	9.0	3.6	8.5	6.3	4.4	7.8	8.4	9.5	12.9	3.0	2.1	3.5	2.3	5.6	12.4	7.8	3.7	4.6	10.5	3.5	0.0	2.1	1.9	5.7	1.6	4.9	4.6	4.5	6.0	4.4	3.8	6.4	4.6	4.8	10.6	1.4	3.5	4.7	2.8	15.3	25.0	27.7	22.3	20.1	11.6	30.4	14.3	21.2	25.7
ZNF696	FLJ14129	ENSG00000185730	"Zinc finger protein 696"	Q9H7X3	8	143289676-143298061	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA057855, HPA072473"	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA057855: , HPA072473: "	"unprognostic (3.23e-2)"	"prognostic unfavourable (6.63e-5)"	"unprognostic (3.62e-2)"	"prognostic unfavourable (3.52e-5)"	"unprognostic (2.58e-1)"	"unprognostic (7.86e-2)"	"unprognostic (2.76e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.02e-1)"	"prognostic favourable (1.41e-4)"	"unprognostic (6.57e-2)"	"unprognostic (8.22e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.42e-3)"	"unprognostic (8.09e-3)"	8.5	6.9	10.3	8.1	10.6	6.3	6.9	13.9	13.7	5.6	5.4	9.8	5.4	13.5	8.8	4.8	5.0	6.6	7.1	5.2	10.4	10.3	7.2	8.1	7.6	8.6	12.6	7.2	9.8	13.7	8.6	6.7	5.5	10.6	7.5	4.1	7.2	11.9	5.1	7.7	13.3	8.0	10.7	8.9	8.3	6.5	6.9	12.8	6.5	7.5	3.0	6.6	7.2	5.2	6.4	6.4	2.3	3.3	5.3	7.5	3.3	6.2	5.8	5.6	6.7	2.4	1.6	12.2	4.9	1.6	3.5	2.1	3.3	4.9	0.4	6.9	1.7	4.4	6.5	2.7	3.1	7.0	14.2	8.4	5.5	5.0	2.4	3.3	10.7	1.4	4.4	2.3	4.9	1.7	17.3	3.8	2.1	12.5	3.6	6.9	8.0	14.9	7.7	3.5	6.2	1.9	4.5	9.6	13.4	7.5	4.9	6.1	7.9	6.1	3.5	4.8	11.1	4.3	8.7	8.0	5.4	7.8	3.3	6.9	5.6	1.1	3.3	2.3	5.3	1.9	5.8	4.2	4.0	5.9	3.7	6.4	7.5	6.2	1.4	5.3	2.9	6.4	1.3	3.3	10.3	10.6	13.9	13.5	10.4	10.3	12.6	7.2	10.6	12.8
ZNF71	"Cos26, EZFIT"	ENSG00000197951	"Zinc finger protein 71"	Q9NQZ8	19	56595264-56626481	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA018124	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA018124: AB_1848339"	"unprognostic (1.93e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.03e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.90e-3)"	"unprognostic (3.91e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.97e-3)"	11.8	6.4	12.9	6.9	8.7	3.5	11.7	12.0	12.5	7.9	9.9	10.2	6.5	6.7	12.3	6.6	8.6	8.7	7.0	10.5	9.3	8.0	6.4	3.4	9.6	10.6	7.7	10.2	12.3	8.8	7.6	8.5	8.0	9.3	8.7	5.0	6.4	8.9	10.5	10.6	7.4	6.0	16.6	8.5	10.2	7.0	8.7	8.2	9.8	7.5	5.9	6.2	10.0	10.7	7.0	4.9	6.8	4.2	9.0	8.3	4.2	3.4	6.6	9.7	8.0	4.0	3.6	6.2	4.0	3.7	2.7	3.9	1.2	1.0	2.9	3.6	3.3	1.2	2.1	3.0	2.4	0.0	20.0	4.4	0.9	2.6	3.4	5.5	4.3	4.1	3.2	2.8	1.8	4.4	2.5	0.0	3.0	0.0	11.2	2.0	7.5	6.5	4.1	6.0	2.4	1.9	3.9	8.6	10.4	2.7	3.7	4.0	2.1	5.6	5.8	9.3	5.2	2.2	6.3	2.8	3.5	4.4	3.1	3.2	2.5	2.9	3.2	6.8	7.7	2.0	8.3	6.5	6.4	7.3	4.9	7.0	7.2	7.4	1.3	9.0	4.2	3.7	6.6	4.2	12.9	8.7	12.0	12.5	9.3	8.0	7.7	10.2	9.3	8.2
ZNF713	FLJ39963	ENSG00000178665	"Zinc finger protein 713"	Q8N859	7	55887475-55942225	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 10.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 6.9"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA059425, HPA062887"	Uncertain		Approved	Nucleoli				Nucleoli		"HPA059425: , HPA062887: "	"unprognostic (5.27e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.07e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.77e-3)"	"unprognostic (7.78e-2)"	"unprognostic (4.80e-2)"	"unprognostic (8.00e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.63e-3)"	2.0	2.7	7.0	2.6	9.7	4.1	4.0	5.6	9.3	3.8	2.2	10.6	2.7	2.7	5.5	3.5	1.7	7.1	2.9	2.4	7.8	6.1	3.9	1.7	2.6	1.7	13.4	4.8	5.6	3.2	4.2	8.1	2.2	7.3	4.1	1.9	2.6	2.4	2.9	4.7	3.1	1.9	3.7	9.8	2.5	4.0	9.4	10.6	6.9	4.9	0.4	1.8	2.1	2.0	2.2	1.7	6.9	1.3	1.4	1.0	0.4	1.7	1.2	7.3	6.6	0.9	1.0	2.6	0.8	0.5	1.0	1.4	0.6	2.3	3.0	2.6	0.6	0.7	1.8	0.6	1.4	1.7	2.9	0.7	2.5	1.9	1.2	3.7	2.0	1.7	1.5	0.5	1.3	1.7	1.9	1.4	1.2	1.6	3.6	2.2	4.9	1.4	3.1	1.8	0.4	3.5	3.2	8.4	10.0	4.2	1.1	1.2	2.7	3.2	1.9	0.9	3.5	0.7	1.2	1.6	2.2	1.3	0.6	2.0	6.2	3.7	1.3	3.3	0.9	1.0	0.6	1.3	0.7	0.6	0.4	2.2	0.9	1.0	6.9	1.4	1.0	1.7	0.4	0.4	7.0	9.7	5.6	9.3	7.8	6.1	13.4	4.8	7.3	10.6
ZNF77	pT1	ENSG00000175691	"Zinc finger protein 77"	Q15935	19	2933218-2944971	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA023397	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA023397: AB_1859447"	"unprognostic (1.17e-2)"	"prognostic favourable (8.49e-4)"	"unprognostic (2.18e-1)"	"prognostic favourable (6.65e-5)"	"unprognostic (2.01e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.21e-1)"	"prognostic favourable (6.79e-6)"	"unprognostic (2.06e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.93e-3)"	"unprognostic (2.65e-3)"	"unprognostic (3.20e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.79e-3)"	6.3	6.6	6.6	5.4	8.9	5.6	13.2	18.2	9.8	8.4	6.1	8.4	9.9	4.1	8.5	8.5	7.5	7.3	4.2	7.4	5.9	5.8	6.4	6.3	12.7	6.6	7.0	7.8	9.7	8.2	8.2	8.2	8.2	6.5	6.9	6.4	8.9	11.4	6.7	6.1	8.3	6.1	8.7	5.5	6.8	8.1	8.3	4.3	9.6	8.8	4.0	9.3	6.4	6.7	5.5	3.7	1.3	3.1	3.9	6.2	3.3	4.7	2.2	10.8	6.3	2.3	3.0	4.9	2.9	4.3	5.8	6.9	7.3	1.9	5.3	2.4	3.2	3.8	7.0	4.7	9.8	0.4	5.2	6.4	3.4	8.1	5.7	0.2	5.3	4.6	6.5	4.5	6.7	8.0	8.4	0.0	3.9	5.2	7.8	4.6	2.4	3.1	8.9	8.3	3.7	4.6	7.4	4.4	8.3	4.4	4.2	5.0	4.0	11.1	3.8	2.4	3.1	6.8	5.2	5.5	5.3	2.5	6.2	0.1	4.4	0.0	2.7	1.3	5.5	2.6	6.2	5.5	5.8	5.9	3.7	5.3	4.5	6.2	0.2	3.9	3.1	3.0	2.8	3.3	6.6	8.9	18.2	9.8	5.9	5.8	7.0	7.8	6.5	4.3
ZNF771	DSC43	ENSG00000179965	"Zinc finger protein 771"	Q7L3S4	16	30407297-30431108	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 26.4;REH: 16.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030730, HPA046672, HPA059398"	Uncertain		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA030730: , HPA046672: , HPA059398: "	"unprognostic (8.21e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.12e-5)"	"unprognostic (3.53e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.99e-3)"	6.6	6.7	15.3	5.0	14.5	4.0	5.3	10.7	18.3	6.6	6.1	4.9	6.6	4.5	10.4	7.2	4.6	7.5	6.1	4.6	13.4	10.6	9.2	8.6	4.1	3.3	8.8	16.9	10.8	7.3	8.1	6.2	2.4	8.8	10.1	5.4	4.0	4.9	12.3	18.2	6.1	4.3	9.6	5.1	3.6	4.8	3.7	8.1	1.9	5.4	3.5	4.2	6.8	5.6	6.6	3.7	1.9	2.5	1.8	6.2	2.7	3.1	3.5	4.9	4.0	7.1	3.0	3.8	4.5	2.2	2.9	3.0	1.5	1.5	3.7	7.8	2.3	2.3	5.1	2.0	3.0	1.3	26.4	3.1	2.4	4.7	3.6	1.5	3.7	4.5	1.6	3.7	2.2	2.9	7.6	2.3	2.4	5.6	3.7	5.1	3.9	2.8	16.9	3.7	2.4	1.7	1.2	7.8	4.8	2.4	2.2	2.9	2.8	1.8	2.6	4.9	5.8	2.8	3.3	3.4	3.7	1.9	3.2	3.4	3.1	1.0	1.1	0.7	3.6	2.5	4.9	2.7	4.3	4.2	2.8	6.6	6.2	3.7	1.9	1.8	0.5	3.7	4.4	2.7	15.3	14.5	10.7	18.3	13.4	10.6	8.8	16.9	8.8	8.1
ZNF787		ENSG00000142409	"Zinc finger protein 787"		19	56087366-56121280	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 43.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035140	Supported		Approved	Nucleoplasm,Nucleoli,Mitochondria				Nucleoplasm	"Nucleoli, Mitochondria"	"HPA035140: AB_10602358"	"unprognostic (1.97e-2)"	"unprognostic (5.86e-2)"	"unprognostic (8.77e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.96e-3)"	7.4	8.0	4.3	7.8	5.2	18.8	7.1	4.7	7.0	8.0	9.8	5.1	8.5	12.8	5.8	6.5	9.8	8.7	8.7	10.2	4.0	4.3	6.4	18.0	6.9	7.7	4.8	4.0	8.7	13.9	3.3	6.6	4.8	4.6	10.0	3.9	7.9	9.6	7.2	28.2	9.3	10.5	6.8	3.1	14.9	11.0	6.8	4.6	4.8	10.0	8.2	5.7	8.7	10.1	3.0	5.5	4.9	2.1	1.2	1.6	0.7	11.8	11.7	3.8	8.0	1.1	2.4	10.0	6.2	2.4	4.2	4.8	6.9	7.4	8.5	0.4	2.6	9.4	2.4	5.0	1.9	11.2	43.4	13.5	5.9	10.4	6.2	12.9	11.9	3.2	4.9	3.5	6.1	3.1	16.1	9.6	2.4	7.5	8.0	16.3	12.1	22.2	10.0	5.6	10.8	4.3	7.9	14.7	14.3	6.5	12.8	11.4	7.9	18.4	6.6	16.0	11.4	6.7	16.9	20.4	14.9	8.2	9.2	8.7	7.4	1.7	2.1	2.6	1.2	1.5	1.6	2.3	0.8	1.0	2.2	3.0	1.3	0.7	4.9	1.2	1.4	5.5	1.3	0.7	4.3	5.2	4.7	7.0	4.0	4.3	4.8	4.0	4.6	4.6
ZNF790	"FLJ20350, MGC62100"	ENSG00000197863	"Zinc finger protein 790"	Q6PG37	19	36817428-36850787	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA056134, HPA060288"	Uncertain		Approved	Nucleoli				Nucleoli		"HPA056134: , HPA060288: "	"unprognostic (1.14e-1)"	"unprognostic (3.79e-2)"	"unprognostic (3.87e-1)"	"prognostic unfavourable (7.66e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.48e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.85e-2)"	6.6	8.9	9.3	9.9	15.9	3.2	7.2	21.5	14.8	7.6	6.4	12.5	7.1	6.4	7.7	7.7	7.5	6.1	8.1	8.8	10.8	7.9	10.3	13.8	6.1	7.9	14.2	7.2	7.8	7.3	11.6	14.5	6.0	13.1	6.8	4.5	7.4	5.7	7.3	7.3	15.6	6.1	6.1	11.4	7.4	7.9	20.4	15.9	8.5	13.2	4.9	6.8	7.7	7.9	9.7	6.8	6.8	6.2	6.7	9.0	3.0	0.0	0.7	6.3	11.5	4.4	4.7	4.1	4.5	6.1	3.6	6.5	0.0	1.4	1.4	9.0	3.2	1.7	5.0	4.0	3.2	10.3	4.5	7.4	0.7	1.7	3.8	3.2	5.5	6.0	3.4	3.1	0.0	6.1	0.2	0.1	7.9	3.5	8.3	2.6	4.3	0.8	1.5	5.3	5.6	3.8	8.3	7.9	7.2	4.2	0.1	2.5	5.2	6.2	6.6	4.9	3.8	4.5	5.8	9.0	12.6	5.2	0.0	0.2	3.9	6.0	3.7	6.8	5.9	6.2	6.1	9.0	8.4	8.3	6.8	9.7	9.0	7.4	1.3	6.7	2.2	5.6	6.8	3.0	9.3	15.9	21.5	14.8	10.8	7.9	14.2	7.2	13.1	15.9
ZNF793		ENSG00000188227	"Zinc finger protein 793"	Q6ZN11	19	37506939-37548762	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.4;RT4: 9.7;U-266/70: 16.9;U-266/84: 11.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA034781	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA034781: AB_10602784"	"unprognostic (4.80e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.26e-1)"	"unprognostic (7.13e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.69e-3)"	"unprognostic (4.16e-3)"	"unprognostic (1.03e-4)"	"unprognostic (4.94e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.62e-1)"	"unprognostic (1.24e-2)"	"unprognostic (8.12e-3)"	3.1	7.7	12.5	4.9	11.9	2.1	6.4	22.1	14.0	6.4	4.2	12.8	4.6	3.0	9.3	6.9	5.2	6.7	4.6	6.8	10.3	8.0	6.2	1.1	3.3	5.6	8.3	10.0	14.1	4.0	15.7	18.4	4.5	11.2	7.5	6.0	8.1	3.6	5.8	3.7	10.7	3.6	6.1	10.1	5.6	5.3	12.3	9.6	2.1	11.0	3.2	4.9	4.9	5.7	4.0	2.1	7.2	1.6	4.0	2.8	1.4	0.1	0.2	4.2	11.4	0.9	0.9	0.2	3.3	0.2	0.7	0.3	0.2	1.3	2.9	5.5	1.7	0.4	0.3	2.8	0.3	0.8	4.2	0.3	0.4	0.3	2.1	0.2	2.6	3.4	2.5	0.6	0.1	0.1	0.1	0.5	0.5	3.2	0.3	0.4	6.9	0.3	0.1	0.1	0.6	2.8	9.7	3.1	6.7	0.2	0.2	0.0	6.4	0.3	0.4	0.1	1.8	0.2	3.2	16.9	11.3	0.2	0.0	0.2	0.5	7.2	1.6	1.2	1.5	0.6	2.3	2.0	2.8	2.5	1.2	4.0	1.9	2.4	4.2	4.0	0.6	2.1	2.2	1.4	12.5	11.9	22.1	14.0	10.3	8.0	8.3	10.0	11.2	9.6
ZNF800		ENSG00000048405	"Zinc finger protein 800"	Q2TB10	7	127346790-127431924	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023090, HPA052194"	Approved		Supported	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA023090: AB_1859457, HPA052194: "	"unprognostic (2.93e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.43e-2)"	"unprognostic (8.99e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.96e-3)"	17.5	11.2	10.8	14.4	11.7	61.7	18.7	18.6	12.7	11.9	11.9	6.3	12.8	10.3	14.6	10.4	15.4	13.5	11.6	9.5	10.2	5.9	8.9	14.4	16.5	20.7	13.5	9.2	15.2	15.3	16.2	18.6	10.8	12.6	10.5	10.5	7.1	15.1	16.1	14.9	22.7	14.8	11.5	15.7	15.2	13.1	19.1	12.8	22.4	12.7	10.9	13.8	14.4	15.5	14.2	12.0	16.9	6.8	18.9	17.2	5.9	8.9	4.7	5.5	9.6	8.0	10.7	5.3	8.7	10.3	9.0	8.7	4.3	8.6	15.3	5.4	8.2	6.6	9.0	9.3	12.4	13.4	5.3	9.8	4.8	4.0	10.1	13.4	18.9	9.1	8.6	9.9	13.4	9.5	12.1	15.8	9.7	6.8	14.8	9.7	4.6	6.2	9.2	7.8	10.1	6.6	11.3	7.9	8.3	8.6	34.1	11.1	4.0	9.2	10.2	15.1	4.8	9.9	10.2	18.9	8.3	22.1	11.2	12.3	12.5	16.9	6.8	10.1	13.3	6.3	14.0	12.0	10.0	13.5	7.0	14.2	16.4	17.2	6.0	18.9	6.6	12.0	13.8	5.9	10.8	11.7	18.6	12.7	10.2	5.9	13.5	9.2	12.6	12.8
ZNF816	ZNF816A	ENSG00000180257	"Zinc finger protein 816"	Q0VGE8	19	52949379-52962911	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 32.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA042466	Uncertain		Approved	Nucleoli				Nucleoli		"HPA042466: AB_10797497"	"unprognostic (1.83e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.91e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.33e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.72e-2)"	"unprognostic (5.36e-3)"	"unprognostic (6.21e-2)"	"unprognostic (5.45e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.39e-2)"	6.2	6.4	4.9	8.0	8.3	2.8	8.0	14.7	6.6	10.2	8.9	4.5	12.5	4.7	6.7	10.1	8.4	12.1	9.8	5.8	5.0	3.3	9.6	3.2	7.0	7.1	10.4	3.4	9.5	8.7	6.7	11.8	9.2	6.1	15.5	10.4	4.5	8.6	9.8	2.4	5.3	7.3	8.0	9.1	11.0	9.4	5.4	8.9	18.9	10.2	5.8	8.5	14.3	9.4	11.6	8.4	14.4	7.7	17.6	17.5	7.4	4.0	0.1	3.7	9.5	6.9	7.6	10.9	3.4	3.5	4.4	6.5	3.2	2.7	10.9	7.2	3.0	2.4	5.3	3.9	4.3	5.4	11.2	5.1	4.2	4.9	2.3	0.0	7.9	3.6	5.0	2.6	5.1	3.7	8.0	0.4	5.5	3.2	8.7	5.8	4.4	5.0	4.9	8.0	5.4	6.9	32.9	2.8	5.2	0.4	5.7	2.2	3.8	5.9	3.5	3.2	3.2	2.1	3.8	3.8	10.9	10.2	0.4	5.4	3.8	10.0	7.3	14.4	13.6	6.2	17.5	9.9	12.7	13.1	8.4	11.6	17.2	13.8	4.1	17.6	7.7	8.3	11.5	7.4	4.9	8.3	14.7	6.6	5.0	3.3	10.4	3.4	6.1	8.9
ZNF837		ENSG00000152475	"Zinc finger protein 837"	Q96EG3	19	58367618-58381060	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 13.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											HPA042833	Uncertain		Uncertain	Nucleoli				Nucleoli		"HPA042833: AB_10806373"	"unprognostic (2.61e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.33e-1)"	"prognostic favourable (1.27e-4)"	"unprognostic (1.07e-1)"	"unprognostic (7.33e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.75e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.37e-3)"	"unprognostic (6.02e-2)"	"prognostic favourable (1.76e-5)"	"unprognostic (2.35e-3)"	"unprognostic (9.74e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.07e-2)"	3.7	3.3	4.2	2.2	5.4	1.1	2.3	1.0	6.1	3.1	2.5	2.9	1.2	4.6	3.6	4.4	3.1	5.2	3.0	1.4	2.0	1.7	5.3	10.8	3.7	2.1	1.6	0.9	4.3	5.1	2.7	4.1	3.7	2.1	3.8	1.0	2.9	4.6	2.5	1.3	5.7	6.1	1.1	1.4	4.7	4.9	2.6	1.2	9.4	7.1	1.3	5.1	2.3	2.2	0.9	0.5	0.1	0.3	0.0	1.7	0.4	2.0	1.0	1.2	1.4	0.2	0.5	2.3	2.0	0.4	0.1	0.2	0.5	2.1	2.5	1.7	0.0	0.6	0.1	0.1	0.1	1.2	13.2	1.1	0.3	0.1	0.5	0.8	0.7	0.8	0.4	0.2	0.1	0.2	1.5	0.7	0.2	2.7	5.7	2.3	3.4	3.3	4.9	0.6	2.4	0.3	1.5	4.0	5.1	1.5	1.3	2.3	1.6	1.1	0.5	3.0	0.1	0.8	0.7	3.1	2.3	2.2	1.9	0.4	0.8	0.0	0.3	0.0	1.3	0.0	1.4	0.5	1.6	0.0	0.4	0.9	1.7	0.2	0.1	0.0	0.0	0.5	0.7	0.4	4.2	5.4	1.0	6.1	2.0	1.7	1.6	0.9	2.1	1.2
ZNF853	DKFZp434J1015	ENSG00000236609	"Zinc finger protein 853"	P0CG23	7	6615617-6624290	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 28.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.5;SH-SY5Y: 21.6;U-2 OS: 14.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 3.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.1;NK-cells: 1.1;T-cells: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA067690	Approved		Approved	Nucleoli				Nucleoli		"HPA067690: "	"unprognostic (1.35e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.17e-2)"	"unprognostic (8.77e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.54e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.87e-3)"	"unprognostic (9.28e-2)"	"prognostic favourable (2.30e-6)"	"unprognostic (4.41e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.30e-3)"	"unprognostic (4.01e-2)"	3.7	3.9	16.6	2.9	14.4	1.0	4.6	4.5	13.5	7.8	7.7	10.4	2.8	1.8	9.4	5.9	5.6	11.8	5.8	12.3	16.1	15.5	3.3	0.9	4.5	4.3	14.8	9.1	15.6	10.6	7.3	4.5	3.7	11.9	7.6	2.5	6.0	6.7	11.5	28.9	2.4	2.7	8.5	10.1	4.3	3.6	3.0	9.9	2.6	9.9	2.7	2.7	6.5	11.7	0.3	0.4	3.1	0.0	1.1	1.5	0.3	0.0	1.1	3.4	14.5	0.1	0.0	0.1	0.3	0.0	1.5	0.3	2.5	0.5	0.0	5.7	0.0	0.0	5.2	0.1	1.5	0.0	1.9	0.4	0.0	2.6	2.1	0.0	0.1	0.5	0.5	0.2	0.0	0.0	2.2	0.0	0.9	0.1	0.3	1.8	5.4	0.0	1.6	5.7	0.1	1.1	5.4	4.6	21.6	0.0	0.2	0.9	0.8	3.0	0.0	1.1	14.5	0.0	1.3	0.3	0.1	0.0	0.0	0.0	5.6	0.0	0.0	3.1	1.2	0.0	1.5	0.3	0.8	1.4	0.0	0.3	0.2	1.4	0.0	1.1	0.0	0.4	0.0	0.3	16.6	14.4	4.5	12.4	16.1	15.5	14.8	9.1	11.9	9.9
ZNF860		ENSG00000197385	"Zinc finger protein 860"	A6NHJ4	3	31981771-31991628	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.2"	"Cell line enriched"	"Detected in many"	4	"BEWO: 31.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	61	"memory B-cell: 9.1;naive B-cell: 6.4"	"Lineage enriched"	"Detected in single"	71	"B-cells: 9.1"									HPA063386	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA063386: "	"unprognostic (1.19e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.15e-3)"	"unprognostic (1.51e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.30e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.75e-3)"	2.0	1.0	0.7	11.2	1.0	0.1	2.8	0.8	1.5	4.3	1.1	0.0	1.7	0.3	4.1	4.9	6.2	1.9	3.6	1.3	0.6	1.6	7.2	0.4	3.7	8.3	1.6	0.6	1.8	0.6	0.1	5.5	8.1	1.1	6.0	1.6	1.6	5.6	2.6	0.4	2.3	3.7	6.7	0.5	9.6	1.1	2.2	0.0	0.5	1.8	4.2	20.2	6.4	3.6	9.1	0.0	0.1	0.0	0.0	0.0	0.2	2.0	0.6	0.0	1.6	0.0	0.0	31.3	0.2	0.1	0.2	0.2	2.0	2.4	2.2	2.3	0.0	1.9	0.7	3.0	0.2	0.0	0.3	0.0	3.1	1.0	0.0	0.0	0.0	0.1	1.3	0.2	6.0	0.6	0.0	0.0	0.2	1.7	0.0	0.0	0.8	3.3	0.0	0.0	0.1	7.1	0.8	0.2	0.0	0.5	3.7	0.0	2.9	0.0	1.2	0.2	2.6	0.0	0.2	0.0	0.0	3.5	0.3	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	1.0	0.8	1.5	0.6	1.6	1.6	0.6	1.1	0.0
ZNF865		ENSG00000261221	"Zinc finger protein 865"	P0CJ78	19	55605405-55617269	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 56.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068079	Approved		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA068079: "	"unprognostic (3.98e-3)"	"unprognostic (2.46e-1)"	"unprognostic (4.72e-3)"	"unprognostic (8.38e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.20e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.05e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.62e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.41e-3)"	12.1	7.5	8.3	11.0	10.5	11.1	8.2	12.3	15.1	8.0	10.0	9.7	6.6	11.0	11.5	6.8	6.2	8.7	7.0	12.2	7.3	5.8	8.3	6.7	8.7	13.3	7.4	8.5	10.3	11.2	9.9	9.5	6.1	7.4	9.9	4.8	8.1	12.1	7.7	56.2	11.1	10.4	7.4	7.3	16.0	12.2	4.7	7.9	14.0	9.5	8.0	9.1	9.3	9.9	1.2	0.5	1.4	0.1	0.1	0.6	0.1	6.3	5.2	2.3	3.7	2.5	1.9	6.2	4.6	2.6	2.5	2.4	1.7	4.2	7.5	5.4	3.3	5.3	1.4	2.8	1.0	7.3	17.4	4.2	3.2	2.2	3.9	4.8	8.4	2.9	4.4	3.0	1.8	1.7	8.1	5.1	1.6	3.0	7.6	5.2	5.2	9.2	11.9	3.6	4.6	2.9	4.4	5.4	8.8	6.3	3.9	3.8	3.1	7.6	5.0	3.8	9.2	3.5	5.7	10.7	9.3	3.9	4.7	3.8	6.1	0.0	0.0	1.4	0.3	0.1	0.2	1.2	0.2	0.1	0.1	0.2	0.1	0.6	0.8	0.1	0.1	0.5	0.0	0.1	8.3	10.5	12.3	15.1	7.3	5.8	7.4	8.5	7.4	7.9
ZNF878		ENSG00000257446	"Zinc finger protein 878"	C9JN71	19	12043805-12052939	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 6.4"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.5"	"Low lineage specificity"	"Detected in single"											HPA052735	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA052735: "	"unprognostic (3.27e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.00e-4)"	"unprognostic (1.42e-1)"	"unprognostic (7.43e-3)"	"unprognostic (2.80e-1)"	"unprognostic (6.67e-2)"	"unprognostic (8.75e-2)"	"unprognostic (3.02e-1)"	"unprognostic (7.65e-3)"	"unprognostic (6.82e-2)"	"unprognostic (4.04e-1)"	"unprognostic (3.62e-2)"	1.1	1.4	0.4	1.5	3.1	5.8	0.8	2.5	2.4	1.5	1.2	0.4	0.0	0.6	1.8	1.2	1.4	1.2	1.4	0.7	1.9	0.5	7.7	2.5	1.5	1.4	4.4	0.3	2.4	5.0	0.8	2.4	5.1	7.4	1.4	1.2	0.4	3.2	0.3	0.5	1.0	1.3	1.4	1.9	1.3	1.2	4.6	2.2	1.7	1.4	0.0	1.3	1.2	1.7	0.3	0.1	0.5	0.0	1.5	0.5	0.1	3.1	0.0	1.7	6.4	0.1	0.0	3.8	1.0	0.5	1.3	1.7	2.5	0.4	1.4	1.5	0.4	0.8	0.6	0.9	1.2	0.0	0.9	1.8	0.0	3.5	0.0	1.2	3.4	0.2	0.0	0.7	0.0	0.0	0.0	0.0	1.3	0.0	2.9	1.7	3.6	0.5	2.5	3.4	0.0	2.2	2.3	1.8	0.4	0.0	0.1	0.3	3.3	3.9	0.0	1.9	1.4	1.5	1.8	1.3	3.8	0.3	0.0	0.6	1.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.5	0.1	0.0	1.5	0.0	0.0	0.0	0.1	0.4	3.1	2.5	2.4	1.9	0.5	4.4	0.3	7.4	2.2
ZSCAN1	"FLJ33779, ZNF915"	ENSG00000152467	"Zinc finger and SCAN domain containing 1"	Q8NBB4	19	58034032-58054631	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 13.7;epididymis: 16.4;pituitary gland: 15.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 6.2;HMC-1: 4.3;NTERA-2: 4.4;T-47d: 6.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA007938	Uncertain		Approved	Nucleoli				Nucleoli		"HPA007938: AB_1080768"	"unprognostic (1.60e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-1)"	"prognostic favourable (7.36e-4)"	"unprognostic (1.41e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.47e-2)"	"unprognostic (3.60e-1)"	0.9	2.2	7.0	0.7	9.5	0.9	3.2	4.0	13.7	2.2	0.8	6.5	1.0	0.8	1.7	16.4	0.8	4.3	1.3	1.6	6.3	9.7	2.8	0.7	1.4	0.8	6.0	6.7	0.9	2.1	7.3	15.8	1.3	8.2	3.7	0.7	3.4	1.6	3.0	0.8	0.8	1.0	1.1	3.7	0.9	1.0	13.3	2.4	0.9	8.1	0.0	0.7	1.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.2	0.0	0.0	1.5	0.1	0.0	0.0	0.0	6.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	4.4	0.0	0.0	0.0	0.0	0.0	1.3	0.4	1.3	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	9.5	4.0	13.7	6.3	9.7	6.0	6.7	8.2	2.4
ZSCAN26	"SRE-ZBP, ZNF187"	ENSG00000197062	"Zinc finger and SCAN domain containing 26"	Q16670	6	28267010-28278224	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027521			Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA027521: "	"unprognostic (1.07e-1)"	"unprognostic (4.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.38e-3)"	"unprognostic (4.60e-3)"	"prognostic unfavourable (7.81e-5)"	"unprognostic (1.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.49e-3)"	"unprognostic (9.01e-2)"	"prognostic unfavourable (6.79e-5)"	"unprognostic (4.45e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.10e-1)"	"prognostic favourable (1.68e-4)"	4.4	5.4	7.4	4.8	10.5	2.5	8.3	17.7	11.4	8.4	4.3	10.5	7.3	4.2	10.5	7.4	4.9	7.9	6.7	6.3	8.1		5.1	3.6	5.2	4.9	7.3	11.5	18.7	4.0	8.9	7.8	4.6	9.6	7.7	5.0	5.7	4.5	10.7	6.4	4.9	4.4	8.9	6.6	7.6	4.9	2.9	9.6	4.0	7.6	2.0	6.1	5.8	4.6	15.2	9.6	10.7	6.2	16.1	16.3	9.6	5.7	5.0	14.0	12.0	15.2	14.7	3.2	11.5	11.5	15.1	15.7	3.6	4.2	3.3	17.7	7.3	4.4	6.5	8.3	16.7	6.9	7.0	8.7	6.8	7.6	10.6	7.1	5.7	12.1	8.0	11.6	10.6	15.2	7.1	6.9	11.9	4.8	7.6	9.9	4.1	7.5	7.7	12.2	5.5	12.8	6.0	10.2	7.9	7.1	3.0	9.5	4.9	4.9	9.9	12.1	8.9	4.3	13.9	7.4	9.8	6.3	4.4	8.1	10.5	10.5	6.2	10.7	13.4	4.8	15.8	13.4	13.1	14.4	9.6	15.2	16.3	13.5	4.4	16.1	4.0	4.5	11.8	9.6										
ZXDC	"FLJ13861, MGC11349"	ENSG00000070476	"ZXD family zinc finger C"	Q2QGD7	3	126437601-126475919	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 7.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049593			Approved	Nucleoli				Nucleoli		"HPA049593: "	"unprognostic (3.06e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.53e-2)"	"prognostic unfavourable (2.27e-4)"	"unprognostic (3.06e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.12e-3)"	13.4	9.7	11.5	8.5	13.1	44.5	12.6	15.9	11.7	12.1	10.6	16.0	12.3	6.9	14.4	12.0	11.9	12.3	10.3	8.5	10.5	5.7	10.2	14.9	10.6	9.9	17.4	7.9	15.7	19.3	19.2	11.9	9.9	10.9	12.4	7.6	13.4	13.2	9.7	28.9	18.0	10.2	10.0	10.5	11.0	9.8	9.0	13.2	14.1	11.6	8.5	9.1	14.5	12.3	1.0	2.2	2.5	7.6	0.8	1.1	0.4	13.9	7.2	9.1	8.5	9.9	7.8	16.1	6.4	7.1	9.4	8.4	10.8	6.1	10.4	10.9	5.7	11.6	12.0	7.4	7.4	5.6	10.2	8.1	8.3	7.0	10.6	12.4	13.3	6.1	14.5	5.7	10.4	9.5	8.7	14.0	7.8	8.1	11.9	6.9	12.8	7.3	13.0	6.1	13.1	6.6	10.1	16.5	9.2	12.3	9.0	16.9	12.2	11.1	9.6	8.6	11.2	12.9	7.7	11.7	5.5	13.8	9.4	9.8	9.5	2.4	0.8	1.6	1.1	0.4	0.4	0.3	0.8	0.8	1.4	1.0	1.1	1.0	2.5	0.8	7.6	2.2	0.5	0.4	11.5	13.1	15.9	11.7	10.5	5.7	17.4	7.9	10.9	13.2